{"years":[2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024,2025],"firms":[{"cik":1800,"name":"ABBOTT LABORATORIES","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001377","doc":"a2222655z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010246","doc":"a2227279z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000744","doc":"a2230875z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-000856","doc":"a2234264z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000624","doc":"a2237733z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-023904","doc":"abt-20191231x10k59d41b.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-025751","doc":"abt-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-025141","doc":"abt-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004026","doc":"abt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-005348","doc":"abt-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-007110","doc":"abt-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-010185","doc":"abt-20251231.htm","q":"Further, the development of new technologies, including disruptive technologies such as artificial intelligence, healthcare products and medicines, and the development of new treatments for disease could significantly change the competitive\u2026"}]},{"cik":1961,"name":"WORLDS INC","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001264931-15-000165","doc":"wddd10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001264931-16-000339","doc":"worldsinc10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001264931-17-000036","doc":"wddd10k2016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001264931-18-000031","doc":"worlds10k1217r.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001264931-19-000040","doc":"wddd10k2018.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001264931-20-000059","doc":"wddd10k2019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001264931-21-000033","doc":"wddd10k20.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001264931-22-000088","doc":"wdddk21.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001264931-23-000006","doc":"wdddk22.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001264931-24-000014","doc":"wdddk2023.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001264931-25-000008","doc":"wddd10k24.htm","q":null}]},{"cik":2488,"name":"ADVANCED MICRO DEVICES INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-054362","doc":"d871455d10k.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0000002488-16-000111","doc":"amd-12262015x10k.htm","q":"In addition to graphics processing, the parallel operation of GPUs are used on multiple sets of data, increasingly used in vector processor for non-graphics applications that require repetitive computations such as supercomputing, deep neur\u2026"},{"fy":2016,"lvl":1,"n":1,"adsh":"0000002488-17-000043","doc":"amd-12312016x10k.htm","q":"In addition to graphics processing, the parallel operation of GPUs are used on multiple sets of data, increasingly used in vector processor for non-graphics applications that require repetitive computations such as supercomputing, deep neur\u2026"},{"fy":2017,"lvl":2,"n":10,"adsh":"0000002488-18-000042","doc":"amd-12302017x10k.htm","q":"In addition to graphics processing, GPUs are used to perform parallel operations on multiple sets of data and are increasingly used to perform vector processing for non-graphics applications that require repetitive computations such as supe\u2026"},{"fy":2018,"lvl":2,"n":9,"adsh":"0000002488-19-000011","doc":"amd-12292018x10k.htm","q":"In addition to graphics processing, GPUs are used to perform parallel operations on multiple sets of data and are increasingly used to perform vector processing for non-graphics applications that require repetitive computations such as supe\u2026"},{"fy":2019,"lvl":2,"n":9,"adsh":"0000002488-20-000008","doc":"amdform10-kfy2019.htm","q":"In addition to graphics processing, GPUs are used to perform parallel operations on multiple sets of data and are increasingly used to perform vector processing for non-graphics applications that require repetitive computations such as supe\u2026"},{"fy":2020,"lvl":3,"n":15,"adsh":"0001628280-21-001185","doc":"amd-20201226.htm","q":"In addition to graphics processing, GPUs are used to perform parallel operations on multiple sets of data and are increasingly used to perform vector processing for non-graphics applications that require repetitive computations such as high\u2026"},{"fy":2021,"lvl":3,"n":17,"adsh":"0000002488-22-000016","doc":"amd-20211225.htm","q":"We also invest in high-performance GPUs and software for markets such as gaming, compute, artificial intelligence, cloud gaming, and virtual and augmented reality."},{"fy":2022,"lvl":3,"n":17,"adsh":"0000002488-23-000047","doc":"amd-20221231.htm","q":"Our strategy is focused on five strategic pillars: compute technology leadership, expanding data center leadership, enabling pervasive artificial intelligence (AI), providing software platforms and developer enablement, and designing custom\u2026"},{"fy":2023,"lvl":3,"n":109,"adsh":"0000002488-24-000012","doc":"amd-20231230.htm","q":"Overview We are a global semiconductor company primarily offering: \u2022 server microprocessors (CPUs), graphics processing units (GPUs), accelerated processing units (APUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs),\u2026"},{"fy":2024,"lvl":3,"n":168,"adsh":"0000002488-25-000012","doc":"amd-20241228.htm","q":"Our technologies advance the future of data centers, powering the cloud services that have become an essential part of how we work, game, and connect to network, PCs, edge computing, and artificial intelligence (AI)."},{"fy":2025,"lvl":3,"n":205,"adsh":"0000002488-26-000018","doc":"amd-20251227.htm","q":"Overview AMD drives innovation in high performance and AI computing to solve the world\u2019s most important challenges."}]},{"cik":3116,"name":"AKORN INC","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001465","doc":"f10k_030215.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-119447","doc":"a16-10650_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002069","doc":"akorn10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002518","doc":"akorn10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002359","doc":"akorn10k12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002314","doc":"akorn10k12312019.htm","q":null}]},{"cik":4127,"name":"SKYWORKS SOLUTIONS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000004127-15-000037","doc":"fy1510k1022015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000004127-16-000068","doc":"fy1610k93016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000004127-17-000033","doc":"fy1710k92917.htm","q":null},{"fy":2018,"lvl":1,"n":3,"adsh":"0000004127-18-000046","doc":"fy1810k92818.htm","q":"Avnera designs and develops analog system-on-chip (\u201cSoC\u201d) technology products for audio, speech, sensor and artificial intelligence (\u201cAI\u201d) applications."},{"fy":2019,"lvl":1,"n":1,"adsh":"0000004127-19-000049","doc":"fy1910k92719.htm","q":"Exhibit Filing Date 2.1 Agreement and Plan of Merger dated as of August 3, 2018, by and among the Company, Avnera Corporation, AI Acquisition Corp., and Shareholder Representative Services LLC, solely in its capacity as the representative a\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0000004127-20-000058","doc":"swks-20201002.htm","q":"Exhibit Filing Date 2.1 Agreement and Plan of Merger dated as of August 3, 2018, by and among the Company, Avnera Corporation, AI Acquisition Corp., and Shareholder Representative Services LLC, solely in its capacity as the representative a\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0000004127-21-000058","doc":"swks-20211001.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000004127-22-000038","doc":"swks-20220930.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000004127-23-000030","doc":"swks-20230929.htm","q":"According to the 2023 Ericsson Mobility Report, global mobile data is expected to double every three years, driven by new users, innovative services, and the convergence of AI and 5G technology."},{"fy":2024,"lvl":3,"n":18,"adsh":"0000004127-24-000131","doc":"swks-20240927.htm","q":"According to the 2024 Ericsson Mobility Report, global mobile data for 5G is estimated to triple in the next three years, driven by new users, innovative services, and the convergence of artificial intelligence (\u201cAI\u201d) and 5G technology, and\u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0000004127-25-000085","doc":"swks-20251003.htm","q":"According to the 2025 Ericsson Mobility Report, global mobile data for 5G subscriptions are forecast to reach 6.3 billion by the end of 2030, driven by new users, innovative services, and the convergence of artificial intelligence (\u201cAI\u201d) an\u2026"}]},{"cik":4904,"name":"AMERICAN ELECTRIC POWER CO INC","industry":"Utilities","sic":4911,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000004904-15-000008","doc":"ye14aepar.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000004904-16-000056","doc":"ye15aepar.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000004904-17-000019","doc":"aep10kfrex1320164q.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000004904-18-000009","doc":"aep10kfrex1320174q.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000004904-19-000009","doc":"aep10kfrex1320184q.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000004904-20-000007","doc":"aep10kfrex1320194q.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000004904-21-000010","doc":"aep-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000004904-22-000024","doc":"aep-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000004904-23-000011","doc":"aep-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000004904-24-000020","doc":"aep-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000004904-25-000027","doc":"aep-20241231.htm","q":"Operating these facilities involves many risks, including: \u2022 Operator error and breakdown or failure of equipment or processes. \u2022 Operating limitations that may be imposed by environmental or other regulatory requirements. \u2022 Labor disputes.\u2026"},{"fy":2025,"lvl":3,"n":16,"adsh":"0000004904-26-000013","doc":"aep-20251231.htm","q":"Much of this demand is driven by interconnecting with and providing power to data centers and other large load customers to serve an increasingly digital economy and to support AI."}]},{"cik":6281,"name":"ANALOG DEVICES INC","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000006281-15-000044","doc":"adi-10312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000006281-16-000097","doc":"adi-10292016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000006281-17-000144","doc":"adi-10282017x10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0000006281-18-000126","doc":"adi-1132018x10k.htm","q":"Additionally, developing markets, such as the Industry 4.0, autonomous driving, artificial intelligence and 5G, require significant investments, resources and technological advancements in order to compete effectively and there can be no as\u2026"},{"fy":2019,"lvl":0,"n":0,"adsh":"0000006281-19-000144","doc":"adi-20191102.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000006281-20-000156","doc":"adi-20201031.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000006281-21-000294","doc":"adi-20211030.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000006281-22-000250","doc":"adi-20221029.htm","q":"With the rapid pace of global transformation, from ubiquitous connectivity, to electrification, to artificial intelligence, to human health and environmental sustainability \u2014 all these trends require reliable and efficient test solutions fr\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000006281-23-000203","doc":"adi-20231028.htm","q":"With the rapid pace of global transformation, from ubiquitous connectivity, to electrification, to artificial intelligence, to human health and environmental sustainability \u2014 all these trends require reliable and efficient test solutions fr\u2026"},{"fy":2024,"lvl":3,"n":34,"adsh":"0000006281-24-000204","doc":"adi-20241102.htm","q":"The Intelligent Edge is characterized by ubiquitous sensing, hyper-scale and edge computing, artificial intelligence (AI) and pervasive connectivity."},{"fy":2025,"lvl":3,"n":46,"adsh":"0000006281-25-000153","doc":"adi-20251101.htm","q":"The Intelligent Edge is characterized by ubiquitous sensing, hyper-scale and edge computing, artificial intelligence (AI) and pervasive connectivity."}]},{"cik":6951,"name":"APPLIED MATERIALS INC /DE","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000006951-15-000034","doc":"amat10252015-10xkdoc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000006951-16-000068","doc":"amat10302016-10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0000006951-17-000038","doc":"amat1029201710-kq42017.htm","q":"The growth of data and new end-market drivers such as artificial intelligence, augmented and virtual reality and smart vehicles are also creating new opportunities for the industry."},{"fy":2018,"lvl":1,"n":2,"adsh":"0000006951-18-000041","doc":"amat1028201810-kq42018.htm","q":"The growth of data and emerging end-market drivers such as artificial intelligence, augmented and virtual reality, the Internet of Things and smart vehicles are also creating new opportunities for the industry."},{"fy":2019,"lvl":1,"n":2,"adsh":"0000006951-19-000046","doc":"amat-20191027.htm","q":"The growth of data and emerging end-market drivers such as artificial intelligence, augmented and virtual reality, the Internet of Things and smart vehicles are also creating new opportunities for the industry."},{"fy":2020,"lvl":1,"n":2,"adsh":"0000006951-20-000048","doc":"amat-20201025.htm","q":"The growth of data and emerging end-market drivers such as artificial intelligence, the Internet of Things, 5G networks, smart vehicles and augmented and virtual reality are also creating the next wave of growth for the industry."},{"fy":2021,"lvl":1,"n":2,"adsh":"0000006951-21-000043","doc":"amat-20211031.htm","q":"The growth of data and emerging end-market drivers such as artificial intelligence, the Internet of Things, 5G networks, smart vehicles and augmented and virtual reality are also creating the next wave of growth for the industry."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000006951-22-000043","doc":"amat-20221030.htm","q":"The growth of data and emerging end-market drivers such as artificial intelligence, the Internet of Things, 5G networks, smart vehicles and augmented and virtual reality are also creating the next wave of growth for the industry."},{"fy":2023,"lvl":2,"n":10,"adsh":"0000006951-23-000041","doc":"amat-20231029.htm","q":"The growth of data and emerging end-market drivers such as artificial intelligence, the Internet of Things, 5G networks, smart vehicles and augmented and virtual reality are also creating the next wave of growth for the industry."},{"fy":2024,"lvl":3,"n":30,"adsh":"0000006951-24-000044","doc":"amat-20241027.htm","q":"Our customers\u2019 products are used in a wide variety of products such as personal computing devices, mobile phones, artificial intelligence (AI) and data center servers, automobiles, connected devices, industrial applications and consumer ele\u2026"},{"fy":2025,"lvl":3,"n":37,"adsh":"0001628280-25-056742","doc":"amat-20251026.htm","q":"Semiconductors provide the foundation for advances in technology that are reshaping the global economy, including artificial intelligence, the internet of things, robotics, electric and autonomous vehicles, and clean energy."}]},{"cik":7623,"name":"ARTS WAY MANUFACTURING CO INC","industry":"Construction machinery","sic":3523,"state":"IA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-001434","doc":"artw20141130_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-024657","doc":"artw20151130_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-001528","doc":"artw20161017_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-001906","doc":"artw20171130_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-001882","doc":"artw20181130_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-001888","doc":"artw20191130_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-002312","doc":"artw20201130_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-003662","doc":"artw20211130_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-003620","doc":"artw20221130_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-005855","doc":"artw20231130c_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-004172","doc":"artw20241130_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-003904","doc":"artw20251130_10k.htm","q":null}]},{"cik":8504,"name":"AGEAGLE AERIAL SYSTEMS INC.","industry":"Aerospace & defense","sic":3721,"state":"KS","cells":[{"fy":2018,"lvl":"x","n":1,"adsh":"0001575705-19-000030","doc":"uavs_10k.htm","q":"From May 1, 2017 to July 18, 2018, he served as Group Product Lead for The Climate Corporation, a subsidiary of Monsanto (recently acquired by Bayer), where he led the satellite imagery team, managed a team focused on using artificial intel\u2026"},{"fy":2019,"lvl":"x","n":1,"adsh":"0001575705-20-000043","doc":"uavs_10k19.htm","q":"From May 1, 2017 to July 18, 2018, he served as Group Product Lead for The Climate Corporation, a subsidiary of Monsanto (recently acquired by Bayer), where he led the satellite imagery team, managed a team focused on using artificial intel\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001575705-21-000158","doc":"uavs_10k20.htm","q":"From May 2017 to July 2018, he served as Group Product Lead for The Climate Corporation, a subsidiary of Monsanto (recently acquired by Bayer), where he led the satellite imagery team, managed a team focused on using artificial intelligence\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001575705-22-000260","doc":"uavs_10k.htm","q":"We believe that by investing in complementary acquisitions, we can accelerate our revenue growth and deliver a broader array of innovative autonomous flight systems and solutions that address specialized market needs within our current targ\u2026"},{"fy":2022,"lvl":"x","n":2,"adsh":"0001654954-23-004388","doc":"uavs_10k.htm","q":"We believe that by investing in complementary acquisitions, we can accelerate our revenue growth and deliver a broader array of innovative autonomous flight systems and solutions that address specialized market needs within our current targ\u2026"},{"fy":2023,"lvl":3,"n":24,"adsh":"0001493152-24-012100","doc":"form10-k.htm","q":"Certain technologies, such as use of autonomous vehicles, remote-controlled equipment, virtual reality, automation and artificial intelligence, present new and significant cybersecurity safety risks that must be analyzed and addressed befor\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001641172-25-001563","doc":"form10-k.htm","q":"Certain technologies, such as use of autonomous vehicles, remote-controlled equipment, virtual reality, automation and artificial intelligence, present new and significant cybersecurity safety risks that must be analyzed and addressed befor\u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001437749-26-010682","doc":"uavs20251231_10k.htm","q":"Certain technologies, such as use of autonomous vehicles, remote-controlled equipment, virtual reality, automation and artificial intelligence, present new and significant cybersecurity safety risks that must be analyzed and addressed befor\u2026"}]},{"cik":12239,"name":"DOMINARI HOLDINGS INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-017738","doc":"f10k2020_aikidopharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015575","doc":"f10k2021_aikidopharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-025306","doc":"f10k2022_dominari.htm","q":null}]},{"cik":12400,"name":"BLACK HILLS POWER INC","industry":"Utilities","sic":4911,"state":"SD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000012400-15-000003","doc":"bhp10k122014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000012400-16-000015","doc":"bhp10k122015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000012400-17-000003","doc":"bhp10k122016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000012400-18-000006","doc":"bhp10k122017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000012400-19-000003","doc":"0000012400-19-000003.txt","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000012400-20-000002","doc":"bhp10k122019.htm","q":null}]},{"cik":12927,"name":"BOEING CO","industry":"Aerospace & defense","sic":3721,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000012927-15-000011","doc":"a201412dec3110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000012927-16-000099","doc":"a201512dec3110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000012927-17-000006","doc":"a201612dec3110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000012927-18-000007","doc":"a201712dec3110k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0000012927-19-000010","doc":"a201812dec3110k.htm","q":"Navy\u2019s first operational carrier-based unmanned aircraft, and we believe that our investment in this contract positions us for long-term leadership in autonomy and artificial intelligence technologies along with additional market opportunit\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0000012927-20-000014","doc":"a201912dec3110k.htm","q":"Navy\u2019s first operational carrier-based unmanned aircraft, and we believe that our investment in this contract positions us for long-term leadership in autonomy and artificial intelligence technologies along with additional market opportunit\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0000012927-21-000011","doc":"ba-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000012927-22-000010","doc":"ba-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000012927-23-000007","doc":"ba-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000012927-24-000010","doc":"ba-20231231.htm","q":"In addition, the techniques used in cyberattacks evolve rapidly, including from emerging technologies, such as advanced forms of automation and artificial intelligence."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000012927-25-000015","doc":"ba-20241231.htm","q":"In addition, the techniques used in cyberattacks evolve rapidly, including from emerging technologies, such as advanced forms of automation and artificial intelligence."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-004357","doc":"ba-20251231.htm","q":"In addition, the techniques used in cyberattacks evolve rapidly, including from emerging technologies, such as advanced forms of automation and artificial intelligence."}]},{"cik":14272,"name":"BRISTOL MYERS SQUIBB CO","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000014272-15-000055","doc":"bmy-20141231x10xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000014272-16-000288","doc":"bmy-20151231x10xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000014272-17-000047","doc":"bmy-20161231x10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000014272-18-000055","doc":"bmy-20171231x10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000014272-19-000047","doc":"bmy-20181231x10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000014272-20-000082","doc":"bmy-20191231x10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000014272-21-000066","doc":"bmy-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000014272-22-000051","doc":"bmy-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000014272-23-000046","doc":"bmy-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000014272-24-000044","doc":"bmy-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0000014272-25-000039","doc":"bmy-20241231.htm","q":"Information Technology and Cybersecurity Risks We are dependent on information technology systems, including artificial intelligence programs, and face risk of cybersecurity incidents that could disrupt our business and result in theft of p\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0000014272-26-000004","doc":"bmy-20251231.htm","q":"Recognizing the transformative role of AI across industries, we are investing in upskilling our workforce to build confidence in the proper use and innovative application of these next-generation tools."}]},{"cik":15615,"name":"MASTEC INC","industry":"Construction","sic":1623,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000015615-15-000053","doc":"mtz12311410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000015615-16-000093","doc":"mtz12311510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000015615-17-000007","doc":"mtz12311610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000015615-18-000007","doc":"mtz12311710-k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0000015615-19-000011","doc":"mtz12311810-k.htm","q":"Increased data usage from video and voice transmission, digital video and music streaming, \u2018smart\u2019 television technology, home automation and connected home monitoring offerings, artificial intelligence, augmented and virtual reality and ot\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0000015615-20-000005","doc":"mtz12311910-k.htm","q":"Increased data usage from video and voice transmission, digital video and music streaming, \u2018smart\u2019 television technology, home automation and connected home monitoring offerings, \u2018Smart City\u2019 initiatives, artificial intelligence, augmented \u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0000015615-21-000006","doc":"mtz-20201231.htm","q":"Contributing to the increase in data usage are video and streaming technologies, \u2018smart\u2019 technologies, including \u2018Smart City\u2019 and \u2018Smart Home\u2019 applications, artificial intelligence and other advanced data services, including video surveilla\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0000015615-22-000011","doc":"mtz-20211231.htm","q":"Contributing to the increase in data usage are video and streaming technologies, \u2018smart\u2019 technologies, including \u2018Smart City\u2019 and \u2018Smart Home\u2019 applications, artificial intelligence and other advanced data services, including video surveilla\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000015615-23-000009","doc":"mtz-20221231.htm","q":"New and upgraded networks will be required to meet the increased level of data traffic from video and streaming technologies, \u2018smart\u2019 technologies, artificial intelligence and other technologies and advanced data services, including video s\u2026"},{"fy":2023,"lvl":2,"n":6,"adsh":"0000015615-24-000021","doc":"mtz-20231231.htm","q":"Increased use of mobile devices, mobile and remote technologies and advancements in the \u201cInternet of Things (IoT)\u201d is expected to require new and upgraded networks to meet the data traffic and reliability demands of these technologies, incl\u2026"},{"fy":2024,"lvl":3,"n":15,"adsh":"0000015615-25-000021","doc":"mtz-20241231.htm","q":"The use of mobile devices, mobile and remote technologies, video streaming usage, acceleration of business transacted online, increased demand of artificial intelligence driving data center growth and advancements in the \u201cInternet of Things\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0000015615-26-000020","doc":"mtz-20251231.htm","q":"These developments include (i) continued expansion in data consumption and the rapid deployment of artificial intelligence (\u201cAI\u201d) applications and data centers; (ii) increasing levels of electrification across commercial, industrial and res\u2026"}]},{"cik":17485,"name":"LIBERATOR MEDICAL HOLDINGS, INC.","industry":"Retail","sic":5912,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001078782-15-002021","doc":"f10k093015_10k.htm","q":null}]},{"cik":18230,"name":"CATERPILLAR INC","industry":"Construction machinery","sic":3531,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000018230-15-000061","doc":"cat_exx13x12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000018230-16-000410","doc":"cat_10-kx12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000018230-17-000041","doc":"cat_10-kx12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000018230-18-000042","doc":"cat_10-kx12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000018230-19-000034","doc":"cat_10-kx12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000018230-20-000056","doc":"0000018230-20-000056.txt","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000018230-21-000063","doc":"cat-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000018230-22-000050","doc":"cat-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000018230-23-000011","doc":"0000018230-23-000011.txt","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000018230-24-000009","doc":"0000018230-24-000009.txt","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0000018230-25-000008","doc":"cat-20241231.htm","q":"Overall strength in Power Generation, for both prime and backup power applications, continues to be driven by increasing energy demands to support data center growth related to cloud computing and generative artificial intelligence (AI)."},{"fy":2025,"lvl":1,"n":3,"adsh":"0000018230-26-000008","doc":"cat-20251231.htm","q":"In Power & Energy, we anticipate growth in Power Generation for both reciprocating engines and turbines and turbine-related services in 2026, driven by increasing energy demand to support data center build-out related to cloud computing and\u2026"}]},{"cik":20740,"name":"CLARCOR INC.","industry":"Auto manufacturing","sic":3714,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000020740-15-000023","doc":"a201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000020740-16-000123","doc":"a201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000020740-17-000006","doc":"a201610k.htm","q":null}]},{"cik":22701,"name":"SUNATION ENERGY, INC.","industry":"Construction","sic":1700,"state":"NY","cells":[{"fy":2025,"lvl":1,"n":1,"adsh":"0000022701-26-000003","doc":"sune-20251231x10k.htm","q":"In addition, he is a board member of Johnsonville Sausage Corporation, a leading US food company, and also a Senior Partner in CGMR Capital, a private equity firm, and Board member of Cambek, a leading manufacturer of specialty wood constru\u2026"}]},{"cik":23111,"name":"COMPUTER TASK GROUP INC","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000023111-15-000002","doc":"ctg201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000023111-16-000014","doc":"ctg201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002360","doc":"ctg-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005661","doc":"ctg-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008025","doc":"ctg-10k_20181231.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-010768","doc":"ctg-10k_20191231.htm","q":"Additionally, the Company will continue to expand the capabilities of its existing solutions by adding elements such as robotic process automation and artificial intelligence."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001564590-21-012830","doc":"ctg-10k_20201231.htm","q":"He also serves as a Board observer at Wevo Conversion, a provider of artificial intelligence and machine learning based digital marketing platform."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001564590-22-010168","doc":"ctg-10k_20211231.htm","q":"Rahmani, the Nominating and Corporate Governance Committee and the Board particularly noted her experience in technology and cyber-security and her extensive management experience within the IT Services industry. 72 Raj Rajgopal President, \u2026"},{"fy":2022,"lvl":3,"n":16,"adsh":"0000950170-23-008194","doc":"ctg-20221231.htm","q":"Through established operations in North and South America, Western Europe, and India, CTG's delivery centers leverage a centralized model to deliver a broad spectrum of high-quality, cost-effective services and solutions. 3 Acquisition of E\u2026"}]},{"cik":25743,"name":"THERAPEUTICSMD, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001387131-15-000875","doc":"txmd-10k_123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001387131-16-004361","doc":"txmd-10k_123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001387131-17-001111","doc":"txmd-10k_123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387131-18-000776","doc":"txmd-10k_123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001387131-19-001471","doc":"txmd-10k_123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001387131-20-002086","doc":"txmd-10k_123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001387131-21-003140","doc":"txmd-10k_123120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011525","doc":"txmd-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-005514","doc":"txmd-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028003","doc":"ea0201465-10k_therapeu.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001013762-25-003442","doc":"ea0232034-10k_therapeu.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-036515","doc":"ea0275992-10k_therape.htm","q":null}]},{"cik":26780,"name":"DANA INC","industry":"Auto manufacturing","sic":3714,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000026780-15-000004","doc":"dan-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000026780-16-000019","doc":"dan-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000026780-17-000004","doc":"dan-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000026780-18-000004","doc":"dan-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000026780-19-000004","doc":"dan-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000026780-20-000006","doc":"dan-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-003221","doc":"dan20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004203","doc":"dan20211123_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-003931","doc":"dan20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-004751","doc":"dan20231231_10k.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001437749-25-004554","doc":"dan20241231_10k.htm","q":"Dana has also embraced the use of artificial intelligence (AI) and machine learning (ML) technologies to enhance both the research and development process and the products we develop."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001437749-26-006076","doc":"dan20251231_10k.htm","q":"Dana has also embraced the use of artificial intelligence (AI) and machine learning (ML) technologies to enhance both the research and development process and the products we develop."}]},{"cik":27430,"name":"DAYTON POWER & LIGHT CO","industry":"Utilities","sic":4931,"state":"OH","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0000027430-26-000011","doc":"dpl-20251231.htm","q":null}]},{"cik":28385,"name":"DTE ELECTRIC CO","industry":"Utilities","sic":4911,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000028385-15-000003","doc":"dteelectric2014123110k.htm","q":null}]},{"cik":28917,"name":"DILLARD'S, INC.","industry":"Retail","sic":5311,"state":"AR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000028917-15-000046","doc":"dds-01312015x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000028917-16-000262","doc":"dds-01302016x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000028917-17-000058","doc":"dds-01282017x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000028917-18-000159","doc":"dds-02032018x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000028917-19-000078","doc":"dds-02022019x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000028917-20-000041","doc":"dds-02012020x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000028917-21-000066","doc":"dds-20210130.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000028917-22-000009","doc":"dds-20220129.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000028917-23-000007","doc":"dds-20230128x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000028917-24-000011","doc":"dds-20240203x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000028917-25-000004","doc":"dds-20250201x10k.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0000028917-26-000006","doc":"dds-20260131x10k.htm","q":"Additionally, to keep pace with changing technology (including artificial intelligence), we must continuously provide for the design and implementation of new information technology systems and enhancements of our existing 10 Table of Conte\u2026"}]},{"cik":29002,"name":"DIODES INC /DEL/","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001204","doc":"diod-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014609","doc":"diod-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002599","doc":"diod-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002396","doc":"diod-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003715","doc":"diod-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004248","doc":"diod-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007008","doc":"diod-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001438","doc":"diod-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002499","doc":"diod-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0000950170-24-013363","doc":"diod-20231231.htm","q":"Our market focus is on high-growth, end-user applications in the following areas: \u2022 Industrial: embedded systems, precision controls, and Artificial Intelligence of Things (\"AIoT\"); \u2022 Automotive: connected driving, comfort/style/safety, and\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-021400","doc":"diod-20241231.htm","q":"Our market focus is on high-growth, end-user applications in the following areas: \u2022 Industrial: embedded systems, precision controls, medical, clean energy, machine to machine, robotics, motor control, and Artificial Intelligence of Things \u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0001193125-26-044918","doc":"0001193125-26-044918.txt","q":"We believe these quality awards reflect the superior quality-control techniques established at the Company and further enhance our credibility as a vendor-of-choice to original equipment manufacturers (\u201cOEMs\u201d) increasingly concerned with qu\u2026"}]},{"cik":31978,"name":"EL PASO ELECTRIC CO /TX/","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000031978-15-000019","doc":"a201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000031978-16-000064","doc":"a201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000031978-17-000010","doc":"a201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000031978-18-000011","doc":"a201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000031978-19-000008","doc":"a201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000031978-20-000006","doc":"a201910-k.htm","q":null}]},{"cik":32689,"name":"EMPIRE DISTRICT ELECTRIC CO","industry":"Utilities","sic":4911,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000973","doc":"a2223078z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010471","doc":"a2227419z10-k.htm","q":null}]},{"cik":34956,"name":"TENAX THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-15-003333","doc":"tenx_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-002098","doc":"tenx_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003517","doc":"tenx_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-003861","doc":"tenx_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-003498","doc":"tenx_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003641","doc":"tenx_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-004036","doc":"tenx_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-003945","doc":"tenx_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001654954-24-003827","doc":"tenx_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-044398","doc":"tennx-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-099393","doc":"tennx-20251231.htm","q":null}]},{"cik":37996,"name":"FORD MOTOR CO","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000037996-15-000013","doc":"f1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000037996-16-000092","doc":"f1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000037996-17-000013","doc":"f1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000037996-18-000015","doc":"f1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000037996-19-000012","doc":"f1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000037996-20-000010","doc":"f1231201910-k.htm","q":null},{"fy":2020,"lvl":3,"n":34,"adsh":"0000037996-21-000012","doc":"f-20201231.htm","q":"Business (Continued) MOBILITY SEGMENT The Mobility segment primarily includes development costs for Ford\u2019s autonomous vehicles and related businesses, Ford\u2019s equity ownership in Argo AI (a developer of autonomous driving systems), and other\u2026"},{"fy":2021,"lvl":3,"n":26,"adsh":"0000037996-22-000013","doc":"f-20211231.htm","q":"Accordingly, the Mobility segment primarily includes development costs for Ford\u2019s autonomous vehicles and related businesses, Ford\u2019s equity ownership in Argo AI (a developer of autonomous driving systems), and other mobility businesses and \u2026"},{"fy":2022,"lvl":3,"n":51,"adsh":"0000037996-23-000012","doc":"f-20221231.htm","q":"Wholesales 2021 2022 2021 2022 Trucks 1,011,198 955,543 942,472 1,051,900 SUVs 827,278 861,256 724,539 911,203 Cars 67,479 47,665 49,470 49,242 Total Vehicles 1,905,955 1,864,464 1,716,481 2,012,345 MOBILITY SEGMENT The Mobility segment pri\u2026"},{"fy":2023,"lvl":3,"n":17,"adsh":"0000037996-24-000009","doc":"f-20231231.htm","q":"The EU has established vehicle safety standards and regulations and is likely to adopt additional or more stringent requirements in the future, especially in the areas of access to in-vehicle data, artificial intelligence, and autonomous ve\u2026"},{"fy":2024,"lvl":3,"n":18,"adsh":"0000037996-25-000013","doc":"f-20241231.htm","q":"The EU has established vehicle safety standards and regulations and is likely to adopt additional or more stringent requirements in the future, especially in the areas of access to in-vehicle data, artificial intelligence, and autonomous ve\u2026"},{"fy":2025,"lvl":2,"n":6,"adsh":"0000037996-26-000015","doc":"f-20251231.htm","q":"The EU has established vehicle safety standards and regulations and is likely to adopt additional or more stringent requirements in the future, especially in the areas of access to in-vehicle data, artificial intelligence, and autonomous ve\u2026"}]},{"cik":39677,"name":"AV HOMES, INC.","industry":"Construction","sic":1531,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001189","doc":"avhomes201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012298","doc":"avhomes201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000996","doc":"avhi-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001034","doc":"avhi-20171231x10k.htm","q":null}]},{"cik":40730,"name":"MOTORS LIQUIDATION CO","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-198682","doc":"d911488d10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001193125-16-601450","doc":"d162429d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001193125-17-183699","doc":"d373963d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-18-189401","doc":"d657135d10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001193125-19-164665","doc":"d737238d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-159505","doc":"d926423d10k.htm","q":null}]},{"cik":42316,"name":"GOLDFIELD CORP","industry":"Construction","sic":1623,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000042316-15-000015","doc":"gv1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000042316-16-000065","doc":"gv1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000042316-17-000014","doc":"gv1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000042316-18-000013","doc":"gv1231201710-k10xk12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000042316-19-000010","doc":"gv1231201810-k10xk12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010101","doc":"gv-10k_20191231.htm","q":null}]},{"cik":47217,"name":"HP INC","industry":"Computers & chips","sic":3570,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-009251","doc":"a2226745z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000047217-16-000093","doc":"hp-103116x10k1.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000047217-17-000045","doc":"hp-103117x10ka.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000047217-18-000052","doc":"hp-103118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000047217-19-000071","doc":"hp-103119x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000047217-20-000045","doc":"hpq-20201031.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000047217-21-000060","doc":"hpq-20211031.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000047217-22-000068","doc":"hpq-20221031.htm","q":null},{"fy":2023,"lvl":3,"n":26,"adsh":"0000047217-23-000100","doc":"hpq-20231031.htm","q":"In partnership with industry thought partners and internal experts, HP offers learning opportunities in key areas such as software development, artificial intelligence, data science, product management, communications, change agility, and s\u2026"},{"fy":2024,"lvl":3,"n":48,"adsh":"0000047217-24-000080","doc":"hpq-20241031.htm","q":"We believe artificial intelligence (\u201cAI\u201d) is playing a critical role in the transformation of how people live and work, and customers are beginning to recognize the benefits in security, speed and cost."},{"fy":2025,"lvl":3,"n":55,"adsh":"0000047217-25-000071","doc":"hpq-20251031.htm","q":"We believe artificial intelligence (\u201cAI\u201d) is playing a critical role in the transformation of how people live and work, and customers are beginning to recognize the benefits in security, speed and cost."}]},{"cik":48732,"name":"CENTERPOINT ENERGY HOUSTON ELECTRIC LLC","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000048732-15-000005","doc":"cehe_10kx12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000048732-16-000021","doc":"cehe_10kx12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000048732-17-000008","doc":"cehe_10kx12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000048732-18-000005","doc":"cehe_10kx12312017.htm","q":null}]},{"cik":50493,"name":"INGLES MARKETS INC","industry":"Retail","sic":5411,"state":"NC","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000050493-15-000023","doc":"imkt-20150926x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000050493-16-000044","doc":"imkt-20160924x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000050493-17-000021","doc":"imkt-20170930x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000050493-18-000024","doc":"imkt-20180929x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000050493-19-000017","doc":"imkt-20190928x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000050493-20-000018","doc":"imkt-20200926x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000050493-21-000017","doc":"imkt-20210925x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000050493-22-000018","doc":"imkt-20220924x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000050493-23-000021","doc":"imkt-20230930x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000050493-24-000018","doc":"imkt-20240928x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000050493-25-000019","doc":"imkt-20250927x10k.htm","q":null}]},{"cik":50863,"name":"INTEL CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000050863-15-000015","doc":"a10kdocument12272014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000050863-16-000105","doc":"a10kdocument12262015q4.htm","q":null},{"fy":2016,"lvl":1,"n":4,"adsh":"0000050863-17-000012","doc":"a10kdocument12312016q4.htm","q":"Intel is adding new products and features to our portfolio to address emerging, high growth workloads such as artificial intelligence, media, and 5G. 2 Table of Contents \u2022 Things and Devices."},{"fy":2017,"lvl":2,"n":11,"adsh":"0000050863-18-000007","doc":"a12302017q4-10kdocument.htm","q":"We add new products and features to our portfolio to address emerging, high-growth workloads such as artificial intelligence, virtual reality systems, and the 5G network."},{"fy":2018,"lvl":3,"n":48,"adsh":"0000050863-19-000007","doc":"a12292018q4-10kdocument.htm","q":"Top-line growth and continued operating margin leverage while investing in key opportunities such as artificial intelligence (AI) and autonomous driving."},{"fy":2019,"lvl":3,"n":71,"adsh":"0000050863-20-000011","doc":"a12282019q4-10kdocument.htm","q":"These include: the rise of AI, the transformation of networks, the intelligent edge 1 emerging with the Internet of Things, and autonomous driving."},{"fy":2020,"lvl":3,"n":66,"adsh":"0000050863-21-000010","doc":"intc-20201226.htm","q":"In this world of distributed intelligence, our three fastest growing opportunities are AI, 5G network transformation, and the intelligent and autonomous edge."},{"fy":2021,"lvl":3,"n":56,"adsh":"0000050863-22-000007","doc":"intc-20211225.htm","q":"The chips include a set of built-in security features, cryptographic acceleration, and AI. 5G network products We also introduced a broad, data-centric portfolio for 5G network infrastructure, including an SoC for wireless base stations, st\u2026"},{"fy":2022,"lvl":3,"n":78,"adsh":"0000050863-23-000006","doc":"intc-20221231.htm","q":"Semiconductors are the underlying technology powering the digitization of everything, and this is being accelerated by five superpowers: ubiquitous compute, pervasive connectivity, cloud-to-edge infrastructure, AI, and sensing."},{"fy":2023,"lvl":3,"n":136,"adsh":"0000050863-24-000010","doc":"intc-20231230.htm","q":"This year, we achieved several key milestones on our product roadmap, including: \u25aa We launched the Intel \u00ae Core\u2122 Ultra processors, featuring our first integrated neural processing unit, for power-efficient AI acceleration and local inferenc\u2026"},{"fy":2024,"lvl":3,"n":121,"adsh":"0000050863-25-000009","doc":"intc-20241228.htm","q":"The demand for compute is being accelerated by five superpowers: ubiquitous compute, pervasive connectivity, cloud-to-edge infrastructure, AI, and sensing."},{"fy":2025,"lvl":3,"n":133,"adsh":"0000050863-26-000011","doc":"intc-20251227.htm","q":"In 2025 and recent years, the semiconductor industry has experienced momentum driven by the following: \u25aa significantly increased compute demand, particularly for GPU systems, driven by generative AI workloads; \u25aa an expansion in the types of\u2026"}]},{"cik":51143,"name":"INTERNATIONAL BUSINESS MACHINES CORP","industry":"Computers & chips","sic":3570,"state":"NY","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001047469-15-001106","doc":"a2222209zex-13.htm","q":"Cognea offers personalized artificial intelligence capabilities designed to serve as an intuitive interface between human users and data-driven information."},{"fy":2015,"lvl":1,"n":1,"adsh":"0001047469-16-010329","doc":"a2226548zex-13.htm","q":"Cognea offers personalized artificial intelligence capabilities designed to serve as an intuitive interface between human users and data-driven information."},{"fy":2016,"lvl":2,"n":5,"adsh":"0001047469-17-001061","doc":"a2230222zex-13.htm","q":"Since Watson\u0092s debut, many technologies have entered the market under the banner of artificial intelligence."},{"fy":2017,"lvl":3,"n":35,"adsh":"0001047469-18-001117","doc":"a2233835zex-13.htm","q":"IBM\u0092s hybrid cloud capabilities make this single platform operate seamlessly. \u00b7 Artificial intelligence (AI)-ready: The IBM Cloud is built from the ground up to handle the demanding data and computational requirements of AI. \u00b7 Secure to the\u2026"},{"fy":2018,"lvl":3,"n":37,"adsh":"0001047469-19-000712","doc":"a2237254zex-13.htm","q":"IBM helps clients harness the power of their data through technologies like AI, analytics and blockchain; on a hybrid cloud that connects data across traditional and new environments; with services that put a client\u0092s data and insight to us\u2026"},{"fy":2020,"lvl":3,"n":71,"adsh":"0001558370-21-001489","doc":"ibm-20201231xex13.htm","q":"NM\u2013Not meaningful Strategic Announcement IBM is redefining its future as a hybrid cloud platform and AI company."},{"fy":2021,"lvl":3,"n":89,"adsh":"0001558370-22-001584","doc":"ibm-20211231xex13.htm","q":"NM\u2013Not meaningful Separation of Kyndryl On November 3, 2021, IBM took an important step in advancing its focus on hybrid cloud and Artificial Intelligence (AI) with the separation of its managed infrastructure services unit into a new publi\u2026"},{"fy":2022,"lvl":3,"n":71,"adsh":"0001558370-23-002376","doc":"ibm-20221231xex13.htm","q":"Overall, gross margin was impacted by the investments we are making to drive our hybrid cloud and artificial intelligence (AI) strategy, higher labor and component costs and the impacts of currency, while the mitigating hedging benefits and\u2026"},{"fy":2023,"lvl":3,"n":101,"adsh":"0000051143-24-000012","doc":"ibm-20231231_d2.htm","q":"In response, clients are leveraging technologies like hybrid cloud and artificial intelligence (AI) that boost productivity and competitiveness."},{"fy":2024,"lvl":3,"n":129,"adsh":"0000051143-25-000015","doc":"ibm-20241231_d2.htm","q":"We increased our investment in innovation and talent and completed eleven acquisitions in 2024, strengthening our hybrid cloud and AI capabilities, all while continuing to return value to shareholders through our dividend."},{"fy":2025,"lvl":3,"n":115,"adsh":"0000051143-26-000010","doc":"ibm-20251231_d2.htm","q":"Table of Contents Management Discussion International Business Machines Corporation and Subsidiary Companies 9 Macroeconomic Environment The strength of our portfolio and the resiliency of our business model underpinned by our software-led \u2026"}]},{"cik":52988,"name":"JACOBS SOLUTIONS INC.","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000052988-15-000155","doc":"fiscal2015form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-16-029571","doc":"jec-10k_20160930.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-024192","doc":"jec-10k_20170929.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000052988-18-000036","doc":"jecfy201810-k.htm","q":null},{"fy":2019,"lvl":2,"n":5,"adsh":"0000052988-19-000069","doc":"jecfy201910-k1.htm","q":"Technology and Consulting includes cybersecurity, data analytics, software application development, enterprise and mission IT, systems integration and other highly technical consulting solutions within Critical Mission Solutions (CMS) and d\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0000052988-20-000070","doc":"jec-20201002.htm","q":"Revenue by Type (Fiscal Year 2020) Page 4 Technology and Consulting includes cybersecurity, data analytics, systems and software application integration services and consulting, enterprise and mission IT services, engineering and design, nu\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0000052988-21-000065","doc":"jec-20211001.htm","q":"Revenue by Type (Fiscal Year 2021) Technology and Consulting includes engineering and design, cybersecurity, data analytics, systems and software application integration services and consulting, enterprise and mission IT services, nuclear s\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0000052988-22-000111","doc":"jec-20220930.htm","q":"StreetLight is a pioneer of mobility analytics who uses its data and machine learning resources to shed light on mobility and enable users to solve complex transportation problems. \u2022 On November 19, 2021, Jacobs acquired BlackLynx, Inc."},{"fy":2023,"lvl":2,"n":7,"adsh":"0000052988-23-000084","doc":"jec-20230929.htm","q":"StreetLight is a pioneer of mobility analytics who uses its data and machine learning resources to shed light on mobility and enable users to solve complex transportation problems. \u2022 On November 19, 2021, Jacobs acquired BlackLynx, Inc."},{"fy":2024,"lvl":3,"n":26,"adsh":"0000052988-24-000065","doc":"jec-20240927.htm","q":"We invest in technology-enhanced and AI solutions to help clients find better, safer and more agile ways of working."},{"fy":2025,"lvl":3,"n":34,"adsh":"0001628280-25-053316","doc":"jec-20250926.htm","q":"Through the expertise of our people and ongoing investment in artificial intelligence (AI) and next-generation digital solutions, we empower our clients' decision-making across the entire asset lifecycle \u2013 from capital planning and operatio\u2026"}]},{"cik":53320,"name":"STRATEGIC INTERNET INVESTMENTS INC","industry":"Software & IT services","sic":7372,"state":"MT","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001472375-15-000088","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001472375-16-000298","doc":"form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001604232-17-000009","doc":"siii10k.htm","q":null}]},{"cik":54441,"name":"FURMANITE CORP","industry":"Construction","sic":1700,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000054441-15-000017","doc":"frm-20141231x10k.htm","q":null}]},{"cik":54507,"name":"WESTAR ENERGY INC /KS","industry":"Utilities","sic":4931,"state":"KS","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000054507-15-000006","doc":"wr-12312014x10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0000054507-16-000043","doc":"wr-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000054507-17-000007","doc":"wr-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000054507-18-000012","doc":"wr-12312017x10k.htm","q":null}]},{"cik":55387,"name":"KENTUCKY UTILITIES CO","industry":"Utilities","sic":4911,"state":"KY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000922224-16-000130","doc":"form10k.htm","q":null}]},{"cik":56873,"name":"KROGER CO","industry":"Retail","sic":5411,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-024557","doc":"a15-1850_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-108277","doc":"a15-23178_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-002198","doc":"kr-20170128x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002753","doc":"kr-20180203x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002756","doc":"kr-20190202x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003501","doc":"kr-20200201x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003706","doc":"kr-20210130x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004595","doc":"kr-20220129x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004767","doc":"kr-20230128x10k.htm","q":null},{"fy":2023,"lvl":"x","n":1,"adsh":"0001558370-24-004603","doc":"kr-20240203x10k.htm","q":"Additionally, the CIO and CISO discuss and present strategies to address geopolitical threats that may affect operations as well as technological changes, such as AI and quantum computing."},{"fy":2024,"lvl":2,"n":10,"adsh":"0001558370-25-004267","doc":"kr-20250201x10k.htm","q":"As we modernize legacy systems, if we are unable to successfully implement those systems in a coordinated manner across internal and external stakeholders, we could be subject to business interruption or reputation risk with our customers, \u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001104659-26-037723","doc":"kr-20260131x10k.htm","q":"If we are not successful in reducing or offsetting the cost of fulfilling orders outside of our in-store channel through efficiencies, expense reductions, or alternative revenues, our financial condition, results of operations or cash flows\u2026"}]},{"cik":56978,"name":"KULICKE & SOFFA INDUSTRIES INC","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000056978-15-000125","doc":"a10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000056978-16-000239","doc":"a10k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000056978-17-000149","doc":"a10k2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000056978-18-000142","doc":"a10-k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000056978-19-000130","doc":"a10-k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000056978-20-000146","doc":"klic-20201003.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000056978-21-000153","doc":"klic-20211002.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000056978-22-000136","doc":"klic-20221001.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000056978-23-000172","doc":"klic-20230930.htm","q":"For example, artificial intelligence (\u201cAI\u201d) may be used to generate cyberattacks with greater scale and efficacy than the traditional threat actors."},{"fy":2024,"lvl":2,"n":5,"adsh":"0000056978-24-000148","doc":"klic-20240928.htm","q":"For example, artificial intelligence (\u201cAI\u201d) may be used to generate cyberattacks with greater scale and efficacy than the traditional threat actors."},{"fy":2025,"lvl":2,"n":7,"adsh":"0000056978-25-000081","doc":"klic-20251004.htm","q":"Engineered for high-volume, at-the-edge AI applications, our vertical wire technology has broken barriers to enable a new level of transistor-dense DRAM and NAND assembly."}]},{"cik":57725,"name":"LANNETT CO INC","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-15-062047","doc":"a15-13005_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-17-053995","doc":"a17-15987_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001104659-18-053976","doc":"a18-14506_110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-19-047753","doc":"a19-12375_110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-20-010874","doc":"lci-20200630x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-012094","doc":"lci-20210630x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-013954","doc":"lci-20220630x10k.htm","q":null}]},{"cik":59478,"name":"ELI LILLY & CO","industry":"Pharma & biotech","sic":2834,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000059478-15-000100","doc":"lly-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000059478-16-000321","doc":"lly-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000059478-17-000098","doc":"lly-20161231x10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000059478-18-000089","doc":"lly-20171231x10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000059478-19-000082","doc":"lly-20181231x10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000059478-20-000057","doc":"lly-20191231x10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000059478-21-000083","doc":"lly-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000059478-22-000068","doc":"lly-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000059478-23-000082","doc":"lly-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":22,"adsh":"0000059478-24-000065","doc":"lly-20231231.htm","q":"Failure of third parties to meet their contractual, regulatory, confidentiality, privacy, security, or other obligations to us, our clinical trial subjects, and our patients could have a material adverse effect on our business. \u2022 Our use of\u2026"},{"fy":2024,"lvl":3,"n":22,"adsh":"0000059478-25-000067","doc":"lly-20241231.htm","q":"Failure of third parties to meet their contractual, regulatory, confidentiality, privacy, security, or other obligations to us, our clinical trial subjects, and our patients could have a material adverse effect on our business and could als\u2026"},{"fy":2025,"lvl":3,"n":29,"adsh":"0000059478-26-000013","doc":"lly-20251231.htm","q":"To support anticipated demand for our current and prospective products and further other business initiatives, we have expanded relationships with contract manufacturing organizations, entities supporting consumer directed access channels, \u2026"}]},{"cik":60977,"name":"LYDALL INC /DE/","industry":"Auto manufacturing","sic":3714,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001400","doc":"ldl-2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011650","doc":"ldl-2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-001585","doc":"ldl-2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-001978","doc":"ldl-2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-001902","doc":"ldl-2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002246","doc":"ldl-2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-002857","doc":"ldl-20201231.htm","q":null}]},{"cik":61339,"name":"MADISON GAS & ELECTRIC CO","industry":"Utilities","sic":4931,"state":"WI","cells":[{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-083622","doc":"ck0000061339-20251231.htm","q":"MGE Power MGE Power, LLC MGE Power Elm Road MGE Power Elm Road, LLC MGE Power West Campus MGE Power West Campus, LLC MGE Services MGE Services, LLC MGE State Energy Services MGE State Energy Services, LLC MGE Transco MGE Transco Investment,\u2026"}]},{"cik":61986,"name":"MANITOWOC CO INC","industry":"Construction machinery","sic":3531,"state":"WI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000061986-15-000014","doc":"mtw-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000061986-16-000073","doc":"mtw-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000061986-17-000007","doc":"mtw-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002976","doc":"mtw-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-002823","doc":"mtw-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004745","doc":"mtw-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005680","doc":"mtw-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001624","doc":"mtw-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004241","doc":"mtw-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-019452","doc":"mtw-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-024838","doc":"mtw-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-057356","doc":"mtw-20251231.htm","q":null}]},{"cik":64472,"name":"GENCOR INDUSTRIES INC","industry":"Construction machinery","sic":3531,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-398371","doc":"d63396d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-783228","doc":"d315038d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-17-362916","doc":"d325772d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-18-348654","doc":"d633666d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-19-310985","doc":"d791776d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-20-320959","doc":"d46502d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-21-361338","doc":"d186986d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-22-306498","doc":"d386341d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001193125-23-294347","doc":"d551240d10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001193125-25-150836","doc":"d877455d10k.htm","q":"Accordingly, no matter how well designed or implemented our controls are, we will not be able to anticipate all security breaches of these types, including security threats that may result from third parties improperly employing artificial \u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-25-312742","doc":"d65222d10k.htm","q":"Accordingly, no matter how well designed or implemented our controls are, we will not be able to anticipate all security breaches of these types, including security threats that may result from third parties improperly employing artificial \u2026"}]},{"cik":64803,"name":"CVS HEALTH CORP","industry":"Retail","sic":5912,"state":"RI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000064803-15-000008","doc":"cvs-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000064803-16-000074","doc":"cvs-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000064803-17-000006","doc":"cvs-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-000707","doc":"cvs-20171231ex13075aa4b.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000064803-19-000013","doc":"cvs-2018231x10k.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0000064803-20-000007","doc":"a2019form10-k.htm","q":"The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate and improve the experience for all of its constituents."},{"fy":2020,"lvl":1,"n":2,"adsh":"0000064803-21-000011","doc":"cvs-20201231.htm","q":"The technology leverages assisted artificial intelligence to deliver insights to the business and bring automation to otherwise manual tasks."},{"fy":2021,"lvl":1,"n":2,"adsh":"0000064803-22-000008","doc":"cvs-20211231.htm","q":"The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate, reduce cost and improve the experience for all of its constituents."},{"fy":2022,"lvl":1,"n":2,"adsh":"0000064803-23-000009","doc":"cvs-20221231.htm","q":"The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate, reduce cost and improve the experience for all of its constituents."},{"fy":2023,"lvl":1,"n":4,"adsh":"0000064803-24-000007","doc":"cvs-20231231.htm","q":"The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate, reduce cost and improve the experience for all of its constituents."},{"fy":2024,"lvl":2,"n":8,"adsh":"0000064803-25-000007","doc":"cvs-20241231.htm","q":"The Company is making concerted investments in emerging technology capabilities such as artificial intelligence (\u201cAI\u201d) to further automate, augment and improve its operational capabilities, and to improve the experience for providers, patie\u2026"},{"fy":2025,"lvl":3,"n":22,"adsh":"0000064803-26-000010","doc":"cvs-20251231.htm","q":"The Company is making concerted investments in emerging technology capabilities such as artificial intelligence (\u201cAI\u201d) to further automate, augment and improve its operational capabilities, and to improve the experience for providers, patie\u2026"}]},{"cik":65759,"name":"MICROPAC INDUSTRIES INC","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001010549-15-000060","doc":"micro10k113014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001010549-16-000492","doc":"micro10k113015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001010549-17-000050","doc":"0001010549-17-000050.txt","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001010549-18-000050","doc":"micro10k113017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001010549-19-000016","doc":"micropac10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001010549-20-000010","doc":"micropac10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001010549-21-000006","doc":"micropac10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001010549-22-000029","doc":"micropac10k3.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001214659-23-001904","doc":"d2823110k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001214659-24-002110","doc":"p2624510k.htm","q":null}]},{"cik":65984,"name":"ENTERGY CORP /DE/","industry":"Utilities","sic":4911,"state":"LA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000065984-15-000102","doc":"etr-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000065984-16-000436","doc":"etr-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000065984-17-000067","doc":"etr-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000065984-18-000072","doc":"etr-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000065984-19-000082","doc":"etr-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000065984-20-000069","doc":"etr-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000065984-21-000096","doc":"etr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000065984-22-000017","doc":"etr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000065984-23-000014","doc":"etr-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000065984-24-000012","doc":"etr-20231231.htm","q":"Given the rapid technological advancements of existing and emerging threats, including threats fueled by artificial intelligence, Entergy\u2019s technology systems remain inherently vulnerable despite implementations and enhancements of the mult\u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0000065984-25-000012","doc":"etr-20241231.htm","q":"These infrastructure investments are being made primarily in connection with electric service agreements with a small number of new customers to provide power for new data centers being constructed to support artificial intelligence and oth\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0000065984-26-000174","doc":"etr-20251231.htm","q":"These infrastructure investments are being made primarily in connection with electric service agreements with a small number of new customers to provide power for new data centers being constructed to support artificial intelligence and oth\u2026"}]},{"cik":66756,"name":"ALLETE INC","industry":"Utilities","sic":4931,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000066756-15-000022","doc":"ale12312014-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000066756-16-000169","doc":"ale12312015-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000066756-17-000035","doc":"ale12312016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000066756-18-000029","doc":"ale12312017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000066756-19-000023","doc":"ale12312018-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000066756-20-000016","doc":"ale12312019-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000066756-21-000025","doc":"ale-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000066756-22-000014","doc":"ale-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000066756-23-000005","doc":"ale-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000066756-24-000007","doc":"ale-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000066756-25-000013","doc":"ale-20241231.htm","q":null}]},{"cik":67215,"name":"DYCOM INDUSTRIES INC","industry":"Construction","sic":1623,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000067215-15-000035","doc":"dyfy201510k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000067215-17-000033","doc":"dyq4fy201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000067215-19-000008","doc":"dyfy201910k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000067215-20-000012","doc":"dyfy202010k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000067215-21-000010","doc":"dy-20210130.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0000067215-22-000011","doc":"dy-20220129.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000067215-23-000011","doc":"dy-20230128.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000067215-24-000014","doc":"dy-20240127.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000067215-25-000012","doc":"dy-20250125.htm","q":"In addition, the advent of AI data centers has created expanding opportunities as hyperscalers look to connect data centers with long-haul, private, redundant fiber networks."}]},{"cik":67347,"name":"MODINE MANUFACTURING CO","industry":"Auto manufacturing","sic":3714,"state":"WI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001140361-15-022274","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-067258","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-022417","doc":"form10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001140361-18-025479","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-009735","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-012690","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-018956","doc":"brhc10025013_10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001140361-22-020696","doc":"brhc10037988_10k.htm","q":"Market demand for data usage and storage continues to rise, driven by the increased use of the IoT (Internet of Things) technology, which connects various devices through the internet, artificial intelligence, smart phones, and digital tran\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001140361-23-026536","doc":"brhc20053265_10k.htm","q":"Market demand for data usage and storage continues to rise, driven by the increased use of IoT (Internet of Things) technology, which connects various devices through the internet, artificial intelligence and machine learning, smart phones,\u2026"},{"fy":2023,"lvl":2,"n":6,"adsh":"0001140361-24-027133","doc":"ef20026276_10k.htm","q":"Market demand for data usage and storage continues to rise, driven by the increased use of IoT (Internet of Things) technology, which connects various devices through the internet, artificial intelligence and machine learning, smart phones,\u2026"},{"fy":2024,"lvl":2,"n":10,"adsh":"0001558370-25-008058","doc":"mod-20250331x10k.htm","q":"For example, we are rapidly expanding our Data Center Cooling business in response to trends in high-performance computing, with significant data center growth fueled by artificial intelligence, resulting in a commensurate need for data cen\u2026"}]},{"cik":69499,"name":"MYLAN INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000069499-15-000003","doc":"myl10k_20141231xdoc.htm","q":null}]},{"cik":70487,"name":"NATIONAL RESEARCH CORP","industry":"Pharma & biotech","sic":8731,"state":"NE","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004044","doc":"nrci20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026817","doc":"nrci20151119_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003759","doc":"nrci20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004585","doc":"nrci20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-004393","doc":"nrc20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-004493","doc":"nrc20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-005096","doc":"nrc20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005273","doc":"nrc20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-005305","doc":"nrc20221231_10k.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0001437749-24-005690","doc":"nrc20231231_10k.htm","q":"Any one of the above situations could have a material adverse effect on our business, financial condition, results of operations and reputation. 9 Table of Contents If we or our third-party service providers sustain cyber-attacks or other p\u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0001437749-25-007867","doc":"nrc20241231_10k.htm","q":"Our comprehensive platform is a next-generation suite of Artificial Intelligence (\u201cAI\u201d)-enabled products that create a natural way to collect, analyze, and deliver feedback."},{"fy":2025,"lvl":2,"n":13,"adsh":"0001437749-26-007002","doc":"nrc20251231_10k.htm","q":"Our comprehensive platform includes a next-generation suite of Artificial Intelligence (\u201cAI\u201d)-enabled products that create a natural way to collect, analyze, and deliver feedback."}]},{"cik":70793,"name":"NBTY INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-008748","doc":"a2226563z10-k.htm","q":null}]},{"cik":71180,"name":"NEVADA POWER CO","industry":"Utilities","sic":4911,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000071180-15-000004","doc":"npc123114form10-k.htm","q":null}]},{"cik":72170,"name":"INERGETICS INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-022924","doc":"v406991_10k.htm","q":null}]},{"cik":72444,"name":"VAXART, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-15-017193","doc":"bota20150630_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-015526","doc":"avir20170630_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001513162-19-000041","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-005683","doc":"vxrt20191213_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-004115","doc":"vxrt20201211_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004354","doc":"vxrt20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-006688","doc":"vxrt20221231_10k.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001437749-24-007865","doc":"vxrt20231231_10k.htm","q":"Artificial intelligence (\u201cAI\u201d) presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2024,"lvl":2,"n":14,"adsh":"0001437749-25-008572","doc":"vxrt20241231_10k.htm","q":"Based on our machine learning and evaluation of more than 13 different immune parameters, norovirus vaccination protection most tightly associates with making a functional antibody response to norovirus in the serum (\u201cNBAA\u201d) and norovirus s\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001437749-26-008023","doc":"vxrt20251231_10k.htm","q":"Based on our machine learning and evaluation of more than 13 different immune parameters, norovirus vaccination protection most tightly associates with making a functional antibody response to norovirus in the serum (\u201cNBAA\u201d) and norovirus s\u2026"}]},{"cik":72741,"name":"EVERSOURCE ENERGY","industry":"Utilities","sic":4911,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000072741-15-000013","doc":"f2014form10kedgar.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000072741-16-000063","doc":"f2015form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000072741-17-000007","doc":"a201610kdocument.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000072741-18-000028","doc":"a201710kdocument.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000072741-19-000017","doc":"a201810kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000072741-20-000008","doc":"a201910kdocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000072741-21-000005","doc":"es-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000072741-22-000015","doc":"es-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000072741-23-000004","doc":"es-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000072741-24-000005","doc":"es-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000072741-25-000007","doc":"es-20241231.htm","q":"Identified areas are monitored and improvements are implemented. \u2022 Eversource participates in information sharing programs both within and outside the utility industry, including with the U.S. government and industry organizations, to be ab\u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001628280-26-008461","doc":"es-20251231.htm","q":"Cyberattacks that seek to exploit potential vulnerabilities in the utility industry and seek to disrupt electric, natural gas and water transmission and distribution systems are increasing in sophistication including artificial intelligence\u2026"}]},{"cik":72903,"name":"XCEL ENERGY INC","industry":"Utilities","sic":4931,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000072903-15-000011","doc":"xcel1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000072903-16-000123","doc":"xcel1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000072903-17-000008","doc":"xcel1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000072903-18-000009","doc":"xcel1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000072903-19-000010","doc":"xcel1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000072903-20-000011","doc":"xcel1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000072903-21-000012","doc":"xel-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000072903-22-000010","doc":"xel-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000072903-23-000007","doc":"xel-20221231.htm","q":"While O&M increased in 2022 due to global inflation pressures and other drivers, our goal is to reduce 2023 O&M expenses 2% from 2022 levels and keep them relatively flat thereafter. \u2022 We continue to invest to reduce operating costs through\u2026"},{"fy":2023,"lvl":2,"n":5,"adsh":"0000072903-24-000034","doc":"xel-20231231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2024,"lvl":2,"n":6,"adsh":"0000072903-25-000029","doc":"xel-20241231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2025,"lvl":1,"n":4,"adsh":"0000072903-26-000009","doc":"xel-20251231.htm","q":"New demand remains robust in our territories as we fuel the rapid growth from AI and data centers, industrial electrification and electric vehicle adoption."}]},{"cik":72909,"name":"NORTHERN STATES POWER CO /WI/","industry":"Utilities","sic":4931,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000072909-15-000003","doc":"nspw1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000072909-16-000018","doc":"nspw1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000072909-17-000003","doc":"nspw1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000072909-18-000003","doc":"nspw1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000072909-19-000004","doc":"nspw1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000072909-20-000003","doc":"nspw1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000072909-21-000006","doc":"nspw-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000072909-22-000003","doc":"nspw-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000072909-23-000003","doc":"nspw-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000072909-24-000004","doc":"nspw-20231231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2024,"lvl":1,"n":4,"adsh":"0000072909-25-000004","doc":"nspw-20241231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2025,"lvl":1,"n":3,"adsh":"0000072909-26-000003","doc":"nspw-20251231.htm","q":"Advancements in artificial intelligence and large language models may increase cybersecurity threats and operational risks."}]},{"cik":73088,"name":"NORTHWESTERN CORP","industry":"Utilities","sic":4931,"state":"SD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000073088-15-000028","doc":"nwe1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000073088-16-000230","doc":"nwe1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000073088-17-000031","doc":"nwe1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000073088-18-000022","doc":"nwe1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000073088-19-000023","doc":"nwe1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000073088-20-000030","doc":"nwe1231201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000073088-21-000026","doc":"nwe-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000073088-22-000019","doc":"nwe-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000073088-23-000028","doc":"nwe-20221231.htm","q":null}]},{"cik":74145,"name":"OKLAHOMA GAS & ELECTRIC CO","industry":"Utilities","sic":4911,"state":"OK","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000074145-15-000002","doc":"a2014oge10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000074145-16-000035","doc":"a2015oge10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000074145-17-000002","doc":"a2016oge10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000074145-18-000004","doc":"a2017oge10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000074145-19-000006","doc":"a2018oge10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000074145-20-000007","doc":"oge-20191231.htm","q":null}]},{"cik":75362,"name":"PACCAR INC","industry":"Auto manufacturing","sic":3711,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065702","doc":"d823556d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-465258","doc":"d45361d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-050405","doc":"d283100d10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-002675","doc":"pcar-10k_20171231.htm","q":"Technology areas of focus include advanced driver assistance systems, artificial intelligence, vehicle connectivity and powertrain electrification."},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003670","doc":"pcar-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005276","doc":"pcar-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006370","doc":"pcar-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006237","doc":"pcar-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-002203","doc":"pcar-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-017900","doc":"pcar-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-023145","doc":"pcar-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001193125-26-057025","doc":"pcar-20251231.htm","q":"The Company is embedding artificial intelligence across its business to drive innovation, profitable growth and enhanced performance for the Company's customers."}]},{"cik":75594,"name":"PACIFICORP /OR/","industry":"Utilities","sic":4911,"state":"OR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000075594-15-000003","doc":"pacificorp123114form10-k.htm","q":null}]},{"cik":76605,"name":"PATRICK INDUSTRIES INC","industry":"Auto manufacturing","sic":3714,"state":"IN","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0000076605-21-000059","doc":"patk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000076605-22-000047","doc":"patk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000076605-23-000050","doc":"patk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000076605-24-000078","doc":"patk-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000076605-25-000062","doc":"patk-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000076605-26-000013","doc":"patk-20251231.htm","q":null}]},{"cik":77543,"name":"TUTOR PERINI CORP","industry":"Construction","sic":1540,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000077543-15-000013","doc":"c543-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000077543-16-000076","doc":"tpc-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000077543-17-000009","doc":"tpc-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000077543-18-000016","doc":"tpc-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000077543-19-000009","doc":"tpc-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000077543-20-000008","doc":"tpc-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000077543-21-000020","doc":"tpc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000077543-22-000013","doc":"tpc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000077543-23-000023","doc":"tpc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000077543-24-000015","doc":"tpc-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000077543-25-000025","doc":"tpc-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0000077543-26-000028","doc":"tpc-20251231.htm","q":"Additionally, the increased prevalence and use of artificial intelligence may heighten the risk that we may be subject to cybersecurity incidents in the future."}]},{"cik":78003,"name":"PFIZER INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000078003-15-000014","doc":"pfe-12312014xex13.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000078003-16-000077","doc":"pfe-12312015x10kexhibit13.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000078003-17-000014","doc":"pfe-12312016x10kexhibit13.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000078003-18-000027","doc":"pfe-exhibit13x12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000078003-19-000015","doc":"pfe-exhibit13x12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000078003-20-000014","doc":"pfe-exhibit13x12312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000078003-21-000038","doc":"pfe-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000078003-22-000027","doc":"pfe-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000078003-23-000024","doc":"pfe-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000078003-24-000039","doc":"pfe-20231231.htm","q":"Such cyber-attacks are of ever-increasing levels of sophistication, including the use of adversarial artificial intelligence techniques, and are made by groups and individuals with a wide range of motives (including, but not limited to, ind\u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0000078003-25-000054","doc":"pfe-20241231.htm","q":"These risks may be heightened by the use of AI in our operations as well as in our digital marketing, including social media, mobile applications and blogger outreach, as well as direct-to-consumer marketing and digital platform offerings."},{"fy":2025,"lvl":3,"n":44,"adsh":"0000078003-26-000026","doc":"pfe-20251231.htm","q":"In addition, we are scaling AI across R&D, manufacturing, commercial and patient engagement to improve productivity and accelerate innovation."}]},{"cik":80035,"name":"PREFORMED LINE PRODUCTS CO","industry":"Construction","sic":1623,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-088960","doc":"d837817d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-501390","doc":"d45086d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003953","doc":"plpc-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005116","doc":"plpc-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007041","doc":"plpc-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009196","doc":"plpc-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011273","doc":"plpc-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002892","doc":"plpc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006020","doc":"plpc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-028605","doc":"plpc-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-012640","doc":"plpc-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0000080035-26-000007","doc":"plpc-20251231.htm","q":"Further, artificial intelligence tools are increasingly being used in our industry, and we are evaluating the use of such tools throughout our company."}]},{"cik":81018,"name":"PUBLIC SERVICE CO OF COLORADO","industry":"Utilities","sic":4931,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000081018-15-000003","doc":"psco1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000081018-16-000019","doc":"psco1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000081018-17-000003","doc":"psco1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000081018-18-000003","doc":"psco1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000081018-19-000004","doc":"psco1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000081018-20-000003","doc":"psco1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000081018-21-000008","doc":"psco-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000081018-22-000003","doc":"psco-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000081018-23-000003","doc":"psco-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000081018-24-000006","doc":"psco-20231231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2024,"lvl":2,"n":5,"adsh":"0000081018-25-000004","doc":"psco-20241231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2025,"lvl":1,"n":3,"adsh":"0000081018-26-000003","doc":"psco-20251231.htm","q":"Advancements in artificial intelligence and large language models may increase cybersecurity threats and operational risks."}]},{"cik":81061,"name":"PUBLIX SUPER MARKETS INC","industry":"Retail","sic":5411,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000081061-15-000002","doc":"publix-10kx12272014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000081061-16-000041","doc":"publix-10kx12262015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000081061-17-000007","doc":"publix-10kx12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000081061-18-000006","doc":"publix-10kx12302017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000081061-19-000010","doc":"publix-10kx12292018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000081061-20-000006","doc":"publix-10kx12282019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000081061-21-000014","doc":"ck0000081061-20201226.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000081061-22-000011","doc":"ck0000081061-20211225.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000081061-23-000009","doc":"ck0000081061-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000081061-24-000009","doc":"ck0000081061-20231230.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000081061-25-000007","doc":"ck0000081061-20241228.htm","q":null},{"fy":2025,"lvl":2,"n":5,"adsh":"0000081061-26-000038","doc":"ck0000081061-20251227.htm","q":"The Company continues to implement strategic business and technology initiatives, and assesses the use of artificial intelligence (AI), as part of the execution of these core strategies."}]},{"cik":81100,"name":"PUGET SOUND ENERGY INC","industry":"Utilities","sic":4911,"state":"WA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001085392-16-000029","doc":"pe-12312015x10k.htm","q":null}]},{"cik":84129,"name":"RITE AID CORP","industry":"Retail","sic":5912,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001047469-15-003838","doc":"a2224297z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-012513","doc":"a2228303z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-003159","doc":"a2231929z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-003207","doc":"a2235393z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-002567","doc":"a2238552z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-004365","doc":"rad-20200427x10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001558370-21-004887","doc":"rad-20210227x10k.htm","q":"Persaud has served on the National Association of Chain Drug Stores\u2019 board of directors and as a board advisor for Profitect, an AI and prescriptive analytics company."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001558370-22-005866","doc":"rad-20220226x10k.htm","q":"Persaud has served on the National Association of Chain Drug Stores\u2019 board of directors and as a board advisor for Profitect, an AI and prescriptive analytics company."},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-007488","doc":"rad-20230304x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-010167","doc":"rad-20230304x10ka.htm","q":null}]},{"cik":85974,"name":"RYLAND GROUP INC","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001188","doc":"a2223121z10-k.htm","q":null}]},{"cik":86144,"name":"SAFEWAY INC","industry":"Retail","sic":5411,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000086144-15-000004","doc":"swy-1315x10k.htm","q":null}]},{"cik":88941,"name":"SEMTECH CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-002037","doc":"smtc-01252015.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-013952","doc":"smtc-01312016x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002859","doc":"smtc-01292017x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003489","doc":"smtc-01282018x10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001628280-19-003241","doc":"smtc-01272019x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000088941-20-000003","doc":"smtc-01262020x10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0000088941-21-000006","doc":"smtc-20210131.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000088941-22-000006","doc":"smtc-20220130.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000088941-23-000006","doc":"smtc-20230129.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000088941-24-000030","doc":"smtc-20240128.htm","q":"Though network capacities have normalized to accommodate remote environments, industry demand within hyperscale data centers expanded to support artificial intelligence-driven applications, as well as general compute data center application\u2026"},{"fy":2024,"lvl":3,"n":19,"adsh":"0000088941-25-000068","doc":"smtc-20250126.htm","q":"This market has expanded to support artificial intelligence-driven applications and general compute data center applications."}]},{"cik":90144,"name":"SIERRA PACIFIC POWER CO","industry":"Utilities","sic":4931,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000090144-15-000005","doc":"sppc123114form10-k.htm","q":null}]},{"cik":91668,"name":"SOLITRON DEVICES INC","industry":"Computers & chips","sic":3674,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001213900-15-004214","doc":"f10k2015_solitrondevices.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-014258","doc":"f10k2016_solitrondevices.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-21-001436","doc":"sodi_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-007088","doc":"sodi_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-22-009676","doc":"sodi_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-23-008351","doc":"sodi_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001654954-24-008904","doc":"sodi_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-018346","doc":"sodi20250228_10k.htm","q":null}]},{"cik":91882,"name":"DOMINION ENERGY SOUTH CAROLINA, INC.","industry":"Utilities","sic":4931,"state":"SC","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007640","doc":"ck91882-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008444","doc":"ck91882-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006597","doc":"ck91882-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003304","doc":"ck0000091882-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-019113","doc":"ck0000091882-20231231.htm","q":"In addition, the techniques used in cyberattacks evolve rapidly, including from emerging technologies, such as advanced forms of automation and artificial intelligence."},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-028391","doc":"ck0000091882-20241231.htm","q":"In addition, the techniques used in cyberattacks evolve rapidly, including from emerging technologies, such as advanced forms of automation and artificial intelligence."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-063138","doc":"ck0000091882-20251231.htm","q":"Emerging technologies, such as advanced forms of automation and artificial intelligence, which are subject to limited government oversight and regulations and evolve rapidly, may result in an increase in the frequency and sophistication of \u2026"}]},{"cik":92122,"name":"SOUTHERN CO","industry":"Utilities","sic":4911,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000092122-15-000015","doc":"so_10-kx12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000092122-16-000126","doc":"so_10-kx12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000092122-17-000007","doc":"so_10-kx12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000092122-18-000012","doc":"so_10-kx12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000092122-19-000006","doc":"so10-k12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000092122-20-000017","doc":"so10-k12312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000092122-21-000006","doc":"so-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000092122-22-000003","doc":"so-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000092122-23-000012","doc":"so-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000092122-24-000009","doc":"so-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000092122-25-000018","doc":"so-20241231.htm","q":"As artificial intelligence continues to evolve, new technologies and increased computing power could lead to new attack techniques and more sophisticated attacks."},{"fy":2025,"lvl":2,"n":5,"adsh":"0000092122-26-000006","doc":"so-20251231.htm","q":"Use of generative artificial intelligence has also increased the frequency, scale, and sophistication of cyber attacks and increased the capability of less sophisticated actors."}]},{"cik":92521,"name":"SOUTHWESTERN PUBLIC SERVICE CO","industry":"Utilities","sic":4931,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000092521-15-000003","doc":"sps1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000092521-16-000019","doc":"sps1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000092521-17-000003","doc":"sps1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000092521-18-000003","doc":"sps1231201710-kproject.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000092521-19-000004","doc":"sps1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000092521-20-000003","doc":"sps1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000092521-21-000003","doc":"sps-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000092521-22-000003","doc":"sps-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000092521-23-000003","doc":"sps-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000092521-24-000006","doc":"sps-20231231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2024,"lvl":2,"n":5,"adsh":"0000092521-25-000009","doc":"sps-20241231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2025,"lvl":1,"n":3,"adsh":"0000092521-26-000003","doc":"sps-20251231.htm","q":"Advancements in artificial intelligence and large language models may increase cybersecurity threats and operational risks."}]},{"cik":93205,"name":"LIVING 3D HOLDINGS, INC.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001445866-15-000440","doc":"living3d10k04102015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001445866-16-001799","doc":"living3d10k12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001445866-17-000462","doc":"ltdh_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001445866-18-000394","doc":"ltdh-20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001445866-19-000316","doc":"ltdh-20181231.htm","q":null}]},{"cik":93389,"name":"STANDARD MOTOR PRODUCTS, INC.","industry":"Auto manufacturing","sic":3714,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-009241","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-055160","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-008300","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-18-009555","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-003526","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-003721","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-005993","doc":"brhc10020623_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-006370","doc":"brhc10034306_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-007960","doc":"brhc10048362_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-008994","doc":"ef20015274_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000093389-25-000012","doc":"smp-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0000093389-26-000012","doc":"smp-20251231.htm","q":"These factors may allow our competitors to: \u2022 respond more quickly than we can to new or emerging technologies, such as the identification of potential uses and successful adoption of artificial intelligence (\"AI\") technologies, and changes\u2026"}]},{"cik":95521,"name":"SUPERVALU INC","industry":"Retail","sic":5411,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000095521-15-000041","doc":"f15form10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000095521-16-000192","doc":"f16form10-k.htm","q":null}]},{"cik":95552,"name":"SUPERIOR INDUSTRIES INTERNATIONAL INC","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000095552-15-000015","doc":"sup10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000095552-16-000033","doc":"sup10k12272015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000095552-17-000003","doc":"sup10k12252016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084240","doc":"d525981d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-067169","doc":"d685768d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007814","doc":"sup-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011252","doc":"sup-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008510","doc":"sup-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005808","doc":"sup-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027903","doc":"sup-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":10,"adsh":"0000950170-25-034599","doc":"sup-20241231.htm","q":"The global automotive industry is experiencing a period of significant technological change, including but not limited to advances in artificial intelligence (\u201cAI\u201d) technologies."}]},{"cik":96271,"name":"TAMPA ELECTRIC CO","industry":"Utilities","sic":4911,"state":"FL","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001400","doc":"ck0000096271-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-001790","doc":"ck0000096271-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003167","doc":"ck0000096271-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004873","doc":"ck0000096271-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005866","doc":"ck0000096271-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001145","doc":"ck0000096271-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003912","doc":"ck0000096271-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-019720","doc":"ck0000096271-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-024539","doc":"ck0000096271-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-062314","doc":"ck0000096271-20251231.htm","q":"TEC is exposed to potential risks related to reliance on technology, the cost of technology, technological vulnerabilities, and the rapid evolution of artificial intelligence, which could cause system failures, disrupt operations or adverse\u2026"}]},{"cik":97216,"name":"TEREX CORP","industry":"Construction machinery","sic":3537,"state":"CT","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000097216-15-000030","doc":"tex201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000097216-16-000245","doc":"tex201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000097216-17-000029","doc":"tex201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000097216-18-000024","doc":"tex201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000097216-19-000024","doc":"tex201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000097216-20-000027","doc":"tex201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000097216-21-000030","doc":"tex-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000097216-22-000013","doc":"tex-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000097216-23-000012","doc":"tex-20221231.htm","q":"Robotic waste sorting equipment consists of smart robots, powered by AI software, designed to pick, sort and recycle waste."},{"fy":2023,"lvl":1,"n":1,"adsh":"0000097216-24-000013","doc":"tex-20231231.htm","q":"Robotic waste sorting equipment consists of smart robots, powered by AI software, designed to pick, sort and recycle waste."},{"fy":2024,"lvl":2,"n":13,"adsh":"0000097216-25-000011","doc":"tex-20241231.htm","q":"Robotic waste sorting equipment consists of smart robots, powered by AI software, designed to pick, sort and recycle waste."},{"fy":2025,"lvl":3,"n":16,"adsh":"0000097216-26-000035","doc":"tex-20251231.htm","q":"Robotic waste sorting equipment consists of smart robots, powered by AI software, designed to pick, sort and recycle waste."}]},{"cik":97476,"name":"TEXAS INSTRUMENTS INC","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000097476-15-000003","doc":"txn-12312014x10xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013126","doc":"txn-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002142","doc":"txn-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002832","doc":"txn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003839","doc":"txn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000097476-20-000009","doc":"txn-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000097476-21-000006","doc":"txn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000097476-22-000009","doc":"txn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000097476-23-000007","doc":"txn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000097476-24-000007","doc":"txn-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000097476-25-000007","doc":"txn-20241231.htm","q":"Breaches, disruptions or other incidents relating to our information technology systems or the systems of our customers, suppliers and other third parties could be caused by factors such as computer viruses, ransomware, malware, software vu\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0000097476-26-000059","doc":"txn-20251231.htm","q":"Breaches, disruptions or other incidents relating to our information technology systems or the systems of our customers, suppliers and other third parties could be caused by factors such as computer viruses, ransomware, malware, software vu\u2026"}]},{"cik":98338,"name":"TSR INC","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-15-005568","doc":"f10k2015_tsrinc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-16-015370","doc":"f10k2016_tsrinc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-17-008805","doc":"f10k2017_tsrinc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-011517","doc":"f10k2018_tsrinc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-19-016899","doc":"f10k2019_tsrinc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-20-022549","doc":"f10k2020_tsrinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-21-044375","doc":"f10k2021_tsrinc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-22-048182","doc":"f10k2022_tsrinc.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-23-066312","doc":"f10k2023_tsrinc.htm","q":null}]},{"cik":100122,"name":"TUCSON ELECTRIC POWER CO","industry":"Utilities","sic":4911,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000100122-15-000003","doc":"tep10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000100122-16-000034","doc":"tep10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000100122-17-000003","doc":"tep10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000100122-18-000005","doc":"tep10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000100122-19-000004","doc":"tep10k12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000100122-20-000006","doc":"tep10k12312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000100122-21-000005","doc":"tep-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000100122-22-000004","doc":"tep-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000100122-23-000004","doc":"tep-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000100122-24-000002","doc":"tep-20231231.htm","q":"Furthermore, the nature and sophistication of cyber-attacks continues to evolve as cyber-attackers use Artificial Intelligence to develop malicious code and sophisticated phishing attempts and other attacks on operational control systems an\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000100122-25-000004","doc":"tep-20241231.htm","q":"Furthermore, the nature and sophistication of cyber-attacks continues to evolve as cyber-attackers use Artificial Intelligence to develop malicious code and sophisticated phishing attempts and other attacks on operational control systems an\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0000100122-26-000006","doc":"tep-20251231.htm","q":"Retail sales may also be affected by emerging economic trends as companies expand operations and adjust supply chains to support growing AI\u2011driven demand for raw materials."}]},{"cik":100591,"name":"ARGAN INC","industry":"Construction","sic":1700,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-131832","doc":"d874911d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-111566","doc":"a16-4306_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-022713","doc":"a17-6908_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-023493","doc":"a18-1126_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001104659-19-020681","doc":"a19-30120_110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-046386","doc":"tm2031096d1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001558370-21-004282","doc":"agx-20210131x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-005383","doc":"agx-20220131x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-006056","doc":"agx-20230131x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-004979","doc":"agx-20240131x10k.htm","q":"Techniques used to attempt to obtain unauthorized access to information systems change frequently, and the rapid development of artificial intelligence poses new cybersecurity risks that we may not timely anticipate."},{"fy":2024,"lvl":3,"n":20,"adsh":"0001558370-25-003819","doc":"agx-20250131x10k.htm","q":"Artificial intelligence poses risks that could adversely affect our business, results of operations, and financial condition."}]},{"cik":102752,"name":"VSE CORP","industry":"Construction","sic":8711,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000102752-15-000017","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000102752-16-000074","doc":"vseform10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000102752-17-000009","doc":"vsec-16x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000102752-18-000010","doc":"vsec-2017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000102752-19-000013","doc":"vsec-2018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000102752-20-000016","doc":"vsec-2019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000102752-21-000039","doc":"vsec-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000102752-22-000013","doc":"vsec-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000102752-23-000012","doc":"vsec-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000102752-24-000017","doc":"vsec-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000102752-25-000014","doc":"vsec-20241231.htm","q":"Additionally, sophistication of cybersecurity threats, including through the use of artificial intelligence, continues to increase, and the controls and preventative actions we take to reduce the risk of cybersecurity incidents and protect \u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0000102752-26-000015","doc":"vsec-20251231.htm","q":"Additionally, sophistication of cybersecurity threats, including through the use of artificial intelligence, continues to increase, and the controls and preventative actions the Company takes to reduce the risk of cybersecurity incidents an\u2026"}]},{"cik":103595,"name":"VILLAGE SUPER MARKET INC","industry":"Retail","sic":5411,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000103595-15-000018","doc":"vlgea201572510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000103595-16-000036","doc":"vlgea2016730-10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000103595-17-000020","doc":"vlgea2017729-10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000103595-18-000017","doc":"vlgea2018728-10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000103595-19-000015","doc":"0000103595-19-000015.txt","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000103595-20-000033","doc":"vlgea-20200725.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000103595-21-000014","doc":"vlgea-20210731.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000103595-22-000019","doc":"vlgea-20220730.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000103595-23-000014","doc":"vlgea-20230729.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000103595-24-000019","doc":"vlgea-20240727.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000103595-25-000015","doc":"vlgea-20250726.htm","q":null}]},{"cik":104918,"name":"AVISTA CORP","industry":"Utilities","sic":4931,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000104918-15-000044","doc":"ava-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000104918-16-000185","doc":"ava-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000104918-17-000053","doc":"ava-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000104918-18-000043","doc":"ava-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000104918-19-000053","doc":"ava-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000104918-20-000036","doc":"ava-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007774","doc":"ava-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001672","doc":"ava-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003546","doc":"ava-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":9,"adsh":"0000950170-24-017421","doc":"ava-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0000950170-25-027077","doc":"ava-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":21,"adsh":"0001193125-26-067872","doc":"ava-20251231.htm","q":"We manage Generative Artificial Intelligence (GenAI) risks through governance and policy to safeguard data and minimize operational risk."}]},{"cik":105418,"name":"WEIS MARKETS INC","industry":"Retail","sic":5411,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000105418-15-000009","doc":"wmk10k2014_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000105418-16-000069","doc":"wmk10k2015_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000105418-17-000007","doc":"wmk10k2016_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000105418-18-000006","doc":"wmk-20171230x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000105418-19-000010","doc":"wmk-20181229x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000105418-20-000007","doc":"wmk-20191228x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000105418-21-000015","doc":"wmk-20201226x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000105418-22-000009","doc":"wmk-20211225x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000105418-23-000008","doc":"wmk-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000105418-24-000015","doc":"wmk-20231230x10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000105418-25-000014","doc":"wmk-20241228x10k.htm","q":"The techniques and sophistication used in breach information technology systems and the rapid evolution and increased adoption of artificial intelligence technologies may intensify the Company\u2019s cyber security risks."},{"fy":2025,"lvl":1,"n":1,"adsh":"0000105418-26-000024","doc":"wmk-20251227x10k.htm","q":"The techniques and sophistication used in breach information technology systems and the rapid evolution and increased adoption of artificial intelligence technologies may intensify the Company\u2019s cybersecurity risks."}]},{"cik":105634,"name":"EMCOR GROUP, INC.","industry":"Construction","sic":1731,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000105634-15-000041","doc":"eme-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000105634-16-000297","doc":"eme-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000105634-17-000043","doc":"eme-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000105634-18-000045","doc":"eme-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000105634-19-000044","doc":"eme-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000105634-20-000043","doc":"eme-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000105634-21-000044","doc":"eme-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000105634-22-000006","doc":"eme-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000105634-23-000005","doc":"eme-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000105634-24-000006","doc":"eme-20231231.htm","q":"The electrical and mechanical construction services industry has experienced growth principally due to the increased content, complexity, and sophistication of electrical and mechanical systems resulting, in part, from growth in digital pro\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0000105634-25-000015","doc":"eme-20241231.htm","q":"The electrical and mechanical construction services industry has experienced growth principally due to the increased content, complexity, and sophistication of electrical and mechanical systems resulting, in part, from growth in digital pro\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0000105634-26-000025","doc":"eme-20251231.htm","q":"The electrical and mechanical construction services industry has experienced growth principally due to the increased content, complexity, and sophistication of electrical and mechanical systems resulting, in part, from growth in digital pro\u2026"}]},{"cik":107815,"name":"WISCONSIN ELECTRIC POWER CO","industry":"Utilities","sic":4911,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000107815-15-000042","doc":"wepco1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000107815-16-000249","doc":"wepco1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000107815-17-000106","doc":"wepco1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000107815-18-000136","doc":"a2017we10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000107815-19-000131","doc":"a2018we10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000107815-20-000091","doc":"a2019we10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000107815-21-000081","doc":"wep-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000107815-22-000118","doc":"wep-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000107815-23-000102","doc":"wep-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000107815-24-000097","doc":"wep-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":23,"adsh":"0000107815-25-000105","doc":"wep-20241231.htm","q":"Cybersecurity threats, including those leveraging AI, continue to increase, and the security measures and preventative actions we take to reduce the risk of cybersecurity incidents and protect our systems against unauthorized access to secu\u2026"},{"fy":2025,"lvl":3,"n":28,"adsh":"0000107815-26-000003","doc":"wep-20251231.htm","q":"We are engaged in discussions with a small number of customers to provide power to large-scale data centers being constructed to support AI and other technology capabilities."}]},{"cik":107833,"name":"WISCONSIN PUBLIC SERVICE CORP","industry":"Utilities","sic":4931,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000107833-15-000002","doc":"a2014wps10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000107815-16-000250","doc":"a2015wps10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000107815-17-000108","doc":"a2016wps10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000107815-18-000138","doc":"a2017wps10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000107815-19-000134","doc":"a2018wps10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000107815-20-000093","doc":"a2019wps10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000107815-21-000083","doc":"wps-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000107815-22-000120","doc":"wps-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000107815-23-000104","doc":"wps-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000107815-24-000099","doc":"wps-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":23,"adsh":"0000107815-25-000107","doc":"wps-20241231.htm","q":"Cybersecurity threats, including those leveraging AI, continue to increase, and the security measures and preventative actions we take to reduce the risk of cybersecurity incidents and protect our systems against unauthorized access to secu\u2026"},{"fy":2025,"lvl":3,"n":24,"adsh":"0000107833-26-000003","doc":"wps-20251231.htm","q":"Cybersecurity threats, including those leveraging AI, continue to increase, and the security measures and preventative actions we take to reduce the risk of cybersecurity incidents and protect our systems against unauthorized access to secu\u2026"}]},{"cik":109657,"name":"GT BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001513160-15-000022","doc":"oxisannualreport2014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001354488-16-006816","doc":"oxis_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002919","doc":"oxis_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002054","doc":"gtbp_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-003697","doc":"gtbp_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-003380","doc":"gtbp_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-004295","doc":"gtbp_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-007883","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009812","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011332","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-007908","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-008443","doc":"form10-k.htm","q":null}]},{"cik":200406,"name":"JOHNSON & JOHNSON","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000200406-15-000004","doc":"a2014122810-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000200406-16-000071","doc":"form10-k20160103.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000200406-17-000006","doc":"form10-k20170101.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000200406-18-000005","doc":"form10-k20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000200406-19-000009","doc":"form10-k20181230.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000200406-20-000010","doc":"form10-k20191229.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000200406-21-000008","doc":"jnj-20210103.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000200406-22-000022","doc":"jnj-20220102.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000200406-23-000016","doc":"jnj-20230101.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0000200406-24-000013","doc":"jnj-20231231.htm","q":"In the EU, multiple directives and laws (including NIS2, EHDS, the Data Act, the Cyber Resilience Act, and the AI Act) are rapidly changing privacy and cybersecurity compliance requirements while introducing new enforcement risks."},{"fy":2024,"lvl":2,"n":13,"adsh":"0000200406-25-000038","doc":"jnj-20241229.htm","q":"In the EU, multiple directives and laws (including NIS2, EHDS, the Data Act, the Cyber Resilience Act, and the AI Act) are rapidly changing privacy and cybersecurity compliance requirements while introducing new enforcement risks."},{"fy":2025,"lvl":2,"n":13,"adsh":"0000200406-26-000016","doc":"jnj-20251228.htm","q":"In the EU, multiple directives and laws (including NIS2, EHDS, the Data Act, the Cyber Resilience Act, and the AI Act) are rapidly changing privacy and cybersecurity compliance requirements while introducing new enforcement risks."}]},{"cik":202058,"name":"L3HARRIS TECHNOLOGIES, INC. /DE/","industry":"Aerospace & defense","sic":3812,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-308363","doc":"d22254d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000202058-17-000037","doc":"hrs630201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000202058-18-000063","doc":"hrs629201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000202058-19-000090","doc":"hrs628201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000202058-21-000008","doc":"hrs-20210101.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000202058-22-000015","doc":"hrs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000202058-23-000014","doc":"hrs-20221230.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000202058-24-000029","doc":"hrs-20231229.htm","q":null},{"fy":2024,"lvl":2,"n":6,"adsh":"0000202058-25-000023","doc":"hrs-20250103.htm","q":"Such collaboration is required by modern market dynamics where competing in our markets requires the ability to fuse hardware, software and artificial intelligence (\u201c AI \u201d) ."},{"fy":2025,"lvl":2,"n":8,"adsh":"0000202058-26-000015","doc":"hrs-20260102.htm","q":"Such collaboration is driven by modern market dynamics where competing in our markets requires the ability to fuse hardware, software and artificial intelligence (\u201cAI\u201d)."}]},{"cik":225628,"name":"PASSUR AEROSPACE, INC.","industry":"Aerospace & defense","sic":3812,"state":"CT","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000909012-16-000364","doc":"t307822.txt","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001096906-17-000013","doc":"passur.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001096906-18-000090","doc":"passur.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001096906-19-000043","doc":"passur.htm","q":"Predictive Accuracy: Our technology uses the power of vast amounts of historical data, machine learning, and a comprehensive view of the real-time environment to generate uniquely accurate, reliable, and relevant forecasting information. 4."},{"fy":2019,"lvl":1,"n":4,"adsh":"0001096906-20-000040","doc":"passur.htm","q":"Predictive Accuracy: Our technology uses the power of vast amounts of historical data, machine learning, and a comprehensive view of the real-time environment to generate uniquely accurate, reliable, and relevant forecasting information. 4."},{"fy":2020,"lvl":1,"n":4,"adsh":"0001096906-21-000191","doc":"pssr_10k.htm","q":"PASSUR continues to be a pioneer applying artificial intelligence powered by machine learning to aviation data, addressing the industry\u2019s most costly challenges, including the management and optimization of airspace, airport assets, aircraf\u2026"},{"fy":2021,"lvl":"x","n":10,"adsh":"0001096906-22-000193","doc":"pssr-20211031.htm","q":"PASSUR continues to be a pioneer applying artificial intelligence powered by machine learning to aviation data, addressing the industry\u2019s most costly challenges, including the management and optimization of airspace, airport assets, aircraf\u2026"}]},{"cik":275053,"name":"NATURES SUNSHINE PRODUCTS INC","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-019269","doc":"a14-26940_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012675","doc":"natr-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002548","doc":"natr-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003302","doc":"natr-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002700","doc":"natr-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000275053-20-000009","doc":"natr-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000275053-21-000002","doc":"natr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000275053-22-000002","doc":"natr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000275053-23-000005","doc":"natr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-010625","doc":"natr-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-012082","doc":"natr-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-016540","doc":"natr-20251231.htm","q":null}]},{"cik":277509,"name":"FEDERAL SIGNAL CORP /DE/","industry":"Auto manufacturing","sic":3711,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000277509-15-000008","doc":"fss10k20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000277509-16-000096","doc":"fss10k20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000277509-17-000008","doc":"fss10k20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000277509-18-000006","doc":"fss10k20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000277509-19-000008","doc":"fss10k20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000277509-20-000006","doc":"fss10k20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000277509-21-000005","doc":"fss-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000277509-22-000006","doc":"fss-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000277509-23-000004","doc":"fss-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000277509-24-000005","doc":"fss-20231231.htm","q":"The introduction of products or processes utilizing new technologies, including those resulting from any new environmental, safety and other regulations, artificial intelligence and machine learning, could require us and our suppliers to ma\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0000277509-25-000012","doc":"fss-20241231.htm","q":"The introduction of products or processes utilizing new technologies, including those resulting from any new environmental, safety, or other regulations, artificial intelligence, and machine learning, could require us and our suppliers to m\u2026"},{"fy":2025,"lvl":2,"n":7,"adsh":"0001628280-26-011576","doc":"fss-20251231.htm","q":"The introduction of products or processes utilizing new technologies, including those resulting from any new environmental, safety, or other regulations, artificial intelligence, and machine learning, could require us and our suppliers to m\u2026"}]},{"cik":310158,"name":"MERCK & CO., INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000310158-15-000005","doc":"mrk1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000310158-16-000063","doc":"mrk1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000310158-17-000010","doc":"mrk1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000310158-18-000005","doc":"mrk1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000310158-19-000014","doc":"mrk1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000310158-20-000005","doc":"mrk1231201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000310158-21-000004","doc":"mrk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000310158-22-000003","doc":"mrk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005061","doc":"mrk-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001628280-24-006850","doc":"mrk-20231231.htm","q":"The Company\u2019s growing use of artificial intelligence (AI) systems to automate processes, analyze data, and support decision-making poses inherent risks."},{"fy":2024,"lvl":2,"n":11,"adsh":"0001628280-25-007732","doc":"mrk-20241231.htm","q":"The Company continues to be a target of cyber-attacks that could lead to a disruption of its worldwide operations, including manufacturing, research and sales operations. \u2022 The Company is increasing its use of artificial intelligence (AI) s\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0000310158-26-000063","doc":"mrk-20251231.htm","q":"The Company continues to be a target of cyber-attacks that could lead to a disruption of its worldwide operations, including manufacturing, research and sales operations. \u2022 The Company is increasing its use of artificial intelligence (AI) s\u2026"}]},{"cik":310568,"name":"MICROSEMI CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000310568-15-000237","doc":"mscc201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000310568-16-000477","doc":"mscc201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000310568-17-000216","doc":"mscc201710k.htm","q":null}]},{"cik":315189,"name":"DEERE & CO","industry":"Construction machinery","sic":3523,"state":"IL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-009300","doc":"a2226814z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-16-017244","doc":"a2230400z10-k.htm","q":null},{"fy":2017,"lvl":1,"n":3,"adsh":"0001047469-17-007719","doc":"a2233505z10-k.htm","q":"Blue River has designed and integrated computer vision and machine learning technology to optimize the use of farm inputs."},{"fy":2018,"lvl":1,"n":3,"adsh":"0001047469-18-007694","doc":"a2236950z10-k.htm","q":"Blue River has designed and integrated computer vision and machine learning technology to optimize the use of farm inputs."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001558370-19-011614","doc":"de-20191103x10k.htm","q":"Blue River has designed and integrated computer vision and machine learning technology to optimize the use of farm inputs."},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-20-014436","doc":"de-20201101x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-016864","doc":"de-20211031x10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001558370-22-018703","doc":"de-20221030x10k.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001558370-23-019812","doc":"de-20231029x10k.htm","q":"Obstacle detection solutions such as SmartDetect\u2122 supplements operator visibility on the jobsite through a combination of cameras, radar, and machine learning."},{"fy":2024,"lvl":3,"n":17,"adsh":"0001558370-24-016169","doc":"de-20241027x10k.htm","q":"The technology stack leverages these core technologies across the enterprise, including digital capabilities, automation and machine learning, autonomy, and alternative power technologies."},{"fy":2025,"lvl":3,"n":23,"adsh":"0001104659-25-122321","doc":"de-20251102x10k.htm","q":"The technology stack leverages these core technologies across the enterprise, including digital capabilities, automation and machine learning, and autonomy."}]},{"cik":315545,"name":"PROVECTUS BIOPHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-088039","doc":"d862762d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-523701","doc":"d105545d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001193125-17-106543","doc":"d289943d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-003771","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-002987","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-003433","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-005194","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008016","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-009563","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-011699","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-000993","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-012726","doc":"form10-k.htm","q":null}]},{"cik":317889,"name":"BULOVA TECHNOLOGIES GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-000640","doc":"blvt20140930_10k.htm","q":null}]},{"cik":318154,"name":"AMGEN INC","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000318154-15-000005","doc":"amgn-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000318154-16-000031","doc":"amgn-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000318154-17-000004","doc":"amgn-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000318154-18-000004","doc":"amgn-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000318154-19-000008","doc":"amgn-12312018x10kq42018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000318154-20-000017","doc":"amgn-12312019x10kq42019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000318154-21-000010","doc":"amgn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000318154-22-000010","doc":"amgn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000318154-23-000017","doc":"amgn-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000318154-24-000011","doc":"amgn-20231231.htm","q":"Reese, age 61, became the Company\u2019s inaugural Executive Vice President and Chief Technology Officer, in December 2023, responsible for accelerating the use of technology and artificial intelligence across the organization."},{"fy":2024,"lvl":3,"n":28,"adsh":"0000318154-25-000010","doc":"amgn-20241231.htm","q":"Further, in 2024, the EU Artificial Intelligence (AI) Act, formally known as Regulation (EU) 2024/1689, was passed into law."},{"fy":2025,"lvl":3,"n":36,"adsh":"0000318154-26-000010","doc":"amgn-20251231.htm","q":"Further, in 2024, the EU Artificial Intelligence (AI) Act, formally known as Regulation (EU) 2024/1689, was passed into law."}]},{"cik":318306,"name":"ABEONA THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-020126","doc":"v405690_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091600","doc":"v435519_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-017709","doc":"v462622_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-015277","doc":"tv488183_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014623","doc":"tv515695-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004015","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006705","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008259","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009381","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-010190","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493152-25-010978","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-010413","doc":"form10-k.htm","q":null}]},{"cik":320017,"name":"LISATA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0000320017-24-000007","doc":"lsta-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000320017-25-000011","doc":"lsta-20241231.htm","q":null}]},{"cik":320193,"name":"APPLE INC","industry":"Computers & chips","sic":3571,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-356351","doc":"d17062d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-16-020309","doc":"a201610-k9242016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000320193-17-000070","doc":"a10-k20179302017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000320193-18-000145","doc":"a10-k20189292018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000320193-19-000119","doc":"a10-k20199282019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000320193-20-000096","doc":"aapl-20200926.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000320193-21-000105","doc":"aapl-20210925.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000320193-22-000108","doc":"aapl-20220924.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000320193-23-000106","doc":"aapl-20230930.htm","q":"The Company\u2019s global operations are subject to complex and changing laws and regulations on subjects, including antitrust; privacy, data security and data localization; consumer protection; advertising, sales, billing and e-commerce; financ\u2026"},{"fy":2024,"lvl":2,"n":5,"adsh":"0000320193-24-000123","doc":"aapl-20240928.htm","q":"The introduction of new and complex technologies, such as artificial intelligence features, can increase these and other safety risks, including exposing users to harmful, inaccurate or other negative content and experiences."},{"fy":2025,"lvl":2,"n":10,"adsh":"0000320193-25-000079","doc":"aapl-20250927.htm","q":"The introduction of new and complex technologies, such as artificial intelligence features, can increase these and other safety risks, including exposing users to harmful, inaccurate or other negative content and experiences."}]},{"cik":320340,"name":"CORECARD CORP","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-004786","doc":"ins20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004712","doc":"ins20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-004719","doc":"ins20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-005308","doc":"ins20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-004982","doc":"ins20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005090","doc":"ins20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-005161","doc":"ins20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-006215","doc":"ins20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-005708","doc":"ins20241231_10k.htm","q":null}]},{"cik":350563,"name":"TECO ENERGY INC","industry":"Utilities","sic":4911,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001057","doc":"te-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013516","doc":"te-10k_20151231.htm","q":null}]},{"cik":350846,"name":"SUPREME INDUSTRIES INC","industry":"Auto manufacturing","sic":3713,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-015334","doc":"a15-1083_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-100382","doc":"a15-23232_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-013792","doc":"a17-1018_110k.htm","q":null}]},{"cik":352541,"name":"ALLIANT ENERGY CORP","industry":"Utilities","sic":4931,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000352541-15-000005","doc":"lnt1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000352541-16-000076","doc":"lnt1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000352541-17-000017","doc":"lnt1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000352541-18-000019","doc":"lnt1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000352541-19-000013","doc":"lnt1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000352541-20-000021","doc":"lnt1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000352541-21-000022","doc":"lnt-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000352541-22-000020","doc":"lnt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000352541-23-000017","doc":"lnt-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000352541-24-000014","doc":"lnt-20231231.htm","q":"Emerging artificial intelligence technologies may be used to develop new hacking tools, exploit vulnerabilities, obscure malicious activities, and increase the difficulty detecting threats."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000352541-25-000014","doc":"lnt-20241231.htm","q":"Emerging artificial intelligence technologies may be used to develop new hacking tools, exploit vulnerabilities, obscure malicious activities, and increase the difficulty detecting threats."},{"fy":2025,"lvl":1,"n":1,"adsh":"0000352541-26-000007","doc":"lnt-20251231.htm","q":"Emerging artificial intelligence technologies may be used to develop new hacking tools, exploit vulnerabilities, obscure malicious activities, and increase the difficulty detecting threats."}]},{"cik":352998,"name":"TELIGENT, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016338","doc":"v404166_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088135","doc":"v433664_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002606","doc":"teligentinc10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003357","doc":"teligentinc10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-003719","doc":"wfx-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-004877","doc":"tlgt-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-008709","doc":"tlgt-20201231.htm","q":null}]},{"cik":353020,"name":"AEGION CORP","industry":"Construction","sic":1623,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000353020-15-000007","doc":"a10k-12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000353020-16-000078","doc":"a10k-12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000353020-17-000007","doc":"a10k-12312016q4.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000353020-18-000017","doc":"a10k-12312017q4.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000353020-19-000002","doc":"a10k-12312018q4.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-004092","doc":"aegn20191231b_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-005577","doc":"aegn20201231_10k.htm","q":null}]},{"cik":353230,"name":"OMNICARE INC","industry":"Retail","sic":5912,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000353230-15-000010","doc":"ocr10-k2014.htm","q":null}]},{"cik":354707,"name":"HAWAIIAN ELECTRIC INDUSTRIES INC","industry":"Utilities","sic":4911,"state":"HI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000354707-15-000016","doc":"he-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000354707-16-000128","doc":"a201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000354707-17-000020","doc":"hei-201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000354707-18-000024","doc":"hei-201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000354707-19-000043","doc":"hei-201810k.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0000354707-20-000045","doc":"hei-201910kuseforsingl.htm","q":"New emerging and breakthrough technological developments (e.g., the commercial development of energy storage, grid support utility interactive inverters, fuel cells, distributed generation, grid modernization, 50 electrification of transpor\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0000354707-21-000036","doc":"he-20201231.htm","q":"New emerging and breakthrough technological developments (e.g., the commercial development of energy storage, grid support utility interactive inverters, fuel cells, distributed generation, grid modernization, electrification of transportat\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0000354707-22-000049","doc":"he-20211231.htm","q":"New emerging and breakthrough technological developments (e.g., the commercial development of long-duration energy storage, grid-forming and black starting inverters in low inertia power systems, microgrids, distributed generation, grid mod\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000354707-23-000032","doc":"he-20221231.htm","q":"New emerging and breakthrough technological developments (e.g., the commercial development of long-duration energy storage, grid-forming and black starting inverters in low inertia power systems, microgrids, distributed generation, grid mod\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0000354707-24-000012","doc":"he-20231231.htm","q":"Technologies that the Utilities are evaluating include the commercial development of advanced protection schemes that would monitor, detect, and isolate falling overhead distribution and transmission lines to reduce wildfire risks and impro\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000354707-25-000013","doc":"he-20241231.htm","q":"The Utilities also start to utilize artificial intelligence and machine learning to test predictive analytics and control through edge computing to help assess the state of health of utility assets and prevent premature failure, and the div\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0000354707-26-000008","doc":"he-20251231.htm","q":"The Utilities rely on evolving and complex operational systems and infrastructure and information systems, networks and other technologies, including artificial intelligence and machine learning, which are interconnected with the systems an\u2026"}]},{"cik":354908,"name":"FLIR SYSTEMS INC","industry":"Aerospace & defense","sic":3812,"state":"OR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000354908-15-000012","doc":"flir-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000354908-16-000103","doc":"flir-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000354908-17-000005","doc":"flir-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000354908-18-000014","doc":"flir-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000354908-19-000018","doc":"flir-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000354908-20-000010","doc":"flir-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000354908-21-000016","doc":"flir-20201231.htm","q":null}]},{"cik":355627,"name":"CTI GROUP HOLDINGS INC","industry":"Software & IT services","sic":7372,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-111874","doc":"d868462d10k.htm","q":null}]},{"cik":355811,"name":"GENTEX CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000355811-15-000015","doc":"gntx12312014-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000355811-16-000063","doc":"gntx12312015-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000355811-17-000013","doc":"gntx12312016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000355811-18-000009","doc":"gntx12312017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000355811-19-000006","doc":"gntx12312018-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000355811-20-000007","doc":"gntx12312019-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000355811-21-000006","doc":"gntx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000355811-22-000006","doc":"gntx-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000355811-23-000011","doc":"gntx-20221231.htm","q":"The system continuously scans, tracks and determines the physical location of every vehicle occupant and object, even without a direct line of sight, by combining two-dimensional video image recognition with 3D depth mapping and optical mot\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0000355811-24-000011","doc":"gntx-20231231.htm","q":"The system continuously scans, tracks and determines the physical location of every vehicle occupant and object, even without a direct line of sight, by combining two-dimensional video image recognition with 3D depth mapping and optical mot\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000355811-25-000009","doc":"gntx-20241231.htm","q":"The system continuously scans, tracks and determines the physical location of every vehicle occupant and object, even without a direct line of sight, by combining two-dimensional video image recognition with 3D depth mapping and optical mot\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0000355811-26-000010","doc":"gntx-20251231.htm","q":"As of both December 31, 2025, and 2024, the carrying value of the Company's investment in Solace Power was $ 7.1 million, and as of December 31, 2025, the Company has an approximately 15 % ownership interest in the investee. 58 GENTEX CORPO\u2026"}]},{"cik":356028,"name":"CA, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000356028-15-000076","doc":"ca-20150331x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000356028-16-000254","doc":"ca-20160331x10k.htm","q":null},{"fy":2016,"lvl":1,"n":4,"adsh":"0000356028-17-000047","doc":"ca-20170331x10k.htm","q":"We support agile development processes and modern languages, as well as tools for development, testing and deployment that support collaboration across the software development lifecycle and across mobile to mainframe teams. \u2022 Operations In\u2026"},{"fy":2017,"lvl":1,"n":4,"adsh":"0000356028-18-000064","doc":"ca-20180331x10k.htm","q":"We are working on opportunities in areas such as containers, data analytics, big data, artificial intelligence, machine learning and open source, some of which may enhance or extend our current product portfolio and others of which may evol\u2026"}]},{"cik":357097,"name":"FIBROCELL SCIENCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000357097-15-000016","doc":"fcsc-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000357097-16-000133","doc":"annualreportonform10-kasof.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000357097-17-000033","doc":"fcsc-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003348","doc":"fcsc-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-003496","doc":"fcsc-20181231x10k.htm","q":null}]},{"cik":357294,"name":"HOVNANIAN ENTERPRISES INC","industry":"Construction","sic":1531,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-15-022517","doc":"hov20151031_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-16-043587","doc":"hov20160921_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-021249","doc":"hov20171031_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-18-022403","doc":"hov20181031_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-19-024673","doc":"hov20191031_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-20-025763","doc":"hov20201031_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-000287","doc":"hov20211031_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-22-029364","doc":"hov20221031_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-23-034783","doc":"hov20231031_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001753926-24-002117","doc":"hov-20241031.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001753926-25-001938","doc":"hov-20251031.htm","q":"In addition, cybersecurity risk is exacerbated with the advancement of technologies like artificial intelligence, which malicious third parties are using to create new, sophisticated and more frequent attacks."}]},{"cik":700923,"name":"MYR GROUP INC.","industry":"Construction","sic":1623,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-015357","doc":"v396871_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-085692","doc":"v427195_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-013721","doc":"v455820_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013353","doc":"v483694_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-012547","doc":"v511680_10k.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001104659-20-029253","doc":"tv536230-ar.htm","q":"We believe much of this potential will continue to be driven by advancements in technology, such as artificial intelligence, self-driving vehicles, and robotics."},{"fy":2020,"lvl":0,"n":0,"adsh":"0000700923-21-000007","doc":"myrg-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000700923-22-000007","doc":"myrg-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000700923-23-000012","doc":"myrg-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000700923-24-000008","doc":"myrg-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000700923-25-000006","doc":"myrg-20241231.htm","q":"We expect to see an increase in the distribution market opportunities during in 2025. 30 TABLE OF CONTENTS We believe the increasing demand for electricity associated with additional power requirements, driven by increased electrification a\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0000700923-26-000007","doc":"myrg-20251231.htm","q":"Increased IT security threats and other more sophisticated computer crimes, including the use of new and emerging technologies such as artificial intelligence, advanced persistent threats, computer viruses, ransomware, other types of malici\u2026"}]},{"cik":703361,"name":"INTEGRATED DEVICE TECHNOLOGY INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-004322","doc":"idti-3292015x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-016557","doc":"idti-4032016x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001628280-17-005725","doc":"idti-4022017x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-006975","doc":"idti-4012018x10k.htm","q":null}]},{"cik":704159,"name":"VBI VACCINES INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-005661","doc":"vbiv20141231_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-026076","doc":"vbiv20151231_10k.htm","q":null}]},{"cik":704562,"name":"AVID BIOSERVICES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001019687-15-002732","doc":"peregrine_10k-043015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001019687-16-006937","doc":"peregrine_10k-043016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-17-001772","doc":"peregrine_10k-043017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-18-001961","doc":"avid_10k-20180430.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001683168-19-002038","doc":"avid_10k-043019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-20-002138","doc":"avid_10k-043020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-21-002764","doc":"avid_10k-043021.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-22-004704","doc":"avid_i10k-043022.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-23-004329","doc":"avid_i10k-043023.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001683168-24-004610","doc":"avid_i10k-043024.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operation\u2026"}]},{"cik":707511,"name":"REGENERX BIOPHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-020097","doc":"v404831_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-093682","doc":"v434404_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-017360","doc":"v462305_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-017995","doc":"tv488786_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-016982","doc":"tv516113_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-036901","doc":"tm205314d1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-030728","doc":"tm211107d1_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001104659-22-040167","doc":"rgrx-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410578-23-000628","doc":"rgrx-20221231x10k.htm","q":null}]},{"cik":711065,"name":"APPLIED MICRO CIRCUITS CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001628280-15-004482","doc":"amcc331201510-k.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001628280-16-016577","doc":"amcc331201610-k.htm","q":"With eight DDR4 memory channels, we expect X\u2011Gene 3 to outclass Xeon E5 in memory bandwidth, making it well suited to hyperscale workloads, such as in-memory databases, big data, machine learning, web search and HPC."}]},{"cik":712515,"name":"ELECTRONIC ARTS INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000712515-15-000033","doc":"ea3312015-q410kdoc.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000712515-16-000111","doc":"ea3312016-q410kdoc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000712515-17-000035","doc":"ea3312017-q410kdoc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000712515-18-000024","doc":"ea3312018-q410kdoc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000712515-19-000019","doc":"ea3312019-q410kdoc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000712515-20-000019","doc":"ea-20200331.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000712515-21-000064","doc":"ea-20210331.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0000712515-22-000011","doc":"ea-20220331.htm","q":"Suh had a 25-year career at Microsoft Corporation, a technology company, serving most recently as Corporate Vice President and Chief Financial Officer of its Cloud & AI division from January 2018 to February 2022 and as General Manager, Inv\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0000712515-23-000028","doc":"ea-20230331.htm","q":"We have teams focused on developing new technologies, such as self-learning artificial intelligence for our games, to enhance existing products and services and to expand the range of our offerings."},{"fy":2023,"lvl":1,"n":3,"adsh":"0000712515-24-000023","doc":"ea-20240331.htm","q":"Additionally, as artificial intelligence capabilities develop rapidly, individuals or groups of hackers and sophisticated organizations, may use these technologies to create new sophisticated attack methods that are increasingly automated, \u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0000712515-25-000022","doc":"ea-20250331.htm","q":"For example, we are investing, and intend to continue to invest, in research and development to incorporate artificial intelligence into our products and services."}]},{"cik":713425,"name":"AMERICAN SOFTWARE INC","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-250260","doc":"d905856d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-648270","doc":"d165679d10k.htm","q":null},{"fy":2017,"lvl":1,"n":4,"adsh":"0001193125-17-228535","doc":"d353589d10k.htm","q":"The Logility platform includes and industry leading integration layer to import/export data while leveraging artificial intelligence to validate and harmonize the data used in the applications (supply chain master data management)."},{"fy":2018,"lvl":2,"n":13,"adsh":"0001193125-18-217611","doc":"d580667d10k.htm","q":"The Logility platform includes an industry leading integration layer to import/export data while leveraging artificial intelligence to validate and harmonize the data used in the applications (supply chain master data management)."},{"fy":2019,"lvl":3,"n":18,"adsh":"0001628280-19-008742","doc":"amswa-20190430x10k.htm","q":"These enriched analytics will leverage interactive visualization, machine learning algorithms, and artificial intelligence (AI) to transform both structured and unstructured data to accelerate business planning performance and proactively i\u2026"},{"fy":2020,"lvl":2,"n":14,"adsh":"0001628280-20-010300","doc":"amswa-20200430x10k.htm","q":null},{"fy":2021,"lvl":2,"n":11,"adsh":"0001628280-21-013701","doc":"amswa-20210430.htm","q":null},{"fy":2022,"lvl":2,"n":10,"adsh":"0001628280-22-018227","doc":"amswa-20220430.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001628280-23-024860","doc":"amswa-20230430.htm","q":null},{"fy":2024,"lvl":3,"n":39,"adsh":"0001628280-24-030530","doc":"amswa-20240430.htm","q":"Effective September 5, 2023, the Company entered into a Stock Purchase Agreement (\u201cGarvis Purchase Agreement\u201d) with privately-held Garvis AI Limited, a private limited company organized and registered under the laws of England and Wales (\u201cG\u2026"}]},{"cik":714284,"name":"SORL AUTO PARTS, INC.","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-019698","doc":"v405073_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091540","doc":"v434813_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-018279","doc":"v462590_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-018719","doc":"tv489554_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-005483","doc":"f10k2018_sorlauto.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-014337","doc":"f10k2019_sorlauto.htm","q":null}]},{"cik":715446,"name":"ANIXA BIOSCIENCES INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":7,"adsh":"0001493152-21-000456","doc":"form10-k.htm","q":"Through this collaboration, we utilized advanced computational methods, machine learning, and molecular modeling techniques to perform in silico screening of over 1.2 billion compounds in chemical libraries (including publicly available com\u2026"},{"fy":2021,"lvl":"x","n":5,"adsh":"0001493152-22-000302","doc":"form10-k.htm","q":"Through this collaboration, we utilized advanced computational methods, machine learning, and molecular modeling techniques to perform in silico screening of over 1.2 billion compounds in chemical libraries (including publicly available com\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001493152-23-000346","doc":"form10-k.htm","q":"Through this collaboration, we utilized advanced computational methods, machine learning, and molecular modeling techniques to perform in silico screening of over 1.2 billion compounds in chemical libraries (including publicly available com\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-002453","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493152-25-001787","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-001845","doc":"form10-k.htm","q":null}]},{"cik":715957,"name":"DOMINION ENERGY, INC","industry":"Utilities","sic":4911,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-067777","doc":"d856078d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-480850","doc":"d126742d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-060413","doc":"d334692d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-059578","doc":"d512216d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-057924","doc":"d662998d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-054469","doc":"d854390d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008442","doc":"d-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006589","doc":"d-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003287","doc":"d-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-019110","doc":"d-20231231.htm","q":"In addition, the techniques used in cyber attacks evolve rapidly, including from emerging technologies, such as advanced forms of automation and artificial intelligence."},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-028387","doc":"d-20241231.htm","q":"Additional projects may be considered in the future, such as those necessary to meet the projected demand growth driven by data centers and artificial intelligence, including to address the concentration of data centers primarily in Loudoun\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001193125-26-063120","doc":"d-20251231.htm","q":null}]},{"cik":718877,"name":"ACTIVISION BLIZZARD, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001298","doc":"a2223239z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010584","doc":"a2227483z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001072","doc":"a2230993z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001114","doc":"a2234634z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000788","doc":"a2237840z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000718877-20-000003","doc":"atvi-12312019x10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-002828","doc":"atvi-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001628280-22-003992","doc":"atvi-20211231.htm","q":"As investments in cloud computing, artificial intelligence and machine learning, data analytics, and user interface and experience capabilities are becoming more competitive, we believe that our recently announced merger and partnership wit\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001628280-23-004842","doc":"atvi-20221231.htm","q":"As investments in cloud computing, artificial intelligence and machine learning, data analytics, and user interface and experience capabilities are becoming more competitive, we believe that our proposed Merger with Microsoft will better en\u2026"}]},{"cik":720154,"name":"INOTIV, INC.","industry":"Pharma & biotech","sic":8731,"state":"IN","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-072763","doc":"v427389_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-16-141558","doc":"v455204_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-065076","doc":"tv481504_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-066005","doc":"tv509358_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-19-076191","doc":"tm1919814d1_10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-138651","doc":"tm2038337d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-016976","doc":"notv-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-000243","doc":"notv-20220930x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-23-041266","doc":"notv-20230930.htm","q":"The goal of this program is to structure our data in a way that, in the future, may allow an AI approach to integrate them to find correlations between discovery and safety data, and clinical outcomes that can innovate and accelerate our tr\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001628280-24-049947","doc":"notv-20240930.htm","q":"The goal of this program is to structure our data in a way that, in the future, may allow an AI approach to integrate them to find correlations between discovery and safety data, and clinical outcomes that can innovate and accelerate our tr\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001628280-25-055483","doc":"notv-20250930.htm","q":"In addition, cybersecurity threats continue to evolve and become more sophisticated, including through the use of artificial intelligence driven social-engineering and ransomware techniques, which may increase the likelihood or severity of \u2026"}]},{"cik":723125,"name":"MICRON TECHNOLOGY INC","industry":"Computers & chips","sic":3674,"state":"ID","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000723125-15-000112","doc":"a2015q4.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000723125-16-000269","doc":"a2016q4.htm","q":null},{"fy":2017,"lvl":1,"n":4,"adsh":"0000723125-17-000131","doc":"a2017q4.htm","q":"Backed by more than 35 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, machine learning, and autonomous vehicles in key market segments like cloud, data center, n\u2026"},{"fy":2018,"lvl":2,"n":14,"adsh":"0000723125-18-000092","doc":"a2018q4.htm","q":"Backed by 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, machine learning, and autonomous vehicles, in key market segments like cloud, data center, networking\u2026"},{"fy":2019,"lvl":2,"n":13,"adsh":"0000723125-19-000094","doc":"a2019q4.htm","q":"Backed by 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, 5G, machine learning, and autonomous vehicles, in key market segments like mobile, data center, clien\u2026"},{"fy":2020,"lvl":3,"n":16,"adsh":"0000723125-20-000082","doc":"mu-20200903.htm","q":"Backed by more than 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, 5G, machine learning, and autonomous vehicles, in key market segments like mobile, data cen\u2026"},{"fy":2021,"lvl":2,"n":9,"adsh":"0000723125-21-000065","doc":"mu-20210902.htm","q":"Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence and 5G applications that unleash opportunities \u2014 from the data center to the intelligent edge and across the client and mo\u2026"},{"fy":2022,"lvl":2,"n":12,"adsh":"0000723125-22-000048","doc":"mu-20220901.htm","q":"Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence and 5G applications that unleash opportunities \u2014 from the data center to the intelligent edge and across the client and mo\u2026"},{"fy":2023,"lvl":3,"n":16,"adsh":"0000723125-23-000054","doc":"mu-20230831.htm","q":"Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence and 5G applications that unleash opportunities \u2014 from the data center to the intelligent edge and across the client and mo\u2026"},{"fy":2024,"lvl":3,"n":50,"adsh":"0000723125-24-000027","doc":"mu-20240829.htm","q":"Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence (AI) and compute-intensive applications that unleash opportunities \u2014 from the data center to the intelligent edge and acro\u2026"},{"fy":2025,"lvl":3,"n":60,"adsh":"0000723125-25-000028","doc":"mu-20250828.htm","q":"Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence (AI) and compute-intensive applications that unleash opportunities \u2014 from the data center to the intelligent edge and acro\u2026"}]},{"cik":723533,"name":"LONGWEN GROUP CORP.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-004390","doc":"f10k2014_alliedventures.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001551163-16-000313","doc":"allied201510kv2finalvedgar6.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001551163-17-000063","doc":"finaledgarv1.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001551163-18-000036","doc":"longwennewedgarized329181.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001551163-19-000090","doc":"draftof4-11-19vedgar6.htm","q":null}]},{"cik":724910,"name":"NVE CORP /NEW/","industry":"Computers & chips","sic":3674,"state":"MN","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000724910-15-000010","doc":"NVE_2015_10K.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000724910-16-000052","doc":"NVE_2016_10K.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000724910-18-000008","doc":"NVE_2018_10K.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000724910-19-000010","doc":"NVE_2019_10K.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000724910-20-000015","doc":"NVE_2020_10K.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000724910-21-000008","doc":"NVE_2021_10K--Draft.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-010855","doc":"nvec20220331_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001376474-23-000283","doc":"nvec-20230331.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001376474-24-000214","doc":"nvec-20240331.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001376474-25-000437","doc":"nvec-20250331.htm","q":null}]},{"cik":725363,"name":"CEL SCI CORP","industry":"Pharma & biotech","sic":2836,"state":"VA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-15-005519","doc":"cvm_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-17-011928","doc":"cvm_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-18-014104","doc":"cvm_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-19-013971","doc":"cvm_10kn.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-20-013975","doc":"cvm_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-21-013417","doc":"cvm_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-22-016959","doc":"cvm_10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001654954-23-015877","doc":"cvm_10k.htm","q":"Baillavoine has been a director, initially non-executive, now executive of ESG.AI, a Canadian Company."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001654954-25-000288","doc":"cvm_10k.htm","q":"Baillavoine has been a director, initially non-executive, now executive of ESG.AI, a Canadian Company."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001654954-25-014303","doc":"cvm_10k.htm","q":"Baillavoine joined ESG.AI Inc\u2019s Board of Directors, in November 2022."}]},{"cik":725876,"name":"FUNCTION(X) INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000725876-15-000071","doc":"vggl-2015x630x10xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000725876-16-000133","doc":"fcnx2016-6x30x10xk.htm","q":null}]},{"cik":727510,"name":"ENZON PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-014238","doc":"v402704_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-089172","doc":"v434165_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-016511","doc":"v461243_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-016199","doc":"tv487473_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-009301","doc":"tv513334_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-022802","doc":"tm205379-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-026712","doc":"tm214060d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000226","doc":"enzn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000136","doc":"enzn-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000245","doc":"enzn-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000177","doc":"enzn-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-022313","doc":"enzn-20251231x10k.htm","q":null}]},{"cik":727634,"name":"ISIGN SOLUTIONS INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000727634-15-000012","doc":"fm_10k12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0000727634-16-000040","doc":"fm_10k123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003126","doc":"f10k2016_isignsolutionsinc.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003811","doc":"f10k2017_isignsolutions.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-005445","doc":"f10k2018_isignsolutions.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-007926","doc":"f10k2019_isignsolutions.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-020616","doc":"f10k2020_isignsolutions.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-016643","doc":"f10k2021_isignsolutions.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-025193","doc":"f10k2022_isignsolutions.htm","q":null}]},{"cik":728387,"name":"PERSPECTIVE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2025,"lvl":2,"n":10,"adsh":"0000728387-26-000004","doc":"catx-20251231.htm","q":"Though animal studies remain a common part of nonclinical development, the FDA has recently announced a shift away from animal testing and greater reliance on artificial intelligence (AI)-based computational modeling."}]},{"cik":728391,"name":"IPALCO ENTERPRISES, INC.","industry":"Utilities","sic":4911,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000728391-15-000003","doc":"ye201410kcomplete.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000728391-16-000035","doc":"ipalco10k20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000728391-17-000017","doc":"ipalco10k20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000728391-18-000013","doc":"ipalco10k20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000728391-19-000012","doc":"ipalco10k20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000728391-20-000005","doc":"ipalco10k20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000728391-21-000015","doc":"ipl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000728391-22-000010","doc":"ipl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000728391-23-000015","doc":"ipl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000728391-24-000010","doc":"ipl-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000728391-25-000017","doc":"ipl-20241231.htm","q":"Utilities Load Growth and Large Load Customers The expansion of data center needs related to the growing use of generative artificial intelligence has the potential to be a significant accelerant to the load growth of the U.S. utilities mar\u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0000728391-26-000007","doc":"ipl-20251231.htm","q":null}]},{"cik":730272,"name":"REPLIGEN CORP","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-095569","doc":"d854858d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478518","doc":"d115476d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-054220","doc":"d319578d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-054262","doc":"d516591d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-060645","doc":"d682580d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-050136","doc":"d862842d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-054675","doc":"d105808d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001430","doc":"rgen-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003793","doc":"rgen-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-018809","doc":"rgen-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":17,"adsh":"0000950170-25-038999","doc":"rgen-20241231.htm","q":"As we expand our customer base, these requirements may vary from customer to customer, further increasing the cost of compliance and doing business. 31 The use of new and evolving technologies, such as artificial intelligence (\u201cAI\u201d), in our\u2026"},{"fy":2025,"lvl":3,"n":29,"adsh":"0001193125-26-076528","doc":"rgen-20251231.htm","q":null}]},{"cik":737207,"name":"ADHERA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001571049-15-001227","doc":"t1500315_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001571049-16-013489","doc":"t1600825_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003272","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-005372","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005482","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0000737207-20-000006","doc":"atrx-20191231x10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008190","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-010064","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-010160","doc":"form10-k.htm","q":null}]},{"cik":737300,"name":"COVER ALL TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001145443-15-000499","doc":"d285329_10k.htm","q":null}]},{"cik":743238,"name":"SHYFT GROUP, INC.","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004162","doc":"spar20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-027109","doc":"spar20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003752","doc":"spar20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-003606","doc":"spar20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-004091","doc":"spar20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-005329","doc":"spar20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007163","doc":"spar20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004361","doc":"shyf20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-004281","doc":"shyf20221231b_10k.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001437749-24-005136","doc":"shyf20231231c_10k.htm","q":"Emerging issues related to the development and use of artificial intelligence (\u201cAI\u201d) could give rise to legal or regulatory action, damage our reputation or otherwise materially harm of our business."},{"fy":2024,"lvl":2,"n":9,"adsh":"0001437749-25-004501","doc":"shyf20241231c_10k.htm","q":"Emerging issues related to the development and use of artificial intelligence (\u201cAI\u201d) could give rise to legal or regulatory action, damage our reputation or otherwise materially harm of our business."}]},{"cik":743316,"name":"MAXIM INTEGRATED PRODUCTS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000743316-15-000029","doc":"maxim10-kfy2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000743316-16-000081","doc":"maxim10-kfy2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000743316-17-000028","doc":"maxim10-kfy2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000743316-18-000031","doc":"maxim10-kfy2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000743316-19-000024","doc":"maxim10-kfy2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000743316-20-000025","doc":"maxim10-kfy2020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000743316-21-000025","doc":"mxim-20210626.htm","q":null}]},{"cik":743988,"name":"XILINX INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000743988-15-000022","doc":"xlnx0328201510k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000743988-16-000063","doc":"xlnx42201610k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000743988-17-000046","doc":"xlnx41201710k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000743988-18-000022","doc":"xlnx331201810k.htm","q":null},{"fy":2018,"lvl":2,"n":6,"adsh":"0000743988-19-000012","doc":"0000743988-19-000012.txt","q":"Central processing units (CPUs) historically have been the most common platform used by software developers but has limitations when used for modern compute tasks ranging from real-time control to machine learning."},{"fy":2019,"lvl":2,"n":5,"adsh":"0000743988-20-000020","doc":"xlnx328202010k.htm","q":"Central processing units (CPUs) historically have been the most common platform used by software developers but have limitations when used for modern compute tasks ranging from real-time control to machine learning."},{"fy":2020,"lvl":"x","n":9,"adsh":"0000743988-21-000016","doc":"xlnx-20210403.htm","q":"Central processing units (CPUs) historically have been the most common platform used by software developers but have limitations when used for modern compute tasks ranging from real-time control to machine learning."}]},{"cik":745543,"name":"PETRO USA, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001377469-17-000064","doc":"alph10k-06302014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001377469-17-000072","doc":"alph10k-06302015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001377469-17-000080","doc":"alph10k-06302016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001377469-17-000088","doc":"alph10k-06312017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001445831-18-000031","doc":"10k_atpt-20180630.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0000745543-20-000014","doc":"atpt06202018_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0000745543-20-000025","doc":"atpt06302020_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0000745543-21-000017","doc":"atpt06302021_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410187-22-000012","doc":"atpt_2022jun30-10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001658521-23-000008","doc":"atpt06302023_10k.htm","q":null}]},{"cik":746210,"name":"TAOWEAVE, INC.","industry":"Software & IT services","sic":7370,"state":"CO","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0000746210-21-000024","doc":"glow-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000746210-22-000023","doc":"glow-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0000746210-23-000011","doc":"glow-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000746210-24-000009","doc":"glow-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001437749-25-008262","doc":"oblg20241231_10k.htm","q":null},{"fy":2025,"lvl":"x","n":16,"adsh":"0001437749-26-009237","doc":"oblg20251231_10k.htm","q":"Business Overview We are a public company focused on the Bittensor ecosystem, a decentralized, open-source protocol that coordinates the development and deployment of artificial intelligence (\u201cAI\u201d) models."}]},{"cik":748268,"name":"RED CAT HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2016,"lvl":"x","n":1,"adsh":"0001554795-17-000149","doc":"tfvr0406form10k.htm","q":"On January 20, 2017, the Company entered into an agreement with a firm to provide their artificial intelligence conversational voice platform for integration into the Company\u2019s product."},{"fy":2017,"lvl":"x","n":1,"adsh":"0001554795-18-000086","doc":"tfvr0404form10k.htm","q":"On January 20, 2017, the Company entered into an agreement with a firm to provide their artificial intelligence conversational voice platform for integration into the Company\u2019s product."},{"fy":2018,"lvl":"x","n":1,"adsh":"0001554795-19-000079","doc":"tfvr0329form10k.htm","q":"Other Agreements On January 20, 2017, the Company entered into an agreement with a firm to provide their artificial intelligence conversational voice platform for integration into the Company\u2019s product."},{"fy":2020,"lvl":"x","n":0,"adsh":"0001554795-20-000206","doc":"rcat0811form10k.htm","q":null},{"fy":2021,"lvl":1,"n":4,"adsh":"0001554795-21-000273","doc":"rcat0716form10k.htm","q":"By applying machine learning to the log files, we can prevent drone flight problems before they happen through artificial intelligence."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001554795-22-000255","doc":"rcat0727form10k.htm","q":"With the growth of mobile devices and personal voice assistants, cloud services and artificial intelligence (\u201cAI\u201d), the number of supporting platforms has grown, and with it the complexity and increased need for us to have business and cont\u2026"},{"fy":2023,"lvl":3,"n":17,"adsh":"0001554795-23-000231","doc":"rcat0721form10k.htm","q":"Some of the unique features and capabilities of the Teal 2, and the partners who developed and helped integrate these technologies into the Teal 2, include: \u0095Teledyne FLIR whose new Hadron 640R sensor provides the highest resolution thermal\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001554795-24-000195","doc":"rcat0808form10k.htm","q":"Anchored by Red Cat\u2019s Teal Drones, the RFI unites the world\u2019s most innovative UAS hardware and software companies focused on AI/ML, swarming, FPV, command and control, and payloads."},{"fy":2025,"lvl":3,"n":29,"adsh":"0001628280-26-019861","doc":"rcat-20251231.htm","q":"Advances in autonomy, sensors, communications, and artificial intelligence have expanded the operational capabilities of these systems and broadened the range of missions they can support."}]},{"cik":748592,"name":"ERNEXA THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-005827","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-014764","doc":"brhc10036185_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-012418","doc":"brhc10049677_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-013254","doc":"ef20015352_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-010051","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-010102","doc":"form10-k.htm","q":null}]},{"cik":749038,"name":"CCUR HOLDINGS, INC.","industry":"Computers & chips","sic":3571,"state":"GA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-15-033559","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-048837","doc":"v474318_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-048540","doc":"tv502024_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001144204-19-042110","doc":"tv528087_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-105213","doc":"tm2024746-1_10k.htm","q":null}]},{"cik":749647,"name":"IMUNON, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004805","doc":"clsn20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-028601","doc":"clsn20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-005235","doc":"clsn20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-005539","doc":"clsn20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004184","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004717","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006382","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008277","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-23-009604","doc":"form10-k.htm","q":"In addition, The Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) will provide artificial intelligence services including biomarker and genomic analysis."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-24-011616","doc":"form10-k.htm","q":"In addition, The Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) will provide artificial intelligence services including biomarker and genomic analysis."},{"fy":2024,"lvl":"x","n":1,"adsh":"0001493152-25-008460","doc":"form10-k.htm","q":"In addition, The Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) will provide artificial intelligence services including biomarker and genomic analysis."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001493152-26-013850","doc":"form10-k.htm","q":"In addition, The Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) will provide artificial intelligence services including biomarker and genomic analysis."}]},{"cik":753308,"name":"NEXTERA ENERGY INC","industry":"Utilities","sic":4911,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000753308-15-000079","doc":"nee-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000753308-16-000337","doc":"nee-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000753308-17-000060","doc":"nee-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000753308-18-000013","doc":"nee-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000753308-19-000039","doc":"nee-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000753308-20-000021","doc":"nee-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000753308-21-000014","doc":"nee-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000753308-22-000014","doc":"nee-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000753308-23-000019","doc":"nee-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000753308-24-000008","doc":"nee-20231231.htm","q":"In addition, the advancement of artificial intelligence has given rise to added vulnerabilities and potential entry points for cyberattacks."},{"fy":2024,"lvl":1,"n":2,"adsh":"0000753308-25-000011","doc":"nee-20241231.htm","q":"In addition, the advancement of artificial intelligence has given rise to added vulnerabilities and potential entry points for cyberattacks."},{"fy":2025,"lvl":3,"n":16,"adsh":"0000753308-26-000015","doc":"nee-20251231.htm","q":"NEE and its subsidiaries, with employees totaling approximately 17,400 as of December 31, 2025, continue to develop and implement enterprise-wide initiatives, including deploying advanced technologies such as artificial intelligence and pro\u2026"}]},{"cik":753568,"name":"EXAR CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-011856","doc":"exar20150331_10k.htm","q":null},{"fy":2015,"lvl":"x","n":2,"adsh":"0001437749-16-032955","doc":"exar20160331_10k.htm","q":"Leza was the founder, Chairman and Chief Executive Officer of AI Research Corporation, an early stage venture capital firm specializing in the areas of business-to-business software, information technology, medical devices and medical analy\u2026"}]},{"cik":754737,"name":"SCANA CORP","industry":"Utilities","sic":4931,"state":"SC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000754737-15-000019","doc":"a12312014-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000754737-16-000089","doc":"a12312015-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000754737-17-000014","doc":"0000754737-17-000014.txt","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000754737-18-000115","doc":"a12312017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000754737-19-000008","doc":"a12312018-10k.htm","q":null}]},{"cik":754813,"name":"HEALTHWAREHOUSE.COM, INC.","industry":"Retail","sic":5912,"state":"KY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001117768-15-000196","doc":"mainbody.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001117768-16-001010","doc":"mainbody.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001117768-17-000232","doc":"mainbody.htm","q":null}]},{"cik":755001,"name":"UNITIL CORP","industry":"Utilities","sic":4931,"state":"NH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-023683","doc":"d837958d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-440721","doc":"d110360d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-028224","doc":"d262254d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-028247","doc":"0001193125-18-028247.txt","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-023132","doc":"d599927d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-019075","doc":"d803735d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-025264","doc":"d67774d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-023936","doc":"d276476d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002696","doc":"utl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-014186","doc":"utl-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-017154","doc":"utl-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-042983","doc":"utl-20251231.htm","q":null}]},{"cik":763744,"name":"LCI INDUSTRIES","industry":"Auto manufacturing","sic":3714,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000763744-15-000037","doc":"dw-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000763744-16-000351","doc":"dw-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000763744-17-000049","doc":"lcii-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000763744-18-000042","doc":"lcii-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000763744-19-000018","doc":"lcii-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000763744-20-000030","doc":"lcii-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000763744-21-000019","doc":"lcii-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000763744-22-000016","doc":"lcii-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000763744-23-000016","doc":"lcii-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000763744-24-000023","doc":"lcii-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000763744-25-000022","doc":"lcii-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0000763744-26-000011","doc":"lcii-20251231.htm","q":"Further, artificial intelligence technologies may be used for certain cybersecurity attacks, and may increase their frequency and intensity, resulting in heightened risks of security breaches and incidents."}]},{"cik":764195,"name":"VBI VACCINES INC/BC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-002629","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-002611","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-002481","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003413","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-005171","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006140","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007351","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-014744","doc":"form10-k.htm","q":null}]},{"cik":764622,"name":"PINNACLE WEST CAPITAL CORP","industry":"Utilities","sic":4911,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000764622-15-000013","doc":"pnw12311410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000764622-16-000087","doc":"pnw2015123110-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000764622-17-000010","doc":"pnw2016123110-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000764622-18-000018","doc":"pnw2017123110-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000764622-19-000019","doc":"pnw2018123110-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000764622-20-000017","doc":"pnw2019123110-kfinal.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000764622-21-000013","doc":"pnw-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000764622-22-000014","doc":"pnw-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000764622-23-000023","doc":"pnw-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000764622-24-000016","doc":"pnw-20231231.htm","q":"The information on Pinnacle West\u2019s website, including the Corporate Responsibility Report, is not incorporated by reference into or otherwise a part of this report. 65 Table of Contents Artificial Intelligence To address the emergence of ar\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0000764622-25-000023","doc":"pnw-20241231.htm","q":"APS is exploring available options for securing sufficient electric generation and transmission to meet these projections of future customer needs; however, there are difficulties in properly forecasting the demands of these extra-large cus\u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0000764622-26-000011","doc":"pnw-20251231.htm","q":"Recent industry trends and projections of load growth reflect significant demand from data centers to support AI as well as onshoring of manufacturing, such as advanced semiconductor manufacturing."}]},{"cik":767920,"name":"PMC SIERRA INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000767920-15-000004","doc":"pmcs-20141227x10k.htm","q":null}]},{"cik":768251,"name":"ALTERA CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000768251-15-000008","doc":"altera10k12312014.htm","q":null}]},{"cik":768710,"name":"RELIV INTERNATIONAL INC","industry":"Pharma & biotech","sic":2834,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-017935","doc":"v404148_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-089980","doc":"v433926_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-016959","doc":"v461861_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-005793","doc":"relv20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-005992","doc":"relv20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-006287","doc":"relv20191231_10k.htm","q":null}]},{"cik":769397,"name":"AUTODESK, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000769397-15-000012","doc":"adsk-0131201510xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000769397-16-000067","doc":"adsk-0131201610xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000769397-17-000014","doc":"adsk-0131201710xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000769397-18-000011","doc":"adsk-0131201810xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000769397-19-000016","doc":"adsk-0131201910xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000769397-20-000013","doc":"adsk-0131202010xk.htm","q":null},{"fy":2020,"lvl":3,"n":18,"adsh":"0000769397-21-000014","doc":"adsk-20210131.htm","q":"We dedicate considerable technical and financial resources to research and development to deliver additional automation and insights to our customers through artificial intelligence, machine learning, and generative design, which increase e\u2026"},{"fy":2021,"lvl":3,"n":20,"adsh":"0000769397-22-000019","doc":"adsk-20220131.htm","q":"We dedicate considerable technical and financial resources to research and development to deliver additional automation and insights to our customers through artificial intelligence, machine learning, and generative design, which increase e\u2026"},{"fy":2022,"lvl":3,"n":16,"adsh":"0000769397-23-000036","doc":"adsk-20230131.htm","q":"We dedicate considerable technical and financial resources to research and development to deliver additional automation and insights to our customers through artificial intelligence, machine learning, and generative design, which increase e\u2026"},{"fy":2023,"lvl":3,"n":38,"adsh":"0000769397-24-000090","doc":"adsk-20240131.htm","q":"We dedicate considerable technical and financial resources to research and development to deliver additional automation and insights to our customers through artificial intelligence (\u201cAI\u201d), machine learning, and generative design, which inc\u2026"},{"fy":2024,"lvl":3,"n":46,"adsh":"0000769397-25-000019","doc":"adsk-20250131.htm","q":"We dedicate considerable technical and financial resources to research and development to deliver additional automation and insights to our customers through artificial intelligence (\u201cAI\u201d), machine learning, and generative design, which inc\u2026"}]},{"cik":771266,"name":"KOPIN CORP","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000771266-15-000006","doc":"kopn-12272014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000771266-16-000071","doc":"kopn-12262015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000771266-17-000016","doc":"kopn-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000771266-18-000012","doc":"kopn-20171230x10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000771266-19-000020","doc":"0000771266-19-000020.txt","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000771266-20-000008","doc":"kopn-20191228x10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-005466","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006784","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-23-007614","doc":"form10-k.htm","q":"Examples of products manufactured by our customers that include our AMLCD components include: \u25cf Weapon sights and target locators for soldiers to enable faster and more accurate target acquisition; \u25cf Weapon sight systems that support artifi\u2026"},{"fy":2023,"lvl":1,"n":4,"adsh":"0001493152-24-009985","doc":"form10-k.htm","q":"Examples of products manufactured by our customers that include our AMLCD and OLED displays include: \u25cf Weapon sights and target locators for soldiers to enable faster and more accurate target acquisition; \u25cf Weapon sight systems that support\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001641172-25-005135","doc":"form10-k.htm","q":"The display is a bi-directional, human-in-the-loop and AI enabled backplane that can be manufactured into microdisplays using either OLED or MicroLED deposition technology."},{"fy":2025,"lvl":3,"n":15,"adsh":"0001493152-26-016338","doc":"form10-k.htm","q":"The display is a bi-directional, human-in-the-loop and artificial intelligence enabled backplane that can be manufactured into microdisplays using either OLED or MicroLED deposition technology."}]},{"cik":771856,"name":"CHAMPIONS ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"MD","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-044834","doc":"v415746_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-16-017936","doc":"csbr10-k4302016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-17-007429","doc":"csbr10-k4302017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-18-009773","doc":"csbr10-k4302018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-19-009139","doc":"csbr10-k4302019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-20-010734","doc":"csbr10-k4302020.htm","q":null},{"fy":2021,"lvl":2,"n":5,"adsh":"0001628280-21-014464","doc":"csbr-20210430.htm","q":"Lumin leverages Champions\u2019 large Datacenter coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001628280-22-019309","doc":"csbr-20220430.htm","q":"Lumin leverages Champions\u2019 large Datacenter coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research."},{"fy":2023,"lvl":2,"n":5,"adsh":"0001628280-23-025464","doc":"csbr-20230430.htm","q":"Lumin leverages Champions\u2019 large Datacenter coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research."},{"fy":2024,"lvl":2,"n":6,"adsh":"0001628280-24-032321","doc":"csbr-20240430.htm","q":"Lumin leverages Champions\u2019 large Datacenter coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001628280-25-035765","doc":"csbr-20250430.htm","q":"Lumin leverages Champions\u2019 large Datacenter coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research."}]},{"cik":772320,"name":"GENE BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-198325","doc":"d843152d10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001564590-16-030523","doc":"crxm-10k_20151231.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001564590-17-014409","doc":"crxm-10k_20161231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-21-009535","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-22-008205","doc":"form10-k.htm","q":null}]},{"cik":772406,"name":"CIRRUS LOGIC, INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-201883","doc":"d862656d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-602269","doc":"d127464d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-181625","doc":"d339118d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000772406-18-000007","doc":"a10-kxcrus53018.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000772406-19-000008","doc":"a10-kxcrus33019.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000772406-20-000007","doc":"crus-20200328.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000772406-21-000013","doc":"crus-20210327.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000772406-22-000014","doc":"crus-20220326.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000772406-23-000019","doc":"crus-20230325.htm","q":null},{"fy":2023,"lvl":2,"n":8,"adsh":"0000772406-24-000031","doc":"crus-20240330.htm","q":"Risks relating to the adoption, use or application of emerging technologies, including artificial intelligence may impact financial results and could result in reputational and financial harm and liability."},{"fy":2024,"lvl":2,"n":13,"adsh":"0000772406-25-000014","doc":"crus-20250329.htm","q":"Artificial intelligence and machine learning also may be used for certain cybersecurity attacks, improving or expanding the existing capabilities of threat actors in manners we cannot predict at this time, resulting in greater risks of secu\u2026"}]},{"cik":773141,"name":"SEKISUI HOUSE U.S., INC.","industry":"Construction","sic":1531,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-001397","doc":"mdc20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-024659","doc":"mdc20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-001467","doc":"mdc20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-001473","doc":"mdc20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-001602","doc":"mdc20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-001403","doc":"mdc20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000773141-21-000024","doc":"mdc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000773141-22-000012","doc":"mdc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000773141-23-000007","doc":"mdc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000773141-24-000004","doc":"mdc-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000773141-25-000004","doc":"mdc-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000773141-26-000011","doc":"mdc-20251231.htm","q":null}]},{"cik":773840,"name":"HONEYWELL INTERNATIONAL INC","industry":"Auto manufacturing","sic":3714,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000930413-15-000621","doc":"c79276_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000930413-16-005457","doc":"c83288_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000930413-17-000391","doc":"c86783_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000930413-18-000292","doc":"c89913_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000930413-19-000366","doc":"c92779_10k.htm","q":null}]},{"cik":775158,"name":"OSHKOSH CORP","industry":"Auto manufacturing","sic":3711,"state":"WI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000775158-15-000172","doc":"osk10k93015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000775158-16-000405","doc":"osk10k93016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000775158-17-000172","doc":"osk10k93017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000775158-18-000147","doc":"osk10k93018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000950123-19-011559","doc":"osk-10k_20190930.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-054491","doc":"osk-10k_20200930.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001564590-21-057221","doc":"osk-10k_20210930.htm","q":"Using systems like Light Detection and Ranging, Radio Detection and Ranging and Global Positioning Systems along with advanced machine learning algorithms, the Company is developing autonomous vehicles and active safety systems."},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003473","doc":"osk-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-022841","doc":"osk-20231231.htm","q":"Currently, we leverage disruptive technologies in several key areas including electrification, autonomy, active-safety, advanced analytics and artificial intelligence."},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-024305","doc":"osk-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":10,"adsh":"0001193125-26-054061","doc":"osk-20251231.htm","q":"As an innovator and integrator, we work directly with our customers to solve real-world challenges \u2013 developing and applying breakthrough technologies in autonomy, artificial intelligence, connectivity and electrification."}]},{"cik":777491,"name":"CH2M HILL COMPANIES LTD","industry":"Construction","sic":8711,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000162","doc":"chm-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003349","doc":"chm-20151225x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001430","doc":"chm-20161230x10k.htm","q":null}]},{"cik":783325,"name":"WEC ENERGY GROUP, INC.","industry":"Utilities","sic":4931,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000107815-15-000040","doc":"wec1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000107815-16-000248","doc":"wec1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000107815-17-000104","doc":"wec1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000107815-18-000134","doc":"a2017wec10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000107815-19-000128","doc":"a2018wec10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000107815-20-000089","doc":"a2019wec10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000107815-21-000079","doc":"wec-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000107815-22-000116","doc":"wec-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000107815-23-000100","doc":"wec-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000107815-24-000095","doc":"wec-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":23,"adsh":"0000107815-25-000103","doc":"wec-20241231.htm","q":"Cybersecurity threats, including those leveraging AI, continue to increase, and the security measures and preventative actions we take to reduce the risk of cybersecurity incidents and protect our systems against unauthorized access to secu\u2026"},{"fy":2025,"lvl":3,"n":28,"adsh":"0000783325-26-000018","doc":"wec-20251231.htm","q":"We are engaged in discussions with a small number of customers to provide power to large-scale data centers being constructed to support AI and other technology capabilities."}]},{"cik":784977,"name":"PORTLAND GENERAL ELECTRIC CO /OR/","industry":"Utilities","sic":4911,"state":"OR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000784977-15-000005","doc":"por201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000784977-16-000067","doc":"por201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000784977-17-000006","doc":"por201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000784977-18-000005","doc":"a201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000784977-19-000010","doc":"a201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000784977-20-000005","doc":"a201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000784977-21-000007","doc":"por-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000784977-22-000009","doc":"por-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000784977-23-000005","doc":"por-20221231.htm","q":"These projects target improvements in electrical system reliability and resiliency, wildfire situational awareness and mitigation, greater communications capabilities, advancements in customer usage analytics using artificial intelligence, \u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0000784977-24-000034","doc":"por-20231231.htm","q":"These projects target improvements in electrical system reliability and resiliency, wildfire situational awareness and mitigation, greater communications capabilities, advancements in customer usage analytics using artificial intelligence, \u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000784977-25-000012","doc":"por-20241231.htm","q":"These projects target improvements in electrical system reliability and resiliency, wildfire situational awareness and mitigation, greater communications capabilities, advancements in customer usage analytics using artificial intelligence, \u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-052750","doc":"por-20251231.htm","q":"These projects target improvements in electrical system reliability and resiliency, wildfire situational awareness and mitigation, greater communications capabilities, advancements in customer usage analytics using artificial intelligence, \u2026"}]},{"cik":786947,"name":"ACURA PHARMACEUTICALS, INC","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-013292","doc":"v400005_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-085018","doc":"v431942_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-018146","doc":"v461049_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-033269","doc":"tv490022_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-044723","doc":"tv528338_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-040632","doc":"tm205365d1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-044760","doc":"tm211138d1_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-23-001462","doc":"acur-20211231x10k.htm","q":null}]},{"cik":787250,"name":"DPL LLC","industry":"Utilities","sic":4931,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000787250-15-000005","doc":"c250-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000787250-16-000035","doc":"dpl10k12312015q4.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000787250-17-000009","doc":"dpl10k12312016q4.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000787250-18-000008","doc":"dpl10k12312017q4.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000787250-19-000013","doc":"dpl10k12312018q4.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000787250-20-000005","doc":"dpl10k12312019q4.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000787250-21-000007","doc":"dpl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000787250-22-000005","doc":"dpl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000787250-23-000006","doc":"dpl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000787250-24-000006","doc":"dpl-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000787250-25-000012","doc":"dpl-20241231.htm","q":"Utilities Load Growth and Large Load Customers - The expansion of data center needs related to the growing use of generative artificial intelligence has the potential to be a significant accelerant to the load growth of the U.S. utilities m\u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0000787250-26-000013","doc":"dpl-20251231.htm","q":null}]},{"cik":788784,"name":"PUBLIC SERVICE ENTERPRISE GROUP INC","industry":"Utilities","sic":4931,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000788784-15-000002","doc":"pseg201410kq4.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000788784-16-000014","doc":"pseg201510kq4.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000788784-17-000003","doc":"pseg201610kq4.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000788784-18-000004","doc":"pseg201710kq4.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000788784-19-000005","doc":"pseg201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000788784-20-000004","doc":"pseg201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000788784-21-000007","doc":"pseg-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003860","doc":"pseg-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004411","doc":"pseg-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":15,"adsh":"0001628280-24-006885","doc":"pseg-20231231.htm","q":"Further, new types of cyberattacks, whether directed at our own infrastructure and technology and operational systems or that of third parties, may be generated or enhanced through the use of Artificial Intelligence (AI)."},{"fy":2024,"lvl":3,"n":18,"adsh":"0000950170-25-026874","doc":"peg-20241231.htm","q":"Further, new types of cyberattacks, whether directed at our own infrastructure and technology and operational systems or that of third parties, may be generated or enhanced through the use of Artificial Intelligence (AI) and/or cloud-based \u2026"},{"fy":2025,"lvl":3,"n":23,"adsh":"0001193125-26-077446","doc":"peg-20251231.htm","q":"Further, new types of cyberattacks, whether directed at our own infrastructure and technology and operational systems or that of third parties, may be generated or enhanced through the use of Artificial Intelligence (AI) and/or cloud-based \u2026"}]},{"cik":788816,"name":"OGLETHORPE POWER CORP","industry":"Utilities","sic":4911,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002793","doc":"a2223681z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011663","doc":"a2227903z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-002021","doc":"a2231461z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-002324","doc":"a2234998z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001779","doc":"a2238163z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003884","doc":"opc-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-005217","doc":"opc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-007375","doc":"opc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009308","doc":"opc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-012944","doc":"opc-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-015552","doc":"opc-20241231.htm","q":"Georgia is projected to experience significant load growth over the next several years resulting from native load growth and the development of several large commercial projects, including data centers to meet the increased demand for artif\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0000788816-26-000009","doc":"opc-20251231.htm","q":"Georgia is experiencing significant load growth, which is projected to continue over the next several years, resulting from native load growth and the development of several large commercial projects, including data centers to meet the incr\u2026"}]},{"cik":788965,"name":"HALLADOR ENERGY CO","industry":"Utilities","sic":4911,"state":"IN","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003141","doc":"hnrg-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-027174","doc":"hnrg-20251231x10k.htm","q":null}]},{"cik":789019,"name":"MICROSOFT CORP","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2015,"lvl":1,"n":2,"adsh":"0001193125-15-272806","doc":"d918813d10k.htm","q":"We will continue to innovate with higher-level services including identity and directory services that manage employee corporate identity and manage and secure corporate information accessed and stored across a growing number of devices, ri\u2026"},{"fy":2016,"lvl":1,"n":2,"adsh":"0001193125-16-662209","doc":"d187868d10k.htm","q":"We continue to innovate with higher-level services including identity and directory services that manage employee corporate identity and manage and secure corporate information accessed and stored across a growing number of devices, rich da\u2026"},{"fy":2017,"lvl":2,"n":14,"adsh":"0001564590-17-014900","doc":"msft-10k_20170630.htm","q":"Our strategy is to build best-in-class platforms and productivity services for an intelligent cloud and an intelligent edge infused with artificial intelligence (\u201cAI\u201d)."},{"fy":2018,"lvl":3,"n":36,"adsh":"0001564590-18-019062","doc":"msft-10k_20180630.htm","q":"Artificial intelligence (\u201cAI\u201d) capabilities are rapidly advancing, fueled by data and knowledge of the world."},{"fy":2019,"lvl":3,"n":40,"adsh":"0001564590-19-027952","doc":"msft-10k_20190630.htm","q":"Artificial intelligence (\u201cAI\u201d) capabilities are rapidly advancing, fueled by data and knowledge of the world."},{"fy":2020,"lvl":3,"n":42,"adsh":"0001564590-20-034944","doc":"msft-10k_20200630.htm","q":"Artificial intelligence (\u201cAI\u201d) capabilities are rapidly advancing, fueled by data and knowledge of the world."},{"fy":2021,"lvl":3,"n":44,"adsh":"0001564590-21-039151","doc":"msft-10k_20210630.htm","q":"Artificial intelligence (\u201cAI\u201d) capabilities are rapidly advancing, fueled by data and knowledge of the world."},{"fy":2022,"lvl":3,"n":46,"adsh":"0001564590-22-026876","doc":"msft-10k_20220630.htm","q":"In the next phase of innovation, artificial intelligence (\u201cAI\u201d) capabilities are rapidly advancing, fueled by data and knowledge of the world."},{"fy":2023,"lvl":3,"n":104,"adsh":"0000950170-23-035122","doc":"msft-20230630.htm","q":"We are creating the platforms and tools, powered by artificial intelligence (\u201cAI\u201d), that deliver better, faster, and more effective solutions to support small and large business competitiveness, improve educational and health outcomes, grow\u2026"},{"fy":2024,"lvl":3,"n":144,"adsh":"0000950170-24-087843","doc":"msft-20240630.htm","q":"OVERVIEW Microsoft is a technology company committed to making digital technology and artificial intelligence (\u201cAI\u201d) available broadly and doing so responsibly, with a mission to empower every person and every organization on the planet to \u2026"},{"fy":2025,"lvl":3,"n":117,"adsh":"0000950170-25-100235","doc":"msft-20250630.htm","q":"OVERVIEW Microsoft is a technology company committed to making digital technology and artificial intelligence (\u201cAI\u201d) available broadly and doing so responsibly, with a mission to empower every person and every organization on the planet to \u2026"}]},{"cik":790715,"name":"SIGMA DESIGNS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-007429","doc":"sigm20150131_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-028944","doc":"sigm20160130_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-005627","doc":"sigm20170128_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-007502","doc":"sigm20180203_10k.htm","q":null}]},{"cik":791907,"name":"LINEAR TECHNOLOGY CORP /CA/","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000791907-15-000099","doc":"c907-20150628x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000791907-16-000207","doc":"lltc-20160703x10k.htm","q":null}]},{"cik":791908,"name":"XOMA ROYALTY CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011358","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014295","doc":"xoma-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004563","doc":"xoma-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004731","doc":"xoma-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006621","doc":"xoma-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002286","doc":"xoma-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002676","doc":"tmb-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003022","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003259","doc":"xoma-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002782","doc":"xoma-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003131","doc":"xoma-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-030872","doc":"xoma-20251231x10k.htm","q":null}]},{"cik":791915,"name":"CYPRESS SEMICONDUCTOR CORP /DE/","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000791915-15-000009","doc":"cy-20141228x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013820","doc":"cy-10k_20160103.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000791915-17-000007","doc":"cy-01012017x10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000791915-18-000007","doc":"cy-12312017x10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000791915-19-000006","doc":"cy-12302018x10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000791915-20-000006","doc":"cy-12292019x10xk.htm","q":null}]},{"cik":792130,"name":"DATAWATCH CORP","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-065237","doc":"v422945_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-16-133226","doc":"v451019_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-060429","doc":"tv477499_10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001144204-18-064355","doc":"tv508536_10k.htm","q":"Datawatch Angoss \u2013 Powerful Predictive Analytics & Data Science Platform Datawatch Angoss solutions enable organizations to make forward-thinking decisions with confidence using patented, Predictive Analytics and Machine Learning techniques\u2026"}]},{"cik":792977,"name":"AMAG PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000871","doc":"a2223053z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003420","doc":"amag-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000792977-17-000007","doc":"amag201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000792977-18-000012","doc":"a201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000792977-19-000036","doc":"a201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000792977-20-000027","doc":"a201910-k.htm","q":null}]},{"cik":792987,"name":"ASTEC INDUSTRIES INC","industry":"Construction machinery","sic":3531,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000792987-15-000010","doc":"f10k-123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000792987-16-000063","doc":"f10k-123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000792987-17-000008","doc":"f10k-123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000792987-18-000008","doc":"f10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000792987-19-000019","doc":"f10k-123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-006100","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000792987-21-000016","doc":"aste-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000792987-22-000013","doc":"aste-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000792987-23-000015","doc":"aste-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000792987-24-000015","doc":"aste-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000792987-25-000013","doc":"aste-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":10,"adsh":"0000792987-26-000011","doc":"aste-20251231.htm","q":"This foundation of connected equipment positions us to develop advanced digital capabilities including digital twins and future innovations in robotics, machine learning and artificial intelligence."}]},{"cik":793171,"name":"VITRO BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001011034-15-000022","doc":"vitro10k2014v10clean.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-004126","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-003942","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-006592","doc":"form10-k.htm","q":null}]},{"cik":794170,"name":"TOLL BROTHERS, INC.","industry":"Construction","sic":1531,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000794170-15-000059","doc":"tol-20151031x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000794170-16-000131","doc":"tol-20161031x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000794170-17-000065","doc":"tol-20171031x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000794170-18-000055","doc":"tol-20181031x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000794170-19-000067","doc":"tol-20191031x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000794170-20-000066","doc":"tol-20201031.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000794170-21-000079","doc":"tol-20211031.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000794170-22-000049","doc":"tol-20221031.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000794170-23-000066","doc":"tol-20231031.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000794170-24-000051","doc":"tol-20241031.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000794170-25-000112","doc":"tol-20251031.htm","q":null}]},{"cik":794367,"name":"MACY'S, INC.","industry":"Retail","sic":5311,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000794367-15-000073","doc":"m-0131201510k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000794367-16-000221","doc":"m-0130201610k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000794367-17-000041","doc":"m-0128201710k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000794367-18-000036","doc":"m-0203201810k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000794367-19-000038","doc":"m-0202201910xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000794367-20-000040","doc":"m-0201202010xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016119","doc":"m-10k_20210130.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011726","doc":"m-10k_20220129.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009154","doc":"m-20230128.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001628280-24-012734","doc":"m-20240203.htm","q":"These investments involve replacing existing systems, some of which are older, legacy systems, outsourcing certain technology and business processes to third-party service providers, including the adoption of Generative AI in certain proces\u2026"},{"fy":2024,"lvl":3,"n":15,"adsh":"0001628280-25-014315","doc":"m-20250201.htm","q":"These investments involve replacing existing systems, some of which are older, legacy systems, outsourcing certain technology and business processes to third-party service providers, including the adoption of Generative artificial intellige\u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001628280-26-021721","doc":"m-20260131.htm","q":"We are applying artificial intelligence to how customers discover, shop and engage with our brands through intelligent shopping assistance, agentic commerce and hyper-personalized experience."}]},{"cik":795266,"name":"KB HOME","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000795266-15-000006","doc":"kbh-11302014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000795266-16-000089","doc":"kbh-11302015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000795266-17-000006","doc":"kbh-11302016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000795266-18-000005","doc":"kbh-11302017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000795266-19-000005","doc":"kbh-11302018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000795266-20-000007","doc":"kbh-11302019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000795266-21-000012","doc":"kbh-20201130.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0000795266-22-000010","doc":"kbh-20211130.htm","q":"We rely on artificial intelligence, machine learning computer network monitoring and antivirus resources, firewall and intrusion detection systems, vendor cloud service defenses, Internet address and content filtering monitoring software th\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000795266-23-000009","doc":"kbh-20221130.htm","q":"We rely on artificial intelligence, machine learning computer network monitoring, malware and antivirus resources, firewall and intrusion detection systems, vendor cloud service defenses, Internet address and content filtering monitoring so\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000795266-24-000008","doc":"kbh-20231130.htm","q":"To help counter the growing volume and sophistication of cyberattacks, including the potential of fraudulently inducing our employees, customers, trade partners and other third parties to disclose information or unknowingly provide access t\u2026"},{"fy":2024,"lvl":2,"n":5,"adsh":"0000795266-25-000014","doc":"kbh-20241130.htm","q":"To help counter the growing volume and sophistication of cyberattacks, including the potential of fraudulently inducing our employees, customers, trade partners and other third parties to disclose information or unknowingly provide access t\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0000795266-26-000017","doc":"kbh-20251130.htm","q":"To help counter the growing volume and sophistication of cyberattacks and other attempts to gain unauthorized access to sensitive business or individuals\u2019 personal information, including the potential of fraudulent schemes inducing our empl\u2026"}]},{"cik":796343,"name":"ADOBE INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":2,"adsh":"0000796343-15-000022","doc":"adbe10kfy14.htm","q":"Prior to joining Adobe, he served as a Principal Scientist and Director of the Applied Artificial Intelligence (AI) group at LNK Corp."},{"fy":2015,"lvl":0,"n":0,"adsh":"0000796343-16-000224","doc":"adbe10kfy15.htm","q":null},{"fy":2016,"lvl":2,"n":6,"adsh":"0000796343-17-000031","doc":"adbe10kfy16.htm","q":"Adobe Sensei leverages machine learning, artificial intelligence (AI) and deep learning capabilities to tackle today\u2019s complex creative experience challenges."},{"fy":2017,"lvl":2,"n":7,"adsh":"0000796343-18-000015","doc":"adbe10kfy17.htm","q":"Adobe Sensei leverages Adobe\u2019s massive content and data assets, as well as its deep domain expertise in the creative, marketing and document segments, within a unified artificial intelligence (\u201cAI\u201d) and machine learning framework to tackle \u2026"},{"fy":2018,"lvl":3,"n":19,"adsh":"0000796343-19-000019","doc":"adbe10kfy18.htm","q":"Adobe Sensei leverages Adobe\u2019s massive content and data assets, as well as its deep domain expertise in the creative, marketing and document segments, within a unified artificial intelligence (\u201cAI\u201d) and machine learning framework to help cu\u2026"},{"fy":2019,"lvl":3,"n":36,"adsh":"0000796343-20-000013","doc":"adbe10kfy19.htm","q":"Adobe Sensei leverages Adobe\u2019s massive content and data assets, as well as its deep domain expertise in the creative, marketing and document segments, within a unified artificial intelligence (\u201cAI\u201d) and machine learning framework to help cu\u2026"},{"fy":2020,"lvl":3,"n":49,"adsh":"0000796343-21-000004","doc":"adbe-20201127.htm","q":"Underpinning Adobe Experience Cloud is our Adobe Experience Platform, which provides businesses and brands with an open and extensible platform for customer experience management that transforms customer data into real-time robust customer \u2026"},{"fy":2021,"lvl":3,"n":45,"adsh":"0000796343-22-000032","doc":"adbe-20211203.htm","q":"The foundation of our offering is Adobe Experience Platform, which provides businesses and brands with an open and extensible system for customer experience management that transforms customer data into robust customer profiles that update \u2026"},{"fy":2022,"lvl":3,"n":58,"adsh":"0000796343-23-000007","doc":"adbe-20221202.htm","q":"The foundation of our offering is Adobe Experience Platform, which provides businesses and brands with an open and extensible system for customer experience management that transforms customer data into robust customer profiles that update \u2026"},{"fy":2023,"lvl":3,"n":146,"adsh":"0000796343-24-000006","doc":"adbe-20231201.htm","q":"We are also empowering creators by putting the power of artificial intelligence (\u201cAI\u201d) in their hands, and doing so in ways we believe are responsible."},{"fy":2024,"lvl":3,"n":195,"adsh":"0000796343-25-000004","doc":"adbe-20241129.htm","q":"We are also empowering creators by putting the power of artificial intelligence (\u201cAI\u201d) in their hands, and doing so in ways we believe are responsible."},{"fy":2025,"lvl":3,"n":190,"adsh":"0000796343-26-000003","doc":"adbe-20251128.htm","q":"In the artificial intelligence (\u201cAI\u201d) era, we are harnessing the power of AI across our solutions by bringing together our commercially safe first-party and leading partner AI models best suited for the job; deploying conversational and age\u2026"}]},{"cik":797542,"name":"VIEWBIX INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004372","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-006123","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-007150","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":3,"n":17,"adsh":"0001493152-23-008765","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":3,"n":47,"adsh":"0001493152-24-011132","doc":"form10-k.htm","q":"If we cannot compete effectively in this market, our revenues are likely to decline; and \u25cf Our implementation and use of artificial intelligence technologies may not be successful, which may impair our ability to compete effectively, result\u2026"},{"fy":2024,"lvl":3,"n":60,"adsh":"0001493152-25-011100","doc":"form10-k.htm","q":"If we cannot compete effectively in this market, our revenues are likely to decline; and \u25cf Our implementation and use of artificial intelligence technologies may not be successful, which may impair our ability to compete effectively, result\u2026"},{"fy":2025,"lvl":3,"n":62,"adsh":"0001493152-26-013205","doc":"form10-k.htm","q":"If we cannot compete effectively in this market, our revenues are likely to decline. \u25cf Our implementation and use of artificial intelligence technologies may not be successful, which may impair our ability to compete effectively, result in \u2026"}]},{"cik":797564,"name":"HST GLOBAL, INC.","industry":"Pharma & biotech","sic":2834,"state":"VA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001360865-16-000021","doc":"hstc10k2015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001674796-17-000002","doc":"hstc10k2016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001674796-18-000005","doc":"hstc10k2017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001674796-19-000049","doc":"hstc-20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001674796-20-000011","doc":"hstc-20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001674796-21-000012","doc":"hstc-20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001674796-22-000007","doc":"hstc-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001674796-23-000007","doc":"hstc-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001674796-24-000003","doc":"hstc-20231231.htm","q":null}]},{"cik":799292,"name":"M/I HOMES, INC.","industry":"Construction","sic":1531,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000799292-15-000009","doc":"mho-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000799292-16-000048","doc":"mho-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000799292-17-000004","doc":"mho-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000799292-18-000009","doc":"mho-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000799292-19-000008","doc":"mho-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000799292-20-000033","doc":"mho-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000799292-21-000032","doc":"mho-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000799292-22-000006","doc":"mho-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000799292-23-000037","doc":"mho-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000799292-24-000014","doc":"mho-20231231.htm","q":"In addition, breaches of our information technology systems or data security systems, including cyberattacks and malicious uses of artificial intelligence, could result in the unintended and/or unauthorized public disclosure or the misappro\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000799292-25-000018","doc":"mho-20241231.htm","q":"In addition, breaches of our information technology systems or data security systems, including cyberattacks and malicious uses of artificial intelligence, could result in the unintended and/or unauthorized public disclosure or the misappro\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0000799292-26-000006","doc":"mho-20251231.htm","q":"In addition, breaches of our information technology systems or data security systems, including cyberattacks and malicious uses of artificial intelligence, could result in the unintended and/or unauthorized public disclosure or the misappro\u2026"}]},{"cik":799698,"name":"LADRX CORP","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000799698-15-000004","doc":"form10k_2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000799698-16-000030","doc":"form10-k_2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000799698-17-000012","doc":"2016_form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000799698-18-000002","doc":"form10-k_2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004165","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004848","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006668","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-007485","doc":"form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-008173","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-011377","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001038","doc":"form10-k.htm","q":null}]},{"cik":799729,"name":"PAREXEL INTERNATIONAL CORP","industry":"Pharma & biotech","sic":8731,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000799729-15-000026","doc":"a201510-kdoc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000799729-17-000044","doc":"a201710-kdoc.htm","q":null}]},{"cik":802257,"name":"MITESCO, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2025,"lvl":"x","n":22,"adsh":"0001185185-26-001385","doc":"miti10k123125.htm","q":"We have retained experienced professionals in the data center, cyber security and infrastructure services areas to support our needs on a per hour basis, which we believe will allow us to control our costs relative to business activity, wit\u2026"}]},{"cik":802724,"name":"INSITE VISION INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-052755","doc":"d841402d10k.htm","q":null}]},{"cik":803578,"name":"FIREFLY NEUROSCIENCE, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001269","doc":"iaic_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001354488-16-006739","doc":"iaic_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002922","doc":"iaic_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-003467","doc":"iaic_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-003832","doc":"iaic_10k.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001437749-20-006517","doc":"iaic20191231_10k.htm","q":"RPA is a relatively new field, using artificial intelligence to automate high-volume repetitive human processes, such as calculations, report generation and distribution, recording transactions, and maintenance of records."},{"fy":2020,"lvl":2,"n":5,"adsh":"0001437749-21-007829","doc":"iaic20201231_10k.htm","q":"Gaining entry into new markets for services offerings such as cybersecurity, cloud services, and artificial intelligence may prove to be unsuccessful."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001437749-22-008763","doc":"iaic20211231_10k.htm","q":"We offer a standard user interface (UI) and user experience (UX) to our customer but have and will continue to offer customized solutions in the defense and intelligence sectors. 7 Our blockchain products are currently deployed in support o\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-010426","doc":"iaic20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":2,"adsh":"0001437749-24-008626","doc":"wavd20231231_10k.htm","q":"Upon closing of the Merger, the combined company will focus on continuing to develop and commercialize Firefly\u2019s Artificial Intelligence driven Brain Network Analytics (BNA\u2122) platform, which was previously cleared by the U.S."},{"fy":2024,"lvl":"x","n":49,"adsh":"0001437749-25-010818","doc":"wavd20241231c_10k.htm","q":"Overview We are an Artificial Intelligence (\u201cAI\u201d) technology company developing innovative neuroscientific solutions with goals to improve brain health outcomes for patients with mental illnesses and neurological disorders."},{"fy":2025,"lvl":3,"n":46,"adsh":"0001437749-26-010500","doc":"aiff20251231_10k.htm","q":"Overview Firefly Neuroscience, Inc. is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual pat\u2026"}]},{"cik":803647,"name":"VERSAR INC","industry":"Construction","sic":8711,"state":"VA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-054941","doc":"v419221_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-002577","doc":"versar_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-17-008786","doc":"a10k_v1.htm","q":null}]},{"cik":805326,"name":"EMISPHERE TECHNOLOGIES INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-114309","doc":"d868964d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-521621","doc":"d123580d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001193125-17-104157","doc":"d317190d10k.htm","q":null}]},{"cik":806592,"name":"SUNWIN STEVIA INTERNATIONAL, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001448788-15-000039","doc":"suwn10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001448788-16-000142","doc":"suwn10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001448788-17-000028","doc":"suwn10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001448788-18-000010","doc":"suwn10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001448788-19-000019","doc":"suwn10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001448788-20-000009","doc":"suwn10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001448788-21-000015","doc":"suwn10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000806592-22-000024","doc":"suwn-20220430.htm","q":null}]},{"cik":808047,"name":"QKL STORES INC.","industry":"Retail","sic":5411,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-022836","doc":"v406753_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-094388","doc":"v436569_10k.htm","q":null}]},{"cik":808326,"name":"EMCORE CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000808326-15-000038","doc":"fy15-form10xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000808326-16-000081","doc":"fy16q4-form10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000808326-17-000031","doc":"fy17q4-form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0000808326-18-000031","doc":"fy18q4-form10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000808326-19-000055","doc":"fy19q4-form10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-20-014229","doc":"tmb-20200930x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000808326-21-000044","doc":"emkr-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000808326-22-000061","doc":"emkr-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000808326-23-000031","doc":"emkr-20230930.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000808326-25-000007","doc":"emkr-20240930.htm","q":null}]},{"cik":808450,"name":"NAVISTAR INTERNATIONAL CORP","industry":"Auto manufacturing","sic":3711,"state":"IL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000808450-15-000065","doc":"nav10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000808450-16-000140","doc":"nav10k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000808450-17-000140","doc":"nav10k2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000808450-18-000227","doc":"nav10k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000808450-19-000241","doc":"nav10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000808450-20-000105","doc":"nav10k2020.htm","q":null}]},{"cik":809933,"name":"ECOLOGY & ENVIRONMENT INC","industry":"Construction","sic":8711,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-15-038953","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-16-086821","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-17-042686","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-010211","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-19-019331","doc":"form10k.htm","q":null}]},{"cik":810136,"name":"PHOTRONICS INC","industry":"Computers & chips","sic":3674,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-000753","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-047150","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-000934","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-17-046903","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-18-045611","doc":"s002591x1_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-19-023041","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-001225","doc":"brhc10018426_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-21-042251","doc":"brhc10031689_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-22-046880","doc":"brhc10045687_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-23-059254","doc":"ef20012464_10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001140361-24-049881","doc":"ef20035608_10k.htm","q":"End markets served with IC photomasks include devices used for artificial intelligence, cloud computing, microprocessors, memory, telecommunications, internet connected devices, automotive, industrial and other applications."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001140361-25-045801","doc":"ef20057458_10k.htm","q":"In addition, we note the role AI is playing in driving the technology roadmap for IC devices and our technology program covers multiple initiatives to deliver AI grade photomasks in IC and advanced packaging applications."}]},{"cik":811156,"name":"CMS ENERGY CORP","industry":"Utilities","sic":4931,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-006843","doc":"a15-1932_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-095725","doc":"a15-23273_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-006823","doc":"a17-1055_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-009493","doc":"a18-1030_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000811156-19-000003","doc":"consumersenergy10k12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000811156-20-000004","doc":"a2019form10-kxcmsenerg.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000811156-21-000016","doc":"cms-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000811156-22-000048","doc":"cms-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000811156-23-000014","doc":"cms-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000811156-24-000044","doc":"cms-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000811156-25-000036","doc":"cms-20241231.htm","q":"Rapid expansion of data centers associated with increasing demand for cloud services, artificial intelligence, and other applications could lead to an unprecedented increase in demand for electric power in MISO and in Consumers\u2019 service ter\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0000811156-26-000004","doc":"cms-20251231.htm","q":"Rapid expansion of data centers associated with increasing demand for cloud services, artificial intelligence, and other applications could lead to an unprecedented increase in demand for electric power in MISO and in Consumers\u2019 service ter\u2026"}]},{"cik":811779,"name":"MULTICELL TECHNOLOGIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"RI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-013227","doc":"v401910_10k.htm","q":null}]},{"cik":812149,"name":"4NET SOFTWARE INC","industry":"Software & IT services","sic":7370,"state":"CT","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-074455","doc":"v427429_10k.htm","q":null}]},{"cik":812306,"name":"PROCYON CORP","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001000096-15-000074","doc":"procyon6302015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001021890-16-000039","doc":"procyon10k2016.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-18-017541","doc":"pcyn20180630_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-19-019252","doc":"pcyn20190630_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001437749-20-020789","doc":"pcyn20200630_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001437749-21-023489","doc":"pcyn20210630_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001437749-22-023194","doc":"pcyn20220630_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-23-027045","doc":"pcyn20230630_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001437749-24-032155","doc":"pcyn20240630_10k.htm","q":null}]},{"cik":812796,"name":"SOLIGENIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002035","doc":"f10k2014_soligenixinc.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-011833","doc":"f10k2015_soligenixinc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-002845","doc":"f10k2016_soligenixinc.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003007","doc":"f10k2017_soligenixinc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004865","doc":"f10k2018_soligenixinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-007959","doc":"f10k2019_soligenixinc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018698","doc":"f10k2020_soligenix.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004605","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005304","doc":"sngx-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-003402","doc":"sngx-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001558370-25-003459","doc":"sngx-20241231x10k.htm","q":null},{"fy":2025,"lvl":"x","n":15,"adsh":"0001104659-26-037701","doc":"sngx-20251231x10k.htm","q":"If any of our key technology fails, our business could be adversely affected. \u25cf Our use of generative artificial intelligence tools in our operations may expose us to risks related to confidentiality, accuracy, regulatory compliance and int\u2026"}]},{"cik":813672,"name":"CADENCE DESIGN SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000813672-15-000008","doc":"cdns0103201510-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000813672-16-000040","doc":"cdns0102201610-k.htm","q":null},{"fy":2016,"lvl":1,"n":2,"adsh":"0000813672-17-000006","doc":"cdns1231201610-k.htm","q":"New categories of electronic systems, such as augmented reality, virtual reality, internet-of-things, or IoT, deep learning and autonomous vehicle sub-systems represent a few of the areas for potential increased investment by our customers."},{"fy":2017,"lvl":1,"n":2,"adsh":"0000813672-18-000008","doc":"cdns1230201710-k.htm","q":"The most promising new opportunities for us involve enabling the design of electronic systems for machine learning, augmented reality, virtual reality, internet-of-things, aerospace and defense and autonomous vehicle sub-systems."},{"fy":2018,"lvl":2,"n":9,"adsh":"0000813672-19-000008","doc":"cdns1229201810-k.htm","q":"Our electronic systems customers deliver entire devices, such as smartphones, laptop computers, gaming systems, automobiles and autonomous driving, servers, cloud datacenter infrastructure, artificial intelligence (\u201cAI\u201d) systems, aerospace \u2026"},{"fy":2019,"lvl":2,"n":10,"adsh":"0000813672-20-000007","doc":"cdns1228201910-k.htm","q":"Our electronic systems customers deliver entire devices, such as smartphones, laptop computers, gaming systems, automobiles and autonomous driving systems, servers, cloud datacenter infrastructure, artificial intelligence (\u201cAI\u201d) systems, ae\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0000813672-21-000009","doc":"cdns-20210102.htm","q":"Our electronic systems customers deliver entire devices, such as smartphones, laptop computers, gaming systems, automobiles and autonomous driving systems, servers, cloud data center infrastructure, artificial intelligence (\u201cAI\u201d) systems, a\u2026"},{"fy":2021,"lvl":2,"n":9,"adsh":"0000813672-22-000012","doc":"cdns-20220101.htm","q":"Our electronic systems customers deliver entire devices, such as smartphones, laptop computers, gaming systems, automobiles and autonomous driving systems, servers, cloud data center infrastructure, artificial intelligence (\u201cAI\u201d) systems, a\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0000813672-23-000011","doc":"cdns-20221231.htm","q":"Our electronic systems customers deliver entire devices, such as smartphones, laptop computers, gaming systems, automobiles and autonomous driving systems, servers, cloud data center infrastructure, artificial intelligence (\u201cAI\u201d) systems, a\u2026"},{"fy":2023,"lvl":3,"n":53,"adsh":"0000813672-24-000034","doc":"cdns-20231231.htm","q":"We are a global company that provides computational software, special-purpose computational hardware, IP and services to multiple vertical sectors including automotive, artificial intelligence (\u201cAI\u201d), aerospace and defense, high-performance\u2026"},{"fy":2024,"lvl":3,"n":96,"adsh":"0000813672-25-000024","doc":"cdns-20241231.htm","q":"Statements including, but not limited to, statements regarding the horizons of artificial intelligence (\u201cAI\"), other technological and market advancements and their impacts on our business; the extent, timing and mix of future revenues and \u2026"},{"fy":2025,"lvl":3,"n":116,"adsh":"0000813672-26-000016","doc":"cdns-20251231.htm","q":"Statements including, but not limited to, statements regarding artificial intelligence (\u201cAI\"), other technological and market advancements and their impacts on our business; the extent, timing and mix of future revenues and customer demand;\u2026"}]},{"cik":813762,"name":"ICAHN ENTERPRISES L.P.","industry":"Auto manufacturing","sic":3714,"state":"FL","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0000813762-17-000010","doc":"a10k-fy2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000813762-18-000029","doc":"a10k-fy2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000813762-19-000006","doc":"a10k-fy2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000813762-20-000008","doc":"iep-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002010","doc":"tmb-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002150","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-002068","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-002090","doc":"tmb-20231231x10k.htm","q":"Moreover, cyberattacks are expected to accelerate on a global basis in both frequency and magnitude as threat actors are becoming increasingly sophisticated in using techniques and tools (including artificial intelligence) that circumvent c\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001558370-25-001612","doc":"tmb-20241231x10k.htm","q":"Moreover, cyberattacks are expected to accelerate on a global basis in both frequency and magnitude as threat actors are becoming increasingly sophisticated in using techniques and tools (including artificial intelligence) that circumvent c\u2026"}]},{"cik":814046,"name":"ALP LIQUIDATING TRUST","industry":"Construction","sic":1531,"state":"IL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000892626-15-000083","doc":"alp-k14.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000892626-16-000411","doc":"alp-k20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000892626-17-000039","doc":"alp10k16.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000892626-18-000046","doc":"alp10k-20171231.htm","q":null}]},{"cik":816284,"name":"CELGENE CORP /DE/","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-000889","doc":"a2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011012","doc":"a2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000816284-17-000003","doc":"a2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000816284-18-000005","doc":"a2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000816284-19-000014","doc":"a2018123110-k.htm","q":null}]},{"cik":816761,"name":"TERADATA CORP /DE/","industry":"Computers & chips","sic":3571,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000816761-15-000008","doc":"0000816761-15-000008.txt","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000816761-16-000045","doc":"tdc-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000816761-17-000010","doc":"tdc-123116x10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0000816761-18-000007","doc":"tdc-123117x10k.htm","q":"We work with our customers enabling them to leverage data and analytics to drive business outcomes such as, but not limited to: \u2022 Improving a customer\u2019s experience through understanding behavioral patterns, 4 Table of Contents \u2022 Driving fin\u2026"}]},{"cik":816761,"name":"TERADATA CORP /DE/","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":1,"n":1,"adsh":"0000816761-19-000010","doc":"tdc-123118x10k.htm","q":"We work with our customers to enable them to optimize the value of their data and analytics to get answers to their toughest business challenges and drive business outcomes, which can include, among other things: \u2022 Improving customer experi\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0000816761-20-000008","doc":"tdc-12311910xk.htm","q":"We work with our customers to enable them to optimize the value of their data and analytics to get answers to their toughest business challenges and drive business outcomes, which can include, among other things: \u2022 Improving customer experi\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0000816761-21-000009","doc":"tdc-20201231.htm","q":"These combined capabilities enable companies to reduce complexity, risk, and cost, while leveraging data as an asset in solving their business challenges and driving business outcomes, which can include, among other things: \u2022 Improving cust\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0000816761-22-000009","doc":"tdc-20211231.htm","q":"With a focus on opening up the platform, we are building out deep integration with cloud data and analytic ecosystems, including advanced analytics and artificial intelligence tools."},{"fy":2022,"lvl":2,"n":7,"adsh":"0000816761-23-000008","doc":"tdc-20221231.htm","q":"Our customers use Teradata \u00ae technologies and innovations in leveraging data to solve their business challenges and drive business outcomes, which can include, among other things: \u2022 digital identity management, \u2022 financial visibility, \u2022 res\u2026"},{"fy":2023,"lvl":3,"n":89,"adsh":"0000816761-24-000023","doc":"tdc-20231231.htm","q":"That is why we built our open and connected cloud analytics and data platform for artificial intelligence (\"AI\")."},{"fy":2024,"lvl":3,"n":123,"adsh":"0000816761-25-000027","doc":"tdc-20241231.htm","q":"That is why we built our open and connected hybrid cloud analytics and data platform for AI."},{"fy":2025,"lvl":3,"n":127,"adsh":"0001628280-26-012671","doc":"tdc-20251231.htm","q":"In the agentic future, AI agents have enterprise context, can act on it in milliseconds and address continuous decisions at enterprise scale."}]},{"cik":817720,"name":"SYNAPTICS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-18-022311","doc":"syna-10k_20180630.htm","q":"The technology embodies a broad range of analog and mixed signal circuits expertise and audio signal processing algorithms, including: \u2022 Noise suppression; \u2022 Acoustic echo cancellation; \u2022 De-reverberation; \u2022 Active noise cancellation; \u2022 Spe\u2026"},{"fy":2019,"lvl":2,"n":9,"adsh":"0001564590-19-032908","doc":"syna-10k_20190629.htm","q":"Our Edge SOCs enable secure artificial intelligence processing on device, for enhanced privacy and responsiveness."},{"fy":2020,"lvl":3,"n":17,"adsh":"0001564590-20-040946","doc":"syna-10k_20200627.htm","q":"Our extensive array of technologies includes chips, firmware, software, mechanical and electrical designs, artificial intelligence, or AI, and algorithm-based pattern recognition, multi-finger touch-sensing technologies, advanced noise miti\u2026"},{"fy":2021,"lvl":3,"n":25,"adsh":"0001564590-21-045326","doc":"syna-10k_20210626.htm","q":"We deliver complete chip, firmware and software semiconductor solutions that include connectivity products, audio input and output System-On-Chips, or SoCs, high-definition video and vision SoCs, SoCs with artificial intelligence capabiliti\u2026"},{"fy":2022,"lvl":3,"n":20,"adsh":"0000950170-22-017628","doc":"syna-20220625.htm","q":"Within the fast-growing consumer IoT market, we continue to expand our footprint in various devices by bringing converged video, vision, audio, and voice technologies coupled with artificial intelligence and wireless connectivity capabiliti\u2026"},{"fy":2023,"lvl":3,"n":26,"adsh":"0000950170-23-043521","doc":"syna-20230624.htm","q":"We supply connectivity, sensors, and AI-enhanced processor solutions to original equipment manufacturers, or OEMs, that design Internet of Things (IoT) products and devices for automobiles, virtual reality, smartphones, tablets, and noteboo\u2026"},{"fy":2024,"lvl":3,"n":35,"adsh":"0000950170-24-100261","doc":"syna-20240629.htm","q":"We supply connectivity, sensors, and artificial intelligence, or AI, enhanced processor solutions to original equipment manufacturers, or OEMs, that design IoT products and devices for automobiles, enterprise workspace devices, virtual real\u2026"},{"fy":2025,"lvl":3,"n":43,"adsh":"0000817720-25-000073","doc":"syna-20250628.htm","q":"BUSINESS Overview Synaptics designs and delivers AI-enabled edge solutions that bring AI closer to end users and transform how we engage with intelligent connected devices, whether at home, at work or on the move."}]},{"cik":817720,"name":"SYNAPTICS INC","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-15-007555","doc":"syna-10k_20150627.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-16-024739","doc":"syna-10k_20160625.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-017839","doc":"syna-10k_20170624.htm","q":null}]},{"cik":817979,"name":"ACCURIDE CORP","industry":"Auto manufacturing","sic":3714,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000817979-15-000010","doc":"acw14-410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000817979-16-000058","doc":"acw15-410k.htm","q":null}]},{"cik":818033,"name":"HERON THERAPEUTICS, INC. /DE/","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001193125-15-091072","doc":"d888999d10k.htm","q":"(Incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.24* Executive Employment Agreement, dated May 1, 2013, by and between the Company and Robert H\u2026"},{"fy":2015,"lvl":1,"n":1,"adsh":"0001193125-16-469890","doc":"d126077d10k.htm","q":"(Incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 96 Table of Contents Exhibit Document Description 10.23* Executive Employment Agreement, dated Ma\u2026"},{"fy":2016,"lvl":1,"n":1,"adsh":"0001193125-17-054088","doc":"d347497d10k.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.20* Executive Employment Agreement, dated May 1, 2013, by and between the Company and Robert H\u2026"},{"fy":2017,"lvl":1,"n":1,"adsh":"0001193125-18-060951","doc":"d530534d10k.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.18* Executive Employment Agreement, dated May 1, 2013, by and between the Company and Robert H\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001193125-19-047780","doc":"d697177d10k.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.18* Executive Employment Agreement, dated May 1, 2013, by and between the Company and Robert H\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-007973","doc":"hrtx-10k_20191231.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.18* Executive Employment Agreement, dated May 1, 2013, by and between the Company and Robert H\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-007841","doc":"hrtx-10k_20201231.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.15 Form of Non-Qualified Stock Option Agreement (incorporated by reference to our Quarterly Re\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-007618","doc":"hrtx-10k_20211231.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.8 Form of Non-Qualified Stock Option Agreement (incorporated by reference to our Quarterly Rep\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-010603","doc":"hrtx-20221231.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.8 Form of Non-Qualified Stock Option Agreement (incorporated by reference to our Quarterly Rep\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-029951","doc":"hrtx-20231231.htm","q":"(incorporated by reference to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, as Exhibit 10-AI, filed on May 10, 2013) 10.8 Form of Non-Qualified Stock Option Agreement (incorporated by reference to our Quarterly Rep\u2026"},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-028374","doc":"0000950170-25-028374.txt","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-073515","doc":"hrtx-20251231.htm","q":null}]},{"cik":818686,"name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-18-039076","doc":"d529462d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-043564","doc":"d613675d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-044221","doc":"d852939d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-036239","doc":"d102112d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-032667","doc":"d130792d10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001193125-23-031250","doc":"d443725d10k.htm","q":"Additionally, we may be subject in the future to various new national, regional and local laws and regulations, such as the NIS2 Directive, the EU Digital Services Act, the European Health Data Space and the EU Artificial Intelligence Regul\u2026"},{"fy":2023,"lvl":2,"n":6,"adsh":"0001193125-24-031005","doc":"d600678d10k.htm","q":"In 2023, we introduced a new talent development system based on artificial intelligence (\u201cAI\u201d) capabilities to match employee skills with development opportunities across the company."},{"fy":2024,"lvl":2,"n":14,"adsh":"0001193125-25-020826","doc":"d865574d10k.htm","q":"In 2023, we introduced a new talent development system based on artificial intelligence (\u201cAI\u201d) capabilities to match employee skills with development opportunities across the company."},{"fy":2025,"lvl":3,"n":37,"adsh":"0001193125-26-034532","doc":"d93612d10k.htm","q":"Artificial Intelligence Initiatives We are committed to integrating, where appropriate, artificial intelligence (\u201cAI\u201d) technologies in our operations, in an effort to deliver innovative solutions to our customers, patients and stakeholders."}]},{"cik":819050,"name":"FRESH TRACKS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065997","doc":"d839151d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014677","doc":"vicl-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003970","doc":"vicl-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005853","doc":"vicl-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005633","doc":"vicl-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000819050-20-000043","doc":"a20191231-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000819050-21-000029","doc":"bbi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000819050-22-000016","doc":"bbi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000819050-23-000037","doc":"frtx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-011460","doc":"frtx-20231231.htm","q":null}]},{"cik":819690,"name":"FUQUAN FINANCIAL CO","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-19-000826","doc":"form10-k.htm","q":null}]},{"cik":820081,"name":"CAMBREX CORP","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-004505","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-024955","doc":"cbm20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-001571","doc":"cbm20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-001987","doc":"cbm20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-002751","doc":"cbm-10k_20181231.htm","q":null}]},{"cik":820380,"name":"INTERNATIONAL AUTOMATED SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001551163-15-000167","doc":"f10kdec312014draft4vedgar3.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001551163-16-000317","doc":"v7edgarreview201510k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001551163-17-000082","doc":"wordv1form10kforapproval0419.htm","q":null}]},{"cik":820738,"name":"TIGERLOGIC CORP","industry":"Software & IT services","sic":7372,"state":"OR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-046189","doc":"a15-7434_110k.htm","q":null}]},{"cik":821995,"name":"JUNIPER PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-096081","doc":"d849346d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500029","doc":"d275921d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003520","doc":"jnp-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005087","doc":"jnp-10k_20171231.htm","q":null}]},{"cik":822370,"name":"EMMAUS LIFE SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-21-001977","doc":"emma-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-022930","doc":"emma-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-013054","doc":"emma-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011328","doc":"emma-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-080918","doc":"emma-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-053744","doc":"emma-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-132925","doc":"emma-20251231.htm","q":null}]},{"cik":822411,"name":"IMMUNOCELLULAR THERAPEUTICS, LTD.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001446","doc":"imuc-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-013931","doc":"imuc-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002439","doc":"imuc-123116x10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0000822411-18-000004","doc":"imuc-123117x10k.htm","q":null}]},{"cik":822416,"name":"PULTEGROUP INC/MI/","industry":"Construction","sic":1531,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000822416-15-000007","doc":"a201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000822416-16-000048","doc":"a201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000822416-17-000008","doc":"a201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000822416-18-000009","doc":"a201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000822416-19-000008","doc":"a201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000822416-20-000007","doc":"a201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000822416-21-000007","doc":"phm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000822416-22-000007","doc":"phm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000822416-23-000007","doc":"phm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000822416-24-000010","doc":"phm-20231231.htm","q":"In particular, the frequency, severity and novelty of cyber-attacks on companies has increased in recent years, including significant ransomware attacks and foreign attacks on prominent companies and computer software programs, as threat ac\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0000822416-25-000007","doc":"phm-20241231.htm","q":"An inability to accurately predict customer preferences or demand, or to respond effectively to technological developments, including artificial intelligence, could materially impact the business."},{"fy":2025,"lvl":2,"n":13,"adsh":"0000822416-26-000007","doc":"phm-20251231.htm","q":"An inability to accurately predict customer preferences or demand, or to respond effectively to technological developments, including artificial intelligence, could materially impact the business."}]},{"cik":823546,"name":"ROCKETFUEL BLOCKCHAIN, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001556244-19-000072","doc":"rkfl-20190331.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-011893","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-017524","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-019346","doc":"form10-k.htm","q":null}]},{"cik":827052,"name":"EDISON INTERNATIONAL","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000827052-15-000035","doc":"eix-sce201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000827052-16-000222","doc":"eix-sce201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000827052-17-000033","doc":"eix-sce201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000827052-18-000046","doc":"eix-sce201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000827052-19-000034","doc":"eix-sceq4201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000827052-20-000026","doc":"eix-sceq4201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000827052-21-000019","doc":"eix-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000827052-22-000006","doc":"eix-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000827052-23-000010","doc":"eix-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000827052-24-000013","doc":"eix-20231231x10k.htm","q":"SCE's current security controls and defenses may also not protect against insider threats, including deliberate and unintentional actions (e.g., human error) and other emerging cybersecurity risks created by artificial intelligence, quantum\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000827052-25-000022","doc":"eix-20241231.htm","q":"SCE's current security controls and defenses may also not protect against insider threats, including deliberate and unintentional actions (e.g., human error) and other emerging cybersecurity risks created by artificial intelligence, quantum\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0000827052-26-000012","doc":"eix-20251231.htm","q":"SCE's current security controls and defenses may also not protect against insider threats, including deliberate and unintentional actions (e.g., human error) and other emerging cybersecurity risks created by artificial intelligence, quantum\u2026"}]},{"cik":827054,"name":"MICROCHIP TECHNOLOGY INC","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000827054-15-000103","doc":"a2015-03x3110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000827054-16-000344","doc":"a2016-03x3110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000827054-17-000098","doc":"a2017-03x3110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-006982","doc":"a2018-03x3110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000827054-19-000143","doc":"a2019-03x3110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000827054-20-000119","doc":"a2020-03x3110k.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0000827054-21-000106","doc":"mchp-20210331.htm","q":"Our synergistic product portfolio empowers disruptive growth trends, including 5G, artificial intelligence and machine learning, Internet of Things (IoT), advanced driver assist systems (ADAS) and autonomous driving, and electric vehicles, \u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0000827054-22-000094","doc":"mchp-20220331.htm","q":"Our synergistic product portfolio empowers disruptive growth trends, including 5G, data centers, artificial intelligence and machine learning, Internet of Things (IoT) and edge computing, advanced driver assist systems (ADAS) and autonomous\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0000827054-23-000080","doc":"mchp-20230331.htm","q":null},{"fy":2023,"lvl":3,"n":26,"adsh":"0000827054-24-000098","doc":"mchp-20240331.htm","q":"Also, as AI continues to evolve, cyber-attackers could use AI to develop malicious code, sophisticated phishing attempts, and convincing deep fakes."},{"fy":2024,"lvl":3,"n":36,"adsh":"0000827054-25-000077","doc":"mchp-20250331.htm","q":"Our synergistic product portfolio empowers disruptive growth trends, including AI/ML, data centers, edge computing and Internet of Things (IoT), E-mobility, networking and connectivity, and sustainability in key end markets such as automoti\u2026"}]},{"cik":827099,"name":"TETRIDYN SOLUTIONS INC","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":1,"adsh":"0001038838-15-000145","doc":"k123114.htm","q":"We perform advanced data mining and statistical correlation methodologies on a hospital\u2019s chargeable items, while also employing artificial intelligence algorithms, to identify services and materials that were expended but never billed."},{"fy":2015,"lvl":"x","n":1,"adsh":"0001038838-16-000224","doc":"k123115.htm","q":"We perform advanced data mining and statistical correlation methodologies on a hospital\u2019s chargeable items, while also employing artificial intelligence algorithms, to identify services and materials that were expended but never billed."},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-17-000784","doc":"tetridyn_10k-123116.htm","q":null}]},{"cik":827099,"name":"OCEAN THERMAL ENERGY CORP","industry":"Utilities","sic":4931,"state":"PA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003464","doc":"cpwr_form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-003067","doc":"cpwr_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-002880","doc":"cpwr_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003485","doc":"cpwr_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-004084","doc":"cpwr_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-011543","doc":"cpwr_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-24-003883","doc":"cpwr_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001654954-25-012217","doc":"cpwr_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001654954-26-002627","doc":"cpwr_10k.htm","q":null}]},{"cik":827809,"name":"NOVELION THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065836","doc":"d832888d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478534","doc":"d70832d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000827809-17-000012","doc":"nvln-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000827809-18-000006","doc":"nvln-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000827809-19-000005","doc":"nvln-12312018x10k.htm","q":null}]},{"cik":827871,"name":"EAGLE PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000827871-16-000049","doc":"egrx_10kx2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000827871-17-000002","doc":"copyofegrx_10kx2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000827871-18-000003","doc":"egrx_10kx2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000827871-19-000008","doc":"egrx_10kx2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000827871-20-000007","doc":"egrx10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000827871-21-000011","doc":"egrx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000827871-22-000008","doc":"egrx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000827871-23-000009","doc":"egrx-20221231.htm","q":null}]},{"cik":831547,"name":"SPECTRUM PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091493","doc":"d856294d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000831547-16-000059","doc":"sppi-201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000831547-17-000020","doc":"sppi-201610xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000831547-18-000015","doc":"sppi-201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000831547-19-000006","doc":"sppi-201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000831547-20-000009","doc":"sppi-201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000831547-21-000009","doc":"sppi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000831547-22-000014","doc":"sppi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000831547-23-000007","doc":"sppi-20221231.htm","q":null}]},{"cik":831641,"name":"TETRA TECH INC","industry":"Construction","sic":8711,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-008864","doc":"a2226599z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-16-016906","doc":"a2230290z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000831641-17-000022","doc":"ttek-10012017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000831641-18-000097","doc":"tt10-kfy18document.htm","q":null},{"fy":2019,"lvl":2,"n":6,"adsh":"0000831641-19-000193","doc":"tt10-kfy19document.htm","q":"We are Leading with Science throughout our operations, with domain experts across multiple disciplines supported by advanced analytics, artificial intelligence (\"AI\"), machine learning, and digital technology."},{"fy":2020,"lvl":2,"n":7,"adsh":"0000831641-20-000154","doc":"ttek-20200927.htm","q":"We are Leading with Science\u00ae throughout our operations, with domain experts across multiple disciplines supported by our advanced analytics, artificial intelligence (\"AI\"), machine learning, and digital technology solutions."},{"fy":2021,"lvl":2,"n":6,"adsh":"0000831641-21-000110","doc":"ttek-20211003.htm","q":"We are Leading with Science\u00ae throughout our operations, with domain experts across multiple disciplines supported by our advanced analytics, artificial intelligence (\"AI\"), machine learning, and digital technology solutions."},{"fy":2022,"lvl":2,"n":6,"adsh":"0000831641-22-000123","doc":"ttek-20221002.htm","q":"We are Leading with Science\u00ae throughout our operations, with domain experts across multiple disciplines supported by our advanced analytics, artificial intelligence (\"AI\"), machine learning and digital technology solutions."},{"fy":2023,"lvl":2,"n":6,"adsh":"0000831641-23-000082","doc":"ttek-20231001.htm","q":"We are Leading with Science\u00ae throughout our operations, with domain experts across multiple disciplines supported by our advanced analytics, artificial intelligence (\"AI\"), machine learning and digital technology solutions."},{"fy":2024,"lvl":2,"n":12,"adsh":"0000831641-24-000063","doc":"ttek-20240929.htm","q":"We are Leading with Science\u00ae throughout our operations, with domain experts across multiple disciplines supported by our advanced analytics, artificial intelligence (\"AI\"), machine learning and digital technology solutions."},{"fy":2025,"lvl":2,"n":11,"adsh":"0000831641-25-000032","doc":"ttek-20250928.htm","q":"We are Leading with Science\u00ae throughout our operations, with domain experts across multiple disciplines supported by our advanced analytics, artificial intelligence (\"AI\"), machine learning and digital technology solutions."}]},{"cik":832488,"name":"MAM SOFTWARE GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-056353","doc":"v420048_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-016462","doc":"mamsg20170630_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-18-017055","doc":"mamsg20180630_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-19-019219","doc":"mamsg20190630_10ka.htm","q":null}]},{"cik":832489,"name":"GEOVAX LABS, INC.","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-005604","doc":"govx20141231_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-027776","doc":"govx20151231_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001437749-17-005201","doc":"govx20161231_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-005301","doc":"govx20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-005682","doc":"govx20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-006029","doc":"govx20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-006906","doc":"govx20201118_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005677","doc":"govx20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-007636","doc":"govx20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-006086","doc":"govx20231231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001437749-25-009614","doc":"govx20241231_10k.htm","q":null},{"fy":2025,"lvl":"x","n":2,"adsh":"0001437749-26-012377","doc":"govx20251231_10k.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence and machine learning technologies may intensify our information security risks."}]},{"cik":833079,"name":"MERITAGE HOMES CORP","industry":"Construction","sic":1531,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000833079-15-000036","doc":"mth-10kx2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000833079-16-000119","doc":"mth-10kx2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000833079-17-000041","doc":"mth2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000833079-18-000007","doc":"mth2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000833079-19-000035","doc":"mth2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000833079-20-000026","doc":"mth-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000833079-21-000019","doc":"mth-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000833079-22-000011","doc":"mth-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000833079-23-000022","doc":"mth-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000833079-24-000015","doc":"mth-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000833079-25-000021","doc":"mth-20241231.htm","q":"In addition to these strategic initiatives, we also remain committed to the following: \u2022 Achieving or maintaining a top 5 market position in all of our markets; \u2022 Targeting a strong, yet sustainable, orders pace through the use of consumer,\u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0000833079-26-000010","doc":"mth-20251231.htm","q":null}]},{"cik":833640,"name":"POWER INTEGRATIONS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000833640-15-000060","doc":"powi-2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000833640-16-000276","doc":"powi-2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000833640-17-000086","doc":"powi-2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000833640-18-000067","doc":"powi-2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000833640-19-000046","doc":"powi-2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000833640-20-000044","doc":"powi-2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000833640-21-000025","doc":"powi-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000833640-22-000021","doc":"powi-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000833640-23-000025","doc":"powi-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000833640-24-000030","doc":"powi-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000833640-25-000043","doc":"powi-20241231x10k.htm","q":"We expect such applications to include power supplies used in data centers delivering artificial intelligence (AI) services, in communications network infrastructure equipment and in onboard-charging circuitry for EVs, among others."},{"fy":2025,"lvl":2,"n":13,"adsh":"0000833640-26-000037","doc":"powi-20251231x10k.htm","q":"We expect such applications to include power supplies used in data centers delivering artificial intelligence (\u201cAI\u201d) services, in communications network infrastructure equipment and in onboard-charging circuitry for EVs, among others."}]},{"cik":835662,"name":"AIXIN LIFE INTERNATIONAL, INC.","industry":"Retail","sic":5912,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-008775","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-007578","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-010029","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-014773","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-013947","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-008967","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-023606","doc":"form10-k.htm","q":null}]},{"cik":835887,"name":"PROGENICS PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000835887-15-000020","doc":"form10_k12312014.htm","q":null},{"fy":2015,"lvl":1,"n":3,"adsh":"0000835887-16-000131","doc":"form10_k12312015.htm","q":"EXINI has demonstrated experience in the successful development and commercialization of technology for medical image analysis and machine learning, which will provide Progenics with in-house development capabilities in these areas that it \u2026"},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-004174","doc":"prog20161231_10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001437749-18-004205","doc":"prog20171231_10k.htm","q":"We are developing, based on data from our 1404 clinical trials, PSMA computer-assisted diagnostic tools (\u201cPSMA CADx\u201d) that will automate reading of PSMA-targeted SPECT images based on deep learning. \u25cf PyL (also known as [18F]DCFPyL) is a fl\u2026"},{"fy":2018,"lvl":3,"n":17,"adsh":"0001437749-19-004951","doc":"prog20181231_10k.htm","q":"(and its subsidiaries collectively the \u201cCompany,\u201d \u201cProgenics\u201d, \u201cwe\u201d, or \u201cus\u201d) is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow can\u2026"},{"fy":2019,"lvl":3,"n":24,"adsh":"0001437749-20-005145","doc":"prog20191231_10k.htm","q":"(and its subsidiaries collectively the \u201cCompany,\u201d \u201cProgenics\u201d, \u201cwe\u201d, or \u201cus\u201d) is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow can\u2026"}]},{"cik":836157,"name":"LINDSAY CORP","industry":"Construction machinery","sic":3523,"state":"NE","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-348274","doc":"d42017d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-740910","doc":"d267725d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000836157-17-000035","doc":"lnn-20170831x10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-18-024810","doc":"lnn-10k_20180831.htm","q":"This technology combines more than 40 years of crop and irrigation science with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specific irrigation r\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0000950123-19-009834","doc":"lnn-10k_20190831.htm","q":"This technology combines more than 40 years of crop and irrigation science with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specific irrigation r\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-20-047271","doc":"lnn-10k_20200831.htm","q":"This technology combines more than 40 years of crop and irrigation science with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specific irrigation r\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-21-051450","doc":"lnn-10k_20210831.htm","q":"This technology combines crop and irrigation science and expertise accumulated since 1955 with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specif\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-22-019799","doc":"lnn-20220831.htm","q":"This technology combines crop and irrigation science and expertise accumulated since 1955 with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specif\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-23-054198","doc":"lnn-20230831.htm","q":"This technology combines crop and irrigation science and expertise accumulated since 1955 with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specif\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-24-117056","doc":"lnn-20240831.htm","q":"This technology combines crop and irrigation science and expertise accumulated since 1955 with FieldNET\u2019s cloud computing capabilities, remote sensing functionality and machine learning to provide farmers with field-specific and crop-specif\u2026"}]},{"cik":836564,"name":"MOSAIC IMMUNOENGINEERING INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-000754","doc":"mosaic_10kt-123120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-000466","doc":"mosaic_i10k-123121.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-23-001237","doc":"mosaic_i10k-123122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-002402","doc":"mosaic_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":12,"adsh":"0001683168-25-002584","doc":"mosaic_i10k-123124.htm","q":"As part of our strategy, on April 26, 2024, we entered into a binding term sheet (\u201cBinding Term Sheet\u201d) with Oncotelic Therapeutics, Inc.(\u201cOncotelic\u201d) pursuant to which we intend to acquire (i) certain rights to Oncotelic\u2019s clinical stage n\u2026"},{"fy":2025,"lvl":"x","n":10,"adsh":"0001683168-26-002977","doc":"mosaic_i10k-123125.htm","q":"As part of our strategy, on April 26, 2024, we entered into a binding term sheet (\u201cBinding Term Sheet\u201d) with Oncotelic Therapeutics, Inc.(\u201cOncotelic\u201d) pursuant to which we intend to acquire (i) certain rights to Oncotelic\u2019s clinical stage n\u2026"}]},{"cik":836690,"name":"INNOVATIVE SOLUTIONS & SUPPORT INC","industry":"Software & IT services","sic":7371,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-089879","doc":"a15-18236_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-16-162610","doc":"a16-22585_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-17-073638","doc":"a17-21212_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001104659-18-074460","doc":"a18-31043_110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-19-075583","doc":"a19-18277_110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-138570","doc":"tm2031767d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-152604","doc":"issc-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-22-127805","doc":"issc-20220930x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-000248","doc":"issc-20230930x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-24-016501","doc":"issc-20240930x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-25-123847","doc":"issc-20250930x10k.htm","q":null}]},{"cik":837852,"name":"IDEANOMICS, INC.","industry":"Auto manufacturing","sic":3711,"state":"NY","cells":[{"fy":2020,"lvl":2,"n":11,"adsh":"0001104659-21-044740","doc":"idex-20201231x10k.htm","q":"The Company built a network of businesses, operating principally in the trading of petroleum products and electronic components that the Company believed had significant potential to recognize benefits from blockchain and artificial intelli\u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001628280-22-024271","doc":"idex-20211231.htm","q":"(g) Intelligenta In 2018, the Company signed an investment agreement with two unrelated parties to establish BDCG, subsequently renamed Intelligenta, for providing block chain services for financial or energy industries by utilizing artific\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-23-009765","doc":"idex-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001628280-24-028863","doc":"idex-20231231.htm","q":"Should it identify promising innovative technology companies in adjacent sectors, such as artificial intelligence and other key technologies relevant to the mobility market, the Company intends to explore strategic partnerships or acquisiti\u2026"}]},{"cik":838796,"name":"KIWIBOX.COM, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001607062-15-000182","doc":"kiwb123114form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001607062-16-000791","doc":"kiwb123115form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001607062-17-000153","doc":"kiwb123116form10k.htm","q":null}]},{"cik":839441,"name":"IMAGENETIX INC /NV/","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001615774-15-001645","doc":"s101364_10k.htm","q":null}]},{"cik":842013,"name":"CORO GLOBAL INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001013762-15-000309","doc":"f10k2014_medefile.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001013762-16-001502","doc":"f10k2015_medefileinternation.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003256","doc":"f10k2016_medefileinter.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-005872","doc":"f10k2017_hashlabsinc.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-006167","doc":"f10k2018_hashlabsinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-009083","doc":"f10k2019_coroglobal.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-019290","doc":"f10k2020_coroglobalinc.htm","q":null}]},{"cik":842023,"name":"BIO-TECHNE CORP","industry":"Pharma & biotech","sic":2836,"state":"MN","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-15-016645","doc":"tech20150630_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-015711","doc":"tech20170630_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-18-016190","doc":"tech20180630_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-19-017565","doc":"tech20190630_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-20-018754","doc":"tech20200630_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-21-020980","doc":"tech20200630b_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-013935","doc":"tmb-20220630x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-23-015226","doc":"tmb-20230630x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-24-012430","doc":"tech-20240630x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001558370-25-011716","doc":"tech-20250630x10k.htm","q":null}]},{"cik":842162,"name":"LEAR CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000842162-15-000004","doc":"lea-2014123110xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000842162-16-000019","doc":"lea-2015123110xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000842162-17-000006","doc":"lea-2016123110xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000842162-18-000007","doc":"lea-2017123110xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000842162-19-000006","doc":"lear-2018123110xk.htm","q":null},{"fy":2019,"lvl":1,"n":3,"adsh":"0000842162-20-000006","doc":"lear-2019123110xk.htm","q":"Our software solutions also include Xevo Journeyware, a thin-client platform for the cloud, vehicles and mobile devices that enables consumer e-commerce, multi-media applications and enterprise services to improve performance and safety, de\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0000842162-21-000010","doc":"lear-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000842162-22-000009","doc":"lear-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000842162-23-000011","doc":"lear-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000842162-24-000008","doc":"lear-20231231.htm","q":"It involves the integration of new technologies, such as Industrial Internet of Things (IIoT), cloud computing, artificial intelligence (AI), machine learning and advanced automation, into production facilities and business operations."},{"fy":2024,"lvl":2,"n":9,"adsh":"0000842162-25-000010","doc":"lear-20241231.htm","q":"It involves the integration of new technologies, such as Industrial Internet of Things (IIoT), cloud computing, artificial intelligence (AI), machine learning and advanced automation, into production facilities and business operations."},{"fy":2025,"lvl":3,"n":25,"adsh":"0000842162-26-000011","doc":"lear-20251231.htm","q":"These investments and transformation involve the integration of new technologies, such as artificial intelligence (\"AI\"), machine learning and advanced automation, into production facilities and business operations."}]},{"cik":847464,"name":"CHINA YCT INTERNATIONAL GROUP, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001096906-15-000749","doc":"cyig10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001096906-16-001729","doc":"china.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001096906-17-000447","doc":"china.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001096906-18-000372","doc":"china.htm","q":null}]},{"cik":849146,"name":"LIFEVANTAGE CORP","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000849146-15-000098","doc":"lfvn_06302015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000849146-16-000207","doc":"lfvn_06302016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000849146-17-000094","doc":"lfvn_06302017x10k.htm","q":null},{"fy":2018,"lvl":2,"n":6,"adsh":"0000849146-18-000074","doc":"lfvn_06302018x10k.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide users on what to share, when to share it, and with whom."},{"fy":2019,"lvl":1,"n":4,"adsh":"0000849146-19-000063","doc":"lfvn0630201910k.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide users on what to 6 share, when to share it, and with whom."},{"fy":2020,"lvl":1,"n":4,"adsh":"0000849146-20-000115","doc":"lfvn-20200630.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide users on what to share, when to share it, and with whom."},{"fy":2021,"lvl":1,"n":4,"adsh":"0000849146-21-000078","doc":"lfvn-20210630.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide independent distributors on what to share, when to share it, and with whom to sell LifeVantage products."},{"fy":2022,"lvl":1,"n":4,"adsh":"0000849146-22-000058","doc":"lfvn-20220630.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide independent distributors on what to share, when to share it, and with whom to sell LifeVantage products."},{"fy":2023,"lvl":1,"n":4,"adsh":"0000849146-23-000102","doc":"lfvn-20230630.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide independent consultants on what to share, when to share it, and with whom to sell LifeVantage products."},{"fy":2024,"lvl":1,"n":4,"adsh":"0000849146-24-000073","doc":"lfvn-20240630.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide independent consultants on what to share, when to share it, and with whom to sell LifeVantage products."},{"fy":2025,"lvl":1,"n":4,"adsh":"0000849146-25-000068","doc":"lfvn-20250630.htm","q":"Ultimately, through artificial intelligence and machine learning, we expect that the app will be able to guide independent consultants on what to share, when to share it, and with whom to sell LifeVantage products."}]},{"cik":849399,"name":"GEN DIGITAL INC.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000849399-15-000007","doc":"symc4315-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000849399-16-000022","doc":"symc4116-10k.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0000849399-17-000009","doc":"symc33117-10k.htm","q":"In addition, we appointed Blue Coat\u2019s Chief Financial Officer to the position of our Executive Vice President and Chief Financial Officer in the third quarter of fiscal 2017. \u2022 In the fourth fiscal quarter, we completed the acquisition of L\u2026"},{"fy":2017,"lvl":1,"n":4,"adsh":"0001193125-18-309091","doc":"d573170d10k.htm","q":"Our business and consumer offerings are powered by the largest civilian threat intelligence network, which uses machine learning and human intelligence to analyze trillions of rows of data every day across hundreds of millions of devices to\u2026"},{"fy":2018,"lvl":2,"n":8,"adsh":"0000849399-19-000005","doc":"symc32919-10k.htm","q":"Our business and consumer offerings are powered by the largest civilian threat intelligence network, which uses artificial intelligence, machine learning, and human intelligence to analyze trillions of rows of data every day across hundreds\u2026"},{"fy":2019,"lvl":0,"n":0,"adsh":"0000849399-20-000004","doc":"nlokfy2010-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000849399-21-000010","doc":"nlok-20210402.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000849399-22-000013","doc":"nlok-20220401.htm","q":null},{"fy":2022,"lvl":3,"n":17,"adsh":"0000849399-23-000014","doc":"gen-20230331.htm","q":"However, with each new digital interaction comes increased risk and exposure for consumers as cybercriminals use a mix of old and new tactics and technology, including phishing, vishing, smishing, based on machine learning and deep fake, to\u2026"},{"fy":2023,"lvl":3,"n":42,"adsh":"0000849399-24-000036","doc":"gen-20240329.htm","q":"However, with each new digital interaction comes increased risk and exposure for consumers as cybercriminals use a mix of old and new tactics and technologies, including phishing, vishing, smishing, based on machine learning and generative \u2026"},{"fy":2024,"lvl":3,"n":78,"adsh":"0000849399-25-000033","doc":"gen-20250328.htm","q":"Cybercriminals use a mix of old and new tactics and technologies, including phishing, vishing, smishing, based on machine learning and generative artificial intelligence (AI) technologies, to execute highly advanced threats and attacks."}]},{"cik":849636,"name":"RESPIRERX PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001071","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008331","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003145","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-005325","doc":"form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005477","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006358","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008869","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-010053","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-012542","doc":"form10-k.htm","q":null}]},{"cik":850261,"name":"SORRENTO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001681","doc":"srne-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014768","doc":"srne-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004944","doc":"srne-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000850261-18-000013","doc":"srne12312017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000850261-19-000002","doc":"srne12312018-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000850261-20-000027","doc":"srne-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006983","doc":"srne-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003472","doc":"srne-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008238","doc":"srne-20221231.htm","q":null}]},{"cik":850693,"name":"ALLERGAN INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000850693-15-000002","doc":"agn10-k2014.htm","q":null}]},{"cik":852437,"name":"RAND WORLDWIDE INC","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-320290","doc":"d78138d10k.htm","q":null}]},{"cik":855654,"name":"IMMUNOGEN, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-007008","doc":"a2225777z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-16-008099","doc":"imgn-20160630x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001641","doc":"imgn-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001432","doc":"imgn-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002399","doc":"imgn-20191231x10kd363eb.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002170","doc":"imgn-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002358","doc":"imgn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002558","doc":"imgn-20221231x10k.htm","q":null}]},{"cik":855658,"name":"LATTICE SEMICONDUCTOR CORP","industry":"Computers & chips","sic":3674,"state":"OR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000855658-15-000035","doc":"a201410-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0000855658-16-000180","doc":"a201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000855658-17-000012","doc":"lscc201610-k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0000855658-18-000027","doc":"lscc201710-k.htm","q":"As such, they need their own computing and learning capabilities to perform functions like face detection, image recognition, and video analytics \u2014 capabilities that we have today through the acquisition of Silicon Image."},{"fy":2018,"lvl":1,"n":3,"adsh":"0000855658-19-000022","doc":"lscc201810-k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u2022 With the growth of data centers, our \u201cprocessor agnostic\u201d solutions are ideal for control and co\u2026"},{"fy":2019,"lvl":2,"n":6,"adsh":"0000855658-20-000025","doc":"lscc201910-k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u2022 With the growth of hyperscale data centers, our \u201cprocessor agnostic\u201d solutions are ideal for con\u2026"},{"fy":2020,"lvl":2,"n":7,"adsh":"0001437749-21-004238","doc":"lscc20201231b_10k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u25cf With the growth of hyperscale data centers, our \u201cprocessor agnostic\u201d solutions are ideal for con\u2026"},{"fy":2021,"lvl":2,"n":14,"adsh":"0001437749-22-004190","doc":"lscc20220101_10k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u25cf With the growth of hyperscale datacenters, our \u201cprocessor agnostic\u201d solutions are ideal for cont\u2026"},{"fy":2022,"lvl":2,"n":14,"adsh":"0001437749-23-003778","doc":"lscc20221231_10k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u25cf With the growth of hyperscale datacenters, our \u201cprocessor agnostic\u201d solutions are ideal for cont\u2026"},{"fy":2023,"lvl":3,"n":39,"adsh":"0001437749-24-004522","doc":"lscc20231206_10k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u25cf With the growth of hyperscale data centers, our \u201cprocessor agnostic\u201d solutions are ideal for dat\u2026"},{"fy":2024,"lvl":3,"n":42,"adsh":"0001437749-25-003987","doc":"lscc20241228_10k.htm","q":"In particular, we believe there are several emerging trends in servers, infrastructure, and smart devices that are opportunities for Lattice: \u25cf With the growth of hyperscale data-centers, our \u201cprocessor agnostic\u201d solutions are ideal for dat\u2026"},{"fy":2025,"lvl":3,"n":64,"adsh":"0001437749-26-004100","doc":"lscc20260103_10k.htm","q":"Our low power, small form factor solutions are ideal for systems and sensor applications. \u25cf With the increase in artificial intelligence (\"AI\") and a multitude of applications at the network edge, Lattice devices support applications like f\u2026"}]},{"cik":857005,"name":"PTC INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2015,"lvl":2,"n":9,"adsh":"0000857005-15-000042","doc":"ptc9-30x1510xk.htm","q":"ColdLight offers solutions for data machine learning and predictive analytics, which expanded our Technology Platform business."},{"fy":2016,"lvl":2,"n":5,"adsh":"0000857005-16-000071","doc":"ptc9-30x1610xk.htm","q":"Additionally, our ThingWorx offerings include a predictive intelligence tool that uses artificial intelligence technology to simplify and automate the processes of creating and operationalizing predictions inside ThingWorx-powered solutions\u2026"},{"fy":2017,"lvl":1,"n":4,"adsh":"0000857005-17-000021","doc":"ptc9-30x1710xk.htm","q":"Additionally, ThingWorx offers sophisticated artificial intelligence and machine learning technology that enables customers to simplify and automate complex analytical processes that enhance industrial IoT solutions through real-time insigh\u2026"},{"fy":2018,"lvl":1,"n":2,"adsh":"0000857005-18-000025","doc":"ptc9-30x1810xk.htm","q":"Additionally, ThingWorx offers sophisticated artificial intelligence and machine learning technology that enables customers to simplify and automate complex analytical processes that enhance industrial IoT solutions through real-time insigh\u2026"},{"fy":2019,"lvl":1,"n":3,"adsh":"0000857005-19-000040","doc":"ptc9-30x1910xk.htm","q":"ThingWorx also offers sophisticated artificial intelligence and machine learning technology that enables customers to simplify and automate complex analytical processes that enhance industrial IoT solutions through real-time insights, predi\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-20-054803","doc":"ptc-10k_20200930.htm","q":"ThingWorx also offers sophisticated artificial intelligence and machine learning technology that enables customers to simplify and automate complex analytical processes, enhancing IIoT solutions through real-time insights, predictions and r\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001564590-21-057806","doc":"ptc-10k_20210930.htm","q":"Align with market demand to deliver technology solutions aligned with secular market trends, including digital transformation, SaaS, remote collaboration and AI."},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-025211","doc":"ptc-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950123-23-011049","doc":"ptc-20230930.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-24-127231","doc":"ptc-20240930.htm","q":null},{"fy":2025,"lvl":3,"n":18,"adsh":"0001193125-25-291326","doc":"ptc-20250930.htm","q":null}]},{"cik":860731,"name":"TYLER TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000744","doc":"tyl-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013137","doc":"tyl-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000860731-17-000006","doc":"tyl12312016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000860731-18-000011","doc":"tyl12312017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000860731-19-000009","doc":"tyl12312018-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000860731-20-000008","doc":"tyl12312019-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000860731-21-000014","doc":"tyl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000860731-22-000011","doc":"0000860731-22-000011.txt","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000860731-23-000009","doc":"tyl-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000860731-24-000006","doc":"tyl-20231231.htm","q":"(\u201cARInspect\u201d), a leading provider of AI powered machine learning solutions for public sector field operations."},{"fy":2024,"lvl":3,"n":26,"adsh":"0000860731-25-000007","doc":"tyl-20241231.htm","q":"For example, the evolving use of artificial intelligence (\u201cAI\u201d) increases the risk of cyberattacks and data breaches, which themselves can evolve more rapidly when artificial intelligence is used to facilitate the attack."},{"fy":2025,"lvl":3,"n":29,"adsh":"0000860731-26-000016","doc":"tyl-20251231.htm","q":"Risks Associated with Our Business, Including Our Software Products Cyber-attacks, the use of artificial intelligence and security vulnerabilities can disrupt our business and harm our competitive position."}]},{"cik":861459,"name":"GRANITE CONSTRUCTION INC","industry":"Construction","sic":1600,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000861459-15-000007","doc":"gva1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000861459-16-000040","doc":"gva1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000861459-17-000012","doc":"gva1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000861459-18-000008","doc":"gva1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003791","doc":"gva-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-21-003662","doc":"gva20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007679","doc":"gva20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004482","doc":"gva20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-004014","doc":"gva20221231_10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000861459-24-000006","doc":"gva-20231231.htm","q":"We have been and may in the future be subject to cybersecurity incidents, which may be through the use of ransomware and other forms of unauthorized access of our digital data with the intent to misappropriate information, corrupt data or c\u2026"},{"fy":2024,"lvl":3,"n":15,"adsh":"0000861459-25-000007","doc":"gva-20241231.htm","q":"Additionally, the increased prevalence and use of artificial intelligence may heighten the risk that we may be subject to cybersecurity incidents in the future."},{"fy":2025,"lvl":2,"n":14,"adsh":"0000861459-26-000004","doc":"gva-20251231.htm","q":"Additionally, the increased prevalence and use of artificial intelligence may heighten the risk that we may be subject to cybersecurity incidents in the future."}]},{"cik":861838,"name":"ACERAGEN, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-088259","doc":"d851678d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-499113","doc":"d79461d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001845","doc":"idra-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001603","doc":"idra-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001585","doc":"idra-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002458","doc":"idra-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002152","doc":"idra-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004903","doc":"idra-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005875","doc":"acgn-20221231x10k.htm","q":null}]},{"cik":862861,"name":"ALT5 SIGMA CORP","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-015260","doc":"jan-20231230.htm","q":"NHW = Non-Hispanic Whites, AA = African American, HS = Hispanics, AS = Asian Americans, AI = American Indians."},{"fy":2024,"lvl":2,"n":11,"adsh":"0001628280-25-015469","doc":"alts-20241228.htm","q":"ALT5 Sigma Canada, Inc. has four wholly owned subsidiaries, ALT5 AI, Inc."}]},{"cik":863894,"name":"VERU INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0000863894-18-000011","doc":"veru-20180930x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000863894-19-000014","doc":"veru-20190930x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000863894-20-000021","doc":"veru-20200930x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000863894-21-000013","doc":"veru-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000863894-22-000017","doc":"veru-20220930x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000863894-23-000017","doc":"veru-20230930x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-24-037576","doc":"veru20240930_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-25-038089","doc":"veru20250930_10k.htm","q":null}]},{"cik":865436,"name":"WHOLE FOODS MARKET INC","industry":"Retail","sic":5411,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000865436-15-000177","doc":"wfm10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000865436-16-000366","doc":"wfm10k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000865436-17-000238","doc":"wfm10k2017.htm","q":null}]},{"cik":866273,"name":"MATRIX SERVICE CO","industry":"Construction","sic":1700,"state":"OK","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000866273-15-000080","doc":"mtrx2015-06x30x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000866273-17-000091","doc":"mtrx2017-06x30x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000866273-18-000082","doc":"mtrx2018-06x3010xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000866273-19-000094","doc":"mtrx2019-06x3010xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000866273-20-000109","doc":"mtrx-20200630.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000866273-21-000088","doc":"mtrx-20210630.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000866273-22-000105","doc":"mtrx-20220630.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000866273-23-000058","doc":"mtrx-20230630.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0000866273-24-000092","doc":"mtrx-20240630.htm","q":"Additionally, as artificial intelligence (\"AI\") technologies become increasingly sophisticated, the security risks associated with their use and the potential for misuse also increase."},{"fy":2025,"lvl":2,"n":5,"adsh":"0000866273-25-000069","doc":"mtrx-20250630.htm","q":"Additionally, as artificial intelligence (\"AI\") technologies become increasingly sophisticated, the security risks associated with their use and the potential for misuse also increase."}]},{"cik":866291,"name":"ALLEGRO MICROSYSTEMS, INC.","industry":"Computers & chips","sic":3674,"state":"NH","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0000866291-21-000020","doc":"algm-20210326.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000866291-22-000011","doc":"algm-20220325.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000866291-23-000017","doc":"algm-20230331.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-063770","doc":"algm-20240329.htm","q":null},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-076059","doc":"algm-20250328.htm","q":null}]},{"cik":866439,"name":"DARKPULSE, INC.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-001169","doc":"klever_10k-123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005572","doc":"klever_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-17-000655","doc":"klever_10k-123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-18-000853","doc":"klever_10k-123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001683168-19-001076","doc":"darkpulse_10k-123118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-20-001905","doc":"darkpulse_10k-123119.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-001436","doc":"darkpulse_10k-123120.htm","q":null},{"fy":2021,"lvl":1,"n":4,"adsh":"0001683168-22-002722","doc":"darkpulse_i10k-123121.htm","q":"We specialize in fully integrated, geo-rectified, 3D modeled mapping and AI for industrial applications, specializing in the energy and environmental industries, with AI and live streaming capabilities anywhere in the world."},{"fy":2022,"lvl":2,"n":7,"adsh":"0001683168-23-004387","doc":"darkpulse_i10k-123122.htm","q":"RI specializes in fully integrated, geo-rectified, 3D modeled mapping and artificial intelligence (\u201c AI \u201d) for industrial applications, specializing in the energy and environmental industries, with AI and live streaming capabilities anywher\u2026"},{"fy":2023,"lvl":"x","n":2,"adsh":"0001683168-24-004848","doc":"darkpulse_i10k-123123.htm","q":"These responses include the use of \u201csmart\u201d AI platformed cameras, facial recognition technologies and multiple drone platforms."},{"fy":2024,"lvl":"x","n":2,"adsh":"0001683168-25-002535","doc":"darkpulse_i10k-123124.htm","q":"These responses include the use of \u201csmart\u201d AI platformed cameras, facial recognition technologies and multiple drone platforms."},{"fy":2025,"lvl":"x","n":2,"adsh":"0001683168-26-002937","doc":"darkpulse_i10k-123125.htm","q":"These responses include the use of \u201csmart\u201d AI platformed cameras, facial recognition technologies and multiple drone platforms."}]},{"cik":867773,"name":"SUNPOWER CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000867773-15-000013","doc":"spwr_12282014x10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000867773-16-000101","doc":"spwr_01032016x10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000867773-17-000013","doc":"spwr_01012017x10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000867773-18-000016","doc":"0000867773-18-000016.txt","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000867773-19-000006","doc":"spwr_12302018x10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000867773-20-000010","doc":"spwr-20191229.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000867773-21-000026","doc":"spwr-20210103.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000867773-22-000016","doc":"spwr-20220102.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000867773-23-000026","doc":"spwr-20230101.htm","q":null}]},{"cik":868278,"name":"PROPHASE LABS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-018860","doc":"v404480_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-16-008343","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-001890","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-004041","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003946","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004807","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007538","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008541","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":1,"n":3,"adsh":"0000868278-23-000004","doc":"prph-20221231.htm","q":"We are also actively collaborating with G42 Healthcare, a leading Abu Dhabi-based artificial intelligence (AI) health-tech company, to explore several collaborative opportunities including, but not limited to, genomic sequencing, artificial\u2026"},{"fy":2023,"lvl":3,"n":24,"adsh":"0000868278-24-000004","doc":"prph-20231231.htm","q":"We are also actively collaborating with G42 Healthcare, a leading Abu Dhabi-based artificial intelligence (\u201cAI\u201d) health-tech company, to explore genomic sequencing and other potential opportunities."},{"fy":2024,"lvl":3,"n":22,"adsh":"0000868278-25-000003","doc":"prph-20241231.htm","q":"We have integrated, and may continue to integrate in the future, machine learning and AI to help us in relation to production and other areas of our business."},{"fy":2025,"lvl":0,"n":0,"adsh":"0000868278-26-000005","doc":"prph-20251231.htm","q":null}]},{"cik":868780,"name":"DORMAN PRODUCTS, INC.","industry":"Auto manufacturing","sic":3714,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-061893","doc":"d845977d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-473016","doc":"d103596d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-058492","doc":"d293461d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003466","doc":"dorm-10k_20171230.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004498","doc":"dorm-10k_20181229.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006734","doc":"dorm-10k_20191228.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007175","doc":"dorm-10k_20201226.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-005966","doc":"dorm-10k_20211225.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005712","doc":"dorm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000868780-24-000011","doc":"dorm-20231231.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."},{"fy":2024,"lvl":2,"n":5,"adsh":"0000868780-25-000009","doc":"dorm-20241231.htm","q":"Investments in artificial intelligence (\u201cAI\u201d) also may impact our ability to develop new products."},{"fy":2025,"lvl":2,"n":10,"adsh":"0000868780-26-000014","doc":"dorm-20251231.htm","q":"Such risks may be compounded by the availability and use of artificial intelligence (\"AI\") by our competitors."}]},{"cik":868857,"name":"AECOM","industry":"Construction","sic":8711,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-008965","doc":"a2226692z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-16-016739","doc":"a2230294z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-17-007051","doc":"a2233808z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-18-007225","doc":"a2237110z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-19-063367","doc":"acm-20190930x10k94a79f.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-126988","doc":"acm-20200930x10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001104659-21-140569","doc":"acm-20210930x10k.htm","q":"It also includes our SewerLogic solution, which is a machine learning cloud-based digital tool that improves efficiencies of asset management and inspection services of sewer lines."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001104659-22-119637","doc":"acm-20220930x10k.htm","q":"For example, in fiscal 2022, we launched PipeInsights\u2122, which is a digital pipe inspection tool that accelerates the time and reduces the cost of inspection with a high degree of accuracy with embedded Machine Learning capabilities."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001104659-23-118329","doc":"acm-20230930x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-24-002030","doc":"acm-20240930x10k.htm","q":null},{"fy":2025,"lvl":3,"n":21,"adsh":"0000868857-25-000013","doc":"acm-20250930.htm","q":"In addition, our industry is poised to capitalize on the benefits of AI and innovation."}]},{"cik":871344,"name":"MOLLER INTERNATIONAL INC","industry":"Aerospace & defense","sic":3721,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001185185-15-003318","doc":"mollerintl10k063015.htm","q":null}]},{"cik":872448,"name":"ATMEL CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000872448-15-000006","doc":"atml-201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000872448-16-000043","doc":"atml-201510k.htm","q":null}]},{"cik":872589,"name":"REGENERON PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001532176-15-000008","doc":"regn-123114x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001532176-16-000045","doc":"regn-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001532176-17-000008","doc":"regn-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001532176-18-000013","doc":"regn-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001532176-19-000009","doc":"regn-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001532176-20-000008","doc":"regn-123119x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001804220-21-000008","doc":"regn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001804220-22-000007","doc":"regn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001804220-23-000008","doc":"regn-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":9,"adsh":"0001804220-24-000009","doc":"regn-20231231.htm","q":"Our ability to protect our trade secrets may be impaired by a number of risks and uncertainties, including those discussed under \"Other Regulatory and Litigation Risks - Increasing use of social media and artificial intelligence-based platf\u2026"},{"fy":2024,"lvl":2,"n":10,"adsh":"0001804220-25-000011","doc":"regn-20241231.htm","q":"Our ability to protect our trade secrets may be impaired by a number of risks and uncertainties, including those discussed under \"Other Regulatory and Litigation Risks - Increasing use of social media and artificial intelligence-based platf\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0000872589-26-000008","doc":"regn-20251231.htm","q":"Our ability to protect our trade secrets may be impaired by a number of risks and uncertainties, including those discussed under \"Other Regulatory and Litigation Risks - The use of social media platforms could give rise to liability, breach\u2026"}]},{"cik":873303,"name":"SAREPTA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-063997","doc":"d835729d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013358","doc":"srpt-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002842","doc":"srpt-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004107","doc":"srpt-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005170","doc":"srpt-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006769","doc":"srpt-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009835","doc":"srpt-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002517","doc":"srpt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005062","doc":"srpt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-022036","doc":"srpt-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0000950170-25-029973","doc":"srpt-20241231.htm","q":"The biotechnology and pharmaceutical industries are highly competitive and subject to significant and rapid technological change, including the use of artificial intelligence (\" AI \")."},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-084144","doc":"srpt-20251231.htm","q":"The biotechnology and pharmaceutical industries are highly competitive and subject to significant and rapid technological change, including the use of artificial intelligence (\u201cAI\u201d)."}]},{"cik":874015,"name":"IONIS PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-009498","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000874015-16-000112","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-009823","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000874015-18-000047","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000874015-19-000045","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-004500","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000874015-21-000056","doc":"form10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000874015-22-000079","doc":"form10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000874015-23-000105","doc":"form10k.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0000874015-24-000116","doc":"form10k.htm","q":"Risks related to cybersecurity, social media and artificial intelligence We are dependent on information technology systems, infrastructure and data, which exposes us to data security risks."},{"fy":2024,"lvl":2,"n":5,"adsh":"0000874015-25-000089","doc":"form10k.htm","q":"PTO. 51 Table of Contents Risks related to personal information, cybersecurity, social media and artificial intelligence We are dependent on data as well as information technology systems and infrastructure, which exposes us to data protect\u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0000874015-26-000115","doc":"form10k.htm","q":"Risks related to personal information, cybersecurity, social media and artificial intelligence 51 We are dependent on data as well as information technology systems and infrastructure, which exposes us to data protection risks."}]},{"cik":874238,"name":"STERLING INFRASTRUCTURE, INC.","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2014,"lvl":1,"n":4,"adsh":"0001171843-15-001420","doc":"f10k_031615.htm","q":"In addition, Aggregate South West Holdings, LLC (\u201cASWH\u201d) and RHB Properties, LLC (\u201cRHBP\u201d), newly formed entities owned by Richard Buenting, the President and Chief Executive Officer of RHB, acquired construction related machinery and equipm\u2026"},{"fy":2015,"lvl":0,"n":0,"adsh":"0001171843-16-008548","doc":"f10k_031416p.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001381","doc":"f10k_030917p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000874238-18-000022","doc":"strl_123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000874238-19-000044","doc":"strl_123118x10kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000874238-20-000033","doc":"strl_123119x10kdocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000874238-21-000010","doc":"strl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000874238-22-000023","doc":"strl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000874238-23-000023","doc":"strl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000874238-24-000032","doc":"strl-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000874238-25-000025","doc":"strl-20241231.htm","q":"These investments are driven by the need to support the increasing use of cloud computing applications, increasing adoption and complexity of artificial intelligence applications and digital transformation across industries."},{"fy":2025,"lvl":2,"n":9,"adsh":"0000874238-26-000024","doc":"strl-20251231.htm","q":"We use artificial intelligence (\u201cAI\u201d) technologies in our business, and the deployment, use, and maintenance of these technologies involve significant technological and legal risks."}]},{"cik":875045,"name":"BIOGEN INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000875045-15-000005","doc":"biib-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000875045-16-000042","doc":"biib-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000875045-17-000009","doc":"biib-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0000875045-18-000005","doc":"biib-20171231x10k.htm","q":"Food and Drug Administration (FDA) recently granted BIIB093 Orphan Drug Designation for severe cerebral edema in patients with acute ischemic (AI) stroke."},{"fy":2018,"lvl":0,"n":0,"adsh":"0000875045-19-000006","doc":"biib-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000875045-20-000005","doc":"biib-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000875045-21-000010","doc":"biib-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0000875045-22-000007","doc":"biib-20211231.htm","q":"The expanded collaboration aims to leverage machine learning and artificial intelligence analysis to develop digital health solutions that may improve patient care, accelerate drug development, and further the understanding of the underlyin\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0000875045-23-000009","doc":"biib-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0000875045-24-000009","doc":"biib-20231231.htm","q":"Recent developments in the threat landscape include use of AI and machine learning, as well as an increased number of cyber extortion attacks, with higher financial ransom demand amounts and increasing sophistication and variety of ransomwa\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0000875045-25-000009","doc":"biib-20241231.htm","q":"Recent developments in the threat landscape include use of adversarial AI techniques and machine learning, as well as an increased number of cyber extortion attacks, with higher financial ransom demand amounts and increasing sophistication \u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0000875045-26-000013","doc":"biib-20251231.htm","q":"Recent developments in the threat landscape include use of adversarial AI techniques and machine learning, as well as an increased number of cyber extortion attacks, with higher financial ransom demand amounts and increasing sophistication \u2026"}]},{"cik":875320,"name":"VERTEX PHARMACEUTICALS INC / MA","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000875320-15-000012","doc":"a201410k-main.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000875320-16-000067","doc":"a201510k-main.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000875320-17-000017","doc":"a201610k-main.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000875320-18-000009","doc":"a201710k-main.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000875320-19-000006","doc":"a201810k-main.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000875320-20-000007","doc":"a201910k-main.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000875320-21-000006","doc":"vrtx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000875320-22-000007","doc":"vrtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000875320-23-000007","doc":"vrtx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000875320-24-000062","doc":"vrtx-20231231.htm","q":"The use of social media platforms and artificial intelligence tools presents risks and challenges."},{"fy":2024,"lvl":1,"n":2,"adsh":"0000875320-25-000053","doc":"vrtx-20241231.htm","q":"The use of social media platforms and artificial intelligence tools presents risks and challenges."},{"fy":2025,"lvl":2,"n":8,"adsh":"0000875320-26-000056","doc":"vrtx-20251231.htm","q":"Recent developments in the threat landscape include the use of adversarial artificial intelligence techniques and machine learning, as well as an increased number of cyber extortion attacks with higher financial ransom demand amounts and in\u2026"}]},{"cik":875622,"name":"BIOSPECIFICS TECHNOLOGIES CORP","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011871","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-057622","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-012337","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-18-013423","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-006323","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-005848","doc":"form10k.htm","q":null}]},{"cik":876167,"name":"PROGRESS SOFTWARE CORP /MA","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000876167-15-000009","doc":"a201410-kmaster.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000876167-16-000060","doc":"a201510-kmaster.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0000876167-17-000007","doc":"a201610-kmaster.htm","q":"As part of the new strategic plan, we are undertaking a new product strategy in which we will provide the platform and tools enterprises need to build next generation applications that drive their businesses known as \u201cCognitive Applications\u2026"},{"fy":2017,"lvl":2,"n":7,"adsh":"0000876167-18-000008","doc":"a201710-kmaster.htm","q":"Progress offers leading technologies for easily building powerful user interfaces across any type of device, a reliable, scalable and secure backend platform to deploy modern applications, leading data connectivity to all sources, and award\u2026"},{"fy":2018,"lvl":2,"n":5,"adsh":"0000876167-19-000026","doc":"a201810-kmaster.htm","q":"Progress offers powerful tools for easily building adaptive user experiences across any type of device or touchpoint, award-winning machine learning that enables cognitive capabilities to be a part of any application, the flexibility of a s\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0000876167-20-000027","doc":"a201910-kmaster.htm","q":"Progress offers powerful tools for easily building adaptive user experiences across any type of device or touchpoint, the flexibility of a cloud-native app dev platform to deliver modern apps, leading data connectivity technology, web conte\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0000876167-21-000030","doc":"prgs-20201130.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0000876167-22-000038","doc":"prgs-20211130.htm","q":"The Kemp Flowmon network detection and response (NDR) solutions combine machine learning, heuristics and advanced analytics to improve network performance, alert on network anomalies and provide early detection of advanced persistent threat\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0000876167-23-000036","doc":"prgs-20221130.htm","q":null},{"fy":2023,"lvl":3,"n":20,"adsh":"0000876167-24-000031","doc":"prgs-20231130.htm","q":"Progress Semaphore: Semantic AI platform that transforms data into meaningful insights, empowering organizations to manage knowledge models, and to automatically extract and classify meaning from both structured and unstructured data."},{"fy":2024,"lvl":3,"n":34,"adsh":"0000876167-25-000010","doc":"prgs-20241130.htm","q":"Business Overview Progress Software Corporation (\"Progress,\" the \"Company,\" \"we,\" \"us,\" or \"our\") provides software products that enable our customers to develop, deploy and manage responsible AI-powered applications and digital experiences\u2026"},{"fy":2025,"lvl":3,"n":48,"adsh":"0000876167-26-000008","doc":"prgs-20251130.htm","q":"Business Overview Progress Software Corporation (\"Progress,\" the \"Company,\" \"we,\" \"us,\" or \"our\") provides software products that enable our customers to develop, deploy, and manage responsible AI-powered applications and digital experience\u2026"}]},{"cik":876343,"name":"LINEAGE CELL THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011259","doc":"form10k.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001140361-16-057879","doc":"form10k.htm","q":"The optimal combination of biomarkers that are to be utilized in the final diagnostic are determined through bioinformatics and machine learning software strategies, and assay/marker reliability and usability."},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-012402","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003416","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003335","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003818","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-005814","doc":"form10-k.htm","q":"Kingsley holds a B.S. degree in economics from the Wharton School of the University of Pennsylvania and a J.D. degree and LLM in taxation from New York University Law School."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006520","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007129","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027988","doc":"lctx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-036309","doc":"lctx-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-093992","doc":"lctx-20251231.htm","q":"There have also been numerous recent developments at the FDA, including implementation of a generative artificial intelligence tool, referred to as Elsa, across all centers at the FDA, announcement of a plan to 57 phase out animal testing f\u2026"}]},{"cik":877890,"name":"CITRIX SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000877890-15-000016","doc":"ctxs12-31x201410xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000877890-16-000184","doc":"ctxs12-31x201510xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000877890-17-000030","doc":"ctxs12-31x201610xk.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0000877890-18-000025","doc":"ctxs12-31x201710xk.htm","q":"As a result of this convergence of cloud, legacy systems, and newer technologies, including artificial intelligence and machine learning, organizations are now seeking to adopt multi-cloud, hybrid-cloud strategies for their IT infrastructur\u2026"},{"fy":2018,"lvl":1,"n":3,"adsh":"0000877890-19-000035","doc":"ctxs12-31x201810xk.htm","q":"As a result of this convergence of cloud, legacy systems, and newer technologies, including artificial intelligence and machine learning, organizations are now seeking to adopt multi-cloud, hybrid-cloud strategies for their IT infrastructur\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0000877890-20-000051","doc":"ctxs-20191231.htm","q":"The application of machine learning to these rich sources of data enables us to provide valuable analytics and insights to customers."},{"fy":2020,"lvl":1,"n":1,"adsh":"0000877890-21-000051","doc":"ctxs-20201231.htm","q":"The aggregation and correlation of data across networks, virtualized applications and desktops, and content collaboration tools enables the generation of valuable insights and more focused actions to address user security threats. \u2022 Citrix \u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0000877890-22-000019","doc":"ctxs-20211231.htm","q":"The aggregation and correlation of data across networks, virtualized applications and desktops, and content collaboration tools enables the generation of valuable insights and more focused actions to address user security threats. \u2022 Citrix \u2026"}]},{"cik":878004,"name":"CHUGACH ELECTRIC ASSOCIATION INC","industry":"Utilities","sic":4911,"state":"AK","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000878004-15-000007","doc":"c004-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000878004-16-000026","doc":"c004-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000878004-17-000014","doc":"c004-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000878004-18-000003","doc":"c004-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000878004-19-000004","doc":"c004-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000878004-20-000006","doc":"c004-20191231x10k.htm","q":null}]},{"cik":878079,"name":"BON TON STORES INC","industry":"Retail","sic":5311,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-003545","doc":"a2224182z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-012172","doc":"a2228180z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-002544","doc":"a2231711z10-k.htm","q":null}]},{"cik":878088,"name":"PAR PHARMACEUTICAL COMPANIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000878088-15-000002","doc":"prx-20141231x10k.htm","q":null}]},{"cik":878560,"name":"CALATLANTIC GROUP, INC.","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000878560-15-000018","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000878560-16-000190","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000878560-17-000025","doc":"form10-k.htm","q":null}]},{"cik":879169,"name":"INCYTE CORP","industry":"Pharma & biotech","sic":8731,"state":"DE","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000858","doc":"a2223029z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003196","doc":"incy-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000594","doc":"incy-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-000722","doc":"incy-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-000682","doc":"incy-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-000774","doc":"incy-20191231x10k6c65b7.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-000825","doc":"incy-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-000902","doc":"incy-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000879169-23-000008","doc":"incy-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0000879169-24-000045","doc":"incy-20231231.htm","q":"Increasing use of social media and new technology, including artificial intelligence software, could give rise to liability, breaches of data security, or reputational damage."},{"fy":2024,"lvl":2,"n":6,"adsh":"0001628280-25-004633","doc":"incy-20241231.htm","q":"Malicious cyber attacks are growing in frequency and sophistication, including the use of artificial intelligence, and can be made by groups and individuals with a wide range of motives, including nation states, organized criminal groups, \u201c\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0000879169-26-000010","doc":"incy-20251231.htm","q":"These include target identification and validation, high-throughput screening, medicinal chemistry, protein sciences and technology, computational and AI-guided drug discovery, structural biology, pharmacology, translational sciences, drug \u2026"}]},{"cik":879407,"name":"ARROWHEAD PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-15-011489","doc":"arwr-10k_20150930.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-16-030217","doc":"arwr-10k_20160930.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-024834","doc":"arwr-10k_20170930.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-030805","doc":"arwr-10k_20180930.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-044376","doc":"arwr-10k_20190930.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-054893","doc":"arwr-10k_20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-057888","doc":"arwr-10k_20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-22-030869","doc":"arwr-20220930.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001628280-23-040219","doc":"arwr-20230930.htm","q":"Additionally, sensitive data could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, personnel\u2019s, vendors\u2019 or partners\u2019 use of generative AI technologies."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-24-049277","doc":"arwr-20240930.htm","q":"Additionally, sensitive data could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, personnel\u2019s, vendors\u2019 or partners\u2019 use of generative AI technologies."},{"fy":2025,"lvl":2,"n":6,"adsh":"0000879407-25-000029","doc":"arwr-20250930.htm","q":"A summary is provided below: \u2022 State-of-the-art laboratories with supporting office space that comprise more than 251,000 total square feet; \u2022 Cell culture laboratories; \u2022 Animal efficacy models for numerous diseases, including cardio metab\u2026"}]},{"cik":879796,"name":"ARI NETWORK SERVICES INC /WI","industry":"Software & IT services","sic":7370,"state":"WI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000879796-15-000024","doc":"aris-20150731x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000879796-16-000056","doc":"aris-20160731x10k.htm","q":null}]},{"cik":879911,"name":"APPLIED ENERGETICS, INC.","industry":"Aerospace & defense","sic":3812,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-022664","doc":"v407102_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-092235","doc":"v435712_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-018119","doc":"v463006_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-18-002699","doc":"s109467_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001615774-19-005086","doc":"s116206_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-008513","doc":"f10k2019_appliedenerge.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-021158","doc":"f10k2020_appliedenerge.htm","q":null},{"fy":2021,"lvl":"x","n":2,"adsh":"0001213900-22-016299","doc":"f10k2021_appliedenerge.htm","q":"His portfolio primarily focused on large-scale strategic transformations, technology and innovation, including big data, advanced analytics, AI and machine learning, blockchain, and Internet of Things (IoT) within DoD entities."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001213900-23-024192","doc":"f10k2022_appliedenerge.htm","q":"His portfolio primarily focused on large-scale strategic transformations, technology and innovation, including big data, advanced analytics, AI and machine learning, blockchain, and Internet of Things (IoT) within DoD entities."},{"fy":2023,"lvl":"x","n":4,"adsh":"0001213900-24-026107","doc":"ea0201691-10k_applied.htm","q":"The submitted papers specify that THETA will emphasize the development of UAS and counter-UAS (CUAS), artificial intelligence (AI), and cybersecurity technologies."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001013762-25-003924","doc":"ea0234361-10k_applied.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-036517","doc":"ea0282312-10k_applied.htm","q":null}]},{"cik":880266,"name":"AGCO CORP /DE","industry":"Construction machinery","sic":3523,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000880266-15-000009","doc":"a2014agco10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000880266-16-000044","doc":"a2015agco10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000880266-17-000005","doc":"a2016agco10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000880266-18-000005","doc":"a2017agco10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000880266-19-000009","doc":"a2018agco10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000880266-20-000006","doc":"a2019agco10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000880266-21-000009","doc":"agco-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0000880266-22-000006","doc":"agco-20211231.htm","q":"We also recently acquired a company that develops and manufactures a robot that moves throughout the barn measuring temperature, air quality, light and noise, enlisting artificial intelligence to spot potential health, welfare and other pro\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000880266-23-000010","doc":"agco-20221231.htm","q":"We also recently acquired a company that develops and manufactures a robot that moves throughout the barn measuring temperature, air quality, light and noise, enlisting artificial intelligence to spot potential health, welfare and other pro\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0000880266-24-000013","doc":"agco-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000880266-25-000011","doc":"agco-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":5,"adsh":"0000880266-26-000010","doc":"agco-20251231.htm","q":"The success of our new products will depend on a number of factors, including: \u2022 our ability to innovate or adapt to new or emerging technologies, such as artificial intelligence; \u2022 customer acceptance; \u2022 the efficiency of our suppliers in \u2026"}]},{"cik":880562,"name":"DAEGIS INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001206774-15-002551","doc":"daegis_10k.htm","q":null}]},{"cik":880771,"name":"SCICLONE PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000880771-15-000021","doc":"scln-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000880771-16-000135","doc":"scln-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000880771-17-000035","doc":"scln-20161231x10k.htm","q":null}]},{"cik":880984,"name":"ACORN ENERGY, INC.","industry":"Construction","sic":8711,"state":"DE","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001493152-15-001145","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-16-008442","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-002980","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-003884","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-003972","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004708","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-006048","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008225","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-007830","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-009150","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493152-25-009325","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001493152-26-008937","doc":"form10-k.htm","q":"The ever-increasing use and evolution of technology, including cloud-based computing and AI, creates opportunities for the unintentional dissemination or intentional destruction or modification of confidential information stored in our, or \u2026"}]},{"cik":881524,"name":"VIVUS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001202","doc":"a2223042z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003936","doc":"vvus-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001460","doc":"vvus-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002019","doc":"vvus-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001077","doc":"vvus-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001956","doc":"vvus-20191231x10k.htm","q":null}]},{"cik":882095,"name":"GILEAD SCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000882095-15-000008","doc":"a2014form10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000882095-16-000039","doc":"a2015form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000882095-17-000006","doc":"a2016form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000882095-18-000008","doc":"a2017form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000882095-19-000006","doc":"a2018form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000882095-20-000006","doc":"a2019form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000882095-21-000008","doc":"gild-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000882095-22-000007","doc":"gild-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000882095-23-000007","doc":"gild-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000882095-24-000007","doc":"gild-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0000882095-25-000006","doc":"gild-20241231.htm","q":"Likewise, data privacy or cybersecurity incidents or breaches by employees or others, including the unauthorized use of artificial intelligence tools, can result in the exposure of sensitive data, including our intellectual property or trad\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0000882095-26-000006","doc":"gild-20251231.htm","q":"In January 2026, the European Medicines Agency and FDA jointly established new artificial intelligence (\u201cAI\u201d) principles in drug development that provide broad guidance on AI use in evidence generation and monitoring across all phases of a \u2026"}]},{"cik":882104,"name":"PDL BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000882104-15-000019","doc":"pdli1231201410-kdoc.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000882104-16-000112","doc":"pdli1231201510-kdoc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000882104-17-000013","doc":"pdli1231201610-kdoc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000882104-18-000012","doc":"pdli1231201710-kdoc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000882104-19-000016","doc":"pdli1231201810-kdoc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000882104-20-000032","doc":"pdli1231201910-kdoc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000882104-21-000035","doc":"pdli-20201231.htm","q":null}]},{"cik":882184,"name":"HORTON D R INC /DE/","industry":"Construction","sic":1531,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000882184-15-000085","doc":"a2015930-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000882184-16-000203","doc":"a2016930-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000882184-17-000103","doc":"a2017930-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000882184-18-000120","doc":"a2018930-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000882184-19-000147","doc":"a2019930-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000882184-20-000143","doc":"dhi-20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000882184-21-000190","doc":"dhi-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000882184-22-000184","doc":"dhi-20220930.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000882184-23-000115","doc":"dhi-20230930.htm","q":"However, because the techniques used to obtain unauthorized access, disable or degrade systems change frequently and increasingly leverage sophisticated technologies such as artificial intelligence, they often are not recognized until launc\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000882184-24-000057","doc":"dhi-20240930.htm","q":"With the use of artificial intelligence, these phishing attacks may contain highly convincing language making them difficult to distinguish from legitimate messages."},{"fy":2025,"lvl":2,"n":5,"adsh":"0000882184-25-000081","doc":"dhi-20250930.htm","q":"We use information technology and other computer resources, including artificial intelligence, to carry out important operational and marketing activities and to maintain our business records."}]},{"cik":882361,"name":"APTOSE BIOSCIENCES INC.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001171843-19-001661","doc":"f10k_031219p.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001171843-20-001617","doc":"f10k_031020p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-002006","doc":"f10k_032321p.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001171843-22-002048","doc":"apto20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009560","doc":"apto-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036537","doc":"apto-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-046366","doc":"apto-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-135012","doc":"none-20251231.htm","q":null}]},{"cik":882508,"name":"QUICKLOGIC CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000882508-15-000004","doc":"quik-2014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000882508-16-000049","doc":"quik-2015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000882508-17-000013","doc":"quik-2016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000882508-18-000005","doc":"quik-2017x10k.htm","q":null},{"fy":2018,"lvl":3,"n":42,"adsh":"0001564590-19-008052","doc":"quik-10k_20181230.htm","q":"Specifically, we are a fabless semiconductor company that develops low power, multi-core semiconductor platforms and intellectual property or IP for artificial intelligence or AI, voice and sensor processing."},{"fy":2019,"lvl":3,"n":44,"adsh":"0001564590-20-010836","doc":"quik-10k_20191229.htm","q":"Specifically, we are a fabless semiconductor company that develops a full stack platform for artificial intelligence or AI, voice and sensor processing."},{"fy":2020,"lvl":3,"n":47,"adsh":"0001437749-21-006923","doc":"quicklo20210103_10k.htm","q":"Specifically, we are a fabless semiconductor company that develops a full stack platform for artificial intelligence or AI, voice and sensor processing."},{"fy":2021,"lvl":3,"n":50,"adsh":"0001437749-22-006925","doc":"quicklo20220102_10k.htm","q":"Specifically, we are a fabless semiconductor company that develops a full stack platform for artificial intelligence or AI, voice and sensor processing."},{"fy":2022,"lvl":3,"n":44,"adsh":"0001437749-23-008214","doc":"quicklo20230101_10k.htm","q":"Specifically, we are a fabless semiconductor company that develops a full stack platform for artificial intelligence or AI, voice and sensor processing."},{"fy":2023,"lvl":3,"n":48,"adsh":"0001437749-24-009469","doc":"quicklo20231127_10k.htm","q":"Specifically, we are a fabless semiconductor company with a variety of products: embedded FPGA (\"eFPGA\") intellectual property (\"IP\"), low power, multi-core semiconductor system-on-chips (\"SoCs\"), discrete FPGAs, and AI software."},{"fy":2024,"lvl":3,"n":39,"adsh":"0001437749-25-009211","doc":"quicklo20241211_10k.htm","q":"Specifically, we are a fabless semiconductor company with a variety of products: embedded FPGA (\"eFPGA\") intellectual property (\"IP\"), low power, multi-core semiconductor system-on-chips (\"SoCs\"), discrete FPGAs, and AI software."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001437749-26-010089","doc":"quicklo20251208_10k.htm","q":"Further, governments and courts are considering new issues in intellectual property law with respect to works created by AI technology, which could result in different intellectual property rights in development processes, procedures, and t\u2026"}]},{"cik":882796,"name":"BIOCRYST PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001186","doc":"gff10k_030215.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001171843-16-008207","doc":"f10k_022616p.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001159","doc":"f10k_022717p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001171843-18-001855","doc":"f10k_022718p.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001171843-19-001727","doc":"f10k_031219p.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001171843-20-001710","doc":"f10k_031320p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-001411","doc":"bcrx20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001171843-22-001460","doc":"bcrx20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005259","doc":"bcrx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001628280-24-007205","doc":"bcrx-20231231.htm","q":"Cyber incidents could also include the use of artificial intelligence (\u201cAI\u201d) and machine learning to launch more automated, targeted and coordinated attacks on targets."},{"fy":2024,"lvl":3,"n":21,"adsh":"0001628280-25-007715","doc":"bcrx-20241231.htm","q":"Similarly, the increasing use of artificial intelligence (\u201cAI\u201d) and machine learning technology in the biopharmaceutical industry presents new risks and challenges, as the disclosure and use of personal data in AI technologies is subject to\u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001628280-26-012240","doc":"bcrx-20251231.htm","q":"Similarly, the increasing use of artificial intelligence (\u201cAI\u201d) and machine learning technology in the biopharmaceutical industry presents new risks and challenges, as the disclosure and use of personal data in AI technologies is subject to\u2026"}]},{"cik":883241,"name":"SYNOPSYS INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000883241-15-000014","doc":"snps10311510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000883241-16-000027","doc":"snps10311610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000883241-17-000014","doc":"snps10311710-k.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0000883241-18-000012","doc":"snps10311810-k.htm","q":"The increasing viability of artificial intelligence and machine learning is driving an increase in the activity of new and existing chip design companies around the world."},{"fy":2019,"lvl":1,"n":2,"adsh":"0000883241-19-000019","doc":"snps10311910-k.htm","q":"The increasing impact of artificial intelligence and machine learning is driving an increase in the activity of new and existing chip and system design companies around the world."},{"fy":2020,"lvl":2,"n":6,"adsh":"0000883241-20-000015","doc":"snps10312010-k.htm","q":"The increasing impact of artificial intelligence and machine learning is driving an increase in the activity of new and existing chip and system design companies around the world."},{"fy":2021,"lvl":2,"n":8,"adsh":"0000883241-21-000022","doc":"snps-20211031.htm","q":"The increasing impact of artificial intelligence and machine learning is driving an increase in the activity of new and existing chip and system design companies around the world."},{"fy":2022,"lvl":2,"n":10,"adsh":"0000883241-22-000017","doc":"snps-20221031.htm","q":"The increasing impact of artificial intelligence and machine learning is driving an increase in the activity of new and existing chip and system design companies around the world."},{"fy":2023,"lvl":3,"n":22,"adsh":"0000883241-23-000019","doc":"snps-20231031.htm","q":"The increasing impact of artificial intelligence (AI) and machine learning is driving an increase in the activity of new and existing chip and system design companies around the world."},{"fy":2024,"lvl":3,"n":48,"adsh":"0000883241-24-000024","doc":"snps-20241031.htm","q":"We are a global leader in supplying the mission-critical EDA software that engineers use to design and test integrated circuits (ICs), also known as chips or silicon, and we are pioneering artificial intelligence (AI) driven chip design acr\u2026"},{"fy":2025,"lvl":3,"n":55,"adsh":"0000883241-25-000028","doc":"snps-20251031.htm","q":"(Synopsys, we, our or us) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products."}]},{"cik":883975,"name":"MICROBOT MEDICAL INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091382","doc":"d873875d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-504472","doc":"d135914d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-002678","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-004562","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004545","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-006338","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":1,"n":3,"adsh":"0001493152-21-007453","doc":"form10-k.htm","q":"Wenderow serves as the President and CEO of Vocalis Health Inc., an AI healthtech company pioneering the development of vocal biomarkers."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001493152-22-008344","doc":"form10-k.htm","q":"Wenderow served as the President and CEO of Vocalis Health Inc., an AI healthtech company pioneering the development of vocal biomarkers."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001493152-23-010223","doc":"form10-k.htm","q":"Wenderow served as the President and CEO of Vocalis Health Inc., an AI healthtech company pioneering the development of vocal biomarkers."}]},{"cik":884363,"name":"EVOLUTIONARY GENOMICS, INC.","industry":"Pharma & biotech","sic":8731,"state":"CO","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001553350-16-001601","doc":"fnam_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001553350-17-000164","doc":"fnam_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001553350-18-000184","doc":"fnam_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001553350-19-000304","doc":"fnam_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001553350-20-000255","doc":"fnam_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001553350-21-000252","doc":"fnam_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001553350-22-000231","doc":"fnam_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001553350-23-000160","doc":"fnam_10k.htm","q":null}]},{"cik":884650,"name":"INFINITE GROUP INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001453","doc":"imci_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001654954-16-000251","doc":"imci_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002807","doc":"infinite-group_form10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-19-007941","doc":"imci_form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-007945","doc":"imci_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-003151","doc":"imci_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-006025","doc":"igi_10k.htm","q":null},{"fy":2023,"lvl":"x","n":10,"adsh":"0001654954-25-012432","doc":"igi_10k.htm","q":"We are building the next generation of Nodeware\u00ae, a patented, cloud native SaaS solution that automates network asset identification, fingerprinting, automated patching and remediation through an integrated generative artificial intelligenc\u2026"},{"fy":2024,"lvl":"x","n":7,"adsh":"0001654954-25-012437","doc":"igi_10k.htm","q":"We are building the next generation of Nodeware\u00ae, a patented, cloud native SaaS solution that automates network asset identification, fingerprinting, automated patching and remediation through an integrated generative artificial intelligenc\u2026"}]},{"cik":884731,"name":"ARIAD PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073392","doc":"d862791d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-485544","doc":"d19643d10k.htm","q":null}]},{"cik":885568,"name":"OLD DOMINION ELECTRIC COOPERATIVE","industry":"Utilities","sic":4911,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-087047","doc":"d889059d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000885568-16-000013","doc":"a201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004253","doc":"cik0000885568-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005585","doc":"cik0000885568-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006434","doc":"cik0000885568-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009940","doc":"cik0000885568-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013460","doc":"cik0000885568-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010597","doc":"cik885568-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007785","doc":"ck0000885568-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-029768","doc":"ck0000885568-20231231.htm","q":"We also could be impacted by the misuse of artificial intelligence, or a physical attack on our facilities."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-040959","doc":"ck0000885568-20241231.htm","q":"We also could be impacted by the misuse of artificial intelligence, or a physical attack on our facilities."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001193125-26-110107","doc":"ck0000885568-20251231.htm","q":"Both the number and size of data centers that are being considered for development and construction in the service territories of our member distribution cooperatives have increased in recent years and we anticipate they will continue to in\u2026"}]},{"cik":885590,"name":"BAUSCH HEALTH COMPANIES INC.","industry":"Pharma & biotech","sic":2834,"state":"QC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000885590-15-000015","doc":"valeant2014form10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000885590-16-000101","doc":"valeant2015form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000885590-17-000015","doc":"valeant2016form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000885590-18-000017","doc":"valeant2017form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000885590-19-000006","doc":"bhc2018form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000885590-20-000006","doc":"bhc2019form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000885590-21-000011","doc":"bhc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000885590-22-000010","doc":"bhc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000885590-23-000009","doc":"bhc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000885590-24-000011","doc":"bhc-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0000885590-25-000007","doc":"bhc-20241231.htm","q":"We utilize artificial intelligence, which could expose us to liability or could have a material adverse effect on our business and financial condition."},{"fy":2025,"lvl":3,"n":29,"adsh":"0000885590-26-000023","doc":"bhc-20251231.htm","q":"We utilize artificial intelligence, which could expose us to liability or could have a material adverse effect on our business and financial condition."}]},{"cik":885639,"name":"KOHLS CORP","industry":"Retail","sic":5311,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000885639-15-000007","doc":"kohls_10kx2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000885639-16-000033","doc":"kohls_10kx2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000885639-17-000007","doc":"kohls_10kx2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006671","doc":"kss-10k_20180203.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009005","doc":"kss-10k_20190202.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011512","doc":"kss-10k_20200201.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014145","doc":"kss-10k_20210130.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004076","doc":"kss-20220129.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008444","doc":"kss-20230128.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-034691","doc":"kss-20240203.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-042662","doc":"kss-20250201.htm","q":null},{"fy":2025,"lvl":3,"n":18,"adsh":"0001193125-26-115982","doc":"kss-20260131.htm","q":null}]},{"cik":886163,"name":"LIGAND PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000886163-15-000028","doc":"lgnd-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000886163-16-000149","doc":"lgnd-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000886163-17-000021","doc":"lgnd-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000886163-18-000030","doc":"lgnd-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000886163-19-000041","doc":"lgnd-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000886163-20-000025","doc":"lgnd-20191231.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0000886163-21-000050","doc":"lgnd-20201231.htm","q":"Our transgenic animals comprise the most diverse host systems available in the industry and they are optimally leveraged within the OmniAb Technology Stack through AI-enhanced antigen design and immunization methods, paired with high-throug\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0000886163-22-000030","doc":"lgnd-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000886163-23-000007","doc":"lgnd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000886163-24-000009","doc":"lgnd-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000886163-25-000012","doc":"lgnd-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0000886163-26-000006","doc":"lgnd-20251231.htm","q":"We may be or become subject to certain data protection laws (e.g., the European Union General Data Protection Regulation and the UK equivalent of the same (collectively, \u201cGDPR\u201d) and the California Consumer Privacy Act of 2018 (as revised an\u2026"}]},{"cik":886328,"name":"E DIGITAL CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-002524","doc":"edigital_10k-033115.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-006760","doc":"edigital_10k-033116.htm","q":null}]},{"cik":886744,"name":"GERON CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001989","doc":"a2223360z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010984","doc":"a2227532z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001123","doc":"a2230923z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006051","doc":"gern-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006759","doc":"gern-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010449","doc":"gern-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012493","doc":"gern-10k_20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-009627","doc":"gern-10k_20211231.htm","q":"Previously, he was Chief Business Officer at ZebiAI Therapeutics, a company spun out of X-Chem, Inc. in order to discover and develop advanced drug discovery programs based on novel machine learning technologies, and which was recently acqu\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-008437","doc":"gern-20221231.htm","q":"From 2020 to 2021, he was Chief Business Officer at ZebiAI Therapeutics, a company spun out of X-Chem, Inc. in order to discover and develop advanced drug discovery programs based on novel machine learning technologies, until its acquisitio\u2026"},{"fy":2023,"lvl":2,"n":13,"adsh":"0000950170-24-022056","doc":"gern-20231231.htm","q":"From 2020 to 2021, he was Chief Business Officer at ZebiAI Therapeutics, a company spun out of X-Chem, Inc. in order to discover and develop advanced drug discovery programs based on novel machine learning technologies, until its acquisitio\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-027982","doc":"gern-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0000886744-26-000008","doc":"gern-20251231.htm","q":"United States Food and Drug Administration Regulatory Approval Process Prior to commencement of clinical trials of new pharmaceutical products in humans, government authorities generally require the completion of laboratory studies as well \u2026"}]},{"cik":887151,"name":"CAPSTONE THERAPEUTICS CORP.","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001171843-15-001437","doc":"f10k_031615.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001171843-16-008910","doc":"f10k_033016.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001171843-17-001524","doc":"f10k_031517.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001171843-18-001546","doc":"f10k_022818.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001171843-19-001915","doc":"f10k_032219.htm","q":null}]},{"cik":887247,"name":"ADAMIS PHARMACEUTICALS CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-002012","doc":"admp-10kt_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001387131-16-004688","doc":"admp_10k-123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001387131-17-001745","doc":"admp_10k-123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387131-18-001080","doc":"admp_10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001387131-19-001966","doc":"admp-10k_123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001387131-20-003438","doc":"admp-10k_123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001387131-21-004529","doc":"admp-10k_123120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001387131-22-004483","doc":"admp-10k_123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001387131-23-003523","doc":"admp-10k_123122.htm","q":null}]},{"cik":887359,"name":"VERICEL CORP","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-022712","doc":"a14-26769_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012668","doc":"vcel12-31x201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002492","doc":"vcel12-31x201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002753","doc":"vcel12-31x201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002007","doc":"vcel12-31x201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002229","doc":"vcel12-31x201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003081","doc":"vcel-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003661","doc":"vcel-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004714","doc":"vcel-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001628280-24-007824","doc":"vcel-20231231.htm","q":"As a result, these competitors may be able to adapt to the market more quickly, take advantage of acquisitions and other opportunities more readily, devote greater resources to the marketing and sale of their products, adopt more aggressive\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001628280-25-008447","doc":"vcel-20241231.htm","q":"For example, the deployment of evolving artificial intelligence tools used to identify vulnerabilities and create more deceptive phishing attempts have the potential to not be recognized until such attacks are launched or have been in place\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0001628280-26-012013","doc":"vcel-20251231.htm","q":"For example, the deployment of evolving artificial intelligence tools used to identify vulnerabilities and create more deceptive phishing attempts have the potential to not be recognized until such attacks are launched or have been in place\u2026"}]},{"cik":887969,"name":"MRV COMMUNICATIONS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000887969-15-000009","doc":"mrv-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000887969-16-000089","doc":"mrv-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000887969-17-000006","doc":"mrv-20161231x10k.htm","q":null}]},{"cik":888504,"name":"LAYNE CHRISTENSEN CO","industry":"Construction","sic":1700,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001564590-15-002552","doc":"layn-10k_20150131.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-016121","doc":"layn-10k_20160131.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-006314","doc":"layn-10k_20170131.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007953","doc":"layn-10k_20180131.htm","q":null}]},{"cik":889971,"name":"LIGHTPATH TECHNOLOGIES INC","industry":"Computers & chips","sic":3674,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001387131-15-002762","doc":"lpth-10k_063015.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387131-17-004685","doc":"lpth-10k_063017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-18-010147","doc":"lpth_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-19-010669","doc":"lpth_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-20-009993","doc":"lpth_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-21-010019","doc":"lpth_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-22-012585","doc":"lpth_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001654954-23-011893","doc":"0001654954-23-011893.txt","q":null},{"fy":2024,"lvl":2,"n":6,"adsh":"0001654954-24-012103","doc":"lpth_10k.htm","q":"Recent examples of such system level capabilities include our development of a novel, unique approach to shutterless imaging that we can apply to any microbolometer, development of a technology for early detection of flames and fires using \u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0001654954-25-011130","doc":"lpth_10k.htm","q":null}]},{"cik":890264,"name":"EXA CORP","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-103290","doc":"d846615d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-511938","doc":"d118879d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001564590-17-005008","doc":"exa-10k_20170131.htm","q":null}]},{"cik":890394,"name":"PERASO INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002166","doc":"a2223385z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011164","doc":"a2227687z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001645383-17-000015","doc":"mosy-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001892","doc":"mosy-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007379","doc":"mosy-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011421","doc":"mosy-10k_20191231.htm","q":null},{"fy":2020,"lvl":"x","n":2,"adsh":"0001564590-21-014203","doc":"mosy-10k_20201231.htm","q":"The target applications are FPGA-based and include a broad range of markets, including test and measurement, 5G networks, router, switching, security, computational storage, database acceleration, Big Data, aerospace and defense, advanced v\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001564590-22-012981","doc":"0001564590-22-012981.txt","q":"The target applications for our memory ICs include a broad range of markets, including test and measurement, 5G networks, router, switching, security, computational storage, database acceleration, Big Data, aerospace and defense, advanced v\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024118","doc":"f10k2022_perasoinc.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-027971","doc":"ea0202249-10k_perasoinc.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001013762-25-004082","doc":"ea0235180-10k_perasoinc.htm","q":"Melder co-founded Cercle.ai, an AI technology company focused on advancing healthcare for women,and currently serves on its board of directors."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-036514","doc":"ea0282892-10k_peraso.htm","q":"Melder co-founded Cercle.ai, an AI technology company focused on advancing healthcare for women, and serves on its board of directors and, in October 2025, was appointed its chief executive officer."}]},{"cik":890465,"name":"NPS PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001136261-15-000049","doc":"form10k.htm","q":null}]},{"cik":890821,"name":"ENVERIC BIOSCIENCES, INC.","industry":"Computers & chips","sic":3674,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":1,"adsh":"0001079974-15-000209","doc":"spatz10k12312014.htm","q":"Bible earned an LLM in Tax from New York University School of Law, a JD with honors from St."},{"fy":2015,"lvl":"x","n":0,"adsh":"0001079974-16-001044","doc":"ameri10kt12312015.htm","q":null},{"fy":2017,"lvl":2,"n":6,"adsh":"0001140361-18-016275","doc":"form10k.htm","q":"Rapid Technology Shifts \u25cf Cloud services, robotic process automation, artificial intelligence and internet of things are increasingly in demand as part of outsourcing engagements."},{"fy":2018,"lvl":1,"n":3,"adsh":"0001140361-19-005573","doc":"form10k.htm","q":"Rapid Technology Shifts \u00b7 Cloud services, robotic process automation, artificial intelligence and internet of things are increasingly in demand as part of outsourcing engagements."},{"fy":2019,"lvl":1,"n":4,"adsh":"0001140361-20-006825","doc":"form10k.htm","q":"Rapid Technology Shifts \u2022 Cloud services, robotic process automation, artificial intelligence and internet of things are increasingly in demand as part of outsourcing engagements."},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-007757","doc":"form10-k.htm","q":null}]},{"cik":890821,"name":"ENVERIC BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001493152-22-008510","doc":"form10-k.htm","q":"To date we have created over 500 molecules that are housed in the Psybrary. - 4 - We screen newly synthesized molecules in the Psybrary\u2122 through PsyAI\u2122, a proprietary artificial intelligence (AI) tool."},{"fy":2022,"lvl":2,"n":8,"adsh":"0001493152-23-010431","doc":"form10-k.htm","q":"To date we have created over 500 molecules that are housed in the Psybrary\u2122. 5 We screen newly synthesized molecules in the Psybrary\u2122 through PsyAI\u2122, a proprietary artificial intelligence (AI) tool."},{"fy":2023,"lvl":"x","n":4,"adsh":"0001493152-24-011210","doc":"form10-k.htm","q":"The Company screens newly synthesized molecules in the Psybrary\u2122 through PsyAI\u2122, a proprietary artificial intelligence (\u201cAI\u201d) tool."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001296","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":15,"adsh":"0001493152-26-013294","doc":"form10-k.htm","q":"Accordingly, the PsyAI trademark remains an asset of Enveric Biosciences Canada, Inc. and is being further evaluated in view of the importance of the term \u201c AI \u201d in commerce."}]},{"cik":891103,"name":"MATCH GROUP, INC.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000891103-22-000020","doc":"mtch-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000891103-23-000013","doc":"mtch-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":47,"adsh":"0000891103-24-000014","doc":"mtch-20231231.htm","q":"Government regulation We are subject to a variety of laws and regulations in the United States and abroad that involve matters that are important to or may otherwise impact our business, including, among others, antitrust and competition is\u2026"},{"fy":2024,"lvl":3,"n":52,"adsh":"0000891103-25-000027","doc":"mtch-20241231.htm","q":"These laws and regulations involve matters including antitrust and competition, broadband internet access, online commerce, advertising, user privacy, data protection, intermediary liability, protection of minors, biometrics, consumer prote\u2026"},{"fy":2025,"lvl":3,"n":67,"adsh":"0000891103-26-000025","doc":"mtch-20251231.htm","q":"Hinge has Video and Voice Prompts, and Voice Notes, in addition to AI-enabled features, which allow users to better showcase who they are at different points in their dating journey."}]},{"cik":891293,"name":"CTI BIOPHARMA CORP","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001582","doc":"ctic-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000891293-16-000105","doc":"cti10k12312015document.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000891293-17-000030","doc":"cti10k12312016document.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000891293-18-000043","doc":"cti10k12312017document.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000891293-19-000021","doc":"cti10k12312018document.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000891293-20-000012","doc":"cti10k12312019document.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000891293-21-000008","doc":"ctic-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000891293-22-000010","doc":"ctic-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000891293-23-000011","doc":"ctic-20221231.htm","q":null}]},{"cik":891417,"name":"PEN INC.","industry":"Pharma & biotech","sic":8731,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001364","doc":"form10-k.htm","q":null}]},{"cik":892482,"name":"QUMU CORP","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000892482-15-000003","doc":"qumu10k10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000892482-16-000029","doc":"qumu10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000892482-17-000024","doc":"qumu10k12312016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0000892482-18-000015","doc":"qumu10k12312017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0000892482-19-000013","doc":"qumu10k12312018.htm","q":null},{"fy":2019,"lvl":"x","n":1,"adsh":"0000892482-20-000007","doc":"qumu10k12312019.htm","q":"Using AI-based transcription and translation technology, CaptionHub adds frame-accurate captions to Qumu enterprise video in real time\u2014and at broadcast quality\u2014in over 50 languages."},{"fy":2020,"lvl":0,"n":0,"adsh":"0000892482-21-000008","doc":"qumu-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000892482-22-000012","doc":"qumu-20211231.htm","q":null}]},{"cik":894158,"name":"THERIVA BIOLOGICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016433","doc":"v397966_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087267","doc":"v433075_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-012545","doc":"v459847_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-010286","doc":"tv485536_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-010592","doc":"tv513906_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-023415","doc":"tm205312-1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-032150","doc":"tm211106d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000405","doc":"syn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000428","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000293","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000285","doc":"tmb-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-026767","doc":"tmb-20251231x10k.htm","q":null}]},{"cik":894501,"name":"GOLD ROCK HOLDINGS, INC.","industry":"Construction","sic":1531,"state":"VA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001091818-22-000025","doc":"grhi10k1221.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001091818-23-000033","doc":"grh2722form10Kdec2022.htm","q":null},{"fy":2023,"lvl":"x","n":4,"adsh":"0001091818-24-000027","doc":"grhi12312310k.htm","q":"Loot8 provides enterprises the capability to oversee and manage their content on IPFS nodes, leveraging AI to make the underlying content interactive as a way to enable small businesses and content creators to scale at a faster pace and to \u2026"}]},{"cik":895051,"name":"CASI PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-018805","doc":"v404921_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-090485","doc":"v434565_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-017953","doc":"v462424_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-017897","doc":"tv489075_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-016832","doc":"tv516177_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-034018","doc":"tm205326d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003735","doc":"casi-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004437","doc":"casi-20211231x10k.htm","q":null}]},{"cik":895419,"name":"WOLFSPEED, INC.","industry":"Computers & chips","sic":3674,"state":"NC","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000895419-15-000058","doc":"cree-06282015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000895419-16-000167","doc":"cree06262016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000895419-17-000055","doc":"a06252017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000895419-18-000067","doc":"a06242018-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000895419-19-000046","doc":"a06302019-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000895419-20-000066","doc":"cree-20200628.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000895419-21-000070","doc":"cree-20210627.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000895419-22-000055","doc":"wolf-20220626.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000895419-23-000061","doc":"wolf-20230625.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000895419-24-000062","doc":"wolf-20240630.htm","q":null},{"fy":2025,"lvl":3,"n":44,"adsh":"0000895419-25-000110","doc":"wolf-20250629.htm","q":"Restrictions on access to our manufacturing facilities or on our support operations or workforce, or similar limitations for our vendors and suppliers, and restrictions or disruptions of transportation, such as reduced availability of air t\u2026"}]},{"cik":896747,"name":"AMERICAN BIO MEDICA CORP","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-019717","doc":"v404629_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-091507","doc":"v434411_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-018013","doc":"v462384_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003884","doc":"abmc_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-004490","doc":"abmc_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-007022","doc":"abmc_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-004250","doc":"abmc_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-005014","doc":"abmc_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-003260","doc":"abmc_10k.htm","q":null}]},{"cik":896841,"name":"AVID TECHNOLOGY, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0000896841-17-000052","doc":"avid-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000896841-18-000036","doc":"avid-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000896841-19-000019","doc":"avid-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000896841-20-000022","doc":"avid-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000896841-21-000035","doc":"avid-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000896841-22-000020","doc":"avid-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000896841-23-000019","doc":"avid-20221231.htm","q":null}]},{"cik":896878,"name":"INTUIT INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000896878-15-000116","doc":"fy15q410-kdocument.htm","q":null},{"fy":2017,"lvl":2,"n":5,"adsh":"0000896878-17-000130","doc":"fy17q410-kdocument.htm","q":"The result is a global market that is shifting from traditional services that are manual in nature to more automated, interconnected services that work on platforms and increasingly rely on artificial intelligence and machine learning."},{"fy":2018,"lvl":2,"n":9,"adsh":"0000896878-18-000171","doc":"fy18q410-kdocument.htm","q":"The result is a global market that is shifting from traditional services that are manual in nature to more automated, interconnected services that work on platforms and increasingly rely on artificial intelligence and machine learning."},{"fy":2019,"lvl":2,"n":14,"adsh":"0000896878-19-000132","doc":"fy19q410-kdocument.htm","q":"We build durable competitive advantage by using the power of artificial intelligence (A.I.) and other advanced technologies to deliver innovative solutions via our trusted open platform that builds connections between customers, partners an\u2026"},{"fy":2020,"lvl":2,"n":13,"adsh":"0000896878-20-000148","doc":"fy20q410-kdocument.htm","q":"The rise of Artificial Intelligence (AI) is fundamentally reshaping our world \u2014 and Intuit is taking advantage of this technological revolution to find new ways to deliver on our mission."},{"fy":2021,"lvl":3,"n":19,"adsh":"0000896878-21-000233","doc":"intu-20210731.htm","q":"The rise of Artificial Intelligence (AI) is fundamentally reshaping our world \u2014 and Intuit is taking advantage of this technological revolution to find new ways to deliver on our mission."},{"fy":2022,"lvl":3,"n":24,"adsh":"0000896878-22-000028","doc":"intu-20220731.htm","q":"The rise of artificial intelligence (AI) is fundamentally reshaping our world \u2014 and Intuit is taking advantage of this technological revolution to find new ways to improve the customer experience and deliver on our mission."},{"fy":2023,"lvl":3,"n":62,"adsh":"0000896878-23-000034","doc":"intu-20230731.htm","q":"The continuing evolution of artificial intelligence (AI) is fundamentally reshaping our world \u2014 and Intuit is taking advantage of this technological revolution to find new ways to improve the customer experience and deliver on our mission."},{"fy":2024,"lvl":3,"n":69,"adsh":"0000896878-24-000039","doc":"intu-20240731.htm","q":"Across our platform, we use the power of data and artificial intelligence (AI) to deliver three core benefits to our customers: helping put more money in their pockets, saving them time by eliminating work, and ensuring that they have compl\u2026"},{"fy":2025,"lvl":3,"n":79,"adsh":"0000896878-25-000035","doc":"intu-20250731.htm","q":"Serving approximately 100 million consumers, small and mid-market businesses, and accountants worldwide, Intuit\u2019s platform brings the power of artificial intelligence (AI) and human intelligence together to fuel customers\u2019 success."}]},{"cik":897075,"name":"REPROS THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016200","doc":"v403265_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087730","doc":"v432873_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-017919","doc":"v462270_10k.htm","q":null}]},{"cik":897077,"name":"ALAMO GROUP INC","industry":"Construction machinery","sic":3523,"state":"TX","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0000897077-15-000011","doc":"a201410k-body.htm","q":"Schwarze equipment includes truck-mounted air, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2015,"lvl":1,"n":1,"adsh":"0000897077-16-000097","doc":"a201510k-body.htm","q":"Schwarze equipment includes truck-mounted air, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2016,"lvl":1,"n":1,"adsh":"0000897077-17-000019","doc":"a201610k-body.htm","q":"Schwarze equipment includes truck-mounted air, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2017,"lvl":1,"n":1,"adsh":"0000897077-18-000010","doc":"a201710k-body.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2018,"lvl":1,"n":1,"adsh":"0000897077-19-000012","doc":"alg-20181231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2019,"lvl":1,"n":1,"adsh":"0000897077-20-000011","doc":"alg-20191231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2020,"lvl":1,"n":1,"adsh":"0000897077-21-000007","doc":"alg-20201231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2021,"lvl":1,"n":1,"adsh":"0000897077-22-000007","doc":"alg-20211231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2022,"lvl":1,"n":1,"adsh":"0000897077-23-000009","doc":"alg-20221231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2023,"lvl":1,"n":1,"adsh":"0000897077-24-000009","doc":"alg-20231231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, pothole patchers and replacement parts."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000897077-25-000007","doc":"alg-20241231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, and replacement parts."},{"fy":2025,"lvl":1,"n":1,"adsh":"0000897077-26-000016","doc":"alg-20251231.htm","q":"Schwarze equipment includes truck-mounted air vacuum, mechanical broom, and regenerative air sweepers, and replacement parts."}]},{"cik":897078,"name":"RESONATE BLENDS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001429","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-010417","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-004321","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-009029","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":6,"adsh":"0001493152-19-004713","doc":"form10-k.htm","q":"The SAM platform has the capacity to bring on several thousand new clients while adding new functionality such as Rich Communication Services (RCS) and Artificial Intelligence (AI)."},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-008581","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008844","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-010171","doc":"form10-ka.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-012539","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-014876","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-014461","doc":"form10-k.htm","q":null}]},{"cik":897448,"name":"AMARIN CORP PLCUK","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-075070","doc":"d855012d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-476872","doc":"d113204d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-065969","doc":"d328533d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003389","doc":"amrn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004655","doc":"amrn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006390","doc":"amrn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008382","doc":"amrn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002401","doc":"amrn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005336","doc":"amrn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-022636","doc":"amrn-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-037620","doc":"amrn-20241231.htm","q":"Our and our partners use of smart products, Internet of Things and artificial intelligence subjects us to increased cyber and technology risks."},{"fy":2025,"lvl":3,"n":19,"adsh":"0001193125-26-085818","doc":"amrn-20251231.htm","q":"Claims that we have violated individuals\u2019 privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend, require us to d\u2026"}]},{"cik":899394,"name":"HARBOR DIVERSIFIED, INC.","industry":"Pharma & biotech","sic":2834,"state":"WI","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-191135","doc":"d926157d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-103375","doc":"d159175d10k.htm","q":null}]},{"cik":899460,"name":"MANNKIND CORP","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073647","doc":"d844485d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505366","doc":"d107849d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-085519","doc":"d305327d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003510","doc":"mnkd-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004263","doc":"mnkd-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006198","doc":"mnkd-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008440","doc":"mnkd-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006702","doc":"mnkd-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-002309","doc":"mnkd-10k_20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-021423","doc":"mnkd-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0000950170-25-027735","doc":"mnkd-20241231.htm","q":"These actions may include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models to limit drug \u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-073516","doc":"mnkd-20251231.htm","q":"We and the third parties with whom we work may be subject to physical threats, such as telecommunications failures, earthquakes, fires or floods, as well as a variety of evolving threats, including but not limited to social-engineering atta\u2026"}]},{"cik":899866,"name":"ALEXION PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000899866-15-000016","doc":"alxn10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000899866-16-000226","doc":"alxn10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000899866-17-000044","doc":"alxn10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000899866-18-000022","doc":"alxn10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000899866-19-000010","doc":"alxn10k12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000899866-20-000012","doc":"alxn10k12312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000899866-21-000014","doc":"alxn-20201231.htm","q":null}]},{"cik":903129,"name":"GENTHERM INC","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":3,"n":44,"adsh":"0001564590-15-001170","doc":"thrm-10k_20141231.htm","q":"Industrial The Industrial reporting segment represents the combined results from our subsidiary, Gentherm Global Power Technologies (\u201cGPT\u201d), a global market leader and developer of thermoelectric generators, and Gentherm\u2019s advanced research\u2026"},{"fy":2015,"lvl":3,"n":36,"adsh":"0001564590-16-013314","doc":"thrm-10k_20151231.htm","q":"Lower oil prices may adversely impact our Gentherm Global Power Technologies (GPT) business A large portion of our GPT products is sold to companies in the oil and gas industry."},{"fy":2016,"lvl":3,"n":29,"adsh":"0001564590-17-002183","doc":"thrm-10k_20161231.htm","q":"Lower oil prices may adversely impact our Gentherm Global Power Technologies (GPT) business A large portion of our GPT products is sold to companies in the oil and gas industry."},{"fy":2017,"lvl":3,"n":18,"adsh":"0001564590-18-003000","doc":"thrm-10k_20171231.htm","q":"Our remote power generation systems business is managed by our subsidiary Gentherm Global Power Technologies (\u201cGPT\u201d) and our patient temperature management and environment test equipment businesses are managed by our subsidiary Cincinnati S\u2026"},{"fy":2018,"lvl":3,"n":43,"adsh":"0001564590-19-004505","doc":"thrm-10k_20181231.htm","q":"Our remote power generation systems business is managed by our subsidiary Gentherm Global Power Technologies (\u201cGPT\u201d) and our patient temperature management and environment test equipment businesses are managed by our subsidiary Cincinnati S\u2026"},{"fy":2019,"lvl":3,"n":40,"adsh":"0001564590-20-005507","doc":"thrm-10k_20191231.htm","q":"On February 1, 2019, the Company completed the divestiture of its environmental test equipment business, Cincinnati Sub Zero industrial chamber business (\u201cCSZ-IC\u201d), and on October 1, 2019, the Company completed the divestiture of its remote\u2026"},{"fy":2020,"lvl":3,"n":37,"adsh":"0001564590-21-009900","doc":"thrm-10k_20201231.htm","q":"Medical In 2018 and 2019, our Industrial reporting segment represented the combined results from our patient temperature management systems business (\u201cMedical\u201d), remote power generation systems business, Gentherm Global Power Technologies (\u2026"},{"fy":2021,"lvl":2,"n":11,"adsh":"0001564590-22-005577","doc":"thrm-10k_20211231.htm","q":"We utilize machine learning to create and optimize state of the art algorithms to make our products smarter and more advanced with each generation. \u25aa Focus on health and wellness \u2013 Consumers have an increased focus on personal health and we\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-004405","doc":"thrm-20221231.htm","q":"We utilize machine learning to create and optimize state of the art algorithms to make our products smarter and more advanced with each generation. \u25aa Focus on health and wellness \u2013 Consumers have an increased focus on personal health and we\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-018007","doc":"thrm-20231231.htm","q":"We utilize machine learning to create and optimize state of the art algorithms to make our products smarter and more advanced with each generation. \u25aa Focus on health and wellness \u2013 Consumers have an increased focus on personal health and we\u2026"},{"fy":2024,"lvl":3,"n":20,"adsh":"0000950170-25-023344","doc":"thrm-20241231.htm","q":"We utilize machine learning to create and optimize state of the art algorithms to make our products smarter and more advanced with each generation. \u25aa Focus on health and wellness \u2013 Consumers have an increased focus on personal health and we\u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0001193125-26-059602","doc":"thrm-20251231.htm","q":"Information technology security threats, including security breaches, computer malware, \u201cransomware\u201d and other cybersecurity incidents, are increasing in frequency, uniqueness and sophistication to evade detection and remove forensic eviden\u2026"}]},{"cik":906163,"name":"NVR INC","industry":"Construction","sic":1531,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000764","doc":"nvr-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012809","doc":"nvr-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001623","doc":"nvr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000906163-18-000007","doc":"a201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000906163-19-000029","doc":"nvr201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000906163-20-000026","doc":"a201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000906163-21-000017","doc":"nvr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000906163-22-000008","doc":"nvr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000906163-23-000023","doc":"nvr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000906163-24-000033","doc":"nvr-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000906163-25-000011","doc":"nvr-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0000906163-26-000018","doc":"nvr-20251231.htm","q":"The rapid evolution and increased adoption of artificial intelligence technologies may also heighten our cybersecurity risks by making cyber-attacks more difficult to detect, contain, and mitigate."}]},{"cik":906192,"name":"SRA INTERNATIONAL, INC.","industry":"Software & IT services","sic":7370,"state":"VA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-283282","doc":"d83729d10k.htm","q":null}]},{"cik":906709,"name":"NEKTAR THERAPEUTICS","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-063338","doc":"d842626d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013759","doc":"nktr-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003064","doc":"nktr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004105","doc":"nktr-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005639","doc":"nktr-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000906709-20-000004","doc":"nktr-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000906709-21-000005","doc":"nktr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000906709-22-000005","doc":"nktr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000906709-23-000004","doc":"nktr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-026249","doc":"nktr-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":22,"adsh":"0000950170-25-039389","doc":"nktr-20241231.htm","q":"Like many companies, we may use artificial intelligence (AI) technologies, including generative AI, to efficiently grow and manage our business."},{"fy":2025,"lvl":3,"n":42,"adsh":"0001193125-26-104547","doc":"nktr-20251231.htm","q":"Like many companies, we may use artificial intelligence (AI) technologies, including generative AI, which presents risks and challenges that can impact our business, including by posing cybersecurity risks to our confidential information, p\u2026"}]},{"cik":907562,"name":"DYAX CORP","industry":"Pharma & biotech","sic":8731,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-012718","doc":"v401127_10k.htm","q":null}]},{"cik":907654,"name":"ORUKA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":2,"n":6,"adsh":"0001213900-25-021165","doc":"ea0230445-10k_orukathe.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and antidiscrimination."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001213900-26-026929","doc":"ea0273300-10k_oruka.htm","q":"Use of artificial intelligence (\u201cAI\u201d) and machine learning technologies in research, analytics, and business operations is subject to a rapidly evolving legal and regulatory landscape."}]},{"cik":908255,"name":"BORGWARNER INC","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000908255-15-000012","doc":"a10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000908255-16-000077","doc":"a10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000908255-17-000011","doc":"a10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000908255-18-000017","doc":"a10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000908255-19-000014","doc":"a2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000908255-20-000014","doc":"a2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000908255-21-000008","doc":"bwa-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000908255-22-000009","doc":"bwa-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000908255-23-000013","doc":"bwa-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000908255-24-000007","doc":"bwa-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0000908255-25-000007","doc":"bwa-20241231.htm","q":"Further, we continually update and expand our information technology systems to enable us to run our business more efficiently, including the potential incorporation of artificial intelligence (\u201cA.I.\u201d) solutions into our information systems\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0000908255-26-000011","doc":"bwa-20251231.htm","q":"If we do not continue to innovate and develop, or acquire, new and compelling products that capitalize upon new technologies, including artificial intelligence (\u201cAI\u201d) and machine learning, or improve in response to OEM and consumer preferen\u2026"}]},{"cik":908259,"name":"ONCOTELIC THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-111261","doc":"d847033d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-518083","doc":"d124220d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-103621","doc":"d312455d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-18-119206","doc":"d506519d10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001193125-19-102832","doc":"d656298d10k.htm","q":null},{"fy":2019,"lvl":3,"n":55,"adsh":"0001493152-20-008845","doc":"form10-k.htm","q":"As a result of the merger of the Company and Oncotelic and the acquisition of PointR in April and November 2019, respectively, we believe we are well positioned as a biotech company with: 1) PointR AI/blockchain for superfast back office su\u2026"},{"fy":2020,"lvl":3,"n":86,"adsh":"0001493152-21-008920","doc":"form10-k.htm","q":"(\u201c PointR \u201d), a Delaware corporation, and EdgePoint AI, Inc."},{"fy":2021,"lvl":3,"n":85,"adsh":"0001493152-22-010094","doc":"form10-k.htm","q":"(\u201c PointR \u201d), a Delaware corporation, and EdgePoint AI, Inc."},{"fy":2022,"lvl":3,"n":73,"adsh":"0001493152-23-012352","doc":"form10-k.htm","q":"(\u201c PointR \u201d), a Delaware corporation, Pet2DAO, Inc., a Delaware and EdgePoint AI, Inc."},{"fy":2023,"lvl":3,"n":50,"adsh":"0001493152-24-014475","doc":"form10-k.htm","q":"(\u201c PointR \u201d), a Delaware corporation, Pet2DAO, Inc., a Delaware and EdgePoint AI, Inc."},{"fy":2024,"lvl":3,"n":36,"adsh":"0001641172-25-004846","doc":"form10-k.htm","q":"(\u201c PointR \u201d), a Delaware corporation, Pet2DAO, Inc., a Delaware corporation; and EdgePoint AI, Inc."},{"fy":2025,"lvl":3,"n":47,"adsh":"0001493152-26-016838","doc":"form10-k.htm","q":"(\u201c PointR \u201d), a Delaware corporation, Pet2DAO, Inc., a Delaware corporation; and EdgePoint AI, Inc."}]},{"cik":910267,"name":"TITAN PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-019881","doc":"v404713_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088046","doc":"v432940_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-014986","doc":"v461168_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-018448","doc":"tv488958_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-017459","doc":"tv516475_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-040354","doc":"tm205305-1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-044732","doc":"tm211758d1_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-22-000518","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":1,"adsh":"0001829126-23-002504","doc":"titanpharma_10k.htm","q":"(OTCMKTS: RIGG), AI Technology Group, Inc., Reliance Global Group, Inc."},{"fy":2023,"lvl":"x","n":1,"adsh":"0001829126-24-002110","doc":"titanpharma_10k.htm","q":"(OTCMKTS: RIGG), AI Technology Group, Inc., Reliance Global Group, Inc."},{"fy":2024,"lvl":"x","n":1,"adsh":"0001829126-25-001934","doc":"titanpharma_10k.htm","q":"Flores is a Mechatronics Engineer with an Artificial Intelligence specialty (2004-2009) Student of the MBA (MBA) at Tecnol\u00f3gico de Monterrey."}]},{"cik":910638,"name":"3D SYSTEMS CORP","industry":"Software & IT services","sic":7372,"state":"SC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000910638-15-000003","doc":"ddd-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000910638-16-000016","doc":"ddd-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000910638-17-000003","doc":"ddd-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000910638-18-000006","doc":"ddd-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000910638-19-000004","doc":"ddd20181231ex1011.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000910638-20-000010","doc":"ddd-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000910638-21-000008","doc":"ddd-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":4,"adsh":"0000910638-22-000013","doc":"ddd-20211231.htm","q":"The cloud-based solution leverages the Industrial Internet of Things, artificial intelligence, and machine learning technologies to deliver solutions to customers seeking to automate their digital manufacturing workflows, scale their operat\u2026"},{"fy":2022,"lvl":2,"n":5,"adsh":"0000910638-23-000009","doc":"ddd-20221231.htm","q":"As part of this relationship, 3D Systems and Enhatch will incorporate the automation and artificial intelligence capabilities of Enhatch\u2019s Intelligent Surgery Ecosystem into 3D Systems\u2019 proven workflow for patient-specific surgical planning\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0000910638-24-000030","doc":"ddd-20231231.htm","q":"The cloud-based solution leverages the Industrial Internet of Things, artificial intelligence, and machine learning technologies to deliver a solution for customers to automate their digital manufacturing workflows, scale their operations a\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000910638-25-000005","doc":"ddd-20241231.htm","q":"Through these platforms, the Company will continue to offer software solutions for design, build preparation simulation, automation of repetitive tasks, inspection, preparing and optimizing CAD and polygon data, increasingly leveraging the \u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001628280-26-015997","doc":"ddd-20251231.htm","q":"We have built unique expertise in polymer printing based on our investment in 3D Sprint where customers\u2019 3D content is optimized for additive manufacturing. 3D Sprint uses artificial intelligence and machine learning, user-friendly interfac\u2026"}]},{"cik":911216,"name":"PALATIN TECHNOLOGIES INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-15-004334","doc":"ptn_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-17-008792","doc":"ptn_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-18-010150","doc":"ptn_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-19-010679","doc":"ptn_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-20-010471","doc":"ptn_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-21-010495","doc":"ptn_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-22-012862","doc":"ptn_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001654954-23-012335","doc":"ptn_10k.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001654954-24-012498","doc":"ptn_10k.htm","q":"To the extent that any disruption or security breach results in a loss of or damage to our data or applications or other data or applications relating to our technology, intellectual property, research and development or product candidates,\u2026"},{"fy":2025,"lvl":"x","n":16,"adsh":"0001654954-25-011030","doc":"ptn_10k.htm","q":"To the extent that any disruption or security breach results in a loss of or damage to our data or applications or other data or applications relating to our technology, intellectual property, research and development or product candidates,\u2026"}]},{"cik":911326,"name":"SYNAGEVA BIOPHARMA CORP","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065709","doc":"d856934d10k.htm","q":null}]},{"cik":912093,"name":"VIAVI SOLUTIONS INC.","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-15-061694","doc":"a15-16909_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000912093-16-000035","doc":"viavq4fy1610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000912093-17-000022","doc":"viavq4fy1710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000912093-18-000059","doc":"viavq4fy1810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000912093-19-000023","doc":"viavq4fy1910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000912093-20-000057","doc":"viavq4fy2010-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000912093-21-000128","doc":"viav-20210703.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0000912093-22-000042","doc":"viav-20220702.htm","q":"The increase in demand for 5G services will be increasingly supported by automation and associated artificial intelligence and machine learning, which will further enable enterprise requirements for private 5G as well as numerous use cases \u2026"},{"fy":2023,"lvl":1,"n":4,"adsh":"0000912093-23-000037","doc":"viav-20230701.htm","q":"These solutions provide our customers enhanced network management, control, optimization and differentiation and a complete service assurance platform for mobile communications, providing operators with network performance, inventory, confi\u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0000912093-24-000063","doc":"viav-20240629.htm","q":"These instruments are enhanced with artificial intelligence and machine learning and built-in automation and analytics with user interfaces that are designed to simplify operations and minimize the training required to operate them."},{"fy":2025,"lvl":2,"n":13,"adsh":"0000912093-25-000096","doc":"viav-20250628.htm","q":"In support of our business segments, we are pursuing a corporate strategy that we believe will best position us for future opportunities as follows: \u2022 Defend and consolidate leadership in core business segments: \u2013 NSE: Lab-to-Field integrat\u2026"}]},{"cik":914475,"name":"NEUROCRINE BIOSCIENCES INC","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-039176","doc":"d833755d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-459862","doc":"d119733d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-043838","doc":"d324435d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-042794","doc":"d520757d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-002328","doc":"nbix-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-003773","doc":"nbix-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000914475-21-000020","doc":"nbix-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000914475-22-000013","doc":"nbix-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000914475-23-000011","doc":"nbix-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0000914475-24-000054","doc":"nbix-20231231.htm","q":"Additionally, if our employees, commercial collaborators or consultants use generative artificial intelligence (AI) technologies to develop our proprietary technology and compounds, it may impact our ability to obtain or successfully defend\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0000914475-25-000037","doc":"nbix-20241231.htm","q":"Additionally, if our employees, commercial collaborators or consultants use generative artificial intelligence (AI) technologies to develop our proprietary technology and compounds, it may impact our ability to obtain or successfully defend\u2026"},{"fy":2025,"lvl":3,"n":22,"adsh":"0000914475-26-000007","doc":"nbix-20251231.htm","q":"Additionally, if our employees, commercial collaborators or consultants use generative artificial intelligence (AI) technologies to develop our proprietary technology and compounds, it may impact our ability to obtain or successfully defend\u2026"}]},{"cik":915778,"name":"DSP GROUP INC /DE/","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-005165","doc":"dspg20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-027709","doc":"dspg20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-004713","doc":"dspg20161231_10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001437749-18-004874","doc":"dspg20171231_10k.htm","q":"In particular, there is a limited supply of RF chip designers and highly-qualified engineers with digital signal processing, machine learning and artificial intelligence experience."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001437749-19-004573","doc":"dspg20181231_10k.htm","q":"In particular, there is a limited supply of RF chip designers and highly-qualified engineers with digital signal processing, machine learning and artificial intelligence experience."},{"fy":2019,"lvl":2,"n":8,"adsh":"0001437749-20-004811","doc":"dspg20191231_10k.htm","q":"(NASDAQ: DSPG) is a global leader in wireless, audio, voice and AI chipsets for a wide range of smart-enabled devices."},{"fy":2020,"lvl":2,"n":10,"adsh":"0001437749-21-006076","doc":"dspg20201231_10k.htm","q":"We have incorporated this HDClear technology into our SmartVoice product family which consists of a comprehensive suite of artificial intelligence (AI) and machine learning (ML) embedded noise suppression and voice quality enhancement produ\u2026"}]},{"cik":915840,"name":"BEAZER HOMES USA INC","industry":"Construction","sic":1531,"state":"GA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000915840-15-000030","doc":"bzh-9301510kdocument.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000915840-16-000135","doc":"bzh-9301610kdocument.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000915840-17-000037","doc":"bzh-9301710kdocument.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000915840-18-000052","doc":"bzh-9301810kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000915840-19-000058","doc":"bzh-9301910kdocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000915840-20-000068","doc":"bzh-20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000915840-21-000055","doc":"bzh-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000915840-22-000035","doc":"bzh-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000915840-23-000053","doc":"bzh-20230930.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0000915840-24-000069","doc":"bzh-20240930.htm","q":"Presently, we employ a limited array of both traditional and generative artificial intelligence (\u201cAI\u201d) solutions for certain functions for our operations."},{"fy":2025,"lvl":2,"n":10,"adsh":"0000915840-25-000075","doc":"bzh-20250930.htm","q":"Presently, we employ a limited array of traditional and generative artificial intelligence (AI) solutions for certain functions for our operations."}]},{"cik":916457,"name":"CALPINE CORP","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000916457-15-000010","doc":"cpn_10kx12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000916457-16-000057","doc":"cpn_10kx12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000916457-17-000007","doc":"cpn_10kx12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000916457-18-000007","doc":"cpn_10kx12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000916457-19-000016","doc":"cpn_10kx12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000916457-20-000007","doc":"cpn_10kx12312019.htm","q":null}]},{"cik":916863,"name":"INTEGRYS ENERGY GROUP, INC.","industry":"Utilities","sic":4931,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000916863-15-000004","doc":"a2014teg10k.htm","q":null}]},{"cik":917273,"name":"RAMBUS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000917273-15-000005","doc":"rmbs-20141231x10xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000917273-16-000027","doc":"rmbs-20151231x10xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000917273-17-000007","doc":"rmbs-20161231x10xk.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0000917273-18-000007","doc":"rmbs-20171231x10xk.htm","q":"Additionally, we announced the GDDR6 (Graphics Double Data Rate) Memory PHY for Artificial Intelligence (AI), automotive and networking, with a comprehensive solution to be offered in conjunction with Micron, Northwest Logic and Avery Desig\u2026"},{"fy":2018,"lvl":2,"n":5,"adsh":"0000917273-19-000006","doc":"rmbs-20181231x10xk.htm","q":"Integrated into a wide array of devices and systems, our products power and secure diverse applications, including data center and networking, artificial intelligence and machine learning, IoT, and automotive."},{"fy":2019,"lvl":2,"n":8,"adsh":"0000917273-20-000005","doc":"rmbs-20191231x10xk.htm","q":"This not only allows us to better serve our traditional data center and communications markets, but also to expand into new, fast-growing markets that demand the highest levels of performance and security, including automotive, artificial i\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0000917273-21-000005","doc":"rmbs-20201231.htm","q":"The ongoing shift to the cloud, along with the widespread advancement of artificial intelligence (\u201cAI\u201d) across the data center, 5G, automotive and Internet of Things (\u201cIoT\u201d), has led to exponential growth in data usage and tremendous demand\u2026"},{"fy":2021,"lvl":2,"n":9,"adsh":"0000917273-22-000010","doc":"rmbs-20211231.htm","q":"The ongoing shift to the cloud, along with the widespread advancement of artificial intelligence (\u201cAI\u201d) across the data center, edge and Internet of Things (\u201cIoT\u201d) end points, has led to exponential growth in data usage and tremendous deman\u2026"},{"fy":2022,"lvl":2,"n":7,"adsh":"0000917273-23-000008","doc":"rmbs-20221231.htm","q":"The ongoing growth of the cloud, along with the widespread advancement of artificial intelligence (\u201cAI\u201d) and other data-intensive workloads, continue to drive an exponential increase in data usage and demands on data infrastructure."},{"fy":2023,"lvl":2,"n":12,"adsh":"0000917273-24-000028","doc":"rmbs-20231231.htm","q":"With the exponential increase in the complexity, size and number of advanced workloads, like generative artificial intelligence (\u201cAI\u201d), the demands on computing infrastructure continue to grow at an accelerated pace."},{"fy":2024,"lvl":3,"n":36,"adsh":"0000917273-25-000021","doc":"rmbs-20241231.htm","q":"Business Overview Rambus is a global semiconductor company dedicated to enabling the future of the data center and artificial intelligence (\u201cAI\u201d) by delivering innovative memory and security solutions that address the evolving needs of the \u2026"},{"fy":2025,"lvl":3,"n":46,"adsh":"0001193125-26-057101","doc":"rmbs-20251231.htm","q":"Business Overview Rambus is a global semiconductor company providing industry-leading chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (\u201cAI\u201d) infrastructure."}]},{"cik":918251,"name":"MOTORCAR PARTS OF AMERICA INC","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-024320","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-069709","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-024968","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-18-028577","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-011947","doc":"hc10002514x1_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-013784","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-020805","doc":"brhc10025622_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-022893","doc":"brhc10038580_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-029664","doc":"brhc20054204_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-029700","doc":"ef20026278_10k.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0001140361-25-021940","doc":"ef20046978_10k.htm","q":"We use artificial intelligence technologies in our business, and the use of these technologies involve technological and legal risk."}]},{"cik":918581,"name":"CIBER INC","industry":"Software & IT services","sic":7371,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000918581-15-000025","doc":"a123114-10kxciber.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000918581-16-000141","doc":"a123115-10kxciber.htm","q":null}]},{"cik":919745,"name":"DARA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001214659-15-001939","doc":"s22615110k.htm","q":null}]},{"cik":920448,"name":"BROADVISION INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000920448-15-000022","doc":"bvsn-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000920448-16-000127","doc":"bvsn-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000920448-17-000021","doc":"bvsn-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000920448-18-000020","doc":"bvsn-20171231x10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001562762-19-000093","doc":"bvsn-20181231x10k.htm","q":null}]},{"cik":920465,"name":"LA JOLLA PHARMACEUTICAL CO","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000920465-15-000009","doc":"ljpc-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000920465-16-000106","doc":"ljpc-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000920465-17-000025","doc":"ljpc-201610xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000920465-18-000007","doc":"ljpc-201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000920465-19-000044","doc":"ljpc-201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000920465-20-000036","doc":"ljpc-201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011366","doc":"ljpc-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009182","doc":"ljpc-10k_20211231.htm","q":null}]},{"cik":920760,"name":"LENNAR CORP /NEW/","industry":"Construction","sic":1520,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-000218","doc":"len-20141130x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-010323","doc":"len-20151130x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-000327","doc":"len-20161130x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-000562","doc":"len-20171130x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-000598","doc":"len-20181130x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-000559","doc":"len-20191130x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-000722","doc":"len-20201130.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-001450","doc":"len-20211130.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-001606","doc":"len-20221130.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-002371","doc":"len-20231130.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001628280-25-002404","doc":"len-20241130.htm","q":"Cyber intrusion efforts are becoming increasingly frequent and sophisticated, including as a result of the use of artificial intelligence, and it is possible that any controls we or third parties have installed could at some time be breache\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001628280-26-003870","doc":"len-20251130.htm","q":"Cyber intrusion efforts are becoming increasingly frequent and sophisticated, including as a result of the use of artificial intelligence (\u201cAI\u201d), and it is possible that any controls we or third parties have installed could at some time be \u2026"}]},{"cik":921114,"name":"ARMATA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-023071","doc":"v407144_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091546","doc":"v429366_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-016833","doc":"v461502_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-014652","doc":"tv487129_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-015711","doc":"tv514748_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002943","doc":"armp-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003202","doc":"armp-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003845","doc":"armp-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004014","doc":"armp-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003706","doc":"armp-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":18,"adsh":"0001558370-25-003406","doc":"armp-20241231x10k.htm","q":"Our ability to respond to these developments or comply with any resulting new legal or regulatory requirements, including those involving economic and trade sanctions, could increase our costs of doing business, reduce our financial flexibi\u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001104659-26-034532","doc":"armp-20251231x10k.htm","q":"Our ability to respond to these developments or comply with any resulting new legal or regulatory requirements, including those involving economic and trade sanctions, could increase our costs of doing business, reduce our financial flexibi\u2026"}]},{"cik":921299,"name":"KYNTRA BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013728","doc":"fgen-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003095","doc":"fgen-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003508","doc":"fgen-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004979","doc":"fgen-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008161","doc":"fgen-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009871","doc":"fgen-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007632","doc":"fgen-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004668","doc":"fgen-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0000950170-24-020161","doc":"fgen-20231231.htm","q":"Additionally, companies that transfer personal data out of the EEA and UK to other jurisdictions are subject to scrutiny from regulators, individual litigants, and activities groups. 45 Our employees and personnel could use generative artif\u2026"},{"fy":2024,"lvl":2,"n":10,"adsh":"0000950170-25-040280","doc":"fgen-20241231.htm","q":"We are planning to bring artificial intelligence (\u201cAI\u201d) into our IT platforms and services."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-108346","doc":"kynb-20251231.htm","q":"We are utilizing artificial intelligence (\u201cAI\u201d) within our IT platforms and services."}]},{"cik":922224,"name":"PPL CORP","industry":"Utilities","sic":4911,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000922224-15-000016","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000922224-17-000010","doc":"ppl-1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000922224-18-000023","doc":"ppl-1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000922224-19-000015","doc":"ppl-1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000922224-20-000005","doc":"ppl-1231201910k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0000922224-21-000006","doc":"ppl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000922224-22-000005","doc":"ppl-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0000922224-23-000010","doc":"ppl-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000922224-24-000008","doc":"ppl-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":20,"adsh":"0000922224-25-000009","doc":"ppl-20241231.htm","q":"Artificial intelligence (AI) is an emerging area of technology that has the potential to impact various aspects of our business operations and customer interactions."},{"fy":2025,"lvl":3,"n":18,"adsh":"0000922224-26-000008","doc":"ppl-20251231.htm","q":"Much of this demand is driven by interconnecting with and providing power to data centers and large load customers to serve an increasingly digital economy and to support artificial intelligence."}]},{"cik":922247,"name":"CYCLO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001437749-23-007064","doc":"ctdh20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-008181","doc":"ctdh20231231c_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-24-037835","doc":"ctdh20231231d_10ka.htm","q":null}]},{"cik":922521,"name":"FALCONSTOR SOFTWARE INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000922521-15-000005","doc":"a12312014-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000922521-16-000034","doc":"a12312015-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000922521-17-000004","doc":"a12312016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003907","doc":"a12312017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-003503","doc":"a12312018-10k.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001628280-20-003823","doc":"a12312019-10k.htm","q":"Additionally, we believe that data archives will play an increasing role in training and validating AI and Machine Learning algorithms and optimizing strategic analytic model outcomes."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001628280-21-004460","doc":"falc-20201231.htm","q":"Additionally, we believe that data archives will play an increasing role in training and validating AI and Machine Learning algorithms and optimizing strategic analytic model outcomes."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001628280-22-005808","doc":"falc-20211231.htm","q":"We believe that data archives will play an increasing role in training and validating artificial intelligence and machine learning algorithms and optimizing strategic analytic model outcomes."},{"fy":2022,"lvl":1,"n":4,"adsh":"0000950170-23-009553","doc":"falc-20221231.htm","q":"We believe that data archives will play an increasing role in training and validating artificial intelligence and machine learning algorithms and optimizing strategic analytic model outcomes."}]},{"cik":923796,"name":"GEO GROUP INC","industry":"Construction","sic":1520,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004713","doc":"geo-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023181","doc":"geo-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0000950170-25-029972","doc":"geo-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001193125-26-071747","doc":"geo-20251231.htm","q":null}]},{"cik":924822,"name":"MILLER INDUSTRIES INC /TN/","industry":"Auto manufacturing","sic":3713,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-001634","doc":"t81593_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-012829","doc":"t1600126_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-002448","doc":"t1700138_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013387","doc":"tv487298_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-012559","doc":"tv514686_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000924822-20-000010","doc":"mlr-20191231x10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0000924822-21-000009","doc":"mlr-20201231x10k.htm","q":"This framework is the foundation of our migration to a multi-tenant cloud environment which includes global ERP, human capital management, data analytics and artificial intelligence."},{"fy":2021,"lvl":0,"n":0,"adsh":"0000924822-22-000013","doc":"mlr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003178","doc":"mlr-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001558370-24-002625","doc":"mlr-20231231x10k.htm","q":"Our industry is marked by rapid technological developments and innovations (such as the use of artificial intelligence and machine learning) and evolving industry standards."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001558370-25-002276","doc":"mlr-20241231x10k.htm","q":"Our industry is marked by rapid technological developments and innovations (such as the use of artificial intelligence and machine learning) and evolving industry standards."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001104659-26-023486","doc":"mlr-20251231x10k.htm","q":"Our industry is marked by rapid technological developments and innovations (such as the use of artificial intelligence and machine learning) and evolving industry standards."}]},{"cik":925741,"name":"BIOCARDIA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004870","doc":"bcda20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-006300","doc":"bcda20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-007405","doc":"bcda20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007543","doc":"bcda20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007544","doc":"bcda20211231_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001437749-23-008312","doc":"bcda20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-009587","doc":"bcda20231231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001437749-25-009397","doc":"bcda20241231_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001437749-26-009587","doc":"bcda20251231_10k.htm","q":null}]},{"cik":926326,"name":"OMNICELL, INC.","industry":"Computers & chips","sic":3571,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000926326-15-000012","doc":"omcl201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000926326-16-000044","doc":"omcl201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000926326-17-000015","doc":"omcl201610-k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0000926326-18-000010","doc":"omcl201710-k.htm","q":"IVX Workflow powered by IVX Cloud is an innovative sterile compounding workflow solution that leverages integrated barcode scanning, gravimetric or volumetric verification, advanced image recognition, photo documentation and label printing \u2026"},{"fy":2018,"lvl":0,"n":0,"adsh":"0000926326-19-000007","doc":"omcl201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000926326-20-000010","doc":"omcl-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000926326-21-000007","doc":"omcl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000926326-22-000007","doc":"omcl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000926326-23-000003","doc":"omcl-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":21,"adsh":"0000926326-24-000008","doc":"omcl-20231231.htm","q":"Additionally, data and digital services regulation continues to expand, particularly with respect to the artificial intelligence (\u201cAI\u201d) and automated decision making, which may further impact our or our customer\u2019s business and regulatory co\u2026"},{"fy":2024,"lvl":3,"n":44,"adsh":"0000926326-25-000003","doc":"omcl-20241231.htm","q":"Artificial Intelligence Data and digital services regulation continues to expand, particularly with respect to the artificial intelligence (\u201cAI\u201d) and automated decision making, which may further impact our and our customer\u2019s business and re\u2026"},{"fy":2025,"lvl":3,"n":50,"adsh":"0000926326-26-000006","doc":"omcl-20251231.htm","q":"The Rule imposes stringent obligations on companies within its scope and prohibits or restricts \u201ccovered data transactions\u201d that grant countries of concern or covered persons access to bulk U.S. sensitive personal data or any amount of \u201cgov\u2026"}]},{"cik":926423,"name":"MIND TECHNOLOGY, INC","industry":"Aerospace & defense","sic":3812,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0000926423-21-000011","doc":"mind-20210131.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-010274","doc":"mind20220131_10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001437749-23-011925","doc":"mind20230131_10k.htm","q":"We also have recently introduced Spectral Ai\u2122, which we believe is a cutting-edge software suite for side scan sonar data."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001437749-24-013973","doc":"mind20240131_10k.htm","q":"Spectral Ai and Software- Prior to the sale of Klein, we developed a data handling and automatic target recognition (\u201cATR\u201d) software system designed specifically for Klein side scan sonar systems which we refer to a Spectral Ai\u2122."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001437749-25-013105","doc":"mind20250131_10k.htm","q":"Spectral Ai and Software \u2013 Prior to the sale of Klein, we developed a data handling and automatic target recognition (\u201cATR\u201d) software system designed specifically for Klein side scan sonar systems which we refer to as Spectral Ai\u2122."}]},{"cik":926844,"name":"FUSS BRANDS CORP.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001829126-21-006356","doc":"chinabotanic_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001829126-21-016607","doc":"chinabotanic_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001829126-23-001055","doc":"fussbrands_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001829126-24-000716","doc":"fussbrands_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001829126-25-000871","doc":"fussbrands_10k.htm","q":null}]},{"cik":927761,"name":"MYMETICS CORP","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001354488-15-001391","doc":"mymx_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-16-006652","doc":"mymx_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002759","doc":"mymx_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003340","doc":"mymx_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-003503","doc":"mymx_10q.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-003481","doc":"mymx_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003626","doc":"mymx_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-004347","doc":"mymx_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-004582","doc":"mymx_10k.htm","q":null}]},{"cik":928576,"name":"MIDAMERICAN ENERGY CO","industry":"Utilities","sic":4911,"state":"IA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000928576-15-000003","doc":"llcmec123114form10-k.htm","q":null}]},{"cik":929940,"name":"ASPEN TECHNOLOGY INC /DE/","industry":"Software & IT services","sic":7371,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-006824","doc":"a2225705z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-16-018906","doc":"azpn-20160630x10k.htm","q":null},{"fy":2017,"lvl":2,"n":5,"adsh":"0000929940-17-000024","doc":"azpn-20170630x10k.htm","q":"We combine decades of process modeling and operations expertise with big data machine-learning and analytics."},{"fy":2018,"lvl":2,"n":6,"adsh":"0000929940-18-000023","doc":"azpn-20180630x10k.htm","q":"We combine decades of process modeling and operations expertise with big data machine-learning and analytics."},{"fy":2019,"lvl":2,"n":7,"adsh":"0000929940-19-000038","doc":"azpn-20190630x10k.htm","q":"We combine decades of process modeling and operations expertise with big data machine-learning and analytics."},{"fy":2020,"lvl":2,"n":10,"adsh":"0000929940-20-000069","doc":"azpn-20200630x10k.htm","q":"We combine decades of process modeling and operations expertise with big data, artificial intelligence, and advanced analytics."},{"fy":2021,"lvl":3,"n":56,"adsh":"0000929940-21-000060","doc":"azpn-20210630.htm","q":"We combine decades of process modeling and operations expertise with big data, artificial intelligence, and advanced analytics."}]},{"cik":932111,"name":"MICREL INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000932111-15-000006","doc":"mcrl-201410k.htm","q":null}]},{"cik":933034,"name":"STRATTEC SECURITY CORP","industry":"Auto manufacturing","sic":3714,"state":"WI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0000950123-15-009734","doc":"strt-10k_426.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000950123-17-008407","doc":"strt-10k_20170702.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000950123-18-009308","doc":"strt-10k_20180701.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-034111","doc":"strt-10k_20190630.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-042414","doc":"strt-10k_20200628.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-046790","doc":"strt-10k_20210627.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-22-031301","doc":"strt-10k_20220703.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-046852","doc":"strt-20230702.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-104109","doc":"strt-20240630.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0000950170-25-111218","doc":"strt-20250629.htm","q":"Cybercriminals have increasingly demonstrated advanced capabilities, such as use of zero-day vulnerabilities, and rapid integration of new technology such as generative artificial intelligence."}]},{"cik":933738,"name":"ENGLOBAL CORP","industry":"Construction","sic":8711,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001185185-15-000495","doc":"englobal10k122714.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001185185-16-003829","doc":"englobal10k122615.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-002297","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001493152-18-003404","doc":"form10-k.htm","q":"As a result, we have started a multi-year strategic initiative to significantly strengthen our Automation capabilities in the areas of distributed control systems design and replacement, advanced data capture design, human machine interface\u2026"},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004079","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004865","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-21-002654","doc":"eng_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-22-002983","doc":"eng_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-23-004118","doc":"eng_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001654954-24-003953","doc":"eng_10k.htm","q":null}]},{"cik":934473,"name":"GENVEC INC","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-002270","doc":"t1500542-10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001571049-16-012779","doc":"t1600102_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001571049-17-002041","doc":"t1700563_10k.htm","q":null}]},{"cik":935036,"name":"ACI WORLDWIDE, INC.","industry":"Software & IT services","sic":7372,"state":"NE","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065399","doc":"d837470d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481404","doc":"d102846d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-065734","doc":"d295784d10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001193125-18-060188","doc":"d527277d10k.htm","q":"The solution is designed to combat existing and emerging fraud threats using a combination of machine learning, fraud and payments data, advanced analytics, flexible rules and agile decision strategies."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001193125-19-058622","doc":"d675313d10k.htm","q":"The solution is designed to combat existing and emerging fraud threats using a combination of machine learning, fraud and payments data, advanced analytics, flexible rules and agile decision strategies."},{"fy":2019,"lvl":1,"n":1,"adsh":"0000935036-20-000009","doc":"aciw-20191231x10k.htm","q":"The solution is designed to combat existing and emerging fraud threats using a combination of machine learning, fraud and payments data, advanced analytics, flexible rules, and agile decision strategies."},{"fy":2020,"lvl":1,"n":3,"adsh":"0000935036-21-000014","doc":"aciw-20201231.htm","q":"ACI Fraud Management \u2122 for financial institutions offers banks and intermediaries a comprehensive, real-time approach to fraud management that uses a superior combination of machine learning, fraud and payments data, and advanced analytics \u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0000935036-22-000010","doc":"aciw-20211231.htm","q":"ACI Fraud Management \u2122 for financial institutions offers banks and intermediaries a comprehensive, real-time approach to fraud management that uses a superior combination of machine learning, fraud and payments data, and advanced analytics \u2026"},{"fy":2022,"lvl":2,"n":5,"adsh":"0000935036-23-000009","doc":"aciw-20221231.htm","q":"ACI Fraud Management for banking is powered by state-of-the-art machine learning and enables financial institutions to fight fraud and money laundering across the enterprise while meeting increasing regulatory and customer demand."},{"fy":2023,"lvl":1,"n":3,"adsh":"0000935036-24-000007","doc":"aciw-20231231.htm","q":"ACI Fraud Management \u2122 for Merchants, ACI\u2019s multi-layered fraud management solution, supports merchants with a comprehensive, real-time approach to fraud management that uses a combination of patented incremental machine learning, fraud and\u2026"},{"fy":2024,"lvl":3,"n":39,"adsh":"0000935036-25-000006","doc":"aciw-20241231.htm","q":"We offer these customers scalable solutions that strategically position them to innovate and achieve growth and cost efficiency, while protecting them against fraud with our artificial intelligence or AI, human, and data expertise."},{"fy":2025,"lvl":3,"n":45,"adsh":"0000935036-26-000011","doc":"aciw-20251231.htm","q":"We offer these customers scalable solutions that strategically position them to innovate and achieve growth and cost efficiency, while protecting them against fraud with our artificial intelligence or AI, human, and data expertise."}]},{"cik":935494,"name":"NATIONAL INSTRUMENTS CORP","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000935494-15-000007","doc":"nati-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000935494-16-000038","doc":"nati-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000935494-17-000007","doc":"nati-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000935494-18-000005","doc":"nati-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000935494-19-000010","doc":"nati-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000935494-20-000007","doc":"nati-20191231x10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0000935494-21-000015","doc":"nati-20201231.htm","q":"The following table summarizes the preliminary purchase price allocation, and the preliminary average remaining useful lives, for identifiable intangible assets acquired (dollars in thousands): Estimated Fair Value Estimated Useful Lives (i\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0000935494-22-000007","doc":"nati-20211231.htm","q":"The following table summarizes the preliminary purchase price allocation, and the preliminary average remaining useful lives, for identifiable intangible assets acquired (dollars in thousands): Estimated Fair Value Estimated Useful Lives (i\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0000935494-23-000008","doc":"nati-20221231.htm","q":null}]},{"cik":936340,"name":"DTE ENERGY CO","industry":"Utilities","sic":4911,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000936340-15-000014","doc":"dteenergy2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000936340-16-000243","doc":"dteenergy2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000936340-17-000064","doc":"dteenergy2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000936340-18-000082","doc":"dteenergy2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000936340-19-000086","doc":"dteenergy2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000936340-20-000127","doc":"dteenergy2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000936340-21-000112","doc":"dte-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000936340-22-000077","doc":"dte-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000936340-23-000073","doc":"dte-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000936340-24-000076","doc":"dte-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000936340-25-000065","doc":"dte-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0000936340-26-000054","doc":"dte-20251231.htm","q":"Technological developments, including advances in artificial intelligence, could have the potential to increase the Registrants' vulnerability to these threats."}]},{"cik":936402,"name":"SHIRE PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":1,"n":4,"adsh":"0000950103-15-001422","doc":"dp53559_10k.htm","q":"At December 31, 2014 XAGRID/AGRYLIN was approved in 47 countries . 16 PLENADREN Adrenal insufficiency (AI) is a rare, chronic and potentially fatal endocrine disorder characterised by failure in the production of the hormone cortisol."},{"fy":2015,"lvl":0,"n":0,"adsh":"0000950103-16-011313","doc":"dp63589_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000936402-17-000008","doc":"q410k-12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000936402-18-000007","doc":"q410k-123117.htm","q":null}]},{"cik":939767,"name":"EXELIXIS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000939767-15-000013","doc":"exel2014123110-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000939767-16-000149","doc":"exel2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000939767-17-000019","doc":"exel2016123110-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000939767-18-000023","doc":"exel2017123110-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000939767-19-000042","doc":"exel2018123110-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000939767-20-000035","doc":"exel2019123110-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-001852","doc":"exel-20210101.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000939767-22-000026","doc":"exel-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000939767-23-000019","doc":"exel-20221230.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000939767-24-000028","doc":"exel-20231229.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000939767-25-000019","doc":"exel-20250103.htm","q":"Artificial intelligence (AI) software is increasingly being used in the biopharmaceutical industry, including, in limited instances, by us."},{"fy":2025,"lvl":0,"n":0,"adsh":"0000939767-26-000021","doc":"exhibit1042.htm","q":null}]},{"cik":940332,"name":"ANADIGICS INC","industry":"Computers & chips","sic":3674,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004339","doc":"anad20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-027554","doc":"anad20151231_10k.htm","q":null}]},{"cik":941436,"name":"MODERN HOLDINGS INC","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001567619-15-000395","doc":"s000809x1_10k.htm","q":null}]},{"cik":941685,"name":"IMAGEWARE SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001415889-15-000923","doc":"iwsy10k_dec312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001415889-16-005090","doc":"iwsy10k_de312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002786","doc":"iwsy10k_dec312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002780","doc":"iwsy10k_dec312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-003493","doc":"iwsy10k_20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-005674","doc":"iwsy10k_dec312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-21-003840","doc":"iwsy10k_12312020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001437749-22-008996","doc":"iwsy20211231_10k.htm","q":null}]},{"cik":943535,"name":"WORLD HEALTH ENERGY HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2020,"lvl":"x","n":6,"adsh":"0001493152-21-008940","doc":"form10-k.htm","q":"Following the merger, we advanced the development of our B2B systems as well as B2C and AI-based Business Behavioral Analysis (BBA) systems."},{"fy":2021,"lvl":"x","n":5,"adsh":"0001493152-22-009921","doc":"form10-k.htm","q":"CyberSecurity Business Through SG and RNA, we are primarily engaged in data security and analytics and provides intelligent security software and services to enterprises and individuals worldwide The Company leverages artificial intelligenc\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001493152-23-012556","doc":"form10-k.htm","q":"This platform will be based on in-house artificial intelligence systems to keep operating costs substantially below market c."},{"fy":2023,"lvl":2,"n":8,"adsh":"0001493152-24-014665","doc":"form10-k.htm","q":"CrossMobile intends during the next 12 months to build a strong telecom brand empowered by \u2018state of the art\u2019 technology, competitive pricing and a product mix including proprietary AI and WHEN\u2019s cybersecurity solutions. 4 Acquisition of In\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001641172-25-004775","doc":"form10-k.htm","q":"(\u201cInstaview\u201d), an emerging technology company in the field of AI-based image processing systems, thermal cameras, home and enterprise security, livestock tracking and control appliances plus much more."}]},{"cik":944075,"name":"SOCKET MOBILE, INC.","industry":"Computers & chips","sic":3571,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000944075-15-000014","doc":"k10-2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000944075-16-000054","doc":"k10-2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000944075-17-000009","doc":"k10-2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000944075-18-000011","doc":"k10-2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000944075-19-000010","doc":"k10-2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000944075-20-000012","doc":"k10-2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000944075-21-000026","doc":"k10-2020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000944075-22-000022","doc":"k10-20215.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000944075-23-000025","doc":"k10-2022.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000944075-24-000015","doc":"k10-2023.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000944075-25-000013","doc":"k10-2024.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000944075-26-000027","doc":"k10-2025.htm","q":null}]},{"cik":944480,"name":"GSE SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000944480-15-000016","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000944480-16-000097","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000944480-17-000013","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000944480-18-000007","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000944480-19-000021","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000944480-20-000043","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-012540","doc":"brhc10022535_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-012368","doc":"brhc10035751_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-018700","doc":"brhc10050348_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-017131","doc":"ef20015336_10k.htm","q":null}]},{"cik":944809,"name":"OPKO HEALTH, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000944809-15-000003","doc":"opk-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000944809-16-000017","doc":"opk-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000944809-17-000003","doc":"opk-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0000944809-18-000014","doc":"opk-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0000944809-19-000017","doc":"opk-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0000944809-20-000007","doc":"opk-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0000944809-21-000015","doc":"opk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000944809-22-000009","doc":"opk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000944809-23-000013","doc":"opk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-006285","doc":"opk20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-005811","doc":"opk20241231_10k.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-076596","doc":"opk-20251231.htm","q":"Such attacks also may be further enhanced in frequency or effectiveness through threat actors' use of artificial intelligence (\"AI\")."}]},{"cik":945384,"name":"CICERO INC","industry":"Software & IT services","sic":7371,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001473","doc":"cicn_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001354488-16-006771","doc":"cicn_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002864","doc":"cicn_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003388","doc":"cicn_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-003609","doc":"cicn_10k.htm","q":null},{"fy":2019,"lvl":"x","n":2,"adsh":"0001654954-20-003366","doc":"cicn_10k.htm","q":"Applying Machine Learning to this data enables more sophisticated analysis and greater scale, which results in use cases including process mapping and improvement, fraud detection and social dynamics."}]},{"cik":945436,"name":"SUNEDISON, INC.","industry":"Computers & chips","sic":3674,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000945436-15-000049","doc":"suned-exhibit13x12312014.htm","q":null}]},{"cik":945699,"name":"IXYS CORP /DE/","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-220431","doc":"d930753d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-616907","doc":"d199288d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-200957","doc":"d348888d10k.htm","q":null}]},{"cik":945989,"name":"ASTEA INTERNATIONAL INC","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000950159-15-000086","doc":"astea10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0000950159-16-000505","doc":"astea10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0000950159-17-000089","doc":"astea10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0000950159-18-000137","doc":"astea10k.htm","q":"Technician-enhancing tools, including team and crew collaboration, \"Google-like\" knowledge base search results, augmented reality and Artificial Intelligence, are all at their fingertips."},{"fy":2018,"lvl":1,"n":1,"adsh":"0000950159-19-000052","doc":"astea10k.htm","q":"Technician-enhancing tools, including team and crew collaboration, \u201cGoogle-like\u201d knowledge base search results, augmented reality and Artificial Intelligence, are all at their fingertips."}]},{"cik":946486,"name":"WINDTREE THERAPEUTICS INC /DE/","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011957","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-059208","doc":"form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001437749-17-005788","doc":"wint20161231_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-007033","doc":"wint20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-007802","doc":"wint20181231_10ka.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-006970","doc":"wint20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007493","doc":"wint20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007757","doc":"wint20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008864","doc":"wint20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-012210","doc":"wint20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-012093","doc":"wint20241231_10k.htm","q":null}]},{"cik":946581,"name":"TAKE TWO INTERACTIVE SOFTWARE INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001047469-15-004959","doc":"a2224758z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-013278","doc":"a2228643z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-005833","doc":"ttwo10k03312017.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-006877","doc":"ttwo10k03312018.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-006691","doc":"ttwo10k03312019.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-008291","doc":"ttwo-20200331.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-010627","doc":"ttwo-20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-014580","doc":"ttwo-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-019851","doc":"ttwo-20230331.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0001628280-24-024623","doc":"ttwo-20240331.htm","q":"In either case, our products and services may be technologically inferior to those of our competitors, less appealing to consumers, or both. 10 The development and use of artificial intelligence (\u201cAI\u201d) into our products may present operatio\u2026"},{"fy":2024,"lvl":3,"n":19,"adsh":"0001628280-25-026694","doc":"ttwo-20250331.htm","q":"The development and use of artificial intelligence (\u201cAI\u201d) into our products may present operational and reputational risks."}]},{"cik":946644,"name":"AIM IMMUNOTECH INC.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0000946644-15-000008","doc":"heb1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001615774-16-004671","doc":"s102655_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-003242","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-004291","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004583","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-005290","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007259","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008324","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-010351","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-012058","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-000847","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-013301","doc":"form10-k.htm","q":null}]},{"cik":948708,"name":"SMITH MICRO SOFTWARE, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001193125-15-069548","doc":"d841063d10k.htm","q":"He earned his B.S. in Mechanical Engineering at the Pennsylvania State University and M.S. in Interactive Technology and Psychology (AI focus) at the University of Southern California with additional course work at the Wharton School of Bus\u2026"},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-498016","doc":"d108733d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004015","doc":"smsi-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007263","doc":"smsi-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009576","doc":"smsi-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010806","doc":"smsi-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011475","doc":"smsi-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009851","doc":"smsi-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000948708-23-000015","doc":"smsi-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000948708-24-000009","doc":"smsi-20231231.htm","q":"These solutions include location tracking, parental controls, driver safety functionality, and enhanced AI/machine learning to optimize and customize families' online experience, provide cyberbulling protection, social media intelligence, a\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000948708-25-000004","doc":"smsi-20241231.htm","q":"These solutions include location tracking, parental controls, driver safety functionality, and enhanced AI/machine learning to optimize and customize families' online experience, provide cyberbullying protection, social media intelligence, \u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001437749-26-007087","doc":"smsi20251231d_10k.htm","q":"We continue to innovate and evolve our business to respond to industry trends and maximize opportunities in growing and evolving markets, such as digital lifestyle services and online safety, the consumer IoT marketplace, and by leveraging \u2026"}]},{"cik":949158,"name":"CRAY INC","industry":"Computers & chips","sic":3571,"state":"WA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0000949158-15-000009","doc":"cray-12312014x10k.htm","q":"Urika-XA enables users to consolidate multiple computing workloads ranging from data integration, machine learning, interactive data exploration, visualization, iterative algorithms and more onto a single analytics platform."},{"fy":2015,"lvl":1,"n":1,"adsh":"0000949158-16-000035","doc":"cray-12312015x10k.htm","q":"Urika-XA enables users to consolidate multiple computing workloads ranging from data integration, machine learning, interactive data exploration, visualization, iterative algorithms and more onto a single analytics platform."},{"fy":2016,"lvl":3,"n":29,"adsh":"0000949158-17-000008","doc":"cray-12312016x10k.htm","q":"Business General We design, develop, manufacture, market and service the high-end of the high performance computing, or HPC, market, primarily categories of systems commonly known as supercomputers and provide data analytics, artificial int\u2026"},{"fy":2017,"lvl":3,"n":69,"adsh":"0000949158-18-000011","doc":"cray-12312017x10k.htm","q":"That means our products are aimed primarily at the high-end of the high performance computing (HPC) and data analytics and artificial intelligence (AI) markets - the segments populated by the pioneers, executives and entrepreneurs leading t\u2026"},{"fy":2018,"lvl":3,"n":67,"adsh":"0000949158-19-000010","doc":"cray-12312018x10k.htm","q":"As we look ahead, we see opportunities at the convergence of data and discovery\u2014where artificial intelligence (AI) and data analytics unite with supercomputing."}]},{"cik":949699,"name":"PHARMACYCLICS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-000826","doc":"pcyc20141231-10xk.htm","q":null}]},{"cik":1000694,"name":"NOVAVAX INC","industry":"Pharma & biotech","sic":2836,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-012379","doc":"v401319_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-084770","doc":"v431853_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-011334","doc":"v459518_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-014686","doc":"tv486897_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014640","doc":"tv512700_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-031944","doc":"tm205233-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001000694-21-000004","doc":"nvax-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001000694-22-000004","doc":"nvax-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001000694-23-000005","doc":"nvax-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001000694-24-000007","doc":"nvax-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0001000694-25-000004","doc":"nvax-20241231.htm","q":"In May 2024, the EU approved a new regulation on AI (the \u201cEU AI Act\u201d), parts of which took effect in late 2024."},{"fy":2025,"lvl":3,"n":17,"adsh":"0001000694-26-000007","doc":"nvax-20251231.htm","q":"In such an event, potential competitors might be able to enter the market with similar or identical products or technology, which could have a material adverse effect on our business, financial condition, results of operations and prospects\u2026"}]},{"cik":1001233,"name":"SANGAMO THERAPEUTICS, INC","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000950","doc":"sgmo-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012882","doc":"sgmo-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002900","doc":"sgmo-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004163","doc":"sgmo-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005808","doc":"sgmo-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002582","doc":"sgmo-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003069","doc":"sgmo-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003819","doc":"sgmo-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004666","doc":"sgmo-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001628280-24-010788","doc":"sgmo-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0001628280-25-013088","doc":"sgmo-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and healthcare models\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001628280-26-022029","doc":"sgmo-20251231.htm","q":"Additionally, our employees and personnel may use generative artificial intelligence, or AI, technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws an\u2026"}]},{"cik":1001288,"name":"LEXMARK INTERNATIONAL INC /KY/","industry":"Computers & chips","sic":3570,"state":"KY","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001001288-15-000013","doc":"form10k.htm","q":"Perceptive Capture\u2019s very high ra te of data extraction is achieved through the use of patented search and machine learning technologies that allow its extraction rate to improve with time."},{"fy":2015,"lvl":0,"n":0,"adsh":"0001001288-16-000062","doc":"form10k.htm","q":null}]},{"cik":1001316,"name":"TG THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016369","doc":"v403478_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088155","doc":"v432524_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-002050","doc":"tgtx_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002638","doc":"v031418_10K.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-002189","doc":"v030119_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001897","doc":"tmb-20191231x10k248225.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002149","doc":"tgtx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002617","doc":"tgtx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002610","doc":"tgtx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-006144","doc":"tgtx20231231_10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001437749-25-005908","doc":"tgtx20241231_10k.htm","q":"Threat actors, including nation state attackers, could also use artificial intelligence for malicious purposes, increasing the frequency and complexity of their attacks."},{"fy":2025,"lvl":3,"n":31,"adsh":"0001437749-26-006133","doc":"tgtx20251231_10k.htm","q":"We, directly or through our third-party service providers, may adopt, use or incorporate artificial intelligence (AI) technology and capabilities into the information technology systems or software that we use in our business and operations\u2026"}]},{"cik":1001426,"name":"PERICOM SEMICONDUCTOR CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001145443-15-001066","doc":"d289920.htm","q":null}]},{"cik":1002225,"name":"ADVENT SOFTWARE INC /DE/","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001120","doc":"a2223148z10-k.htm","q":null}]},{"cik":1002517,"name":"NUANCE COMMUNICATIONS, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2015,"lvl":2,"n":6,"adsh":"0001002517-15-000032","doc":"nuan09302015-10k.htm","q":"Differentiated by speech and artificial intelligence (\u201cAI\u201d) technologies, and complemented by our large professional services organization, our solutions help enterprises reduce or replace human contact center agents with conversational sys\u2026"},{"fy":2016,"lvl":2,"n":13,"adsh":"0001002517-16-000088","doc":"nuan0930201610-k.htm","q":"In addition, our solutions increasingly utilize our innovations in artificial intelligence, cognitive sciences and machine learning to create smarter, more natural experiences with technology."},{"fy":2017,"lvl":2,"n":13,"adsh":"0001002517-17-000040","doc":"nuan0930201710-k.htm","q":"In addition, our solutions increasingly utilize our innovations in artificial intelligence (\"AI\"), including cognitive sciences and machine learning to create smarter, more natural experiences with technology."},{"fy":2018,"lvl":3,"n":15,"adsh":"0001002517-18-000064","doc":"nuan0930201810-k.htm","q":"In addition, our solutions increasingly utilize our innovations in artificial intelligence (\"AI\"), including cognitive sciences and machine learning to create smarter, more natural experiences with technology."},{"fy":2019,"lvl":3,"n":29,"adsh":"0001002517-19-000039","doc":"nuan0930201910-k.htm","q":"Business Overview We are a pioneer and leader in conversational artificial intelligence (\"AI\") innovations that bring intelligence to everyday work and life."},{"fy":2020,"lvl":3,"n":38,"adsh":"0001002517-20-000058","doc":"nuan0930202010-k.htm","q":"(\"We\", \"Nuance\", or the \"Company\") is a technology pioneer and market leader in conversational artificial intelligence (\"AI\") and ambient clinical intelligence."},{"fy":2021,"lvl":3,"n":42,"adsh":"0001002517-21-000052","doc":"nuan-20210930.htm","q":"(\"We\", \"Nuance\", or the \"Company\") is a technology pioneer and market leader in conversational artificial intelligence (\"AI\") and ambient clinical intelligence."}]},{"cik":1002910,"name":"AMEREN CORP","industry":"Utilities","sic":4931,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001002910-15-000075","doc":"aee201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001002910-16-000205","doc":"aee201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001002910-17-000054","doc":"aee201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001002910-18-000069","doc":"aee201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001002910-19-000094","doc":"aee201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001002910-20-000077","doc":"aee201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001002910-21-000065","doc":"aee-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001002910-22-000038","doc":"aee-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001002910-23-000053","doc":"aee-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001002910-24-000056","doc":"aee-20231231.htm","q":"Cyber attacks could include viruses, malicious or destructive code, phishing attacks, denial of service attacks, supply chain attacks, ransomware and other extortion-based attacks, improper access by third parties, attacks on email systems,\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001002910-25-000055","doc":"aee-20241231.htm","q":"Recent industry projections reflect the potential for significant growth in energy demand over the next decade, primarily arising from data centers to support artificial intelligence and further augmented by onshoring and electrification of\u2026"},{"fy":2025,"lvl":2,"n":7,"adsh":"0001002910-26-000009","doc":"aee-20251231.htm","q":"This also includes attacks arising from or generated by artificial intelligence, among various other attempts to compromise systems that can lead to security breaches."}]},{"cik":1003642,"name":"IMPAX LABORATORIES INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-003537","doc":"ipxl20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-025780","doc":"ipxl20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001003642-17-000017","doc":"ipxl-12x31x2016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001003642-18-000038","doc":"ipxl-12x31x2017x10k.htm","q":null}]},{"cik":1004980,"name":"PG&E CORP","industry":"Utilities","sic":4931,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001004980-15-000010","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001004980-16-000065","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001004980-17-000006","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001004980-18-000003","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001004980-19-000004","doc":"pge-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001004980-20-000009","doc":"pcg-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001004980-21-000007","doc":"pcg-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001004980-22-000009","doc":"pcg-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001004980-23-000029","doc":"pcg-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001004980-24-000014","doc":"pcg-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001004980-25-000010","doc":"pcg-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":5,"adsh":"0001004980-26-000009","doc":"pcg-20251231.htm","q":"The personal information that PG&E Corporation and the Utility collect, as well as other commercially-sensitive data that they possess, could nonetheless become compromised or improperly disclosed, including through the use of generative ar\u2026"}]},{"cik":1005201,"name":"ASSERTIO THERAPEUTICS, INC","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001308","doc":"a2223144z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010509","doc":"a2227392z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000959","doc":"depo-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001325","doc":"depo-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001005201-19-000040","doc":"asrt-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001005201-20-000021","doc":"asrt-12312019x10k.htm","q":null}]},{"cik":1005229,"name":"COLUMBUS MCKINNON CORP","industry":"Construction machinery","sic":3531,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001005229-15-000046","doc":"cmco03311510k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001005229-16-000350","doc":"cmco03311610k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001005229-17-000198","doc":"cmco03311710k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001005229-18-000202","doc":"cmco03311810k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001005229-19-000153","doc":"cmco03311910k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001005229-20-000171","doc":"cmco0331202010k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001005229-21-000155","doc":"cmco-20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001005229-22-000157","doc":"cmco-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001005229-23-000169","doc":"cmco-20230331.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001005229-24-000166","doc":"cmco-20240331.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001005229-25-000149","doc":"cmco-20250331.htm","q":"Furthermore, cybersecurity threats are constantly expanding and evolving and becoming increasingly sophisticated and complex, including attacks from highly organized adversaries such as nation state actors and attacks using emerging technol\u2026"}]},{"cik":1005286,"name":"LIFECORE BIOMEDICAL, INC. DE","industry":"Pharma & biotech","sic":2834,"state":"MN","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001005286-22-000047","doc":"lndc-20220529.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001005286-24-000030","doc":"lndc-20230528.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001005286-24-000124","doc":"lndc-20240526.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001005286-25-000108","doc":"lfcr-20250525.htm","q":null}]},{"cik":1006281,"name":"PROTALIX BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-015672","doc":"v403470_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-086642","doc":"v432711_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-015083","doc":"v461290_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013053","doc":"tv486893_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014464","doc":"tv515362_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-032540","doc":"tm205240d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003681","doc":"plx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004823","doc":"plx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002102","doc":"plx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003161","doc":"plx-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003039","doc":"plx-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-029858","doc":"plx-20251231x10k.htm","q":"We have selected pharmaceutical targets with fundamental biological roles in rare renal indications, and Secarna plans to apply OligoCreator \u00ae , its proprietary AI-empowered oligonucleotide discovery and development platform, to design and \u2026"}]},{"cik":1008848,"name":"ACORDA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001008848-15-000009","doc":"report_annual-123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001008848-16-000076","doc":"report_annual-123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002591","doc":"acor-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003967","doc":"acor-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004986","doc":"acor-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007789","doc":"acor-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013318","doc":"acor-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010971","doc":"acor-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007948","doc":"acor-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-039464","doc":"acor-20231231.htm","q":null}]},{"cik":1009356,"name":"SALIX PHARMACEUTICALS LTD","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001199","doc":"slxp-10k_20141231.htm","q":null}]},{"cik":1010086,"name":"SIGA TECHNOLOGIES INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001010086-15-000004","doc":"siga-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001010086-16-000019","doc":"siga-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001010086-17-000005","doc":"siga-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001010086-18-000003","doc":"siga-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001010086-19-000007","doc":"siga-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001010086-20-000006","doc":"siga-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-005031","doc":"siga20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005179","doc":"siga20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-005241","doc":"siga20221231_10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001437749-24-007487","doc":"siga20231231_10k.htm","q":"Also, increasing use of artificial intelligence may increase the risk of cyber attacks."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001437749-25-007056","doc":"siga20241231_10k.htm","q":"Also, increasing use of artificial intelligence may increase the risk of cyber attacks."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001437749-26-007557","doc":"siga20251231_10k.htm","q":"In addition, the increasing use of artificial intelligence technologies, including by our employees and third-party service providers, may increase cybersecurity risks, including risks related to data exposure, misuse of confidential or sen\u2026"}]},{"cik":1011452,"name":"MEDICAL INFORMATION TECHNOLOGY, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001011452-15-000009","doc":"tenk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001011452-16-000020","doc":"2015tenk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001011452-17-000003","doc":"tenk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001011452-18-000003","doc":"tenk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001011452-19-000002","doc":"tenk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001011452-20-000002","doc":"tenk.htm","q":null}]},{"cik":1011835,"name":"MEDIVATION, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-062576","doc":"d850483d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013460","doc":"mdvn-10k_20151231.htm","q":null}]},{"cik":1012477,"name":"AVADEL PHARMACEUTICALS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088149","doc":"v433294_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001012477-17-000021","doc":"avdl201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001012477-18-000008","doc":"avdl201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001012477-19-000002","doc":"avdl201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001012477-20-000007","doc":"avdl201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001012477-21-000004","doc":"avdl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001012477-22-000004","doc":"avdl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001012477-23-000009","doc":"avdl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001012477-24-000008","doc":"avdl-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001012477-25-000010","doc":"avdl-20241231.htm","q":null}]},{"cik":1013237,"name":"FACTSET RESEARCH SYSTEMS INC","industry":"Software & IT services","sic":7370,"state":"CT","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-15-019227","doc":"fds20150831_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-16-040606","doc":"fds20161020_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-017840","doc":"fds20170831_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-18-019028","doc":"fds20180831_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-19-020894","doc":"fds20190831_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001013237-20-000153","doc":"fds-20200831.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001013237-21-000142","doc":"fds-20210831.htm","q":"TVL applies artificial intelligence driven technology to over 100,000 unstructured text sources in multiple languages, including news, trade journals, and non-governmental organizations and industry reports, to provide daily signals that id\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001013237-22-000159","doc":"fds-20220831.htm","q":"TVL applies artificial intelligence driven technology to over 100,000 unstructured text sources in multiple languages, including news, trade journals, and non-governmental organizations and industry reports, to provide daily signals that id\u2026"},{"fy":2023,"lvl":3,"n":15,"adsh":"0001013237-23-000128","doc":"fds-20230831.htm","q":"In addition, we are working to expand our use of artificial intelligence to drive efficiencies for our clients, with anticipated initiatives including automation of tasks and integration of natural language queries."},{"fy":2024,"lvl":3,"n":31,"adsh":"0001013237-24-000141","doc":"fds-20240831.htm","q":"We believe that our breadth of high-quality, connected data will serve as critical raw material for large language models."},{"fy":2025,"lvl":3,"n":66,"adsh":"0001628280-25-045769","doc":"fds-20250831.htm","q":"Our platform delivers expansive data, sophisticated analytics, and flexible, artificial intelligence (\"AI\")-powered technologies used by global financial professionals to power their critical investment workflows."}]},{"cik":1013462,"name":"ANSYS INC","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001013462-15-000004","doc":"anss2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001013462-16-000017","doc":"anss2015123110k.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001013462-17-000003","doc":"anss2016123110k.htm","q":"With ANSYS 17.1, structures, electronics and embedded software customers gained access to entry-level system simulation capabilities to analyze how detailed component physics and embedded controls affect overall system design. \u2022 In the seco\u2026"},{"fy":2017,"lvl":0,"n":0,"adsh":"0001013462-18-000004","doc":"anss2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001013462-19-000003","doc":"anss2018123110k.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001013462-20-000004","doc":"anss2019123110k.htm","q":"From sensors to virtual environments to artificial intelligence, Ansys 2019 R3 includes robust offerings that speed the safe development and deployment of AVs on the road and in the air. \u2022 In June 2019, we released Ansys 2019 R2, which acce\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001013462-21-000009","doc":"anss-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001013462-22-000005","doc":"anss-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":6,"adsh":"0001013462-23-000013","doc":"anss-20221231.htm","q":"Ansys AVxcelerate can generate reliable, synthetic training data enriched with ground truth information for all sensor types; this data is essential for artificial intelligence/machine learning (AI/ML) based perception algorithm training an\u2026"},{"fy":2023,"lvl":3,"n":20,"adsh":"0001013462-24-000007","doc":"anss-20231231.htm","q":"Our investments in artificial intelligence capabilities across our simulation portfolio and technical support services enhance the customer experience, democratize simulation and further next-generation innovation."},{"fy":2024,"lvl":3,"n":32,"adsh":"0001013462-25-000009","doc":"anss-20241231.htm","q":"Through our updated product strategy, we have embraced five key technology pillars: numerics, high-performance computing (HPC), cloud, artificial intelligence (AI) and machine learning (ML), and digital engineering."}]},{"cik":1013871,"name":"NRG ENERGY, INC.","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001013871-15-000004","doc":"a201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001013871-16-000022","doc":"a201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001013871-17-000007","doc":"nrg201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001013871-18-000011","doc":"nrg201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001013871-19-000007","doc":"nrg201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001013871-20-000013","doc":"nrg-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001013871-21-000005","doc":"nrg-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001013871-22-000010","doc":"nrg-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001013871-23-000004","doc":"nrg-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001013871-24-000005","doc":"nrg-20231231.htm","q":"A smart home has multiple devices integrated into a single expandable platform that incorporates artificial intelligence and machine-learning in its operating system allowing customers to interact with and manage their home from anywhere vi\u2026"},{"fy":2024,"lvl":3,"n":19,"adsh":"0001013871-25-000006","doc":"nrg-20241231.htm","q":"Leveraging Google Cloud\u2019s AI and cloud platforms, NRG and Renew Home plan to develop a VPP portfolio of up to 1 GW of load management capacity, with instantaneous dispatch value during peak events and tight supply conditions."},{"fy":2025,"lvl":3,"n":24,"adsh":"0001013871-26-000004","doc":"nrg-20251231.htm","q":"A smart home has multiple devices integrated into a single expandable platform that incorporates artificial intelligence (\u201cAI\u201d) and machine-learning in its operating system, which allows customers to interact with and manage their home from\u2026"}]},{"cik":1014473,"name":"VERISIGN INC/CA","industry":"Software & IT services","sic":7371,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001014473-15-000011","doc":"vrsn-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001014473-16-000086","doc":"vrsn-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001014473-17-000004","doc":"vrsn-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001014473-18-000018","doc":"vrsn-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001014473-19-000005","doc":"vrsn-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001014473-20-000006","doc":"vrsn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001014473-21-000005","doc":"vrsn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001014473-22-000007","doc":"vrsn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001014473-23-000005","doc":"vrsn-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001014473-24-000006","doc":"vrsn-20231231.htm","q":"Recent advances in artificial intelligence have increased the sophistication of these types of attacks as attackers are able to create more personalized and targeted communications using information derived from people\u2019s relationships, onli\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001014473-25-000006","doc":"vrsn-20241231.htm","q":"Recent advances in artificial intelligence have increased the sophistication of these types of attacks as attackers are able to create more personalized and targeted communications using information derived from people\u2019s relationships, onli\u2026"},{"fy":2025,"lvl":3,"n":29,"adsh":"0001014473-26-000006","doc":"vrsn-20251231.htm","q":"Alternative namespaces, new technologies and the expansion of existing technologies, including Artificial Intelligence (\u201cAI\u201d), may increase competitive pressure."}]},{"cik":1014739,"name":"BIOSCRIP, INC.","industry":"Retail","sic":5912,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001014739-15-000004","doc":"bios-20141231x10k.htm","q":null}]},{"cik":1014763,"name":"AINOS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001014763-15-000006","doc":"form10k_12312014.htm","q":null},{"fy":2015,"lvl":"x","n":1,"adsh":"0001014763-16-000029","doc":"form10-k_12312015.htm","q":"Taipei City 115, Taiwan (R.O.C.) 2,133,333 10.59% Ching Lam Carmen Cheung Flat AI, 4/F, Tower A, Wilshire Towers 200 Tin HauTemple Rd."},{"fy":2016,"lvl":"x","n":1,"adsh":"0001014763-17-000003","doc":"form10-k_12312016.htm","q":"Taipei City 115, Taiwan (R.O.C.) 2,133,333 8.13% Ching Lam Carmen Cheung Flat AI, 4/F, Tower A, Wilshire Towers 200 Tin HauTemple Rd."},{"fy":2017,"lvl":"x","n":1,"adsh":"0001014763-18-000006","doc":"form10k-a_12312018.htm","q":"Taipei City 115, Taiwan (R.O.C.) 2,133,333 7.77% Ching Lam Carmen Cheung Flat AI, 4/F, Tower A, Wilshire Towers 200 Tin HauTemple Rd."},{"fy":2018,"lvl":"x","n":0,"adsh":"0001014763-19-000004","doc":"form10k_12312018.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-006575","doc":"amar20191231_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003517","doc":"amar_10k.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001654954-22-003463","doc":"aimd_10k.htm","q":"He concurrently serves as the CEO and Chairman of the Board of Directors of Ainos KY, as the Chairman of the Board of Directors of Taiwan Carbon Nano Technology Co., and as the Chief Executive Officer and director of AI Nose Corporation."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001654954-23-004157","doc":"aimd_10k.htm","q":"He concurrently serves as the CEO and Chairman of the Board of Directors of Ainos KY, as the Chairman of the Board of Directors of Taiwan Carbon Nano Technology Co., and as the Chief Executive Officer and director of AI Nose Corporation."},{"fy":2023,"lvl":3,"n":24,"adsh":"0001654954-24-002897","doc":"aimd_10k.htm","q":"Our product pipeline includes commercial-stage VELDONA Pet cytoprotein supplements, clinical-stage VELDONA human therapeutics and telehealth-friendly POCTs powered by the AI Nose technology platform."},{"fy":2024,"lvl":3,"n":31,"adsh":"0001493152-25-009568","doc":"form10-k.htm","q":"Our product pipeline includes commercial-stage VELDONA Pet supplements, clinical-stage VELDONA human therapeutics and telehealth-friendly POCTs powered by the AI Nose technology platform."},{"fy":2025,"lvl":3,"n":139,"adsh":"0001493152-26-013579","doc":"form10-k.htm","q":"(the \u201cCompany\u201d), incorporated in the State of Texas in 1984, is a dual-platform company advancing artificial intelligence\u2013based smelltech technologies and immune therapeutics."}]},{"cik":1015739,"name":"AWARE INC /MA/","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-001114","doc":"t81354_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-011724","doc":"t1600042_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-001193","doc":"t1700070_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-011461","doc":"tv486650_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-008788","doc":"tv513035_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-022309","doc":"tm205258d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006373","doc":"awre-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010383","doc":"awre-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008185","doc":"awre-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-032239","doc":"awre-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-038714","doc":"awre-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-096448","doc":"awre-20251231.htm","q":"We may also be subject to a growing array of laws aimed at regulating the use of artificial intelligence technologies, creating the potential for compliance and litigation risks."}]},{"cik":1016125,"name":"ULTIMATE SOFTWARE GROUP INC","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001016125-15-000006","doc":"ulti-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001016125-16-000168","doc":"ulti-20151231x10k.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001016125-17-000046","doc":"ulti-20161231x10k.htm","q":"Using the power of the ingrained Natural Language Processing (NLP) engine, UltiPro Perception analyzes feedback in a variety of ways, providing leaders a deeper understanding of employee sentiment while safeguarding employee privacy and ano\u2026"},{"fy":2017,"lvl":1,"n":1,"adsh":"0001016125-18-000039","doc":"ulti-20171231x10k.htm","q":"Using the power of the ingrained Natural Language Processing (NLP) engine, UltiPro Perception analyzes feedback in a variety of ways, providing leaders a deeper understanding of employee sentiment while safeguarding employee privacy and ano\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001016125-19-000041","doc":"ulti-20181231x10k.htm","q":"Using the power of the ingrained Natural Language Processing (NLP) engine, UltiPro Perception analyzes feedback in a variety of ways, providing leaders a deeper understanding of employee sentiment while safeguarding employee privacy and ano\u2026"}]},{"cik":1016504,"name":"INTEGRATED BIOPHARMA INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001016504-15-000010","doc":"inb10k_20150630.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-015520","doc":"inbp20170630_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-18-016922","doc":"inbp20180630_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-19-017611","doc":"inbp20190630_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-20-020123","doc":"inbp20200630_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-21-021375","doc":"inbp20210630_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-22-022334","doc":"inbp20220630_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-23-026022","doc":"inbp20230630_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-24-029768","doc":"inbp20240630_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-25-029711","doc":"inbp20250630_10k.htm","q":null}]},{"cik":1017110,"name":"GENETHERA INC","industry":"Pharma & biotech","sic":2836,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001017110-15-000010","doc":"form10k2014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001017110-16-000028","doc":"f10k2015revbtli51116_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001017110-18-000015","doc":"genethera10k2016_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001017110-18-000029","doc":"superform10k_10k.htm","q":null},{"fy":2018,"lvl":"x","n":2,"adsh":"0001654954-20-001984","doc":"genethera_17887-10k.htm","q":"Our molecular disease assay development business is based on our Molecular Robotic Platform that combines the use of advance robotic hardware with Artificial Intelligence (AI)."},{"fy":2019,"lvl":"x","n":21,"adsh":"0001199835-20-000136","doc":"form-10k.htm","q":"Business Model Molecular Robotic Artificial Intelligence (AI) Integrated Platform (MORAP) It has become evident from the COVID-19 global pandemic that current systems and related technologies are not capable of preventing or successfully co\u2026"},{"fy":2020,"lvl":"x","n":21,"adsh":"0001199835-21-000184","doc":"form-10k.htm","q":"Business Model Molecular Robotic Artificial Intelligence (AI) Integrated Platform (MORAP) It has become evident from the COVID-19 global pandemic that current systems and related technologies are not capable of preventing or successfully co\u2026"},{"fy":2021,"lvl":"x","n":21,"adsh":"0001477932-22-002272","doc":"gthr_10k.htm","q":"Business Model Molecular Robotic Artificial Intelligence (AI) Integrated Platform (MORAP) It has become evident from the COVID-19 global pandemic that current systems and related technologies are not capable of preventing or successfully co\u2026"}]},{"cik":1017491,"name":"SEELOS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001017491-15-000032","doc":"apri12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001017491-16-000112","doc":"apri12311510k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001017491-17-000030","doc":"apri12311610k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001017491-18-000026","doc":"apri12311710k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001136261-19-000121","doc":"body10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001136261-20-000092","doc":"body10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001136261-21-000034","doc":"form10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001136261-22-000156","doc":"body10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-030733","doc":"seel-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001410578-24-000140","doc":"seel-20231231x10k.htm","q":null}]},{"cik":1017968,"name":"EDGEWATER TECHNOLOGY INC/DE/","industry":"Software & IT services","sic":7370,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073068","doc":"d846599d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-501510","doc":"d95834d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-083628","doc":"d290293d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-086033","doc":"d521875d10k.htm","q":null}]},{"cik":1019034,"name":"BIO KEY INTERNATIONAL INC","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-016374","doc":"bkyi20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-019357","doc":"bkyi20231231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":1,"adsh":"0001437749-25-012824","doc":"bkyi20241231_10k.htm","q":"Boumarang is developing sustainable, AI-driven, hydrogen-powered, long-range drone technology."},{"fy":2025,"lvl":"x","n":1,"adsh":"0001437749-26-020446","doc":"bkyi20251231c_10k.htm","q":"Boumarang is developing sustainable, AI-driven, hydrogen-powered, long-range drone technology."}]},{"cik":1019671,"name":"SEACHANGE INTERNATIONAL INC","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-014010","doc":"seac-10k_20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-013077","doc":"seac-20230131.htm","q":null}]},{"cik":1019695,"name":"ARQULE INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-001617","doc":"t1500402-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-012340","doc":"t1600464-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-002172","doc":"t1700123-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-012722","doc":"tv487013-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-012700","doc":"tv514851-10k.htm","q":null}]},{"cik":1019787,"name":"PURADYN FILTER TECHNOLOGIES INC","industry":"Auto manufacturing","sic":3714,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001553350-15-000300","doc":"pfti_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001553350-16-001803","doc":"pfti_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001553350-17-000332","doc":"pfti_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001553350-18-000327","doc":"pfti_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001553350-19-000248","doc":"pfti_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001553350-20-000331","doc":"pfti_10k.htm","q":null}]},{"cik":1021435,"name":"HOPTO INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-006422","doc":"hpto20141231_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008418","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003667","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-005358","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004622","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006399","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-007517","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008556","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-012363","doc":"form10-k.htm","q":null}]},{"cik":1021604,"name":"ON TRACK INNOVATIONS LTD","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001178913-15-001093","doc":"zk1516497.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001178913-16-004887","doc":"zk1618245.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-002900","doc":"f10k2016_ontrackinnovations.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-003667","doc":"f10k2017_ontrackinnovation.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004756","doc":"f10k2018_ontrackinnovation.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-007241","doc":"f10k2019_ontrackinnov.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001213900-21-019217","doc":"f10k2020_ontrackinno.htm","q":"Holtzman co-founded and was the Chief Executive Officer of ExploreGate Ltd., a big data/AI company, and from 2016 until 2018, he was the Chief Executive Officer of Mobilogy Inc., a provider of mobile lifecycle solutions which was acquired i\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-019609","doc":"f10k2021_ontrackinno.htm","q":null}]},{"cik":1021635,"name":"OGE ENERGY CORP.","industry":"Utilities","sic":4911,"state":"OK","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001021635-15-000020","doc":"a2014oge10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001021635-16-000172","doc":"a2015oge10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001021635-17-000013","doc":"a2016ogeenergy10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001021635-18-000015","doc":"a2017ogeenergy10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001021635-19-000015","doc":"a2018ogeenergy10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001021635-20-000016","doc":"oge-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001021635-21-000026","doc":"oge-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001021635-22-000037","doc":"oge-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003858","doc":"oge-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000950170-24-017400","doc":"oge-20231231.htm","q":"A security breach of our information systems due to theft, ransomware, viruses, increased use of artificial intelligence technologies, denial of service, hacking, acts of war or terrorism, or inappropriate release of certain types of inform\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0000950170-25-022560","doc":"oge-20241231.htm","q":"A significant security breach of our information systems due to theft, ransomware, viruses, increased use of artificial intelligence technologies, denial of service, hacking, acts of war or terrorism, or inappropriate release of certain typ\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001193125-26-055414","doc":"oge-20251231.htm","q":"A significant security breach of our information systems due to theft, ransomware, viruses, increased use of artificial intelligence technologies, denial of service, hacking, acts of war or terrorism, or inappropriate release of certain typ\u2026"}]},{"cik":1022899,"name":"PROTAGENIC THERAPEUTICS, INC.NEW","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-010152","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012333","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001600","doc":"form10-k.htm","q":null}]},{"cik":1023024,"name":"ANI PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-011270","doc":"v400483_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-083848","doc":"v430573_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-012507","doc":"v458397_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-011197","doc":"tv484825_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-010541","doc":"tv512330_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-025744","doc":"tm205343d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001023024-21-000007","doc":"anip-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001023024-22-000004","doc":"anip-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001023024-23-000005","doc":"anip-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001023024-24-000026","doc":"anip-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001023024-25-000015","doc":"anip-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":17,"adsh":"0001023024-26-000014","doc":"anip-20251231.htm","q":"Our current and potential future use of artificial intelligence and machine learning may not be successful and introduces emerging risks and challenges to our business."}]},{"cik":1023291,"name":"ENERGY FUTURE HOLDINGS CORP /TX/","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001023291-15-000003","doc":"efh-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001023291-16-000017","doc":"efh-12312015x10k.htm","q":null}]},{"cik":1023364,"name":"AUTOWEB, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001415889-15-000688","doc":"abtl10k_dec312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001415889-16-005012","doc":"abtl-10k_dec312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-001816","doc":"abtl10k_dec312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002634","doc":"auto10k_dec312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-002411","doc":"autoweb_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-20-003358","doc":"auto10k_dec312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-21-002627","doc":"auto10k_dec312020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001851734-22-000161","doc":"auto20211231_10k.htm","q":null}]},{"cik":1024126,"name":"PERNIX THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001354488-15-000878","doc":"ptx_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001136261-16-000419","doc":"body10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001136261-17-000069","doc":"body10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001136261-18-000075","doc":"body10k.htm","q":null}]},{"cik":1024626,"name":"CANNABIS SCIENCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001517126-15-000097","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001517126-16-000323","doc":"cbis-20151231_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001562884-17-000022","doc":"cbis-20161231_10k.htm","q":null}]},{"cik":1024725,"name":"TENNECO INC","industry":"Auto manufacturing","sic":3714,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001024725-15-000005","doc":"ten-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001024725-16-000026","doc":"ten-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001024725-17-000005","doc":"ten-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001024725-18-000006","doc":"ten-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001024725-19-000004","doc":"ten-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001024725-20-000004","doc":"ten-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001024725-21-000004","doc":"ten-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001024725-22-000005","doc":"ten-20211231.htm","q":null}]},{"cik":1024732,"name":"IGATE CORP","industry":"Software & IT services","sic":7371,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-038673","doc":"d836970d10k.htm","q":null}]},{"cik":1025561,"name":"SHARPLINK GAMING LTD.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2022,"lvl":1,"n":4,"adsh":"0001654954-23-004409","doc":"sbet_10k.htm","q":"More specifically, C4: \u00b7 COLLECTS , analyzes and leverages deep learning of behavioral data relating to individual fans; \u00b7 CONNECTS and controls fan engagement with real-time, personalized betting offers sourced from U.S. sportsbooks and ca\u2026"}]},{"cik":1027207,"name":"EPIQ SYSTEMS INC","industry":"Software & IT services","sic":7371,"state":"KS","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001512","doc":"a2223052z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010631","doc":"a2227381z10-k.htm","q":null}]},{"cik":1027884,"name":"CHICAGO BRIDGE & IRON CO N V","industry":"Construction","sic":1700,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001027884-15-000095","doc":"a2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001027884-16-000357","doc":"a2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001027884-17-000082","doc":"a2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001027884-18-000045","doc":"a2017123110k.htm","q":null}]},{"cik":1029125,"name":"PANBELA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MN","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-027017","doc":"snbp20151231_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001437749-17-005554","doc":"snbp20161231_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-005094","doc":"snbp20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-005461","doc":"snbp20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-005968","doc":"snbp20191231_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001437749-21-007154","doc":"snbp20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007101","doc":"snbp20211231_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001437749-23-006899","doc":"pbla20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-009418","doc":"pbla20231231_10k.htm","q":null}]},{"cik":1029142,"name":"DYNAVAX TECHNOLOGIES CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001348","doc":"dvax-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014217","doc":"dvax-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004119","doc":"dvax-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004917","doc":"dvax-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004888","doc":"dvax-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010075","doc":"dvax-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008833","doc":"dvax-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002289","doc":"dvax-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004130","doc":"dvax-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-018766","doc":"dvax-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0001029142-25-000049","doc":"dvax-20241231.htm","q":"Our employees and other personnel can use generative artificial intelligence (\u201cAI\u201d) technologies, from time to time, in certain circumstances to perform portions of their work, and the disclosure and use of personal data in generative AI te\u2026"}]},{"cik":1029581,"name":"MODSYS INTERNATIONAL LTD","industry":"Software & IT services","sic":7371,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001213900-15-002295","doc":"f10k2014_modsysinternational.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-012025","doc":"f10k2015_modsysinternational.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-002203","doc":"f10k2016_modsysinternational.htm","q":null}]},{"cik":1030916,"name":"PREMIER HOLDING CORP.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005881","doc":"premier_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-17-000742","doc":"premier_10k-123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-18-002989","doc":"premier_10k-123117.htm","q":null}]},{"cik":1031296,"name":"FIRSTENERGY CORP","industry":"Utilities","sic":4911,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001031296-15-000011","doc":"fe-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001031296-16-000071","doc":"fe-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001031296-17-000015","doc":"fe-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001031296-18-000015","doc":"fe-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001031296-19-000010","doc":"fe-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001031296-20-000008","doc":"fe-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001031296-21-000020","doc":"fe-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001031296-22-000013","doc":"fe-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001031296-23-000014","doc":"fe-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001031296-24-000008","doc":"fe-20231231.htm","q":"For example, as artificial intelligence continues to evolve, cyber-attackers could use artificial intelligence to develop malicious code, denial-of-service attacks, sophisticated phishing attempts and other attacks leading to data loss, los\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001031296-25-000006","doc":"fe-20241231.htm","q":"We cannot anticipate, detect, or implement fully preventive measures against all cybersecurity threats because the techniques used are increasingly sophisticated and constantly evolving and in some cases, assisted by artificial intelligence\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0001031296-26-000046","doc":"fe-20251231.htm","q":"FirstEnergy leverages opportunities to reduce costs \u2013 such as filling only critical positions, implementing our facility optimization plans, deploying advanced technology, including but not limited to artificial intelligence, and exploring \u2026"}]},{"cik":1031308,"name":"BENTLEY SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2020,"lvl":2,"n":6,"adsh":"0001628280-21-003727","doc":"bsy-20201231.htm","q":"For project delivery, digital twins and machine learning can compare the progress of a current project with similar projects that have been previously completed, and identify in advance potential bottlenecks, in time to take corrective acti\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001628280-22-004474","doc":"bsy-20211231.htm","q":"For project delivery, digital twins and machine learning can compare the progress of a current project with similar projects that have been previously completed, and identify in advance potential bottlenecks, in time to take corrective acti\u2026"},{"fy":2022,"lvl":2,"n":14,"adsh":"0001628280-23-005568","doc":"bsy-20221231.htm","q":"A cloud product that empowers owner-operators\u2019 and their constituents\u2019 insights into critical infrastructure by visualizing and navigating digital twins. iTwin Experience accelerates engineering firms\u2019 \u201cdigital integrator\u201d initiatives to cr\u2026"},{"fy":2023,"lvl":1,"n":4,"adsh":"0001031308-24-000002","doc":"bsy-20231231.htm","q":"Although, we monitor the regulatory environment and have invested in addressing these developments, operating in an increasingly complex regulatory landscape may impact our innovation and business drivers in developing new and emerging tech\u2026"},{"fy":2024,"lvl":3,"n":26,"adsh":"0001031308-25-000002","doc":"bsy-20241231.htm","q":"Through our platform, our existing products are becoming increasingly iTwin -enabled to take advantage of digital twin capabilities, and we are developing a new generation of iTwin -native, data-centric applications that leverage artificial\u2026"},{"fy":2025,"lvl":3,"n":37,"adsh":"0001031308-26-000007","doc":"bsy-20251231.htm","q":"Through our platform, our products are becoming increasingly data-centric to take advantage of digital twin and artificial intelligence (\u201cAI\u201d) capabilities."}]},{"cik":1034670,"name":"AUTOLIV INC","industry":"Auto manufacturing","sic":3714,"state":"UT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-053479","doc":"d820512dex13.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-469305","doc":"d92313dex13.htm","q":null},{"fy":2016,"lvl":2,"n":7,"adsh":"0001193125-17-052888","doc":"d302454dex13.htm","q":"The first version of LIV, the Learning Intelligent Vehicle, utilizes Artificial Intelligence (AI) technology, and coming versions will incorporate on-line and off-line machine learning, utilizing a wide array of data sources and developing \u2026"},{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-002787","doc":"alv-10k_20171231.htm","q":"In 2017, Autoliv added further competence and capabilities to our product offerings by entering several co-operations and partnerships including with Seeing Machines for driver monitoring systems, Velodyne for LiDAR solutions and NVIDIA, to\u2026"},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003571","doc":"alv-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005667","doc":"alv-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006803","doc":"alv-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001528","doc":"alv-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002977","doc":"alv-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-016787","doc":"alv-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-023852","doc":"alv-20241231.htm","q":"In addition, our implementation of certain new technologies, such as those related to artificial intelligence, automation and algorithms, may have unintended consequences due to any limitations or failure to use them effectively."},{"fy":2025,"lvl":3,"n":21,"adsh":"0001193125-26-058162","doc":"alv-20251231.htm","q":"In addition, our implementation of certain new technologies, such as those related to artificial intelligence, automation and algorithms, may have unintended consequences due to any limitations or failure to use them effectively."}]},{"cik":1034842,"name":"RIGEL PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001563","doc":"a2223270z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003898","doc":"rigl-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001428","doc":"rigl-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001555","doc":"rigl-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001310","doc":"rigl-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001624","doc":"rigl-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002254","doc":"rigl-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002551","doc":"rigl-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003035","doc":"rigl-20221231x10k.htm","q":null},{"fy":2023,"lvl":3,"n":26,"adsh":"0001558370-24-002475","doc":"rigl-20231231x10k.htm","q":"Our entities may be in scope of the CER where they qualify as critical entities within the meaning of CER. \u200b In the EU, a number of new laws related to digital data and AI have also recently entered into force, are expected to enter into fo\u2026"},{"fy":2024,"lvl":3,"n":27,"adsh":"0001558370-25-002169","doc":"rigl-20241231x10k.htm","q":"States, such as Colorado, Utah and California, have passed or are considering legislation or regulation governing the development or use of artificial intelligence technologies, supplementing the existing consumer protection, FDA and other \u2026"},{"fy":2025,"lvl":3,"n":39,"adsh":"0001034842-26-000015","doc":"rigl-20251231.htm","q":"The worldwide rights to milademetan were out-licensed from Daiichi to Rain Oncology Inc., now Pathos AI, Inc. 15 Table of Contents Research, Preclinical and Clinical Development Programs We maintain expertise in drug development to leverage\u2026"}]},{"cik":1035354,"name":"ELOXX PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-058919","doc":"v420584_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-16-128038","doc":"v450276_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-052475","doc":"v475709_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007811","doc":"elox-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009148","doc":"elox-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012703","doc":"elox-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012683","doc":"elox-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011360","doc":"elox-20221231.htm","q":null},{"fy":2025,"lvl":"x","n":8,"adsh":"0001193125-26-108687","doc":"elox-20251231.htm","q":null}]},{"cik":1035748,"name":"CALLIDUS SOFTWARE INC","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001035748-15-000003","doc":"cald-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001035748-16-000031","doc":"cald-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001035748-17-000006","doc":"cald-12312016x10k.htm","q":null},{"fy":2017,"lvl":1,"n":3,"adsh":"0001035748-18-000007","doc":"cald-12312017x10k.htm","q":"Technology Cloud \u2022 OrientDB is a multi-model, open source NoSQL Database Management System (\u201cDBMS\u201d) that includes support for graph databases, as well as support for key value, reactive, object-oriented and geospatial models, all combined i\u2026"}]},{"cik":1035983,"name":"COMFORT SYSTEMS USA INC","industry":"Construction","sic":1731,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001294","doc":"a2223211z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010332","doc":"a2227387z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000882","doc":"fix-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-000936","doc":"fix-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-000857","doc":"fix-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001491","doc":"fix-20191231x10ka923f7.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001828","doc":"fix-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001753","doc":"fix-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001757","doc":"fix-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001529","doc":"fix-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001222","doc":"fix-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":4,"adsh":"0001104659-26-017530","doc":"fix-20251231x10k.htm","q":"Moreover, if we do not employ new technologies as quickly or efficiently as our competitors, or if our competitors develop or utilize more cost-effective or customer-preferred technologies (such as data analytics, artificial intelligence an\u2026"}]},{"cik":1036188,"name":"QAD INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001140361-15-015118","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001567619-16-002175","doc":"h10035677x1_10k.htm","q":null},{"fy":2016,"lvl":1,"n":2,"adsh":"0001437749-17-006306","doc":"qada20170131_10k.htm","q":"Industry 4.0, IoT, Artificial Intelligence (AI), Additive Manufacturing (3D Printing) and Digital Transformation are all examples of evolving technologies that can impact the markets in which our customers operate."},{"fy":2017,"lvl":1,"n":4,"adsh":"0001437749-18-006885","doc":"qada20180131_10k.htm","q":"Industry 4.0, Internet of Things (\u201cIoT\u201d), Machine Learning (\u201cML\u201d), Artificial Intelligence (\u201cAI\u201d), Additive Manufacturing (\u201c3D Printing\u201d), Blockchain, Augmented Reality, and Predictive Analytics are all examples of evolving technologies tha\u2026"},{"fy":2018,"lvl":2,"n":6,"adsh":"0001437749-19-007282","doc":"qada20190131_10k.htm","q":"Manufacturers are facing a swiftly changing business environment fueled by exponential growth in underlying Industry 4.0 technologies such as Internet of Things (\u201cIoT\u201d), Machine Learning (\u201cML\u201d), Artificial Intelligence (\u201cAI\u201d), Additive Manu\u2026"},{"fy":2019,"lvl":2,"n":7,"adsh":"0001437749-20-007629","doc":"qada20200131_10k.htm","q":"QAD DynaSys uses artificial intelligence to perform a range of digital planning operations including automated data cleansing, intelligent demand clustering, and forecasting products with complex sales behavior."},{"fy":2020,"lvl":2,"n":6,"adsh":"0001437749-21-008761","doc":"qada20210131_10k.htm","q":"An Adaptive Manufacturing Enterprise requires the following five key capabilities: Effective Enterprise Management, Digital Manufacturing, Complete Customer Management, Integrated Supplier Management and Connected Supply Chain. \u25cf Effective \u2026"}]},{"cik":1036960,"name":"FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-064694","doc":"d841677d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478140","doc":"d112557d10k.htm","q":null}]},{"cik":1036968,"name":"DIADEXUS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001614","doc":"ddxs-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015516","doc":"ddxs-10k_20151231.htm","q":null}]},{"cik":1038074,"name":"SILICON LABORATORIES INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000641","doc":"a2222910z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010039","doc":"a2227220z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000461","doc":"a2230770z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-000522","doc":"a2233960z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000300","doc":"a2237475z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-007928","doc":"slab-20191228x10kc9cad4.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-011613","doc":"slab-20210102x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-010931","doc":"slab-20220101x10k.htm","q":null},{"fy":2022,"lvl":1,"n":3,"adsh":"0001104659-23-009254","doc":"slab-20221231x10k.htm","q":"In fiscal 2022, we introduced a portfolio of Matter development solutions providing support for Matter over Wi-Fi, Matter over Thread, Bluetooth Low Energy (LE) commissioning, and Matter bridges to Zigbee and Z-Wave; an end-to-end developme\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0001104659-24-025535","doc":"slab-20231230x10k.htm","q":"Machine learning is bringing greater intelligence to the edge on battery-powered devices."},{"fy":2024,"lvl":3,"n":16,"adsh":"0001038074-25-000003","doc":"slab-20241228.htm","q":"Machine learning is bringing greater intelligence to the edge on battery-powered devices."},{"fy":2025,"lvl":3,"n":19,"adsh":"0001038074-26-000005","doc":"slab-20260103.htm","q":"Machine learning is bringing greater intelligence to the edge on battery-powered devices."}]},{"cik":1038133,"name":"HESKA CORP","industry":"Pharma & biotech","sic":2836,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001038133-15-000051","doc":"form10k-2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001038133-16-000212","doc":"heska-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001038133-17-000018","doc":"heska-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001038133-18-000007","doc":"heska-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001038133-19-000015","doc":"heska-12312018x10k.htm","q":null}]},{"cik":1039065,"name":"OSI SYSTEMS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-15-001687","doc":"osis-20150630x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-16-015059","doc":"a2229501z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-17-005596","doc":"a2232548z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-18-005819","doc":"a2236541z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-19-004853","doc":"a2239525z10-k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001104659-20-097650","doc":"osis-20200630x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-108619","doc":"osis-20210630x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-22-092999","doc":"osis-20220630x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001104659-23-096477","doc":"osis-20230630x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-24-001571","doc":"osis-20240630x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001410578-25-001887","doc":"osis-20250630x10k.htm","q":null}]},{"cik":1039280,"name":"NETSOL TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-15-004366","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-17-011038","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001493152-18-013757","doc":"form10-k.htm","q":"Revenue could also be boosted as customization requests grow in addition to new business volume. \u25cf The launch of \u201cinnovation lab\u201d to explore and focus on new technologies such as, but not limited to, blockchain, artificial intelligence, and\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001493152-19-014421","doc":"form10-k.htm","q":"The increase in research and development costs is due to our innovation initiatives with Blockchain, AI, and IoT."},{"fy":2020,"lvl":2,"n":11,"adsh":"0001493152-20-018417","doc":"form10-k.htm","q":"Otoz platform is built on cutting-edge technology stack which comprises of Cloud-Native Architecture, Microservices, Artificial Intelligence, Machine Learning, Blockchain, DevOps and APIs."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-21-023957","doc":"form10-k.htm","q":"The decrease in research and development costs is due to less spending on our innovation initiatives with Blockchain, AI, and IoT."},{"fy":2022,"lvl":2,"n":6,"adsh":"0001493152-22-026889","doc":"0001493152-22-026889.txt","q":"Artificial Intelligence A dedicated team has been working with great enthusiasm under the leadership of Dr."},{"fy":2023,"lvl":2,"n":7,"adsh":"0001493152-23-033429","doc":"form10-k.htm","q":"Artificial Intelligence A dedicated team is under the leadership of Dr."},{"fy":2024,"lvl":3,"n":16,"adsh":"0001493152-24-038751","doc":"form10-k.htm","q":"Since its inception in 1996, NETSOL has been at the cutting edge of technology, pioneering innovations with its asset finance solutions and leveraging advanced AI and cloud services to meet the complex needs of the global market."},{"fy":2025,"lvl":3,"n":17,"adsh":"0001493152-25-015950","doc":"form10-k.htm","q":"NETSOL has been at the cutting edge of technology, pioneering innovations with its asset finance solutions and leveraging advanced AI and cloud services to meet the complex needs of the global market."}]},{"cik":1039399,"name":"FORMFACTOR INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001039399-15-000005","doc":"form-20141227x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001039399-16-000037","doc":"form-20151226x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001039399-17-000009","doc":"form-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001039399-18-000014","doc":"form-20171230x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001039399-19-000010","doc":"form-20181229x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001039399-20-000011","doc":"form-20191228.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001039399-21-000009","doc":"form-20201226.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001039399-22-000014","doc":"form-20211225.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001039399-23-000010","doc":"form-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001039399-24-000007","doc":"form-20231230.htm","q":"This may become more difficult to do as the semiconductor industry innovates to address demand for AI-related products, which may develop more slowly than we anticipate or change from one period to another."},{"fy":2024,"lvl":2,"n":7,"adsh":"0001039399-25-000023","doc":"form-20241228.htm","q":"This may become more difficult to do as the semiconductor industry innovates to address demand for AI-related products, which may develop more slowly than we anticipate or change rapidly from one period to another for a variety of reasons, \u2026"},{"fy":2025,"lvl":3,"n":22,"adsh":"0001039399-26-000009","doc":"form-20251227.htm","q":"This may become more difficult to do as the semiconductor industry innovates to address demand for AI-related products, which may develop more slowly than we anticipate or change rapidly from one period to another for a variety of reasons, \u2026"}]},{"cik":1039466,"name":"NOVACCESS GLOBAL INC.","industry":"Pharma & biotech","sic":2834,"state":"OH","cells":[{"fy":2022,"lvl":"x","n":2,"adsh":"0001185185-23-000020","doc":"novaccess20220930_10k.htm","q":"He has led the effort to develop a multi-tenant interoperability solution with infused artificial intelligence powered by InforOS."},{"fy":2023,"lvl":"x","n":2,"adsh":"0001185185-24-000148","doc":"novaccess20230930_10k.htm","q":"He has led the effort to develop a multi-tenant interoperability solution with infused artificial intelligence powered by InforOS."},{"fy":2024,"lvl":"x","n":2,"adsh":"0001185185-26-000158","doc":"novaccess10k093024.htm","q":"He has led the effort to develop a multi-tenant interoperability solution with infused artificial intelligence powered by InforOS."}]},{"cik":1040130,"name":"PETMED EXPRESS INC","industry":"Retail","sic":5912,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001571049-15-004580","doc":"t82385_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-015491","doc":"t1600358_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-005258","doc":"t1700341_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-010847","doc":"pets20180331_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-010894","doc":"pets20190331_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-011720","doc":"pets20200331_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-013213","doc":"pets20210331_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-013417","doc":"pets20220331_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001040130-23-000033","doc":"pets-20230331.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001040130-24-000046","doc":"pets-20240331.htm","q":"Additionally, AI-assisted remote veterinary technicians, through our partnership with AskVet, provide a wide range of telehealth services, from dietary advice to training."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001040130-25-000072","doc":"pets-20250331.htm","q":"Our goal is to create a concierge customer experience through modern technology that incorporates AI, automation, and product management that drives personalized journeys across all touchpoints. \u2022 To cater to a diverse range of budgets, we \u2026"}]},{"cik":1040161,"name":"PIXELWORKS, INC","industry":"Computers & chips","sic":3674,"state":"OR","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001040161-15-000012","doc":"pxlw12312014_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001040161-16-000051","doc":"pxlw12312015_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001040161-17-000010","doc":"pxlw12312016_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001040161-18-000006","doc":"pxlw12312017_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001040161-19-000008","doc":"pxlw12312018_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001040161-20-000010","doc":"pxlw1231201910k.htm","q":null},{"fy":2020,"lvl":1,"n":4,"adsh":"0001040161-21-000005","doc":"pxlw-20201231.htm","q":"Removing halos dramatically improves image quality and is of particular importance on high-resolution displays where artifacts become more visible. \u2022 AI Based Display Processing."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001040161-22-000017","doc":"pxlw-20211231.htm","q":"Removing halos dramatically improves image quality and is of particular importance on high-resolution displays where artifacts become more visible. \u2022 AI Based Display Processing."},{"fy":2022,"lvl":1,"n":4,"adsh":"0001040161-23-000012","doc":"pxlw-20221231.htm","q":"Removing halos dramatically improves image quality and is of particular importance on high-resolution and bright displays where artifacts become more visible. \u2022 AI Based Display Processing."},{"fy":2023,"lvl":2,"n":5,"adsh":"0001040161-24-000010","doc":"pxlw-20231231.htm","q":"Removing halos dramatically improves image quality and is of particular importance on high-resolution and bright displays where artifacts become more visible. \u2022 AI Based Display Processing."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001040161-25-000010","doc":"pxlw-20241231.htm","q":"Removing halos dramatically improves image quality and is of particular importance on high-resolution and bright displays where artifacts become more visible. \u2022 AI Based Display Processing."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001040161-26-000019","doc":"pxlw-20251231.htm","q":"Finally, a new product category of virtual and augmented reality technology, such as Meta AI and Ray Ban glasses and Apple VisionPro headsets, enables a 3D visual experience that is more immersive to the user. 5 This evolution of display te\u2026"}]},{"cik":1040426,"name":"SYNTEL INC","industry":"Software & IT services","sic":7371,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-068604","doc":"d853536d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-482419","doc":"d130338d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-066104","doc":"d305282d10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001193125-18-058590","doc":"d527937d10k.htm","q":"The Company strives to continually enhance its knowledge base by creating competencies in emerging technical fields such as automation, artificial intelligence, Big Data analytics, cloud computing, mobile and embedded technologies, open sou\u2026"}]},{"cik":1040896,"name":"INTELLICHECK, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-019080","doc":"v403924_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-16-008290","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-003045","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003779","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003707","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004295","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007101","doc":"form10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-007684","doc":"form10k.htm","q":"Intellicheck provides access to a wide variety of data signals including device fingerprinting, IP address, phone number, time zone, geo location and more to analyze, using machine learning, the risk of doing business with that person. 5 Ho\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001040896-23-000016","doc":"idn-20221231.htm","q":"Intellicheck provides access to a wide variety of data signals including device fingerprinting, IP address, phone number, time zone, geographic location and more to analyze, using machine learning, the risk of doing business with that perso\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-013949","doc":"idn-20231231.htm","q":"Intellicheck provides access to a wide variety of data signals including device fingerprinting, IP address, phone number, time zone, geographic location and more to analyze, using machine learning, the risk of doing business with that perso\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001628280-25-015555","doc":"idn-20241231.htm","q":"Intellicheck provides access to a wide variety of data signals including device fingerprinting, IP address, phone number, time zone, geographic location and more to analyze, using machine learning, the risk of doing business with that perso\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001040896-26-000009","doc":"idn-20251231.htm","q":"Intellicheck provides access to a wide variety of data signals including device fingerprinting, IP address, phone number, time zone, geographic location and more to analyze, using machine learning, the risk of doing business with that perso\u2026"}]},{"cik":1041024,"name":"ROCKWELL MEDICAL, INC.","industry":"Pharma & biotech","sic":2834,"state":"MI","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-006280","doc":"rmti-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-008830","doc":"rmti-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009774","doc":"rmti-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-012572","doc":"rmti-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-013983","doc":"rmti-20241231.htm","q":"Cybersecurity incidents increasingly involve the use of artificial intelligence and machine learning to launch more automated, targeted, and coordinated attacks on targets."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001628280-26-021186","doc":"rmti-20251231.htm","q":"Cybersecurity incidents increasingly involve the use of artificial intelligence and machine learning to launch more automated, targeted, and coordinated attacks on targets."}]},{"cik":1042074,"name":"CYMABAY THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-101933","doc":"d836765d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-521392","doc":"d41327d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-093759","doc":"d313525d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005831","doc":"cbay-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005435","doc":"cbay-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-074946","doc":"d863964d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-094424","doc":"d41924d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-078287","doc":"d274434d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-077859","doc":"d446975d10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001193125-24-050758","doc":"d719301d10k.htm","q":"We, and/or our third-party service providers, use various methods in identifying and assessing these risks, including, for example, manual and automated tools to identify and combat cybersecurity threats, analyzing reports of threats, condu\u2026"}]},{"cik":1042418,"name":"INHIBITOR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-050220","doc":"d831773d10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001193125-16-446037","doc":"d113219d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001193125-17-048025","doc":"d306040d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-18-047834","doc":"d449269d10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001193125-19-066503","doc":"d668655d10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001193125-20-090201","doc":"d858310d10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001193125-21-095516","doc":"d33379d10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001193125-22-088832","doc":"d205626d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-010383","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-011973","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":1,"adsh":"0001641172-25-001190","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-012751","doc":"form10-k.htm","q":null}]},{"cik":1042773,"name":"CENTERPOINT ENERGY RESOURCES CORP","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001042773-15-000005","doc":"cerc201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001042773-16-000023","doc":"cerc201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001042773-17-000006","doc":"cerc201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001042773-18-000004","doc":"cerc_10kx12312017.htm","q":null}]},{"cik":1043150,"name":"ELINE ENTERTAINMENT GROUP, INC.","industry":"Construction","sic":1520,"state":null,"cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-23-002019","doc":"eline_i10k-123122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-008957","doc":"eline_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-002577","doc":"eline_i10k-123124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-002993","doc":"eegi_i10k-123125.htm","q":null}]},{"cik":1043337,"name":"STONERIDGE INC","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-015961","doc":"v404038_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087901","doc":"v429671_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-012328","doc":"v457712_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013135","doc":"tv487512_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001215","doc":"sri-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001657","doc":"sri-20191231x10kdbf102.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001646","doc":"sri-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002389","doc":"sri-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001043337-23-000013","doc":"sri-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001043337-24-000007","doc":"sri-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001043337-25-000012","doc":"sri-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001043337-26-000023","doc":"sri-20251231.htm","q":null}]},{"cik":1044435,"name":"P10 INDUSTRIES, INC.","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-009371","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001044435-16-000065","doc":"acpw1231201510-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001044435-17-000006","doc":"p101231201610-k.htm","q":null}]},{"cik":1045742,"name":"LIVE VENTURES INC","industry":"Software & IT services","sic":7371,"state":"NV","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001019687-16-004810","doc":"live_10k-093015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001683168-16-001034","doc":"live_10k-093016.htm","q":null}]},{"cik":1045810,"name":"NVIDIA CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":12,"adsh":"0001045810-15-000036","doc":"nvda-2015x10k.htm","q":"And they are used by scientists and researchers to accelerate a wide range of important applications, from simulations of viruses to deep learning and global oil exploration."},{"fy":2015,"lvl":3,"n":30,"adsh":"0001045810-16-000205","doc":"nvda-2016x10k.htm","q":"It enables us to open up new avenues of exploration, facilitate creativity and discovery, and power breakthroughs in new areas like artificial intelligence, virtual reality and autonomous cars."},{"fy":2016,"lvl":3,"n":82,"adsh":"0001045810-17-000027","doc":"nvda-2017x10k.htm","q":"We have extended our emphasis in recent years to the revolutionary field of artificial intelligence, or AI."},{"fy":2017,"lvl":3,"n":99,"adsh":"0001045810-18-000010","doc":"nvda-2018x10k.htm","q":"We have extended our focus in recent years to the revolutionary field of artificial intelligence, or AI."},{"fy":2018,"lvl":3,"n":90,"adsh":"0001045810-19-000023","doc":"nvda-2019x10k.htm","q":"We have extended our focus in recent years to the revolutionary field of artificial intelligence, or AI."},{"fy":2019,"lvl":3,"n":87,"adsh":"0001045810-20-000010","doc":"nvda-2020x10k.htm","q":"Starting with a focus on PC graphics, we extended our focus in recent years to the revolutionary field of artificial intelligence, or AI."},{"fy":2020,"lvl":3,"n":85,"adsh":"0001045810-21-000010","doc":"nvda-20210131.htm","q":"Fueled by the sustained demand for exceptional 3D graphics and the scale of the gaming market, NVIDIA has leveraged its GPU architecture to create platforms for scientific computing, artificial intelligence, or AI, data science, autonomous \u2026"},{"fy":2021,"lvl":3,"n":105,"adsh":"0001045810-22-000036","doc":"nvda-20220130.htm","q":"Fueled by the sustained demand for exceptional 3D graphics and the scale of the gaming market, NVIDIA has leveraged its GPU architecture to create platforms for scientific computing, artificial intelligence, or AI, data science, autonomous \u2026"},{"fy":2022,"lvl":3,"n":128,"adsh":"0001045810-23-000017","doc":"nvda-20230129.htm","q":"Fueled by the sustained demand for exceptional 3D graphics and the scale of the gaming market, NVIDIA has leveraged its GPU architecture to create platforms for scientific computing, artificial intelligence, or AI, data science, autonomous \u2026"},{"fy":2023,"lvl":3,"n":175,"adsh":"0001045810-24-000029","doc":"nvda-20240128.htm","q":"This deep and broad software stack accelerates the performance and eases the deployment of NVIDIA accelerated computing for computationally intensive workloads such as artificial intelligence, or AI, model training and inference, data analy\u2026"},{"fy":2024,"lvl":3,"n":194,"adsh":"0001045810-25-000023","doc":"nvda-20250126.htm","q":"This deep and broad software stack accelerates the performance and eases the deployment of NVIDIA accelerated computing for computationally intensive workloads such as artificial intelligence, or AI, model training and inference, data analy\u2026"}]},{"cik":1046327,"name":"REALNETWORKS INC","industry":"Software & IT services","sic":7371,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001046327-15-000016","doc":"a10k2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001046327-16-000072","doc":"a10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001046327-17-000009","doc":"a10-k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001046327-18-000010","doc":"a10-k2017.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001046327-19-000010","doc":"a10-k2018.htm","q":"Our facial recognition platform, SAFR (Secure Accurate Facial Recognition), detects and matches millions of faces by leveraging artificial intelligence-based machine 4 learning."},{"fy":2019,"lvl":2,"n":11,"adsh":"0001046327-20-000024","doc":"rnwk-20191231.htm","q":"Our computer vision SAFR (Secure Accurate Facial Recognition) platform, a key investment initiative for us, enables new applications for security, convenience, and analytics, and is optimized for live video."},{"fy":2020,"lvl":3,"n":23,"adsh":"0001046327-21-000018","doc":"rnwk-20201231.htm","q":"In recent years, we have increasingly focused on developing artificial intelligence (AI)-based products and services such as our Secure Accurate Facial Recognition (SAFR) computer vision platform and our Kontxt natural language processing-b\u2026"},{"fy":2021,"lvl":3,"n":51,"adsh":"0001046327-22-000016","doc":"rnwk-20211231.htm","q":"In recent years, we have increasingly focused on developing artificial intelligence (AI)-based products and services such as our Secure Accurate Facial Recognition (SAFR) computer vision platform and our KONTXT natural language processing-b\u2026"}]},{"cik":1046859,"name":"REMY INTERNATIONAL, INC.","industry":"Auto manufacturing","sic":3714,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001046859-15-000048","doc":"a201410-k.htm","q":null}]},{"cik":1046995,"name":"EMAGIN CORP","industry":"Computers & chips","sic":3674,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001013762-15-000212","doc":"f10k2014_emagin.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001013762-16-001392","doc":"f10k2015_emagincorp.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001562762-17-000038","doc":"c995-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001562762-18-000120","doc":"eman-20171231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001046995-20-000022","doc":"eman-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001046995-21-000005","doc":"eman-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001046995-22-000007","doc":"eman-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001046995-23-000007","doc":"eman-20221231x10k.htm","q":null}]},{"cik":1047122,"name":"RAYTHEON CO/","industry":"Aerospace & defense","sic":3812,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047122-15-000026","doc":"rtn-1231201410k.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001047122-16-000210","doc":"rtn-1231201510k.htm","q":"SV uniquely combines human and machine learning to prevent insider threats, reduce the amount of time an external threat remains in an organization\u2019s network, and provide actionable intelligence that enables quick mitigation."},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047122-17-000018","doc":"rtn-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047122-18-000022","doc":"rtn-12312017x10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001047122-19-000007","doc":"rtn-12312018x10k.htm","q":"These technologies include additive manufacturing (AM) for rapid prototyping and novel product realization, and data analytics and machine learning to optimize production and product test. 31 Table of Contents FINANCIAL SUMMARY We use the f\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001047122-20-000009","doc":"rtn-12312019x10k.htm","q":"These technologies include additive manufacturing (AM) for rapid prototyping and novel product realization, and data analytics and machine learning to optimize production and product test."}]},{"cik":1047127,"name":"AMKOR TECHNOLOGY, INC.","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047127-15-000010","doc":"amkr12311410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047127-16-000049","doc":"amkr12311510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047127-17-000011","doc":"amkr12311610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047127-18-000009","doc":"amkr12311710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047127-19-000007","doc":"amkr12311810k.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001047127-20-000006","doc":"amkr12311910k.htm","q":"These chips include data accelerators, artificial intelligence and machine learning devices. \u2022 The growth of advanced System-in-Package (\u201cSiP\u201d) modules where multiple semiconductor and other electronic components with different functionalit\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001047127-21-000010","doc":"amkr-20201231.htm","q":"These chips, sometimes referred to as \u201cchiplets,\u201d include data accelerators, artificial intelligence and machine learning devices."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001047127-22-000006","doc":"amkr-20211231.htm","q":"Integration of multiple functions in small form factors, processors, sensors and connectivity devices depends on innovation in advanced packaging. \u2022 Increased data traffic requiring higher networking speed and storage, as well as computing \u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001047127-23-000009","doc":"amkr-20221231.htm","q":"Integration of multiple functions in small form factors, processors, sensors and connectivity devices depends on innovation in advanced packaging. \u2022 Increased data traffic requiring higher networking speed and storage, as well as computing \u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0001047127-24-000019","doc":"amkr-20231231.htm","q":"Amkor was a pioneer in the outsourcing of semiconductor packaging and test services, and over the years we have built a leading position by: \u2022 Designing and developing innovative packaging and test technologies focused on advanced packaging\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001047127-25-000030","doc":"amkr-20241231.htm","q":"Amkor provides turnkey manufacturing services for the communication, computing, automotive and industrial and consumer markets, including smartphones, data centers, artificial intelligence, electric vehicles and wearables."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001047127-26-000014","doc":"amkr-20251231.htm","q":"The company\u2019s comprehensive portfolio includes advanced packaging, wafer-level processing and system-in-package solutions targeting applications for smartphones, data centers, artificial intelligence, automobiles and wearables."}]},{"cik":1047862,"name":"CONSOLIDATED EDISON INC","industry":"Utilities","sic":4931,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-054350","doc":"d821872dex1014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047862-16-000225","doc":"ed-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047862-17-000029","doc":"ed-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047862-18-000037","doc":"ed-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047862-19-000035","doc":"ed-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047862-20-000041","doc":"ed-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001047862-21-000049","doc":"ed-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001047862-22-000039","doc":"ed-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001047862-23-000038","doc":"ed-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001047862-24-000012","doc":"ed-20231231.htm","q":"Cyber threats in general, and in particular to critical infrastructure, are increasing in sophistication, magnitude and frequency and the techniques used in cyberattacks change rapidly, including from emerging technologies, such as artifici\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001047862-25-000011","doc":"ed-20241231.htm","q":"Cyber threats in general, and in particular, to critical infrastructure, are increasing in sophistication, magnitude and frequency and the techniques used in cyber attacks change rapidly, including from emerging technologies, such as artifi\u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001047862-26-000031","doc":"ed-20251231.htm","q":"Cyber threats in general, and in particular, to critical infrastructure, are increasing in sophistication, magnitude and frequency and the techniques used in cyber attacks change rapidly, including from emerging technologies, such as artifi\u2026"}]},{"cik":1048268,"name":"IES HOLDINGS, INC.","industry":"Construction","sic":1731,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-400802","doc":"d103295d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-789187","doc":"d310826d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-17-364439","doc":"d506165d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-18-344274","doc":"d668006d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001048268-19-000007","doc":"a201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001048268-20-000033","doc":"iesc-20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001048268-21-000162","doc":"iesc-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001048268-22-000099","doc":"iesc-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001048268-23-000097","doc":"iesc-20230930.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001048268-24-000134","doc":"iesc-20240930.htm","q":null}]},{"cik":1048477,"name":"BIOMARIN PHARMACEUTICAL INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001140","doc":"bmrn-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013653","doc":"bmrn-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002483","doc":"bmrn-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003114","doc":"bmrn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005033","doc":"bmrn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001048477-20-000009","doc":"bmrn-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001048477-21-000008","doc":"bmrn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001048477-22-000012","doc":"bmrn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001048477-23-000009","doc":"bmrn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001048477-24-000016","doc":"bmrn-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":11,"adsh":"0001048477-25-000007","doc":"bmrn-20241231.htm","q":"Additionally, if our employees, consultants or contractors use generative artificial intelligence (AI) technologies to develop our proprietary technology and compounds, it may impact our ability to obtain or successfully defend certain inte\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001048477-26-000004","doc":"bmrn-20251231.htm","q":"Additionally, if our employees, consultants or contractors use generative artificial intelligence (AI) technologies to develop our proprietary technology and compounds, it may impact our ability to obtain or successfully defend certain inte\u2026"}]},{"cik":1050446,"name":"MICROSTRATEGY INC","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001193125-15-065807","doc":"d831933d10k.htm","q":"With this capability, data mining models, such as neural network algorithms, rule set algorithms, and support vector machines, as well as ensembles of models, can be imported through a single click and automatically converted into a standar\u2026"},{"fy":2015,"lvl":1,"n":1,"adsh":"0001193125-16-479811","doc":"d102713d10k.htm","q":"With this capability, data mining models, such as neural network algorithms, rule set algorithms, and support vector machines, as well as ensembles of models, can be imported through a single click and automatically converted into a standar\u2026"},{"fy":2016,"lvl":1,"n":1,"adsh":"0001564590-17-001395","doc":"mstr-10k_20161231.htm","q":"With this capability, data mining models, such as neural network algorithms, rule set algorithms, and support vector machines, as well as ensembles of models, can be imported through a single click and automatically converted into a standar\u2026"},{"fy":2017,"lvl":1,"n":2,"adsh":"0001564590-18-001547","doc":"mstr-10k_20171231.htm","q":"With this capability, data mining models, such as neural network algorithms, rule set algorithms, and support vector machines, as well as ensembles of models, can be imported through a single click and automatically converted into a standar\u2026"},{"fy":2018,"lvl":2,"n":9,"adsh":"0001564590-19-003468","doc":"mstr-10k_20181231.htm","q":"With HyperIntelligence, users can also leverage APIs to design and deploy artificial intelligence (\u201cAI\u201d) applications that deliver zero-click experiences by integrating with modern third-party technologies and devices, including voice assis\u2026"},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-004679","doc":"mstr-10k_20191231.htm","q":"MicroStrategy 2020 also offers new integrations with leading data science tools to allow data scientists to access trusted, governed data, enrich that data with artificial intelligence (\u201cAI\u201d), and return it back to the MicroStrategy platfor\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005783","doc":"mstr-10k_20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-005287","doc":"mstr-10k_20211231.htm","q":"The MicroStrategy platform also provides out-of-the-box integrations to popular data-science tools like Jupyter and RStudio, allowing users to develop predictive, machine learning-enhanced data models on top of the secure and trusted founda\u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0001564590-23-002012","doc":"mstr-10k_20221231.htm","q":"Anticipate future operations and workflows with augmented analytics, guided machine learning, and artificial intelligence."},{"fy":2023,"lvl":3,"n":40,"adsh":"0000950170-24-015847","doc":"mstr-20231231.htm","q":"We also develop and provide industry-leading AI-powered enterprise analytics software that promotes our vision of Intelligence Everywhere\u0099, and are using our software development capabilities to develop bitcoin applications."}]},{"cik":1050915,"name":"QUANTA SERVICES, INC.","industry":"Construction","sic":1731,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073003","doc":"d834546d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-485494","doc":"d69866d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-064821","doc":"d295903d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001050915-18-000003","doc":"pwr-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001050915-19-000014","doc":"pwr-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001050915-20-000020","doc":"pwr-123119x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001050915-21-000009","doc":"pwr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001050915-22-000008","doc":"pwr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001050915-23-000010","doc":"pwr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001050915-24-000009","doc":"pwr-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001050915-25-000005","doc":"pwr-20241231.htm","q":"Additionally, the technology industry is investing significant capital in the build out of data centers in order to expand cloud-based services and develop artificial intelligence (AI) training and inference."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001050915-26-000006","doc":"pwr-20251231.htm","q":"In addition, the investment of capital into the build out of data centers by technology customers in order to, among other things, expand cloud-based services and develop artificial intelligence (AI) training and inference, increases demand\u2026"}]},{"cik":1051627,"name":"AXT INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001567619-15-000258","doc":"s000768x1_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004062","doc":"axti-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001073","doc":"axti-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001801","doc":"axti-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001765","doc":"axti-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002561","doc":"axti-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003377","doc":"axti-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003664","doc":"axti-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004035","doc":"axti-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":8,"adsh":"0001558370-24-003410","doc":"axti-20231231x10k.htm","q":"We believe the growth of AI applications will increase the need for high-speed data transfer which may lead to an increase in InP substrate demand from such data centers."},{"fy":2024,"lvl":2,"n":7,"adsh":"0001558370-25-003004","doc":"axti-20241231x10k.htm","q":"We believe the growth of AI applications will increase the need for high-speed data transfer which may lead to an increase in InP substrate demand from such data centers."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001437749-26-008612","doc":"axti20251231_10k.htm","q":"We believe the growth of AI applications is increasing the need for high-speed data transfer, which may enable a growing increase in InP substrate demand for such data centers."}]},{"cik":1051771,"name":"BELK INC","industry":"Retail","sic":5311,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-129159","doc":"d881575d10k.htm","q":null}]},{"cik":1052054,"name":"EVOLVING SYSTEMS INC","industry":"Software & IT services","sic":7371,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-020488","doc":"a15-1803_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-105253","doc":"a15-23322_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-019723","doc":"a17-1137_110k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001104659-18-021862","doc":"a18-1082_110k.htm","q":"The platform will provide service providers with unmatched Artificial Intelligence based on smart data and operational predictive analytics functions enabling to improve efficiency and to maximize revenues, all the while reducing time and e\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001104659-19-019960","doc":"a19-30094_110k.htm","q":"The platform will provide service providers with unmatched artificial intelligence based on smart data and operational predictive analytics functions enabling to improve efficiency and to maximize revenues, all the while reducing time and e\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001104659-20-040523","doc":"tm201434-1_10k.htm","q":"This approach produces more relevant and engaging predictions and offers for us to present to customers. 5 The Evolution platform will provide service providers with unmatched artificial intelligence based on smart data and operational pred\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001562762-21-000123","doc":"evol-20201231x10k.htm","q":"The predictions and scoring use tailor-made m odels built using a combination of specialized software such as SAS/R or SPSS, or by using cloud native m achine l earning function relying on classifiers, Na\u00efve Bayes models and a set of other \u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001104659-22-044364","doc":"evol-20211231x10k.htm","q":"The algorithms it is developing are novel but based on the team\u2019s collective experience having built big data and machine learning systems that drove marketing programs for almost a billion consumers in its previous operating businesses at \u2026"}]},{"cik":1053369,"name":"ELITE PHARMACEUTICALS INC /NV/","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-037217","doc":"v412306_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-108327","doc":"v441688_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-032547","doc":"v468485_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-034237","doc":"tv495946_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-011224","doc":"f10k2019_elitepharma.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-016181","doc":"f10k2020_elitepharma.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-032329","doc":"f10k2021_elitepharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-018108","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-022936","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":3,"n":17,"adsh":"0001493152-24-025829","doc":"form10-k.htm","q":"These systems are also vulnerable to attacks by malicious third parties, such as phishing or ransomware attacks, and may be susceptible to intentional or accidental physical damage to the infrastructure maintained by us or by third parties,\u2026"},{"fy":2024,"lvl":3,"n":18,"adsh":"0001641172-25-017134","doc":"form10-k.htm","q":"These systems are also vulnerable to attacks by malicious third parties, such as phishing or ransomware attacks, and may be susceptible to intentional or accidental physical damage to the infrastructure maintained by us or by third parties,\u2026"}]},{"cik":1053691,"name":"CERVOMED INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-025785","doc":"0001104659-15-025785.txt","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-028395","doc":"dffn20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-005713","doc":"dffn20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-006050","doc":"dffn20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-005256","doc":"dffn20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-005469","doc":"dffn20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-006236","doc":"dffn20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-006737","doc":"dffn20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-007795","doc":"dffn20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":11,"adsh":"0001437749-24-010064","doc":"crvo20231231_10k.htm","q":"Artificial intelligence presents risks and challenges that can impact the Company \u2019 s business including by posing security risks to confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":19,"adsh":"0001437749-25-007829","doc":"crvo20241231_10k.htm","q":"Additionally, developments in artificial intelligence and machine learning provide threat actors with the capability to use more sophisticated means to attack the Company\u2019s systems and may exacerbate cybersecurity risk."},{"fy":2025,"lvl":3,"n":42,"adsh":"0001437749-26-008259","doc":"crvo20251231_10k.htm","q":"We may also encounter difficulties in managing our growth, which could disrupt our operations. \u25cf AI presents risks and challenges that can impact our business including by posing security risks to confidential information, proprietary infor\u2026"}]},{"cik":1054374,"name":"BROADCOM CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001054374-15-000012","doc":"a20141231-10k.htm","q":null}]},{"cik":1055726,"name":"INOVIO PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2024,"lvl":3,"n":20,"adsh":"0001055726-25-000012","doc":"ino-20241231.htm","q":"Additionally, sensitive information of ours could be leaked, disclosed, or revealed as a result of or in connection with our personnel\u2019s or vendors\u2019 use of artificial intelligence (AI) technologies, including generative AI, and machine lear\u2026"},{"fy":2025,"lvl":3,"n":19,"adsh":"0001055726-26-000008","doc":"ino-20251231.htm","q":"We and they are subject to a variety of evolving threats, including but not limited to business interruption, loss of information, theft of information or reputational damage from industrial espionage attacks, malware or other cyber-attacks\u2026"}]},{"cik":1056386,"name":"INTERNAP CORP","industry":"Software & IT services","sic":7370,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-001277","doc":"t81348_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-011923","doc":"t1600058_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-002338","doc":"t1700150_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003255","doc":"inap-123117x10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001628280-19-003089","doc":"inap-123118x10k.htm","q":"Technological advances in computer processing, hardware, storage, 6 capacity, component size, artificial intelligence solutions, cloud computing solutions or power management could result in a decreased demand for our data center and hostin\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001628280-20-007086","doc":"inap-123119x10k.htm","q":"Technological advances in computer processing, hardware, storage, capacity, component size, artificial intelligence solutions, cloud computing solutions or power management could result in a decreased demand for our data center and hosting \u2026"}]},{"cik":1056696,"name":"MANHATTAN ASSOCIATES INC","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000520","doc":"manh-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012414","doc":"manh-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-000938","doc":"manh-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-001747","doc":"manh-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-002439","doc":"manh-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-003915","doc":"manh-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-004542","doc":"manh-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-004100","doc":"manh-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-001892","doc":"manh-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-011411","doc":"manh-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":57,"adsh":"0000950170-25-016295","doc":"manh-20241231.htm","q":"We continually invest in artificial intelligence (AI) technology to enhance our functional offerings, with a recent emphasis on generative AI (GenAI) advancements."},{"fy":2025,"lvl":3,"n":50,"adsh":"0001193125-26-037138","doc":"manh-20251231.htm","q":"With AI-driven insights and zero downtime updates, Manhattan delivers innovation seamlessly into customer environments without the need for planned maintenance windows."}]},{"cik":1057076,"name":"RIDGEWOOD POWER GROWTH FUND /NJ","industry":"Utilities","sic":4931,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001214659-15-000240","doc":"a121514010k.htm","q":null}]},{"cik":1057877,"name":"IDACORP INC","industry":"Utilities","sic":4911,"state":"ID","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001057877-15-000043","doc":"ida12311410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001057877-16-000209","doc":"ida12311510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001057877-17-000035","doc":"ida12311610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001057877-18-000027","doc":"ida12311710k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001057877-19-000024","doc":"ida12311810k.htm","q":"IDACORP's board of directors regularly reviews IDACORP's long-term strategy, which as of the date of this report is focused on the following areas and initiatives: Focus Areas Initiatives Grow to Enhance Financial Strength - Execute on Busi\u2026"},{"fy":2019,"lvl":0,"n":0,"adsh":"0001057877-20-000040","doc":"ida12311910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001057877-21-000036","doc":"ida-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001057877-22-000014","doc":"ida-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001057877-23-000007","doc":"ida-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001057877-24-000005","doc":"ida-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001057877-25-000014","doc":"ida-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001057877-26-000028","doc":"ida-20251231.htm","q":null}]},{"cik":1058057,"name":"MARVELL TECHNOLOGY GROUP LTD","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":"x","n":1,"adsh":"0001193125-15-107187","doc":"d849642d10k.htm","q":"Sehat Sutardja Chairman of the Board and Chief Executive Officer (Principal Executive Officer) March 26, 2015 / S / M ICHAEL R ASHKIN Michael Rashkin Chief Financial Officer (Principal Financial and Accounting Officer) March 26, 2015 / S / \u2026"},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-653778","doc":"d164959d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002968","doc":"mrvl-1282017x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001058057-18-000009","doc":"mrvl-2032018x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001058057-19-000010","doc":"mrvl-2022019x10k.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001058057-20-000014","doc":"mrvl-20200201.htm","q":"Custom ASICs We develop custom product solutions tailored to individual customer specifications that deliver system-level differentiation for next-generation carrier, networking, data center, machine learning, automotive, aerospace and defe\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001058057-21-000009","doc":"mrvl-20210130.htm","q":"Custom ASICs We develop custom product solutions tailored to individual customer specifications that deliver system-level differentiation for next-generation carrier, networking, data center, machine learning, automotive, aerospace and defe\u2026"}]},{"cik":1058290,"name":"COGNIZANT TECHNOLOGY SOLUTIONS CORP","industry":"Software & IT services","sic":7371,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001058290-15-000006","doc":"ctsh20141231-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001058290-16-000049","doc":"ctsh20151231-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001058290-17-000008","doc":"ctsh20161231-10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001058290-18-000009","doc":"ctsh20171231-10k.htm","q":"This more demanding environment is partially the result of the broadening use of new digital technologies such as artificial intelligence, analytics, robotic process automation, cybersecurity and hybrid cloud."},{"fy":2018,"lvl":2,"n":6,"adsh":"0001058290-19-000009","doc":"ctsh20181231-10k.htm","q":"Demand in this segment is driven by our customers\u2019 focus on cost optimization in the face of profitability pressures, the need to be compliant with significant regulatory requirements and adaptable to regulatory change, and their adoption a\u2026"},{"fy":2019,"lvl":2,"n":11,"adsh":"0001058290-20-000008","doc":"ctsh20191231-10k.htm","q":"They are therefore redirecting their focus and investment to digital and embracing DevOps and key technologies like IoT, analytics, AI, digital engineering, cloud and automation."},{"fy":2020,"lvl":3,"n":21,"adsh":"0001058290-21-000031","doc":"ctsh-20201231.htm","q":"We are focused on continued investment in four key areas of digital: IoT, AI, experience-driven software engineering and cloud."},{"fy":2021,"lvl":2,"n":12,"adsh":"0001058290-22-000023","doc":"ctsh-20211231.htm","q":"Demand in this segment is driven by our clients\u2019 need to serve their customers while being compliant with significant regulatory requirements and adaptable to regulatory change, as well as our clients' adoption and integration of digital te\u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0001058290-23-000027","doc":"ctsh-20221231.htm","q":"These digital technologies enable customer experience enhancement, robotic process automation, analytics and AI in areas such as digital lending, fraud detection and next generation payments."},{"fy":2023,"lvl":3,"n":37,"adsh":"0001058290-24-000017","doc":"ctsh-20231231.htm","q":"These strategic initiatives include: \u2022 Growing in select industries - investing in prioritized industries to drive differentiation across our value chain; \u2022 Expanding internationally - growing by prioritizing strategic growth accounts; \u2022 Bu\u2026"},{"fy":2024,"lvl":3,"n":96,"adsh":"0001058290-25-000017","doc":"ctsh-20241231.htm","q":"We help clients modernize technology, reimagine processes and transform experiences so they can stay ahead in today's fast-changing world, where AI is beginning to reshape organizations in every field."},{"fy":2025,"lvl":3,"n":124,"adsh":"0001058290-26-000008","doc":"ctsh-20251231.htm","q":"We help clients modernize technology, reimagine processes and transform experiences so they can stay ahead in today's fast-changing world, where AI is reshaping organizations in every field."}]},{"cik":1059784,"name":"GENEREX BIOTECHNOLOGY CORP","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001607062-15-000445","doc":"gnbt73115form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001607062-17-000021","doc":"gnbt073116form10ka.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001607062-17-000349","doc":"gnbt073117form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001607062-18-000361","doc":"gnbt073018form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001607062-19-000429","doc":"gnbt073119form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001607062-20-000327","doc":"gnbt073120form10k.htm","q":null}]},{"cik":1059790,"name":"POZEN INC /NC","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011365","doc":"form10k.htm","q":null}]},{"cik":1060426,"name":"AOXING PHARMACEUTICAL COMPANY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001096906-15-001048","doc":"aoxing.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001096906-16-001934","doc":"aoxing.htm","q":null}]},{"cik":1060736,"name":"SEAGEN INC.","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069861","doc":"d823767d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-470022","doc":"d46527d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-050543","doc":"d481013d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-046213","doc":"d515764d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001060736-19-000010","doc":"a10k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001060736-20-000006","doc":"a10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001060736-21-000012","doc":"sgen-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001060736-22-000016","doc":"sgen-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001060736-23-000009","doc":"sgen-20221231.htm","q":null}]},{"cik":1060755,"name":"RIDGEWOOD ELECTRIC POWER TRUST V","industry":"Utilities","sic":4911,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001214659-15-000242","doc":"s121314010k.htm","q":null}]},{"cik":1061027,"name":"VIRACTA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001589","doc":"snss-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014612","doc":"snss-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003862","doc":"snss-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005146","doc":"snss-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006828","doc":"snss-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009783","doc":"snss-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007784","doc":"snss-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003991","doc":"virx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007905","doc":"virx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027982","doc":"virx-20231231.htm","q":null}]},{"cik":1061983,"name":"CYTOKINETICS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-081081","doc":"d828167d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-491656","doc":"d32802d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-071866","doc":"d307977d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004398","doc":"cytk-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006580","doc":"cytk-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008694","doc":"cytk-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009467","doc":"cytk-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007218","doc":"cytk-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005515","doc":"cytk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-022256","doc":"cytk-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-029206","doc":"cytk-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-076495","doc":"cytk-20251231.htm","q":"Furthermore, cybersecurity incidents increasingly involve the use of artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks."}]},{"cik":1062231,"name":"DAUCH CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001062231-15-000023","doc":"axl201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001062231-16-000091","doc":"axl201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062231-17-000014","doc":"axl201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062231-18-000013","doc":"axl201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001062231-19-000013","doc":"axl201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001062231-20-000009","doc":"axl201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001062231-21-000013","doc":"axl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001062231-22-000008","doc":"axl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001062231-23-000016","doc":"axl-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001062231-24-000007","doc":"axl-20231231.htm","q":"As a result of these competitive pressures and other industry trends, OEMs and suppliers are developing strategies to reduce costs. 15 These strategies include supply base consolidation, as well as in-sourcing, vertical integration, global \u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001062231-25-000008","doc":"axl-20241231.htm","q":"Although we have implemented robust security measures, we cannot be certain that the security measures we have in place to protect these systems and data will be successful or sufficient to protect our IT systems from current and emerging t\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001062231-26-000020","doc":"dch-20251231.htm","q":"Challenges such as malware, unauthorized access and cyber attacks, including those that use advanced artificial intelligence, phishing campaigns that target our associates, as well as other disruptions, continue to evolve and may surpass ou\u2026"}]},{"cik":1062822,"name":"LEXICON PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001062822-15-000013","doc":"form10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001062822-16-000051","doc":"form10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062822-17-000013","doc":"form10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062822-18-000008","doc":"form10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001062822-19-000007","doc":"form10k12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001062822-20-000015","doc":"lxrx-20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001062822-21-000013","doc":"lxrx-20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001062822-22-000005","doc":"lxrx-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001062822-23-000007","doc":"lxrx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001062822-24-000008","doc":"lxrx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001062822-25-000013","doc":"lxrx-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001062822-26-000050","doc":"lxrx-20251231.htm","q":null}]},{"cik":1063104,"name":"PROTEO INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-001156","doc":"proteo_10k-123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005675","doc":"proteo_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-17-000933","doc":"proteo_10k-123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-18-001105","doc":"proteo_10k-123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001683168-19-001045","doc":"proteo_10k-123118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-20-001421","doc":"proteo_10k-123119.htm","q":null}]},{"cik":1063197,"name":"CURAEGIS TECHNOLOGIES, INC.","industry":"Auto manufacturing","sic":3714,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-003953","doc":"tovc20141231_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-027048","doc":"tovc20151231_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001437749-17-004927","doc":"crgs20161231_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-004856","doc":"crgs20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-005985","doc":"crgs20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-006298","doc":"crgs20191231_10k.htm","q":null}]},{"cik":1065078,"name":"NETWORK 1 TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001072613-15-000201","doc":"form10-k_17774.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001072613-16-000745","doc":"form10k_17924.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001072613-17-000192","doc":"form10k_18048.htm","q":null}]},{"cik":1065087,"name":"ALBANY MOLECULAR RESEARCH INC","industry":"Pharma & biotech","sic":8731,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016363","doc":"v403449_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091051","doc":"v432872_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-015129","doc":"v460825_10k.htm","q":null}]},{"cik":1065598,"name":"DIGITALTOWN, INC.","industry":"Computers & chips","sic":3570,"state":"WA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001056520-15-000088","doc":"f10k22815finalaccepted.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001056520-16-000256","doc":"f10k022916draft0531164.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-001222","doc":"dgtw_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-18-001189","doc":"dgtw_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-19-001126","doc":"dgtw_10k.htm","q":null}]},{"cik":1065860,"name":"LIME ENERGY CO.","industry":"Construction","sic":1700,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-024737","doc":"a14-26771_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-108701","doc":"a15-23302_110k.htm","q":null}]},{"cik":1066194,"name":"EGAIN CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":1,"n":1,"adsh":"0001558370-15-001771","doc":"egan-20150630x10k.htm","q":"Our robust online self-service tools, with integrated 4 Table of Contents escalation paths and sophisticated artificial intelligence, help resolve customer inquiries without human assistance. \u00b7 Reduce total cost of ownership through an open\u2026"},{"fy":2017,"lvl":3,"n":15,"adsh":"0001558370-17-007169","doc":"egan-20170630x10k.htm","q":"Our suite includes rich applications for digital interaction, knowledge management, and artificial intelligence (AI)-based process guidance."},{"fy":2018,"lvl":3,"n":24,"adsh":"0001558370-18-007466","doc":"egan-20180630x10k.htm","q":"Connected artificial intelligence (AI), knowledge and analytics capabilities automate self-service across touch points and augment a digital-first, omnichannel agent desktop to reduce service cost, increase upsell, and improve business agil\u2026"},{"fy":2019,"lvl":3,"n":22,"adsh":"0001558370-19-008598","doc":"egan-20190630x10k.htm","q":"A unified customer engagement hub from eGain gives them connected artificial intelligence (AI), knowledge, and analytics capabilities to automate self-service across touch points and augment a digital-first, omnichannel agent desktop to red\u2026"},{"fy":2020,"lvl":3,"n":21,"adsh":"0001558370-20-011132","doc":"egan-20200630x10k.htm","q":"We also refer to trademarks of other corporations and organizations in this report 3 Table of Contents Overview \u200b eGain automates customer engagement with an innovative Software as a service (SaaS) platform, powered by deep digital, Artific\u2026"},{"fy":2021,"lvl":3,"n":22,"adsh":"0001558370-21-012388","doc":"egan-20210630x10k.htm","q":"BUSINESS \u200b Overview \u200b eGain automates customer engagement with an innovative software as a service (SaaS) platform, powered by deep digital, artificial intelligence (AI), and knowledge capabilities."},{"fy":2022,"lvl":2,"n":13,"adsh":"0001558370-22-014362","doc":"egan-20220630x10k.htm","q":"BUSINESS \u200b Overview \u200b eGain automates customer engagement with an innovative knowledge hub, powered by conversational AI and analytics."},{"fy":2023,"lvl":3,"n":18,"adsh":"0001558370-23-015758","doc":"egan-20230630x10k.htm","q":"BUSINESS \u200b Overview \u200b eGain automates customer engagement with an innovative knowledge hub, powered by conversational and generative AI and analytics."},{"fy":2024,"lvl":3,"n":58,"adsh":"0001558370-24-012767","doc":"egan-20240630x10k.htm","q":"BUSINESS \u200b Overview \u200b eGain automates customer engagement with an AI knowledge hub SaaS solution."},{"fy":2025,"lvl":3,"n":79,"adsh":"0001104659-25-089540","doc":"egan-20250630x10k.htm","q":"BUSINESS \u200b Overview \u200b eGain automates customer experience with an AI knowledge hub solution."}]},{"cik":1066764,"name":"BIMERGEN ENERGY CORP","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":1,"adsh":"0001493152-23-010282","doc":"form10-k.htm","q":"(NASDAQ: IVDA), an AI and IoT technology company to assist with financing and uplisting to Nasdaq."},{"fy":2023,"lvl":"x","n":1,"adsh":"0001493152-24-012444","doc":"form10-k.htm","q":"(NASDAQ: IVDA), an AI and IoT technology company to assist with financing and uplisting to Nasdaq."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001641172-25-013018","doc":"form10-k.htm","q":"Battery Energy Storage Systems (BESS) play a crucial role in managing the grid, and their importance is expected to increase as more electrification and AI data centers are installed across the United States and the world."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001493152-26-014356","doc":"form10-k.htm","q":"Battery Energy Storage Systems (BESS) play a crucial role in managing the grid, and their importance is expected to increase as more electrification and AI data centers are installed across the United States and the world."}]},{"cik":1068689,"name":"DATA443 RISK MITIGATION, INC.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006607","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-006652","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008586","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-005934","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":4,"adsh":"0001493152-24-014964","doc":"form10-k.htm","q":"Our industry-leading detection provides real-time blocking of email threats and abuse in any language or format with virtually no false positives. \u25cb Threat InDepth, receives early threat information with real-time technical threat intellige\u2026"},{"fy":2024,"lvl":"x","n":4,"adsh":"0001641172-25-015290","doc":"form10-k.htm","q":"Our industry-leading detection provides real-time blocking of email threats and abuse in any language or format with virtually no false positives. \u25cb Threat InDepth, receives early threat information with real-time technical threat intellige\u2026"},{"fy":2025,"lvl":"x","n":7,"adsh":"0001493152-26-016943","doc":"form10-k.htm","q":"Our industry-leading detection provides real-time blocking of email threats and abuse in any language or format with virtually no false positives. \u25cb Threat InDepth, receives early threat information with real-time technical threat intellige\u2026"}]},{"cik":1069308,"name":"ACER THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001157523-15-000646","doc":"a51043086.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-16-006584","doc":"opxa_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002641","doc":"opxa_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004714","doc":"acer-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006779","doc":"acer-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011639","doc":"acer-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009909","doc":"acer-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008350","doc":"acer-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009992","doc":"acer-20221231.htm","q":null}]},{"cik":1069530,"name":"FILANA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001069530-15-000003","doc":"ptie-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001069530-16-000052","doc":"ptie-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001069530-17-000008","doc":"ptie-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001069530-18-000004","doc":"ptie-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001069530-19-000019","doc":"sava-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001069530-20-000009","doc":"sava-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001069530-21-000020","doc":"sava-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001069530-22-000011","doc":"sava-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001069530-23-000009","doc":"sava-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-005894","doc":"sava20231231_10k.htm","q":null},{"fy":2024,"lvl":2,"n":11,"adsh":"0001437749-25-005919","doc":"sava20241231c_10k.htm","q":"In addition, we are in the early stages of exploring potential artificial intelligence (\u201cAI\u201d) capabilities and related data analytics to target improvements in productivity and efficiency in our business, enhancements to research and develo\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001437749-26-007962","doc":"sava20251231_10k.htm","q":"In addition, we are exploring and incorporating artificial intelligence (AI) capabilities and related data analytics to target improvements in productivity and efficiency in our business, enhancements to research and development activities,\u2026"}]},{"cik":1069899,"name":"PHIBRO ANIMAL HEALTH CORP","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-15-007431","doc":"t1502030_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001571049-17-007711","doc":"t1702407-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-046489","doc":"tv500864-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001144204-19-041832","doc":"tv527742-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-098687","doc":"tm2024863-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-109354","doc":"pahc-20210630x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-013940","doc":"pahc-20220630x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-23-015357","doc":"pahc-20230630x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-24-012517","doc":"pahc-20240630x10k.htm","q":null},{"fy":2025,"lvl":3,"n":15,"adsh":"0001558370-25-011776","doc":"pahc-20250630x10k.htm","q":"In addition, we may not have sufficient funds to finance repayment of any of such indebtedness upon any such \u201cchange in control.\u201d We use machine learning and artificial intelligence (AI) in our business, and challenges with properly managin\u2026"}]},{"cik":1070050,"name":"APPTECH PAYMENTS CORP.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001575705-20-000035","doc":"apptech_10k2019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001575705-21-000156","doc":"apcx_10k20.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001575705-22-000237","doc":"apcx_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001903596-23-000201","doc":"apcx_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-002017","doc":"apptech_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-002130","doc":"apptech_i10k-123124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-002518","doc":"apptech_i10k-123125.htm","q":null}]},{"cik":1070081,"name":"PTC THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001457","doc":"a2223091z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010589","doc":"a2227494z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001070081-17-000062","doc":"ptct1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001070081-18-000042","doc":"ptct1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001070081-19-000018","doc":"ptct1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001070081-20-000064","doc":"ptct1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001070081-21-000009","doc":"ptct-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001070081-22-000011","doc":"ptct-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001070081-23-000011","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002196","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001070081-25-000012","doc":"tmb-20241231x10k.htm","q":"We may also be subject to additional industry-specific privacy, cybersecurity, data protection, operational and information systems resilience, and artificial intelligence-related laws in the EU/EEA, Switzerland and the UK which may subject\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-017575","doc":"tmb-20251231x10k.htm","q":"We may also be subject to additional industry-specific privacy, cybersecurity, data protection, operational and information systems resilience, and artificial intelligence-related laws in the EU/EEA, Switzerland and the UK which may subject\u2026"}]},{"cik":1070235,"name":"BLACKBERRY LTD","industry":"Software & IT services","sic":7372,"state":"ON","cells":[{"fy":2019,"lvl":"x","n":32,"adsh":"0001070235-20-000025","doc":"bbry-20200229.htm","q":"Based in Waterloo, Ontario, the company leverages artificial intelligence (\u201cAI\u201d) and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy, and is a leader in the areas of endpoint security \u2026"},{"fy":2020,"lvl":3,"n":28,"adsh":"0001070235-21-000029","doc":"bbry-20210228.htm","q":"Based in Waterloo, Ontario, the Company leverages artificial intelligence (\u201cAI\u201d) and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy, and is a leader in the areas of endpoint security,\u2026"},{"fy":2021,"lvl":3,"n":28,"adsh":"0001070235-22-000048","doc":"bbry-20220228.htm","q":"Based in Waterloo, Ontario, the Company leverages artificial intelligence (\u201cAI\u201d) and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy, and is a leader in the areas of endpoint security,\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001070235-23-000054","doc":"psaexhibita-11.htm","q":null},{"fy":2023,"lvl":3,"n":33,"adsh":"0001070235-24-000057","doc":"bbry-20240229.htm","q":"Its Cybersecurity division is a pioneer in the use of artificial intelligence (\u201cAI\u201d) and machine learning to deliver innovative solutions in the areas of cybersecurity and data privacy."},{"fy":2024,"lvl":3,"n":20,"adsh":"0001070235-25-000068","doc":"bbry-20250228.htm","q":"Key trends include the integration of artificial intelligence and machine learning to enhance device management capabilities, the adoption of Bring Your Own Device policies to improve employee productivity, and the shift towards cloud-based\u2026"}]},{"cik":1070336,"name":"ACHILLION PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-078840","doc":"d862236d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478314","doc":"d115302d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-054009","doc":"d323090d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-052951","doc":"d507705d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-067172","doc":"d678011d10k.htm","q":null}]},{"cik":1070494,"name":"ACADIA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-066078","doc":"d838665d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-483533","doc":"d127067d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002866","doc":"acad-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003526","doc":"acad-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004596","doc":"acad-10k_20181231.htm","q":"If approved, pimavanserin for the treatment of dementia-related psychosis wou ld compete with off-label use of antipsychotic drugs, including the generic drugs risperidone and quetiapine, and drugs indicated for the treatment of Alzheimer\u2019s\u2026"},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006889","doc":"acad-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008372","doc":"acad-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002392","doc":"acad-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004757","doc":"acad-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-021473","doc":"acad-20231231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0000950170-25-029253","doc":"acad-20241231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0001193125-26-072519","doc":"acad-20251231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"}]},{"cik":1070698,"name":"RAPTOR PHARMACEUTICAL CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-009703","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013558","doc":"rptp-10k_20151231.htm","q":null}]},{"cik":1070789,"name":"HYORC CORP","industry":"Construction","sic":8711,"state":"CA","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-013412","doc":"form10-k.htm","q":null}]},{"cik":1071411,"name":"FUSION TELECOMMUNICATIONS INTERNATIONAL INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-16-006709","doc":"fsnn_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-002194","doc":"fsnn_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002943","doc":"fsnn_10k.htm","q":null}]},{"cik":1072379,"name":"NORTHWEST BIOTHERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016579","doc":"v403266_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088301","doc":"v433750_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-020754","doc":"v464066_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-020971","doc":"tv491101_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-017803","doc":"tv517288_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-034145","doc":"tm205288-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-044832","doc":"nwbo-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000244","doc":"nwbo-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000185","doc":"nwbo-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000133","doc":"nwbo-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000598","doc":"nwbo-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-043806","doc":"nwbo-20251231x10k.htm","q":null}]},{"cik":1072842,"name":"FIRST CAPITAL INTERNATIONAL INC","industry":"Computers & chips","sic":3571,"state":"TX","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001185185-22-000457","doc":"firstcap20211231_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001185185-23-000295","doc":"firstcap20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001185185-24-000346","doc":"firstcap20231231_10k.htm","q":null}]},{"cik":1073349,"name":"BOTTOMLINE TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"NH","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-306606","doc":"d78911d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-17-269991","doc":"d377508d10k.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001193125-18-261251","doc":"d770967d10k.htm","q":"Examples include the addition of new electronic payment types, the incorporation of machine learning and predictive analytics into processes and services such as our Intelligent Engagement Model for Vendor onboarding and Intelligent Payment\u2026"},{"fy":2019,"lvl":1,"n":3,"adsh":"0001073349-19-000054","doc":"fy19q410kdoc.htm","q":"Examples include the addition of electronic invoicing functionality, robust security features, the inclusion of an application programming interface library, the availability of multiple enterprise resource planning (ERP)-specific connector\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001073349-20-000095","doc":"epay-20200630.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001073349-21-000114","doc":"epay-20210630.htm","q":"Key elements of our strategy are aimed at accelerating the digital transformation of business payments and banking for large enterprises and banks and include: \u2022 growing our payment platforms by adding payers, vendors, channel partners and \u2026"}]},{"cik":1076682,"name":"POLARITYTE, INC.","industry":"Pharma & biotech","sic":2836,"state":"UT","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-000547","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003780","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007159","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008097","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009124","doc":"form10-k.htm","q":null}]},{"cik":1076682,"name":"POLARITYTE, INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-004622","doc":"v395264_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-077792","doc":"v425248_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-16-005166","doc":"cool10k_oct312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-001228","doc":"form10-k.htm","q":null}]},{"cik":1076744,"name":"EMAV HOLDINGS, INC.","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001096906-15-000428","doc":"emav.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001096906-16-001525","doc":"emav10k.htm","q":null}]},{"cik":1077638,"name":"SENSE TECHNOLOGIES INC","industry":"Auto manufacturing","sic":3714,"state":"NE","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001185185-15-002049","doc":"sensetechnologies10k022815.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001185185-16-005212","doc":"sensetech10k022916.htm","q":null}]},{"cik":1080014,"name":"INNOVIVA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001415","doc":"a2223147z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010381","doc":"a2227287z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001057","doc":"a2230992z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001016","doc":"a2234562z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000541","doc":"a2237693z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-022807","doc":"inva-20191231x10k49b2bc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-028328","doc":"inva-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002169","doc":"inva-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005168","doc":"inva-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023237","doc":"inva-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":18,"adsh":"0000950170-25-027864","doc":"inva-20241231.htm","q":"The use or anticipated use of artificial intelligence (\u201cAI\u201d) technologies, including generative AI, by us or third parties, may increase or create new operational risks."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001193125-26-071776","doc":"inva-20251231.htm","q":"The use or anticipated use of artificial intelligence (\u201cAI\u201d) technologies, including generative AI, by us or third parties, may increase or create new operational risks."}]},{"cik":1080029,"name":"DOUGHERTY'S PHARMACY, INC.","industry":"Retail","sic":5912,"state":"TX","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-18-000801","doc":"dougherty_10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-001381","doc":"doughertys_10k-123118.htm","q":null}]},{"cik":1080099,"name":"INFORMATICA CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001080099-15-000006","doc":"infa-20141231x10k.htm","q":null}]},{"cik":1080319,"name":"ELYS GAME TECHNOLOGY, CORP.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001017386-18-000073","doc":"newg_2017dec31-10k.htm","q":null},{"fy":2018,"lvl":1,"n":4,"adsh":"0001017386-19-000064","doc":"nwgi_2018dec31-10k.htm","q":"In addition, our clients can use the built-in artificial intelligence and adaptive business intelligence modules to evaluate actual performance and leverage insights from analytics to make informed, timely decisions to drive future business\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001017386-20-000196","doc":"nwgi_2019dec31-10k.htm","q":"In addition, our clients can use the built-in artificial intelligence and adaptive business intelligence modules to evaluate actual performance and leverage insights from analytics to make informed, timely decisions to drive future business\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001017386-21-000091","doc":"elys_2020dec31-10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001017386-22-000150","doc":"elys_2021dec31-10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001017386-23-000159","doc":"elys_2022dec31-10k.htm","q":null}]},{"cik":1080709,"name":"ARENA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073420","doc":"d833036d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011994","doc":"arna-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004354","doc":"arna-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005660","doc":"arna-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005441","doc":"arna-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007399","doc":"arna-10k_20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001564590-21-007609","doc":"arna-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001080709-22-000006","doc":"arna-20211231.htm","q":null}]},{"cik":1081078,"name":"API TECHNOLOGIES CORP.","industry":"Computers & chips","sic":3674,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-041538","doc":"d834928d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-490221","doc":"d25132d10k.htm","q":null}]},{"cik":1081745,"name":"INTELLINETICS, INC.","industry":"Software & IT services","sic":7372,"state":"OH","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-020108","doc":"v402954_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-090633","doc":"v434367_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003050","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":1,"adsh":"0001493152-18-004461","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2018,"lvl":"x","n":1,"adsh":"0001493152-19-004530","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2019,"lvl":"x","n":1,"adsh":"0001493152-20-005034","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-007156","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-007657","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001493152-23-009074","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001493152-24-011731","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2024,"lvl":2,"n":6,"adsh":"0001641172-25-000274","doc":"form10-k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2025,"lvl":2,"n":10,"adsh":"0001493152-26-013568","doc":"form10-k.htm","q":"We continue to devote significant efforts, in both development and marketing, in enhancing all routes to market. 2 Competition and Market Position The market for our products is competitive, and we expect that competition will continue to i\u2026"}]},{"cik":1081938,"name":"CANNAPHARMARX, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001683168-18-002697","doc":"cannapharmarx_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-18-002736","doc":"cannapharmarx_10k-123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-18-002744","doc":"cannapharmarx_10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-000940","doc":"cannapharmarx_10k-123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001683168-20-001748","doc":"canna_10k-123119.htm","q":null},{"fy":2020,"lvl":"x","n":1,"adsh":"0001683168-21-001389","doc":"cannapharm_10k-123120.htm","q":"In addition, since January 2018 he has been the owner and co-founder of Titan Technologies, Inc., Vancouver, British Columbia, Canada, a development stage privately held technology company focused on AI powered block chain solutions for bus\u2026"},{"fy":2021,"lvl":"x","n":1,"adsh":"0001683168-22-002703","doc":"charmarx_i10k-123121.htm","q":"In addition, since January 2018 he has been the owner and co-founder of Titan Technologies, Inc., Vancouver, British Columbia, Canada, a development stage privately held technology company focused on AI powered block chain solutions for bus\u2026"},{"fy":2022,"lvl":"x","n":1,"adsh":"0001683168-23-006237","doc":"cannarx_i10k-123122.htm","q":"In addition, since January 2018 he has been the owner and co-founder of Titan Technologies, Inc., Vancouver, British Columbia, Canada, a development stage privately held technology company focused on AI powered block chain solutions for bus\u2026"},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-003575","doc":"cannapharmarx_i10k-123123.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001654954-25-004122","doc":"canna_10k.htm","q":"He completed the Venture Capital Certificate Program at Startup@Berkeley Law and an LLM in Securities and Financial Regulation."},{"fy":2025,"lvl":"x","n":1,"adsh":"0001654954-26-003108","doc":"canna_10k.htm","q":"He completed the Venture Capital Certificate Program at Startup@Berkeley Law and received an LLM in Securities and Financial Regulation."}]},{"cik":1082038,"name":"DURECT CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-074853","doc":"d849815d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-488358","doc":"d142291d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004451","doc":"drrx-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004889","doc":"drrx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007004","doc":"drrx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008923","doc":"drrx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011240","doc":"drrx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009097","doc":"drrx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006743","doc":"drrx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038141","doc":"drrx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-046209","doc":"drrx-20241231.htm","q":null}]},{"cik":1082198,"name":"PERNIX GROUP, INC.","industry":"Construction","sic":1520,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001376474-15-000044","doc":"pern_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001376474-16-000608","doc":"prnx_10k.htm","q":null}]},{"cik":1082278,"name":"ENVIRONMENTAL SOLUTIONS WORLDWIDE INC","industry":"Auto manufacturing","sic":3714,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001082278-15-000018","doc":"kfinal7.htm","q":null}]},{"cik":1082506,"name":"GREAT ELM CAPITAL GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-319576","doc":"d95734d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-018750","doc":"gec-10k_20170630.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-023113","doc":"gec-10k_20180630.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-035765","doc":"gec-10k_20190630.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-043896","doc":"gec-10k_20200630.htm","q":null}]},{"cik":1082510,"name":"UIL HOLDINGS CORP","industry":"Utilities","sic":4911,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-009017","doc":"form10k.htm","q":null}]},{"cik":1082526,"name":"SCIQUEST INC","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000831","doc":"sqi-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013005","doc":"sqi-10k_20151231.htm","q":null}]},{"cik":1082554,"name":"UNITED THERAPEUTICS CORP","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001069","doc":"a2223076z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010392","doc":"a2227374z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000802","doc":"a2230931z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-000911","doc":"a2234069z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000724","doc":"a2237754z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-025009","doc":"uthr-20191231x10k0be536.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001082554-21-000008","doc":"uthr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001082554-22-000004","doc":"uthr-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001082554-23-000005","doc":"uthr-20221231.htm","q":"Professor of Management, The Wharton School of the University of Pennsylvania Ray Kurzweil Principal Researcher and AI Visionary, Google Inc."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001082554-24-000005","doc":"uthr-20231231.htm","q":"Professor of Management, The Wharton School of the University of Pennsylvania Ray Kurzweil Principal Researcher and AI Visionary, Google Inc."},{"fy":2024,"lvl":2,"n":7,"adsh":"0001082554-25-000005","doc":"uthr-20241231.htm","q":"The increasing use of social media platforms and artificial intelligence-based software presents new risks and challenges."},{"fy":2025,"lvl":2,"n":7,"adsh":"0001082554-26-000006","doc":"uthr-20251231.htm","q":"The increasing use of social media platforms and artificial intelligence-based software presents new risks and challenges."}]},{"cik":1082733,"name":"VISIUM TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7371,"state":"FL","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-19-014676","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-20-010986","doc":"visium10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-21-011057","doc":"visium10-k2021v4.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-22-013289","doc":"vism_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-23-012664","doc":"vism_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001654954-24-012507","doc":"vism_10k.htm","q":null},{"fy":2025,"lvl":"x","n":8,"adsh":"0001654954-25-011506","doc":"vism_10k.htm","q":"Visium is a provider of IT infrastructure professional services including network engineering, system engineering, converged infrastructure deployment, software development, Artificial Intelligence application development, and cybersecurity\u2026"}]},{"cik":1083706,"name":"ENXNET INC","industry":"Software & IT services","sic":7372,"state":"OK","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000721748-15-000539","doc":"exnt10k071315.htm","q":null}]},{"cik":1084577,"name":"CYREN LTD.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2018,"lvl":1,"n":3,"adsh":"0001213900-19-005130","doc":"f10k2018_cyrenltd.htm","q":"GlobalView analyzes over 25 billion security transactions each day, using big data analytics, artificial intelligence, machine learning and advanced heuristics to rapidly detect and prevent sophisticated attacks."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001213900-20-008016","doc":"f10k2019_cyrenltd.htm","q":"Previously, he served as Chief Executive Officer of Digital Reasoning, an artificial intelligence analytics software company, from April 2017 to February 2019."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001213900-21-018692","doc":"f10k2020_cyrenltd.htm","q":"Previously, he served as Chief Executive Officer of Digital Reasoning, an artificial intelligence analytics software company, from April 2017 to February 2019."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001213900-22-014854","doc":"f10k2021_cyrenltd.htm","q":"Previously, he served as Chief Executive Officer of Digital Reasoning, an artificial intelligence analytics software company, from April 2017 to February 2019."}]},{"cik":1085277,"name":"SKINVISIBLE, INC.","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001255294-15-000200","doc":"mainbody.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001663577-16-000117","doc":"mainbody.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001663577-17-000119","doc":"mainbody.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001663577-18-000138","doc":"mainbody.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001663577-19-000163","doc":"mainbody.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001663577-20-000147","doc":"skvi10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001663577-21-000186","doc":"skvi10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001663577-22-000171","doc":"skvi10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001663577-23-000137","doc":"skvi10k123122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001663577-24-000119","doc":"skvi10k_123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001663577-25-000110","doc":"skvi10k123124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001663577-26-000087","doc":"skvi10k_123125.htm","q":null}]},{"cik":1085392,"name":"PUGET ENERGY INC /WA","industry":"Utilities","sic":4911,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001085392-15-000006","doc":"pe-12312014x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001085392-17-000008","doc":"pe-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001085392-18-000012","doc":"pe-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001085392-19-000007","doc":"pe-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001085392-20-000003","doc":"psd-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001085392-21-000011","doc":"psd-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001085392-22-000009","doc":"psd-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001085392-23-000007","doc":"psd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001085392-24-000008","doc":"psd-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001085392-25-000009","doc":"psd-20241231.htm","q":"The potential increase in competition for energy resources, including generation and transmission, may be influenced by a variety of factors, including by (1) entities\u2019 commitments to reduce carbon emissions and their increased reliance on \u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001085392-26-000008","doc":"psd-20251231.htm","q":"The potential increase in competition for energy resources, including generation and transmission, may be influenced by a variety of factors, including (1) entities\u2019 commitments to reduce carbon emissions and their increased reliance on ren\u2026"}]},{"cik":1085596,"name":"ANGIOGENEX, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001469709-18-000055","doc":"aggx10k_123117apg.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001469709-19-000043","doc":"aggx10k_123118apg.htm","q":null}]},{"cik":1085621,"name":"ACTUA CORP","industry":"Software & IT services","sic":7371,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001219","doc":"acta-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001085621-16-000012","doc":"actuacorp12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001085621-17-000004","doc":"actuacorp12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001085621-18-000003","doc":"actuacorp12312017.htm","q":null}]},{"cik":1085869,"name":"PERFICIENT INC","industry":"Software & IT services","sic":7371,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001085869-15-000008","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001085869-16-000055","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001085869-17-000008","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001085869-18-000009","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001085869-19-000010","doc":"perficientinc10-k2018.htm","q":null},{"fy":2019,"lvl":2,"n":13,"adsh":"0001085869-20-000010","doc":"perficientinc10-k20192.htm","q":"We assess and mitigate risks, redesign communications and delivery processes, ensure higher quality, and support increased automation of critical IT tasks that limit productivity of key IT resources. \u2022 Artificial Intelligence (\u201cAI\u201d) and Mac\u2026"},{"fy":2020,"lvl":2,"n":6,"adsh":"0001085869-21-000021","doc":"prft-20201231.htm","q":"We empower clients to understand and navigate their vast amounts of digital data in order to make smarter, more informed business solutions and navigate the new digital data ecosystem with offerings in: analytics, artificial intelligence an\u2026"},{"fy":2021,"lvl":2,"n":10,"adsh":"0001085869-22-000036","doc":"prft-20211231.htm","q":"We empower clients to understand and navigate their vast amounts of digital data in order to make smarter, more-informed business solutions and navigate the digital data ecosystem with offerings in: analytics, artificial intelligence and ma\u2026"},{"fy":2022,"lvl":2,"n":10,"adsh":"0001085869-23-000030","doc":"prft-20221231.htm","q":"We empower clients to understand and navigate their vast amounts of digital data in order to make smarter, more-informed business solutions and navigate the digital data ecosystem with offerings in: analytics, artificial intelligence and ma\u2026"},{"fy":2023,"lvl":2,"n":10,"adsh":"0001085869-24-000040","doc":"prft-20231231.htm","q":"We empower clients to understand and navigate their vast amounts of digital data in order to make smarter, more-informed business solutions and navigate the digital data ecosystem with offerings in analytics, artificial intelligence and mac\u2026"}]},{"cik":1086082,"name":"CANNAPOWDER, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004621","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006349","doc":"form10-k.htm","q":null}]},{"cik":1086303,"name":"HEYU BIOLOGICAL TECHNOLOGY CORP","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001548123-15-000093","doc":"pweb_201410kv4.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001086303-17-000012","doc":"pacificwebworkssuper10k_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001086303-18-000008","doc":"pweb201710k_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-005075","doc":"f10k2018_heyubiological.htm","q":null}]},{"cik":1086909,"name":"BROADSOFT, INC.","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001086909-15-000005","doc":"bsft-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001086909-16-000021","doc":"bsft-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001086909-17-000006","doc":"bsft-20161231x10k.htm","q":null}]},{"cik":1087294,"name":"CUMBERLAND PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001629","doc":"a2014-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012682","doc":"a2015-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002485","doc":"a2016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003034","doc":"a2017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002785","doc":"cpix-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003880","doc":"cpix-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-004654","doc":"cpix-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-005942","doc":"cpix-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-007727","doc":"cpix-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-010725","doc":"cpix-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-011366","doc":"cpix-20241231.htm","q":"As cyber threats continue to evolve (including through the use of artificial intelligence), we may be required to expend significant capital and other resources to protect against the threat of security breaches or to mitigate and alleviate\u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0001087294-26-000020","doc":"cpix-20251231.htm","q":"As cyber threats continue to evolve (including through the use of artificial intelligence), we may be required to expend significant capital and other resources to protect against the threat of security breaches or to mitigate and alleviate\u2026"}]},{"cik":1087423,"name":"RED HAT INC","industry":"Software & IT services","sic":7370,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-153023","doc":"d836093d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-556503","doc":"d131236d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-139562","doc":"d293614d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001087423-18-000010","doc":"rht-10kq4fy18.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001087423-19-000012","doc":"rht-10kq4fy19.htm","q":null}]},{"cik":1087934,"name":"INCONTACT, INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001273","doc":"saas-10k_20141231.htm","q":null},{"fy":2015,"lvl":1,"n":2,"adsh":"0001564590-16-014014","doc":"saas-10k_20151231.htm","q":"The first acquisition, Attensity, brings us tremendous opportunity in Big Data and Analytics using natural language processing technology to analyze large amounts of unstructured data."}]},{"cik":1088856,"name":"CORCEPT THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001562762-15-000080","doc":"cort-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001088856-16-000011","doc":"cort-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003493","doc":"cort-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003840","doc":"cort-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-001879","doc":"cort12311810-kdoc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002122","doc":"cort12311910-kdoc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-002861","doc":"cort-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-002714","doc":"cort-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005581","doc":"0001628280-23-005581.txt","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-005055","doc":"cort-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-008167","doc":"cort-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-011091","doc":"cort-20251231.htm","q":"These actions and proposals may, for example, include directives: (1) reducing agency workforce and cutting programs; (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMNI, to\u2026"}]},{"cik":1089819,"name":"CLECO CORPORATE HOLDINGS LLC","industry":"Utilities","sic":4911,"state":"LA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001089819-15-000019","doc":"cnl-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001089819-16-000071","doc":"cnl-12312015x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001089819-17-000007","doc":"cnl-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001089819-18-000006","doc":"cnl-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001089819-19-000010","doc":"cnl-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001089819-20-000004","doc":"cnl-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001089819-21-000003","doc":"cnl-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001089819-22-000006","doc":"cnl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001089819-23-000003","doc":"cnl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001089819-24-000006","doc":"cnl-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001089819-25-000003","doc":"cnl-20241231.htm","q":"Due to the evolving nature of such cyber breach threats, including emerging artificial intelligence technologies that may be used to develop new hacking tools, exploit vulnerabilities, obscure malicious activities, and increase the difficul\u2026"},{"fy":2025,"lvl":2,"n":7,"adsh":"0001089819-26-000002","doc":"cnl-20251231.htm","q":"Increased energy demand or significant accelerated growth in demand due to new data centers (including as a result of increasing capital investment in, and anticipated demand for, artificial intelligence infrastructure), widespread adoption\u2026"}]},{"cik":1090908,"name":"DETERMINE, INC.","industry":"Software & IT services","sic":7372,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-013046","doc":"sltc20150331_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-034757","doc":"dtrm20160331_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-011144","doc":"dtrm20170331_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-012687","doc":"dtrm20180331_10k.htm","q":null}]},{"cik":1091326,"name":"VG LIFE SCIENCES INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-001463","doc":"vgls_10k-123114.htm","q":null}]},{"cik":1092662,"name":"CHEMBIO DIAGNOSTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001092662-15-000024","doc":"form10_k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001092662-16-000121","doc":"form10_k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001092662-17-000023","doc":"form10_k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001092662-18-000013","doc":"form10_k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-005069","doc":"form10_k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-005780","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-008210","doc":"brhc10021388_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-007735","doc":"brhc10034606_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-014526","doc":"brhc10050381_10k.htm","q":null}]},{"cik":1092699,"name":"SPS COMMERCE INC","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-056499","doc":"d845442d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-476036","doc":"d105391d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-059313","doc":"d282145d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003249","doc":"spsc-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003903","doc":"spsc-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006450","doc":"spsc-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007614","doc":"spsc-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-005952","doc":"spsc-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001092699-23-000006","doc":"spsc-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001092699-24-000012","doc":"spsc-20231231.htm","q":"The industry in which we compete is characterized by rapid technological change, frequent introductions of new products, and evolving industry standards, which may include advancements in artificial intelligence."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001092699-25-000011","doc":"spsc-20241231.htm","q":"The industry in which we compete is characterized by rapid technological change, frequent introductions of new products, and evolving industry standards, which may include advancements in artificial intelligence."},{"fy":2025,"lvl":3,"n":27,"adsh":"0001092699-26-000012","doc":"0001092699-26-000012.txt","q":"In furtherance of that strategy, we deployed an artificial intelligence (\"AI\")-enabled learning platform that provides our employees with visibility to in-demand skills and offers personalized learning content supporting their professional \u2026"}]},{"cik":1094038,"name":"MARKER THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001424884-15-000039","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001193125-16-541539","doc":"d106912d10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-014490","doc":"v460466_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-016734","doc":"tv487788_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014350","doc":"tv514406_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-032463","doc":"tm205467-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-033855","doc":"mrkr-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000418","doc":"mrkr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000324","doc":"mrkr-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000297","doc":"mrkr-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000549","doc":"mrkr-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-031274","doc":"mrkr-20251231x10k.htm","q":null}]},{"cik":1094285,"name":"TELEDYNE TECHNOLOGIES INC","industry":"Aerospace & defense","sic":3812,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001094285-15-000037","doc":"tdy-20141228x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001094285-16-000177","doc":"tdy-20160103x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001094285-17-000031","doc":"tdy-2016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001094285-18-000053","doc":"tdy-2017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001094285-19-000064","doc":"tdy-2018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001094285-20-000045","doc":"tdy-20191229.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001094285-21-000066","doc":"tdy-20210103.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001094285-22-000049","doc":"tdy-20220102.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001094285-23-000053","doc":"tdy-20230101.htm","q":null},{"fy":2023,"lvl":3,"n":23,"adsh":"0001094285-24-000044","doc":"tdy-20231231.htm","q":"New technologies, including generative AI, quantum computing, new uses of QR codes and other innovations in digital communications, introduce new attack vectors, and new potential compromise scenarios, which malicious adversaries can exploi\u2026"},{"fy":2024,"lvl":3,"n":23,"adsh":"0001094285-25-000053","doc":"tdy-20241229.htm","q":"New technologies, including generative artificial intelligence (\u201cAI\u201d), quantum computing, new uses of QR codes and other innovations in digital communications, introduce new attack vectors, and new potential compromise scenarios, which mali\u2026"},{"fy":2025,"lvl":3,"n":28,"adsh":"0001094285-26-000017","doc":"tdy-20251228.htm","q":"Some of our product sales are tied to artificial intelligence (\u201cAI\u201d)-related capital expenditures and data center infrastructure."}]},{"cik":1094739,"name":"FINISAR CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001094739-15-000021","doc":"fnsr-50315x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001094739-16-000131","doc":"fnsr-10kx50116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001094739-17-000051","doc":"fnsr-10kx43017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001094739-18-000035","doc":"fnsr10kfy18.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001094739-19-000038","doc":"fnsr10kfy19.htm","q":null}]},{"cik":1094847,"name":"ONCOVISTA INNOVATIVE THERAPIES, INC","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-022873","doc":"v406669_10k.htm","q":null}]},{"cik":1095291,"name":"WEB.COM GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001095291-15-000028","doc":"wwww-2014123110xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001095291-16-000109","doc":"wwww-2015123110xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001095291-17-000013","doc":"web-2016123110xk.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001095291-18-000022","doc":"web-2017123110xk.htm","q":"Acquisio provides machine-learning technology to online advertising management."}]},{"cik":1095565,"name":"HEALTHSTREAM INC","industry":"Software & IT services","sic":7370,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069659","doc":"d853459d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481909","doc":"d111635d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-059135","doc":"d308859d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-058490","doc":"d488459d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004096","doc":"hstm-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006849","doc":"hstm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008985","doc":"hstm-10k_20201231.htm","q":null},{"fy":2021,"lvl":1,"n":3,"adsh":"0001437749-22-004615","doc":"hstm20211231_10k.htm","q":"They accomplish this by utilizing a combination of established and cutting-edge technologies, such as initiative and workflow management capabilities; proprietary taxonomy engines; dynamic engagement models; artificial intelligence (AI) dri\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001437749-23-004908","doc":"hstm20221231_10k.htm","q":"They accomplish this by utilizing a combination of established and cutting-edge technologies, such as initiative and workflow management capabilities; proprietary taxonomy engines; dynamic engagement models; artificial intelligence (AI) dri\u2026"},{"fy":2023,"lvl":2,"n":12,"adsh":"0001437749-24-005530","doc":"hstm20231231_10k.htm","q":"They accomplish this by utilizing a combination of established and cutting-edge technologies, such as initiative and workflow management capabilities; proprietary taxonomy engines; dynamic engagement models; artificial intelligence (AI) dri\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001437749-25-005705","doc":"hstm20241231_10k.htm","q":"They accomplish this by utilizing a combination of established and cutting-edge technologies, such as initiative and workflow management capabilities; proprietary taxonomy engines; dynamic engagement models; artificial intelligence and mach\u2026"},{"fy":2025,"lvl":3,"n":85,"adsh":"0001437749-26-005916","doc":"hstm20251231_10k.htm","q":"Increasingly, our hStream technology platform extends artificial intelligence (AI) capabilities to the applications it powers and serves as the system of record on which healthcare workforce AI relies."}]},{"cik":1095858,"name":"ERBA DIAGNOSTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-010391","doc":"erb20141231_10k.htm","q":null}]},{"cik":1095996,"name":"WILLIAM LYON HOMES","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001730","doc":"wlh-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012633","doc":"wlh-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002431","doc":"wlh-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002079","doc":"wlh-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002280","doc":"wlh-12312018x10k.htm","q":null}]},{"cik":1096275,"name":"WORKSPORT LTD","industry":"Auto manufacturing","sic":3714,"state":"NY","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-004548","doc":"fnhi_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-003081","doc":"fnhi_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-006941","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-008723","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008647","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":1,"n":4,"adsh":"0001493152-22-008564","doc":"form10-k.htm","q":"The Board reserved 1,250,000 shares of Common Stock issuable upon the grant of awards under the 2021 Plan. 12 Unregistered Sales of Equity Securities \u25cf 20,000 Common Shares issued to TraDigital Marketing Group, LLC on September 27, 2021 for\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-23-010294","doc":"form10-k.htm","q":"Siegel \u2014Director 60,000 (6) * % All officers and directors as a group (6 persons) 2,772,538 16.13 % 5%+ Shareholders: AI Media Data LLC (7) 1,525,000 8.77 % Leonite Fund I, LP 894,134 5.21 % *Less than 1%."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011808","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001641172-25-000850","doc":"form10-k.htm","q":"(NASDAQ: KULR), focused on advancing battery technology and strengthening domestic manufacturing, including, without limitation, joint battery pack development, thermal runaway protection and AI-integrated battery management system software\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001493152-26-012945","doc":"form10-k.htm","q":"(NASDAQ: KULR), focused on advancing battery technology and strengthening domestic manufacturing, including, without limitation, joint battery pack development, thermal runaway protection and AI-integrated battery management system software\u2026"}]},{"cik":1096325,"name":"INTERSIL CORP/DE","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001096325-15-000008","doc":"isil-20150102x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001096325-16-000077","doc":"isil-20160101x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001096325-17-000006","doc":"isil-20161230x10k.htm","q":null}]},{"cik":1096637,"name":"SAVICORP","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-002454","doc":"svmi_10k-123114.htm","q":null}]},{"cik":1097864,"name":"ON SEMICONDUCTOR CORP","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069358","doc":"d875301d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-475009","doc":"d138223d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-062207","doc":"d332046d10k.htm","q":null},{"fy":2017,"lvl":2,"n":5,"adsh":"0001193125-18-051397","doc":"d508456d10k.htm","q":"Form 10-K Summary 92 Signatures 93 (See the glossary immediately following this table of contents for definitions of certain abbreviated terms) Table of Contents ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES FORM 10-K GLOSSARY OF SELECTED A\u2026"},{"fy":2018,"lvl":2,"n":7,"adsh":"0001193125-19-045025","doc":"d664850d10k.htm","q":"Form 10-K Summary 92 Signatures 93 (See the glossary immediately following this table of contents for definitions of certain abbreviated terms) Table of Contents ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES FORM 10-K GLOSSARY OF SELECTED A\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001193125-20-041751","doc":"d864442d10k.htm","q":"Our broad range of product offerings delivers excellent pixel performance, sensor functionality and camera systems capabilities in which high quality visual imagery is becoming increasingly important to our customers and their end-users, pa\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001628280-21-002219","doc":"on-20201231.htm","q":"Our broad range of product offerings delivers excellent pixel performance, sensor functionality and camera systems capabilities in which high quality visual imagery is becoming increasingly important to our customers and their end-users, pa\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001628280-22-002416","doc":"on-20211231.htm","q":"Our broad range of product offerings delivers excellent pixel performance, sensor functionality and camera systems capabilities in which high quality visual imagery is becoming increasingly important to our customers and their end-users, pa\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001628280-23-002350","doc":"on-20221231.htm","q":"Our broad range of product offerings delivers excellent pixel performance, sensor functionality and camera systems capabilities in which high quality visual imagery is becoming increasingly important to our customers and their end-users, pa\u2026"},{"fy":2023,"lvl":2,"n":5,"adsh":"0001628280-24-003201","doc":"on-20231231.htm","q":"Our broad range of product offerings delivers excellent pixel performance, sensor functionality and camera systems capabilities in which high quality visual imagery is becoming increasingly important to our customers and their end-users, pa\u2026"},{"fy":2024,"lvl":3,"n":26,"adsh":"0001628280-25-004557","doc":"on-20241231.htm","q":"We are utilizing our extensive range of power technologies to help address the growing power demands of AI and data centers."},{"fy":2025,"lvl":3,"n":53,"adsh":"0001097864-26-000006","doc":"on-20251231.htm","q":"We offer intelligent power and intelligent sensing solutions that drive electrification, energy efficiency, safety, and automation in automotive, industrial, and other end-markets, including AI data center."}]},{"cik":1098009,"name":"AMERICA GREAT HEALTH","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001098009-16-000023","doc":"f10k2016ed2.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001185185-17-002175","doc":"americagreathealth10k063017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001185185-18-002115","doc":"amgreat20180630_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001185185-21-000363","doc":"amgreat20190630_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001185185-21-000951","doc":"amgreat20200630_10k.htm","q":null},{"fy":2021,"lvl":"x","n":1,"adsh":"0001185185-22-000080","doc":"amgreat20210630_10k.htm","q":"Overview of Business Our mission is to invest in innovative technologies, intergrated with business development in the healthcare ecosystem. 8 Table of Contents We are focused on protein and peptide small molecular drugs research and develo\u2026"},{"fy":2022,"lvl":"x","n":4,"adsh":"0001185185-22-001238","doc":"amgreat20220630_10k.htm","q":"The research fields involve biomedicine, clinical medicine, health management, information technology, data analysis, software development, artificial intelligence, industrial planning, financial investment, etc."},{"fy":2023,"lvl":"x","n":4,"adsh":"0001185185-23-001064","doc":"amgreat20230630_10k.htm","q":"The research fields involve biomedicine, clinical medicine, health management, information technology, data analysis, software development, artificial intelligence, industrial planning, financial investment, etc."},{"fy":2024,"lvl":"x","n":4,"adsh":"0001185185-25-000157","doc":"amgreat10k063024.htm","q":"The research fields involve biomedicine, clinical medicine, health management, information technology, data analysis, software development, artificial intelligence, industrial planning, financial investment, etc."},{"fy":2025,"lvl":"x","n":4,"adsh":"0001185185-26-001339","doc":"aagh10k063025.htm","q":"The research fields involve biomedicine, clinical medicine, health management, information technology, data analysis, software development, artificial intelligence, industrial planning, financial investment, etc."}]},{"cik":1098880,"name":"INTELGENX TECHNOLOGIES CORP.","industry":"Pharma & biotech","sic":2834,"state":"QC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001062993-15-001631","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001062993-16-008565","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-17-001520","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062993-18-001414","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001062993-19-001372","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001062993-20-001503","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001062993-21-002995","doc":"form10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001062993-22-008487","doc":"form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001062993-23-008012","doc":"form10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001062993-24-006905","doc":"form10k.htm","q":null}]},{"cik":1098972,"name":"AGENUS INC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001809","doc":"agen-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014840","doc":"agen-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004618","doc":"agen-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006093","doc":"agen-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008311","doc":"agen-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011221","doc":"agen-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013619","doc":"agen-10k_20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-007867","doc":"agen-10k_20211231.htm","q":"We believe our fully integrated, end-to-end capabilities from our artificial intelligence-powered VISION platform for novel target discovery, antibody generation, cell line development, to cGMP manufacturing and clinical development and ope\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-008517","doc":"agen-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-031620","doc":"agen-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-040289","doc":"agen-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":25,"adsh":"0001193125-26-108632","doc":"agen-20251231.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, or AI, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary inform\u2026"}]},{"cik":1099215,"name":"PROTALEX INC","industry":"Pharma & biotech","sic":8731,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-15-042456","doc":"v414846_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-16-113158","doc":"v444032_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-17-044755","doc":"v472805_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-18-049024","doc":"tv502356_10k.htm","q":null}]},{"cik":1099369,"name":"DESTINY MEDIA TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"BC","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001062993-15-006436","doc":"form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001062993-16-012523","doc":"form10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001062993-17-005109","doc":"form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001062993-18-004829","doc":"form10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001062993-19-004514","doc":"form10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001062993-20-005782","doc":"form10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001062993-21-011409","doc":"form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001062993-22-021911","doc":"form10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001062993-23-021487","doc":"form10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001062993-24-019439","doc":"form10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001062993-25-016994","doc":"form10k.htm","q":null}]},{"cik":1099509,"name":"VERTICAL COMPUTER SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001615774-15-000761","doc":"s100968_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001615774-16-004971","doc":"s102971_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-17-001835","doc":"s105840_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-18-003553","doc":"s109647_10k.htm","q":null}]},{"cik":1100397,"name":"AYALA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001493152-15-000050","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-16-006703","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-000250","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-17-014889","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-000489","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-19-019523","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-001656","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-004469","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-004167","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001493152-24-014822","doc":"form10-k.htm","q":"Berlin 59 President and Chief Executive Officer, Director Roy Golan, CPA, LLM 50 Chief Financial Officer Executive Officers Kenneth Berlin has served as our President and Chief Executive Officer and a member of our Board of Directors since \u2026"}]},{"cik":1100412,"name":"ARRAY BIOPHARMA INC","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001100412-15-000023","doc":"a6301510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001100412-16-000048","doc":"a06301610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-17-008555","doc":"a06301710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001100412-18-000026","doc":"a06301810-k.htm","q":null}]},{"cik":1100644,"name":"VALIDIAN CORP","industry":"Software & IT services","sic":7372,"state":"ON","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001052918-15-000146","doc":"validian10kapr1315v2.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001052918-16-000957","doc":"validian10kapr1416final.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001052918-17-000213","doc":"validian10kapr1417v4.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001052918-18-000124","doc":"validian10k2017final.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001052918-19-000089","doc":"validian10kapr1-19.htm","q":null}]},{"cik":1100682,"name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","industry":"Pharma & biotech","sic":8731,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-000785","doc":"crl1227201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001100682-16-000006","doc":"crl1226201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001100682-17-000003","doc":"crl1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001100682-18-000005","doc":"crl1230201710-k.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001100682-19-000004","doc":"crl1229201810-k.htm","q":"For example, our Safety and Assessment businesses have a program to evaluate the utility of induced pluripotent stems cells, advanced in vitro models, \u201corgan-on-a-chip\u201d technologies, artificial intelligence and machine learning in preclinic\u2026"},{"fy":2019,"lvl":1,"n":3,"adsh":"0001100682-20-000005","doc":"crl1228201910-k.htm","q":"Through strategic partnerships we also offer an ultra-high throughput screening laboratory, a human antibody discovery and development platform, an artificial intelligence drug design platform and a human stem cell model platform."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001100682-21-000005","doc":"crl-20201226.htm","q":"Through strategic partnerships, we also offer a human antibody discovery and development platform, an artificial intelligence drug design platform and a human stem cell model platform."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001100682-22-000007","doc":"crl-20211225.htm","q":"Through strategic partnerships, we also offer an artificial intelligence drug design platform, 3D in vitro oncology models, implantable micro device in animal tumor models to investigate pharmacological effects of multiple substances simult\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001100682-23-000006","doc":"crl-20221231.htm","q":"Through strategic partnerships, we also offer an artificial intelligence drug design platform, a human stem cell model platform, and 3D in vitro oncology models."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001100682-24-000007","doc":"crl-20231230.htm","q":"Through strategic partnerships, we also offer an artificial intelligence drug design platform, a human stem cell model platform, and 3D in vitro oncology models."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001100682-25-000011","doc":"crl-20241228.htm","q":"Our offerings include: \u2022 target discovery and validation; \u2022 disease biology; \u2022 target deconvolution through proteomics and cell microarray technology; \u2022 hit identification, hit-to-lead progression and lead optimization to deliver candidate \u2026"},{"fy":2025,"lvl":3,"n":16,"adsh":"0001100682-26-000022","doc":"crl-20251227.htm","q":"Our offerings include: \u2022 target discovery and validation; \u2022 disease biology; \u2022 target deconvolution through proteomics and cell microarray technology; \u2022 hit identification, hit-to-lead progression and lead optimization to deliver candidate \u2026"}]},{"cik":1101026,"name":"ZIVO BIOSCIENCE, INC.","industry":"Pharma & biotech","sic":2836,"state":"MI","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-005298","doc":"zivo_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-002845","doc":"zivo_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-24-003228","doc":"zivo_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001654954-25-002948","doc":"zivo_10k.htm","q":null}]},{"cik":1101865,"name":"NET MEDICAL XPRESS SOLUTIONS, INC.","industry":"Software & IT services","sic":7372,"state":"NM","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000149","doc":"nmxs_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000807","doc":"nmxs_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001393905-17-000097","doc":"nmxs_10k.htm","q":null}]},{"cik":1102541,"name":"EARTHLINK HOLDINGS CORP.","industry":"Software & IT services","sic":7370,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001102541-15-000003","doc":"elnk-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001102541-16-000040","doc":"elnk-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001102541-17-000014","doc":"elnk-20161231x10k.htm","q":null}]},{"cik":1102934,"name":"CMC MATERIALS, INC.","industry":"Computers & chips","sic":3674,"state":"IL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001102934-15-000033","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001102934-16-000064","doc":"form10k.htm","q":null},{"fy":2017,"lvl":1,"n":4,"adsh":"0001102934-17-000028","doc":"form10k.htm","q":"Tungsten slurries are also used in advanced logic devices for a multitude of end use applications including MIDs such as smart phones and tablets, gaming devices, and in high-performance computing and artificial intelligence, as well as in \u2026"},{"fy":2018,"lvl":2,"n":5,"adsh":"0001102934-18-000028","doc":"form10k.htm","q":"Tungsten slurries are also used in advanced logic devices for a multitude of end use applications including MIDs such as smart phones and tablets, gaming devices, and in high-performance computing and artificial intelligence, as well as in \u2026"},{"fy":2019,"lvl":2,"n":6,"adsh":"0001102934-19-000058","doc":"ccmp-20190930.htm","q":"Tungsten slurries are also used in advanced logic devices for a multitude of end use applications including MIDs such as smart phones and tablets, gaming devices, and in high-performance computing and artificial intelligence, as well as in \u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001102934-20-000055","doc":"ccmp-20200930.htm","q":"INDUSTRY TRENDS SEMICONDUCTOR INDUSTRY Demand within the semiconductor industry is driven by smart phones, tablets, personal computers (\u201cPCs\u201d), servers, and a wide range of other electronic applications, including high-performance computing\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001102934-21-000052","doc":"ccmp-20210930.htm","q":"INDUSTRY TRENDS SEMICONDUCTOR INDUSTRY Demand within the semiconductor industry is driven by smart phones, tablets, personal computers (\u201cPCs\u201d), servers, and a wide range of other electronic applications, including high-performance computing\u2026"}]},{"cik":1102993,"name":"LIVEPERSON INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001628280-15-001726","doc":"a201410-kliveperson.htm","q":"The acquisition provides the Company with sophisticated, machine-learning predictive modeling that it expects to leverage across multiple engagement channels, enhancing its real-time intelligent engagement platform."},{"fy":2015,"lvl":0,"n":0,"adsh":"0001102993-16-000020","doc":"a201510-kliveperson.htm","q":null},{"fy":2016,"lvl":2,"n":6,"adsh":"0001102993-17-000005","doc":"a201610-kliveperson.htm","q":"We have also integrated LiveEngage with several artificial intelligence/bots vendors."},{"fy":2017,"lvl":3,"n":26,"adsh":"0001102993-18-000030","doc":"a201710-kliveperson.htm","q":"LiveEngage, the Company\u2019s enterprise-class, cloud-based platform, enables businesses and consumers to connect through conversational interfaces, such as in-app and mobile messaging, while leveraging bots and Artificial Intelligence (AI) to \u2026"},{"fy":2018,"lvl":3,"n":117,"adsh":"0001102993-19-000016","doc":"a201810-kliveperson.htm","q":"These messaging conversations harness human agents, bots and Artificial Intelligence (AI) to power convenient, personalized and content-rich journeys across the entire consumer lifecycle, from discovery and research, to sales, service and s\u2026"},{"fy":2019,"lvl":3,"n":166,"adsh":"0001102993-20-000017","doc":"a201910-kliveperson.htm","q":"(\u201cLivePerson\u201d, the \u201cCompany\u201d, \u201cwe\u201d or \u201cour\u201d) makes life easier for people and brands everywhere through messaging powered by AI and humans."},{"fy":2020,"lvl":3,"n":204,"adsh":"0001102993-21-000031","doc":"lpsn-20201231.htm","q":"(\u201cLivePerson\u201d, the \u201cCompany\u201d, \u201cwe\u201d or \u201cour\u201d) makes life easier for people and brands everywhere through trusted Conversational AI."},{"fy":2021,"lvl":3,"n":236,"adsh":"0001102993-22-000015","doc":"lpsn-20211231.htm","q":"(\u201cLivePerson\u201d, the \u201cCompany\u201d, \u201cwe\u201d or \u201cour\u201d) is a leading Conversational AI company creating digital experiences that are Curiously Human."},{"fy":2022,"lvl":3,"n":169,"adsh":"0001102993-23-000019","doc":"lpsn-20221231.htm","q":"(\u201cLivePerson\u201d, the \u201cCompany\u201d, \u201cwe\u201d or \u201cour\u201d) is a global leader in AI-powered customer conversations."},{"fy":2023,"lvl":3,"n":160,"adsh":"0001102993-24-000037","doc":"lpsn-20231231.htm","q":"These digital and artificial intelligence (\u201cAI\u201d)-powered conversations decrease costs and increase revenue for our brands, resulting in more convenient, personalized and content-rich journeys across the entire consumer lifecycle, and across\u2026"},{"fy":2024,"lvl":3,"n":178,"adsh":"0001102993-25-000018","doc":"lpsn-20241231.htm","q":"These digital and artificial intelligence (\u201cAI\u201d)-powered conversations decrease costs and increase revenue for our brands, resulting in more convenient, personalized and content-rich journeys across the entire consumer lifecycle, and across\u2026"},{"fy":2025,"lvl":3,"n":204,"adsh":"0001102993-26-000014","doc":"lpsn-20251231.htm","q":"These digital and artificial intelligence (\u201cAI\u201d)-powered conversations decrease costs and increase revenue for our brands, resulting in more convenient, personalized and content-rich journeys across the entire consumer lifecycle, and across\u2026"}]},{"cik":1103021,"name":"BIODELIVERY SCIENCES INTERNATIONAL INC","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-094062","doc":"d831797d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500290","doc":"d119484d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-085497","doc":"d298257d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084193","doc":"d463750d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-074893","doc":"d676269d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001103021-20-000042","doc":"bdsi-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001103021-21-000029","doc":"bdsi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001103021-22-000051","doc":"bdsi-20211231.htm","q":null}]},{"cik":1104280,"name":"SANGUI BIOTECH INTERNATIONAL INC","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001551163-15-000227","doc":"f201506_sgbi10kvedgar3.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001551163-16-000496","doc":"f10112016sgbi_10kvedgar4.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001551163-17-000171","doc":"sgbi10k2017vedgarfinal1.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001551163-18-000148","doc":"sgbi10k2018_final_20180928ve.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001445866-19-001219","doc":"sgbi-20190630.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001551163-20-000082","doc":"10kvedgar6.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001096906-21-002362","doc":"sgbi-20210630.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001096906-22-002384","doc":"sgbi-20220630.htm","q":null}]},{"cik":1104506,"name":"INSMED INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001346","doc":"a2222985z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010395","doc":"a2227323z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000856","doc":"a2230968z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104506-18-000002","doc":"insmed10k2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001104506-19-000009","doc":"insmed10k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104506-20-000007","doc":"insm-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104506-21-000005","doc":"insm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104506-22-000008","doc":"insm-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":4,"adsh":"0001104506-23-000009","doc":"insm-20221231.htm","q":"Our early-stage research programs encompass a wide range of technologies and modalities, including gene therapy, artificial intelligence-driven protein engineering, and protein manufacturing."},{"fy":2023,"lvl":3,"n":26,"adsh":"0001104506-24-000008","doc":"insm-20231231.htm","q":"Our early-stage research programs encompass a wide range of technologies and modalities, including gene therapy, artificial intelligence-driven protein engineering, protein manufacturing, RNA-end joining, and synthetic rescue."},{"fy":2024,"lvl":3,"n":26,"adsh":"0001104506-25-000009","doc":"insm-20241231.htm","q":"Our pre-clinical research programs encompass a wide range of technologies and modalities, including gene therapy, artificial intelligence-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue."},{"fy":2025,"lvl":3,"n":26,"adsh":"0001104506-26-000009","doc":"insm-20251231.htm","q":"Our pre-clinical research programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. 6 A summary of our commercial pro\u2026"}]},{"cik":1105533,"name":"ARGOS THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001750","doc":"f10k_033115.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001171843-16-008919","doc":"f10k_033016p.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001572","doc":"f10k_031617p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001171843-18-002425","doc":"f10k_040218p.htm","q":null}]},{"cik":1106644,"name":"CHINA PHARMA HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001010549-15-000090","doc":"cphi10k123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001010549-16-000541","doc":"cphi10k123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001010549-17-000112","doc":"cphi10k123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-003895","doc":"f10k2017_chinapharma.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-005094","doc":"f10k2018_chinapharmahold.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-008020","doc":"f10k2019_chinapharmahold.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-017981","doc":"f10k2020_chinapharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016151","doc":"f10k2021_chinapharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024710","doc":"f10k2022_chinapharma.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028731","doc":"ea0202772-10k_china.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001213900-25-026280","doc":"ea0234263-10k_chinapharm.htm","q":"Laws and regulations governing cybersecurity, information security, privacy and data protection, the use of the Internet as a commercial medium, the use of data in artificial intelligence and machine learning, and data sovereignty requireme\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001213900-26-038521","doc":"0001213900-26-038521.txt","q":"Laws and regulations governing cybersecurity, information security, privacy and data protection, the use of the Internet as a commercial medium, the use of data in artificial intelligence and machine learning, and data sovereignty requireme\u2026"}]},{"cik":1106645,"name":"DEBT RESOLVE INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009778","doc":"drsv_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001774","doc":"drsv_10k.htm","q":null}]},{"cik":1106838,"name":"SONNET BIOTHERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-023801","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-21-031781","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-035581","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-23-044896","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-24-050341","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-25-027978","doc":"form10-k.htm","q":null}]},{"cik":1106851,"name":"OMNIVISION TECHNOLOGIES INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":1,"n":1,"adsh":"0001047469-15-005854","doc":"a2225024z10-k.htm","q":"The OVM6211 is capable of capturing 400 \u00d7 400 video at 120 FPS, and has an ultra-low power mode for machine and computer vision applications."}]},{"cik":1107421,"name":"ALAUNOS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-046668","doc":"d325809d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-067077","doc":"d531986d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-063978","doc":"d678734d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-058863","doc":"d861766d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-063387","doc":"d20446d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004972","doc":"tcrt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006377","doc":"tcrt-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-038868","doc":"tcrt-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":13,"adsh":"0000950170-25-047758","doc":"tcrt-20241231.htm","q":"These competitors include 35 Pharma, Aardvark Tx, Altimmune, Amgen, Amplifier, Aphaia Pharma, Ascletis, AstraZeneca, Astrizi, BioAge Labs, Biomea Fusion, Biomed Industries, Boehringer Ingelheim, Clearmind, Corbus Pharma, Corxel, Currax Phar\u2026"},{"fy":2025,"lvl":"x","n":17,"adsh":"0001193125-26-134720","doc":"tcrt-20251231.htm","q":"Litigation is usually expensive and diverts management\u2019s attention and resources, which could adversely affect our business and cash resources and our ability to consummate a potential strategic transaction or the ultimate value our stockho\u2026"}]},{"cik":1107694,"name":"RACKSPACE HOSTING, INC.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001107694-15-000010","doc":"rax1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001107694-16-000063","doc":"rax1231201510-k.htm","q":null}]},{"cik":1107843,"name":"QUALYS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001107843-15-000003","doc":"qlys-2014x1231x10kq42014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001107843-16-000022","doc":"qlys-2015x1231x10kq42015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001107843-17-000003","doc":"qlys-2016x1231x10k.htm","q":null},{"fy":2017,"lvl":2,"n":11,"adsh":"0001107843-18-000003","doc":"qlys-2017x1231x10k.htm","q":"Today, the suite of solutions offered on our cloud platform, which we refer to as the Qualys Cloud Apps, includes: Asset Inventory (AI), CMDB Sync (SYN), VM, Continuous Monitoring (CM), Cloud Agent Platform (CAP), Threat Protection (TP), Se\u2026"},{"fy":2018,"lvl":2,"n":9,"adsh":"0001628280-19-002099","doc":"qlys-2018x1231x10k.htm","q":"These solutions and their Cloud Apps address and include: \u2022 IT Security: Vulnerability Management (VM), Threat Protection (TP), Continuous Monitoring (CM), indication of Compromise (IOC), Certificate Assessment (CRA); \u2022 Compliance Monitorin\u2026"},{"fy":2019,"lvl":2,"n":9,"adsh":"0001628280-20-001963","doc":"qlys-2019x1231x10kq412.htm","q":"These Cloud Apps address and include: \u2022 IT Security: Vulnerability Management (VM), Threat Protection (TP), Continuous Monitoring (CM), Patch Management (PM), Indication of Compromise (IOC); \u2022 Compliance Monitoring: Policy Compliance (PC), \u2026"},{"fy":2020,"lvl":2,"n":11,"adsh":"0001437749-21-003648","doc":"qlys20201231_10k.htm","q":"These Cloud Apps address and include: \u2022 IT Security: Vulnerability Management (VM), Vulnerability Management, Detection and Response (VMDR), Threat Protection (TP), Continuous Monitoring (CM), Patch Management (PM), Multi-Vector Endpoint De\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004075","doc":"qlys20211231_10k.htm","q":null},{"fy":2022,"lvl":2,"n":8,"adsh":"0001437749-23-004384","doc":"qlys20221231_10k.htm","q":"Network Detection and Response (NDR): Network detection and response monitors network traffic and analyzes it using deep learning artificial intelligence (AI) to detect cyber threats in data centers and in the public cloud."},{"fy":2023,"lvl":3,"n":30,"adsh":"0001107843-24-000008","doc":"qlys-20231231.htm","q":"In 2022, we acquired certain intangible assets of Blue Hexagon Inc., enabling us to leverage our cloud platform with deep learning AI and machine learning (ML) technologies to uncover behavior patterns including active vulnerability exploit\u2026"},{"fy":2024,"lvl":3,"n":41,"adsh":"0001107843-25-000009","doc":"qlys-20241231.htm","q":"In 2022, we acquired certain intangible assets of Blue Hexagon Inc., enabling us to leverage our cloud platform with deep learning AI and machine learning (ML) technologies to uncover behavior patterns including active vulnerability exploit\u2026"},{"fy":2025,"lvl":3,"n":39,"adsh":"0001107843-26-000008","doc":"qlys-20251231.htm","q":"ETM further enables automated remediation through policy-based response rules and AI-driven workflows that integrate with Qualys\u2019 TruRisk Eliminate solutions, IT service management platforms, and other third-party systems."}]},{"cik":1108205,"name":"CURIS INC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-060006","doc":"d846591d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-484817","doc":"d124290d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001108205-17-000006","doc":"cris-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001108205-18-000005","doc":"cris-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001108205-19-000004","doc":"cris-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001108205-20-000003","doc":"cris-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001108205-21-000003","doc":"cris-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001108205-22-000002","doc":"cris-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001108205-23-000023","doc":"cris-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001108205-24-000010","doc":"cris-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001108205-25-000031","doc":"cris-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001108205-26-000043","doc":"cris-20251231.htm","q":null}]},{"cik":1108426,"name":"TXNM ENERGY INC","industry":"Utilities","sic":4911,"state":"NM","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001108426-15-000008","doc":"pnm1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001108426-16-000165","doc":"pnm1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001108426-17-000006","doc":"pnm1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001108426-18-000011","doc":"pnm1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001108426-19-000020","doc":"pnm1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001108426-20-000014","doc":"pnm1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001108426-21-000010","doc":"pnm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001108426-22-000010","doc":"pnm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001108426-23-000006","doc":"pnm-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001108426-24-000008","doc":"pnm-20231231.htm","q":"However, despite steps the Company may take to detect, mitigate, and/or eliminate threats and respond to security incidents, the techniques used by those who wish to obtain unauthorized access, and possibly disable or sabotage systems and/o\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0001108426-25-000014","doc":"pnm-20241231.htm","q":"However, despite steps the Company may take to detect, mitigate, and/or eliminate threats and respond to security incidents, the techniques used by those who wish to obtain unauthorized access, and possibly disable or sabotage systems and/o\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001108426-26-000006","doc":"pnm-20251231.htm","q":"However, despite steps the Company may take to detect, mitigate, and/or eliminate threats and respond to security incidents, the techniques used by those who wish to obtain unauthorized access, and possibly disable or sabotage systems and/o\u2026"}]},{"cik":1108524,"name":"SALESFORCE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":2,"adsh":"0001108524-15-000008","doc":"crm-2015131x10k.htm","q":"Progress in data science and machine learning will move companies beyond just automating business processes to more data-driven, predictive computing."},{"fy":2015,"lvl":1,"n":2,"adsh":"0001108524-16-000053","doc":"crm-2016131x10k.htm","q":"Progress in data science and machine learning is moving companies beyond just automating business processes to more data-driven, predictive computing solutions."},{"fy":2016,"lvl":2,"n":11,"adsh":"0001108524-17-000006","doc":"crm-2017131x10k.htm","q":"Our core mission is to empower our customers to connect with their customers in entirely new ways through cloud, mobile, social, Internet of Things (\u201cIoT\u201d) and artificial intelligence technologies."},{"fy":2017,"lvl":3,"n":18,"adsh":"0001108524-18-000011","doc":"crmq4fy1810-k.htm","q":"Our core mission is to empower our customers to connect with their customers in entirely new ways through cloud, mobile, social, Internet of Things (\u201cIoT\u201d) and artificial intelligence (\u201cAI\u201d) technologies."},{"fy":2018,"lvl":3,"n":20,"adsh":"0001108524-19-000009","doc":"crmq4fy1910-k.htm","q":"Founded in 1999, Salesforce empowers companies of every size and industry to connect with their customers in new ways through existing and emerging technologies, including cloud, mobile, social, Internet of Things (\u201cIoT\u201d) and artificial int\u2026"},{"fy":2019,"lvl":3,"n":18,"adsh":"0001108524-20-000014","doc":"crm-20200131.htm","q":"Founded in 1999, Salesforce enables companies of every size and industry to connect with their customers in new ways through existing and emerging technologies, including cloud, mobile, social, blockchain, voice and artificial intelligence \u2026"},{"fy":2021,"lvl":3,"n":17,"adsh":"0001108524-22-000013","doc":"crm-20220131.htm","q":"Founded in 1999, we enable companies of every size and industry to take advantage of powerful technologies, including cloud, mobile, social, blockchain and artificial intelligence, to connect to their customers in a whole new way and help t\u2026"},{"fy":2022,"lvl":3,"n":26,"adsh":"0001108524-23-000011","doc":"crm-20230131.htm","q":"Our industry-leading Customer 360 platform spans sales, service, marketing, commerce, collaboration, integration, artificial intelligence, analytics, automation and more."},{"fy":2023,"lvl":3,"n":84,"adsh":"0001108524-24-000005","doc":"crm-20240131.htm","q":"Founded in 1999, we enable companies of every size and industry to connect with their customers through the power of data, AI, CRM and trust."},{"fy":2024,"lvl":3,"n":133,"adsh":"0001108524-25-000006","doc":"crm-20250131.htm","q":"(\u201cSalesforce,\u201d the \u201cCompany,\u201d \u201cwe\u201d or \u201cour\u201d) is a global leader in customer relationship management (\u201cCRM\u201d) technology, enabling companies of every size and industry to connect with their customers through the power of data, artificial inte\u2026"},{"fy":2025,"lvl":3,"n":144,"adsh":"0001108524-26-000060","doc":"crm-20260131.htm","q":"Our artificial intelligence (\u201cAI\u201d) powered Agentforce 360 Platform unites our offerings \u2014 spanning sales, service, marketing, commerce, collaboration, data management, integration, analytics, IT service, industry verticals and more \u2014 on a s\u2026"}]},{"cik":1108645,"name":"CORRELATE ENERGY CORP.","industry":"Construction","sic":8711,"state":"ID","cells":[{"fy":2023,"lvl":"x","n":3,"adsh":"0001477932-24-001631","doc":"cipi_10k.htm","q":"The process continues by acquiring building data to analyze energy consumption to quickly identify savings (and hence, improved NOI) with intelligent machine learning."}]},{"cik":1108645,"name":"CORRELATE INFRASTRUCTURE PARTNERS, INC.","industry":"Utilities","sic":4931,"state":"LA","cells":[{"fy":2022,"lvl":"x","n":1,"adsh":"0001477932-23-002057","doc":"cipi_10k.htm","q":"Step-by-Step Sale to Project Completion Process The customer engagement process begins by benchmarking and prioritizing goals of our potential customer, followed by acquiring building data to analyze energy consumption to quickly identify s\u2026"}]},{"cik":1109196,"name":"MABVAX THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001415889-16-005062","doc":"mbvx10k_dec312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-001584","doc":"mbvx10k_dec312016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003518","doc":"mbvx10k_dec312017.htm","q":null}]},{"cik":1109357,"name":"EXELON CORP","industry":"Utilities","sic":4931,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-049964","doc":"d858551d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-457652","doc":"d129102d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-039639","doc":"d339405d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-001324","doc":"exc-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-001107","doc":"exc-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001109357-20-000053","doc":"exc-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001109357-21-000022","doc":"exc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001109357-22-000039","doc":"exc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001109357-23-000018","doc":"exc-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001109357-24-000053","doc":"exc-20231231.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify the Registrants' cybersecurity risks."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001109357-25-000043","doc":"exc-20241231.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify the Registrants' cybersecurity risks."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001109357-26-000018","doc":"exc-20251231.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify the Registrants' cybersecurity risks. 23 Table of Contents A security breach of the Registrants' physical assets or information sy\u2026"}]},{"cik":1110361,"name":"EROOMSYSTEM TECHNOLOGIES INC","industry":"Computers & chips","sic":3570,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001185185-15-000550","doc":"eroomsystemtech10k123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-028505","doc":"erms20151231_10k.htm","q":null}]},{"cik":1110611,"name":"ON24 INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":12,"adsh":"0001110611-22-000011","doc":"ontf-20211231.htm","q":"Our ON24 Experience products are backed by our solutions, including: \u2022 ON24 Intelligence: analytics backbone that captures first-person data to power the insights, benchmarking, reporting and artificial intelligence and machine learning, or\u2026"},{"fy":2022,"lvl":3,"n":28,"adsh":"0001110611-23-000005","doc":"ontf-20221231.htm","q":"Our ON24 Core Platform Experience products are backed by our solutions, including: \u2022 ON24 Intelligence: analytics backbone that captures first-person data to power the insights, benchmarking, reporting and artificial intelligence and machin\u2026"},{"fy":2023,"lvl":3,"n":77,"adsh":"0001110611-24-000009","doc":"ontf-20231231.htm","q":"With the launch of our intelligent engagement platform that includes our new AI-powered Analytics and Content Engine (\u201cACE\u201d) in January 2024, we are strategically positioned to help businesses and their sales and marketing organizations mak\u2026"},{"fy":2024,"lvl":3,"n":79,"adsh":"0001110611-25-000004","doc":"ontf-20241231.htm","q":"With the launch of our intelligent engagement platform that includes our AI-powered Analytics and Content Engine (\u201cACE\u201d), we are strategically positioned to help businesses and their sales and marketing organizations make this transition."},{"fy":2025,"lvl":3,"n":88,"adsh":"0001628280-26-017337","doc":"ontf-20251231.htm","q":"With the launch of our intelligent engagement platform that includes our AI-powered Analytics and Content Engine (\u201cACE\u201d), we are strategically positioned to help businesses and their sales, marketing and other customer-facing organizations \u2026"}]},{"cik":1110647,"name":"OCLARO, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-15-006832","doc":"oclaro10k2015-06x27.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-16-019264","doc":"oclaro10k2016-07x02.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-17-008773","doc":"oclaro10k2017-07x01.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-18-011325","doc":"oclaro10k2018-06x30.htm","q":null}]},{"cik":1111335,"name":"VISTEON CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001111335-15-000003","doc":"visteon201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001111335-16-000018","doc":"visteon201510-k.htm","q":null},{"fy":2016,"lvl":1,"n":2,"adsh":"0001111335-17-000003","doc":"visteon201610-k.htm","q":"The acquisition adds greater scale and depth to the Company's infotainment software capabilities. \u2022 Expand into Autonomous Driving - The Company's approach to autonomous driving is to feature fail-safe centralized domain hardware, designed \u2026"},{"fy":2017,"lvl":2,"n":5,"adsh":"0001111335-18-000004","doc":"visteon201710-k.htm","q":"Levels one and two are already popular in the market while levels three and above require multiple sensors, radars, camera and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of monitoring t\u2026"},{"fy":2018,"lvl":1,"n":4,"adsh":"0001111335-19-000003","doc":"visteon201810-k.htm","q":"Visteon also delivers artificial intelligence-based technologies, connected car, cybersecurity, interior sensing, embedded multimedia and smartphone connectivity software solutions."},{"fy":2019,"lvl":2,"n":5,"adsh":"0001111335-20-000003","doc":"visteon201910-k.htm","q":"Levels one and two are already popular in the market while levels three and above require a combination of sensors, radars, camera and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of moni\u2026"},{"fy":2020,"lvl":2,"n":5,"adsh":"0001111335-21-000006","doc":"vc-20201231.htm","q":"Levels one and two are already popular in the market while levels three and above utilize a combination of sensors, radars, cameras and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of mon\u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001111335-22-000014","doc":"vc-20211231.htm","q":"Levels one and two are already popular in the market while levels three and above utilize a combination of sensors, radars, cameras and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of mon\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001111335-23-000009","doc":"vc-20221231.htm","q":"Levels three and above utilize a combination of sensors, radars, cameras and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of monitoring the environment."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001111335-24-000018","doc":"vc-20231231.htm","q":"Levels three and above utilize a combination of sensors, radars, cameras and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of monitoring the environment."},{"fy":2024,"lvl":2,"n":11,"adsh":"0001111335-25-000006","doc":"vc-20241231.htm","q":"Levels three and above utilize a combination of sensors, radars, cameras and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of monitoring the environment."},{"fy":2025,"lvl":2,"n":14,"adsh":"0001111335-26-000006","doc":"vc-20251231.htm","q":"Levels three and above utilize a combination of sensors, radars, cameras and LiDARs, requiring sensor fusion and machine learning technologies, as the system assumes the role of monitoring the environment."}]},{"cik":1111665,"name":"TELECOMMUNICATION SYSTEMS INC /FA/","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001639","doc":"tsys-10k_20141231.htm","q":null}]},{"cik":1111711,"name":"NISOURCE INC.","industry":"Utilities","sic":4931,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001111711-15-000008","doc":"ni-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001111711-16-000049","doc":"ni-20151231x10kq4.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001111711-17-000011","doc":"ni-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001111711-18-000008","doc":"ni-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001111711-19-000008","doc":"ni-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001111711-20-000013","doc":"ni-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001111711-21-000010","doc":"nix-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001111711-22-000007","doc":"nix-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001111711-23-000006","doc":"nix-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001111711-24-000011","doc":"nix-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001111711-25-000008","doc":"nix-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001111711-26-000027","doc":"nix-20251231.htm","q":"Deployment or adoption of new or emerging business technologies, including artificial intelligence, Internet of Things (IoT) devices, and cloud-based platforms, increased reliance on third-party vendors, cloud service providers and software\u2026"}]},{"cik":1111928,"name":"IPG PHOTONICS CORP","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001111928-15-000040","doc":"ipgp-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001111928-16-000159","doc":"ipgp-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001111928-17-000055","doc":"ipgp-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001111928-18-000034","doc":"ipgp-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001111928-19-000035","doc":"ipgp-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001111928-20-000030","doc":"ipgp-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001111928-21-000026","doc":"ipgp-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001111928-22-000025","doc":"ipgp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001111928-23-000039","doc":"ipgp-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001111928-24-000019","doc":"ipgp-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001111928-25-000023","doc":"ipgp-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001111928-26-000040","doc":"ipgp-20251231.htm","q":null}]},{"cik":1112920,"name":"GLOBALSCAPE INC","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001185185-15-000679","doc":"globalscape10k123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001185185-16-003826","doc":"globalscape10k123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001185185-17-000658","doc":"globalscape10k123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001185185-18-001117","doc":"globalscape10k123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001185185-19-000384","doc":"globalscap20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001185185-20-000310","doc":"globalscap20191231_10k.htm","q":null}]},{"cik":1113148,"name":"INFINITY PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-060050","doc":"d850830d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-473445","doc":"d115525d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001113148-17-000003","doc":"infi-1231201610xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001113148-18-000004","doc":"infi-1231201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001113148-19-000002","doc":"infi-1231201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001113148-20-000004","doc":"infi-1231201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001113148-21-000007","doc":"infi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001113148-22-000007","doc":"infi-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0001113148-23-000003","doc":"infi-20221231.htm","q":"He previously co-founded Paige.AI, an artificial intelligence company focused on computational pathology, where he was a board member from May 2017 to January 2020."}]},{"cik":1113256,"name":"MERITOR, INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001113256-15-000031","doc":"mtor-20150930x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001113256-16-000092","doc":"meritor_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001113256-17-000116","doc":"mtor-20170930x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001113256-18-000120","doc":"mtor-20180930x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001113256-19-000096","doc":"mtor-20190930x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001113256-20-000123","doc":"mtor-20200927.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001113256-21-000128","doc":"mtor-20211003.htm","q":null}]},{"cik":1113481,"name":"MEDICINES CO /DE","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001113481-15-000011","doc":"mdco-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001113481-16-000058","doc":"mdco-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001113481-17-000010","doc":"mdco-12312016x10kxye2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001113481-18-000017","doc":"mdco-12312017x10kxq42017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001113481-19-000005","doc":"mdco-12312018x10kxq42018.htm","q":null}]},{"cik":1113513,"name":"MOBILESMITH, INC.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001266","doc":"most_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001654954-16-000180","doc":"most_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002271","doc":"most_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003338","doc":"most_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-003629","doc":"most_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-003088","doc":"most_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003131","doc":"most_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-003803","doc":"most_10k.htm","q":null}]},{"cik":1114220,"name":"KERYX BIOPHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069937","doc":"d846100d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481950","doc":"d116816d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001114220-17-000006","doc":"kerx-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001114220-18-000029","doc":"kerx-12312017x10k.htm","q":null}]},{"cik":1117106,"name":"NETSUITE INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001117106-15-000011","doc":"a2014netsuiteform10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001117106-16-000050","doc":"a2015netsuiteform10-k.htm","q":null}]},{"cik":1117480,"name":"CHIMERIX INC","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001582","doc":"a20141231cmrx10-kdocument.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001117480-16-000034","doc":"a20151231cmrx10-kdocument.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001117480-17-000004","doc":"0001117480-17-000004.txt","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001117480-18-000008","doc":"a20171231cmrx10-kdocument.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001117480-19-000010","doc":"a20181231cmrx10-kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001117480-20-000006","doc":"a20191231cmrx10-kdocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001117480-21-000006","doc":"cmrx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001117480-22-000008","doc":"cmrx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001117480-23-000006","doc":"cmrx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001117480-24-000005","doc":"cmrx-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001117480-25-000004","doc":"cmrx-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1118417,"name":"MODEL N, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-15-010979","doc":"modn-10k_20150930.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-16-029481","doc":"modn-10k_20160930.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-023880","doc":"modn-10k_20170930.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001118417-18-000009","doc":"modn10-k2018x09x30.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001118417-19-000095","doc":"modn10-k2019x09x30.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001118417-20-000129","doc":"modn-20200930.htm","q":"It also provides access and facilitates the synchronization with the de-normalized analytics database where the revenue management data used by analytics and AI/ML solutions are stored."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001118417-21-000166","doc":"modn-20210930.htm","q":"It also provides access and facilitates the synchronization with the de-normalized analytics database where the revenue management data used by analytics and AI/ML solutions are stored."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001118417-22-000135","doc":"modn-20220930.htm","q":"It also provides access and facilitates the synchronization with the de-normalized analytics database where the revenue management data used by analytics and AI/ML solutions are stored."},{"fy":2023,"lvl":3,"n":17,"adsh":"0001118417-23-000209","doc":"modn-20230930.htm","q":"It also provides access and facilitates the synchronization with the de-normalized analytics database where the revenue management data used by analytics and AI/ML solutions are stored."}]},{"cik":1120914,"name":"PDF SOLUTIONS INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-003857","doc":"pdfs20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026490","doc":"pdfs20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-004058","doc":"pdfs20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004863","doc":"pdfs20171231_10k.htm","q":null},{"fy":2018,"lvl":2,"n":7,"adsh":"0001437749-19-004374","doc":"pdfs20181231_10k.htm","q":"Also, for example, our integrated device manufacturers (or IDMs) and fabless customers use our solutions to generate unique, differentiated data that can be analyzed with our machine learning (ML) and artificial intelligence (AI) algorithms\u2026"},{"fy":2019,"lvl":2,"n":11,"adsh":"0001437749-20-004708","doc":"pdfs20191231_10k.htm","q":"Also, for example, our IDM and fabless customers use our solutions to generate unique, differentiated data that can be analyzed with our machine learning (or ML) and artificial intelligence (or AI) algorithms to\ufeff predict downstream manufact\u2026"},{"fy":2020,"lvl":2,"n":11,"adsh":"0001437749-21-005696","doc":"pdfs20201231_10k.htm","q":"By way of further example, our IDM and fabless customers use our solutions to generate unique, differentiated data that can be analyzed with our machine learning (or ML) and artificial intelligence (or AI) algorithms to predict downstream m\u2026"},{"fy":2021,"lvl":2,"n":10,"adsh":"0001558370-22-002561","doc":"pdfs-20211231x10k.htm","q":"Our products and services are used by many Fortune 500 companies across the semiconductor ecosystem to achieve smart manufacturing goals by connecting and controlling equipment, collecting data generated during manufacturing and test operat\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001558370-23-002586","doc":"pdfs-20221231x10k.htm","q":"By way of further example, our IDM and fabless customers use our solutions to generate unique, differentiated data that can be analyzed with our machine learning (\u201cML\u201d) and artificial intelligence (\u201cAI\u201d) algorithms to predict downstream man\u2026"},{"fy":2023,"lvl":3,"n":37,"adsh":"0001558370-24-001843","doc":"pdfs-20231231x10k.htm","q":"By way of further example, our IDM and fabless customers use our solutions to generate unique, differentiated data that can be analyzed with our machine learning (\u201cML\u201d) and artificial intelligence (\u201cAI\u201d) algorithms to predict downstream man\u2026"},{"fy":2024,"lvl":3,"n":49,"adsh":"0001558370-25-001813","doc":"pdfs-20241231x10k.htm","q":"By way of further example, our IDM and fabless customers use our solutions to generate unique, differentiated data that can be analyzed with our machine learning (\u201cML\u201d) and artificial intelligence (\u201cAI\u201d) algorithms, which are designed to pr\u2026"},{"fy":2025,"lvl":3,"n":52,"adsh":"0001437749-26-005366","doc":"pdfs20251231d_10k.htm","q":"Additionally, we believe that valuable, trusted, production-ready applications of AI in an industrial context need to be anchored on that type of robust, scalable, and secure data platform."}]},{"cik":1121788,"name":"GARMIN LTD","industry":"Aerospace & defense","sic":3812,"state":null,"cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001144204-15-010586","doc":"v400231_10k.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2015,"lvl":1,"n":1,"adsh":"0001615774-16-004243","doc":"s102606_10k.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2016,"lvl":1,"n":1,"adsh":"0001615774-17-000765","doc":"s105240_10k.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2017,"lvl":1,"n":1,"adsh":"0001615774-18-001344","doc":"s109029_10k.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001615774-19-002739","doc":"s116041_10k.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-005133","doc":"grmn-10k_20191228.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-006192","doc":"grmn-10k_20201226.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School."},{"fy":2021,"lvl":1,"n":1,"adsh":"0000950170-22-001303","doc":"grmn-20211225.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School. 28 All executive officers are elected by and serve at the discretion of the Company\u2019s Board of Directors."},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-003566","doc":"grmn-20221231.htm","q":"Etkind holds BA, MA and LLM degrees from Cambridge University, England and a JD degree from the University of Michigan Law School. 29 All executive officers are elected by and serve at the discretion of the Company\u2019s Board of Directors."},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-017559","doc":"grmn-20231230.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-022760","doc":"grmn-20241228.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-056028","doc":"grmn-20251227.htm","q":null}]},{"cik":1121793,"name":"JAGGED PEAK, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-006096","doc":"jgpk20150103_10k.htm","q":null}]},{"cik":1121795,"name":"GHST WORLD INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2021,"lvl":"x","n":6,"adsh":"0001553350-21-000852","doc":"ghst_10k-063021.htm","q":"Product Development The Company has completed the Beta testing of the functionality of the Smart Shin Guard is now in the industrial development phase which involves a focus on further development of the electronic component (including mini\u2026"},{"fy":2022,"lvl":"x","n":6,"adsh":"0001553350-22-000798","doc":"ghst_10k.htm","q":"Product Development The Company has completed the Beta testing of the functionality of the Smart Shin Guard is now in the industrial development phase which involves a focus on further development of the electronic component (including mini\u2026"},{"fy":2023,"lvl":"x","n":9,"adsh":"0001553350-23-000446","doc":"ghst_10k.htm","q":"IoTT World Inc. will manage the data platform for all sports resulting from the recently signed a joint venture agreement with the cross-Ing, an artificial intelligence (AI) company, as described below at page 3."},{"fy":2024,"lvl":"x","n":6,"adsh":"0001079973-24-001394","doc":"ghst_10k.htm","q":"IoTT World Inc. will manage the data platform for all sports resulting from the recently signed a joint venture agreement with the cross-Ing, an artificial intelligence (AI) company, as described below at page 2."},{"fy":2025,"lvl":"x","n":18,"adsh":"0001079973-25-001605","doc":"ghst_10k-063025.htm","q":"IoTT World Inc. will manage the data platform for all sports resulting from the recently signed a joint venture agreement with the Cross-Ing, an artificial intelligence (AI) company, as described below at page 2."}]},{"cik":1122342,"name":"ALLIANCE FIBER OPTIC PRODUCTS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001206774-15-000893","doc":"afop_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001206774-16-004875","doc":"afop_10k.htm","q":null}]},{"cik":1122388,"name":"ELLIE MAE INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001122388-15-000021","doc":"elli20141231-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001122388-16-000074","doc":"elli-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001122388-17-000011","doc":"elli-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001122388-18-000010","doc":"elli-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001122388-19-000013","doc":"elli-20181231x10k.htm","q":null}]},{"cik":1122897,"name":"CVENT INC","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093509","doc":"d831399d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001122897-16-000029","doc":"cvent10k.htm","q":null}]},{"cik":1123852,"name":"NORTHERN STATES POWER CO","industry":"Utilities","sic":4931,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001123852-15-000003","doc":"nspm1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001123852-16-000018","doc":"nspm1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001123852-17-000003","doc":"nspm1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001123852-18-000003","doc":"nspm1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001123852-19-000004","doc":"nspm1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001123852-20-000003","doc":"nspm1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001123852-21-000008","doc":"nspm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001123852-22-000004","doc":"nspm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001123852-23-000004","doc":"nspm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001123852-24-000004","doc":"nspm-20231231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001123852-25-000005","doc":"nspm-20241231.htm","q":"Generative Artificial Intelligence, such as large language models like ChatGPT, present a range of challenges and potential risks as we consider impacts to the business."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001123852-26-000003","doc":"nspm-20251231.htm","q":"Advancements in artificial intelligence and large language models may increase cybersecurity threats and operational risks."}]},{"cik":1123979,"name":"SENOMYX INC","industry":"Pharma & biotech","sic":8731,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-003459","doc":"snmx20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026749","doc":"snmx20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003670","doc":"snmx20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004201","doc":"snmx20171231_10k.htm","q":null}]},{"cik":1124105,"name":"GYRE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093871","doc":"d856974d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-498295","doc":"d117011d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003722","doc":"cbio-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006216","doc":"cbio-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006879","doc":"cbio-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005546","doc":"cbio-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010823","doc":"cbio-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012877","doc":"cbio-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-004830","doc":"cbio-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037242","doc":"gyre-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-040279","doc":"gyre-20241231.htm","q":"Additionally, sensitive data could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, personnel\u2019s, vendors\u2019 or partners\u2019 use of generative AI technologies."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001193125-26-106251","doc":"gyre-20251231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."}]},{"cik":1124140,"name":"EXACT SCIENCES CORP","industry":"Pharma & biotech","sic":8731,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000227","doc":"exas-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003446","doc":"exas-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000714","doc":"exas-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001558370-18-000941","doc":"exas-20171231x10k.htm","q":"Freenome Inc. is developing a blood-based test that uses artificial intelligence capabilities to screen for certain cancers and pre-cancers."},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-000854","doc":"exas-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001124140-20-000010","doc":"exas-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001124140-21-000029","doc":"exas-20201231.htm","q":null}]},{"cik":1124198,"name":"FLUOR CORP","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000891","doc":"a2222981z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010220","doc":"a2227314z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000724","doc":"a2230876z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-000900","doc":"a2234507z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-001658","doc":"flr12-31x201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-013900","doc":"flr10kq42019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003360","doc":"flr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003231","doc":"flr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004139","doc":"flr-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-005451","doc":"flr-20231231.htm","q":"For example, the rapid evolution and increased adoption of artificial intelligence may intensify our cybersecurity risks."},{"fy":2024,"lvl":3,"n":22,"adsh":"0001628280-25-005924","doc":"flr-20241231.htm","q":"We may use artificial intelligence, machine learning, data science and similar technologies in our business, and challenges with properly managing such technologies could result in reputational harm, competitive harm, and legal liability, a\u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001124198-26-000007","doc":"flr-20251231.htm","q":"Our capital allocation priorities include investing in our people and growth markets, maintaining low debt leverage and returning capital to shareholders. \u2022 Foster a high-performance culture of project delivery by using A.I. and technology \u2026"}]},{"cik":1124524,"name":"CRYOPORT, INC.","industry":"Pharma & biotech","sic":2834,"state":"TN","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-031407","doc":"tm205293-1_10k.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001104659-21-030112","doc":"cyrx-20201231x10k.htm","q":"The Cryosphere is expected to be launched during the second half of 2021 \u25cf Research and development of advanced real-time condition monitoring systems \u25cf Predictive performance, maintenance and failure using Artificial Intelligence and Machi\u2026"},{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-22-000232","doc":"cyrx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000188","doc":"cyrx-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001558370-24-003128","doc":"cyrx-20231231x10k.htm","q":"Tec4med provides next generation pharmaceutical supply chain visibility by integrating condition monitoring, cloud and artificial intelligence (AI) solutions."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-002509","doc":"cyrx-20241231x10k.htm","q":"Tec4med provides next generation pharmaceutical supply chain visibility by integrating condition monitoring, cloud and artificial intelligence (AI) solutions."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001104659-26-024180","doc":"cyrx-20251231x10k.htm","q":"We plan to further support these capabilities through the development and application of artificial intelligence (\u201cAI\u201d) and advanced analytics to aggregated platform data, enabling the Company to manage and anticipate network risks, improve\u2026"}]},{"cik":1124610,"name":"VMWARE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001124610-15-000005","doc":"vmw-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001124610-16-000040","doc":"vmw-1231201510xk.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001124610-17-000009","doc":"vmw-1231201610xk.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001124610-18-000012","doc":"vmw-22201810xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001124610-19-000012","doc":"vmw-21201910xk.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001124610-20-000019","doc":"vmw-131202010xk.htm","q":"We are increasingly developing and maintaining large data sets and relying on machine learning, artificial intelligence and analytics to provide services to our customers and partners."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001124610-21-000015","doc":"vmw-20210129.htm","q":"Some of the factors that contribute to significant cyber risks include: \u2022 We increasingly develop and maintain large data sets and rely on machine learning, artificial intelligence and analytics to provide services to our customers and part\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001124610-22-000009","doc":"vmw-20220128.htm","q":"Additionally, we are partnering to deliver an AI-Ready Enterprise platform that combines vSphere with the NVIDIA AI Enterprise suite to enable customers to rapidly deploy, manage and scale AI in production with confidence. \u2022 vSAN and VxRail\u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0001124610-23-000015","doc":"vmw-20230203.htm","q":"Both provide stateful firewalling with intrusion detection and prevention, sandboxing, network traffic analysis and network detection and response to provide complete visibility into applications and workload flows with policy automation th\u2026"}]},{"cik":1124796,"name":"NLIGHT, INC.","industry":"Computers & chips","sic":3674,"state":"WA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001124796-19-000032","doc":"nlightq4201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001124796-20-000037","doc":"nlightq4201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001124796-21-000048","doc":"lasr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001124796-22-000028","doc":"lasr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001124796-23-000018","doc":"lasr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001124796-24-000018","doc":"lasr-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001124796-25-000021","doc":"lasr-20241231.htm","q":"Proposed regulations would impose a worldwide licensing requirement on certain ICs and computing resources that are used for training of AI models."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001124796-26-000012","doc":"lasr-20251231.htm","q":null}]},{"cik":1125345,"name":"MACROGENICS INC","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-075224","doc":"d838054d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001125345-16-000046","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001125345-17-000041","doc":"mgnx-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001125345-18-000022","doc":"mgnx-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001125345-19-000046","doc":"mgnx-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001125345-20-000031","doc":"mgnx-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001125345-21-000035","doc":"mgnx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001125345-22-000013","doc":"mgnx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001125345-23-000059","doc":"a1025_hqlease.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001125345-24-000060","doc":"mgnx-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes and the use of Artificial Intelligence (AI)), which may be incre\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0001125345-25-000042","doc":"mgnx-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and healthcare models to limit \u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001125345-26-000017","doc":"mgnx-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes and the use of Artificial Intelligence (AI), which may be increas\u2026"}]},{"cik":1126003,"name":"ALTERNET SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":1,"adsh":"0001062993-15-001644","doc":"form10k.htm","q":"Principles of Consolidation These consolidated financial statements include the accounts of the following companies: \u2022 Alternet Systems Inc. \u2022 AI Systems Group, Inc., a wholly owned subsidiary of Alternet \u2022 Tekvoice Communications, Inc., a \u2026"},{"fy":2015,"lvl":"x","n":1,"adsh":"0001062993-16-008578","doc":"form10k.htm","q":"AI Systems Group, Inc., a wholly owned subsidiary of Alternet ."}]},{"cik":1126115,"name":"LZG INTERNATIONAL, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2022,"lvl":3,"n":34,"adsh":"0001213900-22-055586","doc":"f10k2022_lzginter.htm","q":"The intellectual property is comprised of an AI Technology with many commercial applications, the first being \u201cAngelina FX\u201d."}]},{"cik":1126234,"name":"LUMOS PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001126234-15-000054","doc":"nlnk-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001126234-16-000235","doc":"nlnk-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001126234-17-000025","doc":"nlnk-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001126234-18-000026","doc":"nlnk-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001126234-19-000026","doc":"nlnk-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001126234-20-000018","doc":"nlnk-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001126234-21-000034","doc":"nlnk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001126234-22-000021","doc":"nlnk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001126234-23-000035","doc":"nlnk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001126234-24-000025","doc":"nlnk-20231231.htm","q":null}]},{"cik":1126294,"name":"GENON ENERGY, INC.","industry":"Utilities","sic":4911,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001126294-15-000005","doc":"genon201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001126294-16-000024","doc":"genon201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001126294-17-000006","doc":"genon201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001126294-18-000004","doc":"genon201710-k.htm","q":null}]},{"cik":1126741,"name":"GSI TECHNOLOGY INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-001072","doc":"gsit-20150331x10k.htm","q":null},{"fy":2015,"lvl":2,"n":14,"adsh":"0001558370-16-006362","doc":"gsit-20160331x10k.htm","q":"(\u201cMikaMonu\u201d), discussed below, we have expanded our strategy to include the development of in-place associative computing solutions for applications in evolving new markets such as \u201cbig data\u201d (including machine learning and deep convolution\u2026"},{"fy":2016,"lvl":2,"n":12,"adsh":"0001558370-17-004663","doc":"gsit-20170331x10k.htm","q":"Subsequent to our acquisition of MikaMonu, our principal strategic objective has been the development of in-place associative computing solutions for applications in evolving new markets such as \u201cbig data\u201d (including machine learning and de\u2026"},{"fy":2017,"lvl":3,"n":16,"adsh":"0001558370-18-005106","doc":"gsit-20180331x10k.htm","q":"Subsequent to our acquisition of MikaMonu, our principal strategic objective has been the development of in-place associative computing solutions for applications in evolving new markets such as \u201cbig data\u201d (including machine learning and de\u2026"},{"fy":2018,"lvl":3,"n":18,"adsh":"0001558370-19-005677","doc":"gsit-20190331x10k.htm","q":"Beginning in November 2015 with the acquisition of an Israeli company, our principal strategic objective has been the development of in-place associative computing solutions for applications in evolving new markets such as \u201cbig data\u201d (inclu\u2026"},{"fy":2019,"lvl":3,"n":19,"adsh":"0001558370-20-007308","doc":"gsit-20200331x10k.htm","q":"Beginning in November 2015 with the acquisition of an Israeli company, our principal strategic objective has been the development of in-place associative computing solutions for applications in evolving new markets such as \u201cbig data\u201d (inclu\u2026"},{"fy":2020,"lvl":3,"n":19,"adsh":"0001558370-21-008016","doc":"gsit-20210331x10k.htm","q":"Beginning in November 2015 with the acquisition of an Israeli company, our principal strategic objective has been the development of in-place associative computing solutions for applications in evolving new markets such as \u201cbig data\u201d (inclu\u2026"},{"fy":2021,"lvl":3,"n":35,"adsh":"0001558370-22-010443","doc":"gsit-20220331x10k.htm","q":"Business Overview GSI provides in-place associative computing solutions for applications in high growth markets such as artificial intelligence (AI) and high-performance computing (HPC), including natural language processing and computer vi\u2026"},{"fy":2022,"lvl":3,"n":35,"adsh":"0001558370-23-011516","doc":"gsit-20230331x10k.htm","q":"Business Overview GSI provides in-place associative computing solutions for applications in high growth markets such as artificial intelligence (\u201cAI\u201d) and high-performance computing (\u201cHPC\u201d), including natural language processing and compute\u2026"},{"fy":2023,"lvl":3,"n":33,"adsh":"0001558370-24-009139","doc":"gsit-20240331x10k.htm","q":"Business Overview GSI provides in-place associative computing solutions for applications in high growth markets such as artificial intelligence (\u201cAI\u201d) and high-performance computing (\u201cHPC\u201d), including natural language processing and compute\u2026"},{"fy":2024,"lvl":3,"n":40,"adsh":"0001558370-25-008723","doc":"gsit-20250331x10k.htm","q":"Business Overview GSI provides in-place associative computing solutions for applications in high growth markets such as artificial intelligence (\u201cAI\u201d) and high-performance computing (\u201cHPC\u201d), including natural language processing and compute\u2026"}]},{"cik":1128189,"name":"PROTOKINETIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"OH","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001079973-15-000278","doc":"pktx_10k-123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001079973-16-000885","doc":"pktx_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001079973-17-000127","doc":"pktx_10k-123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001079973-18-000141","doc":"pktx_10k-123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001079973-19-000124","doc":"pktx_10k-123118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001079973-20-000119","doc":"pktx_10k-123119.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001079973-21-000148","doc":"pktx_10k-123120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001079973-22-000230","doc":"pktx_10k-123121.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001079973-23-000353","doc":"pktx_10k-123122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001079973-24-000403","doc":"pktx_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001079973-25-000516","doc":"pktx_10k-123124.htm","q":null}]},{"cik":1129928,"name":"ONCOLYTICS BIOTECH INC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2025,"lvl":"x","n":12,"adsh":"0001129928-26-000020","doc":"oncy-20251231.htm","q":"Moreover, we face increased competition from other companies that are using AI in drug discovery and development."}]},{"cik":1130166,"name":"BIO GREEN MED SOLUTION, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-002527","doc":"t1500580-10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-013439","doc":"t1600767-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-003095","doc":"t1700098-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001571049-18-000206","doc":"tv489461-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-016652","doc":"tv516922-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002077","doc":"cycc-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002093","doc":"cycc-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004769","doc":"cycc-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003163","doc":"cycc-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-003713","doc":"cycc-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001558370-25-004331","doc":"cycc-20241231x10k.htm","q":null},{"fy":2025,"lvl":"x","n":2,"adsh":"0001493152-26-013669","doc":"form10-k.htm","q":"Real-time monitoring and integration with Building Management Systems (\u201cBMS\u201d) are becoming standard for modern office complexes. \u25cf Advanced Detection: Shift toward addressable/intelligent panels and AI-powered fire detection that minimizes \u2026"}]},{"cik":1130310,"name":"CENTERPOINT ENERGY INC","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001130310-15-000008","doc":"cnp_10kx12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001130310-16-000031","doc":"cnp_10kx12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001130310-17-000006","doc":"cnp_10kx12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001130310-18-000003","doc":"cnp_10kx12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001130310-19-000016","doc":"cnp_10kx12312018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001130310-20-000016","doc":"cnp10k12312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001130310-21-000009","doc":"cnp-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001130310-22-000023","doc":"cnp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001130310-23-000013","doc":"cnp-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":26,"adsh":"0001130310-24-000010","doc":"cnp-20231231.htm","q":"Ryan currently serves on the boards of the Lone Star Flight Museum and the Association of Electric Companies of Texas and on the advisory board of the Strategic AI Program at Houston Christian University."},{"fy":2024,"lvl":3,"n":29,"adsh":"0001130310-25-000040","doc":"cnp-20241231.htm","q":"Ryan currently serves on the boards of the Lone Star Flight Museum and the Association of Electric Companies of Texas and on the advisory board of the Strategic AI Program at Houston Christian University."},{"fy":2025,"lvl":3,"n":35,"adsh":"0001130310-26-000008","doc":"cnp-20251231.htm","q":"The sophistication of cybersecurity threats, including those leveraging AI, continues to increase, and the controls and preventative actions we take to reduce the risk of cybersecurity incidents and protect our systems, including the regula\u2026"}]},{"cik":1130464,"name":"BLACK HILLS CORP /SD/","industry":"Utilities","sic":4911,"state":"SD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001130464-15-000083","doc":"bkh10k122014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001130464-16-000176","doc":"bkh10k122015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001130464-17-000010","doc":"bkh10k122016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001130464-18-000014","doc":"bkh10k122017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001130464-19-000012","doc":"bkh10k122018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001130464-20-000006","doc":"bkh10k122019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001130464-21-000007","doc":"bkh-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001130464-22-000004","doc":"bkh-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002759","doc":"bkh-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-015090","doc":"bkh-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0000950170-25-018647","doc":"bkh-20241231.htm","q":"In addition, the advancement of AI has given rise to additional vulnerabilities and potential entry points for cyberattacks."},{"fy":2025,"lvl":2,"n":10,"adsh":"0001193125-26-046028","doc":"bkh-20251231.htm","q":"Additionally, artificial intelligence, including generative artificial intelligence, may be used to facilitate or perpetrate these cybersecurity threats, and our use of generative artificial intelligence (and use by our vendors and agents) \u2026"}]},{"cik":1130591,"name":"XENOPORT INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069675","doc":"d849886d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-482271","doc":"d103345d10k.htm","q":null}]},{"cik":1130598,"name":"TRAWS PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002952","doc":"a2223977z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011628","doc":"a2227962z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-002146","doc":"a2231491z10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001047469-18-001777","doc":"a2234139z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001839","doc":"a2238283z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-20-001878","doc":"a2241137z10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-038452","doc":"tm211024-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004015","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005107","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004525","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-004165","doc":"tmb-20241231x10k.htm","q":null}]},{"cik":1131554,"name":"SYNCHRONOSS TECHNOLOGIES INC","industry":"Software & IT services","sic":7371,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001131554-15-000005","doc":"c554-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001131554-16-000033","doc":"sncr-20151231x10k.htm","q":null},{"fy":2016,"lvl":2,"n":5,"adsh":"0001131554-17-000037","doc":"sncr-12311610xk.htm","q":"Our Synchronoss Analytics platform analyzes substantial volumes of data from internal and external sources to deliver daily business insights to our customers\u2019 executives and leverages data science, machine learning, artificial intelligence\u2026"},{"fy":2017,"lvl":1,"n":3,"adsh":"0001131554-18-000025","doc":"sncr-12311710xk.htm","q":"Advanced Analytics Synchronoss Advanced Analytics is a patent pending insight generation system, applying machine learning and artificial intelligence to the uniquely valuable data sets from network, devices and applications to deliver meas\u2026"},{"fy":2018,"lvl":2,"n":12,"adsh":"0001131554-19-000024","doc":"sncr-12311810xk.htm","q":"Data-driven: Our platforms, products and solutions operate with the assistance of analytics, smart tagging, artificial intelligence, natural language processing, reporting and other data-driven insights."},{"fy":2019,"lvl":2,"n":12,"adsh":"0001131554-20-000025","doc":"sncr-12311910xk.htm","q":"The Synchronoss Digital Platform is a suite of technology, tools and solutions that includes digital experience creation and management, automated provisioning, artificial intelligence and financial analytics and service a broad swatch of T\u2026"},{"fy":2020,"lvl":2,"n":7,"adsh":"0001131554-21-000012","doc":"sncr-20201231.htm","q":"AI and Machine Learning: Our platforms, products and solutions operate with the assistance of analytics, smart tagging, artificial intelligence, natural language processing, reporting and other data-driven insights."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001131554-22-000018","doc":"sncr-20211231.htm","q":"It also offers the ability to highlight programs and revenue generating initiatives during the setup process, such as loyalty programs, third-party partnerships and value-added services. \u2022 Digital Experience Platform (DXP) The Synchronoss D\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001131554-23-000013","doc":"sncr-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":14,"adsh":"0001131554-24-000018","doc":"sncr-20231231.htm","q":"The industries we serve are characterized by rapid technological change and frequent new service offerings and are highly competitive with respect to the need for innovation, including the use of artificial intelligence and machine learning\u2026"},{"fy":2024,"lvl":3,"n":23,"adsh":"0001131554-25-000029","doc":"sncr-20241231.htm","q":"With Artificial Intelligence (\u201cAI\u201d) powered features that enrich user experiences, we help operators create new revenue streams, lower innovation costs, and strengthen customer loyalty, all while ensuring secure and effortless content manag\u2026"}]},{"cik":1133416,"name":"GALECTIN THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-096928","doc":"d826567d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-504330","doc":"d20778d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-098753","doc":"d314087d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-18-100592","doc":"d498563d10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001193125-19-064705","doc":"d675303d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-073907","doc":"d862694d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-101402","doc":"d30125d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-012058","doc":"brhc10035119_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-014658","doc":"brhc10049486_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-016452","doc":"ef20015363_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001140361-25-011169","doc":"ef20039001_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001140361-26-012155","doc":"ef20060823_10k.htm","q":null}]},{"cik":1133421,"name":"NORTHROP GRUMMAN CORP /DE/","industry":"Aerospace & defense","sic":3812,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001133421-15-000008","doc":"noc-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001133421-16-000065","doc":"noc-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001133421-17-000008","doc":"noc-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001133421-18-000005","doc":"noc-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001133421-19-000007","doc":"noc-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001133421-20-000006","doc":"noc-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001133421-21-000006","doc":"noc-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":4,"adsh":"0001133421-22-000004","doc":"noc-20211231.htm","q":"The company is a leading provider of space systems, advanced aircraft, missile defense, advanced weapons and long-range fires capabilities, mission systems, networking and communications, strategic deterrence systems, and breakthrough techn\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001133421-23-000006","doc":"noc-20221231.htm","q":"The company is a leading provider of space systems, advanced aircraft, missile defense, advanced weapons and long-range fires capabilities, mission systems, networking and communications, strategic deterrence systems, and breakthrough techn\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0001133421-24-000006","doc":"noc-20231231.htm","q":"Employees utilize curated, career-specific resources such as My Learning Experience, a machine learning enabled content aggregator that creates a personalized learning experience for each employee."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001133421-25-000006","doc":"noc-20241231.htm","q":"Employees utilize curated, career-specific resources such as My Learning Experience, a machine learning enabled content aggregator that creates a personalized learning experience for each employee."},{"fy":2025,"lvl":2,"n":9,"adsh":"0001133421-26-000003","doc":"noc-20251231.htm","q":"Our success in competing depends, in part, on our ability to remain price- and cost-competitive, respond to changes in customer acquisition strategies and preferences, accurately anticipate our customers\u2019 needs, successfully effect our digi\u2026"}]},{"cik":1133818,"name":"BIO-PATH HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088178","doc":"v433524_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-014602","doc":"v461046_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-018611","doc":"tv488319_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-014855","doc":"tv515879_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-029711","doc":"tm205374-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-033789","doc":"tm211142d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003298","doc":"bpth-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005081","doc":"bpth-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-002730","doc":"bpth-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001558370-25-003837","doc":"bpth-20241231x10k.htm","q":null}]},{"cik":1133869,"name":"CAPRICOR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016469","doc":"v403079_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091632","doc":"v433695_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-014866","doc":"v461171_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-016468","doc":"tv487725_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-016787","doc":"tv513994_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-039272","doc":"tm205377d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-036410","doc":"tm211144d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003341","doc":"capr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004124","doc":"capr-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002861","doc":"capr-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003707","doc":"capr-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-029580","doc":"capr-20251231x10k.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to use of AI to review product applications."}]},{"cik":1135361,"name":"ILLINOIS POWER GENERATING CO","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001135361-15-000004","doc":"gen-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001135361-16-000019","doc":"gen-20151231x10k.htm","q":null}]},{"cik":1135906,"name":"EPIRUS BIOPHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002966","doc":"a2223738z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004428","doc":"eprs-20151231x10k.htm","q":null}]},{"cik":1135971,"name":"PEPCO HOLDINGS INC","industry":"Utilities","sic":4931,"state":"DC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-066324","doc":"d828307d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-468556","doc":"d92251d10k.htm","q":null}]},{"cik":1136294,"name":"WILLIAMS INDUSTRIAL SERVICES GROUP INC.","industry":"Construction","sic":1600,"state":"GA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002713","doc":"wlms-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003280","doc":"wlms-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003832","doc":"wlms-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003770","doc":"wlms-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005302","doc":"wlms-20221231x10k.htm","q":null}]},{"cik":1137883,"name":"BRAINSTORM CELL THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-018682","doc":"v403621_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-086932","doc":"v432184_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-017265","doc":"v460019_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013470","doc":"tv486802_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-017041","doc":"tv512716_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-022244","doc":"tm205304d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-011928","doc":"bcli-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000554","doc":"bcli-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410578-23-000426","doc":"bcli-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001410578-24-000385","doc":"bcli-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":18,"adsh":"0001410578-25-000545","doc":"bcli-20241231x10k.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"},{"fy":2025,"lvl":"x","n":18,"adsh":"0001104659-26-037927","doc":"bcli-20251231x10k.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"}]},{"cik":1138724,"name":"GLOBAL ARENA HOLDING, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001425203-22-000008","doc":"gahc-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001756125-23-000673","doc":"form10K.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001756125-24-000982","doc":"form10k.htm","q":null},{"fy":2024,"lvl":"x","n":2,"adsh":"0001493152-25-015825","doc":"form10-k.htm","q":"Threat actors may also utilize emerging technologies, such as AI and machine learning."}]},{"cik":1138776,"name":"AEVI GENOMIC MEDICINE, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-008677","doc":"v398803_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-084435","doc":"v428554_10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-013576","doc":"v460404_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-014238","doc":"tv487967_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-017064","doc":"tv517001_10k.htm","q":null}]},{"cik":1140098,"name":"OCATA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-000981","doc":"ocata_10k-123114.htm","q":null}]},{"cik":1140310,"name":"ENSYNC, INC.","industry":"Utilities","sic":4911,"state":"WI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001102624-15-001490","doc":"ensync10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-050035","doc":"v475416_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-050724","doc":"tv502271_10k.htm","q":null}]},{"cik":1142129,"name":"FIRST NATIONAL ENERGY CORP.","industry":"Utilities","sic":4911,"state":"ON","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008335","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-005793","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-008419","doc":"form10-k.htm","q":null}]},{"cik":1142701,"name":"UNITED ONLINE INC","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001433","doc":"a2223271z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010690","doc":"a2227403z10-k.htm","q":null}]},{"cik":1143068,"name":"GREAT PLAINS ENERGY INC","industry":"Utilities","sic":4911,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001143068-15-000015","doc":"gxp-12312014x10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001143068-16-000106","doc":"gxp-12312015x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001143068-17-000011","doc":"gxp-12312016x10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001143068-18-000015","doc":"gxp-12312017x10k.htm","q":null}]},{"cik":1144879,"name":"APPLIED BLOCKCHAIN, INC.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2022,"lvl":2,"n":6,"adsh":"0001628280-22-023816","doc":"apld-20220531.htm","q":"Initially, these datacenters will primarily host servers securing the Bitcoin network but can also host hardware for other applications such as artificial intelligence, machine learning and other blockchain networks in the future."}]},{"cik":1145604,"name":"NIKA PHARMACEUTICALS, INC","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001826466-25-000030","doc":"form-10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001826466-26-000026","doc":"form-10k.htm","q":null}]},{"cik":1156784,"name":"CARBONMETA TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001214659-15-006266","doc":"c81415010k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001214659-16-011727","doc":"l51416010k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-013105","doc":"form10-k.htm","q":null}]},{"cik":1157075,"name":"PHARMACYTE BIOTECH, INC.","industry":"Pharma & biotech","sic":2836,"state":"NV","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-19-002559","doc":"pharmacyte_10k-043019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-20-002680","doc":"pharmacyte_10k-043020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-21-003377","doc":"pharmacyte_10k-043021.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-22-005189","doc":"pharmacyte_i10k-043022.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-23-005175","doc":"pharmacyte_i10k-043023.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001683168-24-005575","doc":"pharmacyte_i10k-043024.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001683168-25-005821","doc":"pharmacyte_i10k-043025.htm","q":null}]},{"cik":1157601,"name":"MADRIGAL PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002022","doc":"a2223524z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011140","doc":"a2227746z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-002260","doc":"a2231593z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001557","doc":"a2234835z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000725","doc":"a2237824z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-049021","doc":"d796399d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-056164","doc":"d103755d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-051569","doc":"d243442d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-045575","doc":"d437449d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-007376","doc":"mdgl-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0001628280-25-007980","doc":"mdgl-20241231.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"},{"fy":2025,"lvl":3,"n":36,"adsh":"0001628280-26-009514","doc":"mdgl-20251231.htm","q":"Attempts to disrupt or gain unauthorized access to our and our third-party vendors\u2019 information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or\u2026"}]},{"cik":1157602,"name":"VITAE PHARMACEUTICALS, INC","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":1,"n":2,"adsh":"0001047469-15-003000","doc":"a2223784z10-k.htm","q":"We refer to these targets as \"difficult-to-drug.\" Contour's computational software uses artificial intelligence and sophisticated algorithms to model the assembly of molecular fragments, which are chemical structures consisting of one to se\u2026"},{"fy":2015,"lvl":1,"n":2,"adsh":"0001047469-16-010789","doc":"a2227568z10-k.htm","q":"We refer to these targets as \"difficult-to-drug.\" Contour's computational software uses artificial intelligence and sophisticated algorithms to model the assembly of molecular fragments, which are chemical structures consisting of one to se\u2026"}]},{"cik":1157762,"name":"CHINA AUTOMOTIVE SYSTEMS INC","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-018486","doc":"v404302_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091114","doc":"v434432_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-017409","doc":"v462087_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-017693","doc":"tv488705_10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001144204-19-016630","doc":"tv516484_10k.htm","q":"Tung is currently developing the \"green\" produce distribution channels for the Taiwanese markets and working on in incorporating Artificial Intelligence technologies into language learning products."},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-061126","doc":"tm205260d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-043566","doc":"tm211741d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000626","doc":"caas-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000424","doc":"caas-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000335","doc":"caas-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001104659-25-029080","doc":"caas-20241231x10k.htm","q":null}]},{"cik":1158114,"name":"APPLIED OPTOELECTRONICS, INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001019687-15-000833","doc":"aaoi_10k-123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001019687-16-005442","doc":"applied_10k-123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001556","doc":"aaoi-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001271","doc":"aaoi-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001078","doc":"aaoi-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-003909","doc":"aaoi20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-004108","doc":"aaoi20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004349","doc":"aaoi20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-004648","doc":"aaoi20221231_10k.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001437749-24-005367","doc":"aaoi20231231_10k.htm","q":"Our internet data center market is also experiencing substantial growth as hyperscale data center operators build and upgrade their infrastructure to support artificial intelligence (\"AI\") applications which are compute and bandwidth intens\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001437749-25-005575","doc":"aaoi20241231_10k.htm","q":"In addition, we believe that the significant automation employed in our production process for data center optical modules gives us advantages over our competitors in the ability to scale production rapidly, which is beneficial because the \u2026"},{"fy":2025,"lvl":3,"n":23,"adsh":"0001437749-26-005875","doc":"aaoi20251231_10k.htm","q":"In addition, we believe that the significant automation employed in our production process for data center optical modules gives us advantages over our competitors in the ability to scale production rapidly, which is beneficial because the \u2026"}]},{"cik":1158324,"name":"COGENT COMMUNICATIONS HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"DC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001355","doc":"a2223182z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010372","doc":"a2227147z10-k.htm","q":null}]},{"cik":1158780,"name":"PLURI INC.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001178913-15-002818","doc":"zk1517290.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001178913-17-002643","doc":"zk1720512.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001178913-18-002512","doc":"zk1822069.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-19-017859","doc":"f10k2019_pluristemtherap.htm","q":null},{"fy":2020,"lvl":1,"n":4,"adsh":"0001213900-20-026105","doc":"f10k2020_pluristemtherap.htm","q":"CRISPR-IL brings together the leading experts in life science and computer science from academia, medicine, and industry, to develop AI based end-to-end genome-editing solutions."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001213900-21-047664","doc":"f10k2021_pluristemtherap.htm","q":"CRISPR-IL brings together the leading experts in life science and computer science from academia, medicine, and industry, to develop Artificial Intelligence, or AI, based end-to-end genome-editing solutions."},{"fy":2022,"lvl":1,"n":4,"adsh":"0001213900-22-057677","doc":"f10k2022_pluriinc.htm","q":"CRISPR-IL brings together the leading experts in life science and computer science from academia, medicine, and industry, to develop Artificial Intelligence, or AI, based end-to-end genome-editing solutions."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001213900-23-076079","doc":"f10k2023_pluriinc.htm","q":"CRISPR-IL brings together the leading experts in life science and computer science from academia, medicine, and industry, to develop Artificial Intelligence, or AI, based on end-to-end genome-editing solutions."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001213900-24-079861","doc":"ea0213910-10k_pluriinc.htm","q":"CRISPR-IL brings together the leading experts in life science and computer science from academia, medicine, and industry, to develop Artificial Intelligence, or AI, based on end-to-end genome-editing solutions."},{"fy":2025,"lvl":2,"n":8,"adsh":"0001213900-25-088578","doc":"ea0256130-10k_pluriinc.htm","q":"CRISPR-IL brings together the leading experts in life science and computer science from academia, medicine, and industry, to develop Artificial Intelligence (\u201cAI\u201d), based on end-to-end genome-editing solutions."}]},{"cik":1159019,"name":"TRIBUTE PHARMACEUTICALS CANADA INC.","industry":"Pharma & biotech","sic":2834,"state":"ON","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001354488-15-000926","doc":"tbuff_10k.htm","q":null}]},{"cik":1159036,"name":"HALOZYME THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001159036-15-000041","doc":"halo-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001159036-16-000100","doc":"halo-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001159036-17-000014","doc":"halo-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001159036-18-000011","doc":"halo2017-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001159036-19-000006","doc":"halo2018-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001159036-20-000013","doc":"halo2019-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001159036-21-000014","doc":"halo-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001159036-22-000014","doc":"halo-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001159036-23-000012","doc":"halo-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001159036-24-000008","doc":"halo-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001159036-25-000010","doc":"halo-20241231.htm","q":"Additionally, artificial intelligence (\u201cAI\u201d) based software is increasingly being used in the biopharmaceutical industry."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001159036-26-000024","doc":"halo-20251231.htm","q":"Additionally, artificial intelligence (\u201cAI\u201d) based software is increasingly being used in the biopharmaceutical industry including by companies with which we compete."}]},{"cik":1160308,"name":"SAVARA INC","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001934","doc":"mstx-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014658","doc":"mstx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003487","doc":"mstx-10k_20161231.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-005610","doc":"svra-10k_20171231.htm","q":"Eur Respir J 27(3): 585-93. 5 Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, et al."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-007585","doc":"svra-10k_20181231.htm","q":"Eur Respir J 27(3): 585-93. 7 Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, et al."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-010465","doc":"svra-10k_20191231.htm","q":"Eur Respir J 27(3): 585-93. 7 Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, et al."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-011919","doc":"svra-10k_20201231.htm","q":"Eur Respir J 27(3): 585-93. 5 Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, et al."},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005045","doc":"svra-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010967","doc":"svra-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027920","doc":"svra-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-045731","doc":"svra-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-105076","doc":"svra-20251231.htm","q":null}]},{"cik":1160951,"name":"DUCK CREEK TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001564590-21-052973","doc":"dct-10k_20210831.htm","q":"Carriers can better analyze risk through enhanced pricing models, artificial intelligence and machine learning technology."},{"fy":2022,"lvl":1,"n":4,"adsh":"0000950170-22-020470","doc":"dct-20220831.htm","q":null}]},{"cik":1160958,"name":"INPHI CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004659","doc":"iphi20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026372","doc":"iphi20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003530","doc":"iphi20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-003532","doc":"iphi20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-003645","doc":"iphi20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-004130","doc":"iphi20191231_10k.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001437749-21-004113","doc":"iphi20201231_10k.htm","q":"Based on our Porrima\u2122 PAM4 DSP platform, the new Alcor platform includes our PAM4 DSP technology, linear TIA and driver to provide even higher levels of integration and lower power for high-performance hyperscale data center, cloud computin\u2026"}]},{"cik":1161315,"name":"YODLEE INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":2,"adsh":"0001171843-15-001265","doc":"f10k_030215.htm","q":"As our platform usage grows and is exposed to more users and use cases, the system benefits from machine learning algorithms to better normalize, categorize and process high volumes of transaction-level data captured on our platform, allowi\u2026"}]},{"cik":1164888,"name":"KYTO TECHNOLOGY & LIFE SCIENCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001078782-19-000455","doc":"f10k033119_10k.htm","q":null}]},{"cik":1164964,"name":"GLOBAL FUTURE CITY HOLDING INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-001262","doc":"globalfuture_10k-123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005849","doc":"global_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-17-000962","doc":"ftcy_10k-123116.htm","q":null}]},{"cik":1165231,"name":"PROCERA NETWORKS, INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011624","doc":"form10k.htm","q":null}]},{"cik":1166126,"name":"J C PENNEY CO INC","industry":"Retail","sic":5311,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001166126-15-000013","doc":"jcp-0131201510k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001166126-16-000069","doc":"jcp-0130201610k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001166126-17-000013","doc":"jcp-0128201710k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001166126-18-000014","doc":"jcp-0203201810k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001166126-19-000012","doc":"jcp-0202201910k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001166126-20-000022","doc":"jcp-0201202010k.htm","q":null}]},{"cik":1166380,"name":"QUANTUM FUEL SYSTEMS TECHNOLOGIES WORLDWIDE, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001166380-15-000014","doc":"a201410-k.htm","q":null}]},{"cik":1168220,"name":"ULURU INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001168220-15-000026","doc":"form10k_123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001168220-16-000159","doc":"form10k_123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001168220-17-000020","doc":"form10k_123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001168220-18-000008","doc":"form10k-2017_033018.htm","q":null}]},{"cik":1169245,"name":"PHASEBIO PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009364","doc":"phas-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001169245-20-000043","doc":"a10-k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001169245-21-000024","doc":"phas-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001169245-22-000028","doc":"phas-20211231.htm","q":null}]},{"cik":1169445,"name":"TRUBRIDGE, INC.","industry":"Software & IT services","sic":7371,"state":"AL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001169445-15-000004","doc":"cpsi10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001169445-16-000020","doc":"cpsi10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001169445-17-000002","doc":"cpsi10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001169445-18-000006","doc":"cpsi10k12312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001169445-19-000002","doc":"cpsi-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001169445-20-000002","doc":"cpsi-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-004641","doc":"cpsi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001169445-22-000003","doc":"cpsi-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001169445-23-000003","doc":"cpsi-20221231.htm","q":"Looking beyond 2022, we believe there will be continued pressure on hospital staffing, creating greater demand for automation and machine learning to allow staff to focus on patient care."},{"fy":2023,"lvl":3,"n":26,"adsh":"0001169445-24-000017","doc":"cpsi-20231231.htm","q":"Looking beyond 2023, we believe there will be continued pressure on hospital staffing, creating greater demand for automation and machine learning to allow staff to focus on patient care."},{"fy":2024,"lvl":3,"n":35,"adsh":"0001169445-25-000042","doc":"tbrg-20241231.htm","q":"Artificial Intelligence We see both the value and risk of generative AI being leveraged in healthcare delivery and are committed to ensuring our client population is not left behind as this rapidly advancing technology is being implemented \u2026"},{"fy":2025,"lvl":3,"n":57,"adsh":"0001169445-26-000006","doc":"tbrg-20251231.htm","q":"Artificial Intelligence We see both the value and risk of generative AI being leveraged in healthcare delivery and are committed to ensuring our client population is not left behind as this rapidly advancing technology is being implemented \u2026"}]},{"cik":1169561,"name":"COMMVAULT SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001628280-15-003946","doc":"a2015033110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001169561-16-000029","doc":"a2016033110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001169561-17-000014","doc":"a2017033110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001169561-18-000018","doc":"a2018033110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001169561-19-000022","doc":"a2019033110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001169561-20-000018","doc":"a2020033110k.htm","q":null},{"fy":2020,"lvl":1,"n":4,"adsh":"0001169561-21-000018","doc":"cvlt-20210331.htm","q":"To do this, we provide capabilities which enable our customers to accelerate their digital transformation in today's ever evolving workforce using tools that are light touch and utilize artificial intelligence and machine learning to drive \u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001169561-22-000018","doc":"cvlt-20220331.htm","q":"Our product portfolio includes intuitive tools and powerful machine learning technology that drives automation, reduces complexity, reigns in data fragmentation, and accelerates a customer\u2019s cloud journey."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001169561-23-000044","doc":"cvlt-20230331.htm","q":"Our solutions\u2019 unique indexing, cataloging, data movement, media management, AI/ML, and policy technologies are the source of the performance, scale, management, cost of ownership benefits and seamless interoperability inherent in all of ou\u2026"},{"fy":2023,"lvl":2,"n":13,"adsh":"0001169561-24-000039","doc":"cvlt-20240331.htm","q":"Our Commvault Cloud platform powered by Metallic AI aims to deliver the highest security, most intelligence, and fastest recovery across on-premises, hybrid and multi-cloud environments."},{"fy":2024,"lvl":3,"n":20,"adsh":"0001169561-25-000034","doc":"cvlt-20250331.htm","q":"Additionally, we leverage Arlie, our artificial intelligence (\"AI\")-powered assistant within the Commvault Cloud platform, to enhance support with real-time, actionable insights."}]},{"cik":1169652,"name":"CHANNELADVISOR CORP","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001169652-15-000024","doc":"ecom2014123110-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001169652-16-000122","doc":"ecom1231201510-k.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001169652-17-000014","doc":"ecom1231201610-k.htm","q":"In 2016, we launched a new Algorithmic Repricer, which offers predictive analytics and machine learning that may help our customers make more sales while maximizing margin. \u2022 Advertising management."},{"fy":2017,"lvl":1,"n":1,"adsh":"0001169652-18-000011","doc":"ecom1231201710-k.htm","q":"Our Algorithmic Repricer offers predictive analytics and machine learning that may help our customers make more sales while maximizing margin. \u2022 Advertising management."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001169652-19-000008","doc":"ecom1231201810-k.htm","q":"Our Algorithmic Repricer offers predictive analytics and machine learning that may help our customers make more sales while maximizing margin. \u2022 Advertising management."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001169652-20-000008","doc":"ecom1231201910-k.htm","q":"Our Algorithmic Repricer offers predictive analytics and machine learning that may help our customers make more sales while maximizing margin. \u2022 Advertising management."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001169652-21-000007","doc":"ecom-20201231.htm","q":"Algorithmic repricing uses predictive analytics and machine learning that may help our customers increase sales while maximizing margin. \u2022 Advertising management ."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001169652-22-000007","doc":"ecom-20211231.htm","q":"Algorithmic repricing uses predictive analytics and machine learning that may help our customers increase sales while maximizing their margins. \u2022 Shoppable Media solutions for brand sites ."}]},{"cik":1172069,"name":"P2 SOLAR, INC.","industry":"Construction","sic":1700,"state":null,"cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001640334-23-001477","doc":"ptos_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001640334-24-001124","doc":"ptos_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-25-001215","doc":"ptos_10k.htm","q":null}]},{"cik":1172136,"name":"US GEOTHERMAL INC","industry":"Utilities","sic":4911,"state":"ID","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001062993-15-001360","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001062993-16-008266","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-17-001274","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001062993-18-001121","doc":"form10k.htm","q":null}]},{"cik":1173281,"name":"NEUBASE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001387131-15-003603","doc":"ohrp-10k_093015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001387131-16-008696","doc":"ohrp-10k_093016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387131-17-005845","doc":"ohrp-10k_093017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001387131-19-000051","doc":"ohr-10k_093018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-003043","doc":"tm1927377-1_10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001104659-20-139139","doc":"tm2038825d1_10k.htm","q":"(Nasdaq: LTRN) and its audit and nominating committees, a member of the board of directors of Perimeter Medical Imaging AI, Inc."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-21-000599","doc":"tmb-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-22-003576","doc":"tmb-20220930x10k.htm","q":null}]},{"cik":1173313,"name":"ABVC BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-000304","doc":"f10k2016_americanbrivision.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-000537","doc":"f10k2017_americanbrivision.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-006364","doc":"f10k2018_americanbrivision.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-012685","doc":"f10k2019_americanbriv.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-015729","doc":"f10k2020_americanbrivi.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016726","doc":"f10k2021_abvcbio.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-025554","doc":"f10k2022_abvcbiopharma.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-022235","doc":"ea0201142-10k_abvcbio.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-032118","doc":"ea0232540-10k_abvcbio.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-023063","doc":"ea0278313-10k_abvcbio.htm","q":null}]},{"cik":1173489,"name":"CEVA INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":2,"n":7,"adsh":"0001193125-15-091210","doc":"d853544d10k.htm","q":"Our DSP IP portfolio includes comprehensive platforms for multimode 2G/3G/LTE/LTE-A baseband processing in cellular and infrastructure, computer vision and computational photography for any camera-enabled device, audio/voice/speech and ultr\u2026"},{"fy":2015,"lvl":2,"n":8,"adsh":"0001193125-16-501526","doc":"d127989d10k.htm","q":"Our ultra-low-power IPs for vision, audio, communications and connectivity include comprehensive DSP-based platforms for LTE/LTE-A/5G baseband processing in handsets, infrastructure and machine-to-machine devices, computer vision and comput\u2026"},{"fy":2016,"lvl":3,"n":19,"adsh":"0001193125-17-078780","doc":"d332181d10k.htm","q":"Our ultra-low-power IPs for vision, sound, long and short range wireless, include comprehensive DSP-based platforms for LTE/LTE-A/5G baseband processing in handsets, infrastructure and IoT devices, advanced imaging, computer vision and deep\u2026"},{"fy":2017,"lvl":3,"n":79,"adsh":"0001193125-18-067193","doc":"d528001d10k.htm","q":"BUSINESS Company Overview Headquartered in Mountain View, California, CEVA is the leading licensor of signal processing platforms and artificial intelligence processors for a smarter, connected world."},{"fy":2018,"lvl":3,"n":82,"adsh":"0001437749-19-003949","doc":"ceva20181231_10k.htm","q":"BUSINESS Company Overview Headquartered in Mountain View, California, CEVA is the leading licensor of signal processing platforms and artificial intelligence processors for a smarter, connected world."},{"fy":2019,"lvl":3,"n":86,"adsh":"0001437749-20-003932","doc":"ceva20191231_10k.htm","q":"We offer a variety of Digital Signal Processors, AI processors, wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence, all of which are key enabling tech\u2026"}]},{"cik":1173489,"name":"CEVA INC","industry":"Software & IT services","sic":7370,"state":"MD","cells":[{"fy":2020,"lvl":3,"n":84,"adsh":"0001437749-21-004597","doc":"ceva20201231_10k.htm","q":"We offer Digital Signal Processors, AI processors, wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence, all of which are key enabling technologies for \u2026"},{"fy":2021,"lvl":3,"n":89,"adsh":"0001437749-22-004905","doc":"ceva20211231_10k.htm","q":"We offer Digital Signal Processors, AI processors, wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence, all of which are key enabling technologies for \u2026"},{"fy":2022,"lvl":3,"n":86,"adsh":"0001437749-23-005106","doc":"ceva20221231_10k.htm","q":"We offer Digital Signal Processors, AI processors, short and long range connectivity solutions, 5G wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence,\u2026"},{"fy":2023,"lvl":3,"n":91,"adsh":"0001437749-24-006970","doc":"ceva20231231_10k.htm","q":"With the industry\u2019s only portfolio of comprehensive communications and scalable Edge AI IP, Ceva powers the connectivity, sensing, and inference in today\u2019s most advanced smart edge products across consumer IoT, mobile, automotive, infrastru\u2026"},{"fy":2024,"lvl":3,"n":126,"adsh":"0001437749-25-005523","doc":"ceva20241231_10k.htm","q":"Commanding 67% of the wireless connectivity market share based on IP design revenues in 2023, according to IPnest, we believe we have the industry\u2019s broadest portfolio of comprehensive wireless communications and processor IP platforms and \u2026"},{"fy":2025,"lvl":3,"n":171,"adsh":"0001437749-26-006091","doc":"ceva20251231_10k.htm","q":"BUSINESS Company Overview We are the leader in silicon and software intellectual property (\u201cIP\u201d) enabling Physical AI - the intelligence embedded directly into billions of devices that connect, sense, and infer data in the real world."}]},{"cik":1173514,"name":"HYSTER-YALE, INC.","industry":"Construction machinery","sic":3537,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001173514-15-000022","doc":"hy201410kv2.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001173514-16-000108","doc":"hy201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001173514-17-000019","doc":"hy201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001173514-18-000014","doc":"hy201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001173514-19-000010","doc":"hy201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001173514-20-000015","doc":"hy201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001173514-21-000022","doc":"hy-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001173514-22-000013","doc":"hy-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001173514-23-000011","doc":"hy-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001173514-24-000014","doc":"hy-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001173514-25-000015","doc":"hy-20241231.htm","q":"The introduction of new and complex technologies, such as artificial intelligence features, can also create challenges and compliance and safety risks."},{"fy":2025,"lvl":2,"n":13,"adsh":"0001173514-26-000049","doc":"hy-20251231.htm","q":"The Company also utilizes artificial intelligence tools to analyze, design and enhance the efficiency and innovation of its product development process."}]},{"cik":1174940,"name":"ORAGENICS INC","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-070177","doc":"d833684d10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001193125-16-523810","doc":"d52763d10k.htm","q":null},{"fy":2016,"lvl":"x","n":1,"adsh":"0001193125-17-058912","doc":"d315487d10k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University. 67 Table of Contents Mr."},{"fy":2017,"lvl":"x","n":1,"adsh":"0001193125-18-048564","doc":"d442467d10k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University."},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010173","doc":"ogen-10k_20181231.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001493152-20-003343","doc":"form10-k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-005122","doc":"form10-k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-007664","doc":"form10-k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001493152-23-012617","doc":"form10-k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University."},{"fy":2023,"lvl":"x","n":1,"adsh":"0001493152-24-011979","doc":"form10-k.htm","q":"Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-010389","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-010282","doc":"form10-k.htm","q":null}]},{"cik":1175505,"name":"FIVE PRIME THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001804","doc":"fprx-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014596","doc":"fprx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002299","doc":"fprx-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003511","doc":"fprx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004472","doc":"fprx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007407","doc":"fprx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014463","doc":"fprx-10k_20201231.htm","q":null}]},{"cik":1175609,"name":"CAVIUM, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001206","doc":"cavm-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013000","doc":"cavm-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002880","doc":"cavm-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004100","doc":"cavm-10k_20171231.htm","q":null}]},{"cik":1175680,"name":"CYTODYN INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001193125-15-250418","doc":"d944111d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-651305","doc":"d190912d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-17-231500","doc":"d395273d10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001193125-18-229738","doc":"d840102d10k.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001193125-19-221300","doc":"d40614d10k.htm","q":"It leverages technology using an artificial intelligence approach based on gene signatures."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001193125-20-220598","doc":"d923315d10k.htm","q":"It leverages technology using an artificial intelligence approach based on gene signatures."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-009730","doc":"cydy-20210531x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-013680","doc":"cydy-20220531x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001558370-23-015718","doc":"cydy-20230531x10k.htm","q":"Arman became the Company\u2019s Senior Vice President, Business Operations on July 9, 2023, following a brief medical leave of absence; \u25cf Strengthening the Company\u2019s Board of Directors through the addition of two highly qualified and experienced\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001558370-24-012328","doc":"cydy-20240531x10k.htm","q":"Pre-Clinical Development of Long-Acting CCR5 Antagonist In March 2023, the Company entered into a joint development agreement with a third-party generative AI drug discovery and development company to develop one or more longer-acting molec\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0001558370-25-009617","doc":"cydy-20250531x10k.htm","q":"Syneos Health leverages advanced data analytics and AI/ML capabilities to improve outcomes at every stage of the asset lifecycle, from clinical development to commercialization. \u200b 5 \u200b Table of Contents In November 2024, the Company received\u2026"}]},{"cik":1176309,"name":"ORAMED PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-15-009096","doc":"f10k2015_oramedpharma.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-16-018954","doc":"f10k2016_oramedpharma.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-17-012754","doc":"f10k2017_oramedpharma.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-016666","doc":"f10k2018_oramedpharma.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-19-024940","doc":"f10k2019_oramedpharma.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-20-038924","doc":"f10k2020_oramedpharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-21-062009","doc":"f10k2021_oramedpharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-017837","doc":"f10k2022_oramedpharma.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-020485","doc":"ea0200896-10k_oramedph.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001013762-25-003450","doc":"ea0234394-10k_oramed.htm","q":"BioXcel is a biopharmaceutical company leveraging artificial intelligence to develop innovative medicines in neuroscience and immuno-oncology."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-034835","doc":"ea0282618-10k_oramed.htm","q":"BioXcel is a biopharmaceutical company leveraging artificial intelligence to develop innovative medicines in neuroscience and immuno-oncology."}]},{"cik":1177648,"name":"ENANTA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-401602","doc":"0001193125-15-401602.txt","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-789660","doc":"d245582d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-024794","doc":"enta-10k_20170930.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-030275","doc":"enta-10k_20180930.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-044729","doc":"enta-10k_20190930.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-055233","doc":"enta-10k_20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-21-004895","doc":"enta-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-025667","doc":"enta-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-065884","doc":"enta-20230930.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-131260","doc":"enta-20240930.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-288121","doc":"enta-20250930.htm","q":null}]},{"cik":1177845,"name":"XPLORE TECHNOLOGIES CORP","industry":"Computers & chips","sic":3570,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-013053","doc":"xplr20150331_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001185185-16-004898","doc":"xploretech10k033116.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001185185-17-001390","doc":"xploretech10k033117.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001185185-18-001256","doc":"xploretech10k033118.htm","q":null}]},{"cik":1178253,"name":"SCYNEXIS INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001178253-15-000034","doc":"scyx-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001178253-16-000144","doc":"scyx-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001178253-17-000001","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005461","doc":"scyx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007834","doc":"scyx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009875","doc":"scyx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015962","doc":"scyx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012199","doc":"scyx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011138","doc":"scyx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-038046","doc":"scyx-20231231.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operation\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-038044","doc":"scyx-20241231.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operation\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001178253-26-000007","doc":"scyx-20251231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"}]},{"cik":1178377,"name":"EMARINE GLOBAL INC.","industry":"Aerospace & defense","sic":3812,"state":null,"cells":[{"fy":2018,"lvl":1,"n":3,"adsh":"0001493152-19-005251","doc":"form10-k.htm","q":"We also believe that we will maintain our position as a market leader by applying Big Data and Augmented Reality & Artificial Intelligence (\u201cAR/AI\u201d) technology to both our planned and future AtoN projects, such as our Integrated Maritime We\u2026"},{"fy":2019,"lvl":1,"n":3,"adsh":"0001493152-20-008709","doc":"form10-k.htm","q":"We also believe that we will maintain our position as a market leader by applying Big Data and Augmented Reality & Artificial Intelligence (\u201cAR/AI\u201d) technology to both our planned and future AtoN projects, such as our Integrated Maritime We\u2026"}]},{"cik":1178670,"name":"ALNYLAM PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-050223","doc":"d835246d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-462538","doc":"d19384d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001649","doc":"alny-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002152","doc":"alny-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003022","doc":"alny-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001178670-20-000004","doc":"alny-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001178670-21-000010","doc":"alny-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001178670-22-000013","doc":"alny-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001178670-23-000005","doc":"alny-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001178670-24-000008","doc":"alny-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001178670-25-000026","doc":"alny-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-007497","doc":"alny-20251231.htm","q":null}]},{"cik":1178711,"name":"PARATEK PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-117033","doc":"d853473d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014314","doc":"prtk-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003144","doc":"prtk-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004551","doc":"prtk-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006315","doc":"prtk-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009802","doc":"prtk-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016154","doc":"prtk-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009957","doc":"prtk-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-008187","doc":"prtk-20221231.htm","q":null}]},{"cik":1178727,"name":"COMSOVEREIGN HOLDING CORP.","industry":"Aerospace & defense","sic":3721,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001013762-16-001358","doc":"f10k2015_droneaviation.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-002536","doc":"f10k2016_droneaviation.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003379","doc":"f10k2017_droneaviation.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-004682","doc":"f10k2018_droneaviation.htm","q":null},{"fy":2019,"lvl":1,"n":3,"adsh":"0001213900-20-016652","doc":"f10k2019_comsovereignhold.htm","q":"As a result, data centers and many of the other functions will require virtualization and eventually artificial intelligence (AI) algorithms and machine learning to route data requests to these virtualized data centers to keep latency to a \u2026"}]},{"cik":1178879,"name":"AMICUS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001585","doc":"a2223191z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010563","doc":"a2227425z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001128","doc":"a2231065z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001199","doc":"a2232459z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001178879-19-000024","doc":"amicus1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001178879-20-000015","doc":"amicus1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001178879-21-000004","doc":"fold-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001178879-22-000006","doc":"fold-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001178879-23-000004","doc":"fold-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":9,"adsh":"0001178879-24-000003","doc":"fold-20231231.htm","q":"We may use artificial intelligence in our business, and challenges with properly managing its use could adversely affect our business."},{"fy":2024,"lvl":3,"n":17,"adsh":"0001178879-25-000003","doc":"fold-20241231.htm","q":"We may use artificial intelligence in our business, and challenges with properly managing its use could adversely affect our business."},{"fy":2025,"lvl":3,"n":17,"adsh":"0001178879-26-000005","doc":"fold-20251231.htm","q":"We may use artificial intelligence in our business, and challenges with properly managing its use could adversely affect our business."}]},{"cik":1182325,"name":"TANGOE INC","industry":"Software & IT services","sic":7372,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002289","doc":"a2223511z10-k.htm","q":null}]},{"cik":1182731,"name":"CONNEXIONONE CORP.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2023,"lvl":"x","n":5,"adsh":"0001683168-24-001257","doc":"cnnn_10k-123123.htm","q":"Our social media platform also incorporates AI-powered content creation assistance feature by analyzing the user's input and providing suggestions to improve the quality and relevance of the content."}]},{"cik":1183765,"name":"MOLECULAR TEMPLATES, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001251","doc":"thld-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014457","doc":"thld-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005351","doc":"thld-10k_20161231.htm","q":"This is related to the fact that suppressive cells such as myeloid-derived suppressor cells (MDSCs) preferentially reside in the hypoxic regions of tumors (Ai et al 2015; Chiu et al. 2016; Chouaib et al. 2016) and because effector T cells a\u2026"},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007268","doc":"mtem-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010145","doc":"mtem-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010667","doc":"mtem-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014250","doc":"mtem-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012055","doc":"mtem-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-004898","doc":"mtem-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004332","doc":"mtem-20231231x10k.htm","q":null}]},{"cik":1187953,"name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"AZ","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-007873","doc":"v458672_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-017967","doc":"tv488947_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-017462","doc":"tv516069_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-043660","doc":"tm205316d1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-001495","doc":"celz_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001477932-22-001741","doc":"celz_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001477932-23-002123","doc":"celz_10k.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001477932-24-001431","doc":"celz_10k.htm","q":null},{"fy":2024,"lvl":"x","n":13,"adsh":"0001477932-25-001736","doc":"celz_10k.htm","q":"In July 2024, we announced that we initiated a program to diagnose and treat patients exposed to biological and chemical weapons by combining artificial intelligence (AI) with our proprietary \u201ciPSC\u201d."},{"fy":2025,"lvl":"x","n":26,"adsh":"0001477932-26-001517","doc":"celz_10k.htm","q":"In July 2024, we announced that we initiated a program to diagnose and treat patients exposed to biological and chemical weapons by combining artificial intelligence (AI) with our proprietary \u201ciPSC\u201d."}]},{"cik":1191070,"name":"NEUPHORIA THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-24-082909","doc":"ea0213573-10k_bionomic.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-223338","doc":"neup-20250630.htm","q":null}]},{"cik":1191334,"name":"CHUN CAN CAPITAL GROUP","industry":"Computers & chips","sic":3674,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001483798-20-000045","doc":"cncn10k-20141231.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0000717588-20-000004","doc":"cncn10k-20151231.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0000717588-20-000012","doc":"cncn10k-20161231.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0000717588-20-000020","doc":"cncn10k-20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0000717588-20-000028","doc":"cncn10k-20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0000717588-20-000037","doc":"cncn10k-20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001191334-21-000005","doc":"cncn12312021_10k.htm","q":null}]},{"cik":1193311,"name":"ONCOR ELECTRIC DELIVERY CO LLC","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193311-15-000004","doc":"c311-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193311-16-000035","doc":"c311-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193311-17-000005","doc":"c311-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193311-18-000005","doc":"c311-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193311-19-000011","doc":"c311-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193311-20-000013","doc":"c311-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193311-21-000006","doc":"c311-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193311-22-000004","doc":"c311-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193311-23-000005","doc":"c311-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001193311-24-000005","doc":"c311-20231231x10k.htm","q":"In addition, we believe demand in ERCOT could be significantly increased as a result of large load customers utilizing growing computing power needs related to cryptocurrency mining, artificial intelligence technology, data storage and othe\u2026"},{"fy":2024,"lvl":3,"n":19,"adsh":"0001193311-25-000006","doc":"c311-20241231x10k.htm","q":"The excess of the purchase price over the fair values of assets and liabilities is recorded as goodwill AFUDC Allowance for funds used during construction AI Artificial intelligence AOCI Accumulated other comprehensive income (loss) AR Faci\u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001193311-26-000007","doc":"c311-20251231x10k.htm","q":"The excess of the purchase price over the fair values of assets and liabilities is recorded as goodwill AFUDC Allowance for funds used during construction AI Artificial intelligence AOCI Accumulated other comprehensive income (loss) APBO Ac\u2026"}]},{"cik":1195116,"name":"ARNO THERAPEUTICS, INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-020148","doc":"v404674_10k.htm","q":null},{"fy":2015,"lvl":"x","n":2,"adsh":"0001144204-16-091477","doc":"v434593_10k.htm","q":"Beneficial ownership includes: (i) 25,000 shares of our common stock and 46,728 shares issuable upon the exercise of warrants held by Auriga Global Investors SV, SA; (ii) 811,222 shares of our common stock and 919,117 shares issuable upon t\u2026"}]},{"cik":1201663,"name":"AUDIENCE INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001193125-15-083399","doc":"d850547d10k.htm","q":"Several voice quality improvements for handset usage have also been made, including: new noise suppression algorithms based on machine learning techniques, signal-to-noise ratio improvements enabling clear calls in challenging environments,\u2026"}]},{"cik":1205922,"name":"VACCINEX, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007458","doc":"vcnx-10k_20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001564590-20-009251","doc":"vcnx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016874","doc":"vcnx-10k_20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001564590-22-012778","doc":"vcnx-10k_20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0000950170-23-011354","doc":"vcnx-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-039700","doc":"vcnx-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-054318","doc":"vcnx-20241231.htm","q":null}]},{"cik":1207074,"name":"VIRTUSA CORP","industry":"Software & IT services","sic":7371,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001047469-15-004926","doc":"a2224790z10-k.htm","q":null},{"fy":2015,"lvl":1,"n":3,"adsh":"0001047469-16-013504","doc":"a2228778z10-k.htm","q":"New advances in areas like internet of things (\"IoT\"), artificial intelligence (\"AI\"), robotics process automation (\"RPA\") are now pushing the boundaries of how technology can disrupt traditional business models and deliver significant valu\u2026"},{"fy":2016,"lvl":2,"n":6,"adsh":"0001047469-17-003676","doc":"a2232232z10-k.htm","q":"New advances in areas like internet of things (\"IoT\"), artificial intelligence (\"AI\"), machine learning (\"ML\"), and robotics process automation (\"RPA\") are now pushing the boundaries of how technology can disrupt traditional business models\u2026"},{"fy":2017,"lvl":2,"n":6,"adsh":"0001047469-18-004068","doc":"a2235781z10-k.htm","q":"New advances in areas like internet of things (\"IoT\"), artificial intelligence (\"AI\"), machine learning (\"ML\"), and robotics process automation (\"RPA\") are now pushing the boundaries of how technology can disrupt traditional business models\u2026"},{"fy":2018,"lvl":2,"n":6,"adsh":"0001558370-19-005297","doc":"vrtu-20190331x10k.htm","q":"New advances in areas like the internet of things (\u201cIoT\u201d), artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), and robotics process automation (\u201cRPA\u201d) are now pushing the boundaries of how technology can disrupt traditional business mo\u2026"},{"fy":2019,"lvl":2,"n":9,"adsh":"0001558370-20-007083","doc":"vrtu-20200528x10k.htm","q":"Continued advances in areas like the internet of things (\u201cIoT\u201d), artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), robotics process automation (\u201cRPA\u201d) and the cloud now pushing the boundaries of how technology can disrupt traditional\u2026"}]},{"cik":1208261,"name":"IMMUNE PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-023077","doc":"v405335_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-091621","doc":"v434974_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-028202","doc":"v466981_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-018699","doc":"tv489491_10k.htm","q":null}]},{"cik":1210618,"name":"SPI ENERGY CO., LTD.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-006488","doc":"sopw20141231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-002280","doc":"spi_i10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-002397","doc":"spi_i10k-123122.htm","q":null}]},{"cik":1211583,"name":"FENNEC PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-020272","doc":"v404663_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-090604","doc":"v433857_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-017299","doc":"v461464_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-017571","doc":"tv488216_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014220","doc":"tv515201_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-021132","doc":"tm205262d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-043756","doc":"tm21107d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002334","doc":"fencf-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004948","doc":"fencf-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004383","doc":"fencf-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001558370-25-003710","doc":"fencf-20241231x10k.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, which could materially disrupt our systems and operatio\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-036182","doc":"fencf-20251231x10k.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, which could materially disrupt our systems and operatio\u2026"}]},{"cik":1211759,"name":"CONNECTURE INC","industry":"Software & IT services","sic":7372,"state":"WI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505342","doc":"d103040d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005808","doc":"cnxr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007376","doc":"cnxr-10k_20171231.htm","q":null}]},{"cik":1211805,"name":"MY SIZE, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003777","doc":"f10k2016_mysizeinc.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003274","doc":"f10k2017_mysizeinc.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-004966","doc":"f10k2018_mysizeinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-006893","doc":"f10k2019_mysizeinc.htm","q":null},{"fy":2020,"lvl":"x","n":1,"adsh":"0001213900-21-018354","doc":"0001213900-21-018354.txt","q":"In particular, we seek not only to deliver size recommendations but to provide a robust, end-to-end, AI-driven platform that inspires consumer confidence and drives revenue growth by providing a superior consumer journey to both online and \u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001493152-22-007224","doc":"form10-k.htm","q":"BUSINESS Overview MySize is a provider of an innovative artificial intelligence driven measurement solutions that are designed to address shortcomings in multiple verticals, including the e-commerce fashion/apparel, shipping/parcel and do i\u2026"},{"fy":2022,"lvl":"x","n":14,"adsh":"0001493152-23-012237","doc":"form10-k.htm","q":"BUSINESS Overview We are an omnichannel e-commerce platform and provider of AI-driven apparel sizing and digital experience solutions that drive revenue growth and reduce costs for our business clients for online shopping and physical store\u2026"},{"fy":2023,"lvl":"x","n":16,"adsh":"0001493152-24-012542","doc":"form10-k.htm","q":"BUSINESS Overview We are an omnichannel e-commerce platform and provider of AI-driven SaaS measurement solutions, including MySizeID and our recently acquired subsidiaries, Naiz Fit, which provides SaaS technology solutions that solve size \u2026"},{"fy":2024,"lvl":3,"n":32,"adsh":"0001641172-25-000990","doc":"form10-k.htm","q":"BUSINESS Overview We are an omnichannel e-commerce platform and provider of AI-driven SaaS measurement solutions and our recently acquired subsidiaries, Naiz Fit, which provides SaaS technology solutions that solve size and fit issues and A\u2026"},{"fy":2025,"lvl":3,"n":69,"adsh":"0001493152-26-016874","doc":"form10-k.htm","q":"Through our subsidiaries, we provide end-to-end support across the fashion value chain: Naiz Fit, our technology subsidiary, delivers AI-driven size and fit solutions for fashion e-commerce companies, and includes ShoeSize.Me, a European AI\u2026"}]},{"cik":1213037,"name":"CARDIFF ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-019213","doc":"a15-1864_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012562","doc":"trov-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002601","doc":"trov-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002226","doc":"trov-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002546","doc":"trov-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002424","doc":"trov-123119x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003277","doc":"trov-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003808","doc":"crdf-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-006037","doc":"crdf-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-007948","doc":"crdf-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-028992","doc":"crdf-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-067464","doc":"crdf-20251231.htm","q":null}]},{"cik":1213809,"name":"DYADIC INTERNATIONAL INC","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001213809-20-000018","doc":"dyai-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007644","doc":"dyai20201008_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007554","doc":"dyai20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008425","doc":"dyai20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":3,"adsh":"0001437749-24-009857","doc":"dyai20231231_10k.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."},{"fy":2024,"lvl":"x","n":19,"adsh":"0001437749-25-009350","doc":"dyai20241231_10k.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."},{"fy":2025,"lvl":"x","n":22,"adsh":"0001493152-26-012672","doc":"form10-k.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."}]},{"cik":1218683,"name":"WIZE PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002045","doc":"f10k2014_ophithalix.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-011299","doc":"f10k2015_ophthalixinc.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-002745","doc":"f10k2016_ophthalixinc.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003682","doc":"f10k2017_wizepharmainc.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-005537","doc":"f10k2018_wizepharmainc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-008074","doc":"f10k2019_wizepharmainc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-012577","doc":"f10k2020_wizepharmainc.htm","q":null}]},{"cik":1224133,"name":"MARCHEX INC","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2025,"lvl":3,"n":64,"adsh":"0001193125-26-125205","doc":"mchx-20251231.htm","q":"Marchex harnesses the power of artificial intelligence (\u201cAI\u201d) and conversation intelligence to provide actionable insights derived from prescriptive vertical market data analytics."}]},{"cik":1226616,"name":"MEDICINOVA INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-089483","doc":"d843164d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013409","doc":"mnov-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001547","doc":"mnov-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-001957","doc":"mnov-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-002835","doc":"mnov-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004605","doc":"mnov-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006771","doc":"mnov-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-005388","doc":"mnov-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003054","doc":"mnov-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-015920","doc":"mnov-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-023301","doc":"mnov-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-100432","doc":"mnov-20251231.htm","q":null}]},{"cik":1227025,"name":"NEOPHOTONICS CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001751","doc":"nptn-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004127","doc":"nptn-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001227025-17-000020","doc":"nptn-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001227025-18-000009","doc":"nptn12311710k.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001227025-19-000013","doc":"nptn12311810k.htm","q":"Smartphones and related portable devices have emerged as the preferred vehicle connecting the digital world, such that today there are more than 20 billion connected devices and machine learning and artificial intelligence will continue to \u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001227025-20-000020","doc":"nptn12311910k.htm","q":"New applications requiring massive data manipulation are emerging continually, such as autonomous cars, virtual reality, smart homes, tele-medicine, genomics, artificial intelligence and machine learning."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001227025-21-000034","doc":"nptn-20201231.htm","q":"These include applications such as autonomous vehicles, virtual reality, smart homes, tele-medicine, genomics, artificial intelligence and machine learning."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001227025-22-000014","doc":"nptn-20211231.htm","q":"Examples include applications such as cloud computing, autonomous vehicles, virtual reality, smart homes, tele-medicine, genomics, artificial intelligence and machine learning."}]},{"cik":1227930,"name":"ENTROPIC COMMUNICATIONS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001227930-15-000006","doc":"entr2014123110-k.htm","q":null}]},{"cik":1228627,"name":"OPUS GENETICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011969","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-057543","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-009132","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-18-012817","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-004539","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-003785","doc":"form10k.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001140361-21-008099","doc":"brhc10021462_10k.htm","q":"The primary endpoints of this trial were measurement of the rate of change in the glutamic pyruvate transaminase (GPT) level, degree of improvement in liver function and assessment of general performance status. \u2022 APX_CLN_0008 A 3-step, Pha\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001140361-22-011015","doc":"brhc10035368_10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001140361-23-014868","doc":"brhc10050364_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-012399","doc":"ef20015277_10k.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001140361-25-011410","doc":"ef20039022_10k.htm","q":"Our competitors may also render our technologies obsolete by advances in existing technological approaches or the development of new or different approaches, such as using artificial intelligence and machine learning, potentially eliminatin\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001140361-26-009247","doc":"ef20060643_10k.htm","q":"Our competitors may also render our technologies obsolete by advances in existing technological approaches or the development of new or different approaches, such as using artificial intelligence and machine learning, potentially eliminatin\u2026"}]},{"cik":1231339,"name":"ASTRA ENERGY, INC.","industry":"Utilities","sic":4911,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001477932-22-009338","doc":"astra_10ka.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-000210","doc":"asre_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001477932-24-008111","doc":"asre_10k.htm","q":null}]},{"cik":1231457,"name":"GENELUX CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-24-011946","doc":"form10-k.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0001641172-25-001184","doc":"form10-k.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (CMMI) to consider new payment and healthcare models to\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001493152-26-011616","doc":"form10-k.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"}]},{"cik":1232524,"name":"JAZZ PHARMACEUTICALS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001232524-15-000030","doc":"jazz1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001232524-16-000194","doc":"jazz1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001232524-17-000024","doc":"jazz1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001232524-18-000018","doc":"jazz1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001232524-19-000013","doc":"jazz1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001232524-20-000016","doc":"jazz1231201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001232524-21-000016","doc":"jazz-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001232524-22-000012","doc":"jazz-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001232524-23-000015","doc":"jazz-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001232524-24-000015","doc":"jazz-20231231.htm","q":"In addition to the extraction of important information, such threats could include the deployment of harmful malware, ransomware, denial-of-service attacks, social engineering, malicious code, credential harvesting, personnel misconduct or \u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001232524-25-000011","doc":"jazz-20241231.htm","q":"These actions may include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare & Medicaid Innovation to consider new payment and healthcare models to limit drug spending an\u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001232524-26-000013","doc":"jazz-20251231.htm","q":"We continue to sharpen the capabilities that fuel our performance \u2013 investing in capability development in key areas such as patient insights and evidence generation, clinical development excellence, AI-enabled tools, and customer experienc\u2026"}]},{"cik":1235007,"name":"ENDOCYTE INC","industry":"Pharma & biotech","sic":2834,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-015921","doc":"v403251_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-086648","doc":"v432293_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001674","doc":"ecyt-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001164","doc":"ecyt-20171231x10k.htm","q":null}]},{"cik":1235010,"name":"MOMENTA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001399","doc":"a2223226z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010502","doc":"a2227441z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001235010-17-000003","doc":"mnta1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001235010-18-000004","doc":"mnta1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001235010-19-000002","doc":"mnta1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001235010-20-000003","doc":"mnta1231201910k.htm","q":null}]},{"cik":1236997,"name":"COUNTERPATH CORP","industry":"Software & IT services","sic":7372,"state":"BC","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001062993-15-003908","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-16-010548","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062993-17-003211","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001062993-18-003013","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001062993-19-002868","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001062993-20-003383","doc":"form10k.htm","q":null}]},{"cik":1237746,"name":"ENDURANCE INTERNATIONAL GROUP HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069664","doc":"d852887d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-485478","doc":"d109510d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-001732","doc":"eigi12311610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002065","doc":"eigi12311710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-001696","doc":"eigi1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-001590","doc":"eigi1231201910-k.htm","q":null}]},{"cik":1239819,"name":"LUNA INNOVATIONS INC","industry":"Pharma & biotech","sic":8731,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001239819-15-000023","doc":"luna-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001239819-16-000112","doc":"luna-20151231x10kx1.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001239819-17-000022","doc":"luna-20161231x10kx1.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001239819-18-000008","doc":"luna-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001239819-19-000029","doc":"luna-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001239819-20-000032","doc":"luna-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001239819-21-000027","doc":"luna-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001239819-22-000034","doc":"luna-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001239819-23-000044","doc":"luna-20221231.htm","q":null}]},{"cik":1244937,"name":"ENERNOC INC","industry":"Software & IT services","sic":7370,"state":"MA","cells":[{"fy":2014,"lvl":1,"n":3,"adsh":"0001193125-15-089688","doc":"d845956d10k.htm","q":"We deliver shared value for both the utility and its customers by combining our deep expertise with enterprise customers with energy data analytics, machine learning, and predictive algorithms to deliver segmentation and targeting capabilit\u2026"},{"fy":2015,"lvl":2,"n":5,"adsh":"0001244937-16-000017","doc":"enoc201510k.htm","q":"We deliver shared value for both the utility and its customers by combining our deep expertise with commercial, institutional and industrial end-users of energy, or C&I end-users, with energy data analytics, machine learning, and predictive\u2026"},{"fy":2016,"lvl":1,"n":2,"adsh":"0001244937-17-000025","doc":"enoc201610k.htm","q":"We use big data and machine-learning approaches to analyze this data for cost-saving opportunities and to predict future outcomes that can help our enterprise customers make better business decisions."}]},{"cik":1245104,"name":"GLOBEIMMUNE INC","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001755","doc":"gbim-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014874","doc":"gbim-10k_20151231.htm","q":null}]},{"cik":1251769,"name":"APOLLO ENDOSURGERY, INC.","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-022093","doc":"a14-26926_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004287","doc":"lptn-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001251769-17-000013","doc":"form10k.htm","q":null}]},{"cik":1253689,"name":"CRESCENT BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093802","doc":"d838695d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003688","doc":"glyc-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001198","doc":"glyc-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001553","doc":"glyc-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001537","doc":"glyc-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001723","doc":"glyc-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002222","doc":"glyc-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002737","doc":"glyc-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004864","doc":"glyc-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001558370-24-004013","doc":"glyc-20231231x10k.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake\u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001558370-25-000948","doc":"glyc-20241231x10k.htm","q":"We and the third parties upon which we may rely could also be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to ident\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-011983","doc":"cbio-20251231.htm","q":"Furthermore, any integration of artificial intelligence in our or any third party\u2019s operations, products or services is expected to pose new or unknown cybersecurity risks and challenges."}]},{"cik":1254419,"name":"MEDASSETS INC","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073413","doc":"d825932d10k.htm","q":null}]},{"cik":1260990,"name":"ONCTERNAL THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002283","doc":"a2223461z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011178","doc":"a2227626z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001982","doc":"a2231118z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001564","doc":"a2234404z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001382","doc":"a2238103z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011213","doc":"onct-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012588","doc":"onct-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009702","doc":"onct-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007062","doc":"onct-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027984","doc":"onct-20231231.htm","q":null}]},{"cik":1261249,"name":"AGILE THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002798","doc":"a2223880z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010929","doc":"a2227594z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001623","doc":"a2231308z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001539","doc":"a2234770z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001136","doc":"a2237968z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-20-000966","doc":"a2240759z10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002163","doc":"agrx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004758","doc":"agrx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004386","doc":"agrx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004262","doc":"agrx-20231231x10k.htm","q":null}]},{"cik":1261333,"name":"DOCUSIGN, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001261333-19-000012","doc":"fy1910k.htm","q":null},{"fy":2019,"lvl":2,"n":7,"adsh":"0001261333-20-000033","doc":"docu-20200131.htm","q":"The Agreement Cloud also includes several other applications for automating pre- and post-signature processes\u2014for example, automatically generating an agreement from data in other systems, supporting negotiation workflow, collecting payment\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0001261333-21-000059","doc":"docu-20210131.htm","q":"The Agreement Cloud also includes several other applications for automating pre- and post-signature processes\u2014for example, automatically generating an agreement from data in other systems, supporting negotiation workflow, collecting payment\u2026"},{"fy":2021,"lvl":2,"n":11,"adsh":"0001261333-22-000049","doc":"docu-20220131.htm","q":"The DocuSign Agreement Cloud also includes several other applications for automating pre- and post-signature processes\u2014for example, automatically generating an agreement from data in other systems, supporting negotiation workflow, verifying\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001261333-23-000050","doc":"docu-20230131.htm","q":"We offer applications for automating pre- and post-signature processes, including automatically generating an agreement from data in other systems, supporting negotiation workflow, verifying identities, enabling remote online notarization, \u2026"},{"fy":2023,"lvl":3,"n":42,"adsh":"0001261333-24-000045","doc":"docu-20240131.htm","q":"This includes automatically generating an agreement from data in other systems, supporting negotiation workflows, verifying identities, enabling remote online notarization, collecting payment after signatures, and using artificial intellige\u2026"},{"fy":2024,"lvl":3,"n":53,"adsh":"0001261333-25-000024","doc":"docu-20250131.htm","q":"Docusign\u2019s IAM platform automates agreement workflows, uncovers actionable insights, and leverages AI capabilities, enabling organizations to create, commit, and manage agreements, from virtually anywhere in the world, securely."}]},{"cik":1261694,"name":"TESSERA TECHNOLOGIES INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-000991","doc":"tsra-20141231x10xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011480","doc":"tsra-20151231x10xk.htm","q":null}]},{"cik":1261734,"name":"AEOLUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001102624-15-001827","doc":"aeolus10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001199073-16-000300","doc":"aeolus10k.htm","q":null}]},{"cik":1262104,"name":"LITE STRATEGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-309992","doc":"d937976d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-17-276135","doc":"d410307d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-18-263586","doc":"d533269d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-19-232454","doc":"d783135d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-20-242169","doc":"d58841d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-21-001655","doc":"meip-20210630.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-018236","doc":"meip-20220630.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-049927","doc":"meip-20230630.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-108185","doc":"meip-20240630.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-220421","doc":"lits-20250630.htm","q":null}]},{"cik":1264587,"name":"STEMLINE THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-020076","doc":"a14-25823_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-104922","doc":"a15-23369_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-017199","doc":"a17-1159_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-018361","doc":"a18-1093_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001104659-19-015293","doc":"a19-30101_110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-034154","doc":"tm2031081-1_10k.htm","q":null}]},{"cik":1265521,"name":"POLOMAR HEALTH SERVICES, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2025,"lvl":"x","n":1,"adsh":"0001493152-26-021488","doc":"form10-k.htm","q":"In addition, breaches of our information technology systems or data security systems, including cyberattacks and malicious uses of artificial intelligence, could result in the unintended and/or unauthorized public disclosure or the misappro\u2026"}]},{"cik":1267097,"name":"TRW AUTOMOTIVE HOLDINGS CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000812","doc":"a2222951z10-k.htm","q":null}]},{"cik":1267565,"name":"COLLEGIUM PHARMACEUTICAL, INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004252","doc":"coll-20151231x10k.htm","q":"For example, the Budget Control Act of 2011 resulted in aggregate reductions in Medicare payments to providers of up to 2% per fiscal year, starting in 2013 and, due to the Bipartisan Budget Act of 2015, will rem ai n in effect through 2025\u2026"},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001629","doc":"coll-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001644","doc":"coll-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001187","doc":"coll-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001625","doc":"coll-20191231x10k3059df.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001814","doc":"coll-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001927","doc":"coll-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001900","doc":"coll-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001526","doc":"coll-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001801","doc":"coll-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":29,"adsh":"0001628280-26-011992","doc":"coll-20251231.htm","q":"The use of artificial intelligence technologies in our business could expose us to significant data privacy and regulatory risks."}]},{"cik":1267602,"name":"ALIMERA SCIENCES INC","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001267602-15-000018","doc":"alim-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001267602-16-000119","doc":"alim-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001267602-17-000021","doc":"alim-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001267602-18-000047","doc":"alim-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001267602-19-000043","doc":"alim-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001267602-20-000029","doc":"a12-31x201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001267602-21-000013","doc":"alim-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001267602-22-000013","doc":"alim-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001267602-23-000027","doc":"alim-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001267602-24-000019","doc":"alim-20231231x10k.htm","q":null}]},{"cik":1267813,"name":"MARINUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-019211","doc":"a15-2993_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003873","doc":"mrns-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001650","doc":"mrns-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001587","doc":"mrns-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001860","doc":"mrns-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002792","doc":"mrns-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002646","doc":"mrns-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004279","doc":"mrns-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003305","doc":"mrns-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002479","doc":"mrns-20231231x10k.htm","q":null}]},{"cik":1267919,"name":"SIGNATURE DEVICES INC","industry":"Software & IT services","sic":7372,"state":"WY","cells":[{"fy":2019,"lvl":"x","n":7,"adsh":"0001376474-21-000344","doc":"sdv-20191231.htm","q":"Signature Devices combines the best of the technologies underpinning the popular Morpheus media server, Tazerwear\u2019s AI Software, Truck IT's beacon platform with Knoton\u2019s hardware, infrastructure, and software."},{"fy":2020,"lvl":"x","n":7,"adsh":"0001376474-21-000336","doc":"sdv-20201231.htm","q":"Signature Devices combines the best of the technologies underpinning the popular Morpheus media server, Tazerwear\u2019s AI Software, Truck IT's beacon platform with Knoton\u2019s hardware, infrastructure, and software."}]},{"cik":1269021,"name":"PORTOLA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001190","doc":"ptla-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013714","doc":"ptla-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003123","doc":"ptla-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004153","doc":"ptla-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005772","doc":"ptla-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002568","doc":"ptla-20191231x10k.htm","q":null}]},{"cik":1270073,"name":"INTERCEPT PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-013338","doc":"v403073_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-085037","doc":"v429662_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-012180","doc":"v456571_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-011793","doc":"v485049_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-011650","doc":"v511409_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001314","doc":"icpt-20191231x10k93558c.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001804","doc":"icpt-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002666","doc":"icpt-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002693","doc":"icpt-20221231x10k.htm","q":null}]},{"cik":1271024,"name":"LINKEDIN CORP","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001271024-15-000008","doc":"a20141231-10xkdocument.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001271024-16-000035","doc":"a20151231-10xkdocument.htm","q":"Subsequent Events In February 2016, the Company entered into a definitive agreement to acquire Connectifier, an industry leader in machine learning-based searching and matching technology."}]},{"cik":1273636,"name":"APPLIED GENETIC TECHNOLOGIES CORP","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-15-007858","doc":"agtc-10k_20150630.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-280588","doc":"d373861d10ka.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-018636","doc":"agtc-10k_20170630.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-022913","doc":"agtc-10k_20180630.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-19-255968","doc":"d758657d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-20-249103","doc":"d864197d10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001193125-21-280686","doc":"d183935d10k.htm","q":"Together with a third-party vendor, we have developed a machine learning algorithm that, on a patient-by-patient basis, predicts the loci most likely to improve through evaluation of baseline visual sensitivity."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001193125-22-252231","doc":"d374747d10k.htm","q":"Together with a third-party vendor, we have developed a machine learning algorithm based on the available microperimetry data from Horizon and Skyline expansion trials that, on a patient-by-patient basis, predicts the loci most likely to im\u2026"}]},{"cik":1273988,"name":"FUTUREWORLD CORP.","industry":"Software & IT services","sic":7371,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001557240-15-000585","doc":"fwdg-2015mar31_10k.htm","q":null}]},{"cik":1274057,"name":"HOSPIRA INC","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001274057-15-000012","doc":"hsp-201410xk.htm","q":null}]},{"cik":1274494,"name":"FIRST SOLAR, INC.","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001274494-15-000006","doc":"fslrdec1410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001274494-16-000067","doc":"fslr10-k12x31x2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001274494-17-000006","doc":"fslr10-k12x31x2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001274494-18-000011","doc":"fslr10-k12x31x2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001274494-19-000004","doc":"fslr10-k12x31x2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001274494-20-000011","doc":"fslr10-k12x31x2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003343","doc":"fslr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001274494-22-000009","doc":"fslr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001274494-23-000002","doc":"fslr-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001274494-24-000004","doc":"fslr-20231231.htm","q":"Recent developments in the threat landscape include use of artificial intelligence and machine learning, as well as an increased number of cyber extortion attacks, with higher financial ransom demand amounts and increasing sophistication an\u2026"},{"fy":2024,"lvl":3,"n":27,"adsh":"0001274494-25-000010","doc":"fslr-20241231.htm","q":"Further, overall electric load growth, especially as a result of artificial intelligence (\u201cAI\u201d)-driven data center demand, continues to increase."},{"fy":2025,"lvl":3,"n":27,"adsh":"0001274494-26-000021","doc":"fslr-20251231.htm","q":"Further, overall electric load growth, especially as a result of artificial intelligence (\u201cAI\u201d)-driven data center demand, continues to increase."}]},{"cik":1274644,"name":"OCERA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001274644-15-000013","doc":"ocera10-k2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001274644-16-000107","doc":"ocera10-k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001274644-17-000014","doc":"ocera10-k2016.htm","q":null}]},{"cik":1274792,"name":"MERRIMACK PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069143","doc":"d851670d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-480919","doc":"d125943d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003026","doc":"mack-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005246","doc":"mack-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006385","doc":"mack-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010531","doc":"mack-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012087","doc":"mack-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009320","doc":"mack-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007063","doc":"mack-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-027966","doc":"mack-20231231.htm","q":"We manage, identify and assess risks from cybersecurity threats by monitoring and evaluating our threat environment and risk profile using various methods including, for example: through the use of automated tools, including but not limited\u2026"}]},{"cik":1275014,"name":"ULTRA CLEAN HOLDINGS, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-087568","doc":"d824683d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-498459","doc":"0001193125-16-498459.txt","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004405","doc":"0001564590-17-004405.txt","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005652","doc":"uctt-10k_20171229.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009033","doc":"uctt-10k_20181228.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001564590-20-010037","doc":"uctt-10k_20191227.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow based on demand from a broad range of drivers, including applications such as autonomous vehicles, the Internet of Things, high performance computing, ar\u2026"},{"fy":2020,"lvl":1,"n":4,"adsh":"0001564590-21-007569","doc":"uctt-10k_20201225.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow due to multi-year industry demand from a broad range of drivers including mobile demand driven by 5G, new CPU architectures which are enabling higher per\u2026"},{"fy":2021,"lvl":"x","n":6,"adsh":"0001564590-22-008065","doc":"uctt-10k_20211231.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow due to multi-year industry demand from a broad range of drivers including mobile demand driven by 5G, new CPU architectures that enable higher performanc\u2026"},{"fy":2022,"lvl":2,"n":7,"adsh":"0000950170-23-005148","doc":"uctt-20221230.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow due to multi-year industry demand from a broad range of drivers, such as new CPU architectures that enable higher performance servers necessary for cloud\u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0000950170-24-027213","doc":"uctt-20231229.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow due to multi-year industry demand from a broad range of drivers, such as new CPU architectures that enable higher performance servers necessary for cloud\u2026"},{"fy":2024,"lvl":3,"n":17,"adsh":"0001628280-25-007865","doc":"uctt-20241227.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow due to multi-year industry demand from a broad range of drivers, such as new device architecture (e.g. gate all around) and memory devices (e.g. high ban\u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001628280-26-010744","doc":"uctt-20251226.htm","q":"Over the long-term, we believe the semiconductor market we serve will continue to grow due to multi-year industry demand from a broad range of drivers, such as new device architecture (e.g. gate all around and backside power distribution), \u2026"}]},{"cik":1279704,"name":"CELLECTAR BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-017897","doc":"v403920_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-087438","doc":"v432922_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-014611","doc":"v460347_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-016175","doc":"tv488090_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-009973","doc":"tv514137_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-030742","doc":"tm205334-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-030445","doc":"tm211114d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000436","doc":"clrb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000224","doc":"clrb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000307","doc":"clrb-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000329","doc":"clrb-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-023167","doc":"clrb-20251231x10k.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to the use of artificial intelligence to review product applications."}]},{"cik":1280058,"name":"BLACKBAUD INC","industry":"Software & IT services","sic":7372,"state":"SC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001280058-15-000007","doc":"form10-k2014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001280058-16-000045","doc":"a201510-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001280058-17-000006","doc":"a201610-k.htm","q":null},{"fy":2017,"lvl":"x","n":15,"adsh":"0001280058-18-000007","doc":"a201710-k.htm","q":"During 2017, we introduced SKY AI\u2122 and SKY Analytics\u2122, the intelligence engine behind the growing number of insights integrated into Blackbaud cloud software solutions, powered by artificial intelligence including machine learning, cognitiv\u2026"},{"fy":2018,"lvl":"x","n":1,"adsh":"0001280058-19-000007","doc":"a201810-k.htm","q":"Blackbaud\u2019s SKY Intelligence\u00ae is a unique, comprehensive approach through which we combine artificial intelligence, analytics, big data, and expertise in cloud-based services and other channels."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001280058-20-000011","doc":"a201910-k.htm","q":"Blackbaud\u2019s Intelligence for Good\u00ae is a unique, comprehensive approach through which we combine artificial intelligence, analytics, big data, and expertise in cloud services and other channels."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001280058-21-000006","doc":"blkb-20201231.htm","q":"Blackbaud\u2019s Intelligence for Good\u00ae is a unique, comprehensive approach through which we combine artificial intelligence, analytics, big data, and expertise in cloud services and other channels."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001280058-22-000010","doc":"blkb-20211231.htm","q":"Blackbaud\u2019s Intelligence for Good\u00ae is our unique, comprehensive approach through which we combine artificial intelligence, analytics, big data, and expertise to deliver high-impact data intelligence."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001280058-23-000006","doc":"blkb-20221231.htm","q":"Blackbaud\u2019s Intelligence for Good\u00ae is our unique, comprehensive approach through which we combine artificial intelligence, analytics, big data, and expertise to deliver high-impact data intelligence."},{"fy":2023,"lvl":3,"n":44,"adsh":"0001280058-24-000013","doc":"blkb-20231231.htm","q":"We expect to make them generally available in the first half of 2024. \u2022 Prospect Insights Pro for Raiser\u2019s Edge NXT\u00ae: New add-on capability within Raiser\u2019s Edge NXT\u00ae that gives fundraisers access to AI-driven insights to support planned and\u2026"},{"fy":2024,"lvl":3,"n":68,"adsh":"0001280058-25-000010","doc":"blkb-20241231.htm","q":"Our focus has been on two areas, artificial intelligence (AI) and enhancements that continue to improve the connectivity of our suite of solutions."},{"fy":2025,"lvl":3,"n":138,"adsh":"0001280058-26-000006","doc":"blkb-20251231.htm","q":"BUSINESS Description of Business We are the world's leading provider of AI-powered solutions for social impact."}]},{"cik":1280263,"name":"AMBARELLA INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001564590-15-002116","doc":"amba-10k_20150131.htm","q":null},{"fy":2015,"lvl":3,"n":18,"adsh":"0001564590-16-015290","doc":"amba-10k_20160131.htm","q":"In flying camera applications this potentially eliminates the need for a mechanical gimbal system. 6 \u00b7 Computer Vision."},{"fy":2016,"lvl":3,"n":34,"adsh":"0001564590-17-005590","doc":"amba-10k_20170131.htm","q":"We combine our processor design capabilities with our expertise in video, image processing, and computer vision algorithms and software to provide a technology platform that is designed to be easily scalable across multiple applications in \u2026"},{"fy":2017,"lvl":3,"n":77,"adsh":"0001564590-18-007226","doc":"amba-10k_20180131.htm","q":"We combine our processor design capabilities with our expertise in video and image processing, computer vision algorithms and software to provide a technology platform that is designed to be easily scalable across multiple applications in a\u2026"},{"fy":2018,"lvl":3,"n":105,"adsh":"0001564590-19-010114","doc":"amba-10k_20190131.htm","q":"We combine our processor design capabilities with our expertise in video and image processing, computer vision algorithms and software development to provide a technology platform that is designed to be easily scalable across multiple appli\u2026"},{"fy":2019,"lvl":3,"n":113,"adsh":"0001564590-20-013513","doc":"amba-10k_20200131.htm","q":"Over the last several years, our development efforts have focused on creating advanced artificial intelligence, or AI, computer vision algorithms and high-performance, low-power hardware platforms to enhance processing acceleration, which w\u2026"},{"fy":2020,"lvl":3,"n":151,"adsh":"0001564590-21-016988","doc":"amba-10k_20210131.htm","q":"BUSINESS Overview Ambarella is a leading developer of low-power system-on-a-chip, or SoC, semiconductors providing powerful artificial intelligence, or AI, processing, advanced image signal processing and high-resolution video compression."},{"fy":2021,"lvl":3,"n":153,"adsh":"0001564590-22-013224","doc":"amba-10k_20220131.htm","q":"BUSINESS Overview Ambarella is a leading developer of low-power system-on-a-chip, or SoC, semiconductors providing powerful artificial intelligence, or AI, processing, advanced image signal processing and high-resolution video compression."},{"fy":2022,"lvl":3,"n":154,"adsh":"0000950170-23-011305","doc":"amba-20230131.htm","q":"B USINESS Overview Ambarella is a leading developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications."},{"fy":2023,"lvl":3,"n":207,"adsh":"0000950170-24-038555","doc":"amba-20240131.htm","q":"B USINESS Overview Ambarella is a leading developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications."},{"fy":2024,"lvl":3,"n":229,"adsh":"0000950170-25-046499","doc":"amba-20250131.htm","q":"B USINESS Overview Incorporated in 2004, Ambarella is a leading developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications."}]},{"cik":1280396,"name":"VETANOVA INC.","industry":"Utilities","sic":4911,"state":"CO","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-006857","doc":"form10-k.htm","q":null}]},{"cik":1280452,"name":"MONOLITHIC POWER SYSTEMS INC","industry":"Computers & chips","sic":3674,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-003820","doc":"mpwr20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026344","doc":"mpwr20151119_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003558","doc":"mpwr20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-003639","doc":"mpwr20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-003798","doc":"mpwr20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-003943","doc":"mpwr20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-004587","doc":"mpwr20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004460","doc":"mpwr20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-004540","doc":"mpwr20221231_10k.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0001437749-24-006133","doc":"mpwr20231231_10k.htm","q":"The following table is a summary of the various end market applications for our products, and those markets\u2019 contribution as a percentage of our total revenue: Percentage of Total Revenue End Markets Applications 2023 2022 2021 Storage and \u2026"},{"fy":2024,"lvl":3,"n":22,"adsh":"0001437749-25-005903","doc":"mpwr20241231_10k.htm","q":"The following table is a summary of the various key end market applications for our products, and those markets\u2019 contribution as a percentage of our total revenue: Percentage of Total Revenue End Markets Applications 2024 2023 2022 Enterpri\u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001437749-26-006113","doc":"mpwr20251231_10k.htm","q":"The following table is a summary of the various key end market applications for our products, and those markets\u2019 contribution as a percentage of our total revenue for the periods presented: Percentage of Total Revenue End Markets Applicatio\u2026"}]},{"cik":1280600,"name":"ACCELERON PHARMA INC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001280600-15-000009","doc":"xlrn-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001280600-16-000072","doc":"xlrn-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001280600-17-000008","doc":"xlrn-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001280600-18-000016","doc":"xlrn-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001280600-19-000012","doc":"xlrn-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001280600-20-000012","doc":"xlrn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001280600-21-000017","doc":"xlrn-20201231.htm","q":null}]},{"cik":1280776,"name":"IMMUNIC, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-098980","doc":"d833958d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012388","doc":"vtl-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001280776-17-000010","doc":"vtl-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001280776-18-000013","doc":"vtl-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001280776-19-000025","doc":"vtl-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001280776-20-000009","doc":"imux-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001280776-21-000009","doc":"imux-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001280776-22-000006","doc":"imux-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001280776-23-000004","doc":"imux-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001280776-24-000004","doc":"imux-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001280776-25-000005","doc":"imux-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001280776-26-000005","doc":"imux-20251231.htm","q":null}]},{"cik":1281895,"name":"ROCKET PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-514228","doc":"d263529d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004532","doc":"itek-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004621","doc":"rckt-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-004603","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-005056","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-006677","doc":"brhc10020974_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-007036","doc":"brhc10034550_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-009252","doc":"brhc10048995_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021096","doc":"rckt-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-029002","doc":"rckt-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-076551","doc":"rckt-20251231.htm","q":null}]},{"cik":1281984,"name":"SOCIAL LIFE NETWORK, INC.","industry":"Software & IT services","sic":7370,"state":"CO","cells":[{"fy":2018,"lvl":"x","n":5,"adsh":"0001213900-19-004264","doc":"f10k2018_sociallifenetwork.htm","q":"Our platform uses machine learning (A.I.) that interpolates the user behavior data through their online social activity to better connect the right people and businesses together, at the right time when online in our social network."},{"fy":2019,"lvl":"x","n":13,"adsh":"0001493152-20-004440","doc":"form10-k.htm","q":"Our platform uses machine learning (A.I.) that interpolates the user behavior data through their online social activity to better connect the right people and businesses together, at the right time when online in our social network."},{"fy":2020,"lvl":"x","n":9,"adsh":"0001493152-21-007516","doc":"form10-k.htm","q":"Our seed technology is an artificial intelligence (AI) powered social network and Ecommerce platform that leverages blockchain technology to increase speed, security and accuracy on the niche social networks that we license to the companies\u2026"},{"fy":2021,"lvl":"x","n":8,"adsh":"0001493152-22-009607","doc":"form10-k.htm","q":"Our seed technology is an artificial intelligence (AI) powered social network and Ecommerce platform that leverages blockchain technology to increase speed, security, and accuracy on the niche social networks that we license to the companie\u2026"}]},{"cik":1282631,"name":"NETLIST INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000396","doc":"nlst-20141227x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003849","doc":"nlst-20160102x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-002349","doc":"nlst-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001558370-18-002615","doc":"nlst-20171230x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications is resulting in the creation of unprecedented amounts of unstructured data."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001558370-19-002368","doc":"nlst-20181229x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications is resulting in the creation of unprecedented amounts of unstructured data."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001558370-20-002284","doc":"nlst-20191228x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications is resulting in the creation of unprecedented amounts of unstructured data."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001558370-21-003540","doc":"nlst-20210102x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications is resulting in the creation of unprecedented amounts of unstructured data."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001558370-22-002590","doc":"nlst-20220101x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications is resulting in the creation of unprecedented amounts of unstructured data."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001558370-23-002384","doc":"nlst-20221231x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications has resulted in the accelerating creation and transmission of data."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-001626","doc":"nlst-20231230x10k.htm","q":"The proliferation of mobile devices, social media platforms, cognitive/artificial intelligence systems and cloud-based software applications has resulted in the accelerating creation and transmission of data."},{"fy":2024,"lvl":3,"n":33,"adsh":"0001558370-25-004010","doc":"nlst-20241228x10k.htm","q":"With a rich portfolio of patented technologies, we have consistently driven innovation in the field of cutting-edge enterprise memory and storage, advancing artificial intelligence (\u201cAI\u201d) and empowering businesses and industries to thrive i\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001104659-26-032152","doc":"nlst-20251227x10k.htm","q":"With a rich portfolio of patented technologies, our inventions are foundational to the advancement of artificial intelligence (\u201cAI\u201d) computing. \u200b Our Industry \u200b The global high-performance memory market is driven by increasing demand from d\u2026"}]},{"cik":1284454,"name":"YONG BAI CHAO NEW RETAIL CORP","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-003467","doc":"evcc_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001813","doc":"ybcn_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-002791","doc":"ybcn_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-002091","doc":"ybcn_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-25-002561","doc":"ybcn_10k.htm","q":null}]},{"cik":1285543,"name":"ZERIFY, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-002476","doc":"sfor_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009705","doc":"sfor_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001731","doc":"sfor_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001529","doc":"sfor_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-001740","doc":"sfor_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-002343","doc":"sfor_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-002231","doc":"sfor_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-002284","doc":"sfor_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-002547","doc":"zrfy_10k.htm","q":null}]},{"cik":1285819,"name":"OMEROS CORP","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001285819-15-000003","doc":"omer-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001285819-16-000014","doc":"omer-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001285819-17-000004","doc":"omer-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001285819-18-000003","doc":"omer-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002324","doc":"omer-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001891","doc":"omer-20191231x10k21f5b6.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002177","doc":"omer-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002582","doc":"omer-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003575","doc":"omer-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-010416","doc":"omer20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-010216","doc":"omer20241231_10k.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0001437749-26-010636","doc":"omer20251231_10k.htm","q":"Our use of artificial intelligence exposes us to deficient outputs, unintentional disclosures, and an evolving regulatory landscape."}]},{"cik":1286225,"name":"REALPAGE, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001286225-15-000014","doc":"rp-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001286225-16-000061","doc":"rp-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001286225-17-000010","doc":"rp-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001286225-18-000008","doc":"rp-20171231x10k.htm","q":"(\u201cWayBlazer\u201d), which is an unrelated company that specializes in an artificial intelligence platform for the travel industry."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001286225-19-000007","doc":"rp-20181231x10k.htm","q":"(\u201cWayBlazer\u201d), which was an unrelated company that specialized in an artificial intelligence platform for the travel industry."},{"fy":2019,"lvl":2,"n":7,"adsh":"0001286225-20-000011","doc":"rp-20191231x10k.htm","q":"Our leasing and marketing solutions category consists of the following primary solutions: Online Leasing, Contact Center, Websites & Syndication, Intelligent Lease Management, LeaseLabs, AI Resident Screening and MyNewPlace."},{"fy":2020,"lvl":2,"n":6,"adsh":"0001286225-21-000007","doc":"rp-20201231.htm","q":"Our leasing and marketing solutions category consists of the following primary 10 solutions: Online Leasing, Contact Center, Websites & Syndication, Intelligent Lease Management, LeaseLabs, Modern Message, AI Resident Screening, and MyNewPl\u2026"}]},{"cik":1287098,"name":"MAXCYTE, INC.","industry":"Pharma & biotech","sic":8731,"state":"MD","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004081","doc":"mxct-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003911","doc":"mxct-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003001","doc":"mxct-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002721","doc":"mxct-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-034557","doc":"mxct-20251231x10k.htm","q":null}]},{"cik":1287213,"name":"DOUGLAS DYNAMICS, INC","industry":"Construction machinery","sic":3531,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000337","doc":"plow-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003908","doc":"plow-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001675","doc":"plow-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001358","doc":"plow-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001106","doc":"plow-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001328","doc":"plow-20191231x10kc2fca4.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001470","doc":"plow-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001580","doc":"plow-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-003961","doc":"plow20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-005713","doc":"plow20231231_10k.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0001437749-25-005050","doc":"plow20241231_10k.htm","q":"We may use artificial intelligence in our business and operations, and challenges with effectively managing its use could harm our business and expose us to costly liability."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001437749-26-005316","doc":"plow20251231_10k.htm","q":"We may use artificial intelligence in our business and operations, and challenges with effectively managing its use could harm our business and expose us to costly liability."}]},{"cik":1287808,"name":"HILL INTERNATIONAL, INC.","industry":"Construction","sic":8711,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002173","doc":"a2223525z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011694","doc":"a2227987z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-002267","doc":"a2231587z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001287808-18-000020","doc":"hil-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001287808-19-000004","doc":"hil-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001287808-20-000014","doc":"hil-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001287808-21-000008","doc":"hil-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001287808-22-000011","doc":"hil-20211231.htm","q":null}]},{"cik":1288469,"name":"MAXLINEAR, INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001288469-15-000002","doc":"mxl-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001288469-16-000053","doc":"a12311510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001288469-17-000004","doc":"a12311610-k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001288469-18-000006","doc":"a12311710-k.htm","q":"Cloud services and machine learning are dependent upon the ability to interconnect vast numbers of servers and storage inside a data center as efficiently as possible, enabling the entire data center to act as a single computing or data pro\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001288469-19-000006","doc":"a12311810-k.htm","q":"Cloud services and machine learning are dependent upon the ability to interconnect vast numbers of servers and storage inside a data center as efficiently as possible, enabling the entire data center to act as a single computing or data pro\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001288469-20-000013","doc":"a12311910-k.htm","q":"Cloud services and machine learning are dependent upon the ability to interconnect vast numbers of servers and storage inside a data center as efficiently as possible, enabling the entire data center to act as a single computing or data pro\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0001288469-21-000013","doc":"mxl-20201231.htm","q":"We expect this trend to continue owing to: \u2022 The rapid rise of social media and crowd-sourced real-time content; \u2022 The proliferation of on-demand Over-The-Top (OTT) video services such as Netflix and Amazon Prime; \u2022 Rapid growth in data cen\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001288469-22-000029","doc":"mxl-20211231.htm","q":"We expect this trend to continue owing to: \u2022 The rapid rise of social media and crowd-sourced real-time content; \u2022 The proliferation of on-demand Over-The-Top, or OTT, video services such as Netflix and Amazon Prime; \u2022 Rapid growth in data \u2026"},{"fy":2022,"lvl":2,"n":7,"adsh":"0001288469-23-000009","doc":"mxl-20221231.htm","q":"We expect this trend to continue owing to: \u2022 The rapid rise of social media and crowd-sourced real-time content; \u2022 The proliferation of on-demand Over-The-Top, or OTT, video services such as Netflix and Amazon Prime; \u2022 Rapid growth in data \u2026"},{"fy":2023,"lvl":3,"n":15,"adsh":"0001288469-24-000015","doc":"mxl-20231231.htm","q":"We expect this trend to continue owing to: \u2022 Accelerated expansion of advanced data center technologies and cloud-based services including, Amazon Web Service, or AWS, Google Cloud Platform, and software as service, or SAAS, in general; \u2022 T\u2026"},{"fy":2024,"lvl":3,"n":17,"adsh":"0001288469-25-000008","doc":"mxl-20241231.htm","q":"We expect this trend to continue owing to: \u2022 Accelerated expansion of advanced data center technologies and cloud-based services including, Amazon Web Service, or AWS, Google Cloud Platform, and software as service, or SAAS, in general; \u2022 T\u2026"},{"fy":2025,"lvl":3,"n":34,"adsh":"0001288469-26-000011","doc":"mxl-20251231.htm","q":"We expect this trend to continue owing to: \u2022 Accelerated expansion of advanced data center technologies and cloud-based services including, Amazon Web Service, or AWS, Google Cloud Platform, and software as service, or SAAS, in general; \u2022 T\u2026"}]},{"cik":1288776,"name":"GOOGLE INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001288776-15-000008","doc":"goog2014123110-k.htm","q":null}]},{"cik":1290149,"name":"SIERRA ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-490742","doc":"d80749d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-066582","doc":"d280476d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-059374","doc":"d522898d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-055556","doc":"d683457d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-059703","doc":"d843782d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012234","doc":"srra-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009473","doc":"srra-10k_20211231.htm","q":null}]},{"cik":1290658,"name":"IIOT-OXYS, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2017,"lvl":"x","n":1,"adsh":"0001683168-18-001033","doc":"iiot_10k-123117.htm","q":"From our actual experience and according to many technical experts in the field (see for example the discussion on edge data in \u201cStructural Health Monitoring\u201d A Machine Learning Perspective,\u201d by C.R."},{"fy":2018,"lvl":"x","n":16,"adsh":"0001683168-19-001071","doc":"iiot_10k-123118.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2019,"lvl":"x","n":10,"adsh":"0001683168-20-002038","doc":"iiot_10k-123119.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2020,"lvl":"x","n":6,"adsh":"0001683168-21-001249","doc":"iiotoxys_10k-123120.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2021,"lvl":"x","n":8,"adsh":"0001683168-22-002671","doc":"iiot_i10k-123121.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2022,"lvl":"x","n":17,"adsh":"0001683168-23-002351","doc":"iiot_i10k-123122.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2023,"lvl":"x","n":12,"adsh":"0001683168-24-004655","doc":"iiot_i10k-123123.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2024,"lvl":"x","n":12,"adsh":"0001683168-25-002978","doc":"iiot_i10k-123124.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."},{"fy":2025,"lvl":"x","n":9,"adsh":"0001683168-26-003672","doc":"iiot_i10k-123125.htm","q":"We use domain-specific Artificial Intelligence to solve industrial and environmental challenges."}]},{"cik":1290900,"name":"COMMERCIAL VEHICLE GROUP, INC.","industry":"Auto manufacturing","sic":3714,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093795","doc":"d834609d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012603","doc":"cvgi-12312015x10xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002449","doc":"cvgi-12312016x10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003101","doc":"cvgi-12312017x10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002781","doc":"cvgi-12312018x10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003659","doc":"a2019-10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-004275","doc":"cvgi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004584","doc":"cvgi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-006568","doc":"cvgi-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-011213","doc":"cvgi-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-012913","doc":"cvgi-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-016520","doc":"cvgi-20251231.htm","q":null}]},{"cik":1293310,"name":"HUMANIGEN, INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000364","doc":"kbio-20141231x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001214659-17-001799","doc":"p3217010k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001214659-18-002397","doc":"p31318010k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001214659-19-002284","doc":"p21319110k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001214659-20-002661","doc":"d21920010k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001214659-21-002990","doc":"hgen342110k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001214659-22-003416","doc":"hgen10k1221.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001214659-23-004512","doc":"hgen-20221231.htm","q":null}]},{"cik":1293971,"name":"BLUEBIRD BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000948","doc":"blue-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013381","doc":"blue-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002015","doc":"blue-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002704","doc":"blue-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003694","doc":"blue-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001293971-20-000007","doc":"blue-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001293971-21-000013","doc":"blue-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001293971-22-000016","doc":"blue-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001293971-23-000007","doc":"blue-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001293971-24-000037","doc":"blue-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001293971-25-000009","doc":"blue-20241231.htm","q":null}]},{"cik":1294924,"name":"INVENSENSE INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-204243","doc":"d917637d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-602397","doc":"d179874d10k.htm","q":null}]},{"cik":1295947,"name":"PRESTIGE CONSUMER HEALTHCARE INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001295947-15-000015","doc":"pbh10kmarch312015.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001295947-16-000051","doc":"pbh10kmarch312016.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001295947-17-000018","doc":"pbh10kmarch312017.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001295947-18-000013","doc":"pbh10kmarch312018.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001295947-19-000015","doc":"pbh10kmarch312019.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001295947-20-000018","doc":"pbh-20200331.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001295947-21-000021","doc":"pbh-20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001295947-22-000015","doc":"pbh-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001295947-23-000017","doc":"pbh-20230331.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001295947-24-000017","doc":"pbh-20240331.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0001295947-25-000017","doc":"pbh-20250331.htm","q":"In addition, the rapid evolution and growing adoption of artificial intelligence (\"AI\") and machine learning technologies presents emerging risks to the security of our information, as well as the information of our customers and business p\u2026"}]},{"cik":1296445,"name":"ORMAT TECHNOLOGIES, INC.","industry":"Utilities","sic":4911,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-003544","doc":"ora20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026139","doc":"ora20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003516","doc":"ora20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004850","doc":"ora20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-003760","doc":"ora20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-004072","doc":"ora20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-004274","doc":"ora20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004440","doc":"ora20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-004477","doc":"ora20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-005322","doc":"ora20231231_10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001628280-25-008531","doc":"ora-20241231.htm","q":"Involvement in continuous innovation by research and development efforts aimed at enhancing the efficiency of our operations, including through the use of AI technologies."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001296445-26-000006","doc":"ora-20251231.htm","q":null}]},{"cik":1297184,"name":"AMPHASTAR PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001654","doc":"f10k_032515.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004146","doc":"amph-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001297184-17-000007","doc":"amph-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001297184-18-000011","doc":"amph-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001297184-19-000013","doc":"amph-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001297184-20-000007","doc":"amph-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001297184-21-000008","doc":"amph-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001297184-22-000007","doc":"amph-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001297184-23-000019","doc":"amph-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001297184-24-000009","doc":"amph-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001297184-25-000008","doc":"amph-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001297184-26-000009","doc":"amph-20251231x10k.htm","q":null}]},{"cik":1299969,"name":"COMSTOCK HOLDING COMPANIES, INC.","industry":"Construction","sic":1531,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-129688","doc":"d882673d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-528197","doc":"d93740d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-126231","doc":"d314334d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-123577","doc":"d512324d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010210","doc":"chci-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-016780","doc":"chci-10k_20191231.htm","q":null}]},{"cik":1300699,"name":"ATHENEX, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006715","doc":"atnx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007092","doc":"atnx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008138","doc":"atnx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009879","doc":"atnx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003973","doc":"atnx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008734","doc":"atnx-20221231.htm","q":null}]},{"cik":1300938,"name":"ABCO ENERGY, INC.","industry":"Construction","sic":1700,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001185185-15-001702","doc":"abcoenergy10k123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001185185-16-004190","doc":"abcoenergy10k123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001185185-17-000938","doc":"abcoenergy10k123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001185185-18-000715","doc":"abcoenergy10k123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001185185-19-000544","doc":"abcoenergy20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001185185-20-001098","doc":"abcoenergy20191231_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001185185-21-000536","doc":"abcoenergy20201231_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001185185-22-000468","doc":"abcoenergy20211231_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001185185-23-000350","doc":"abcoenergy20221231_10k.htm","q":null}]},{"cik":1301031,"name":"DEMANDWARE INC","industry":"Software & IT services","sic":7371,"state":"MA","cells":[{"fy":2014,"lvl":1,"n":2,"adsh":"0001193125-15-073636","doc":"d838302d10k.htm","q":"We will invest in building technology applications that provide our clients with predictive and actionable business intelligence through sophisticated machine learning. \u0095 Experience ."},{"fy":2015,"lvl":1,"n":3,"adsh":"0001564590-16-013563","doc":"dwre-10k_20151231.htm","q":"Our predictive merchandising capabilities apply machine learning and predictive analytics across our platform data to enable our customers to create highly personalized shopping experiences for consumers. 7 Our Strategy Our strategy is to e\u2026"}]},{"cik":1301501,"name":"ACHAOGEN, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001797","doc":"akao-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001301501-16-000046","doc":"akao-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004283","doc":"akao-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003544","doc":"akao-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010412","doc":"akao-10k_20181231.htm","q":null}]},{"cik":1301704,"name":"GO-PAGE CORP","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001594062-15-000105","doc":"form10k.htm","q":null}]},{"cik":1302573,"name":"ONCOMED PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-089346","doc":"d851015d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014426","doc":"omed-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003874","doc":"omed-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005014","doc":"omed-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006795","doc":"omed-10k_20181231.htm","q":null}]},{"cik":1303330,"name":"CHINA HOUSING & LAND DEVELOPMENT, INC.","industry":"Construction","sic":1520,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-020158","doc":"v405867_10k.htm","q":null}]},{"cik":1303652,"name":"TABLEAU SOFTWARE INC","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001303652-15-000009","doc":"a10k2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001303652-16-000039","doc":"a10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001303652-17-000008","doc":"a10k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001303652-18-000011","doc":"a10k2017.htm","q":null},{"fy":2018,"lvl":1,"n":4,"adsh":"0001303652-19-000007","doc":"a10k2018.htm","q":"For example, in February 2019, we released Tableau 2019.1 which introduced Ask Data, which leverages natural language processing to enable users to ask questions in plain language and get a visual response in Tableau."}]},{"cik":1305253,"name":"EIGER BIOPHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-112793","doc":"d843760d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-523887","doc":"d53576d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005079","doc":"eigr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005123","doc":"eigr-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007830","doc":"eigr-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010645","doc":"eigr-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011758","doc":"eigr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009697","doc":"eigr-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001305253-23-000005","doc":"eigr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-015297","doc":"eigr-20231231.htm","q":null}]},{"cik":1305294,"name":"QLIK TECHNOLOGIES INC","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069646","doc":"d845787d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481915","doc":"d82344d10k.htm","q":null}]},{"cik":1309057,"name":"CHINA HEALTH INDUSTRIES HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001062993-15-005384","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-16-011575","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062993-17-004265","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-013171","doc":"f10k2018_chinahealthindus.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-19-017723","doc":"f10k2019_chinahealthindust.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-20-031015","doc":"f10k2020_chinahealth.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-21-048756","doc":"f10k2021_chinahealth.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-22-056075","doc":"f10k2022_chinahealth.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-23-085612","doc":"f10k2023_chinahealth.htm","q":null}]},{"cik":1309442,"name":"INSPRO TECHNOLOGIES CORP","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-002489","doc":"t81839_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-013457","doc":"t1600156_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-003043","doc":"t1700182_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-018074","doc":"tv489087_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-017159","doc":"tv516518_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-038302","doc":"tm206785-1_10k.htm","q":null}]},{"cik":1310067,"name":"SEARS HOLDINGS CORP","industry":"Retail","sic":5311,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001310067-15-000009","doc":"shld201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001310067-16-000059","doc":"shld201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001310067-17-000005","doc":"shld201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001310067-18-000006","doc":"shld201710k.htm","q":null}]},{"cik":1311241,"name":"INTERMOLECULAR INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001311241-15-000022","doc":"a10k-20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004422","doc":"imi-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003326","doc":"imi-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004255","doc":"imi-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007009","doc":"imi-10k_20181231.htm","q":null}]},{"cik":1311596,"name":"TOBIRA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-046763","doc":"d854576d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013992","doc":"tbra-10k_20151231.htm","q":null}]},{"cik":1313911,"name":"RALLY SOFTWARE DEVELOPMENT CORP","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-003228","doc":"a2224057z10-k.htm","q":null}]},{"cik":1313938,"name":"SIBANNAC, INC.","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001127855-15-000017","doc":"naprodis10k083114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005296","doc":"sibannac_10k-083115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-16-000946","doc":"sibannac_10k-083116.htm","q":null}]},{"cik":1314052,"name":"ANAVEX LIFE SCIENCES CORP.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001615774-15-003756","doc":"s102397_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-16-008914","doc":"s104917_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001615774-17-007272","doc":"s108360_10k.htm","q":null},{"fy":2018,"lvl":1,"n":3,"adsh":"0001615774-18-014328","doc":"s114606_10k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA & RNA data in patients exposed to ANAVEX \u00ae 2-73."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001731122-19-000784","doc":"e1624_10k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA & RNA data in patients exposed to ANAVEX \u00ae 2-73."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001731122-20-001338","doc":"e2298_10k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA & RNA data in patients exposed to ANAVEX \u00ae 2-73."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001731122-21-002062","doc":"e3306_10-k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA & RNA data in patients exposed to ANAVEX \u00ae 2-73."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001731122-22-002062","doc":"e4251_10k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA and RNA data in patients treated with ANAVEX \u00ae 2-73."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001731122-23-002197","doc":"e5240_10k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA and RNA data in patients treated with ANAVEX \u00ae 2-73."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001731122-24-002041","doc":"e6219_10-k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA and RNA data in patients treated with ANAVEX \u00ae 2-73."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001731122-25-001596","doc":"e7052_10-k.htm","q":"More than 33,000 genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA and RNA data in patients treated with ANAVEX \u00ae 2-73."}]},{"cik":1314196,"name":"OLB GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-001997","doc":"f10k2014_theolbgroup.htm","q":null}]},{"cik":1314223,"name":"AMBER ROAD, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001314223-15-000007","doc":"ambr-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001314223-16-000021","doc":"ambr-1231201510xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001314223-17-000009","doc":"ambr-1231201610xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001314223-18-000002","doc":"ambr-1231201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001314223-19-000007","doc":"ambr-20181231.htm","q":null}]},{"cik":1315098,"name":"ROBLOX CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":6,"adsh":"0001315098-22-000058","doc":"rblx-20211231.htm","q":"Using advanced pattern matching and machine learning, our chat filters are constantly evolving and process billions of messages per day."},{"fy":2022,"lvl":3,"n":17,"adsh":"0001315098-23-000035","doc":"rblx-20221231.htm","q":"Using advanced pattern matching and machine learning, our chat filters are constantly evolving and process billions of messages per day."},{"fy":2023,"lvl":3,"n":54,"adsh":"0001315098-24-000026","doc":"rblx-20231231.htm","q":"Using advanced pattern matching and machine learning, our chat filters are constantly evolving and process billions of messages per day."},{"fy":2024,"lvl":3,"n":67,"adsh":"0001315098-25-000033","doc":"rblx-20241231.htm","q":"Using advanced pattern matching and machine learning, our chat filters are constantly evolving and process billions of messages per day."},{"fy":2025,"lvl":3,"n":108,"adsh":"0001315098-26-000024","doc":"rblx-20251231.htm","q":"Because a large number of our users are children, our Community Standards and moderation enforcement are purpose-built to be strict and we strive to quickly remove violative content and bad actors from our community. 11 Table of Contents Mo\u2026"}]},{"cik":1316016,"name":"AQUANTIA CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-004736","doc":"aq-10k_20171231.htm","q":"Developing a fully autonomous vehicle requires innovation in the areas of image processing, fast and multi-dimensional decision making processes, and deep learning, similar to some of the most advanced facial recognition algorithms or compl\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-006495","doc":"aq-10k_20181231.htm","q":"Developing a fully autonomous vehicle requires innovation in the areas of image processing, fast and multi-dimensional decision-making processes, and deep learning, similar to some of the most advanced facial recognition algorithms or compl\u2026"}]},{"cik":1316175,"name":"ANTHERA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001214659-15-002302","doc":"a3615010k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001214659-16-010295","doc":"s3416010k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001214659-17-002018","doc":"d3917010k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001214659-18-001789","doc":"a22118010k.htm","q":null}]},{"cik":1316360,"name":"IHS INC.","industry":"Software & IT services","sic":7370,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001316360-15-000007","doc":"q41410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001316360-16-000114","doc":"q41510k.htm","q":null}]},{"cik":1316517,"name":"KANDI TECHNOLOGIES GROUP, INC.","industry":"Auto manufacturing","sic":3711,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001062993-15-001343","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001062993-16-008324","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-17-001411","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-003097","doc":"f10k2017_kanditechnologies.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004189","doc":"f10k2018_kanditechnologies.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-010244","doc":"f10k2019_kanditechnologies.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018480","doc":"f10k2020_kanditech.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-012325","doc":"test.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-020551","doc":"f10k2022_kanditech.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-022676","doc":"ea0201374-10k_kanditech.htm","q":null}]},{"cik":1316625,"name":"SILICON GRAPHICS INTERNATIONAL CORP","industry":"Computers & chips","sic":3571,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001316625-15-000017","doc":"sgi10k-2015.htm","q":null}]},{"cik":1317630,"name":"ITC HOLDINGS CORP.","industry":"Utilities","sic":4911,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001100","doc":"itc2014123110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011699","doc":"itc2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-001412","doc":"itc2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001317630-18-000005","doc":"itc2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001317630-19-000003","doc":"itc2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001317630-20-000004","doc":"itc2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001317630-21-000008","doc":"itc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001317630-22-000003","doc":"itc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001317630-23-000004","doc":"itc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001317630-24-000005","doc":"itc-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001317630-25-000002","doc":"itc-20241231.htm","q":"These cyber threats and attacks are becoming more sophisticated and dynamic, including as a result of the advancement of technologies like artificial intelligence, which malicious third parties are using to create new, sophisticated and mor\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001317630-26-000006","doc":"itc-20251231.htm","q":"These cyber threats and attacks are becoming more sophisticated and dynamic, including as a result of 17 Table of Contents the advancement of technologies like artificial intelligence, which malicious third parties are using to create new, \u2026"}]},{"cik":1317880,"name":"PLANDAI BIOTECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2015,"lvl":"x","n":2,"adsh":"0001262463-16-000987","doc":"plpl2015.htm","q":"Jamen Shively \u2013 Director Jamen Shively has a background in engineering and marketing, with specialties in artificial intelligence, the modeling and optimization of complex networks, and the creation and positioning of new categories of prod\u2026"}]},{"cik":1318605,"name":"TESLA, INC.","industry":"Auto manufacturing","sic":3711,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001031","doc":"tsla-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013195","doc":"tsla-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003118","doc":"tsla-10k_20161231.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001564590-18-002956","doc":"tsla-10k_20171231.htm","q":"An overhaul of the underlying architecture of our software has been completed, which has enabled a step-change improvement in the collection and analysis of data and fundamentally enhanced its machine learning capabilities."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-003165","doc":"tsla-10k_20181231.htm","q":"Our neural net and functionality continue to improve, and we frequently release minor software updates and from time to time release key version updates."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001564590-20-004475","doc":"tsla-10k_20191231.htm","q":"Combined with technical advancements in our powertrain system, Autopilot and Full Self-Driving (\u201cFSD\u201d) hardware, and neural net, our electric vehicles boast advantages such as leading range and recharging flexibility; superior acceleration,\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-21-004599","doc":"tsla-10k_20201231.htm","q":"Our FSD Computer runs our neural networks in our vehicles, and we are also developing additional computer hardware to better enable the massive amounts of field data captured by our vehicles to continually train and improve these neural net\u2026"},{"fy":2021,"lvl":2,"n":6,"adsh":"0000950170-22-000796","doc":"tsla-20211231.htm","q":"Our FSD Computer runs our neural networks in our vehicles, and we are also developing additional computer hardware to better enable the massive amounts of field data captured by our vehicles to continually train and improve these neural net\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0000950170-23-001409","doc":"tsla-20221231.htm","q":"Self-Driving Development and Artificial Intelligence We have expertise in developing technologies, systems and software to enable self-driving vehicles using primarily vision-based technologies."},{"fy":2023,"lvl":2,"n":13,"adsh":"0001628280-24-002390","doc":"tsla-20231231.htm","q":"Self-Driving Development and Artificial Intelligence We have expertise in developing technologies, systems and software to enable self-driving vehicles using primarily vision-based technologies."},{"fy":2024,"lvl":3,"n":25,"adsh":"0001628280-25-003063","doc":"tsla-20241231.htm","q":"Self-Driving Development and Artificial Intelligence We have expertise in developing technologies, systems and software to enable self-driving vehicles using primarily vision-based technologies."},{"fy":2025,"lvl":3,"n":60,"adsh":"0001628280-26-003952","doc":"tsla-20251231.htm","q":"BUSINESS Overview We are focused on bringing artificial intelligence (\u201cAI\u201d) into the real world, through products and services like Full Self-Driving (\u201cFSD\u201d) (Supervised) and Robotaxi, as well as working to develop and commercialize AI robo\u2026"}]},{"cik":1318641,"name":"STATERA BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-067307","doc":"d853708d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001318641-16-000009","doc":"cbli-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001318641-17-000012","doc":"cbli-123116x10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001318641-18-000005","doc":"cbli-12x31x17x10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001318641-19-000005","doc":"cbli-12x31x18x10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-007716","doc":"cbli20191231b_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001437749-21-006758","doc":"cbli20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-023703","doc":"cbli20211231_10k.htm","q":null}]},{"cik":1320461,"name":"COOPER-STANDARD HOLDINGS INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001320461-15-000038","doc":"a1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001320461-16-000094","doc":"a1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001320461-17-000014","doc":"a1231201610-k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001320461-18-000004","doc":"a201710-k.htm","q":"Examples include but are not limited to wireless communications and connectivity, computers and data mining, artificial intelligence, autonomy and mobility, among others."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001320461-19-000009","doc":"a201810-k.htm","q":"Among recently introduced technologies is Cooper Standard\u2019s artificial intelligence-enhanced development cycle for polymer compounds that has shortened material development times while realizing rapid discovery of new compounds that offer s\u2026"},{"fy":2019,"lvl":2,"n":5,"adsh":"0001320461-20-000009","doc":"a201910-k.htm","q":"The initiative is focused in the areas of materials science, manufacturing and process technology, digital/artificial intelligence and advanced product technology."},{"fy":2020,"lvl":2,"n":5,"adsh":"0001320461-21-000045","doc":"cps-20201231.htm","q":"The initiative is focused in the areas of materials science, manufacturing and process technology, digital/artificial intelligence and advanced product technology."},{"fy":2021,"lvl":2,"n":5,"adsh":"0001320461-22-000038","doc":"cps-20211231.htm","q":"The initiative is focused in the areas of materials science, manufacturing and process technology, digital/artificial intelligence and advanced product technology."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001320461-23-000047","doc":"cps-20221231.htm","q":"The initiative is focused in the areas of materials science, manufacturing and process technology, digital/artificial intelligence and advanced product technology."},{"fy":2023,"lvl":2,"n":11,"adsh":"0001320461-24-000034","doc":"cps-20231231.htm","q":"The initiative is focused in the areas of materials science, manufacturing and process technology, digital/artificial intelligence and advanced product technology."},{"fy":2024,"lvl":2,"n":12,"adsh":"0001320461-25-000033","doc":"cps-20241231.htm","q":"We continue to adopt proprietary artificial intelligence (\u201cA.I.\u201d) based solutions where they deliver business value."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001320461-26-000012","doc":"cps-20260213.htm","q":"Cooper Standard is also implementing digital technologies across manufacturing, from core enterprise systems to advanced analytics and artificial intelligence (\u201cA.I.\u201d)."}]},{"cik":1321655,"name":"PALANTIR TECHNOLOGIES INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2020,"lvl":2,"n":14,"adsh":"0001193125-21-060650","doc":"d65934d10k.htm","q":"Our software brings diverse decision makers within an organization together: data engineers, data scientists, and machine learning experts, as well as senior executives, prime ministers, and four-star generals."},{"fy":2021,"lvl":2,"n":13,"adsh":"0001193125-22-050913","doc":"d273589d10k.htm","q":"Those controls were further supported by auditing capabilities to ensure that data processing satisfied legitimate purposes under the relevant regulations. \u2022 A multinational insurer sought to build and apply machine-learning models to surfa\u2026"},{"fy":2022,"lvl":3,"n":15,"adsh":"0001321655-23-000011","doc":"pltr-20221231.htm","q":"Those controls were further supported by auditing capabilities to ensure that data processing satisfied legitimate purposes under the relevant regulations. \u2022 A multinational insurer sought to build and apply machine-learning models to surfa\u2026"},{"fy":2023,"lvl":3,"n":64,"adsh":"0001321655-24-000022","doc":"pltr-20231231.htm","q":"We have built four principal software platforms, Palantir Gotham (\u201cGotham\u201d), Palantir Foundry (\u201cFoundry\u201d), Palantir Apollo (\u201cApollo\u201d), and Palantir Artificial Intelligence Platform (\u201cAIP\u201d)."},{"fy":2024,"lvl":3,"n":96,"adsh":"0001321655-25-000022","doc":"pltr-20241231.htm","q":"We have built four principal software platforms, Palantir Gotham (\u201cGotham\u201d), Palantir Foundry (\u201cFoundry\u201d), Palantir Apollo (\u201cApollo\u201d), and Palantir Artificial Intelligence Platform (\u201cAIP\u201d)."},{"fy":2025,"lvl":3,"n":110,"adsh":"0001321655-26-000011","doc":"pltr-20251231.htm","q":"We have built four principal software platforms, Palantir Gotham (\u201cGotham\u201d), Palantir Foundry (\u201cFoundry\u201d), Palantir Apollo (\u201cApollo\u201d), and our Artificial Intelligence Platform (\u201cAIP\u201d)."}]},{"cik":1322505,"name":"ALBIREO PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001145443-15-001341","doc":"d299162_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-16-030440","doc":"albo-10k_20160930.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006847","doc":"albo-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001601","doc":"albo-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001905","doc":"albo-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001730","doc":"albo-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002501","doc":"albo-20211231x10k.htm","q":null}]},{"cik":1322554,"name":"XACTLY CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001564590-16-016412","doc":"xtly-10k_20160131.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-006440","doc":"xtly-10k_20170131.htm","q":null}]},{"cik":1322705,"name":"SPANSION INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-002287","doc":"code20141231_10k.htm","q":null}]},{"cik":1324245,"name":"SOLERA HOLDINGS, INC","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001324245-15-000053","doc":"slh0630201510k.htm","q":null}]},{"cik":1324772,"name":"APIGEE CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-343835","doc":"d65720d10k.htm","q":null},{"fy":2016,"lvl":1,"n":4,"adsh":"0001628280-16-019998","doc":"apic201610-k.htm","q":"Apigee Sense leverages sophisticated machine learning algorithms to detect bad bots at the API layer."}]},{"cik":1325702,"name":"MAGNACHIP SEMICONDUCTOR CORP","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-204040","doc":"d834273d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-470674","doc":"d103672d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-050458","doc":"d298174d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-054078","doc":"d527108d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-048327","doc":"d695091d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-044746","doc":"d878295d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-073817","doc":"d846606d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-050017","doc":"d282977d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-044850","doc":"d425515d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001193125-24-063674","doc":"d183811d10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001193125-25-054851","doc":"d920621d10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-108435","doc":"mx-20251231.htm","q":null}]},{"cik":1325879,"name":"AVEO PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-079651","doc":"d846897d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014772","doc":"aveo-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005015","doc":"aveo-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005386","doc":"aveo-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007804","doc":"aveo-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011145","doc":"aveo-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013607","doc":"aveo-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-006093","doc":"aveo-20211231.htm","q":null}]},{"cik":1326110,"name":"IMMUNITYBIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001564590-16-015596","doc":"nk-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004430","doc":"nk-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005290","doc":"nk-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007562","doc":"nk-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012816","doc":"nk-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010945","doc":"nk-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001326110-22-000011","doc":"ibrx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001326110-23-000018","doc":"ibrx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001326110-24-000037","doc":"ibrx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001326110-25-000033","doc":"ibrx-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":12,"adsh":"0001326110-26-000030","doc":"ibrx-20251231.htm","q":"We have initiated or completed a series of trials evaluating the safety and feasibility of the technology including: \u2022 NK2022 & NK2023 (Cancer Patients & Healthy Donors): 64 subjects completed apheresis and M-ceNK manufacturing cell therapy\u2026"}]},{"cik":1326160,"name":"DUKE ENERGY CORP","industry":"Utilities","sic":4931,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001326160-15-000008","doc":"duk-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001326160-16-000221","doc":"duk-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001326160-17-000016","doc":"duk-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001326160-18-000034","doc":"duk-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001326160-19-000057","doc":"duk-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001326160-20-000034","doc":"duk-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001326160-21-000063","doc":"duk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001326160-22-000072","doc":"duk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001326160-23-000073","doc":"duk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001326160-24-000037","doc":"duk-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001326160-25-000072","doc":"duk-20241231.htm","q":"This involves significant development and implementation costs to keep pace with changing technologies, including artificial intelligence, and customer demand."},{"fy":2025,"lvl":3,"n":30,"adsh":"0001326160-26-000014","doc":"duk-20251231.htm","q":"Furthermore, AI, including generative AI, may be used to facilitate or perpetrate these cybersecurity threats."}]},{"cik":1326190,"name":"ALTIMMUNE, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001144204-15-015393","doc":"v403190_10k.htm","q":"(9) 49 10.44 Contract with the National Institutes of Health for the Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine (#N01-AI-30052) (\u201cNIH Prime Contract-Anthrax\u201d), dated September 29, 2003."},{"fy":2015,"lvl":1,"n":1,"adsh":"0001144204-16-087617","doc":"v433058_10k.htm","q":"(9) 10.44 Contract with the National Institutes of Health for the Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine (#N01-AI-30052) (\u201cNIH Prime Contract-Anthrax\u201d), dated September 29, 2003."},{"fy":2016,"lvl":1,"n":1,"adsh":"0001144204-17-014528","doc":"v461002_10k.htm","q":"Description 10.9 Contract with the National Institutes of Health for the Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine (#N01-AI-30052) (\u201cNIH Prime Contract-Anthrax\u201d), dated September 29, 2003."},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-103623","doc":"d514795d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010429","doc":"alt-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013377","doc":"alt-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008422","doc":"alt-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003659","doc":"alt-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001326190-23-000008","doc":"alt-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001326190-24-000010","doc":"alt-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001326190-25-000015","doc":"alt-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":41,"adsh":"0001326190-26-000018","doc":"alt-20251231x10k.htm","q":"A supplemental AI-based analysis demonstrated statistically significant reductions in fibrosis, including 31% of subjects receiving pemvidutide 1.8 mg achieving a 60% or more reduction in fibrosis compared to 8% receiving placebo (p< 0.001)\u2026"}]},{"cik":1326205,"name":"IGC PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2022,"lvl":2,"n":7,"adsh":"0001185185-23-000693","doc":"igcpharma20230331_10k.htm","q":"Additionally, we are integrating machine learning technologies into our software framework."},{"fy":2023,"lvl":3,"n":35,"adsh":"0001185185-24-000650","doc":"igcpharma20240331_10k.htm","q":"We are also harnessing the power of Artificial Intelligence (\u201cAI\u201d) to develop early detection models, optimize clinical trials, and explore new applications for our drugs."},{"fy":2024,"lvl":"x","n":51,"adsh":"0001185185-25-000706","doc":"igc10k033125.htm","q":"We are also investing in our early-stage pipeline of investigational therapies and exploring Artificial Intelligence (AI) powered models designed to identify early markers of Alzheimer\u2019s."},{"fy":2025,"lvl":"x","n":50,"adsh":"0001185185-26-000941","doc":"igc10kt123125.htm","q":"The Company is also developing MINT-AD , a proprietary, artificial intelligence, enabled data platform designed to support risk stratification and longitudinal assessment in Alzheimer\u2019s disease using multimodal datasets."}]},{"cik":1326732,"name":"XENCOR INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000112","doc":"xncr-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003900","doc":"xncr-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001196","doc":"xncr-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001202","doc":"xncr-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001049","doc":"xncr-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001256","doc":"xncr-20191231x10k128a17.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001522","doc":"xncr-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001969","doc":"xncr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005127","doc":"xncr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001326732-24-000006","doc":"xncr-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0001326732-25-000029","doc":"xncr-20241231.htm","q":"Our employees and personnel use generative artificial intelligence, or AI, technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy ob\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001326732-26-000015","doc":"xncr-20251231.htm","q":"These actions and proposals may, for example, include directives: (1) reducing agency workforce and cutting programs; (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMNI, to\u2026"}]},{"cik":1326801,"name":"META PLATFORMS, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001326801-15-000006","doc":"fb-12312014x10k.htm","q":null},{"fy":2015,"lvl":1,"n":2,"adsh":"0001326801-16-000043","doc":"fb-12312015x10k.htm","q":"We are also investing in a number of longer-term initiatives, such as connectivity efforts, artificial intelligence research, and virtual reality, to develop technologies that we believe will help us better serve our communities and pursue \u2026"},{"fy":2016,"lvl":1,"n":2,"adsh":"0001326801-17-000007","doc":"fb-12312016x10k.htm","q":"We are also investing in a number of longer-term initiatives, such as connectivity efforts and artificial intelligence research, to develop technologies that we believe will help us better serve our communities and pursue our mission to mak\u2026"},{"fy":2017,"lvl":1,"n":2,"adsh":"0001326801-18-000009","doc":"fb-12312017x10k.htm","q":"We are also investing in a number of longer-term initiatives, such as connectivity efforts, artificial intelligence research, and augmented and virtual reality, to develop technologies that we believe will help us better serve our communiti\u2026"},{"fy":2018,"lvl":1,"n":4,"adsh":"0001326801-19-000009","doc":"fb-12312018x10k.htm","q":"We are also investing in other consumer hardware products and a number of longer-term initiatives, such as connectivity efforts, artificial intelligence (AI), and augmented reality, to develop technologies that we believe will help us bette\u2026"},{"fy":2019,"lvl":2,"n":11,"adsh":"0001326801-20-000013","doc":"fb-12312019x10k.htm","q":"We are also investing heavily in other consumer hardware products and a number of longer-term initiatives, such as augmented reality, artificial intelligence (AI), and connectivity efforts, to develop technologies that we believe will help \u2026"},{"fy":2020,"lvl":2,"n":12,"adsh":"0001326801-21-000014","doc":"fb-20201231.htm","q":"As our user base grows, as engagement with products like video and VR increases, and as we deepen our investment in new technologies like artificial intelligence, our computing needs continue to expand."},{"fy":2021,"lvl":2,"n":12,"adsh":"0001326801-22-000018","doc":"fb-20211231.htm","q":"As our user base grows, as engagement with products like video and VR increases, and as we deepen our investment in new technologies like artificial intelligence, our computing needs continue to expand."},{"fy":2022,"lvl":3,"n":32,"adsh":"0001326801-23-000013","doc":"meta-20221231.htm","q":"This includes exploring new technologies such as neural interfaces using electromyography, which lets people control their devices using neuromuscular signals, as well as innovations in artificial intelligence (AI) and hardware to help buil\u2026"},{"fy":2023,"lvl":3,"n":85,"adsh":"0001326801-24-000012","doc":"meta-20231231.htm","q":"Across our work, we are innovating in artificial intelligence (AI) technologies to build new experiences that help make our platform more social, useful, and immersive."},{"fy":2024,"lvl":3,"n":109,"adsh":"0001326801-25-000017","doc":"meta-20241231.htm","q":"Across our work, we are innovating in artificial intelligence (AI) technologies to build new experiences that help make our platform more social, useful, and immersive."},{"fy":2025,"lvl":3,"n":164,"adsh":"0001628280-26-003942","doc":"meta-20251231.htm","q":"Our products enable people to connect and share through mobile devices, personal computers, virtual reality (VR) headsets, and AI glasses."}]},{"cik":1327318,"name":"TRUECAR, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000322","doc":"true-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001327318-16-000026","doc":"truecar201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001327318-17-000009","doc":"truecar201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001327318-18-000019","doc":"truecar201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001327318-19-000009","doc":"truecar201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001327318-20-000009","doc":"truecar201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001327318-21-000019","doc":"true-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001327318-22-000005","doc":"true-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001327318-23-000006","doc":"true-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001327318-24-000006","doc":"true-20231231.htm","q":"If we are unable to incorporate features or technological advancements that become commonplace in other consumer-facing products, including those of our competitors, such as the integration of artificial intelligence, machine learning and o\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001327318-25-000006","doc":"true-20241231.htm","q":"If we are unable to incorporate features or technological advancements that become commonplace in other consumer-facing products, including those of our competitors, such as the integration of artificial intelligence, machine learning and o\u2026"}]},{"cik":1327467,"name":"CELATOR PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016717","doc":"v403198_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-089052","doc":"v432927_10k.htm","q":null}]},{"cik":1328015,"name":"IMPRIVATA INC","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-087481","doc":"d847207d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013831","doc":"impr-10k_20151231.htm","q":null}]},{"cik":1328143,"name":"ADAMAS PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001576","doc":"a2223253z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003389","doc":"adms-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-001888","doc":"adms1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002045","doc":"adms1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001328143-19-000011","doc":"adms1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001328143-20-000012","doc":"adms-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001328143-21-000019","doc":"adms-20201231.htm","q":null}]},{"cik":1328655,"name":"AFFINIA GROUP INTERMEDIATE HOLDINGS INC.","industry":"Auto manufacturing","sic":3714,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-095590","doc":"d854273d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-016125","doc":"afn-10k_20151231.htm","q":null}]},{"cik":1330421,"name":"BAZAARVOICE INC","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-235103","doc":"d929871d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001330421-16-000057","doc":"bv0430201610-kq4.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001330421-17-000018","doc":"bv0430201710-kq4.htm","q":null}]},{"cik":1333822,"name":"SEMILEDS CORP","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-009225","doc":"a2225930z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-16-010197","doc":"leds-20160831x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-024319","doc":"leds-10k_20170831.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-030063","doc":"leds-10k_20180831.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-043920","doc":"leds-10k_20190831.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-054257","doc":"leds-10k_20200831.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-058603","doc":"leds-10k_20210831.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-022841","doc":"leds-20220831.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-066243","doc":"leds-20230831.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-24-131245","doc":"leds-20240831.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-25-301379","doc":"leds-20250831.htm","q":null}]},{"cik":1334325,"name":"CODA OCTOPUS GROUP, INC.","industry":"Aerospace & defense","sic":3812,"state":"FL","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-001259","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":1,"n":3,"adsh":"0001493152-19-001229","doc":"form10-k.htm","q":"Our recently launched Survey Engine Automatic Object Detection (based on Artificial Intelligence techniques) is complementary to this product set."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001493152-20-001193","doc":"form10-k.htm","q":"We continue to advance this range of products and in 2018 we launched our first product based on Artificial Intelligence techniques which allows us to automatically identify boulders on the seabed (\u201cSurvey Engine Automatic Object Detection\u201d\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001493152-21-001943","doc":"form10-k.htm","q":"With the launch of the new products based on Artificial Intelligence technology for which we believe there is increased demand we would anticipate our revenues from this line to increase over time."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001493152-22-004191","doc":"form10-k.htm","q":"With the launch of the new products based on Artificial Intelligence technology for which we believe there is increased demand we would anticipate our revenues from this product line to increase over time."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-23-002840","doc":"form10-k.htm","q":"With the launch of the new products based on Artificial Intelligence technology for which we believe there is increased demand we would anticipate our revenues from this product line to increase over time."},{"fy":2023,"lvl":1,"n":2,"adsh":"0001493152-24-004039","doc":"form10-k.htm","q":"We continue to advance this range of products and in 2018 we launched our first product based on Artificial Intelligence techniques which allows us to automatically identify boulders on the seabed \u2013 SEADP \u2013 \u201cSurvey Engine Automatic Object D\u2026"},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493152-25-004075","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001493152-26-004135","doc":"form10-k.htm","q":"The launch by the Company of its Echoscope PIPE NANO Gen Series \u00ae in fiscal year 2025, our ultra-compact real time 3D imaging sonar marks a critical step in enabling next-generation subsea AI enabled autonomy."}]},{"cik":1334740,"name":"UTILICRAFT AEROSPACE INDUSTRIES, INC.","industry":"Aerospace & defense","sic":3721,"state":"NV","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-004880","doc":"uita_10k.htm","q":null}]},{"cik":1335103,"name":"PROTEA BIOSCIENCES GROUP, INC.","industry":"Pharma & biotech","sic":2834,"state":"WV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-009007","doc":"v400114_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-088486","doc":"v432195_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-020500","doc":"v462304_10k.htm","q":null}]},{"cik":1335105,"name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001047","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008321","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-002940","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-003806","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-003870","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004697","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-006882","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-007327","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-009386","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-010427","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-000208","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-014052","doc":"form10-k.htm","q":null}]},{"cik":1337272,"name":"SUNGARD CAPITAL CORP","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-104907","doc":"d888267d10k.htm","q":null}]},{"cik":1337553,"name":"AERIE PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001188","doc":"aeri-1231201410xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012101","doc":"aeri-1231201510xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002421","doc":"aeri-1231201610xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002651","doc":"aeri-1231201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002369","doc":"aeri-1231201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002027","doc":"aeri-1231201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003345","doc":"aeri-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001337553-22-000013","doc":"aeri-20211231.htm","q":null}]},{"cik":1337675,"name":"JAZZ TECHNOLOGIES, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001178913-15-001221","doc":"zk1516567.htm","q":null}]},{"cik":1337905,"name":"INTELLECT NEUROSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001615774-15-002920","doc":"s101998_10k.htm","q":null}]},{"cik":1338042,"name":"AEGERION PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073654","doc":"d846748d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004149","doc":"aegr-20151231x10k.htm","q":null}]},{"cik":1338095,"name":"NEPHROGENEX, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001338095-15-000016","doc":"nrx201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001338095-16-000103","doc":"nrx201510-k.htm","q":null}]},{"cik":1339469,"name":"CHIASMA, INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-508691","doc":"d116551d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-085487","doc":"d304275d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-089176","doc":"d500787d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-069153","doc":"d684858d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-074902","doc":"d841062d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010965","doc":"chma-10k_20201231.htm","q":null}]},{"cik":1339970,"name":"ATYR PHARMA INC","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015652","doc":"life-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004631","doc":"life-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006333","doc":"life-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009381","doc":"life-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013208","doc":"life-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014940","doc":"life-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010441","doc":"life-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007873","doc":"life-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-031584","doc":"life-20231231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-038888","doc":"atyr-20241231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001339970-26-000008","doc":"atyr-20251231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"}]},{"cik":1340476,"name":"DIRTT ENVIRONMENTAL SOLUTIONS LTD","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-048711","doc":"d845228d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008164","doc":"drtt-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006322","doc":"drtt-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003814","doc":"drtt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-018049","doc":"drttf-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0000950170-25-027896","doc":"drttf-20241231.htm","q":"We continue to evaluate artificial intelligence (\u201cAI\u201d) for software development, including catalogue creation."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-072003","doc":"drttf-20251231.htm","q":null}]},{"cik":1340652,"name":"CHEMOCENTRYX, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-090602","doc":"d835597d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-503608","doc":"d115170d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-082093","doc":"d324073d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-079260","doc":"d488701d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-070954","doc":"d682096d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009787","doc":"ccxi-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009883","doc":"ccxi-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002561","doc":"ccxi-20211231.htm","q":null}]},{"cik":1340786,"name":"FUEL SYSTEMS SOLUTIONS, INC.","industry":"Auto manufacturing","sic":3714,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001538","doc":"fsys-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014718","doc":"fsys-10k_20151231.htm","q":null}]},{"cik":1341235,"name":"ALDEYRA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-101703","doc":"d851682d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-523952","doc":"d105518d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-104228","doc":"d318309d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-102077","doc":"d519779d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006997","doc":"aldx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010493","doc":"aldx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012501","doc":"aldx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004111","doc":"aldx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006998","doc":"aldx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-027933","doc":"aldx-20231231.htm","q":"Furthermore, the growing use of generative AI presents an increased risk of unintentional and/or unauthorized disclosure or use of our intellectual property rights."},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-030102","doc":"aldx-20241231.htm","q":"Furthermore, the growing use of generative AI presents an increased risk of unintentional and/or unauthorized disclosure or use of our intellectual property rights."},{"fy":2025,"lvl":2,"n":5,"adsh":"0001193125-26-083012","doc":"aldx-20251231.htm","q":"We may be targeted by parties using fraudulent spoofing and phishing emails or artificial intelligence to misappropriate passwords, payment information, or other personal information, or to introduce viruses through Trojan horse programs or\u2026"}]},{"cik":1341439,"name":"ORACLE CORP","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-235239","doc":"d920711d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-16-628942","doc":"d203801d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-17-214833","doc":"d385998d10k.htm","q":null},{"fy":2018,"lvl":2,"n":8,"adsh":"0001193125-18-201034","doc":"d568983d10k.htm","q":"Our SaaS offerings are designed to incorporate emerging technologies such as Internet-of-Things (IoT), Artificial Intelligence (AI) and Machine Learning (ML), blockchain and advances in the \u0093human interface\u0094 and how users interact with our \u2026"},{"fy":2019,"lvl":2,"n":10,"adsh":"0001564590-19-023119","doc":"orcl-10k_20190531.htm","q":"Our SaaS offerings are also designed to incorporate emerging technologies such as Internet-of-Things (IoT), Artificial Intelligence (AI), Machine Learning (ML), blockchain, and advances in the \u201chuman interface\u201d and how users in teract with \u2026"},{"fy":2020,"lvl":2,"n":8,"adsh":"0001564590-20-030125","doc":"orcl-10k_20200531.htm","q":"For example, the Oracle Autonomous Database is designed to deliver transformational infrastructure through an Oracle Cloud IaaS offering that utilizes Oracle\u2019s Generation 2 Cloud Infrastructure\u2019s machine learning capabilities."},{"fy":2021,"lvl":2,"n":11,"adsh":"0001564590-21-033616","doc":"orcl-10k_20210531.htm","q":"For example, the Oracle Autonomous Database is designed to deliver transformational infrastructure through an Oracle Cloud IaaS offering that utilizes Oracle\u2019s Next-Generation Cloud Infrastructure\u2019s machine learning capabilities."},{"fy":2022,"lvl":2,"n":10,"adsh":"0001564590-22-023675","doc":"orcl-10k_20220531.htm","q":"For example, the Oracle Autonomous Database is designed to deliver transformational infrastructure as an OCI offering that utilizes machine learning capabilities."},{"fy":2023,"lvl":2,"n":14,"adsh":"0000950170-23-028914","doc":"orcl-20230531.htm","q":"For example, the Oracle Autonomous Database is designed to deliver transformational infrastructure as an OCI offering that uses machine learning capabilities to automate many traditionally manual functions."},{"fy":2024,"lvl":3,"n":43,"adsh":"0000950170-24-075605","doc":"orcl-20240531.htm","q":"Using Oracle technologies, our customers build, deploy, run, manage and support their internal and external products, services and business operations, including, for example, an artificial intelligence (AI) product company that uses Oracle\u2026"},{"fy":2025,"lvl":3,"n":66,"adsh":"0000950170-25-087926","doc":"orcl-20250531.htm","q":"Using Oracle technologies, our customers build, deploy, run, manage and support their internal and external products, services and business operations, including, for example, an artificial intelligence (AI) product company that uses OCI to\u2026"}]},{"cik":1341878,"name":"B-SCADA, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000036","doc":"scda_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000706","doc":"scda_10k.htm","q":null}]},{"cik":1342792,"name":"WORLDWIDE STRATEGIES INC","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2021,"lvl":"x","n":3,"adsh":"0001683168-21-005134","doc":"worldwide_10k-073121.htm","q":"The Fitwell Personal Fitness Coach app is an Artificial intelligence (\u201cAI\u201d) powered fit-tech mobile application that optimizes health and fitness through a state of the art mobile app and chatbot."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001683168-22-007155","doc":"wwsg_10k-073122.htm","q":"We plan to enhance and improve the software, by i) adding fitness content, generated internally by fitness professionals which we plan to hire and through collaborations with fitness influencers, who we plan to work with to generate content\u2026"}]},{"cik":1343009,"name":"CNBX PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-16-000925","doc":"cannabics_10k-083116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-17-003260","doc":"cannabics_10k-083117.htm","q":null},{"fy":2018,"lvl":"x","n":2,"adsh":"0001683168-18-003584","doc":"cannabics_10k-083118.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001683168-19-003852","doc":"cannabics_10k-083119.htm","q":null},{"fy":2020,"lvl":"x","n":1,"adsh":"0001683168-20-003686","doc":"cannabics_10k-083120.htm","q":null},{"fy":2021,"lvl":"x","n":4,"adsh":"0001683168-21-006005","doc":"cannabics_10k-083121.htm","q":"Maymon-Pomeranchik is the founder & CEO of AgChimedes Group Ltd., a company focused on the convergence of science, innovation and investment in the field of food security; she also founded BioDiligence, a biotech investment consultancy; Exe\u2026"},{"fy":2022,"lvl":"x","n":4,"adsh":"0001683168-22-008095","doc":"cnbx_i10k-083122.htm","q":"Maymon-Pomeranchik is the founder & CEO of AgChimedes Group Ltd., a company focused on the convergence of science, innovation and investment in the field of food security; she also founded BioDiligence, a biotech investment consultancy; Exe\u2026"},{"fy":2023,"lvl":"x","n":1,"adsh":"0001683168-23-008557","doc":"cnbx_i10k-083123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-24-008433","doc":"cnbx_i10k-83124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-25-008736","doc":"cnbx_i10k-083125.htm","q":null}]},{"cik":1344413,"name":"ALEXZA PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091455","doc":"d852872d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015401","doc":"alxa-10k_20151231.htm","q":null}]},{"cik":1345126,"name":"COMPASS DIVERSIFIED HOLDINGS","industry":"Auto manufacturing","sic":3714,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001345126-15-000005","doc":"codi-12312014x10k.htm","q":null}]},{"cik":1346302,"name":"XERIS PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001346302-19-000009","doc":"a2018form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001346302-20-000007","doc":"a2019form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001346302-21-000026","doc":"xers-20201231.htm","q":null}]},{"cik":1346830,"name":"TVARDI THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-107249","doc":"d841355d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500345","doc":"d110352d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-077107","doc":"d316484d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005879","doc":"cara-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007389","doc":"cara-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001659","doc":"cara-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001839","doc":"cara-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002555","doc":"cara-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002913","doc":"cara-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-002609","doc":"cara-20231231x10k.htm","q":"Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. 38 Table of Contents \u200b We an\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-002705","doc":"cara-20241231x10k.htm","q":"Cara and the third parties upon which Cara relies are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as f\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001104659-26-037729","doc":"tvrd-20251231x10k.htm","q":"For example, the European Union\u2019s General Data Protection Regulation (EU GDPR), the United Kingdom\u2019s GDPR (UK GDPR) (collectively, GDPR), and India\u2019s Information Technology Act and supplementary rules, and India\u2019s new privacy legislation, t\u2026"}]},{"cik":1346973,"name":"PRAXSYN CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001493152-15-001436","doc":"form10-k.htm","q":null}]},{"cik":1347078,"name":"BITZIO, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001446","doc":"form10-k.htm","q":null}]},{"cik":1347178,"name":"VANDA PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"DC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091300","doc":"d824216d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-461076","doc":"d97997d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-047317","doc":"d474152d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-046425","doc":"d503767d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001347178-19-000003","doc":"vnda1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001347178-20-000003","doc":"vnda1231201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001347178-21-000005","doc":"vnda-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003629","doc":"vnda-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-002857","doc":"vnda-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-003785","doc":"vnda-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-005761","doc":"vnda-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-007460","doc":"vnda-20251231.htm","q":"There is also increasing use of data analytics, machine learning and artificial intelligence software, which our competitors may be able to use or implement more effectively than we are able to do."}]},{"cik":1347242,"name":"LIPELLA PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001753926-23-000352","doc":"g083446_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001753926-24-000403","doc":"g084018_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001753926-25-000507","doc":"g084734_10k.htm","q":null}]},{"cik":1347613,"name":"SYNERGY PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-020147","doc":"a15-1897_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-100066","doc":"a15-23224_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001347613-17-000003","doc":"sgyp-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001347613-18-000003","doc":"sgyp-123117x10k.htm","q":null}]},{"cik":1348036,"name":"AVALARA, INC.","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2018,"lvl":1,"n":2,"adsh":"0001564590-19-005454","doc":"avlr-10k_20181231.htm","q":"In February 2019, we acquired intellectual property and other assets of Indix Corporation, an artificial intelligence company providing comprehensive product descriptions for more than one billion products sold and shipped worldwide."},{"fy":2019,"lvl":2,"n":6,"adsh":"0001564590-20-007791","doc":"avlr-10k_20191231.htm","q":"In February 2019, we acquired intellectual property and other assets of Indix Corporation (\u201cIndix\u201d), an artificial intelligence company providing comprehensive product descriptions for more than one billion products sold and shipped worldwi\u2026"},{"fy":2020,"lvl":2,"n":7,"adsh":"0001564590-21-008919","doc":"avlr-10k_20201231.htm","q":"Since 2018, we have acquired beverage alcohol tax, cross-border transaction (e.g., tariffs and duties) solutions, and artificial intelligence technology and expertise."},{"fy":2021,"lvl":2,"n":6,"adsh":"0001564590-22-006696","doc":"avlr-10k_20211231.htm","q":"Since 2018, we have acquired beverage alcohol tax, cross-border transaction (e.g., tariffs and duties) solutions, business licenses, insurance tax compliance solutions, and artificial intelligence technology and expertise."}]},{"cik":1348362,"name":"LEXARIA BIOSCIENCE CORP.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001640334-21-002981","doc":"lxrp_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001640334-22-002512","doc":"lxrp_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001640334-23-002227","doc":"lxrp_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001640334-24-001787","doc":"lxrp_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-25-002225","doc":"lxrp_10k.htm","q":null}]},{"cik":1348649,"name":"COLUCID PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015194","doc":"clcd-10k_20151231.htm","q":null}]},{"cik":1348911,"name":"KALVISTA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015646","doc":"cbyl-10k_20151231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-014286","doc":"kalv-10k_20170430.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-017915","doc":"kalv-10k_20180430.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-025009","doc":"kalv-10k_20190430.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-20-031501","doc":"kalv-10k_20200430.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-036441","doc":"kalv-10k_20210430.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-012521","doc":"kalv-20220430.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-032298","doc":"kalv-20230430.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-082965","doc":"kalv-20240430.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0000950170-25-095011","doc":"kalv-20250430.htm","q":null}]},{"cik":1350102,"name":"ASCENT SOLAR TECHNOLOGIES, INC.","industry":"Computers & chips","sic":3674,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001350102-15-000015","doc":"asti-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001350102-16-000140","doc":"asti-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001350102-17-000041","doc":"asti-20161231x10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001350102-18-000006","doc":"asti-20171231x10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001350102-19-000030","doc":"asti-20181231x10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001564590-21-003381","doc":"asti-10k_20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001564590-21-027744","doc":"asti-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010099","doc":"asti-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007284","doc":"asti-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-017977","doc":"asti-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-047692","doc":"asti-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001193125-26-117839","doc":"asti-20251231.htm","q":null}]},{"cik":1351285,"name":"ROSETTA STONE INC","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001351285-15-000015","doc":"a1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001351285-16-000100","doc":"a1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001351285-17-000023","doc":"a1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001351285-18-000038","doc":"a1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006492","doc":"rst-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010072","doc":"rst-10k_20191231.htm","q":null}]},{"cik":1351288,"name":"GW PHARMACEUTICALS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-030224","doc":"gwph-10k_20180930.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007319","doc":"gwph-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009430","doc":"gwph-10k_20201231.htm","q":null}]},{"cik":1351636,"name":"SOUNDTHINKING, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2017,"lvl":2,"n":6,"adsh":"0001564590-18-006972","doc":"ssti-10k_20171231.htm","q":"When a potential gunfire incident is detected by our sensors, our software uses quantitative computational analysis and artificial intelligence methods to precisely locate and classify the sound."},{"fy":2018,"lvl":3,"n":17,"adsh":"0001564590-19-006063","doc":"ssti-10k_20181231.htm","q":"When a potential gunfire incident is detected by our sensors, our system applies machine learning combined with a human review to analyze and validate the incident and precisely locate where the incident occurred."},{"fy":2019,"lvl":2,"n":13,"adsh":"0001564590-20-010636","doc":"ssti-10k_20191231.htm","q":"This cloud-based patrol management solution uses artificial intelligence-driven analysis to help police departments strategically plan directed patrol missions and tactics for more effective crime deterrence."},{"fy":2020,"lvl":2,"n":10,"adsh":"0001564590-21-016134","doc":"ssti-10k_20201231.htm","q":"Our patrol management software, ShotSpotter Connect (formerly ShotSpotter Missions), uses artificial intelligence-driven analysis to help strategically plan directed patrols and have consistent use of tactics to deter a broad set of crime t\u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0000950170-22-004805","doc":"ssti-20211231.htm","q":"ShotSpotter Connect applies risk modeling and artificial intelligence to help forecast when and where crimes are likely to emerge and recommends directed patrols that can deter these events."},{"fy":2022,"lvl":2,"n":9,"adsh":"0000950170-23-007845","doc":"ssti-20221231.htm","q":"Our patrol management software, ShotSpotter Connect, uses artificial intelligence-driven analysis to help strategically plan directed patrols for maximum impact across a diverse set of crime types."},{"fy":2023,"lvl":3,"n":79,"adsh":"0000950170-24-039479","doc":"ssti-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake\u2026"},{"fy":2024,"lvl":3,"n":82,"adsh":"0000950170-25-047539","doc":"ssti-20241231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake\u2026"},{"fy":2025,"lvl":3,"n":101,"adsh":"0001193125-26-132104","doc":"ssti-20251231.htm","q":"In particular, we have previously and expect to continue to expend substantial financial and other resources on: \u2022 higher costs to procure the sensors required for our solutions due to inflationary pressures or tariffs; \u2022 sales and marketin\u2026"}]},{"cik":1352010,"name":"EPAM SYSTEMS, INC.","industry":"Software & IT services","sic":7371,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001352010-15-000006","doc":"epam-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001352010-16-000030","doc":"epam-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001352010-17-000006","doc":"epam-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001352010-18-000011","doc":"epam-20171231x10k.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001352010-19-000008","doc":"epam-20181231x10k.htm","q":"We are continually expanding our service capabilities, moving beyond traditional services into business consulting, design and physical product development and areas such as artificial intelligence, robotics and virtual reality."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001352010-20-000012","doc":"epam-20191231x10k.htm","q":"We are continually expanding our service capabilities, moving beyond traditional services into business consulting, design and physical product development and areas such as artificial intelligence, robotics and virtual reality."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001352010-21-000010","doc":"epam-20201231.htm","q":"We are continually expanding our service capabilities, moving beyond traditional services into business consulting, design and physical product development and areas such as artificial intelligence, robotics and virtual reality."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001352010-22-000020","doc":"epam-20211231.htm","q":"We are continually expanding our service capabilities, moving beyond traditional services into business consulting, design and physical product development and areas such as artificial intelligence, robotics and virtual reality."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001352010-23-000013","doc":"epam-20221231.htm","q":"We are continually expanding our service capabilities, moving beyond our traditional services into business consulting, design and physical product development and areas such as artificial intelligence, robotics and virtual reality. 1 Table\u2026"},{"fy":2023,"lvl":3,"n":44,"adsh":"0001352010-24-000008","doc":"epam-20231231.htm","q":"Business Overview EPAM has used its software engineering expertise to become a leading global provider of digital engineering, cloud and artificial intelligence-enabled transformation services, as well as a leading business and experience c\u2026"},{"fy":2024,"lvl":3,"n":48,"adsh":"0001352010-25-000007","doc":"epam-20241231.htm","q":"Business Overview EPAM has used its software engineering expertise to become a leading global provider of digital engineering, cloud and artificial intelligence-enabled transformation services, and a leading business and experience consulti\u2026"},{"fy":2025,"lvl":3,"n":70,"adsh":"0001352010-26-000015","doc":"epam-20251231.htm","q":"Business Overview EPAM has used its software engineering expertise to become a leading global provider of digital engineering, cloud and artificial intelligence-enabled transformation services, and a leading business and experience consulti\u2026"}]},{"cik":1353283,"name":"SPLUNK INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001353283-15-000006","doc":"a01311510k.htm","q":null},{"fy":2015,"lvl":1,"n":3,"adsh":"0001353283-16-000033","doc":"a01311610k.htm","q":"Splunk premium solutions are sold separately and include: \u2022 Splunk Enterprise Security - Addresses emerging security threats and security information and event management (\u201cSIEM\u201d) use cases through monitoring, alerts and analytics. \u2022 Splunk\u2026"},{"fy":2016,"lvl":2,"n":8,"adsh":"0001353283-17-000008","doc":"a01311710k.htm","q":"Our technology delivers speed, scalability and advanced analytics including machine learning when processing massive amounts of machine data."},{"fy":2017,"lvl":3,"n":17,"adsh":"0001353283-18-000004","doc":"a01311810k.htm","q":"Our technology delivers speed, scalability and advanced analytics including machine learning when processing massive amounts of machine data for anomaly detection, event grouping, prediction and other methods."},{"fy":2018,"lvl":2,"n":14,"adsh":"0001353283-19-000005","doc":"a01311910k.htm","q":"Our technology delivers speed, scalability and advanced analytics including machine learning when processing massive amounts of machine data for anomaly detection, event grouping, prediction and other methods."},{"fy":2019,"lvl":2,"n":13,"adsh":"0001353283-20-000008","doc":"a01312010k.htm","q":"Our technology delivers speed, scalability and advanced analytics including machine learning when processing massive amounts of data for anomaly detection, event grouping, prediction and other methods."},{"fy":2020,"lvl":3,"n":15,"adsh":"0001353283-21-000009","doc":"splk-20210131.htm","q":"We also believe our offerings empower operational transformation, helping customers move from reactive, non-scalable and ineffective approaches to proactive, automated, and AI-assisted processes that drive better outcomes even as the scale \u2026"},{"fy":2021,"lvl":3,"n":15,"adsh":"0001353283-22-000011","doc":"splk-20220131.htm","q":"We also believe our offerings empower operational transformation, helping customers move from reactive, non-scalable and ineffective approaches to proactive, automated, and AI-assisted processes that drive better outcomes even as the scale \u2026"},{"fy":2022,"lvl":2,"n":10,"adsh":"0001353283-23-000011","doc":"splk-20230131.htm","q":"We also believe our offerings empower operational transformation, helping customers move from reactive, non-scalable and ineffective approaches to proactive, automated, and machine learning (\u201cML\u201d)-assisted processes that drive better outcom\u2026"}]},{"cik":1353538,"name":"APPGATE, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2021,"lvl":2,"n":5,"adsh":"0001628280-22-008075","doc":"apgt-20211231.htm","q":"By contrast, our RBA approach uses real-time behavioral risk assessments, context-based authentication and machine learning, all designed to protect individuals against targeted attacks."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001628280-23-010179","doc":"apgt-20221231.htm","q":"By contrast, our RBA approach uses real-time behavioral risk assessments, context-based authentication and machine learning, all designed to protect individuals against targeted attacks."}]},{"cik":1353633,"name":"UNIFUNDS LTD","industry":"Construction machinery","sic":3531,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001062993-15-001574","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001062993-16-009328","doc":"form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001062993-17-002600","doc":"form10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001062993-18-002327","doc":"form10k.htm","q":null}]},{"cik":1355250,"name":"INNOVATION PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001477932-15-005843","doc":"ctix_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-17-004400","doc":"ipix_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-18-004457","doc":"ipix_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-19-005611","doc":"ipix_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-20-005387","doc":"ipix_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001477932-21-006717","doc":"ipix_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001477932-22-007292","doc":"ipix_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-23-007158","doc":"ipix_10k.htm","q":null}]},{"cik":1355754,"name":"INSTRUCTURE INC","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001381","doc":"inst-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002204","doc":"inst-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003461","doc":"inst-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007826","doc":"inst-10k_20191231.htm","q":null}]},{"cik":1355790,"name":"INTERNATIONAL STEM CELL CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001564590-15-002078","doc":"isco-10k_20141231.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001564590-16-015688","doc":"isco-10k_20151231.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001564590-17-005854","doc":"isco-10k_20161231.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001564590-18-007802","doc":"isco-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-011540","doc":"isco-10k_20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001564590-20-027718","doc":"isco-10k_20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001564590-21-016653","doc":"isco-10k_20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001564590-22-012221","doc":"isco-10k_20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0000950170-23-010977","doc":"isco-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-038092","doc":"isco-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-046745","doc":"isco-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001193125-26-131723","doc":"isco-20251231.htm","q":null}]},{"cik":1355839,"name":"INTELLIGENT PROTECTION MANAGEMENT CORP.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2024,"lvl":3,"n":21,"adsh":"0001013762-25-001600","doc":"ea0233784-10k_intelligent.htm","q":"In the future, we plan to make arrangements with third parties to incorporate artificial intelligence (\u201cAI\u201d) features into our secure private cloud offerings."},{"fy":2025,"lvl":3,"n":32,"adsh":"0001213900-26-029095","doc":"ea0277611-10k_intelligent.htm","q":"We actively engage with third parties to enhance our secure private cloud offerings with artificial intelligence (\u201cAI\u201d) features and benefits."}]},{"cik":1356090,"name":"PRECIGEN, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001356090-15-000004","doc":"xon-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001356090-16-000092","doc":"xon-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001356090-17-000003","doc":"xon-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001356090-18-000002","doc":"xon-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001356090-19-000004","doc":"xon-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002699","doc":"pgen-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001356090-21-000003","doc":"pgen-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001356090-22-000002","doc":"pgen-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001356090-23-000004","doc":"pgen-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001356090-24-000007","doc":"pgen-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001356090-25-000007","doc":"pgen-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":17,"adsh":"0001356090-26-000009","doc":"pgen-20251231.htm","q":"Some these actions include (1) directing agencies to reduce workforce and make program cuts, (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and\u2026"}]},{"cik":1356104,"name":"MELLANOX TECHNOLOGIES, LTD.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001439","doc":"a2223237z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001356104-16-000011","doc":"a2015123110k.htm","q":null},{"fy":2016,"lvl":2,"n":6,"adsh":"0001356104-17-000007","doc":"a2016123110k.htm","q":"Leading companies in HPC, machine learning, storage, Web 2.0, cloud, big data, EDCs and financial services, utilize these technologies to develop distributed applications and services which are able to scale to serve millions of end custome\u2026"},{"fy":2017,"lvl":2,"n":7,"adsh":"0001356104-18-000010","doc":"a2017123110k.htm","q":"Together these products form a total end-to-end networking solution focused on computing, storage and communication applications used in multiple markets, including high-performance computing (\"HPC\"), cloud, Web 2.0, Big Data, machine learn\u2026"},{"fy":2018,"lvl":2,"n":10,"adsh":"0001356104-19-000009","doc":"0001356104-19-000009.txt","q":"Together these products form a total end-to-end integrated networking solution focused on computing, storage and communication applications used in multiple markets, including cloud, Web 2.0, High Performance Computing (\"HPC\"), Big Data, ma\u2026"},{"fy":2019,"lvl":2,"n":10,"adsh":"0001356104-20-000008","doc":"a2019123110-k.htm","q":"Together these products form a total end-to-end integrated networking solution focused on computing, storage and communication applications used in multiple markets, including cloud, Web 2.0, High Performance Computing (\"HPC\"), Big Data, ma\u2026"}]},{"cik":1356564,"name":"LEO MOTORS, INC.","industry":"Auto manufacturing","sic":3711,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001445866-15-000365","doc":"leo10k12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001445866-16-001832","doc":"form10k12312015.htm","q":null},{"fy":2016,"lvl":"x","n":24,"adsh":"0001445866-17-000475","doc":"leom-20161231.htm","q":"With the acquisition, the Company was engaged in connected car and artificial intelligence (AI) related businesses for smart city."}]},{"cik":1356576,"name":"SUPERNUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002068","doc":"a2223510z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010884","doc":"a2227616z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001684","doc":"a2231272z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001210","doc":"a2234132z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000828","doc":"a2237838z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001356576-20-000010","doc":"supn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001356576-21-000028","doc":"supn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001356576-22-000025","doc":"supn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001356576-23-000016","doc":"supn-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001356576-24-000013","doc":"supn-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0001356576-25-000017","doc":"supn-20241231.htm","q":"There was enormous growth and visibility for artificial intelligence (AI) systems and tools in 2023, leading to increased calls for regulation and oversight."},{"fy":2025,"lvl":2,"n":8,"adsh":"0001356576-26-000011","doc":"supn-20251231.htm","q":"On October 30, 2023, the Biden Administration issued an Executive Order on the Safe, Secure, and Trustworthy Development and Use of AI, which addressed the use of AI in health care and the safety and integrity of data stored and generated b\u2026"}]},{"cik":1357459,"name":"PALISADE BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016085","doc":"v400409_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087765","doc":"v432641_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001704","doc":"f10k_031617p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001171843-18-002404","doc":"f10k_031518p.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001171843-19-001917","doc":"f10k_032919p.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001171843-20-002061","doc":"f10k_032720p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-001965","doc":"f10k_031521p.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0000950170-22-004093","doc":"pali-20211231.htm","q":"Alto Neuroscience is a U.S. based private biopharmaceutical company focused on precision-medicine for central nervous system disorders, including depression, using artificial intelligence-based brain biomarkers."},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-009226","doc":"pali-20221231.htm","q":"Alto Neuroscience is a U.S. based private biopharmaceutical company focused on precision-medicine for central nervous system disorders, including depression, using artificial intelligence-based brain biomarkers."},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036402","doc":"pali-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-043859","doc":"pali-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001357459-26-000004","doc":"pali-20251231.htm","q":null}]},{"cik":1357615,"name":"KBR, INC.","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001357615-15-000027","doc":"kbr1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001357615-16-000245","doc":"kbr1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001357615-17-000035","doc":"kbr1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001357615-18-000033","doc":"kbr1231201710-k.htm","q":null},{"fy":2018,"lvl":1,"n":4,"adsh":"0001357615-19-000030","doc":"kbr1231201810-k.htm","q":"We are also implementing machine learning and artificial intelligence to enhance our digital solutions of the GS sector by predicting and diagnosing issues before equipment, device or facility is failed or completely utilized. \u25e6 Hydrocarbon\u2026"},{"fy":2019,"lvl":1,"n":3,"adsh":"0001357615-20-000034","doc":"kbr1231201910-k.htm","q":"The budget includes a number of measures to strengthen emerging technologies including cyber-science and technologies, artificial intelligence, hypersonic capabilities, and emerging biotechnologies."},{"fy":2020,"lvl":2,"n":8,"adsh":"0001357615-21-000040","doc":"kbr-20201231.htm","q":"We provide the following capabilities and offerings to a diverse customer base, including domestic and foreign governments, and domestic and international integrated energy and industrial companies: \u2022 Scientific research such as quantum sci\u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0001357615-22-000012","doc":"kbr-20211231.htm","q":"Our capabilities and offerings include the following: \u2022 Scientific research such as quantum science and computing; health and human performance; materials science; life science research; and earth sciences; \u2022 Defense systems engineering suc\u2026"},{"fy":2022,"lvl":2,"n":10,"adsh":"0001357615-23-000030","doc":"kbr-20221231.htm","q":"Our capabilities and offerings include the following: \u2022 Scientific research such as quantum science and computing; health and human performance; materials science; life science research; and earth sciences; \u2022 Defense systems engineering suc\u2026"},{"fy":2023,"lvl":3,"n":18,"adsh":"0001357615-24-000016","doc":"kbr-20231229.htm","q":"Our capabilities and offerings include the following: \u2022 Scientific research such as quantum science and computing; health and human performance; materials science; life science research; and earth sciences; \u2022 Defense systems engineering suc\u2026"},{"fy":2024,"lvl":3,"n":37,"adsh":"0001357615-25-000018","doc":"kbr-20250103.htm","q":"Included in Government Solutions is the LinQuest Corporation (\"LinQuest\"), an engineering, data analytics and digital integration company acquired in fiscal 2024 that develops and integrates advanced technology solutions to meet the most ch\u2026"},{"fy":2025,"lvl":3,"n":33,"adsh":"0001357615-26-000051","doc":"kbr-20260102.htm","q":"Technical Professionals For our Technical Talent, our One KBR Tech Fellows program provides funding and opportunities for these world-leading scientists and technical professionals to conduct advanced research into topics ranging from carbo\u2026"}]},{"cik":1357874,"name":"PRECISION BIOSCIENCES INC","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-009541","doc":"dtil-10k_20191231.htm","q":"Our informatics platform is built on principles of machine learning that allow us to synthesize, sequence and phenotype information from both public and internal datasets to correlate genome sequence with plant characteristics."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-014005","doc":"dtil-10k_20201231.htm","q":"Our informatics platform is built on principles of machine learning that allow us to synthesize, sequence and phenotype information from both public and internal datasets to correlate genome sequence with plant characteristics."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010222","doc":"dtil-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006838","doc":"dtil-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036817","doc":"dtil-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-044775","doc":"dtil-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-017019","doc":"dtil-20251231.htm","q":"Furthermore, any integration of artificial intelligence in our or any third party\u2019s operations, products or services is expected to pose new or unknown cybersecurity risks and challenges."}]},{"cik":1357878,"name":"REGENEREX PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001472375-22-000055","doc":"ixform10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001472375-23-000090","doc":"ixform10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001472375-24-000045","doc":"ixform10k.htm","q":null},{"fy":2024,"lvl":"x","n":2,"adsh":"0001472375-25-000070","doc":"ixform10k.htm","q":"Perhaps most exciting is our development of a proprietary AI-driven information system that promises to revolutionize our approach to wound management, patient adherence tracking, and personalized medication protocols."}]},{"cik":1357971,"name":"ENERGY SERVICES OF AMERICA CORP","industry":"Construction","sic":1623,"state":"WV","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-15-010029","doc":"t83822_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-16-020673","doc":"t1600793_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-063923","doc":"tv481131_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-066521","doc":"tv509747_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-19-074753","doc":"tm1919819d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-000500","doc":"tm2038975d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-21-000612","doc":"esoa-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-22-003581","doc":"esoa-20220930x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000014","doc":"esoa-20230930x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-24-002104","doc":"esoa-20240930x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-25-121185","doc":"esoa-20250930x10k.htm","q":null}]},{"cik":1358099,"name":"OCEAN ELECTRIC INC.","industry":"Utilities","sic":4911,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001515971-15-000094","doc":"ocel10k123114.htm","q":null}]},{"cik":1358403,"name":"BELLICUM PHARMACEUTICALS, INC","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001358403-16-000158","doc":"a2015q410k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001358403-17-000050","doc":"a2016q410k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001358403-18-000037","doc":"a2017q410k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001358403-19-000038","doc":"a2018q410k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001358403-20-000007","doc":"a201910k1.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-006164","doc":"blcm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-007196","doc":"blcm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-010145","doc":"blcm-20221231.htm","q":null}]},{"cik":1358651,"name":"NEIMAN MARCUS GROUP LTD LLC","industry":"Retail","sic":5311,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001358651-15-000014","doc":"a2015080110-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001358651-17-000010","doc":"a2017072910-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001358651-18-000013","doc":"a2018072810-k.htm","q":null}]},{"cik":1358762,"name":"REATA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003245","doc":"reta-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004193","doc":"reta-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005161","doc":"reta-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005272","doc":"reta-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009624","doc":"reta-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007338","doc":"reta-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004236","doc":"reta-20221231.htm","q":null}]},{"cik":1359931,"name":"PROTARA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001528","doc":"f10k_031815.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001171843-16-008541","doc":"f10k_031416p.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001555","doc":"f10k_031417p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001171843-18-001934","doc":"f10k_031318p.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001171843-19-001687","doc":"f10k_031219p.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001171843-20-001860","doc":"f10k_031820p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-014709","doc":"f10k2020_protaratherapeutics.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-011208","doc":"f10k2021_protarathera.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-018373","doc":"f10k2022_protarathera.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001213900-24-021982","doc":"f10k2023_protarathera.htm","q":"These threats are becoming increasingly difficult to detect especially as more advanced artificial intelligence and machine learning become available and increasingly used."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001213900-25-020368","doc":"ea0231646-10k_protara.htm","q":"These threats are becoming increasingly difficult to detect especially as more advanced artificial intelligence and machine learning become available and increasingly used."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001213900-26-025433","doc":"ea0277639-10k_protara.htm","q":"These threats are becoming increasingly difficult to detect especially as more advanced artificial intelligence and machine learning become available and increasingly used."}]},{"cik":1360214,"name":"HARROW, INC.","industry":"Pharma & biotech","sic":2834,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001493152-15-000811","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-16-008212","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-002687","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003095","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003188","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003862","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-005583","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006525","doc":"form-10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-008718","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-24-010518","doc":"form10-k.htm","q":"As the cyber-threat landscape evolves, these attacks are growing in frequency, sophistication, and intensity, and are becoming increasingly difficult to detect and increasingly sophisticated in using techniques and tools\u2014including artificia\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001641172-25-000925","doc":"form10-k.htm","q":"As the cyber-threat landscape evolves, these attacks are growing in frequency, sophistication, and intensity, and are becoming increasingly difficult to detect and increasingly sophisticated in using techniques and tools\u2014including artificia\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001493152-26-008562","doc":"form10-k.htm","q":"As the cyber-threat landscape evolves, these attacks are growing in frequency, sophistication, and intensity, and are becoming increasingly difficult to detect and increasingly sophisticated in using techniques and tools\u2014including artificia\u2026"}]},{"cik":1360565,"name":"WHERE FOOD COMES FROM, INC.","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001387131-15-000597","doc":"wfcf-10k_123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001387131-16-004244","doc":"wfcf-10k_123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001387131-17-001106","doc":"wfcf-10k_123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387131-18-001346","doc":"wfcf-10k_123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001387131-19-002315","doc":"wfcf-10k_123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001387131-20-002583","doc":"wfcf-10k_123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-004235","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-005648","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-005851","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-006846","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001493152-25-007682","doc":"form10-k.htm","q":"Major trends in the forecast period include focusing on improving labelling and packaging, exploring opportunities to invest in new product launches, leveraging artificial intelligence (ai) for organic farming, developing zero-calorie soft \u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001493152-26-008155","doc":"form10-k.htm","q":"Major trends in the forecast period include focusing on improving labelling and packaging, exploring opportunities to invest in new product launches, leveraging artificial intelligence (ai) for organic farming, developing zero-calorie soft \u2026"}]},{"cik":1360886,"name":"OSIRIS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002532","doc":"a2223659z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-002273","doc":"a2234906z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002094","doc":"osir-20181231x10k.htm","q":null}]},{"cik":1361113,"name":"VARONIS SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001193125-15-054287","doc":"d846864d10k.htm","q":"Our technological advantage stems from us having developed a way to do each of the following: \u0095 determine which metadata to capture; \u0095 capture that metadata without imposing any strains or latencies on the enterprise\u0092s computing infrastruct\u2026"},{"fy":2015,"lvl":1,"n":1,"adsh":"0001171843-16-007861","doc":"f10k_021216.htm","q":"Our technological advantage stems from us having developed a way to do each of the following: \u2022 determine which metadata to capture; \u2022 capture that metadata without imposing any strains or latencies on the enterprise\u2019s computing infrastruct\u2026"},{"fy":2016,"lvl":1,"n":2,"adsh":"0001171843-17-000799","doc":"f10k_020917p.htm","q":"Our technological advantage stems from us having developed a way to do each of the following: \u2022 determine which metadata to capture; \u2022 capture that metadata without imposing any strains or latencies on the enterprise\u2019s computing infrastruct\u2026"},{"fy":2017,"lvl":1,"n":2,"adsh":"0001171843-18-001113","doc":"f10k_021318p.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001628280-19-001223","doc":"vrns-12312018x10k.htm","q":null},{"fy":2019,"lvl":1,"n":3,"adsh":"0001628280-20-001362","doc":"vrns-12312019x10k.htm","q":"DatAdvantage identifies where users have unnecessary access based on user behavior and machine learning. \u2022 The Automation Engine, a module introduced in 2017, helps customers accelerate the enforcement of least privilege by limiting broad a\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001628280-21-001677","doc":"vrns-20201231.htm","q":"DatAdvantage identifies where users have unnecessary access based on user behavior and machine learning."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001628280-22-002017","doc":"vrns-20211231.htm","q":"DatAdvantage identifies where users have unnecessary access based on user behavior and machine learning."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-23-002580","doc":"vrns-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":33,"adsh":"0001628280-24-003498","doc":"vrns-20231231.htm","q":"We believe the adoption of generative artificial intelligence (\u201cGen AI\u201d) tools in the enterprise will dramatically compound data growth and introduce new data security challenges that can only be addressed with automation."},{"fy":2024,"lvl":3,"n":40,"adsh":"0001628280-25-004187","doc":"vrns-20241231.htm","q":"Data continues to grow in new and existing data stores both in the cloud and on-premises, a trend we have seen accelerate as companies worldwide undergo waves of digital transformation and artificial intelligence (\"AI\") initiatives that hav\u2026"},{"fy":2025,"lvl":3,"n":57,"adsh":"0001628280-26-005450","doc":"vrns-20251231.htm","q":"Cloud transformation and artificial intelligence (\"AI\") initiatives are pushing data into more systems, across more environments and making it accessible to more users, applications and AI agents."}]},{"cik":1361248,"name":"TETRALOGIC PHARMACEUTICALS CORP","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000186","doc":"tlog-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004186","doc":"tlog-20151231x10k.htm","q":null}]},{"cik":1361538,"name":"PRIMORIS SERVICES CORP","industry":"Construction","sic":1623,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-020037","doc":"a14-26190_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-100990","doc":"a16-2603_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001117","doc":"prim-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001107","doc":"prim-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001230","doc":"prim-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001249","doc":"prim-20191231x10ke43d96.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001389","doc":"prim-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002400","doc":"prim-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002191","doc":"prim-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001719","doc":"prim-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-001397","doc":"prim-20241231x10k.htm","q":"Many factors, including the financial condition of and potential disruptions related to artificial intelligence in the industries we serve, could adversely affect our customers and their willingness to fund capital expenditures in the futur\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001104659-26-018677","doc":"prim-20251231x10k.htm","q":"Many factors, including the financial condition of and potential disruptions related to artificial intelligence (\u201cAI\u201d) in the industries we serve, could adversely affect our customers and their willingness to fund capital expenditures in th\u2026"}]},{"cik":1362190,"name":"AUDIOEYE INC","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001104659-15-050689","doc":"a15-1781_110k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-091312","doc":"v434574_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-017567","doc":"v462148_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-018523","doc":"tv488829_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-016348","doc":"tv516009_10k.htm","q":null},{"fy":2019,"lvl":3,"n":16,"adsh":"0001104659-20-040172","doc":"tm205327d1_10k.htm","q":"AudioEye stands out among its competitors because it delivers machine-learning/artificial intelligence (\u201cAI\u201d)-driven accessibility without fundamental changes to the website architecture."},{"fy":2020,"lvl":2,"n":11,"adsh":"0001104659-21-035092","doc":"tm211111d1_10k.htm","q":"Our solutions are backed by AudioEye\u2019s machine-learning/AI-driven technology that finds and fixes common accessibility errors."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001410578-22-000353","doc":"aeye-20211231x10k.htm","q":"Our solutions are backed by machine-learning/AI-driven technology that finds and fixes common accessibility errors."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001410578-23-000236","doc":"aeye-20221231x10k.htm","q":"Our solutions are backed by machine-learning/AI-driven technology that finds and fixes common accessibility errors."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001410578-24-000150","doc":"aeye-20231231x10k.htm","q":"Our solutions are backed by machine-learning/AI-driven technology that finds and fixes common accessibility errors."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001558370-25-002819","doc":"aeye-20241231x10k.htm","q":"Our solutions are backed by machine-learning/AI-driven technology that finds and fixes common accessibility errors."},{"fy":2025,"lvl":3,"n":15,"adsh":"0001104659-26-027159","doc":"aeye-20251231x10k.htm","q":"Our solutions are backed by machine-learning/AI-driven technology that finds and fixes common accessibility errors."}]},{"cik":1362703,"name":"THERALINK TECHNOLOGIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"LA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-004010","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-008075","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004539","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004730","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-21-023839","doc":"form10-k.htm","q":"The key ingredients to our commercial success will be: 1) A proprietary technology that provides a credible point of entry to a well-defined medical market; 2) A previous potential pipeline of commercial partners that believe in the viabili\u2026"},{"fy":2021,"lvl":"x","n":2,"adsh":"0001493152-22-001167","doc":"form10-k.htm","q":"Theralink, our flagship product for our commercial strategy, will focus on precision health screening for oncologists. 8 The key ingredients to our commercial success will be: 1) A proprietary technology that provides a credible point of en\u2026"},{"fy":2022,"lvl":"x","n":2,"adsh":"0001493152-22-036824","doc":"form10-k.htm","q":"The key ingredients to our commercial success will be: \u25cf A proprietary technology that provides a credible point of entry to a well-defined medical market; \u25cf Comprehensive protocols for cancer biomarkers positioned for seamless integration \u2026"},{"fy":2023,"lvl":"x","n":3,"adsh":"0001493152-24-001515","doc":"form10-k.htm","q":"These milestones include: \u25cf Hiring additional lab techs and strategic sales consultants and deploying the expanded workforce to drive growth, revenue and meaningful patient results; \u25cf Completion of outcomes studies with key NCCN (National C\u2026"}]},{"cik":1364962,"name":"IMPERVA INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073203","doc":"d840649d10k.htm","q":null},{"fy":2015,"lvl":1,"n":3,"adsh":"0001564590-16-013548","doc":"impv-10k_20151231.htm","q":"CounterBreach CounterBreach : designed to protect enterprise data from theft and loss due to compromised, malicious and careless users CounterBreach uses machine learning to analyze how users access data in order to spotlight dangerous data\u2026"},{"fy":2016,"lvl":2,"n":5,"adsh":"0001564590-17-002479","doc":"impv-10k_20161231.htm","q":"Our Imperva CounterBreach product line uses machine learning to analyze how users access data and to spotlight data breach activity."},{"fy":2017,"lvl":2,"n":5,"adsh":"0001564590-18-003043","doc":"impv-10k_20171231.htm","q":"Our Imperva CounterBreach product line uses machine learning to analyze how users access data and to spotlight data breach activity."}]},{"cik":1365216,"name":"SUCAMPO PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001318","doc":"f10k_030515.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001171843-16-008505","doc":"exh_1038.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001354","doc":"f10k_030817p.htm","q":null}]},{"cik":1366246,"name":"GLU MOBILE INC","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000352","doc":"glu-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003851","doc":"gluu-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001621","doc":"gluu-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001808","doc":"gluu-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001331","doc":"gluu-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001804","doc":"gluu-20191231x10kf63199.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002009","doc":"gluu-20201231x10k.htm","q":null}]},{"cik":1366527,"name":"CARBON BLACK, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2018,"lvl":2,"n":5,"adsh":"0001558370-19-001718","doc":"cblk-20181231x10k.htm","q":"Our solutions apply a full 8 Table of Contents spectrum of technologies including application whitelisting and advanced analytics techniques\u2014such as behavioral analysis, reputation analysis, artificial intelligence and machine learning\u2014to a\u2026"}]},{"cik":1366541,"name":"Q THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-114403","doc":"d900336d10k.htm","q":null}]},{"cik":1366561,"name":"SMARTSHEET INC","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2018,"lvl":"x","n":6,"adsh":"0001366561-19-000014","doc":"fy2019smar10-k.htm","q":"We employ an efficient inside sales team that utilizes machine learning and lead 5 Table of Contents scoring to respond to and convert other interested users within new and existing organizations."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001366561-20-000019","doc":"fy2020smar10-k.htm","q":"We employ an efficient inside sales team that utilizes machine learning and lead scoring to respond to and convert other interested users within new and existing organizations."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001366561-21-000036","doc":"smar-20210131.htm","q":"We employ an efficient inside sales team that utilizes machine learning and lead scoring to respond to and convert other interested users within new and existing organizations."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001366561-22-000045","doc":"exhibit1017.htm","q":null},{"fy":2022,"lvl":1,"n":4,"adsh":"0001366561-23-000030","doc":"smar-20230131.htm","q":"We employ an efficient inside sales team that utilizes machine learning and lead scoring to respond to and convert other interested users within new and existing organizations."},{"fy":2023,"lvl":3,"n":30,"adsh":"0001366561-24-000062","doc":"smar-20240131.htm","q":"We employ an efficient inside sales team that utilizes machine learning and lead scoring to respond to and convert other interested users within new and existing organizations."}]},{"cik":1367083,"name":"SONOMA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001683168-17-001670","doc":"sonoma_10k-033117.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-18-001786","doc":"sonoma_10k-033118.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-002069","doc":"sonoma_10k-033119.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001683168-20-002234","doc":"sonoma_10k-033120.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-002977","doc":"sonoma_10k-033121.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-004940","doc":"sonoma_i10k-033122.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-004323","doc":"sonoma_i10k-033123.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-24-004275","doc":"sonoma_i10k-033124.htm","q":null}]},{"cik":1367644,"name":"EMERGENT BIOSOLUTIONS INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001367644-16-000059","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001367644-17-000014","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001367644-18-000014","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001367644-19-000016","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001367644-20-000010","doc":"ebs-2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001367644-21-000033","doc":"ebs-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001367644-22-000024","doc":"ebs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001367644-23-000046","doc":"ebs-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001367644-24-000033","doc":"ebs-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001367644-25-000021","doc":"ebs-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0001367644-26-000015","doc":"ebs-20251231.htm","q":"As states continue to introduce and expand comprehensive privacy frameworks, several have also begun addressing emerging issues associated with automated decision\u2011making and AI\u2011enabled processing."}]},{"cik":1367920,"name":"CONCERT PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073586","doc":"d832927d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001367920-16-000014","doc":"cnce201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001367920-17-000009","doc":"cnce201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001367920-18-000012","doc":"cnce201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001367920-19-000009","doc":"cnce201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001367920-20-000013","doc":"cnce201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001367920-21-000013","doc":"cnce-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001367920-22-000018","doc":"cnce-20211231.htm","q":null}]},{"cik":1368148,"name":"ATHERSYS, INC / NEW","industry":"Pharma & biotech","sic":2834,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-089411","doc":"d841893d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500404","doc":"d128866d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-078969","doc":"d328702d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084081","doc":"d542167d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002976","doc":"athx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001368148-20-000020","doc":"athx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001368148-21-000037","doc":"athx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001368148-22-000020","doc":"athx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001368148-23-000025","doc":"athx-20221231.htm","q":null}]},{"cik":1368514,"name":"ADMA BIOLOGICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193805-15-000352","doc":"e613392_10k-adma.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193805-16-002889","doc":"e614766_10k-adma.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193805-17-000330","doc":"e615811_10k-adma.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193805-18-000470","doc":"e617768_10k-adma.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193805-19-000281","doc":"e618283_10k-adma.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193805-20-000348","doc":"e619435_10k-adma.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193805-21-000411","doc":"adma_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-011030","doc":"brhc10035480_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-013467","doc":"brhc10049985_10k.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001140361-24-010147","doc":"ef20015264_10k.htm","q":"We began to realize these benefits in the fourth quarter of 2023. 8 Table of Contents \u2022 Broadly Implement Innovative AI Program, ADMAlytics, to improve efficiencies across our supply chain and production operations."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001140361-25-009257","doc":"ef20038923_10k.htm","q":"This expansion has improved the product\u2019s margin profile and increased plant production capacity as fewer batches are needed to support revenue goals. 8 Table of Contents \u2022 Broadly Implement Innovative AI Program, ADMAlytics, to improve eff\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001140361-26-006815","doc":"ef20059416_10-k.htm","q":"Our procurement of RSV plasma primarily from third parties reflects a deliberate shift toward a more flexible, capital-efficient supply model which is expected to deliver accretive cost savings beginning in fiscal year 2026, improve capital\u2026"}]},{"cik":1368622,"name":"AEROVIRONMENT INC","industry":"Aerospace & defense","sic":3721,"state":"VA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-005880","doc":"a2225241z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-16-006514","doc":"avav-20160430x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-17-004963","doc":"avav-20170430x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-18-005457","doc":"avav-20180430x10k.htm","q":null},{"fy":2019,"lvl":1,"n":3,"adsh":"0001558370-19-005898","doc":"avav-20190430x10k.htm","q":"Our core technological capabilities, developed through more than 45 years of innovation, include robotics; sensor design, development, miniaturization and integration; embedded software and firmware; miniature, low power wireless digital co\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001558370-20-007720","doc":"avav-20200623x10k.htm","q":"The following list highlights a number of our key technological capabilities: \u200b \u25cf robotics and robotics systems autonomy technologies; \u200b \u25cf sensor design, development, miniaturization and integration; \u200b \u25cf embedded software and firmware, anal\u2026"},{"fy":2021,"lvl":"x","n":15,"adsh":"0001558370-21-008684","doc":"avav-20210430x10k.htm","q":"UAS that are capable of operating in an affordable manner for extended periods of time over an area of interest without gaps in availability while carrying a communications or observation payload could help to satisfy this need. \u200b Advanced \u2026"},{"fy":2022,"lvl":2,"n":10,"adsh":"0001558370-22-010392","doc":"avav-20220430x10k.htm","q":"UAS that are capable of operating in an affordable manner for extended periods of time over an area of interest while communicating directly with available handheld mobile devices without gaps in availability and carrying a communications o\u2026"},{"fy":2023,"lvl":2,"n":12,"adsh":"0001558370-23-011469","doc":"avav-20230430x10k.htm","q":"Further, these HAPS platforms can carry a wide array of communications and sensing payloads that can be readily installed, upgraded and swapped based on evolving customer and mission needs. \u200b Advanced Artificial Intelligence and Autonomy \u200b \u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0001558370-24-009515","doc":"avav-20240430x10k.htm","q":"Further, these HAPS platforms can carry a wide array of communications and sensing payloads that can be readily installed, upgraded and swapped based on evolving customer and mission needs. \u200b Advanced Artificial Intelligence and Autonomy \u200b \u2026"},{"fy":2025,"lvl":3,"n":48,"adsh":"0001558370-25-008838","doc":"avav-20250430x10k.htm","q":"This autonomous system, powered by artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d), defeats Group 1 and 2 drones, providing non-specialist operators with comprehensive situational awareness and defensive capabilities against UAS \u2026"}]},{"cik":1369203,"name":"HK BATTERY TECHNOLOGY INC","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001078782-16-002638","doc":"f10k123115_10k.htm","q":null}]},{"cik":1369568,"name":"CATALYST PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091323","doc":"d838315d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505167","doc":"d133632d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-083667","doc":"d298820d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-082292","doc":"d503533d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-078253","doc":"d668736d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-075048","doc":"d838851d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-081545","doc":"d29693d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-077228","doc":"d159262d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-071299","doc":"d421867d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001193125-24-050908","doc":"d723690d10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-027714","doc":"cprx-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-071525","doc":"cprx-20251231.htm","q":null}]},{"cik":1369786,"name":"SAGENT PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093810","doc":"d855921d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-495377","doc":"d121715d10k.htm","q":null}]},{"cik":1369868,"name":"CHINA BIOLOGIC PRODUCTS, INC.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-013977","doc":"v400524_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-084312","doc":"v430212_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-010658","doc":"v459520_10k.htm","q":null}]},{"cik":1370053,"name":"ANAPTYSBIO, INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001370053-18-000014","doc":"anab-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001370053-19-000006","doc":"anab-12311810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001370053-20-000009","doc":"anab-12311910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001370053-21-000019","doc":"anab-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001370053-22-000009","doc":"anab-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001370053-23-000020","doc":"anab-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001370053-24-000011","doc":"anab-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001370053-25-000024","doc":"anab-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-088290","doc":"anab-20251231.htm","q":null}]},{"cik":1370450,"name":"WILLDAN GROUP, INC.","industry":"Construction","sic":8711,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-003021","doc":"a2223957z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004177","doc":"wldn-20160101x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001619","doc":"wldn-20161230x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001811","doc":"wldn-20171229x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001690","doc":"wldn-20181228x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002100","doc":"wldn-20191227x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003104","doc":"wldn-20210101x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003337","doc":"wldn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003367","doc":"wldn-20221230x10k.htm","q":"The customized peer group consists of American Superconductor Corporation, Atlas Technical Consultants, Inc., Bowman Consulting Group Ltd., C3.ai, Inc., Charah Solutions, Inc., Exponent, Inc., FTC Solar, Inc., ICF International, Inc., Limba\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002758","doc":"wldn-20231229x10k.htm","q":"The customized peer group consists of American Superconductor Corporation, Atlas Technical Consultants, Inc., Bowman Consulting Group Ltd., C3.ai, Inc., Charah Solutions, Inc., Exponent, Inc., FTC Solar, Inc., ICF International, Inc., Limba\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0001558370-25-002429","doc":"wldn-20241227x10k.htm","q":"In addition, the rapid growth in artificial intelligence is creating increased power demand from data centers and thus becoming a new catalyst in expanding the energy services market."},{"fy":2025,"lvl":2,"n":8,"adsh":"0001104659-26-020767","doc":"wldn-20260102x10k.htm","q":"We believe that we are well positioned to capitalize on the ongoing expansion and transformation of the energy and infrastructure environments as they adapt to climate change and other environmental challenges, electrification, and technolo\u2026"}]},{"cik":1370702,"name":"QUANTENNA COMMUNICATIONS INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001370702-18-000004","doc":"quantenna-12312017x10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001370702-19-000006","doc":"0001370702-19-000006.txt","q":null}]},{"cik":1371534,"name":"GOLD DYNAMICS CORP.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001372167-15-000160","doc":"gold10kjul2015.htm","q":null}]},{"cik":1372020,"name":"GREAT LAKES DREDGE & DOCK CORP","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-081253","doc":"d817806d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013760","doc":"gldd-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002889","doc":"gldd-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003940","doc":"gldd-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004521","doc":"gldd-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006778","doc":"gldd-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008165","doc":"gldd-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006231","doc":"gldd-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003211","doc":"gldd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-016412","doc":"gldd-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-024407","doc":"gldd-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-064007","doc":"gldd-20251231.htm","q":"They are also subject to evolving cybersecurity threats, including malware, ransomware, phishing, spoofing, unauthorized access attempts, supply chain compromises, data corruption, data exfiltration, denial-of-service attacks, zero-day vuln\u2026"}]},{"cik":1372167,"name":"PAN OCEAN CONTAINER SUPPLIES, LTD.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001372167-15-000104","doc":"nevaeh10kapril302015.htm","q":null}]},{"cik":1372299,"name":"OCUGEN, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-004221","doc":"ocgn-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-005124","doc":"ocgn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004085","doc":"ocgn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005382","doc":"0001628280-23-005382.txt","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-016378","doc":"ocgn-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":26,"adsh":"0001628280-25-010271","doc":"ocgn-20241231.htm","q":"Moreover, as a result of the broad scale release and availability of Artificial Intelligence (AI) technologies such as generative AI, there is a global trend towards more regulation (e.g., the EU AI Act and AI laws passed in states of the U\u2026"},{"fy":2025,"lvl":3,"n":39,"adsh":"0001628280-26-014435","doc":"ocgn-20251231.htm","q":"Moreover, as a result of the broad scale release and availability of Artificial Intelligence (AI) technologies such as generative AI, there is a global trend towards more regulation (e.g., the EU AI Act and AI laws passed in states of the U\u2026"}]},{"cik":1372514,"name":"KIORA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-091485","doc":"v434534_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-010635","doc":"v459809_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-012542","doc":"tv486567_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-011634","doc":"tv514566_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-029162","doc":"tm205287d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-041515","doc":"tm211090d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000925","doc":"kprx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001372514-23-000050","doc":"kprx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001372514-24-000026","doc":"kprx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001372514-25-000012","doc":"kprx-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001372514-26-000024","doc":"kprx-20251231.htm","q":null}]},{"cik":1372612,"name":"BOX INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001564590-16-015649","doc":"box-10k_20160131.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005227","doc":"box-10k_20170131.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006572","doc":"box-10k_20180131.htm","q":null},{"fy":2018,"lvl":1,"n":4,"adsh":"0001564590-19-008669","doc":"box-10k_20190131.htm","q":"This allows customers to accelerate the flow of information through their organizations and increase the efficiency of their business processes. \u2022 Box Skills Kit for applying artificial intelligence to content in Box ."},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-011799","doc":"box-10k_20200131.htm","q":"It also detects potential insider threats and compromised accounts through alerts powered by Box's machine learning capabilities. \u2022 Administrative Controls."},{"fy":2020,"lvl":1,"n":4,"adsh":"0001564590-21-014377","doc":"box-10k_20210131.htm","q":"Box Shield uses machine learning to provide granular, real-time prevention and detection capabilities."},{"fy":2021,"lvl":1,"n":4,"adsh":"0000950170-22-003913","doc":"box-20220131.htm","q":"Box Shield uses machine learning to provide granular, real-time threat detection and prevention capabilities."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-007573","doc":"box-20230131.htm","q":"Box Shield also uses advanced machine learning to scan files for sophisticated malware (including ransomware) and identify suspicious user behavior to help organizations detect and prevent threats before they become data breaches."},{"fy":2023,"lvl":3,"n":69,"adsh":"0000950170-24-029241","doc":"box-20240131.htm","q":"Four core capabilities differentiate Box from competitors: advanced data protection and compliance, modern workflow and collaboration experiences, a flexible and interoperable platform, and integration with advanced artificial intelligence \u2026"},{"fy":2024,"lvl":3,"n":101,"adsh":"0000950170-25-036261","doc":"box-20250131.htm","q":"Four core capabilities differentiate Box from competitors: advanced data protection and compliance, modern workflow and collaboration experiences, a flexible and interoperable platform, and integration with advanced artificial intelligence \u2026"}]},{"cik":1373670,"name":"GREEN BRICK PARTNERS, INC.","industry":"Construction","sic":1531,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001373670-15-000015","doc":"a1231201410-kgrbk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001373670-16-000053","doc":"a1231201510-kgrbk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001373670-17-000004","doc":"a1231201610-kgrbk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001373670-18-000015","doc":"a1231201710-kgrbk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001373670-19-000005","doc":"a1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001373670-20-000005","doc":"a201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001373670-21-000016","doc":"grbk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001373670-22-000008","doc":"grbk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001373670-23-000006","doc":"grbk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001373670-24-000008","doc":"grbk-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0001373670-25-000007","doc":"grbk-20241231.htm","q":"It is conceivable that we might integrate artificial intelligence (\u201cAI\u201d) solutions into our information systems in the future, potentially assuming a more critical role in our operations over time."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001628280-26-011798","doc":"grbk-20251231.htm","q":"It is conceivable that we might integrate artificial intelligence (\u201cAI\u201d) solutions into our information systems in the future, potentially assuming a more critical role in our operations over time."}]},{"cik":1373707,"name":"TETRAPHASE PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-081060","doc":"d847135d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013419","doc":"ttph-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004141","doc":"ttph-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004528","doc":"ttph-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008034","doc":"ttph-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010220","doc":"ttph-10k_20191231.htm","q":null}]},{"cik":1373715,"name":"SERVICENOW, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001373715-15-000067","doc":"now-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001373715-16-000324","doc":"now-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001373715-17-000026","doc":"now-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001373715-18-000058","doc":"now-20171231x10k.htm","q":"The markets in which we compete have evolved rapidly, and the pace of innovation will continue to accelerate, as cloud, mobile, workflow, consumer product-like user experiences, social, collaboration, machine learning, artificial intelligen\u2026"},{"fy":2018,"lvl":1,"n":2,"adsh":"0001373715-19-000070","doc":"now-20181231x10k.htm","q":"The markets in which we compete continue to evolve rapidly, and the pace of innovation will continue to accelerate, as public and private cloud solutions and infrastructure, massively scalable databases, mobile, workflow, consumer product-l\u2026"},{"fy":2019,"lvl":2,"n":11,"adsh":"0001373715-20-000072","doc":"now-20191231x10kxinpro.htm","q":"National and local governments or agencies have in the past adopted, and may in the future adopt, laws and regulations affecting data privacy, the use of the Internet as a commercial medium, the use of data in contexts referred to as artifi\u2026"},{"fy":2020,"lvl":3,"n":27,"adsh":"0001373715-21-000061","doc":"now-20201231.htm","q":"Our increasing use of artificial intelligence and machine learning also allows for the creation of many workflows to quickly become fully automated."},{"fy":2021,"lvl":3,"n":19,"adsh":"0001373715-22-000024","doc":"now-20211231.htm","q":"The automation of workflows on our platform is enhanced by additional services we offer, such as artificial intelligence (\u201cAI\u201d), machine learning, robotic process automation, performance analytics, electronic service catalogs and portals, c\u2026"},{"fy":2022,"lvl":3,"n":21,"adsh":"0001373715-23-000035","doc":"now-20221231.htm","q":"The automation of workflows on our platform can be enhanced by additional functionality, such as artificial intelligence (\u201cAI\u201d), machine learning, robotic process automation, process mining, performance analytics, electronic service catalog\u2026"},{"fy":2023,"lvl":3,"n":60,"adsh":"0001373715-24-000030","doc":"now-20231231.htm","q":"Our intelligent platform, the Now Platform, is a cloud-based solution with embedded artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) capabilities that helps global enterprises across industries, universities and governments unify \u2026"},{"fy":2024,"lvl":3,"n":94,"adsh":"0001373715-25-000010","doc":"now-20241231.htm","q":"Artificial Intelligence (\u201cAI\u201d), particularly Generative AI (\u201cGenAI\u201d) and agentic AI, is driving a new wave of technology transformation."},{"fy":2025,"lvl":3,"n":147,"adsh":"0001373715-26-000007","doc":"now-20251231.htm","q":"Business Overview ServiceNow delivers solutions that help public and private organizations govern, secure and manage artificial intelligence and digitalize and streamline workflows to drive collaboration, productivity and better experiences\u2026"}]},{"cik":1374339,"name":"PROMIS NEUROSCIENCES INC.","industry":"Pharma & biotech","sic":2834,"state":"ON","cells":[{"fy":2022,"lvl":"x","n":2,"adsh":"0001558370-23-003167","doc":"pmn-20221231x10k.htm","q":"ProMIS\u2019 technology platform is an example of the advances in drug discovery enabled by computational power, in silico discovery, and/or artificial intelligence."},{"fy":2023,"lvl":3,"n":20,"adsh":"0001558370-24-004532","doc":"pmn-20231231x10k.htm","q":"ProMIS\u2019 technology platform is an example of the advances in drug discovery enabled by computational power, in silico discovery, and/or artificial intelligence."},{"fy":2024,"lvl":3,"n":23,"adsh":"0001558370-25-004068","doc":"pmn-20241231x10k.htm","q":"ProMIS\u2019 technology platform is an example of the advances in drug discovery enabled by computational power, in silico discovery, and/or artificial intelligence."},{"fy":2025,"lvl":"x","n":43,"adsh":"0001104659-26-034554","doc":"pmn-20251231x10k.htm","q":"ProMIS\u2019 technology platform is an example of the advances in drug discovery enabled by computational power, in silico discovery, and/or artificial intelligence."}]},{"cik":1374684,"name":"MULESOFT, INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001374684-18-000006","doc":"mule10-k12312017.htm","q":null}]},{"cik":1374690,"name":"LARIMAR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-103624","doc":"d846636d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505173","doc":"d138931d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-078784","doc":"d313576d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-077456","doc":"d537290d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007863","doc":"zfgn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008984","doc":"zfgn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011003","doc":"lrmr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004637","doc":"lrmr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007855","doc":"lrmr-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-031529","doc":"lrmr-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to, social engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, \u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-043925","doc":"lrmr-20241231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to, social engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, \u2026"},{"fy":2025,"lvl":3,"n":26,"adsh":"0001193125-26-115878","doc":"lrmr-20251231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to, social engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, \u2026"}]},{"cik":1374881,"name":"KINGFISH HOLDING CORP","industry":"Construction","sic":1540,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-15-007741","doc":"king_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-22-001114","doc":"king_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-22-001122","doc":"king_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-22-001140","doc":"king_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-22-001151","doc":"king_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-22-001153","doc":"king_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001161","doc":"king_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-22-009583","doc":"king_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-23-009244","doc":"king_10k.htm","q":null}]},{"cik":1375151,"name":"ZOGENIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001375151-15-000004","doc":"zgnx-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001375151-16-000021","doc":"zgnx-20151231x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001375151-17-000008","doc":"zgnx-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001375151-18-000006","doc":"zgnx-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001375151-19-000016","doc":"zgnx-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001375151-20-000011","doc":"zgnx-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001375151-21-000012","doc":"zgnx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001375151-22-000015","doc":"zgnx-20211231.htm","q":null}]},{"cik":1375365,"name":"SUPER MICRO COMPUTER, INC.","industry":"Computers & chips","sic":3571,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-15-007025","doc":"smci-2015630x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-16-019274","doc":"smci-2016630x10k.htm","q":null},{"fy":2017,"lvl":2,"n":5,"adsh":"0001375365-19-000039","doc":"smci-2017630x10kxa.htm","q":"We develop and provide end-to-end green computing solutions to the cloud computing, data center, enterprise, artificial intelligence and machine learning, big data, hyper-converged, OEM, high performance computing (\"HPC\"), and Internet of T\u2026"},{"fy":2019,"lvl":2,"n":6,"adsh":"0001375365-19-000079","doc":"smci-2019630x10k.htm","q":"We develop and provide end-to-end green computing solutions to the cloud computing, data centers, enterprise, big data, artificial intelligence (\"AI\"), High-Performance Computing (\"HPC\"), edge computing and Internet of Things/embedded (\u201cIoT\u2026"},{"fy":2020,"lvl":2,"n":6,"adsh":"0001375365-20-000064","doc":"smci-2020630x10k.htm","q":"Business Our Company We are a Silicon Valley-based provider of application-optimized high performance and high-efficiency server and storage systems for a variety of markets, including enterprise data centers, cloud computing, artificial in\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001375365-21-000060","doc":"smci-20210630.htm","q":"Business Our Company We are a Silicon Valley-based provider of application-optimized high-performance and high-efficiency server and storage systems for various markets, including enterprise data centers, cloud computing, artificial intelli\u2026"},{"fy":2022,"lvl":2,"n":7,"adsh":"0001375365-22-000103","doc":"smci-20220630.htm","q":"Business Our Company We are a Silicon Valley-based provider of accelerated compute platforms that are application-optimized high-performance and high-efficiency server and storage systems for various markets, including enterprise data cente\u2026"},{"fy":2023,"lvl":3,"n":19,"adsh":"0001375365-23-000036","doc":"smci-20230630.htm","q":"Business Our Company We are a Silicon Valley-based provider of accelerated compute platforms that are application-optimized high performance and high-efficiency server and storage systems for a variety of markets, including enterprise data \u2026"},{"fy":2024,"lvl":3,"n":52,"adsh":"0001375365-25-000004","doc":"smci-20240630.htm","q":"We deliver rack-scale solutions optimized for various workloads, including artificial intelligence (\u201cAI\u201d) and high-performance computing (\u201cHPC\u201d), where acceleration is critical and we also produce an extensive portfolio of server and storag\u2026"},{"fy":2025,"lvl":3,"n":52,"adsh":"0001375365-25-000027","doc":"smci-20250630.htm","q":"We deliver rack-scale solutions optimized for various workloads, including artificial intelligence (\u201cAI\u201d) and high-performance computing (\u201cHPC\u201d), where acceleration is critical."}]},{"cik":1375557,"name":"GUIDANCE SOFTWARE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-013463","doc":"a14-25798_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-099794","doc":"a15-23428_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-013038","doc":"a17-1010_110k.htm","q":null}]},{"cik":1376231,"name":"VPR BRANDS, LP.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001580957-15-000039","doc":"jobi121410k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001580957-16-000586","doc":"vpr10k2015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001580957-17-000309","doc":"jobi121610k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001580957-18-000200","doc":"vprb1217-10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0000891092-19-005562","doc":"e2903-10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0000891092-20-007529","doc":"e10027-10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0000891092-21-003500","doc":"e11798-10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-020167","doc":"f10k2021_vprbrands.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-029512","doc":"f10k2022_vprbrands.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-034236","doc":"ea0202877-10k_vpr.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-032573","doc":"ea0237438-10k_vprbrand.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-037425","doc":"ea0283694-10k_vprbrands.htm","q":null}]},{"cik":1376321,"name":"ZW DATA ACTION TECHNOLOGIES INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001878","doc":"f10k_033117p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001171843-18-002741","doc":"f10k_040218p.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001171843-19-002416","doc":"f10k_040819p.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001171843-20-004001","doc":"f10k_051420p.htm","q":"Finally, as stated previously, the reward point issued in form of token is not equivalent to any cryptocurrency and will not be listed on any exchange. 4 We appointed a new Chief Technology Officer in December 2019 and a Chief Business Offi\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-002452","doc":"f10k_040721p.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001171843-22-002601","doc":"cnet20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001171843-23-002333","doc":"cnet20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001171843-24-003699","doc":"cnet20231231_10k.htm","q":null},{"fy":2024,"lvl":2,"n":6,"adsh":"0001171843-25-002214","doc":"cnet20241231_10k.htm","q":"We are also seeking to acquire and build teams with AI capabilities and proprietary intellectual properties that enable more accurate marketing solutions and cost-effective content creation so that we can better service our clients."},{"fy":2025,"lvl":"x","n":15,"adsh":"0001171843-26-002058","doc":"cnet20251231_10k.htm","q":"We are also seeking to acquire and build teams with AI capabilities and proprietary intellectual properties that enable more accurate marketing solutions and cost-effective content creation so that we can better service our clients."}]},{"cik":1376986,"name":"TENNESSEE VALLEY AUTHORITY","industry":"Utilities","sic":4911,"state":"TN","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001376986-15-000047","doc":"tve-09302015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001376986-16-000080","doc":"tve-09302016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001376986-17-000031","doc":"tve-09302017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001376986-18-000046","doc":"tve-10xk09302018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001376986-19-000037","doc":"tve-10xk09302019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001376986-20-000030","doc":"tve-20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001376986-21-000028","doc":"tve-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001376986-22-000023","doc":"tve-20220930.htm","q":null},{"fy":2023,"lvl":2,"n":13,"adsh":"0001376986-23-000022","doc":"tve-20230930.htm","q":"The emergence of artificial intelligence technology could harm TVA."},{"fy":2024,"lvl":3,"n":23,"adsh":"0001376986-24-000029","doc":"tve-20240930.htm","q":"The emergence of artificial intelligence technology could create challenges for TVA, and TVA may not be able to adopt the use of technology in step with private utilities."},{"fy":2025,"lvl":3,"n":30,"adsh":"0001376986-25-000056","doc":"tve-20250930.htm","q":"Key research and development priorities include advanced nuclear solutions, storage integration, and regional grid transformation. 22 Table of Contents This research supports both TVA and national strategic interests to help enable growing \u2026"}]},{"cik":1377121,"name":"PROTAGONIST THERAPEUTICS, INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-073383","doc":"d310331d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001637","doc":"ptgx-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001853","doc":"ptgx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002334","doc":"ptgx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002715","doc":"ptgx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002385","doc":"ptgx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003906","doc":"ptgx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001850","doc":"ptgx-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-001317","doc":"ptgx-20241231x10k.htm","q":"Additionally, sensitive data could be leaked, disclosed or revealed as a result of or in connection with our employees\u2019, personnel\u2019s, vendors\u2019 or partners\u2019 use of generative artificial intelligence technologies."},{"fy":2025,"lvl":2,"n":5,"adsh":"0001104659-26-019696","doc":"ptgx-20251231x10k.htm","q":"Moreover, we also face increased competition from other companies that are using artificial intelligence, some of whom may be able to more quickly and effectively identify and develop novel product candidates compared to us and our business\u2026"}]},{"cik":1377888,"name":"POWER OF THE DREAM VENTURES INC","industry":"Construction","sic":8711,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001262463-15-000249","doc":"pwrv2014k.htm","q":"Ev e n if we are succ e ssful i n d efen d ing a g ai n st t h ese claims, s u ch liti g ati o n c ou l d res u lt i n s u bsta n tial c o sts a n d b e a distracti o n t o ma n a g e m e n t."}]},{"cik":1378125,"name":"TOGA LTD","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001640334-21-000290","doc":"togl_10ka.htm","q":null}]},{"cik":1378140,"name":"OCEAN POWER TECHNOLOGIES, INC.","industry":"Utilities","sic":4911,"state":"NJ","cells":[{"fy":2015,"lvl":1,"n":1,"adsh":"0001437749-15-013346","doc":"optt20150629_10k.htm","q":"Naval Academy, a Master of Science degree in Computer Science with a subspecialty in Artificial Intelligence from the Florida Institute of Technology and a Master of Arts degree in National Security and Strategic Studies from the Naval Warf\u2026"},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-16-035299","doc":"optt20160430_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-012603","doc":"optt20170627_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-18-010086","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-19-010930","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-20-012094","doc":"form10-k.htm","q":"We continuously monitor non-traditional competitive threats, such as multi domain drones and artificial intelligence tools utilizing satellite data."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001493152-21-017188","doc":"form10-k.htm","q":"Since then, we have been developing a Maritime Domain Awareness solution (\u201cMDA-S\u201d or \u201cMDA\u201d) to introduce edge computing and artificial intelligence modules that can be delivered to customers via cyber secure cloud environments."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001493152-22-019173","doc":"form10-k.htm","q":"We continuously monitor non-traditional competitive threats, such as multi-domain drones and artificial intelligence tools utilizing satellite data."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-23-025878","doc":"form10-k.htm","q":"We continuously monitor non-traditional competitive threats, such as multi-domain drones and artificial intelligence tools utilizing satellite data."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001493152-24-029074","doc":"form10-k.htm","q":"This integration enables the use of artificial intelligence and Machine Learning not only to improve data accuracy and operational efficiency but also delivery of actionable intelligence."},{"fy":2025,"lvl":3,"n":23,"adsh":"0001641172-25-020888","doc":"form10-k.htm","q":"These systems consist of a variety of platforms including the PowerBuoy\u00ae, our persistent sensor and power solution, the WAM-V\u00ae (Wave Adaptive Modular Vessel), our autonomous unmanned surface vehicle, and Merrows\u2122, our user interface and com\u2026"}]},{"cik":1378590,"name":"BRIDGELINE DIGITAL, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-15-022760","doc":"blin20150930_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-16-043488","doc":"blin20160901_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-021027","doc":"blin20170930_10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001437749-18-022735","doc":"blin20180930_10k.htm","q":"Kahn received his Ph.D. in Computer Science and Artificial Intelligence from the University of Chicago."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001437749-19-024964","doc":"blin20190930_10k.htm","q":"This software is available as a SaaS license and is reported as subscription licenses in the accompanying consolidated financial statements. \u25cf Celebros Search by Bridgeline is a commerce oriented, site search product that provides for Natur\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0001437749-20-025835","doc":"blin20200930_10k.htm","q":"Celebros Search, delivered through a cloud-based SaaS, is a commerce-oriented site search product that provides for Natural Language Processing with artificial intelligence to present very relevant search results based on long-tail keyword \u2026"},{"fy":2021,"lvl":3,"n":17,"adsh":"0001437749-21-028984","doc":"blin20210827_10k.htm","q":"OrchestraCMS is the only content and digital experience platform built 100% native on Salesforce and helps customers create websites and intranets for their customers, partners, and employees; uniquely combining content with business data, \u2026"},{"fy":2022,"lvl":3,"n":17,"adsh":"0001437749-22-029477","doc":"blin20220930_10k.htm","q":"HawkSearch leverages advanced artificial intelligence, machine learning and industry-leading merchandising features to deliver accurate and highly relevant results and recommendations derived from multiple data sources."},{"fy":2023,"lvl":2,"n":13,"adsh":"0001437749-23-035439","doc":"blin20230930c_10k.htm","q":"Celebros Search: a commerce-oriented site search product that provides Natural Language Processing with artificial intelligence to present relevant search results based on long-tail keyword searches."},{"fy":2024,"lvl":3,"n":48,"adsh":"0001437749-24-038328","doc":"blin20240930_10k.htm","q":"Overview Bridgeline Digital is an AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more visitors to their websites, converting more visitors to purchasers, and increa\u2026"},{"fy":2025,"lvl":3,"n":54,"adsh":"0001437749-25-038337","doc":"blin20250930_10k.htm","q":"Overview Bridgeline Digital is an AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more visitors to their websites, converting more visitors to purchasers, and increa\u2026"}]},{"cik":1378624,"name":"CELLULAR BIOMEDICINE GROUP, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001354488-15-001428","doc":"cbmg_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-16-006531","doc":"cbmg_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-001934","doc":"cbmg10-k.htm","q":"Wuhan Dangdai Technology & Industries Group Inc. is controlled by Hansheng Zhou, Xiaodong Zhang, Luming Ai, Xuehai Wang, Lei Yu, Xiaoling Du and Haichun Chen."},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002152","doc":"cbmg_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-001756","doc":"cbmg_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-20-002065","doc":"cbmg_10k.htm","q":null}]},{"cik":1378706,"name":"AMERICAN DG ENERGY INC","industry":"Utilities","sic":4931,"state":"MA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001378706-16-000176","doc":"adge-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001378706-17-000008","doc":"adge-20161231x10k.htm","q":null}]},{"cik":1379006,"name":"NANOVIRICIDES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-011466","doc":"v402032_10ka.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-054864","doc":"v418491_10k.htm","q":null},{"fy":2017,"lvl":1,"n":3,"adsh":"0001144204-17-050412","doc":"v474679_10k.htm","q":null},{"fy":2018,"lvl":1,"n":3,"adsh":"0001144204-18-053665","doc":"tv501564_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001144204-19-041547","doc":"tv525970_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-114577","doc":"tm2024737-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-125343","doc":"tm2124471d1_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-22-002878","doc":"nnvc-20220630x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-23-002146","doc":"nnvc-20230630x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-24-001650","doc":"nnvc-20240630x10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001104659-25-094527","doc":"nnvc-20250630x10k.htm","q":null}]},{"cik":1379895,"name":"DYNEGY INC.","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001379895-15-000005","doc":"dyn-20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001379895-16-000022","doc":"dyn-20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001379895-17-000004","doc":"dyn-20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001379895-18-000003","doc":"dyn-20171231_10k.htm","q":null}]},{"cik":1381054,"name":"HYDROGEN FUTURE CORP","industry":"Pharma & biotech","sic":8731,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-000264","doc":"hfco_10k.htm","q":null}]},{"cik":1381507,"name":"LIMEADE, INC","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2022,"lvl":1,"n":4,"adsh":"0001381507-23-000012","doc":"lme-20221231.htm","q":"Other core competitive strengths of our business include: \u2022 ability to promote essential health & well-being benefits from third-party providers in unique ways; \u2022 ability to infuse well-being into the flow of work, including integration wit\u2026"}]},{"cik":1381871,"name":"BOWMO, INC.","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2023,"lvl":"x","n":6,"adsh":"0001213900-24-086614","doc":"ea0214383-10k_bowmo.htm","q":"Our goal is to constantly improve our HR-Tech platform to address present and future market needs by offering a unique combination of proprietary artificial intelligence (\u201cAI\u201d) based technology with a do-it-yourself sourcing experience able\u2026"}]},{"cik":1382101,"name":"SUTRO BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010253","doc":"stro-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010890","doc":"stro-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013945","doc":"stro-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002312","doc":"stro-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010976","doc":"stro-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":9,"adsh":"0000950170-24-035949","doc":"stro-20231231.htm","q":"For example, targeted deep fakes supported by sophisticated AI tools and other forms of impersonation of our executives are becoming increasingly prevalent."},{"fy":2024,"lvl":2,"n":9,"adsh":"0000950170-25-038884","doc":"stro-20241231.htm","q":"Our employees could also inappropriately utilize artificial intelligence, or AI, in connection with their social media communications, introducing another potential source of reputational damage or other potential legal or financial exposur\u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-119873","doc":"stro-20251231.htm","q":"Our employees could also inappropriately utilize artificial intelligence, or AI, in connection with their social media or other internal communications and workplace processes, introducing another potential source of reputational damage or \u2026"}]},{"cik":1382574,"name":"SCIENTURE HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2024,"lvl":3,"n":23,"adsh":"0001641172-25-000657","doc":"form10-k.htm","q":"These claims could be extremely costly to defend, could require us to pay significant damages and limit our ability to operate, and could distract our personnel from normal responsibilities. \u25cf European patents and patent applications could \u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001493152-26-013475","doc":"form10-k.htm","q":"Our use, or the use by our third party collaborators and service providers, of new and evolving technologies, such as artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d), may result in spending additional resources and present new ri\u2026"}]},{"cik":1382911,"name":"OREXIGEN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069192","doc":"d844845d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481707","doc":"d118305d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005547","doc":"orex-10k_20161231.htm","q":null}]},{"cik":1382943,"name":"PREDICTIVE TECHNOLOGY GROUP, INC.","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001091818-19-000239","doc":"pred09272019form10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001091818-20-000224","doc":"pred10082020form10Kjune2020.htm","q":"By combining our state-of-the-art proprietary screening assay and related artificial intelligence capabilities with Atrin's breakthrough DDR therapy candidates, we have the potential to become a leader in development of improved personalize\u2026"}]},{"cik":1383088,"name":"CYTTA CORP.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-000209","doc":"cyca_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-000200","doc":"cyca_10k.htm","q":null},{"fy":2023,"lvl":"x","n":1,"adsh":"0001477932-24-000156","doc":"cyca_10k.htm","q":"Her specific expertise lies in the safety and security technology sector, encompassing fintech, DeFi, video streaming and compression, cyber security, web3, and AI."},{"fy":2024,"lvl":"x","n":5,"adsh":"0001477932-25-000239","doc":"cyca_10k.htm","q":"Her specific expertise lies in the safety and security technology sector, encompassing fintech, DeFi, video streaming and compression, cyber security, web3, and AI."}]},{"cik":1383701,"name":"HISTOGEN INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091168","doc":"d838509d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014564","doc":"cnat-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004617","doc":"cnat-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004914","doc":"cnat-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007030","doc":"cnat-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010122","doc":"cnat-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012536","doc":"hsto-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009664","doc":"hsto-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007056","doc":"hsto-20221231.htm","q":null}]},{"cik":1384365,"name":"RAADR, INC.","industry":"Software & IT services","sic":7371,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000477","doc":"ptoo_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000844","doc":"rdar_10k.htm","q":null}]},{"cik":1385228,"name":"BIND THERAPEUTICS, INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-087467","doc":"d837520d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014829","doc":"bind-10k_20151231.htm","q":null}]},{"cik":1385292,"name":"MONOTYPE IMAGING HOLDINGS INC.","industry":"Software & IT services","sic":7371,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069684","doc":"d843908d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481975","doc":"d101166d10k.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001193125-17-060429","doc":"d321156d10k.htm","q":"Some of our most important patents are related to our dynamic subsetting, font compression and machine learning technologies."},{"fy":2017,"lvl":1,"n":4,"adsh":"0001193125-18-060842","doc":"d507580d10k.htm","q":"Further, we continue to advance our machine learning capabilities across the business."},{"fy":2018,"lvl":2,"n":8,"adsh":"0001193125-19-049831","doc":"d646546d10k.htm","q":"This has been fueled by advancements in technologies such as artificial intelligence, or AI, and by greater access to data than ever before."}]},{"cik":1385508,"name":"OPIANT PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001385508-21-000035","doc":"opnt-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001385508-22-000038","doc":"opnt-20211231.htm","q":null}]},{"cik":1385818,"name":"AYTU BIOPHARMA, INC","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-333046","doc":"d85936d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-046061","doc":"v473641_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-012209","doc":"f10k2018_aytubioscience.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-19-011147","doc":"aytu_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-20-010891","doc":"aytu_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-012825","doc":"aytu-20210630x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-014652","doc":"aytu-20220630x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-23-016393","doc":"aytu-20230630x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-24-030062","doc":"aytu20240630_10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001437749-25-029723","doc":"aytu20250630c_10k.htm","q":"Our business and operations would suffer in the event of system failures, cybersecurity attacks, data leakages or other security breaches. \u200b We utilize information technology, or IT, and some of our vendors utilize artificial intelligence a\u2026"}]},{"cik":1385867,"name":"COUPA SOFTWARE INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":2,"adsh":"0001564590-17-005877","doc":"coup-10k_20170131.htm","q":"Spend360 is an analytics solution that uses deep machine learning and artificial intelligence to structure and cleanse data in a format that is usable to finance and procurement professionals."},{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-006986","doc":"coup-10k_20180131.htm","q":"Customers can also leverage our artificial intelligence capabilities to automate complex business spend data classification."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001564590-19-009608","doc":"coup-10k_20190131.htm","q":"Customers can also leverage our artificial intelligence capabilities to automate complex business spend data classification."},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-011878","doc":"coup-10k_20200131.htm","q":"Our Community Intelligence capabilities apply artificial intelligence and machine learning to spend transactions happening across the growing Coupa community to identify and prescribe best practices that have helped customers to optimize sp\u2026"},{"fy":2020,"lvl":2,"n":6,"adsh":"0001385867-21-000011","doc":"coup-20210131.htm","q":"Our Community Intelligence capabilities apply artificial intelligence and machine learning to spend transactions across the growing Coupa community to identify trends and prescribe best practices that help customers optimize spend, reduce r\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001385867-22-000010","doc":"coup-20220131.htm","q":"In addition, the increasing number of transactions on our platform leads to incrementally powerful prescriptive spend insights and risk management recommendations from our Coupa Community.ai capabilities, creating more value for customers a\u2026"}]},{"cik":1386026,"name":"ZENERGY BRANDS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004916","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005348","doc":"form10-k.htm","q":null}]},{"cik":1386858,"name":"HYPERION THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-076774","doc":"d847402d10k.htm","q":null}]},{"cik":1387467,"name":"ALPHA & OMEGA SEMICONDUCTOR LTD","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001387467-15-000074","doc":"aosl630201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001387467-16-000204","doc":"aosl630201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387467-17-000057","doc":"aosl630201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001387467-18-000046","doc":"aosl630201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001387467-19-000040","doc":"aosl630201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001387467-20-000047","doc":"aosl630202010k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001387467-21-000063","doc":"aosl-20210630.htm","q":"We also announced a new series of Smart Power Stages (SPS) targeting multiphase VR regulators powering high-performance GPU and CPU in desktop Add-In Graphics Cards (AICs), gaming laptops, servers, data storage, artificial intelligence, and\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001387467-22-000066","doc":"aosl-20220630.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001387467-23-000049","doc":"aosl-20230630.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001387467-24-000073","doc":"aosl-20240630.htm","q":"Introduction of these 4 multiphase controllers has enabled AOS to become a complete solution level provider, across multiple compute platforms from PCs, graphics cards to AI and datacenter."},{"fy":2025,"lvl":2,"n":8,"adsh":"0001628280-25-041297","doc":"aosl-20250630.htm","q":"While we have made progress in our diversification and expansion into additional applications, we continue to support and grow our computing business by expanding bill-of-material content, gaining market share, acquiring new customers, and \u2026"}]},{"cik":1388195,"name":"PHARMERICA CORP","industry":"Retail","sic":5912,"state":"KY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-009509","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001388195-16-000017","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001388195-17-000004","doc":"form10k.htm","q":null}]},{"cik":1388319,"name":"U.S. STEM CELL, INC.","industry":"Pharma & biotech","sic":8731,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001145443-15-000378","doc":"bioheart_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001185185-16-003859","doc":"usstemcell10k123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001185185-17-000574","doc":"usstemcell10k123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001185185-18-000705","doc":"usstemcell10k123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001185185-19-000351","doc":"usstem20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001185185-21-000986","doc":"usstem20191231_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001185185-21-000990","doc":"usstem20201231_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001185185-22-000363","doc":"usstem20211231_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001185185-23-000339","doc":"usstem20221231_10k.htm","q":null}]},{"cik":1388320,"name":"ACTINIUM PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-001800","doc":"f10k2014_actiniumpharma.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-011534","doc":"f10k2015_actiniumpharma.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-002461","doc":"f10k2016_actiniumpharma.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-003091","doc":"f10k2017_actiniumpharma.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004269","doc":"f10k2018_actiniumpharma.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-011475","doc":"f10k2019_actiniumpharma.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-019297","doc":"f10k2020_actiniumpharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015208","doc":"f10k2021_actiniumpharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-025597","doc":"f10k2022_actiniumph.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028038","doc":"f10k2023_actinium.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-026371","doc":"ea0232395-10k_actinium.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-036504","doc":"ea0279291-10k_actinium.htm","q":"Other recent actions and proposals include, for example, (1) reducing federal agencies workforces; (2) directing program cuts; (3) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to \u2026"}]},{"cik":1388410,"name":"PARALLAX HEALTH SCIENCES, INC.","industry":"Retail","sic":5912,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001388410-17-000024","doc":"f20151231prlx10krev9final.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001388410-18-000030","doc":"20161231form10kprlxfinal.htm","q":null}]},{"cik":1388486,"name":"SPOTLIGHT INNOVATION INC.","industry":"Pharma & biotech","sic":2834,"state":"IA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001949","doc":"stlt_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001913","doc":"stlt_10k.htm","q":null}]},{"cik":1389067,"name":"TAUTACHROME INC.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001556","doc":"ttcm_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-001766","doc":"ttcm_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-001617","doc":"ttcm_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-001762","doc":"ttcm_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001603","doc":"ttcm_10k.htm","q":null},{"fy":2022,"lvl":"x","n":1,"adsh":"0001477932-23-003924","doc":"ttcm_10k.htm","q":"Invention enabling users to create AR objects permanently and correctly placed in any spot in the visible environment near shopping centers and housing complexes Patent pending Disclosure filed by Tautachrome using . four advanced AI techni\u2026"}]},{"cik":1389415,"name":"INFRASTRUCTURE DEVELOPMENTS CORP.","industry":"Construction","sic":8711,"state":"UT","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001551163-15-000108","doc":"f10k2014finalvedgar1.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001551163-16-000368","doc":"f10k2015finalmay2vedgar1.htm","q":null}]},{"cik":1389545,"name":"NOVABAY PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-006065","doc":"nby20150320_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-026877","doc":"nby20151201_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-005131","doc":"nby20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-005177","doc":"nby20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-006017","doc":"nby20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-006213","doc":"nby20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007158","doc":"nby20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007543","doc":"nby20211231b_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008843","doc":"nby20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-009417","doc":"nby20231231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001437749-25-010730","doc":"nby20241231_10k.htm","q":null},{"fy":2025,"lvl":"x","n":2,"adsh":"0001437749-26-009090","doc":"nby20251231_10k.htm","q":"Cybersecurity Risks Our cybersecurity risks include risks arising from unauthorized access to information systems, data breaches, malware or ransomware attacks (including those leveraging artificial intelligence), phishing or social-enginee\u2026"}]},{"cik":1390478,"name":"SELLAS LIFE SCIENCES GROUP, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001390478-15-000012","doc":"gale-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001390478-16-000088","doc":"gale-20151231x10xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001390478-17-000020","doc":"gale-20161231x10xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-117053","doc":"d556278d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001390478-19-000017","doc":"sls-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001390478-20-000007","doc":"sls-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001390478-21-000007","doc":"sls-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001390478-22-000006","doc":"sls-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001390478-23-000005","doc":"sls-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":12,"adsh":"0001390478-24-000004","doc":"sls-20231231.htm","q":"These mutated peptides are designed using artificial intelligence (AI) to elicit strong T-cell response against both mutated peptides and naturally occurring peptides in cancer cells."},{"fy":2024,"lvl":2,"n":12,"adsh":"0001390478-25-000003","doc":"sls-20241231.htm","q":"These mutated peptides are designed using artificial intelligence, or AI, by researchers at MSK, to elicit strong T-cell response against both mutated peptides and naturally occurring peptides in cancer cells."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001390478-26-000003","doc":"sls-20251231.htm","q":"These mutated peptides are designed using artificial intelligence, or AI, by researchers at MSK, to elicit strong T-cell response against both mutated peptides and naturally occurring peptides in cancer cells."}]},{"cik":1390844,"name":"WABCO HOLDINGS INC.","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001390844-15-000003","doc":"wbc10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001390844-16-000017","doc":"wbc10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001390844-17-000004","doc":"wbc10k12312016.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001390844-18-000003","doc":"wbc10k12312017.htm","q":"G7 is dedicated to implementing telematics, artificial intelligence and big-data algorithms in the logistics industry."},{"fy":2018,"lvl":1,"n":3,"adsh":"0001390844-19-000004","doc":"wbc10k12312018.htm","q":"G7 is dedicated to implementing telematics, artificial intelligence and big-data algorithms in the logistics industry."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001390844-20-000003","doc":"wbc10k12312019.htm","q":"G7 is dedicated to implementing telematics, artificial intelligence and big-data algorithms in the logistics industry."}]},{"cik":1391135,"name":"LFTD PARTNERS INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001096906-22-000719","doc":"lifd_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001096906-23-000607","doc":"lsfp_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001096906-24-000671","doc":"lsfp_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001096906-25-000346","doc":"lsfp_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001096906-26-000454","doc":"lftp_10k.htm","q":null}]},{"cik":1391135,"name":"ACQUIRED SALES CORP","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001445866-15-000356","doc":"acquired10k03242015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001445866-16-001766","doc":"acquired10k12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001445866-18-000905","doc":"aqsp_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001445866-18-000980","doc":"aqsp-20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001445866-19-000245","doc":"aqsp_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001445866-20-000276","doc":"aqsp_10k.htm","q":null}]},{"cik":1392363,"name":"CHINA ADVANCED CONSTRUCTION MATERIALS GROUP, INC","industry":"Construction","sic":1700,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001062993-15-005181","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-16-011584","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062993-17-004297","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-017165","doc":"f10k2018_chinaadvancedconst.htm","q":null}]},{"cik":1392449,"name":"GREEN PLANET BIO ENGINEERING CO. LTD.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001495","doc":"gplb_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001354488-16-006797","doc":"gplb_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-001883","doc":"gplb_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-002291","doc":"gplb_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-002154","doc":"gplb_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-002496","doc":"gplb_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003636","doc":"gplb_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-003076","doc":"gplb_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-003905","doc":"gplb_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-24-003942","doc":"gplb_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001654954-25-002462","doc":"gplb_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001654954-26-003081","doc":"gplb_10k.htm","q":null}]},{"cik":1392477,"name":"XTREME GREEN ELECTRIC VEHICLES INC.","industry":"Auto manufacturing","sic":3711,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001511164-15-000162","doc":"f323adraft10knew.htm","q":null}]},{"cik":1392522,"name":"FREESCALE SEMICONDUCTOR, LTD.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001392522-15-000003","doc":"a201410-k.htm","q":null}]},{"cik":1392545,"name":"LIGHTNING GAMING, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000890163-15-000028","doc":"s22-15582_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0000890163-16-000116","doc":"s22-16731_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0000890163-17-000026","doc":"s22-17851_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0000890163-18-000015","doc":"s22-19175_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0000890163-19-000014","doc":"s22-20304_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0000890163-20-000013","doc":"s22-21515_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0000890163-22-000031","doc":"s22-22301_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0000890163-23-000019","doc":"s22-22941_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000890163-24-000008","doc":"s22-23526_10k.htm","q":null}]},{"cik":1392972,"name":"PROS HOLDINGS, INC.","industry":"Software & IT services","sic":7371,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001392972-15-000046","doc":"pro-20141231x10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001392972-16-000143","doc":"pro-20151231x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001392972-17-000038","doc":"pro-20161231x10k.htm","q":null},{"fy":2017,"lvl":"x","n":17,"adsh":"0001392972-18-000068","doc":"pro-20171231x10k.htm","q":"Fueled by artificial intelligence, machine learning and proven science, our solutions make it possible for companies to price, configure and sell their products and services in an omnichannel environment with speed, precision and consistenc\u2026"},{"fy":2018,"lvl":3,"n":34,"adsh":"0001392972-19-000067","doc":"pro-20181231x10k.htm","q":"Business Overview PROS provides artificial intelligence (\"AI\") solutions that power commerce in the digital economy by providing fast, frictionless and personalized buying experiences."},{"fy":2019,"lvl":3,"n":35,"adsh":"0001392972-20-000059","doc":"pro-20191231x10k.htm","q":"Business Overview PROS provides artificial intelligence (\"AI\") solutions that power commerce in the digital economy by providing fast, frictionless and personalized buying experiences."},{"fy":2020,"lvl":3,"n":35,"adsh":"0001392972-21-000039","doc":"pro-20201231.htm","q":"PROS solutions leverage artificial intelligence (\"AI\"), self-learning and automation to ensure that every transactional experience is fast, frictionless and personalized for every shopper, supporting both business-to-business (\"B2B\") and bu\u2026"},{"fy":2021,"lvl":3,"n":33,"adsh":"0001392972-22-000031","doc":"pro-20211231.htm","q":"PROS solutions leverage artificial intelligence (\"AI\"), self-learning and automation to ensure that every transactional experience is fast, frictionless and personalized for every shopper, supporting both business-to-business (\"B2B\") and bu\u2026"},{"fy":2022,"lvl":3,"n":36,"adsh":"0001392972-23-000026","doc":"pro-20221231.htm","q":"PROS solutions leverage artificial intelligence (\"AI\"), self-learning and automation to ensure that every transactional experience is fast, frictionless and personalized for every shopper, supporting both business-to-business (\"B2B\") and bu\u2026"},{"fy":2023,"lvl":3,"n":56,"adsh":"0001392972-24-000025","doc":"pro-20231231.htm","q":"PROS solutions are used by both business-to-business (\"B2B\") and business-to-consumer (\"B2C\") companies across industry verticals to help drive profitable growth by leveraging our artificial intelligence (\"AI\"), self-learning and automation\u2026"},{"fy":2024,"lvl":3,"n":61,"adsh":"0001392972-25-000019","doc":"pro-20241231.htm","q":"Our solutions leverage proprietary artificial intelligence (\"AI\") and automation to help drive profitable growth at scale by enabling fast, frictionless and personalized transactional experiences across diverse go-to-market channels."}]},{"cik":1393052,"name":"VEEVA SYSTEMS INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001564590-15-002300","doc":"veev-10k_20150131.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015753","doc":"veev-10k_20160131.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005637","doc":"veev-10k_20170131.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007164","doc":"veev-10k_20180131.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-009853","doc":"veev-10k_20190131.htm","q":"Nitro eliminates the time and effort of custom data warehouse development and maintenance and provides a foundation for artificial intelligence and advanced analytics."},{"fy":2019,"lvl":2,"n":10,"adsh":"0001628280-20-004385","doc":"veev-20200131x10k.htm","q":"Key existing and recently announced innovative capabilities of our Veeva CRM and Veeva Medical CRM solutions include: \u25e6 Powered by data science, Veeva CRM Suggestions is a dashboard included within Veeva CRM that offers life sciences sales \u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001393052-21-000015","doc":"veev-20210131.htm","q":"Crossix DIFA uses that data to enable real-time measurement and optimization of complex, cross-channel media campaigns aimed at patients and healthcare professionals. \u2022 Veeva Data Cloud provides longitudinal U.S. patient data for both retai\u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0001393052-22-000017","doc":"veev-20220131.htm","q":"Crossix DIFA uses that data to enable real-time measurement and optimization of complex, cross-channel media campaigns aimed at patients and healthcare professionals. \u2022 Veeva Data Cloud provides longitudinal U.S. patient data for both retai\u2026"},{"fy":2022,"lvl":"x","n":0,"adsh":"0001393052-23-000025","doc":"veev-20230131.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0001393052-24-000013","doc":"veev-20240131.htm","q":"If our competitors\u2019 products, services, or technologies become more accepted than our solutions, if they are successful in bringing their products or services to market earlier than we are, if their products or services are more technologic\u2026"},{"fy":2024,"lvl":3,"n":20,"adsh":"0001393052-25-000022","doc":"veev-20250131.htm","q":"For instance, as artificial intelligence (AI) technologies, including generative AI models, develop rapidly, threat actors are using these technologies to create sophisticated new attack methods that are increasingly automated, targeted, co\u2026"}]},{"cik":1393434,"name":"OCULAR THERAPEUTIX, INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-099288","doc":"d858657d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-499184","doc":"d46606d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001627","doc":"ocul-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001678","doc":"ocul-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001659","doc":"ocul-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002537","doc":"ocul-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002813","doc":"ocul-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002363","doc":"ocul-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002908","doc":"ocul-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002902","doc":"ocul-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002000","doc":"ocul-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":4,"adsh":"0001104659-26-010664","doc":"ocul-20251231x10k.htm","q":"Further, although we have governance procedures in place to vet the selection of specific software tools, the use of artificial intelligence solutions by us or any of our business partners may lead to the inadvertent disclosure of our confi\u2026"}]},{"cik":1393548,"name":"CLICKSTREAM CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":1,"adsh":"0001214659-17-005393","doc":"d82817110k.htm","q":"Esterhuizen founded Contextuall, an award-winning machine learning consultancy."}]},{"cik":1393772,"name":"WEED, INC.","industry":"Pharma & biotech","sic":8731,"state":"AZ","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-004420","doc":"weed_10k-17636b.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001199835-20-000096","doc":"form-10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001199835-21-000170","doc":"form-10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001199835-22-000183","doc":"weed-10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001199835-23-000186","doc":"weed-10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001096906-24-000701","doc":"weed-10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001096906-25-000350","doc":"budz-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":2,"adsh":"0001096906-26-000507","doc":"budz_10k.htm","q":"During fiscal 2025, the Company focused on asset preservation and the modernization of its business model, which included streamlining international operations and exploring the integration of blockchain and AI technologies within the regul\u2026"}]},{"cik":1393935,"name":"THINSPACE TECHNOLOGY, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001013762-15-000275","doc":"f10k2014_thinspace.htm","q":null}]},{"cik":1394056,"name":"ONE STOP SYSTEMS, INC.","industry":"Computers & chips","sic":3571,"state":"CA","cells":[{"fy":2018,"lvl":3,"n":18,"adsh":"0001564590-19-008790","doc":"0001564590-19-008790.txt","q":"These applications include computationally intense areas like artificial intelligence (AI), deep learning, seismic exploration, media and entertainment, test and measurement, medical imaging, genomics, cyber security and defense."},{"fy":2019,"lvl":3,"n":26,"adsh":"0001564590-20-013196","doc":"oss-10k_20191231.htm","q":"Through our AI on the Fly \u00ae initiative, we are delivering innovative specialized high-performance edge computing building blocks and platforms used by our customers to develop products for scientists, engineers, creators and other professio\u2026"},{"fy":2020,"lvl":3,"n":32,"adsh":"0001564590-21-015480","doc":"oss-10k_20201231.htm","q":"Factors such as increase in load on the cloud infrastructure globally and rises in artificial intelligence (AI) applications, are the major factors driving the growth of the edge computing market."},{"fy":2021,"lvl":3,"n":65,"adsh":"0001564590-22-011679","doc":"oss-10k_20211231.htm","q":"The third segment is called AI Transportables."},{"fy":2022,"lvl":3,"n":122,"adsh":"0000950170-23-009473","doc":"oss-20221231.htm","q":"The Company designs, manufactures, and markets specialized high-performance compute and storage hardware, software, and systems, which are designed to target edge artificial intelligence (\u201cAI\u201d) Transportable deployments."},{"fy":2023,"lvl":3,"n":109,"adsh":"0000950170-24-034668","doc":"oss-20231231.htm","q":"The Company designs, manufactures, and markets specialized rugged high-performance compute (\"HPC\"), high speed switch fabrics and storage systems, which are designed to target edge applications for artificial intelligence (\"AI\") / machine l\u2026"},{"fy":2024,"lvl":3,"n":82,"adsh":"0000950170-25-041974","doc":"oss-20241231.htm","q":"The Company designs, manufactures, and markets specialized rugged high-performance compute (\"HPC\"), high speed switch fabrics and storage systems, which are designed to target edge applications for artificial intelligence (\"AI\") / machine l\u2026"},{"fy":2025,"lvl":3,"n":84,"adsh":"0001193125-26-114051","doc":"oss-20251231.htm","q":"The Company designs, manufactures, and markets specialized rugged high-performance compute (\"HPC\"), high speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence (\"AI\") / machine \u2026"}]},{"cik":1394319,"name":"TRACON PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2015,"lvl":1,"n":1,"adsh":"0001558370-16-003288","doc":"tcon-20151231x10k.htm","q":"Bitar is a certified public accountant and received an M.A.I.S. from the University of West Florida and a B.S. in Business Administration (Accounting) from Old Dominion University."},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002953","doc":"tcon-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003925","doc":"tcon-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005597","doc":"tcon-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007520","doc":"tcon-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008957","doc":"tcon-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010475","doc":"tcon-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-003313","doc":"tcon-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-026205","doc":"tcon-20231231.htm","q":null}]},{"cik":1395848,"name":"ADESTO TECHNOLOGIES CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-523800","doc":"d153286d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005169","doc":"iots-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001978","doc":"iots-20171231x10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001558370-19-002243","doc":"iots-20181231x10k.htm","q":"A sample of our portfolio of full-custom ASICs includes: \u00b7 Satellite L-band transceivers \u00b7 Analog-baseband ASIC for broadband wireless access \u00b7 Embedded ASIC for critical industrial flow-control 5 Table of Contents \u00b7 Precision digitization \u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001558370-20-002795","doc":"iots-20191231x10k.htm","q":"A sample of our portfolio of full-custom ASICs includes: \u00b7 Satellite L-band transceivers \u00b7 Analog-baseband ASIC for broadband wireless access \u00b7 Embedded ASIC for critical industrial flow-control \u00b7 Precision digitization ASIC for portable DN\u2026"}]},{"cik":1395937,"name":"SYNDAX PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-081863","doc":"d322633d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004911","doc":"sndx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006772","doc":"sndx-10k_20181231.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-009016","doc":"sndx-10k_20191231.htm","q":"Subsequent Events On January 30, 2020, the Company entered into a securities purchase agreement (the \u201cPurchase Agreement\u201d) with five life sciences investors, including Biotechnology Value Fund, L.P., Boxer Capital and AI Life Sciences Inves\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012607","doc":"sndx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008112","doc":"sndx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005079","doc":"sndx-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":15,"adsh":"0000950170-24-021253","doc":"sndx-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":17,"adsh":"0000950170-25-030394","doc":"sndx-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-076536","doc":"sndx-20251231.htm","q":null}]},{"cik":1396536,"name":"DUOS TECHNOLOGIES GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":2,"adsh":"0001264931-15-000168","doc":"iosa10k_r1.htm","q":"Since its inception Duos has provided a broad variety of sophisticated, artificial intelligence-based technology applications and turnkey engineered solutions to a growing range of clientele."},{"fy":2015,"lvl":"x","n":3,"adsh":"0001553350-16-001818","doc":"duot_10k.htm","q":"(\u0093Duos\u0094 or the \u0093Company\u0094) is primarily engaged in the design and deployment of state-of-the-art, artificial intelligence driven intelligent technologies systems and IT Infrastructure services."},{"fy":2016,"lvl":"x","n":9,"adsh":"0001553350-17-000333","doc":"duot_10k.htm","q":"Tunnel and Bridge Security \u00b7 A suite of artificial intelligence-based homeland security applications for the security of critical tunnels and bridges."},{"fy":2017,"lvl":"x","n":11,"adsh":"0001553350-18-000285","doc":"duot_10k.htm","q":"The anomalies are detected through a combination of visual inspections, utilizing the Company\u0092s proprietary remote user interface which displays ultra-high definition images of a 360-degree view of each rail car, and by a growing number of \u2026"},{"fy":2018,"lvl":3,"n":27,"adsh":"0001553350-19-000375","doc":"duot_10k.htm","q":"In January 2019, the Company launched a dedicated Artificial Intelligence program truevue360\u0099 through its subsidiary, TrueVue360, Inc., (\u0093TrueVue360\u0094) with the objective of focusing the Company\u0092s advanced intelligent technologies in the are\u2026"},{"fy":2020,"lvl":"x","n":57,"adsh":"0001553350-21-000232","doc":"duot_10k.htm","q":"The Company, based in Jacksonville, Florida, oversees its wholly owned subsidiary, duostech\u0099 which employs approximately 59 people and is a technology integrator, software applications and artificial intelligence (\u0093AI\u0094) company with a stron\u2026"},{"fy":2021,"lvl":"x","n":46,"adsh":"0001553350-22-000281","doc":"duot_10k.htm","q":"The Company, based in Jacksonville, Florida, oversees its wholly owned subsidiary, duostech\u2122 which employs approximately 68 people and is a technology company which designs, develops, deploys and operates intelligent technology solutions wi\u2026"},{"fy":2022,"lvl":3,"n":52,"adsh":"0001553350-23-000241","doc":"duot_10k.htm","q":"The Company, based in Jacksonville, Florida, oversees its wholly owned subsidiary, duostech\u2122 and employs approximately 75 people and is a technology company which designs, develops, deploys and operates intelligent technology solutions with\u2026"},{"fy":2023,"lvl":3,"n":47,"adsh":"0001079973-24-000473","doc":"duot_10k-123123.htm","q":"The Company, based in Jacksonville, Florida, oversees its wholly owned subsidiary, duostech\u2122 and employs approximately 71 people and is a technology company which designs, develops, deploys and operates intelligent technology solutions with\u2026"},{"fy":2024,"lvl":3,"n":86,"adsh":"0001079973-25-000555","doc":"duos_10k-123124.htm","q":"Still headquartered in Jacksonville, Florida, Duos now manages three, wholly owned subsidiaries, duostech\u2122, Duos Edge AI Inc., (\u201cDuos Edge\u201d) and Duos Energy Corporation (\u201cDuos Energy\u201d)."},{"fy":2025,"lvl":3,"n":103,"adsh":"0001079973-26-000405","doc":"duos_10k-123125.htm","q":"Still headquartered in Jacksonville, Florida, Duos now manages three, wholly owned subsidiaries, duostech\u00ae, Duos Edge AI Inc., (\u201cDuos Edge\u201d) and Duos Energy Corporation (\u201cDuos Energy\u201d)."}]},{"cik":1396633,"name":"SUMMER ENERGY HOLDINGS INC","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001445866-15-000352","doc":"summerenergy10k12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001445866-16-001803","doc":"summer10k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001445866-17-000333","doc":"summer10k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001445866-18-000304","doc":"sume_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001445866-19-000404","doc":"sume_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001445866-20-000261","doc":"sume_10k.htm","q":null}]},{"cik":1396814,"name":"PACIRA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001396814-15-000003","doc":"pcrx-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011728","doc":"pcrx-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001396814-17-000009","doc":"pcrx-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001396814-18-000009","doc":"pcrx-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001396814-19-000008","doc":"pcrx-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001396814-20-000008","doc":"pcrx-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001396814-21-000014","doc":"pcrx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001396814-22-000021","doc":"pcrx-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":3,"adsh":"0001396814-23-000010","doc":"pcrx-20221231.htm","q":"A simulation lab is equipped with eight advanced ultrasound machines equipped with artificial intelligence and 3-D training software in addition to professional medical lighting and in-ceiling cameras."},{"fy":2023,"lvl":2,"n":14,"adsh":"0001396814-24-000030","doc":"pcrx-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":15,"adsh":"0001396814-25-000041","doc":"pcrx-20241231.htm","q":"In addition, certain factors, such as growth through acquisitions, rapid technology evolution, including increased adoption of artificial intelligence, and geopolitical events, have increased cybersecurity risks."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001628280-26-012297","doc":"pcrx-20251231.htm","q":"In addition, certain factors, such as growth through acquisitions, rapid technology evolution, including increased adoption of artificial intelligence, or AI, and geopolitical events, have increased cybersecurity risks."}]},{"cik":1397183,"name":"IVEDA SOLUTIONS, INC.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-016334","doc":"v403562_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-010721","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":30,"adsh":"0001493152-22-008309","doc":"form10-k.htm","q":"General Iveda specializes in AI and digital transformation technologies with real-world applications that improve quality of life and safety worldwide."},{"fy":2022,"lvl":"x","n":31,"adsh":"0001493152-23-010283","doc":"form10-k.htm","q":"Overview Iveda specializes in AI and digital transformation technologies with real-world applications that improve quality of life and safety worldwide."},{"fy":2023,"lvl":"x","n":50,"adsh":"0001493152-24-012417","doc":"form10-k.htm","q":"Overview Iveda specializes in AI and digital transformation technologies with real-world applications that improve quality of life and safety worldwide."},{"fy":2024,"lvl":"x","n":34,"adsh":"0001641172-25-004833","doc":"form10-k.htm","q":"Overview Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients wo\u2026"},{"fy":2025,"lvl":"x","n":34,"adsh":"0001493152-26-014179","doc":"form10-k.htm","q":"Overview Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients wo\u2026"}]},{"cik":1397951,"name":"CYBERGY HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001477932-15-002383","doc":"cybg_10k.htm","q":null}]},{"cik":1398529,"name":"GREENKRAFT, INC.","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001517126-15-000103","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001517126-16-000328","doc":"gkit-20151231_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001511164-17-000237","doc":"f10kv18532017.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001511164-18-000234","doc":"greenkraft10-kdraftv4revised.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-007088","doc":"form10-k.htm","q":null}]},{"cik":1398733,"name":"AQUESTIVE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-004934","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-005499","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-007811","doc":"brhc10021358_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-005393","doc":"aqst-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-010180","doc":"aqst-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-009010","doc":"aqst-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-010506","doc":"aqst-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":34,"adsh":"0001398733-26-000018","doc":"aqst-20251231.htm","q":"We rely significantly on information technology and any failure, inadequacy, interruption or security lapse of that technology, including any cybersecurity incidents (including those facilitated by AI) , could harm our ability to operate ou\u2026"}]},{"cik":1398805,"name":"BEAM GLOBAL","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001019687-15-001181","doc":"envision_10k-123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005621","doc":"envision_10k-123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001683168-17-000730","doc":"envision_10k-123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-18-000836","doc":"envision_10k-123117.htm","q":null},{"fy":2018,"lvl":"x","n":6,"adsh":"0001683168-19-000735","doc":"envision_10k-123118.htm","q":"We have recently engaged an artificial intelligence (AI) company, Kriya Ai, to assist us in the identification of prospective customers."},{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-20-001022","doc":"envision_10k-123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-001097","doc":"beam_10k-123120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-002236","doc":"beam_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-002090","doc":"beam_i10k-123122.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001683168-24-002470","doc":"beam_i10k-123123.htm","q":"We believe that the U.S. and global utility grids lack sufficient capacity to supply enough electricity to all the new EVs, AI, data centers, electrified industry and other electrical devices which are becoming increasingly available to con\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001683168-25-002475","doc":"beam_i10k-123124.htm","q":"We believe that combining machine learning with AI in the type of sensor rich environments which we can deploy will create significant revenue opportunities."}]},{"cik":1399488,"name":"IN MEDIA CORP","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001078782-15-000491","doc":"f10k123114_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001078782-17-001397","doc":"f10k123115_10k.htm","q":null}]},{"cik":1399529,"name":"DICERNA PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-089221","doc":"d851674d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500111","doc":"d100392d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-104169","doc":"d327055d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-075129","doc":"d507480d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001399529-19-000005","doc":"a2018drna_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001399529-20-000009","doc":"a2019_drnax10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001399529-21-000042","doc":"drna-20201231.htm","q":null}]},{"cik":1400118,"name":"SAGIMET BIOSCIENCES INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2023,"lvl":3,"n":34,"adsh":"0001558370-24-003812","doc":"sgmt-20231231x10k.htm","q":"Denifanstat-treated patients also showed statistically significant fibrosis improvement by \u2265 1 stage with no worsening of MASH (denifanstat 41% vs. placebo 18%, p=0.0051), and also showed statistical significance in fibrosis improvement by \u2026"},{"fy":2024,"lvl":3,"n":46,"adsh":"0001558370-25-002747","doc":"sgmt-20241231x10k.htm","q":"Denifanstat showed also statistical significance in fibrosis improvement as measured by an artificial intelligence (AI) digital pathology-based qFibrosis assessment."},{"fy":2025,"lvl":3,"n":54,"adsh":"0001104659-26-026140","doc":"sgmt-20251231x10k.htm","q":"Only the FASN inhibitor, but not semaglutide, showed significant reduction of liver fibrosis by a digital AI pathology assessment."}]},{"cik":1400482,"name":"KUBOTA PHARMACEUTICAL HOLDINGS CO LTD","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001400482-15-000033","doc":"acucela-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001400482-16-000127","doc":"acucela2015q410k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001400482-17-000031","doc":"acucela2016q410k.htm","q":null}]},{"cik":1401040,"name":"DIAMEDICA THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MN","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-005272","doc":"dmtp20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-005906","doc":"dmtp20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-005541","doc":"dmtp20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-006163","doc":"dmtp20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008189","doc":"dmtp20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-008522","doc":"dmtp20231231_10k.htm","q":null},{"fy":2024,"lvl":2,"n":7,"adsh":"0001437749-25-008018","doc":"dmtp20241231_10k.htm","q":"We believe these enrollment difficulties may be due, in part, to hospital and medical facility staffing shortages; inclusion/exclusion criteria in the study protocol; concerns managing logistics and protocol compliance for participants disc\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001437749-26-010342","doc":"dmtp20251231_10k.htm","q":"We believe these conditions may be due to hospital and medical facility staffing shortages; inclusion/exclusion criteria in the study protocol; concerns managing logistics and protocol compliance for participants discharged from the hospita\u2026"}]},{"cik":1401395,"name":"NEPTUNE WELLNESS SOLUTIONS INC.","industry":"Pharma & biotech","sic":2834,"state":"QC","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0000950170-22-012532","doc":"nept-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-033091","doc":"nept-20230331.htm","q":null}]},{"cik":1401667,"name":"PUMA BIOTECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001193","doc":"pbyi-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013716","doc":"pbyi-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003090","doc":"pbyi-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005152","doc":"pbyi-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005830","doc":"pbyi-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007591","doc":"pbyi-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009840","doc":"pbyi-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005164","doc":"pbyi20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-005233","doc":"pbyi20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-006121","doc":"pbyi20231231_10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001437749-25-005496","doc":"pbyi20241231_10k.htm","q":"Further, Washington State enacted a broadly applicable law to protect the privacy of personal health information known as the \u201cMy Health My Data Act,\u201d which generally requires affirmative consent for the collection, use, or sharing of any \u201c\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001437749-26-005891","doc":"pbyi20251231_10k.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques \u2013 including artificial intelligence \u2013 that are designed to circumvent controls, to av\u2026"}]},{"cik":1401680,"name":"CORNERSTONE ONDEMAND INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":4,"adsh":"0001401680-15-000006","doc":"a10-k20141231.htm","q":"In addition, the acquisition adds a seasoned team with deep machine learning and big data analytics expertise to our portfolio of talented professionals which is expected to create synergies and continue to strengthen our core talent manage\u2026"},{"fy":2015,"lvl":1,"n":4,"adsh":"0001401680-16-000026","doc":"a10-k20151231q4.htm","q":"In addition, we believe the acquisition adds a team with deep machine learning and big data analytics expertise to our portfolio of talented professionals which is expected to create synergies and continue to strengthen our core talent mana\u2026"},{"fy":2016,"lvl":1,"n":3,"adsh":"0001401680-17-000004","doc":"a10-k20161231q4.htm","q":"These solutions provide robust standard and custom reporting and dashboards as well as machine learning and prescriptive and predictive analytics to enable clients to make smarter, more strategic, and more informed decisions."},{"fy":2017,"lvl":1,"n":2,"adsh":"0001401680-18-000004","doc":"a10-k20171231q4.htm","q":"The access to personalized content delivered at scale with Cornerstone\u2019s machine learning technology builds a culture of continuous learning, boosting employee engagement and retention."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001401680-19-000006","doc":"a10-k20181231q4.htm","q":"Our platform leverages technology powered by a highly refined machine learning system for human capital management."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001401680-20-000004","doc":"a10-k20191231q4.htm","q":"Our solution leverages technology powered by a highly refined machine learning system for people development."},{"fy":2020,"lvl":2,"n":5,"adsh":"0001401680-21-000011","doc":"csod-20201231.htm","q":"Our solutions leverage technology powered by a highly refined machine learning system for people development."}]},{"cik":1401708,"name":"NANOSTRING TECHNOLOGIES INC","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091371","doc":"d832779d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-501709","doc":"d53508d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001401708-17-000015","doc":"nstg-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001401708-18-000058","doc":"nstg-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001401708-19-000055","doc":"nstg-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001401708-20-000039","doc":"nstg-123119x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001401708-21-000033","doc":"nstg-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001401708-22-000051","doc":"nstg-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":3,"adsh":"0001401708-23-000052","doc":"nstg-20221231.htm","q":"This cell segmentation process uses cell membrane and protein morphology images, a machine-learning augmented cell segmentation algorithm and transcript-based segmentation refinement to achieve precise single-cell segmentation results from \u2026"}]},{"cik":1401914,"name":"DARE BIOSCIENCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001834","doc":"ceru-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014403","doc":"ceru-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005798","doc":"ceru-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006989","doc":"dare-10k_20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001401914-19-000015","doc":"dare-20181231x10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001401914-20-000042","doc":"dare-20191231x10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001401914-21-000041","doc":"dare-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001401914-22-000032","doc":"dare-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001401914-23-000013","doc":"dare-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001401914-24-000016","doc":"dare-20231231.htm","q":"However, cyber-related criminal activities continue to evolve and increase in frequency and sophistication, including as a result of advancements in generative artificial intelligence technology, and our security measures and controls may n\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001401914-25-000012","doc":"dare-20241231.htm","q":"However, cyber-related criminal activities continue to evolve and increase in frequency and sophistication, including as a result of advancements in generative artificial intelligence technology, and our security measures and controls may n\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001401914-26-000004","doc":"dare-20251231.htm","q":"The measures include (1) initiating rulemaking to close the \u201cadequate provision\u201d requirement, which permits drug manufacturers to include a general statement of risk alongside a webpage or publication and 1-800 number to access the full pro\u2026"}]},{"cik":1402328,"name":"SUNSHINE BIOPHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001354488-16-006700","doc":"sbfm_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-003365","doc":"sbfm_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003495","doc":"smbf_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-004354","doc":"sbfm_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-004731","doc":"sbfm_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003507","doc":"sbfm_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-001788","doc":"sunshine_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-002128","doc":"sunshine_i10k-123122.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-24-001818","doc":"sunshine_i10k-123123.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001683168-25-002184","doc":"sunshine_i10k-123124.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001683168-26-002644","doc":"sunshine_i10k-123125.htm","q":"Natan has served as a member of the Board of Directors and Audit Committee Chair of FIEE, Inc., a technology company specializing in SAAS solutions and AI software development."}]},{"cik":1402371,"name":"ELRAY RESOURCES, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-002222","doc":"elra_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009287","doc":"elra_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001669","doc":"elra_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001760","doc":"elra_10k.htm","q":null}]},{"cik":1402436,"name":"SS&C TECHNOLOGIES HOLDINGS INC","industry":"Software & IT services","sic":7372,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065621","doc":"d858109d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013602","doc":"ssnc-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002806","doc":"ssnc-10k_20161231.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-003827","doc":"ssnc-10k_20171231.htm","q":"New technology incorporating machine learning and Robotic Process Automation (\u201cRPA\u201d) are gaining traction in the financial technology industry."},{"fy":2018,"lvl":2,"n":5,"adsh":"0001564590-19-005753","doc":"ssnc-10k_20181231.htm","q":"New technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning and Robotic Process Automation (\u201cRPA\u201d) are gaining traction in the financial technology industry."},{"fy":2019,"lvl":2,"n":5,"adsh":"0001564590-20-007695","doc":"ssnc-10k_20191231.htm","q":"New technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning and Robotic Process Automation (\u201cRPA\u201d), are gaining traction in the financial technology industry."},{"fy":2020,"lvl":2,"n":7,"adsh":"0001564590-21-008862","doc":"ssnc-10k_20201231.htm","q":"New technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning and Robotic Process Automation (\u201cRPA\u201d), are gaining traction in the financial technology industry."},{"fy":2021,"lvl":2,"n":9,"adsh":"0000950170-22-002107","doc":"ssnc-20211231.htm","q":"In addition, new technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning and Robotic Process Automation (\u201cRPA\u201d), is gaining traction in the financial technology industry."},{"fy":2022,"lvl":2,"n":10,"adsh":"0000950170-23-005072","doc":"ssnc-20221231.htm","q":"In addition, new technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning and Robotic Process Automation (\u201cRPA\u201d), is gaining traction in the financial technology industry."},{"fy":2023,"lvl":2,"n":10,"adsh":"0000950170-24-022080","doc":"ssnc-20231231.htm","q":"In addition, new technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning and Robotic Process Automation (\u201cRPA\u201d), is gaining traction in the financial technology industry."},{"fy":2024,"lvl":3,"n":36,"adsh":"0000950170-25-030421","doc":"ssnc-20241231.htm","q":"In addition, new technology incorporating artificial intelligence (\u201cAI\u201d), including machine learning, Robotic Process Automation (\u201cRPA\u201d), and Generative AI, is gaining traction in the financial technology industry."},{"fy":2025,"lvl":3,"n":79,"adsh":"0001193125-26-076745","doc":"ssnc-20251231.htm","q":"In addition, our 2022 acquisition of Blue Prism enables us to deploy intelligent automation and robotic process automation (\u201cRPA\u201d), including artificial intelligence (\u201cAI\u201d) driven and agentic solutions, to improve the efficiency of our own \u2026"}]},{"cik":1402479,"name":"MEDAVAIL HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"ON","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002145","doc":"f10k2014_myoscorporation.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-012069","doc":"f10k2015_myosrenstech.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003042","doc":"f10k2016_myosrenstech.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003522","doc":"f10k2017_myosrenstechnology.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-004963","doc":"f10k2018_myosrenstech.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-007278","doc":"f10k2019_myosrenstech.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-006267","doc":"medavail-20201231.htm","q":null}]},{"cik":1402479,"name":"MEDAVAIL HOLDINGS, INC.","industry":"Retail","sic":5912,"state":"AZ","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001402479-22-000029","doc":"medavail-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001402479-23-000029","doc":"medavail-20221231.htm","q":null}]},{"cik":1402829,"name":"ORION GROUP HOLDINGS INC","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001402829-15-000007","doc":"orn12312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001402829-16-000040","doc":"orn12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001402829-17-000009","doc":"orn12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001402829-18-000003","doc":"orn1231201710-kdoc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001402829-19-000010","doc":"orn1231201810-kdoc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001402829-20-000007","doc":"orn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001402829-21-000004","doc":"orn-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001402829-22-000007","doc":"orn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001402829-23-000010","doc":"orn-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001402829-24-000015","doc":"orn-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001402829-25-000005","doc":"orn-20241231x10k.htm","q":"Additionally, as population and suburban areas grow, so does the continued need for medical and educational facilities. 6 Table of Contents Data centers Data centers are critical infrastructure for Artificial Intelligence (AI), and the numb\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001402829-26-000011","doc":"orn-20251231x10k.htm","q":"A rapidly growing portion of our concrete activity relates to data centers, which are critical infrastructure supporting artificial intelligence, cloud computing, and increased digital consumption."}]},{"cik":1402945,"name":"PROGRESSIVE CARE INC.","industry":"Retail","sic":5912,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009839","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-011671","doc":"rxmd20221231_10k.htm","q":null}]},{"cik":1403433,"name":"AMERICA GREENER TECHNOLOGIES, INC.","industry":"Construction","sic":1700,"state":"AZ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001354488-15-004619","doc":"agrn_10k.htm","q":null}]},{"cik":1403708,"name":"EVOKE PHARMA INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001287","doc":"evok-10k_20141231.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001564590-16-014408","doc":"evok-10k_20151231.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001564590-17-004426","doc":"evok-10k_20161231.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001564590-18-004725","doc":"evok-10k_20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001564590-19-006404","doc":"evok-10k_20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001564590-20-010254","doc":"evok-10k_20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001564590-21-012510","doc":"evok-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009118","doc":"evok-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008942","doc":"evok-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-031435","doc":"evok-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-038712","doc":"evok-20241231.htm","q":null}]},{"cik":1403752,"name":"ZYMEWORKS INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-065609","doc":"d662324d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-058902","doc":"d829510d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001403752-21-000005","doc":"zyme-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001403752-22-000005","doc":"zyme-20211231.htm","q":null}]},{"cik":1404281,"name":"ELEDON PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-107051","doc":"d832380d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-499163","doc":"d227183d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-069741","doc":"d291766d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007314","doc":"nvus-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009631","doc":"nvus-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011260","doc":"nvus-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016828","doc":"nvus-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011698","doc":"eldn-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011011","doc":"eldn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038091","doc":"eldn-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-042754","doc":"eldn-20241231.htm","q":"Further, cybersecurity threats and the techniques used in cyberattacks change, develop and evolve rapidly, including from emerging technologies, such as advanced forms of artificial intelligence and quantum computing."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-116164","doc":"eldn-20251231.htm","q":"Further, cybersecurity threats and the techniques used in cyberattacks change, develop and evolve rapidly, including from emerging technologies, such as advanced forms of artificial intelligence and quantum computing."}]},{"cik":1404644,"name":"NEUROGENE INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093873","doc":"d851032d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-503435","doc":"d124615d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-076939","doc":"d342545d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-079210","doc":"d478892d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-066506","doc":"d640252d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-071545","doc":"d882730d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-005630","doc":"nltx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004491","doc":"nltx-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":10,"adsh":"0001628280-23-008602","doc":"nltx-20221231.htm","q":"With the introduction of machine learning to this process, we believe timelines for developing potential candidates can be accelerated."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001404644-24-000020","doc":"ngne-20231231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and anti-discrimination."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001404644-25-000012","doc":"ngne-20241231.htm","q":"The proposals are intended to improve patient safety and public health through appropriate regulatory oversight, improve the traceability of medical devices, improve the regulation of the rules governing software and AI as medical devices a\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001404644-26-000019","doc":"ngne-20251231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias and discrimination. 25 Table \u2026"}]},{"cik":1404655,"name":"HUBSPOT INC","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-079000","doc":"d849700d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013204","doc":"hubs-10k_20151231.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001564590-17-001694","doc":"hubs-10k_20161231.htm","q":null},{"fy":2017,"lvl":2,"n":5,"adsh":"0001564590-18-001962","doc":"hubs-10k_20171231.htm","q":"Business Acquisition and Purchase of Technology On September 20, 2017, the Company acquired 100% of the equity interests of Motion AI, Inc., a Delaware technology corporation that allows users to scale one-to-one communications."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-002699","doc":"hubs-10k_20181231.htm","q":"Business Acquisition and Purchase of Technology On September 20, 2017, the Company acquired 100% of the equity interests of Motion AI, Inc., a Delaware technology corporation that allows users to scale one-to-one communications."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-004381","doc":"hubs-10k_20191231.htm","q":"In 2017, the Company acquired 100 % of the equity interests of Motion AI, Inc., a Delaware technology corporation that allows users to scale one-to-one communications."},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006083","doc":"hubs-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001221","doc":"hubs-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":6,"adsh":"0000950170-23-003077","doc":"hubs-20221231.htm","q":"The European Union is also currently in the process of finalizing its Artificial Intelligence Act (\u201cAI Act\u201d), which aims to ensure that AI systems are safe and lawful and respect fundamental rights."},{"fy":2023,"lvl":3,"n":54,"adsh":"0000950170-24-015277","doc":"hubs-20231231.htm","q":"The following is a summary of the risk factors detailed in Item 1A: \u2022 We are dependent upon customer renewals, the addition of new customers, increased revenue from existing customers and the continued growth of the market for a customer pl\u2026"},{"fy":2024,"lvl":3,"n":91,"adsh":"0000950170-25-018873","doc":"hubs-20241231.htm","q":"The following is a summary of the risk factors detailed in Item 1A: \u2022 We are dependent upon customer renewals, the addition of new customers, increased revenue from existing customers and the continued growth of the market for a customer pl\u2026"},{"fy":2025,"lvl":3,"n":173,"adsh":"0001193125-26-046646","doc":"hubs-20251231.htm","q":"We deliver seamless connection for customer-facing teams with a unified platform that includes three layers: Artificial Intelligence (\"AI\")-powered agents and engagement hubs, a Smart customer relationship management product (\u201cCRM\u201d), and a \u2026"}]},{"cik":1404804,"name":"OMNITEK ENGINEERING CORP","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001445866-15-000348","doc":"omnitek10k03182015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001445866-16-001805","doc":"omnitek10k12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001445866-17-000370","doc":"omtk_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001445866-18-000309","doc":"omtk_10k1.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001445866-19-000341","doc":"omtk_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001445866-20-000452","doc":"omtk_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001096906-21-000663","doc":"omtk_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001096906-22-000786","doc":"omtk-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001096906-23-000840","doc":"omtk-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001096906-24-000839","doc":"omtk-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001096906-25-000515","doc":"omtk-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001096906-26-000551","doc":"omtk-20251231_10k.htm","q":null}]},{"cik":1404935,"name":"THC THERAPEUTICS, INC.","industry":"Construction machinery","sic":3523,"state":"NV","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-20-006275","doc":"thct_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001755","doc":"thct_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-22-008875","doc":"thct_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-000896","doc":"thct_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-26-001083","doc":"thct_10k.htm","q":null}]},{"cik":1404943,"name":"METASTAT, INC.","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001415889-15-001903","doc":"mtst10k_feb282015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001415889-16-006045","doc":"mtst10k_feb292016.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001415889-17-000875","doc":"mtst10k_feb282017.htm","q":null}]},{"cik":1404943,"name":"METASTAT, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-006005","doc":"mtst10k_feb282018.htm","q":null}]},{"cik":1408057,"name":"ICORECONNECT INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-005443","doc":"vmci_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-001309","doc":"vmci_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-001558","doc":"icct_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-002582","doc":"icct_10ka.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-002455","doc":"icct_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-001672","doc":"icct_10k.htm","q":null}]},{"cik":1408278,"name":"SYNACOR, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001408278-15-000007","doc":"sync-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-513635","doc":"d127163d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005022","doc":"sync-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006086","doc":"sync-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007648","doc":"sync-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001408278-20-000055","doc":"sync-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001408278-21-000050","doc":"sync-20201231.htm","q":null}]},{"cik":1408356,"name":"SOLARCITY CORP","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000897","doc":"scty-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012549","doc":"scty-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003084","doc":"scty-10k_20161231.htm","q":null}]},{"cik":1408443,"name":"MILESTONE PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"QC","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002106","doc":"mist-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003631","doc":"mist-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004205","doc":"mist-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004871","doc":"mist-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001558370-24-003666","doc":"mist-20231231x10k.htm","q":"Our internal computer systems and those of our current and any future collaborators and other contractors or consultants are vulnerable to a variety of evolving threats, including but not limited to damage from malicious code (such as compu\u2026"},{"fy":2024,"lvl":3,"n":27,"adsh":"0001558370-25-002849","doc":"mist-20241231x10k.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and healthcare models to limit \u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001104659-26-032415","doc":"mist-20251231x10k.htm","q":"Our internal computer systems and those of our current and any future collaborators, contractors, consultants, or other third parties with whom we work, are vulnerable to a variety of evolving threats, including but not limited to damage fr\u2026"}]},{"cik":1409197,"name":"BESPOKE EXTRACTS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-017377","doc":"f10k2018_bespokeextracts.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-19-026230","doc":"f10k2019_bespokeextracts.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-20-043297","doc":"f10k2020_bespokeextracts.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-21-065002","doc":"f10k2021_bespoke.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-033118","doc":"f10k2022_bespoke.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-033935","doc":"ea0202767-10k_bespoke.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-033608","doc":"ea0233625-10k_bespoke.htm","q":null}]},{"cik":1410098,"name":"CORMEDIX INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001120","doc":"crmd_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001354488-16-006585","doc":"crmd_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001654954-17-002094","doc":"crmd_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002777","doc":"crmd_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-006521","doc":"f10k2019_cormedixinc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018684","doc":"f10k2020_cormedixinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015852","doc":"f10k2021_cormedixinc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024310","doc":"f10k2022_cormedixinc.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001213900-24-021585","doc":"ea0201177-10k_cormedix.htm","q":"For example, as artificial intelligence continues to evolve, cyber-attackers could also use artificial intelligence to develop malicious code and sophisticated phishing attempts."},{"fy":2024,"lvl":0,"n":0,"adsh":"0001013762-25-001852","doc":"ea0234537-10k_cormedix.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-023889","doc":"ea0278169-10k_cormedix.htm","q":null}]},{"cik":1410172,"name":"RUBICON TECHNOLOGY, INC.","industry":"Computers & chips","sic":3674,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-090644","doc":"d859564d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-502855","doc":"d287501d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-085369","doc":"d123979d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-003197","doc":"f10k2017_rubicontechno.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004650","doc":"f10k2018_rubicontech.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-007034","doc":"f10k2019_rubicontech.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-017083","doc":"f10k2020_rubicontech.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015233","doc":"f10k2021_rubicontech.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024745","doc":"f10k2022_rubicontech.htm","q":null}]},{"cik":1410384,"name":"Q2 HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001410384-15-000021","doc":"a123114qtwo10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001410384-16-000173","doc":"a123115qtwo10k.htm","q":null},{"fy":2016,"lvl":1,"n":2,"adsh":"0001410384-17-000017","doc":"a123116qtwo10k.htm","q":"We also recently introduced Q2 SMART, which utilizes machine learning and statistical analysis to unlock actionable customer insights to drive improved targeting, products, growth and revenue across channels."},{"fy":2017,"lvl":1,"n":3,"adsh":"0001410384-18-000012","doc":"a123117qtwo10k.htm","q":"We also introduced Q2 SMART, which utilizes machine learning and statistical analysis to unlock actionable customer insights to drive improved targeting, products, growth and revenue across channels."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001410384-19-000015","doc":"a181231qtwo10k.htm","q":null},{"fy":2019,"lvl":2,"n":5,"adsh":"0001410384-20-000025","doc":"a191231qtwo10k.htm","q":"With the PrecisionLender acquisition, we added to our portfolio of solutions PrecisionLender's data-driven sales enablement, pricing and portfolio management platform to support commercial lending for financial institutions globally, as wel\u2026"},{"fy":2020,"lvl":2,"n":5,"adsh":"0001410384-21-000022","doc":"qtwo-20201231.htm","q":"With the PrecisionLender acquisition, we added to our portfolio of solutions PrecisionLender's data-driven sales enablement, pricing and portfolio management platform to support commercial lending for financial institutions globally, as wel\u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001410384-22-000013","doc":"qtwo-20211231.htm","q":"Our digital banking platform customers who leverage our Q2 Sentinel product are able to identify and block suspected fraudulent activity in real-time at the application layer, based on machine-learning and behavioral analytics, and notify o\u2026"},{"fy":2022,"lvl":3,"n":18,"adsh":"0001410384-23-000015","doc":"qtwo-20221231.htm","q":"Our digital banking platform customers who leverage our Q2 Sentinel product are able to identify and block suspected fraudulent activity in real-time at the application layer, based on machine-learning and behavioral analytics, and notify o\u2026"},{"fy":2023,"lvl":3,"n":43,"adsh":"0001410384-24-000015","doc":"qtwo-20231231.htm","q":"Our digital banking platform customers who leverage our Q2 Sentinel product are able to identify and block suspected fraudulent activity in real-time at the application layer, based on machine-learning and behavioral analytics, and notify o\u2026"},{"fy":2024,"lvl":3,"n":43,"adsh":"0001410384-25-000010","doc":"qtwo-20241231.htm","q":"The methods by which criminals seek to commit fraud are constantly changing, including the increasing use of AI to facilitate attacks, requiring financial services providers and their technology providers to continually modify their securit\u2026"},{"fy":2025,"lvl":3,"n":55,"adsh":"0001410384-26-000006","doc":"qtwo-20251231.htm","q":"At the same time, advancements in data analytics, automation, and AI are increasing the importance of modern, fast, flexible technology platforms that can support innovation while meeting stringent regulatory, security and resiliency requir\u2026"}]},{"cik":1410708,"name":"EMO CAPITAL CORP.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001372167-15-000063","doc":"emo10kajuly2014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001372167-15-000158","doc":"emo10kjul2015.htm","q":null}]},{"cik":1410939,"name":"IVERIC BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001507","doc":"a2223280zex-10_8.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010519","doc":"a2227440z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-001894","doc":"opth1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001410939-18-000013","doc":"opth1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001410939-19-000012","doc":"opth1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001410939-20-000009","doc":"iveric1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001410939-21-000007","doc":"opht-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410939-22-000015","doc":"isee-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410939-23-000025","doc":"isee-20221231.htm","q":null}]},{"cik":1411057,"name":"CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.","industry":"Pharma & biotech","sic":8731,"state":"TX","cells":[{"fy":2024,"lvl":"x","n":1,"adsh":"0001683168-24-006402","doc":"cannabisbio_i10k-053124.htm","q":"We have also engaged artificial intelligence services to generate translations of these materials in up to 100 additional languages."},{"fy":2025,"lvl":"x","n":1,"adsh":"0001683168-25-007174","doc":"cannabisbio_i10k-053125.htm","q":"Artificial intelligence services have also been engaged to generate translations of these materials in up to 100 additional languages."}]},{"cik":1411158,"name":"ANACOR PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002293","doc":"a2223421z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010583","doc":"a2227469z10-k.htm","q":null}]},{"cik":1411207,"name":"ALLISON TRANSMISSION HOLDINGS INC","industry":"Auto manufacturing","sic":3714,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-055034","doc":"d825977d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-469168","doc":"d107528d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-056079","doc":"d290286d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-047233","doc":"d503860d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001411207-19-000050","doc":"alsn-q410xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007355","doc":"alsn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006709","doc":"alsn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001427","doc":"alsn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002967","doc":"alsn-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-015192","doc":"alsn-20231231.htm","q":"Cyberattacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are increasingly using tools \u2013 including artificial intelligence \u2013 to evade detection and even remove forensic evidence."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-019379","doc":"alsn-20241231.htm","q":"Cyberattacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are increasingly using tools \u2013 including artificial intelligence \u2013 to evade detection and even remove forensic evidence."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-065627","doc":"alsn-20251231.htm","q":"Cyberattacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are increasingly using tools - including artificial intelligence - to evade detection and even remove forensic evidence."}]},{"cik":1411685,"name":"VISTAGEN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001415889-15-002221","doc":"vsta10k_mar312015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001415889-16-006331","doc":"vsta10k_mar312016.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-005976","doc":"vtgn10k_mar312017.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-006990","doc":"vtgn_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-007632","doc":"vtgn10k_mar312019.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-20-007107","doc":"vtgn10k_mar312020.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-007380","doc":"vtgn_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001851734-22-000349","doc":"vtgn20220331_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-018793","doc":"vtgn20230331_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001411685-24-000022","doc":"vtgn-20240331.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001411685-25-000041","doc":"vtgn-20250331.htm","q":null}]},{"cik":1411730,"name":"SOLARIS POWER CELLS, INC.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001528","doc":"form10-k.htm","q":null}]},{"cik":1411879,"name":"INNOVUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001415889-15-001153","doc":"innv10k_dec312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001415889-16-005397","doc":"innv_dec312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-001819","doc":"innv_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003500","doc":"innv10k_dec312017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-006219","doc":"innv20181231_10k.htm","q":null}]},{"cik":1411906,"name":"AMPIO PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-059240","doc":"d826182d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-479780","doc":"d63069d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-015100","doc":"v461079_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013087","doc":"tv487181_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002244","doc":"ampe-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001123","doc":"ampe-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002314","doc":"ampe-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004619","doc":"ampe-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004723","doc":"ampe-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-004090","doc":"ampe-20231231x10k.htm","q":null}]},{"cik":1412043,"name":"OPOWER, INC.","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091478","doc":"d831669d10k.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001193125-16-495278","doc":"d108897d10k.htm","q":"Our platform has integrated more than 500 billion pieces of customer information and subjected that data to advanced analysis and machine learning."}]},{"cik":1412067,"name":"CASCADIAN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":8731,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-085561","doc":"d884239d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-503582","doc":"d59850d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-076986","doc":"d323687d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-075320","doc":"d640776d10k.htm","q":null}]},{"cik":1412486,"name":"COCRYSTAL PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001415889-15-001157","doc":"cocp10k_dec312014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001415889-16-005091","doc":"cocp10k_dec312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-003110","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003708","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004386","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004916","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006211","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-007551","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009385","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":3,"n":15,"adsh":"0001493152-24-011613","doc":"form10-k.htm","q":"Artificial intelligence presents risks and challenges that can negatively impact our business."},{"fy":2024,"lvl":3,"n":15,"adsh":"0001641172-25-001496","doc":"form10-k.htm","q":"Artificial intelligence presents risks and challenges that can negatively impact our business."},{"fy":2025,"lvl":"x","n":20,"adsh":"0001493152-26-013838","doc":"form10-k.htm","q":"Artificial intelligence presents risks and challenges that can negatively impact our business."}]},{"cik":1413263,"name":"CHINA JO-JO DRUGSTORES, INC.","industry":"Retail","sic":5912,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-011825","doc":"f10k2019_chinajojodrugstores.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-017170","doc":"f10k2020_chinajojodrug.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-034697","doc":"f10k2021_chinajojodrugstores.htm","q":null}]},{"cik":1413447,"name":"NXP SEMICONDUCTORS N.V.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001413447-20-000009","doc":"nxp10-k.htm","q":"The four end-markets are Automotive, Industrial & IoT, Mobile, and Communication Infrastructure & Others. 4 Automotive Industrial & IoT Mobile Comm Infra & Others Key Applications ADAS/Radar Connected Infotainment Vehicle Networks Electrifi\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001413447-21-000011","doc":"nxpi-20201231.htm","q":"The four end-markets are Automotive, Industrial & IoT, Mobile, and Communication Infrastructure & Other. 3 Automotive Industrial & IoT Mobile Comm Infra & Other Key Applications ADAS/Radar Connected Infotainment Vehicle Networks Electrifica\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001413447-22-000008","doc":"nxpi-20211231.htm","q":"Our i.MX 9 series of application processors integrates hardware neural processing units across the entire series for acceleration of machine learning applications at the edge."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001413447-23-000006","doc":"nxpi-20221231.htm","q":"Our i.MX 9 series of application processors integrates hardware neural processing units across the entire series for acceleration of machine learning applications at the edge."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001413447-24-000013","doc":"nxpi-20231231.htm","q":"The MCX series also integrates our machine learning neural processing unit for machine learning applications."},{"fy":2024,"lvl":3,"n":18,"adsh":"0001413447-25-000019","doc":"nxpi-20241231.htm","q":"The MCX series also integrates our machine learning neural processing unit for machine learning applications. ii."},{"fy":2025,"lvl":3,"n":33,"adsh":"0001413447-26-000008","doc":"nxpi-20251231.htm","q":"The Kinara acquisition complements and expands NXP\u2019s solutions for AI-powered edge systems in the Industrial & IoT and Automotive end markets. 3 Reporting Segment NXP has one reportable segment representing the entity as a whole, which refl\u2026"}]},{"cik":1413488,"name":"CANNABIS GLOBAL, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001017386-18-000008","doc":"mctc_2015aug31-10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001017386-18-000021","doc":"mctc_2016aug31-10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001017386-18-000041","doc":"mctc_2017august31-10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001017386-18-000367","doc":"mctc_20180831-10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001079974-19-000543","doc":"mctc10k_8312019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001079973-20-000894","doc":"cbgl_10k-083120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001079973-21-001237","doc":"cbgl_10k-083121.htm","q":null}]},{"cik":1413754,"name":"MARIZYME INC","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001078782-18-001376","doc":"f10ka123117_10kz.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001078782-19-000201","doc":"f10k123118_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001078782-20-000251","doc":"f10k123119_10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-008936","doc":"form10-k.htm","q":"Additionally, if during the filing decision or the substantive review FDA determines a sponsor need provide additional information (AI), the sponsor has 180 days to provide requested information and during such time, the FDA review clock is\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-008531","doc":"form10-k.htm","q":"Additionally, if during the filing decision or the substantive review the FDA determines a sponsor must provide additional information (AI), the sponsor has 180 days to provide requested information and during such time, the FDA review cloc\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001493152-23-008914","doc":"form10-k.htm","q":"Additionally, if during the filing decision or the substantive review the FDA determines a sponsor must provide additional information (AI), the sponsor has 180 days to provide requested information and during such time, the FDA review cloc\u2026"}]},{"cik":1413990,"name":"PORTLOGIC SYSTEMS INC.","industry":"Software & IT services","sic":7372,"state":"ON","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-15-007000","doc":"f10k2015_portlogicsystems.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-16-017077","doc":"f10k2016_portlogicsystems.htm","q":null}]},{"cik":1414043,"name":"FRIENDABLE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001199835-15-000136","doc":"ihookup_10ka-16364.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001199835-16-000746","doc":"friendable_10ka-16829.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-003389","doc":"fdbl_10k-17114.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-004044","doc":"friendable_10k-17352.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001199835-21-000226","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":3,"adsh":"0001199835-22-000250","doc":"frnd-10k.htm","q":"The Company\u0092s preliminary estimate of the fair value of the purchase consideration was $1,047,150, consisting of $637,150 for the initial shares, based on the closing price of the Company\u0092s common stock on the acquisition date, and $410,000\u2026"}]},{"cik":1415684,"name":"MUSCLEPHARM CORP","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001728","doc":"mslp-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-507417","doc":"d103625d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001415684-17-000012","doc":"mslp201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-003486","doc":"mslp_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-20-009485","doc":"mslp_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007088","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-010161","doc":"form10-k.htm","q":null}]},{"cik":1416792,"name":"RELYPSA INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001540","doc":"rlyp-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013394","doc":"rlyp-10k_20151231.htm","q":null}]},{"cik":1417892,"name":"EMEREN GROUP LTD","industry":"Computers & chips","sic":3674,"state":"CT","cells":[{"fy":2023,"lvl":1,"n":3,"adsh":"0001410578-24-001141","doc":"tmb-20231231x10k.htm","q":"One of the most exciting developments in the renewable energy sector is the booming demand for solar power to support artificial intelligence (AI) operations."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001410578-25-000439","doc":"tmb-20241231x10k.htm","q":"Furthermore, any failure or security breach of information systems or data could result in a violation of applicable privacy, artificial intelligence and other laws, significant legal and financial exposure, damage to our reputation or a lo\u2026"}]},{"cik":1418091,"name":"TWITTER, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001159","doc":"twtr-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013646","doc":"twtr-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002584","doc":"twtr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003046","doc":"twtr-10k_20171231.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001564590-19-003523","doc":"twtr-10k_20181231.htm","q":"In 2018, our machine learning efforts continued to improve, making it harder for malicious accounts to manipulate our service through multiple accounts and evading suspension, resulting in the suspension of millions of spammy and suspicious\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001418091-20-000037","doc":"twtr-20191231.htm","q":"In 2019, we improved our machine-learning models to provide more relevant content in people\u2019s Home timelines and notifications."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001418091-21-000031","doc":"twtr-20201231.htm","q":"We also continue to invest in protecting the safety, security and integrity of our platform by investing in both people and technology, including machine learning."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001418091-22-000029","doc":"twtr-20211231.htm","q":"We also continue to invest in protecting the safety, security and integrity of our platform by investing in both people and technology, including machine learning."}]},{"cik":1418100,"name":"AVAYA HOLDINGS CORP.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2022,"lvl":3,"n":35,"adsh":"0001418100-23-000041","doc":"avya-20220930.htm","q":"During fiscal 2022, we expanded our portfolio to include new cloud-based solutions, and we continued to integrate Artificial Intelligence (\"AI\") to create enhanced user experiences and improve performance. \u2022 Contact Center: Avaya\u2019s industry\u2026"}]},{"cik":1418133,"name":"BIOSTAR PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001185185-15-000919","doc":"biostarpharma10k123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001185185-16-004237","doc":"biostarpharma10k123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001185185-17-000916","doc":"biostarpharma10k123116.htm","q":null}]},{"cik":1419041,"name":"FORTE BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005132","doc":"toca-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004933","doc":"toca-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007402","doc":"toca-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013249","doc":"fbrx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012987","doc":"fbrx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011355","doc":"fbrx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-032843","doc":"fbrx-20231231.htm","q":"Generative artificial intelligence (AI) resources that are publicly available also present a risk that Forte may inadvertently obtain, incorporate, or use a third party\u2019s intellectual property."},{"fy":2024,"lvl":2,"n":5,"adsh":"0000950170-25-046749","doc":"fbrx-20241231.htm","q":"Moreover, advancements in technology, such as artificial intelligence and machine learning, are changing and may continue to change the way companies are subjected to attempts to gain unauthorized access and disrupt systems, thereby increas\u2026"},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-134498","doc":"fbrx-20251231.htm","q":"Moreover, advancements in technology, such as artificial intelligence and machine learning, are changing and may continue to change the way companies are subjected to attempts to gain unauthorized access and disrupt systems, thereby increas\u2026"}]},{"cik":1419581,"name":"FEDERAL-MOGUL HOLDINGS LLC","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001112","doc":"fdml-2014123110xk.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001628280-16-011881","doc":"fdml-2015123110xk.htm","q":"(Korea) 33.6 % 33.6 % 33.6 % Federal-Mogul TP Liner Europe Otomotiv Limited Sirketi (Turkey) 25.0 % 25.0 % 25.0 % Farloc Argentina S.A.I.C."},{"fy":2016,"lvl":1,"n":1,"adsh":"0001628280-17-001567","doc":"fdml-2016123110xk.htm","q":"(Korea) 33.6 % 33.6 % 33.6 % Federal-Mogul TP Liner Europe Otomotiv Limited Sirketi (Turkey) 25.0 % 25.0 % 25.0 % Farloc Argentina S.A.I.C."}]},{"cik":1419582,"name":"BLUE SPHERE CORP.","industry":"Software & IT services","sic":7370,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-001983","doc":"v397874_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001387131-16-003897","doc":"blsp-10k_093015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001387131-17-000944","doc":"blsp-10k_123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001387131-18-001623","doc":"blsp-10k_123117.htm","q":null}]},{"cik":1419600,"name":"FLEXION THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-103253","doc":"d834253d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-501453","doc":"d134391d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004006","doc":"flxn-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004912","doc":"flxn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005465","doc":"flxn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010490","doc":"flxn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012050","doc":"flxn-10k_20201231.htm","q":null}]},{"cik":1419612,"name":"SOLAREDGE TECHNOLOGIES, INC.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001178913-15-002692","doc":"zk1517232.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001178913-16-006268","doc":"zk1618870.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001178913-18-000655","doc":"zk1821213.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001178913-19-000721","doc":"zk1922755.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001178913-20-000672","doc":"sedg10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001178913-21-000696","doc":"sedg10k2020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001178913-22-000760","doc":"zk2227328.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001178913-23-000707","doc":"zk2329263.htm","q":"The adoption of this ASU has a minor impact on the disclosures to the annual consolidated financial statements. ai."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001178913-24-000717","doc":"zk2431010.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001178913-25-000605","doc":"zk2532709.htm","q":"ONE is based on AI algorithms that gather & process data from three sources: external data (weather forecasts, utility rates), internal data (homeowner usage patterns & PV system parameters), and homeowner preferences and schedules."},{"fy":2025,"lvl":3,"n":30,"adsh":"0001178913-26-000632","doc":"zk2634374.htm","q":"ONE is based on AI algorithms that gather & process data from three sources: external data (weather forecasts, utility rates), internal data (homeowner usage patterns & PV system parameters), and homeowner preferences and schedules."}]},{"cik":1419625,"name":"APPTIO INC","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001774","doc":"0001564590-17-001774.txt","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002705","doc":"apti-10k_20171231.htm","q":null}]},{"cik":1419793,"name":"ORIGINCLEAR, INC.","industry":"Construction","sic":1623,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-030192","doc":"f10k2022_originclear.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-034111","doc":"ea0203700-10k_originclear.htm","q":null}]},{"cik":1420030,"name":"TARGETED MEDICAL PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001421","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008933","doc":"form10-k.htm","q":null}]},{"cik":1420302,"name":"LOGMEIN, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-055090","doc":"d845471d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-469163","doc":"d133436d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-063977","doc":"d301311d10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001193125-18-050503","doc":"d506130d10k.htm","q":"Bold360 ai is an automated customer service, help-desk and CRM platform that uses automation, bots, machine learning and user interface to build and maintain a knowledge base, or KB, and make it available to support agents, employees and en\u2026"},{"fy":2018,"lvl":2,"n":5,"adsh":"0001564590-19-003676","doc":"logm-10k_20181231.htm","q":"Our customer engagement services leverage artificial intelligence and machine-learning technology to help customer service and helpdesk technicians engage with their customers across multiple platforms, boosting agent efficiency and effecti\u2026"},{"fy":2019,"lvl":2,"n":10,"adsh":"0001564590-20-004769","doc":"logm-10k_20191231.htm","q":"Our customer engagement services leverage artificial intelligence and machine-learning technology to help customer service and helpdesk technicians engage with their customers across multiple platforms, boosting agent efficiency and effecti\u2026"}]},{"cik":1420520,"name":"ATOMERA INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001683168-17-000713","doc":"atomera_10k-123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-18-000599","doc":"atomera_10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-000596","doc":"atomera_10k-123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001683168-20-000799","doc":"atomera_10k-123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-000648","doc":"atomera_10k-123120.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001683168-22-001031","doc":"0001683168-22-001031.txt","q":"Cloud computing and artificial intelligence technologies have provided people with new ways to create, store and share information."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001683168-23-000938","doc":"atomera_i10k-123122.htm","q":"Cloud computing and artificial intelligence technologies have provided people with new ways to create, store and share information."},{"fy":2023,"lvl":1,"n":2,"adsh":"0001683168-24-001031","doc":"atomera_i10k-123123.htm","q":"Cloud computing and artificial intelligence technologies have provided people with new ways to create, store and share information."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001683168-25-001330","doc":"atomera_i10k-123124.htm","q":"Cloud computing and artificial intelligence technologies have provided people with new ways to create, store and share information."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001683168-26-001291","doc":"atomera_i10k-123125.htm","q":"The market is projected to grow to $755 billion in 2025 and continue expanding at an approximately 15% compound annual growth rate through 2032, driven almost entirely by artificial intelligence (AI) workloads."}]},{"cik":1420565,"name":"REIN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007403","doc":"alrn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010007","doc":"alrn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-014155","doc":"alrn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015115","doc":"alrn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004774","doc":"alrn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008767","doc":"alrn-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-044508","doc":"alrn-20231231.htm","q":"The application of newly developed artificial intelligence and other technologies which are widely anticipated to reduce the development time to bring new products to market may materially increase the volume of applications for product app\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-051566","doc":"rntx-20241231.htm","q":"The application of newly developed artificial intelligence and other technologies which are widely anticipated to reduce the development time to bring new products to market may materially increase the volume of applications for product app\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-126385","doc":"rntx-20251231.htm","q":"The application of newly developed artificial intelligence and other technologies which are widely anticipated to reduce the development time to bring new products to market may materially increase the volume of applications for product app\u2026"}]},{"cik":1420720,"name":"IBIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-059224","doc":"v420530_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-16-127993","doc":"v449304_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-048249","doc":"v474890_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-049866","doc":"tv502648_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001144204-19-041659","doc":"tv527664_10k.htm","q":null},{"fy":2020,"lvl":1,"n":4,"adsh":"0001104659-20-114567","doc":"tm2024769d1_10k.htm","q":"Collaboration with EdgePoint AI, a division of Mateon Therapeutics, Inc."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001558370-21-012819","doc":"ibio-20210630x10k.htm","q":"Effective upon such termination, among other things, RubrYc shall assign to us exclusive ownership of the RTX-003, including all relevant intellectual property rights. 8 Table of Contents Collaboration, Option and License Agreement: We ente\u2026"},{"fy":2022,"lvl":3,"n":39,"adsh":"0001420720-22-000064","doc":"ibio-20220630x10k.htm","q":"(\u201cwe\u201d, \u201cus\u201d, \u201cour\u201d, \u201ciBio\u201d, \u201ciBio, Inc\u201d or the \u201cCompany\u201d) is a developer of next-generation biopharmaceuticals using our proprietary Artificial Intelligence (\u201cAI\u201d)-Driven Discovery Platform and FastPharming \u00ae Manufacturing System."},{"fy":2023,"lvl":3,"n":97,"adsh":"0001420720-23-000045","doc":"ibio-20230630x10k.htm","q":"(also referred to as \"we\", \"us\", \"our\", \"iBio\", or the \"Company\") is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies."},{"fy":2024,"lvl":3,"n":95,"adsh":"0001420720-24-000038","doc":"ibio-20240630x10k.htm","q":"(also referred to as \"we\", \"us\", \"our\", \"iBio\", or the \"Company\") is a preclinical stage biotechnology company leveraging the power of Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies."},{"fy":2025,"lvl":3,"n":98,"adsh":"0001558370-25-011888","doc":"ibio-20250630x10k.htm","q":"(also referred to as \"we\", \"us\", \"our\", \"iBio\", or the \"Company\") is a preclinical stage biotechnology company leveraging the power of Artificial Intelligence (\u201cAI\u201d) for the development of hard-to-drug precision antibodies in the cardiometa\u2026"}]},{"cik":1421204,"name":"REBUS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-017836","doc":"v404696_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-091511","doc":"v434243_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-17-001721","doc":"s105817_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-19-006339","doc":"s117409_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-014714","doc":"f10k2018_inspyrtherapeutics.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-012301","doc":"f10k2019_inspyrthera.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001829126-21-002058","doc":"inspyrtherap_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001829126-22-007156","doc":"rebusholdings_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001829126-23-002497","doc":"rebusholdings_10k.htm","q":null}]},{"cik":1421766,"name":"CEELOX INC.","industry":"Software & IT services","sic":7372,"state":"KS","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001002014-15-000158","doc":"celo10k-12312014.htm","q":null}]},{"cik":1422109,"name":"BLUE EARTH, INC.","industry":"Utilities","sic":4911,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001393905-15-000109","doc":"bblu_10k.htm","q":null}]},{"cik":1422142,"name":"WHITEHAWK THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005868","doc":"arpo-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006602","doc":"arpo-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011174","doc":"arpo-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012252","doc":"arpo-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010721","doc":"aadi-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009583","doc":"aadi-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-010901","doc":"aadi-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-015269","doc":"aadi-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0001193125-26-104158","doc":"whwk-20251231.htm","q":"RNA sequencing data (Tempus AI, Inc.) were used to examine MUC16 expression across ovarian cancer histologic subtypes."}]},{"cik":1422143,"name":"KURA ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014998","doc":"kura-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004291","doc":"kura-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005293","doc":"kura-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006263","doc":"kura-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006391","doc":"kura-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007822","doc":"kura-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001967","doc":"kura-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004107","doc":"kura-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-021094","doc":"kura-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-029975","doc":"kura-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0001193125-26-092567","doc":"kura-20251231.htm","q":null}]},{"cik":1422930,"name":"PUBMATIC, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":25,"adsh":"0001422930-22-000009","doc":"pubm-20211231.htm","q":"Sophisticated, Purpose-built Technology that Delivers Superior Outcomes: Since our founding, we have believed that data-driven decisions would be the future of advertising and have accordingly invested in developing our machine learning cap\u2026"},{"fy":2022,"lvl":3,"n":26,"adsh":"0001422930-23-000008","doc":"pubm-20221231.htm","q":"Sophisticated, Purpose-built Technology that Delivers Superior Outcomes : Since our founding, we have believed that data-driven decisions would be the future of advertising and have accordingly invested in developing our machine learning ca\u2026"},{"fy":2023,"lvl":3,"n":34,"adsh":"0001422930-24-000012","doc":"pubm-20231231.htm","q":"Companies must continue to innovate and find efficiencies in their data processing, including through the use of machine learning and artificial intelligence, to maintain pace with growing volumes of transactions to maintain profitability."},{"fy":2024,"lvl":3,"n":39,"adsh":"0001422930-25-000012","doc":"pubm-20241231.htm","q":"Companies must continue to innovate and find efficiencies in their data processing, including through the use of machine learning and artificial intelligence, to maintain pace with growing volumes of transactions to maintain profitability."},{"fy":2025,"lvl":3,"n":126,"adsh":"0001422930-26-000010","doc":"pubm-20251231.htm","q":"(\u201cwe\u201d, or \u201cus) is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance."}]},{"cik":1423774,"name":"ZUORA INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001423774-19-000026","doc":"a2019131q410kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001423774-20-000036","doc":"zuo-20200131.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001423774-21-000020","doc":"zuo-20210131.htm","q":"We recently announced the addition of machine learning capabilities to the automated dunning capabilities of Zuora Collect to improve overall electronic payments success rates and reduce involuntary churn."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001423774-22-000067","doc":"zuo-20220131.htm","q":"We recently announced the addition of machine learning capabilities to the automated dunning capabilities of Zuora Collect to improve overall electronic payments success rates and reduce involuntary churn."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001423774-23-000044","doc":"zuo-20230131.htm","q":"In addition, Zuora Collect's machine learning capabilities automate dunning functionality to improve overall electronic payment success rates and reduce involuntary churn. \u2022 Zephr ."},{"fy":2023,"lvl":3,"n":17,"adsh":"0001423774-24-000079","doc":"zuo-20240131.htm","q":"Risks Related to Information Technology, Intellectual Property, and Data Security and Privacy \u2022 If our security measures are breached or if unauthorized access to customer, employee or other confidential data is otherwise obtained, or if ou\u2026"}]},{"cik":1423824,"name":"ALDER BIOPHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001662","doc":"aldr-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013074","doc":"aldr-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002198","doc":"aldr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003221","doc":"aldr-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004084","doc":"aldr-10k_20181231.htm","q":null}]},{"cik":1424151,"name":"NEXUS BIOPHARMA INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-007185","doc":"f10k2017_nexusbiopharma.htm","q":null}]},{"cik":1424328,"name":"MULTIMEDIA PLATFORMS INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-002073","doc":"mmpw_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009297","doc":"mmpw_10k.htm","q":null}]},{"cik":1424812,"name":"AMARANTUS BIOSCIENCE HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-021238","doc":"v401261_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-013437","doc":"f10k2015_amarantusbioscience.htm","q":null}]},{"cik":1425203,"name":"ASTRO AEROSPACE LTD.","industry":"Construction","sic":1700,"state":"TX","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001014897-17-000042","doc":"cpsm10k2016v5.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001014897-18-000020","doc":"swmm-20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001014897-19-000047","doc":"asdn-20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001014897-20-000027","doc":"astroaerospace10k2019.htm","q":null}]},{"cik":1425205,"name":"IOVANCE BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016315","doc":"v403564_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087506","doc":"v432870_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-013535","doc":"v460270_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-014151","doc":"tv485173_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-010702","doc":"tv513795_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-024830","doc":"iova-20191231x10kab9a30.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001858","doc":"iova-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001976","doc":"iova-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002419","doc":"iova-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002036","doc":"iova-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001834","doc":"iova-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":30,"adsh":"0001104659-26-018899","doc":"iova-20251231x10k.htm","q":"We, directly or through our third-party service providers, may adopt, use or incorporate artificial intelligence, or AI, technology and capabilities into the information technology systems or software that we use in our business and operati\u2026"}]},{"cik":1425287,"name":"WORKHORSE GROUP INC.","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001013762-15-000252","doc":"f10k2014_ampholding.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001013762-16-001424","doc":"f10k2015_workhorsegroup.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-002275","doc":"f10k2016_workhorsegroup.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-002957","doc":"f10k2017_workhorsegroup.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004319","doc":"f10k2018_workhorsegroup.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003532","doc":"wkhs-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003538","doc":"wkhs-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001425287-22-000031","doc":"wkhs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001425287-23-000055","doc":"wkhs-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001425287-24-000068","doc":"wkhs-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001425287-25-000024","doc":"wkhs-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-022417","doc":"wkhs-20251231.htm","q":null}]},{"cik":1425565,"name":"REAL GOODS SOLAR, INC.","industry":"Construction","sic":1700,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-114348","doc":"d876063d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-013587","doc":"t1600128_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-002212","doc":"t1700152_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-018683","doc":"tv488343_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-019699","doc":"tv513901_10k.htm","q":null}]},{"cik":1426332,"name":"NGM BIOPHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011422","doc":"ngm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013179","doc":"ngm-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004526","doc":"ngm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005569","doc":"ngm-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-010232","doc":"ngm-20231231.htm","q":null}]},{"cik":1426800,"name":"ASSEMBLY BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001144204-15-015700","doc":"v403581_10k.htm","q":"This program involves collaboration with leading academic medical centers with relevant expertise, and includes special methods of identifying colonic strains from CDAD patients receiving FMT, use of machine learning-derived predictive algo\u2026"},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087539","doc":"v433004_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-012234","doc":"v460245_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013474","doc":"tv486659_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-011361","doc":"tv514070_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008696","doc":"asmb-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008878","doc":"asmb-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009855","doc":"asmb-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009184","doc":"asmb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038057","doc":"asmb-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-042673","doc":"asmb-20241231.htm","q":"There are changes in the regulatory landscape relating to new and emerging technologies such as artificial intelligence (AI), which we use in a limited capacity solely to assist our employees in selecting chemical compounds to evaluate."},{"fy":2025,"lvl":3,"n":15,"adsh":"0001193125-26-115992","doc":"asmb-20251231.htm","q":"There are changes in the regulatory landscape relating to new and emerging technologies such as artificial intelligence (AI), which we use in a limited capacities, including to assist our employees in selecting chemical compounds to evaluat\u2026"}]},{"cik":1427570,"name":"VYOME HOLDINGS, INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001558370-25-004477","doc":"rsls-20241231x10k.htm","q":null},{"fy":2025,"lvl":"x","n":32,"adsh":"0001213900-26-029500","doc":"ea0280821-10k_vyomehold.htm","q":"As of February 20, 2026, pursuant to the terms of the LOI, the Company entered into a Notes Purchase and Exchange Agreement (the \u201cAgreement\u201d) by and among LICH, LICH AI Inc."}]},{"cik":1427925,"name":"TALPHERA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004946","doc":"acrx20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026987","doc":"acrx20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-003702","doc":"acrx20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-004222","doc":"acrx20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-004353","doc":"acrx20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-005304","doc":"acrx20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-006074","doc":"acrx20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005888","doc":"acrx20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008737","doc":"acrx20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-006849","doc":"acrx20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-010250","doc":"acrx20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-009387","doc":"acrx20251231_10k.htm","q":null}]},{"cik":1428389,"name":"BLOX, INC.","industry":"Utilities","sic":4911,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001273511-15-000079","doc":"f150331bloxform10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001273511-16-000192","doc":"f160331bloxform10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001273511-17-000054","doc":"f170331bloxform10kv2.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001273511-18-000040","doc":"f180331bloxform10k2018final.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-011846","doc":"f10k2019_bloxinc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-20-017478","doc":"f10k2020a_bloxinc.htm","q":null}]},{"cik":1428522,"name":"RADIUS HEALTH, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001917","doc":"a2223411zex-10_15.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001047469-16-010440","doc":"a2227368z10-k.htm","q":"Therefore, SERDs should have the potential to treat ER-dependent tumors without allowing ligand-independent resistance to develop, and to act on AI- and SERM-resistant ER-positive tumors."},{"fy":2016,"lvl":1,"n":1,"adsh":"0001628280-17-001727","doc":"rdus1231201610-k.htm","q":"Therefore, SERDs should have the potential to treat ER-dependent tumors without allowing ligand-independent resistance to develop, and to act on AI- and SERM-resistant ER-positive tumors."},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002666","doc":"rdus1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002275","doc":"rdus1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002354","doc":"rdus1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003172","doc":"rdus-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003660","doc":"rdus-20211231.htm","q":null}]},{"cik":1428669,"name":"SOLARWINDS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001428669-15-000011","doc":"swi-20141231x10k.htm","q":null}]},{"cik":1429260,"name":"FORTRESS BIOTECH, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-016397","doc":"v403230_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-088262","doc":"v432923_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-015137","doc":"v461010_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-015301","doc":"tv487010_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014617","doc":"tv514739_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-034133","doc":"tm205350d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003815","doc":"fbio-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004487","doc":"fbio-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005282","doc":"fbio-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004272","doc":"fbio-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001558370-25-004160","doc":"fbio-20241231x10k.htm","q":"The use of artificial intelligence in the healthcare industry and challenges with properly managing its use could adversely affect our business."},{"fy":2025,"lvl":3,"n":16,"adsh":"0001104659-26-037874","doc":"fbio-20251231x10k.htm","q":"Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. 68 Table of Contents The use of artificial intelligence in the healthcare industry and challenges with properly managing i\u2026"}]},{"cik":1429386,"name":"PHASERX, INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-016759","doc":"v461653_10k.htm","q":null}]},{"cik":1429560,"name":"TREVENA INC","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002400","doc":"a2223726z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010926","doc":"a2227657z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001472","doc":"trvn-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001429560-18-000004","doc":"trvn-201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001898","doc":"trvn-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002472","doc":"trvn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002598","doc":"trvn-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004825","doc":"trvn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004988","doc":"trvn-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004445","doc":"trvn-20231231x10k.htm","q":null}]},{"cik":1430306,"name":"TONIX PHARMACEUTICALS HOLDING CORP.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-012769","doc":"v402310_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-085821","doc":"v432316_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001615774-17-001665","doc":"s105661_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001615774-18-001762","doc":"s109195_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001387131-20-003189","doc":"tnxp-10k_123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001387131-21-003550","doc":"tnxp-10k_123120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001387131-22-003640","doc":"tnxp-10k_123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001387131-23-003377","doc":"tnxp-10k_123122.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001999371-24-004297","doc":"tnxp-10k_123123.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001999371-25-002786","doc":"tnxp-10k_123124.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001999371-26-005730","doc":"tnxp-10k_123125.htm","q":null}]},{"cik":1431959,"name":"META MATERIALS INC.","industry":"Computers & chips","sic":3674,"state":"NS","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002601","doc":"mmat-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-009314","doc":"mmat-20221231.htm","q":"Speed of Discovery. \u25aa Rapid design : Using artificial intelligence and machine learning to mine our library of nanopatterns allows META to create functional prototypes much faster than traditional chemical synthesis. \u25aa Multi-physics modelin\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-038010","doc":"mmat-20231231.htm","q":"Onboard computer hardware and software allow for 50+ simultaneous live video streams throughout the observational area with AI-based multi-object tracking and DVR-like analytical capability."}]},{"cik":1432133,"name":"KALTURA INC","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":2,"n":10,"adsh":"0001178913-22-000830","doc":"zk2227356.htm","q":"With embeddable experience components, application developers can shorten time to market, while bringing a complete and mature experience to their users. 7 \u2022 Ecosystem: We have built a rich ecosystem of over 125 technology partners, extendi\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001432133-23-000035","doc":"kltr-20221231.htm","q":"Partner Ecosystem We have built an ecosystem consisting of over 120 partners that have integrated with our solutions, and extend our products and platform capabilities with creation, AI, transcripts, and delivery capabilities."},{"fy":2023,"lvl":"x","n":71,"adsh":"0001432133-24-000088","doc":"kltr-20231231.htm","q":"Moreover, generative AI enables real-time, automatic production of highly personalized and contextually-relevant content, including video and rich media, that we believe would materially boost the creation, consumption, and business impact \u2026"},{"fy":2024,"lvl":3,"n":202,"adsh":"0001432133-25-000025","doc":"kltr-20241231.htm","q":"(\u201cKaltura,\u201d \u201cwe,\u201d \u201cus,\u201d or \u201cour\u201d), are a market-leading provider of live, real-time, and on-demand video offerings for enterprises, with a mission to create and power AI-infused hyper-personalized video experiences that boost customer and e\u2026"},{"fy":2025,"lvl":3,"n":303,"adsh":"0001628280-26-018182","doc":"kltr-20251231.htm","q":"Kaltura's Digital Experience Platform enables organizations to create, manage, and deliver video and rich media experiences that increasingly incorporate agentic artificial intelligence (\u201cAI\u201d) capabilities, including conversational interfac\u2026"}]},{"cik":1432150,"name":"GIGPEAK, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-012276","doc":"form10k.htm","q":null},{"fy":2015,"lvl":1,"n":2,"adsh":"0001140361-16-057556","doc":"form10k.htm","q":"Anagog is perfecting the mobility status algorithms that allow for advanced on-phone machine learning capabilities for the best user experience with ultra-low battery consumption and a high level of privacy protection."},{"fy":2016,"lvl":1,"n":2,"adsh":"0001140361-17-012134","doc":"form10k.htm","q":"Anagog is perfecting the mobility status algorithms that allow for advanced on-phone machine learning capabilities for the best user experience with ultra-low battery consumption and a high level of privacy protection."}]},{"cik":1433195,"name":"APPFOLIO INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001433195-16-000016","doc":"appf201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001433195-17-000010","doc":"appf201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001433195-18-000011","doc":"appf201710-k.htm","q":null},{"fy":2018,"lvl":2,"n":5,"adsh":"0001433195-19-000016","doc":"appf12311810-k.htm","q":"In early 2019, we acquired Dynasty Marketplace, Inc., or Dynasty, and expect the team and technology related to this acquisition, combined with our internal resources, technology and data, to serve as a foundation for future artificial-inte\u2026"},{"fy":2019,"lvl":2,"n":10,"adsh":"0001433195-20-000019","doc":"appf12311910-k.htm","q":"In January 2019, we acquired Dynasty Marketplace, Inc., (\"Dynasty\"), a provider of advanced artificial intelligence (\"AI\") solutions for the real estate market, and began offering an AI Leasing Assistant, Lisa, as a Value+ service to our pr\u2026"},{"fy":2020,"lvl":2,"n":7,"adsh":"0001433195-21-000024","doc":"appf-20201231.htm","q":"Our software solutions are offered as a service, are hosted using a modern cloud-based architecture, and in part, use artificial intelligence technologies."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001433195-22-000023","doc":"appf-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001433195-23-000021","doc":"appf-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":39,"adsh":"0001433195-24-000023","doc":"appf-20231231.htm","q":"AppFolio\u2019s intuitive interface, streamlined workflows, and artificial intelligence (\"AI\") powered automation services make it easier for our customers to eliminate redundant and manual processes so they can deliver a great experience for th\u2026"},{"fy":2024,"lvl":3,"n":35,"adsh":"0001433195-25-000013","doc":"appf-20241231.htm","q":"Our platform is enhanced with AppFolio Realm, a suite of AI-powered tools that assist with leasing, maintenance, accounting, and other business critical tasks."},{"fy":2025,"lvl":3,"n":42,"adsh":"0001433195-26-000011","doc":"appf-20251231.htm","q":"Building upon this foundation, AppFolio Realm integrates artificial intelligence, or AI, directly into the platform\u2019s workflows."}]},{"cik":1433269,"name":"DILIGENT CORP","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002272","doc":"a2223662z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011110","doc":"a2227754z10-k.htm","q":null}]},{"cik":1434316,"name":"FATE THERAPEUTICS INC","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002070","doc":"a2223519z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013981","doc":"fate-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004614","doc":"fate-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004394","doc":"fate-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006258","doc":"fate-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008141","doc":"fate-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008086","doc":"fate-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002293","doc":"fate-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005067","doc":"fate-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-020158","doc":"fate-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":19,"adsh":"0000950170-25-033510","doc":"fate-20241231.htm","q":"The increasing use of artificial intelligence-based software (including machine learning) may result in reputational harm or liability or could otherwise adversely affect our business."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001193125-26-073699","doc":"fate-20251231.htm","q":"The increasing use of artificial intelligence-based software (including machine learning) may result in reputational harm or liability or could otherwise adversely affect our business."}]},{"cik":1434418,"name":"CONSTELLATION PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007860","doc":"cnst-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009735","doc":"cnst-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007783","doc":"cnst-10k_20201231.htm","q":null}]},{"cik":1434477,"name":"SUNVALLEY SOLAR, INC.","industry":"Construction","sic":1600,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001551163-15-000101","doc":"f11529cleanvedgar5.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001551163-17-000077","doc":"ssol10kvedgar8.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001551163-18-000051","doc":"ssol10k123117vedgar20.htm","q":null}]},{"cik":1434647,"name":"ZEVRA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014881","doc":"kmph-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-004317","doc":"kmph20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-005932","doc":"kmph20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-003789","doc":"kmph20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-003965","doc":"kmph20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-005785","doc":"kmph20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007725","doc":"kmph20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-005703","doc":"kmph20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-010430","doc":"zvra20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-007320","doc":"zvra20241231_10k.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001434647-26-000011","doc":"zvra-20251231.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques \u2013 including artificial intelligence (\u201cAI\u201d) \u2013 that are designed to circumvent controls\u2026"}]},{"cik":1434868,"name":"ESPERION THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001908","doc":"a2223469z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010437","doc":"a2227421z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000831","doc":"a2230972z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-000899","doc":"a2234199z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000791","doc":"a2237755z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-026203","doc":"espr-20191231x10k209bec.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-002865","doc":"espr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003263","doc":"espr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004167","doc":"espr-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001628280-24-007066","doc":"espr-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":23,"adsh":"0001628280-25-011154","doc":"espr-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":44,"adsh":"0001628280-26-016522","doc":"espr-20251231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."}]},{"cik":1435049,"name":"CHINOOK THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014215","doc":"adro-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003099","doc":"adro-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004135","doc":"adro-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004942","doc":"adro-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009364","doc":"adro-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-018017","doc":"kdny-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010862","doc":"kdny-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-002589","doc":"kdny-10k_20221231.htm","q":null}]},{"cik":1436126,"name":"MISTRAS GROUP, INC.","industry":"Construction","sic":8711,"state":"NJ","cells":[{"fy":2015,"lvl":1,"n":4,"adsh":"0001436126-15-000018","doc":"mg-201553110k.htm","q":"These packaged solutions use proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to compare test results against our prior testing data or national and internation\u2026"},{"fy":2016,"lvl":1,"n":4,"adsh":"0001436126-16-000062","doc":"mg-201653110k.htm","q":"These packaged solutions use proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to compare test results against our prior testing data or national and internation\u2026"},{"fy":2017,"lvl":1,"n":4,"adsh":"0001436126-18-000017","doc":"mg-2017123110k.htm","q":"These capabilities are available through our state-of-the-art testing equipment and expertise in our grid of in-house testing laboratories across the U.S., Canada and Europe. \u2022 Proprietary Products & Systems: A proprietary and customized po\u2026"},{"fy":2018,"lvl":1,"n":2,"adsh":"0001436126-19-000014","doc":"mg-2018123110k.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001436126-20-000018","doc":"mg-20191231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001436126-21-000013","doc":"mg-20201231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001436126-22-000013","doc":"mg-20211231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001436126-23-000014","doc":"mg-20221231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0001436126-24-000025","doc":"mg-20231231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001436126-25-000026","doc":"mg-20241231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"},{"fy":2025,"lvl":3,"n":26,"adsh":"0001628280-26-016765","doc":"mg-20251231.htm","q":"We also sell integrated service-and-system technology packages, in which our field technicians utilize our proprietary and specialized testing procedures and hardware, advanced pattern recognition, neural network software and databases to c\u2026"}]},{"cik":1436161,"name":"UNITED CANNABIS CORP","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001553350-17-000260","doc":"cnab_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001553350-18-000252","doc":"cnab_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001553350-19-000273","doc":"cnab_10k.htm","q":null}]},{"cik":1436229,"name":"BTCS INC.","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001415889-15-001341","doc":"btcs10k_dec312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-007517","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-007086","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-003362","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-001464","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004512","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-001796","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006666","doc":"form10-k.htm","q":null}]},{"cik":1436304,"name":"KYTHERA BIOPHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001515","doc":"a2223273z10-k.htm","q":null}]},{"cik":1437283,"name":"REGO PAYMENT ARCHITECTURES, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001214659-15-002338","doc":"v3415010k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001214659-16-010883","doc":"vp41116010k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001214659-17-002272","doc":"s32417010k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001214659-18-002542","doc":"r32018010k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001214659-19-002415","doc":"d32119010k.htm","q":null},{"fy":2019,"lvl":"x","n":6,"adsh":"0001214659-20-005078","doc":"r582010k.htm","q":"Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030."},{"fy":2020,"lvl":"x","n":7,"adsh":"0001214659-21-003694","doc":"r32621010k.htm","q":"Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030."},{"fy":2021,"lvl":"x","n":7,"adsh":"0001214659-22-004581","doc":"rpmt10k1221.htm","q":"Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030."},{"fy":2022,"lvl":"x","n":10,"adsh":"0001214659-23-004597","doc":"rpmt-20221231.htm","q":"There is evidence to support the primary uses of P2P money transfers is the exchange of money between family and friends. 4 Table of Contents Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030\u2026"},{"fy":2023,"lvl":"x","n":10,"adsh":"0001214659-24-005793","doc":"0001214659-24-005793.txt","q":"Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030."},{"fy":2024,"lvl":"x","n":10,"adsh":"0001214659-25-005083","doc":"rpmt-20241231.htm","q":"Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030."},{"fy":2025,"lvl":"x","n":10,"adsh":"0001214659-26-004112","doc":"rpmt-20251231.htm","q":"Artificial intelligence (\u201cAI\u201d) is projected to reduce bank operating costs by 22% by the year 2030."}]},{"cik":1437352,"name":"EVERBRIDGE, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005159","doc":"evbg-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005318","doc":"evbg-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005821","doc":"evbg-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007797","doc":"evbg-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009422","doc":"evbg-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007193","doc":"evbg-10k_20211231.htm","q":null},{"fy":2022,"lvl":2,"n":6,"adsh":"0000950170-23-004382","doc":"evbg-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":67,"adsh":"0000950170-24-020652","doc":"evbg-20231231.htm","q":null}]},{"cik":1437402,"name":"ARDELYX, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001336","doc":"ardx-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-493375","doc":"d133887d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-047972","doc":"d338826d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002056","doc":"ardx-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001583","doc":"ardx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002138","doc":"ardx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002500","doc":"ardx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004226","doc":"ardx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-006041","doc":"ardx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-006393","doc":"ardx-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":10,"adsh":"0001628280-25-006653","doc":"ardx-20241231.htm","q":"In addition, we use AI Technologies in our business."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001437402-26-000013","doc":"ardx-20251231.htm","q":"In addition, we use AI Technologies in our business."}]},{"cik":1437491,"name":"MAGNOLIA SOLAR CORP","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001013762-15-000265","doc":"f10k2014_magnoliasolar.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001013762-16-001343","doc":"f10k2015_magnoliasolar.htm","q":null}]},{"cik":1437517,"name":"CYBERLOQ TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001010549-15-000136","doc":"act10k123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001010549-16-000566","doc":"acrt10k123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001010549-17-000101","doc":"act10k123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001010549-18-000094","doc":"act10k123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-003191","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006007","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-007319","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008545","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-009418","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-011921","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001165","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-010037","doc":"form10-k.htm","q":null}]},{"cik":1437786,"name":"IMMUNE DESIGN CORP.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-002068","doc":"imdz-form10xk2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437786-16-000031","doc":"imdz-form10xk2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437786-17-000014","doc":"imdz-form10xk2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437786-18-000013","doc":"imdz-form10xk2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437786-19-000006","doc":"imdz-form10xk2018.htm","q":null}]},{"cik":1437925,"name":"MERIDIAN HOLDINGS INC./NV","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001477932-22-000236","doc":"gmgi_10kt.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001477932-23-000591","doc":"gmgi_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001477932-24-000230","doc":"gmgi_10k.htm","q":null},{"fy":2024,"lvl":2,"n":10,"adsh":"0001477932-25-001897","doc":"gmgi_10k.htm","q":null},{"fy":2025,"lvl":3,"n":45,"adsh":"0001477932-26-001750","doc":"meridian_10k.htm","q":"Risks Related to the Use of Artificial Intelligence \u00b7 AI outputs depend on the quality and representativeness of underlying data; inaccurate or biased data may lead to unreliable recommendations. \u00b7 AI models may fail to perform as intended \u2026"}]},{"cik":1438423,"name":"EVERSPIN TECHNOLOGIES INC.","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-002252","doc":"mram-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002138","doc":"mram-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002175","doc":"mram-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002576","doc":"mram-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002369","doc":"mram-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003158","doc":"mram-20211231x10k.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0001558370-23-002697","doc":"mram-20221231x10k.htm","q":"They are ideal for use in electronic systems where data persistence and integrity, low power, low latency, and security are paramount, such as industrial IoT, artificial intelligence (AI), network/enterprise infrastructure, process automati\u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0001558370-24-002185","doc":"mram-20231231x10k.htm","q":"They are ideal for use in electronic systems where data persistence and integrity, low power, low latency, and security are paramount, such as industrial IoT, artificial intelligence (AI), network/enterprise infrastructure, process automati\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-001827","doc":"mram-20241231x10k.htm","q":"They are ideal for use in electronic systems where data persistence and integrity, low power, low latency, and security are paramount, such as industrial IoT, artificial intelligence (AI), network/enterprise infrastructure, process automati\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001628280-26-014733","doc":"mram-20251231.htm","q":"They are ideal for use in electronic systems where data persistence and integrity, low power, low latency, and security are paramount, such as industrial IoT, artificial intelligence (AI), network/enterprise infrastructure, process automati\u2026"}]},{"cik":1438533,"name":"TRAVERE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-001817","doc":"t1500483_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011857","doc":"rtrx-201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001438533-17-000005","doc":"rtrx-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001438533-18-000006","doc":"rtrx-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001438533-19-000003","doc":"rtrx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001438533-20-000004","doc":"rtrx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001438533-21-000008","doc":"rtrx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001438533-22-000008","doc":"rtrx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001438533-23-000008","doc":"tvtx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001438533-24-000005","doc":"tvtx-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of other evolving threats, including, but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify\u2026"},{"fy":2024,"lvl":3,"n":34,"adsh":"0001438533-25-000010","doc":"tvtx-20241231.htm","q":"These actions may include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and healthcare models to limit drug spending \u2026"},{"fy":2025,"lvl":3,"n":37,"adsh":"0001438533-26-000014","doc":"tvtx-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of other evolving threats, including, but not limited to, social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fak\u2026"}]},{"cik":1438943,"name":"RANGE IMPACT, INC.","industry":"Construction","sic":1600,"state":"OH","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001343","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-013689","doc":"form10-k.htm","q":null}]},{"cik":1438943,"name":"RANGE IMPACT, INC.","industry":"Pharma & biotech","sic":8731,"state":"OH","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001438943-16-000026","doc":"stvf-20160331x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-007271","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-009376","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-010644","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-012098","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-012226","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008273","doc":"form10-kt.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-009955","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-24-011906","doc":"form10-k.htm","q":"Despite well-designed controls, we acknowledge the inability to foresee all security breaches, including those stemming from third-party misuse of AI technologies, and the potential challenges in implementing timely preventive measures."}]},{"cik":1439222,"name":"AGIOS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-060046","doc":"d854960d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481973","doc":"d113932d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-046795","doc":"d289600d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001439222-18-000004","doc":"agio-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001439222-19-000004","doc":"agio-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001439222-20-000014","doc":"agio-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001439222-21-000029","doc":"agio-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001439222-22-000024","doc":"agio-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001439222-23-000039","doc":"agio-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001439222-24-000035","doc":"agio-20231231.htm","q":"Attackers may use artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001439222-25-000009","doc":"agio-20241231.htm","q":"Attackers may use artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001439222-26-000025","doc":"agio-20251231.htm","q":"Attackers may use artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets."}]},{"cik":1441634,"name":"AVAGO TECHNOLOGIES LTD","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001441634-15-000089","doc":"avgo-110115x10k.htm","q":null}]},{"cik":1441683,"name":"APPIAN CORP","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2017,"lvl":1,"n":4,"adsh":"0001441683-18-000023","doc":"appn1231201710-k.htm","q":"In addition, our platform allows our customers to embed artificial intelligence, or AI, concepts into their business processes and to use our pre-built integrations to leading providers of AI services."},{"fy":2018,"lvl":1,"n":4,"adsh":"0001441683-19-000047","doc":"appn-20181231.htm","q":"In addition, our platform allows our customers to embed artificial intelligence, or AI, concepts into their business processes and to use our pre-built integrations to leading providers of AI services."},{"fy":2019,"lvl":2,"n":9,"adsh":"0001441683-20-000020","doc":"appn-20191231.htm","q":"Our applications take advantage of a complete stack of automation technologies, including our industry-leading workflow engine, rules engine, native Robotic Process Automation, or RPA, capabilities, leading case management capabilities, and\u2026"},{"fy":2020,"lvl":2,"n":10,"adsh":"0001441683-21-000018","doc":"appn-20201231.htm","q":"Our customers take advantage of our complete automation capabilities, including our industry-leading workflow engine, rules engine, native Robotic Process Automation, or RPA, capabilities, leading case management capabilities, and integrate\u2026"},{"fy":2021,"lvl":2,"n":12,"adsh":"0001441683-22-000023","doc":"appn-20211231.htm","q":"Our customers take advantage of our process mining, industry-leading workflow engine, dynamic case management, and complete automation capabilities, which include our rules engine, native Robotic Process Automation, or RPA, native Intellige\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001441683-23-000021","doc":"appn-20221231.htm","q":"Today, we are one of the only enterprise software vendors that offer Workflow, Artificial Intelligence, or AI, Robotic Process Automation, or RPA, Data Fabric, and Process Mining in one fully integrated low-code platform."},{"fy":2023,"lvl":3,"n":121,"adsh":"0001441683-24-000016","doc":"appn-20231231.htm","q":"Overview Appian Corporation (together with its subsidiaries, \u201cAppian,\u201d \u201cthe Company,\u201d \u201cwe,\u201d or \u201cour\u201d) is a software company that automates business processes and operationalizes artificial intelligence (\u201cAI\u201d) with low-code design, providing\u2026"},{"fy":2024,"lvl":3,"n":115,"adsh":"0001441683-25-000017","doc":"appn-20241231.htm","q":"Appian tightly integrates data fabric; robotic process automation, or RPA; intelligent document processing, or IDP; generative artificial intelligence, or generative AI; artificial intelligence agents, or AI agents; low-code design; applica\u2026"},{"fy":2025,"lvl":3,"n":101,"adsh":"0001441683-26-000013","doc":"appn-20251231.htm","q":"Our capabilities include business rules engines, pre-built connections, Application Program Interface (API) integrations, intelligent document processing (IDP), robotic process automation (RPA), and artificial intelligence (AI). \u2022 Unified D\u2026"}]},{"cik":1441816,"name":"MONGODB, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001441816-18-000028","doc":"mdb-013118x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001441816-19-000067","doc":"mdb-013119x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001441816-20-000067","doc":"mdb-013120x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001441816-21-000051","doc":"mdb-20210131.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001441816-22-000059","doc":"mdb-20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001441816-23-000027","doc":"mdb-20230131.htm","q":null},{"fy":2023,"lvl":3,"n":60,"adsh":"0001441816-24-000049","doc":"mdb-20240131.htm","q":"In 2023, generative artificial intelligence (\u201cAI\u201d) emerged as a significant technology trend."},{"fy":2024,"lvl":3,"n":90,"adsh":"0001441816-25-000057","doc":"mdb-20250131.htm","q":"In 2023, generative artificial intelligence (\u201cAI\u201d) emerged as a significant technology trend."}]},{"cik":1442836,"name":"MERSANA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002479","doc":"mer-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001720","doc":"mrsn-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001726","doc":"mrsn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003370","doc":"mrsn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004101","doc":"mrsn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005376","doc":"mrsn-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":8,"adsh":"0001628280-24-007407","doc":"mrsn-20231231.htm","q":"Increasing use of social media and artificial intelligence-based platforms could give rise to liability, breaches of data security and privacy laws, or reputational damage."},{"fy":2024,"lvl":2,"n":9,"adsh":"0001628280-25-009246","doc":"mrsn-20241231.htm","q":"Increasing use of social media and artificial intelligence-based platforms could give rise to liability, breaches of data security and privacy laws, or reputational damage."}]},{"cik":1444192,"name":"GRACE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001171843-20-004613","doc":"f10k_062620p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-004462","doc":"f10k_062221p.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-011842","doc":"acst-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-029498","doc":"acst-20230331.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-075875","doc":"acst-20240331.htm","q":null},{"fy":2024,"lvl":2,"n":7,"adsh":"0001140361-25-023259","doc":"ef20047573_10k.htm","q":"Moreover, as a result of the broad scale release and availability of Artificial Intelligence (\u201cAI\u201d) technologies such as generative AI, there is a global trend towards more regulation (e.g., the EU AI Act and AI laws passed in U.S. states) \u2026"}]},{"cik":1444307,"name":"ONCOSEC MEDICAL INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-15-070660","doc":"a15-17780_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-16-013999","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-17-012058","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-18-014674","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-19-016036","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-20-020071","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-21-026721","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-22-029990","doc":"form10-k.htm","q":null}]},{"cik":1445049,"name":"ENERGY FUTURE COMPETITIVE HOLDINGS CO LLC","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001445049-15-000003","doc":"efch-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001445049-16-000016","doc":"efch-12312015x10k.htm","q":null}]},{"cik":1445146,"name":"ENERGY FUTURE INTERMEDIATE HOLDING CO LLC","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001445146-15-000003","doc":"efih-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001445146-16-000019","doc":"efih-12312015x10k.htm","q":null}]},{"cik":1445283,"name":"KINETA, INC./DE","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005625","doc":"pti-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005657","doc":"pti-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006999","doc":"pti-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009767","doc":"pti-10k_20191231.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001193125-21-101509","doc":"d51046d10k.htm","q":"Additionally, the use of imaging and digital technology, artificial intelligence and large analytical data repositories now allows for more precise monitoring of disease stage, progression, and response to treatment."},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004564","doc":"ymtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011364","doc":"ka-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034676","doc":"ka-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-034880","doc":"kant-20241231.htm","q":null}]},{"cik":1445305,"name":"WORKIVA INC","industry":"Software & IT services","sic":7372,"state":"IA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001445305-15-000028","doc":"workiva10-k12x31x2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001445305-16-000085","doc":"workiva10-k12x31x2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001445305-17-000008","doc":"workiva10-k12x31x2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001445305-18-000054","doc":"wk-20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001445305-19-000032","doc":"wk-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001445305-20-000037","doc":"wk-20191231.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001445305-21-000035","doc":"wk-20201231.htm","q":"The ESEF tagging capabilities use machine learning to power search recommendations for taxonomy concepts in annual reports."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001445305-22-000041","doc":"wk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001445305-23-000042","doc":"wk-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":33,"adsh":"0001445305-24-000021","doc":"wk-20231231.htm","q":"Vanderploeg transitioned from CEO to the role of Non-Executive Chair of the Board of Directors. \u2022 In Q2, we promoted experienced executives into the roles of Chief Technology Officer, Chief Customer Officer, and Chief Marketing Officer. \u2022 I\u2026"},{"fy":2024,"lvl":3,"n":25,"adsh":"0001445305-25-000034","doc":"wk-20241231.htm","q":"The app also streamlines mobile executive reviews, allowing for faster feedback and improved alignment with reporting cycles. \u2022 In July 2024, our directors authorized a share repurchase program for up to $100 million of our outstanding Clas\u2026"},{"fy":2025,"lvl":3,"n":47,"adsh":"0001445305-26-000016","doc":"0001445305-26-000016.txt","q":"Business Overview Workiva is a leading, AI-powered platform for trust, transparency, and accountability."}]},{"cik":1445499,"name":"IMPEL PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004939","doc":"impl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009981","doc":"impl-20221231.htm","q":null}]},{"cik":1445815,"name":"BIOXYTRAN, INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-004006","doc":"f10k2018_bioxytraninc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-006766","doc":"f10k2019_bioxytraninc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001785982-21-000076","doc":"sf0106h_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001539497-22-000793","doc":"n2583-x37_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-010104","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-011014","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-002614","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-016798","doc":"form10-k.htm","q":null}]},{"cik":1445883,"name":"GIFA, INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001096906-15-000755","doc":"firefish10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001096906-18-000420","doc":"gifa.htm","q":null}]},{"cik":1446847,"name":"IRONWOOD PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000916","doc":"a2223033z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010251","doc":"a2227342z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000793","doc":"irwd-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-000927","doc":"irwd-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001005","doc":"irwd-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-000779","doc":"irwd-20191231x10k2b6bd4.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001136","doc":"irwd-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001368","doc":"irwd-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001462","doc":"irwd-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001275","doc":"irwd-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-004072","doc":"irwd-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-020489","doc":"irwd-20251231x10k.htm","q":null}]},{"cik":1447028,"name":"ARBUTUS BIOPHARMA CORP","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001171843-15-001398","doc":"f10k_031215.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012462","doc":"arbutus10k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002760","doc":"arbutus10k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003276","doc":"arbutus10k2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001447028-19-000006","doc":"arbutus10k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001447028-20-000038","doc":"arbutus10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001447028-21-000021","doc":"abus-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001447028-22-000019","doc":"abus-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001447028-23-000018","doc":"abus-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001447028-24-000035","doc":"abus-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001447028-25-000083","doc":"abus-20241231.htm","q":"Although we are not directly subject to HIPAA \u2014 other than with respect to providing certain employee benefits \u2014 we could potentially be subject to criminal penalties if we, our affiliates, or our agents knowingly receive individually ident\u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001447028-26-000017","doc":"abus-20251231.htm","q":"As a result of the broad-scale release and availability of Artificial Intelligence (AI) technologies, such as generative AI, there is a global trend towards more regulation (e.g., the EU AI Act and AI laws passed in U.S. states) to ensure t\u2026"}]},{"cik":1447380,"name":"MOBIVITY HOLDINGS CORP.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001415889-15-001163","doc":"mfon10k_dec312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001562762-16-000365","doc":"mfon-20151231x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001562762-17-000041","doc":"mfon-20161231x10k.htm","q":null},{"fy":2017,"lvl":"x","n":9,"adsh":"0001562762-18-000130","doc":"mfon-20171231x10k.htm","q":"We believe that these trends reveal a material insight into how the market is converging towards our value proposition and will further propel our growth; as the market increasingly convinces itself of the upside of targeting its marketing \u2026"},{"fy":2018,"lvl":2,"n":9,"adsh":"0001445866-19-000425","doc":"mfon_10k.htm","q":"Data driven marketing will also leverage the rapidly emerging field of \u201ccognitive computing,\u201d where computers are becoming intelligent \u2013 often referred to as \u201cartificial intelligence\u201d."},{"fy":2019,"lvl":2,"n":13,"adsh":"0001445866-20-000286","doc":"mfon_10k.htm","q":"Analytics Powered by Machine Learning Recurrency uses Machine Learning (\u201cML\u201d) to uncover patterns in the buying behaviors of consumers and leverages that data to suggest pricing optimizations, and guide marketing campaigns."},{"fy":2020,"lvl":2,"n":13,"adsh":"0001562762-21-000136","doc":"mfon-20201231x10k.htm","q":"The result is a clean useful dataset upon which to predict and influence customers\u2019 buying behavior and deliver basket-level insights. \ufeff Analytics Powered by Machine Learning Recurrency uses Machine Learning (\u201cML\u201d) to uncover patterns in th\u2026"},{"fy":2021,"lvl":"x","n":13,"adsh":"0001562762-22-000152","doc":"mfon-20211231x10k.htm","q":"Analytics Powered by Machine Learning Recurrency uses Machine Learning (\u201cML\u201d) to uncover patterns in the buying behaviors of consumers and leverages that data to suggest pricing optimizations, and guide marketing campaigns."},{"fy":2022,"lvl":"x","n":13,"adsh":"0001437749-23-008892","doc":"mobv20221231_10k.htm","q":"Analytics Powered by Machine Learning Recurrency uses Machine Learning (\u201cML\u201d) to uncover patterns in the buying behaviors of consumers and leverages that data to suggest pricing optimizations, and guide marketing campaigns. 3."},{"fy":2023,"lvl":"x","n":1,"adsh":"0001493152-24-014966","doc":"form10-k.htm","q":"We also employ Amazon Sagemaker for machine learning tasks and internally host Apache Superset on the AWS platform for data visualization. a) All environments are isolated using credentials and accounts b) We are following a plan to ensure \u2026"},{"fy":2024,"lvl":"x","n":2,"adsh":"0001641172-25-002942","doc":"form10-k.htm","q":"We also employ Amazon Sagemaker for machine learning tasks and internally host Apache Superset on the AWS platform for data visualization. a) All environments are isolated using credentials and accounts b) We are following a plan to ensure \u2026"}]},{"cik":1447599,"name":"FITBIT, INC.","industry":"Computers & chips","sic":3571,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001447599-16-000018","doc":"fitbit1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001447599-17-000010","doc":"fitbit1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002658","doc":"fitbit1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002374","doc":"fitbit1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001447599-20-000016","doc":"fit-20191231.htm","q":null}]},{"cik":1447669,"name":"TWILIO INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":1,"n":1,"adsh":"0001047469-17-000800","doc":"a2230935z10-k.htm","q":"A task can be a phone call, SMS, lead, support ticket or even machine learning from a connected device."},{"fy":2017,"lvl":1,"n":1,"adsh":"0001047469-18-001207","doc":"a2234636z10-k.htm","q":"A task can be a phone call, SMS, chat message, lead, support ticket or even machine learning from a connected device."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001047469-19-000807","doc":"a2237834z10-k.htm","q":"Business Combinations Fiscal 2018 Acquisitions VAI Technologies, LLC In November 2018, the Company acquired certain assets from VAI Technologies, LLC, a Delaware corporation and a developer of a natural language processing platform."},{"fy":2019,"lvl":0,"n":0,"adsh":"0001447669-20-000045","doc":"twlo-20191231x10k.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001447669-21-000070","doc":"twlo-20201231.htm","q":"The technology industry is subject to intense media, political and regulatory scrutiny, including on issues related to antitrust, privacy, and artificial intelligence, which exposes us to government investigations, legal actions and penalti\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001447669-22-000049","doc":"twlo-20211231.htm","q":"The technology industry is subject to intense media, political and regulatory scrutiny, both domestic and foreign, including on issues related to antitrust, privacy, and artificial intelligence, which exposes us to government investigations\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001447669-23-000049","doc":"twlo-20221231.htm","q":"For example, the EU\u2019s Digital Services Act and Digital Markets Act recently entered into force, whereas proposed laws in Europe include the Artificial Intelligence Act and the Data Act."},{"fy":2023,"lvl":3,"n":43,"adsh":"0001447669-24-000034","doc":"twlo-20231231.htm","q":"In 2023, we revealed CustomerAI, which refers to generative and predictive artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) capabilities and initiatives that we believe have the potential to increase the power and reach of our pla\u2026"},{"fy":2024,"lvl":3,"n":65,"adsh":"0001447669-25-000035","doc":"twlo-20241231.htm","q":"By combining our leading communications capabilities, plus rich contextual data, plus generative and predictive artificial intelligence (\u201cAI\u201d), we enable businesses of all sizes to revolutionize how they engage with their customers by deliv\u2026"},{"fy":2025,"lvl":3,"n":64,"adsh":"0001447669-26-000021","doc":"twlo-20251231.htm","q":"By combining our leading communications capabilities with rich contextual data and artificial intelligence (\u201cAI\u201d), we provide the infrastructure for businesses of all sizes to revolutionize how they engage with their customers by delivering\u2026"}]},{"cik":1448056,"name":"NEW RELIC, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-204300","doc":"d881811d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-604334","doc":"d116564d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001448056-17-000010","doc":"newr10k3312017.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001448056-18-000016","doc":"newr10k3312018.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001448056-19-000020","doc":"newr10k3312019.htm","q":"(\u201cSignifAI\u201d), an event intelligence company specializing in artificial intelligence and machine learning."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001448056-20-000014","doc":"newr-20200331.htm","q":"(\u201cSignifAI\u201d), an event intelligence company specializing in artificial intelligence and machine learning."},{"fy":2020,"lvl":2,"n":12,"adsh":"0001448056-21-000025","doc":"newr-20210331.htm","q":"Engineers act on the collected telemetry via a unified and AI-enabled user interface which converges all observability workflows into one cohesive experience."},{"fy":2021,"lvl":2,"n":8,"adsh":"0001448056-22-000021","doc":"newr-20220331.htm","q":"Engineers act on the collected telemetry via a unified and AI-enabled user interface which converges all observability workflows into one cohesive experience."},{"fy":2022,"lvl":2,"n":11,"adsh":"0001448056-23-000033","doc":"newr-20230331.htm","q":"Our platform ingests significant amounts of telemetry data from a wide array of sources and modalities - including metrics, events, logs, and traces - and seamlessly delivers them to our users through an intuitive and unified, Artificial In\u2026"}]},{"cik":1448558,"name":"GROW CAPITAL, INC.","industry":"Software & IT services","sic":7371,"state":"NV","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001445866-20-001527","doc":"grwc_10k.htm","q":null}]},{"cik":1448780,"name":"MOBILEBITS HOLDINGS CORP","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-001042","doc":"f10k2014_mobilebits.htm","q":null}]},{"cik":1449278,"name":"TUBEMOGUL INC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":2,"adsh":"0001564590-15-002274","doc":"tube-10k_20141231.htm","q":"Our machine learning team leverages the massive data sets captured by our platform to build predictive models around user demographic attributes to maximize alignment with Nielsen Online Campaign Ratings and/or Comscore Validated Campaign E\u2026"},{"fy":2015,"lvl":1,"n":2,"adsh":"0001564590-16-014450","doc":"tube-10k_20151231.htm","q":"Our machine learning team leverages the massive data sets captured by our platform to build predictive models around user demographic attributes to maximize alignment with Nielsen Online Campaign Ratings and/or Comscore Validated Campaign E\u2026"}]},{"cik":1449447,"name":"ENTEST GROUP, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001607062-15-000525","doc":"entb83115form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001607062-16-001077","doc":"entb083116form10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001607062-17-000423","doc":"entb083117form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001607062-18-000462","doc":"entb083118form10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-19-002635","doc":"etni_10k.htm","q":null}]},{"cik":1449574,"name":"BRAVATEK SOLUTIONS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-004869","doc":"ecry_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-17-003466","doc":"bvtk_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-004744","doc":"bvtk_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-002167","doc":"bvtk_10kt.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-003478","doc":"bvtk_10k.htm","q":null}]},{"cik":1450708,"name":"AURUM, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001157523-17-002583","doc":"a51688007.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001157523-17-002587","doc":"a51688012.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001157523-17-002634","doc":"a51691076.htm","q":null}]},{"cik":1451809,"name":"SITIME CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008145","doc":"sitm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005867","doc":"sitm-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002096","doc":"sitm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004647","doc":"sitm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001451809-24-000052","doc":"sitm-20231231.htm","q":"Below are some examples of end markets in which we believe our silicon-based timing is enabling or has the potential to enable, greater functionality than legacy solutions: Communications, Datacenter, and Enterprise Communications infrastru\u2026"},{"fy":2024,"lvl":2,"n":5,"adsh":"0001451809-25-000034","doc":"sitm-20241231.htm","q":"The resilience of our products becomes an increasing advantage as equipment is placed in dense, harsh environments and moves closer to the customer with the rollout of 5G, the rapid expansion in cloudification, and deployment of hyperscale \u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001451809-26-000012","doc":"sitm-20251231.htm","q":"Our products have been designed into over 400 applications across our target markets, including artificial intelligence (\"AI\") systems, datacenter, communications, enterprise, automotive, industrial, aerospace, defense, mobile, Internet of \u2026"}]},{"cik":1452804,"name":"PEAK PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001137050-15-000010","doc":"form10ksept2014v8bclean.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001137050-16-000192","doc":"form10ksept2015edgarized.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-008392","doc":"peak_10k-17232.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001199835-18-000004","doc":"peakpharma-form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001199835-22-000806","doc":"pkph093018-10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001199835-22-000814","doc":"pkph093019-10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001199835-22-000822","doc":"pkph093020-10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001199835-22-000830","doc":"pkph093021-10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001199835-22-000838","doc":"pkph093022-10k.htm","q":null}]},{"cik":1453001,"name":"VACCINOGEN INC","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-023058","doc":"v407000_10k.htm","q":null}]},{"cik":1453593,"name":"XTANT MEDICAL HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-017019","doc":"v402499_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-090163","doc":"v427833_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-017200","doc":"v461974_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-019363","doc":"tv490179_10ka.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004396","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003410","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-004676","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-006240","doc":"form10-k.htm","q":"McNamara has previously served as the Senior Vice President and Chief Financial Officer for publicly traded medical device companies including Accuray Inc., a stereotactic radiation company focused on treating cancer using AI robotics, Somn\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001493152-23-006881","doc":"form10-k.htm","q":"McNamara has previously served as the Senior Vice President and Chief Financial Officer for publicly traded medical device companies including Accuray Inc., a stereotactic radiation company focused on treating cancer using AI robotics, Somn\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-24-012145","doc":"form10-k.htm","q":"McNamara has previously served as the Senior Vice President and Chief Financial Officer for publicly traded medical device companies including Accuray Inc., a stereotactic radiation company focused on treating cancer using AI robotics, Somn\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001493152-25-009391","doc":"form10-k.htm","q":"McNamara has previously served as the Senior Vice President and Chief Financial Officer for publicly traded medical device companies including Accuray Inc., a stereotactic radiation company focused on treating cancer using AI robotics, Somn\u2026"}]},{"cik":1453687,"name":"CARTESIAN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001453687-17-000014","doc":"selectabiosciences10-k1231.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001453687-18-000012","doc":"selectabiosciences10-k1231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001453687-19-000032","doc":"selectabiosciences10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001453687-20-000028","doc":"selectabiosciences10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001453687-21-000031","doc":"selb-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001453687-22-000051","doc":"selb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001453687-23-000040","doc":"selb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001453687-24-000036","doc":"rnac-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001453687-25-000060","doc":"rnac-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001453687-26-000064","doc":"rnac-20251231.htm","q":null}]},{"cik":1453814,"name":"MEDIDATA SOLUTIONS, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001453814-15-000059","doc":"a10-kxq42014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001453814-16-000174","doc":"a10-kxq42015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001453814-17-000063","doc":"a10-k2016.htm","q":null},{"fy":2017,"lvl":2,"n":5,"adsh":"0001453814-18-000052","doc":"a10-k2017.htm","q":"Medical terms can be coded automatically with natural language processing and machine learning. 1 Table of Contents Rich Data Capture Leads to Pioneering Analytics The Medidata Clinical Cloud is underpinned by the Medidata Enterprise Data S\u2026"},{"fy":2018,"lvl":2,"n":5,"adsh":"0001453814-19-000061","doc":"a10-k12312018.htm","q":"Our cloud-based platform of solutions, data analytics, and AI enables efficiency and improves quality throughout clinical development programs by accelerating processes, enhancing decision-making, minimizing operational risk, reducing costs\u2026"}]},{"cik":1454189,"name":"AUSPEX PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001735","doc":"aspx-10k_20141231.htm","q":null}]},{"cik":1454742,"name":"GOOD GAMING, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-010031","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-011324","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012092","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001868","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-015189","doc":"form10-k.htm","q":null}]},{"cik":1454789,"name":"ASTRIA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011175","doc":"a2227770z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001682","doc":"a2231344z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001688","doc":"a2234670z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001212","doc":"a2237988z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-20-001338","doc":"a2240917z10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-032475","doc":"atxs-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-035584","doc":"atxs-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001410578-24-000127","doc":"atxs-20231231x10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2024,"lvl":2,"n":10,"adsh":"0001410578-25-000309","doc":"atxs-20241231x10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."}]},{"cik":1454938,"name":"TEADS HOLDING CO.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":2,"n":9,"adsh":"0001454938-22-000003","doc":"outbrain-20211231.htm","q":"Our recommendation engine relies on advanced artificial intelligence technology and machine learning algorithms."},{"fy":2022,"lvl":3,"n":15,"adsh":"0001454938-23-000029","doc":"outbrain-20221231.htm","q":"Our success in delivering user engagement stems from long-developed artificial intelligence (\u201cAI\u201d) and prediction capabilities that allow us to improve advertisers\u2019 return on ad spend (\u201cROAS\u201d) thus unlocking more advertising spend and attra\u2026"},{"fy":2023,"lvl":3,"n":100,"adsh":"0001454938-24-000024","doc":"outbrain-20231231.htm","q":"Outbrain\u2019s artificial intelligence (\u201cAI\u201d) prediction engine powers a two-sided platform for advertisers and media owners that delivers concrete business outcomes."},{"fy":2024,"lvl":3,"n":89,"adsh":"0001454938-25-000020","doc":"outbrain-20241231.htm","q":"As digital has become the mainstream delivery method for content, publishers continue to invest in existing as well as new forms of digital content and content distribution (CTV apps and video content, short videos, curated user-generated c\u2026"},{"fy":2025,"lvl":3,"n":140,"adsh":"0001454938-26-000015","doc":"tead-20251231.htm","q":"Our solution is designed to directly address some of the largest challenges in the advertising industry today \u2014 including inefficient supply chains and fragmentation, the threat to publisher page views from generative artificial intelligenc\u2026"}]},{"cik":1455365,"name":"COGNITION THERAPEUTICS INC","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004672","doc":"cgtx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004401","doc":"cgtx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003949","doc":"cgtx-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003341","doc":"cgtx-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":17,"adsh":"0001104659-26-034880","doc":"cgtx-20251231x10k.htm","q":"Failure to comply with U.S. and foreign data protection laws and regulations could result in government investigations and/or enforcement actions, fines, civil or criminal penalties, private litigation or adverse publicity and could negativ\u2026"}]},{"cik":1455694,"name":"SIGNPATH PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001096906-15-000373","doc":"signpath.htm","q":null},{"fy":2015,"lvl":"x","n":1,"adsh":"0001493152-16-008758","doc":"form10-k.htm","q":null}]},{"cik":1455926,"name":"IRONCLAD ENCRYPTION CORP","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001052918-18-000123","doc":"iec10kapr16-18v3.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001052918-19-000219","doc":"iec10kjuly16-19final.htm","q":null}]},{"cik":1456212,"name":"BLACKRIDGE TECHNOLOGY INTERNATIONAL, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001096906-18-000181","doc":"blackridge.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001096906-19-000134","doc":"blackridge.htm","q":"Furthermore, unlike VPN and tunneling technologies that encrypt network traffic, our solution enables customers to continue to use their advanced analytical and machine learning tools."}]},{"cik":1457612,"name":"GENOCEA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-014851","doc":"a15-1794_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001457612-16-000048","doc":"gnca-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001457612-17-000009","doc":"gnca-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001457612-18-000019","doc":"gnca-20171231x10k.htm","q":null},{"fy":2018,"lvl":1,"n":3,"adsh":"0001457612-19-000027","doc":"gnca-20181231x10k.htm","q":"We believe that ATLAS, which recreates each individual's T cell immune responses to their tumor in the laboratory, affords Genocea advantages in the design of novel cancer immunotherapies relative to our peers, who we believe rely primarily\u2026"},{"fy":2019,"lvl":0,"n":0,"adsh":"0001457612-20-000015","doc":"gnca-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001457612-21-000022","doc":"gnca-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001457612-22-000039","doc":"gnca-20211231.htm","q":null}]},{"cik":1459200,"name":"ALARM.COM HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001459200-16-000024","doc":"alarmcom10-k2015dec312015.htm","q":null},{"fy":2016,"lvl":1,"n":3,"adsh":"0001459200-17-000007","doc":"alarmcom10-kdecember312016.htm","q":"Our proprietary machine learning algorithms help safeguard connected properties by learning the unique activity patterns at the property and automatically notifying the subscriber of unexpected activity. \u25e6 Real-Time Alerts."},{"fy":2017,"lvl":1,"n":4,"adsh":"0001459200-18-000013","doc":"alarmcom10-kdecember312017.htm","q":"Our proprietary machine learning algorithms help safeguard connected properties by learning the unique activity patterns at the property and automatically notifying the subscriber of unexpected activity. \u25e6 Real-Time Alerts."},{"fy":2018,"lvl":2,"n":5,"adsh":"0001459200-19-000007","doc":"alarmcom10-kdecember312018.htm","q":"Our proprietary machine learning algorithms help safeguard connected properties by learning the unique activity patterns at the property and automatically notifying the subscriber of unexpected activity."},{"fy":2019,"lvl":1,"n":4,"adsh":"0001459200-20-000005","doc":"alarmcom10-kdecember31.htm","q":"Our proprietary machine learning algorithms help safeguard connected properties by learning the unique activity patterns at the property and automatically notifying the subscriber of unexpected activity."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001459200-21-000012","doc":"alrm-20201231.htm","q":"Our proprietary machine learning algorithms help safeguard connected properties by learning the unique activity patterns at the property and automatically notifying the subscriber of unexpected activity."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001459200-22-000008","doc":"alrm-20211231.htm","q":"With Smart Gateway, Alarm.com's service provider partners can also more efficiently deploy video cameras and services with better connectivity and leverage wireless spectrum maximized for performance. \u25e6 AI-powered Enhancements to Profession\u2026"},{"fy":2022,"lvl":2,"n":5,"adsh":"0001459200-23-000006","doc":"alrm-20221231.htm","q":"With Smart Gateway, Alarm.com's service provider partners can also more efficiently deploy video cameras and services with better connectivity and leverage wireless spectrum maximized for performance. \u25e6 AI-powered Enhancements to Profession\u2026"},{"fy":2023,"lvl":3,"n":28,"adsh":"0001459200-24-000008","doc":"alrm-20231231.htm","q":"An on-board neural network rapidly identifies people while optimizing energy usage for extended battery life. \u25e6 Intelligent Integration."},{"fy":2024,"lvl":3,"n":35,"adsh":"0001459200-25-000004","doc":"alrm-20241231.htm","q":"Alarm.com's artificial intelligence, or AI, driven video analytics engine provides object classification and object tracking capabilities that can distinguish between people, vehicles and animals, determine an object's direction of movement\u2026"},{"fy":2025,"lvl":3,"n":42,"adsh":"0001459200-26-000005","doc":"alrm-20251231.htm","q":"Alarm.com's artificial intelligence, or AI, driven video analytics engine provides object classification and object tracking capabilities that can distinguish between people, vehicles and animals, detect package deliveries, determine an obj\u2026"}]},{"cik":1459266,"name":"ZS PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091221","doc":"d846181d10k.htm","q":null}]},{"cik":1459417,"name":"2U, INC.","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001305","doc":"a2223062z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010989","doc":"a2227489z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-000950","doc":"a2231003zex-10_16.htm","q":null},{"fy":2017,"lvl":1,"n":4,"adsh":"0001047469-18-001109","doc":"a2234625z10-k.htm","q":"These two components are tightly integrated and each is optimized with data analysis and machine learning techniques. 4 Table of Contents Front-End Technology and Services We provide the following front-end technology and services to studen\u2026"},{"fy":2018,"lvl":2,"n":5,"adsh":"0001104659-19-010491","doc":"a19-30045_410k.htm","q":"These two components are tightly integrated and optimized with data analysis and machine learning techniques. 2UOS delivers technology with a human touch and is the keystone of our commitment to provide our university clients the tools they\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001459417-20-000003","doc":"a2u201910-k.htm","q":"Through 2UOS, we provide front-end and back-end cloud-based SaaS technology and technology-enabled services, which are tightly integrated and optimized with data analysis and machine learning techniques."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001459417-21-000003","doc":"twou-20201231.htm","q":"Through 2UOS, we provide front-end and back-end cloud-based SaaS technology and technology-enabled services, which are tightly integrated and optimized with data analysis and machine learning techniques."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001459417-22-000004","doc":"twou-20211231.htm","q":"Degree Program Segment: Technology and Services In the Degree Program Segment, we provide front-end and back-end cloud-based SaaS technology and technology-enabled services, which are tightly integrated and optimized with data analysis and \u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001459417-23-000004","doc":"twou-20221231.htm","q":"Through data analytics and machine learning techniques, we connect learners with the appropriate high-quality learning experiences based on their skill sets and learning goals."},{"fy":2023,"lvl":3,"n":35,"adsh":"0001459417-24-000011","doc":"twou-20231231.htm","q":"Our offerings cover a wide range of topics, including artificial intelligence, business, healthcare, education, and social work, and provide learners with an affordable pathway to achieve both short-term and long-term professional and educa\u2026"}]},{"cik":1460602,"name":"ORGENESIS INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001062993-15-000971","doc":"form10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001062993-16-008107","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001062993-17-001138","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001062993-18-001019","doc":"form10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001062993-19-000780","doc":"form10k.htm","q":"We consider the following to be the four pillars in order to advance our PT business strategy: \u00b7 Innovation \u2013 This leverages our unique know-how and expertise for industrial processes, operational excellence, process development and optimiz\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001062993-20-001299","doc":"form10k.htm","q":"We consider the following to be the four pillars in order to advance our POC business strategy: Innovation - This leverages our unique know-how and expertise for industrial processes, operational excellence, process development and optimiza\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-005653","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001493152-22-008157","doc":"form10-k.htm","q":"Deep Med IO Ltd Joint Venture Agreement Development and commercialization of an AI-powered system to be used in the manufacturing and/or quality control of CGTs."},{"fy":2022,"lvl":2,"n":7,"adsh":"0001493152-23-008574","doc":"form10-k.htm","q":"The grant is for technologies enabling the production of autologous induced pluripotent stem cells (iPSCs) using microfluidic technologies and artificial intelligence (AI). \u25cf Orgenesis Italy SRL which was incorporated in 2022 and is current\u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0001493152-24-014652","doc":"form10-k.htm","q":"The grant is for technologies enabling the production of autologous induced pluripotent stem cells (iPSCs) using microfluidic technologies and artificial intelligence (AI). \u25cf Orgenesis Italy SRL which is currently focused on R&D activities."},{"fy":2024,"lvl":"x","n":8,"adsh":"0001493152-26-012845","doc":"form10-k.htm","q":"The grant is for technologies enabling the production of autologous induced pluripotent stem cells (iPSCs) using microfluidic technologies and artificial intelligence (AI). \u25cf Orgenesis Italy SRL which is currently focused on R&D activities.\u2026"}]},{"cik":1460702,"name":"QUALIGEN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001493152-16-008162","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-001929","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003532","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004362","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-005503","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007476","doc":"form10-kt.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008431","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-015184","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-013400","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-017212","doc":"form10-k.htm","q":null}]},{"cik":1461993,"name":"MELINTA THERAPEUTICS, INC. /NEW/","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001019","doc":"cemp-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013362","doc":"cemp-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002719","doc":"cemp-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005947","doc":"mlnt-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002907","doc":"mlnt-123118x10k.htm","q":null}]},{"cik":1462047,"name":"PRIME GLOBAL CAPITAL GROUP INC","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001019687-16-004966","doc":"pgcg_10k-103115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001683168-17-000276","doc":"primeglobal_10k-103116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-18-000252","doc":"prime_10k-103117.htm","q":null}]},{"cik":1462056,"name":"BACKBLAZE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001628280-22-007434","doc":"blze-20211231.htm","q":"Customers leverage B2 Cloud Storage for a wide range of use cases, including public, hybrid and multi-cloud data storage; application development and DevOps; content delivery and edge computing; security and ransomware protection; media man\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001462056-23-000119","doc":"blze-20221231.htm","q":"Customers leverage B2 Cloud Storage for a wide range of use cases, including public, hybrid and multi-cloud data storage; application development and DevOps; content delivery and edge computing; security and ransomware protection; media man\u2026"},{"fy":2023,"lvl":2,"n":10,"adsh":"0001462056-24-000033","doc":"blze-20231231.htm","q":"This Infrastructure-as-a-Service (IaaS) enables use cases including backups, multi-cloud, application storage, ransomware protection, and storage for AI/ML workflows. \u2022 Backblaze Computer Backup: Automatically backs up data from laptops and\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0001462056-25-000015","doc":"blze-20241231.htm","q":"Customers use us to support their AI workflows, help ensure the cyber-resilience of their organizations, streamline their media workflows, and enable a variety of other data-focused application and IT needs."},{"fy":2025,"lvl":3,"n":94,"adsh":"0001628280-26-016395","doc":"blze-20251231.htm","q":"Business Overview We are a high-performance cloud storage platform for data-intensive use cases in the artificial intelligence (\u201cAI\u201d) era and across a broad range of modern cloud workloads, designed to help customers address complex storage\u2026"}]},{"cik":1462223,"name":"NIXXY, INC.","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2019,"lvl":"x","n":18,"adsh":"0001213900-20-011374","doc":"f10k2019_recruitercomgroup.htm","q":"BUSINESS Overview We help businesses accelerate and streamline their recruiting and hiring processes by leveraging our expert network of recruiters aided by cutting edge artificial intelligence-based candidate sourcing and matching technolo\u2026"},{"fy":2020,"lvl":"x","n":45,"adsh":"0001213900-21-014153","doc":"f10k2020_recruitercom.htm","q":"Businesses of all sizes recruit talent faster using the Recruiter.com platform, which is powered by virtual teams of Recruiters On Demand and Video and Artificial Intelligence (\u201cAI\u201d) job-matching technology."},{"fy":2021,"lvl":"x","n":46,"adsh":"0001654954-22-004330","doc":"recruiter_10k.htm","q":"We offer recruiting software and services through an online, AI-powered sourcing platform and network of on-demand recruiters."},{"fy":2022,"lvl":3,"n":31,"adsh":"0001654954-23-004101","doc":"recruiter_10k.htm","q":"We utilize Upsider\u2019s machine learning artificial intelligence to provide a more predictive and efficient recruiting tool that enhances our current technology."},{"fy":2023,"lvl":3,"n":18,"adsh":"0001654954-24-004693","doc":"rcrt_10k.htm","q":"Under the GOLQ Licensing Agreement, GOLQ grants the Company a worldwide, exclusive license (the \u201cGOLQ License\u201d) to the Company to develop its fintech technology (the \u201cGOLQ Technology\u201d) and sell products derived thereof, including its Create\u2026"},{"fy":2024,"lvl":"x","n":103,"adsh":"0001654954-25-003709","doc":"nixx_10k.htm","q":"(\u201cGoLogiq\u201d), to operate its fintech technology (the \u201cGOLQ Technology\u201d) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products."},{"fy":2025,"lvl":3,"n":44,"adsh":"0001683168-26-002951","doc":"nixxy_i10k-123125.htm","q":"(\u201cNixxy,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus,\u201d or \u201cour\u201d) is a Nevada corporation focused on building an artificial intelligence-enabled communications and data infrastructure platform that supports global telecommunications services and emerging tran\u2026"}]},{"cik":1463101,"name":"ENPHASE ENERGY, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001463101-15-000017","doc":"enph-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001463101-16-000040","doc":"a10-k12312015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001463101-17-000024","doc":"a10-k12312016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001463101-18-000030","doc":"a10-k12312017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001463101-19-000033","doc":"a2018form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001463101-20-000021","doc":"a2019q410-kdoc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001463101-21-000016","doc":"enph-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001463101-22-000016","doc":"enph-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001463101-23-000025","doc":"enph-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001463101-24-000024","doc":"enph-20231231.htm","q":"The devices work in coordination with the Enphase Energy System and deploy artificial intelligence-based solar production forecasting, consumption forecasting, and an optimization engine to maximize self-consumption."},{"fy":2024,"lvl":2,"n":9,"adsh":"0001463101-25-000024","doc":"enph-20241231.htm","q":"The devices work in coordination with the Enphase Energy System and deploy artificial intelligence-based solar production forecasting, consumption forecasting, and an optimization engine to maximize self-consumption."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001463101-26-000013","doc":"enph-20251231.htm","q":"These devices monitor and control energy usage between the Enphase Energy System, EV chargers and heat pumps, working in coordination with our system intelligence to deploy AI\u2011based solar production forecasting, consumption forecasting and \u2026"}]},{"cik":1463361,"name":"UNITY BIOTECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006397","doc":"ubx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010071","doc":"ubx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014854","doc":"ubx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010232","doc":"ubx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008171","doc":"ubx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-044237","doc":"ubx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-035564","doc":"ubx-20241231.htm","q":null}]},{"cik":1463729,"name":"RECEPTOS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-071752","doc":"d846329d10k.htm","q":null}]},{"cik":1464165,"name":"PIVOT PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-003314","doc":"neukd_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009996","doc":"pvotf_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-002007","doc":"pvotf_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-002135","doc":"pvotf_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-002311","doc":"pvotf_10k.htm","q":null}]},{"cik":1464766,"name":"EPCYLON TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"ON","cells":[{"fy":2015,"lvl":"x","n":1,"adsh":"0001062993-15-005011","doc":"form10k.htm","q":null}]},{"cik":1465509,"name":"XCELMOBILITY INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-021718","doc":"v405269_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-094963","doc":"v437025_10k.htm","q":null}]},{"cik":1466301,"name":"CLOVIS ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001099","doc":"clvs-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013672","doc":"clvs-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000902","doc":"clvs-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001172","doc":"clvs-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001212","doc":"clvs-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001500","doc":"clvs-20191231x10k5eb4cb.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001668","doc":"clvs-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001810","doc":"clvs-20211231x10k.htm","q":null}]},{"cik":1466593,"name":"OTTER TAIL CORP","industry":"Utilities","sic":4911,"state":"MN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001571049-15-001534","doc":"t81442_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001571049-16-012346","doc":"t1600062_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-001533","doc":"t1700069_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-002843","doc":"ottr20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-003150","doc":"ottr20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-003157","doc":"ottr20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001466593-21-000011","doc":"ottr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001466593-22-000010","doc":"ottr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001466593-23-000053","doc":"ottr-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001466593-24-000039","doc":"ottr-20231231.htm","q":"Cyber-attacks or other security breaches may also be perpetrated through the use of artificial intelligence, which could introduce additional complexity to such an attack or breach."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001466593-25-000034","doc":"ottr-20241231.htm","q":"Cyber-attacks or other security breaches may also be perpetrated through the use of artificial intelligence, which could introduce additional complexity to such an attack or breach."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001466593-26-000008","doc":"ottr-20251231.htm","q":"Cyber attacks or other security breaches may also be perpetrated through the use of artificial intelligence, which could introduce additional complexity to such an attack or breach."}]},{"cik":1467154,"name":"NOVAN, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004762","doc":"novn-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006881","doc":"novn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001467154-19-000018","doc":"novn-12312018x10kx2018sc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001467154-20-000014","doc":"novn-12312019x10kx2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001467154-21-000012","doc":"novn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001467154-22-000012","doc":"novn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001467154-23-000029","doc":"novn-20221231.htm","q":null}]},{"cik":1467623,"name":"DROPBOX, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":1,"n":2,"adsh":"0001467623-19-000005","doc":"a12311810-k.htm","q":"Machine learning further improves the user experience by enabling more intelligent search and better organization and utility of information."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001467623-20-000011","doc":"a12311910-k.htm","q":"Machine learning further improves the user experience by enabling more intelligent search, better organization, and utility of information."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001467623-21-000012","doc":"dbx-20201231.htm","q":"Machine learning further improves the user experience by enabling more intelligent search, better organization, and utility of information."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001467623-22-000015","doc":"dbx-20211231.htm","q":"Machine learning further improves the user experience by enabling more intelligent search, better organization, and utility of information."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001467623-23-000012","doc":"dbx-20221231.htm","q":"Machine learning further improves the user experience by enabling more intelligent search, better organization, and utility of information."},{"fy":2023,"lvl":3,"n":25,"adsh":"0001467623-24-000008","doc":"dbx-20231231.htm","q":"Machine learning further improves the user experience by enabling more intelligent search, better organization, and utility of information."},{"fy":2024,"lvl":3,"n":34,"adsh":"0001467623-25-000011","doc":"dbx-20241231.htm","q":"Products like Dropbox Passwords, Dropbox Backup, Dropbox Sign, DocSend, Dropbox Dash for Business (\"Dash\"), Dropbox Replay, Dropbox Transfer, and Reclaim.ai, Inc."},{"fy":2025,"lvl":3,"n":41,"adsh":"0001467623-26-000008","doc":"dbx-20251231.htm","q":"Products like Dropbox Backup, Dropbox Sign, DocSend, Dropbox Dash (\"Dash\"), Dropbox Replay, Dropbox Transfer, and Reclaim.ai, Inc."}]},{"cik":1467652,"name":"NEOS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011314","doc":"a2227841z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001586","doc":"a2231299z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001730","doc":"a2234488z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001344","doc":"a2238031z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002684","doc":"neos-20191231x10k.htm","q":null}]},{"cik":1467858,"name":"GENERAL MOTORS CO","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001467858-15-000036","doc":"gm201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001467858-16-000255","doc":"gm201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001467858-17-000028","doc":"gm201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001467858-18-000022","doc":"gm201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001467858-19-000033","doc":"gm201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001467858-20-000028","doc":"gm201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001467858-21-000037","doc":"gm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001467858-22-000034","doc":"gm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001467858-23-000029","doc":"gm-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001467858-24-000031","doc":"gm-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001467858-25-000032","doc":"gm-20241231.htm","q":"To successfully execute our long-term strategy, we must continue to develop and commercialize new products and services, including products and services that are outside of our historically core ICE business, such as EVs and AVs, software-e\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001467858-26-000013","doc":"gm-20251231.htm","q":"Building on a century of innovation, we are leveraging software, hardware, artificial intelligence (AI), and sensors to produce safer, smarter, and more fuel efficient vehicles."}]},{"cik":1468639,"name":"VICAPSYS LIFE SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-022984","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-006994","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-012267","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-041809","doc":"form10-k.htm","q":null}]},{"cik":1468666,"name":"SECUREWORKS CORP","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2016,"lvl":"x","n":3,"adsh":"0001468666-17-000015","doc":"scwx10-kfy2017x02032017.htm","q":"Foresee, our behavioral and self-learning technology, identifies malicious events through the use of machine learning algorithms to determine the probability and confidence that a particular event or a collection of events is malicious."},{"fy":2017,"lvl":"x","n":5,"adsh":"0001468666-18-000011","doc":"scwx10-kfy2018x02022018.htm","q":"We combine visibility from thousands of clients, machine learning and automation from our industry-leading SecureWorks Counter Threat Platform TM , and actionable insights from our team of elite researchers, analysts and consultants to crea\u2026"},{"fy":2018,"lvl":2,"n":6,"adsh":"0001468666-19-000022","doc":"scwx10-kfy2019x02012019.htm","q":"We combine visibility from thousands of customers, machine learning and automation from our industry-leading SecureWorks Counter Threat Platform TM , and actionable insights from our team of elite researchers, analysts and consultants to cr\u2026"},{"fy":2019,"lvl":2,"n":9,"adsh":"0001468666-20-000019","doc":"scwx10-kfy2020x01312020.htm","q":"We combine deep experience from service to thousands of customers, machine learning and automation from our proprietary technology, and actionable insights from our team of elite researchers, analysts, and consultants to create a powerful n\u2026"},{"fy":2020,"lvl":2,"n":13,"adsh":"0001468666-21-000012","doc":"scwx-20210129.htm","q":"We combine considerable experience from securing thousands of customers, deep and machine-learning capabilities in our software platform, and actionable insights from our team of elite researchers, analysts and consultants to create a power\u2026"},{"fy":2021,"lvl":2,"n":14,"adsh":"0001468666-22-000011","doc":"scwx-20220128.htm","q":"We combine considerable experience from securing thousands of customers, machine-learning capabilities in our software platform, and actionable insights from our team of elite researchers, analysts and consultants to create a powerful netwo\u2026"},{"fy":2022,"lvl":2,"n":13,"adsh":"0001468666-23-000013","doc":"scwx-20230203.htm","q":"We combine considerable experience from securing thousands of customers, machine-learning capabilities in our software platform, and actionable insights from our team of elite researchers, analysts and consultants to create a powerful netwo\u2026"},{"fy":2023,"lvl":3,"n":47,"adsh":"0001468666-24-000016","doc":"scwx-20240202.htm","q":"We combine considerable experience from securing thousands of customers and processing billions of customer events, incorporate artificial intelligence and machine-learning in our security platform, and utilize actionable insights from our \u2026"}]},{"cik":1468748,"name":"KODIAK SCIENCES INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009601","doc":"kod-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011186","doc":"kod-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009946","doc":"kod-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002555","doc":"kod-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010314","doc":"kod-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-038025","doc":"kod-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes and phishing attacks), malicious code (such as viruses and wo\u2026"},{"fy":2024,"lvl":2,"n":10,"adsh":"0000950170-25-046098","doc":"kod-20241231.htm","q":"VETi is an autonomous AI- and machine-learning-enabled headset that engages directly into the eye."},{"fy":2025,"lvl":3,"n":21,"adsh":"0001193125-26-134887","doc":"0001193125-26-134887.txt","q":"In DAYBREAK, patients are treated on an every 1-month through every 6-month treatment interval, depending on an AI-driven assessment of disease activity."}]},{"cik":1468978,"name":"SOUTHERN ITS INTERNATIONAL, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-23-008761","doc":"sitsf_10k.htm","q":null}]},{"cik":1470099,"name":"MOBILEIRON, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001558370-15-000233","doc":"mobl-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003380","doc":"mobl-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000593","doc":"mobl-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001558370-18-001924","doc":"mobl-20171231x10k.htm","q":"In addition, MobileIron AppConnect is an SDK and wrapper that third-party developers can integrate into their applications to provide a higher level of security through additional encryption and advanced security controls. \u00b7 Threat intellig\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001558370-19-000918","doc":"mobl-20181231x10k.htm","q":"In addition, MobileIron Tunnel provides secure connectivity through a per-app VPN to connect applications to back-end services. \u00b7 MobileIron Threat Defense uses machine learning-based analytics to identify zero-day threats on the device, ac\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001558370-20-002145","doc":"mobl-20191231x10k.htm","q":"In addition, MobileIron Tunnel provides secure connectivity through a per-app VPN to connect applications to back-end services. \u00b7 MobileIron Threat Defense (MTD) uses machine learning-based analytics to identify zero-day threats on a device\u2026"}]},{"cik":1470129,"name":"VISITIQ CORP.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2025,"lvl":"x","n":60,"adsh":"0001753926-26-000917","doc":"g085722_10k.htm","q":"We have invested nearly $10 million into the development of our Artificial Intelligence (\u201cAI\u201d)-driven go-to-market (\u201cGTM\u201d) platform."}]},{"cik":1471781,"name":"GOPHER PROTOCOL INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001615774-15-000751","doc":"s100970_10k.htm","q":null}]},{"cik":1471968,"name":"ENZYMEBIOSYSTEMS","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-17-011573","doc":"form10k.htm","q":null}]},{"cik":1472012,"name":"IMMUNOME INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003493","doc":"tmb-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004420","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003964","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":3,"n":15,"adsh":"0001558370-24-004247","doc":"tmb-20231231x10k.htm","q":"Our employees and personnel have used, and may in the future use, generative artificial intelligence, or AI, technologies to perform their work, and the disclosure and use of personal information in generative AI technologies is subject to \u2026"},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003302","doc":"tmb-20241231xex10d28.htm","q":null},{"fy":2025,"lvl":3,"n":19,"adsh":"0001193125-26-088172","doc":"imnm-20251231.htm","q":"Our personnel use artificial intelligence (\u201cAI\u201d) technologies, including generative AI, to support aspects of their work, and the disclosure and use of personal information in AI technologies is subject to various privacy laws and other pri\u2026"}]},{"cik":1472091,"name":"PDS BIOTECHNOLOGY CORP","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-16-056994","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-010287","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-18-011218","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001140361-19-003636","doc":"form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001140361-20-007252","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-009142","doc":"brhc10021904_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-012244","doc":"brhc10035378_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-014279","doc":"brhc10050281_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-016265","doc":"ef20015299_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001140361-25-010717","doc":"ef20039023_10k.htm","q":null},{"fy":2025,"lvl":2,"n":9,"adsh":"0001140361-26-012030","doc":"ef20060644_10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."}]},{"cik":1473579,"name":"NANOMIX CORP","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001102624-15-000441","doc":"boston10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001102624-16-002414","doc":"bostontherapeutics10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-17-001275","doc":"s105634_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-18-002112","doc":"s109430_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001615774-19-005825","doc":"s117415_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-014377","doc":"f10k2019_bostontherapeutics.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-022666","doc":"f10k2020_bostontherapeutics.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-019462","doc":"f10k2021_nanomixcorp.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-028171","doc":"f10k2022_nanomixcorp.htm","q":null}]},{"cik":1473654,"name":"LEVELBLOX, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001161697-15-000179","doc":"form_10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001161697-16-000787","doc":"form_10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001161697-17-000172","doc":"form_10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001161697-18-000164","doc":"form_10-k.htm","q":null},{"fy":2018,"lvl":"x","n":1,"adsh":"0001161697-19-000122","doc":"form_10-k.htm","q":"Member of the Board of Directors Katya Fisher, Esq. focuses on representing international businesses and entrepreneurs with a specific focus on media and technologies such as blockchain, cybersecurity, cryptocurrency and A.I."}]},{"cik":1474439,"name":"TELENAV, INC.","industry":"Aerospace & defense","sic":3812,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001474439-15-000068","doc":"tnav630201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001474439-16-000184","doc":"tnav630201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001474439-17-000036","doc":"tnav630201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001474439-18-000038","doc":"tnav630201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001474439-19-000039","doc":"tnav630201910k.htm","q":null},{"fy":2020,"lvl":2,"n":6,"adsh":"0001474439-20-000029","doc":"tnav630202010k.htm","q":"The advent of connectivity, sensors and big data (AI/ML) opens up newer and more intelligent ways of offering coverage tailored to each driver\u2019s unique driving behavior and patterns."}]},{"cik":1475115,"name":"EVENTBRITE, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2018,"lvl":1,"n":1,"adsh":"0001475115-19-000007","doc":"ebform10-kx2018123118.htm","q":"We have built a risk and fraud system that uses machine-learning models and business rules to evaluate every transaction processed for fraud and malicious use in milliseconds."},{"fy":2019,"lvl":0,"n":0,"adsh":"0001475115-20-000021","doc":"eb-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001475115-21-000020","doc":"eb-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001475115-22-000032","doc":"eb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001475115-23-000040","doc":"eb-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":31,"adsh":"0001475115-24-000042","doc":"eb-20231231.htm","q":"We plan to use a combination of artificial intelligence, machine learning, and human curation to further personalize the search experience and enable consumers to more easily browse, filter, and discover events that are relevant to their in\u2026"},{"fy":2024,"lvl":3,"n":35,"adsh":"0001475115-25-000026","doc":"eb-20241231.htm","q":"We invested in improving the machine learning models driving our search and discovery experiences, where we seek to deliver relevant local and personalized collections of events as consumers search and browse for things to do."},{"fy":2025,"lvl":3,"n":48,"adsh":"0001475115-26-000005","doc":"eb-20251231.htm","q":"We also continue to explore the use of artificial intelligence to improve discovery and engagement, while maintaining a trusted experience for users."}]},{"cik":1476840,"name":"EXPENSIFY, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":9,"adsh":"0001476840-22-000016","doc":"exfy-20211231.htm","q":"Concierge, our AI-powered customer support engine, helps new members set up an account, connect teammates, assign company policies and immediately sync Expensify with existing accounting, HR and travel systems."},{"fy":2022,"lvl":2,"n":9,"adsh":"0001476840-23-000032","doc":"exfy-20221231.htm","q":"Concierge, our proprietary AI-powered customer support engine, helps new members set up an account, connect teammates, assign company policies and immediately sync Expensify with existing accounting, HR and travel systems."},{"fy":2023,"lvl":2,"n":10,"adsh":"0001476840-24-000016","doc":"exfy-20231231.htm","q":"Concierge, our proprietary AI-powered customer support engine, helps new members set up an account, connect teammates, assign company policies and immediately sync Expensify with existing accounting, HR and travel systems."},{"fy":2024,"lvl":3,"n":79,"adsh":"0001476840-25-000018","doc":"exfy-20241231.htm","q":"Concierge, our proprietary AI-powered customer support engine, helps new members set up an account, connect teammates, assign company policies and immediately sync Expensify with existing accounting, HR and travel systems."},{"fy":2025,"lvl":3,"n":75,"adsh":"0001476840-26-000009","doc":"exfy-20251231.htm","q":"Concierge, our proprietary customer support engine powered by artificial intelligence (\u201cAI\u201d), helps new members set up an account, connect teammates, assign company policies and immediately sync Expensify with existing accounting, HR and tr\u2026"}]},{"cik":1476963,"name":"SCORPIUS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001553350-15-000277","doc":"htbx_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001553350-16-001596","doc":"htbx_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001553350-17-000337","doc":"htbx_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001553350-18-000174","doc":"htbx_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001553350-19-000267","doc":"htbx_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001553350-20-000252","doc":"htbx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003460","doc":"htbx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003452","doc":"htbx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005289","doc":"nhwk-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-005902","doc":"scpx-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-005986","doc":"scpx-20241231x10k.htm","q":null}]},{"cik":1477009,"name":"TREES CORP (COLORADO)","industry":"Retail","sic":5912,"state":"CO","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004397","doc":"cann-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-006067","doc":"cann-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-031818","doc":"ea0202425-10k_trees.htm","q":null}]},{"cik":1477200,"name":"ROCKET FUEL INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":3,"n":18,"adsh":"0001477200-15-000027","doc":"form10-kdocumentfy2014.htm","q":"BUSINESS Overview Rocket Fuel is a technology company, incorporated in Delaware in 2008, that has developed an Artificial Intelligence and Big Data-driven predictive modeling and automated decision-making platform."},{"fy":2015,"lvl":3,"n":15,"adsh":"0001477200-16-000159","doc":"form10-kdocumentfy2015.htm","q":"BUSINESS Overview Rocket Fuel is a technology company that brings the power of machine learning to the world of digital marketing, offering a Programmatic Marketing Platform designed to help marketers and their agencies connect with consume\u2026"},{"fy":2016,"lvl":2,"n":14,"adsh":"0001477200-17-000044","doc":"form10-kdocumentfy2016.htm","q":"BUSINESS Overview Rocket Fuel is a technology company that brings the power of machine learning to the world of digital marketing, offering a Predictive Marketing Platform designed to help marketers and their agencies connect with consumers\u2026"}]},{"cik":1477333,"name":"CLOUDFLARE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2019,"lvl":1,"n":2,"adsh":"0001477333-20-000010","doc":"cloud-20191231.htm","q":"Our machine learning systems improve our products with every customer\u2019s request, optimizing our security, performance, and reliability globally."},{"fy":2020,"lvl":3,"n":16,"adsh":"0001477333-21-000009","doc":"cloud-20201231.htm","q":"Our Chinese operations are substantially dependent on our relationships with JD Cloud & AI and, in the short term, Baidu, and due to economic and political challenges in servicing the Chinese market, the loss of this arrangement could have \u2026"},{"fy":2021,"lvl":3,"n":15,"adsh":"0001477333-22-000008","doc":"cloud-20211231.htm","q":"Our key security product offerings include: \u2022 Cloud Firewall : Protects a customer\u2019s Internet properties from common vulnerabilities like SQL injection attacks, cross-site scripting, and cross-site forgery requests, with no changes to its e\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001477333-23-000017","doc":"cloud-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0001477333-24-000013","doc":"cloud-20231231.htm","q":"We serve comprehensive customer needs across security and connectivity, and increasingly, the distributed and programmable nature of our network is resulting in customers building their applications on top of our network, too \u2014 including bo\u2026"},{"fy":2024,"lvl":3,"n":28,"adsh":"0001477333-25-000043","doc":"cloud-20241231.htm","q":"We serve comprehensive customer needs across security and connectivity, and increasingly, the distributed and programmable nature of our network is resulting in customers building their applications on top of our network, too \u2014 including bo\u2026"},{"fy":2025,"lvl":3,"n":50,"adsh":"0001477333-26-000016","doc":"cloud-20251231.htm","q":"We serve comprehensive customer needs across security and connectivity, and increasingly, the distributed and programmable nature of our network is resulting in customers building their applications on top of our network, too \u2014 including bo\u2026"}]},{"cik":1477720,"name":"ASANA, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001477720-21-000007","doc":"asan-20210131.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001477720-22-000012","doc":"asan-20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001477720-23-000012","doc":"asan-20230131.htm","q":null},{"fy":2023,"lvl":3,"n":85,"adsh":"0001477720-24-000011","doc":"asan-20240131.htm","q":"Our secure and scalable platform with AI-powered features adds structure to unstructured work, creating clarity, accountability, and impact for everyone within an organization\u2014executives, department heads, team leads, and individuals\u2014so eve\u2026"},{"fy":2024,"lvl":3,"n":104,"adsh":"0001477720-25-000045","doc":"asan-20250131.htm","q":"Our secure and scalable platform with AI-powered features adds structure to unstructured work, creating clarity, accountability, and impact for everyone within an organization\u2014executives, department heads, team leads, and individuals."}]},{"cik":1477845,"name":"ANNOVIS BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001558370-21-002303","doc":"anvs-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002668","doc":"anvs-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-040275","doc":"anvs-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004393","doc":"anvs-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003482","doc":"anvs-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-027751","doc":"anvs-20251231x10k.htm","q":null}]},{"cik":1477960,"name":"CATALYST CREW TECHNOLOGIES CORP.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2024,"lvl":"x","n":73,"adsh":"0001477932-25-002922","doc":"cbbb_10k.htm","q":"In contrast to the dark 1980s, everyone in society now understands the value of AI, and their trust in it has returned."},{"fy":2025,"lvl":"x","n":10,"adsh":"0001477932-26-002294","doc":"cctc_10k.htm","q":"Technology Overview The Company is developing facial recognition technology (\u201cFRT\u201d) software that leverages artificial intelligence, machine learning, and computer vision techniques to analyze facial images and video data for identification\u2026"}]},{"cik":1478069,"name":"CONTRAFECT CORP","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-107237","doc":"d845954d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505381","doc":"d109824d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-083861","doc":"d280078d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084172","doc":"d522711d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-074982","doc":"d638257d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-077242","doc":"d830886d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-100376","doc":"d134420d10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001193125-22-084065","doc":"d298033d10k.htm","q":"Barer serves as Chairman of the board of directors of the public companies Teva Pharmaceutical Industries and Neximmune and the private company Centrexion and as a board member of the private companies 3DBio Therapeutics and Zephyr AI."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001193125-23-087990","doc":"d470422d10k.htm","q":"Barer serves as Chairman of the board of directors of the public companies Teva Pharmaceutical Industries and Neximmune and the private company Centrexion and as a board member of the private companies 3DBio Therapeutics and Zephyr AI."}]},{"cik":1478121,"name":"PFENEX INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-093661","doc":"d827234d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500204","doc":"d117377d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-083690","doc":"d297921d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084044","doc":"d518655d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-070864","doc":"d684691d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010090","doc":"pfnx-10k_20191231.htm","q":null}]},{"cik":1478242,"name":"IQVIA HOLDINGS INC.","industry":"Pharma & biotech","sic":8731,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-045845","doc":"d831296d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012629","doc":"q-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-046709","doc":"d321341d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002340","doc":"iqv-10k_20171231.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-003180","doc":"iqv-10k_20181231.htm","q":"We help healthcare stakeholders meet their increasing demand for faster insights and evidence by applying digital technology, scientific expertise, and machine learning to ever-expanding rich clinical data."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-004901","doc":"iqv-10k_20191231.htm","q":"Our Natural Language Processing capabilities help us create structured data from unstructured clinical notes."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001478242-21-000020","doc":"iqv-20201231.htm","q":"Our Natural Language Processing capabilities help us create structured data from unstructured clinical notes."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001478242-22-000041","doc":"iqv-20211231.htm","q":"Our Natural Language Processing capabilities help us create structured data from unstructured clinical notes."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001478242-23-000044","doc":"iqv-20221231.htm","q":"Our Natural Language Processing capabilities help us create structured data from unstructured clinical notes."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001478242-24-000038","doc":"iqv-20231231.htm","q":"Our Natural Language Processing capabilities help us create structured data from unstructured clinical notes."},{"fy":2024,"lvl":3,"n":63,"adsh":"0001478242-25-000045","doc":"iqv-20241231.htm","q":"IQVIA\u2019s portfolio of solutions are powered by IQVIA Connected Intelligence\u2122 to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI\u2122, advanced analytics, the latest technologies and extensive domai\u2026"},{"fy":2025,"lvl":3,"n":83,"adsh":"0001628280-26-008322","doc":"iqv-20251231.htm","q":"IQVIA\u2019s portfolio of solutions are powered by IQVIA Connected Intelligence\u2122 to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI \u00ae , advanced analytics, the latest technologies and extensive dom\u2026"}]},{"cik":1478320,"name":"ADAPTIVE BIOTECHNOLOGIES CORP","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2019,"lvl":3,"n":28,"adsh":"0001564590-20-006830","doc":"adpt-10k_20191231.htm","q":"We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and services that we are tailoring to eac\u2026"},{"fy":2020,"lvl":3,"n":25,"adsh":"0001564590-21-008124","doc":"adpt-10k_20201231.htm","q":"We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use these insights to develop and commercialize clinical products and services that we are tailor\u2026"},{"fy":2021,"lvl":3,"n":29,"adsh":"0001564590-22-005228","doc":"adpt-10k_20211231.htm","q":"We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use these insights to develop and commercialize clinical products and services that we are tailor\u2026"},{"fy":2022,"lvl":3,"n":28,"adsh":"0000950170-23-002792","doc":"adpt-20221231.htm","q":"We capture these insights in our dynamic clinical immunomics database, which is underpinned by computational biology and machine learning, and use these insights to develop and commercialize clinical products and services that we are tailor\u2026"},{"fy":2023,"lvl":3,"n":27,"adsh":"0000950170-24-023095","doc":"adpt-20231231.htm","q":"We capture these insights in our dynamic clinical immunomics database and related antigen annotations, which are underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and serv\u2026"},{"fy":2024,"lvl":3,"n":37,"adsh":"0000950170-25-030913","doc":"adpt-20241231.htm","q":"We capture these insights in our dynamic clinical immunomics database and related antigen annotations, which are underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and serv\u2026"},{"fy":2025,"lvl":3,"n":36,"adsh":"0001193125-26-076902","doc":"adpt-20251231.htm","q":"We capture these insights in our dynamic clinical immunomics database and related antigen annotations, which are underpinned by computational biology and machine learning, and use them to develop and commercialize clinical products and serv\u2026"}]},{"cik":1479290,"name":"REVANCE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001461","doc":"rvnc1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001479290-16-000031","doc":"rvnc1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001479290-17-000013","doc":"rvnc1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001479290-18-000038","doc":"rvnc1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001479290-19-000030","doc":"rvnc1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001479290-20-000042","doc":"rvnc1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001479290-21-000057","doc":"rvnc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001479290-22-000034","doc":"rvnc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001479290-23-000028","doc":"rvnc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001479290-24-000038","doc":"rvnc-20231231.htm","q":null}]},{"cik":1479419,"name":"KALA BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002697","doc":"kala-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001825","doc":"kala-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-000733","doc":"kala-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001797","doc":"kala-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004624","doc":"kala-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002746","doc":"kala-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004326","doc":"kala-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-004081","doc":"kala-20241231x10k.htm","q":null},{"fy":2025,"lvl":"x","n":310,"adsh":"0001104659-26-043782","doc":"kala-20251231x10k.htm","q":"Business In this Annual Report on Form 10-K, unless the context otherwise requires, references to \u201cwe,\u201d \u201cus,\u201d \u201cour,\u201d \u201cour company,\u201d \u201cKALA,\u201d \u201cKALA BIO\u201d and \u201cCompany\u201d refer to KALA BIO, Inc. and its subsidiaries. \u200b Overview We are a biopharma\u2026"}]},{"cik":1479615,"name":"SILENCE THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-029129","doc":"sln-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving cybersecurity threats, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly more difficult to 46 identi\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001193125-26-092591","doc":"sln-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fake, 48 an\u2026"}]},{"cik":1479915,"name":"CQENS TECHNOLOGIES INC.","industry":"Pharma & biotech","sic":2834,"state":"MN","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003976","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004104","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004240","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006176","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008850","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-009882","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-012242","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-014570","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001625","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-016895","doc":"form10-k.htm","q":null}]},{"cik":1481028,"name":"SUNHYDROGEN, INC.","industry":"Computers & chips","sic":3674,"state":"IA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-15-007369","doc":"f10k2015_hypersolar.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-17-009890","doc":"f10k2017_hypersolarinc.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-012992","doc":"f10k2018_hypersolarinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-19-019234","doc":"f10k2019_hypersolarinc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-20-028026","doc":"f10k2020_sunhydrogeninc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-21-052059","doc":"f10k2021_sunhydrogen.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-22-062803","doc":"f10k2022_sunhydrogen.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-23-081088","doc":"f10k2023_sunhydrogen.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-24-083387","doc":"ea0215762-10k_sunhydro.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-25-087311","doc":"ea0256289-10k_sunhydro.htm","q":null}]},{"cik":1481504,"name":"XERIANT, INC.","industry":"Aerospace & defense","sic":3721,"state":"FL","cells":[{"fy":2020,"lvl":"x","n":9,"adsh":"0001477932-20-005677","doc":"banj_10k.htm","q":"Advancements in structural design, propulsion systems, materials, sensors, artificial intelligence (AI), batteries and high-speed connectivity have dramatically enhanced energy efficiency, acoustics, emissions, safety and autonomy, making f\u2026"},{"fy":2021,"lvl":"x","n":8,"adsh":"0001477932-21-007235","doc":"xeri_10k.htm","q":"Advancements in structural design, propulsion systems, materials, sensors, artificial intelligence (AI), batteries and high-speed connectivity have dramatically enhanced energy efficiency, acoustics, emissions, safety and autonomy, making f\u2026"},{"fy":2022,"lvl":"x","n":4,"adsh":"0001477932-22-007622","doc":"xeri_10k.htm","q":"Next-generation aircraft are more efficient, sustainable, reliable, automated and safer through technological improvements in design optimization and modeling, advanced materials, AI, alternative propulsion systems and manufacturing process\u2026"},{"fy":2023,"lvl":"x","n":4,"adsh":"0001477932-23-007646","doc":"xeri_10k.htm","q":"Next-generation aircraft are more efficient, sustainable, reliable, automated and safer through technological improvements in design optimization and modeling, advanced materials, artificial intelligence, alternative propulsion systems and \u2026"},{"fy":2024,"lvl":"x","n":8,"adsh":"0001477932-24-006252","doc":"xeri_10k.htm","q":"The areas of focus that are reshaping the future of aerospace include advanced materials, advanced air mobility, unmanned aerial systems, AI, hypersonics, communications, cybersecurity, satellites, and renewable energy technology."},{"fy":2025,"lvl":"x","n":11,"adsh":"0001477932-25-007303","doc":"xeri_10k.htm","q":"The areas of focus that are reshaping the future of aerospace include advanced materials, advanced air mobility, unmanned aerial systems (drones), AI, hypersonics, communications, cybersecurity, satellites, and renewable energy technology."}]},{"cik":1481512,"name":"RA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001292","doc":"a2231138z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001637","doc":"a2234137z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-000968","doc":"a2237949z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-20-001072","doc":"a2240828z10-k.htm","q":null}]},{"cik":1482080,"name":"CELLULAR DYNAMICS INTERNATIONAL, INC.","industry":"Pharma & biotech","sic":2836,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001482080-15-000025","doc":"cdi10k20141231.htm","q":null}]},{"cik":1484565,"name":"SOLENO THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-071808","doc":"slno-20251231.htm","q":"These controls also support our responsible AI adoption strategy by limiting exposure of highly sensitive information in generative AI tools and enforcing identity-based and policy-driven safeguards around the use of such data. \u2022 Incident R\u2026"}]},{"cik":1485003,"name":"CARISMA THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-081274","doc":"d854880d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001485003-16-000068","doc":"ebio-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001485003-17-000018","doc":"ebio-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001485003-18-000034","doc":"ebio-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001485003-19-000015","doc":"sesn-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001485003-20-000038","doc":"sesn-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001485003-21-000044","doc":"sesn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001485003-22-000033","doc":"sesn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001485003-23-000090","doc":"sesn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001485003-24-000005","doc":"carm-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-015673","doc":"carm-20241231.htm","q":null}]},{"cik":1485074,"name":"FREEZE TAG, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-002134","doc":"frzt_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009356","doc":"frzt_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001489","doc":"frzt_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001638","doc":"frzt_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-001360","doc":"frzt_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-001686","doc":"frzt_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-001920","doc":"frzt_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001871","doc":"frzt_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-002129","doc":"frzt_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-001717","doc":"frzt_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-25-002250","doc":"frzt_10k.htm","q":null}]},{"cik":1485469,"name":"TOWER INTERNATIONAL, INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-012552","doc":"v401878_10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-084980","doc":"v432044_10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-011747","doc":"towr-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-011448","doc":"towr-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-010395","doc":"tv514427-10k.htm","q":null}]},{"cik":1487522,"name":"INNOVISION LABS, INC","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-020152","doc":"v405170_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001615774-16-004617","doc":"s102832_10k.htm","q":null}]},{"cik":1487931,"name":"FISION CORP","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001642","doc":"fssn_10k.htm","q":null}]},{"cik":1487941,"name":"MEDL MOBILE HOLDINGS, INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001078782-15-000448","doc":"f10k123114_10k.htm","q":null}]},{"cik":1488039,"name":"ATOSSA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-18-001693","doc":"s109144_10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001437749-19-005927","doc":"atos20181231_10k.htm","q":"We commonly seek patent claims directed to compositions of matter, including Endoxifen, Fulvestrant, and other Selective Estrogen Receptor Modulators (SERMs), Selective Estrogen Receptor Downregulators (SERDs), and Aromatase Inhibitors (AI)\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001437749-20-006155","doc":"atos20191231_10k.htm","q":"We commonly seek patent claims directed to compositions of matter to therapeutics, including Endoxifen, Fulvestrant, and other Selective Estrogen Receptor Modulators (SERMs), Selective Estrogen Receptor Downregulators (SERDs), and Aromatase\u2026"},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007756","doc":"atos20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-004614","doc":"atos20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-007531","doc":"atos20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-039306","doc":"atos-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":30,"adsh":"0000950170-25-044099","doc":"atos-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."},{"fy":2025,"lvl":3,"n":30,"adsh":"0001193125-26-124396","doc":"atos-20251231.htm","q":"Additionally, the use of artificial intelligence and machine learning tools by us and the third parties upon which we rely may be subject to rapidly evolving and sometimes conflicting global artificial intelligence, privacy, and consumer pr\u2026"}]},{"cik":1488075,"name":"INTRALINKS HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001488075-15-000009","doc":"il-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001488075-16-000145","doc":"il-20151231x10k.htm","q":null}]},{"cik":1488139,"name":"AMERESCO, INC.","industry":"Construction","sic":1700,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001488139-15-000011","doc":"amrc1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001488139-16-000091","doc":"amrc1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001488139-17-000008","doc":"amrc1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001488139-18-000015","doc":"amrc1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001488139-19-000022","doc":"amrc1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001488139-20-000014","doc":"amrc1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001488139-21-000036","doc":"amrc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001488139-22-000014","doc":"amrc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001488139-23-000014","doc":"amrc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001488139-24-000014","doc":"amrc-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001488139-25-000018","doc":"amrc-20241231.htm","q":"This risk may increase as we implement artificial intelligence features into our operations."}]},{"cik":1489979,"name":"FRESH MARKET, INC.","industry":"Retail","sic":5411,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001489979-15-000018","doc":"tfm10k01252015.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001489979-16-000058","doc":"tfm10k01312016.htm","q":null}]},{"cik":1490054,"name":"VERDE BIO HOLDINGS, INC.","industry":"Software & IT services","sic":7371,"state":"TX","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001445866-15-000967","doc":"appiphany10k04302015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001445866-16-002546","doc":"appiphany10k06302016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001445866-17-001297","doc":"aphd_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001445866-19-000932","doc":"aphd_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001445866-20-000067","doc":"aphd-20190430.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001445866-20-001088","doc":"vbhi_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001096906-21-002272","doc":"aphd-20210430.htm","q":null}]},{"cik":1490660,"name":"MARKETO, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2014,"lvl":1,"n":1,"adsh":"0001047469-15-002073","doc":"a2222513z10-k.htm","q":"Built on machine learning and big data analytics, the solution automatically displays the most compelling content for an individual to drive deeper engagement and better account targeting."},{"fy":2015,"lvl":1,"n":1,"adsh":"0001047469-16-010782","doc":"a2227487z10-k.htm","q":"Marketo Predictive Content leverages machine learning and predictive analytics to present real-time content recommendations to targeted individuals browsing a company's website, continuously optimizing engagement rates. \u0095 Marketing Calendar\u2026"}]},{"cik":1490978,"name":"SCHRODINGER, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":3,"n":40,"adsh":"0001564590-21-010727","doc":"sdgr-10k_20201231.htm","q":"One of the primary computational methods that many companies have attempted to deploy is machine learning, often referred to as artificial intelligence, or AI."},{"fy":2021,"lvl":3,"n":39,"adsh":"0001564590-22-006713","doc":"sdgr-10k_20211231.htm","q":"One of the primary computational methods that many companies have attempted to deploy is machine learning, often referred to as artificial intelligence, or AI."},{"fy":2022,"lvl":3,"n":47,"adsh":"0001490978-23-000024","doc":"sdgr-20221231.htm","q":"One of the primary computational methods that many companies have attempted to deploy is machine learning, often referred to as artificial intelligence, or AI."},{"fy":2023,"lvl":3,"n":49,"adsh":"0001490978-24-000018","doc":"sdgr-20231231.htm","q":"One of the primary computational methods that many companies have attempted to deploy is machine learning, often referred to as artificial intelligence, or AI."},{"fy":2024,"lvl":3,"n":49,"adsh":"0001490978-25-000014","doc":"0001490978-25-000014.txt","q":"One of the primary computational methods that many companies have attempted to deploy is machine learning, often referred to as artificial intelligence, or AI."},{"fy":2025,"lvl":3,"n":52,"adsh":"0001490978-26-000010","doc":"sdgr-20251231.htm","q":"One of the primary computational methods that many companies have attempted to deploy is machine learning, often referred to as artificial intelligence, or AI."}]},{"cik":1491419,"name":"LOTON, CORP","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001615774-15-001776","doc":"s101447_10k.htm","q":null}]},{"cik":1491576,"name":"TESARO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-013852","doc":"a14-26186_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003631","doc":"tsro-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001160","doc":"tsro-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001248","doc":"tsro-20171231x10k.htm","q":null}]},{"cik":1492151,"name":"WORLD MOTO, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":1,"adsh":"0001594062-16-000651","doc":"form10k.htm","q":"Ziomkowski is experienced in the design of taxi meters for motorcycles, and has experience in artificial intelligence, practical programs and telecommunications."},{"fy":2016,"lvl":"x","n":1,"adsh":"0001594062-17-000216","doc":"form10k.htm","q":"Ziomkowski is experienced in the design of taxi meters for motorcycles, and has experience in artificial intelligence, practical programs and telecommunications."}]},{"cik":1492422,"name":"APELLIS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006193","doc":"apls-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004492","doc":"apls-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007350","doc":"apls-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008800","doc":"apls-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007606","doc":"apls-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003438","doc":"apls-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-020614","doc":"apls-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-029507","doc":"apls-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-065179","doc":"apls-20251231.htm","q":null}]},{"cik":1492426,"name":"HORIZON THERAPEUTICS PUBLIC LTD CO","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-067257","doc":"d843160d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013652","doc":"hznp-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002491","doc":"hznp-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003661","doc":"hznp-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004667","doc":"hznp-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006575","doc":"hznp-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007818","doc":"hznp-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007863","doc":"hznp-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005337","doc":"hznp-20221231.htm","q":null}]},{"cik":1493526,"name":"PROTECT PHARMACEUTICAL CORP","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001551163-15-000098","doc":"f10kdec312014vedgar5.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001551163-16-000347","doc":"f10kdec312015vedgar6.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001551163-17-000043","doc":"prttform10kv2cleansgacomment.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-19-002214","doc":"form10-k.htm","q":null}]},{"cik":1493566,"name":"OTONOMY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-096931","doc":"d843158d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-495186","doc":"d126504d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003217","doc":"otic-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004915","doc":"otic-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006043","doc":"otic-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007386","doc":"otic-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005551","doc":"otic-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002299","doc":"otic-20211231.htm","q":null}]},{"cik":1493594,"name":"MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-15-387199","doc":"d92356d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493594-16-000016","doc":"mtsi10-k2016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493594-17-000055","doc":"mtsi10-k2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493594-18-000034","doc":"mtsi10-k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493594-19-000064","doc":"mtsi10-k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493594-20-000063","doc":"mtsi-20201002.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493594-21-000079","doc":"mtsi-20211001.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493594-22-000047","doc":"mtsi-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493594-23-000081","doc":"mtsi-20230929.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493594-24-000060","doc":"mtsi-20240927.htm","q":null},{"fy":2025,"lvl":2,"n":5,"adsh":"0001493594-25-000054","doc":"mtsi-20251003.htm","q":"The Data Center market supports applications like artificial intelligence (AI), Machine Learning and high performance computing demand from Data Center operators for faster data transmission speeds at lower power and latency is growing rapi\u2026"}]},{"cik":1494162,"name":"KINERJAPAY CORP.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001295345-15-000057","doc":"sfex12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001295345-16-000435","doc":"sfex12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001295345-17-000103","doc":"kpay12312016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-005531","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005809","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-019106","doc":"form10-k.htm","q":null}]},{"cik":1494650,"name":"OPTINOSE, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001494650-18-000025","doc":"optn12-31x201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001494650-19-000020","doc":"optn12-31x201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001494650-20-000020","doc":"optn-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001494650-21-000010","doc":"optn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001494650-22-000019","doc":"optn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001494650-23-000020","doc":"optn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001494650-24-000018","doc":"optn-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001494650-25-000064","doc":"optn-20241231.htm","q":null}]},{"cik":1495648,"name":"BLACKWELL 3D CONSTRUCTION CORP.","industry":"Construction","sic":1520,"state":"FL","cells":[{"fy":2025,"lvl":"x","n":3,"adsh":"0001477932-25-006767","doc":"bdcc_10k.htm","q":"Moreover, in his role as CTO, he has executed deep learning models for extracting data from National ID\u2019s (India, Malaysia, Nigeria, Tanzania) for KYC onboarding, strategizing and executing a patented KYC based blockchain (Belrium) for cryp\u2026"}]},{"cik":1495899,"name":"ENERPULSE TECHNOLOGIES, INC.","industry":"Auto manufacturing","sic":3714,"state":"NM","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-019545","doc":"v405043_10k.htm","q":null}]},{"cik":1496323,"name":"IGM BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013183","doc":"igms-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016675","doc":"igms-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004842","doc":"igms-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010920","doc":"igms-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027924","doc":"igms-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-034597","doc":"igms-20241231.htm","q":null}]},{"cik":1496383,"name":"ILUSTRATO PICTURES INTERNATIONAL INC.","industry":"Auto manufacturing","sic":3711,"state":"NY","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001663577-23-000157","doc":"ilus10k123122.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-038595","doc":"ea0203891-10k_ilustrato.htm","q":null}]},{"cik":1496671,"name":"CALITHERA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-002028","doc":"cala-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014785","doc":"cala-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004620","doc":"cala-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004953","doc":"cala-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006798","doc":"cala-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010058","doc":"cala-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013599","doc":"cala-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005227","doc":"cala-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011047","doc":"cala-20221231.htm","q":null}]},{"cik":1496963,"name":"SQUARESPACE, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001496963-22-000005","doc":"sqsp-20211231.htm","q":"In September 2021, we launched our new employee development program, SQSP Learning, which allows employees to explore AI-recommended and personalized content based on their role and unique learning goals."},{"fy":2022,"lvl":0,"n":0,"adsh":"0001496963-23-000010","doc":"sqsp-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001496963-24-000010","doc":"sqsp-20231231.htm","q":"Squarespace offers: Squarespace Blueprint, our guided website design system providing professionally-curated layouts and styling options; Fluid Engine, our flexible content editing system; Squarespace AI, our generative AI integration to he\u2026"}]},{"cik":1497130,"name":"NANO MOBILE HEALTHCARE, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-15-004781","doc":"form10-k.htm","q":null}]},{"cik":1497253,"name":"VIVOSIM LABS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-004951","doc":"onvo-10k_20150331.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-020442","doc":"onvo-10k_20160331.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-012240","doc":"onvo-10k_20170331.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-014814","doc":"onvo-10k_20180331.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-021444","doc":"onvo-10k_20190331.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-027310","doc":"onvo-10k_20200331.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-032980","doc":"onvo-10k_20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-022994","doc":"onvo-10k_20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-032889","doc":"onvo-20230331.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-067301","doc":"onvo-20240331.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-082312","doc":"vivs-20250331.htm","q":null}]},{"cik":1497504,"name":"PLX PHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002607","doc":"a2223278z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011428","doc":"a2227816z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-003148","doc":"v456656_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-005277","doc":"plxp20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-004386","doc":"plxp20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-005044","doc":"plxp20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-005803","doc":"plxp20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-005920","doc":"plxp20211231_10k.htm","q":null}]},{"cik":1498067,"name":"SKYTECH ORION GLOBAL CORP.","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002225","doc":"brdt12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001295345-16-000498","doc":"brdt12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001295345-17-000121","doc":"tecr10k2016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004338","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004104","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":2,"adsh":"0001493152-20-008284","doc":"form10-k.htm","q":"In addition, Ilan is co-founder and an active board member of Superb Reality, which integrates machine learning, vision algorithms, AI, imaging optics and 3D into AR and VR imaging devices, and is investor and shareholder in Nicast Ltd., Na\u2026"},{"fy":2020,"lvl":"x","n":16,"adsh":"0001493152-21-008866","doc":"form10-k.htm","q":"There are currently hundreds of companies researching medical pharma-grade cannabinoid drugs for treating diseases, such as cancer, epilepsy, autism, as well as companies developing solutions for using big data and artificial intelligence (\u2026"},{"fy":2021,"lvl":"x","n":2,"adsh":"0001493152-22-009403","doc":"form10-k.htm","q":"Ben-Ishay is co-founder and an active board member of Superb Reality, which integrates machine learning, vision algorithms, AI, imaging optics and 3D into AR and VR imaging devices, and is investor and shareholder in Nicast Ltd., Nanomedic \u2026"},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-008554","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001641172-25-026351","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":4,"adsh":"0001641172-25-026370","doc":"form10-k.htm","q":"As a result, the SkyTech Center is being established as a national flagship project and a strategic assembly and production hub in Israel, dedicated to the defense sector, with a focus on UAVs, drones, AI-powered platforms, Western-grade cr\u2026"},{"fy":2025,"lvl":"x","n":30,"adsh":"0001493152-26-016841","doc":"form10-k.htm","q":"Key components of the SkyTech Center include: \u25cf Assembly & Production \u2013 Advanced UAV and drone manufacturing and assembly lines, including 3D-printing capabilities. \u25cf Research & Development \u2013 Hardware, software, and AI development and custo\u2026"}]},{"cik":1498148,"name":"ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001161697-15-000262","doc":"form_10-k.htm","q":null},{"fy":2016,"lvl":"x","n":9,"adsh":"0001161697-18-000118","doc":"form_10-kt.htm","q":"Following the RAD acquisition, our business consists of delivering artificial intelligence and robotic solutions for operational, security and monitoring needs."},{"fy":2017,"lvl":"x","n":19,"adsh":"0001161697-18-000335","doc":"form_10-k.htm","q":"Following the RAD acquisition, our business consists of delivering artificial intelligence (\u201cAI\u201d) based solutions to solve complex enterprise problems and challenges while delivering an immediate return on investment."},{"fy":2019,"lvl":"x","n":58,"adsh":"0001161697-19-000356","doc":"form_10-k.htm","q":"BUSINESS Business Overview Artificial Intelligence Technology Solutions Inc."},{"fy":2020,"lvl":"x","n":59,"adsh":"0001161697-20-000345","doc":"form_10-k.htm","q":"BUSINESS Business Overview Artificial Intelligence Technology Solutions Inc."},{"fy":2022,"lvl":"x","n":60,"adsh":"0001161697-23-000356","doc":"form_10-k.htm","q":"Artificial Intelligence Technology Solutions Inc."}]},{"cik":1498148,"name":"ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.","industry":"Software & IT services","sic":7372,"state":"MI","cells":[{"fy":2023,"lvl":"x","n":62,"adsh":"0001493152-24-021634","doc":"form10-k.htm","q":"Artificial Intelligence Technology Solutions Inc."},{"fy":2024,"lvl":"x","n":152,"adsh":"0001641172-25-012903","doc":"form10-k.htm","q":"Artificial Intelligence Technology Solutions Inc."}]},{"cik":1498233,"name":"CEPTON, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-149315","doc":"tm2134465d1_10ka.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001498233-23-000018","doc":"gcac-20221231.htm","q":"As many sectors transform in this manner, they are leveraging technologies that combine physical infrastructure and sensors with advanced digital technologies including the internet of things, artificial intelligence, and cloud and edge com\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001498233-24-000021","doc":"gcac-20231231.htm","q":"As many sectors transform in this manner, they are leveraging technologies that combine physical infrastructure and sensors with advanced digital technologies including the internet of things, artificial intelligence, and cloud and edge com\u2026"}]},{"cik":1498382,"name":"TUHURA BIOSCIENCES, INC./NV","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001013762-15-000885","doc":"f10k2015_delmarpharma.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-17-010055","doc":"f10k2017_delmarpharma.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-012876","doc":"f10k2018_delmarpharma.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-19-017497","doc":"f10k2019_delmarpharma.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001564590-20-044019","doc":"ktra-10k_20200630.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-049235","doc":"ktra-10k_20210630.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-018865","doc":"ktra-20220630.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-23-048588","doc":"ktra-20230630.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-113321","doc":"ktra-20240630.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-134950","doc":"hura-20251231.htm","q":null}]},{"cik":1499275,"name":"SANTO MINING CORP.","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2024,"lvl":"x","n":15,"adsh":"0001139020-25-000069","doc":"sanp-20241231.htm","q":"Through its subsidiary, Santo Blockchain Labs of Colombia, S.A.S., the Company continued its principal focus on blockchain, cryptography, artificial intelligence, web3, and fourth industrial revolution (4IR) software development. \u00b7 On Febru\u2026"}]},{"cik":1499961,"name":"MULLEN AUTOMOTIVE INC.","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2024,"lvl":1,"n":3,"adsh":"0001437749-25-001816","doc":"muln20240930_10k.htm","q":"Any failure to comply with applicable laws and regulations, failure to maintain our technology resources, manage new technologies such as generative AI tools, and misuse of or failure to secure personal information could also result in viol\u2026"}]},{"cik":1500412,"name":"AMBIQ MICRO, INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2025,"lvl":3,"n":176,"adsh":"0001193125-26-094004","doc":"ambq-20251231.htm","q":"Overview We are a pioneer and leading provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute \u2013 especially at the edge."}]},{"cik":1501112,"name":"MIX 1 LIFE, INC.","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001477932-15-007667","doc":"mixx_10k.htm","q":null}]},{"cik":1501697,"name":"X4 PHARMACEUTICALS, INC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007097","doc":"asns-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003484","doc":"xfor-20191231.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001628280-21-005202","doc":"xfor-20201231.htm","q":"Based on a broad online survey of physicians to validate current prevalence estimates and additional research using artificial intelligence, which interrogated a database of more than 300 million anonymized patient records that spanned 10 y\u2026"},{"fy":2021,"lvl":1,"n":4,"adsh":"0001628280-22-006547","doc":"xfor-20211231.htm","q":"Qessential m arket research, 2019 and IPM. ai artificial intelligence study, 2020 3."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-23-008745","doc":"xfor-20221231.htm","q":"In addition, we have also completed a study using artificial intelligence, interrogating a database of approximately 300 million American lives that included up to 10 years of insurance claims on diagnoses, drug treatments, procedures, and \u2026"},{"fy":2023,"lvl":1,"n":2,"adsh":"0001628280-24-012578","doc":"xfor-20231231.htm","q":"In addition, we have also completed a study using artificial intelligence, interrogating a database of approximately 300 million American lives that included up to 10 years of insurance claims on diagnoses, drug treatments, procedures, and \u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-014805","doc":"xfor-20241231.htm","q":"We also completed a study using artificial intelligence, interrogating a database of approximately 300 million American lives that included up to 10 years of insurance claims on diagnoses, drug treatments, procedures, and treatment pathways\u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0001501697-26-000018","doc":"xfor-20251231.htm","q":null}]},{"cik":1501756,"name":"ADVERUM BIOTECHNOLOGIES, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-078923","doc":"d849882d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014022","doc":"aavl-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003759","doc":"advm-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004560","doc":"advm-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006536","doc":"advm-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010503","doc":"advm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003623","doc":"advm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-007698","doc":"advm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009899","doc":"advm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-011648","doc":"advm-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0001628280-25-017767","doc":"advm-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1501796,"name":"AURA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004425","doc":"aura-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008166","doc":"aura-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":20,"adsh":"0000950170-24-036814","doc":"aura-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":24,"adsh":"0000950170-25-043943","doc":"aura-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":34,"adsh":"0001193125-26-130401","doc":"aura-20251231.htm","q":"Despite the implementation of security measures, our internal computer systems and infrastructure, and those of our CROs and other third parties on which we rely, are vulnerable to damage from computer viruses, unauthorized access and misus\u2026"}]},{"cik":1501989,"name":"CYTOMX THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014091","doc":"ctmx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003229","doc":"ctmx-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004727","doc":"ctmx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004890","doc":"ctmx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007395","doc":"ctmx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008081","doc":"ctmx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002519","doc":"ctmx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009991","doc":"ctmx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-029191","doc":"ctmx-20231231.htm","q":"McCarthy. 10-Q 8/8/2023 10.2 10.12(a) Lease dated as of December 10, 2015, by and between CytomX Therapeutics, Inc. and HCP Oyster Point III LLC. 8-K 12/16/2015 10.1 10.12(b) Sublease Agreement dated as of March 24, 2023, by and between Cyt\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-034575","doc":"ctmx-20241231.htm","q":"McCarthy. 10-Q 8/8/2023 10.2 10.12(a) Lease dated as of December 10, 2015, by and between CytomX Therapeutics, Inc. and HCP Oyster Point III LLC. 8-K 12/16/2015 10.1 10.12(b) Sublease Agreement dated as of March 24, 2023, by and between Cyt\u2026"},{"fy":2025,"lvl":3,"n":24,"adsh":"0001193125-26-107146","doc":"ctmx-20251231.htm","q":"Our business may be affected by the evolving regulatory framework for AI Technologies We use artificial intelligence (\u201cAI\u201d), machine learning, and automated decision-making technologies, (collectively, \u201cAI Technologies\u201d) throughout our busi\u2026"}]},{"cik":1502152,"name":"GLOBESTAR THERAPEUTICS CORP","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001161697-18-000046","doc":"form_10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001185185-19-000011","doc":"angiosoma20180930_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001185185-19-001771","doc":"angiosoma20190930_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001161697-20-000517","doc":"form_10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001161697-22-000027","doc":"form_10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001161697-23-000049","doc":"form_10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001161697-24-000049","doc":"form_10-k.htm","q":null}]},{"cik":1503458,"name":"FOOTHILLS EXPLORATION, INC.","industry":"Retail","sic":5411,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000186","doc":"kla_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000782","doc":"kla_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001615774-17-001704","doc":"s105853_10k.htm","q":null}]},{"cik":1503802,"name":"KARYOPHARM THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091264","doc":"d824483d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505181","doc":"d113778d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-084396","doc":"d282276d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084024","doc":"d529132d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-057610","doc":"d690023d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-049115","doc":"d853399d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-054811","doc":"d53064d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002548","doc":"kpti-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003129","doc":"kpti-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-022650","doc":"kpti-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-022765","doc":"kpti-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":22,"adsh":"0001193125-26-049397","doc":"kpti-20251231.htm","q":"We use artificial intelligence in our business processes, which could adversely impact our business and operations, including by posing security and other risks to our confidential or proprietary information, including personal information,\u2026"}]},{"cik":1503985,"name":"ORANGEHOOK, INC.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001117768-17-000852","doc":"mainbody.htm","q":null}]},{"cik":1504167,"name":"BIOPHARMX CORP","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001047469-15-002954","doc":"a2223386z10-k.htm","q":null}]},{"cik":1504167,"name":"TIMBER PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001047469-16-012794","doc":"a2228403z10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001558370-17-002791","doc":"bpmx-20170131x10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001558370-18-003341","doc":"bpmx-20180131x10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001558370-19-002016","doc":"bpmx-20190131x10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001558370-20-003019","doc":"bpmx-20200131x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-040402","doc":"tm215519d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004943","doc":"tmbr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005284","doc":"tmbr-20221231x10k.htm","q":null}]},{"cik":1504222,"name":"HIGH PERFORMANCE BEVERAGES CO.","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-000500","doc":"f10k2014_highperformance.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-15-008858","doc":"f10k2015_highperformance.htm","q":null}]},{"cik":1504239,"name":"POINT OF CARE NANO-TECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-15-008947","doc":"f10k2015_pointofcarenano.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001199835-22-000608","doc":"pcnt-10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001199835-24-000476","doc":"pcnt-10k.htm","q":null}]},{"cik":1504389,"name":"RICH PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001647488-15-000107","doc":"mainbody.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001662252-16-000212","doc":"rcha10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001662252-17-000182","doc":"rcha10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001662252-18-000076","doc":"rcha10k.htm","q":null}]},{"cik":1505155,"name":"UPLAND SOFTWARE, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-002099","doc":"uplandsoftware201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-013941","doc":"a10-k2015.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-003190","doc":"a201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002967","doc":"a201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001505155-19-000017","doc":"a201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001505155-20-000015","doc":"upld-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001505155-21-000011","doc":"upld-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001505155-22-000017","doc":"upld-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001505155-23-000017","doc":"upld-20221231.htm","q":"Compliance with the GDPR, the new state laws, and other current and future applicable U.S. and international privacy, data protection, cybersecurity, artificial intelligence and other data-related laws can be costly and time-consuming."},{"fy":2023,"lvl":3,"n":24,"adsh":"0001505155-24-000013","doc":"upld-20231231.htm","q":"Delays inherent to our sales cycles could cause significant variability in our revenue and operating results for any particular period. 16 The failure to timely and accurately implement Artificial Intelligence (\u201cAI\u201d), and other new technolo\u2026"},{"fy":2024,"lvl":3,"n":42,"adsh":"0001505155-25-000024","doc":"upld-20241231.htm","q":"Features include AI-driven search, content recommendations, and workflow integrations aimed at improving information accessibility and operational efficiency. \u2022 Content Lifecycle and Workflow Automation."},{"fy":2025,"lvl":3,"n":55,"adsh":"0001505155-26-000007","doc":"upld-20251231.htm","q":"Business Upland is a leader in AI-powered knowledge and content management software."}]},{"cik":1505512,"name":"REGULUS THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-052948","doc":"d842033d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011521","doc":"rgls20151231-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002123","doc":"rgls20161231-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002874","doc":"rgls20171231-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-003037","doc":"rgls20181231-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003483","doc":"rgls20191231-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-004294","doc":"rgls-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-005771","doc":"rgls-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009061","doc":"rgls-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001628280-24-012543","doc":"rgls-20231231.htm","q":"We and third parties we rely on may also be the subject of a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0001628280-25-012627","doc":"rgls-20241231.htm","q":"We and third parties with whom we work are also subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"}]},{"cik":1505611,"name":"DECISIONPOINT SYSTEMS, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001013762-15-000231","doc":"f10k2014_decisionpoint.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-017545","doc":"f10k2021_decisionpoint.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-023973","doc":"f10k2022_decisionpoint.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028228","doc":"ea0202360-10k_decision.htm","q":null}]},{"cik":1505952,"name":"DOMO, INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2018,"lvl":"x","n":30,"adsh":"0001505952-19-000016","doc":"domofy1910-k.htm","q":"Algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited."},{"fy":2019,"lvl":3,"n":28,"adsh":"0001505952-20-000018","doc":"domofy2010-k.htm","q":"Algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited."},{"fy":2020,"lvl":3,"n":28,"adsh":"0001505952-21-000007","doc":"domo-20210131.htm","q":"Algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited."},{"fy":2021,"lvl":3,"n":28,"adsh":"0001505952-22-000012","doc":"domo-20220131.htm","q":"Algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited."},{"fy":2022,"lvl":3,"n":31,"adsh":"0001505952-23-000021","doc":"domo-20230131.htm","q":"Algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited."},{"fy":2023,"lvl":3,"n":66,"adsh":"0001505952-24-000015","doc":"domo-20240131.htm","q":"Artificial intelligence algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited."},{"fy":2024,"lvl":3,"n":113,"adsh":"0001505952-25-000045","doc":"domo-20250131.htm","q":"Our cloud-based platform is a modern AI and data products platform that enables processes that are critically dependent on business intelligence data \u2013 which historically could take weeks, months or longer \u2013 to be done on-the-fly, in as fas\u2026"}]},{"cik":1506251,"name":"CITIUS PHARMACEUTICALS, INC.","industry":"Auto manufacturing","sic":3714,"state":"MA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-15-007617","doc":"ctxr_10k.htm","q":null}]},{"cik":1506251,"name":"CITIUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001477932-16-014315","doc":"ctxr_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-17-013191","doc":"f10k2017_citiuspharma.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-017214","doc":"f10k2018_citiuspharma.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-19-026259","doc":"f10k2019_citiuspharma.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-20-043004","doc":"f10k2020_citiuspharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-21-065464","doc":"f10k2021_citiuspharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-22-082217","doc":"f10k2022_citiuspharma.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-23-099889","doc":"f10k2023_citiuspharma.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-24-113149","doc":"ea0225656-10k_citius.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-25-125333","doc":"ea0270098-10k_citius.htm","q":"In addition, Citius Oncology has contracted with EVERSANA an innovative AI platform, to support the launch and commercialization of LYMPHIR whereby EVERSANA provides an integrated suite of pre- and post-launch services, including medical in\u2026"}]},{"cik":1506293,"name":"PINTEREST, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2019,"lvl":2,"n":13,"adsh":"0001506293-20-000013","doc":"pins-20191231.htm","q":"We have invested heavily in computer vision to help people discover possibilities that traditional text-based search queries cannot offer."},{"fy":2020,"lvl":3,"n":15,"adsh":"0001506293-21-000025","doc":"pins-20201231.htm","q":"We have invested heavily in computer vision to help people discover possibilities that traditional text-based search queries cannot offer."},{"fy":2021,"lvl":2,"n":9,"adsh":"0001506293-22-000016","doc":"pins-20211231.htm","q":"The \u201cBrowse\u201d tab is Pinterest\u2019s traditional inspiration feed (consisting of a two column grid featuring a variety of Standard, Video, Product and Idea Pins), while the \u201cWatch\u201d tab is an immersive feed of full-screen, auto-playing Idea Pins.\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001506293-23-000023","doc":"pins-20221231.htm","q":"This experience is powered by computer vision (that can identify objects and attributes within scenes) as well as by our catalog of shoppable inventory."},{"fy":2023,"lvl":3,"n":56,"adsh":"0001506293-24-000018","doc":"pins-20231231.htm","q":"Our related pins surface is powered by our recommendation models that use computer vision designed to identify products in the Pin, and show other relevant organic or ads content that the user might find valuable to their inspiration to act\u2026"},{"fy":2024,"lvl":3,"n":69,"adsh":"0001506293-25-000022","doc":"pins-20241231.htm","q":"The unique, first party, intent-based signal we receive from user actions on Pinterest helps power the AI based recommendation systems that we use to surface relevant and engaging content to our users."},{"fy":2025,"lvl":3,"n":90,"adsh":"0001506293-26-000021","doc":"pins-20251231.htm","q":"Business Overview Pinterest is an AI-powered visual search and discovery platform, positioned at the intersection of search, social, and commerce."}]},{"cik":1506295,"name":"VIZCONNECT, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-003896","doc":"vizc_10k.htm","q":null}]},{"cik":1506439,"name":"SHARPSPRING, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-003069","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-002630","doc":"shsp_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001654954-19-002262","doc":"shsp_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-20-002682","doc":"shsp_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-21-003521","doc":"shsp_10k.htm","q":null}]},{"cik":1507957,"name":"IDEAL POWER INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-037832","doc":"ipwr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-039133","doc":"ipwr-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-010360","doc":"ipwr20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-009911","doc":"ipwr20241231_10k.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001437749-26-009995","doc":"ipwr20251231_10k.htm","q":"In recent years, there has been greater demand placed on the power grid to support the substantial growth in AI data centers as well as vehicle electrification and renewable energy sources, this in turn is driving the quest for energy-savin\u2026"}]},{"cik":1509190,"name":"ARATANA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"KS","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001509190-15-000005","doc":"petx-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001509190-16-000061","doc":"petx-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001509190-17-000010","doc":"petx-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001509190-18-000010","doc":"petx-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001509190-19-000018","doc":"petx-20181231x10k.htm","q":null}]},{"cik":1509223,"name":"MOATABLE, INC.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2023,"lvl":2,"n":6,"adsh":"0001410578-24-000425","doc":"mtbl-20231231x10k.htm","q":"The platform combines IDX (internet data exchange) websites, lead generation, marketing automation, advanced lead management, and powerful AI to cost-effectively capture and convert leads into new business."},{"fy":2024,"lvl":2,"n":6,"adsh":"0001410578-25-000746","doc":"mtbl-20241231x10k.htm","q":"The platform combines IDX (internet data exchange) websites, lead generation, marketing automation, advanced lead management, and powerful AI to cost-effectively capture and convert leads into new business."}]},{"cik":1509261,"name":"REZOLUTE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-057284","doc":"v420245_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-16-125780","doc":"v448917_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-049237","doc":"v474916_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-18-053849","doc":"tv503852_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001144204-19-043983","doc":"tv528754_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-20-114497","doc":"tm2024743-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-115980","doc":"tm2126910d1_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-014432","doc":"rzlt-20220630x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-23-015755","doc":"rzlt-20230630x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-24-012901","doc":"rzlt-20240630x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-25-090848","doc":"rzlt-20250630x10k.htm","q":null}]},{"cik":1509351,"name":"EVENTURE INTERACTIVE, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-022660","doc":"v405279_10k.htm","q":null}]},{"cik":1509745,"name":"CYPHERPUNK TECHNOLOGIES INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-000976","doc":"a2234497z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001830","doc":"a2238110z10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001047469-20-001500","doc":"a2240891z10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-035227","doc":"tm2039290-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-032638","doc":"lptx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-036239","doc":"lptx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000218","doc":"lptx-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000454","doc":"lptx-20241231x10k.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001104659-26-028566","doc":"cyph-20251231x10k.htm","q":"We face risks relating to the potential compromise of the Zcash Network security by emerging technologies, including artificial intelligence and quantum computing, which may materially and adversely impact our operations and financial condi\u2026"}]},{"cik":1509786,"name":"INSPIRED BUILDERS, INC.","industry":"Construction","sic":1520,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-006481","doc":"f10k2014_inspiredbuilders.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-010118","doc":"f10k2015_inspiredbuilders.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-011191","doc":"f10k2016_inspiredbuilders.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-17-012492","doc":"f10k2017_inspiredbuilders.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-017070","doc":"f10k2018_inspiredbuilders.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-19-022874","doc":"f10k2019_inspiredbuilders.htm","q":null}]},{"cik":1509957,"name":"CANBIOLA, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001511164-17-000176","doc":"f2016wrapform10kv12clean.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001511164-18-000217","doc":"f10-kcanbiola2017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005557","doc":"form10-ka.htm","q":null}]},{"cik":1510487,"name":"PRINCIPIA BIOPHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008448","doc":"prnb-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009756","doc":"prnb-10k_20191231.htm","q":null}]},{"cik":1510580,"name":"KITE PHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001985","doc":"kite-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013699","doc":"kite-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001510580-17-000003","doc":"kite20161231-10k.htm","q":null}]},{"cik":1510832,"name":"BIOPOWER OPERATIONS CORP","industry":"Construction","sic":1700,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-012871","doc":"form10-ka.htm","q":null},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-21-022000","doc":"form10-k.htm","q":"In the future we may consider NFTs in the areas of medicine, space, internet & computing, artificial intelligence, robotics, nanotechnology, precious metals, and/or precious gems, for example."},{"fy":2021,"lvl":"x","n":1,"adsh":"0001493152-22-004827","doc":"form10k.htm","q":"In the future we may consider NFTs in the areas of medicine, space, internet & computing, artificial intelligence, robotics and nanotechnology, for example."}]},{"cik":1510891,"name":"YSTRATEGIES CORP.","industry":"Software & IT services","sic":7371,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001079974-15-000270","doc":"india10k12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001079974-16-001120","doc":"india10k12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001079974-17-000161","doc":"ystrat10k12312016.htm","q":null}]},{"cik":1510964,"name":"CV SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-18-000816","doc":"cvsciences_10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001510964-19-000007","doc":"cvsi-20181231x10xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001510964-20-000026","doc":"cvsi-20191231x10xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001510964-21-000012","doc":"cvsi-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001510964-22-000033","doc":"0001510964-22-000033.txt","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001510964-23-000016","doc":"cvsi-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038736","doc":"cvsi-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-046180","doc":"cvsi-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-126598","doc":"cvsi-20251231.htm","q":null}]},{"cik":1511820,"name":"STEMTECH CORP","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-15-005932","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-16-015756","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-17-014604","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-18-017531","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-19-019136","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-023476","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008815","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-23-002487","doc":"stemtech_i10k-123122.htm","q":null}]},{"cik":1512673,"name":"BLOCK, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":1,"n":2,"adsh":"0001628280-17-001754","doc":"a10-kfilingsquareinc2016.htm","q":"We have high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of our approach to risk management that emphasizes data science and machine learning."},{"fy":2017,"lvl":1,"n":2,"adsh":"0001512673-18-000004","doc":"a10-kfilingsquareinc2017.htm","q":"We have high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of our approach to risk management that emphasizes data science and machine learning."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001512673-19-000003","doc":"a10-kfilingsquareinc2018.htm","q":"We achieve high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of our approach to risk management that emphasizes data science and machine learning."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001628280-20-002303","doc":"sq-20191231.htm","q":"It is also integrated with Square Assistant which is an artificial intelligence enabled automated messaging tool that responds to buyers directly, quickly, and professionally saving sellers time and helping prevent no-shows. \u2022 Square for Re\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001512673-21-000008","doc":"sq-20201231.htm","q":"It is also integrated with Square Assistant which is an artificial intelligence enabled automated messaging tool that responds to buyers efficiently and professionally, saving sellers' time and helping prevent no-shows. \u2022 Square for Retail \u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0001628280-22-003825","doc":"sq-20211231.htm","q":"It is also integrated with Square Assistant, an artificial intelligence enabled automated messaging tool that responds to buyers efficiently and professionally, saving sellers' time and helping prevent no-shows. \u2022 Square for Retail is tailo\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001628280-23-004840","doc":"sq-20221231.htm","q":"It is also integrated with Square Assistant, an artificial intelligence-enabled automated messaging tool that responds to buyers efficiently and professionally, saving sellers' time and helping prevent missed appointments. \u2022 Square for Reta\u2026"},{"fy":2023,"lvl":3,"n":25,"adsh":"0001628280-24-006354","doc":"sq-20231231.htm","q":"Strategic Priorities: Our focus for Square is on four priorities: maintaining our secure, and flexible multi-product platform, providing a \u201clocal\u201d experience to sellers of all sizes, growing with artificial intelligence (\u201cAI\u201d), and further \u2026"},{"fy":2024,"lvl":3,"n":30,"adsh":"0001628280-25-007376","doc":"sq-20241231.htm","q":"Strategic Priorities Our focus for Square is on four priorities: maintaining our secure, and flexible multi-product platform, providing a \u201clocal\u201d experience to sellers of all sizes, growing with artificial intelligence (\u201cAI\u201d), and further d\u2026"},{"fy":2025,"lvl":3,"n":68,"adsh":"0001628280-26-012254","doc":"xyz-20251231.htm","q":"We apply data, automation, and AI to improve the speed, accuracy, and usability of our products."}]},{"cik":1512762,"name":"COHERUS ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001896","doc":"chrs-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013726","doc":"chrs-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004176","doc":"chrs-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004947","doc":"chrs-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005470","doc":"chrs-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007416","doc":"chrs-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001829","doc":"chrs-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001764","doc":"chrs-20211231x10k.htm","q":null},{"fy":2022,"lvl":2,"n":13,"adsh":"0001558370-23-002917","doc":"chrs-20221231x10k.htm","q":"In addition to the currently marketed pre-filled syringe (\u201cPFS\u201d) presentation, we are also developing additional presentations of UDENYCA, such as a proprietary on-body injector (\u201c OBI\u201d) and an autoinjector (\u201cAI\u201d) ."},{"fy":2023,"lvl":2,"n":9,"adsh":"0001558370-24-003436","doc":"chrs-20231231x10k.htm","q":"The FDA approved the prior approval supplement (\u201cPAS\u201d) for an autoinjector (\u201cAI\u201d) presentation of UDENYCA on March 3, 2023, and on May 22, 2023 we announced the availability of UDENYCA AI for commercial sale."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001558370-25-003126","doc":"chrs-20241231x10k.htm","q":"UDENYCA is currently approved by the FDA in three presentations: pre-filled syringe (\u201cPFS\u201d), autoinjector (\u201cAI\u201d) and UDENYCA ONBODY."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-025308","doc":"chrs-20251231x10k.htm","q":null}]},{"cik":1512922,"name":"PETVIVO HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-16-009141","doc":"petv_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-012044","doc":"petv_10k.htm","q":null}]},{"cik":1513153,"name":"FCA US LLC","industry":"Auto manufacturing","sic":3711,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001513153-15-000010","doc":"fcausllc-2014123110k.htm","q":null}]},{"cik":1513525,"name":"ADIAL PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"VA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-002769","doc":"f10k2018_adialpharma.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-007020","doc":"f10k2019_adialpharma.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-017009","doc":"f10k2020_adialpharmaceutical.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-015562","doc":"f10k2021_adialpharma.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024719","doc":"f10k2022_adialpharma.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-028701","doc":"ea0202434-10k_adial.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-019771","doc":"ea0232194-10k_adial.htm","q":null},{"fy":2025,"lvl":"x","n":3,"adsh":"0001213900-26-024175","doc":"ea0279150-10k_adial.htm","q":"Their mandate was to pressure test all assumptions using deep biostatistical expertise and proprietary analytic platforms that integrate multiple statistical methodologies, Artificial Intelligence (AI), and machine learning tools."}]},{"cik":1513818,"name":"ARAVIVE, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001404","doc":"vsar-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014158","doc":"vsar-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003907","doc":"vsar-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004569","doc":"vsar-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007911","doc":"arav-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013390","doc":"arav-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013312","doc":"arav-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007827","doc":"arav20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-006587","doc":"arav20221231_10k.htm","q":null}]},{"cik":1513856,"name":"NEUROTROPE, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-018676","doc":"v405175_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-086383","doc":"v433080_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-014012","doc":"v461285_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013105","doc":"tv487391_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-013080","doc":"tv515407_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-033198","doc":"tm205336d1_10k.htm","q":null}]},{"cik":1514056,"name":"TITAN ENVIRONMENTAL SOLUTIONS INC.","industry":"Software & IT services","sic":7371,"state":"WA","cells":[{"fy":2019,"lvl":"x","n":1,"adsh":"0001493152-20-010196","doc":"form10-k.htm","q":"Once you attach a sensor to it, a physical object (whether a tiny one like a pill that goes through your body, or a very large one like a plane or building) starts functioning a lot like any other digital solution \u2013 it emits data about its \u2026"},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-21-006526","doc":"form10-k.htm","q":"Using artificial intelligence technology, the software analyzes online activity and delivers real-time, automated recommendations and personalized content, including such items as personalized, always-updated coupons, funds, tickets and loy\u2026"},{"fy":2021,"lvl":"x","n":10,"adsh":"0001493152-22-008274","doc":"form10-k.htm","q":"Rohuma dba Kringle.ai is a California based software solutions company that enables digital and mobile commerce by providing enterprise class applications that cover loyalty and rewards products, payments, online ordering, distribution logi\u2026"},{"fy":2022,"lvl":"x","n":3,"adsh":"0001493152-23-010251","doc":"form10-k.htm","q":"As the number of product and services offerings in the artificial intelligence, mobile payments and task worker markets increases and functionalities increasingly overlap, we may become increasingly subject to infringement claims."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-014667","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-001897","doc":"form10-k.htm","q":null}]},{"cik":1514183,"name":"SILO PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001013762-25-004139","doc":"ea0234891-10k_silopharma.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-035576","doc":"ea0282804-10k_silo.htm","q":null}]},{"cik":1514416,"name":"BANDWIDTH INC.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001514416-18-000003","doc":"bandwidthinc10-k123117doc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001514416-19-000011","doc":"band-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001514416-20-000027","doc":"band-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001514416-21-000092","doc":"band-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001514416-22-000054","doc":"band-20211231.htm","q":"For the largest global companies, trying to migrate these systems to a modern, cloud-based solution can move slowly, or even be blocked by the need to retain critical call data to power third-party integrations such as voice authentication,\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001514416-23-000048","doc":"band-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":23,"adsh":"0001514416-24-000024","doc":"band-20231231.htm","q":"Bandwidth\u2019s business benefits from multiple global megatrends, including enterprise migration to the cloud, adoption of Contact Center as a Service platforms, the need to be able to work from anywhere, reinvention of customer experience, gr\u2026"},{"fy":2024,"lvl":3,"n":42,"adsh":"0001514416-25-000024","doc":"band-20241231.htm","q":"Bandwidth\u2019s business benefits from multiple global megatrends, including enterprise migration to the cloud, adoption of Contact Center as a Service platforms, the need to be able to work from anywhere, reinvention of customer experience, gr\u2026"},{"fy":2025,"lvl":3,"n":78,"adsh":"0001514416-26-000017","doc":"band-20251231.htm","q":"Backed by the Bandwidth Communications Cloud, our global owned-and-operated network spanning more than 65 countries reaching over 90 percent of global gross domestic product (\u201cGDP\u201d), innovative enterprises use Bandwidth\u2019s Application Progra\u2026"}]},{"cik":1514946,"name":"AXIM BIOTECHNOLOGIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001078782-18-000306","doc":"f10k123118_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001078782-19-000304","doc":"f10k123118_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001096906-22-000902","doc":"axim_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001096906-23-000858","doc":"axim_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001096906-24-000864","doc":"axim_10k.htm","q":null}]},{"cik":1515115,"name":"SOUL & VIBE INTERACTIVE INC.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-020119","doc":"v405414_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-16-092295","doc":"v435128_10k.htm","q":null}]},{"cik":1515673,"name":"ULTRAGENYX PHARMACEUTICAL INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-002066","doc":"rare-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013430","doc":"rare-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001714","doc":"rare-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002535","doc":"rare-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003324","doc":"rare-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004667","doc":"rare-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005610","doc":"rare-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001284","doc":"rare-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003096","doc":"rare-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-017879","doc":"rare-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-023312","doc":"rare-20241231.htm","q":"We face intense competition and rapid technological change, including the use of artificial intelligence, or AI, and the possibility that our competitors may develop therapies that are similar, more advanced, or more effective than ours, wh\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001193125-26-057329","doc":"rare-20251231.htm","q":"We face intense competition and rapid technological change, including the use of artificial intelligence, or AI, and the possibility that our competitors may develop therapies that are similar, more advanced, or more effective than ours, wh\u2026"}]},{"cik":1515740,"name":"PREMIER BIOMEDICAL INC","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-002010","doc":"biei_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009264","doc":"biei_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-002100","doc":"biei_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001754","doc":"biei_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-004408","doc":"biei_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-005676","doc":"biei_10k.htm","q":null}]},{"cik":1516479,"name":"INSYS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-003988","doc":"insy20141231_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-026220","doc":"insy20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005856","doc":"insy-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005187","doc":"insy-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007444","doc":"insy-10k_20181231.htm","q":null}]},{"cik":1516513,"name":"DOXIMITY, INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":6,"adsh":"0001516513-22-000037","doc":"docs-20220331.htm","q":"We leverage artificial intelligence, or AI, including machine learning, or ML, to create a personalized and curated newsfeed for each of our members."},{"fy":2022,"lvl":3,"n":17,"adsh":"0001516513-23-000036","doc":"docs-20230331.htm","q":"We leverage artificial intelligence, or AI, including machine learning, or ML, to create a personalized and curated newsfeed for each of our members."},{"fy":2023,"lvl":3,"n":43,"adsh":"0001516513-24-000035","doc":"docs-20240331.htm","q":"Our \u201cProductivity Solutions,\u201d which include our telehealth, on-call scheduling, and AI-supported medical correspondence tools, are designed to help clinicians streamline their clinical workflow and easily connect with patients and colleague\u2026"},{"fy":2024,"lvl":3,"n":45,"adsh":"0001516513-25-000056","doc":"docs-20250331.htm","q":"Our \u201cWorkflow Solutions,\u201d which include our telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and easily connect with patie\u2026"}]},{"cik":1516551,"name":"SKYE BIOSCIENCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001640334-16-000847","doc":"2015dec31-nmus_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-000456","doc":"nmus_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-18-000482","doc":"nmus_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-19-000379","doc":"nemus_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-20-000582","doc":"embi_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-21-000483","doc":"skye_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001516551-22-000004","doc":"skye-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001516551-23-000038","doc":"skye-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001516551-24-000048","doc":"skye-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001516551-25-000027","doc":"skye-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001628280-26-016394","doc":"skye-20251231.htm","q":"The increasing use of social media and artificial intelligence-based platforms presents new risks and challenges."}]},{"cik":1516805,"name":"MOXIAN, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2015,"lvl":1,"n":1,"adsh":"0001213900-15-009654","doc":"f10k2015_moxianinc.htm","q":"Key components of our technology include: Data Science Our data science technology serves various types of data-intensive computational needs, including deep learning, high-volume batch processing and multi-variable and multi-dimensional re\u2026"},{"fy":2016,"lvl":"x","n":1,"adsh":"0001213900-16-019618","doc":"f10k2016_moxianinc.htm","q":"Key components of our technology include: Data Science Our data science technology serves various types of data-intensive computational needs, including deep learning, high-volume batch processing and multi-variable and multi-dimensional re\u2026"},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-001287","doc":"tv481385_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-001744","doc":"tv509703_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-000570","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-001052","doc":"form10-k.htm","q":null}]},{"cik":1516887,"name":"WELLNESS CENTER USA, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001078782-17-000062","doc":"f10k093016_10k.htm","q":null},{"fy":2018,"lvl":"x","n":3,"adsh":"0001493152-19-000631","doc":"form10-k.htm","q":"Comprised of a suite of powerful analytical tools, including artificial intelligence and social-psychology, the service provides timely and actionable intelligence to clients."},{"fy":2019,"lvl":"x","n":2,"adsh":"0001493152-20-001273","doc":"form10-k.htm","q":"Comprised of a suite of powerful analytical tools, including artificial intelligence and social-psychology, the service provides timely and actionable intelligence to clients."},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-21-002909","doc":"form10-k.htm","q":"Comprised of a suite of powerful analytical tools, including artificial intelligence and social-psychology, the service provides timely and actionable intelligence to clients."},{"fy":2021,"lvl":"x","n":2,"adsh":"0001493152-22-004617","doc":"form10-k.htm","q":"Comprised of a suite of powerful analytical tools, including artificial intelligence and social-psychology, the service provides timely and actionable intelligence to clients."}]},{"cik":1517022,"name":"AKEBIA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001260","doc":"akba-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014700","doc":"akba-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003466","doc":"akba-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005286","doc":"akba-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009340","doc":"akba-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010491","doc":"akba-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003283","doc":"akba-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004522","doc":"akba-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-007539","doc":"akba-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001628280-24-011270","doc":"akba-20231231.htm","q":"In addition, we and our collaborators, contractors and other third parties rely on information technology networks and systems, including the Internet and artificial intelligence based software, to process, transmit and store clinical trial\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0001628280-25-012470","doc":"akba-20241231.htm","q":"In addition, we and our collaborators, contractors and other third parties rely on information technology networks and systems, including the Internet and artificial intelligence based software, to process, transmit and store clinical trial\u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001517022-26-000020","doc":"akba-20251231.htm","q":"Security breaches and unauthorized use of our information technology systems and information, or the information technology systems or information in the possession of our collaborators, contractors and other third parties, including those \u2026"}]},{"cik":1517375,"name":"SPROUT SOCIAL, INC.","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2020,"lvl":1,"n":1,"adsh":"0001517375-21-000009","doc":"spt-20201231.htm","q":"Viralpost uses machine learning to determine the best times to reach a customer\u2019s most engaged audience. \u2022 Content performance reporting ."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001517375-22-000009","doc":"spt-20211231.htm","q":"Viralpost uses machine learning to determine the best times to reach a customer\u2019s most engaged audience. 15 \u2022 Content performance reporting ."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001517375-23-000019","doc":"spt-20221231.htm","q":"Viralpost uses machine learning to determine the best times to reach a customer\u2019s most engaged audience. \u2022 Content performance reporting ."},{"fy":2023,"lvl":3,"n":61,"adsh":"0001517375-24-000020","doc":"spt-20231231.htm","q":"Viralpost uses machine learning to determine the best times to reach a customer\u2019s most engaged audience. \u2022 Content performance reporting ."},{"fy":2024,"lvl":3,"n":103,"adsh":"0001517375-25-000022","doc":"spt-20241231.htm","q":"Our human-centric AI and advanced analytics deliver real-time insights from more than 1 billion daily messages, driving impact quickly and boosting productivity."},{"fy":2025,"lvl":3,"n":137,"adsh":"0001517375-26-000015","doc":"spt-20251231.htm","q":"Our human-centric AI and advanced analytics - powered by Trellis, our proprietary AI agent - deliver real-time social intelligence from more than 1 billion daily messages, driving impact quickly and boosting productivity."}]},{"cik":1517389,"name":"JUBILANT FLAME INTERNATIONAL, LTD","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-003721","doc":"jfil_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-011114","doc":"jfil_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-002170","doc":"jfil_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-002584","doc":"jfil_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-002948","doc":"jfil_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-002534","doc":"jfil_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-002933","doc":"jfil_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-003101","doc":"jfil_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-003218","doc":"jfil_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-002544","doc":"jfil_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-25-002447","doc":"jfil_10k.htm","q":null}]},{"cik":1517413,"name":"FASTLY, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001517413-20-000043","doc":"fsly-10kx123119.htm","q":"We operate between the \"big 3\" origin cloud platforms and a growing community of companies that provide big data, machine learning, and security solutions."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001517413-21-000030","doc":"fsly-20201231.htm","q":null},{"fy":2021,"lvl":2,"n":6,"adsh":"0001517413-22-000038","doc":"fsly-20211231.htm","q":"We operate between and complement the \"big 3\" origin cloud platforms, Amazon Web Services (\"AWS\"), Microsoft Azure, and Google Cloud Platform, and a growing community of companies that provide big data, machine learning, and security soluti\u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0001517413-23-000035","doc":"fsly-20221231.htm","q":"We operate between and complement the \"big 3\" origin cloud platforms, Amazon Web Services (\"AWS\"), Microsoft (Azure), and Google Cloud Platform, and a growing community of companies that provide big data, machine learning, and security solu\u2026"},{"fy":2023,"lvl":3,"n":19,"adsh":"0001517413-24-000048","doc":"fsly-20231231.htm","q":"We operate between and complement the \u201cbig 3\u201d origin cloud platforms, Amazon Web Services (\u201cAWS\u201d), Microsoft (Azure), and Google Cloud Platform, and a growing community of companies that provide big data, machine learning, and security solu\u2026"},{"fy":2024,"lvl":3,"n":36,"adsh":"0001517413-25-000063","doc":"fsly-20241231.htm","q":"Objects stored in Fastly Object Storage are accessible via an S3 - compatible interface. \u2022 AI Accelerator ."},{"fy":2025,"lvl":3,"n":143,"adsh":"0001517413-26-000053","doc":"fsly-20251231.htm","q":"As the internet approaches an inflection point where automated, artificial intelligence (\u201cAI\u201d)-driven traffic increases demands on infrastructure, Fastly is the essential platform to deliver resilient, highly performant, always-on software \u2026"}]},{"cik":1517650,"name":"INTERACTIVE INTELLIGENCE GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"IN","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001517650-15-000013","doc":"inin-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001517650-16-000118","doc":"inin-20151231x10k.htm","q":null}]},{"cik":1517681,"name":"PROPANC BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-15-057458","doc":"v420861_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-16-125808","doc":"v449148_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-17-011027","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-18-013392","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-19-015529","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-018726","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-023973","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-027033","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-23-034632","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-24-038815","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-25-016069","doc":"form10-k.htm","q":null}]},{"cik":1518171,"name":"JADE GLOBAL HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001294606-16-000203","doc":"mediaanalyticsform10-k2015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001640334-16-001279","doc":"meda_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-006779","doc":"f10k2017_jadeglobalhold.htm","q":null}]},{"cik":1518336,"name":"DREAM HOMES & DEVELOPMENT CORP.","industry":"Construction","sic":1531,"state":"NJ","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-004861","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-017910","doc":"form10-k.htm","q":null}]},{"cik":1518520,"name":"ICAGEN, INC.","industry":"Pharma & biotech","sic":8731,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-001993","doc":"f10k2014_xrprosciences.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-012530","doc":"f10k2015_icageninc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-003877","doc":"f10k2016_icageninc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-004605","doc":"f10k2017_icageninc.htm","q":null},{"fy":2018,"lvl":3,"n":15,"adsh":"0001213900-19-006256","doc":"f10k2018_icageninc.htm","q":"The Icagen platform is unique as it integrates our current state of the art drug discovery engine along with an artificial intelligence (AI) computational platform that enables an accelerated path to drug discovery."}]},{"cik":1519472,"name":"SOLARMAX TECHNOLOGY, INC.","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001640334-24-000675","doc":"solarmax_10k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001640334-25-000556","doc":"solarmax_10k.htm","q":"Artificial Intelligence Our business does not use and is not dependent upon artificial intelligence."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001640334-26-000651","doc":"solarmax_10k.htm","q":"Artificial Intelligence Our business does not use and is not dependent upon artificial intelligence. 16 Table of Contents Historical Operations in China In 2015, we commenced operations in the PRC with this acquisition of two companies, and\u2026"}]},{"cik":1519751,"name":"FORTUNE BRANDS HOME & SECURITY, INC.","industry":"Construction","sic":1520,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-062500","doc":"d852986d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478315","doc":"d121353d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-062357","doc":"d341756d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-063999","doc":"d486021d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-049951","doc":"d654795d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006812","doc":"fbhs-10k_20191231.htm","q":null}]},{"cik":1520262,"name":"ALKERMES PLC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001083","doc":"a2223141z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003498","doc":"alks-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001520262-17-000007","doc":"alks-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001520262-18-000016","doc":"alks-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003060","doc":"alks-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004489","doc":"alks-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005593","doc":"alks-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-005304","doc":"alks-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-002020","doc":"alks-10k_20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-017883","doc":"alks-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0000950170-25-019011","doc":"alks-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":10,"adsh":"0001193125-26-068925","doc":"alks-20251231.htm","q":"Moreover, the prevalent use of mobile devices to access confidential information, remote working practices, and the increased use of artificial intelligence present new and increased risk of security breaches."}]},{"cik":1521013,"name":"PULSE NETWORK, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-004476","doc":"tpni_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-18-001018","doc":"tpni_10k.htm","q":null}]},{"cik":1521332,"name":"APTIV PLC","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001521332-15-000014","doc":"dlph1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001521332-16-000084","doc":"dlph1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001521332-17-000013","doc":"dlph1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001521332-18-000013","doc":"aptv1231201710k.htm","q":null},{"fy":2018,"lvl":1,"n":4,"adsh":"0001521332-19-000007","doc":"aptv1231201810k.htm","q":"Our achievements in 2018 included the following: \u2022 Accelerating our end-market diversification strategy through the acquisition of Winchester Interconnect, a leading provider of advanced interconnect solutions for harsh environment applicat\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001521332-20-000012","doc":"aptv1231201910-k.htm","q":"During the fourth quarter of 2018, the Company\u2019s Advanced Safety and User Experience segment made a $15 million investment in Affectiva, Inc., a leader in human perception artificial intelligence technology."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001521332-21-000009","doc":"aptv-20201231.htm","q":"During the fourth quarter of 2018, the Company\u2019s Advanced Safety and User Experience segment made a $15 million investment in Affectiva, Inc., a leader in human perception artificial intelligence technology."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001521332-22-000010","doc":"aptv-20211231.htm","q":"She joined Aptiv from Microsoft Corporation, where she served as the chief technology officer of Artificial Intelligence and product head of Power Apps Edge within their Business Application Group from February 2020 to January 2022, and pre\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001521332-23-000013","doc":"aptv-20221231.htm","q":"She joined Aptiv from Microsoft Corporation, where she served as the chief technology officer of Artificial Intelligence and product head of Power Apps Edge within their Business Application Group from February 2020 to January 2022, and pre\u2026"},{"fy":2023,"lvl":2,"n":6,"adsh":"0001521332-24-000011","doc":"aptv-20231231.htm","q":"She joined Aptiv from Microsoft Corporation, where she served as the chief technology officer of Artificial Intelligence and product head of Power Apps Edge within their Business Application Group from February 2020 to January 2022, and pre\u2026"},{"fy":2024,"lvl":2,"n":9,"adsh":"0001521332-25-000010","doc":"aptv-20241231.htm","q":"We are also continuing to develop market-leading automated driving solutions such as automated driving software, sensing and perception technologies enhanced through artificial intelligence and machine learning, as well as the underlying ar\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001521332-26-000009","doc":"aptv-20251231.htm","q":"These technologies are designed to seamlessly integrate vehicles into their operating environment, while providing drivers with connectivity to consumer ecosystems, and data and insights to OEMs via over-the-air (\u201cOTA\u201d) technology. 7 Table \u2026"}]},{"cik":1522540,"name":"MARQETA, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001522540-22-000013","doc":"mq-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001522540-23-000015","doc":"mq-20221231.htm","q":"We are directly subject to regulation in areas inclu ding privacy, data protection and information security, and anti-bribery, and our contractual relationships with customers, Issuing Banks and Card Networks may subject us to additional re\u2026"},{"fy":2023,"lvl":2,"n":8,"adsh":"0001628280-24-007663","doc":"mq-20231231.htm","q":"For example, in the past year generative artificial intelligence (\u201cAI\u201d) solutions have emerged as an opportunity for us, our customers, our partners, and our vendors to innovate more quickly and efficiently and better serve our customers."},{"fy":2024,"lvl":3,"n":31,"adsh":"0001628280-25-008232","doc":"mq-20241231.htm","q":"We have incorporated and may continue to incorporate artificial intelligence (\u201cAI\u201d) solutions and features (including AI solutions utilizing generative AI) into our platform and other aspects of our business and operations."},{"fy":2025,"lvl":3,"n":38,"adsh":"0001522540-26-000017","doc":"mq-20251231.htm","q":"Unauthorized parties have attempted and will continue to attempt to gain access to our platform, systems, or facilities, and those of our customers, vendors, and other third parties with which we do business using a variety of methods such \u2026"}]},{"cik":1522602,"name":"COHBAR, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-011989","doc":"f10k2015_cohbarinc.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003096","doc":"f10k2016_cohbarinc.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003845","doc":"f10k2017_cohbarinc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004358","doc":"f10k2018_cohbarinc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-006115","doc":"f10k2019_cohbarinc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018680","doc":"f10k2020_cohbarinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015833","doc":"f10k2021_cohbarinc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-018882","doc":"f10k2022_cohbarinc.htm","q":null}]},{"cik":1522724,"name":"GLOBAL GREEN INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001557240-15-000249","doc":"dec3114-gogc_10k.htm","q":null}]},{"cik":1526119,"name":"VERASTEM, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001877","doc":"a2223073z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003821","doc":"vstm-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-002065","doc":"vstm-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001953","doc":"vstm-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001852","doc":"vstm-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002421","doc":"vstm-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003211","doc":"vstm-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004498","doc":"vstm-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003738","doc":"vstm-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003250","doc":"vstm-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003372","doc":"vstm-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-023444","doc":"vstm-20251231x10k.htm","q":null}]},{"cik":1526160,"name":"FLEETMATICS GROUP PLC","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-069780","doc":"d835284d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-481972","doc":"d125231d10k.htm","q":null}]},{"cik":1526520,"name":"TRIPADVISOR, INC.","industry":"Software & IT services","sic":7370,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-000721","doc":"trip-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012862","doc":"trip-10k_20151231.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001564590-17-001783","doc":"trip-10k_20161231.htm","q":"In addition, many of our competitors, including online search companies, continue to expand their voice and artificial intelligence capabilities, which may provide them with a competitive advantage in travel."},{"fy":2017,"lvl":1,"n":3,"adsh":"0001564590-18-002664","doc":"trip-10k_20171231.htm","q":"In addition, many of our competitors, including online search companies, continue to expand their voice and artificial intelligence capabilities, which may provide them with a competitive advantage in travel."},{"fy":2018,"lvl":1,"n":3,"adsh":"0001564590-19-003889","doc":"trip-10k_20181231.htm","q":"In addition, many of our competitors, including online search companies, continue to expand their voice and artificial intelligence capabilities, which may provide them with a competitive advantage in travel."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001564590-20-005269","doc":"trip-10k_20191231.htm","q":"In addition, many of our competitors, including online search companies, continue to expand their voice and artificial intelligence capabilities, which may provide them with a competitive advantage in travel."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001564590-21-006939","doc":"trip-10k_20201231.htm","q":"Our long-term growth strategy aims to increase customer engagement on our platform and drive profitable growth through: \u2022 building products that delight travelers by reducing friction throughout the travel planning and trip-taking journey; \u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0000950170-22-001481","doc":"trip-20211231.htm","q":"We expect to enable our growth through investment in: \u2022 organic investment in marketing and technology (e.g., machine learning) to further improve the experiences we can deliver to consumers and travel partners on our platform; and \u2022 inorga\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-003200","doc":"trip-20221231.htm","q":"Many of our competitors continue to expand their voice and artificial intelligence capabilities, which may provide them with a competitive advantage in travel."},{"fy":2023,"lvl":2,"n":13,"adsh":"0000950170-24-016553","doc":"trip-20231231.htm","q":"Across our three segments, we primarily compete, and in some cases partner, with the following businesses: \u2022 General OTAs, such as Expedia, Booking Holdings, Airbnb, traveloka, Despegar, Trip.com, and their respective subsidiaries and opera\u2026"},{"fy":2024,"lvl":3,"n":26,"adsh":"0000950170-25-023736","doc":"trip-20241231.htm","q":"Particularly, we believe we have been successful with the strategic use of a number of cost effective online and offline marketing channels to reach travelers and diners, including our own platform channels (i.e., websites and apps), online\u2026"},{"fy":2025,"lvl":3,"n":56,"adsh":"0001193125-26-051281","doc":"trip-20251231.htm","q":"In addition, the breadth, depth, and scale of first party data is uniquely valuable in the Company\u2019s pursuit to innovate in the application of artificial intelligence (\u201cAI\u201d) for travel and experiences discovery, planning, and booking."}]},{"cik":1526726,"name":"HORIZON MINERALS CORP.","industry":"Auto manufacturing","sic":3714,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000139","doc":"sfdy_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000896","doc":"hznm_10k.htm","q":null},{"fy":2016,"lvl":"x","n":1,"adsh":"0001393905-17-000084","doc":"hznm_10k.htm","q":"In 1986, following his graduation, he attended the University of Cambridge, graduating with a degree in law in 1988 and an LLM in 1989."}]},{"cik":1527096,"name":"MIROMATRIX MEDICAL INC.","industry":"Pharma & biotech","sic":2836,"state":"MN","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004763","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005278","doc":"miro-20221231x10k.htm","q":null}]},{"cik":1527599,"name":"SYNLOGIC, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004457","doc":"mirn-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001527599-17-000004","doc":"mirn_12312016x10kdocument.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006323","doc":"sybx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007367","doc":"sybx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010261","doc":"sybx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015256","doc":"sybx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010714","doc":"sybx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010428","doc":"sybx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-033146","doc":"sybx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-034820","doc":"sybx-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-104262","doc":"sybx-20251231.htm","q":null}]},{"cik":1527728,"name":"LUNAI BIOWORKS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002253","doc":"f10k2014_dandritbio.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-15-007370","doc":"f10kt2015_dandritbio.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-16-017105","doc":"f10k2016_dandritbiotech.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-17-010130","doc":"f10k2017_dandritbiotech.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001731122-18-000094","doc":"e1146_form10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001731122-19-000575","doc":"e1514_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001731122-20-000975","doc":"e2119_10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001731122-21-001565","doc":"e3109_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001731122-23-000271","doc":"e4443_10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001731122-23-001770","doc":"e5061_10k.htm","q":"On September 28, 2023, the Company signed a Purchase Agreement to acquire Gedi Cube, a cutting-edge health AI company, in which the Company will acquire all the issued and outstanding stock of Gedi Cube."},{"fy":2024,"lvl":3,"n":167,"adsh":"0001731122-24-001578","doc":"e5986_10-k.htm","q":"As described above, the engineered allogenic dendritic cell drug substance is thought to be able to be loaded with various cancer antigens for specific solid tumors but could or may be loaded with infectious disease antigens to elicit a mor\u2026"},{"fy":2025,"lvl":"x","n":189,"adsh":"0001731122-25-001316","doc":"e6882_10-k.htm","q":"Renovaro Cube Overview Renovaro Cube is an AI-driven healthcare technology company focusing on the earliest possible detection of cancer and its recurrence."}]},{"cik":1528098,"name":"SALEEN AUTOMOTIVE, INC.","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-002943","doc":"form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-015009","doc":"form10-k.htm","q":null}]},{"cik":1528103,"name":"EUROSITE POWER INC.","industry":"Utilities","sic":4931,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001528103-15-000006","doc":"eusp-20141231x10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001528103-16-000087","doc":"eusp-20151231x10k.htm","q":null}]},{"cik":1528115,"name":"ANNEXON, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015262","doc":"annx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008044","doc":"annx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006232","doc":"annx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-036408","doc":"annx-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":10,"adsh":"0000950170-25-030849","doc":"annx-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001193125-26-131782","doc":"annx-20251231.htm","q":null}]},{"cik":1528172,"name":"ENDONOVO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001469709-16-000755","doc":"endv10k_123115apg.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003917","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004879","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005267","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-007577","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008661","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-009861","doc":"form10-k.htm","q":null}]},{"cik":1528356,"name":"GENIE ENERGY LTD.","industry":"Utilities","sic":4931,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001213900-15-001804","doc":"f10k2014_genieenergy.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-16-011620","doc":"f10k2015_genieenergyltd.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001213900-17-002459","doc":"f10k2016_genieenergy.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-003067","doc":"f10k2017_genieenergy.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-004396","doc":"MainDocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-006416","doc":"MainDocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-015538","doc":"gne-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-012716","doc":"gne-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-020226","doc":"gne-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-022573","doc":"gne-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-024009","doc":"gne-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-014294","doc":"gne20251231_10k.htm","q":null}]},{"cik":1528396,"name":"GUIDEWIRE SOFTWARE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001528396-15-000019","doc":"gwre-7312015x10k.htm","q":null},{"fy":2017,"lvl":1,"n":3,"adsh":"0001528396-17-000025","doc":"gwre-7312017x10k.htm","q":"The most significant changes include: \u2022 a rise in customer expectations for digital, omni-channel interaction; \u2022 a growth in demand for personalized products and services; \u2022 an increase in technology-driven changes in vehicular risk; \u2022 dema\u2026"},{"fy":2018,"lvl":1,"n":2,"adsh":"0001528396-18-000037","doc":"gwre-7312018x10k.htm","q":"The most significant changes include: \u2022 a rise in customer expectations for digital, omni-channel interaction; \u2022 a growth in demand for personalized products and services; \u2022 an increase in technology-driven changes in vehicular risk; \u2022 dema\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001528396-19-000032","doc":"gwre-7312019x10k.htm","q":"The most significant changes include: \u2022 a rise in customer expectations for digital, omni-channel interaction; \u2022 a growth in demand for personalized products and services; \u2022 an increase in technology-driven changes in vehicular risk; \u2022 dema\u2026"},{"fy":2020,"lvl":2,"n":12,"adsh":"0001528396-20-000053","doc":"gwre-20200731.htm","q":"Guidewire\u2019s platform combines core operations, digital engagement, analytics, and artificial intelligence (AI) applications delivered as a cloud service or self-managed software."},{"fy":2021,"lvl":2,"n":11,"adsh":"0001528396-21-000095","doc":"gwre-20210731.htm","q":"Guidewire\u2019s platform combines core operations, digital engagement, analytics, and artificial intelligence (\u201cAI\u201d) applications delivered as a cloud service or self-managed software."},{"fy":2022,"lvl":3,"n":15,"adsh":"0001528396-22-000106","doc":"gwre-20220731.htm","q":"Guidewire\u2019s platform combines core operations, digital engagement, analytics, and artificial intelligence (\u201cAI\u201d) applications delivered as a cloud service or self-managed software."},{"fy":2023,"lvl":3,"n":71,"adsh":"0001528396-23-000089","doc":"gwre-20230731.htm","q":"Guidewire\u2019s platform combines core operations, digital engagement, analytics, machine learning, and artificial intelligence (\u201cAI\u201d) applications delivered as a cloud service or self-managed software."},{"fy":2024,"lvl":3,"n":96,"adsh":"0001528396-24-000105","doc":"gwre-20240731.htm","q":"Our core systems leverage data and analytics, digital, and AI."},{"fy":2025,"lvl":3,"n":90,"adsh":"0001528396-25-000221","doc":"gwre-20250731.htm","q":"Our platform combines core systems of record with digital, analytics, and artificial intelligence (\u201cAI\u201d) capabilities."}]},{"cik":1528760,"name":"EXEO ENTERTAINMENT, INC.","industry":"Computers & chips","sic":3570,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001199835-15-000041","doc":"exeo_10k-16296.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001199835-16-000645","doc":"exeo_10k-16756.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-002162","doc":"exeo_10k-17317.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-002782","doc":"exeo_10k-17617.htm","q":null}]},{"cik":1528875,"name":"ANPULO FOOD DEVELOPMENT, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001144204-15-057053","doc":"v420592_10k.htm","q":null}]},{"cik":1529113,"name":"XTI AEROSPACE, INC.","industry":"Software & IT services","sic":7371,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001213900-15-002111","doc":"f10k2014_sysorexglobal.htm","q":null},{"fy":2015,"lvl":1,"n":2,"adsh":"0001213900-16-012053","doc":"f10k2015_sysorexglobal.htm","q":"It supports both traditional SQL-based business intelligence and analytics applications as well as a host of integrated statistical, machine learning and artificial intelligence algorithms allowing it to provide supercomputer-like performan\u2026"},{"fy":2016,"lvl":1,"n":2,"adsh":"0001213900-17-003902","doc":"f10k2016_inpixon.htm","q":"The system supports both traditional SQL-based business intelligence and analytics applications as well as a host of integrated statistical, machine learning and artificial intelligence algorithms allowing it to provide supercomputer-like p\u2026"},{"fy":2017,"lvl":3,"n":15,"adsh":"0001213900-18-003538","doc":"f10k2017_inpixon.htm","q":"In connection with that goal, our 2018 product roadmap development plans include the use of blockchain technology to maintain and propagate device reputation, enforcing security policies and attaining compliance, artificial intelligence for\u2026"},{"fy":2018,"lvl":3,"n":17,"adsh":"0001213900-19-005135","doc":"f10k2018_inpixon.htm","q":"In connection with that goal, our product roadmap development plans include the use of blockchain technology to maintain and propagate device reputation, artificial intelligence for amassing anonymous device information, integrating video i\u2026"},{"fy":2019,"lvl":2,"n":7,"adsh":"0001213900-20-005326","doc":"f10k2019_inpixon.htm","q":"In connection with that goal, our product roadmap development plans include expanding the use of ultra-wideband technology for asset tracking, furthering our efforts towards a voice-assisted analytics interface, understanding worldwide 5G d\u2026"},{"fy":2020,"lvl":2,"n":10,"adsh":"0001628280-21-006279","doc":"inpx-20201231.htm","q":"In addition, we may seek to expand our capabilities around security, artificial intelligence, augmented reality and virtual reality or other high growth sectors."},{"fy":2021,"lvl":2,"n":10,"adsh":"0001628280-22-006421","doc":"inpx-20211231.htm","q":"In connection with that goal, our product roadmap development plans include expanding the use of both UWB and CSS technology for precise asset tracking, furthering our efforts towards 3D mapping, with a specific focus on light detection and\u2026"},{"fy":2022,"lvl":2,"n":11,"adsh":"0001628280-23-011793","doc":"inpx-20221231.htm","q":"Our RTLS solution leverages cutting-edge technologies such as IoT, AI, and big data analytics to provide real-time tracking and monitoring of assets, machines, and people within industrial environments."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001628280-24-016449","doc":"inpx-20231231.htm","q":"Our RTLS solution leverages cutting-edge technologies such as IoT, AI, and big data analytics to provide real-time tracking and monitoring of assets, machines, and people within industrial environments."},{"fy":2024,"lvl":3,"n":15,"adsh":"0001213900-25-032213","doc":"ea0235307-10k_xtiaerospace.htm","q":"Our RTLS solutions leverage cutting-edge technologies such as IoT, AI, and big data analytics to provide real-time tracking and monitoring of assets, machines, and people within industrial environments."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001213900-26-043785","doc":"ea0279149-10k_xtiaero.htm","q":"In addition, advancements in drone platforms, sensors, batteries, communications systems, autonomy, artificial intelligence and data processing technologies may quickly render existing products less competitive or obsolete."}]},{"cik":1529133,"name":"CHATAND, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001095","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008295","doc":"form10-k.htm","q":null}]},{"cik":1529274,"name":"ALKAMI TECHNOLOGY, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001529274-22-000034","doc":"alk-20211231.htm","q":"Biometric and multi-factor authentication, combined with machine learning wrapped in a leading user experience, creates a more secure user experience."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001529274-23-000037","doc":"alk-20221231.htm","q":"Biometric and multi-factor authentication, combined with machine learning wrapped in a leading user experience, creates a more secure user experience."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001529274-24-000029","doc":"alk-20231231.htm","q":"Biometric and multi-factor authentication, combined with machine learning wrapped in a leading user experience, creates a more secure user experience."},{"fy":2024,"lvl":2,"n":9,"adsh":"0001529274-25-000031","doc":"alk-20241231.htm","q":"Biometric and multi-factor authentication, combined with machine learning wrapped in a leading user experience, creates a more secure user experience."},{"fy":2025,"lvl":3,"n":67,"adsh":"0001529274-26-000009","doc":"alk-20251231.htm","q":"Powered by data scientists and artificial intelligence (\u201cAI\u201d), Segmint\u2019s innovative product line offers a variety of ways to optimally use account holder data to deepen relationships and grow the account holder\u2019s business."}]},{"cik":1530185,"name":"AMERITEK VENTURES, INC.","industry":"Auto manufacturing","sic":3714,"state":"NV","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001376474-24-000150","doc":"atvk-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001376474-25-000312","doc":"atvk-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-044162","doc":"ea0286450-10k_ameritek.htm","q":null}]},{"cik":1530746,"name":"KAYA HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0000721748-16-001298","doc":"kays10k041416.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0000721748-17-000257","doc":"kaya10k041117.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001721868-18-000294","doc":"f2s10kkays041018.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001721868-19-000207","doc":"f2skays10k040819.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001721868-20-000213","doc":"f2skays10k040220.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001721868-21-000184","doc":"f2skays10k031921.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001903596-22-000199","doc":"sfs10k040722kays.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001903596-23-000342","doc":"kays_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001903596-24-000238","doc":"kays_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001903596-25-000213","doc":"kays_10k.htm","q":null}]},{"cik":1531744,"name":"SHEA HOMES LIMITED PARTNERSHIP","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-081609","doc":"d828229d10k.htm","q":null}]},{"cik":1532063,"name":"EXPRESS SCRIPTS HOLDING CO.","industry":"Retail","sic":5912,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001532063-15-000004","doc":"esrx-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001532063-16-000017","doc":"esrx-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001532063-17-000004","doc":"esrx-12312016x10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001532063-18-000004","doc":"esrx-12312017x10k.htm","q":"They also use predictive modeling, machine learning and other analytical tools in the development and improvement of our products and services."}]},{"cik":1532346,"name":"ATRECA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002406","doc":"atre-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001932","doc":"atre-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002785","doc":"bcel-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004916","doc":"bcel-20221231x10k.htm","q":null}]},{"cik":1532383,"name":"VANJIA CORP","industry":"Construction","sic":1531,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001552781-15-000346","doc":"vj10k12312015.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001552781-16-001449","doc":"vj12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001552781-17-000162","doc":"vanjia_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001552781-18-000126","doc":"vj_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001017386-19-000079","doc":"vrc_20181231-10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001017386-20-000068","doc":"vnja_20191231-10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001017386-21-000067","doc":"vnja_10k-20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001017386-22-000066","doc":"vnja_10k-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001017386-23-000078","doc":"vnja_2022dec31-10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001017386-24-000046","doc":"vnja_2023dec31-10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001017386-25-000050","doc":"vnja_2024dec31-10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001017386-26-000019","doc":"vnja_2025dec31-10k.htm","q":null}]},{"cik":1532828,"name":"TRIO RESOURCES, INC.","industry":"Construction","sic":8711,"state":"ON","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-000143","doc":"form10k.htm","q":null}]},{"cik":1533040,"name":"PHIO PHARMACEUTICALS CORP.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-110334","doc":"d856407d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-523721","doc":"d108245d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-102730","doc":"d325199d10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001193125-18-096053","doc":"d488401d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-000795","doc":"phio_10k-123118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-20-000969","doc":"phio_10k-123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-001062","doc":"phio_10k-123120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-001833","doc":"phio_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-001678","doc":"phio_i10k-123122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-002021","doc":"phio_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-002134","doc":"phio_i10k-123124.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001437749-26-007078","doc":"phio20251231_10k.htm","q":"Although we have information security policies and controls in place designed to prevent and protect against unauthorized access, use AI, and disclosure of confidential information, including non-public personal information, there can be no\u2026"}]},{"cik":1533743,"name":"HEATWURX, INC.","industry":"Construction machinery","sic":3531,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000193","doc":"hwux_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-17-000190","doc":"hwux_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001393905-17-000290","doc":"hwux_10k.htm","q":null}]},{"cik":1533743,"name":"PROCESSA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-005248","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-004137","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003534","doc":"form10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006807","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008156","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-009730","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-011976","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-000070","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":3,"adsh":"0001493152-26-011204","doc":"form10-k.htm","q":"In addition, we currently use some artificial intelligence (AI) solutions for certain administrative and other functions."}]},{"cik":1534120,"name":"AVALO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004299","doc":"cerc-20151231x10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001628280-17-002566","doc":"cerc10-k20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003890","doc":"cerc10-k20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-003078","doc":"cerc10-k20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-003395","doc":"cerc10-k20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-004162","doc":"cerc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004671","doc":"avtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009630","doc":"avtx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-013786","doc":"avtx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-013986","doc":"avtx-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":35,"adsh":"0001534120-26-000011","doc":"avtx-20251231.htm","q":"These attacks and activity are also being facilitated or enhanced by evolving technologies, including artificial intelligence."}]},{"cik":1534133,"name":"CALCIMEDICA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011305","doc":"gray-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009728","doc":"gray-10k_20211231.htm","q":null},{"fy":2022,"lvl":2,"n":8,"adsh":"0000950170-23-006795","doc":"gray-20221231.htm","q":"GB-701 is a new chemical entity currently being developed in collaboration with Insilico Medicine, a clinical-stage, end-to-end artificial intelligence (\u201cAI\u201d)-drug discovery company."},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038064","doc":"calc-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-046035","doc":"ck0001534133-20241231.htm","q":"Despite our implementation of security measures, given their size and complexity and the increasing amounts of confidential information that they maintain, our information technology systems and those of our third-party CROs, contractors, c\u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-088147","doc":"ck0001534133-20251231.htm","q":"Our employees, personnel, and third parties with whom we work may use AI and machine learning (\u201cML\u201d) technologies to Our employees, personnel, and third parties with whom we work may use generative artificial intelligence (\u201cAI\u201d) and/or auto\u2026"}]},{"cik":1534154,"name":"AUTHID INC.","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001615774-15-000611","doc":"s100928_10k.htm","q":null},{"fy":2015,"lvl":"x","n":1,"adsh":"0001615774-16-007936","doc":"s104047_10k.htm","q":"Seltzer holds a BS Economics from Brooklyn College, a JD from George Washington University Law Center and an LLM from New York City School of Law."},{"fy":2016,"lvl":1,"n":2,"adsh":"0001615774-17-003593","doc":"s106516_10k.htm","q":"Selzer holds a BS Economics from Brooklyn College, a JD from George Washington University Law Center, an LLM in Taxation from New York University Law School and an LLM from New York City School of Law."},{"fy":2017,"lvl":1,"n":1,"adsh":"0001615774-18-001911","doc":"s109261_10k.htm","q":"Selzer holds a BS Economics from Brooklyn College, a JD from George Washington University Law Center, an LLM in Taxation from New York University Law School."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001615774-19-003800","doc":"s116223_10k.htm","q":"Selzer holds a BS Economics from Brooklyn College, a JD from George Washington University Law Center, an LLM in Taxation from New York University Law School."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001213900-20-007957","doc":"f10k2019_ipsidyinc.htm","q":"Selzer holds a BS Economics from Brooklyn College, a JD from George Washington University Law Center, an LLM in Taxation from New York University Law School."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001213900-21-013989","doc":"f10k2020_ipsidyinc.htm","q":"Selzer holds a BS Economics from Brooklyn College, a JD from George Washington University Law Center, an LLM in Taxation from New York University Law School."},{"fy":2021,"lvl":3,"n":27,"adsh":"0001213900-22-014214","doc":"f10k2021_ipsidyinc.htm","q":"Business Overview Ipsidy Inc. dba authID.ai (together with its subsidiaries, the \u201cCompany\u201d, \u201cauthID.ai\u201d, \u201cwe\u201d or \u201cour\u201d) is a leading provider of secure, mobile, biometric identity verification software products delivered by an easy to integ\u2026"},{"fy":2022,"lvl":"x","n":18,"adsh":"0001213900-23-024677","doc":"f10k2022_authidinc.htm","q":"At its core, the Company\u2019s offering, combining its proprietary and acquired biometric and artificial intelligence technologies (or AI), is intended to facilitate frictionless commerce, whether in the physical or digital world."},{"fy":2023,"lvl":2,"n":9,"adsh":"0001213900-24-024363","doc":"ea0201335-10k_authidinc.htm","q":"Further it is predicted that Artificial Intelligence (AI) will almost certainly increase the volume and heighten the impact of cyberattacks over the next two years (NCSC Assessment, Jan 1, 2024)."},{"fy":2024,"lvl":3,"n":40,"adsh":"0001213900-25-023697","doc":"ea0231860-10k_authid.htm","q":"Global Market Opportunity The momentum towards a digital economy in recent years, accompanied by a massive growth in cyberattacks, fraud, and account takeovers fueled by Artificial Intelligence are driving the demand for more streamlined an\u2026"},{"fy":2025,"lvl":"x","n":48,"adsh":"0001213900-26-037459","doc":"ea0275977-10k_authid.htm","q":"Our Platform Our cloud-based platform was developed with internally developed software as well as acquired and licensed technology and provides the following core services: \u25cf Biometric Identity Verification \u2013 Proof TM \u25cf Biometric Identity A\u2026"}]},{"cik":1534155,"name":"AMERI METRO, INC. (FORMERLY YELLOWWOOD)","industry":"Construction","sic":1600,"state":"PA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001534155-16-000089","doc":"f10k20160731r2.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001534155-18-000012","doc":"f10k20171031.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001534155-19-000020","doc":"ameri10ka20180731r2.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001534155-20-000125","doc":"b10k20190731.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001534155-20-000215","doc":"a10k20200731.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001534155-21-000024","doc":"amgi10k0721.htm","q":null}]},{"cik":1534248,"name":"CHEMOMAB THERAPEUTICS LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2019,"lvl":2,"n":7,"adsh":"0001104659-20-034835","doc":"tm206813d1_10k.htm","q":"Clal Industries Ltd. is wholly owned by Access AI Ltd., which is owned by AI Diversified Holdings S.\u00e0 r.l., which is owned by AI Diversified Parent S.\u00e0 r.l., which is owned by AI Diversified Holdings Limited (\u201cAIDH Limited\u201d)."},{"fy":2020,"lvl":"x","n":6,"adsh":"0001104659-21-033822","doc":"tm211174d1_10k.htm","q":"Clal Industries Ltd. is wholly owned by Access AI Ltd., which is owned by AI Diversified Holdings S.\u00e0 r.l., which is owned by AI Diversified Parent S.\u00e0 r.l., which is owned by AI Diversified Holdings Limited, or AIDH Limited."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001178913-22-001304","doc":"zk2227534.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001178913-23-001041","doc":"zk2329403.htm","q":null}]},{"cik":1534525,"name":"XENETIC BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001019687-15-001465","doc":"xenetic_10k-123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001019687-16-005662","doc":"xenetic_10k-123115.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001683168-17-000749","doc":"xenetic_10k-123116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001683168-18-000831","doc":"xenetic_10k-123117.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-000840","doc":"xenetic_10k-123118.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001683168-20-000967","doc":"xenetic_10k-123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-000969","doc":"xenetic_10k-123120.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-001839","doc":"xenetic_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-001674","doc":"xenetic_i10k-123122.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-24-001594","doc":"xenetic_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-001686","doc":"xenetic_i10k-123124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-001737","doc":"xenetic_i10k-123125.htm","q":null}]},{"cik":1535079,"name":"MCX TECHNOLOGIES CORP","industry":"Software & IT services","sic":7372,"state":"ID","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001002014-15-000128","doc":"tpoi10k-12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001002014-16-000632","doc":"mcx10k-12312015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001437749-17-005781","doc":"mccx20161205_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-005752","doc":"mccx20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-006163","doc":"mccx20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-006337","doc":"mccx20191231_10k.htm","q":null},{"fy":2020,"lvl":"x","n":4,"adsh":"0001437749-21-009014","doc":"mccx20201231_10k.htm","q":"General MCX Technologies Corporation (formerly McorpCX, Inc) (\u201cwe,\u201d \u201cus,\u201d \u201cour,\u201d or the \u201cCompany\u201d) is currently focused on delivering digital transformation solutions to customer-centric organizations through integrated marketing, data scie\u2026"},{"fy":2021,"lvl":"x","n":1,"adsh":"0001437749-22-009043","doc":"mccx20211231_10k.htm","q":"We are currently focused on delivering digital transformation solutions to customer-centric organizations through integrated marketing, data science, analytics, commerce, and machine learning."},{"fy":2022,"lvl":"x","n":0,"adsh":"0001437749-23-008798","doc":"mccx20221231_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-012072","doc":"mccx20231231_10k.htm","q":null}]},{"cik":1535379,"name":"CLOUDERA, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":38,"adsh":"0001628280-18-004005","doc":"fy-18cldr10k.htm","q":"We have developed the modern platform for machine learning and analytics, optimized for the cloud."},{"fy":2018,"lvl":3,"n":45,"adsh":"0001628280-19-003670","doc":"fy-19cldr10k.htm","q":"We empower people to transform data into clear and actionable insights through an integrated suite of data analytics and management products from the Edge to artificial intelligence (AI)."},{"fy":2019,"lvl":3,"n":34,"adsh":"0001628280-20-004231","doc":"cldr-20200131.htm","q":"We deliver a modern enterprise data platform to manage and secure the data lifecycle from the Edge to AI, spanning any cloud or data center."},{"fy":2020,"lvl":3,"n":33,"adsh":"0001628280-21-005632","doc":"cldr-20210131.htm","q":"We deliver an enterprise data cloud for any data, anywhere, from the Edge to AI."}]},{"cik":1535527,"name":"CROWDSTRIKE HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2019,"lvl":"x","n":33,"adsh":"0001535527-20-000006","doc":"crwd-20200131.htm","q":"We turned the tables on the adversaries by taking a fundamentally new approach that leverages the network effects of crowdsourced data applied to modern technologies such as AI, cloud computing, and graph databases."},{"fy":2020,"lvl":3,"n":35,"adsh":"0001535527-21-000007","doc":"crwd-20210131.htm","q":"We turned the tables on the adversaries by taking a fundamentally new approach that leverages the network effects of crowdsourced data applied to modern technologies such as AI, cloud computing, and graph databases."},{"fy":2021,"lvl":3,"n":24,"adsh":"0001535527-22-000006","doc":"crwd-20220131.htm","q":"Using cloud-scale AI, our Security Cloud enriches and correlates trillions of cybersecurity events per week with indicators of attack, threat intelligence and enterprise data (including data from across endpoints, workloads, identities, Dev\u2026"},{"fy":2022,"lvl":3,"n":25,"adsh":"0001535527-23-000008","doc":"crwd-20230131.htm","q":"Using cloud-scale AI, our Security Cloud enriches and correlates trillions of cybersecurity events per week with indicators of attack, threat intelligence and enterprise data (including data from across endpoints, workloads, identities, IT \u2026"},{"fy":2023,"lvl":3,"n":81,"adsh":"0001535527-24-000007","doc":"crwd-20240131.htm","q":"We took a fundamentally different approach to solve this problem with the AI-native CrowdStrike Falcon XDR platform \u2013 the first, true, cloud-native platform built with artificial intelligence (\u201cAI\u201d) at the core, capable of harnessing vast a\u2026"},{"fy":2024,"lvl":3,"n":117,"adsh":"0001535527-25-000009","doc":"crwd-20250131.htm","q":"BUSINESS Overview Founded in 2011, CrowdStrike reinvented cybersecurity for the cloud and artificial intelligence (\u201cAI\u201d) era and transformed the way cybersecurity is delivered and experienced by customers."}]},{"cik":1535955,"name":"LIPOCINE INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-015256","doc":"v401145_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-087232","doc":"v432726_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-012930","doc":"v460000_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-013981","doc":"tv486805_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-012434","doc":"tv514295_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-032764","doc":"tm205342-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-034761","doc":"tm211119d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006353","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007178","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-009127","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493152-25-010146","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-009411","doc":"form10-k.htm","q":null}]},{"cik":1536035,"name":"ROUNDY'S, INC.","industry":"Retail","sic":5411,"state":"WI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-091201","doc":"d839543d10k.htm","q":null}]},{"cik":1536089,"name":"VIRTUAL INTERACTIVE TECHNOLOGIES CORP.","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-036777","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-014885","doc":"form10-k.htm","q":null}]},{"cik":1537663,"name":"HEALTH-RIGHT DISCOVERIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001615774-16-004922","doc":"s103001_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-17-001500","doc":"s105795_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-18-002693","doc":"s109683_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001615774-19-005718","doc":"s117301_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001753926-20-000065","doc":"g081937_10k.htm","q":null}]},{"cik":1537917,"name":"TYME TECHNOLOGIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001161697-16-000766","doc":"form_10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001161697-17-000284","doc":"form_10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-191626","doc":"d574128d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-022300","doc":"tyme-10k_20190331.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-026661","doc":"tyme-10k_20200331.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-032445","doc":"tyme-10k_20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-021213","doc":"tyme-10k_20220331.htm","q":null}]},{"cik":1538210,"name":"NEXIMMUNE, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001538210-22-000008","doc":"nexi-20211231.htm","q":"He has served as chair and a member of the board of directors of IN8bio, Inc., a public biotechnology company, since September 2020; chair and a member of the board of directors of UTILITY therapeutics Ltd., a private biotechnology company,\u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0001538210-23-000007","doc":"nexi-20221231.htm","q":"Some of our collaborations, such as with the target-identifying AI company Zephyr, highlight the potential to validate targets and create therapeutics."},{"fy":2023,"lvl":"x","n":8,"adsh":"0001538210-24-000003","doc":"nexi-20231231.htm","q":"Some of our collaborations, such as with the target-identifying AI company Zephyr, highlight the potential to validate targets and create therapeutics."}]},{"cik":1538495,"name":"EARTH SCIENCE TECH, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-009983","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-015102","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-024029","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-019367","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-021787","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-025578","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-016717","doc":"form10-k.htm","q":null}]},{"cik":1538927,"name":"FORMA THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016642","doc":"fmtx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002527","doc":"fmtx-20211231.htm","q":null}]},{"cik":1539029,"name":"CLEARSIDE BIOMEDICAL, INC.","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004643","doc":"clsd-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006055","doc":"clsd-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007887","doc":"clsd-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010810","doc":"clsd-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013027","doc":"clsd-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003468","doc":"clsd-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007732","doc":"clsd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-030126","doc":"clsd-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-046134","doc":"clsd-20241231.htm","q":null}]},{"cik":1539551,"name":"SPORTS FIELD HOLDINGS, INC.","industry":"Construction","sic":1540,"state":"IL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002779","doc":"f10k2014_sportsfield.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-012432","doc":"f10k2015_sportsfieldhold.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003174","doc":"f10k2016_sportsfieldholdings.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003886","doc":"f10k2017_sportsfieldhold.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005367","doc":"form10-k.htm","q":null}]},{"cik":1539778,"name":"RAYONT, INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-017203","doc":"f10k2018_veltinternational.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-006669","doc":"f10k2019_rayontinc.htm","q":null},{"fy":2020,"lvl":"x","n":1,"adsh":"0001493152-20-023879","doc":"form10-k.htm","q":"With new developments in leading technology such as AI, Gamification and AR/VR, Rayont is looking to be a leader in the corporate learning market."}]},{"cik":1540159,"name":"EDESA BIOTECH, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-15-070753","doc":"v426081_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-16-139528","doc":"v453489_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-17-061791","doc":"tv479298_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-062614","doc":"tv506256_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-19-013878","doc":"edsa_10kt.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-20-013236","doc":"edsa_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-21-013551","doc":"edsa_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-22-016633","doc":"edsa_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-23-015632","doc":"edsa_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001171843-24-006946","doc":"edsa20240930_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001171843-25-007914","doc":"edsa20250930_10k.htm","q":null}]},{"cik":1540184,"name":"MEDALLIA, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2019,"lvl":"x","n":23,"adsh":"0001540184-20-000011","doc":"mdla-20200131.htm","q":"Our SaaS platform, the Medallia Experience Cloud, is built on modern technology and open architecture, utilizing artificial intelligence (AI) and machine learning to analyze massive amounts of data."},{"fy":2020,"lvl":3,"n":26,"adsh":"0001540184-21-000004","doc":"mdla-20210131.htm","q":"Our SaaS (software-as-a-service) platform, the Medallia Experience Cloud, is built on modern technology and open architecture, utilizing artificial intelligence (AI) and machine learning to analyze massive amounts of data."}]},{"cik":1540755,"name":"ANAPLAN, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":10,"adsh":"0001193125-19-092804","doc":"d702600d10k.htm","q":"We continue to invest in artificial intelligence, including machine learning, to further enhance the predictive capabilities of our platform."},{"fy":2019,"lvl":2,"n":13,"adsh":"0001564590-20-014183","doc":"plan-10k_20200131.htm","q":"Our cloud platform offers complex scenario modeling, automated data analysis, machine learning, and predictive and advanced analytical capabilities to help all organizations drive growth and business outcomes, with a focus on large global e\u2026"},{"fy":2020,"lvl":2,"n":10,"adsh":"0001564590-21-012868","doc":"plan-10k_20210131.htm","q":"Our platform also allows customers to leverage intelligent forecasting capabilities backed by machine learning to understand future market drivers, analyze the impact of hypothetical planning scenarios, and quickly pinpoint accurate forecas\u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0001540755-22-000018","doc":"plan-20220131.htm","q":"Our platform also allows customers to leverage intelligent forecasting capabilities backed by machine learning and artificial intelligence to understand future market drivers, analyze the impact of hypothetical planning scenarios, and quick\u2026"}]},{"cik":1541157,"name":"AKARI THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-007770","doc":"v400442_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-089697","doc":"v434647_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-038661","doc":"aktx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-054278","doc":"aktx-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001493152-26-013664","doc":"form10-k.htm","q":"Cyber-attacks also may be further enhanced in frequency or effectiveness through threat actors\u2019 use of artificial intelligence."}]},{"cik":1541165,"name":"ONE 4 ART LTD","industry":"Auto manufacturing","sic":3714,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-001761","doc":"uspo_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001829126-21-005561","doc":"one4art_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001829126-22-005496","doc":"one4art_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001829126-23-002453","doc":"one4art_10ka.htm","q":null}]},{"cik":1542335,"name":"BLACK STALLION OIL & GAS INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-002071","doc":"blkg_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009495","doc":"blkg_10k.htm","q":null}]},{"cik":1543272,"name":"MJ BIOTECH, INC.","industry":"Software & IT services","sic":7370,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001543272-15-000014","doc":"bnbi10k_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001504412-16-000230","doc":"mjtv201510k_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001543272-17-000011","doc":"mjtv2016_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001543272-18-000016","doc":"mjbio10k2017_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001543272-19-000026","doc":"mjb10k2018_10k.htm","q":null}]},{"cik":1543652,"name":"FREE FLOW, INC.","industry":"Construction","sic":1700,"state":"VA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001065949-15-000101","doc":"freeflow10k2014vfinal.txt","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001165527-16-000743","doc":"g8189a.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001165527-17-000077","doc":"g8391.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001165527-18-000049","doc":"g8536.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001165527-19-000059","doc":"g8681.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-20-000786","doc":"fflo_10k.htm","q":null}]},{"cik":1543916,"name":"FORGEROCK, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":12,"adsh":"0001543916-22-000016","doc":"forg-20211231.htm","q":"The ForgeRock Identity Platform includes a full suite of identity management, access management, identity governance, and AI-powered autonomous identity capabilities to serve the CIAM, AM, and IGA needs of enterprises."},{"fy":2022,"lvl":2,"n":13,"adsh":"0001543916-23-000017","doc":"forg-20221231.htm","q":"The ForgeRock Identity Platform includes a full suite of identity management, access management, identity governance, and AI-powered autonomous identity capabilities to serve the CIAM, AM, and IGA needs of enterprises."}]},{"cik":1544227,"name":"TEMPEST THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002286","doc":"a2223498z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001544227-16-000008","doc":"ovas-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001544227-17-000002","doc":"ovas-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001544227-18-000002","doc":"ovas-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002660","doc":"mind-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001544227-20-000004","doc":"mlnd-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001544227-21-000018","doc":"mlnd-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-007717","doc":"tpst-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009237","doc":"tpst-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-033555","doc":"tpst-20231231.htm","q":"Cyberattacks could include wrongful conduct by hostile foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware, denial-of-service attacks, social engineering attacks (including\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-046144","doc":"tpst-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding an executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models to limit drug spendi\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-130490","doc":"tpst-20251231.htm","q":"Cyberattacks could include wrongful conduct by hostile foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware (including as a result of advanced persistent threat intrusions),\u2026"}]},{"cik":1544229,"name":"ENGILITY HOLDINGS, INC.","industry":"Construction","sic":8711,"state":"VA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001544229-15-000008","doc":"egl10-k2014.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001544229-16-000063","doc":"egl10-k15q4.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003880","doc":"egl-10k_20161231.htm","q":null},{"fy":2017,"lvl":1,"n":4,"adsh":"0001564590-18-004252","doc":"egl-10k_20171231.htm","q":null}]},{"cik":1544238,"name":"CARDAX, INC.","industry":"Pharma & biotech","sic":2834,"state":"HI","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-000835","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008455","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003138","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-003937","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004071","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-005021","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008813","doc":"form10-k.htm","q":null}]},{"cik":1544522,"name":"FRESHWORKS INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":6,"adsh":"0001628280-22-003537","doc":"frsh-20211231.htm","q":"Freshservice capabilities increase employee productivity and job satisfaction so that each employee can best contribute to desired business outcomes. 7 Table of Content s Freshservice Freshservice enables organizations to use its AI-powered\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001544522-23-000016","doc":"frsh-20221231.htm","q":"Freshsales also provides configure-price-quote functionality to quickly create quotes and AI-driven pipeline management to help salespeople predict deals performance and make smarter decisions to accelerate the sales cycle."},{"fy":2023,"lvl":3,"n":128,"adsh":"0001544522-24-000012","doc":"frsh-20231231.htm","q":"We deliver modern and innovative AI-guided customer and employee service solutions that enable companies of all sizes to drive delightful engagement and increase productivity."},{"fy":2024,"lvl":3,"n":135,"adsh":"0001544522-25-000010","doc":"frsh-20241231.htm","q":"Business Overview We provide people-first, AI service software that organizations use to deliver exceptional customer and employee experiences."},{"fy":2025,"lvl":3,"n":146,"adsh":"0001544522-26-000036","doc":"frsh-20251231.htm","q":"Business Overview We provide people-first AI service software that organizations use to deliver exceptional employee and customer experiences."}]},{"cik":1546296,"name":"PROFESSIONAL DIVERSITY NETWORK, INC.","industry":"Software & IT services","sic":7370,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001214659-15-002738","doc":"pdn32015010k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001214659-16-010553","doc":"p32916110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001214659-17-002274","doc":"pdn32917010k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-004258","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005364","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-007579","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008401","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-008384","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-010178","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-010111","doc":"ipdn20231231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":20,"adsh":"0001437749-25-010108","doc":"ipdn20241231_10k.htm","q":"According to the University of Georgia's Selig Center for Economic Growth, the combined buying power of African American, Asian American, and Native American consumers represents nearly 17.5% of the total U.S. buying power in 2023, signifyi\u2026"},{"fy":2025,"lvl":3,"n":38,"adsh":"0001437749-26-010515","doc":"ipdn20251231_10k.htm","q":"According to the University of Georgia\u2019s Selig Center for Economic Growth, the combined buying power of African American, Asian American, and Native American consumers represents nearly 17.5% of the total U.S. buying power in 2023, signifyi\u2026"}]},{"cik":1546392,"name":"GAWK INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001640334-16-001154","doc":"gawk_10k-01312016.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-002224","doc":"gawk_10q.htm","q":null}]},{"cik":1546589,"name":"GRAY FOX PETROLEUM CORP.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001096906-15-000717","doc":"grayfox.htm","q":null}]},{"cik":1546853,"name":"SKKYNET CLOUD SYSTEMS, INC.","industry":"Software & IT services","sic":7372,"state":"ON","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-001039","doc":"skky_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-008580","doc":"skky_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-000776","doc":"skky_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-000782","doc":"skky_10k.htm","q":null},{"fy":2018,"lvl":"x","n":1,"adsh":"0001477932-19-000452","doc":"skky_10k.htm","q":null},{"fy":2019,"lvl":"x","n":1,"adsh":"0001477932-20-000603","doc":"skky_10k.htm","q":null},{"fy":2020,"lvl":"x","n":1,"adsh":"0001477932-21-000699","doc":"skky_10k.htm","q":null},{"fy":2021,"lvl":"x","n":1,"adsh":"0001477932-22-000442","doc":"skky_10k.htm","q":null},{"fy":2022,"lvl":"x","n":1,"adsh":"0001477932-23-000586","doc":"skky_10k.htm","q":null},{"fy":2023,"lvl":"x","n":1,"adsh":"0001477932-24-000359","doc":"skky_10k.htm","q":null},{"fy":2024,"lvl":"x","n":25,"adsh":"0001477932-25-000608","doc":"skky_10k.htm","q":"There are other aspects of the same remote capabilities: we have determined a growing need for large enterprise to have the ability to safely share information on operations to third parties (e.g. suppliers, or contract manufacturers), and \u2026"},{"fy":2025,"lvl":"x","n":29,"adsh":"0001477932-26-000435","doc":"skky_10k.htm","q":"There are other aspects of the same remote capabilities: we have determined a growing need for large enterprise to have the ability to safely share information on operations to third parties (e.g. suppliers, or contract manufacturers), and \u2026"}]},{"cik":1547015,"name":"US-DADI FERTILIZER INDUSTRY INTERNATIONAL, INC.","industry":"Construction machinery","sic":3523,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001017386-15-000088","doc":"usdadi_2014dec31-10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001017386-16-000410","doc":"usdadi_2015dec31-10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001830","doc":"usdadi_10k.htm","q":null}]},{"cik":1547459,"name":"NATURAL GROCERS BY VITAMIN COTTAGE, INC.","industry":"Retail","sic":5411,"state":"CO","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-15-021984","doc":"ngvc20150930_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-16-043133","doc":"ngvc20160817_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-17-020347","doc":"ngvc20170930_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-18-021661","doc":"ngvc20180930_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-19-023923","doc":"ngvc20190930_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-20-025108","doc":"ngvc20200930_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-21-028226","doc":"ngvc20210930_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-22-028744","doc":"ngvc20220930_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-23-033880","doc":"ngvc20230930_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-24-037351","doc":"ngvc20240930_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-25-037556","doc":"ngvc20250930_10k.htm","q":null}]},{"cik":1547716,"name":"SUNVAULT ENERGY, INC.","industry":"Utilities","sic":4931,"state":"AB","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-004544","doc":"svlt_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009826","doc":"svlt_10k.htm","q":null}]},{"cik":1548309,"name":"SEARS HOMETOWN & OUTLET STORES, INC.","industry":"Retail","sic":5311,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001548309-15-000009","doc":"sho-13115x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001548309-16-000077","doc":"sho-13016x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001548309-17-000038","doc":"sho-12817x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001548309-18-000062","doc":"sho-020318x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001548309-19-000069","doc":"sho-020219x10k.htm","q":null}]},{"cik":1549595,"name":"NURIX THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-006071","doc":"nrix-10k_20201130.htm","q":"We have built a suite of custom analytical tools including machine learning for interpretation and prioritization of our DEL binder outputs, which routinely contain thousands of productive hits."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-003007","doc":"nrix-10k_20211130.htm","q":"We have built a suite of custom analytical tools including machine learning for interpretation and prioritization of our DEL binder outputs, which routinely contain thousands of productive hits."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001549595-23-000021","doc":"nrix-20221130.htm","q":"We have also developed machine learning and high throughput methods for nanoscale hit resynthesis and affinity selection mass spectroscopy that allow a more comprehensive and industrialized process for finding the best chemical starting poi\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0001549595-24-000025","doc":"nrix-20231130.htm","q":"We have also developed machine learning and high throughput methods for nanoscale hit resynthesis and affinity selection mass spectroscopy that allow a more comprehensive and industrialized process for finding the best chemical starting poi\u2026"},{"fy":2024,"lvl":3,"n":85,"adsh":"0001549595-25-000016","doc":"nrix-20241130.htm","q":"Powered by a fully artificial intelligence (AI)-integrated discovery engine capable of tackling any protein class, and coupled with leading ligase expertise, Nurix has built a significant advantage in translating the science of protein degr\u2026"},{"fy":2025,"lvl":3,"n":84,"adsh":"0001549595-26-000016","doc":"nrix-20251130.htm","q":"Powered by a fully artificial intelligence (AI)-integrated discovery engine capable of tackling any protein class, and coupled with leading ligase expertise, Nurix has built a significant advantage in translating the science of protein degr\u2026"}]},{"cik":1550518,"name":"CANTABIO PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":1,"adsh":"0001424884-17-000049","doc":"cantabio_10k.htm","q":"In 2016, he was appointed a Director of Cognetivity Ltd, a UK based company developing an artificial intelligence driven diagnostic test for dementia."},{"fy":2017,"lvl":"x","n":1,"adsh":"0001654954-18-007670","doc":"a10-kcantabio.htm","q":"In 2016, he was appointed a Director of Cognetivity Ltd, a UK based company developing an artificial intelligence driven diagnostic test for dementia."}]},{"cik":1550737,"name":"SECTOR 5, INC.","industry":"Computers & chips","sic":3571,"state":"VA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-18-000871","doc":"sect_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001732","doc":"sfiv_10k.htm","q":null}]},{"cik":1551152,"name":"ABBVIE INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-000995","doc":"a2223058z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010239","doc":"a2227341z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001551152-17-000004","doc":"abbv-12312016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001551152-18-000014","doc":"abbv-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001551152-19-000008","doc":"abbv-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001551152-20-000007","doc":"abbv-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001551152-21-000008","doc":"abbv-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001551152-22-000007","doc":"abbv-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001551152-23-000011","doc":"abbv-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001551152-24-000011","doc":"abbv-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001551152-25-000020","doc":"abbv-20241231.htm","q":"AbbVie depends on information technology and a failure of, or significant disruption to, those systems, or a failure to adequately adopt emerging technologies such as artificial intelligence, could have a material adverse effect on AbbVie's\u2026"},{"fy":2025,"lvl":2,"n":7,"adsh":"0001551152-26-000008","doc":"abbv-20251231.htm","q":"AbbVie has invested significantly in equipping employees with foundational artificial intelligence (AI) skills, 13 | 2025 Form 10-K reflecting both the opportunities AI presents and its commitment to supporting employees as work evolves."}]},{"cik":1551887,"name":"DUESENBERG TECHNOLOGIES INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000721","doc":"vgrbf_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001393905-17-000017","doc":"vgrbf_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001393905-18-000049","doc":"vgrbf_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001393905-19-000032","doc":"vgrbf_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001393905-20-000034","doc":"vgrbf_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001393905-21-000025","doc":"dusyf_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001393905-22-000041","doc":"dusyf-20211031.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001393905-23-000079","doc":"dusyf-20221031.htm","q":null}]},{"cik":1551986,"name":"9 METERS BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-014481","doc":"tv487458_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001551986-19-000019","doc":"innt1231201810-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001551986-20-000050","doc":"innt1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001551986-21-000033","doc":"nmtr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001551986-22-000030","doc":"nmtr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001551986-23-000021","doc":"nmtr-20221231.htm","q":null}]},{"cik":1552451,"name":"MYOKARDIA INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015044","doc":"myok-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004088","doc":"myok-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004940","doc":"myok-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005543","doc":"myok-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007418","doc":"myok-10k_20191231.htm","q":null}]},{"cik":1553264,"name":"AQUA POWER SYSTEMS INC.","industry":"Utilities","sic":4911,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-042453","doc":"v414556_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-004681","doc":"aquapower_i10k-033122.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-22-004721","doc":"aquapower_i10k-033122.htm","q":null}]},{"cik":1553643,"name":"RELMADA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001213900-15-006928","doc":"f10k2015_relmada.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-17-010097","doc":"f10k2017_relmadatherap.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-013238","doc":"f10k2018_relmadatherapeutics.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-19-018787","doc":"f10k2019_relmadatherapeutics.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-017556","doc":"f10k2020_relmadatherapeutic.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015012","doc":"f10k2021_relmadatherap.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-022463","doc":"f10k2022_relmadatherap.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-024013","doc":"f10k2023_relmadatherap.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001013762-25-003426","doc":"ea0229064-10k_relmada.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-031862","doc":"ea0273255-10k_relmada.htm","q":"Threat actors are increasingly leveraging artificial intelligence and automation to enhance the scale, speed, and effectiveness of these attacks, making them more difficult to detect and prevent."}]},{"cik":1555280,"name":"ZOETIS INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001555280-15-000057","doc":"zoetis-20141231x10kye.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001555280-16-000344","doc":"zoetis-20151231x10kye.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001555280-17-000044","doc":"zoetis-20161231x10kye.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001555280-18-000053","doc":"zoetis-20171231x10kye.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001555280-19-000041","doc":"zoetis-20181231x10kye.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001555280-20-000054","doc":"zoetis-20191231x10kye.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001555280-21-000098","doc":"zts-20201231.htm","q":"Imagyst uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence to deliver rapid testing results to veterinary clinics."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001555280-22-000078","doc":"zts-20211231.htm","q":"Imagyst uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence (AI) to deliver rapid testing results to veterinary clinics."},{"fy":2022,"lvl":1,"n":4,"adsh":"0001555280-23-000074","doc":"zts-20221231.htm","q":"Imagyst uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence (AI) to deliver rapid testing results to veterinary clinics."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001555280-24-000143","doc":"zts-20231231.htm","q":"In 2020, the company launched Vetscan Imagyst \u00ae , which uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence (AI) to deliver rapid testing results to veterinary clinics."},{"fy":2024,"lvl":2,"n":8,"adsh":"0001555280-25-000102","doc":"zts-20241231.htm","q":"In 2023, the company enhanced its Vetscan Imagyst platform by adding artificial intelligence (AI) dermatology and AI fecal for equine, which uses a combination of image recognition technology, algorithms and cloud-based AI to deliver rapid \u2026"},{"fy":2025,"lvl":3,"n":46,"adsh":"0001555280-26-000011","doc":"zts-20251231.htm","q":"In 2023, the company enhanced its Vetscan Imagyst \u00ae platform by adding artificial intelligence (AI) dermatology and AI fecal for equine, which uses a combination of image recognition technology, algorithms and cloud-based AI to deliver rapi\u2026"}]},{"cik":1555492,"name":"FAIRWAY GROUP HOLDINGS CORP","industry":"Retail","sic":5411,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001558370-15-000970","doc":"fwm-20150329x10k.htm","q":null}]},{"cik":1555877,"name":"BOOMER VENTURES INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001372167-15-000162","doc":"boomer10kuly2015.htm","q":null}]},{"cik":1556148,"name":"INFOR, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2015,"lvl":1,"n":2,"adsh":"0001193125-15-236198","doc":"d941033d10kt.htm","q":"Building on Infor 10x, Infor Xi will deliver a major step in achieving the company\u0092s vision for cloud applications that address specific industry needs with responsive design infused with machine-learning and big data analytics."},{"fy":2016,"lvl":1,"n":2,"adsh":"0001193125-16-629549","doc":"d163360d10k.htm","q":"Building on our previous release, Infor 10x, Infor Xi delivers a major step in achieving our vision for cloud applications that address specific industry needs with responsive design infused with machine-learning and big data analytics."},{"fy":2017,"lvl":1,"n":3,"adsh":"0001193125-17-212858","doc":"d303410d10k.htm","q":"Building on our previous release, Infor 10x, Infor Xi delivers a major step in achieving our vision for cloud applications that address specific industry needs with responsive design infused with machine-learning and big data analytics. 29 \u2026"},{"fy":2018,"lvl":2,"n":9,"adsh":"0001193125-18-206521","doc":"d841073d10k.htm","q":"Powered by the cloud, Infor\u0092s complete industry suites incorporate network, analytics, and artificial intelligence (AI) capabilities to make connections across the enterprise and beyond, providing the visibility, insights, and information c\u2026"},{"fy":2019,"lvl":3,"n":21,"adsh":"0001193125-19-180557","doc":"d750655d10k.htm","q":"Coleman is Infor\u0092s enterprise-grade, industry-specific artificial intelligence (AI) platform for our CloudSuite applications, which mines data and uses powerful machine learning to improve processes such as inventory management, transportat\u2026"}]},{"cik":1556263,"name":"SYROS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001938","doc":"syrs-20161231x10k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001558370-18-001860","doc":"syrs-20171231x10k.htm","q":"Patients who relapse following treatment with an AI in combination with a CDK4/6 inhibitor currently have few effective treatment options."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-006610","doc":"syrs-10k_20181231.htm","q":"Patients who relapse following treatment with an AI in combination with a CDK4/6 inhibitor currently have few effective and tolerable treatment options 14 SY-5609 Based on our belief in the broad potential of CDK7 inhibition, we generated a\u2026"},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008795","doc":"syrs-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010709","doc":"syrs-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010214","doc":"syrs-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005702","doc":"syrs-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036808","doc":"syrs-20231231.htm","q":null}]},{"cik":1556898,"name":"TECHPOINT, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005581","doc":"ck0001556898-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007988","doc":"ck0001556898-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010783","doc":"ck0001556898-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012839","doc":"ck1556898-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009800","doc":"ck1556898-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-005632","doc":"ck1556898-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-032070","doc":"ck0001556898-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-033305","doc":"ck0001556898-20241231.htm","q":null}]},{"cik":1557142,"name":"KADMON HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001557142-17-000036","doc":"kdmn-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001557142-18-000021","doc":"kdmn-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001557142-19-000020","doc":"kdmn-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001557142-20-000015","doc":"kdmn-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001557142-21-000022","doc":"kdmn-20201231x10k.htm","q":null}]},{"cik":1557340,"name":"OPTEC INTERNATIONAL, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001271008-15-000061","doc":"gm-10k63015edgar.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001570931-16-000087","doc":"gm-63020152016moreviewr4.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001079973-17-000565","doc":"optec_10k-063017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001079973-18-000551","doc":"optec_10k-063018.htm","q":null}]},{"cik":1557376,"name":"ZEO SCIENTIFIX, INC.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001829126-23-001524","doc":"organicell_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001829126-24-000541","doc":"organicellregen_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001829126-25-000536","doc":"zeoscientifix_10k.htm","q":null}]},{"cik":1557421,"name":"IGNYTA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-089406","doc":"d833843d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-503432","doc":"d102028d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-082031","doc":"d331243d10k.htm","q":null}]},{"cik":1557746,"name":"ACLARIS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004311","doc":"acrs-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001802","doc":"acrs-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001866","doc":"acrs-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002211","doc":"acrs-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001325","doc":"acrs-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001717","doc":"acrs-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001838","doc":"acrs-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001829","doc":"acrs-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-001753","doc":"acrs-20231231x10k.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operation\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001558370-25-001819","doc":"acrs-20241231x10k.htm","q":"During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operation\u2026"},{"fy":2025,"lvl":3,"n":47,"adsh":"0001104659-26-020540","doc":"acrs-20251231x10k.htm","q":"If we are unable to identify successful product candidates for preclinical and clinical development and regulatory approval in a timely matter or at all, we could experience significant delays or an inability to successfully identify and co\u2026"}]},{"cik":1557883,"name":"DERMIRA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002713","doc":"a2223853z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010731","doc":"a2227570z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002872","doc":"derm-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002915","doc":"derm-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004452","doc":"derm-10k_20181231.htm","q":null}]},{"cik":1558465,"name":"PETROGRESS, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001554795-15-000121","doc":"ethg0327form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001554795-16-000639","doc":"pgas0415form10k.htm","q":null}]},{"cik":1558569,"name":"ISPECIMEN INC.","industry":"Pharma & biotech","sic":8731,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001558370-22-004077","doc":"ispc-20211231x10k.htm","q":"As we continue to ingest and generate more data, there are additional business opportunities to leverage this our platform and continue to evolve the iSpecimen Marketplace using modern approaches such as robotic process automation and artif\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001558370-23-004231","doc":"ispc-20221231x10k.htm","q":"As we continue to ingest and generate more data, there are additional business opportunities to leverage our platform and continue to evolve the iSpecimen Marketplace using modern approaches such as robotic process automation and artificial\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0001558370-24-003129","doc":"ispc-20231231x10k.htm","q":"As we continue to ingest and generate more data, there are additional business opportunities to leverage our platform and continue to evolve the iSpecimen Marketplace using modern approaches such as robotic process automation and artificial\u2026"},{"fy":2024,"lvl":"x","n":4,"adsh":"0001213900-25-031639","doc":"ea0237797-10k_ispecimen.htm","q":"As we continue to ingest and generate more data, there are additional business opportunities to leverage our platform and continue to evolve the iSpecimen Marketplace using modern approaches such as robotic process automation and artificial\u2026"},{"fy":2025,"lvl":"x","n":5,"adsh":"0001213900-26-038607","doc":"ea0283252-10k_ispecimen.htm","q":"As we continue to ingest and generate more data, there are additional business opportunities to leverage our platform and continue to evolve the iSpecimen Marketplace using modern approaches such as robotic process automation and artificial\u2026"}]},{"cik":1559053,"name":"PROTHENA CORP PUBLIC LTD CO","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001559053-15-000006","doc":"prta201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001559053-16-000051","doc":"prta201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001559053-17-000005","doc":"prta201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001559053-18-000008","doc":"prta201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001559053-19-000007","doc":"prta201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001559053-20-000005","doc":"prta201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001559053-21-000008","doc":"prta-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001559053-22-000008","doc":"prta-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001559053-23-000005","doc":"prta-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001559053-24-000008","doc":"prta-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001559053-25-000009","doc":"prta-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001559053-26-000008","doc":"prta-20251231.htm","q":null}]},{"cik":1559356,"name":"BIOSTAX CORP.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001354488-15-001524","doc":"tnib_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-008400","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-003099","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004485","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005481","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":1,"adsh":"0001493152-20-008717","doc":"form10-k.htm","q":"Sander previously served as Executive Vice President of Columbia Capital Consulting Group (formerly known as RTC Pacific), an FDIC-registered contractor for financial institutions, from December 2008 to November 2010; Senior Vice President \u2026"},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008834","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-007249","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-011692","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-014710","doc":"form10-k.htm","q":null}]},{"cik":1560241,"name":"G1 THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-002706","doc":"gthx-10k_20171231.htm","q":"Therefore, it is believed that SERDs have the potential to treat ER+ tumors without allowing ligand-independent resistance to develop, and to act on AI- and SERM-resistant ER-positive tumors."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-005520","doc":"gthx-10k_20181231.htm","q":"Therefore, it is believed that SERDs have the potential to treat ER+ tumors without allowing ligand-independent resistance to develop, and to act on AI- and SERM-resistant ER-positive tumors. 8 Currently only one SERD, Faslodex, is approved\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-006846","doc":"gthx-10k_20191231.htm","q":"Therefore, it is believed that SERDs have the potential to treat ER+ tumors without allowing ligand-independent resistance to develop, and to act on AI- and SERM-resistant ER-positive tumors."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-008171","doc":"gthx-10k_20201231.htm","q":"Therefore, it is believed that SERDs have the potential to treat ER+ tumors without allowing ligand-independent resistance to develop, and to act on AI- and SERM-resistant ER-positive tumors."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006299","doc":"gthx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005853","doc":"gthx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001628280-24-007601","doc":"gthx-20231231.htm","q":"Changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, for the treatment of health and patient data, along with increased customer demands for enhanced data security infrastructure, could \u2026"}]},{"cik":1560327,"name":"RAPID7, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-500210","doc":"d114334d10k.htm","q":null},{"fy":2016,"lvl":1,"n":1,"adsh":"0001193125-17-076894","doc":"d319803d10k.htm","q":"With their extensive experience, our team of experts leverage attacker behavior analytics, machine learning algorithms, and threat intelligence to hunt attackers in our customers\u0092 environments."},{"fy":2017,"lvl":1,"n":2,"adsh":"0001560327-18-000032","doc":"rapid710-k.htm","q":"These solutions combine the collection of massive amounts of data with our core analytics and machine-learning-driven user behavioral analytics to simplify the task of identifying and responding to potential breaches. \u2022 Our IT Analytics and\u2026"},{"fy":2018,"lvl":0,"n":0,"adsh":"0001560327-19-000046","doc":"rapid7201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001560327-20-000046","doc":"rp-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001560327-21-000043","doc":"rp-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001560327-22-000026","doc":"rp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001560327-23-000016","doc":"rp-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":41,"adsh":"0001560327-24-000021","doc":"rp-20231231.htm","q":"In today's rapidly evolving IT environment, customers are encountering escalating challenges due to the widening spectrum of attackers and techniques, including the proliferation of cyberattacks leveraging artificial intelligence (\u201cAI\u201d) and\u2026"},{"fy":2024,"lvl":3,"n":45,"adsh":"0001560327-25-000021","doc":"rp-20241231.htm","q":"In today's rapidly evolving IT environment, customers are encountering escalating challenges due to the widening spectrum of attackers and techniques, including the proliferation of cyberattacks leveraging artificial intelligence (\u201cAI\u201d) and\u2026"},{"fy":2025,"lvl":3,"n":54,"adsh":"0001560327-26-000008","doc":"rp-20251231.htm","q":"In today's rapidly evolving IT environment, customers are encountering escalating challenges due to the widening spectrum of attackers and techniques, including the proliferation of cyberattacks leveraging AI."}]},{"cik":1560905,"name":"TORTEC GROUP CORP","industry":"Construction","sic":8711,"state":"WY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001010412-15-000105","doc":"f10kannualreportmarch312015w.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001010412-16-000244","doc":"f10kannualreportmarch312016v.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001010412-17-000052","doc":"f10k033117rb3v082117lwbclean.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001548123-18-000164","doc":"f10kgeopointresourcesinc3311.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001548123-19-000131","doc":"f1269710-kgeopointresourcesc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001548123-20-000089","doc":"f12973tortec10-k3-31-20v7-8-.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001548123-21-000113","doc":"trtk10k0321.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001548123-22-000130","doc":"trtk-20220331.htm","q":null}]},{"cik":1561257,"name":"HELPFUL ALLIANCE CO","industry":"Construction","sic":1531,"state":"FL","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-001910","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004071","doc":"form10-k.htm","q":null}]},{"cik":1561550,"name":"DATADOG, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2019,"lvl":2,"n":8,"adsh":"0001564590-20-006422","doc":"ddog-10k_20191231.htm","q":"Our integrations provide for comprehensive data point aggregation and consistent, up-to-date, high-quality customer experiences across heterogeneous IT environments as they are fully maintained by Datadog. \u2022 Powered by robust analytics and \u2026"},{"fy":2020,"lvl":2,"n":8,"adsh":"0001564590-21-009770","doc":"ddog-10k_20201231.htm","q":"Our integrations provide for comprehensive data point aggregation and consistent, up-to-date, high-quality customer experiences across heterogeneous IT environments as they are fully maintained by Datadog. \u2022 Powered by robust analytics and \u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0001561550-22-000009","doc":"ddog-20211231.htm","q":"Our integrations provide for comprehensive data point aggregation and consistent, up-to-date, high-quality customer experiences across heterogeneous IT environments as they are fully maintained by Datadog. \u2022 Powered by robust analytics and \u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001561550-23-000006","doc":"ddog-20221231.htm","q":"Our integrations provide for comprehensive data point aggregation and consistent, up-to-date, high-quality customer experiences across heterogeneous IT environments as they are fully maintained by Datadog. \u2022 Powered by robust machine-learni\u2026"},{"fy":2023,"lvl":3,"n":33,"adsh":"0001561550-24-000009","doc":"ddog-20231231.htm","q":"Our integrations provide for comprehensive data point aggregation and consistent, up-to-date, high-quality customer experiences across heterogeneous IT environments as they are fully maintained by Datadog. \u2022 Powered by robust machine-learni\u2026"},{"fy":2024,"lvl":3,"n":49,"adsh":"0001561550-25-000025","doc":"ddog-20241231.htm","q":"In 2024, we launched Event Management to aggregate and consolidate alerts to accelerate remediation, and LLM Observability to help customers investigate how they can safely deploy and manage their models in production."},{"fy":2025,"lvl":3,"n":67,"adsh":"0001628280-26-008819","doc":"ddog-20251231.htm","q":"Business Overview Datadog is the AI-powered observability and security platform for cloud applications."}]},{"cik":1561551,"name":"ENUMERAL BIOMEDICAL HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001615774-15-000522","doc":"s100870_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001615774-16-004680","doc":"s102860_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-17-001281","doc":"s105622_10k.htm","q":null}]},{"cik":1561660,"name":"PATTERN ENERGY GROUP INC.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-073104","doc":"d842437d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-011961","doc":"pegi2015123110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001561660-17-000029","doc":"pegi2016123110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001561660-18-000033","doc":"pegi2017123110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001561660-19-000036","doc":"pegi2018123110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001561660-20-000027","doc":"pegi2019123110k.htm","q":null}]},{"cik":1561680,"name":"TRI POINTE HOMES, INC.","industry":"Construction","sic":1531,"state":"NV","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001605","doc":"tph-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013570","doc":"tph-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001561680-17-000008","doc":"tph1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001561680-18-000015","doc":"tph1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001561680-19-000022","doc":"tph1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001561680-20-000021","doc":"tph1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001561680-21-000023","doc":"tph-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001561680-22-000009","doc":"tph-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001561680-23-000015","doc":"tph-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001561680-24-000017","doc":"tph-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001561680-25-000029","doc":"tph-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001561680-26-000008","doc":"tph-20251231.htm","q":null}]},{"cik":1561743,"name":"KINDRED BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001561743-15-000013","doc":"kindredbio201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001561743-16-000051","doc":"kindredbio201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001561743-17-000008","doc":"kindredbio201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001561743-18-000026","doc":"kindredbio201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001561743-19-000030","doc":"kindredbio201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001561743-20-000009","doc":"kindredbio201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001561743-21-000024","doc":"kin-20201231.htm","q":null}]},{"cik":1562088,"name":"DUOLINGO, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2021,"lvl":2,"n":14,"adsh":"0001562088-22-000039","doc":"duol-20211231.htm","q":"Our products are powered by sophisticated data analytics and artificial intelligence that make it easier for learners to stay motivated, master new material, and achieve their learning goals."},{"fy":2022,"lvl":3,"n":38,"adsh":"0001562088-23-000052","doc":"duol-20221231.htm","q":"Our products are powered by sophisticated data analytics and artificial intelligence and delivered with world-class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning\u2026"},{"fy":2023,"lvl":3,"n":99,"adsh":"0001562088-24-000050","doc":"duol-20231231.htm","q":"Our products are powered by sophisticated data analytics and AI and delivered with world-class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning goals."},{"fy":2024,"lvl":3,"n":128,"adsh":"0001562088-25-000042","doc":"duol-20241231.htm","q":"Our products are powered by sophisticated data analytics and AI and delivered with world-class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning goals."},{"fy":2025,"lvl":3,"n":127,"adsh":"0001628280-26-012494","doc":"duol-20251231.htm","q":"Our products are powered by sophisticated data analytics and AI and delivered with world-class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning goals."}]},{"cik":1562476,"name":"TAYLOR MORRISON HOME CORP","industry":"Construction","sic":1531,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-070090","doc":"d839495d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001562476-16-000005","doc":"tmhc-123115x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-001498","doc":"tmhc-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-001960","doc":"tmhc-123117x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-001592","doc":"tmhc-123118x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-001799","doc":"tmhc-123119x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003044","doc":"tmhc-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-003466","doc":"tmhc-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004524","doc":"tmhc-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-017842","doc":"tmhc-20231231.htm","q":"Our full suite of online shopping products includes: an artificial intelligence enhanced chatbot to help provide information, engage the shopper, and leads; online self-service appointments to help customers schedule an appointment with eas\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-006416","doc":"tmhc-20241231.htm","q":"Our full suite of online shopping products includes: an artificial intelligence enhanced chatbot to help provide information, engage the shopper, and generate leads; online self-service appointments to help customers schedule an appointment\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001628280-26-009030","doc":"tmhc-20251231.htm","q":"Our full suite of online shopping products includes: online self-service appointments to help customers schedule an appointment with ease; self-guided tours to enable customers to tour our homes privately, safely, and outside of normal busi\u2026"}]},{"cik":1563190,"name":"COMPASS, INC.","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2021,"lvl":3,"n":17,"adsh":"0001193125-22-058265","doc":"d82155d10k.htm","q":"The platform also uses proprietary data, analytics, artificial intelligence, and machine learning to deliver high value recommendations and outcomes for Compass agents and their clients."},{"fy":2022,"lvl":3,"n":16,"adsh":"0001563190-23-000038","doc":"comp-20221231.htm","q":"The platform also uses proprietary data, analytics, artificial intelligence, and machine learning to deliver high-value recommendations and outcomes for Compass agents and their clients."},{"fy":2023,"lvl":3,"n":49,"adsh":"0001563190-24-000039","doc":"comp-20231231.htm","q":"Our platform also uses proprietary data, analytics, AI, and machine learning to simplify workflows of agents and deliver high-value recommendations and outcomes for both agents and their clients."},{"fy":2024,"lvl":3,"n":46,"adsh":"0001563190-25-000050","doc":"comp-20241231.htm","q":"The Compass platform also uses proprietary data, analytics, AI, and machine learning to simplify workflows of agents and deliver high-value recommendations and outcomes for both agents and their clients."}]},{"cik":1563407,"name":"SMART & FINAL STORES, INC.","industry":"Retail","sic":5411,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002730","doc":"a2223829z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011125","doc":"a2227596z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001703","doc":"a2231069z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001719","doc":"a2234755z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001282","doc":"a2237977z10-k.htm","q":null}]},{"cik":1563568,"name":"ENVIROTECH VEHICLES, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001171843-18-001854","doc":"f10k_031218p.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003196","doc":"adom-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009553","doc":"adom-10k_20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001564590-21-017115","doc":"adom-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-120451","doc":"d240582d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-026704","doc":"adom20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-009818","doc":"adom20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-012095","doc":"adom20241231_10k.htm","q":null},{"fy":2025,"lvl":"x","n":79,"adsh":"0001437749-26-012170","doc":"adom20251231_10k.htm","q":"We are also exploring opportunities to develop and deploy energy-integrated artificial intelligence (\u201cAI\u201d) compute infrastructure."}]},{"cik":1563577,"name":"GALERA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009542","doc":"grtx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012244","doc":"grtx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003292","doc":"grtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006588","doc":"grtx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037614","doc":"grtx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-047798","doc":"grtx-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":2,"adsh":"0001563577-26-000005","doc":"grtx-20251231.htm","q":null}]},{"cik":1563855,"name":"SOPHIRIS BIO INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001437749-15-004644","doc":"sphs20141231_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001437749-16-028559","doc":"sphs20151231_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001437749-17-005320","doc":"sphs20161231_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001437749-18-005174","doc":"sphs20171231_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001437749-19-004801","doc":"sphs20181231_10k.htm","q":null}]},{"cik":1563880,"name":"TREVI THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010996","doc":"trvi-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015506","doc":"trvi-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010875","doc":"trvi-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008472","doc":"trvi-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0000950170-24-034167","doc":"trvi-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":11,"adsh":"0000950170-25-041194","doc":"trvi-20241231.htm","q":"In an effort to deter and detect cyber threats, we annually provide all employees, including part-time and temporary employees, with a data protection, cybersecurity training and compliance program, which covers timely and relevant topics, \u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-110783","doc":"trvi-20251231.htm","q":"In an effort to deter and detect cyber threats, we annually provide all employees, including part-time and temporary employees, with a data protection, cybersecurity training and compliance program, which covers timely and relevant topics, \u2026"}]},{"cik":1563922,"name":"GREENBACKER RENEWABLE ENERGY CO LLC","industry":"Utilities","sic":4911,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001615774-15-000539","doc":"s100851_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001615774-16-004441","doc":"s102627_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001615774-17-000937","doc":"s105256_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001615774-18-001699","doc":"s109009_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001615774-19-003864","doc":"s115843_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-006368","doc":"f10k2019_greenbackerrenew.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-005446","doc":"cik0001563922-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001563922-22-000005","doc":"cik0001563922-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001563922-23-000002","doc":"cik0001563922-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001563922-24-000001","doc":"cik0001563922-20231231.htm","q":"We utilize automation and artificial intelligence enabled tools to address threats."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001563922-25-000004","doc":"cik0001563922-20241231.htm","q":"With the continued emergence of artificial intelligence and growth in cloud computing, technology, companies are investing heavily in data center development, significantly increasing the electricity demand."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001563922-26-000006","doc":"cik0001563922-20251231.htm","q":"Expanding data center activity, driven by advances in cloud computing and artificial intelligence, has also contributed to higher electricity demand."}]},{"cik":1564273,"name":"IMMAGE BIOTHERAPEUTICS CORP.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-16-002184","doc":"immg_10k.htm","q":null}]},{"cik":1564408,"name":"SNAP INC","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-002721","doc":"snap-10k_20171231.htm","q":"In addition, in 2016, we acquired all outstanding shares of a research and development-driven computer vision software company and substantially all of the assets of various companies that specialize in the areas of software and advertising\u2026"},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-002053","doc":"snap-10k_20181231.htm","q":"In addition, in 2016, we acquired all outstanding shares of a research and development-driven computer vision software company and substantially all of the assets of various companies that specialize in the areas of software and advertising\u2026"},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-003323","doc":"snap-10k_20191231.htm","q":"Business Acquisitions and Divestitures 2019 Acquisitions and Divestiture AI Factory, Inc."},{"fy":2020,"lvl":2,"n":5,"adsh":"0001564590-21-004377","doc":"snap-10k_20201231.htm","q":"Snap Ads include the following: \u25cf Single Image or Video Ads: These are full screen ads that are skippable, and can contain an attachment to enable Snapchatters to swipe up and take action. \u25cf Story Ads: Story Ads are branded tiles that live \u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001564590-22-003868","doc":"snap-10k_20211231.htm","q":"Snap Ads include the following: \u2022 Single Image or Video Ads: These are full screen ads that are skippable, and can contain an attachment to enable Snapchatters to swipe up and take action. \u2022 Story Ads: Story Ads are branded tiles that live \u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0001564408-23-000013","doc":"snap-20221231.htm","q":"Snap Ads include the following: \u2022 Single Image or Video Ads: These are full screen ads that are skippable, and can contain an attachment to enable Snapchatters to swipe up and take action. 7 Table of Contents \u2022 Story Ads: Story Ads are bran\u2026"},{"fy":2023,"lvl":3,"n":37,"adsh":"0001564408-24-000019","doc":"snap-20231231.htm","q":"We also offer My AI, our AI-powered chatbot, which helps our community foster creativity and connection with friends, receive real-world recommendations, and learn more about their interests and favorite subjects."},{"fy":2024,"lvl":3,"n":45,"adsh":"0001564408-25-000019","doc":"snap-20241231.htm","q":"We also offer My AI, our AI-powered chatbot, which helps our community foster creativity and connection with friends, receive real-world recommendations, and learn more about their interests and favorite subjects."},{"fy":2025,"lvl":3,"n":79,"adsh":"0001564408-26-000013","doc":"snap-20251231.htm","q":"We also offer My AI, our AI-powered chatbot, which helps our community foster creativity and connection with friends, receive real-world recommendations, and learn more about their interests and favorite subjects."}]},{"cik":1564824,"name":"ALLAKOS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007820","doc":"allk-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006408","doc":"allk-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009651","doc":"allk-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002542","doc":"allk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006248","doc":"allk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-031516","doc":"allk-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-037933","doc":"allk-20241231.htm","q":null}]},{"cik":1565337,"name":"TEXTURA CORP","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001565337-15-000012","doc":"txtr10k123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001565337-16-000140","doc":"txtr10k123115.htm","q":null}]},{"cik":1565687,"name":"INTAPP, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2022,"lvl":3,"n":15,"adsh":"0001564590-22-031398","doc":"inta-10k_20220630.htm","q":"The platform facilitates greater team collaboration, digitizes complex workflows to optimize deal and engagement execution, and leverages proprietary AI to help nurture relationships and originate new business."},{"fy":2023,"lvl":3,"n":59,"adsh":"0000950170-23-047051","doc":"inta-20230630.htm","q":"The platform facilitates greater team collaboration, digitizes complex workflows to optimize deal and engagement execution, and leverages proprietary AI to help nurture relationships and originate new business."},{"fy":2024,"lvl":3,"n":113,"adsh":"0000950170-24-100587","doc":"inta-20240630.htm","q":"Overview Intapp is a leading global provider of AI-powered solutions for professionals at advisory, capital markets and legal firms."},{"fy":2025,"lvl":3,"n":144,"adsh":"0001193125-25-184080","doc":"inta-20250630.htm","q":"Overview We are a leading global provider of AI-powered solutions for the world\u2019s premier accounting, consulting, investment banking, legal, private capital and real assets firms."}]},{"cik":1566044,"name":"VYNE THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-003726","doc":"mnlo12311710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005451","doc":"mnlo-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008442","doc":"mnlo-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001566044-21-000010","doc":"vyne-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-006545","doc":"vyne-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-007900","doc":"vyne-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0001628280-24-008178","doc":"vyne-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0001628280-25-010908","doc":"vyne-20241231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (\u2026"},{"fy":2025,"lvl":3,"n":24,"adsh":"0001566044-26-000002","doc":"vyne-20251231.htm","q":"The ever-increasing use and evolution of technology, including cloud-based computing and proliferation of artificial intelligence, creates opportunities for the unintentional dissemination or intentional destruction of confidential informat\u2026"}]},{"cik":1566049,"name":"ARCTURUS THERAPEUTICS LTD.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008092","doc":"arct-10k_20181231.htm","q":null}]},{"cik":1566265,"name":"AXIOM CORP.","industry":"Construction","sic":1540,"state":"ON","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001294606-15-000070","doc":"axiomcorp-form10kfor2014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-011957","doc":"f10k2015_axiomcorp.htm","q":null}]},{"cik":1566373,"name":"F-STAR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001545","doc":"sbph-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002474","doc":"sbph-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007078","doc":"sbph-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004684","doc":"sbph-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-100530","doc":"d77314d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003650","doc":"fstx-20211231.htm","q":null}]},{"cik":1566895,"name":"NCINO, INC.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2020,"lvl":"x","n":13,"adsh":"0001566895-21-000007","doc":"ncno-20210131.htm","q":"Our solution, the nCino Bank Operating System\u00ae, digitizes, automates, and streamlines inefficient and complex processes and workflow and utilizes data analytics and artificial intelligence and machine learning (\"AI/ML\") to enable financial \u2026"}]},{"cik":1567094,"name":"CNH INDUSTRIAL N.V.","industry":"Construction machinery","sic":3531,"state":null,"cells":[{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-23-005522","doc":"cnhi-20221231.htm","q":"Our technology stack includes satellite guided positioning, telemetric connectivity, automation software, ruggedized sensors and cross validation/machine learning aided by edge and cloud computing."},{"fy":2023,"lvl":2,"n":5,"adsh":"0001628280-24-007899","doc":"cnhi-20231231.htm","q":"Their technology utilizes edge computing, computer vision, and machine learning and translates images into agronomic insights."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001628280-25-009007","doc":"cnhi-20241231.htm","q":"Further, we utilize automation and machine learning and artificial intelligence in some of our products."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001567094-26-000006","doc":"cnhi-20251231.htm","q":"The Company's \"Iron + Tech\" strategy aims to advance product leadership and technology integration by: \u2022 Expanding full line offerings across harvesters, tractors, crop protection, and production equipment. \u2022 Internalizing foundational tech\u2026"}]},{"cik":1567098,"name":"LUCKWEL PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001185185-17-001459","doc":"luckycom10k033117.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-009999","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-010056","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-21-014053","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-022312","doc":"0001493152-21-022312.txt","q":null}]},{"cik":1567264,"name":"INTENSITY THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CT","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-011207","doc":"intensity-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001567264-25-000010","doc":"intensity-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001567264-26-000024","doc":"intensity-20251231.htm","q":null}]},{"cik":1567514,"name":"INTRA-CELLULAR THERAPIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-089426","doc":"d857051d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478475","doc":"d101832d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-065749","doc":"d285960d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-067144","doc":"d518852d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-054119","doc":"d678830d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-057888","doc":"d863619d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-055751","doc":"d106177d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-059849","doc":"d234590d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-055176","doc":"d436875d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-006156","doc":"itci-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-006993","doc":"itci-20241231.htm","q":null}]},{"cik":1567683,"name":"CLEARWAY ENERGY, INC.","industry":"Utilities","sic":4911,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001567683-15-000003","doc":"yieldinc1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001567683-16-000031","doc":"yieldinc1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001567683-17-000010","doc":"yieldinc201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001567683-18-000008","doc":"yieldinc201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001567683-19-000014","doc":"clearwayinc201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001567683-20-000008","doc":"clearwayinc201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001567683-21-000009","doc":"cwen-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001567683-22-000006","doc":"cwen-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001567683-23-000011","doc":"cwen-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001567683-24-000007","doc":"cwen-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001567683-25-000007","doc":"cwen-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-010952","doc":"cwen-20251231.htm","q":null}]},{"cik":1567892,"name":"KEENOVA THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001567892-15-000047","doc":"mnk10-k92515.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001567892-16-000098","doc":"mnk10-k93016.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001567892-18-000010","doc":"mnk10-k122917.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001567892-19-000009","doc":"mnk10-k122818.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001567892-20-000005","doc":"mnk10-k122719.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001567892-21-000011","doc":"mnk-20201225.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001567892-22-000007","doc":"mnk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001567892-23-000014","doc":"mnk-20221230.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001567892-24-000008","doc":"mnk-20231229.htm","q":"However, we have been the target of previous cyber attacks and anticipate we will continue to face risks of incidents through various types of attacks, including those using sophisticated techniques and evolving technologies such as artific\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001567892-25-000010","doc":"mnk-20241227.htm","q":"As with all information technology, our systems are vulnerable to potential damage or interruptions from natural disasters, power outages, telecommunications failures and other unexpected events, as well as physical and cyber intrusions, sa\u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001628280-26-025238","doc":"mnk-20251231.htm","q":"As with all information technology, our systems are vulnerable to potential damage or interruptions from natural disasters, power outages, telecommunications failures and other unexpected events, as well as physical and cyber intrusions, sa\u2026"}]},{"cik":1567900,"name":"BLACKBOXSTOCKS INC.","industry":"Software & IT services","sic":7371,"state":"TX","cells":[{"fy":2018,"lvl":"x","n":3,"adsh":"0001010549-19-000088","doc":"blackbox10k.htm","q":"Our Blackbox System platform employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that can result in the rapid change in a stock\u2019s price."},{"fy":2019,"lvl":"x","n":3,"adsh":"0001437749-20-007802","doc":"blkbx20191231_10k.htm","q":"Our Blackbox System platform employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that can result in the rapid change in a stock\u2019s price."},{"fy":2020,"lvl":"x","n":3,"adsh":"0001437749-21-007800","doc":"blkbx20201231_10k.htm","q":"Our web-based software (the \u201cBlackbox System\u201d) employs \u201cpredictive technology\u201d enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in the price of a stock or option."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001437749-22-007867","doc":"blkbx20211231_10k.htm","q":"Our web-based software (the \u201cBlackbox System\u201d) employs \u201cpredictive technology\u201d enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in the price of a stock or option."},{"fy":2022,"lvl":"x","n":3,"adsh":"0001437749-23-010333","doc":"blkbx20221231_10k.htm","q":"Our web-based platform and native iOS and Android applications (the \u201cBlackbox System\u201d) employ \u201cpredictive technology\u201d enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in \u2026"},{"fy":2023,"lvl":"x","n":3,"adsh":"0001437749-24-010302","doc":"blkbx20231231_10k.htm","q":"Our web-based platform and native iOS and Android applications (the \u201cBlackbox System\u201d) employ \u201cpredictive technology\u201d enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in \u2026"},{"fy":2024,"lvl":"x","n":3,"adsh":"0001437749-25-008773","doc":"blkbx20241231_10k.htm","q":"Our web-based platform and native iOS and Android applications (the \u201cBlackbox System\u201d) employ \u201cpredictive technology\u201d enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in \u2026"}]},{"cik":1568100,"name":"PAGERDUTY, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2019,"lvl":"x","n":8,"adsh":"0001568100-20-000013","doc":"pagerdutyq42020-10k.htm","q":"Using machine learning and automation, we bring together the right people with the right information so they can resolve issues and act on opportunities in minutes and seconds, not hours."},{"fy":2020,"lvl":2,"n":12,"adsh":"0001568100-21-000011","doc":"pd-20210131.htm","q":"It sits at the center of a company\u2019s digital ecosystem ingesting signals and using machine learning and automation to prevent and automate real time work, predict and avoid downtime."},{"fy":2021,"lvl":3,"n":15,"adsh":"0001568100-22-000014","doc":"pd-20220131.htm","q":"We collect data and digital signals from virtually any software-enabled system or device and leverage powerful machine learning to correlate, process, and predict opportunities and issues."},{"fy":2022,"lvl":3,"n":16,"adsh":"0001568100-23-000013","doc":"pd-20230131.htm","q":"We collect data and digital signals from virtually any software-enabled system or device and leverage powerful machine learning to correlate, process, and predict opportunities and issues."},{"fy":2023,"lvl":3,"n":57,"adsh":"0001568100-24-000013","doc":"pd-20240131.htm","q":"We collect data and digital signals from virtually any software-enabled system or device and leverage powerful machine learning (ML) to correlate, process, and predict opportunities and incidents."},{"fy":2024,"lvl":3,"n":96,"adsh":"0001568100-25-000023","doc":"pd-20250131.htm","q":"The PagerDuty Operations Cloud combines artificial intelligence (\u201cAI\u201d) operations (\u201cAIOps\u201d), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platf\u2026"}]},{"cik":1568385,"name":"BRIGHT MOUNTAIN MEDIA, INC.","industry":"Software & IT services","sic":7371,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001553350-15-000306","doc":"bmaq_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001553350-16-001760","doc":"bmtm_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001553350-17-000347","doc":"bmtm_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001553350-18-000282","doc":"bmtm_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-004348","doc":"bmtm_10k.htm","q":null},{"fy":2019,"lvl":1,"n":3,"adsh":"0001493152-20-008847","doc":"form10-k.htm","q":"Leveraging machine learning data, S&W provides technology for content creators to deploy, distribute, and monetize their content."},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-032437","doc":"form10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-016601","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":1,"n":4,"adsh":"0001628280-23-009609","doc":"bmtm-20221231.htm","q":"Programmatic advertising relies on artificial intelligence powered software programs that leverage data and proprietary algorithms to match the optimal selection of an ad with bid price offered by advertisers."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001628280-24-014146","doc":"bmtm-20231231.htm","q":"Artificial intelligence has the potential to exacerbate cybersecurity threats, increasing their frequency and sophistication."},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-036193","doc":"bmtm-20241231.htm","q":"Artificial intelligence has the potential to exacerbate cybersecurity threats, increasing their frequency and sophistication."},{"fy":2025,"lvl":3,"n":19,"adsh":"0001193125-26-121933","doc":"bmtm-20251231.htm","q":"Artificial intelligence has the potential to exacerbate cybersecurity threats, increasing their frequency and sophistication."}]},{"cik":1568628,"name":"BIOQUEST CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-019755","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-022442","doc":"form10-k.htm","q":null}]},{"cik":1568969,"name":"APPYEA, INC","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001640334-15-000255","doc":"appyea_10k-06302015.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-16-001748","doc":"appyea_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-17-002176","doc":"appyea_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-18-001936","doc":"apyp_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-19-002076","doc":"apyp_10k.htm","q":null},{"fy":2022,"lvl":"x","n":8,"adsh":"0001493152-23-009907","doc":"form10-k.htm","q":"Our solutions are based on our proprietary intellectual property portfolio comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other physical parameters during slee\u2026"},{"fy":2023,"lvl":"x","n":8,"adsh":"0001493152-24-012283","doc":"form10-k.htm","q":"Our solutions are based on our proprietary intellectual property portfolio comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other physical parameters during slee\u2026"},{"fy":2024,"lvl":"x","n":8,"adsh":"0001641172-25-004834","doc":"form10-k.htm","q":"Our solutions are based on our proprietary intellectual property portfolio comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other physical parameters during slee\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001493152-26-016968","doc":"form10-k.htm","q":"Our solutions in the digital health area are based on our proprietary intellectual property portfolio comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other phys\u2026"}]},{"cik":1569055,"name":"STL MARKETING GROUP, INC.","industry":"Utilities","sic":4911,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001573","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-16-009073","doc":"form10-k.htm","q":null}]},{"cik":1569340,"name":"CELL SOURCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-015954","doc":"v401669_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001165527-16-000733","doc":"g8190a.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001165527-18-000154","doc":"g8593.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001165527-19-000034","doc":"g8673.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-20-000672","doc":"clcs_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-21-000923","doc":"clcs_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-010133","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-027069","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-024903","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-26-015359","doc":"form10-k.htm","q":null}]},{"cik":1569345,"name":"SPRINKLR, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":"x","n":76,"adsh":"0001569345-22-000006","doc":"cxm-20220131.htm","q":"We do this with a new category of enterprise software \u2013 Unified Customer Experience Management (\u201cUnified-CXM\u201d) \u2013 that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across int\u2026"},{"fy":2022,"lvl":3,"n":74,"adsh":"0001569345-23-000023","doc":"cxm-20230131.htm","q":"We do this with a new category of enterprise software \u2013 Unified Customer Experience Management (\u201cUnified-CXM\u201d) \u2013 that enables every customer-facing function across the front office, from Customer Service to Marketing, to collaborate across \u2026"},{"fy":2023,"lvl":3,"n":202,"adsh":"0001569345-24-000019","doc":"cxm-20240131.htm","q":"We do this with a new category of enterprise software \u2013 Unified Customer Experience Management (\u201cUnified-CXM\u201d) \u2013 that enables customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate acros\u2026"},{"fy":2024,"lvl":3,"n":282,"adsh":"0001569345-25-000019","doc":"cxm-20250131.htm","q":"We do this with our evolving enterprise software \u2013 Unified Customer Experience Management (\u201cUnified-CXM\u201d) \u2013 that enables customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across dig\u2026"}]},{"cik":1570562,"name":"EVOLUS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001570562-19-000038","doc":"evolus12311810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001570562-20-000061","doc":"evolus12311910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001570562-21-000093","doc":"eols-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001570562-22-000067","doc":"eols-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001570562-23-000038","doc":"eols-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001570562-24-000041","doc":"eols-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001570562-25-000020","doc":"eols-20241231.htm","q":"The risk of a security incident or system disruption, particularly through cybersecurity incidents, including by computer hackers, foreign governments and cybercriminals, has generally increased as the number, intensity and sophistication o\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001628280-26-014001","doc":"eols-20251231.htm","q":"The risk of a security incident or system disruption, particularly through cybersecurity incidents, including by computer hackers, foreign governments and cybercriminals, has generally increased as the number, intensity and sophistication o\u2026"}]},{"cik":1571274,"name":"CONTINENTAL CEMENT COMPANY, L.L.C.","industry":"Construction","sic":1540,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-058330","doc":"d840623d10k.htm","q":null}]},{"cik":1571371,"name":"SUMMIT MATERIALS, LLC","industry":"Construction","sic":1540,"state":"DC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-058310","doc":"d840621d10k.htm","q":null}]},{"cik":1571498,"name":"EPIZYME, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-088459","doc":"d869037d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-497434","doc":"d114608d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-079460","doc":"d336387d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005397","doc":"epzm-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004237","doc":"epzm-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007398","doc":"epzm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007292","doc":"epzm-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002552","doc":"epzm-20211231.htm","q":null}]},{"cik":1571636,"name":"NANOFLEX POWER CORP","industry":"Computers & chips","sic":3674,"state":"AZ","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003462","doc":"f10k2017_nanoflexpower.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-006455","doc":"f10k2018_nanoflexpower.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-006414","doc":"f10k2019_nanoflexpower.htm","q":null}]},{"cik":1571934,"name":"SYNAPTOGENIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-043923","doc":"tm2110636d1_10k.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001410578-22-000610","doc":"snpx-20211231x10k.htm","q":"On August 5, 2021, the Company announced its memorandum of understanding with Nemours A.I."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001410578-23-000319","doc":"snpx-20221231x10k.htm","q":"On August 5, 2021, the Company announced its memorandum of understanding with Nemours A.I."},{"fy":2023,"lvl":1,"n":3,"adsh":"0001410578-24-000410","doc":"snpx-20231231x10k.htm","q":"Nemours Agreement On September 5, 2018, we announced a collaboration with Nemours A.I."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001410578-25-000518","doc":"snpx-20241231x10k.htm","q":"Nemours Agreement On September 5, 2018, we announced a collaboration with Nemours A.I."}]},{"cik":1571996,"name":"DELL TECHNOLOGIES INC.","industry":"Computers & chips","sic":3571,"state":"TX","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001571996-17-000004","doc":"delltechnologiesfy1710k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001571996-18-000004","doc":"delltechnologiesfy1810k.htm","q":"Our investment areas include storage, software-defined networking, management and orchestration, security, machine learning and artificial intelligence, Big Data and analytics, cloud, Internet of Things, and software development operations."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001571996-19-000008","doc":"delltechnologiesfy1910k.htm","q":"Our investment areas include storage, software-defined networking, management and orchestration, security, machine learning and artificial intelligence, Big Data and analytics, cloud, Internet of Things (\u201cIoT\u201d), and software development ope\u2026"},{"fy":2019,"lvl":"x","n":6,"adsh":"0001571996-20-000017","doc":"delltechnologiesfy2010k.htm","q":"Our server portfolio includes high-performance rack, blade, tower, and hyperscale servers, optimized for artificial intelligence and machine learning workloads."},{"fy":2020,"lvl":2,"n":9,"adsh":"0001571996-21-000007","doc":"dell-20210129.htm","q":"Our server portfolio includes high-performance rack, blade, tower, and hyperscale servers, optimized for artificial intelligence and machine learning workloads."},{"fy":2021,"lvl":2,"n":8,"adsh":"0001571996-22-000009","doc":"dell-20220128.htm","q":"We continue to make enhancements to our storage solutions offerings and expect that these offerings will drive long-term improvements in the business. 6 Table of Contents Our server portfolio includes high-performance rack, blade, tower, an\u2026"},{"fy":2022,"lvl":3,"n":22,"adsh":"0001571996-23-000007","doc":"dell-20230203.htm","q":"We are organized into two business units which are also our reportable segments, referred to as Infrastructure Solutions Group and Client Solutions Group. \u2022 Infrastructure Solutions Group (\u201cISG\u201d) \u2014 ISG enables our customers\u2019 digital transfo\u2026"},{"fy":2023,"lvl":3,"n":41,"adsh":"0001571996-24-000036","doc":"dell-20240202.htm","q":"We provide customers with a broad and innovative solutions portfolio for the data and artificial intelligence (\u201cAI\u201d) era, including traditional and modern infrastructure."},{"fy":2024,"lvl":3,"n":82,"adsh":"0001571996-25-000034","doc":"dell-20250131.htm","q":"ITEM 1 \u2014 BUSINESS Company Overview Dell Technologies is a leader in the global technology industry focused on providing broad and innovative technology solutions for the data and artificial intelligence (\u201cAI\u201d) era."}]},{"cik":1572552,"name":"ASTERIAS BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001140361-15-011245","doc":"form10k.htm","q":null},{"fy":2015,"lvl":1,"n":1,"adsh":"0001140361-16-059357","doc":"form10k.htm","q":"Kingsley holds a BS degree in economics from the Wharton School of the University of Pennsylvania, and a J.D. degree and LLM in taxation from New York University Law School. 82 Table of Contents Mr."},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-17-013626","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001140361-18-013695","doc":"h10051697x1_10k.htm","q":null}]},{"cik":1572684,"name":"UCP, INC.","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001572684-15-000011","doc":"ucp1231201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001572684-16-000037","doc":"ucp1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001572684-17-000019","doc":"ucp1231201610-k.htm","q":null}]},{"cik":1574094,"name":"RENOVORX, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008080","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-010332","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012357","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001932","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001193125-26-131928","doc":"rnxt-20251231.htm","q":null}]},{"cik":1574135,"name":"PIVOTAL SOFTWARE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001574135-19-000009","doc":"pvtl-20190201x10k.htm","q":null}]},{"cik":1574235,"name":"PULMATRIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-036361","doc":"v412118_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-499264","doc":"d134038d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-077912","doc":"d310831d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-080793","doc":"d481342d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-043624","doc":"d680911d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-086168","doc":"d862269d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006602","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-007957","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009609","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011630","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-011084","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-008130","doc":"form10-k.htm","q":null}]},{"cik":1574532,"name":"WCI COMMUNITIES, INC.","industry":"Construction","sic":1531,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-062759","doc":"d839632d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-471714","doc":"d103561d10k.htm","q":null}]},{"cik":1574596,"name":"NEW HOME CO INC.","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001574596-15-000032","doc":"nwhm10-k_q4x14.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001574596-16-000124","doc":"nwhm10-k_q4x15.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001574596-17-000012","doc":"nwhm10-k_q4x16.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001574596-18-000023","doc":"nwhm10-k_q4x17.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001574596-19-000017","doc":"nwhm10-k_q4x18.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-002645","doc":"nwhm20191231_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-002617","doc":"nwhm20201231_10k.htm","q":null}]},{"cik":1574676,"name":"GALENFEHA, INC.","industry":"Construction","sic":8711,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001062993-15-002005","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001062993-16-008593","doc":"form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001062993-17-001588","doc":"form10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001062993-18-001373","doc":"form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001062993-19-002370","doc":"form10k.htm","q":null}]},{"cik":1575142,"name":"BIOADAPTIVES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001640334-22-000689","doc":"bdpt_10k.htm","q":null},{"fy":2022,"lvl":"x","n":1,"adsh":"0001640334-23-000532","doc":"bdpt_10k.htm","q":"On March 23, 2023, the Company signed a Letter of Intent with Dr.David Allen, World Wellness, Inc for the Launching of a Weight Management System Including an AI Supported Body Composition Measuring App and New Health Products. 38 Table of \u2026"},{"fy":2023,"lvl":"x","n":6,"adsh":"0001640334-24-000602","doc":"bdpt_10k.htm","q":"Since March 2023, the Company has been studying the FitYourOutfit \u00ae system, a low-cost AI smart phone app body composition tracking system to detect unwanted muscle mass loss reported with obesity management and also fat loss."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001640334-25-000660","doc":"bdpt_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-26-000718","doc":"bdpt_10k.htm","q":null}]},{"cik":1575189,"name":"MATCH GROUP, INC.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001575189-16-000006","doc":"mtch-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001575189-17-000003","doc":"mtch-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001575189-18-000019","doc":"mtch10-k20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001575189-19-000020","doc":"mtch10-k20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001575189-20-000018","doc":"mtch-20191231.htm","q":null}]},{"cik":1575515,"name":"SPROUTS FARMERS MARKET, INC.","industry":"Retail","sic":5411,"state":"AZ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065978","doc":"d854295d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013299","doc":"sfm-10k_20160103.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002108","doc":"sfm-10k_20170101.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002782","doc":"sfm-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003562","doc":"sfm-10k_20181230.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005552","doc":"sfm-10k_20191229.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008832","doc":"0001564590-21-008832.txt","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001976","doc":"sfm-20220102.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005723","doc":"sfm-20230101.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-018768","doc":"sfm-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001575515-25-000011","doc":"sfm-20241229.htm","q":"To further strengthen our capabilities, we continue to integrate emerging technologies such as artificial intelligence, machine learning, and cloud computing to advance automation, generate real-time insights, and improve scalability."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001575515-26-000008","doc":"sfm-20251228.htm","q":"To further develop our capabilities, we continue to evaluate and integrate emerging technologies such as artificial intelligence, machine learning, and cloud computing to support automation, generate more timely insights, and enhance scalab\u2026"}]},{"cik":1575659,"name":"RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001393905-21-000119","doc":"rtsl-20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001393905-22-000069","doc":"rtsl-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001393905-23-000156","doc":"rtsl-20221231.htm","q":null}]},{"cik":1576169,"name":"BENEFITFOCUS, INC.","industry":"Software & IT services","sic":7372,"state":"SC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-070241","doc":"d861802d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-478532","doc":"d52297d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002411","doc":"bnft-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005797","doc":"bnft-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004453","doc":"bnft-10k_20181231.htm","q":null},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-008764","doc":"bnft-10k_20191231.htm","q":"Our platform includes artificial intelligence functionality designed to help consumers identify and evaluate benefit options available to them."},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011839","doc":"bnft-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008597","doc":"bnft-10k_20211231.htm","q":null}]},{"cik":1576263,"name":"MIRATI THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001628280-15-001687","doc":"mrtx-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001628280-16-012476","doc":"mrtx-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-17-002407","doc":"mrtx-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002942","doc":"mrtx-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-19-002289","doc":"mrtx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-002301","doc":"mrtx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003315","doc":"mrtx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004246","doc":"mrtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005576","doc":"mrtx-20221231.htm","q":null}]},{"cik":1576724,"name":"VILACTO BIO INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001165527-15-000282","doc":"g7880.txt","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001165527-16-000821","doc":"g8253a.txt","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001663577-17-000218","doc":"mainbody.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001663577-18-000342","doc":"mainbody2.htm","q":null}]},{"cik":1576885,"name":"ACUMEN PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-086775","doc":"d298784d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001576885-23-000017","doc":"abos-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001576885-24-000047","doc":"abos-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001576885-25-000049","doc":"abos-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-021413","doc":"abos-20251231.htm","q":null}]},{"cik":1576914,"name":"MIX TELEMATICS LTD","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001628280-20-010583","doc":"mixt-20200331.htm","q":null},{"fy":2020,"lvl":1,"n":3,"adsh":"0001628280-21-012152","doc":"mixt-20210331.htm","q":"Major updates to the MiX Vision solution were developed in fiscal year 2021, with MiX Vision AI poised for launch in calendar year 2021. \u25e6 MiX Rovi , an in-vehicle display and communications system allowing fleet operators to streamline the\u2026"},{"fy":2021,"lvl":3,"n":18,"adsh":"0001628280-22-017109","doc":"mixt-20220331.htm","q":"With MiX Vision AI which was launched in fiscal year 2022 we will better be able to serve the video telematics market."},{"fy":2022,"lvl":3,"n":38,"adsh":"0001628280-23-023049","doc":"mixt-20230331.htm","q":"With MiX Vision AI which was launched in fiscal year 2022 and enhanced with multiple software and hardware updates in 2023, we are meeting an ever-broader range of needs in the video telematics market."}]},{"cik":1576940,"name":"CENTURY COMMUNITIES, INC.","industry":"Construction","sic":1531,"state":"CO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001562762-15-000061","doc":"ccs-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001576940-16-000025","doc":"ccs-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001576940-17-000023","doc":"ccs-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001576940-18-000052","doc":"ccs-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001576940-19-000023","doc":"ccs-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001562762-20-000031","doc":"ccs-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001576940-21-000009","doc":"ccs-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001576940-22-000006","doc":"ccs-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001576940-23-000005","doc":"ccs-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001576940-24-000005","doc":"ccs-20231231x10k.htm","q":"General Risk Factors \uf0b7 We are subject to several other risks of which other public companies are subject, including without limitation, the effect of negative publicity; increased scrutiny related to our environmental, social and governance\u2026"},{"fy":2024,"lvl":2,"n":10,"adsh":"0001576940-25-000006","doc":"ccs-20241231x10k.htm","q":"General Risk Factors \uf0b7 We are subject to several other risks of which other public companies are subject, including without limitation, the effect of negative publicity; increased scrutiny and evolving expectations related to our environmen\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0001576940-26-000005","doc":"ccs-20251231x10k.htm","q":"General Risk Factors \uf0b7 We are subject to several other general risks, including without limitation, IT failures or data security breaches; the rise of artificial intelligence; and the possibility of becoming a target of activist investors."}]},{"cik":1577445,"name":"SCOUTCAM INC.","industry":"Software & IT services","sic":7370,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-003781","doc":"inll_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-011070","doc":"inll_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-003077","doc":"inll_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-003358","doc":"inll_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001558891-19-000058","doc":"inll-20190331_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004026","doc":"form10-k.htm","q":null}]},{"cik":1577526,"name":"C3.AI, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":880,"adsh":"0001628280-21-012990","doc":"ai-20210430.htm","q":"BUSINESS Overview C3 AI is the Enterprise AI application software company."},{"fy":2022,"lvl":3,"n":718,"adsh":"0001628280-22-017829","doc":"ai-20220430.htm","q":"BUSINESS Overview C3 AI is the Enterprise AI application software company."},{"fy":2023,"lvl":3,"n":787,"adsh":"0001628280-23-022983","doc":"ai-20230430.htm","q":"BUSINESS Overview C3 AI is the Enterprise AI application software company."},{"fy":2024,"lvl":3,"n":944,"adsh":"0001628280-24-028786","doc":"ai-20240430.htm","q":"BUSINESS Overview C3 AI is the Enterprise AI application software company."},{"fy":2025,"lvl":3,"n":1051,"adsh":"0001628280-25-032604","doc":"ai-20250430.htm","q":"BUSINESS Overview C3 AI is the Enterprise AI application software company."}]},{"cik":1578845,"name":"ALLERGAN PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-052898","doc":"d842874d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013478","doc":"agn-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002433","doc":"agn-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002345","doc":"agn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003111","doc":"0001564590-19-003111.txt","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005038","doc":"agn-10k_20191231.htm","q":null}]},{"cik":1579298,"name":"BURLINGTON STORES, INC.","industry":"Retail","sic":5311,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-105212","doc":"d846695d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014854","doc":"burl-10k_20160130.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004636","doc":"burl-10k_20170128.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006339","doc":"burl-10k_20180203.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008656","doc":"burl-10k_20190202.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010835","doc":"burl-10k_20200201.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013162","doc":"burl-10k_20210130.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003963","doc":"burl-20220129.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007586","doc":"burl-20230128.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-032207","doc":"burl-20240203.htm","q":"Additionally, existing competitors may consolidate with other retailers, expand their merchandise offerings, expand their e-commerce capabilities, and/or add new sales channels, change their pricing strategies, or use technology more effect\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-040472","doc":"burl-20250201.htm","q":"Additionally, existing competitors may consolidate with other retailers, expand their merchandise offerings, expand their e-commerce capabilities, and/or add new sales channels, change their pricing strategies, or use technology more effect\u2026"},{"fy":2025,"lvl":2,"n":6,"adsh":"0001193125-26-116001","doc":"burl-20260131.htm","q":"Additionally, existing competitors may consolidate with other retailers, expand their merchandise offerings, expand their e-commerce capabilities, and/or add new sales channels, change their pricing strategies, or use technology more effect\u2026"}]},{"cik":1579428,"name":"AXSOME THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001426","doc":"axsm-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001639","doc":"axsm-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002068","doc":"axsm-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002573","doc":"axsm-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009924","doc":"axsm-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002568","doc":"axsm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004728","doc":"axsm-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-019118","doc":"axsm-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-022457","doc":"axsm-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-064267","doc":"axsm-20251231.htm","q":null}]},{"cik":1579878,"name":"FIGMA, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":278,"adsh":"0001628280-26-009228","doc":"fig-20251231.htm","q":"In Figma, designers work alongside developers, product managers (\u201cPMs\u201d), researchers, marketers, writers, and other non-designers who, in the three months ended December 31, 2025, made up approximately two-thirds of our monthly active users\u2026"}]},{"cik":1579910,"name":"RESONANT INC","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-023395","doc":"a15-5907_110k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001579910-16-000020","doc":"resn20151231-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001579910-17-000006","doc":"resn20161231-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001579910-18-000002","doc":"resn20171231-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001579910-19-000003","doc":"resn20181231-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001579910-20-000003","doc":"resn20191231-10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001579910-21-000005","doc":"resn-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001579910-22-000005","doc":"resn-20211231.htm","q":"Caballero joined Microsoft Corporation, as Corporate Vice President of Engineering for Hardware Design and Technology, where his role is to oversee Mixed Reality and AI, enhancing the capabilities of Microsoft\u2019s hardware products, including\u2026"}]},{"cik":1580063,"name":"BIORA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010973","doc":"bior-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-039423","doc":"bior-20231231.htm","q":null}]},{"cik":1580149,"name":"BIOVIE INC.","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001520138-15-000410","doc":"nnab-20150630_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001520138-16-001180","doc":"bivi-20160630_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001520138-17-000286","doc":"bivi-20170630_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001520138-18-000269","doc":"bivi-20180630_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001520138-19-000336","doc":"bivi-20190630_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001520138-20-000356","doc":"bivi-20200630_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001520138-21-000509","doc":"bivi-20210630_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001520138-22-000437","doc":"bivi-20220630_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001520138-23-000325","doc":"bivi-20230630_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001520138-24-000324","doc":"bivi-20240630_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001520138-25-000268","doc":"bivi-20250630_10k.htm","q":null}]},{"cik":1580670,"name":"LGI HOMES, INC.","industry":"Construction","sic":1531,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001580670-15-000023","doc":"lgih12311410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001580670-16-000172","doc":"lgih12311510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001580670-17-000017","doc":"a12311610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001580670-18-000011","doc":"a12311710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001580670-19-000022","doc":"a12311810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001580670-20-000017","doc":"a12311910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001580670-21-000020","doc":"lgih-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001580670-22-000023","doc":"lgih-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001580670-23-000020","doc":"lgih-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001580670-24-000012","doc":"lgih-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001580670-25-000016","doc":"lgih-20241231.htm","q":"In addition, cybersecurity risk is exacerbated with the advancement of technologies like artificial intelligence, which malicious third parties are using to create new, sophisticated and more frequent attacks."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001580670-26-000019","doc":"lgih-20251231.htm","q":"In addition, cybersecurity risk is exacerbated with the advancement of technologies like artificial intelligence, which malicious third parties are using to create new, sophisticated and more frequent attacks."}]},{"cik":1580905,"name":"INSTALLED BUILDING PRODUCTS, INC.","industry":"Construction","sic":1520,"state":"OH","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-090717","doc":"d846579d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-498539","doc":"d119055d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-062227","doc":"d310839d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-064142","doc":"d519411d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-057931","doc":"d675567d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-052757","doc":"d853980d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003085","doc":"ibp-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001580905-22-000004","doc":"ibp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001580905-23-000013","doc":"ibp-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001580905-24-000008","doc":"ibp-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001580905-25-000010","doc":"ibp-20241231.htm","q":"Advancements in artificial intelligence could be used by threat actors to attack our systems by creating increasingly effective phishing emails, false images or voice cloning to access our data."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001580905-26-000004","doc":"ibp-20251231.htm","q":"Competitors could use artificial intelligence to develop new products or methods of enhancing internal operations to gain advantages if we are unable to develop similar changes."}]},{"cik":1581280,"name":"TWIST BIOSCIENCE CORP","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-19-313115","doc":"d65251d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-20-303904","doc":"d92559d10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001104659-21-142700","doc":"twst-20210930x10k.htm","q":"In the antibody discovery market, we compete with clinical research organizations, such as LakePharma (mouse hybridoma, llama immune libraries, XOMA phage display library) and Aldevron, LLC (genetic mouse immunization coupled with hybridoma\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-22-030817","doc":"twst-20220930.htm","q":null},{"fy":2023,"lvl":3,"n":22,"adsh":"0001628280-23-039767","doc":"twst-20230930.htm","q":"Artificial intelligence/Machine learning for antibody discovery We work with a variety of organizations and have an internal team focused on library design, lead selection and lead optimization as well as other activities to deliver antibod\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0001628280-24-048262","doc":"twst-20240930.htm","q":"Currently, we are pursuing research and development projects with respect to the following: \u2022 process development for highest quality oligos; \u2022 develop proprietary enzymes to optimize SynBio and NGS products and workflows; \u2022 silicon process\u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001581280-25-000025","doc":"twst-20250930.htm","q":"Customers pursuing artificial intelligence (\u201cAI\u201d) enabled antibody discovery platforms may use Twist to generate not only the antibodies of interest but also comprehensive high quality characterization data that is critical for use in the d\u2026"}]},{"cik":1581378,"name":"CHANGING TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001161697-15-000432","doc":"form_10-k.htm","q":null}]},{"cik":1581720,"name":"LOXO ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001104659-15-023499","doc":"a15-3886_110k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-105213","doc":"a15-23151_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-014836","doc":"a17-1074_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-014107","doc":"a18-1042_1ex10d19.htm","q":null}]},{"cik":1582249,"name":"ACTAVIA LIFE SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-16-125830","doc":"v449384_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001628280-17-011941","doc":"a093017rasna10-kproject.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-017775","doc":"rasp-20180930.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-000885","doc":"rasp-20190930.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-002479","doc":"rasp-20200930.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-010081","doc":"f10k2021_rasnathera.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-009695","doc":"f10k2022_rasnathera.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-001370","doc":"f10k2023_actavialife.htm","q":null}]},{"cik":1582313,"name":"XENON PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001612","doc":"xene-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014222","doc":"xene-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003716","doc":"xene-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004750","doc":"xene-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006514","doc":"xene-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009385","doc":"xene-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009905","doc":"xene-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008060","doc":"xene-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005582","doc":"xene-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023177","doc":"xene-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-029149","doc":"xene-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-076650","doc":"xene-20251231.htm","q":"Our expanding use of artificial intelligence exposes us to operational, regulatory, legal, and ethical risks that could adversely affect our business, reputation, financial condition, and results of operations."}]},{"cik":1582554,"name":"MATINAS BIOPHARMA HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-019575","doc":"v405277_10k.htm","q":null},{"fy":2015,"lvl":"x","n":1,"adsh":"0001144204-16-091635","doc":"v434866_10k.htm","q":"MAT9001 also outperformed Vascepa in reductions in apolipoproteins (apo) and PCSK9 as compared to baseline: \u00b7 MAT9001 reduced median apolipoprotein B levels by 3.8 percent compared to 0.7 percent for Vascepa (P-Value = 0.058); \u00b7 MAT9001 red\u2026"},{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-17-018184","doc":"v461054_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003518","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001493152-19-004560","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001493152-20-003558","doc":"form10-k.htm","q":"MAT9001 achieved greater median percentage reduction than Vascepa in multiple key lipid measures: \u25cf MAT9001 significantly reduced median TG levels by 33.2 percent compared to 10.5 percent for Vascepa (p <0.001); \u25cf MAT9001 significantly redu\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-006979","doc":"form10-k.htm","q":"In comparison to Vascepa, treatment with LYPDISO provided significantly greater reductions in TGs, very low-density lipoprotein cholesterol (VLDL) non-HDL cholesterol, total cholesterol, apolipoprotein AI, apolipoprotein CIII, and PCSK9."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-006231","doc":"form10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007726","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011493","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-004882","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-014132","doc":"form10-k.htm","q":null}]},{"cik":1582961,"name":"DIGITALOCEAN HOLDINGS, INC.","industry":"Software & IT services","sic":7370,"state":"CO","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001582961-22-000010","doc":"docn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001582961-23-000009","doc":"docn-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":107,"adsh":"0001582961-24-000031","doc":"docn-20231231.htm","q":"Our customers use our platform across numerous industry verticals and for a wide range of use cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, managed services, and, most rece\u2026"},{"fy":2024,"lvl":3,"n":147,"adsh":"0001582961-25-000035","doc":"docn-20241231.htm","q":"BUSINESS Overview Our mission is to simplify cloud computing and artificial intelligence (AI) to allow builders to spend more time creating software that changes the world."},{"fy":2025,"lvl":3,"n":191,"adsh":"0001582961-26-000019","doc":"docn-20251231.htm","q":"BUSINESS Overview Our mission is to empower AI-driven and digital-native businesses to build, run, and scale intelligent applications with speed, simplicity and predictable economics through an agentic inference cloud platform that reduces \u2026"}]},{"cik":1582982,"name":"CARECLOUD, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001144204-15-019947","doc":"v404808_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001144204-16-090133","doc":"v434023_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-003230","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001493152-18-003026","doc":"form10-k.htm","q":"It is our vision with talkEHR to design a user-friendly, intuitive platform that automates and increases patient charting efficiency by using artificial intelligence and natural language processing. talkEHR is offered free of cost to all U.\u2026"},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003653","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":1,"n":1,"adsh":"0001493152-20-003146","doc":"form10-k.htm","q":"The Analytics and AI sub-segment was estimated to be approximately $30 billion, growing at a 27% CAGR and the Telehealth market is estimated to be approximately $20 billion with a CAGR of 17%."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-004837","doc":"form10-k.htm","q":"The Analytics and AI sub-segment was estimated to be approximately $30 billion, growing at a 27% CAGR and the Telehealth market is estimated to be approximately $20 billion with a CAGR of 17%."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-006785","doc":"form10-k.htm","q":"The Analytics and AI sub-segment was estimated to be approximately $30 billion, growing at a 27% CAGR and the Telehealth market is estimated to be approximately $20 billion with a CAGR of 17%."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001493152-23-006580","doc":"form10-k.htm","q":"Our portfolio of proprietary software and business services includes: technology-enabled business solutions that maximize revenue cycle management and create efficiencies through platform agnostic AI-driven applications; cloud-based softwar\u2026"},{"fy":2023,"lvl":3,"n":26,"adsh":"0001493152-24-010800","doc":"form10-k.htm","q":"Our portfolio of proprietary software and business services includes: technology-enabled business solutions that maximize revenue cycle management and create efficiencies through platform agnostic AI-driven applications; cloud-based softwar\u2026"},{"fy":2024,"lvl":3,"n":28,"adsh":"0001493152-25-010217","doc":"form10-k.htm","q":"Business Overview CareCloud, Inc., (together with its consolidated subsidiaries, \u201cCareCloud\u201d, the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d and/or \u201cour\u201d) is a leading provider of technology-enabled services and generative AI solutions that redefine the healthc\u2026"},{"fy":2025,"lvl":3,"n":46,"adsh":"0001493152-26-009872","doc":"form10-k.htm","q":"Business Overview CareCloud, Inc., (together with its consolidated subsidiaries, \u201cCareCloud,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d and/or \u201cour\u201d) is a leading provider of technology-enabled services and generative AI solutions that redefine the healthc\u2026"}]},{"cik":1583107,"name":"THERAVANCE BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002175","doc":"a2223389z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011039","doc":"a2227703z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001086","doc":"a2231044z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001160","doc":"a2234657z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001346","doc":"tbph-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001644","doc":"tbph-20191231x10kc43919.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002006","doc":"tbph-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002373","doc":"tbph-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002595","doc":"tbph-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002267","doc":"tbph-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002447","doc":"tbph-20241231x10k.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001104659-26-033077","doc":"tbph-20251231x10k.htm","q":"As a result of the broad-scale release and availability of Artificial Intelligence (\u201cAI\u201d) technologies, such as generative AI, there is a global trend towards more regulation (e.g., the EU AI Act and AI laws passed in US states) to ensure t\u2026"}]},{"cik":1583648,"name":"PALVELLA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-109883","doc":"d889766d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-514870","doc":"d111873d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-102052","doc":"d325265d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001583648-18-000017","doc":"pirs12-31x201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001583648-19-000011","doc":"pirs12-31x201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001583648-20-000015","doc":"pirs12-31x201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001583648-21-000005","doc":"pirs-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001583648-22-000016","doc":"pirs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008834","doc":"pirs20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-010123","doc":"pirs20231231_10k.htm","q":null},{"fy":2024,"lvl":3,"n":18,"adsh":"0000950170-25-047212","doc":"pvla-20241231.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"},{"fy":2025,"lvl":3,"n":34,"adsh":"0001193125-26-133372","doc":"pvla-20251231.htm","q":"Attempts to disrupt or gain unauthorized access to our and our third-party vendors\u2019 information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or\u2026"}]},{"cik":1583708,"name":"SENTINELONE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":61,"adsh":"0001583708-22-000016","doc":"s-20220131.htm","q":"We envisioned a revolutionary data and artificial intelligence (AI) paradigm where technology alone could autonomously prevent, detect, and respond to cyberattacks."},{"fy":2022,"lvl":3,"n":62,"adsh":"0001583708-23-000014","doc":"s-20230131.htm","q":"We envisioned a revolutionary data and artificial intelligence (AI) paradigm where technology alone could autonomously prevent, detect, and respond to cyberattacks."},{"fy":2023,"lvl":3,"n":116,"adsh":"0001583708-24-000016","doc":"s-20240131.htm","q":"We envisioned a revolutionary data and AI paradigm where technology alone could autonomously prevent, detect, and respond to cyberattacks."},{"fy":2024,"lvl":3,"n":158,"adsh":"0001583708-25-000051","doc":"s-20250131.htm","q":"We are in the midst of a generational shift in cybersecurity, ushered in by the ongoing digital transformation of the enterprise and the rise of AI."}]},{"cik":1583771,"name":"HEPION PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001104659-15-067379","doc":"a15-12155_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-16-147194","doc":"a16-17622_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-17-059696","doc":"a17-15959_110k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001104659-19-014652","doc":"a19-30142_110k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-061587","doc":"tm2031108-1_10k.htm","q":null},{"fy":2020,"lvl":3,"n":39,"adsh":"0001558370-21-003836","doc":"c771-20201231x10k.htm","q":"Artificial Intelligence (AI) We have created a proprietary AI tool called, \u201cAI-POWR TM to optimize the outcomes of our current clinical programs and to potentially identify novel indications for CRV431 and possibly identify new targets and \u2026"},{"fy":2021,"lvl":3,"n":45,"adsh":"0001583771-22-000003","doc":"hepa-20211231.htm","q":"Artificial Intelligence (AI) We have created a proprietary AI tool called, \u201cAI-POWR \u2122 to optimize the outcomes of our current clinical programs and to potentially identify novel indications for Rencofilstat and possibly identify new targets\u2026"},{"fy":2022,"lvl":3,"n":46,"adsh":"0001583771-23-000003","doc":"hepa-20221231.htm","q":"Artificial Intelligence (AI) We have created a proprietary AI tool called, \u201cAI-POWR \u2122 to optimize the outcomes of our current clinical programs and to potentially identify novel indications for rencofilstat and possibly identify new targets\u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0001583771-24-000003","doc":"hepa-20231231.htm","q":"These interruptions or failures could also impede commercialization of our product candidate and impair our competitive position. 27 Table of Contents Our approach to the discovery and development of product candidates based on AI-POWR\u2122 is \u2026"},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-003250","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-009755","doc":"form10-k.htm","q":null}]},{"cik":1584137,"name":"ONCOLIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001291","doc":"oncx_10k.htm","q":null}]},{"cik":1584480,"name":"GREENTECH INNOVATIONS, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001558891-15-000101","doc":"uppe-20150531_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001558891-17-000041","doc":"ursl-20170531_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-18-002089","doc":"ursl_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-19-001721","doc":"ursl_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-20-002219","doc":"laab_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001640334-21-001872","doc":"laab_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001640334-22-001828","doc":"laab_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001640334-23-001638","doc":"laab_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001640334-24-001367","doc":"laab_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-25-001606","doc":"laab_10k.htm","q":null}]},{"cik":1584584,"name":"AXIOM HOLDINGS, INC.","industry":"Utilities","sic":4911,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001640334-17-000624","doc":"axiom_10k.htm","q":null}]},{"cik":1584701,"name":"TOPS HOLDING II CORP","industry":"Retail","sic":5411,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-107131","doc":"d854312d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015178","doc":"tops-10k_20160102.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005623","doc":"ck0001584701-10k_20161231.htm","q":null}]},{"cik":1585364,"name":"PERRIGO CO PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001585364-15-000100","doc":"a2015q410k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001585364-17-000071","doc":"cy16q410k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001585364-18-000015","doc":"cy17q410k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001585364-19-000016","doc":"cy18q410k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001585364-20-000013","doc":"cy19q410k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001585364-21-000012","doc":"prgo-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001585364-22-000011","doc":"prgo-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001585364-23-000006","doc":"prgo-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001585364-24-000009","doc":"prgo-20231231.htm","q":"In addition, the rapid evolution and increased adoption of new technologies, such as artificial intelligence, may intensify our cybersecurity risks."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001585364-25-000014","doc":"prgo-20241231.htm","q":"In addition, the rapid evolution and increased adoption of new technologies, such as artificial intelligence, may intensify our cybersecurity risks."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001585364-26-000009","doc":"prgo-20251231.htm","q":"In addition, the rapid evolution and increased adoption of new technologies, such as artificial intelligence, may intensify our cybersecurity risks."}]},{"cik":1585521,"name":"ZOOM COMMUNICATIONS, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001585521-20-000095","doc":"zm-20200131.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001585521-21-000048","doc":"zm-20210131.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001585521-22-000037","doc":"zm-20220131.htm","q":"Key integrations include Google Workspace, Calendly, Slack, Microsoft Teams, Salesforce, Otter.ai, Hubspot, Asana, Kahoot! and Miro."},{"fy":2022,"lvl":2,"n":12,"adsh":"0001585521-23-000035","doc":"zm-20230131.htm","q":"Lastly, we launched Zoom Virtual Agent, an AI-powered chatbot that understands customer questions and provides accurate answers quickly."},{"fy":2023,"lvl":3,"n":77,"adsh":"0001585521-24-000030","doc":"zm-20240131.htm","q":"Artificial Intelligence (\u201cAI\u201d) has been core to Zoom\u2019s product DNA over many years, grounded in our conviction that AI can make work more human by strengthening collaboration, productivity, and inclusivity."},{"fy":2024,"lvl":3,"n":120,"adsh":"0001585521-25-000042","doc":"zm-20250131.htm","q":"BUSINESS Overview Our mission is to provide an AI-first work platform for human connection."}]},{"cik":1585608,"name":"JAGUAR HEALTH, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011700","doc":"a2227875z10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001047469-17-000684","doc":"a2230899z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-002654","doc":"a2235058z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002908","doc":"jagx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003581","doc":"jagx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003811","doc":"jagx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003435","doc":"jagx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004572","doc":"jagx-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":8,"adsh":"0001558370-24-004439","doc":"jagx-20231231x10k.htm","q":"Additionally, an allegation or perception that we have not taken sufficient action in these areas could negatively harm our reputation. \u200b The growing use of AI systems to automate processes, analyze data, and support decision-making poses i\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0000950170-25-047184","doc":"jagx-20241231.htm","q":"The growing use of AI systems to automate processes, analyze data, and support decision-making poses inherent risks."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001193125-26-144470","doc":"jagx-20251231.htm","q":"Additionally, an allegation or perception that we have not taken sufficient action in these areas could negatively harm our reputation. 47 Table of Contents The growing use of AI systems to automate processes, analyze data, and support deci\u2026"}]},{"cik":1585755,"name":"ARIAS INTEL CORP.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-007403","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":1,"adsh":"0001493152-18-009994","doc":"form10-k.htm","q":"The wagers have odds associated with them, which relate to the probable outcome of the proposition being wagered upon, and the odds are adjusted in real-time to balance the betting using algorithms and artificial intelligence software to re\u2026"}]},{"cik":1585854,"name":"SUNEDISON SEMICONDUCTOR LTD","industry":"Computers & chips","sic":3674,"state":"MO","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001585854-15-000020","doc":"ssl-exhibit13x123114.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001585854-16-000093","doc":"ssl-exhibit13x123115.htm","q":null}]},{"cik":1586105,"name":"ZYLA LIFE SCIENCES","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-002296","doc":"a2223665z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004071","doc":"eglt-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001692","doc":"eglt-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002180","doc":"eglt-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002647","doc":"eglt-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003190","doc":"zcor-20191231x10k.htm","q":null}]},{"cik":1586495,"name":"BLOW & DRIVE INTERLOCK CORP","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001493152-15-001067","doc":"form10-k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001551163-16-000354","doc":"bdidraft10k123115vedgar3.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-004041","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-19-008856","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-010838","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-005251","doc":"form10-k.htm","q":null}]},{"cik":1586495,"name":"LEET TECHNOLOGY INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-000913","doc":"bdic_10k-123120.htm","q":null},{"fy":2021,"lvl":"x","n":2,"adsh":"0001683168-22-002694","doc":"leet_i10k-123121.htm","q":"He helped build the core functionality of the fraud-detection system using machine learning models and algorithms."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001683168-23-005314","doc":"leet_i10k-123122.htm","q":"He helped build the core functionality of the fraud-detection system using machine learning models and algorithms."},{"fy":2023,"lvl":"x","n":2,"adsh":"0001683168-24-002370","doc":"leet_i10k-123123.htm","q":"He helped build the core functionality of the fraud-detection system using machine learning models and algorithms."},{"fy":2024,"lvl":"x","n":2,"adsh":"0001683168-25-001960","doc":"leet_i10k-123124.htm","q":"He helped build the core functionality of the fraud-detection system using machine learning models and algorithms."}]},{"cik":1587063,"name":"IMC HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-009713","doc":"imc_10k.htm","q":null}]},{"cik":1587221,"name":"ZOSANO PHARMA CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-521425","doc":"d121789d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-063319","doc":"d289827d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-078418","doc":"d501837d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001587221-19-000006","doc":"q4fy1810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001587221-20-000004","doc":"a10kfy2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001587221-21-000007","doc":"zsan-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001587221-22-000022","doc":"zsan-20211231.htm","q":null}]},{"cik":1587285,"name":"SOMO, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001587285-15-000012","doc":"f10k_.htm","q":null}]},{"cik":1587476,"name":"PRINCIPAL SOLAR, INC.","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001437749-15-005266","doc":"psww20150303_10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001437749-16-029500","doc":"psww20151231_10k.htm","q":null}]},{"cik":1588014,"name":"ADM ENDEAVORS, INC.","industry":"Construction","sic":1700,"state":"TX","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001445866-15-000345","doc":"adm10k12312014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001493152-17-000762","doc":"form10-k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-006266","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-005367","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005499","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-008454","doc":"form10-k.htm","q":null}]},{"cik":1588972,"name":"SOCIETAL CDMO, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-104307","doc":"d863027d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-516045","doc":"d117112d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003830","doc":"reph-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004277","doc":"reph-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003187","doc":"reph-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008538","doc":"reph-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009198","doc":"reph-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002545","doc":"reph-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005586","doc":"sctl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-035480","doc":"sctl-20231231.htm","q":null}]},{"cik":1589149,"name":"MASSROOTS, INC.","industry":"Software & IT services","sic":7370,"state":"CO","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0000721748-15-000192","doc":"mrst10k033115.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0000721748-16-001131","doc":"mrst10k033016.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0000721748-17-000211","doc":"msrt10k032217.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001721868-18-000284","doc":"f2s10msrt040118.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-006509","doc":"f10k2018_massrootsinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-017657","doc":"f10k2019_massroots.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-021821","doc":"f10k2020_massrootsinc.htm","q":null}]},{"cik":1589150,"name":"REGEN BIOPHARMA INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001607062-17-000122","doc":"rgbp093115form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001607062-16-000576","doc":"rgbp010516form10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001607062-16-001092","doc":"0001607062-16-001092.txt","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001607062-18-000006","doc":"rgbp093017form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001607062-18-000491","doc":"rgbp093018form10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001607062-21-000165","doc":"rgbp093019form10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001607062-21-000250","doc":"rgbp093020form10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001607062-21-000641","doc":"rgbp093021form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001607062-22-000694","doc":"rgbp093022form10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001607062-23-000524","doc":"rgbp093023form10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-009968","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-25-029526","doc":"form10-k.htm","q":null}]},{"cik":1589526,"name":"BLUE BIRD CORP","industry":"Auto manufacturing","sic":3713,"state":"GA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001213900-15-001423","doc":"f10k2014_hennessycapital.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001589526-15-000089","doc":"a10-k2015100315.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001589526-16-000199","doc":"a10-k2016100116.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001589526-17-000057","doc":"a10-k201793017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001589526-18-000102","doc":"a10-k201892918.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001589526-19-000054","doc":"a10-k201993019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001589526-20-000112","doc":"a10-k2020100320.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001589526-21-000140","doc":"blbd-20211002.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001589526-22-000091","doc":"blbd-20221001.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001589526-23-000124","doc":"blbd-20230930.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001589526-24-000119","doc":"blbd-20240928.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001589526-25-000100","doc":"blbd-20250927.htm","q":null}]},{"cik":1589919,"name":"PREMIER PACIFIC CONSTRUCTION, INC.","industry":"Construction","sic":1520,"state":"CA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001127855-15-000151","doc":"ppci1k123114.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001127855-16-000582","doc":"ppci10k123115.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001127855-17-000111","doc":"ppci10ka1123116.htm","q":null}]},{"cik":1590560,"name":"UNIQURE N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001589","doc":"a2231181z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002042","doc":"qure-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001305","doc":"qure-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001883","doc":"qure-20191231x10k5849ab.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002186","doc":"qure-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002050","doc":"qure-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002110","doc":"qure-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001915","doc":"qure-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001699","doc":"qure-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":15,"adsh":"0001104659-26-021898","doc":"qure-20251231x10k.htm","q":"The costs associated with an alleged or actual violation of any of the foregoing could be substantial and could cause irreparable harm to our reputation or otherwise have a material adverse effect on our business, financial condition, and r\u2026"}]},{"cik":1590750,"name":"VIRIDIAN THERAPEUTICS, INC.DE","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2025,"lvl":3,"n":19,"adsh":"0001590750-26-000007","doc":"vrdn-20251231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and anti-discrimination."}]},{"cik":1590877,"name":"REGENXBIO INC.","industry":"Pharma & biotech","sic":2836,"state":"MD","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013941","doc":"rgnx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003576","doc":"rgnx-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004532","doc":"rgnx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004920","doc":"rgnx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006826","doc":"rgnx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009855","doc":"rgnx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008055","doc":"rgnx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005085","doc":"rgnx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021161","doc":"rgnx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-038770","doc":"rgnx-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-094013","doc":"rgnx-20251231.htm","q":null}]},{"cik":1590955,"name":"PAYCOM SOFTWARE, INC.","industry":"Software & IT services","sic":7372,"state":"OK","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-065707","doc":"d851377d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013001","doc":"payc-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-001891","doc":"payc-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002088","doc":"payc-10k_20171231.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-002998","doc":"payc-10k_20181231.htm","q":"This sophisticated machine learning technology gives an employer greater insight into employees at risk of leaving its organization."},{"fy":2019,"lvl":1,"n":3,"adsh":"0001564590-20-004636","doc":"payc-10k_20191231.htm","q":"This sophisticated machine learning technology gives an employer greater insight into employees at risk of leaving its organization."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-21-006660","doc":"payc-10k_20201231.htm","q":"This sophisticated machine learning technology gives an employer greater insight into employees at risk of leaving its organization."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001564590-22-005562","doc":"payc-10k_20211231.htm","q":"This sophisticated machine learning technology gives an employer greater insight into employees at risk of leaving the organization."},{"fy":2022,"lvl":3,"n":15,"adsh":"0000950170-23-003049","doc":"payc-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":43,"adsh":"0000950170-24-015863","doc":"payc-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":51,"adsh":"0000950170-25-024136","doc":"payc-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":82,"adsh":"0001193125-26-059372","doc":"payc-20251231.htm","q":"We believe our strategy of focusing on incorporating artificial intelligence (\u201cAI\u201d) and automation across our full solution is an important differentiator for attracting new clients and key to long-term client satisfaction and client retent\u2026"}]},{"cik":1591157,"name":"POCKET GAMES INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001391609-15-000028","doc":"f10k_pocketgames2014.htm","q":null}]},{"cik":1591698,"name":"PAYLOCITY HOLDING CORP","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-15-060024","doc":"a15-12835_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-16-139345","doc":"a16-12777_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-17-006561","doc":"pcty-20170630x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-18-006955","doc":"pcty-20180630x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-19-007859","doc":"pcty-20190630x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-20-009960","doc":"pcty-20200630x10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001558370-21-010711","doc":"pcty-20210630x10k.htm","q":"It also gives employees the ability to post accolades on their profiles and share with co-workers. \u200b Analytics & Insights \u200b Modern Workforce Index \u2013 The Modern Workforce Index (MWI) leverages patent-pending AI and data from more than 25,000\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001591698-22-000094","doc":"pcty-20220630.htm","q":"Our dashboards use advanced AI to deliver actionable next steps to improve efficiency and build a healthier workforce. \u2022 Leading Customer Service - We supplement our comprehensive software solutions with an integrated implementation and cli\u2026"},{"fy":2023,"lvl":2,"n":13,"adsh":"0001591698-23-000115","doc":"pcty-20230630.htm","q":"Our platform provides tools to communicate, connect to organizations and peers, and focus on career development and growth, which drives engagement and adoption of self-service processes \u2013 and drives HR automation and digital transformation\u2026"},{"fy":2024,"lvl":3,"n":29,"adsh":"0001591698-24-000151","doc":"pcty-20240630.htm","q":"Our platform provides tools to communicate, connect to organizations and peers, and focus on career development and growth, which drives engagement, fosters connection across the organization and prioritizes flexibility and well-being for t\u2026"},{"fy":2025,"lvl":3,"n":37,"adsh":"0001591698-25-000087","doc":"pcty-20250630.htm","q":"Our platform provides tools to communicate, connect to organizations and peers, and focus on career development and growth, which drives engagement, fosters connection across the organization and prioritizes flexibility and well-being for t\u2026"}]},{"cik":1592288,"name":"DIMENSION THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015204","doc":"dmtx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003781","doc":"dmtx-10k_20161231.htm","q":null}]},{"cik":1593034,"name":"ENDO INTERNATIONAL PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001593034-15-000005","doc":"endp-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001593034-16-000051","doc":"endp-12312015x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001593034-17-000009","doc":"endp-12312016x10k.htm","q":null},{"fy":2017,"lvl":1,"n":2,"adsh":"0001593034-18-000010","doc":"endp-12312017x10k.htm","q":"Somar On June 30, 2017, the Company entered into a definitive agreement to sell Somar and all of the securities thereof, to AI Global Investments (Netherlands) PCC Limited acting for and on behalf of the Soar Cell (the Purchaser)."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001593034-19-000009","doc":"endp-12312018x10k.htm","q":"Somar On June 30, 2017, the Company entered into a definitive agreement to sell Somar and all of the securities thereof, to AI Global Investments (Netherlands) PCC Limited acting for and on behalf of the Soar Cell (the Purchaser)."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001593034-20-000019","doc":"endp-12312019x10k.htm","q":"Somar On June 30, 2017, the Company entered into a definitive agreement to sell Somar and all of the securities thereof, to AI Global Investments (Netherlands) PCC Limited acting for and on behalf of the Soar Cell (the purchaser)."},{"fy":2020,"lvl":0,"n":0,"adsh":"0001593034-21-000012","doc":"endp-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001593034-22-000012","doc":"endp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001593034-23-000007","doc":"endp-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001593034-24-000007","doc":"endp-20231231.htm","q":null}]},{"cik":1593184,"name":"BIOREGENX, INC.","industry":"Software & IT services","sic":7370,"state":"TN","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-23-002125","doc":"findit_i10k-123122.htm","q":null},{"fy":2023,"lvl":"x","n":15,"adsh":"0001683168-24-002317","doc":"bioregenx_i10k-123123.htm","q":"Technology DocSun combines three proven technologies in the DocSun Artificial Intelligence (AI) Engine."},{"fy":2024,"lvl":"x","n":20,"adsh":"0001683168-25-002614","doc":"bioregenx_i10k-123124.htm","q":"Technology DocSun combines three proven technologies in the DocSun Artificial Intelligence (AI) Engine."},{"fy":2025,"lvl":"x","n":19,"adsh":"0001683168-26-002975","doc":"bioregenx_i10k-123125.htm","q":"Pursuant to the Securities Exchange Agreement, BioRegenx acquired all of the issued and outstanding securities of DocSun in exchange for 76,800,000 BioRegenx common shares. 1 Technology DocSun combines three technologies in the DocSun Artif\u2026"}]},{"cik":1593204,"name":"HUAIZHONG HEALTH GROUP, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-000780","doc":"adhh_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-004517","doc":"adad_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-000107","doc":"adad_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-21-000625","doc":"huaizhong_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001640334-22-000182","doc":"adad_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001640334-23-000444","doc":"huaizhong_10k.htm","q":null}]},{"cik":1593470,"name":"BLUE WATER BAR & GRILL, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001593470-15-000004","doc":"sfm_form10k2014.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001593470-16-000037","doc":"bwbg_form10k2015.htm","q":null}]},{"cik":1593549,"name":"LIVENTO GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2022,"lvl":3,"n":15,"adsh":"0001493152-23-009940","doc":"form10-k.htm","q":"Livento Group operations started in 2017 as the internal team spearheaded the development of financial management software based on artificial intelligence for investment entities."},{"fy":2023,"lvl":3,"n":16,"adsh":"0001493152-24-012301","doc":"form10-k.htm","q":"Livento Group operations started in 2017 as the internal team spearheaded the development of financial management software based on artificial intelligence for investment entities."},{"fy":2024,"lvl":3,"n":16,"adsh":"0001641172-25-005145","doc":"form10-k.htm","q":"Livento Group operations started in 2017 as the internal team spearheaded the development of financial management software based on artificial intelligence for investment entities."},{"fy":2025,"lvl":3,"n":16,"adsh":"0001493152-26-020899","doc":"form10-k.htm","q":"Livento Group operations started in 2017 as the internal team spearheaded the development of financial management software based on artificial intelligence for investment entities."}]},{"cik":1593773,"name":"AMJ GLOBAL TECHNOLOGY","industry":"Software & IT services","sic":7371,"state":"NV","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001593773-15-000003","doc":"kange201510kfinal42315.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-008804","doc":"kngr_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001017","doc":"kgnr_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001947","doc":"kgnr_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-21-004952","doc":"kgnr_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-006333","doc":"kgnr_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001348","doc":"kgnr_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-000738","doc":"kgnr_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-001155","doc":"kgnr_10k.htm","q":null},{"fy":2024,"lvl":"x","n":9,"adsh":"0001477932-25-001401","doc":"kgnr_10k.htm","q":"The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and relat\u2026"}]},{"cik":1593899,"name":"ATEA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016724","doc":"avir-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007672","doc":"avir-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005186","doc":"avir-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-022226","doc":"avir-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-034808","doc":"avir-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-094159","doc":"avir-20251231.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques, including artificial intelligence (\u201cAI\u201d), that are designed to circumvent controls, \u2026"}]},{"cik":1594337,"name":"CORIUM INTERNATIONAL, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-15-002852","doc":"cori-20150930x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-16-010582","doc":"cori-20160930x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-17-009458","doc":"cori-20170930x10k.htm","q":null}]},{"cik":1594805,"name":"SHOPIFY INC.","industry":"Software & IT services","sic":7372,"state":"ON","cells":[{"fy":2024,"lvl":3,"n":42,"adsh":"0001594805-25-000012","doc":"shop-20241231.htm","q":"We expect to continue to leverage emerging technologies including data analytics, machine learning and AI in our products, to help our merchants increase productivity, improve workflows, make smarter decisions and spend less time on operati\u2026"},{"fy":2025,"lvl":3,"n":54,"adsh":"0001594805-26-000007","doc":"shop-20251231.htm","q":"As owners and operators, merchants set their course, while Shopify offers them the tools to seamlessly manage, market and sell their products across various sales channels, including online storefronts, physical retail spaces, AI platforms,\u2026"}]},{"cik":1594864,"name":"JUNO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-485620","doc":"d80362d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001594864-17-000009","doc":"juno-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001594864-18-000005","doc":"juno-123117x10k.htm","q":null}]},{"cik":1595097,"name":"CORBUS PHARMACEUTICALS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-040326","doc":"d854695d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015403","doc":"crbp-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001493152-17-002256","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001493152-18-003208","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003143","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-004077","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-006016","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003145","doc":"crbp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006469","doc":"crbp-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-030133","doc":"crbp-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-037335","doc":"crbp-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-098530","doc":"crbp-20251231.htm","q":null}]},{"cik":1595248,"name":"GENPREX, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001564590-18-008342","doc":"gnpx-10k_20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001564590-19-010279","doc":"gnpx-10k_20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-006522","doc":"gnpx20191231b_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007317","doc":"gnpx20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007680","doc":"gnpx20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008847","doc":"gnpx20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-010426","doc":"gnpx20231231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001437749-25-010311","doc":"gnpx20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-010346","doc":"gnpx20251231_10k.htm","q":null}]},{"cik":1595326,"name":"3D TOTAL SOLUTIONS INC.","industry":"Software & IT services","sic":7370,"state":"CT","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001144204-15-022652","doc":"v407003_10k.htm","q":null}]},{"cik":1595585,"name":"TRICIDA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001595585-19-000069","doc":"a2018123110kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001595585-20-000032","doc":"tcda-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001595585-21-000046","doc":"tcda-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001595585-22-000028","doc":"tcda-20211231.htm","q":null}]},{"cik":1595893,"name":"TURNING POINT THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011492","doc":"tptx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009849","doc":"tptx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002302","doc":"tptx-20211231.htm","q":null}]},{"cik":1595974,"name":"MAGNITE, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2014,"lvl":3,"n":19,"adsh":"0001628280-15-001546","doc":"0001628280-15-001546.txt","q":"Our Advertising Automation Cloud incorporates proprietary machine-learning algorithms, sophisticated data processing, high-volume storage, detailed analytics capabilities, and a distributed infrastructure."},{"fy":2015,"lvl":3,"n":16,"adsh":"0001628280-16-012273","doc":"rubi10k12-31x2015.htm","q":"Table of Contents Our platform incorporates proprietary machine-learning algorithms, sophisticated data processing, high-volume storage, detailed analytics capabilities, and a distributed infrastructure."},{"fy":2016,"lvl":2,"n":11,"adsh":"0001628280-17-002588","doc":"0001628280-17-002588.txt","q":"Our platform incorporates proprietary machine-learning algorithms, sophisticated data processing, high-volume storage, robust analytics capabilities, and a distributed infrastructure."},{"fy":2017,"lvl":2,"n":9,"adsh":"0001595974-18-000020","doc":"rubi10k2017.htm","q":"Our platform incorporates proprietary machine-learning algorithms, sophisticated data processing, robust high-volume analytics capabilities, and a distributed infrastructure."},{"fy":2018,"lvl":"x","n":10,"adsh":"0001595974-19-000043","doc":"rubiq42018.htm","q":"Our platform incorporates proprietary machine-learning algorithms, sophisticated data processing, robust high-volume analytics capabilities, and a distributed infrastructure."},{"fy":2019,"lvl":2,"n":11,"adsh":"0001595974-20-000026","doc":"rubiq42019.htm","q":"Big Data Analytics and Machine-Learning Algorithms A core aspect of our value proposition is our big data and machine-learning/artificial intelligence platform that is able to discover unique insights from our massive data repositories cont\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0001595974-21-000016","doc":"mgni-20201231.htm","q":"Big Data Analytics and Machine-Learning Algorithms; Bid Filtering A core aspect of our value proposition is our big data and machine-learning platform that is able to discover unique insights from our massive data repositories."},{"fy":2021,"lvl":2,"n":9,"adsh":"0001595974-22-000010","doc":"mgni-20211231.htm","q":"Big Data Analytics and Machine-Learning Algorithms; Bid Filtering A core aspect of our value proposition is our big data and machine-learning platform that is able to discover unique insights from our massive data repositories."},{"fy":2022,"lvl":2,"n":11,"adsh":"0001595974-23-000010","doc":"mgni-20221231.htm","q":"(\"Nth Party\"), a developer of cryptographic software for secure audience data sharing and analysis, and in February 2022, we acquired Carbon (AI) Limited (\"Carbon\"), a platform that enables publishers to measure, manage, and monetize audien\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0001595974-24-000014","doc":"exhibit1028-creditagreemen.htm","q":null},{"fy":2024,"lvl":3,"n":28,"adsh":"0001595974-25-000008","doc":"mgni-20241231.htm","q":"Big Data Analytics and Machine-Learning Algorithms; Bid Filtering A core aspect of our value proposition is our big data and machine-learning platform, a subcategory of artificial intelligence, which is able to discover unique insights from\u2026"},{"fy":2025,"lvl":3,"n":67,"adsh":"0001595974-26-000007","doc":"mgni-20251231.htm","q":"This transition is likely to be accelerated by advancements in AI, which have simplified the process and reduced the cost of producing TV-ready ad creatives."}]},{"cik":1596062,"name":"Q BIOMED INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001424884-17-000008","doc":"qbio_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-001966","doc":"qbio_10k113017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-012723","doc":"tv515343_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-027119","doc":"tm205231d1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-029985","doc":"tm211065d1_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-22-000230","doc":"tmb-20211130x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410578-23-001376","doc":"tmb-20221130x10k.htm","q":null}]},{"cik":1596062,"name":"ISMO TECH SOLUTIONS, INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001393905-15-000084","doc":"ismo_10k.htm","q":null}]},{"cik":1596089,"name":"ETERIS B.V.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001193125-15-081181","doc":"d846278d10k.htm","q":null}]},{"cik":1596783,"name":"CATALENT, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001596783-15-000026","doc":"a10-kfy15xq4.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001596783-17-000148","doc":"a10-kfy17xq4.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001596783-18-000101","doc":"a10-kfy18xq4.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001596783-19-000183","doc":"ctlt-20190630.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001596783-20-000155","doc":"ctlt-20200630.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001596783-21-000110","doc":"ctlt-20210630.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001596783-22-000129","doc":"ctlt-20220630.htm","q":"We are changing our approach to employee engagement surveys and will launch a \"pulse survey\" approach in fiscal 2023, using artificial intelligence to deliver an updated engagement score at least every 6 months."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001596783-23-000185","doc":"ctlt-20230630.htm","q":"Artificial intelligence-based platforms present new risks and challenges to our business."},{"fy":2024,"lvl":3,"n":15,"adsh":"0001596783-24-000087","doc":"ctlt-20240630.htm","q":"Artificial intelligence-based platforms present new risks and challenges to our business."}]},{"cik":1596961,"name":"RIDENOW GROUP, INC.","industry":"Software & IT services","sic":7371,"state":"AZ","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001077048-15-000013","doc":"form10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001393905-16-000769","doc":"svtc_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-001101","doc":"svtc_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001654954-18-001935","doc":"rmbl10k.htm","q":null},{"fy":2018,"lvl":1,"n":2,"adsh":"0001654954-19-003849","doc":"rmbl_10k.htm","q":"Included in these new technology development projects and initiatives were modules or significant upgrades to existing platforms for: (i) Retail online auction; (ii) Native App in IOS and Android; (iii) new architecture on website design an\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001654954-20-006126","doc":"rmbl_10k.htm","q":"Included in these new technology development projects and initiatives were modules or significant upgrades to existing platforms for: (i) Retail online auction; (ii) Native App in IOS and Android; (iii) new architecture on website design an\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001654954-21-003633","doc":"rmbl_10k.htm","q":"Included in these new technology development projects and initiatives are modules or significant upgrades to the existing platforms for: (i) Retail and dealer online auctions; (ii) native IOS and Android apps; (iii) new architecture on webs\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0001596961-22-000008","doc":"rmbl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001596961-23-000007","doc":"rmbl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001596961-24-000021","doc":"rmbl-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001596961-25-000024","doc":"rmbl-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001596961-26-000015","doc":"rdnw-20251231.htm","q":"Additionally, any integration of artificial intelligence in our or any service providers\u2019 operations, products or services is expected to pose new or unknown cybersecurity risks and challenges."}]},{"cik":1597033,"name":"SABRE CORP","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001223","doc":"sabr-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001597033-16-000136","doc":"sabr-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001597033-17-000026","doc":"sabr1231201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001597033-18-000023","doc":"sabr1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001597033-19-000018","doc":"sabr1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001597033-20-000026","doc":"sabr-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001597033-21-000022","doc":"sabr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001597033-22-000015","doc":"sabr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001597033-23-000011","doc":"sabr-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":13,"adsh":"0001597033-24-000020","doc":"sabr-20231231.htm","q":"A variety of products and services run on this technology infrastructure: high-volume air and hotel shopping systems; sales and support applications for airlines, hotels, and travel agencies; airline and hotel inventory management and opera\u2026"},{"fy":2024,"lvl":3,"n":22,"adsh":"0001597033-25-000027","doc":"sabr-20241231.htm","q":"We expect to see ongoing improvements in developer productivity, operational efficiency, and customer capabilities by utilizing generative artificial intelligence (\"AI\") technologies."},{"fy":2025,"lvl":3,"n":27,"adsh":"0001628280-26-008800","doc":"sabr-20251231.htm","q":"In 2024, we launched SabreMosaic TM Airline Technology, a proprietary offer and order retailing platform for airlines that is designed and built on a modular, artificial intelligence (\"AI\")-enabled open technology structure, enabling airlin\u2026"}]},{"cik":1597264,"name":"BLUEPRINT MEDICINES CORP","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004066","doc":"bpmc-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001547","doc":"bpmc-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-000862","doc":"bpmc-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001094","doc":"bpmc-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-000784","doc":"bpmc-20191231x10k2c5dea.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001141","doc":"bpmc-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001316","doc":"bpmc-20211231x10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001558370-23-001465","doc":"bpmc-20221231x10k.htm","q":"For example, in February 2022 we entered into a collaboration with Proteovant to research and advance novel targeted protein degrader therapies leveraging Proteovant\u2019s artificial intelligence-enhanced targeted protein degradation platform a\u2026"},{"fy":2023,"lvl":3,"n":17,"adsh":"0001558370-24-001254","doc":"bpmc-20231231x10k.htm","q":"For example, in February 2022 we entered into a collaboration with Proteovant to research and advance novel targeted protein degrader therapies leveraging Proteovant\u2019s artificial intelligence-enhanced targeted protein degradation platform a\u2026"},{"fy":2024,"lvl":3,"n":35,"adsh":"0001558370-25-000953","doc":"bpmc-20241231x10k.htm","q":"Cyber-attacks also could include wrongful conduct by employees or vendors, phishing attempts or e-mail fraud to cause payments or information to be transmitted to an unintended recipient and could include the use of artificial intelligence \u2026"}]},{"cik":1597553,"name":"SAGE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001193125-15-081090","doc":"d862496d10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-485683","doc":"d111598d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002434","doc":"sage-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002772","doc":"sage-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003191","doc":"sage-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007021","doc":"sage-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007819","doc":"sage-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006495","doc":"sage-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002964","doc":"sage-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-014934","doc":"sage-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0000950170-25-017909","doc":"sage-20241231.htm","q":"In addition, cyber-attacks against us or against third parties we do business with could also utilize phishing attempts, email fraud, or attempts to cause payments, confidential or sensitive information, or other data to be transmitted to a\u2026"}]},{"cik":1598014,"name":"IHS MARKIT LTD.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001598014-17-000024","doc":"q41610k.htm","q":null},{"fy":2017,"lvl":1,"n":1,"adsh":"0001598014-18-000020","doc":"q41710k.htm","q":"Current areas of significant technological change include artificial intelligence, mobility, cloud-based computing, blockchain, speed of availability of data, and the processing and analyzing of large amounts of data."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001598014-19-000017","doc":"q41810k.htm","q":"Current areas of significant technological change include artificial intelligence, mobility, cloud-based computing, blockchain, speed of availability of data, and the storing, processing, and analysis of large amounts of data."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001598014-20-000008","doc":"q41910k.htm","q":"Current areas of significant technological change include artificial intelligence, mobility, cloud-based computing, blockchain, speed of availability of data, and the storing, processing, and analysis of large amounts of data."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001598014-21-000015","doc":"info-20201130.htm","q":"Current areas of significant technological change include artificial intelligence, mobility, cloud-based computing, blockchain, speed of availability of data, and the storing, processing, and analysis of large amounts of data."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001598014-22-000011","doc":"info-20211130.htm","q":"Current areas of significant technological change include artificial intelligence, mobility, cloud-based computing, blockchain, speed of availability of data, and the storing, processing, and analysis of large amounts of data."}]},{"cik":1598646,"name":"MINERVA NEUROSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-002008","doc":"nerv-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014641","doc":"nerv-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004048","doc":"nerv-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005224","doc":"nerv-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007246","doc":"nerv-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009243","doc":"nerv-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011340","doc":"nerv-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007853","doc":"nerv-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006577","doc":"nerv-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-018392","doc":"nerv-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-026055","doc":"nerv-20241231.htm","q":"We and the third parties with whom we work may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake,\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001193125-26-101117","doc":"nerv-20251231.htm","q":"We and the third parties with whom we work may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake,\u2026"}]},{"cik":1599298,"name":"SUMMIT THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001599298-21-000011","doc":"smmt-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001599298-22-000032","doc":"smmt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001599298-23-000034","doc":"smmt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001599298-24-000031","doc":"smmt-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001599298-25-000048","doc":"smmt-20241231.htm","q":"Advances in computer capabilities, discoveries in the field of artificial intelligence, cryptography, inadequate facility security or other developments may result in a compromise or breach of the technology we use to safeguard sensitive in\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001599298-26-000015","doc":"smmt-20251231.htm","q":"Advances in computer capabilities, discoveries in the field of artificial intelligence, cryptography, inadequate facility security or other developments may result in a compromise or breach of the technology we use to safeguard sensitive in\u2026"}]},{"cik":1599901,"name":"AVIDITY BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013157","doc":"rna-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008049","doc":"rna-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001599901-23-000009","doc":"rna-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001599901-24-000025","doc":"rna-20231231.htm","q":"Generative artificial intelligence (AI) resources that are publicly available also present a risk that a company may inadvertently obtain, incorporate or use a third party's intellectual property."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001599901-25-000059","doc":"rna-20241231.htm","q":"Generative artificial intelligence (AI) resources that are publicly available also present a risk that a company may inadvertently obtain, incorporate or use a third party's intellectual property."},{"fy":2025,"lvl":3,"n":16,"adsh":"0001599901-26-000031","doc":"rna-20251231.htm","q":"Generative artificial intelligence (AI) resources that are publicly available also present a risk that a company may inadvertently obtain, incorporate or use a third party's intellectual property."}]},{"cik":1599947,"name":"TERRAFORM POWER, INC.","industry":"Utilities","sic":4911,"state":"NY","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001599947-15-000013","doc":"terp201410-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001599947-16-000244","doc":"terp201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001599947-17-000076","doc":"terp201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001599947-18-000017","doc":"terp201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001599947-19-000004","doc":"terp201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001599947-20-000012","doc":"terp-20191231.htm","q":null}]},{"cik":1600132,"name":"BELLEROPHON THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001600132-16-000025","doc":"blph12312015-10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001600132-17-000006","doc":"blph12312016-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001600132-18-000034","doc":"blph-12312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001600132-19-000056","doc":"blph-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001600132-20-000039","doc":"blph-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002768","doc":"blph-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004898","doc":"blph-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-005200","doc":"blph-20221231x10k.htm","q":null}]},{"cik":1600620,"name":"AURINIA PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"AB","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-003060","doc":"auph-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004082","doc":"auph-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005341","doc":"auph-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001600620-24-000012","doc":"auph-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001600620-25-000011","doc":"auph-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001600620-26-000017","doc":"auph-20251231.htm","q":null}]},{"cik":1600847,"name":"GAMIDA CELL LTD.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2021,"lvl":2,"n":9,"adsh":"0001213900-22-014643","doc":"f10k2021_gamidacellltd.htm","q":"(2) Consists of: (i) 1,533,744 ordinary shares and 160,743 ordinary shares issuable upon exercise of outstanding warrants held by Clal Biotechnology Industries Ltd., or CBI; (ii) 1,374,377 ordinary shares held by Bio Medical Investment (199\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001213900-23-024935","doc":"f10k2022_gamidacell.htm","q":"Consists of: (i) 1,507,369 ordinary shares held by Clal Biotechnology Industries Ltd., or CBI; (ii) 1,374,377 ordinary shares held by Bio Medical Investment (1997) Ltd., or Bio Medical, a wholly owned subsidiary of CBI; (iii) 3,750,000 ordi\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001213900-24-026229","doc":"ea0202430-10k_gamida.htm","q":"During times of war and other major conflicts, we, the third parties upon which we rely, and our customers may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our syste\u2026"}]},{"cik":1601485,"name":"ELICIO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001601485-22-000022","doc":"angn-20211231.htm","q":"Omenn has served as a director of Galectin Therapeutics Inc., a biotechnology company (Nasdaq: GALT), and since 2020 as a director of Amesite Inc, an AI-based educational technology company (Nasdaq: AMST)."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001601485-23-000011","doc":"angn-20221231.htm","q":"Omenn has served as a director of Galectin Therapeutics Inc., a biotechnology company (Nasdaq: GALT), and since 2020 as a director of Amesite Inc, an AI-based educational technology company (Nasdaq: AMST)."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001601485-24-000023","doc":"angn-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001601485-25-000049","doc":"angn-20241231.htm","q":"We are subject to, and may in the future become subject to, U.S. federal and state, and foreign, stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy, artificial intell\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001601485-26-000027","doc":"angn-20251231.htm","q":"We are subject to, and may in the future become subject to, U.S. federal and state, and foreign, stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy, artificial intell\u2026"}]},{"cik":1601830,"name":"RECURSION PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"UT","cells":[{"fy":2021,"lvl":3,"n":22,"adsh":"0001601830-22-000012","doc":"rxrx-20211231.htm","q":"Contemporaneously, technological innovations, such as machine learning (ML) have transformed complex industries - from media to transportation to e-commerce - through the creation of scalable and continuously improving iterative cycles of d\u2026"},{"fy":2022,"lvl":3,"n":44,"adsh":"0001601830-23-000010","doc":"rxrx-20221231.htm","q":"Development of one of the largest fit-for-purpose proprietary biological and chemical datasets in the world at a time when advances in AI paired with the right training data are creating disruptive value."},{"fy":2023,"lvl":3,"n":187,"adsh":"0001601830-24-000019","doc":"rxrx-20231231.htm","q":"Our world is transiting its next industrial revolution based on extraordinary progress in automation, computation, machine learning (ML), and artificial intelligence (AI)."},{"fy":2024,"lvl":3,"n":244,"adsh":"0001601830-25-000035","doc":"rxrx-20241231.htm","q":"We believe that rapid commoditization of artificial intelligence creates a once-in-a-generation market opportunity for companies with the ability to build the right datasets in biology and chemistry to win."},{"fy":2025,"lvl":3,"n":226,"adsh":"0001601830-26-000039","doc":"rxrx-20251231.htm","q":"This platform provides end-to-end, AI-native capabilities that span from novel biological ideas through the clinic, integrating multimodal biological data generation, AI-powered small molecule synthesis, and AI-enabled clinical development."}]},{"cik":1602409,"name":"FINGERMOTION, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-014775","doc":"fngr20180228_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-011984","doc":"fngr20190228_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001520138-21-000306","doc":"fngr-20210228_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001520138-22-000237","doc":"fngr-20220228_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001520138-23-000249","doc":"fngr-20230228_10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001520138-24-000219","doc":"fngr-20240229_10k.htm","q":"Sapientus is strategically focused on developing and promoting our core analytic products to the market, specifically: \u25a0 enhancing modeling precision by incorporating additional insurance datasets; \u25a0 expanding modeling efforts to cover vari\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001520138-25-000162","doc":"fngr-20250228_10k.htm","q":"By leveraging our expertise in data integration, mobile and satellite communications, and software development, we launched an Advanced Mobile Integrated Command and Communication Platform (the \u201c C2 Platform \u201d) which equips emergency respon\u2026"}]},{"cik":1603015,"name":"VIA TRANSPORTATION, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2025,"lvl":3,"n":94,"adsh":"0001603015-26-000008","doc":"via-20251231.htm","q":"BUSINESS Overview Via transforms antiquated and siloed public transportation systems into smart, data-driven, and AI-powered efficient digital networks."}]},{"cik":1603145,"name":"XPLR INFRASTRUCTURE, LP","industry":"Utilities","sic":4911,"state":"FL","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001603145-15-000019","doc":"nep-12312014x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001603145-16-000139","doc":"nep1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001603145-17-000013","doc":"nep1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001603145-18-000007","doc":"nep1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001603145-19-000014","doc":"nep1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001603145-20-000006","doc":"nep-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001603145-21-000008","doc":"nep-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001603145-22-000012","doc":"nep-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001603145-23-000005","doc":"nep-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001603145-24-000005","doc":"nep-20231231.htm","q":"In addition, the advancement of artificial intelligence has given rise to added vulnerabilities and potential entry points for cyberattacks."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001603145-25-000006","doc":"xplr-20241231.htm","q":"In addition, the advancement of artificial intelligence has given rise to added vulnerabilities and potential entry points for cyberattacks."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001603145-26-000007","doc":"xplr-20251231.htm","q":"In addition, the advancement of artificial intelligence has given rise to added vulnerabilities and potential entry points for cyberattacks."}]},{"cik":1603207,"name":"NOTABLE LABS, LTD.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007533","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-24-014342","doc":"form10-k.htm","q":"From December 2020 to March 2021 he served as a senior advisor to Ordaos, an AI drug design and development company."}]},{"cik":1603345,"name":"AGENTIX CORP.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-005401","doc":"agtx_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001477932-25-005077","doc":"agtx_10k.htm","q":null}]},{"cik":1604191,"name":"GRIDAI TECHNOLOGIES CORP.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001654954-17-002925","doc":"azrx10k_dec312016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-002715","doc":"azrx10k123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-003863","doc":"azrx10k_dec312018.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001654954-20-003530","doc":"azrx10k_dec312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-21-003659","doc":"azrx10k_dec312020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-012347","doc":"brhc10035487_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410578-23-000299","doc":"fwbi-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":8,"adsh":"0001410578-24-000364","doc":"fwbi-20231231x10k.htm","q":"Research on Capeserod and subsequent artificial intelligence (\u201c AI \u201d) empowered analyses suggest that the drug possesses a unique mechanism of action that is applicable to several GI indications underserved by currently available therapeuti\u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001410578-25-000618","doc":"ento-20241231x10k.htm","q":"Research on Capeserod and subsequent artificial intelligence (\u201c AI \u201d) empowered analyses suggest that the drug possesses a unique mechanism of action that is applicable to several GI indications underserved by currently available therapeuti\u2026"},{"fy":2025,"lvl":3,"n":363,"adsh":"0001104659-26-054106","doc":"grdx-20251231x10k.htm","q":"BUSINESS \u200b Overview GridAI Technologies Corp., formerly known as Entero Therapeutics, Inc., is a diversified technology and life sciences company operating through two principal areas: (i) energy orchestration and grid optimization software\u2026"}]},{"cik":1604464,"name":"ATARA BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001564590-15-001038","doc":"atra-10k_20141231.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014061","doc":"atra-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003792","doc":"atra-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003390","doc":"atra-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004275","doc":"atra-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007027","doc":"atra-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009854","doc":"atra-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007633","doc":"atra-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002185","doc":"atra-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037644","doc":"atra-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-035507","doc":"atra-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-108361","doc":"atra-20251231.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to use of AI to review product applications."}]},{"cik":1604477,"name":"SQZ BIOTECHNOLOGIES CO","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013996","doc":"sqz-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003930","doc":"sqz-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009203","doc":"sqz-20221231.htm","q":null}]},{"cik":1604778,"name":"QORVO, INC.","industry":"Computers & chips","sic":3674,"state":"NC","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001604778-15-000051","doc":"qorvo20150328-10xk.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001604778-16-000175","doc":"qorvo2016040210-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001604778-17-000031","doc":"qorvo2017040110-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001604778-18-000023","doc":"qorvo2018033110-k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001604778-19-000031","doc":"qorvo2019033010-k.htm","q":"We are also engaged with overall ecosystem providers to develop products that enable new use cases and markets in the smart home, such as artificial intelligence-based systems that enable the elderly to continue to live safely in their home\u2026"},{"fy":2019,"lvl":"x","n":0,"adsh":"0001604778-20-000030","doc":"qorvo2020032810-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001604778-21-000032","doc":"rfmd-20210403.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001604778-22-000029","doc":"rfmd-20220402.htm","q":"This is enabling new data-driven intelligent applications that combine global hyper-connectivity with artificial intelligence and machine learning capabilities."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001604778-23-000055","doc":"rfmd-20230401.htm","q":"This is enabling new data-driven intelligent applications that combine global connectivity with advanced capabilities, including artificial intelligence and machine learning."},{"fy":2023,"lvl":2,"n":8,"adsh":"0001604778-24-000036","doc":"rfmd-20240330.htm","q":"Infrastructure Data-intensive use cases such as machine learning, industrial automation, robotics and augmented reality/virtual reality (\"AR/VR\") are increasing the performance and capacity requirements of wired and wireless 5G networks."},{"fy":2024,"lvl":2,"n":13,"adsh":"0001604778-25-000041","doc":"rfmd-20250329.htm","q":"In the infrastructure market, data-intensive use cases such as machine learning, industrial automation, robotics and augmented reality/virtual reality (\"AR/VR\") are increasing the performance and capacity requirements of wired and wireless \u2026"}]},{"cik":1604950,"name":"SCPHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008726","doc":"0001564590-19-008726.txt","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012500","doc":"scph-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014898","doc":"scph-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004297","doc":"scph-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009201","doc":"scph-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-030780","doc":"scph-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-042159","doc":"scph-20241231.htm","q":null}]},{"cik":1605024,"name":"IDDRIVEN, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-000628","doc":"iddr_10k.htm","q":null}]},{"cik":1605674,"name":"STALLION SYNERGIES, INC","industry":"Pharma & biotech","sic":8731,"state":"NY","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001213900-15-002090","doc":"f10k2014_stallionsynergies.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001019687-16-005514","doc":"stallion_10k-123115.htm","q":null}]},{"cik":1605931,"name":"CODE NAVY","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001002334-15-000063","doc":"codenavy10k2015.htm","q":null}]},{"cik":1606163,"name":"LIMBACH HOLDINGS, INC.","industry":"Construction","sic":1700,"state":"PA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-020753","doc":"v462647_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-018709","doc":"tv487628_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-019702","doc":"tv516315_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001628280-20-007572","doc":"lmb-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-005652","doc":"lmb-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-006391","doc":"lmb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-007012","doc":"lmb-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-010995","doc":"lmb-20231231.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."},{"fy":2024,"lvl":2,"n":13,"adsh":"0001628280-25-011745","doc":"lmb-20241231.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks by introducing new vulnerabilities."},{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-013285","doc":"lmb-20251231.htm","q":"The increasing sophistication of cyber threats, growing reliance on cloud-based and third-party platforms, greater system interconnectivity, and the expanding use of artificial intelligence technologies may further increase our exposure to \u2026"}]},{"cik":1606268,"name":"VIA RENEWABLES, INC.","industry":"Utilities","sic":4931,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001606268-15-000035","doc":"spke1231201410k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001606268-16-000225","doc":"spke1231201510k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001606268-17-000012","doc":"spke1231201610k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001606268-18-000017","doc":"spke1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001606268-19-000008","doc":"spke1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001606268-20-000008","doc":"spke1231201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001606268-21-000015","doc":"spke-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001606268-22-000008","doc":"spke-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001606268-23-000009","doc":"spke-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001606268-24-000008","doc":"spke-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001606268-25-000006","doc":"spke-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001606268-26-000013","doc":"spke-20251231.htm","q":"Our use of automation, artificial intelligence and third-party tools could expose us to operational, legal, regulatory and reputational risks."}]},{"cik":1607678,"name":"VIKING THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014212","doc":"vktx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004911","doc":"vktx-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004757","doc":"vktx-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007584","doc":"vktx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006766","doc":"vktx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006406","doc":"vktx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-004429","doc":"vktx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-001685","doc":"vktx-10k_20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-012322","doc":"vktx-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-027824","doc":"vktx-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-046876","doc":"vktx-20251231.htm","q":"These actions and proposals may, for example, include directives: (1) reducing agency workforce and cutting programs; (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMNI, to\u2026"}]},{"cik":1609151,"name":"WEAVE COMMUNICATIONS, INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001609151-22-000008","doc":"weav-20211231.htm","q":"Customer Success and Support We offer phone, AI-driven support solutions, web-chat and email-based support staff to resolve technical and operational issues for our customers, if and when such issues arise."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001609151-23-000004","doc":"weav-20221231.htm","q":"Customer Success and Support We offer phone, AI-driven support solutions, web-chat and email-based support staff to resolve technical and operational issues for our customers, if and when such issues arise."},{"fy":2023,"lvl":3,"n":20,"adsh":"0001609151-24-000021","doc":"weav-20231231.htm","q":"Weave\u2019s Response Assistant uses generative AI technology to create custom, relevant responses to patient reviews to increase reputation management efficiency."},{"fy":2024,"lvl":3,"n":31,"adsh":"0001609151-25-000022","doc":"weav-20241231.htm","q":"Instead of a fragmented set of tools, Weave offers an AI-powered solution that spans all forms of communication and engagement including physical and softphones, messaging, email marketing, insurance verification, online appointment schedul\u2026"},{"fy":2025,"lvl":3,"n":53,"adsh":"0001609151-26-000016","doc":"weav-20251231.htm","q":"Overview Weave is a leading AI-powered patient communications, engagement, and payments platform purpose-built for small and medium-sized (\u201cSMB\u201d) healthcare practices."}]},{"cik":1609351,"name":"SPARK THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001609351-16-000020","doc":"spark-201510xk.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001609351-17-000017","doc":"spark-201610xk.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001609351-18-000026","doc":"spark-201710xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001609351-19-000042","doc":"spark-201810xk.htm","q":null}]},{"cik":1609472,"name":"GH CAPITAL INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001520138-16-001306","doc":"ghci-20160930_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001520138-17-000383","doc":"ghhc-20170930_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001520138-18-000353","doc":"ghhc-20180930_10k.htm","q":null}]},{"cik":1609809,"name":"SERES THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014692","doc":"mcrb-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004551","doc":"mcrb-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004830","doc":"mcrb-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006423","doc":"mcrb-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008002","doc":"mcrb-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010057","doc":"mcrb-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002435","doc":"mcrb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006374","doc":"mcrb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-025464","doc":"mcrb-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-038427","doc":"mcrb-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":19,"adsh":"0001193125-26-103276","doc":"mcrb-20251231.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques, including artificial intelligence (\"AI\"), that are designed to circumvent controls, \u2026"}]},{"cik":1610092,"name":"DIPLOMAT PHARMACY, INC.","industry":"Retail","sic":5912,"state":"MI","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001047469-15-001589","doc":"a2223290z10-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001104659-16-101031","doc":"a16-5240_110k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-015229","doc":"a17-1189_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-014114","doc":"a18-1109_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001104659-19-015644","doc":"a19-30111_110k.htm","q":null}]},{"cik":1610532,"name":"HORTONWORKS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-505199","doc":"d78327d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-083587","doc":"d311847d10k.htm","q":null},{"fy":2017,"lvl":1,"n":3,"adsh":"0001193125-18-084131","doc":"d506884d10k.htm","q":"We have the expertise, experience and proven solutions to power modern data applications, including streaming analytics, data science, artificial intelligence and more."}]},{"cik":1610618,"name":"CIDARA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015007","doc":"cdtx-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001610618-17-000013","doc":"cdtx10-k2016x12x31.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001610618-18-000011","doc":"cdtx10-k2017x12x31.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001610618-19-000012","doc":"cdtx10-k2018x12x31.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001610618-20-000011","doc":"cdtx10-k2019x12x31.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001610618-21-000008","doc":"cdtx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001610618-22-000007","doc":"cdtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001610618-23-000021","doc":"cdtx-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0001610618-24-000041","doc":"cdtx-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, \u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0001610618-25-000017","doc":"cdtx-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to, social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fake, and \u2026"}]},{"cik":1610820,"name":"BRIACELL THERAPEUTICS CORP.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-22-029742","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0001493152-23-038298","doc":"form10-k.htm","q":"Using artificial intelligence (\u201cAI\u201d) with ImmunoPrecise Antibodies and Receptor AI, BriaPro will identify drug candidates."},{"fy":2024,"lvl":"x","n":7,"adsh":"0001493152-24-042743","doc":"form10-k.htm","q":"Using artificial intelligence (\u201cAI\u201d) with ImmunoPrecise Antibodies and Receptor AI, BriaPro will identify drug candidates."},{"fy":2025,"lvl":2,"n":7,"adsh":"0001493152-25-018212","doc":"form10-k.htm","q":null}]},{"cik":1610950,"name":"SYNEOS HEALTH, INC.","industry":"Pharma & biotech","sic":8731,"state":"NC","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001610950-15-000007","doc":"incr-20141231x10k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001610950-16-000036","doc":"a2015form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001610950-17-000005","doc":"a2016form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001610950-18-000006","doc":"a2017form10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001610950-19-000008","doc":"a2018form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001610950-20-000043","doc":"synh-20191231.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001564590-21-006471","doc":"synh-10k_20201231.htm","q":"In addition, the emergence of the use of real world evidence and new tools such as machine learning and artificial intelligence that capitalize on the availability of large data sets may reduce the time and costs of the discovery and develo\u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0001564590-22-005428","doc":"synh-10k_20211231.htm","q":"StudyKIK expands our portfolio of patient-direct, technology-enabled solutions while RxDataScience helps biopharma ceutical customers solve challenging problems through advanced analytics, data management, and artificial intelligence."},{"fy":2022,"lvl":2,"n":6,"adsh":"0000950170-23-002928","doc":"synh-20221231.htm","q":"These initiatives include enhancing customer engagement and infusing innovation and insights throughout our operations, integrating artificial intelligence and predictive analytics to drive faster data insights and patient outcomes, leverag\u2026"}]},{"cik":1611019,"name":"CALEMINDER INC","industry":"Software & IT services","sic":7370,"state":"MD","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001558891-15-000033","doc":"clmr-20141231_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001558891-16-000197","doc":"cmnd-20151231_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-001452","doc":"cmnd_10k.htm","q":null}]},{"cik":1611052,"name":"PROCORE TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":12,"adsh":"0001564590-22-008783","doc":"pcor-10k_20211231.htm","q":"We also expect to leverage this data to build artificial intelligence and machine learning functionality into the Procore platform in order to provide customers with ways to automate repetitive tasks, uncover hidden information, and glean a\u2026"},{"fy":2022,"lvl":2,"n":14,"adsh":"0001564590-23-002828","doc":"pcor-10k_20221231.htm","q":"Construction Intelligence is a set of holistic solutions that offers advanced analytics and business intelligence capabilities, allowing customers to capture, manage, and learn from data for streamlined and robust project and portfolio repo\u2026"},{"fy":2023,"lvl":3,"n":27,"adsh":"0001628280-24-006848","doc":"pcor-20231231.htm","q":"Construction Intelligence is a set of holistic products that offers advanced analytics and business intelligence capabilities, allowing customers to capture, manage, and learn from data for streamlined and robust project and portfolio repor\u2026"},{"fy":2024,"lvl":3,"n":34,"adsh":"0001628280-25-008121","doc":"pcor-20241231.htm","q":"Our platform capabilities include: \u2022 Artificial Intelligence (\u201cAI\u201d)."},{"fy":2025,"lvl":3,"n":81,"adsh":"0001628280-26-011055","doc":"pcor-20251231.htm","q":"We also offer agentic AI capabilities to automate workflows across the entire construction lifecycle."}]},{"cik":1611747,"name":"BIONDVAX PHARMACEUTICALS LTD.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-030228","doc":"f10k2022_biondvax.htm","q":null}]},{"cik":1613011,"name":"CODE REBEL CORP","industry":"Software & IT services","sic":7372,"state":"HI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001415889-16-005533","doc":"coderebel10k_dec2015.htm","q":null}]},{"cik":1613780,"name":"DBV TECHNOLOGIES S.A.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-084223","doc":"d929944d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-070467","doc":"d170742d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-058309","doc":"d440378d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001193125-24-062357","doc":"d683856d10k.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001613780-25-000006","doc":"dbvt-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and healthcare models\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-021504","doc":"dbvt-20251231.htm","q":"We and the third parties with whom we work may be subject to a variety of evolving threats, including, but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fak\u2026"}]},{"cik":1613859,"name":"PRA HEALTH SCIENCES, INC.","industry":"Pharma & biotech","sic":8731,"state":"NC","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-010410","doc":"a2227375z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000864","doc":"prah-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-002026","doc":"q4201710kdocument.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001613859-19-000008","doc":"q4201810kdocument.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001613859-20-000007","doc":"q4201910kdocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001613859-21-000011","doc":"prah-20201231.htm","q":null}]},{"cik":1614067,"name":"ARIDIS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001721","doc":"a2238214z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-20-002189","doc":"a2241140z10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-044023","doc":"tm211048-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-045482","doc":"ards-20220330x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-018590","doc":"form10-k.htm","q":null}]},{"cik":1615063,"name":"INSPIRED ENTERTAINMENT, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001615774-17-007114","doc":"s108317_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001615774-18-014163","doc":"s114509_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-007980","doc":"f10k2019_inspiredenter.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018067","doc":"f10k2020_inspiredentertain.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008568","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007974","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-014609","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001641172-25-000737","doc":"0001641172-25-000737.txt","q":"Failure to remediate these material weaknesses or any other material weaknesses that we identify in the future could result in material misstatements in our financial statements. \u25cf Particularly in our Virtuals business, we rely on a relativ\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001493152-26-009479","doc":"form10-k.htm","q":"Notwithstanding this progress, and management\u2019s expectation that all identified material weaknesses will be remedied in the year ending December 31, 2026, failure to remediate these material weaknesses or any other material weaknesses that \u2026"}]},{"cik":1615219,"name":"DECOY THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2014,"lvl":0,"n":0,"adsh":"0001615219-15-000004","doc":"flks2014123110-k.htm","q":null},{"fy":2015,"lvl":0,"n":0,"adsh":"0001615219-16-000118","doc":"flks2015123110-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001615219-17-000021","doc":"flks2016123110-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001615219-18-000018","doc":"flks2017123110-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001615219-19-000008","doc":"flks2018123110-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001615219-20-000014","doc":"flks-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001615219-21-000026","doc":"flks-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001615219-22-000028","doc":"flks-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001615219-23-000030","doc":"flks-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001615219-24-000025","doc":"flks-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001615219-25-000037","doc":"flks-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":53,"adsh":"0001193125-26-134897","doc":"dcoy-20251231.htm","q":"Our IMP 3 ACT\u0099 platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (\"ML\") and artificial intelligence (\"AI\") tools alongside high-speed synthesis techniques to rapidly engi\u2026"}]},{"cik":1615999,"name":"NEUROPATHIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001078782-19-000306","doc":"f10k123118_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001607062-20-000083","doc":"klfe12312019form10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001607062-21-000063","doc":"nptx123120form10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001607062-22-000284","doc":"nptx123121form10k.htm","q":null}]},{"cik":1615999,"name":"TYG SOLUTIONS CORP.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001615999-17-000003","doc":"tyg_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001078782-18-000726","doc":"f10k123117_10k.htm","q":null}]},{"cik":1616156,"name":"WEWARDS, INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001553350-18-001050","doc":"wewa_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001553350-19-000976","doc":"wewa_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001553350-20-000816","doc":"wewa_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001553350-21-000757","doc":"wewa_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001553350-22-000730","doc":"wewa_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001553350-23-000413","doc":"wewa_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001079973-24-001330","doc":"wewa_10k-053124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001079973-25-001354","doc":"wewa_10k.htm","q":null}]},{"cik":1616212,"name":"TRILLIUM THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"ON","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-038350","doc":"tm219504d1_10k.htm","q":null}]},{"cik":1616533,"name":"PENGUIN SOLUTIONS, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-019480","doc":"sgh-10k_20170825.htm","q":null},{"fy":2018,"lvl":3,"n":17,"adsh":"0001564590-18-025456","doc":"sgh-10k_20180831.htm","q":"As a result of our acquisition of Penguin Computing, Inc., or Penguin Computing, in June 2018 and the creation of a new business unit, SMART Specialty Compute & Storage Solutions, or SCSS, we have expanded our serviceable markets into areas\u2026"},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-19-041109","doc":"sgh-10k_20190830.htm","q":"As a result, we have expanded our serviceable markets into areas requiring specialized computing platforms in artificial intelligence, or AI, machine learning, or ML, advanced modeling and high performance computing, or HPC."},{"fy":2020,"lvl":1,"n":4,"adsh":"0001564590-20-047291","doc":"sgh-10k_20200828.htm","q":"In our Specialty Compute and Storage Solutions, or SCSS, product group, we have expanded our serviceable markets into areas requiring specialized computing platforms in artificial intelligence, or AI, machine learning, or ML, advanced model\u2026"},{"fy":2021,"lvl":2,"n":9,"adsh":"0001564590-21-051710","doc":"sgh-10k_20210827.htm","q":"Penguin Computing offers specialized platform solutions for high-performance computing (\u201cHPC\u201d), artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d) and advanced modeling for technology research."},{"fy":2022,"lvl":2,"n":10,"adsh":"0001628280-22-026409","doc":"sgh-20220826.htm","q":"Penguin Computing offers specialized platform solutions for high-performance computing (\u201cHPC\u201d), artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d) and advanced modeling for technology research."},{"fy":2023,"lvl":2,"n":14,"adsh":"0001628280-23-034807","doc":"sgh-20230825.htm","q":"Products include dynamic random access memory (\u201cDRAM\u201d) modules, solid-state/flash storage and other advanced memory solutions critical to networking and telecom, data analytics, artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d)."},{"fy":2024,"lvl":3,"n":50,"adsh":"0001628280-24-043646","doc":"peng-20240830.htm","q":"As part of this transformation, on October 15, 2024 we rebranded as Penguin Solutions\u2122, reflecting our ongoing commitment to delivering leading-edge solutions that solve the complexity of AI."},{"fy":2025,"lvl":3,"n":112,"adsh":"0001616533-25-000061","doc":"peng-20250829.htm","q":"As part of this transformation, on October 15, 2024, we rebranded as Penguin Solutions \u00ae , reflecting our ongoing commitment to delivering leading-edge solutions that solve the complexity of AI."}]},{"cik":1616543,"name":"ASN TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7370,"state":"UT","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001647488-15-000110","doc":"mainbody.htm","q":null}]},{"cik":1616817,"name":"METALDYNE PERFORMANCE GROUP INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013736","doc":"mpg-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003447","doc":"mpg-10k_20161231.htm","q":null}]},{"cik":1617553,"name":"ZIPRECRUITER, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":23,"adsh":"0001617553-22-000012","doc":"zip-20211231.htm","q":"Unique Data and Artificial Intelligence Provide Better Outcomes for Employers and Job Seekers."},{"fy":2022,"lvl":3,"n":30,"adsh":"0001617553-23-000007","doc":"zip-20221231.htm","q":"Unique Data and Artificial Intelligence Provide Better Outcomes for Employers and Job Seekers."},{"fy":2023,"lvl":3,"n":42,"adsh":"0001617553-24-000011","doc":"zip-20231231.htm","q":"Unique Data and Artificial Intelligence Provide Better Outcomes for Employers and Job Seekers."},{"fy":2024,"lvl":3,"n":86,"adsh":"0001617553-25-000011","doc":"zip-20241231.htm","q":"Unique Data and Artificial Intelligence Provide Better Outcomes for Employers and Job Seekers."},{"fy":2025,"lvl":3,"n":111,"adsh":"0001617553-26-000016","doc":"zip-20251231.htm","q":"Our AI-powered marketplace acts as a dedicated matchmaker."}]},{"cik":1617669,"name":"UNIQUE FABRICATING, INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001617669-16-000044","doc":"ufab131610-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001617669-17-000006","doc":"ufab111710-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001617669-18-000012","doc":"ufab12311710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001617669-19-000010","doc":"ufab12301810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001617669-20-000005","doc":"ufab12291910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001617669-21-000022","doc":"ufab-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001617669-22-000021","doc":"ufab-20211231.htm","q":null}]},{"cik":1618561,"name":"NEXVET BIOPHARMA PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-15-007727","doc":"nvet-10k_20150630.htm","q":null}]},{"cik":1618732,"name":"NUTANIX, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001618732-17-000123","doc":"ntnx-07312017x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001618732-18-000131","doc":"ntnx-07312018x10kxq4x18.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001618732-19-000114","doc":"ntnx-07312019x10kxq419.htm","q":"Powered by X-Fit, a purpose-built machine learning technology, and X-Play, a codeless task-automation engine, Prism Pro analyzes large volumes of system data to generate actionable insights and automate remediation and everyday tasks."},{"fy":2020,"lvl":0,"n":0,"adsh":"0001618732-20-000112","doc":"ntnx-20200731.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-21-001852","doc":"ntnx-20210731.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-018732","doc":"ntnx-20220731.htm","q":null},{"fy":2023,"lvl":3,"n":56,"adsh":"0000950170-23-049179","doc":"ntnx-20230731.htm","q":"The Nutanix Cloud Platform\u2019s scale-out architecture, enterprise-grade data services and freedom of infrastructure choice enable customers to standardize on the Nutanix Cloud Platform as a single cloud platform to run a wide variety of their\u2026"},{"fy":2024,"lvl":3,"n":89,"adsh":"0000950170-24-108159","doc":"ntnx-20240731.htm","q":"Nutanix Cloud Platform supports a wide variety of workloads with varied compute, storage, and network requirements, including business-critical applications, data platforms (including SQL and NoSQL databases and business intelligence applic\u2026"},{"fy":2025,"lvl":3,"n":112,"adsh":"0001193125-25-213801","doc":"ntnx-20250731.htm","q":"(\"we,\" \"us,\" \"our,\" or \"Nutanix\") is a hybrid multicloud computing leader, offering organizations a unified software platform for running applications and AI and managing data anywhere."}]},{"cik":1618835,"name":"EVOFEM BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015451","doc":"neot-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005093","doc":"neot-10k_20161231.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001564590-18-003259","doc":"evfm-10k_20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001618835-19-000031","doc":"evfm-1231201810xk.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001618835-20-000047","doc":"evfm-1231201910xk.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001618835-21-000040","doc":"evfm-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001618835-22-000057","doc":"evfm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001618835-23-000023","doc":"evfm-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011404","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-000188","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-009686","doc":"form10-k.htm","q":null}]},{"cik":1618921,"name":"WALGREENS BOOTS ALLIANCE, INC.","industry":"Retail","sic":5912,"state":"IL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001140361-15-038791","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001140361-16-083198","doc":"form10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001618921-17-000069","doc":"wba-2017831x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001628280-18-012472","doc":"wba-2018831x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001618921-19-000069","doc":"wba-2019831x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001618921-20-000082","doc":"wba-20200831.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001618921-21-000085","doc":"wba-20210831.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001618921-22-000064","doc":"wba-20220831.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001618921-23-000062","doc":"wba-20230831.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001618921-24-000084","doc":"wba-20240831.htm","q":"There are also substantial risks associated with our continued integration of artificial intelligence and machine learning within our technology systems."}]},{"cik":1619087,"name":"STEADYMED LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-16-011705","doc":"a2227769z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-002147","doc":"a2231548z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-002396","doc":"a2235047z10-k.htm","q":null}]},{"cik":1619227,"name":"CLOUDWEB, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-000788","doc":"clow_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-18-000594","doc":"clow_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-19-000398","doc":"clow_10q.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-20-000719","doc":"clow_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-21-000556","doc":"clow_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001640334-22-000465","doc":"clow_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001640334-23-000500","doc":"clow_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001640334-24-000460","doc":"clow_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001640334-25-000318","doc":"clow_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-26-000750","doc":"clow_10k.htm","q":null}]},{"cik":1619856,"name":"CARIBOU BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004233","doc":"crbu-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001619856-23-000037","doc":"crbu-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001619856-24-000013","doc":"crbu-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001619856-25-000015","doc":"crbu-20241231.htm","q":"The disruption and volatility in the global and domestic capital markets resulting from heightened inflation, capital market volatility, interest rate and currency rate fluctuations, artificial intelligence, government agency changes under \u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001619856-26-000008","doc":"crbu-20251231.htm","q":"Any of these factors could depress economic activity and restrict our access to capital, which could materially and adversely affect our business, financial condition, and results of operations. 66 Table of Contents Our use of artificial in\u2026"}]},{"cik":1620463,"name":"LEONABIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015495","doc":"atha-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004782","doc":"atha-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009498","doc":"atha-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-018787","doc":"atha-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-029069","doc":"atha-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-134565","doc":"lona-20251231.htm","q":"ELAINE-1 (NCT03781063) was an open-label, randomized, multicenter, Phase 2 trial, designed as a proof-of-concept of lasofoxifene compared to fulvestrant for the treatment of pre- and postmenopausal women with locally advanced or metastatic \u2026"}]},{"cik":1620546,"name":"BAXALTA INC","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-491806","doc":"d102269d10k.htm","q":null}]},{"cik":1620702,"name":"TERRAFORM GLOBAL, INC.","industry":"Utilities","sic":4911,"state":"MD","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001620702-16-000197","doc":"glbl201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001620702-17-000058","doc":"tfglbl201610-k.htm","q":null}]},{"cik":1621221,"name":"ARTELO BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001640334-21-002983","doc":"artl_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001640334-23-000509","doc":"artl_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001640334-24-000473","doc":"artl_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001640334-25-000335","doc":"artl_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-26-000368","doc":"artl_10k.htm","q":null}]},{"cik":1621227,"name":"ADAPTIMMUNE THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-016024","doc":"a16-22178_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-017694","doc":"a17-27708_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001209","doc":"adap-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001571","doc":"adap-20191231x10kb99908.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001827","doc":"adap-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003489","doc":"adap-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002907","doc":"adap-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002537","doc":"adap-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003544","doc":"adap-20241231x10k.htm","q":null}]},{"cik":1621443,"name":"ZYNERBA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004082","doc":"zync-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-002155","doc":"zyne-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001906","doc":"zyne-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001742","doc":"zyne-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002280","doc":"zyne-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002669","doc":"zyne-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002451","doc":"zyne-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004765","doc":"zyne-20221231x10k.htm","q":null}]},{"cik":1621499,"name":"ALTERNUS ENERGY INC.","industry":"Utilities","sic":4911,"state":"NY","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001477932-20-005725","doc":"altn_10k.htm","q":null}]},{"cik":1622057,"name":"NASCENT BIOTECH INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2014,"lvl":"x","n":0,"adsh":"0001477932-15-004210","doc":"nbio_10k.htm","q":null},{"fy":2015,"lvl":"x","n":0,"adsh":"0001477932-16-011373","doc":"nbio_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-003089","doc":"nbio_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-003263","doc":"nbio_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-19-004048","doc":"nbio_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-003479","doc":"nbio_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-004504","doc":"nbio_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-004396","doc":"nbio_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-004894","doc":"nbio_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-004020","doc":"nbio_10k.htm","q":null}]},{"cik":1622229,"name":"COGENT BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-089299","doc":"d648044d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013188","doc":"umrx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013325","doc":"cogt-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010238","doc":"cogt-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007729","doc":"cogt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-019770","doc":"cogt-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-026115","doc":"cogt-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-053334","doc":"cogt-20251231.htm","q":null}]},{"cik":1622244,"name":"ONE WORLD PRODUCTS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NV","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-010154","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-008948","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-009974","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-017550","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-021067","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-013341","doc":"form10-k.htm","q":null}]},{"cik":1622244,"name":"ONE WORLD PHARMA, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001622244-15-000016","doc":"punto10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-004264","doc":"f10k2016_puntogroup.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-004042","doc":"f10k2017_puntogroupcorp.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-005441","doc":"f10k2018_oneworldpharma.htm","q":null}]},{"cik":1622536,"name":"TALEN ENERGY CORP","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001622536-16-000111","doc":"tln-20151231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001628280-25-008786","doc":"tln-20241231.htm","q":"We are well-positioned to capture this significant growth opportunity, as data centers serving artificial intelligence increasingly demand more reliable, clean power."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001622536-26-000017","doc":"tln-20251231.htm","q":"We are well-positioned to serve this growing industry, as artificial intelligence data centers increasingly demand more reliable power."}]},{"cik":1622676,"name":"TAXUS PHARMACEUTICALS HOLDINGS, INC.","industry":"Retail","sic":5912,"state":"NY","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001549727-15-000093","doc":"txspform10kjune302015v3.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001549727-17-000052","doc":"txspform10kjune302017v4.htm","q":null}]},{"cik":1623526,"name":"STOKE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-012202","doc":"stok-10k_20191231.htm","q":"We leverage large internal datasets of RNAseq from key tissues known to be addressable with antisense, such as the CNS, eye, liver and kidney, that are purpose-built to enhance the capture of non-productive events. 9 We employ machine learn\u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-011760","doc":"stok-10k_20201231.htm","q":"We employ machine learning to iteratively refine our search and scoring criteria for the most addressable non-productive mRNA elements based on internal target validation and Hit identification data."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-009634","doc":"stok-10k_20211231.htm","q":"We employ machine learning to iteratively refine our search and scoring criteria for the most addressable non-productive mRNA elements based on internal target validation and Hit identification data."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001564590-23-003175","doc":"stok-10k_20221231.htm","q":"We employ machine learning to iteratively refine our search and scoring criteria for the most addressable non-productive mRNA elements based on internal target validation and hit identification data."},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-035912","doc":"stok-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-041170","doc":"stok-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-108362","doc":"stok-20251231.htm","q":null}]},{"cik":1623613,"name":"MYLAN N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001623613-16-000046","doc":"myl10k_20151231xdoc.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001623613-17-000007","doc":"myl10k_20161231xdoc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001623613-18-000010","doc":"myl10k_20171231xdoc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001623613-19-000008","doc":"myl10k_20181231xdoc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001623613-20-000011","doc":"myl10k20191231doc.htm","q":null}]},{"cik":1623715,"name":"IMAGO BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004569","doc":"imgo-20211231.htm","q":null}]},{"cik":1624025,"name":"HEAVENSTONE CORP","industry":"Construction","sic":1531,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001010549-16-000743","doc":"hstone10k063016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001104659-19-066998","doc":"tm1920517d1_10k.htm","q":null}]},{"cik":1624658,"name":"ALLENA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006811","doc":"alna-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006630","doc":"alna-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010991","doc":"alna-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012238","doc":"alna-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005192","doc":"alna-20211231.htm","q":null}]},{"cik":1625095,"name":"GLOBAL SMART CAPITAL CORP.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001625095-16-000015","doc":"todexform10kfeb19updated.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-000895","doc":"tod_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-18-001998","doc":"tdxp_10k.htm","q":null}]},{"cik":1625288,"name":"NEXIEN BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-18-013863","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-19-014714","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-018396","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-025119","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-026974","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-23-034480","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-24-041978","doc":"form10-k.htm","q":null}]},{"cik":1625297,"name":"INDIVIOR PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"VA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001625297-25-000016","doc":"indv-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":11,"adsh":"0001628280-26-012237","doc":"indv-20251231.htm","q":"Risks Related to Information Security and Data Privacy \u2022 We are at risk for business interruptions or breaches of data security. \u2022 We are required to maintain the privacy and security of personal information. \u2022 Artificial intelligence prese\u2026"}]},{"cik":1625641,"name":"CS DISCO, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2021,"lvl":3,"n":25,"adsh":"0001625641-22-000025","doc":"law-20211231.htm","q":"Business Overview DISCO provides a cloud-native, artificial intelligence-powered legal solution that simplifies ediscovery, legal document review and case management for enterprises, law firms, legal services providers and governments."},{"fy":2022,"lvl":3,"n":29,"adsh":"0001625641-23-000032","doc":"law-20221231.htm","q":"Business Overview DISCO provides a cloud-native, artificial intelligence-powered legal solution that simplifies legal hold, legal request, ediscovery, legal document review and case management for enterprises, law firms, legal services prov\u2026"},{"fy":2023,"lvl":3,"n":66,"adsh":"0001625641-24-000043","doc":"law-20231231.htm","q":"Business Overview DISCO provides cloud-native, artificial intelligence-powered legal product offerings that simplify legal hold, legal request, ediscovery, legal document review and case management for enterprises, law firms, legal services\u2026"},{"fy":2024,"lvl":3,"n":75,"adsh":"0001625641-25-000027","doc":"law-20241231.htm","q":"Business Overview DISCO provides cloud-native, artificial intelligence-powered legal product offerings that simplify legal hold, legal request, ediscovery, legal document review and case management for enterprises, law firms, legal services\u2026"},{"fy":2025,"lvl":3,"n":84,"adsh":"0001625641-26-000044","doc":"law-20251231.htm","q":"Business Overview DISCO provides cloud-native, artificial intelligence-powered legal product offerings that simplify legal hold, legal request, ediscovery, legal document review and case management for enterprises, law firms, legal services\u2026"}]},{"cik":1626078,"name":"SAVDEN GROUP CORP.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-17-009622","doc":"f10k2017_savdengroup.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-18-012963","doc":"f10k2018_savdengroup.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-19-017919","doc":"f10k2019_savdengroup.htm","q":null}]},{"cik":1626199,"name":"ALPINE IMMUNE SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003896","doc":"nvls-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-000560","doc":"nvls-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006916","doc":"alpn-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001626199-19-000010","doc":"a10k_2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001626199-20-000009","doc":"a10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001626199-21-000038","doc":"alpn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001626199-22-000032","doc":"alpn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001626199-23-000037","doc":"alpn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001626199-24-000048","doc":"alpn-20231231.htm","q":null}]},{"cik":1626450,"name":"COMMERCE.COM, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009501","doc":"bigc-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008093","doc":"bigc-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005598","doc":"bigc-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":13,"adsh":"0000950170-24-022864","doc":"bigc-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0000950170-25-029211","doc":"bigc-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":80,"adsh":"0001193125-26-085687","doc":"bigc-20251231.htm","q":"Overview We are positioned to become the leading provider of an open, AI-driven commerce ecosystem designed to help businesses operate, innovate, and grow as AI-driven and agentic commerce increasingly shape how buyers engage with merchants\u2026"}]},{"cik":1626745,"name":"FORTUNE VALLEY TREASURES, INC.","industry":"Software & IT services","sic":7370,"state":"ON","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001078782-15-001959","doc":"f10k083115_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-16-015846","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-17-013760","doc":"form10-k.htm","q":null}]},{"cik":1626853,"name":"MAJESCO","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001571049-16-015473","doc":"t1601284_10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-17-006007","doc":"t1701520_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001571049-18-000368","doc":"tv494305-10k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001213900-19-009815","doc":"f10k2019_majesco.htm","q":"Based on our forward-thinking and research, we early on identified a technology shift from \u201cold technology monolithic or componentized solutions primarily on-premise\u201d to \u201cmodern technology componentized solutions moving to cloud, microservi\u2026"},{"fy":2019,"lvl":1,"n":1,"adsh":"0001213900-20-016927","doc":"f10k2020_majesco.htm","q":"Based on our forward-thinking and research, we early on identified a technology shift from \u201cold technology monolithic or componentized solutions primarily on-premise\u201d to \u201cmodern technology componentized solutions moving to cloud, microservi\u2026"}]},{"cik":1626878,"name":"XBIOTECH INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001171843-16-008925","doc":"f10k_033016p.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001171843-17-001571","doc":"f10k_031517p.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001171843-18-002043","doc":"f10k_031618p.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001171843-19-001708","doc":"f10k_031319p.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001171843-20-001761","doc":"f10k_031620p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-001828","doc":"xbit20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001171843-22-001904","doc":"xbit20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001171843-23-001705","doc":"xbit20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001171843-24-001382","doc":"xbit20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001171843-25-001527","doc":"xbit20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001171843-26-001561","doc":"xbit20251231_10k.htm","q":null}]},{"cik":1626971,"name":"CORVUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001459","doc":"a2231221z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001209","doc":"a2234682z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001660","doc":"crvs-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002232","doc":"crvs-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003462","doc":"crvs-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003281","doc":"crvs-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-004792","doc":"crvs-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003567","doc":"crvs-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003621","doc":"crvs-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-027047","doc":"crvs-20251231x10k.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques \u2013 including artificial intelligence \u2013 that are designed to circumvent controls, to av\u2026"}]},{"cik":1627014,"name":"BLACK KNIGHT, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001627014-16-000037","doc":"bkfs2015form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001627014-17-000012","doc":"bkfs2016form10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001627014-18-000016","doc":"bki2017form10-k.htm","q":null},{"fy":2018,"lvl":2,"n":12,"adsh":"0001627014-19-000013","doc":"bki2018form10-k.htm","q":"This includes an enhanced digital experience along with the application of artificial intelligence, robotic process automation and adaptive learning."},{"fy":2019,"lvl":2,"n":14,"adsh":"0001627014-20-000005","doc":"bki2019form10-k.htm","q":"This includes an enhanced digital experience along with the application of artificial intelligence, robotic process automation and adaptive learning."},{"fy":2020,"lvl":2,"n":8,"adsh":"0001627014-21-000005","doc":"bki-20201231.htm","q":"This includes an enhanced digital experience along with the application of artificial intelligence, robotic process automation and adaptive learning."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001558370-22-002149","doc":"bki-20211231xex99d2.htm","q":"Lattice is an artificial intelligence powered customer data platform, enabling business-to-business organizations to scale their account-based marketing and sales programs across every channel."},{"fy":2022,"lvl":1,"n":4,"adsh":"0001558370-23-002252","doc":"bki-20221231x10k.htm","q":"This includes an enhanced digital experience along with the application of artificial intelligence, robotic process automation and adaptive learning."}]},{"cik":1627041,"name":"VISIBER57 CORP.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-16-015909","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-17-013854","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-18-016730","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-19-018419","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-022651","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-000377","doc":"form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-035659","doc":"form10-k.htm","q":null}]},{"cik":1627452,"name":"ME RENEWABLE POWER CORP","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001627452-16-000015","doc":"jarex10kfye12312015feb92.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-000592","doc":"jrsc_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001017386-20-000370","doc":"mepw_20171231-10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001017386-20-000379","doc":"mepw_20181231-10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001017386-20-000389","doc":"mepw_20191231-10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001017386-21-000121","doc":"mepw_20201231-10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001017386-22-000208","doc":"mepw_2021dec31-10k.htm","q":null}]},{"cik":1627611,"name":"12 RETECH CORP","industry":"Software & IT services","sic":7371,"state":"NV","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001640334-16-001285","doc":"2015nov30-dvgg_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-001091","doc":"devago_10k.htm","q":null},{"fy":2017,"lvl":"x","n":2,"adsh":"0001493152-18-005212","doc":"form10-k.htm","q":"As CEO of artificial intelligence startup Rokid, Mr."},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005320","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-011425","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-015518","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":8,"adsh":"0001493152-22-008422","doc":"form10-k.htm","q":"Our AI Social Shopping platform App, which is currently in development, will allow merchants to connect with consumers directly, and will give merchants tools to protect their brand and lower their marketing costs which will be focused on r\u2026"}]},{"cik":1627631,"name":"GLOBAL GARD, INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001494733-17-000036","doc":"f10kdecember312016.htm","q":null}]},{"cik":1627857,"name":"SAILPOINT TECHNOLOGIES HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2018,"lvl":1,"n":4,"adsh":"0001564590-19-008122","doc":"sail-10k_20181231.htm","q":"It then applies machine learning technologies to identify suspicious or anomalous behaviors."},{"fy":2019,"lvl":2,"n":13,"adsh":"0001564590-20-006045","doc":"sail-10k_20191231.htm","q":"This is especially true when it comes to our new and expanded SaaS offerings, including artificial intelligence (\u201cAI\u201d) and cloud governance."},{"fy":2020,"lvl":3,"n":21,"adsh":"0001628280-21-003310","doc":"sail-20201231.htm","q":"Organizations globally are investing in technologies such as cloud computing, artificial intelligence (\"AI\") and machine learning (\"ML\") to improve employee productivity, business agility and competitiveness."},{"fy":2021,"lvl":3,"n":22,"adsh":"0001627857-22-000030","doc":"sail-20211231.htm","q":"Organizations globally are investing in technologies such as cloud computing, artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) to improve employee productivity, business agility and competitiveness."}]},{"cik":1628104,"name":"XSPORT GLOBAL, INC.","industry":"Software & IT services","sic":7370,"state":"NC","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001308411-15-000141","doc":"tlltform10k150930.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-17-000060","doc":"tllt_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001140361-18-014328","doc":"form10k.htm","q":null},{"fy":2018,"lvl":"x","n":1,"adsh":"0001140361-19-001959","doc":"form10k.htm","q":"We will continue to target key industries such as home furnishings, automotive, professional services and medical and look to extend more into retail ecommerce development, artificial intelligence applications and SEM/SEO services."}]},{"cik":1628171,"name":"REVOLUTION MEDICINES, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010276","doc":"rvmd-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002297","doc":"rvmd-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004645","doc":"rvmd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-020145","doc":"rvmd-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-027736","doc":"rvmd-20241231.htm","q":"Further, although we have implemented policies regarding limited permitted use of generative artificial intelligence (AI) by our employees, Confidential Information could be leaked, disclosed or revealed as a result of or in connection with\u2026"},{"fy":2025,"lvl":3,"n":33,"adsh":"0001193125-26-071563","doc":"rvmd-20251231.htm","q":"Iambic Collaboration In May 2025, we entered into a collaboration with Iambic Therapeutics (Iambic), pursuant to which Iambic uses its artificial intelligence capabilities to generate customized models through training with our proprietary \u2026"}]},{"cik":1628228,"name":"OPTILEAF, INC.","industry":"Software & IT services","sic":7372,"state":"KS","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001213900-16-012108","doc":"f10k2015_optileafincorp.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003745","doc":"f10k2016_optileafincorp.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-005046","doc":"f10k2017_optileafinc.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-20-043998","doc":"f10k2018_optileafinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-21-035335","doc":"f10k2019_optileafinc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-067598","doc":"f10k2020_optileafinc.htm","q":null}]},{"cik":1628738,"name":"AUDENTES THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004021","doc":"bold-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005154","doc":"bold-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005838","doc":"bold-10k_20181231.htm","q":null}]},{"cik":1629137,"name":"GLOBAL BLOOD THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001629137-16-000028","doc":"a2015form10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001193125-17-080322","doc":"d335897d10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-060818","doc":"d518438d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-054260","doc":"d675140d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-050084","doc":"d843865d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-054629","doc":"d63231d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001781","doc":"gbt-20211231.htm","q":null}]},{"cik":1629205,"name":"INNOVATION1 BIOTECH INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-17-006105","doc":"mycloudz_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-18-005998","doc":"gmvp_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-19-007157","doc":"gmvp_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-20-007273","doc":"gmvp_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-21-009127","doc":"gmvp_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001477932-22-009309","doc":"ivbt_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-000223","doc":"ivbt_10k.htm","q":null}]},{"cik":1630212,"name":"AVALON GLOBOCARE CORP.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024687","doc":"f10k2022_avalonglob.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001213900-24-033023","doc":"ea0202604-10k_avalon.htm","q":"The device is also paired with an \u201cAI Nutritionist\u201d software program (via Bluetooth connection) which is downloadable from Google Play (for Android mobile phones, approved) and iPhone (the app is currently being reviewed by Apple iOS AppSto\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001213900-25-026308","doc":"ea0233310-10k_avalon.htm","q":"The device is also paired with an \u201cAI Nutritionist\u201d software program (via Bluetooth connection) which is downloadable from Google Play (for Android mobile phones, approved) and iPhone It helps users monitor and manage their ketogenic diet a\u2026"}]},{"cik":1630212,"name":"AVALON GLOBOCARE CORP.","industry":"Software & IT services","sic":7371,"state":"NJ","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001558891-16-000191","doc":"glbl-20151231_10k.htm","q":null},{"fy":2025,"lvl":3,"n":130,"adsh":"0001213900-26-036474","doc":"ea0283138-10k_avalon.htm","q":"We are actively seeking complementary bolt-on AI acquisitions that could generate near-term revenue to supplement our current operations as both segments continue to develop."}]},{"cik":1631282,"name":"DATASEA INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001615774-18-009518","doc":"s112591_10k.htm","q":null},{"fy":2019,"lvl":"x","n":2,"adsh":"0001213900-19-020387","doc":"f10k2019_dataseainc.htm","q":null},{"fy":2020,"lvl":"x","n":9,"adsh":"0001213900-20-028670","doc":"f10k2020_dataseainc.htm","q":"As we are currently focusing our effort in the research and development (\u201cR&D\u201d) of our products and software to assist schools and communities in addressing the coronavirus outbreak, providing possible remedy and prevention for the future o\u2026"},{"fy":2021,"lvl":"x","n":40,"adsh":"0001213900-21-050298","doc":"f10k2021_dataseainc.htm","q":"We are currently focusing our efforts on the research and development (\u201cR&D\u201d) of our products and software to assist schools and communities in addressing public health and safety matters, expanding the artificial intelligence application a\u2026"},{"fy":2022,"lvl":3,"n":37,"adsh":"0001213900-22-059573","doc":"f10k2022_dataseainc.htm","q":"(\u201cShuhai Jingwei\u201d) combine artificial intelligence technology and acoustic technology to offer dynamic instead of static products, and demonstrates our vision, ability and advantage to stay ahead of the emerging market trends in acoustic in\u2026"},{"fy":2023,"lvl":"x","n":61,"adsh":"0001213900-23-079920","doc":"f10k2023_datasea.htm","q":"Datasea Acoustics LLC, established on July 31, 2023, represents our strategy of targeting the global market, including the U.S. market, and provides \u201cintelligent acoustics\u201d technology and products, which is a transformative blend of acousti\u2026"},{"fy":2024,"lvl":3,"n":259,"adsh":"0001213900-24-082285","doc":"ea0214480-10k_datasea.htm","q":"Risks Relating to Our Business and Industry We have a limited operating history as a developer of acoustics high tech, 5G AI multimodal digital and other products and services."},{"fy":2025,"lvl":"x","n":227,"adsh":"0001213900-25-092109","doc":"ea0258028-10k_datasea.htm","q":"Risks Relating to and financial condition and Capital Requirements We have a limited operating history as a developer of acoustics high tech, AI multimodal digital and other products and services."}]},{"cik":1631547,"name":"ROID GROUP, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001504412-16-000227","doc":"roidform10k123115_10k.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001511164-17-000418","doc":"f10k12312016.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001511164-19-000025","doc":"0001511164-19-000025.txt","q":null}]},{"cik":1631574,"name":"WAVE LIFE SCIENCES LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001193125-16-523890","doc":"d132744d10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004649","doc":"wve-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005308","doc":"wve-10k_20171231.htm","q":null},{"fy":2018,"lvl":2,"n":5,"adsh":"0001564590-19-005671","doc":"wve-10k_20181231.htm","q":"By exploring these interactions through iterative analysis of in vitro and in vivo outcomes and artificial intelligence-driven predictive modeling, we continue to define design principles that we deploy across programs to rapidly develop an\u2026"},{"fy":2019,"lvl":1,"n":3,"adsh":"0001564590-20-007972","doc":"wve-10k_20191231.htm","q":"By exploring these interactions through iterative analysis of in vitro and in vivo outcomes and artificial intelligence-driven predictive modeling, we continue to define design principles that we deploy across programs to rapidly develop an\u2026"},{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-21-010718","doc":"wve-10k_20201231.htm","q":"By exploring these interactions through iterative analysis of in vitro and in vivo outcomes and machine learning-driven predictive modeling, we continue to define design principles that we deploy across programs to rapidly develop and manuf\u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0001564590-22-008414","doc":"wve-10k_20211231.htm","q":"Through continued exploration of these interactions using iterative analysis of in vitro and in vivo outcomes and machine learning-driven predictive modeling, we also continue to refine our design principles that we deploy across subsequent\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-009319","doc":"wve-20221231.htm","q":"Moreover, through continued exploration of these interactions using iterative analysis of in vitro and in vivo outcomes and machine learning-driven predictive modeling, we also continue to refine our design principles that we deploy across \u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-026876","doc":"wve-20231231.htm","q":"Utilizing our proprietary \u201cedit-verse,\u201d which is powered by genetic datasets and deep learning models, we have identified several RNA editing targets that leverage easily accessible biomarkers, offer efficient paths to proof-of-concept in h\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-031322","doc":"wve-20241231.htm","q":"Utilizing our proprietary \u201cedit-verse,\u201d which is powered by genetic datasets and deep learning models, we have identified several RNA editing targets in indications that leverage easily accessible biomarkers, offer efficient paths to proof-\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-073472","doc":"wve-20251231.htm","q":"We are utilizing a combination of human genetics and AI for target discovery and oligonucleotide design, and we have initiated a number of preclinical RNA editing and RNAi programs supported by evidence from human genetics, that leverage ea\u2026"}]},{"cik":1631650,"name":"AIMMUNE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-013998","doc":"aimt-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004466","doc":"aimt-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-002466","doc":"aimt-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005514","doc":"aimt-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007384","doc":"aimt-10k_20191231.htm","q":null}]},{"cik":1633070,"name":"AXCELLA HEALTH INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2019,"lvl":1,"n":2,"adsh":"0001633070-20-000012","doc":"axla-20191231.htm","q":"Ultimately, we envision utilizing AxcellaKB and its internal machine learning capabilities to identify EMM compositions, predict their effects on biology and identify new target areas for our platform."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001633070-21-000009","doc":"axla-20201231.htm","q":"Ultimately, we envision utilizing AxcellaKB and its internal machine learning capabilities to identify EMM compositions, predict their effects on biology and identify new target areas for our platform."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001633070-22-000010","doc":"axla-20211231.htm","q":"This platform integrates advanced data science, cell biology capability, and expertise, leveraging artificial intelligence, machine learning and big data sets that are available both publicly and through institutional human data registries."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001633070-23-000007","doc":"axla-20221231.htm","q":"This platform integrates advanced data science, cell biology capability, and expertise, leveraging artificial intelligence, machine learning and big data sets that are available both publicly and through institutional human data registries."}]},{"cik":1633931,"name":"TOPBUILD CORP","industry":"Construction","sic":1700,"state":"FL","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-003817","doc":"bld-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001142","doc":"bld-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001168","doc":"bld-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001088","doc":"bld-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001326","doc":"bld-20191231x10ka9e256.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001466","doc":"bld-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001590","doc":"bld-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001903","doc":"bld-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001999","doc":"bld-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001495","doc":"bld-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-020481","doc":"bld-20251231x10k.htm","q":null}]},{"cik":1633932,"name":"ESSA PHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-20-014403","doc":"tmb-20200930x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-016181","doc":"tmb-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-018570","doc":"tmb-20220930x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-23-019732","doc":"tmb-20230930x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-24-016318","doc":"epix-20240930x10k.htm","q":null}]},{"cik":1634379,"name":"METACRINE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014178","doc":"mtcr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012606","doc":"mtcr-10k_20211231.htm","q":null}]},{"cik":1634424,"name":"POWERCOMM HOLDINGS INC.","industry":"Construction","sic":1700,"state":"VA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001615774-17-002478","doc":"s106088_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001615774-18-004924","doc":"s110584_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001615774-19-005835","doc":"s117413_10k.htm","q":null}]},{"cik":1634432,"name":"STRONGBRIDGE BIOPHARMA PLC","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001865","doc":"sbbp-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001146","doc":"sbbp-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001720","doc":"sbbp-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002288","doc":"sbbp-20201231x10k.htm","q":null}]},{"cik":1634447,"name":"ISUN, INC.","industry":"Computers & chips","sic":3674,"state":"VT","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-008539","doc":"brhc10021750_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-014703","doc":"brhc10036271_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-012598","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-014892","doc":"form10-k.htm","q":null}]},{"cik":1634942,"name":"BROKE OUT INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001640334-16-000753","doc":"2015-12-31_brko_10k.htm","q":null}]},{"cik":1634997,"name":"AVANGRID, INC.","industry":"Utilities","sic":4911,"state":"CT","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-015808","doc":"agr-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004016","doc":"agr-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006767","doc":"agr-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001634997-19-000009","doc":"agr201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001634997-20-000017","doc":"agr201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001634997-21-000024","doc":"agr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001634997-22-000013","doc":"agr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001634997-23-000023","doc":"agr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001634997-24-000031","doc":"agr-20231231.htm","q":null}]},{"cik":1635088,"name":"ROIVANT SCIENCES LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2021,"lvl":"x","n":6,"adsh":"0001193125-22-183362","doc":"d307489d10k.htm","q":"Our small molecule discovery engine is powered by leading computational physics and machine learning (\u201cML\u201d) capabilities for in silico drug design."},{"fy":2022,"lvl":2,"n":8,"adsh":"0001140361-23-031798","doc":"brhc20054745_10k.htm","q":"Degraders are engineered to induce the degradation of specific disease-causing proteins through the ubiquitin-proteasome system, which ordinarily tags and degrades proteins that have been misfolded or have already fulfilled their biological\u2026"},{"fy":2023,"lvl":3,"n":27,"adsh":"0001140361-24-028145","doc":"ef20026301_10k.htm","q":"Our healthcare technology Vants, including Lokavant, a clinical trial technology company, and VantAI, which uses machine learning to build computational models to generate new molecular entities for targets of interest, face competition fro\u2026"},{"fy":2024,"lvl":3,"n":45,"adsh":"0001140361-25-020715","doc":"ef20047582_10k.htm","q":"The manufacturing facilities we rely on may incorporate a significant level of automation of equipment with integration of several digital systems, including those that may utilize AI, to improve efficiency of operations."},{"fy":2025,"lvl":3,"n":80,"adsh":"0001635088-26-000061","doc":"roiv-20260331.htm","q":"Additionally, 72 Table of Contents uncertainty remains as to how the FDA\u2019s agency-wide implementation of ELSA, a generative artificial intelligence tool, including for review of drug product applications, as well as its deployment of agenti\u2026"}]},{"cik":1635136,"name":"DUO WORLD INC","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-007372","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":1,"adsh":"0001493152-18-009434","doc":"form10-k.htm","q":"FaceTone also uses artificial intelligence to facilitate automated customer communication."},{"fy":2018,"lvl":"x","n":7,"adsh":"0001493152-19-012152","doc":"form10-k.htm","q":"Facetone also uses artificial intelligence to facilitate automated customer communication."},{"fy":2019,"lvl":"x","n":7,"adsh":"0001493152-20-012018","doc":"form10-k.htm","q":"Facetone also uses artificial intelligence to facilitate automated customer communication."},{"fy":2020,"lvl":"x","n":7,"adsh":"0001493152-21-015504","doc":"form10-k.htm","q":"Facetone also uses artificial intelligence to facilitate automated customer communication."},{"fy":2021,"lvl":"x","n":7,"adsh":"0001493152-22-019073","doc":"form10-k.htm","q":"Facetone also uses artificial intelligence to facilitate automated customer communication."},{"fy":2022,"lvl":"x","n":7,"adsh":"0001493152-23-024397","doc":"form10-k.htm","q":"Facetone also uses artificial intelligence to facilitate automated customer communication."}]},{"cik":1635327,"name":"FLUTTER ENTERTAINMENT PLC","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2024,"lvl":3,"n":36,"adsh":"0001628280-25-009852","doc":"flut-20241231.htm","q":"Similarly, the EU\u2019s Artificial Intelligence Act (the \u201cAI Act\u201d) will have implications for how AI technology is used in our business and across the industry generally and may increase our overall risk exposure."},{"fy":2025,"lvl":3,"n":41,"adsh":"0001635327-26-000005","doc":"flut-20251231.htm","q":"In the absence of comprehensive federal legislation, there is also an emerging multi-state patchwork of artificial intelligence regulation, which is likely to impose compliance costs on our business and constrain our ability to fully levera\u2026"}]},{"cik":1635581,"name":"8POINT3 ENERGY PARTNERS LP","industry":"Utilities","sic":4911,"state":null,"cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-012046","doc":"cafd-10kt_20151130.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-000660","doc":"cafd-10k_20161130.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001628280-18-001014","doc":"a8point31130201710k.htm","q":null}]},{"cik":1636050,"name":"SIO GENE THERAPIES INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001636050-16-000042","doc":"a3311610k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001636050-17-000029","doc":"axovant3311710k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001636050-18-000014","doc":"axovant3311810k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001636050-19-000053","doc":"axovant3311910k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001636050-20-000028","doc":"axovant3312010k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001636050-21-000059","doc":"siox-20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001636050-22-000035","doc":"siox-20220331.htm","q":null}]},{"cik":1636282,"name":"SPYRE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":1,"n":2,"adsh":"0001564590-17-005137","doc":"agle-10k_20161231.htm","q":"Director March 23, 2017 George Georgiou, Ph.D. /s/ Sandesh Mahatme, LLM Director March 23, 2017 Sandesh Mahatme, LLM /s/ Anthony G."},{"fy":2017,"lvl":1,"n":2,"adsh":"0001564590-18-005404","doc":"agle-10k_20171231.htm","q":"Director March 13, 2018 George Georgiou, Ph.D. /s/ Sandesh Mahatme, LLM Director March 13, 2018 Sandesh Mahatme, LLM /s/ Armen Shanafelt, Ph.D."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001564590-19-006771","doc":"agle-10k_20181231.htm","q":"Cox /s/ Sandesh Mahatme, LLM Director March 7, 2019 Sandesh Mahatme, LLM /s/ Armen Shanafelt, Ph.D."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001564590-20-005888","doc":"agle-10k_20191231.htm","q":"Cox /s/ Sandesh Mahatme, LLM Director February 24, 2020 Sandesh Mahatme, LLM /s/ Armen Shanafelt, Ph.D."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001564590-21-014021","doc":"agle-10k_20201231.htm","q":"Cox /s/ Sandesh Mahatme, LLM Director March 18, 2021 Sandesh Mahatme, LLM /s/ Armen Shanafelt, Ph.D."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001564590-22-008995","doc":"agle-10k_20211231.htm","q":"Cox /s/ Sandesh Mahatme, LLM Director March 8, 2022 Sandesh Mahatme, LLM /s/ Armen Shanafelt, Ph.D."},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005705","doc":"agle-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001636282-24-000005","doc":"syre-20231231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and antidiscrimination."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001636282-25-000020","doc":"syre-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."},{"fy":2025,"lvl":3,"n":34,"adsh":"0001636282-26-000020","doc":"syre-20251231.htm","q":"Our use of artificial intelligence (\u201cAI\u201d) and machine learning technologies in research, analytics, and business operations is subject to a rapidly evolving legal and regulatory landscape."}]},{"cik":1636422,"name":"HEALTH CATALYST, INC.","industry":"Software & IT services","sic":7370,"state":"UT","cells":[{"fy":2019,"lvl":2,"n":9,"adsh":"0001636422-20-000016","doc":"hcat-20191231x10k.htm","q":"This reusable, healthcare data content enables customers to achieve analytic value more quickly than leveraging homegrown or cross-industry products and services. \u2022 Machine learning."},{"fy":2020,"lvl":2,"n":10,"adsh":"0001636422-21-000026","doc":"hcat-20201231.htm","q":"This reusable, healthcare data content enables customers to achieve analytic value more quickly than leveraging homegrown or cross-industry products and services. \u2022 Machine learning."},{"fy":2021,"lvl":2,"n":13,"adsh":"0001636422-22-000011","doc":"hcat-20211231.htm","q":"We believe this reusable, healthcare data content enables customers to achieve analytic value more quickly than leveraging homegrown or cross-industry products and services. \u2022 Machine learning ."},{"fy":2022,"lvl":3,"n":17,"adsh":"0001636422-23-000033","doc":"hcat-20221231.htm","q":"Certain components of DOS may be sold on a standalone basis, including Healthcare.AI, Pop Analyzer, IDEA, and other DOS platform components."},{"fy":2023,"lvl":3,"n":18,"adsh":"0001636422-24-000016","doc":"hcat-20231231.htm","q":"Certain components of DOS may be sold on a standalone basis, including Healthcare.AI, Pop Analyzer, IDEA, and other DOS platform components."},{"fy":2024,"lvl":3,"n":80,"adsh":"0001636422-25-000028","doc":"hcat-20241231.htm","q":"Load client's files into Ignite Data and Analytics to populate for data mart build and downstream analytics. \u25e6 Healthcare.AI."},{"fy":2025,"lvl":3,"n":92,"adsh":"0001636422-26-000035","doc":"hcat-20251231.htm","q":"Load client's files into Ignite Data and Analytics to populate for data mart build and downstream analytics. \u25e6 Healthcare.AI."}]},{"cik":1636651,"name":"OVID THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007152","doc":"ovid-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006804","doc":"ovid-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010108","doc":"ovid-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013016","doc":"ovid-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003668","doc":"ovid-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-007648","doc":"ovid-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001628280-24-009809","doc":"ovid-20231231.htm","q":"Recent advances in synthetic methodology, formulation technology, generative artificial intelligence and biology target research have unlocked more opportunities for innovative and creative medicines."},{"fy":2024,"lvl":3,"n":16,"adsh":"0001628280-25-011844","doc":"ovid-20241231.htm","q":"Additionally, science is beginning to illuminate the systemic and damaging effects of over-excitation on neural networks, including its relationship to cell inflammation, stress, and apoptosis."},{"fy":2025,"lvl":2,"n":13,"adsh":"0001628280-26-019438","doc":"ovid-20251231.htm","q":"Recent advances in genetics and artificial intelligence enable us to employ predictive in vitro and in vivo models of specific brain diseases and symptoms."}]},{"cik":1637147,"name":"ZSPACE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-036940","doc":"zspc-20251231x10k.htm","q":null}]},{"cik":1637655,"name":"HORIZON GLOBAL CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001637655-16-000083","doc":"hzn201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001637655-17-000010","doc":"hzn201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001637655-18-000011","doc":"hzn201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001637655-19-000030","doc":"hzn201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001637655-20-000026","doc":"hzn201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001637655-21-000040","doc":"hzn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001637655-22-000062","doc":"hzn-20211231.htm","q":null}]},{"cik":1637715,"name":"ONKURE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004158","doc":"rphm-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009978","doc":"rphm-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-038009","doc":"rphm-20231231.htm","q":"Our employees and personnel may use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy o\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-036252","doc":"okur-20241231.htm","q":"With positive data in the metastatic setting, we would consider developing OKI-219 in combination with an AI+ a CDK inhibitor in the adjuvant setting."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-104147","doc":"okur-20251231.htm","q":"Following disease progression on both AI and SERDs, mBC is typically considered to be estrogen insensitive, and patients may be treated with an ADC or chemotherapy."}]},{"cik":1637736,"name":"ELECTRAMECCANICA VEHICLES CORP.","industry":"Auto manufacturing","sic":3711,"state":"BC","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000675","doc":"solo-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000164","doc":"solo-20231231x10k.htm","q":null}]},{"cik":1637757,"name":"CLEARWAY ENERGY LLC","industry":"Utilities","sic":4911,"state":"NJ","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001637757-16-000016","doc":"yieldllc1231201510-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001637757-17-000007","doc":"yieldllc201610-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001637757-18-000004","doc":"yieldllc201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001637757-19-000002","doc":"clearwayllc201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001637757-20-000003","doc":"clearwayllc201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001637757-21-000004","doc":"cwen-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001637757-22-000004","doc":"cwen-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001637757-23-000004","doc":"cwen-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001637757-24-000003","doc":"cwen-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001637757-25-000004","doc":"cwen-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001637757-26-000001","doc":"cwen-20251231.htm","q":null}]},{"cik":1637880,"name":"TRI-STATE GENERATION & TRANSMISSION ASSOCIATION, INC.","industry":"Utilities","sic":4911,"state":"CO","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004089","doc":"tris-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001593","doc":"tris-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001771","doc":"tris-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001696","doc":"tris-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002516","doc":"tris-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-004006","doc":"tris-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001637880-22-000006","doc":"tris-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001637880-23-000006","doc":"tris-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001637880-24-000019","doc":"tris-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001637880-25-000010","doc":"tris-20241231.htm","q":"Both the number and size of these high impact load requests are increasing and expected to further increase substantially with the growth of artificial intelligence and other factors, thereby potentially materially increasing our aggregate \u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001637880-26-000012","doc":"tris-20251231.htm","q":"There appears to be an increasing level of activity, sophistication, and maturity of threat actors and increase using of artificial intelligence for such attacks, in particular nation state actors, that wish to disrupt the U.S. bulk power s\u2026"}]},{"cik":1638097,"name":"ENTERA BIO LTD.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001178913-22-000994","doc":"zk2227416.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001178913-23-001272","doc":"zk2329447.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001178913-24-000881","doc":"zk2431054.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001178913-25-001112","doc":"zk2532895.htm","q":null},{"fy":2025,"lvl":2,"n":9,"adsh":"0001178913-26-001797","doc":"zk2634461.htm","q":"Additionally, the FDA expanded its oversight on social medial promotional activities, including influencer partnerships, algorithm-driven targeted advertising, and AI-generated health content, to ensure compliance with the FDA\u2019s advertiseme\u2026"}]},{"cik":1638287,"name":"METAVIA INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001962","doc":"gemp-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002275","doc":"gemp-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002192","doc":"gemp-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003385","doc":"nrbo-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-004356","doc":"nrbo-20201231x10k.htm","q":"This was repeated for 4-8 weeks. \u25cf Niclosamide prevented tactile hypoesthesia and thermal hyperalgesia and abrogated membrane hyperexcitability and also prevented intraepidermal nerve fiber density reduction and demyelination. \u25cf No drug-rel\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004958","doc":"nrbo-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005127","doc":"nrbo-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004246","doc":"nrbo-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003386","doc":"mtva-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001104659-26-034911","doc":"mtva-20251231x10k.htm","q":null}]},{"cik":1638381,"name":"INTEC PHARMA LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-003211","doc":"f10k2018_intecpharmaltd.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-006334","doc":"f10k2019_intecpharmaltd.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-015763","doc":"f10k2020_intecpharma.htm","q":null}]},{"cik":1638826,"name":"SERVICETITAN, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":104,"adsh":"0000950170-25-048834","doc":"ttan-20250131.htm","q":"If our research and development investments do not accurately anticipate customer demand, if we fail to realize the benefits of these investments by not achieving market acceptance, or our new products or platform enhancements suffer from p\u2026"}]},{"cik":1638911,"name":"DUKE ROBOTICS CORP.","industry":"Aerospace & defense","sic":3721,"state":null,"cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001548123-16-000516","doc":"f10kv4clean.htm","q":null},{"fy":2016,"lvl":"x","n":0,"adsh":"0001548123-17-000043","doc":"f10kv6uas.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001548123-18-000038","doc":"f10kv3.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001548123-19-000045","doc":"f10kfinal.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-009056","doc":"f10k2019_uasdronecorp.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-018451","doc":"f10k2020_uasdrone.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-010947","doc":"f10k2021_uasdrone.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-022590","doc":"f10k2022_uasdronecorp.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-022826","doc":"ea0200793-10k_uasdrone.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-025286","doc":"ea0233012-10k_duke.htm","q":null},{"fy":2025,"lvl":"x","n":12,"adsh":"0001213900-26-026927","doc":"ea0279194-10k_duke.htm","q":"AEROTRACE\u2122 integrates aerial data capture with software-driven analytics, including AI-assisted image analysis, and may be deployed as a standalone solution or in conjunction with our IC Drone services."}]},{"cik":1639225,"name":"LIVONGO HEALTH, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2019,"lvl":3,"n":43,"adsh":"0001628280-20-003960","doc":"lvgo-20191231x10k.htm","q":"Our Engine - AI+AI Our multidisciplinary team has built a flexible and robust technology engine capable of processing data from our devices as well as other data sources and turning that information into valuable Health Signals."}]},{"cik":1640147,"name":"SNOWFLAKE INC.","industry":"Software & IT services","sic":7372,"state":"MT","cells":[{"fy":2020,"lvl":"x","n":9,"adsh":"0001640147-21-000073","doc":"snow-20210131.htm","q":"Customers can share and provide access to each other\u2019s data, augment data science and machine learning algorithms with more data sets, connect global supply chains through data hubs, and create new monetization channels by connecting data p\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001640147-22-000023","doc":"snow-20220131.htm","q":"Customers can share and provide access to each other\u2019s data, augment data science and machine learning algorithms with more data sets, connect global supply chains through data hubs, and create new monetization channels by connecting data p\u2026"},{"fy":2022,"lvl":3,"n":20,"adsh":"0001640147-23-000030","doc":"snow-20230131.htm","q":"Our platform supports a wide range of workloads that enable our customers\u2019 most important business objectives, including data warehousing, data lakes, and Unistore, as well as collaboration, data engineering, cybersecurity, data science and\u2026"},{"fy":2023,"lvl":3,"n":87,"adsh":"0001640147-24-000101","doc":"snow-20240131.htm","q":"BUSINESS We believe that a cloud computing platform that puts data and AI at its core will offer great benefits to organizations by allowing them to realize the value of the data that powers their businesses."},{"fy":2024,"lvl":3,"n":168,"adsh":"0001640147-25-000052","doc":"snow-20250131.htm","q":"BUSINESS We believe that a cloud computing platform that puts data and artificial intelligence (AI) at its core will offer great benefits to organizations by allowing them to realize the value of the data that powers their businesses."}]},{"cik":1640266,"name":"VOYAGER THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001558370-16-004222","doc":"vygr-20151231x10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001797","doc":"vygr-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002038","doc":"vygr-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001105","doc":"vygr-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001974","doc":"vygr-20191231x10k79fed2.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001865","doc":"vygr-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003015","doc":"vygr-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002989","doc":"vygr-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001988","doc":"vygr-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002703","doc":"vygr-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-025197","doc":"vygr-20251231x10k.htm","q":null}]},{"cik":1640428,"name":"EVERQUOTE, INC.","industry":"Software & IT services","sic":7370,"state":"MA","cells":[{"fy":2018,"lvl":1,"n":2,"adsh":"0001193125-19-094588","doc":"d683980d10k.htm","q":"Bind We combine consumer-submitted information and our internal data with proprietary machine learning algorithms to optimize matching and bind rates for consumers and insurance providers."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001193125-20-072378","doc":"d854488d10k.htm","q":"Bind We combine consumer-submitted information and our internal data with proprietary machine learning algorithms to optimize matching and bind rates for consumers and insurance providers."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001193125-21-063397","doc":"d105758d10k.htm","q":"Our proprietary data assets and machine learning algorithms efficiently attract consumers, match them with relevant insurance providers and drive our overall business model."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001193125-22-054390","doc":"d287160d10k.htm","q":"Our proprietary data assets and machine learning algorithms efficiently attract consumers, match them with relevant insurance providers and drive our overall business model."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-004649","doc":"ever-20221231.htm","q":"Our proprietary data assets and machine learning algorithms efficiently attract consumers, match them with relevant insurance providers and drive our overall business model."},{"fy":2023,"lvl":3,"n":23,"adsh":"0000950170-24-021082","doc":"ever-20231231.htm","q":"Our proprietary data assets and machine learning algorithms efficiently attract consumers, match them with relevant insurance providers and drive our overall business model."},{"fy":2024,"lvl":3,"n":23,"adsh":"0000950170-25-026724","doc":"ever-20241231.htm","q":"Our proprietary data assets and machine learning algorithms efficiently attract consumers, match them with relevant insurance providers and drive our overall business model."},{"fy":2025,"lvl":3,"n":28,"adsh":"0001193125-26-066957","doc":"ever-20251231.htm","q":"Our proprietary data assets and machine learning algorithms efficiently attract consumers, match them with relevant insurance providers and drive our overall business model."}]},{"cik":1640455,"name":"JOUNCE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001640455-18-000030","doc":"jnce1231201710-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001640455-19-000021","doc":"jnce1231201810-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001640455-20-000034","doc":"jnce1231201910-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001640455-21-000055","doc":"jnce-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001640455-22-000029","doc":"jnce-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001640455-23-000024","doc":"jnce-20221231.htm","q":null}]},{"cik":1640997,"name":"ETERNAL SPEECH, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001494733-18-000067","doc":"form10kafebruary282017.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001494733-18-000063","doc":"form10-kafebruary282018.htm","q":null}]},{"cik":1641281,"name":"BOLT BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005047","doc":"bolt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010613","doc":"bolt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034692","doc":"bolt-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-043873","doc":"bolt-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-104121","doc":"bolt-20251231.htm","q":null}]},{"cik":1641489,"name":"VTV THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001564590-16-014035","doc":"vtvt-10k_20151231.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002317","doc":"vtvt-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003515","doc":"vtvt-10k_20171231.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001564590-19-004516","doc":"vtvt-10k_20181231.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001564590-20-005627","doc":"vtvt-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008149","doc":"vtvt-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012258","doc":"vtvt-10k_20211231.htm","q":null},{"fy":2022,"lvl":2,"n":6,"adsh":"0001641489-23-000008","doc":"vtvt-20221231.htm","q":"Collaboration Agreements G42 Transaction On May 31, 2022, the Company and G42 Investments AI Holding RSC Ltd, a private limited company (\u201cG42 Investments\u201d), entered into a Common Stock Purchase Agreement (the \u201cG42 Purchase Agreement\u201d), purs\u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0001641489-24-000012","doc":"vtvt-20231231.htm","q":"In addition, we continue to work with our partner, G42 Investments AI Holding RSC Ltd."},{"fy":2024,"lvl":2,"n":6,"adsh":"0001641489-25-000014","doc":"vtvt-20241231.htm","q":"We continue to work with our partner, G42 Investments AI Holding RSC Ltd."},{"fy":2025,"lvl":3,"n":19,"adsh":"0001641489-26-000010","doc":"vtvt-20251231.htm","q":"In December 20 25, together with our partner G42 Investments AI Holding RSC Ltd."}]},{"cik":1641640,"name":"NABRIVA THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001104659-17-019162","doc":"a17-8508_110k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001768","doc":"a2234062z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001047469-19-001138","doc":"a2237963z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002547","doc":"nbrv-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002824","doc":"nbrv-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004615","doc":"nbrv-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-006062","doc":"nbrv-20221231x10k.htm","q":null}]},{"cik":1642375,"name":"GUARDION HEALTH SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2016,"lvl":"x","n":3,"adsh":"0001144204-17-017714","doc":"v461578_10k.htm","q":"A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as age-related macular degeneration (\u201cAMD\u201d), computer vision syndrome (\u201cCVS\u201d) and diabetic retinopathy."},{"fy":2017,"lvl":"x","n":3,"adsh":"0001144204-18-011242","doc":"tv486829_10k.htm","q":"A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as age-related macular degeneration (\u201cAMD\u201d), computer vision syndrome (\u201cCVS\u201d) and diabetic retinopathy."},{"fy":2018,"lvl":"x","n":2,"adsh":"0001144204-19-007374","doc":"tv512992_10k.htm","q":"A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as age-related macular degeneration (\u201cAMD\u201d), computer vision syndrome (\u201cCVS\u201d) and diabetic retinopathy."},{"fy":2019,"lvl":1,"n":2,"adsh":"0001493152-20-005000","doc":"form10-k.htm","q":"A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as adult dry macular degeneration (\u201cAMD\u201d) and computer vision syndrome (\u201cCVS\u201d)."},{"fy":2020,"lvl":"x","n":1,"adsh":"0001493152-21-006883","doc":"form10-k.htm","q":"A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as adult dry macular degeneration (\u201cAMD\u201d) and computer vision syndrome (\u201cCVS\u201d)."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008581","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-012449","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011813","doc":"form10-k.htm","q":null}]},{"cik":1643269,"name":"SUMO LOGIC, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":10,"adsh":"0001643269-21-000006","doc":"sumo-20210131.htm","q":"Continuous intelligence leverages artificial intelligence and machine learning capabilities, and is provided as a multi-tenant cloud service that allows organizations to more rapidly deliver reliable applications and digital services, prote\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001643269-22-000007","doc":"sumo-20220131.htm","q":"We are also able to infer and extract schema on demand without requiring ingest time parsing. \u2022 Machine learning ."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001643269-23-000016","doc":"sumo-20230131.htm","q":"We are also able to infer and extract schema on demand without requiring ingest time parsing. \u2022 Machine learning ."}]},{"cik":1643301,"name":"AVENIR WELLNESS SOLUTIONS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001477932-21-001927","doc":"curr_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001477932-22-001921","doc":"curr_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-005602","doc":"curr_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-003092","doc":"avrw_10k.htm","q":null}]},{"cik":1643848,"name":"PATHEON N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001643848-16-000032","doc":"a201610-kxdocument.htm","q":null}]},{"cik":1644675,"name":"MIMECAST LTD","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":2,"adsh":"0001564590-18-014514","doc":"mime-10k_20180331.htm","q":"For example, in fiscal 2017, we acquired substantially all of the business of iSheriff, Inc., a cloud security provider, and in fiscal 2018, we acquired machine learning-based malware detection technology."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001564590-19-020753","doc":"mime-10k_20190331.htm","q":"For example, in fiscal 2017, we acquired substantially all of the business of iSheriff, Inc., a cloud security provider, and in fiscal 2018, we acquired machine learning-based malware detection technology."},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-026744","doc":"mime-10k_20200331.htm","q":null},{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-21-030433","doc":"mime-10k_20210331.htm","q":"It detects sophisticated, highly targeted email threats using machine learning and identity graph technology to identify anomalies in sender and recipient behaviors that could be indicative of a malicious email."}]},{"cik":1644963,"name":"AVENUE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-012321","doc":"tv486678_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-013543","doc":"tv514657_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-040345","doc":"tm205363-1_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-044358","doc":"tm2140561_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-22-000516","doc":"atxi-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410578-23-000557","doc":"atxi-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-008294","doc":"atxi20221231_10k.htm","q":null},{"fy":2024,"lvl":"x","n":16,"adsh":"0001437749-25-010196","doc":"atxi20241231_10k.htm","q":"Our failure to comply with these laws and regulations also may result in substantial fines, penalties, or other sanctions. 30 Table of Contents The use of artificial intelligence in the healthcare industry and challenges with properly manag\u2026"},{"fy":2025,"lvl":"x","n":16,"adsh":"0001437749-26-010359","doc":"atxi20251231_10k.htm","q":"Our failure to comply with these laws and regulations also may result in substantial fines, penalties, or other sanctions. 29 Table of Contents The use of artificial intelligence in the healthcare industry and challenges with properly manag\u2026"}]},{"cik":1645155,"name":"WEBSTAR TECHNOLOGY GROUP INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2018,"lvl":"x","n":2,"adsh":"0001493152-19-007087","doc":"form10-k.htm","q":"Our core objective is to build the Webstar brand as a premier provider of Software as a Service (SaaS) in the Software Technology industry with the ability to enhance any and all industries by specializing in the optimization of data delive\u2026"},{"fy":2019,"lvl":"x","n":2,"adsh":"0001493152-20-004510","doc":"form10-k.htm","q":"Our core objective is to build the Webstar brand as a premier provider of Software as a Service (SaaS) in the Software Technology industry with the ability to enhance any and all industries by specializing in the optimization of data delive\u2026"},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-21-008640","doc":"form10-k.htm","q":"Our core objective is to build the Webstar brand as a premier provider of Software as a Service (SaaS) in the Software Technology industry with the ability to enhance any and all industries by specializing in the optimization of data delive\u2026"},{"fy":2021,"lvl":"x","n":2,"adsh":"0001493152-22-007923","doc":"form10-k.htm","q":"Our core objective is to build the Webstar brand as a premier provider of Software as a Service (SaaS) in the Software Technology industry with the ability to enhance any and all industries by specializing in the optimization of data delive\u2026"},{"fy":2022,"lvl":"x","n":2,"adsh":"0001493152-23-012181","doc":"form10-k.htm","q":"Our core objective is to build the Webstar brand as a premier provider of Software as a Service (SaaS) in the Software Technology industry with the ability to enhance any and all industries by specializing in the optimization of data delive\u2026"},{"fy":2023,"lvl":"x","n":2,"adsh":"0001493152-24-011912","doc":"form10-k.htm","q":"Our core objective is to build the Webstar brand as a premier provider of Software as a Service (SaaS) in the Software Technology industry with the ability to enhance any and all industries by specializing in the optimization of data delive\u2026"},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-008374","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-016894","doc":"form10-k.htm","q":null}]},{"cik":1645460,"name":"CUE BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007832","doc":"cue-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010212","doc":"cue-10k_20191231.htm","q":null},{"fy":2020,"lvl":1,"n":4,"adsh":"0001564590-21-011777","doc":"cue-10k_20201231.htm","q":"Platform Development and Progress in Immuno-oncology 18 Platform Development and Progress in Auto-immune and inflammation 19 Autoimmune Disease For applications in autoimmune, or AI, diseases, our strategy has focused on two broad themes of\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003969","doc":"cue-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008927","doc":"cue-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038059","doc":"cue-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-047677","doc":"cue-20241231.htm","q":"In response to the complexity and evolving nature of cybersecurity threats, incidents and risks, we engage with a range of third-party experts, including cybersecurity penetration testers, data protection services, security awareness and tr\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-108287","doc":"cue-20251231.htm","q":"In response to the complexity and evolving nature of cybersecurity threats, incidents and risks, we engage with a range of third-party experts, including cybersecurity penetration testers, data protection services, security awareness and tr\u2026"}]},{"cik":1645469,"name":"MONOPAR THERAPEUTICS","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001654954-18-003136","doc":"mnpr_form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001654954-19-002003","doc":"mnpr_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654954-20-003363","doc":"mnpr_10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654954-21-003243","doc":"a10-k12312020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-22-003701","doc":"mnpr_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654954-23-003384","doc":"mnpr_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-009687","doc":"mnpr20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-009979","doc":"mnpr20241231_10k.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0001437749-26-010025","doc":"mnpr20251231_10k.htm","q":"In addition, the widespread availability, adoption and rapid evolution of artificial intelligence technologies may increase our cybersecurity risk, including the use of generative artificial intelligence to augment existing or create new ma\u2026"}]},{"cik":1645569,"name":"DICE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001564590-22-011972","doc":"dice-10k_20211231.htm","q":"We presently have a collaboration with Insitro, which is designed to combine our DELSCAPE platform and Insitro\u2019s machine learning-enabled drug discovery capabilities for the discovery and prediction of potential therapeutic candidates."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-008119","doc":"dice-20221231.htm","q":null}]},{"cik":1645590,"name":"HEWLETT PACKARD ENTERPRISE CO","industry":"Computers & chips","sic":3570,"state":"TX","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001047469-15-009279","doc":"a2226746z10-k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001628280-16-022051","doc":"hpe-10312016x10k.htm","q":null},{"fy":2017,"lvl":1,"n":3,"adsh":"0001628280-17-012383","doc":"hpe-10312017x10k.htm","q":"Our workload optimized server portfolio includes the HPE Apollo for high performance computing and artificial intelligence, HPE Cloudline for cloud data centers, HPE Edgeline for computing at the network edge, HPE Integrity for mission-crit\u2026"},{"fy":2018,"lvl":2,"n":11,"adsh":"0001628280-18-015054","doc":"hpe-10312018x10k.htm","q":"Our workload optimized server portfolio includes the HPE Apollo for high performance computing and artificial intelligence, HPE Cloudline for cloud data centers, HPE Edgeline for computing at the network edge, HPE Integrity for mission-crit\u2026"},{"fy":2023,"lvl":3,"n":128,"adsh":"0001645590-23-000117","doc":"hpe-20231031.htm","q":"Our Strategy Over the last several years, new megatrends around edge, cloud, data, and artificial intelligence (\u201cAI\u201d) have emerged to shape customer expectations for enterprise technology."},{"fy":2024,"lvl":3,"n":140,"adsh":"0001645590-24-000139","doc":"hpe-20241031.htm","q":"Our Strategy Over the last several years, new megatrends around edge, cloud, data, and artificial intelligence (\u201cAI\u201d) have emerged to shape customer expectations for enterprise technology."},{"fy":2025,"lvl":3,"n":170,"adsh":"0001645590-25-000130","doc":"hpe-20251031.htm","q":"Our Strategy Over the last several years, HPE has observed megatrends around networking, cloud, data, and artificial intelligence (\u201cAI\u201d) emerging to shape customer expectations for enterprise technology."}]},{"cik":1645666,"name":"KEZAR LIFE SCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009369","doc":"kzr-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010498","doc":"kzr-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012525","doc":"kzr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004085","doc":"kzr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007871","doc":"kzr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-031494","doc":"kzr-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":11,"adsh":"0001645666-25-000010","doc":"kzr-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a prior executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and healthcare models to limit drug \u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001628280-26-021737","doc":"kzr-20251231.htm","q":"Our employees and personnel may use generative artificial intelligence, or AI, technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privac\u2026"}]},{"cik":1645842,"name":"ZYMERGEN INC.","industry":"Pharma & biotech","sic":8731,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":19,"adsh":"0001645842-22-000046","doc":"zy-20211231.htm","q":"While traditional approaches to natural product drug discovery are no longer considered effective, advances in metagenomics, machine learning, and synthetic biology have the potential to transform how natural products are discovered and dev\u2026"}]},{"cik":1646972,"name":"ALBERTSONS COMPANIES, INC.","industry":"Retail","sic":5411,"state":"ID","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001646972-18-000017","doc":"acify1710-k.htm","q":null},{"fy":2018,"lvl":1,"n":1,"adsh":"0001646972-19-000036","doc":"acify1810-k.htm","q":"Turner has served as President and Chief Executive Officer of Core Scientific, an emerging leader in blockchain and artificial intelligence infrastructure, hosting, transaction processing and application development, since July 2018."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001646972-20-000022","doc":"acify1910-k.htm","q":"Turner has served as President and Chief Executive Officer of Core Scientific, an emerging leader in blockchain and artificial intelligence infrastructure, hosting, transaction processing and application development, since July 2018."},{"fy":2020,"lvl":"x","n":0,"adsh":"0001646972-21-000026","doc":"aci-20210227.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001646972-22-000031","doc":"aci-20220226.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001646972-23-000045","doc":"aci-20230225.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001646972-24-000060","doc":"aci-20240224.htm","q":"We and our third parties may use artificial intelligence in our business, which could result in competitive and reputational harm, and legal liability, and adversely affect our results of operations."},{"fy":2024,"lvl":2,"n":14,"adsh":"0001646972-25-000052","doc":"aci-20250222.htm","q":"In addition, ongoing geopolitical conflicts and the development of sophisticated artificial intelligence systems may increase the risk of cyberattacks which could impact our operations."},{"fy":2025,"lvl":3,"n":27,"adsh":"0001646972-26-000032","doc":"aci-20260228.htm","q":"We may be limited in our ability to implement automation-related technological changes or artificial intelligence in certain of our operations if we are unable to negotiate appropriate terms in our contracts with our labor unions."}]},{"cik":1647170,"name":"TAPINATOR, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-005708","doc":"tapm20181231_10k.htm","q":null}]},{"cik":1647822,"name":"JINGBO TECHNOLOGY, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-17-001847","doc":"savmobi_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001683168-20-003241","doc":"savmobi_10k-053118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-20-003249","doc":"savmobi_10k-053119.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-20-003260","doc":"savmobi_10k-053120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-031044","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-026160","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001493152-23-034950","doc":"form10-k.htm","q":"Internet companies have combined their advantages in artificial intelligence, mobile payment and other technologies with smart parking platforms for strategic cooperation."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001641172-25-014855","doc":"form10-k.htm","q":"Internet companies have combined their advantages in artificial intelligence, mobile payment and other technologies with smart parking platforms for strategic cooperation."}]},{"cik":1649094,"name":"VAXCYTE, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016110","doc":"pcvx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002281","doc":"pcvx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004654","doc":"pcvx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-021145","doc":"pcvx-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":22,"adsh":"0001649094-25-000028","doc":"pcvx-20241231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to software bugs; malicious code (such as viruses and worms); social-engineering attacks (including through deep fakes, whic\u2026"},{"fy":2025,"lvl":3,"n":22,"adsh":"0001649094-26-000007","doc":"pcvx-20251231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including, but not limited to, software bugs; malicious code (such as viruses and worms); social-engineering attacks (including through deep fakes, wh\u2026"}]},{"cik":1649338,"name":"BROADCOM LTD","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001649338-16-000151","doc":"avgo-10302016x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001649338-17-000158","doc":"avgo-10292017x10k.htm","q":null}]},{"cik":1649345,"name":"BROADCOM CAYMAN L.P.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001649345-16-000016","doc":"avgo-10302016x10k.htm","q":null}]},{"cik":1649904,"name":"RHYTHM PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001923","doc":"rytm-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001698","doc":"rytm-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001896","doc":"rytm-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002121","doc":"rytm-20201231x10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001558370-22-002543","doc":"rytm-20211231x10k.htm","q":"MHRA seeks to amend the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive and the EU In Vitro Diagnostic Medical Devices Directive), in particular to create new access pathway\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001558370-23-002613","doc":"rytm-20221231x10k.htm","q":"MHRA seeks to amend the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive and the EU In Vitro Diagnostic Medical Devices Directive), in particular to create new access pathway\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-002181","doc":"rytm-20231231x10k.htm","q":"In this response the MHRA confirmed that it would bring forward legislative changes to the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive and the (EU) IVDD), in particular \u2026"},{"fy":2024,"lvl":3,"n":17,"adsh":"0001558370-25-001889","doc":"rytm-20241231x10k.htm","q":"In this response the MHRA confirmed that it would bring forward legislative changes to the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive and the (EU) IVDD), in particular \u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0001628280-26-012399","doc":"rytm-20251231.htm","q":"In addition, we may use artificial intelligence, or AI, machine learning, and automated decision-making technologies, collectively, AI Technologies, in our business."}]},{"cik":1649989,"name":"OUTLOOK THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001571049-16-020882","doc":"t1602975-10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001571049-17-008779","doc":"tv481722-10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-18-065142","doc":"tv508180-10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-19-074095","doc":"tm1919825d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-20-014540","doc":"otlk-20200930x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-21-017007","doc":"otlk-20210930x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-22-019036","doc":"otlk-20220930x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-23-020000","doc":"otlk-20230930x10k.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0001558370-24-016491","doc":"otlk-20240930x10k.htm","q":"Our employees and personnel use generative artificial intelligence, or AI, technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy ob\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001104659-25-123264","doc":"otlk-20250930x10k.htm","q":"Our employees and personnel use generative artificial intelligence, or AI, technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy ob\u2026"}]},{"cik":1650372,"name":"ATLASSIAN CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2023,"lvl":3,"n":46,"adsh":"0001650372-23-000040","doc":"team-20230630.htm","q":"It enables modern and connected experiences across teams, tools, workflows, and data, including collaboration, analytics, automation, and artificial intelligence capabilities."},{"fy":2024,"lvl":3,"n":94,"adsh":"0001650372-24-000036","doc":"team-20240630.htm","q":"Together, our connected portfolio of products form integrated solutions that are deeply entrenched in how teams collaborate and how organizations run, and provide customers all the benefits of analytics, automation, and now AI, as well as i\u2026"},{"fy":2025,"lvl":3,"n":85,"adsh":"0001650372-25-000036","doc":"team-20250630.htm","q":"Our deeply interconnected portfolio of apps, AI agents, and Collections, each with discrete value propositions, delivers solutions for software teams, IT operations and support teams, leadership and business teams."}]},{"cik":1650648,"name":"4D MOLECULAR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015502","doc":"fdmt-10k_20201231.htm","q":null},{"fy":2021,"lvl":2,"n":6,"adsh":"0000950170-22-004794","doc":"fdmt-20211231.htm","q":"Berkeley professor covering investigations into how machine learning approaches may enhance AAV capsid engineering (the \u201cMachine Learning SRA\u201d)."},{"fy":2022,"lvl":2,"n":11,"adsh":"0000950170-23-008142","doc":"fdmt-20221231.htm","q":"Berkeley professor covering investigations into how machine learning approaches may enhance AAV capsid engineering (the \u201cMachine Learning SRA\u201d)."},{"fy":2023,"lvl":2,"n":10,"adsh":"0000950170-24-023183","doc":"fdmt-20231231.htm","q":"Berkeley professor covering investigations into how machine learning approaches may enhance AAV capsid engineering (the \u201cMachine Learning SRA\u201d)."},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-030056","doc":"fdmt-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":22,"adsh":"0001193125-26-114075","doc":"fdmt-20251231.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques, including artificial intelligence, that are designed to circumvent controls, to avoi\u2026"}]},{"cik":1650664,"name":"EDITAS MEDICINE, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001340","doc":"edit-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001721","doc":"edit-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001364","doc":"edit-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-001476","doc":"edit-20191231x10k624cb2.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001915","doc":"edit-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001950","doc":"edit-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001764","doc":"edit-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001650664-24-000008","doc":"edit-20231231.htm","q":"Additionally, sensitive data could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, vendors\u2019 or partners\u2019 use of generative AI technologies."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001650664-25-000022","doc":"edit-20241231.htm","q":"Additionally, sensitive data could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, vendors\u2019 or partners\u2019 use of generative AI technologies."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001650664-26-000017","doc":"edit-20251231.htm","q":"Additionally, sensitive data could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, vendors\u2019 or partners\u2019 use of generative artificial intelligence (\u201cAI\u201d) technologies or public AI platforms."}]},{"cik":1651235,"name":"ACACIA COMMUNICATIONS, INC.","industry":"Computers & chips","sic":3674,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002222","doc":"acia-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001651235-18-000045","doc":"acia1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001651235-19-000042","doc":"acia1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001651235-20-000022","doc":"aciaq4201910k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001651235-21-000044","doc":"acia-20201231.htm","q":null}]},{"cik":1651308,"name":"BEONE MEDICINES LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001890","doc":"a2231423z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001303","doc":"bgne-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001651308-19-000018","doc":"bgne-20181231_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001651308-20-000020","doc":"bgne-2019123110k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001651308-21-000039","doc":"bgne-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001651308-22-000032","doc":"bgne-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001651308-23-000036","doc":"bgne-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0001651308-24-000014","doc":"bgne-20231231.htm","q":"The increasing use of artificial intelligence-based software (including machine learning) and social media platforms may result in reputation harm or liability or could otherwise adversely affect our business."},{"fy":2024,"lvl":3,"n":18,"adsh":"0001651308-25-000031","doc":"bgne-20241231.htm","q":"The increasing use of artificial intelligence-based software (including machine learning) and social media platforms may result in reputation harm or liability or could otherwise adversely affect our business."},{"fy":2025,"lvl":3,"n":28,"adsh":"0001628280-26-011946","doc":"bgne-20251231.htm","q":"Such threats are prevalent and continue to rise, are increasingly difficult to detect, and come from a variety of sources, and now include potential attacks enhanced or facilitated by artificial intelligence."}]},{"cik":1651311,"name":"MERUS N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011100","doc":"mrus-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013584","doc":"mrus-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007622","doc":"mrus-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005070","doc":"mrus-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-022055","doc":"mrus-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-029024","doc":"mrus-20241231.htm","q":"Prior to that, from 2015 to 2016, he served as Chief Financial Officer and Chief Operating Officer of BERG, an artificial intelligence-based analytics biopharma company, and from 2001to 2015, at Bristol-Myers Squibb in a variety of finance,\u2026"}]},{"cik":1651407,"name":"CHECKPOINT THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-015434","doc":"v460919_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-015101","doc":"tv487632_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014409","doc":"tv515276_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-032004","doc":"tm205356d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-035291","doc":"tmb-20201230x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000556","doc":"ckpt-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000565","doc":"ckpt-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001410578-24-000283","doc":"ckpt-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001410578-25-000528","doc":"ckpt-20241231x10k.htm","q":null}]},{"cik":1651431,"name":"CHECKMATE PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-098414","doc":"d18214d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-088386","doc":"d275568d10k.htm","q":null}]},{"cik":1651562,"name":"COURSERA, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":7,"adsh":"0000950170-22-002807","doc":"cour-20211231.htm","q":"Ng, one of our co-founders and Chairman of our board of directors, owns DeepLearning.AI Corp., a developer of educational content relating to artificial intelligence that offers courses through our platform."},{"fy":2022,"lvl":2,"n":13,"adsh":"0000950170-23-004143","doc":"cour-20221231.htm","q":"The delivery of degree programs online at educational institutions has not yet achieved widespread acceptance, and administrators and faculty members may have concerns regarding the perceived loss of control over the educational process tha\u2026"},{"fy":2023,"lvl":3,"n":75,"adsh":"0001651562-24-000012","doc":"cour-20231231.htm","q":"We believe that recent advancements in artificial intelligence (\u201cAI\u201d) and other emerging technologies will reshape how we live, learn, and work."},{"fy":2024,"lvl":3,"n":83,"adsh":"0001651562-25-000013","doc":"cour-20241231.htm","q":"We believe that advancements in artificial intelligence (\u201cAI\u201d) and other emerging technologies will reshape how we live, learn, and work."},{"fy":2025,"lvl":3,"n":105,"adsh":"0001651562-26-000015","doc":"cour-20251231.htm","q":"We believe that advancements in artificial intelligence (\u201cAI\u201d) and other emerging technologies are reshaping how we live, learn, and work, and we expect these changes will further increase the global skills gap."}]},{"cik":1651716,"name":"HD VIEW 360 INC.","industry":"Construction","sic":1700,"state":"FL","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001549212-16-000047","doc":"hdview360form10k4816edit2.htm","q":null}]},{"cik":1651992,"name":"APPSOFT TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2016,"lvl":"x","n":1,"adsh":"0001144204-17-020889","doc":"v464177_10k.htm","q":"The App uses sophisticated image recognition that will enable users to take screenshots of their Pok\u00e9mon and have GoDex calculate its statistic, IV percentage, combat power calculations, and other statistics that players deem relevant to th\u2026"},{"fy":2017,"lvl":"x","n":3,"adsh":"0001144204-18-020968","doc":"tv490272_10k.htm","q":"The App uses sophisticated image recognition that will enable users to take screenshots of their Pok\u00e9mon and have GoDex calculate its statistic, IV percentage, combat power calculations, and other statistics that players deem relevant to th\u2026"},{"fy":2018,"lvl":"x","n":2,"adsh":"0001144204-19-035544","doc":"tv518689_10k.htm","q":"Using high quality image recognition software, the user will be told what the image is, and if the software is wrong they can challenge the system and then ask their friends and post their own answers on their friends\u2019 pictures."},{"fy":2019,"lvl":"x","n":2,"adsh":"0001477932-20-007062","doc":"asft_10k.htm","q":"Using high quality image recognition software, the user will be told what the image is, and if the software is wrong, they can challenge the system and then ask their friends and post their own answers on their friends\u2019 pictures."},{"fy":2020,"lvl":"x","n":2,"adsh":"0001477932-21-003616","doc":"asft_10k.htm","q":"Using high quality image recognition software, the user will be told what the image is, and if the software is wrong, they can challenge the system and then ask their friends and post their own answers on their friends\u2019 pictures."},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-001695","doc":"asft_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-002714","doc":"asft_10k.htm","q":null},{"fy":2023,"lvl":"x","n":2,"adsh":"0001477932-24-001977","doc":"asft_10k.htm","q":"Despite well-designed controls, we acknowledge the inability to foresee all security breaches, including those stemming from third-party misuse of artificial intelligence (\u201cAI\u201d) technologies, and the potential challenges in implementing tim\u2026"},{"fy":2024,"lvl":"x","n":2,"adsh":"0001477932-25-002769","doc":"asft_10k.htm","q":"Despite well-designed controls, we acknowledge the inability to foresee all security breaches, including those stemming from third-party misuse of artificial intelligence (\u201cAI\u201d) technologies, and the potential challenges in implementing tim\u2026"},{"fy":2025,"lvl":"x","n":5,"adsh":"0001477932-26-002564","doc":"asft_10k.htm","q":"AI Profit Lab In early 2025, AppSoft embarked on a venture we call AI Profit Lab."}]},{"cik":1652044,"name":"ALPHABET INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2015,"lvl":0,"n":0,"adsh":"0001652044-16-000012","doc":"goog10-k2015.htm","q":null},{"fy":2016,"lvl":2,"n":9,"adsh":"0001652044-17-000008","doc":"goog10-kq42016.htm","q":"The power of machine learning Across the company, machine learning and artificial intelligence (AI) are increasingly driving many of our latest innovations."},{"fy":2017,"lvl":2,"n":11,"adsh":"0001652044-18-000007","doc":"goog10-kq42017.htm","q":"The power of machine learning Across the company, machine learning and artificial intelligence (AI) are increasingly driving many of our latest innovations."},{"fy":2018,"lvl":2,"n":14,"adsh":"0001652044-19-000004","doc":"goog10-kq42018.htm","q":"The power of machine learning Across the company, machine learning and artificial intelligence (AI) are increasingly driving many of our latest innovations."},{"fy":2019,"lvl":3,"n":17,"adsh":"0001652044-20-000008","doc":"goog10-k2019.htm","q":"We do not intend to become one.\" That unconventional spirit has been a driving force throughout our history \u2014 inspiring us to do things like tackling deep computer science problems, such as our investments in artificial intelligence (AI) an\u2026"},{"fy":2020,"lvl":3,"n":17,"adsh":"0001652044-21-000010","doc":"goog-20201231.htm","q":"We do not intend to become one.\" That unconventional spirit has been a driving force throughout our history, inspiring us to tackle big problems, and invest in moonshots like artificial intelligence (\"AI\") research and quantum computing."},{"fy":2021,"lvl":2,"n":13,"adsh":"0001652044-22-000019","doc":"goog-20211231.htm","q":"We do not intend to become one.\" That unconventional spirit has been a driving force throughout our history, inspiring us to tackle big problems and invest in moonshots like artificial intelligence (AI) research and quantum computing."},{"fy":2022,"lvl":3,"n":28,"adsh":"0001652044-23-000016","doc":"goog-20221231.htm","q":"We do not intend to become one.\" That unconventional spirit has been a driving force throughout our history, inspiring us to tackle big problems and invest in moonshots, such as our long-term opportunities in artificial intelligence (AI)."},{"fy":2023,"lvl":3,"n":124,"adsh":"0001652044-24-000022","doc":"goog-20231231.htm","q":"It led us to be a pioneer in the development of AI and, since 2016, an AI-first company."},{"fy":2024,"lvl":3,"n":125,"adsh":"0001652044-25-000014","doc":"goog-20241231.htm","q":"It led us to be a pioneer in the development of AI and, since 2016, an AI-first company."},{"fy":2025,"lvl":3,"n":127,"adsh":"0001652044-26-000018","doc":"goog-20251231.htm","q":"It led us to be a pioneer in the development of artificial intelligence (AI) and, since 2016, be an AI-first company."}]},{"cik":1652535,"name":"ICHOR HOLDINGS, LTD.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005482","doc":"ichr-10k_20171229.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006988","doc":"ichr-10k_20181228.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009069","doc":"ichr-10k_20191227.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011114","doc":"ichr-10k_20201225.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007613","doc":"ichr-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-002383","doc":"ichr-10k_20221230.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001628280-24-006527","doc":"ichr-20231229.htm","q":"We believe that our future success will depend upon our ability to design, engineer and manufacture products that meet the changing needs of our current and potential customers, including potentially through the incorporation or use of soft\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-006992","doc":"ichr-20241227.htm","q":"We believe that our future success will depend upon our ability to design, engineer and manufacture products that meet the changing needs of our current and potential customers, including potentially through the incorporation or use of soft\u2026"},{"fy":2025,"lvl":3,"n":59,"adsh":"0001652535-26-000012","doc":"ichr-20251226.htm","q":"We believe that our future success will depend upon our ability to design, engineer and manufacture products that meet the changing needs of our current and potential customers, including potentially through the incorporation or use of soft\u2026"}]},{"cik":1652923,"name":"AVEXIS, INC.","industry":"Pharma & biotech","sic":2836,"state":"IL","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001047469-17-001695","doc":"a2231367z10-k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-001313","doc":"avxs-20171231x10k.htm","q":null}]},{"cik":1652935,"name":"ACTUATE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2024,"lvl":"x","n":3,"adsh":"0001683168-25-001581","doc":"actuate_i10k-123124.htm","q":"Animal tumor model data, Phase 1/2 clinical data and AI-based computational approaches have identified a number of areas of unmet clinical need in cancer treatment where elraglusib may play an interventional role, including pancreatic, meta\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001683168-26-002257","doc":"actuate_i10k-123125.htm","q":"Animal tumor model data, clinical trial data and AI-based computational approaches have identified a number of areas of unmet clinical need in cancer treatment where elraglusib may play an interventional role, including pancreatic, metastat\u2026"}]},{"cik":1653087,"name":"ALECTOR, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012520","doc":"alec-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008860","doc":"alec-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001979","doc":"alec-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005111","doc":"alec-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021183","doc":"alec-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-027758","doc":"alec-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":27,"adsh":"0001193125-26-071593","doc":"alec-20251231.htm","q":null}]},{"cik":1653482,"name":"GITLAB INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001628280-22-008836","doc":"gtlb-20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009925","doc":"gtlb-20230131.htm","q":null},{"fy":2023,"lvl":3,"n":48,"adsh":"0001628280-24-012963","doc":"gtlb-20240131.htm","q":"Our platform is uniquely built as a single application with native artificial intelligence, or AI, assisted workflows, and a single interface with a unified data model, enabling all stakeholders in the software delivery lifecycle \u2013 from dev\u2026"},{"fy":2024,"lvl":3,"n":60,"adsh":"0001628280-25-014344","doc":"gtlb-20250131.htm","q":"In the fourth quarter of fiscal year 2025, we announced a promising partnership with AWS 6 Table of Contents to bring together a new, jointly developed artificial intelligence, or AI, solution named GitLab Duo with Amazon Q."}]},{"cik":1653629,"name":"HYPGEN INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001662252-18-000048","doc":"hypgen_10ka.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001662252-18-000094","doc":"hpgn10k.htm","q":null}]},{"cik":1653821,"name":"CEN BIOTECH INC","industry":"Pharma & biotech","sic":2834,"state":"ON","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001437749-17-006551","doc":"cenb20161231_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001437749-18-006949","doc":"cenb20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001437749-19-007304","doc":"cenb20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001437749-20-007659","doc":"cenb20191231_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001437749-21-005883","doc":"cenb20201231_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001437749-22-008982","doc":"cenb20211231_10k.htm","q":null}]},{"cik":1653876,"name":"MOMENTOUS HOLDINGS CORP.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001019687-16-006952","doc":"momentous_10k-053116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001683168-17-001860","doc":"momentous_10k-053117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001683168-18-002223","doc":"momentous_10k-053118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-19-004014","doc":"momentous_10k-053119.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-000728","doc":"momentous_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001829126-23-006106","doc":"momentous_10k.htm","q":null}]},{"cik":1653979,"name":"JACC STUDIOS INC.","industry":"Software & IT services","sic":7371,"state":"NV","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001520138-17-000172","doc":"jacc-20161231_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001520138-18-000062","doc":"jacc-20171231_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001520138-19-000071","doc":"jacc-20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001520138-20-000204","doc":"jacc-20191231_10k.htm","q":null}]},{"cik":1654151,"name":"DECIPHERA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-099539","doc":"d424769d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-074791","doc":"d686263d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001654151-20-000003","doc":"dcph-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001654151-21-000003","doc":"dcph-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001654151-22-000003","doc":"dcph-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001654151-23-000003","doc":"dcph-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001654151-24-000004","doc":"dcph-20231231.htm","q":"Any of these events could materially adversely impact our business and results of operations. 64 Table of Contents Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our \u2026"}]},{"cik":1655349,"name":"MESSAGEBGONE, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001477932-16-013648","doc":"mess_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-17-006061","doc":"mess_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-000228","doc":"messagebgone_i10k-083121.htm","q":null}]},{"cik":1655759,"name":"ARVINAS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009357","doc":"arvn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011004","doc":"arvn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009857","doc":"arvn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004262","doc":"arvn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001655759-23-000010","doc":"arvn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001655759-24-000018","doc":"arvn-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0001655759-25-000016","doc":"arvn-20241231.htm","q":"The PROTAC Discovery En gine includes advanced screening capabilities, including in-house high-throughput DNA-encoded library screening, computational and machine learning abilities that are tailored to the needs of incorporation into PROTA\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-011226","doc":"arvn-20251231.htm","q":"Our Discovery Platform \u2014 PROTAC Discovery Engine Our PROTAC Discovery Engine is an interlocking suite of tools and expertise that assists with our goal of creating and advancing clinical-stage programs with the potential to help patients, a\u2026"}]},{"cik":1655923,"name":"ALPHA COGNITION INC.","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-026225","doc":"ea0233390-10k_alpha.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-037614","doc":"ea0280314-10k_alphacog.htm","q":null}]},{"cik":1656053,"name":"TRAQER CORP","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001144204-16-136247","doc":"v451730_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001185185-17-002610","doc":"traqercorp10k083117.htm","q":null},{"fy":2018,"lvl":"x","n":2,"adsh":"0001640334-18-002371","doc":"taqr_10k.htm","q":"In addition, Wuhan University of Technology will be responsible for the experimental verification of new eco-friendly mortar that has been researched and developed and to assist us in developing, building and promoting artificial intelligen\u2026"}]},{"cik":1656328,"name":"SIENNA BIOPHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-084145","doc":"d696689d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-074162","doc":"d659927d10k.htm","q":null}]},{"cik":1656536,"name":"DECIBEL THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004130","doc":"dbtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007849","doc":"dbtx-20221231.htm","q":null}]},{"cik":1656634,"name":"GRITSTONE BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2018,"lvl":2,"n":8,"adsh":"0001564590-19-009825","doc":"grts-10k_20181231.htm","q":"The first pillar of our tumor-specific cancer immunotherapy approach is our understanding of TSNA and the application of our artificial intelligence based, proprietary Gritstone EDGE platform to predict the presence of a patient\u2019s unique TS\u2026"},{"fy":2019,"lvl":2,"n":9,"adsh":"0001564590-20-009886","doc":"grts-10k_20191231.htm","q":"Our programs are built on two key pillars\u2014first, our proprietary Gritstone EDGE artificial intelligence platform which enables us to identify TSNA with high accuracy; and second, a potent immunotherapy platform which we have engineered to d\u2026"},{"fy":2020,"lvl":2,"n":9,"adsh":"0001564590-21-012260","doc":"grts-10k_20201231.htm","q":"Our programs are built on two key pillars \u2013 first, our proprietary Gritstone EDGE artificial intelligence platform, which enables us to identify antigens that can be recognized by the immune system with high accuracy; and second, a potent i\u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0000950170-22-003366","doc":"grts-20211231.htm","q":"Our programs are built on two key platforms, the first being our proprietary Gritstone EDGE\u0099 artificial intelligence platform, which enables us to identify antigens that can be recognized by the immune system with a high degree of accuracy."},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-007022","doc":"grts-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0000950170-24-025855","doc":"grts-20231231.htm","q":null}]},{"cik":1657249,"name":"ROAD MARSHALL, INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001690824-17-000002","doc":"rdmr_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001599916-18-000010","doc":"rdmr_10k2017.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001599916-18-000224","doc":"rdmr_10k2018.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001599916-19-000172","doc":"rdmr_10k2019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001599916-20-000158","doc":"rdmr_10k2020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001599916-22-000013","doc":"rdmr10k2021outfi.htm","q":null}]},{"cik":1657312,"name":"VERONA PHARMA PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001657312-21-000004","doc":"vrna-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001657312-22-000010","doc":"vrna-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001657312-23-000006","doc":"vrna-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001657312-24-000007","doc":"vrna-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001657312-25-000010","doc":"vrna-20241231.htm","q":null}]},{"cik":1657803,"name":"INBIT CORP","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001493152-17-002853","doc":"form10-k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004208","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-004166","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004857","doc":"form10-k.htm","q":null}]},{"cik":1658247,"name":"CRINETICS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007561","doc":"crnx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009365","doc":"crnx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016719","doc":"crnx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005050","doc":"crnx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005132","doc":"crnx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-022108","doc":"crnx-20231231.htm","q":"Despite the implementation of security measures, our information technology systems and those of our current and any future CROs and other contractors, consultants and collaborators are vulnerable to attack, interruption and damage from com\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0000950170-25-029050","doc":"crnx-20241231.htm","q":"The increasing use of social media and artificial intelligence-based platforms presents new risks and challenges."},{"fy":2025,"lvl":2,"n":9,"adsh":"0001658247-26-000012","doc":"crnx-20251231.htm","q":"The increasing use of social media and artificial intelligence-based platforms presents new risks and challenges."}]},{"cik":1658520,"name":"OS SUPPORT, INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-19-004259","doc":"os_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001477932-20-003376","doc":"os_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-20-004495","doc":"os_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-20-005404","doc":"os_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-21-008973","doc":"os_10q.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-22-008704","doc":"os_10k.htm","q":null}]},{"cik":1658551,"name":"AMYLYX PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007609","doc":"amlx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-018447","doc":"amlx-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-031309","doc":"amlx-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":33,"adsh":"0001193125-26-086645","doc":"amlx-20251231.htm","q":"Our use of new and evolving technologies, including artificial intelligence, presents risks and challenges that can impact our business including by posing cybersecurity and other risks to our confidential information, proprietary informati\u2026"}]},{"cik":1659323,"name":"ITERUM THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009089","doc":"itrm-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010242","doc":"itrm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012694","doc":"itrm-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011897","doc":"itrm-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008300","doc":"itrm-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037615","doc":"itrm-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-015857","doc":"itrm-20241231.htm","q":"The disruption and volatility in the global and domestic capital markets resulting from heightened inflation, capital market volatility, interest rate and currency rate fluctuations, artificial intelligence, regulatory changes under the new\u2026"}]},{"cik":1659352,"name":"CODIAK BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013870","doc":"cdak-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003373","doc":"cdak-20211231.htm","q":null}]},{"cik":1659617,"name":"MOLECULIN BIOTECH, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-018352","doc":"v462503_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001659617-18-000027","doc":"a2017q410-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001659617-19-000018","doc":"mbx-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001659617-20-000066","doc":"mbx-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-006940","doc":"mbrx20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007103","doc":"mbrx20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-007537","doc":"mbrx20221231_10k.htm","q":null},{"fy":2023,"lvl":2,"n":13,"adsh":"0001437749-24-009044","doc":"mbrx20231231_10k.htm","q":"A lack of regularly published research about our business could cause trading volume or our stock price to decline. \u2022 Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party \u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001437749-25-008751","doc":"mbrx20241231_10k.htm","q":"A lack of regularly published research about our business could cause trading volume or our stock price to decline. \u2022 Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party \u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001437749-26-008841","doc":"mbrx20251231_10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing security risks to our confidential information, proprietary information and personal data ."}]},{"cik":1660134,"name":"OKTA, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001660134-18-000007","doc":"okta-1312018_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001660134-19-000006","doc":"okta-1312019_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001660134-20-000006","doc":"okta-131202010k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001660134-21-000007","doc":"okta-20210131.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001660134-22-000010","doc":"okta-20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001660134-23-000013","doc":"okta-20230131.htm","q":null},{"fy":2023,"lvl":3,"n":38,"adsh":"0001660134-24-000025","doc":"okta-20240131.htm","q":"For example, in fiscal 2024 we announced Okta AI, which is designed to use AI 7 models and Okta\u2019s unique crowdsourced threat intelligence identity data to power real-time identity actions, such as the industry\u2019s first real Universal Logout \u2026"},{"fy":2024,"lvl":3,"n":45,"adsh":"0001660134-25-000049","doc":"okta-20250131.htm","q":"Okta AI, a suite of AI-powered capabilities using our unique threat intelligence identity data to power real-time identity actions, is infused into several products available on our two platforms."}]},{"cik":1660280,"name":"TENABLE HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2018,"lvl":1,"n":1,"adsh":"0001660280-19-000012","doc":"q42018tenablefinancial.htm","q":"Predictive Prioritization combines Tenable vulnerability data with third party threat and vulnerability data across 150 data sources using a proprietary machine learning algorithm developed by the Tenable Research data science team to predi\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001660280-20-000012","doc":"q42019tenablefinancial.htm","q":"Through machine learning algorithms, we provide insights 4 Table of Contents that help organizations focus based on business impact."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001660280-21-000027","doc":"tenb-20201231.htm","q":"It combines Tenable vulnerability data with third-party threat and vulnerability data across more than 150 data sources using a proprietary machine learning algorithm developed by Tenable Research and data science teams to provide clear gui\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001660280-22-000035","doc":"tenb-20211231.htm","q":"It combines Tenable vulnerability data with third-party threat and vulnerability data across more than 150 data sources using a proprietary machine learning algorithm developed by Tenable Research and data science teams to provide clear gui\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001660280-23-000032","doc":"tenb-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001660280-24-000033","doc":"tenb-20231231.htm","q":"Tenable One leverages artificial intelligence, or AI, and machine learning, or ML, to rapidly analyze and interpret vast data sets, deliver rapid prioritization of exposures and assets and the likelihood of exploit, deliver recommendations,\u2026"},{"fy":2024,"lvl":3,"n":53,"adsh":"0001660280-25-000034","doc":"tenb-20241231.htm","q":"For most organizations, the modern attack surface has expanded to include: \u2022 Complex and dynamic multi-cloud environments, which organizations are rapidly adopting even as they face a shortage of cloud security expertise; \u2022 Artificial intel\u2026"},{"fy":2025,"lvl":3,"n":119,"adsh":"0001660280-26-000005","doc":"tenb-20251231.htm","q":"Exposure management is an increasingly critical category that extends foundational vulnerability management capabilities to advance risk assessment and prioritization across the entire attack surface \u2013 from IT infrastructure and cloud envir\u2026"}]},{"cik":1660334,"name":"VERRICA PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006800","doc":"vrca-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010832","doc":"vrca-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013876","doc":"vrca-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002685","doc":"vrca-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006118","doc":"vrca-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":9,"adsh":"0000950170-24-022659","doc":"vrca-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0000950170-25-037172","doc":"vrca-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0001660334-26-000008","doc":"vrca-20251231.htm","q":"Our employees and personnel may use generative artificial intelligence, or AI, or automated decision-making technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various \u2026"}]},{"cik":1660719,"name":"ARALEZ PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"ON","cells":[{"fy":2015,"lvl":"x","n":0,"adsh":"0001140361-16-057746","doc":"form10k.htm","q":null},{"fy":2016,"lvl":0,"n":0,"adsh":"0001558370-17-001659","doc":"arlz-20161231x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002031","doc":"arlz-20171231x10k.htm","q":null}]},{"cik":1660839,"name":"PHOENIX APPS INC.","industry":"Software & IT services","sic":7371,"state":"ON","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001640334-17-000743","doc":"phoenix_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-18-000756","doc":"phoenix_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-19-000401","doc":"pxpp_10k.htm","q":null}]},{"cik":1661059,"name":"NEXTCURE, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2019,"lvl":1,"n":2,"adsh":"0001558370-20-002566","doc":"nxtc-20191231x10k.htm","q":"For example, we are developing our FIND-AI platform, a new platform focused on discovery efforts in autoimmunity and inflammation. \u00b7 Extending the reach of our product candidates through strategic partnerships and collaborations ."},{"fy":2020,"lvl":1,"n":2,"adsh":"0001558370-21-002384","doc":"nxtc-20201231x10k.htm","q":"For example, we are developing our FIND-AI platform, a new platform focused on discovery efforts in autoimmunity and inflammation. \u25cf Extending the reach of our product candidates through strategic partnerships and collaborations ."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002824","doc":"nxtc-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002698","doc":"nxtc-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003672","doc":"nxtc-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002402","doc":"nxtc-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-024137","doc":"nxtc-20251231x10k.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to the use of artificial intelligence to review product applications."}]},{"cik":1661181,"name":"ORGANOGENESIS HOLDINGS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-002068","doc":"ahpa-20171231x10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-078332","doc":"d716594d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-067198","doc":"d844864d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-082849","doc":"d96488d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-061686","doc":"d283851d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005585","doc":"orgo-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023150","doc":"orgo-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-029137","doc":"orgo-20241231.htm","q":"We have also identified the potential for cybersecurity risks stemming from the use of artificial intelligence (AI) tools developed by third parties."},{"fy":2025,"lvl":2,"n":5,"adsh":"0001193125-26-076730","doc":"orgo-20251231.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to use of AI to review product applications."}]},{"cik":1661460,"name":"POSEIDA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012509","doc":"pstx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009681","doc":"pstx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007030","doc":"pstx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-027998","doc":"pstx-20231231.htm","q":null}]},{"cik":1661998,"name":"Q32 BIO INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007250","doc":"fixx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010441","doc":"fixx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012490","doc":"fixx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004401","doc":"fixx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006995","doc":"fixx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-030478","doc":"fixx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-036823","doc":"qttb-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":30,"adsh":"0001193125-26-099339","doc":"qttb-20251231.htm","q":"Bad actors around the world use increasingly sophisticated methods, including the use of artificial intelligence, to engage in illegal activities involving the theft and misuse of personal information, confidential information and intellect\u2026"}]},{"cik":1662244,"name":"CYTEIR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003914","doc":"cyt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009486","doc":"cyt-20221231.htm","q":null}]},{"cik":1662524,"name":"AKCEA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001662524-18-000007","doc":"form10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005745","doc":"akca-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008119","doc":"akca-10k_20191231.htm","q":null}]},{"cik":1662574,"name":"GROM SOCIAL ENTERPRISES, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001683168-19-001077","doc":"grom_10k-2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001683168-20-002140","doc":"grom_10k-123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-001364","doc":"grom_10k-2020.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-002738","doc":"grom_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-002483","doc":"grom_i10k-123122.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-24-002468","doc":"grom_i10k-123123.htm","q":null}]},{"cik":1662579,"name":"C4 THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012531","doc":"cccc-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006499","doc":"cccc-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-004711","doc":"cccc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-006144","doc":"cccc-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-008433","doc":"cccc-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":19,"adsh":"0001628280-26-012000","doc":"cccc-20251231.htm","q":"Artificial Intelligence (AI) is increasingly being used in the pharmaceutical industry."}]},{"cik":1662706,"name":"TRUPAL MEDIA, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001594062-17-000254","doc":"0001594062-17-000254.txt","q":null}]},{"cik":1662774,"name":"QUINCE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011165","doc":"crtx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009867","doc":"crtx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002571","doc":"crtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008148","doc":"qncx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-039440","doc":"qncx-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001662774-25-000012","doc":"qncx-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and healthcare models to limit \u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-151364","doc":"qncx-20251231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and healthcare models\u2026"}]},{"cik":1662907,"name":"IASO BIOMED, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001511164-18-000236","doc":"iaso10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005827","doc":"form10-k.htm","q":null}]},{"cik":1664106,"name":"LOGICBIO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-094593","doc":"d696862d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011170","doc":"logc-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013165","doc":"logc-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-008771","doc":"logc-10k_20211231.htm","q":null}]},{"cik":1664710,"name":"KEROS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001664710-21-000018","doc":"kros-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001664710-22-000011","doc":"kros-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001664710-23-000021","doc":"kros-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001664710-24-000017","doc":"kros-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0001664710-25-000018","doc":"kros-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fake, and p\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001664710-26-000018","doc":"kros-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving 69 threats, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1664998,"name":"KNOWBE4, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2021,"lvl":3,"n":27,"adsh":"0001664998-22-000025","doc":"knbe-20211231.htm","q":"We are pioneering an integrated approach to security awareness that incorporates cloud-based software, machine learning, artificial intelligence, advanced analytics and insights with engaging content."}]},{"cik":1665658,"name":"COMMERCEHUB, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001665658-17-000011","doc":"commercehub-123116x10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001665658-18-000014","doc":"commercehub-123117x10k.htm","q":null}]},{"cik":1666071,"name":"CARDLYTICS, INC.","industry":"Software & IT services","sic":7370,"state":"GA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001666071-19-000017","doc":"cdlx_form10-kx2018q4.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001666071-20-000054","doc":"cdlxform10-k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001666071-21-000029","doc":"cdlx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001666071-22-000022","doc":"cdlx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001666071-23-000032","doc":"cdlx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001666071-24-000037","doc":"cdlx-20231231.htm","q":"We also may be the subject of viruses, malware installation, server malfunction, software or hardware failures, loss of data or other computer assets, adware, malicious or unintentional actions or in actions by employees or others with auth\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0001666071-25-000034","doc":"cdlx-20241231.htm","q":"We also may be the subject of viruses, malware installation, server malfunction, software or hardware failures, loss of data or other computer assets, adware, malicious or unintentional actions or in actions by employees or others with auth\u2026"},{"fy":2025,"lvl":3,"n":32,"adsh":"0001666071-26-000010","doc":"cdlx-20251231.htm","q":"We also may be the subject of viruses, malware installation, server malfunction, software or hardware failures, loss of data or other computer assets, adware, malicious or unintentional actions or in actions by employees or others with auth\u2026"}]},{"cik":1666134,"name":"BLACKLINE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-004011","doc":"bl-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004923","doc":"bl-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005462","doc":"bl-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007371","doc":"bl-10k_20191231.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001666134-21-000004","doc":"bl-20201231.htm","q":"Embedded machine learning then reduces the manual effort involved in the process, which can release working capital for our customers."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001666134-22-000003","doc":"bl-20211231.htm","q":"Embedded machine learning then reduces the manual effort involved in the process and releases working capital for our customers. \u2022 Credit & Risk Management brings customer and payment behavior data together to enable optimal risk strategies\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001666134-23-000003","doc":"bl-20221231.htm","q":"Embedded machine learning then reduces the manual effort involved in the process and releases working capital for our customers. \u2022 Credit & Risk Management brings customer and payment behavior data together to enable optimal risk strategies\u2026"},{"fy":2023,"lvl":3,"n":27,"adsh":"0001666134-24-000003","doc":"bl-20231231.htm","q":"With the recent acceleration of AI innovation and applications in the broader economy, we expect to further explore and possibly leverage such new and innovative technologies for optimized workflow, efficiencies, and value creation for our \u2026"},{"fy":2024,"lvl":3,"n":40,"adsh":"0001666134-25-000003","doc":"bl-20241231.htm","q":"BlackLine\u2019s recently launched Studio360 Platform addresses these challenges by providing an infrastructure and capabilities to further unify our products and services that includes: \u2022 Studio360 Integrate: Powerful and flexible capabilities \u2026"},{"fy":2025,"lvl":3,"n":77,"adsh":"0001628280-26-011915","doc":"bl-20251231.htm","q":"BlackLine\u2019s Studio360 Platform, Verity AI capabilities, and our comprehensive record-to-report and invoice-to-cash solutions uniquely address the increasing complexity of data, systems, and processes."}]},{"cik":1667011,"name":"ARTERIS, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":62,"adsh":"0001667011-22-000010","doc":"aip-20211231.htm","q":"Growth in the total addressable market (TAM) for our solutions is being driven by the addition of more processors, channels of memory access, machine learning sections, chiplets, additional input/output (I/O) interface standards and other s\u2026"},{"fy":2022,"lvl":3,"n":33,"adsh":"0001667011-23-000009","doc":"aip-20221231.htm","q":"Our leading proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/o\u2026"},{"fy":2023,"lvl":3,"n":37,"adsh":"0001667011-24-000010","doc":"aip-20231231.htm","q":"Our leading proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/o\u2026"},{"fy":2024,"lvl":3,"n":38,"adsh":"0001667011-25-000010","doc":"aip-20241231.htm","q":"Our leading proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/o\u2026"},{"fy":2025,"lvl":3,"n":56,"adsh":"0001628280-26-007726","doc":"aip-20251231.htm","q":"Integration of processors, accelerators, machine learning subsystems, sophisticated multi-channel memories, and an ever-larger number of interface standards has increased the need to move data efficiently inside the SoC and between SoC chip\u2026"}]},{"cik":1667313,"name":"ZEDGE, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2016,"lvl":1,"n":1,"adsh":"0001213900-16-017726","doc":"f10k2016_zedgeinc.htm","q":"Our Technology Zedge has developed a scalable distributed platform that is comprised of both open source and proprietary technologies centered on content management and discovery, web and app development, data mining and analytics, deep lea\u2026"},{"fy":2017,"lvl":1,"n":1,"adsh":"0001213900-17-011082","doc":"f10k2017_zedgeinc.htm","q":"Our Technology We have developed a scalable distributed platform that is comprised of both open source and proprietary technologies centered on content management and discovery, web and app development, data mining and analytics, deep learn\u2026"},{"fy":2018,"lvl":1,"n":2,"adsh":"0001213900-18-014592","doc":"f10k2018_zedge.htm","q":"Our Technology We have developed our Zedge app as a scalable distributed platform that is comprised of both open source and proprietary technologies centered on content management and discovery, web and app development, data mining and anal\u2026"},{"fy":2019,"lvl":"x","n":2,"adsh":"0001213900-19-021279","doc":"f10k2019_zedgeinc.htm","q":"Our Technology Our Zedge app as a scalable distributed platform that is comprised of both open source and proprietary technologies centered on content management and discovery, web and app development, data mining and analytics, deep learni\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001213900-20-033714","doc":"f10k2020_zedgeinc.htm","q":"Our Technology Our Zedge app is powered by a scalable distributed platform that is comprised of both open source and proprietary technologies centered on content management and discovery, web and app development, data mining and analytics, \u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001213900-21-057733","doc":"f10k2021_zedgeinc.htm","q":"On August 1, 2021, we acquired Emojipedia, the world\u2019s leading authority dedicated to providing up-to-date and well-researched emoji definitions, information, and news as well as World Emoji Day and the annual World Emoji Awards, and Emojit\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001213900-22-072153","doc":"f10k2022_zedgeinc.htm","q":"GuruShots currently generates revenue from selling digital resources that, if used skillfully, can provide additional visibility to competitors\u2019 photographs, a critical factor in securing votes for competitive ranking. 7 Our Technology Our \u2026"},{"fy":2023,"lvl":3,"n":79,"adsh":"0001213900-23-081544","doc":"f10k2023_zedgeinc.htm","q":"Our leading products include Zedge Ringtones and Wallpapers, a freemium digital content marketplace offering mobile phone wallpapers, video wallpapers, ringtones, and notification sounds as well as pAInt, a generative AI wallpaper maker, Gu\u2026"},{"fy":2024,"lvl":3,"n":101,"adsh":"0001213900-24-091735","doc":"ea0218596-10k_zedge.htm","q":"Our leading products include Zedge Ringtones and Wallpapers, which we refer to as our \u201cZedge App,\u201d a freemium digital content marketplace offering mobile phone wallpapers, video wallpapers, ringtones, and notification sounds as well as pAIn\u2026"},{"fy":2025,"lvl":3,"n":226,"adsh":"0001213900-25-103098","doc":"ea0262035-10k_zedge.htm","q":"Our leading products include Zedge Ringtones and Wallpapers, which we refer to as our \u201cZedge App,\u201d a freemium digital content marketplace offering mobile phone wallpapers, video wallpapers, ringtones, and notification sounds as well as pAIn\u2026"}]},{"cik":1667633,"name":"FORTY SEVEN, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009879","doc":"ftsv-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012062","doc":"ftsv-10k_20191231.htm","q":null}]},{"cik":1668105,"name":"TALEND S.A.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2018,"lvl":2,"n":10,"adsh":"0001668105-19-000005","doc":"tlnd-20181231x10k.htm","q":"The growing capabilities of cloud data warehouses have created a powerful and easy-to-use alternative to on-premise infrastructure that is accelerating the shift of data to the cloud and expanding the availability of big data and machine le\u2026"},{"fy":2019,"lvl":2,"n":10,"adsh":"0001668105-20-000035","doc":"tlnd-20191231x10k.htm","q":"We help organizations overcome the barriers that stand in the way of harnessing data, enabling them to discover it across systems, aggregate it to power analytics, clean it to correct errors, transform it through machine learning, share it \u2026"},{"fy":2020,"lvl":2,"n":6,"adsh":"0001668105-21-000016","doc":"tlnd-20201231.htm","q":"We believe organizations everywhere are seeking ways to gain competitive advantages by collecting, governing, transforming, and sharing their data. \u2022 Modular software is on the rise , in response to demands to move at scale with best-in-cla\u2026"}]},{"cik":1668243,"name":"UROGEN PHARMA LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005323","doc":"urgn-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007970","doc":"urgn-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014016","doc":"urgn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-006778","doc":"urgn20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-007710","doc":"urgn20221231_10k.htm","q":null},{"fy":2023,"lvl":3,"n":15,"adsh":"0001437749-24-007753","doc":"urgn20231231_10k.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":3,"n":17,"adsh":"0001437749-25-006842","doc":"urgn20241231_10k.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models \u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001437749-26-006234","doc":"urgn20251231_10k.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including, but not limited to, social engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, \u2026"}]},{"cik":1668397,"name":"MEDPACE HOLDINGS, INC.","industry":"Pharma & biotech","sic":8731,"state":"OH","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-002839","doc":"medp-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-003500","doc":"medp-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004451","doc":"medp-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006385","doc":"medp-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006072","doc":"medp-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001280","doc":"medp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001668397-23-000008","doc":"medp-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":19,"adsh":"0001668397-24-000013","doc":"medp-20231231.htm","q":"Continued evolution and use of machine learning and generative artificial intelligence (\"AI\"), including risks arising from insufficient human oversight of AI or a lack of controls and procedures monitoring the use of AI in day-to-day opera\u2026"},{"fy":2024,"lvl":3,"n":21,"adsh":"0001668397-25-000017","doc":"medp-20241231.htm","q":"Industry Risks \u2022 Outsourcing trends in the biopharmaceutical industry and changes in aggregate expenditures and R&D budgets could adversely affect our operating results and growth rate. \u2022 We may be affected by healthcare reform and potentia\u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001668397-26-000006","doc":"medp-20251231.htm","q":"Industry Risks \u2022 Outsourcing trends in the biopharmaceutical industry and changes in aggregate expenditures and R&D budgets could adversely affect our operating results and growth rate. \u2022 We may be affected by healthcare reform and potentia\u2026"}]},{"cik":1669513,"name":"APP INCLINE CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001594062-16-000721","doc":"form10k.htm","q":null}]},{"cik":1670538,"name":"MON SPACE NET INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-003888","doc":"f10k2016_monspacenet.htm","q":null}]},{"cik":1670541,"name":"ADIENT PLC","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001670541-17-000071","doc":"a9302017adientform10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001670541-18-000065","doc":"a9302018adientform10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001670541-19-000057","doc":"adnt-20190930.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001670541-20-000080","doc":"adnt-20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001670541-21-000133","doc":"adnt-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001670541-22-000118","doc":"adnt-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001670541-23-000153","doc":"adnt-20230930.htm","q":null},{"fy":2024,"lvl":3,"n":15,"adsh":"0001670541-24-000109","doc":"adnt-20240930.htm","q":"Investing in Technology Adient continues to invest in technology and innovation by utilizing automation in metals, foam, trim and complete seat operations as well as expanding the use of artificial intelligence (\u201cAI\u201d)."},{"fy":2025,"lvl":3,"n":15,"adsh":"0001670541-25-000152","doc":"adnt-20250930.htm","q":"Investing in Technology Adient continues to invest in technology and innovation by utilizing automation in metals, foam, trim and complete seat operations as well as expanding the use of artificial intelligence (\u201cAI\u201d)."}]},{"cik":1671502,"name":"QUOIN PHARMACEUTICALS, LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001410578-25-000336","doc":"qnrx-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-035251","doc":"qnrx-20251231x10k.htm","q":null}]},{"cik":1671584,"name":"APTEVO THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"WA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-005738","doc":"apvo-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005384","doc":"apvo-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008184","doc":"apvo-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012791","doc":"apvo-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016875","doc":"apvo-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011575","doc":"apvo-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010757","doc":"apvo-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-025428","doc":"apvo-20231231.htm","q":"Abdun-Nabi earned a bachelor degree in political science from the University of Massachusetts Amherst, a J.D. from the University of San Diego School of Law and an LLM from Georgetown 97 University Law Center."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-020467","doc":"apvo-20241231.htm","q":"Abdun-Nabi earned a bachelor degree in political science from the University of Massachusetts Amherst, a J.D. from the University of San Diego School of Law and an LLM from Georgetown 100 University Law Center."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-126278","doc":"apvo-20251231.htm","q":"Abdun-Nabi earned a bachelor degree in political science from the University of Massachusetts Amherst, a J.D. from the University of San Diego School of Law and an LLM from Georgetown 99 University Law Center."}]},{"cik":1671818,"name":"ONCORUS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012059","doc":"oncr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003228","doc":"oncr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009725","doc":"oncr-20221231.htm","q":null}]},{"cik":1671858,"name":"ARS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005202","doc":"sbtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009491","doc":"spry-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034689","doc":"spry-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-042320","doc":"spry-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as a fake, \u2026"},{"fy":2025,"lvl":3,"n":31,"adsh":"0001193125-26-097478","doc":"spry-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as a fake, \u2026"}]},{"cik":1671927,"name":"IMMUNOCORE HOLDINGS PLC","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2023,"lvl":1,"n":3,"adsh":"0001140361-24-009921","doc":"ef20015345_10k.htm","q":"We and the third parties upon whom we rely face a variety of evolving threats including but not limited to breakdown\u037e breach\u037e interruption or damage from computer viruses\u037e malicious code (such as worms)\u037e social-engineering attacks (includin\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0001671927-25-000006","doc":"imcr-20241231.htm","q":"Our employees and personnel use generative artificial intelligence (\"AI\") technologies to perform their work, including in our research and development activities and the disclosure and use of personal data in generative AI technologies is \u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001671927-26-000005","doc":"imcr-20251231.htm","q":"Competing products may gain faster or greater market acceptance than our products, if any, and medical advances or rapid technological development by competitors, including increased use of artificial intelligence-based technologies, may re\u2026"}]},{"cik":1671933,"name":"TRADE DESK, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2016,"lvl":1,"n":1,"adsh":"0001193125-17-046742","doc":"d306969d10k.htm","q":"This data is fed back into our optimization engine to improve campaign performance, and into machine-learning models for user demographic predictive modeling."},{"fy":2017,"lvl":1,"n":1,"adsh":"0001564590-18-003611","doc":"ttd-10k_20171231.htm","q":"This data is fed back into our optimization engine to improve campaign performance, and into machine-learning models for user demographic predictive modeling."},{"fy":2018,"lvl":1,"n":2,"adsh":"0001564590-19-003906","doc":"ttd-10k_20181231.htm","q":"Our platform enables clients to license a broad selection of data from third-party vendors in a seamless and easy manner, allowing them to further optimize their campaigns with the most relevant data. \u2022 Koa Artificial Intelligence."},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-007498","doc":"ttd-10k_20191231.htm","q":"Our platform enables clients to license a broad selection of data from third-party vendors in a seamless and easy manner, allowing them to further optimize their campaigns with the most relevant data. \u2022 Koa Artificial Intelligence."},{"fy":2020,"lvl":1,"n":4,"adsh":"0001564590-21-006726","doc":"ttd-10k_20201231.htm","q":"Our platform enables clients to license a broad selection of data from third-party vendors in a seamless and easy manner, allowing them to further optimize their campaigns with the most relevant data. \u2022 Koa Artificial Intelligence."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001564590-22-005385","doc":"ttd-10k_20211231.htm","q":"We also offer a broad selection of third-party measurement partners, which provides our clients with increased optionality to assess campaign performance. \u2022 Koa Artificial Intelligence."},{"fy":2022,"lvl":1,"n":4,"adsh":"0001671933-23-000007","doc":"ttd-20221231.htm","q":"We also offer a broad selection of third-party measurement partners, which provides our clients with increased optionality to assess campaign performance. \u2022 Koa Artificial Intelligence."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001671933-24-000014","doc":"ttd-20231231.htm","q":"We also empower our clients with an extensive set of measurement capabilities, both through a number of proprietary benchmarking tools and indices, and through integrations with a broad selection of third-party measurement partners. 7 Table\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0001671933-25-000029","doc":"ttd-20241231.htm","q":"We also empower our clients with an extensive set of measurement capabilities, both through a number of proprietary benchmarking tools and indices, and through integrations with a broad selection of third-party measurement partners. \u2022 Artif\u2026"},{"fy":2025,"lvl":3,"n":49,"adsh":"0001671933-26-000014","doc":"ttd-20251231.htm","q":"Our platform\u2019s depth, artificial intelligence (\u201cAI\u201d) capabilities and rich ecosystem of inventory, publisher and data partner integrations enable superior reach and decisioning for clients."}]},{"cik":1672619,"name":"ENLIVEN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011098","doc":"imra-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010216","doc":"imra-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-001729","doc":"imra-10k_20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-031495","doc":"elvn-20231231.htm","q":"Generative artificial intelligence resources that are publicly available present a risk that a company may inadvertently obtain, incorporate, or use a third party\u2019s intellectual property."},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-038758","doc":"elvn-20241231.htm","q":"Generative artificial intelligence resources that are publicly available present a risk that a company may inadvertently obtain, incorporate, or use a third party\u2019s intellectual property."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-088232","doc":"elvn-20251231.htm","q":"Recent developments at the FDA include implementation of Elsa, a generative AI tool, across all centers at the agency, announcement of a plan to phase out animal testing for monoclonal antibodies and certain other drugs, and the announcemen\u2026"}]},{"cik":1672688,"name":"ABSCI CORP","industry":"Pharma & biotech","sic":8731,"state":"WA","cells":[{"fy":2021,"lvl":3,"n":103,"adsh":"0001628280-22-006925","doc":"absi-20211231.htm","q":"Combining innovative approaches, including synthetic biology, high-throughput single-cell screening, and deep learning artificial intelligence (AI), we seek to identify optimal drug candidates by exploring expansive protein sequence solutio\u2026"},{"fy":2022,"lvl":3,"n":106,"adsh":"0001628280-23-009908","doc":"absi-20221231.htm","q":"Business Our Mission Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster."},{"fy":2023,"lvl":3,"n":142,"adsh":"0001628280-24-012366","doc":"absi-20231231.htm","q":"Business Our Mission Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster."},{"fy":2024,"lvl":3,"n":159,"adsh":"0001628280-25-013464","doc":"absi-20241231.htm","q":"Business Our Mission We are a data-first generative AI drug creation company with the mission to design differentiated antibody therapeutics."},{"fy":2025,"lvl":3,"n":142,"adsh":"0001672688-26-000068","doc":"absi-20251231.htm","q":"Business Overview We are a clinical-stage biopharmaceutical company using an AI-native approach to develop differentiated antibody therapeutics."}]},{"cik":1673481,"name":"LOTTERY.COM INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-017159","doc":"f10k2021_lotterycom.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-021506","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-022440","doc":"form10-ka.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-005663","doc":"form10-ka.htm","q":null}]},{"cik":1673772,"name":"RAPT THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-014162","doc":"rapt-10k_20191231.htm","q":"Key to our rapid discovery of small molecules is our use of structure and pharmacophore-based drug design strategies, and machine-learning assisted structure-activity-relationships to improve potency, selectivity and pharmacokinetic (\u201cPK\u201d) \u2026"},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-012250","doc":"rapt-10k_20201231.htm","q":"Key to our rapid discovery of small molecules is our use of structure and pharmacophore-based drug design strategies, and machine-learning assisted structure-activity-relationships to improve potency, selectivity and pharmacokinetic propert\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-009488","doc":"rapt-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007710","doc":"rapt-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000950170-24-027594","doc":"rapt-20231231.htm","q":"We and the third parties we rely on are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phish\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0000950170-25-034185","doc":"rapt-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforces, rescinding a prior executive order tasking CMMI to consider new payment and healthcare models to limit drug spending and eliminating a prior executive order tha\u2026"}]},{"cik":1674365,"name":"APTINYX INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002351","doc":"aptx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003369","doc":"aptx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003428","doc":"aptx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004153","doc":"aptx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005096","doc":"aptx-20221231x10k.htm","q":null}]},{"cik":1674416,"name":"CRISPR THERAPEUTICS AG","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001564590-17-003977","doc":"crsp-10k_20161231.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-004920","doc":"crsp-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-004115","doc":"crsp-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-004355","doc":"crsp-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-006074","doc":"crsp-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001282","doc":"crsp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003441","doc":"crsp-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-017571","doc":"crsp-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-017899","doc":"crsp-20241231.htm","q":"Claims that we have violated individuals' privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time consuming to defend and could result\u2026"},{"fy":2025,"lvl":3,"n":39,"adsh":"0001193125-26-048957","doc":"crsp-20251231.htm","q":"Using AI-guided structural modeling and large-scale screening, the polymerase was optimized to support gene correction activity based on synthetic nucleotide templates."}]},{"cik":1674440,"name":"CONNEXA SPORTS TECHNOLOGIES INC.","industry":"Software & IT services","sic":7370,"state":"DE","cells":[{"fy":2025,"lvl":3,"n":43,"adsh":"0001641172-25-023612","doc":"form10-k.htm","q":"Through YYEM, we own advanced patents and other proprietary technology which we license out, and we are using this intellectual property to develop an AI-powered matchmaking platform to license to partners worldwide, enabling them to create\u2026"}]},{"cik":1676238,"name":"BRAZE, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":"x","n":4,"adsh":"0001676238-22-000005","doc":"brze-20220131.htm","q":"For example, we continue to develop our artificial intelligence capabilities to enable brands to better analyze and act on customer data."},{"fy":2022,"lvl":2,"n":11,"adsh":"0001676238-23-000031","doc":"brze-20230131.htm","q":"This can be as simple as capturing a user\u2019s music or show preferences and alerting that user to similar new content on a media streaming service, or as advanced as using predictive AI to accompany a customer throughout their new user journe\u2026"},{"fy":2023,"lvl":3,"n":85,"adsh":"0001676238-24-000049","doc":"brze-20240131.htm","q":"This product architecture supports differentiated use of AI and machine learning through its comprehensive access to first party-data, and an ability to directly take action to guide the customer journey."},{"fy":2024,"lvl":3,"n":87,"adsh":"0001676238-25-000054","doc":"brze-20250131.htm","q":"We vertically integrate our data activation, insights and segmentation, orchestration, personalization and relevance capabilities and also leverage artificial intelligence (\u201cAI\u201d) investments across each layer of the stack, so coordinating b\u2026"}]},{"cik":1676580,"name":"VISION HYDROGEN CORP","industry":"Construction","sic":1700,"state":"NJ","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004463","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-003939","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-004724","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-005901","doc":"form10-k.htm","q":null}]},{"cik":1676725,"name":"IDEAYA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012501","doc":"idya-10k_20191231.htm","q":null},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-014676","doc":"idya-10k_20201231.htm","q":"We are applying these capabilities and resources to integrate using proprietary algorithms and unsupervised machine learning across each of the orthogonal data sets in our platform."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-010922","doc":"idya-10k_20211231.htm","q":"We are applying these capabilities and resources to integrate using proprietary algorithms and unsupervised machine learning across each of the orthogonal data sets in our platform."},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-006456","doc":"idya-20221231.htm","q":"We are applying these capabilities and resources to integrate using proprietary algorithms and unsupervised machine learning across each of 14 the orthogonal data sets in our platform."},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-017093","doc":"idya-20231231.htm","q":"The drug discovery platform includes our proprietary chemical library, INQUIRE\u0099, structure-based drug design enabled by extensive structural biology and crystallography capabilities, and our proprietary content-based machine-learning engine\u2026"},{"fy":2024,"lvl":3,"n":15,"adsh":"0000950170-25-022183","doc":"idya-20241231.htm","q":"Our approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are most likely to benefit from these\u2026"},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-054533","doc":"idya-20251231.htm","q":"Our discovery platform includes our proprietary chemical library, INQUIRE\u0099, structure-based drug design enabled by extensive structural biology and crystallography capabilities with over 200,000 chemical compounds, and our proprietary conte\u2026"}]},{"cik":1676852,"name":"OMNIA WELLNESS INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001676852-17-000011","doc":"glolex_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001676852-18-000004","doc":"glolex_10k-2v3.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001676852-19-000006","doc":"glolex_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-013249","doc":"form10-k.htm","q":null}]},{"cik":1677077,"name":"ALZAMEND NEURO, INC.","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001214659-21-007963","doc":"d72421010k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001214659-22-008985","doc":"g7722110k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001214659-23-010076","doc":"al71823010k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001214659-24-013191","doc":"x71924010k.htm","q":null},{"fy":2025,"lvl":"x","n":2,"adsh":"0001214659-25-010763","doc":"u7925110k.htm","q":"Ault is also the Executive Chairman and single largest stockholder (through his control of Ault & Co.) of HDI, a publicly traded diversified holding company that owns and operates a data center at which it mines digital assets and offers co\u2026"}]},{"cik":1677897,"name":"UPAY","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001552781-18-000282","doc":"e1100_10k.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001552781-18-000502","doc":"e18437_upay-10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001552781-19-000288","doc":"e19318_upay-10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001552781-20-000416","doc":"e20425_upay-10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001552781-21-000544","doc":"e21438_upay-10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001552781-22-000463","doc":"e22350_upyy-10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001575872-23-001038","doc":"upyy-20230228.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001575872-24-000650","doc":"upyy-20240229.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001575872-25-000377","doc":"upyy-20250228.htm","q":null}]},{"cik":1677940,"name":"BEYONDSPRING INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001171843-25-001758","doc":"bysi20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001171843-26-001908","doc":"bysi20251231_10k.htm","q":null}]},{"cik":1678660,"name":"PRELUDE THERAPEUTICS INC","industry":"Pharma & biotech","sic":2834,"state":"DE","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013330","doc":"prld-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010723","doc":"prld-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007989","doc":"prld-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-016016","doc":"prld-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":18,"adsh":"0000950170-25-035921","doc":"prld-20241231.htm","q":"We are no longer developing our PRMT5 inhibitor, PRT811, and are dependent on our license agreement with Pathos AI, Inc. to develop and commercialize the asset."},{"fy":2025,"lvl":3,"n":32,"adsh":"0001193125-26-099428","doc":"prld-20251231.htm","q":"We are no longer developing our PRMT5 inhibitor, PRT811, and are dependent on our license agreement with Pathos AI, Inc. to develop and commercialize the asset."}]},{"cik":1679082,"name":"MYOVANT SCIENCES LTD.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001679082-17-000009","doc":"myovant10kmarch31217.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001679082-18-000016","doc":"myovant10kmarch312018.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001679082-19-000019","doc":"myovant10kmarch312019.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001679082-20-000026","doc":"myovant10kmarch312020.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001679082-21-000017","doc":"myov-20210331.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001679082-22-000071","doc":"myov-20220331.htm","q":null}]},{"cik":1679363,"name":"MORPHIC HOLDING, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2019,"lvl":1,"n":2,"adsh":"0001558370-20-001653","doc":"morf-20191231x10k.htm","q":"We believe that product candidates identified with our MInT Platform may offer an optimized therapeutic approach by taking advantage of conformational targeting next\u2011generation physics\u2011based technologies augmented with machine learning and \u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001558370-21-002073","doc":"morf-20201231x10k.htm","q":"We believe that product candidates identified with our MInT Platform may offer an optimized therapeutic approach by 47 Table of Contents taking advantage of conformational targeting next-generation physics-based technologies augmented with \u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0001679363-22-000010","doc":"morf-20211231.htm","q":"Our ability to generate product candidates from our tunable product engine is significantly accelerated by our exclusive computational collaboration with Schr\u00f6dinger, which uses advanced physics-based modeling and machine learning to create\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001679363-23-000011","doc":"morf-20221231.htm","q":"Our ability to generate product candidates from our tunable product engine is significantly accelerated by our exclusive computational collaboration with Schr\u00f6dinger, which uses advanced physics-based modeling and machine learning to create\u2026"},{"fy":2023,"lvl":2,"n":12,"adsh":"0001679363-24-000013","doc":"morf-20231231.htm","q":"Together, this enables us to discover novel product candidates that bind and revert disease-specific integrin conformations to a non-disease physiologic state. 4 Table of Contents Since June, 2015 we have had an exclusive integrin focused c\u2026"}]},{"cik":1679628,"name":"JUPITER NEUROSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001261","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":18,"adsh":"0001493152-26-014687","doc":"form10-k.htm","q":"Further, artificial intelligence (AI)-based platforms and tools are increasingly being used in the medical industry, including by regulatory authorities, such as the FDA to assist with the review of regulatory filings and other activities."}]},{"cik":1679826,"name":"PING IDENTITY HOLDING CORP.","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2019,"lvl":3,"n":20,"adsh":"0001558370-20-002034","doc":"ping-20191231x10ke3d03d.htm","q":"Our Intelligent Identity Platform can leverage artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) to analyze device, network, application and user behavior data to make real-time authentication and security control decisions, enhanc\u2026"},{"fy":2020,"lvl":3,"n":21,"adsh":"0001558370-21-001638","doc":"ping-20201231x10k.htm","q":"We leverage artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) to analyze device, network, application and user behavior data to make real-time authentication and security control decisions, enhancing the user experience."},{"fy":2021,"lvl":3,"n":19,"adsh":"0001558370-22-001977","doc":"ping-20211231x10k.htm","q":"We deliver on this mission by providing intelligent identity solutions for the enterprise, leveraging artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) to provide real-time authentication."}]},{"cik":1680048,"name":"MUSTANG BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2016,"lvl":0,"n":0,"adsh":"0001144204-17-017831","doc":"v462107_10k.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-017988","doc":"tv486570_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-014624","doc":"tv515572_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-034130","doc":"tm205359d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003433","doc":"tmb-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004143","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004979","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002899","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001558370-25-003913","doc":"tmb-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-032063","doc":"tmb-20251231x10k.htm","q":null}]},{"cik":1680367,"name":"SHATTUCK LABS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001680367-21-000008","doc":"sttk-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001680367-22-000005","doc":"sttk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001680367-23-000019","doc":"sttk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001680367-24-000014","doc":"sttk-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001680367-25-000012","doc":"sttk-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and anti-discrimination."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001628280-26-014989","doc":"sttk-20251231.htm","q":"The CCPA and numerous other comprehensive privacy laws that have passed or are being considered in other states, as well as at the federal and local levels, exempt PHI that is subject to HIPAA; and others exempt covered entities and busines\u2026"}]},{"cik":1680581,"name":"FULCRUM THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-008951","doc":"fulc-10k_20191231.htm","q":"In addition, 10 of these subjects are enrolled in a three-month sub-study to assess mobility at home using a touchless sensor and machine learning platform for health analytics."},{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-21-010715","doc":"fulc-10k_20201231.htm","q":"We employ computational biology, such as machine learning algorithms, using our FulcrumSeek database and other databases to guide drug target selection and generate hypotheses on other drug targets that might be related along a gene regulat\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0000950170-22-002727","doc":"fulc-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-006841","doc":"fulc-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021074","doc":"fulc-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-026068","doc":"fulc-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":24,"adsh":"0001193125-26-065197","doc":"fulc-20251231.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, or AI, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary inform\u2026"}]},{"cik":1681087,"name":"TECTONIC THERAPEUTIC, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-085321","doc":"d677215d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011144","doc":"avro-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014190","doc":"avro-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010895","doc":"avro-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009527","doc":"avro-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-031635","doc":"avro-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":6,"adsh":"0000950170-25-042648","doc":"tecx-20241231.htm","q":"We have also taken a machine learning guided protein engineering approach to generate G-protein mimetics that can stabilize GPCRs in their active state conformation."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001193125-26-076793","doc":"tecx-20251231.htm","q":"For example, these threats may include (without limitation) malware, viruses, software vulnerabilities and bugs, software or hardware failure, hacking, denial of service attacks, social engineering (including through deep fakes, which may b\u2026"}]},{"cik":1681400,"name":"CELEBIDDY, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":1,"adsh":"0001213900-18-004096","doc":"f10k2017_celebiddyinc.htm","q":"With the advent of artificial intelligence and virtual reality looming, such advances in technology may lead to a significant shift in the user experience of online dating, upon which Celebiddy\u2019s business relies."},{"fy":2018,"lvl":"x","n":1,"adsh":"0001493152-20-011113","doc":"form10-k.htm","q":"With the advent of artificial intelligence and virtual reality looming, such advances in technology may lead to a significant shift in the user experience of online dating, upon which Celebiddy\u2019s business relies."}]},{"cik":1681689,"name":"BIOVERATIV INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001558370-18-000672","doc":"bivv-20171231x10k.htm","q":null}]},{"cik":1681941,"name":"IFRESH INC","industry":"Retail","sic":5411,"state":"NY","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001213900-17-006991","doc":"f10k2017_ifreshinc.htm","q":null},{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-008533","doc":"f10k2018_ifreshinc.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-011790","doc":"f10k2019_ifreshinc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-021922","doc":"f10k2020_ifreshinc.htm","q":null}]},{"cik":1682149,"name":"DATAVAULT AI INC.","industry":"Computers & chips","sic":3674,"state":"OR","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001144204-19-016754","doc":"tv517167_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001104659-20-037958","doc":"tm205294d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-036564","doc":"tm211095d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000337","doc":"wisa-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000276","doc":"wisa-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001410578-24-000412","doc":"wisa-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":71,"adsh":"0001410578-25-000600","doc":"dvlt-20241231x10k.htm","q":"On December 31, 2024, we purchased certain intellectual property assets from EOS Technology Holdings Inc., followed by changing our name to Datavault AI Inc. on February 13, 2025."}]},{"cik":1682265,"name":"ONAR HOLDING CORP","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001580695-18-000189","doc":"rhi-10k_123117.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001580695-19-000124","doc":"rhi-10k_123118.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001580695-20-000146","doc":"relt-10k_123119.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-001929","doc":"relt_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-002247","doc":"reliant_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-002344","doc":"relt_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-002220","doc":"relt_10k.htm","q":null},{"fy":2024,"lvl":"x","n":59,"adsh":"0001477932-25-002756","doc":"onar_10k.htm","q":"We believe our ability to leverage a technology-first approach, proprietary artificial intelligence (\u201cAI\u201d), data, middle market focus, and synergies across our diverse holdings gives us a competitive advantage relative to traditional agency\u2026"},{"fy":2025,"lvl":"x","n":57,"adsh":"0001477932-26-003805","doc":"onar_10k.htm","q":"Following the acquisition, ONAR merged its existing Storia agency operations with Juice Labs under the unified JUICE brand. 4 Table of Contents Retina AI Acquisition."}]},{"cik":1682639,"name":"HYPERION DEFI, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001144204-18-018682","doc":"tv488528_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-016350","doc":"tv516651_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-040118","doc":"tm205388-1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-043991","doc":"tm211152d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000649","doc":"eyen-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000511","doc":"eyen-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000226","doc":"eyen-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001410578-25-000743","doc":"eyen-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0001104659-26-036286","doc":"hypd-20251231x10k.htm","q":"If these validators were to be compromised or act maliciously, it could result in network disruption, loss of funds, or other adverse effects that could materially impact the value of our HYPE token holdings. \u200b HYPE is subject to technologi\u2026"}]},{"cik":1682852,"name":"MODERNA, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":2,"n":13,"adsh":"0001682852-19-000009","doc":"moderna10-k12312018.htm","q":"We design and implement digital operations to control or support complex workflows, accelerate learnings across our enterprise real-time, and provide deeper insights through analytical tools, artificial intelligence, and custom automation."},{"fy":2019,"lvl":2,"n":13,"adsh":"0001682852-20-000006","doc":"moderna10-k12312019.htm","q":"We design and implement digital operations to control or support complex workflows, accelerate learnings across our enterprise real-time, and provide deeper insights through analytical tools, artificial intelligence, and custom automation."},{"fy":2020,"lvl":3,"n":16,"adsh":"0001682852-21-000006","doc":"mrna-20201231.htm","q":"In addition, multiple integrated algorithms that leverage artificial intelligence and machine learning optimize manufacturability, reduce failures, and increase quality of mRNA sequences."},{"fy":2021,"lvl":3,"n":20,"adsh":"0001682852-22-000012","doc":"mrna-20211231.htm","q":"In addition, multiple integrated algorithms that leverage artificial intelligence and machine learning optimize manufacturability, reduce failures, and increase quality of mRNA sequences."},{"fy":2022,"lvl":3,"n":19,"adsh":"0001682852-23-000011","doc":"mrna-20221231.htm","q":"In addition, multiple integrated algorithms that leverage artificial intelligence and machine learning optimize manufacturability, reduce failures and increase quality of mRNA sequences. 33 Table of Content Supply for Clinical Development W\u2026"},{"fy":2023,"lvl":3,"n":39,"adsh":"0001682852-24-000015","doc":"mrna-20231231.htm","q":"In addition, multiple integrated algorithms that leverage artificial intelligence and machine learning optimize manufacturability, reduce failures and increase quality of mRNA sequences."},{"fy":2024,"lvl":3,"n":45,"adsh":"0001682852-25-000022","doc":"mrna-20241231.htm","q":"Our INT, mRNA-4157, uses next generation sequencing and a machine-learning based algorithm to design an mRNA that encodes up to 34 neoantigens against each individual patient\u2019s tumor mutations with specificity to their HLA type, and is pred\u2026"},{"fy":2025,"lvl":3,"n":61,"adsh":"0001682852-26-000033","doc":"mrna-20251231.htm","q":"We plan to leverage our global production network, artificial intelligence (AI) and digital tools to improve cost efficiency. 3."}]},{"cik":1683553,"name":"SPRUCE BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014593","doc":"sprb-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003582","doc":"sprb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008456","doc":"sprb-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-032819","doc":"sprb-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to physical or electronic break-ins, social engineering attempts (including through deep fakes, phishing and spam emails), m\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0000950170-25-053945","doc":"sprb-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and healthcare models to limit \u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-097558","doc":"sprb-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to physical or electronic break-ins, social engineering attempts (including through deep fakes, which may be increasingly mor\u2026"}]},{"cik":1684144,"name":"ZOMEDICA CORP.","industry":"Pharma & biotech","sic":2834,"state":"MI","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001171843-18-001549","doc":"f10k_022818p.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001171843-19-001229","doc":"f10k_022619p.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001171843-20-001304","doc":"f10k_022620p.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001171843-21-001378","doc":"f10k_022621p.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-22-002343","doc":"zom_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003899","doc":"zom-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001558370-24-004517","doc":"zom-20231231x10k.htm","q":"Additionally, among the professional competitive set, a keen focus on the return on investment (ROI) of racehorses has driven more competition and an increased utilization of veterinary services. \u200b We believe that these factors, along with \u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-002904","doc":"zom-20241231x10k.htm","q":"Additionally, among the professional competitive set, a keen focus on the return on investment (ROI) of racehorses has driven more competition and an increased utilization of veterinary services. \u200b We believe that these factors, along with \u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001104659-26-028450","doc":"zom-20251231x10k.htm","q":"Additionally, among the professional competitive set, a keen focus on the return on investment (ROI) of racehorses has driven more competition and an increased utilization of veterinary services. \u200b We believe that these factors, along with \u2026"}]},{"cik":1684508,"name":"CANNIS, INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001684508-17-000010","doc":"zartexincform10kdec13.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001684508-18-000015","doc":"zartexincform10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001477932-19-007149","doc":"cann_10k.htm","q":null}]},{"cik":1685071,"name":"DOVA PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001104659-18-010386","doc":"a17-28738_110k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001685071-19-000008","doc":"dova201810-k.htm","q":null}]},{"cik":1685316,"name":"OBSEVA SA","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005276","doc":"obsa-20221231x10k.htm","q":null}]},{"cik":1686515,"name":"ECCO AUTO WORLD CORP","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-007888","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-010845","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-016379","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-22-020095","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-020096","doc":"form10-k.htm","q":null}]},{"cik":1687221,"name":"REV GROUP, INC.","industry":"Auto manufacturing","sic":3711,"state":"WI","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-17-025241","doc":"revg-10k_20171031.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-18-031125","doc":"revg-10k_20181031.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-19-046328","doc":"revg-10k_20191031.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-000486","doc":"revg-10k_20201031.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-060365","doc":"revg-10k_20211031.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-026493","doc":"revg-20221031.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-069876","doc":"revg-20231031.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-135208","doc":"revg-20241031.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-313470","doc":"revg-20251031.htm","q":null}]},{"cik":1687999,"name":"EMR TECHNOLOGY SOLUTIONS, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2016,"lvl":"x","n":0,"adsh":"0001387131-17-001590","doc":"emr-10k_123116.htm","q":null},{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-003734","doc":"f10k2017_emrtechnologysolu.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-006526","doc":"f10k2018_emrtechnology.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-019663","doc":"f10k2019_emrtechnology.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-046855","doc":"f10k2020_emrtechnology.htm","q":null}]},{"cik":1688667,"name":"FRANKLY INC","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2017,"lvl":1,"n":1,"adsh":"0001493152-18-004557","doc":"form10-k.htm","q":"We will continue to enhance our current experience in responsive web, native applications, OTT apps and video solutions, and expand into new, emerging platforms where the audience consumes media through new IP-enabled experiences such as Am\u2026"}]},{"cik":1689066,"name":"SUNSET ISLAND GROUP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001477932-19-001148","doc":"sigo_10k.htm","q":null}]},{"cik":1689084,"name":"QRONS INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001594062-18-000048","doc":"form10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001731122-19-000136","doc":"e1286form10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001594062-20-000026","doc":"form10k.htm","q":null},{"fy":2020,"lvl":"x","n":8,"adsh":"0001594062-21-000046","doc":"form10k.htm","q":"We seek to engage in strategic arrangements with companies and institutions that are developing breakthrough technologies in the fields of artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), molecular biology, stem cells and tissue eng\u2026"},{"fy":2021,"lvl":"x","n":7,"adsh":"0001477932-22-001307","doc":"qron_10k.htm","q":"We seek to engage in strategic arrangements with companies and institutions that are developing breakthrough technologies in the fields of artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), molecular biology, stem cells and tissue eng\u2026"},{"fy":2022,"lvl":"x","n":7,"adsh":"0001477932-23-002090","doc":"qron_10k.htm","q":"Our approach is to marshal and leverage our proprietary research with developing breakthrough technologies in the fields of artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), molecular biology, stem cells and tissue engineering, for d\u2026"},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-24-002100","doc":"qron_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-25-002791","doc":"qron_10k.htm","q":null}]},{"cik":1689375,"name":"ENTRADA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003614","doc":"trda-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001689375-23-000019","doc":"trda-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0001689375-24-000016","doc":"trda-20231231.htm","q":"Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations. 112 Table of Contents The use of new and evolving technologies, such as artificial intelligence, in our offerings may \u2026"},{"fy":2024,"lvl":3,"n":18,"adsh":"0001689375-25-000011","doc":"trda-20241231.htm","q":"The use of new and evolving technologies, such as artificial intelligence, in our offerings may result in spending material resources and presents risks and challenges that can impact our business including by posing security and other risk\u2026"},{"fy":2025,"lvl":3,"n":39,"adsh":"0001689375-26-000011","doc":"trda-20251231.htm","q":"Furthermore, the use of artificial intelligence (\u201cAI\u201d) technologies by use and third-party vendors can also give rise to cybersecurity risks as well as intellectual property risks, including the disclosure or compromise of our confidential \u2026"}]},{"cik":1689548,"name":"PRAXIS PRECISION MEDICINES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001689548-21-000016","doc":"prax-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001689548-22-000014","doc":"prax-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001689548-23-000044","doc":"prax-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001689548-24-000034","doc":"prax-20231231.htm","q":"Our cybersecurity risk management program includes: \u2022 risk assessments designed to help identify material cybersecurity risks to our critical systems, information, products, services and our broader enterprise-IT environment; \u2022 adoption of \u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0001689548-25-000040","doc":"prax-20241231.htm","q":"In addition, we use artificial intelligence, or AI, machine learning, and automated decision-making technologies, collectively, AI Technologies, in our business from time to time."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001689548-26-000029","doc":"prax-20251231.htm","q":"In addition, we use artificial intelligence, or AI, machine learning, and automated decision-making technologies, collectively, AI Technologies, in our business from time to time."}]},{"cik":1689813,"name":"BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001047469-18-001326","doc":"a2234751z10-k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001689813-19-000014","doc":"bhvn-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001689813-20-000016","doc":"bhvn-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001689813-21-000024","doc":"bhvn-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001689813-22-000014","doc":"bhvn-20211231.htm","q":null}]},{"cik":1689923,"name":"ALTERYX, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-073878","doc":"d530988d10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001689923-19-000006","doc":"ayx12311810-k.htm","q":"We natively support output to most visual formats such as those offered by Microsoft, Qlik, or Tableau and also to auto modeling solutions such as those offered by DataRobot, Inc. and H2O.ai, Inc."},{"fy":2019,"lvl":2,"n":7,"adsh":"0001689923-20-000006","doc":"ayx1231201910-k.htm","q":"For example, in April 2019, we acquired ClearStory Data Inc., or ClearStory Data, to add talented developers and compelling technology to our organization; and in October 2019, we acquired Feature Labs, Inc., or Feature Labs, to augment our\u2026"},{"fy":2020,"lvl":2,"n":12,"adsh":"0001689923-21-000024","doc":"ayx-20201231.htm","q":"For example, in June 2020, we introduced Alteryx Analytics Hub, our next-generation automation and collaboration product, and Alteryx Intelligence Suite, our augmented machine learning, auto-modeling, and text mining product."},{"fy":2021,"lvl":3,"n":28,"adsh":"0001689923-22-000023","doc":"ayx-20211231.htm","q":"For example, in 2021, we introduced limited availability offerings of Alteryx Designer Cloud, our web browser-accessible version of Alteryx Designer for automating analytics, and Alteryx Machine Learning, our automated machine learning solu\u2026"},{"fy":2022,"lvl":3,"n":28,"adsh":"0001689923-23-000012","doc":"ayx-20221231.htm","q":"The Alteryx Analytics Automation Platform empowers \u201canalytics for all\u201d by delivering easy, end-to-end automation of data engineering, analytics, reporting, machine learning, and data science processes, enabling enterprises to democratize da\u2026"},{"fy":2023,"lvl":3,"n":131,"adsh":"0001689923-24-000006","doc":"ayx-20231231.htm","q":"The Alteryx Analytics Automation Platform empowers \u201canalytics for all\u201d by delivering easy, end-to-end automation of data engineering, analytics, reporting, machine learning, or ML, and data science processes."}]},{"cik":1690080,"name":"180 LIFE SCIENCES CORP.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-036392","doc":"f10k2020_180lifesciences.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016352","doc":"f10k2021_180lifesci.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-025521","doc":"f10k2022_180lifesci.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-025262","doc":"ea0200233-10k_180lif.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001213900-25-026273","doc":"ea0235286-10k_180life.htm","q":"Furthermore, maintaining customer loyalty in an oversaturated market is increasingly difficult, pushing companies to invest heavily in loyalty programs, responsible gaming initiatives, and cutting-edge technology like artificial intelligenc\u2026"}]},{"cik":1690585,"name":"DIANTHUS THERAPEUTICS, INC. /DE/","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-078948","doc":"d650042d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-059835","doc":"d527383d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-066707","doc":"d76599d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-068759","doc":"d237577d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009331","doc":"mgta-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000950170-24-034681","doc":"dnth-20231231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and anti-discrimination."},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-037131","doc":"dnth-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and anti-discrimination."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001690585-26-000006","doc":"dnth-20251231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and anti-discrimination."}]},{"cik":1690622,"name":"XTRIBE P.L.C.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004323","doc":"form10-k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005446","doc":"form10-k.htm","q":null}]},{"cik":1690666,"name":"XPERI CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2016,"lvl":2,"n":6,"adsh":"0001628280-17-001795","doc":"tsra-20161231x10xk.htm","q":"Along with its operating subsidiaries, Xperi creates, develops and licenses innovative audio, computational imaging, computer vision and semiconductor packaging and interconnect technologies."},{"fy":2017,"lvl":2,"n":9,"adsh":"0001628280-18-002149","doc":"xper-20171231x10xk.htm","q":"Imaging Solutions: FotoNation, a pioneer in computer vision and computational imaging solutions, provides many of the critical technologies that enable millions of consumers to take incredible pictures with their smartphones."},{"fy":2018,"lvl":2,"n":13,"adsh":"0001564590-19-003460","doc":"xper-10k_20181231.htm","q":"Imaging Solutions: FotoNation, a pioneer in computer vision and computational imaging solutions, provides critical imaging technologies that enable millions of consumers to take incredible pictures with their smartphones."},{"fy":2019,"lvl":3,"n":17,"adsh":"0001564590-20-005044","doc":"xper-10k_20191231.htm","q":"Imaging Solutions: Our subsidiary, FotoNation, a pioneer in computer vision and computational imaging solutions, provides critical imaging technologies that enable millions of consumers to take incredible pictures with their smartphones."}]},{"cik":1690881,"name":"ASV HOLDINGS, INC.","industry":"Construction machinery","sic":3531,"state":"MN","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-006561","doc":"asv-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-010131","doc":"asv-10k_20181231.htm","q":null}]},{"cik":1691082,"name":"LB PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2025,"lvl":2,"n":14,"adsh":"0001193125-26-126368","doc":"lbrx-20251231.htm","q":"Our use of artificial intelligence (including machine learning) may also be subject to evolving laws and regulations, including those related to controlling for data bias and anti-discrimination."}]},{"cik":1692819,"name":"VISTRA CORP.","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001692819-18-000018","doc":"vistra-12312017x10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001692819-19-000005","doc":"vistra-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001692819-20-000005","doc":"vistra-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001692819-21-000004","doc":"vistra-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001692819-22-000005","doc":"vistra-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001692819-23-000005","doc":"vistra-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":11,"adsh":"0001692819-24-000012","doc":"vistra-20231231.htm","q":"As we adopt new technologies, like artificial intelligence (AI), there is a risk that the content, analyses, recommendations, or judgments that AI applications assist in producing are alleged to be deficient, inaccurate, biased, or infringe\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0001692819-25-000013","doc":"vistra-20241231.htm","q":"Multiple demand drivers such as emergence of large load data centers, including in response to transformations in technologies like artificial intelligence (AI) and electrification of oil field operations (specifically in the Permian Basin \u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001692819-26-000006","doc":"vistra-20251231.htm","q":"Multiple demand drivers such as emergence of large load data centers, including in response to transformations in technologies like artificial intelligence (AI) and electrification of oil field operations (specifically in the Permian Basin \u2026"}]},{"cik":1692830,"name":"SATSUMA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009753","doc":"stsa-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015557","doc":"stsa-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010433","doc":"stsa-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010338","doc":"stsa-20221231.htm","q":null}]},{"cik":1693011,"name":"INOZYME PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015250","doc":"inzy-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003789","doc":"inzy-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009053","doc":"inzy-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-029673","doc":"inzy-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-035940","doc":"inzy-20241231.htm","q":null}]},{"cik":1693415,"name":"TRANSLATE BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008803","doc":"tbio-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001193125-20-071633","doc":"d867804d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-062223","doc":"d105883d10k.htm","q":null}]},{"cik":1694187,"name":"NEON THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":1,"n":2,"adsh":"0001694187-19-000026","doc":"ntgn-201810xk.htm","q":"We intend to strengthen our leading position in bioinformatics and identification of therapeutic neoantigens by using data generated from our ongoing and future clinical trials, coupled with our machine learning expertise, to continue to re\u2026"},{"fy":2019,"lvl":1,"n":2,"adsh":"0001694187-20-000020","doc":"ntgn-201910xk.htm","q":"We intend to continue to strengthen our leading position in bioinformatics and identification of therapeutic neoantigens by using data generated from our ongoing and future clinical trials, coupled with our machine learning expertise, to co\u2026"}]},{"cik":1694665,"name":"EVELO BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001694665-19-000013","doc":"evelo10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001694665-20-000017","doc":"evelo10-k12312019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001694665-21-000037","doc":"evlo-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001694665-22-000047","doc":"evlo-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001694665-23-000024","doc":"evlo-20221231.htm","q":null}]},{"cik":1695357,"name":"PROVENTION BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003588","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003770","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-004781","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-005304","doc":"form10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009516","doc":"form10-k.htm","q":null}]},{"cik":1695473,"name":"GREATER CANNABIS COMPANY, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005257","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-006408","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-006897","doc":"0001493152-21-006897.txt","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-009683","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":1,"adsh":"0001493152-23-012132","doc":"form10-k.htm","q":"Zacharin was actively involved in Slinger\u2019s acquisition of three companies, most notably a Softbank and Verizon Ventures backed artificial intelligence sports company for $100 million."},{"fy":2023,"lvl":"x","n":1,"adsh":"0001493152-24-012098","doc":"form10-k.htm","q":"Zacharin was actively involved in Slinger\u2019s acquisition of three companies, most notably a Softbank and Verizon Ventures backed artificial intelligence sports company for $100 million."},{"fy":2024,"lvl":"x","n":1,"adsh":"0001641172-25-000512","doc":"form10-k.htm","q":"Zacharin was actively involved in Slinger\u2019s acquisition of three companies, most notably a Softbank and Verizon Ventures backed artificial intelligence sports company for $100 million."},{"fy":2025,"lvl":"x","n":1,"adsh":"0001493152-26-014210","doc":"form10-k.htm","q":"Zacharin was actively involved in Slinger\u2019s acquisition of three companies, most notably a Softbank and Verizon Ventures backed artificial intelligence sports company for $100 million."}]},{"cik":1697152,"name":"FORUM MERGER CORP","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001213900-18-002071","doc":"f10k2017_forummergercorp.htm","q":null}]},{"cik":1697532,"name":"APPLIED THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002630","doc":"aplt-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003180","doc":"aplt-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003206","doc":"aplt-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004398","doc":"aplt-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002541","doc":"aplt-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-053840","doc":"aplt-20241231.htm","q":"Our internal computer systems, cloud-based computing services and those of our current and any future collaborators and other contractors or consultants are vulnerable to damage or interruption from computer viruses, data corruption, cyber-\u2026"}]},{"cik":1697805,"name":"XYNOMIC PHARMACEUTICALS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-19-003564","doc":"f10k2018_bisoncapitalacq.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-013743","doc":"f10k2019_xynomicpharma.htm","q":null}]},{"cik":1697884,"name":"VITASPRING BIOMEDICAL CO. LTD.","industry":"Pharma & biotech","sic":8731,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001697884-21-000003","doc":"vsbc10kjan2021.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001697884-22-000006","doc":"vsbc10k_2022.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001640334-25-002237","doc":"vsbc_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001640334-26-000426","doc":"vsbc_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001640334-26-001019","doc":"vsbc_10k.htm","q":null}]},{"cik":1698530,"name":"EXICURE, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001698530-18-000007","doc":"exicure10-k2017.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001698530-19-000015","doc":"exicure10k2018.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001698530-20-000013","doc":"exicure10k2019.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001698530-21-000031","doc":"xcur-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001698530-22-000019","doc":"xcur-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001698530-23-000029","doc":"xcur-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001698530-24-000051","doc":"xcur-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001698530-25-000019","doc":"xcur-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001698530-26-000028","doc":"xcur-20251231.htm","q":"Kim began serving in June 2025 as Chief Executive Officer and a director of AGEDB Technology Ltd., a TSXV-listed company specializing in the development of advanced graph database management system software and AI-powered data solutions."}]},{"cik":1699126,"name":"CICLET HOLDINGS INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001640334-20-002990","doc":"ciclet_10k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-21-001340","doc":"ciclet_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001640334-21-002101","doc":"ciclet_10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-21-002616","doc":"ciclet_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001640334-22-000876","doc":"ciclet_10k.htm","q":null}]},{"cik":1699382,"name":"PMV PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010578","doc":"pmvp-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007860","doc":"pmvp-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005345","doc":"pmvp-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023062","doc":"pmvp-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-030414","doc":"pmvp-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-095014","doc":"pmvp-20251231.htm","q":null}]},{"cik":1699759,"name":"PAY MY TIME LTD","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001493152-18-004337","doc":"form10-k.htm","q":null}]},{"cik":1699838,"name":"CONFLUENT, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0000950170-22-002008","doc":"cflt-20211231.htm","q":"Meanwhile, machine learning is extending the scope and role of software to new domains and processes."},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-004815","doc":"cflt-20221231.htm","q":"Meanwhile, machine learning is extending the scope and role of software to new domains and processes."},{"fy":2023,"lvl":2,"n":5,"adsh":"0000950170-24-018036","doc":"cflt-20231231.htm","q":"We see the potential for broad, cross-industry customer adoption of use cases around GenAI, machine learning, IoT, data integration, real-time analytics, real-time logistics, customer data unification, cloud migration, microservices, data s\u2026"},{"fy":2024,"lvl":3,"n":31,"adsh":"0000950170-25-022369","doc":"cflt-20241231.htm","q":"The Data Streaming Platform is emerging as one of the most strategic parts of the next-generation technology stack, enabling modern companies to serve their customers, improve their offerings, outpace their competition, and win in a digital\u2026"},{"fy":2025,"lvl":3,"n":56,"adsh":"0001699838-26-000006","doc":"cflt-20251231.htm","q":"Business Overview Confluent is pioneering the Data Streaming Platform category, setting data in motion to power the world\u2019s real-time operations, analytics, and artificial intelligence (\u201cAI\u201d)."}]},{"cik":1700357,"name":"CRANK MEDIA INC","industry":"Software & IT services","sic":7372,"state":"BC","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001262463-18-000091","doc":"team123117k.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001262463-19-000093","doc":"team36010k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001262463-20-000158","doc":"team360201910k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001640334-21-000954","doc":"crkm_10k.htm","q":null}]},{"cik":1701040,"name":"CISION LTD.","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-18-014399","doc":"tv486988_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001144204-19-011638","doc":"tv513936_10k.htm","q":null}]},{"cik":1701108,"name":"SPERO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-007402","doc":"spro-10k_20171231.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007805","doc":"spro-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010998","doc":"spro-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012514","doc":"spro-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005194","doc":"spro-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010921","doc":"spro-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-030767","doc":"spro-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-046125","doc":"spro-20241231.htm","q":"Finally, developments in artificial intelligence and machine learning provide threat actors with the capability to use more sophisticated means to attack our systems and may exacerbate cybersecurity risk."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-126192","doc":"spro-20251231.htm","q":"Finally, developments in artificial intelligence and machine learning provide threat actors with the capability to use more sophisticated means to attack our systems and may exacerbate cybersecurity risk."}]},{"cik":1701478,"name":"AZITRA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2023,"lvl":"x","n":17,"adsh":"0001493152-24-010091","doc":"form10-k.htm","q":"The platform is augmented by an artificial intelligence and machine learning technology that analyzes, predicts and helps screen our library of strains for drug like molecules."},{"fy":2024,"lvl":"x","n":17,"adsh":"0001701478-25-000012","doc":"aztr-20241231.htm","q":"The platform is augmented by an artificial intelligence and machine learning technology that analyzes, predicts and helps screen our library of strains for drug like molecules."},{"fy":2025,"lvl":"x","n":32,"adsh":"0001701478-26-000013","doc":"aztr-20251231.htm","q":"The platform is augmented by an artificial intelligence and machine learning technology that analyzes, predicts and helps screen our library of strains for drug like molecules."}]},{"cik":1701541,"name":"BLACK DIAMOND THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001701541-20-000009","doc":"bdtx-20191231.htm","q":"We use our algorithm as a machine learning tool to classify mutations as either pathogenic or benign and predict the probability, or MAP score, that a mutation is pathogenic. \u2022 Reveal \u2014We confirm the oncogenicity of the identified mutations\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001701541-21-000018","doc":"bdtx-20201231.htm","q":"We use our algorithm as a machine-learning tool to predict the oncogenicity of various uncharacterized mutations, thereby isolating oncogenic driver mutations from those mutations that are not believed to cause cancer, which are referred to\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001701541-22-000007","doc":"bdtx-20211231.htm","q":"We use our algorithm as a machine-learning tool to predict the oncogenicity of various uncharacterized mutations, thereby isolating oncogenic driver mutations from those mutations that are not believed to cause cancer, and which are referre\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001701541-23-000020","doc":"bdtx-20221231.htm","q":"We use our algorithm as a machine-learning tool to predict the oncogenicity of various uncharacterized mutations, thereby isolating oncogenic driver mutations from those mutations that are not believed to cause cancer, and which are referre\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0001701541-24-000011","doc":"bdtx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001701541-25-000016","doc":"bdtx-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":31,"adsh":"0001701541-26-000009","doc":"bdtx-20251231.htm","q":"Furthermore, the use of artificial intelligence (AI) technologies by use and third-party vendors can also give rise to cybersecurity risks as well as intellectual property risks, including the disclosure or compromise of our confidential in\u2026"}]},{"cik":1701732,"name":"ALTAIR ENGINEERING INC.","industry":"Software & IT services","sic":7372,"state":"MI","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001193125-18-090811","doc":"d503331d10k.htm","q":null},{"fy":2018,"lvl":2,"n":5,"adsh":"0001564590-19-005799","doc":"altr-10k_20181231.htm","q":"These tools are all driven by simulation and machine learning algorithms."},{"fy":2019,"lvl":2,"n":6,"adsh":"0001564590-20-008059","doc":"altr-10k_20191231.htm","q":"These tools are all driven by simulation and machine learning algorithms."},{"fy":2020,"lvl":3,"n":72,"adsh":"0001564590-21-009427","doc":"altr-10k_20201231.htm","q":"(\u201cAltair,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a global technology company providing software and cloud solutions in the areas of simulation, high-performance computing (HPC), data analytics, and artificial intelligence (AI)."},{"fy":2021,"lvl":3,"n":70,"adsh":"0001564590-22-007651","doc":"altr-10k_20211231.htm","q":"(\u201cAltair,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a global leader in computational science and artificial intelligence enabling organizations across broad industry segments to drive smarter decisions in an increasingly connected world."},{"fy":2022,"lvl":3,"n":73,"adsh":"0000950170-23-004281","doc":"altr-20221231.htm","q":"(\u201cAltair,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a global leader in computational science and artificial intelligence enabling organizations across broad industry segments to drive smarter decisions in an increasingly connected world."},{"fy":2023,"lvl":3,"n":93,"adsh":"0000950170-24-018804","doc":"altr-20231231.htm","q":"(\u201cAltair,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a global leader in computational science and artificial intelligence enabling organizations across broad industry segments to drive smarter decisions in an increasingly connected world."},{"fy":2024,"lvl":3,"n":94,"adsh":"0000950170-25-024197","doc":"altr-20241231.htm","q":"(\u201cAltair,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (\"HPC\"), data analytics, and artificial intelligence (\"AI\")\u2026"}]},{"cik":1702541,"name":"RIVEX TECHNOLOGY CORP.","industry":"Software & IT services","sic":7372,"state":"MT","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001702541-18-000005","doc":"f10krivexmay302018.htm","q":null},{"fy":2018,"lvl":"x","n":0,"adsh":"0001640334-19-001250","doc":"rivx_10k.htm","q":null}]},{"cik":1703057,"name":"ABCELLERA BIOLOGICS INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2021,"lvl":3,"n":32,"adsh":"0001564590-22-007077","doc":"abcl-10k_20211231.htm","q":"Our full-stack, artificial intelligence-, or AI, powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs."},{"fy":2022,"lvl":3,"n":17,"adsh":"0001564590-23-002128","doc":"abcl-10k_20221231.htm","q":"We believe that managing data and leveraging the proprietary datasets in this way allows us to continually refine our approach to antibody drug development and leverage the benefits of artificial intelligence and machine learning methods."},{"fy":2023,"lvl":3,"n":19,"adsh":"0001703057-24-000019","doc":"abcl-20231231.htm","q":"We believe that managing data and leveraging the proprietary datasets in this way allows us to continually refine our approach to antibody drug development and leverage the benefits of artificial intelligence and machine learning methods."},{"fy":2024,"lvl":3,"n":20,"adsh":"0001628280-25-008689","doc":"abcl-20241231.htm","q":"We believe that managing data and leveraging the proprietary datasets in this way allows us to continually refine our approach to antibody drug development and leverage the benefits of artificial intelligence and machine learning methods."},{"fy":2025,"lvl":3,"n":21,"adsh":"0001703057-26-000012","doc":"abcl-20251231.htm","q":"We are continually refining our data systems to ensure high data quality and standardization, improve access and flexibility, and integrate artificial intelligence (\u201cAI\u201d) and other computational tools with our experimental workflows."}]},{"cik":1703157,"name":"SECURETECH INNOVATIONS, INC.","industry":"Auto manufacturing","sic":3714,"state":"MN","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001703157-19-000003","doc":"securetech_form10k2018.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001703157-20-000005","doc":"securetech_form10k2019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001703157-21-000003","doc":"securetech_form10k2020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001017386-22-000084","doc":"scth_20211231-10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001017386-23-000145","doc":"scth_form10k12312022.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001017386-24-000116","doc":"scth_form10k12312023.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001017386-25-000028","doc":"scth_form10k12312024.htm","q":null},{"fy":2025,"lvl":3,"n":135,"adsh":"0001017386-26-000016","doc":"scth_form10k2025.htm","q":"For a more detailed discussion of the risks and uncertainties that 42 Table of Contents could cause actual results to differ from those described in these forward-looking statements, you should read \u201cCautionary Note Regarding Forward-Lookin\u2026"}]},{"cik":1703647,"name":"KORRO BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012977","doc":"freq-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016117","doc":"freq-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003655","doc":"freq-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007140","doc":"freq-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":25,"adsh":"0000950170-24-036396","doc":"krro-20231231.htm","q":"We iteratively optimize the editing efficiency of our product candidates using a combination of ADAR biology, chemistry and machine learning expertise."},{"fy":2024,"lvl":3,"n":26,"adsh":"0000950170-25-040759","doc":"krro-20241231.htm","q":"We iteratively optimize the editing efficiency of our product candidates using a combination of ADAR biology, chemistry and machine learning expertise."},{"fy":2025,"lvl":3,"n":37,"adsh":"0001193125-26-104156","doc":"krro-20251231.htm","q":"We iteratively optimize the editing efficiency of our oligonucleotides using a combination of ADAR biology, chemistry and machine learning expertise."}]},{"cik":1703956,"name":"CONCRETE PUMPING HOLDINGS, INC.","industry":"Construction","sic":1700,"state":"CO","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001437749-20-000638","doc":"bbpp20191031_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-000581","doc":"bbpp20201031_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-000815","doc":"bbpp20211031_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-002137","doc":"bbpp20221031_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-001415","doc":"bbpp20231031_10k.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001437749-25-000800","doc":"bbpp20241031_10k.htm","q":"The rapid development and adoption of artificial intelligence technologies (\"AI\") further exacerbates these concerns, as AI can be used to both enhance the capabilities of attackers and help defenders develop more advanced security measures\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001437749-26-001203","doc":"bbpp20251031_10k.htm","q":"The rapid development and adoption of artificial intelligence technologies (\"AI\") further exacerbates these concerns, as AI can be used to both enhance the capabilities of attackers and help defenders develop more advanced security measures\u2026"}]},{"cik":1703975,"name":"NOTES INC","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001213900-18-008505","doc":"f10k2018_notesinc.htm","q":null}]},{"cik":1704292,"name":"ZAI LAB LTD","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-062279","doc":"d85279d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-061312","doc":"d261426d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005832","doc":"zlab-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-007235","doc":"zlab-20231231.htm","q":"Additionally, some of our competitors may successfully adopt or use emerging technologies, including artificial intelligence, to enhance their clinical or business operations before we are able to do so, which could leave us at a competitiv\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001628280-25-008409","doc":"zlab-20241231.htm","q":"Additionally, some of our competitors may successfully adopt or use emerging technologies, including artificial intelligence, to enhance their clinical or business operations before we are able to do so, which could leave us at a competitiv\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001704292-26-000015","doc":"zlab-20251231.htm","q":"We may experience operational, regulatory, and competitive risks due to our use of artificial intelligence."}]},{"cik":1704795,"name":"BANTEC, INC.","industry":"Aerospace & defense","sic":3721,"state":"NJ","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001144204-17-065943","doc":"tv482181_10k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001213900-18-018073","doc":"f10k2018_bantekinc.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-002774","doc":"f10k2019_bantecinc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-001662","doc":"f10k2020_bantecinc.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-001080","doc":"f10k2021_bantecinc.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-002427","doc":"f10k2022_bantecinc.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-010113","doc":"f10k2023_bantecinc.htm","q":null}]},{"cik":1706431,"name":"VIR BIOTECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2019,"lvl":1,"n":2,"adsh":"0001564590-20-013194","doc":"vir-10k_20191231.htm","q":"This is enabled using clustered regularly interspaced short palindromic repeats , or CRISPR , -based genomics, computational biology and machine learning to identify key host factors necessary for each pathogen\u2019s survival and the protective\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001564590-21-008915","doc":"vir-10k_20201231.htm","q":"This is enabled using clustered regularly interspaced short palindromic repeats, or CRISPR, -based genomics, computational biology and machine learning to identify key host factors necessary for each pathogen\u2019s survival and the protective e\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0000950170-22-002295","doc":"vir-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-005118","doc":"vir-20221231.htm","q":"This is enabled using clustered regularly interspaced short palindromic repeats, or CRISPR, -based genomics, computational biology and machine learning to identify key host factors necessary for each pathogen\u2019s survival and the protective e\u2026"},{"fy":2023,"lvl":3,"n":39,"adsh":"0001628280-24-006852","doc":"vir-20231231.htm","q":"Our growth and pursuit of scientific innovation is fueled by our world-class leading monoclonal antibody (mAb) platform that has a proven track record and is further strengthened by our artificial intelligence-led mAb optimization and engin\u2026"},{"fy":2024,"lvl":3,"n":31,"adsh":"0001628280-25-008245","doc":"vir-20241231.htm","q":"Our antibody platform leverages artificial intelligence and machine learning (collectively referred to as AI) for optimization, while the PRO-XTEN \u2122 platform allows for the development of potentially best-in-class TCEs with improved safety \u2026"},{"fy":2025,"lvl":3,"n":31,"adsh":"0001628280-26-010749","doc":"vir-20251231.htm","q":"These research and development efforts are driven by Vir Bio\u2019s discovery engine, comprised of our exceptional protein engineering and antibody discovery expertise and our two core technology platforms \u2014 our proprietary dAIsY\u2122 (data, AI stru\u2026"}]},{"cik":1707092,"name":"DELPHI TECHNOLOGIES PLC","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001707092-18-000008","doc":"dlph1231201710k.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001707092-19-000004","doc":"dlph1231201810k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001707092-20-000004","doc":"dlph1231201910k.htm","q":null}]},{"cik":1707258,"name":"AMESITE INC.","industry":"Software & IT services","sic":7372,"state":"MI","cells":[{"fy":2018,"lvl":"x","n":17,"adsh":"0001213900-18-011368","doc":"f10kt2018_amesiteinc.htm","q":"Amesite OpCo, which was originally incorporated in the State of Delaware on November 14, 2017, is a development stage artificial intelligence software company targeting the college course market."},{"fy":2019,"lvl":"x","n":15,"adsh":"0001213900-19-019289","doc":"f10k2019_amesiteinc.htm","q":"Overview We are a development stage artificial intelligence software company targeting the college course market."},{"fy":2020,"lvl":"x","n":16,"adsh":"0001213900-20-026967","doc":"f10k2020_amesiteinc.htm","q":"Overview We are an artificial intelligence driven platform and course designer that rapidly provides customized, high performance and scalable online products for schools and businesses."}]},{"cik":1707502,"name":"SOLID BIOSCIENCES INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007462","doc":"sldb-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010247","doc":"sldb-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013153","doc":"sldb-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-009963","doc":"sldb-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009318","doc":"sldb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-030508","doc":"sldb-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-034644","doc":"sldb-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-115928","doc":"sldb-20251231.htm","q":null}]},{"cik":1707753,"name":"ELASTIC N.V.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2019,"lvl":2,"n":8,"adsh":"0001564590-19-024066","doc":"estc-10k_20190430.htm","q":"Using natural language processing to analyze user sentiment is search."},{"fy":2020,"lvl":2,"n":5,"adsh":"0001628280-20-009982","doc":"estc-20200430.htm","q":"Using natural language processing to analyze user sentiment is search."},{"fy":2021,"lvl":2,"n":6,"adsh":"0001707753-21-000026","doc":"estc-20210430.htm","q":"Using natural language processing to analyze user sentiment is search."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001707753-22-000025","doc":"estc-20220430.htm","q":"Paid proprietary features in the Elastic Stack enable capabilities such as automating anomaly detection on time series data at scale through machine learning, facilitating compliance with data security and privacy regulations, supporting se\u2026"},{"fy":2023,"lvl":3,"n":27,"adsh":"0001707753-23-000021","doc":"estc-20230430.htm","q":"Our platform, which is available as both a hosted, managed service across public clouds as well as self-managed software, allows our customers to find insights and drive artificial intelligence (\u201cAI\u201d) and machine learning use cases from lar\u2026"},{"fy":2024,"lvl":3,"n":105,"adsh":"0001707753-24-000014","doc":"estc-20240430.htm","q":"Business Elastic, the Search AI Company, enables our customers to find the answers they need in real time, using all of their data, at scale."},{"fy":2025,"lvl":3,"n":137,"adsh":"0001707753-25-000021","doc":"estc-20250430.htm","q":"Business Overview Elastic, the Search AI Company, enables its customers to transform data into answers, actions, and outcomes with Search AI."}]},{"cik":1707919,"name":"CENNTRO INC.","industry":"Auto manufacturing","sic":3711,"state":"NJ","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-032460","doc":"brhc20055095_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-016853","doc":"ef20015317_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001140361-25-011607","doc":"ef20038940_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001140361-26-014773","doc":"ef20060665_10k.htm","q":"On January 1, 2026, Cenntro Inc. incorporated its wholly-owned subsidiaries, Averra Electric Mobility Inc and Autotrax.ai Inc. in the state of Delaware."}]},{"cik":1708331,"name":"VIRPAX PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016740","doc":"f10k2021_virpaxpharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-022071","doc":"f10k2022_virpaxpharm.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-025781","doc":"ea0201565-10k_virpax.htm","q":null},{"fy":2024,"lvl":"x","n":2,"adsh":"0001731122-25-000316","doc":"e6385_10k.htm","q":"His recent experience includes serving as a director or in management roles for numerous Canadian private and public companies, including his current positions as a director of Bayridge Resources Inc., Trilogy AI Corp, and Green Battery Min\u2026"}]},{"cik":1708493,"name":"HARPOON THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007829","doc":"harp-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010479","doc":"harp-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012063","doc":"harp-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003375","doc":"harp-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010030","doc":"harp-20221231.htm","q":null}]},{"cik":1708527,"name":"ELUTIA INC.","industry":"Pharma & biotech","sic":2836,"state":"MD","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-036360","doc":"tm214229d1_10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001558370-22-003073","doc":"azyo-20211231x10k.htm","q":"The consultation proposes amendments to the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the Medical Devices Directive), in particular to create new access pathways to support innovation, create an innov\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001558370-23-004475","doc":"azyo-20221231x10k.htm","q":"The MHRA proposes amendments to the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive), in particular to create new access pathways to support innovation, create an innovative\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-002864","doc":"elut-20231231x10k.htm","q":"The MHRA's proposed amendments to the UK Medical Devices Regulations 2002 aim to foster innovation, regulate software and artificial intelligence in medical devices, reform in vitro diagnostic regulation, and promote sustainability."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001558370-25-002719","doc":"elut-20241231x10k.htm","q":"The MHRA's proposed amendments to the UK Medical Devices Regulations 2002 aim to foster innovation, regulate software and artificial intelligence in medical devices, reform in vitro diagnostic regulation, and promote sustainability."},{"fy":2025,"lvl":2,"n":5,"adsh":"0001104659-26-027664","doc":"elut-20251231x10k.htm","q":"In addition, digital technologies, including artificial intelligence (\u201cAI\u201d) and machine learning capabilities, have and may continue to increase in their applicability and importance to various aspects of our business, operating and competi\u2026"}]},{"cik":1708599,"name":"SERINA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"AL","cells":[{"fy":2018,"lvl":1,"n":1,"adsh":"0001493152-19-004614","doc":"form10-k.htm","q":"Artificial intelligence algorithms were used to parse millions of gene expression data points and the results were published in late 2017 ."},{"fy":2020,"lvl":"x","n":1,"adsh":"0001493152-21-007461","doc":"form10-k.htm","q":"Artificial intelligence algorithms were used to parse millions of gene expression data points and the results were published in late 2017."},{"fy":2021,"lvl":"x","n":1,"adsh":"0001493152-22-008028","doc":"form10-k.htm","q":"Artificial intelligence algorithms were used to parse millions of gene expression data points and the results were published in late 2017."},{"fy":2022,"lvl":"x","n":1,"adsh":"0001493152-23-010285","doc":"form10-k.htm","q":"Artificial intelligence algorithms were used to parse millions of gene expression data points and the results were published in late 2017."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011022","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001708599-25-000027","doc":"age-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001708599-26-000016","doc":"ser-20251231.htm","q":null}]},{"cik":1709401,"name":"RUBIUS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002516","doc":"ruby-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002475","doc":"ruby-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001412","doc":"ruby-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002057","doc":"ruby-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001709401-23-000005","doc":"ruby-20221231.htm","q":null}]},{"cik":1709628,"name":"CLOUDASTRUCTURE, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":92,"adsh":"0001683168-25-002122","doc":"cloudastructure_i10k-123124.htm","q":"We provide an award-winning cloud-based artificial intelligence (\u201cAI\u201d) video surveillance and Remote Guarding (as described below) service built on AI and machine learning platforms."},{"fy":2025,"lvl":3,"n":89,"adsh":"0001683168-26-002561","doc":"cloudastructure_i10k-123125.htm","q":"(\u201cCloudastructure,\u201d \u201cwe,\u201d \u201cour,\u201d or \u201cthe Company\u201d) is an award-winning innovator in cloud-native, AI-powered security solutions, delivering comprehensive, real-time situational awareness to enterprises to protect people, property, and brand\u2026"}]},{"cik":1709941,"name":"BIOAGE LABS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-042759","doc":"bioa-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-120873","doc":"bioa-20251231.htm","q":null}]},{"cik":1710072,"name":"EDGEWISE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CO","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001850","doc":"ewtx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001895","doc":"ewtx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001467","doc":"ewtx-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002006","doc":"ewtx-20241231x10k.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0001104659-26-020112","doc":"ewtx-20251231x10k.htm","q":"Recent developments at the FDA include implementation of Elsa, a generative AI tool, across all centers at the agency, announcement of a plan to phase out animal testing for monoclonal antibodies and certain other drugs, and the announcemen\u2026"}]},{"cik":1710340,"name":"ETON PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001493152-19-003817","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001493152-20-003451","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":1,"n":4,"adsh":"0001493152-21-006122","doc":"form10-k.htm","q":"The product was approved by the FDA in September 2020 as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001493152-22-006990","doc":"form10-k.htm","q":"Some of our orphan drug products include: Alkindi Sprinkle \u00ae (hydrocortisone granules) - This product was approved by the FDA in September 2020 as a replacement therapy for Adrenocortical Insufficiency (\u201cAI\u201d) in children under 17 years of a\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001493152-23-007933","doc":"form10-k.htm","q":"ALKINDI SPRINKLE\u00ae (hydrocortisone granules) - This product was approved by the FDA in September 2020 as a replacement therapy for Adrenocortical Insufficiency (\u201cAI\u201d) in children under 17 years of age."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001437749-24-007853","doc":"eton20231231_10k.htm","q":"ALKINDI SPRINKLE \u00ae (hydrocortisone granules) \u2013 This product was approved by the FDA in September 2020 as a replacement therapy for Adrenocortical Insufficiency (\u201cAI\u201d) in children under 17 years of age."},{"fy":2024,"lvl":2,"n":9,"adsh":"0001437749-25-008136","doc":"eton20241231_10k.htm","q":"ALKINDI SPRINKLE\u00ae \u2013 This product was approved by the FDA in September 2020 as a replacement therapy for Adrenocortical Insufficiency (\u201cAI\u201d) in children under 17 years of age."},{"fy":2025,"lvl":2,"n":9,"adsh":"0001437749-26-009059","doc":"eton20251231_10k.htm","q":"ALKINDI SPRINKLE\u00ae \u2013 This product was approved by the FDA in September 2020 as a replacement therapy for Adrenocortical Insufficiency (\u201cAI\u201d) in children under 17 years of age."}]},{"cik":1710495,"name":"PINEAPPLE EXPRESS CANNABIS CO","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001710495-19-000006","doc":"minaro10k_january2019.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001710495-20-000006","doc":"minaro10kjan2020.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001710495-21-000005","doc":"minaro10kjan2021.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001710495-22-000004","doc":"minaro10kreport.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-018877","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-022263","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001139020-25-000132","doc":"pnxp-20250131.htm","q":null}]},{"cik":1710583,"name":"SWITCH, INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2017,"lvl":1,"n":1,"adsh":"0001710583-18-000034","doc":"swch12311710-k.htm","q":"Further, the public cloud's shared servers are not an efficient computing environment to run analytics such as advanced machine-learning algorithms, analyze sensitive medical device data or manage autonomous vehicle networks."},{"fy":2018,"lvl":1,"n":1,"adsh":"0001710583-19-000010","doc":"swch12311810-k.htm","q":"Further, the public cloud\u2019s shared servers are not an efficient computing environment to run analytics such as advanced machine-learning algorithms, analyze sensitive medical device data or manage autonomous vehicle networks."},{"fy":2019,"lvl":1,"n":1,"adsh":"0001710583-20-000007","doc":"swch12311910-k.htm","q":"Further, the public cloud\u2019s shared servers are not an efficient computing environment to run analytics such as advanced machine-learning algorithms, analyze sensitive medical device data or manage autonomous vehicle networks."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001710583-21-000013","doc":"swch-20201231.htm","q":"Further, the public cloud\u2019s shared servers are not an efficient computing environment to run analytics such as advanced machine-learning algorithms, analyze sensitive medical device data or manage autonomous vehicle networks."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001710583-22-000009","doc":"swch-20211231.htm","q":"Further, the public cloud\u2019s shared servers are not an efficient computing environment to run analytics such as advanced machine-learning algorithms, analyze sensitive medical device data or manage autonomous vehicle networks."}]},{"cik":1711269,"name":"EVERGY, INC.","industry":"Utilities","sic":4931,"state":"MO","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001711269-19-000013","doc":"evrg-12312018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001711269-20-000012","doc":"evrg-12312019x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001711269-21-000023","doc":"evrg-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001711269-22-000008","doc":"evrg-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001711269-23-000011","doc":"evrg-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001711269-24-000007","doc":"evrg-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":17,"adsh":"0001711269-25-000004","doc":"evrg-20241231.htm","q":"Artificial intelligence (AI) is an emerging area of technology that has the potential to impact various aspects of the Evergy Companies' business operations and customer interactions."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001711269-26-000017","doc":"evrg-20251231.htm","q":"Much of this demand is driven by interconnecting with and providing power to data centers and large load customers to serve an increasingly digital economy and to support artificial intelligence."}]},{"cik":1711279,"name":"KRYSTAL BIOTECH, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2017,"lvl":0,"n":0,"adsh":"0001564590-18-005252","doc":"krys-10k_20171231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009550","doc":"krys-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001711279-21-000006","doc":"krys-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001711279-22-000004","doc":"krys-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001711279-23-000008","doc":"krys-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001711279-24-000005","doc":"krys-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":23,"adsh":"0001711279-25-000008","doc":"krys-20241231.htm","q":"Artificial intelligence presents risks and challenges that could negatively impact our business."},{"fy":2025,"lvl":3,"n":23,"adsh":"0001711279-26-000016","doc":"krys-20251231.htm","q":"Artificial intelligence presents risks and challenges that could negatively impact our business."}]},{"cik":1711675,"name":"NIGHTSTAR THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008341","doc":"nite-10k_20181231.htm","q":null}]},{"cik":1711754,"name":"INMUNE BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001640334-19-000466","doc":"inmb_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-005916","doc":"f10k2019_inmunebioinc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-013456","doc":"f10k2020_inmunebioinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-010573","doc":"f10k2021_inmunebioinc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-016875","doc":"f10k2022_inmunebioinc.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-027206","doc":"ea0201084-10k_inmune.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001013762-25-003354","doc":"ea0229965-10k_inmune.htm","q":null},{"fy":2025,"lvl":3,"n":37,"adsh":"0001213900-26-036370","doc":"ea0279078-10k_inmune.htm","q":"Additionally, our use of artificial intelligence, or AI, and machine learning may be subject to laws and evolving regulations regarding the use of AI and machine learning, controlling for data bias, and antidiscrimination."}]},{"cik":1711786,"name":"HOTH THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2018,"lvl":"x","n":1,"adsh":"0001213900-19-005307","doc":"f10k2018_hoththerapeutics.htm","q":"Rice received his BSBA from Babson College, his MBA from Babson College, his Juris Doctorate from Suffolk University Law School and his LLM from Boston University Law School."},{"fy":2019,"lvl":"x","n":1,"adsh":"0001213900-20-005186","doc":"f10k2019_hoththerapeutics.htm","q":"Rice received his Bachelor of Science degree from Babson College, his MBA from Babson College, his Juris Doctorate from Suffolk University Law School and his LLM from Boston University Law School."},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-015764","doc":"f10k2020_hoththerapeuticsinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015909","doc":"f10k2021_hoththera.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-025455","doc":"f10k2022_hoththera.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-027213","doc":"ea0202303-10k_hoth.htm","q":"(together with its wholly-owned subsidiaries, merveille.ai and Hoth Therapeutics Australia Pty Ltd, the \u201cCompany\u201d) was incorporated under the laws of the State of Nevada on May 16, 2017 ."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001013762-25-004108","doc":"ea0233805-10k_hoth.htm","q":"On June 5, 2019, we formed our wholly owned subsidiary, Hoth Therapeutics Australia Pty Ltd, under the laws of the State of Victoria in Australia and, on October 4, 2023, we formed our wholly owned subsidiary, merveille.ai, under the laws o\u2026"},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-035625","doc":"ea0279196-10k_hoth.htm","q":"On June 5, 2019, we formed our wholly owned subsidiary, Hoth Therapeutics Australia Pty Ltd, under the laws of the State of Victoria in Australia and, on October 4, 2023, we formed our wholly owned subsidiary, merveille.ai, under the laws o\u2026"}]},{"cik":1712762,"name":"BIOAFFINITY TECHNOLOGIES, INC.","industry":"Pharma & biotech","sic":8731,"state":"TX","cells":[{"fy":2022,"lvl":2,"n":12,"adsh":"0001493152-23-010186","doc":"form10-k.htm","q":"CyPath \u00ae Lung uses flow cytometry and automated data analysis developed by artificial intelligence (AI) that allows for an entire sample of sputum to be examined for cost-effective, large-scale screening or diagnosis."},{"fy":2023,"lvl":"x","n":15,"adsh":"0001493152-24-012358","doc":"form10-k.htm","q":"We develop proprietary noninvasive diagnostic tests using flow cytometry and automated analysis developed by artificial intelligence (\u201cAI\u201d)."},{"fy":2024,"lvl":"x","n":18,"adsh":"0001641172-25-001840","doc":"form10-k.htm","q":"Business Business Overview We develop proprietary noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial intel\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0001493152-26-010143","doc":"form10-k.htm","q":"Business Business Overview We develop noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial in\u2026"}]},{"cik":1713683,"name":"ZSCALER, INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2018,"lvl":1,"n":2,"adsh":"0001628280-18-011833","doc":"zs7311810-k.htm","q":"Subsequent Events In August 2018, we acquired certain artificial intelligence and machine learning technology and the development team of security startup TrustPath Inc."},{"fy":2019,"lvl":0,"n":0,"adsh":"0001713683-19-000030","doc":"zs-20190731.htm","q":null},{"fy":2020,"lvl":1,"n":2,"adsh":"0001713683-20-000163","doc":"zs-20200731.htm","q":"The cloud platform applies machine learning across our well over 100 billion daily transactions to identify and block unknown threats quickly."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001713683-21-000175","doc":"zs-20210731.htm","q":"The cloud platform applies machine learning across our well over 160 billion daily transactions to identify and block unknown threats quickly."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001713683-22-000081","doc":"zs-20220731.htm","q":"The cloud platform applies machine learning across our well over 250 billion daily transactions to quickly identify and block unknown threats."},{"fy":2023,"lvl":3,"n":35,"adsh":"0001713683-23-000113","doc":"zs-20230731.htm","q":"We are integrating our proprietary large language models, or LLMs, with our Zero Trust Exchange to leverage our data lake built on our more than 320 billion daily transactions."},{"fy":2024,"lvl":3,"n":39,"adsh":"0001713683-24-000109","doc":"zs-20240731.htm","q":"We are integrating our proprietary large language models, or LLMs, with our Zero Trust Exchange to leverage our data lake built on our more than 500 billion daily transactions."},{"fy":2025,"lvl":3,"n":131,"adsh":"0001713683-25-000158","doc":"zs-20250731.htm","q":"The emergence and rapid adoption of artificial intelligence, or AI, is revolutionizing the transformational impact of cloud adoption and mobility."}]},{"cik":1713863,"name":"RAFAEL HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-24-095111","doc":"ea0217275-10k_rafael.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-25-103549","doc":"ea0262395-10k_rafael.htm","q":null}]},{"cik":1714798,"name":"PREVAIL THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012986","doc":"prvl-10k_20191231.htm","q":null}]},{"cik":1714899,"name":"DENALI THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001714899-19-000015","doc":"dnli-20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001714899-20-000026","doc":"dnli-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001714899-21-000033","doc":"dnli-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001714899-22-000058","doc":"dnli-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001714899-23-000049","doc":"dnli-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001714899-24-000086","doc":"dnli-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001714899-25-000066","doc":"dnli-20241231.htm","q":"Generative artificial intelligence (\"AI\") resources that are publicly available may also present a risk that a company may inadvertently obtain, incorporate or use a third party's intellectual property."},{"fy":2025,"lvl":3,"n":15,"adsh":"0001714899-26-000021","doc":"dnli-20251231.htm","q":"Generative artificial intelligence (\"AI\") resources that are publicly available may also present a risk that a company may inadvertently obtain, incorporate, or use a third party's intellectual property."}]},{"cik":1715433,"name":"LEADER CAPITAL HOLDINGS CORP.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-18-017491","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-19-018573","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":2,"adsh":"0001493152-20-023636","doc":"form10-k.htm","q":"Key services include real-time Taiwan stock market quotes, financial industry information and news, social media activities, on-line live broadcast, A.I. stock selection and other features. 4 Acquisition of Nice Products Inc."},{"fy":2021,"lvl":"x","n":6,"adsh":"0001493152-21-031425","doc":"form10-k.htm","q":"Key services include real-time Taiwan stock market quotes, financial industry information and news, social media activities, on-line live broadcast, A.I. stock selection and other features."},{"fy":2022,"lvl":"x","n":6,"adsh":"0001493152-22-035440","doc":"form10-k.htm","q":"Key services include real-time Taiwan stock market quotes, financial industry information and news, social media activities, on-line live broadcast, A.I. stock selection and other features."}]},{"cik":1715611,"name":"BODY & MIND INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001640334-18-002142","doc":"bodymind_10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001640334-19-002284","doc":"bmmj_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001640334-20-003083","doc":"bmmj_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001640334-21-002905","doc":"bmmj_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001640334-23-000071","doc":"bmmj_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001640334-23-002116","doc":"bmmj_10k.htm","q":null}]},{"cik":1715768,"name":"TRANSPHORM, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001715768-21-000035","doc":"none-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001715768-22-000028","doc":"tgan-20220331.htm","q":"Department of Defense, Department of Army, and Intelligence Community procurement with a focus on Space applications, Artificial Intelligence, Cyber, and IT technologies in defense acquisition, program management, logistics and technology."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001715768-23-000047","doc":"tgan-20230331.htm","q":"Department of Defense, Department of Army, and Intelligence Community procurement with a focus on Space applications, Artificial Intelligence, Cyber, and IT technologies in defense acquisition, program management, logistics and technology."}]},{"cik":1715942,"name":"DATA VISION, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001520138-19-000093","doc":"dtvn-20181231_10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001520138-20-000202","doc":"dtvn-20191231_10k.htm","q":null}]},{"cik":1716947,"name":"ENSYSCE BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-013767","doc":"form10ka.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008438","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-009844","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-009993","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-009703","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-013633","doc":"form10-k.htm","q":null}]},{"cik":1717115,"name":"TEMPUS AI, INC.","industry":"Software & IT services","sic":7370,"state":"IL","cells":[{"fy":2024,"lvl":3,"n":321,"adsh":"0000950170-25-025603","doc":"tem-20241231.htm","q":"Overview We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare."},{"fy":2025,"lvl":3,"n":302,"adsh":"0001193125-26-066961","doc":"tem-20251231.htm","q":"Overview We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare."}]},{"cik":1717452,"name":"ODONATE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-003806","doc":"odt-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-005407","doc":"odt-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-007296","doc":"odt-10k_20201231.htm","q":null}]},{"cik":1718108,"name":"SURFACE ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006783","doc":"surf-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-009521","doc":"surf-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001718108-21-000013","doc":"surf-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001718108-22-000006","doc":"surf-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001718108-23-000004","doc":"surf-20221231.htm","q":null}]},{"cik":1718227,"name":"CONSTRUCTION PARTNERS, INC.","industry":"Construction","sic":1600,"state":"AL","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001718227-18-000014","doc":"road-09302018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001718227-19-000098","doc":"road-20190930.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001718227-20-000093","doc":"road-20200930.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001718227-21-000107","doc":"road-20210930.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001718227-22-000103","doc":"road-20220930.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001718227-23-000081","doc":"road-20230930.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001718227-24-000102","doc":"road-20240930.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-25-053871","doc":"road-20250930.htm","q":null}]},{"cik":1718644,"name":"ZANDER THERAPEUTICS, INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001607062-18-000292","doc":"zander063018form10k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001607062-19-000354","doc":"zander063019form10k.htm","q":null}]},{"cik":1718852,"name":"PROMETHEUS BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001564590-22-009321","doc":"rxdx-10k_20211231.htm","q":"This, in combination with our state-of-the-art machine-learning methodologies, make Prometheus360 a discovery engine for novel precision therapeutics and companion diagnostics."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-005097","doc":"rxdx-20221231.htm","q":null}]},{"cik":1718939,"name":"T STAMP INC","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2021,"lvl":"x","n":14,"adsh":"0001410578-22-000838","doc":"idai-20211231x10k.htm","q":"Trust Stamp develops proprietary artificial intelligence powered solutions; researching and leveraging cutting edge technology including biometric science, cryptography, and data mining to deliver insightful identity and trust predictions w\u2026"},{"fy":2022,"lvl":"x","n":10,"adsh":"0001410578-23-000453","doc":"idai-20221231x10k.htm","q":"Trust Stamp develops proprietary artificial intelligence-powered identity and trust solutions at the intersection of biometrics, privacy, and cybersecurity, that enable organizations to protect themselves and their users, while empowering i\u2026"},{"fy":2023,"lvl":"x","n":17,"adsh":"0001718939-24-000043","doc":"idai-20231231.htm","q":"Trust Stamp develops proprietary artificial intelligence-powered identity and trust solutions at the intersection of biometrics, privacy, and cybersecurity, that enable organizations to protect themselves and their users while empowering in\u2026"},{"fy":2024,"lvl":"x","n":35,"adsh":"0001718939-25-000080","doc":"idai-20241231.htm","q":"Trust Stamp primarily develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning artificial intelligence, including computer vision, cryptography, and data mining, to process and protect data\u2026"},{"fy":2025,"lvl":3,"n":58,"adsh":"0001718939-26-000024","doc":"idai-20251231.htm","q":"Examples of federal (US) and European statutes we could be subject to are: \u2022 Health Insurance Portability and Accountability Act (HIPAA) \u2022 Health Information Technology for Economic and Clinical Health Act (HITECH) \u2022 General Data Protection\u2026"}]},{"cik":1719323,"name":"ENERGY CONVERSION SERVICES, INC.","industry":"Utilities","sic":4911,"state":"NV","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001731122-19-000345","doc":"e1376_10k.htm","q":null}]},{"cik":1719406,"name":"NRX PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"DE","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001654954-21-003783","doc":"brpa_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004899","doc":"nrxp-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005292","doc":"nrxp-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":5,"adsh":"0001558370-24-004396","doc":"nrxp-20231231x10k.htm","q":"Replacement of the Company\u2019s traditional study site-based approaches to clinical trial recruitment with an internet/AI-based nationally-focused clinical trial recruitment strategy, in partnership with 1-N-Nealth, Inc., a digital marketing o\u2026"},{"fy":2024,"lvl":"x","n":2,"adsh":"0001437749-25-007743","doc":"nrxp20241231c_10k.htm","q":"We implemented an artificial intelligence (\u201cAI\u201d) based national recruitment strategy designed to identify and recruit participants who are sincerely looking for the potential benefit offered by NRX-101."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001437749-26-009418","doc":"nrxp20251231_10k.htm","q":"Between 2016 to 2021, he served on the board of directors of Ingine Inc., a healthcare artificial intelligence company."}]},{"cik":1719714,"name":"MEREO BIOPHARMA GROUP PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-037348","doc":"mreo-20231231.htm","q":"We consider alvelestat\u2019s closest potential competitors to be the Janus Kinase (JAK1) inhibitor, itacitinib, and JAK2 inhibitor, ruxolitinib, (Incyte Corporation) in Phase 1/Phase2 studies in lung transplant-associated and SCT-associated BOS\u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0000950170-25-044787","doc":"mreo-20241231.htm","q":"The increasing use of artificial intelligence (\u201cAI\u201d)-based software (including machine learning) in our industry introduces additional risks that could impact our business."},{"fy":2025,"lvl":2,"n":7,"adsh":"0001193125-26-115226","doc":"mreo-20251231.htm","q":"Even if identified, we may be unable to adequately investigate or remediate incidents or breaches due to attackers increasingly using tools and techniques, including artificial intelligence, that are designed to circumvent controls, to avoi\u2026"}]},{"cik":1720116,"name":"RED VIOLET, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2018,"lvl":2,"n":5,"adsh":"0001564590-19-006615","doc":"rdvt-10k_20181231.htm","q":"Through machine learning and advanced analytics, we use the power of data fusion to ingest and analyze data at a massive scale."},{"fy":2019,"lvl":2,"n":5,"adsh":"0001564590-20-010508","doc":"rdvt-10k_20191231.htm","q":"Leveraging proprietary technology and applying machine learning and advanced analytical and decision-making capabilities, CORE provides compelling solutions to public and private sector organizations through intuitive, easy-to-use analytica\u2026"},{"fy":2020,"lvl":2,"n":7,"adsh":"0001564590-21-012098","doc":"rdvt-10k_20201231.htm","q":"Leveraging cloud-native proprietary technology and applying machine learning and advanced analytical capabilities, CORE provides essential solutions to public and private sector organizations through intuitive, easy-to-use analytical interf\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0000950170-22-003240","doc":"rdvt-20211231.htm","q":"Leveraging cloud-native proprietary technology and applying machine learning and advanced analytical capabilities, CORE provides essential solutions to public and private sector organizations through intuitive, easy-to-use analytical interf\u2026"},{"fy":2022,"lvl":2,"n":7,"adsh":"0000950170-23-006736","doc":"rdvt-20221231.htm","q":"Leveraging cloud-native proprietary technology and applying machine learning and advanced analytical capabilities, CORE provides essential solutions to public and private sector organizations through intuitive, easy-to-use analytical interf\u2026"},{"fy":2023,"lvl":3,"n":16,"adsh":"0000950170-24-028115","doc":"rdvt-20231231.htm","q":"Our AI/ML-driven identity intelligence platform, CORE TM , is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence."},{"fy":2024,"lvl":3,"n":29,"adsh":"0000950170-25-029184","doc":"rdvt-20241231.htm","q":"Our AI/ML-driven identity intelligence platform, CORE TM , is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence."},{"fy":2025,"lvl":3,"n":74,"adsh":"0001193125-26-091708","doc":"rdvt-20251231.htm","q":"Our cloud-native, AI-enabled identity intelligence platform, CORE TM , is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence."}]},{"cik":1720580,"name":"ADICET BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-008262","doc":"torc-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010474","doc":"torc-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012664","doc":"acet-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003753","doc":"acet-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008130","doc":"acet-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":20,"adsh":"0000950170-24-033482","doc":"acet-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":22,"adsh":"0000950170-25-034587","doc":"acet-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":26,"adsh":"0001720580-26-000008","doc":"acet-20251231.htm","q":"We expect the CAC and additional Chinese regulators to maintain a high level of scrutiny in the data security, cross-border data transfer and artificial intelligence space."}]},{"cik":1720671,"name":"HASHICORP, INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0000950170-22-004668","doc":"hcp-20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009241","doc":"hcp-20230131.htm","q":null},{"fy":2023,"lvl":3,"n":23,"adsh":"0001628280-24-012350","doc":"hcp-20240131.htm","q":"We also have incorporated artificial intelligence, or AI, features into certain of our offerings, and may continue to incorporate additional AI features into our offerings in the future."}]},{"cik":1720725,"name":"OYSTER POINT PHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001720725-20-000006","doc":"oyst-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001720725-21-000023","doc":"oyst-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001720725-22-000028","doc":"oyst-20211231.htm","q":null}]},{"cik":1720893,"name":"BIOXCEL THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2018,"lvl":3,"n":24,"adsh":"0001558370-19-001798","doc":"btai-20181231x10k.htm","q":"Business Overview We are a clinical stage biopharmaceutical company utilizing novel artificial intelligence-based approaches to identify the next wave of medicines across neuroscience and immuno-oncology."},{"fy":2019,"lvl":3,"n":24,"adsh":"0001558370-20-002196","doc":"btai-20191231x10k.htm","q":"Business Overview BTI is a clinical stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology."},{"fy":2020,"lvl":3,"n":31,"adsh":"0001558370-21-002916","doc":"btai-20201231x10k.htm","q":"Business Overview We are a clinical stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology."},{"fy":2021,"lvl":3,"n":39,"adsh":"0001558370-22-003335","doc":"btai-20211231x10k.htm","q":"Business Overview We are a clinical stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology."},{"fy":2022,"lvl":3,"n":43,"adsh":"0001558370-23-003940","doc":"btai-20221231x10k.htm","q":"(\u201cBTI\u201d or the \u201cCompany\u201d) is a biopharmaceutical company utilizing artificial intelligence (\u201cAI\u201d) approaches to develop transformative medicines in neuroscience and immuno-oncology."},{"fy":2023,"lvl":3,"n":80,"adsh":"0001558370-24-003784","doc":"btai-20231231x10k.htm","q":"(\u201cBTI,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a biopharmaceutical company utilizing artificial intelligence (\u201cAI\u201d) to develop transformative medicines in neuroscience and, through the Company\u2019s wholly owned subsidiary, OnkosXcel Therapeuti\u2026"},{"fy":2024,"lvl":3,"n":79,"adsh":"0001558370-25-003985","doc":"btai-20241231x10k.htm","q":"(\u201cBTI,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus\u201d or \u201cour\u201d) is a biopharmaceutical company utilizing artificial intelligence (\u201cAI\u201d) to develop transformative medicines in neuroscience and, through the Company\u2019s wholly owned subsidiary, OnkosXcel Therapeuti\u2026"},{"fy":2025,"lvl":3,"n":72,"adsh":"0001104659-26-036214","doc":"btai-20251231x10k.htm","q":"(Nasdaq: BTAI, \u201cthe Company\u201d) is a biopharmaceutical company built on artificial intelligence (\u201cAI\u201d) to develop transformative medicines in neuroscience."}]},{"cik":1720990,"name":"FISKER INC./DE","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2020,"lvl":1,"n":4,"adsh":"0001193125-21-100857","doc":"d138330d10k.htm","q":"We intend to equip Fisker Ocean with a class-competitive suite of Advanced Driving Assistance features supported by a sensor suite that includes state-of-the-art computer vision technology and digital imaging radar. \u2022 Solar roof ."},{"fy":2021,"lvl":2,"n":5,"adsh":"0001720990-22-000010","doc":"fsr-20211231.htm","q":"We intend to equip Fisker Ocean with a class-competitive suite of Advanced Driving Assistance features supported by a sensor suite that includes state-of-the-art computer vision technology and digital imaging radar. \u2022 Solar roof ."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001720990-23-000020","doc":"fsr-20221231.htm","q":"We intend to equip Fisker Ocean with a class-competitive suite of Advanced Driving Assistance features supported by a sensor suite that includes state-of-the-art computer vision technology and digital imaging radar. \u2022 Solar roof ."},{"fy":2023,"lvl":2,"n":5,"adsh":"0001720990-24-000045","doc":"fsr-20231231.htm","q":"We intend to equip Fisker Ocean 7 Table of Contents Index to Financial Statements with a class-competitive suite of Advanced Driving Assistance System (ADAS) features supported by a sensor suite that includes state-of-the-art computer visio\u2026"}]},{"cik":1721386,"name":"LANDSEA HOMES CORP","industry":"Construction","sic":1531,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001731122-21-000373","doc":"e2494_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001721386-22-000004","doc":"lhi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001721386-23-000005","doc":"lhi-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001721386-24-000007","doc":"lhi-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001721386-25-000008","doc":"lsea-20241231.htm","q":null}]},{"cik":1721484,"name":"LONGEVERON INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-011894","doc":"f10k2021_longeveroninc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-020006","doc":"f10k2022_longeveron.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-017521","doc":"ea0200564-10k_longeveron.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-029968","doc":"lgvn-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-110664","doc":"lgvn-20251231.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to use of artificial intelligence to review product applications."}]},{"cik":1721947,"name":"JAMF HOLDING CORP.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002391","doc":"jamf-20201231x10k.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001628280-22-004530","doc":"jamf-20211231.htm","q":"Some of our product features are powered by ML and AI, which depend on datasets and algorithms that could be flawed, including through inaccurate, insufficient, outdated, or biased data."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-23-005848","doc":"jamf-20221231.htm","q":"Some of our product features are powered by machine learning and artificial intelligence, which depend on datasets and algorithms that could be flawed, including through inaccurate, insufficient, outdated, or biased data."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001628280-24-007212","doc":"jamf-20231231.htm","q":"The development and use of generative AI and ML technologies in our platform and our business, as well as our potential failure to effectively implement, use, and market these technologies, may result in reputation harm or liability, or cou\u2026"},{"fy":2024,"lvl":3,"n":19,"adsh":"0001628280-25-008642","doc":"jamf-20241231.htm","q":"The development and use of generative AI and ML technologies in our platform and our business, as well as our potential failure to effectively implement, use, and market these technologies, may result in reputation harm or liability, or cou\u2026"}]},{"cik":1722271,"name":"AKOUOS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003583","doc":"akus-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004606","doc":"akus-20211231x10k.htm","q":null}]},{"cik":1722731,"name":"FDCTECH, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001493152-19-005374","doc":"form10-k.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-005931","doc":"form10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-005266","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-007869","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-012515","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-041145","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-001853","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":1,"n":3,"adsh":"0001493152-26-017945","doc":"form10-k.htm","q":"In parallel, the global AI trading platform market is forecast to grow from approximately $11.2 billion in 2024 to $33.5 billion by 2030, reflecting a CAGR of about 20% as firms deploy AI for execution, analytics, and risk management (8) ."}]},{"cik":1722964,"name":"Y-MABS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002375","doc":"ymab-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002551","doc":"ymab-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002172","doc":"ymab-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002567","doc":"ymab-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005073","doc":"ymab-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001558370-24-002188","doc":"ymab-20231231x10k.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001558370-25-002105","doc":"ymab-20241231x10k.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1722969,"name":"NXU, INC.","industry":"Auto manufacturing","sic":3713,"state":"AZ","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001214659-23-003900","doc":"at3923010k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001214659-24-005647","doc":"d31424110k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001214659-25-004401","doc":"nxu3425010k.htm","q":null}]},{"cik":1723059,"name":"BIO ESSENCE CORP","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-22-016613","doc":"f10k2021_bioessence.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024571","doc":"f10k2022_bioessence.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-032898","doc":"ea0203811-10k_bioessence.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001013762-25-003850","doc":"ea0235539-10k_bioessence.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-035467","doc":"ea0283075-10k_bioessence.htm","q":null}]},{"cik":1723128,"name":"AMNEAL PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2017,"lvl":"x","n":0,"adsh":"0001723128-18-000005","doc":"atlas-20173112x10xk.htm","q":null},{"fy":2018,"lvl":0,"n":0,"adsh":"0001723128-19-000028","doc":"amrx-12x31x201810kdoc.htm","q":null},{"fy":2019,"lvl":1,"n":4,"adsh":"0001564590-20-008179","doc":"amrx-10k_20191231.htm","q":"Recent Transactions We engaged in the following business transactions in 2019: \u2022 On March 30, 2019, we sold substantially all of our operations in the United Kingdom to AI Sirona (Luxembourg) S.a.r.l. for net cash consideration of approxima\u2026"},{"fy":2020,"lvl":1,"n":4,"adsh":"0001723128-21-000013","doc":"amrx-20201231.htm","q":"Divestitures UK Divestiture On March 30, 2019, the Company sold 100 % of the stock of its Creo Pharma Holding Limited subsidiary, which comprised substantially all of the Company's operations in the United Kingdom, to AI Sirona (Luxembourg)\u2026"},{"fy":2021,"lvl":1,"n":4,"adsh":"0001723128-22-000006","doc":"amrx-20211231.htm","q":"Divestitures UK Divestiture On March 30, 2019, the Company sold 100 % of the stock of its Creo Pharma Holding Limited subsidiary, which comprised substantially all of the Company's operations in the United Kingdom, to AI Sirona (Luxembourg)\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001723128-23-000009","doc":"amrx-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":18,"adsh":"0001723128-24-000014","doc":"amrx-20231231.htm","q":"The principal competitive factors in the pharmaceutical market include: \u2022 introduction of other generic drug manufacturers\u2019 products in direct competition with our generic drug products; \u2022 introduction of authorized generic drug products in\u2026"},{"fy":2024,"lvl":3,"n":20,"adsh":"0001723128-25-000012","doc":"amrx-20241231.htm","q":"The principal competitive factors in the pharmaceutical market include: \u2022 introduction of other generic drug manufacturers\u2019 products in direct competition with our generic drug products; \u2022 introduction of authorized generic drug products in\u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001723128-26-000011","doc":"amrx-20251231.htm","q":"We also enhanced our talent management capabilities via My Amneal Career, an AI-enabled platform focused on expanding organization-wide skills and talent visibility, supported by leadership engagement and broad employee participation with 7\u2026"}]},{"cik":1723866,"name":"SELECT INTERIOR CONCEPTS, INC.","industry":"Construction","sic":1520,"state":"GA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-007998","doc":"ck0001723866-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010375","doc":"ck1723866-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013373","doc":"ck1723866-10k_20201231.htm","q":null}]},{"cik":1724344,"name":"ENTASIS THERAPEUTICS HOLDINGS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002588","doc":"ettx-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002414","doc":"ettx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003348","doc":"ettx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002788","doc":"ettx-20211231x10k.htm","q":null}]},{"cik":1724521,"name":"ARCUS BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006274","doc":"rcus-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008972","doc":"rcus-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008270","doc":"rcus-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001788","doc":"rcus-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005112","doc":"rcus-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0001724521-24-000052","doc":"rcus-20231231.htm","q":"Our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, personnel\u2019s, or the third parties' upon whom we rely use of generative artificial intelligence (AI) technologies."},{"fy":2024,"lvl":2,"n":6,"adsh":"0001724521-25-000040","doc":"rcus-20241231.htm","q":"Our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with the use of generative artificial intelligence (\"AI\") technologies by our employees, personnel, or the third parties upon whom we rely."},{"fy":2025,"lvl":2,"n":8,"adsh":"0001724521-26-000009","doc":"rcus-20251231.htm","q":"Furthermore, as the cyber threat landscape evolves, these attacks are growing in frequency, sophistication and intensity, and becoming increasingly difficult to detect as threat actors use techniques and tools \u2013 including artificial intelli\u2026"}]},{"cik":1724570,"name":"DATTO HOLDING CORP.","industry":"Software & IT services","sic":7372,"state":"CT","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001724570-21-000015","doc":"msp-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001724570-22-000011","doc":"msp-20211231.htm","q":null}]},{"cik":1724979,"name":"RAIN ONCOLOGY INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001564590-22-008531","doc":"rain-10k_20211231.htm","q":"Also in June 2021, we announced a master program and a genomic analysis platform agreement for comprehensive genomic profiling tests utilizing the genomic analysis platform of Tempus, an artificial intelligence and precision medicine compan\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003331","doc":"rain-20221231x10k.htm","q":null}]},{"cik":1725057,"name":"DAYFORCE, INC.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005517","doc":"cday-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007850","doc":"cday-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009508","doc":"cday-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002143","doc":"cday-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":6,"adsh":"0000950170-23-005559","doc":"cday-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":27,"adsh":"0000950170-24-022100","doc":"day-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":60,"adsh":"0000950170-25-029980","doc":"day-20241231.htm","q":null}]},{"cik":1725160,"name":"ZENTALIS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":1,"n":4,"adsh":"0001725160-21-000075","doc":"zntl-20201231.htm","q":"In a randomized double-blind, placebo-controlled trial in treatment of na\u00efve advanced and metastatic breast cancer patients, treatment with 500 mg of fulvestrant resulted in median progression free survival, or PFS, of 16.6 months versus 13\u2026"},{"fy":2021,"lvl":1,"n":3,"adsh":"0001725160-22-000053","doc":"zntl-20211231.htm","q":"Our approach centers on utilizing our Integrated Discovery Engine with functional screens, preclinical models, machine learning and chemistry, to identify such targets and subsequently develop product candidates with translational science t\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001725160-23-000048","doc":"zntl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001725160-24-000080","doc":"zntl-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0001725160-25-000067","doc":"zntl-20241231.htm","q":"In addition, we selectively use artificial intelligence, or AI, in our business."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001725160-26-000014","doc":"zntl-20251231.htm","q":"As the regulatory guidance and enforcement landscape in relation to data transfers continue to develop, we could incur additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer per\u2026"}]},{"cik":1725579,"name":"PLURALSIGHT, INC.","industry":"Software & IT services","sic":7370,"state":"UT","cells":[{"fy":2018,"lvl":2,"n":7,"adsh":"0001725579-19-000007","doc":"ps201810k.htm","q":"Our platform is powered by Iris, our proprietary machine-learning driven skill and role assessment algorithm and recommendation engine, which enables businesses to more effectively quantify and develop skills across technologies."},{"fy":2019,"lvl":2,"n":5,"adsh":"0001725579-20-000008","doc":"ps10-k123119.htm","q":"Our platform is powered by Iris, our proprietary machine-learning driven skill and role assessment algorithm and recommendation engine, which enables businesses to more effectively quantify and develop skills across technologies."},{"fy":2020,"lvl":2,"n":9,"adsh":"0001725579-21-000010","doc":"ps-20201231.htm","q":"Our platform is powered by Iris, our proprietary machine learning driven skill and role assessment algorithm and recommendation engine, which enables businesses to more effectively quantify and develop skills across technologies."}]},{"cik":1726711,"name":"ADITXT, INC.","industry":"Pharma & biotech","sic":2834,"state":"VA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-017776","doc":"f10k2020_aditxtherap.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016723","doc":"f10k2021_aditxtinc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-030316","doc":"f10k2022_aditxtinc.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001213900-24-033466","doc":"ea0203762-10k_aditxt.htm","q":"In addition to our current programs, Adimune and Pearsanta, we look to bring in future health innovations in the areas of software and AI, medical devices, therapeutics, and other technologies that take a fundamentally different approach to\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001213900-25-026256","doc":"ea0235549-10k_aditxt.htm","q":"In addition to our current programs, Adimune and Pearsanta, we look to bring in future health innovations in the areas of software and AI, medical devices, therapeutics, and other technologies that take a fundamentally different approach to\u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-037529","doc":"ea0283141-10k_aditxt.htm","q":null}]},{"cik":1727196,"name":"SCHOLAR ROCK HOLDING CORP","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002252","doc":"srrk-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002536","doc":"srrk-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002641","doc":"srrk-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002928","doc":"srrk-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002992","doc":"srrk-20221231x10k.htm","q":null},{"fy":2023,"lvl":3,"n":17,"adsh":"0001558370-24-003540","doc":"srrk-20231231x10k.htm","q":"See the section in this Annual Report on Form 10-K for the fiscal year ended December 31, 2023 entitled \u201cBusiness \u2013 Government Regulation \u2013 European General Data Protection Regulation and \u201cBusiness \u2013 Government Regulation \u2013 Other Healthcare\u2026"},{"fy":2024,"lvl":3,"n":23,"adsh":"0001558370-25-001682","doc":"srrk-20241231x10k.htm","q":"See the section in this Annual Report entitled \u201cBusiness \u2013 Government Regulation \u2013 European General Data Protection Regulation and \u201cBusiness \u2013 Government Regulation \u2013 Other Healthcare and Privacy Laws.\u201d Artificial intelligence presents risk\u2026"},{"fy":2025,"lvl":3,"n":23,"adsh":"0001104659-26-022551","doc":"srrk-20251231x10k.htm","q":"See the section in this Annual Report entitled \u201cBusiness \u2013 Government Regulation \u2013 European General Data Protection Regulation\u201d and \u201cBusiness \u2013 Government Regulation \u2013 Other Healthcare and Privacy Laws.\u201d Artificial intelligence presents ris\u2026"}]},{"cik":1728117,"name":"GOSSAMER BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012323","doc":"goss-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001728117-21-000019","doc":"goss-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001728117-22-000019","doc":"goss-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001728117-23-000010","doc":"goss-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001728117-24-000019","doc":"goss-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001728117-25-000021","doc":"goss-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":6,"adsh":"0001728117-26-000017","doc":"goss-20251231.htm","q":"In addition, we selectively use artificial intelligence, or AI, in our business."}]},{"cik":1728328,"name":"INMED PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001213900-21-049679","doc":"f10k2021_inmedpharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-22-058355","doc":"f10k2022_inmedpharma.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-23-080842","doc":"f10k2023_inmedpharma.htm","q":null},{"fy":2024,"lvl":3,"n":38,"adsh":"0001213900-24-082843","doc":"ea0214241-10k_inmed.htm","q":"More recently, President Biden signed an executive order that will make it more difficult for U.S. firms to invest in certain Chinese companies\u2014citing national security concerns, the executive order prohibits investments in AI and quantum c\u2026"},{"fy":2025,"lvl":3,"n":37,"adsh":"0001213900-25-090210","doc":"ea0253959-10k_inmed.htm","q":"The methods and techniques used by cyber threat actors to gain entry into our network and access our computer systems, software and data will become more advanced with the use of Artificial Intelligence (\u201cAI\u201d) and may become increasingly di\u2026"}]},{"cik":1729427,"name":"CNS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001683168-20-000781","doc":"cns_10k-123119.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001683168-21-000533","doc":"cns_10k-123120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-001401","doc":"cns_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-002086","doc":"cns_i10k-2022.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-002032","doc":"cnspharma_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-002139","doc":"cns_i10k-123124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-002550","doc":"cns_i10k-123125.htm","q":null}]},{"cik":1730168,"name":"BROADCOM INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001730168-18-000084","doc":"avgo-11042018x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001730168-19-000144","doc":"avgo-11032019x10k.htm","q":null},{"fy":2020,"lvl":2,"n":5,"adsh":"0001730168-20-000226","doc":"avgo-20201101.htm","q":"Software Portfolio Portfolio Description Major Portfolio Offerings Mainframe Software \u2022 Solutions for DevOps, AIOps and cyber security that accelerate enterprise innovation \u2022 Operational Analytics & management \u2022 Automation \u2022 Database & Data\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001730168-21-000153","doc":"avgo-20211031.htm","q":"Our Symantec solutions utilize rich threat intelligence from a global network of security engineers, threat analyst and researchers, as well as advanced AI and machine-learning engines, enabling customers to protect data, connect authorized\u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0001730168-22-000118","doc":"avgo-20221030.htm","q":"Ethernet Network Interface Card (\u201cNIC\u201d) Controllers: Our Ethernet NIC controllers are designed for high-performance virtualization, intelligent flow processing, secure data center connectivity, and machine learning."},{"fy":2023,"lvl":2,"n":8,"adsh":"0001730168-23-000096","doc":"avgo-20231029.htm","q":"Ethernet NIC Controllers: Our Ethernet network interface card (\u201cNIC\u201d) controllers are designed for high-performance virtualization, intelligent flow processing, secure data center connectivity, and machine learning."},{"fy":2024,"lvl":3,"n":57,"adsh":"0001730168-24-000139","doc":"avgo-20241103.htm","q":"We offer thousands of products that are used in end products such as enterprise and data center networking, including artificial intelligence (\u201cAI\u201d) networking and connectivity, home connectivity, set-top boxes (\u201cSTB\u201d), broadband access, te\u2026"},{"fy":2025,"lvl":3,"n":82,"adsh":"0001730168-25-000121","doc":"avgo-20251102.htm","q":"Our solutions are used in a wide array of environments, end products and applications, such as enterprise and artificial intelligence (\u201cAI\u201d) data centers, servers and networking and connectivity equipment, as well as storage systems, home c\u2026"}]},{"cik":1730430,"name":"KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-001857","doc":"knsa-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002081","doc":"knsa-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001821","doc":"knsa-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001932","doc":"knsa-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002684","doc":"knsa-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001558370-24-002005","doc":"knsa-20231231x10k.htm","q":"Technologies such as artificial intelligence and machine learning are additionally being used to create more sophisticated attacks on targets, including targeted social engineering attempts."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-001505","doc":"knsa-20241231x10k.htm","q":"Technologies such as artificial intelligence and machine learning are additionally being used to create more sophisticated attacks on targets, including targeted social engineering attempts."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001104659-26-019168","doc":"knsa-20251231x10k.htm","q":"Technologies such as artificial intelligence and machine learning are additionally being used to create more sophisticated attacks on targets, including targeted social engineering attempts."}]},{"cik":1730463,"name":"AUTOLUS THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2023,"lvl":1,"n":4,"adsh":"0001730463-24-000048","doc":"autl-20231231.htm","q":"During times of war and other major conflicts, we, and the third parties upon which we rely, may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operati\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0001730463-25-000019","doc":"autl-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models \u2026"},{"fy":2025,"lvl":3,"n":23,"adsh":"0001730463-26-000038","doc":"autl-20251231.htm","q":"These companies may also render our product candidates obsolete or non-competitive via advances in existing technological approaches or the development of new or different approaches, such as using AI and machine learning, potentially elimi\u2026"}]},{"cik":1730732,"name":"3FORCES INC.","industry":"Software & IT services","sic":7370,"state":"AZ","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001445866-20-000255","doc":"live-20191231.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001096906-21-000625","doc":"live-20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001096906-22-000634","doc":"live-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001096906-23-000237","doc":"live-20221231.htm","q":null}]},{"cik":1730869,"name":"EVERYTHING BLOCKCHAIN, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001662252-19-000034","doc":"obitxform10kv4.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001662252-20-000041","doc":"obitxform10kv5.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001477932-21-003268","doc":"obitx_10k.htm","q":null},{"fy":2021,"lvl":"x","n":4,"adsh":"0001477932-22-003122","doc":"ebi_10k.htm","q":"On June 21, 2021, we acquired all of the equity interests of 832. 832, which is located in Texas, has developed many innovations in the areas of distributed computing, artificial intelligence and blockchain technologies."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001477932-23-003007","doc":"ebi_10k.htm","q":"On June 21, 2021, we acquired all of the equity interests of 832. 832, which is located in Texas, has developed many innovations in the areas of distributed computing, artificial intelligence and blockchain technologies."},{"fy":2023,"lvl":1,"n":3,"adsh":"0001477932-24-002949","doc":"ebi_10k.htm","q":"She is also Advisor within the Strategic Advisory Group at Paladin Capital Group (Cyber Venture Capital) and Adjunct Professor at the Mohamed Bin Zayed University of Artificial Intelligence."}]},{"cik":1731289,"name":"NIKOLA CORP","industry":"Auto manufacturing","sic":3711,"state":"AZ","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001731289-21-000006","doc":"nkla-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001731289-22-000016","doc":"nkla-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001731289-23-000013","doc":"nkla-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001731289-24-000053","doc":"nkla-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001731289-25-000065","doc":"nkla-20241231.htm","q":null}]},{"cik":1731831,"name":"EIDOS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-011575","doc":"eidx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-006823","doc":"eidx-10k_20191231.htm","q":null}]},{"cik":1731911,"name":"EPHS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"QC","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001553350-19-000394","doc":"ephs_10k.htm","q":null}]},{"cik":1733186,"name":"VEONEER, INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2018,"lvl":2,"n":7,"adsh":"0001733186-19-000044","doc":"veoneer_10k.htm","q":"By using deep learning (artificial intelligence) and sensor fusion, algorithms in the ADAS ECU can likely be improved in such a way that the vehicle will be able to make better decisions than a human driver could."},{"fy":2019,"lvl":2,"n":7,"adsh":"0001733186-20-000032","doc":"vne-20191231.htm","q":"Utilizing deep learning (artificial intelligence) and sensor fusion, algorithms in the ADAS ECU can likely be enhanced in such a way that the vehicle will be able to make better decisions than a human driver."},{"fy":2020,"lvl":2,"n":8,"adsh":"0001733186-21-000039","doc":"vne-20201231.htm","q":"Fifth generation vision systems, which are in the early development stages, and planned for production in 2024 will offer more than five times higher image resolution than the current generations of camera solutions and deep learning, as we\u2026"},{"fy":2021,"lvl":2,"n":6,"adsh":"0001733186-22-000012","doc":"vne-20211231.htm","q":"Fifth generation vision systems, which are in a development stage and planned for production in 2024 will offer more than five times higher image resolution than the current generations of camera solutions and deep learning, as well as offe\u2026"}]},{"cik":1733257,"name":"FINCH THERAPEUTICS GROUP, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":2,"n":6,"adsh":"0000950170-22-005243","doc":"fnch-20211231.htm","q":"Core to this strategy is our ability to deploy our proprietary machine learning algorithms to mine clinical data generated internally and by third parties, including experience with fecal microbiota transplantation, or FMT, a procedure that\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009490","doc":"fnch-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-035952","doc":"fnch-20231231.htm","q":null}]},{"cik":1733294,"name":"GENERATION BIO CO.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-085043","doc":"d108483d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-001957","doc":"gbio-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001916","doc":"gbio-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002616","doc":"gbio-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002907","doc":"gbio-20241231x10k.htm","q":null}]},{"cik":1733413,"name":"TFF PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-007544","doc":"f10k2019_tffpharma.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-014575","doc":"f10k2020_tffpharma.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-014844","doc":"f10k2021_tffpharma.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-025454","doc":"f10k2022_tffpharma.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-027185","doc":"ea0201339-10k_tffpharma.htm","q":null}]},{"cik":1733861,"name":"REST EZ INC.","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001185185-22-000827","doc":"restez20220331_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001185185-23-000944","doc":"restez20230331_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001185185-25-000130","doc":"restez20240331_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001185185-25-002060","doc":"restez10k033125.htm","q":null}]},{"cik":1734517,"name":"VIELA BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012848","doc":"vie-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009902","doc":"vie-10k_20201231.htm","q":null}]},{"cik":1734722,"name":"UIPATH, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":"x","n":27,"adsh":"0001734722-22-000006","doc":"path-20220131.htm","q":"Our platform leverages the power of artificial intelligence (\"AI\") based computer vision to enable our software robots to perform a vast array of actions as a human would when executing business processes."},{"fy":2022,"lvl":3,"n":35,"adsh":"0001734722-23-000017","doc":"path-20230131.htm","q":"Business Overview First established in a Bucharest, Romania apartment in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations and developing computer vision technology, whic\u2026"},{"fy":2023,"lvl":3,"n":121,"adsh":"0001734722-24-000011","doc":"path-20240131.htm","q":"Business Overview First established in a Bucharest, Romania apartment in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations and developing computer vision technology, whic\u2026"},{"fy":2024,"lvl":3,"n":160,"adsh":"0001734722-25-000007","doc":"path-20250131.htm","q":"Business Overview First established in a Bucharest, Romania apartment in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations, starting with computer vision technology and u\u2026"}]},{"cik":1735438,"name":"MEIRAGTX HOLDINGS PLC","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001193125-19-086735","doc":"d690523d10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002429","doc":"mgtx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002773","doc":"mgtx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003302","doc":"mgtx-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-003674","doc":"mgtx-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003309","doc":"mgtx-20231231x10k.htm","q":null},{"fy":2024,"lvl":2,"n":13,"adsh":"0001558370-25-002867","doc":"mgtx-20241231x10k.htm","q":"Hologen is a leading developer of multi-modal generative AI foundation models of real-world clinical data for clinical medicine and pharmaceutical drug development."},{"fy":2025,"lvl":3,"n":43,"adsh":"0001104659-26-036494","doc":"mgtx-20251231x10k.htm","q":"Hologen is a leading developer of multi-modal generative AI foundation models of real-world clinical data for clinical medicine and pharmaceutical drug development."}]},{"cik":1735707,"name":"GARRETT MOTION INC.","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-005824","doc":"gtx-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007405","doc":"gtx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005918","doc":"gtx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001735707-22-000027","doc":"gtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001735707-23-000018","doc":"gtx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001735707-24-000012","doc":"gtx-20231231.htm","q":"This system, enabled by artificial intelligence, can detect known and hidden capabilities of our employees."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001735707-25-000013","doc":"gtx-20241231.htm","q":"This system, enabled by artificial intelligence, can detect known and hidden capabilities of our employees."},{"fy":2025,"lvl":2,"n":5,"adsh":"0001735707-26-000009","doc":"gtx-20251231.htm","q":"This system, enabled by artificial intelligence, can detect known and hidden capabilities of our employees."}]},{"cik":1736243,"name":"ACURX PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000399","doc":"acxp-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-003929","doc":"acxp-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-003401","doc":"acxp-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":21,"adsh":"0001558370-25-003117","doc":"acxp-20241231x10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":"x","n":21,"adsh":"0001104659-26-027052","doc":"acxp-20251231x10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."}]},{"cik":1736297,"name":"ASTERA LABS, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":75,"adsh":"0001736297-25-000003","doc":"alab-20241231.htm","q":"Business Overview Our mission is to innovate, design, and deliver semiconductor-based connectivity solutions that are purpose-built to unleash the full potential of cloud and AI infrastructure."},{"fy":2025,"lvl":3,"n":89,"adsh":"0001736297-26-000010","doc":"alab-20251231.htm","q":"Business Overview Our mission is to innovate, design, and deliver semiconductor-based connectivity solutions that are purpose-built to unleash the full potential of cloud and AI infrastructure."}]},{"cik":1736730,"name":"CAMP4 THERAPEUTICS CORP","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2024,"lvl":1,"n":2,"adsh":"0001736730-25-000022","doc":"camp-20241231.htm","q":"These data empower our proprietary machine learning algorithm, known as EPIC, to identify the specific control elements that regulate any gene of interest in the most specific manner, including elements that may restrict gene expression to \u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001736730-26-000016","doc":"camp-20251231.htm","q":"These data empower our proprietary machine learning algorithm, known as EPIC, to identify the specific control elements that regulate any gene of interest in the most specific manner, including elements that may restrict gene expression to \u2026"}]},{"cik":1737193,"name":"LUDUSON G INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-001054","doc":"luduson_10k-123120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-002719","doc":"luduson_i10k-123121.htm","q":null}]},{"cik":1737287,"name":"ALLOGENE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-006991","doc":"allo-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001737287-20-000012","doc":"allo-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001737287-21-000009","doc":"allo-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001737287-22-000013","doc":"allo-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001737287-23-000018","doc":"allo-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":5,"adsh":"0001737287-24-000021","doc":"allo-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001737287-25-000036","doc":"allo-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a previous executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models to limit dru\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0001628280-26-017242","doc":"allo-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1737372,"name":"SYSOREX, INC.","industry":"Software & IT services","sic":7371,"state":"VA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001213900-19-005105","doc":"f10k2018_sysorexinc.htm","q":null},{"fy":2019,"lvl":"x","n":0,"adsh":"0001213900-20-008250","doc":"f10k2019_sysorexinc.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001213900-21-018255","doc":"f10k2020_sysorexinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-019723","doc":"f10k2021_sysorexinc.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0001213900-23-048561","doc":"f10k2022_sysorexinc.htm","q":"Most of the TTM Digital assets can be utilized for Artificial Intelligence, Machine Learning, or other non-mining uses that require significant GPU computer resources."}]},{"cik":1737953,"name":"REPLIMUNE GROUP, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001047469-19-003946","doc":"a2239140z10-k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001047469-20-003318","doc":"a2241747z10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-069611","doc":"tm2114346-1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001737953-22-000010","doc":"repl-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001737953-23-000009","doc":"repl-20230331.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001737953-24-000008","doc":"repl-20240331.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001737953-25-000009","doc":"repl-20250331.htm","q":"We may also be subject to additional industry-specific privacy, cybersecurity, data protection, operational and information systems resilience, and artificial intelligence-related laws in Europe which may subject us to additional similar ri\u2026"}]},{"cik":1738021,"name":"COMPASS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011110","doc":"cmpx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004156","doc":"cmpx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001171843-23-001691","doc":"cmpx20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001171843-24-001516","doc":"cmpx20231231_10k.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001171843-25-001106","doc":"cmpx20241231_10k.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001171843-26-001337","doc":"cmpx20251231_10k.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"}]},{"cik":1739104,"name":"ELANCO ANIMAL HEALTH INC","industry":"Pharma & biotech","sic":2834,"state":"IN","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001739104-19-000006","doc":"elanco-20181231document10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001739104-20-000005","doc":"elan-20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001739104-21-000004","doc":"elan-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001739104-22-000005","doc":"elan-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001739104-23-000004","doc":"elan-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":15,"adsh":"0001739104-24-000009","doc":"elan-20231231.htm","q":"We use machine learning and AI in our business, and challenges with properly managing its use could result in competitive or reputational harm and legal liability and adversely affect our results of operations."},{"fy":2024,"lvl":3,"n":17,"adsh":"0001739104-25-000014","doc":"elan-20241231.htm","q":"Failure to appropriately anticipate inventory levels in our distribution channels could materially adversely affect our financial condition and results of operations. 22 Table of Contents We use machine learning and artificial intelligence \u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001739104-26-000012","doc":"elan-20251231.htm","q":"We use machine learning and artificial intelligence (AI) in our business, and challenges with properly managing its use could result in operational, competitive or reputational harm and legal liability."}]},{"cik":1739174,"name":"BIOMX INC.","industry":"Pharma & biotech","sic":2836,"state":"DE","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001213900-20-007405","doc":"f10k2019_biomxinc.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-019233","doc":"f10k2020_biomxinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016136","doc":"f10k2021_biomxinc.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024122","doc":"f10k2022_biomxinc.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-030053","doc":"ea0202988-10k_biomx.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001013762-25-002283","doc":"ea0234724-10k_biomx.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-018231","doc":"ea0276826-10k_biomxinc.htm","q":null}]},{"cik":1739410,"name":"RALLYBIO CORP","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2021,"lvl":2,"n":11,"adsh":"0000950170-22-003767","doc":"rlyb-20211231.htm","q":"Artificial Intelligence Drug Discovery Collaboration We have established a partnership with Exscientia, an Oxford, UK-based artificial intelligence and machine learning drug discovery company with a proprietary chemical design platform, to \u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0000950170-23-006264","doc":"rlyb-20221231.htm","q":"Artificial Intelligence Drug Discovery Collaboration We have established a partnership with Exscientia Limited (\"Exscientia\"), an Oxford, UK-based artificial intelligence (\"AI\") and machine learning drug discovery company with a proprietary\u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0001739410-24-000035","doc":"rlyb-20231231.htm","q":"Artificial Intelligence Drug Discovery Collaboration In July 2019, we formed a joint venture with Exscientia Limited (\"Exscientia\"), an Oxford, UK-based artificial intelligence (\"AI\") and machine learning drug discovery company with a propr\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001739410-25-000040","doc":"rlyb-20241231.htm","q":"Artificial Intelligence Drug Discovery Collaboration In July 2019, we formed a joint venture with Exscientia Limited (\"Exscientia\"), an Oxford, UK-based artificial intelligence (\"AI\") and machine learning drug discovery company with a propr\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001628280-26-018261","doc":"rlyb-20251231.htm","q":"Artificial Intelligence Drug Discovery Collaboration In July 2019, we formed a joint venture with Exscientia Limited (\"Exscientia\"), an Oxford, UK-based artificial intelligence (\"AI\") and machine learning drug discovery company with a propr\u2026"}]},{"cik":1739426,"name":"RVL PHARMACEUTICALS PLC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001558370-19-002499","doc":"osmt-20181231x10k.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002906","doc":"osmt-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003726","doc":"osmt-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004770","doc":"rvlp-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004211","doc":"rvlp-20221231x10k.htm","q":null}]},{"cik":1739445,"name":"ARCOSA, INC.","industry":"Construction machinery","sic":3523,"state":"TX","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001739445-19-000020","doc":"aca1231201810k-q4.htm","q":null}]},{"cik":1739614,"name":"INHIBRX, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001739614-21-000047","doc":"inbx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001739614-22-000023","doc":"inbx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001739614-23-000020","doc":"inbx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001739614-24-000006","doc":"inbx-20231231.htm","q":null}]},{"cik":1739936,"name":"MOMENTIVE GLOBAL INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2018,"lvl":2,"n":5,"adsh":"0001564590-19-004449","doc":"svmk-10k_20181231.htm","q":"Our library of customizable survey templates and certified questions, designed by a team of survey scientists and further enhanced by our machine learning and AI-based analysis of the millions of surveys on our survey platform, facilitates \u2026"},{"fy":2019,"lvl":2,"n":5,"adsh":"0001564590-20-007349","doc":"svmk-10k_20191231.htm","q":"Our library of customizable survey templates and certified questions, designed by a team of survey scientists and further enhanced by our machine learning and AI-based analysis of the millions of surveys on our survey platform, facilitates \u2026"},{"fy":2020,"lvl":2,"n":7,"adsh":"0001564590-21-006682","doc":"svmk-10k_20201231.htm","q":"Our platform provides functionality that supports our survey products, including: \u2022 Templates: Our library of more than 180 customizable survey templates and certified questions, designed by a team of survey scientists and further enhanced \u2026"},{"fy":2021,"lvl":2,"n":11,"adsh":"0000950170-22-001217","doc":"mntv-20211231.htm","q":"We offer artificial intelligence powered solutions that help our customers reshape their businesses across five major categories of use cases: 1) Market Insights; 2) Brand Insights; 3) Customer Experience; 4) Employee Experience; and 5) Pro\u2026"},{"fy":2022,"lvl":2,"n":14,"adsh":"0000950170-23-003212","doc":"mntv-20221231.htm","q":"Our solutions are powered by a platform that combines audience panels, artificial intelligence, and advanced analytics capabilities that help make our products easy-to-use, yet powerful, to deliver speed-to-insights for our customers."}]},{"cik":1739942,"name":"SOLARWINDS CORP","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001739942-19-000010","doc":"swi-2018123110xk.htm","q":null},{"fy":2019,"lvl":1,"n":2,"adsh":"0001739942-20-000011","doc":"swi-2019123110xk.htm","q":"We help our customers manage their employee service challenge needs whether through simple ticketing or a powerful ITSM solution, removing the manual burden of managing incoming tickets and tracking technology assets with the products cutti\u2026"},{"fy":2020,"lvl":1,"n":2,"adsh":"0001739942-21-000043","doc":"swi-20201231.htm","q":"We help our customers manage their employee service challenge needs whether through simple ticketing or a powerful ITSM solution, removing the manual burden of managing incoming tickets and tracking technology assets with the products cutti\u2026"},{"fy":2021,"lvl":1,"n":2,"adsh":"0001739942-22-000020","doc":"swi-20211231.htm","q":"We help our customers manage their employee service challenge needs whether through simple ticketing or a powerful service desk solution, removing the manual burden of managing incoming tickets and tracking technology assets with the produc\u2026"},{"fy":2022,"lvl":2,"n":13,"adsh":"0001739942-23-000019","doc":"swi-20221231.htm","q":"We help our customers manage their employee service challenge needs whether through simple ticketing or a powerful service desk solution, removing the manual burden of managing incoming tickets and tracking technology assets with the produc\u2026"},{"fy":2023,"lvl":3,"n":33,"adsh":"0001739942-24-000020","doc":"swi-20231231.htm","q":"We help our customers manage their employee service 6 Table of Contents challenge needs whether through simple ticketing or a powerful service desk solution, removing the manual burden of managing incoming tickets and tracking technology as\u2026"},{"fy":2024,"lvl":3,"n":50,"adsh":"0001739942-25-000013","doc":"swi-20241231.htm","q":"We help our customers manage their employee service challenge needs whether through simple ticketing or a powerful service desk solution, removing the manual burden of managing incoming tickets and tracking technology assets with the produc\u2026"}]},{"cik":1740279,"name":"IN8BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004101","doc":"inab-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010997","doc":"inab-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-031486","doc":"inab-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0000950170-25-038738","doc":"inab-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-104181","doc":"inab-20251231.htm","q":null}]},{"cik":1740547,"name":"UROVANT SCIENCES LTD.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":"x","n":0,"adsh":"0001564590-19-022570","doc":"urov-10k_20190331.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-029968","doc":"urov-10k_20200331.htm","q":null}]},{"cik":1740742,"name":"UNICOIN INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001829126-22-014453","doc":"transparent_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001829126-23-002515","doc":"unicoininc_10k.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001829126-24-002120","doc":"unicoininc_10k.htm","q":"He has served on the Board of Directors of Blue Shield of California from September 2020 to the present, and is currently the CEO of Conectado, Inc., a company he founded, which is an AI platform that accelerates classroom to career opportu\u2026"},{"fy":2024,"lvl":0,"n":0,"adsh":"0001829126-25-002700","doc":"unicoininc_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001829126-26-003043","doc":"unicoininc_10k.htm","q":null}]},{"cik":1741257,"name":"BANGFU TECHNOLOGY GROUP CO., LTD.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001741257-19-000010","doc":"kelinda-10-kjune302019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001731122-20-001042","doc":"e2150_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001731122-21-001587","doc":"e3125_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001731122-22-001723","doc":"e4103_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001731122-23-001899","doc":"e5127_10k.htm","q":null}]},{"cik":1741830,"name":"KRONOS BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001741830-21-000018","doc":"kron-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001741830-22-000006","doc":"kron-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001741830-23-000011","doc":"kron-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0001741830-24-000021","doc":"kron-20231231.htm","q":"Network features should be explanatory: To overcome limitations in other network and machine learning approaches that are more \u201cblack box\u201d or correlative in their construction, TRN networks should be mechanistic in nature i.e., edges betwee\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001741830-25-000009","doc":"kron-20241231.htm","q":"Network features should be explanatory: To overcome limitations in other network and machine learning approaches that are more \u201cblack box\u201d or correlative in their construction, TRN networks should be mechanistic in nature i.e., edges betwee\u2026"}]},{"cik":1742927,"name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001437749-21-006681","doc":"rvph20201230_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-006332","doc":"rvph20211231_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008502","doc":"rvph20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-011955","doc":"rvph20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-010791","doc":"rvph20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-010126","doc":"rvph20251231_10k.htm","q":null}]},{"cik":1743725,"name":"GRID DYNAMICS HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2019,"lvl":1,"n":4,"adsh":"0001213900-20-005395","doc":"f10k2019_chasergtech.htm","q":"Since its inception in 2006 in Menlo Park, California, as a grid and cloud consultancy firm, Grid Dynamics has been on the forefront of digital transformation, working on big ideas like cloud computing, NOSQL, DevOps, microservices, big dat\u2026"},{"fy":2020,"lvl":2,"n":13,"adsh":"0001213900-21-013771","doc":"f10k2020_griddynamics.htm","q":"Since its inception in 2006 in Menlo Park, California, as a grid and cloud consultancy firm, Grid Dynamics has been on the forefront of digital transformation, working on big ideas like cloud computing, NOSQL, DevOps, microservices, big dat\u2026"},{"fy":2021,"lvl":2,"n":13,"adsh":"0001628280-22-004939","doc":"gdyn-20211231.htm","q":"Our specialty is working on big ideas like cloud migrations, DevOps, microservices, big data and artificial intelligence (\u201cAI\u201d)."},{"fy":2022,"lvl":2,"n":13,"adsh":"0001628280-23-005637","doc":"gdyn-20221231.htm","q":"Our specialty is working on big ideas like cloud migrations, DevOps, microservices, big data and artificial intelligence (\u201cAI\u201d)."},{"fy":2023,"lvl":3,"n":57,"adsh":"0001628280-24-007971","doc":"gdyn-20231231.htm","q":"A key differentiator for Grid Dynamics is our 7+ years of experience and leadership in Enterprise artificial intelligence (\u201cAI\u201d), supported by profound expertise and ongoing investment in cloud, data, advanced analytics, and customer experi\u2026"},{"fy":2024,"lvl":3,"n":70,"adsh":"0001628280-25-008723","doc":"gdyn-20241231.htm","q":"A key differentiator for Grid Dynamics is our 8+ years of experience and leadership in enterprise artificial intelligence (\u201cAI\u201d), supported by profound expertise and ongoing investment in cloud, data, advanced analytics, and customer experi\u2026"},{"fy":2025,"lvl":3,"n":174,"adsh":"0001743725-26-000007","doc":"gdyn-20251231.htm","q":"(\u201cGrid Dynamics,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus,\u201d or \u201cour\u201d) is an Enterprise Artificial Intelligence (\u201cAI\u201d) transformation partner for the Fortune 1000."}]},{"cik":1743881,"name":"BRIDGEBIO PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-008260","doc":"bbio-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008969","doc":"bbio-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002030","doc":"bbio-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004145","doc":"bbio-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-018811","doc":"bbio-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":23,"adsh":"0000950170-25-024119","doc":"bbio-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":29,"adsh":"0001743881-26-000009","doc":"bbio-20251231.htm","q":"Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. 102 Table of Contents Artificial intelligence presents risks and challenges that can impact our b\u2026"}]},{"cik":1744659,"name":"AKERO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002798","doc":"akro-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003043","doc":"akro-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002052","doc":"akro-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008566","doc":"akro-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-022644","doc":"akro-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing security risks to our confidential information , proprietary information and personal data."},{"fy":2024,"lvl":3,"n":22,"adsh":"0000950170-25-029514","doc":"akro-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing security risks to our confidential information, proprietary information and personal data."}]},{"cik":1745020,"name":"THESEUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003216","doc":"thrx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003251","doc":"thrx-20221231x10k.htm","q":null}]},{"cik":1745999,"name":"BEAM THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013190","doc":"beam-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002166","doc":"beam-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004866","doc":"beam-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-020622","doc":"beam-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-026076","doc":"beam-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-065194","doc":"beam-20251231.htm","q":"Any of the above could have a material adverse effect on our business, financial condition, results of operations or prospects. 106 Artificial intelligence presents risks and challenges that can impact our business including by posing secur\u2026"}]},{"cik":1746214,"name":"BIOPLUS LIFE CORP.","industry":"Retail","sic":5912,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001493152-20-009844","doc":"form10-k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-21-026939","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-22-033768","doc":"form10-k.htm","q":null}]},{"cik":1746278,"name":"GOLOGIQ, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001746278-20-000002","doc":"f1219lovarra10k.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001746278-21-000016","doc":"f2020lovarra10k312020.htm","q":null},{"fy":2021,"lvl":"x","n":1,"adsh":"0001213900-22-019613","doc":"f10k2021_lovarra.htm","q":"Key initiatives include development of easy to use self-serve platforms for SMBs, and continued development of AI-driven marketing technologies."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001575872-23-000447","doc":"golq-20221231.htm","q":"Key initiatives include development of easy-to-use self-serve platforms for SMBs, and continued development of AI-driven marketing technologies."}]},{"cik":1746466,"name":"EQUILLIUM, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2018,"lvl":0,"n":0,"adsh":"0001564590-19-009580","doc":"eq-10k_20181231.htm","q":null},{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013207","doc":"eq-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015103","doc":"eq-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004407","doc":"eq-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009492","doc":"eq-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-035919","doc":"eq-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":3,"n":22,"adsh":"0000950170-25-045726","doc":"eq-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and healthcare models\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0001193125-26-124143","doc":"eq-20251231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"}]},{"cik":1746473,"name":"PLIANT THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013589","doc":"plrx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001746473-22-000010","doc":"plrx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001746473-23-000008","doc":"plrx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001746473-24-000043","doc":"plrx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001746473-25-000054","doc":"plrx-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001746473-26-000037","doc":"plrx-20251231.htm","q":"The administration and government agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to the use of artificial intelligence to review product applications."}]},{"cik":1747748,"name":"QUALTRICS INTERNATIONAL INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2021,"lvl":2,"n":7,"adsh":"0001628280-22-004535","doc":"xm-20211231.htm","q":"Instead, our XM Operating System is a single, secure, cloud-native platform that enables organizations to bring together all of their experience data, both structured and unstructured, analyze it with native advanced AI-powered analytics, a\u2026"},{"fy":2022,"lvl":2,"n":13,"adsh":"0001628280-23-005051","doc":"xm-20221231.htm","q":"In addition to using surveys to collect post-transaction feedback to monitor trends in satisfaction scores, our XM Platform enables organizations to bring together all of their experience data, both structured and unstructured, analyze it w\u2026"}]},{"cik":1748621,"name":"ALBERTON ACQUISITION CORP","industry":"Construction","sic":1700,"state":null,"cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-020254","doc":"f10k2020_albertonacq.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-013314","doc":"f10k2021_albertonacq.htm","q":null}]},{"cik":1748907,"name":"ORCHARD THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007353","doc":"ortx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010035","doc":"ortx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012325","doc":"ortx-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007708","doc":"ortx-20221231.htm","q":null}]},{"cik":1750019,"name":"TCR2 THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013856","doc":"tcrr-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013563","doc":"tcrr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004299","doc":"tcrr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009312","doc":"tcrr-20221231.htm","q":null}]},{"cik":1750149,"name":"INHIBIKASE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"DE","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005203","doc":"ikt-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-011133","doc":"ikt-20221231.htm","q":"Werner is a protein biochemist and structural biologist by training, enabling him and the team of principals and advisors we have assembled to develop and characterize a portfolio of novel c-Abl inhibitors and to rapidly determine their uti\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037160","doc":"ikt-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0000950170-25-046096","doc":"ikt-20241231.htm","q":"Should any of these events occur, they could have a material adverse effect on our business, prospects, financial condition and results of operations. 59 The use of new and evolving technologies, such as artificial intelligence, in our offe\u2026"},{"fy":2025,"lvl":3,"n":35,"adsh":"0001193125-26-126371","doc":"ikt-20251231.htm","q":"The use of new and evolving technologies, such as artificial intelligence, in our offerings may result in spending material resources and presents risks and challenges that can impact our business including by posing security and other risk\u2026"}]},{"cik":1750153,"name":"CANOO INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2020,"lvl":2,"n":5,"adsh":"0001558370-21-003823","doc":"goev-20201231x10k.htm","q":"Our proprietary Driver Monitoring System also utilizes state-of-the-art eye gaze tracking and machine learning to track a driver\u2019s focal point and attentiveness to deliver an alert only when most needed, e.g., when a driver is looking in th\u2026"},{"fy":2021,"lvl":1,"n":1,"adsh":"0001628280-22-004514","doc":"goev-20211231.htm","q":"As the founder and former CEO, Tony built Solera Holdings into a leader in vehicle lifecycle management software and services, with over 5 petabytes of data gathered through AI driven data and solutions."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001628280-23-009932","doc":"goev-20221231.htm","q":"As the founder and former CEO, Tony built Solera Holdings into a leader in vehicle lifecycle management software and services, with over 5 petabytes of data gathered through AI driven data and solutions."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-014075","doc":"goev-20231231.htm","q":"As the founder and former CEO, Tony built Solera Holdings into a leader in vehicle lifecycle management software and services, with over 5 petabytes of data gathered through AI driven data and solutions."}]},{"cik":1750284,"name":"OLEMA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001558370-22-002388","doc":"olma-20211231x10k.htm","q":"Inhibitors of CDK4/6, such as palbociclib, ribociclib and abemaciclib, used in combination with an AI or fulvestrant, led to significant increases in progression- free survival and overall survival."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001558370-23-003318","doc":"olma-20221231x10k.htm","q":"Inhibitors of CDK4/6, such as palbociclib, ribociclib and abemaciclib, used in combination with an AI or fulvestrant, led to significant increases in progression-free survival and overall survival."},{"fy":2023,"lvl":2,"n":13,"adsh":"0000950170-24-029281","doc":"olma-20231231.htm","q":"Inhibitors of CDK4/6, such as palbociclib, ribociclib and abemaciclib, used in combination with an AI or fulvestrant, led to significant increases in progression-free survival and overall survival."},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-041204","doc":"olma-20241231.htm","q":"Inhibitors of CDK4/6, such as palbociclib, ribociclib and abemaciclib, used in combination with an AI or fulvestrant, led to significant increases in progression-free survival and overall survival."},{"fy":2025,"lvl":3,"n":16,"adsh":"0001193125-26-107169","doc":"olma-20251231.htm","q":"CDK4/6 inhibitors, such as palbociclib, ribociclib, and abemaciclib, used in combination with an AI or fulvestrant, led to significant increases in progression-free survival and overall survival."}]},{"cik":1750384,"name":"CARECLIX HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001065949-21-000038","doc":"careclix10k2019.htm","q":null}]},{"cik":1751008,"name":"APPLOVIN CORP","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":11,"adsh":"0001751008-22-000005","doc":"app-20211231.htm","q":"Our Core Technologies consist of our AXON machine-learning recommendation engine, our App Graph, and our elastic cloud infrastructure."},{"fy":2022,"lvl":2,"n":11,"adsh":"0001751008-23-000006","doc":"app-20221231.htm","q":"The key elements of our solutions are delivered through the AppLovin Core Technologies and AppLovin Software Platform: \u2022 AppLovin Core Technologies : Our Core Technologies consist of our AXON machine-learning recommendation engine, our App \u2026"},{"fy":2023,"lvl":3,"n":47,"adsh":"0001751008-24-000012","doc":"app-20231231.htm","q":"Our software platform provides end-to-end software and artificial intelligence-powered (\"AI\") solutions for businesses to reach, monetize and grow their global audience (\"Software Platform\")."},{"fy":2024,"lvl":3,"n":61,"adsh":"0001751008-25-000018","doc":"app-20241231.htm","q":"We provide end-to-end artificial intelligence-powered (\"AI\") advertising solutions for businesses to reach, monetize and grow their global audience (\"Advertising\")."},{"fy":2025,"lvl":3,"n":65,"adsh":"0001751008-26-000010","doc":"app-20251231.htm","q":"We provide end-to-end artificial intelligence-powered (\"AI\") advertising solutions for businesses to reach, monetize and grow their global audience."}]},{"cik":1751299,"name":"KALEIDO BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-007969","doc":"kldo-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010420","doc":"kldo-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005256","doc":"kldo-20211231.htm","q":null}]},{"cik":1752474,"name":"KLDISCOVERY INC.","industry":"Software & IT services","sic":7370,"state":"MN","cells":[{"fy":2019,"lvl":1,"n":1,"adsh":"0001564590-20-013043","doc":"kld-10k_20191231.htm","q":"Finally, our experience and expertise in machine learning in eDiscovery positions us well to extend our archiving offering into the regulatory compliance intelligence market. 10 Data Recovery Services Data Recovery ."},{"fy":2020,"lvl":1,"n":1,"adsh":"0001564590-21-014159","doc":"kld-10k_20201231.htm","q":"Finally, our experience and expertise in machine learning in eDiscovery positions us well to extend our archiving offering into the regulatory compliance intelligence market."},{"fy":2021,"lvl":3,"n":31,"adsh":"0001564590-22-010868","doc":"kld-10k_20211231.htm","q":"We leverage our proprietary technology solutions and extensive industry expertise to provide a more reliable, secure and seamless experience for our clients when tackling \u201cbig data\u201d volume, velocity, and veracity challenges. 5 A key example\u2026"},{"fy":2022,"lvl":3,"n":23,"adsh":"0000950170-23-008474","doc":"kld-20221231.htm","q":"A key example of our purpose-built innovation is Nebula, our flagship, end-to-end artificial intelligence/machine learning, or AI/ML, powered solution that serves as a singular platform of engagement for legal data."},{"fy":2023,"lvl":3,"n":23,"adsh":"0000950170-24-038058","doc":"kldi-20231231.htm","q":"A key example of our purpose-built innovation is Nebula, our flagship, end-to-end artificial intelligence/machine learning, or AI/ML, powered solution that serves as a singular platform of engagement for legal data."}]},{"cik":1752828,"name":"CELULARITY INC","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-013228","doc":"f10k2020_gxacquisitioncorp.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-013004","doc":"celu-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011440","doc":"celu-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-087886","doc":"celu-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-009319","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-020424","doc":"form10-k.htm","q":null}]},{"cik":1752836,"name":"COVETRUS, INC.","industry":"Retail","sic":5912,"state":"ME","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001752836-20-000060","doc":"cvet_20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001752836-21-000041","doc":"cvet-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001752836-22-000018","doc":"cvet-20211231.htm","q":null}]},{"cik":1753391,"name":"TANCHENG GROUP CO., LTD.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001753391-19-000025","doc":"bigeon-10k-july312019.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001753391-20-000012","doc":"bigeon10kjuly312020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001753391-21-000010","doc":"bigeon10k2021.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001753391-22-000019","doc":"bigeon_form10k2022.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-001846","doc":"tancheng_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-001892","doc":"tancheng_i10k-123124.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-002488","doc":"tancheng_i10k-123125.htm","q":null}]},{"cik":1753931,"name":"SHENGDA NETWORK TECHNOLOGY, INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001165527-19-000160","doc":"g8746.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-021320","doc":"form10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-024032","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-22-030682","doc":"form10-ka.htm","q":null}]},{"cik":1753945,"name":"OPTI-HARVEST, INC.","industry":"Construction machinery","sic":3523,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":15,"adsh":"0001493152-23-012557","doc":"form10-k.htm","q":"Opti-View is a proprietary and highly sophisticated AI and machine learning based system that integrates data from our own suite of sensors with data streams from strategic partners."}]},{"cik":1754068,"name":"KALARIS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-005652","doc":"alvr-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001075","doc":"alvr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002830","doc":"alvr-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-031879","doc":"alvr-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":23,"adsh":"0000950170-25-035143","doc":"alvr-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact AlloVir\u2019s business including by posing security risks to its confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-110659","doc":"klrs-20251231.htm","q":null}]},{"cik":1755237,"name":"CYCLERION THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001104659-20-032554","doc":"tm206168d1_10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008434","doc":"cycn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001958","doc":"cycn-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-009223","doc":"cycn-20221231.htm","q":"In this open-label, single-arm study of the oral, once-daily sGC stimulator in eight adults aged 18 or older with MELAS, improvements were seen across a range of endpoints reflecting multiple domains of disease activity, including mitochond\u2026"},{"fy":2023,"lvl":2,"n":5,"adsh":"0000950170-24-025935","doc":"cycn-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of other evolving threats, including, but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify\u2026"},{"fy":2024,"lvl":"x","n":5,"adsh":"0000950170-25-032037","doc":"cycn-20241231.htm","q":"We and the third parties upon which we rely may be subject to a variety of other evolving threats, including, but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify\u2026"},{"fy":2025,"lvl":"x","n":5,"adsh":"0001193125-26-132193","doc":"cycn-20251231.htm","q":"We and the third parties upon which we rely may be subject to a variety of other evolving threats, including, but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify\u2026"}]},{"cik":1757499,"name":"SHUTTLE PHARMACEUTICALS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-007686","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-010822","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-008300","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":3,"n":33,"adsh":"0001493152-26-014131","doc":"form10-k.htm","q":"Business On November 21, 2025, we acquired substantially all of the assets and liabilities of Molecule.ai, a pharmaceutical software company building an artificial intelligence (\u201cAI\u201d) driven platform for molecular discovery and early-stage \u2026"}]},{"cik":1757932,"name":"ROMEO POWER, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2020,"lvl":1,"n":2,"adsh":"0001104659-21-050862","doc":"rmo-20201231x10k.htm","q":"By using machine learning, we can maximize our customers\u2019 fleet efficiency, providing our customers with a key competitive advantage over their competitors."},{"fy":2021,"lvl":1,"n":1,"adsh":"0001757932-22-000019","doc":"rmo-20211231.htm","q":"By using machine learning, we can maximize our customers\u2019 fleet efficiency, providing our customers with a key competitive advantage over their competitors."}]},{"cik":1758009,"name":"QUANTUM COMPUTING INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2018,"lvl":"x","n":27,"adsh":"0001213900-19-005062","doc":"f10k2018_quantumcomputing.htm","q":"Our Company QCI focuses on quantum computing and artificial intelligence software development."},{"fy":2019,"lvl":"x","n":14,"adsh":"0001213900-20-007719","doc":"f10k2019_quantumcomputing.htm","q":"Government initiatives in quantum computing and AI, including grants and funding, that are fostering U.S. innovation in those domains."},{"fy":2020,"lvl":2,"n":9,"adsh":"0001213900-21-016296","doc":"f10k2020_quantumcomputing.htm","q":"The ability to solve NP-complete problems in a reasonable period of time is of particular interest in compute-heavy fields that include, but are not limited to: big data, artificial intelligence, healthcare, and cybersecurity."},{"fy":2021,"lvl":2,"n":7,"adsh":"0001213900-22-012564","doc":"f10k2021_quantumcomp.htm","q":"The ability to solve NP-complete problems in a reasonable period of time is of particular interest in compute-heavy fields that include, but are not limited to: big data, artificial intelligence, healthcare, and cybersecurity."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001213900-23-024218","doc":"f10k2022_quantumcomp.htm","q":"While quantum computing is generally still used mainly at universities and laboratories for research and science experiments, a larger user community is emerging, demanding greater capabilities from quantum systems, leading to frustration a\u2026"},{"fy":2023,"lvl":3,"n":18,"adsh":"0001213900-24-028799","doc":"ea0202448-10k_quantum.htm","q":"In addition to our photonic computing platform, we have leveraged QCi\u2019s core technology to demonstrate powerful quantum sensing use cases in LIDAR (Light Detection and Ranging), reservoir computing (a form of neural network that can be used\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001213900-25-025561","doc":"ea0234742-10k_quantum.htm","q":"The recent emergence of artificial intelligence, large language models, and machine learning algorithms has added to the need for efficient processing of vast volumes of data."},{"fy":2025,"lvl":3,"n":19,"adsh":"0001213900-26-022417","doc":"ea0278445-10k_quantum.htm","q":"The recent emergence of artificial intelligence (\u201cAI\u201d), large language models (\u201cLLMs\u201d), and machine learning (\u201cML\u201d) algorithms has added to the need for efficient processing of vast volumes of data."}]},{"cik":1758057,"name":"LUMINAR TECHNOLOGIES, INC./DE","industry":"Auto manufacturing","sic":3714,"state":"FL","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-006908","doc":"lazr-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001628280-22-004366","doc":"lazr-20211231.htm","q":"She previously served on the board of directors of Nuance Communications, a technology pioneer and market leader in conversational artificial intelligence and ambient clinical intelligence, from 1999 to 2018."},{"fy":2022,"lvl":2,"n":6,"adsh":"0001628280-23-005649","doc":"lazr-20221231.htm","q":"In 2022, Daimler and Scale.AI, in 2021, Daimler and Volvo and in 2020, Volvo accounted for more than 10% of our annual revenue."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001628280-24-007616","doc":"lazr-20231231.htm","q":"Our Order Book as of the date of this filing consists of greater than 25 vehicle lines and commercial programs, including 20+ consumer production vehicle lines across automakers; the remaining including commercial programs with customers in\u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0001628280-25-015432","doc":"lazr-20241231.htm","q":"The U.S. restriction on the export of certain AI chips and support in the CHIPS and Sciences Act for sponsoring domestic semiconductor development, U.S. restrictions on purchasing of certain Chinese LiDAR technology, Chinese restrictions on\u2026"},{"fy":2025,"lvl":2,"n":6,"adsh":"0001140361-26-011477","doc":"ef20067963-10k.htm","q":"Abrams also previously served as the chief financial officer of K Health, an AI-driven growth stage healthcare company."}]},{"cik":1758699,"name":"TRANSUITE.ORG INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2021,"lvl":"x","n":2,"adsh":"0001758699-22-000005","doc":"transuite10k.htm","q":null},{"fy":2022,"lvl":"x","n":2,"adsh":"0001758699-23-000004","doc":"report10k_30nov2022.htm","q":null},{"fy":2023,"lvl":"x","n":2,"adsh":"0001758699-24-000012","doc":"trso_10k30nov2023.htm","q":null},{"fy":2024,"lvl":"x","n":41,"adsh":"0001640334-25-000412","doc":"trans_10k.htm","q":"TRSO is actively building an AI-driven ecosystem that integrates advanced AI translation systems, innovative AI applications, and intelligent device management platforms."},{"fy":2025,"lvl":"x","n":14,"adsh":"0001640334-26-000952","doc":"trso_10k.htm","q":"During the year ended December 31, 2025, the Company generated revenue from its AI-Driven Ecosystem Product Planning consulting service of $115,000 and the Company\u2019s wholly owned subsidiary Solan (Shenzhen) Technology Co., Ltd. recognized o\u2026"}]},{"cik":1759138,"name":"CABALETTA BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-013929","doc":"caba-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-013329","doc":"caba-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010726","doc":"caba-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008298","doc":"caba-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034422","doc":"caba-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-047201","doc":"caba-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":33,"adsh":"0001759138-26-000011","doc":"caba-20251231.htm","q":"Attempts to disrupt or gain unauthorized access to our and our third-party vendors\u2019 information systems from malicious third parties or insider threats may be enhanced or facilitated by evolving technologies, including artificial intelligen\u2026"}]},{"cik":1759186,"name":"COEPTIS THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-23-001850","doc":"coeptis_i10k-123122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-24-001685","doc":"coeptis_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":3,"adsh":"0001683168-25-001942","doc":"coeptis_i10k-123124.htm","q":"This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency."}]},{"cik":1759425,"name":"MIRUM PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-010471","doc":"mirm-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011756","doc":"mirm-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003229","doc":"mirm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006715","doc":"mirm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-032289","doc":"mirm-20231231.htm","q":"We and the third parties upon which we rely may be subject to a variety of threats, including but not limited to errors or malfeasance by our personnel or the personnel of the third parties, malware (including as a result of advanced persis\u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001759425-25-000014","doc":"mirm-20241231.htm","q":"We also publish privacy policies, marketing materials and other statements, such as statements related to compliance with certain certifications or self-regulatory principles, concerning artificial intelligence, data privacy and security."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001759425-26-000013","doc":"mirm-20251231.htm","q":"We also publish privacy policies, marketing materials and other statements, such as statements related to compliance with certain certifications or self-regulatory principles, concerning artificial intelligence, data privacy and security."}]},{"cik":1759546,"name":"NU RIDE INC.","industry":"Auto manufacturing","sic":3711,"state":"NY","cells":[{"fy":2020,"lvl":1,"n":3,"adsh":"0001558370-21-003449","doc":"ride-20201231x10k.htm","q":"Kowitz has served as the President and Chief Executive Officer of ClinMunications LLC, a leading artificial intelligence communications provider serving the largest hospitals, since November 2017."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002265","doc":"ride-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002862","doc":"ride-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002081","doc":"ride-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-001195","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-013005","doc":"0001493152-26-013005.txt","q":null}]},{"cik":1759631,"name":"HYLIION HOLDINGS CORP.","industry":"Auto manufacturing","sic":3713,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-011788","doc":"f10k2020_hyliionholdings.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001759631-22-000014","doc":"hyln-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001759631-23-000011","doc":"hyln-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001759631-24-000015","doc":"hyln-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001759631-25-000051","doc":"hyln-20241231.htm","q":"Additional growth drivers include the widespread adoption of automation, artificial intelligence, expanding data centers and the electrification of transportation."},{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-011278","doc":"hyln-20251231.htm","q":"Additional growth drivers include the widespread adoption of automation, artificial intelligence, expanding data centers and the electrification of transportation."}]},{"cik":1760542,"name":"HOOKIPA PHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002928","doc":"hook-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003176","doc":"hook-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004211","doc":"hook-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003778","doc":"hook-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0001558370-24-003738","doc":"hook-20231231x10k.htm","q":"Our employees and personnel use generative artificial intelligence (\u201cAI\u201d) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy obl\u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0001558370-25-001853","doc":"hook-20241231x10k.htm","q":"Other states are considering and may adopt similar laws. 109 Table of Contents Our employees and personnel use generative artificial intelligence (\u201cAI\u201d) technologies to perform their work, and the disclosure and use of personal data in gene\u2026"}]},{"cik":1760683,"name":"EAST STONE ACQUISITION CORP","industry":"Software & IT services","sic":7370,"state":"MA","cells":[{"fy":2020,"lvl":2,"n":6,"adsh":"0001213900-21-031720","doc":"f10kt2020_eaststone.htm","q":"Insurtech incorporates AI and online-to-offline (O2O) integration by tapping into casualty P&C homogeneous-like auto insurance and health insurance segments."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-020136","doc":"f10k2021_eaststone.htm","q":null}]},{"cik":1761612,"name":"BICYCLE THERAPEUTICS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002278","doc":"bcyc-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002758","doc":"bcyc-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002457","doc":"bcyc-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002238","doc":"bcyc-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001558370-24-001324","doc":"bcyc-20231231x10k.htm","q":"We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially r\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0001558370-25-001438","doc":"bcyc-20241231x10k.htm","q":"Other states are considering and may adopt similar laws. \u200b Our employees and personnel may use generative artificial intelligence technologies to perform their work, and the disclosure and use of personal data in generative artificial intel\u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001104659-26-028971","doc":"bcyc-20251231x10k.htm","q":"Other states have passed, are considering, and may adopt similar laws. \u200b Our employees and personnel use generative artificial intelligence technologies to perform their work, and the disclosure and use of personal data in generative artifi\u2026"}]},{"cik":1761918,"name":"ERASCA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004557","doc":"eras-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009496","doc":"eras-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000950170-24-037193","doc":"eras-20231231.htm","q":"We supplement our medicinal chemistry efforts with fragment screens and machine learning approaches."},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-042682","doc":"eras-20241231.htm","q":"Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives, \u2026"},{"fy":2025,"lvl":3,"n":23,"adsh":"0001193125-26-104150","doc":"eras-20251231.htm","q":"Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives, \u2026"}]},{"cik":1763950,"name":"LANTERN PHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2020,"lvl":3,"n":95,"adsh":"0001213900-21-014576","doc":"f10k2020_lanternpharma.htm","q":"Business Overview We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (\u201cA.I.\u201d), machine learning and genomic data to streamline the drug development process and to identify the patients that will ben\u2026"},{"fy":2021,"lvl":3,"n":87,"adsh":"0001213900-22-011581","doc":"f10k2021_lanternpharma.htm","q":"Business Overview We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (\u201cA.I.\u201d), machine learning and genomic data to streamline the drug development process and to identify the patients that will ben\u2026"},{"fy":2022,"lvl":3,"n":90,"adsh":"0001493152-23-008241","doc":"form10-k.htm","q":"Business Overview We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (\u201cA.I.\u201d), machine learning and genomic data to streamline the drug development process and to identify the patients that will ben\u2026"},{"fy":2023,"lvl":3,"n":89,"adsh":"0001493152-24-010302","doc":"form10-k.htm","q":"Business Overview We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (\u201cA.I.\u201d), machine learning and biomarker data to streamline the drug development process and to identify the patients that will b\u2026"},{"fy":2024,"lvl":3,"n":102,"adsh":"0001641172-25-000926","doc":"form10-k.htm","q":"Business Overview We are an artificial intelligence (A.I.) focused company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development."},{"fy":2025,"lvl":3,"n":124,"adsh":"0001493152-26-013612","doc":"form10-k.htm","q":"Business Overview We are an artificial intelligence (A.I.) focused company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development."}]},{"cik":1764013,"name":"IMMUNOVANT, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0000950123-20-006444","doc":"d919375d10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001764013-21-000052","doc":"imvt-20210331.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001764013-22-000059","doc":"imvt-20220331.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001764013-23-000065","doc":"imvt-20230331.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001764013-24-000109","doc":"imvt-20240331.htm","q":"Additionally, our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with the use of generative AI technologies by our employees, personnel, or vendors, even if such use is not authorized by us or \u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0001764013-25-000092","doc":"imvt-20250331.htm","q":"These actions include, for example, (1) directives to reduce agency workforce and cut programs; (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and health\u2026"}]},{"cik":1764925,"name":"SLACK TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":1,"n":2,"adsh":"0001764925-21-000050","doc":"work-20210131.htm","q":"Finally, the content on Slack is available through powerful search and discovery tools, powered by machine learning, which improve through usage. \u2022 Slack helps organizations improve culture and employees\u2019 feelings of empowerment."}]},{"cik":1764974,"name":"TURNSTONE BIOLOGICS CORP.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034974","doc":"tsbx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-047111","doc":"tsbx-20241231.htm","q":null}]},{"cik":1765048,"name":"GUOCHUN INTERNATIONAL INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001765048-20-000003","doc":"report10charmt.htm","q":null},{"fy":2020,"lvl":"x","n":0,"adsh":"0001765048-21-000003","doc":"charmt10-kdecember312020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001765048-22-000004","doc":"charmt10k2021.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001765048-23-000003","doc":"chmt10k_2022.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001765048-24-000010","doc":"gcgj10k_31december2023.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001765048-25-000016","doc":"gcgjreport10k_2024.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001765048-26-000009","doc":"gcgjform10k_2025.htm","q":null}]},{"cik":1766140,"name":"UNICYCIVE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016384","doc":"f10k2021_unicycivethera.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024901","doc":"f10k2022_unicycive.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-027202","doc":"ea0202007-10k_unicy.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-025828","doc":"ea0235049-10k_unicycive.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-035903","doc":"ea0281982-10k_unicycive.htm","q":"While there are more than 10,000 total prescribers of phosphate lowering therapies (PLTs), our data shows that the approximately 2,100 highest prescribers are responsible for half of the prescriptions written for PLTs annually. \u25cf Specialty \u2026"}]},{"cik":1766352,"name":"CARRIER EQ, LLC","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2019,"lvl":"x","n":9,"adsh":"0001553350-20-000047","doc":"airfox_10k.htm","q":"Overview BanQi is a digital banking application capable of leveraging machine learning capabilities to build alternative, smartphone-based credit risk models."},{"fy":2020,"lvl":2,"n":9,"adsh":"0001553350-21-000027","doc":"airfox_10k.htm","q":"Our wallet application, banQi is a digital banking application capable of leveraging machine learning capabilities to build alternative, smartphone-based credit risk models. banQi, available on Android and iOS, aims to eliminate the need fo\u2026"},{"fy":2021,"lvl":"x","n":3,"adsh":"0001553350-22-000052","doc":"airfox_10k-093021.htm","q":"The wallet application, banQi is a digital banking application capable of leveraging machine learning capabilities to build alternative, smartphone-based credit risk models. banQi, available on Android and iOS, aims to eliminate the need fo\u2026"}]},{"cik":1768012,"name":"GOLDEN NUGGET ONLINE GAMING, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-044733","doc":"tm211156d1_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003693","doc":"gnog-20211231x10k.htm","q":null}]},{"cik":1768224,"name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011037","doc":"arct-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-009872","doc":"arct-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007832","doc":"arct-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010380","doc":"arct-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-031156","doc":"arct-20231231.htm","q":"Our existing competitors and new market entrants may respond more quickly to or integrate new or emerging technologies such as artificial intelligence and machine learning, undertake more extensive marketing campaigns, have greater access t\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-034787","doc":"arct-20241231.htm","q":"Our existing competitors and new market entrants may respond more quickly to or integrate new or emerging technologies such as artificial intelligence and machine learning, undertake more extensive marketing campaigns, have greater access t\u2026"},{"fy":2025,"lvl":3,"n":17,"adsh":"0001193125-26-088391","doc":"arct-20251231.htm","q":"High-resolution computed tomography (HRCT) lung scans analyzed using FDA 510(k)-cleared AI technology, revealed reductions in mucus burden in four of six Class I CF participants."}]},{"cik":1768267,"name":"CERENCE INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2020,"lvl":3,"n":16,"adsh":"0001564590-20-054595","doc":"crnc-10k_20200930.htm","q":"Overview Cerence builds AI powered virtual assistants for the mobility/transportation market."},{"fy":2021,"lvl":2,"n":13,"adsh":"0001564590-21-057931","doc":"crnc-10k_20210930.htm","q":"Overview Cerence builds AI powered virtual assistants for the mobility/transportation market."},{"fy":2022,"lvl":2,"n":13,"adsh":"0000950170-22-025785","doc":"crnc-20220930.htm","q":"Overview Cerence builds AI powered virtual assistants for the mobility/transportation market."},{"fy":2023,"lvl":3,"n":39,"adsh":"0000950170-23-066654","doc":"crnc-20230930.htm","q":"Overview Cerence builds AI powered virtual assistants for the mobility/transportation market."},{"fy":2024,"lvl":3,"n":45,"adsh":"0000950170-24-130642","doc":"crnc-20240930.htm","q":"Overview Cerence builds AI powered virtual assistants for the mobility/transportation market."},{"fy":2025,"lvl":3,"n":71,"adsh":"0001628280-25-053372","doc":"crnc-20250930.htm","q":"Overview Cerence builds conversational and agentic AI solutions that make interaction with technology feel effortless."}]},{"cik":1768446,"name":"CLIMB BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0000950170-22-002998","doc":"elym-20211231.htm","q":"The extrasynaptic \u03b14, \u03b16 and \u00df2/3 and d subunit-containing GABA A Rs mediate tonic inhibition, potentially generating a more powerful and broader modulation of cortical neural-network activity that is relevant in multiple CNS disease states\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-006279","doc":"elym-20221231.htm","q":"S-1 333-257980 2.2 July 16, 2021 2.3 Agreement and Plan of Merger and Reorganization, dated October 15, 2020, by and among the Registrant, Athena Merger Sub Inc., Athenen Therapeutics, Inc., AI ETI LLC, as Eliem Representative and Adam Rose\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-038023","doc":"elym-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-044350","doc":"clym-20241231.htm","q":"In the ordinary course of our business, we may collect, store, use, transmit, disclose, or otherwise process proprietary, confidential, and sensitive data, including personal data (such as health-related data), intellectual property, and tr\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-092546","doc":"clym-20251231.htm","q":"In the ordinary course of our business, we may collect, store, use, transmit, disclose, or otherwise process proprietary, confidential, and sensitive data, including personal data (such as health-related data), intellectual property, and tr\u2026"}]},{"cik":1769628,"name":"COREWEAVE, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2025,"lvl":3,"n":275,"adsh":"0001769628-26-000104","doc":"crwv-20251231.htm","q":"Business Overview CoreWeave is The Essential Cloud for AI TM , purpose-built to accelerate breakthroughs by AI pioneers, from leading research labs to enterprises fueling business growth."}]},{"cik":1770069,"name":"MAPLIGHT THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":32,"adsh":"0001193125-26-125072","doc":"mplt-20251231.htm","q":"In addition, use of artificial intelligence or machine learning technology is subject to evolving laws and regulations, including obligations to mitigate risks of bias and anti-discrimination."}]},{"cik":1770121,"name":"SANA BIOTECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010539","doc":"sana-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001564590-23-003798","doc":"sana-10k_20221231.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0000950170-24-023119","doc":"sana-20231231.htm","q":"Further, our personnel, and those of any third parties involved in our operations, including vendors, service providers, collaborators, contractors, and consultants, may develop and use artificial intelligence technologies in the course of \u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-040254","doc":"sana-20241231.htm","q":"Further, our personnel, and those of any third parties involved in our operations, including vendors, service providers, collaborators, contractors, and consultants, may develop and use artificial intelligence technologies in the course of \u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001193125-26-088215","doc":"sana-20251231.htm","q":"This risk may be exacerbated by the availability and continued development and evolution of artificial intelligence and machine learning technologies (AI Technologies), which may enable threat actors to use more sophisticated means to damag\u2026"}]},{"cik":1771515,"name":"GROCERY OUTLET HOLDING CORP.","industry":"Retail","sic":5411,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001771515-20-000005","doc":"go-20191228.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001771515-21-000009","doc":"go-20210102.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001771515-22-000011","doc":"go-20220101.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001771515-23-000009","doc":"go-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001771515-24-000016","doc":"go-20231230.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001771515-25-000017","doc":"go-20241228.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001771515-26-000015","doc":"go-20260103.htm","q":null}]},{"cik":1771706,"name":"VIREO GROWTH INC.","industry":"Pharma & biotech","sic":2834,"state":"MN","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003583","doc":"gdnsf-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-005294","doc":"gdnsf-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004519","doc":"gdnsf-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002130","doc":"vreof-20241231xex19.htm","q":"A l t h o u gh t he V i c e P r e s i d e n t of I n v e s tor R e l a t i o n s , t he Vi c e P r e s i d e n t of C o m m u ni c at i o ns or s u c h ot h er e m p l o y ee of t h e C orpora t i o n a c t i ng i n a s i m il ar r o l e a \u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-029561","doc":"vreof-20251231x10k.htm","q":null}]},{"cik":1771910,"name":"ADC THERAPEUTICS SA","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-010843","doc":"adc-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001628280-25-015131","doc":"adc-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":8,"adsh":"0001628280-26-016491","doc":"adc-20251231.htm","q":"Artificial intelligence As a result of the broad-scale release and availability of Artificial Intelligence (AI) technologies, such as generative AI, there is a global trend towards more regulation (e.g., the EU AI Act and AI laws passed in \u2026"}]},{"cik":1771917,"name":"KARUNA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-012311","doc":"krtx-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-008416","doc":"krtx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001855","doc":"krtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003929","doc":"krtx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":7,"adsh":"0000950170-24-018395","doc":"0000950170-24-018395.txt","q":null}]},{"cik":1772028,"name":"SCOPUS BIOPHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001104659-21-043355","doc":"tm219286d1_10k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-22-000947","doc":"scps-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001410578-23-000666","doc":"scps-20221231x10k.htm","q":null}]},{"cik":1772695,"name":"SUNNOVA ENERGY INTERNATIONAL INC.","industry":"Utilities","sic":4931,"state":"TX","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001772695-20-000016","doc":"a2019form10-kdocument.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001772695-21-000022","doc":"a12344345-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001772695-22-000011","doc":"nova-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001772695-23-000011","doc":"nova-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001772695-24-000008","doc":"nova-20231231.htm","q":"Cyberattacks, including those leveraging artificial intelligence, are becoming more sophisticated and include, but are not limited to, malicious software, attempts to gain unauthorized access to data and other electronic security breaches t\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001772695-25-000020","doc":"nova-20241231.htm","q":"Cyberattacks, including those leveraging artificial intelligence, are becoming more sophisticated and include malicious software, attempts to gain unauthorized access to data and other electronic security breaches that could lead to disrupt\u2026"}]},{"cik":1772720,"name":"SPRUCE POWER HOLDING CORP","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-019311","doc":"f10k2020_xlfleetcorp.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-010097","doc":"f10k2021_xlfleetcorp.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-009917","doc":"xl1-20221231.htm","q":null}]},{"cik":1772720,"name":"SPRUCE POWER HOLDING CORP","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-015334","doc":"spru-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001628280-25-015702","doc":"spru-20241231.htm","q":"Information technology systems are a critical component of our long-term competitive strategy, and if we fail to timely and responsibly implement, adopt, and innovate in response to rapidly evolving technological developments, including the\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001628280-26-022506","doc":"spru-20251231.htm","q":"Information technology systems are a critical component of our long-term competitive strategy, and if we fail to timely and responsibly implement, adopt, and innovate in response to rapidly evolving technological developments, including the\u2026"}]},{"cik":1773383,"name":"DYNATRACE, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2019,"lvl":"x","n":28,"adsh":"0001773383-20-000053","doc":"dynatrace10-kfy20.htm","q":"Our platform utilizes artificial intelligence at its core and continuous automation to provide answers, not just data, about the performance of applications, the underlying hybrid cloud infrastructure, and the experience of our customers\u2019 u\u2026"},{"fy":2020,"lvl":3,"n":21,"adsh":"0001773383-21-000054","doc":"dt-20210331.htm","q":"The Dynatrace \u00ae platform leverages an automatic instrumentation technology called OneAgent \u00ae , a real-time dependency mapping system called SmartScape \u00ae , our transaction-centric code analysis technology called PurePath \u00ae , and an open arti\u2026"},{"fy":2021,"lvl":2,"n":8,"adsh":"0001773383-22-000053","doc":"dt-20220331.htm","q":"Dynatrace \u00ae provides out-of-the-box configuration for the leading cloud platforms, such as AWS, Azure, Google Cloud Platform, Red Hat OpenShift, VMware Tanzu, and SAP, as well as coverage for traditional on-premises systems, including mainf\u2026"},{"fy":2022,"lvl":3,"n":15,"adsh":"0001773383-23-000055","doc":"dt-20230331.htm","q":"Our Dynatrace \u00ae platform combines the only fully unified end-to-end solution for comprehensive observability and continuous runtime application security together with advanced artificial intelligence (\u201cAI\u201d) for IT operations (\u201cAIOps\u201d) to pr\u2026"},{"fy":2023,"lvl":3,"n":55,"adsh":"0001773383-24-000076","doc":"dt-20240331.htm","q":"Dynatrace offers the only end-to-end platform that combines broad and deep observability and continuous runtime application security with advanced artificial intelligence (\u201cAI\u201d) for IT operations to provide answers and intelligent automatio\u2026"},{"fy":2024,"lvl":3,"n":84,"adsh":"0001773383-25-000065","doc":"dt-20250331.htm","q":"By leveraging AI-powered insights, Dynatrace enables organizations to analyze, automate, and innovate faster to drive their business forward."}]},{"cik":1773427,"name":"SPRINGWORKS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CT","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-002563","doc":"swtx-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-001708","doc":"swtx-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001773427-22-000011","doc":"swtx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001773427-23-000010","doc":"swtx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001773427-24-000010","doc":"swtx-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001773427-25-000010","doc":"swtx-20241231.htm","q":"The use of new and evolving technologies, such as artificial intelligence, in our business may result in spending material resources and presents risks and challenges that can impact our business including by posing security and other risks\u2026"}]},{"cik":1774155,"name":"BTRS HOLDINGS INC.","industry":"Software & IT services","sic":7371,"state":"NJ","cells":[{"fy":2020,"lvl":2,"n":6,"adsh":"0001140361-21-009706","doc":"brhc10021993_10k.htm","q":"Our software also performs granular data analysis, delivering smart recommendations while our artificial intelligence (\u201cAI\u201d)-assisted data weighting and scoring increases accuracy."},{"fy":2021,"lvl":2,"n":8,"adsh":"0001774155-22-000033","doc":"brts-20211231.htm","q":"The machine learning capabilities and rules engine within our SaaS platform continuously evolve to solve order-to-cash challenges and deliver a higher rate of touchless transactions."}]},{"cik":1774675,"name":"SKILLSOFT CORP.","industry":"Software & IT services","sic":7372,"state":"NH","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-035775","doc":"tm211072d1_10k.htm","q":null},{"fy":2021,"lvl":"x","n":8,"adsh":"0001558370-22-005527","doc":"skil-20220131x10k.htm","q":"The Company\u2019s award-winning, AI-driven, immersive learning platform, Percipio, is purpose built to make learning easier, more accessible, and more effective."},{"fy":2022,"lvl":2,"n":6,"adsh":"0001437749-23-010319","doc":"skil20230206_10k.htm","q":"Skillsoft Compliance offers: \u25cf Scalability to reach a global audience \u25cf Subject matter expertise \u25cf Continuously added and updated content \u25cf Availability anytime, anywhere 3 Table of Contents SKILLSOFT PERCIPIO PLATFORM Skillsoft\u2019s advanced \u2026"},{"fy":2023,"lvl":3,"n":57,"adsh":"0001437749-24-012054","doc":"skil20240131_10k.htm","q":"Additionally, we utilize modern and innovative technologies - including generative Artificial Intelligence (\"GenAI\") - across our solutions to address new and emerging customer needs and to differentiate ourselves in the market."},{"fy":2024,"lvl":3,"n":86,"adsh":"0001437749-25-011912","doc":"skil20250131_10k.htm","q":"Powered by artificial intelligence (\"AI\") and strengthened by a broad ecosystem of partners, the Skillsoft platform helps customers solve some of today\u2019s most complex business challenges including bridging skill gaps, improving talent reten\u2026"}]},{"cik":1774857,"name":"AARDVARK THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":17,"adsh":"0001193125-26-119770","doc":"ck0001774857-20251231.htm","q":"These actions and proposals may, for example, include directives: (1) reducing agency workforce and cutting programs; (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMNI, to\u2026"}]},{"cik":1776111,"name":"MBX BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"IN","cells":[{"fy":2024,"lvl":3,"n":32,"adsh":"0000950170-25-039838","doc":"mbx-20241231.htm","q":"The use of new and evolving technologies, such as artificial intelligence (\"AI\") in our operations may require us to expend material resources and may present risks and challenges that can impact our business including by posing security an\u2026"},{"fy":2025,"lvl":3,"n":44,"adsh":"0001193125-26-103121","doc":"mbx-20251231.htm","q":"Our internal computer and information technology systems and those of our current and any future third-party vendors, collaborators, contractors, consultants or other third parties, are vulnerable to damage or interruption from, among other\u2026"}]},{"cik":1777921,"name":"AVEPOINT, INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2020,"lvl":1,"n":1,"adsh":"0001213900-21-014139","doc":"f10k2020_apextechnology.htm","q":"His thematic areas of focus include Machine Learning, Big Data, Cybersecurity, Internet of Things, Autonomous Logistics, Data Analytics, Cloud Computing, Personal/Mobile Commerce, FinTech, and Enterprise Software."},{"fy":2021,"lvl":1,"n":2,"adsh":"0001437749-22-007895","doc":"avpt20211231_10k.htm","q":"The intelligence engine driving the Confidence Platform ensures continuing value for customers by using AI to maximize relevant data, providing insights, automating operations, and enabling our Control, Fidelity, and Resilience software sui\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-008808","doc":"avpt20221231_10k.htm","q":null},{"fy":2023,"lvl":3,"n":23,"adsh":"0001437749-24-006145","doc":"avpt20231231_10k.htm","q":"In addition, many organizations are beginning to realize the potential of generative artificial intelligence (\u201c AI \u201d) to drive competitive advantage and value creation, including (1) extracting greater value from complex datasets, (2) makin\u2026"},{"fy":2024,"lvl":3,"n":32,"adsh":"0001437749-25-005526","doc":"avpt20241231_10k.htm","q":"In a world where data is sprawling across hybrid work environments and generative artificial intelligence (\u201c AI \u201d) technologies are rapidly emerging, AvePoint stands out with its platform-first strategy."},{"fy":2025,"lvl":3,"n":65,"adsh":"0001437749-26-005907","doc":"avpt20251231_10k.htm","q":"Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as they adopt cloud collaboration and artificial intelligence (\" AI \")-driven advanced tools and workfl\u2026"}]},{"cik":1777946,"name":"IRONNET, INC.","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2021,"lvl":"x","n":18,"adsh":"0000950170-22-006874","doc":"irnt-20220131.htm","q":"IronDefense is an NDR cybersecurity product that uses artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), behavioral analytics, and operational tradecraft expertise to quickly identify specific network behaviors or events indicative of\u2026"},{"fy":2022,"lvl":3,"n":16,"adsh":"0000950170-23-022530","doc":"irnt-20230131.htm","q":"The platform uses IronDefense\u2019s artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d), behavioral analytics, and operational tradecraft expertise to quickly identify specific network behaviors or events indicative of malicious threats."}]},{"cik":1779474,"name":"WM TECHNOLOGY, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001140361-21-007696","doc":"brhc10021071_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001779474-22-000010","doc":"maps-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001779474-23-000023","doc":"maps-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001779474-24-000023","doc":"maps-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0001779474-25-000007","doc":"maps-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001779474-26-000013","doc":"maps-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1781174,"name":"ACRIVON THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-010331","doc":"acrv-20221231.htm","q":"The data are highly structured and amenable to machine learning, which has enabled us to create a streamlined process and to integrate all the analytical steps into a single workflow."},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-037618","doc":"acrv-20231231.htm","q":"The data are highly structured and amenable to machine learning, which has enabled us to create a streamlined process and to integrate all the analytical steps into a single workflow."},{"fy":2024,"lvl":3,"n":24,"adsh":"0000950170-25-046056","doc":"acrv-20241231.htm","q":"Our AP3 Interactome, a proprietary, computational analytics platform driven by Generative Phosphoproteomics machine learning has been developed by us for integrated comprehensive analyses across all large, in-house AP3 phosphoproteomic drug\u2026"},{"fy":2025,"lvl":3,"n":27,"adsh":"0001193125-26-115123","doc":"acrv-20251231.htm","q":"The platform is comprised of a growing suite of powerful, internally developed tools, including the AP3 Interactome, the AP3 Kinase Substrate Relationship Predictor, the AP3 Data Portal, designed to enable the conversion of multimodal data \u2026"}]},{"cik":1781405,"name":"ODYSSEY SEMICONDUCTOR TECHNOLOGIES, INC.","industry":"Computers & chips","sic":3674,"state":"NY","cells":[{"fy":2019,"lvl":"x","n":0,"adsh":"0001731122-20-000606","doc":"e1949_10k.htm","q":null},{"fy":2020,"lvl":"x","n":1,"adsh":"0001731122-21-000549","doc":"e2552_10k.htm","q":"Ogawa currently also serves on the board of directors of Amesite Inc., an SEC reporting company in the artificial intelligence software industry, since February 2018."},{"fy":2021,"lvl":"x","n":2,"adsh":"0001731122-22-000641","doc":"e3601_10-k.htm","q":"Edmunds has also been serving as the interim part-time Chief Financial Officer of Mythic Inc., a late stage private artificial intelligence semiconductor company called in Redwood City, California."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001731122-23-000547","doc":"e4533_10k.htm","q":"Edmunds has also been serving as the interim part-time Chief Financial Officer of Mythic Inc., a late stage private artificial intelligence semiconductor company called in Redwood City, California."}]},{"cik":1781629,"name":"ANKAM, INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001781629-23-000004","doc":"ankam10k_2022.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001781629-24-000005","doc":"ankm_10k2023.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-001603","doc":"ankam_i10k-113024.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-001925","doc":"ankam_i10k-113025.htm","q":null}]},{"cik":1781983,"name":"APREA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001558370-20-003257","doc":"apre-20191231x10k.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003083","doc":"apre-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003671","doc":"apre-20211231x10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001558370-23-005126","doc":"apre-20221231x10k.htm","q":"This integrated proteomic, genomic and machine learning approach is designed to identify response factors that both participate in the molecular response to drug treatment and are highly mutated in cancers."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001558370-24-003886","doc":"apre-20231231x10k.htm","q":"This integrated proteomic, genomic and machine learning approach is designed to identify response factors that both participate in the molecular response to drug treatment and are highly mutated in cancers."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001558370-25-003588","doc":"apre-20241231x10k.htm","q":"This integrated proteomic, genomic and machine learning approach is designed to identify response factors that both participate in the molecular response to drug treatment and are highly mutated in cancers."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-028068","doc":"apre-20251231x10k.htm","q":null}]},{"cik":1782107,"name":"ONCONETIX, INC.","industry":"Pharma & biotech","sic":2834,"state":"OH","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-018635","doc":"f10k2022_bluewater.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001213900-24-032225","doc":"ea0201701-10k_onconetix.htm","q":"Singh was the President and CEO of BioImagene, a company specializing in AI-based Cancer Diagnostics, based in California."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001213900-25-049687","doc":"ea0244122-10k_onconetix.htm","q":"Fedasz worked with various clients, including a not-for-profit and an early-stage artificial intelligence and data-driven health and wellness tracker."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001213900-26-027725","doc":"ea0280547-10k_onconetix.htm","q":"Fedasz worked with various clients, including a not-for-profit and an early-stage artificial intelligence and data-driven health and wellness tracker."}]},{"cik":1782223,"name":"PYXIS ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004850","doc":"pyxs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009046","doc":"pyxs-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034868","doc":"pyxs-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-040771","doc":"pyxs-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-118532","doc":"pyxs-20251231.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to the use of artificial intelligence to review product applications."}]},{"cik":1782303,"name":"BOUNDLESS BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-045725","doc":"bold-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-097543","doc":"bold-20251231.htm","q":null}]},{"cik":1783032,"name":"ELEVATION ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002715","doc":"elev-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003247","doc":"elev-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002535","doc":"elev-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002397","doc":"elev-20241231x10k.htm","q":null}]},{"cik":1783183,"name":"PHATHOM PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011712","doc":"phat-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-016682","doc":"phat-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002536","doc":"phat-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":14,"adsh":"0000950170-23-004875","doc":"phat-20221231.htm","q":"These tests revealed trace levels of a nitrosamine impurity, N -nitroso-vonoprazan, or NVP, that is not described within the FDA guidance document entitled \u201cControl of Nitrosamine Impurities in Human Drugs \u2013 Guidance for Industry.\u201d In Janua\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-027910","doc":"phat-20231231.htm","q":"The complete response letters formalized the FDA\u2019s prior request that we provide additional stability data to demonstrate that levels of NVP will remain at or below 96 ng/day, the acceptable daily intake level (AI) for NVP established by th\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-034183","doc":"phat-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":14,"adsh":"0001193125-26-073379","doc":"phat-20251231.htm","q":null}]},{"cik":1783317,"name":"MCAFEE CORP.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":2,"n":13,"adsh":"0001564590-21-009891","doc":"mcfe-10k_20201226.htm","q":"The platform is continuously enriched by artificial intelligence, machine learning and the telemetry gathered from over one billion sensors across our consumer, enterprise, and government customer base."},{"fy":2021,"lvl":3,"n":22,"adsh":"0000950170-22-001804","doc":"mcfe-20211225.htm","q":"We have a differentiated ability to secure the consumers\u2019 digital experience against cyberthreats, using our proprietary advanced artificial intelligence and machine learning capabilities combined with our real-time threat intelligence that\u2026"}]},{"cik":1783328,"name":"TSCAN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003175","doc":"tcrx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006589","doc":"tcrx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-026875","doc":"tcrx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-033077","doc":"tcrx-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-089884","doc":"tcrx-20251231.htm","q":"Bad actors around the world use increasingly sophisticated methods, including the use of artificial intelligence, to engage in illegal activities involving the theft and misuse of personal information, confidential information and intellect\u2026"}]},{"cik":1784168,"name":"FORUM MERGER III CORP","industry":"Auto manufacturing","sic":3711,"state":"FL","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-019197","doc":"f10k2020_forummerger3.htm","q":null}]},{"cik":1784535,"name":"PORCH GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003776","doc":"prch-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003720","doc":"prch-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004016","doc":"prch-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001784535-24-000019","doc":"prch-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001784535-25-000011","doc":"prch-20241231.htm","q":"If we do not keep pace with evolving online, market and industry trends, including the introduction of new and enhanced digital devices, use of artificial intelligence (\u201cAI\u201d), and changes in the preferences and needs of consumers and servic\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0001784535-26-000008","doc":"prch-20251231.htm","q":"We may be attacked by perpetrators of malicious technology-related events, including related to the use of AI, such as the use of botnets, malware or other destructive or disruptive software, distributed denial of service attacks, phishing,\u2026"}]},{"cik":1784567,"name":"HARBOR CUSTOM DEVELOPMENT, INC.","industry":"Construction","sic":1531,"state":"WA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007553","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001784567-22-000011","doc":"hcdi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001784567-23-000033","doc":"hcdi-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011935","doc":"form10-k.htm","q":null}]},{"cik":1784570,"name":"BETA TECHNOLOGIES, INC.","industry":"Aerospace & defense","sic":3721,"state":"VT","cells":[{"fy":2025,"lvl":3,"n":28,"adsh":"0001628280-26-015838","doc":"bta-20251231.htm","q":"This system enables end-to-end visibility and control over their electric aircraft fleets, including real-time flight monitoring and charging infrastructure management, AI-powered predictive maintenance and network planning and battery heal\u2026"}]},{"cik":1785173,"name":"89BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2019,"lvl":0,"n":0,"adsh":"0001564590-20-011636","doc":"etnb-10k_20191231.htm","q":null},{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015214","doc":"etnb-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011706","doc":"etnb-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007929","doc":"etnb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-024008","doc":"etnb-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-029243","doc":"etnb-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."}]},{"cik":1785279,"name":"METAGENOMI THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":35,"adsh":"0000950170-25-040217","doc":"mgx-20241231.htm","q":"Our platform combines artificial intelligence (\u201cAI\u201d), ancestral state reconstruction, and proprietary algorithms run on expansive cloud computing infrastructure to identify novel clustered regularly interspaced short palindromic repeat (\u201cCR\u2026"},{"fy":2025,"lvl":3,"n":41,"adsh":"0001193125-26-093976","doc":"mgx-20251231.htm","q":"We leverage machine learning and artificial intelligence to enhance our signature gene editing systems."}]},{"cik":1785345,"name":"LANDOS BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"VA","cells":[{"fy":2021,"lvl":2,"n":6,"adsh":"0000950170-22-004559","doc":"labp-20211231.htm","q":"We leverage our proprietary advanced artificial intelligence-based integrated computational and experimental precision medicine platform, our LANCE platform, to identify novel therapeutic targets based on predictions of immunometabolic func\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-009334","doc":"labp-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-034438","doc":"labp-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"}]},{"cik":1785493,"name":"RHINO BITCOIN INC.","industry":"Construction","sic":1700,"state":"FL","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001493152-20-020196","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-028105","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-22-029798","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-23-038585","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-24-044955","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-25-022052","doc":"form10-k.htm","q":null}]},{"cik":1785530,"name":"WEREWOLF THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001785530-22-000014","doc":"howl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001785530-23-000009","doc":"howl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001785530-24-000012","doc":"howl-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001785530-25-000008","doc":"howl-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001785530-26-000006","doc":"howl-20251231.htm","q":"The administration and agencies have also made abrupt announcements about new or changed regulatory policies, such as policies related to use of artificial intelligence to review product applications."}]},{"cik":1785592,"name":"LEAFLY HOLDINGS, INC. /DE","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-061630","doc":"f10k2020a2_meridamerger1.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-008014","doc":"lfly-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010402","doc":"lfly-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-039515","doc":"lfly-20231231.htm","q":"From time to time, third parties have copied information from our platform, through website scraping, artificial intelligence or other means, and publish or aggregate it with other information for their own benefit."},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-047893","doc":"lfly-20241231.htm","q":"From time to time, third parties have copied information from our platform, through website scraping, artificial intelligence or other means, and publish or aggregate it with other information for their own benefit."}]},{"cik":1786205,"name":"ARCELLX, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":2,"n":12,"adsh":"0000950170-23-010610","doc":"aclx-20221231.htm","q":"We are also integrating AI-powered discovery and computational tools to expand the applicability of our platforms."},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-022048","doc":"aclx-20231231.htm","q":"We are also integrating AI-powered discovery and computational tools to expand the applicability of our platforms."},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-029150","doc":"aclx-20241231.htm","q":"We are also integrating AI-powered discovery and computational tools to expand the applicability of our platforms."},{"fy":2025,"lvl":3,"n":33,"adsh":"0001193125-26-076876","doc":"aclx-20251231.htm","q":"We are also integrating AI-powered discovery and computational tools to expand the applicability of our platforms."}]},{"cik":1786255,"name":"ICOSAVAX, INC.","industry":"Pharma & biotech","sic":2836,"state":"WA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005064","doc":"icvx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010983","doc":"icvx-20221231.htm","q":null}]},{"cik":1786352,"name":"BILL HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":3,"n":25,"adsh":"0001564590-20-041865","doc":"bill-10k_20200630.htm","q":"Our purpose-built, artificial-intelligence (AI)-enabled financial software platform creates seamless connections between our customers, their suppliers, and their clients."},{"fy":2021,"lvl":3,"n":21,"adsh":"0001564590-21-046383","doc":"bill-10k_20210630.htm","q":"Our purpose-built, artificial-intelligence (AI)-enabled financial software platform creates seamless connections between our customers, their suppliers, and their clients."},{"fy":2022,"lvl":3,"n":17,"adsh":"0001786352-22-000017","doc":"bill-20220630.htm","q":"Bill.com's purpose-built, artificial-intelligence (AI)-enabled financial software platform creates seamless connections between our customers, their suppliers, and their clients."},{"fy":2023,"lvl":3,"n":30,"adsh":"0001786352-23-000054","doc":"bill-20230630.htm","q":"BILL's purpose-built, artificial intelligence (AI)-enabled financial software platform creates seamless connections between our customers, their suppliers, and their clients."},{"fy":2024,"lvl":3,"n":37,"adsh":"0001786352-24-000035","doc":"bill-20240630.htm","q":"BILL's purpose-built, artificial intelligence (AI)-enabled financial software platform creates seamless connections between our customers, their suppliers, and their clients."},{"fy":2025,"lvl":3,"n":58,"adsh":"0001786352-25-000037","doc":"bill-20250630.htm","q":"BILL's purpose-built, artificial intelligence (AI)-enabled financial software platform creates seamless connections between our customers, their suppliers, and their clients."}]},{"cik":1786471,"name":"APTERA MOTORS CORP","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-013581","doc":"form10-k.htm","q":null}]},{"cik":1787297,"name":"PASSAGE BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-002287","doc":"pasg-20201231x10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002719","doc":"pasg-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002833","doc":"pasg-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002310","doc":"pasg-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002101","doc":"pasg-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-022549","doc":"pasg-20251231x10k.htm","q":null}]},{"cik":1787306,"name":"ARCUTIS BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001628280-21-002272","doc":"arqt-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001787306-22-000009","doc":"arqt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001787306-23-000023","doc":"arqt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001787306-24-000031","doc":"arqt-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0001787306-25-000029","doc":"arqt-20241231.htm","q":"Key elements of our cybersecurity risk management program include but are not limited to the following: \u2022 risk assessments designed to help identify material risks from cybersecurity threats to our critical systems and information; \u2022 a secu\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001787306-26-000018","doc":"arqt-20251231.htm","q":"We depend on our information technology systems, and any failure of these systems, including due to the use of artificial intelligence (AI), or those of our CROs or other contractors or consultants we may utilize, could harm our business."}]},{"cik":1787400,"name":"NKARTA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015517","doc":"nktx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004095","doc":"nktx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008523","doc":"nktx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034735","doc":"nktx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-045262","doc":"nktx-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":14,"adsh":"0001787400-26-000006","doc":"nktx-20251231.htm","q":"Further, generative artificial intelligence (\"AI\") resources that are publicly available present a risk that our employees, consultants, contractors or collaborators may inadvertently obtain, incorporate or use a third party\u2019s intellectual \u2026"}]},{"cik":1788028,"name":"JASPER THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-013592","doc":"f10k2021_jaspertherap.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-018542","doc":"f10k2022_jaspertherap.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-020114","doc":"f10k2023_jaspertherap.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0001213900-25-018384","doc":"ea0231788-10k_jasper.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001213900-26-036426","doc":"ea0282128-10k_jasper.htm","q":"Our employees and personnel may use generative artificial intelligence technologies to perform their work, and the disclosure and use of personal data in generative artificial intelligence technologies is subject to various privacy laws and\u2026"}]},{"cik":1788999,"name":"XPERI INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2022,"lvl":3,"n":16,"adsh":"0000950170-23-006053","doc":"xper-20221231.htm","q":"\u201cSmart\u201d devices have created attractive opportunities to deliver personalized content discovery and highly differentiated experiences in the car, on par with consumers\u2019 home media devices. \u2022 New Use Cases for Edge AI Computing : Artificial \u2026"},{"fy":2023,"lvl":3,"n":16,"adsh":"0000950170-24-023915","doc":"xper-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":41,"adsh":"0000950170-25-029159","doc":"xper-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":108,"adsh":"0001193125-26-076849","doc":"xper-20251231.htm","q":null}]},{"cik":1789029,"name":"AEVA TECHNOLOGIES, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-014857","doc":"f10k2020_interprivateacq.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002379","doc":"aeva-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009764","doc":"aeva-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-032299","doc":"aeva-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-042849","doc":"aeva-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-116518","doc":"aeva-20251231.htm","q":null}]},{"cik":1789330,"name":"MJ HARVEST, INC.","industry":"Construction machinery","sic":3523,"state":"NV","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001721868-20-000407","doc":"f2smjhi10k091020.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001721868-21-000609","doc":"f2smjhi10k090821.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001903596-22-000606","doc":"sfsmjhi10k092122.htm","q":null}]},{"cik":1789769,"name":"INSTIL BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001789769-22-000008","doc":"til-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001789769-23-000035","doc":"til-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001789769-24-000036","doc":"til-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001789769-25-000017","doc":"til-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMMI, to consider new payment and healthcare models\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001789769-26-000019","doc":"til-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly difficult to identify as fake, and phishi\u2026"}]},{"cik":1789972,"name":"CULLINAN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004002","doc":"cgem-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006839","doc":"cgem-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-031143","doc":"cgem-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-028346","doc":"cgem-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":38,"adsh":"0001193125-26-099362","doc":"cgem-20251231.htm","q":"Regulations regarding the use and development of artificial intelligence (\u201cAI\u201d) are being introduced in various jurisdictions globally."}]},{"cik":1790169,"name":"FLORA GROWTH CORP.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001477932-23-002112","doc":"flora_10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001062993-24-007367","doc":"form10k.htm","q":"Taylor has served as the Chairman of NetraMark Holdings Inc., a Canadian publicly traded AI health technology company trading under the symbol \"AIAI.\" Previously, Mr."},{"fy":2024,"lvl":0,"n":0,"adsh":"0001062993-25-006145","doc":"form10k.htm","q":null}]},{"cik":1790340,"name":"IMMUNEERING CORP","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":2,"n":6,"adsh":"0001558370-22-003208","doc":"imrx-20211231x10k.htm","q":"Leveraging our computational biology expertise to develop machine learning algorithms to detect patterns across biological data and find subgroups based on distinct patterns."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001558370-23-002905","doc":"imrx-20221231x10k.htm","q":"Unlike some algorithms or artificial intelligence, or AI, approaches, the results originating from DCT are designed to be interpretable from a computational and biological perspective."},{"fy":2023,"lvl":2,"n":5,"adsh":"0001790340-24-000024","doc":"imrx-20231231.htm","q":"Unlike some algorithms or artificial intelligence (\"AI\") approaches, the results originating from DCT are designed to be interpretable from a computational and biological perspective."},{"fy":2024,"lvl":2,"n":5,"adsh":"0001790340-25-000042","doc":"imrx-20241231.htm","q":"Unlike some algorithms or artificial intelligence (\"AI\") approaches, the results originating from DCT are designed to be interpretable from a computational and biological perspective."},{"fy":2025,"lvl":2,"n":12,"adsh":"0001790340-26-000042","doc":"imrx-20251231.htm","q":"Unlike some algorithms or artificial intelligence (\"AI\") approaches, the results originating from DCT are designed to be interpretable from a computational and biological perspective."}]},{"cik":1792044,"name":"VIATRIS INC","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001792044-21-000009","doc":"vtrs-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001792044-22-000010","doc":"vtrs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001792044-23-000008","doc":"vtrs-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":11,"adsh":"0001792044-24-000008","doc":"vtrs-20231231.htm","q":"In addition, AI-based solutions, including generative AI, are increasingly being used in the pharmaceutical industry, including by us, and we expect to use other systems and tools that incorporate AI-based technologies in the future."},{"fy":2024,"lvl":2,"n":11,"adsh":"0001792044-25-000008","doc":"vtrs-20241231.htm","q":"In addition, AI-based solutions, including generative AI, are increasingly being used in the pharmaceutical industry, including by us, and we expect to use other systems and tools that incorporate AI-based technologies in the future."},{"fy":2025,"lvl":3,"n":22,"adsh":"0001792044-26-000013","doc":"vtrs-20251231.htm","q":"Incorporating ML, AI and other emerging technologies into our products, services and operations may result in legal and regulatory risks, reputational harm or have other adverse consequences to our business, financial condition or results o\u2026"}]},{"cik":1792581,"name":"KIROMIC BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2020,"lvl":3,"n":15,"adsh":"0001558370-21-003774","doc":"krbp-20201231x10k.htm","q":"We are a target discovery and gene-editing company utilizing artificial intelligence and our proprietary neural network platform with a therapeutic focus on immuno-oncology."},{"fy":2021,"lvl":3,"n":19,"adsh":"0001558370-22-005217","doc":"krbp-20211231x10k.htm","q":"(together with its subsidiaries, \u201cwe,\u201d \u201cus,\u201d \u201cour\u201d or the \u201cCompany\u201d) is an artificial intelligence (\u201cAI\u201d) driven, end-to-end allogenic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits t\u2026"},{"fy":2022,"lvl":3,"n":17,"adsh":"0001558370-23-006085","doc":"krbp-20221231x10k.htm","q":"(together with its subsidiaries, \u201cwe,\u201d \u201cus,\u201d \u201cour\u201d or the \u201cCompany\u201d) is an artificial intelligence (\u201cAI\u201d) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits \u2026"},{"fy":2023,"lvl":2,"n":14,"adsh":"0001558370-24-003520","doc":"krbp-20231231x10k.htm","q":"The Company is an allogeneic Gamma Delta T-cell therapy company featuring unique, proprietary end-to-end bioinformatic, AI targeting, and manufacturing technologies to address solid tumors."},{"fy":2024,"lvl":"x","n":14,"adsh":"0001437749-25-004000","doc":"krbp20241231_10k.htm","q":"We are an allogeneic Gamma Delta T-cell therapy company featuring unique, proprietary end-to-end bioinformatic, AI targeting and manufacturing technologies to address solid tumors."}]},{"cik":1793294,"name":"PPD, INC.","industry":"Pharma & biotech","sic":8731,"state":"NC","cells":[{"fy":2020,"lvl":1,"n":1,"adsh":"0001793294-21-000009","doc":"ppdi-20201231.htm","q":"Hill contributes to our Board his substantial experience in healthcare technologies, in particular technologies related to the use of data and machine learning in the biopharmaceutical industry."}]},{"cik":1794515,"name":"ZOOMINFO TECHNOLOGIES INC.","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2020,"lvl":2,"n":10,"adsh":"0001794515-21-000061","doc":"zi-20201231.htm","q":"We are able to deliver high-quality intelligence at scale by leveraging an artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) powered engine that gathers data from millions of sources in real time and standardizes, matches to entiti\u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001794515-22-000015","doc":"zi-20211231.htm","q":"We are able to deliver high-quality intelligence at scale by leveraging an artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) powered engine that gathers data from millions of sources in real time and standardizes, matches to entiti\u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0001794515-23-000034","doc":"zi-20221231.htm","q":"We are able to deliver high-quality intelligence at scale by leveraging an artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) powered engine that gathers data from millions of sources and standardizes, matches to entities, verifies,\u2026"},{"fy":2023,"lvl":3,"n":37,"adsh":"0001794515-24-000016","doc":"zi-20231231.htm","q":"In OperationsOS, our sales operations customers use a suite of products, services, and solutions to ingest, match, enrich, and connect data feeds into multiple systems. 1 Table of Contents We are able to deliver high-quality intelligence at\u2026"},{"fy":2024,"lvl":3,"n":60,"adsh":"0001794515-25-000045","doc":"zi-20241231.htm","q":"Our go-to-market intelligence platform empowers businesses with AI-ready insights, trusted data, and advanced automation providing sales, marketing, operations, and recruiting professionals accurate information and insights on the organizat\u2026"},{"fy":2025,"lvl":3,"n":104,"adsh":"0001794515-26-000012","doc":"zi-20251231.htm","q":"Our go-to-market intelligence platform empowers businesses with AI-ready insights, trusted data, agent-assisted selling and advanced automation providing sales, marketing, operations, and recruiting professionals accurate information and in\u2026"}]},{"cik":1794621,"name":"QUANERGY SYSTEMS, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-355252","doc":"d257921d10ka.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001193125-22-092660","doc":"d280005d10ka.htm","q":"Signore served as Chief Marketing Officer of FixStream Network, Inc., an AI software company."}]},{"cik":1794905,"name":"CYXTERA TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001794905-22-000022","doc":"cyxt-20211231.htm","q":"Enterprise Bare Metal offers the best of all worlds \u2013 rapid access to high-performance compute power to solve for even the most bandwidth-intensive AI and ML workloads, the ability to rapidly scale up and down in accordance with business re\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001794905-23-000010","doc":"cyxt-20221231.htm","q":"Enterprise Bare Metal offers the best of all worlds \u2013 rapid access to high-performance compute power to solve for even the most bandwidth-intensive AI and ML workloads, the ability to rapidly scale up and down in accordance with business re\u2026"}]},{"cik":1795091,"name":"OS THERAPIES INC","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-026238","doc":"ea0235597-10k_ostherap.htm","q":null},{"fy":2025,"lvl":"x","n":11,"adsh":"0001213900-26-036629","doc":"ea0283146-10k_ostherap.htm","q":"Use of artificial intelligence, machine learning and algorithmic tools involves risks that could materially and adversely affect our business, results of operations and development timelines."}]},{"cik":1796129,"name":"VINCERX PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-089563","doc":"d132337d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-087454","doc":"d418334d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-082258","doc":"d470783d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001193125-24-081994","doc":"d739497d10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001193125-25-065487","doc":"d789305d10k.htm","q":null}]},{"cik":1796209,"name":"API GROUP CORP","industry":"Construction","sic":1700,"state":"MN","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014986","doc":"apg-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002474","doc":"apg-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005456","doc":"apg-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-007573","doc":"apg-20231231.htm","q":null}]},{"cik":1796280,"name":"ORIC PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014865","doc":"oric-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004239","doc":"oric-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008483","doc":"oric-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0000950170-24-029298","doc":"oric-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":7,"adsh":"0000950170-25-022273","doc":"oric-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":22,"adsh":"0001193125-26-064005","doc":"oric-20251231.htm","q":null}]},{"cik":1797336,"name":"OLD AYALA, INC","industry":"Pharma & biotech","sic":2836,"state":"DE","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-092589","doc":"d119472d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-015423","doc":"f10k2021_ayalapharma.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024952","doc":"f10k2022_oldayalainc.htm","q":null}]},{"cik":1797768,"name":"KINNATE BIOPHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-011381","doc":"brhc10035646_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001140361-23-011846","doc":"brhc10049535_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001140361-24-016132","doc":"ef20015360_10k.htm","q":null}]},{"cik":1798749,"name":"JADE BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-008189","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001798749-23-000015","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001798749-24-000015","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-003750","doc":"avte-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":15,"adsh":"0001193125-26-096550","doc":"ck0001798749-20251231.htm","q":"We may be unable in the future to detect vulnerabilities in our information technology systems because threat actors are becoming increasingly sophisticated in using techniques and tools \u2013 including artificial intelligence \u2013 that circumvent\u2026"}]},{"cik":1799332,"name":"GAN LTD","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-010132","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-012201","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-009759","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001493152-25-010404","doc":"form10-k.htm","q":null}]},{"cik":1799448,"name":"ALIGOS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014872","doc":"algs-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003365","doc":"algs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007033","doc":"algs-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-029953","doc":"algs-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":9,"adsh":"0000950170-25-035929","doc":"algs-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":13,"adsh":"0001193125-26-092614","doc":"algs-20251231.htm","q":null}]},{"cik":1799788,"name":"GREENWICH LIFESCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001493152-21-007532","doc":"form10-k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-007377","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-010284","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-014625","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-004819","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-026651","doc":"form10-k.htm","q":null}]},{"cik":1799850,"name":"RENOVACOR, INC.","industry":"Pharma & biotech","sic":2836,"state":"CT","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004543","doc":"rcor-20211231.htm","q":null}]},{"cik":1800227,"name":"IAC INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001800227-21-000004","doc":"iaci-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001800227-22-000007","doc":"iaci-20211231.htm","q":"Through iTranslate , subscribers can connect and communicate across numerous languages, and Grammatica provides AI-powered writing assistant services, including grammar, spelling and punctuation checks."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001800227-23-000009","doc":"iaci-20221231.htm","q":"In addition, if there are changes in the usage and functioning of search engines and/or decreases in consumer use of search engines, for example, as a result of the continued development of artificial intelligence technology, this could neg\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0001800227-24-000011","doc":"iaci-20231231.htm","q":"In addition, if there are changes in the usage and functioning of search engines or decreases in consumer use of search engines, for example, as a result of the continued development of artificial intelligence technology, this could negativ\u2026"},{"fy":2024,"lvl":3,"n":18,"adsh":"0001800227-25-000013","doc":"iaci-20241231.htm","q":"Licensing and other revenue include symbolic licenses, which include direct-to-retail product partnerships based on Dotdash Meredith's brands, and functional licenses, which consist of content use and distribution relationships, including u\u2026"},{"fy":2025,"lvl":3,"n":41,"adsh":"0001628280-26-009997","doc":"iaci-20251231.htm","q":"Content licensing royalties are earned from our relationship with AppleNews+ as well as other content use and distribution relationships, including utilization in large-language models and other artificial intelligence (\u201cAI\") related activi\u2026"}]},{"cik":1800315,"name":"DAMORA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015916","doc":"glto-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-005569","doc":"glto-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006807","doc":"glto-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-028610","doc":"glto-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-041981","doc":"glto-20241231.htm","q":"Additionally, developments in artificial intelligence and machine learning provide threat actors with the capability to use more sophisticated means to attack our systems and may exacerbate cybersecurity risk."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-115922","doc":"dmra-20251231.htm","q":"The proposals are intended to improve patient safety and public health through appropriate regulatory oversight, improve the traceability of medical devices, improve the regulation of the rules governing software and AI as medical devices a\u2026"}]},{"cik":1800392,"name":"MICROALGO INC.","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001829126-22-006763","doc":"venusacquisition_10k.htm","q":null},{"fy":2022,"lvl":3,"n":30,"adsh":"0001829126-23-002347","doc":"microalgo_10k.htm","q":"For more information on how we provide services to our customers, please see \u201cBusiness\u2014Our Business Model.\u201d In addition, due to the versatility of our central processing algorithm solutions and our proven commitment to research and developm\u2026"}]},{"cik":1800667,"name":"JFROG LTD","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-041470","doc":"d98623d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001123","doc":"frog-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-002329","doc":"frog-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":38,"adsh":"0000950170-24-015873","doc":"frog-20231231.htm","q":"We enable organizations to build and release software faster and more securely while empowering developers, security teams and Machine Learning Operations (MLOps) teams to be more efficient."},{"fy":2024,"lvl":3,"n":117,"adsh":"0000950170-25-021340","doc":"frog-20241231.htm","q":"Our goal is to function as the single source of truth for an organization\u2019s software footprint, bridging digital gaps between developers, security teams, machine learning engineers, data scientists, and other business units to empower a wor\u2026"},{"fy":2025,"lvl":3,"n":187,"adsh":"0001193125-26-051382","doc":"frog-20251231.htm","q":"Business Overview JFrog\u2019s goal is to provide a system of record for the software supply chain in the Artificial Intelligence (\u201cAI\u201d) era."}]},{"cik":1801602,"name":"SPRINGBIG HOLDINGS, INC.","industry":"Software & IT services","sic":7371,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-009138","doc":"brhc10034870_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001801602-23-000028","doc":"wdq-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-013998","doc":"wdq-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001013762-25-003507","doc":"ea0230282-10k_springbig.htm","q":"On March 17, 2025, the Company announced the intent to acquire VICE CRM, an AI-enabled performance marketing platform designed to optimize return on investment for consumer marketing campaigns in highly regulated industries, and the appoint\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-034944","doc":"ea0276062-10k_springbig.htm","q":"NOTE 6 \u2013 GOODWILL On July 31, 2025, the Company completed the acquisition of VICE CRM, an AI-enabled performance marketing platform designed to optimize return on investment for consumer marketing campaigns in highly regulated industries."}]},{"cik":1801777,"name":"APPLIED MOLECULAR TRANSPORT INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014378","doc":"amti-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-006698","doc":"amti-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001801777-23-000017","doc":"amti-20221231.htm","q":null}]},{"cik":1802255,"name":"GUARDIAN PHARMACY SERVICES, INC.","industry":"Retail","sic":5912,"state":"GA","cells":[{"fy":2024,"lvl":"x","n":1,"adsh":"0001193125-25-064082","doc":"d830848d10k.htm","q":"It also leverages artificial intelligence and barcode scanning software to detect the correct National Drug Code number (or NDC) and size, shape, and color of pills in order to help flag problems for our pharmacies."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-102172","doc":"d16111d10k.htm","q":"It also leverages artificial intelligence and barcode scanning software to detect the correct National Drug Code number (or NDC) and size, shape, and color of pills in order to help flag problems for our pharmacies."}]},{"cik":1802665,"name":"HARMONY BIOSCIENCES HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015274","doc":"hrmy-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002257","doc":"hrmy-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-001574","doc":"hrmy-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-001466","doc":"hrmy-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001441","doc":"hrmy-20241231x10k.htm","q":null},{"fy":2025,"lvl":3,"n":28,"adsh":"0001104659-26-018859","doc":"hrmy-20251231x10k.htm","q":"Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, \u2026"}]},{"cik":1802749,"name":"LIGHTNING EMOTORS, INC.","industry":"Auto manufacturing","sic":3711,"state":"CO","cells":[{"fy":2020,"lvl":1,"n":3,"adsh":"0001564590-21-017109","doc":"gik-10k_20201231.htm","q":"He was also the co-founder of Cognizer, a software company specializing in deep-learning powered natural language artificial intelligence, and was the Executive Chairman of Cognizer\u2019s board of directors from its inception in December 2018 u\u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004767","doc":"zev-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001802749-23-000023","doc":"zev-20221231.htm","q":null}]},{"cik":1802768,"name":"ROYALTY PHARMA PLC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001802768-21-000006","doc":"rprx-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001802768-22-000011","doc":"rprx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001802768-23-000007","doc":"rprx-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001802768-24-000012","doc":"rprx-20231231.htm","q":"In addition, the use of artificial intelligence-based software (including machine learning) is increasingly being used in our industry."},{"fy":2024,"lvl":2,"n":10,"adsh":"0001802768-25-000010","doc":"rprx-20241231.htm","q":"If these information technology systems suffer severe damage or disruption and the issues are not resolved in a timely manner, our business, financial condition or operations could be adversely affected. 43 In addition, the use of artificia\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001802768-26-000003","doc":"rprx-20251231.htm","q":"General Risk Factors Cybersecurity vulnerabilities, failures in information systems or risks associated with the use of artificial intelligence could result in information theft, data corruption and significant disruption of our business op\u2026"}]},{"cik":1803696,"name":"XPERI HOLDING CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2020,"lvl":3,"n":20,"adsh":"0001564590-21-009444","doc":"xper-10k_20201231.htm","q":"The Product segment consists primarily of licensing our internally-developed audio, digital radio, imaging, edge-based machine learning and multi-channel video user experience (\u201cUX\u201d) solutions."},{"fy":2021,"lvl":2,"n":11,"adsh":"0001564590-22-006778","doc":"xper-10k_20211231.htm","q":"Content-first and AI-powered, it\u2019s the one place for all of today\u2019s amazing TV shows, movies, sports and more across live, recorded, on-demand and streaming TV."}]},{"cik":1804585,"name":"NUGENEREX IMMUNO-ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001607062-20-000307","doc":"ngio073120form10k.htm","q":null}]},{"cik":1804591,"name":"23ANDME HOLDING CO.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":2,"adsh":"0000950170-22-010852","doc":"me-20220331.htm","q":"We analyze this data using our proprietary machine learning and other analytic techniques in order to discover insights into whether and how particular genetic variants affect the likelihood of individuals developing specific diseases."},{"fy":2022,"lvl":1,"n":4,"adsh":"0000950170-23-024232","doc":"me-20230331.htm","q":"We analyze this data using our proprietary machine learning and other analytic techniques in order to discover insights into whether and how particular genetic variants affect the likelihood of individuals developing specific diseases."},{"fy":2023,"lvl":3,"n":27,"adsh":"0001804591-24-000038","doc":"me-20240331.htm","q":"We analyze these data using our machine learning and other analytic techniques in order to discover new biological insights."},{"fy":2024,"lvl":3,"n":29,"adsh":"0001628280-25-030786","doc":"mehcq-20250331.htm","q":"We analyze these data using our machine learning and other analytic techniques in order to discover new biological insights."}]},{"cik":1805087,"name":"GELESIS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-143392","doc":"cpsr-20211123x10ka.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-041326","doc":"gls-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010349","doc":"gls-20221231.htm","q":null}]},{"cik":1805387,"name":"CEREVEL THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":3,"n":27,"adsh":"0001564590-21-015106","doc":"cere-10k_20201231.htm","q":"Due to our understanding of the specificity and dynamic range of neural networks and how to modulate them, we believe that our product candidates have the potential to achieve optimal therapeutic activity while minimizing unintended side ef\u2026"},{"fy":2021,"lvl":3,"n":26,"adsh":"0000950170-22-002516","doc":"cere-20211231.htm","q":null},{"fy":2022,"lvl":3,"n":25,"adsh":"0000950170-23-003777","doc":"cere-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-021078","doc":"cere-20231231.htm","q":null}]},{"cik":1805521,"name":"FARADAY FUTURE INTELLIGENT ELECTRIC INC.","industry":"Auto manufacturing","sic":3711,"state":"NY","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-019210","doc":"f10k2020_propertysolution.htm","q":null},{"fy":2021,"lvl":3,"n":23,"adsh":"0001628280-22-014386","doc":"ffie-20211231.htm","q":"Technology FF\u2019s technology innovations include its proprietary Variable Platform Architecture (\u201cVPA\u201d), propulsion system, and Internet, Autonomous Driving, and Intelligence (\u201cI.A.I.\u201d) system."},{"fy":2022,"lvl":3,"n":36,"adsh":"0001628280-23-007358","doc":"ffie-20221231.htm","q":"For a detailed description of risks related to our PRC operations, see \u201c Risk Factors \u2013 Risks Related to FF\u2019s Operations in China. \u201d 3 Technology FF\u2019s technology innovations include its proprietary Variable Platform Architecture (\u201cVPA\u201d), pr\u2026"},{"fy":2023,"lvl":3,"n":33,"adsh":"0001628280-24-025420","doc":"ffie-20231231.htm","q":"For a detailed description of risks related to our PRC operations, see \u201c Risk Factors \u2013 Risks Related to FF\u2019s Operations in China. \u201d 3 Technology FF\u2019s technology innovations include its proprietary Variable Platform Architecture (\u201cVPA\u201d), pr\u2026"},{"fy":2024,"lvl":3,"n":71,"adsh":"0001628280-25-015548","doc":"ffie-20241231.htm","q":"The Company has developed a proprietary platform architecture \u2013 Variable Platform Architecture (\u201cVPA\u201d), advanced propulsion systems, and a proprietary intelligent computing ecosystem \u2013 Internet, Autonomous Driving, and Intelligence (\u201cI.A.I.\u2026"},{"fy":2025,"lvl":3,"n":123,"adsh":"0001628280-26-022509","doc":"ffie-20251231.htm","q":"(the \u201cCompany\u201d) is a California-based technology company focused on the design, engineering, and development of intelligent, connected electric vehicles and related artificial intelligence-enabled technologies."}]},{"cik":1805651,"name":"MARKETWISE, INC.","industry":"Software & IT services","sic":7372,"state":"MD","cells":[{"fy":2020,"lvl":1,"n":2,"adsh":"0001193125-21-156453","doc":"d158336d10ka.htm","q":"Gerhard has been the Co-Founder, Chief Executive Officer and Chief Technology Officer of Disruptional Ltd (f/k/a Playfusion Ltd), an artificial intelligence technology and gaming studio that is involved in creating a next generation mixed-r\u2026"},{"fy":2021,"lvl":2,"n":6,"adsh":"0001628280-22-005651","doc":"mktw-20211231.htm","q":"We have invested significant resources into our efforts around consumer marketing, including enterprise-wide customer relationship management (\u201cCRM\u201d) systems, the leveraging of artificial intelligence (\u201cAI\u201d) to analyze this data, and a robu\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001628280-23-010019","doc":"mktw-20221231.htm","q":"We have invested significant resources into our efforts around consumer marketing, including enterprise-wide customer relationship management (\u201cCRM\u201d) systems, the leveraging of artificial intelligence (\u201cAI\u201d) to analyze this data, and a robu\u2026"},{"fy":2023,"lvl":2,"n":9,"adsh":"0001628280-24-009542","doc":"mktw-20231231.htm","q":"We have invested significant resources into our efforts around consumer marketing, including enterprise-wide customer relationship management (\u201cCRM\u201d) systems, the leveraging of artificial intelligence (\u201cAI\u201d) to analyze this data, and a robu\u2026"},{"fy":2024,"lvl":3,"n":32,"adsh":"0001628280-25-010781","doc":"mktw-20241231.htm","q":"We have invested significant resources into our efforts around consumer marketing, including enterprise-wide customer relationship management (\u201cCRM\u201d) systems, the leveraging of artificial intelligence (\u201cAI\u201d) to analyze this data, and a robu\u2026"},{"fy":2025,"lvl":3,"n":32,"adsh":"0001805651-26-000016","doc":"mktw-20251231.htm","q":"We have invested significant resources into our efforts around consumer marketing, including enterprise-wide customer relationship management (\u201cCRM\u201d) systems, the leveraging of artificial intelligence (\u201cAI\u201d) to analyze this data, and a robu\u2026"}]},{"cik":1805833,"name":"SYSTEM1, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-145306","doc":"treb-20201231x10ka.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001104659-22-040410","doc":"sst-20211231x10k.htm","q":"First, RAMP utilizes machine learning to identify and direct marketing campaigns to potential customers across major advertising networks."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001805833-23-000078","doc":"sst-20221231.htm","q":"The components of RAMP include our programmatic buying platform, ad media interface, content and ad engine monetization decisioning, real-time revenue attribution, machine learning and data science algorithms, and back-end systems."},{"fy":2023,"lvl":3,"n":28,"adsh":"0001805833-24-000041","doc":"sst-20231231.htm","q":"The key components of RAMP include our programmatic buying platform, ad media interface, dynamic content and monetization serving, real-time revenue attribution, machine learning and data science algorithms, and back-end reporting systems."},{"fy":2024,"lvl":3,"n":28,"adsh":"0001628280-25-011690","doc":"sst-20241231.htm","q":"The key components of RAMP include our programmatic buying platform, ad media interface, dynamic content and monetization serving, real-time revenue attribution, machine learning and data science algorithms, and back-end reporting systems."},{"fy":2025,"lvl":3,"n":39,"adsh":"0001805833-26-000014","doc":"sst-20251231.htm","q":"We operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a best-in-class customer acquisition and marketing platform powered by Artificial Intelligence (\"AI\") and machine learning."}]},{"cik":1805890,"name":"FUSION PHARMACEUTICALS INC.","industry":"Pharma & biotech","sic":2836,"state":"ON","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015271","doc":"fusn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-010720","doc":"fusn-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008310","doc":"fusn-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":16,"adsh":"0000950170-24-034172","doc":"fusn-20231231.htm","q":null}]},{"cik":1806310,"name":"TAYSHA GENE THERAPIES, INC.","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2020,"lvl":1,"n":2,"adsh":"0001564590-21-010433","doc":"tsha-10k_20201231.htm","q":"Novel Capsid Identification We are developing a novel AAV capsid platform that utilizes machine learning, capsid shuffling and directed evolution to improve targeted delivery."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-012782","doc":"tsha-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010343","doc":"tsha-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-033484","doc":"tsha-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-027348","doc":"tsha-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-115202","doc":"tsha-20251231.htm","q":null}]},{"cik":1806837,"name":"VERTEX, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001558370-21-003017","doc":"verx-20201231x10k.htm","q":null},{"fy":2021,"lvl":1,"n":2,"adsh":"0001558370-22-003777","doc":"verx-20211231x10k.htm","q":"We continue to invest in our research and development capabilities with significant focus on Emerging Technologies such as Edge Computing, Artificial Intelligence/Machine Learning, Data Fabric/Mesh platforms, Blockchain, Application Program\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001558370-23-003469","doc":"verx-20221231x10k.htm","q":"We continue to invest in our research and development capabilities with significant focus on emerging technologies such as edge computing, artificial intelligence/machine learning, data fabric/mesh platforms, blockchain, application program\u2026"},{"fy":2023,"lvl":2,"n":10,"adsh":"0001558370-24-002192","doc":"verx-20231231x10k.htm","q":"We continue to invest in our research and development capabilities with significant focus on emerging technologies such as edge computing, artificial intelligence/machine learning, data fabric/mesh platforms, blockchain, application program\u2026"},{"fy":2024,"lvl":3,"n":30,"adsh":"0001558370-25-001820","doc":"verx-20241231x10k.htm","q":"Recently, we entered into an asset purchase agreement to acquire tax-specific artificial intelligence (\u201cAI\u201d) capabilities to more effectively manage the complexity of tax mapping."},{"fy":2025,"lvl":3,"n":61,"adsh":"0001104659-26-019165","doc":"verx-20251231x10k.htm","q":"Vertex AI powers intelligence across the Vertex platform to help customers operate more efficiently, reduce risk, and improve decision-making across the compliance lifecycle."}]},{"cik":1806952,"name":"LYELL IMMUNOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001628280-22-007708","doc":"lyel-20211231.htm","q":"Food and Drug Administration\u2019s Current Good Manufacturing Practices (cGMP). \u2022 Implement digital technologies and cloud solutions to accelerate and enhance our science and operations. \u2014 High-performance cloud computing, scalable cloud storag\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-23-005572","doc":"0001628280-23-005572.txt","q":"We also operate in areas such as data capture and analytics, machine learning and artificial intelligence."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-007592","doc":"lyel-20231231.htm","q":"We and the third parties on which we rely face a variety of evolving threats that could cause security incidents, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficul\u2026"},{"fy":2024,"lvl":2,"n":10,"adsh":"0001628280-25-011978","doc":"lyel-20241231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various data privacy laws and other privacy \u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001628280-26-017253","doc":"lyel-20251231.htm","q":"We and the third parties with whom we work face a variety of evolving threats that could cause security incidents, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly more difficult \u2026"}]},{"cik":1807120,"name":"DESIGN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003369","doc":"dsgn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007869","doc":"dsgn-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-033492","doc":"dsgn-20231231.htm","q":"Our employees and personnel may use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy o\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-035910","doc":"dsgn-20241231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform certain tasks at work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other pr\u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-098491","doc":"dsgn-20251231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) and/or automated decision-making technologies to perform certain tasks at work, and the disclosure and use of personal data in AI technologies is subject to various pri\u2026"}]},{"cik":1807166,"name":"AMESITE INC.","industry":"Software & IT services","sic":7372,"state":"MI","cells":[{"fy":2021,"lvl":3,"n":17,"adsh":"0001213900-21-047257","doc":"f10k2021_amesiteinc.htm","q":"Amesite is a high tech artificial intelligence software company offering a cloud-based platform and content creation services for business and university-delivered education and upskilling."},{"fy":2022,"lvl":"x","n":16,"adsh":"0001213900-22-059740","doc":"f10k2022_amesiteinc.htm","q":"Amesite is a high tech artificial intelligence software company offering a cloud-based platform and content creation services for business and university-delivered education and upskilling."},{"fy":2023,"lvl":"x","n":16,"adsh":"0001213900-23-081208","doc":"f10k2023_amesiteinc.htm","q":"Amesite is a high-tech artificial intelligence software company offering a cloud-based platform and content creation services for business and university-delivered education and upskilling."},{"fy":2024,"lvl":"x","n":22,"adsh":"0001213900-24-083458","doc":"ea0214870-10k_amesite.htm","q":"BUSINESS Overview Our mission is to empower people with AI tools."},{"fy":2025,"lvl":"x","n":29,"adsh":"0001213900-25-093213","doc":"ea0254427-10k_amesite.htm","q":"BUSINESS Overview Amesite is a technology company focused on building and commercializing AI-powered solutions for the healthcare sector, with particular emphasis on the post-acute care market."}]},{"cik":1807594,"name":"MALACCA STRAITS ACQUISITION CO LTD","industry":"Auto manufacturing","sic":3711,"state":null,"cells":[{"fy":2022,"lvl":"x","n":1,"adsh":"0001213900-23-025655","doc":"f10k2022_malaccastraits.htm","q":"Stanley Wang , our Chief Financial Officer and a director since July 14, 2020, has been the founder and managing director of K2 Venture Capital Company Limited, a venture capital investment company focused on investments in financial techno\u2026"}]},{"cik":1807794,"name":"CREDO TECHNOLOGY GROUP HOLDING LTD","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2022,"lvl":1,"n":2,"adsh":"0001628280-22-016593","doc":"crdo-20220430.htm","q":"Industry Overview We believe we are well positioned to benefit from the strong secular tailwinds driving the data infrastructure market, which is being driven by several factors, including: Explosion of Data Generation and Network Traffic: \u2026"},{"fy":2023,"lvl":3,"n":64,"adsh":"0001628280-23-023187","doc":"crdo-20230429.htm","q":"The multibillion-dollar data infrastructure market that we serve is driven largely by hyperscale data centers (hyperscalers), as well as general compute, Artificial Intelligence and Machine Learning (AI/ML) infrastructure, multi-service ope\u2026"},{"fy":2024,"lvl":3,"n":66,"adsh":"0001628280-24-029629","doc":"crdo-20240427.htm","q":"Our solutions target the data infrastructure market, where bandwidth requirements are increasing exponentially, driven by the accelerating deployment of leading edge Artificial Intelligence infrastructure and applications."},{"fy":2025,"lvl":3,"n":79,"adsh":"0001628280-25-033813","doc":"crdo-20250503.htm","q":"Business Company Overview At Credo, our mission is to redefine high-speed connectivity by delivering breakthrough solutions that enable the next generation of AI-driven applications."}]},{"cik":1807901,"name":"PANDION THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012895","doc":"pand-10k_20201231.htm","q":null}]},{"cik":1808158,"name":"REPARE THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"QC","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-011011","doc":"rptx-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002560","doc":"rptx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005113","doc":"rptx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021651","doc":"rptx-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-030405","doc":"rptx-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models \u2026"}]},{"cik":1808665,"name":"ASSERTIO HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001808665-21-000019","doc":"asrt-20201231.htm","q":null},{"fy":2021,"lvl":1,"n":1,"adsh":"0001808665-22-000012","doc":"asrt-20211231.htm","q":"The promotion of our products is now executed by a virtual model, implementing artificial intelligence to support our omnichannel marketing and selling approach."},{"fy":2022,"lvl":0,"n":0,"adsh":"0001808665-23-000019","doc":"asrt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001808665-24-000012","doc":"asrt-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001808665-25-000009","doc":"asrt-20241231.htm","q":"This omni-channel sales platform supports Sympazan and our other products through a non-personal promotion model that blends digital channels, remote virtual representatives, and machine learning (\u201cML\u201d)."},{"fy":2025,"lvl":3,"n":16,"adsh":"0001808665-26-000011","doc":"asrt-20251231.htm","q":"Cybersecurity incidents increasingly involve the use of artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) to launch more automated, targeted and coordinated attacks on targets."}]},{"cik":1808865,"name":"ITEOS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-015146","doc":"itos-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004409","doc":"itos-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007971","doc":"itos-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-026866","doc":"itos-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-033066","doc":"itos-20241231.htm","q":null}]},{"cik":1808898,"name":"BENITEC BIOPHARMA INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-20-252381","doc":"d899221d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-21-276758","doc":"d182332d10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001193125-22-237075","doc":"d360350d10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001193125-23-239121","doc":"d549728d10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001193125-24-226968","doc":"d640181d10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-211361","doc":"d57150d10k.htm","q":null}]},{"cik":1810019,"name":"RACKSPACE TECHNOLOGY, INC.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2020,"lvl":2,"n":5,"adsh":"0001810019-21-000038","doc":"rxt-20201231.htm","q":"These include automation, artificial intelligence, predictive analytics and proprietary tools that make our services even more reliable and easier to use and extend our advantage over both our competitors and our customers\u2019 ability to repli\u2026"},{"fy":2021,"lvl":2,"n":9,"adsh":"0001810019-22-000036","doc":"rxt-20211231.htm","q":"All of these workloads run more efficiently in the flexible, agile, variable-cost environment of cloud technologies with its associated highly scaled data storage. \u2022 The need to compete with \u201cdigital natives\u201d (technology companies that bega\u2026"},{"fy":2022,"lvl":2,"n":10,"adsh":"0001810019-23-000034","doc":"rxt-20221231.htm","q":"All of these workloads run more efficiently in the flexible, agile, variable-cost environment of cloud technologies with its associated highly scaled data storage. \u2022 The need to compete with \u201cdigital natives\u201d (technology companies that bega\u2026"},{"fy":2023,"lvl":3,"n":33,"adsh":"0001810019-24-000042","doc":"rxt-20231231.htm","q":"ITEM 1 \u2013 BUSINESS Overview Rackspace Technology is a leading end-to-end, hybrid, multicloud and AI solutions company."},{"fy":2024,"lvl":3,"n":52,"adsh":"0001810019-25-000043","doc":"rxt-20241231.htm","q":"ITEM 1 \u2013 BUSINESS Overview Rackspace Technology is a leading end-to-end, hybrid cloud and AI solutions company."},{"fy":2025,"lvl":3,"n":80,"adsh":"0001810019-26-000015","doc":"rxt-20251231.htm","q":"ITEM 1 \u2013 BUSINESS Overview Rackspace Technology is a leading end-to-end hybrid cloud and AI solutions company."}]},{"cik":1810182,"name":"ALX ONCOLOGY HOLDINGS INC","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-014169","doc":"alxo-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-007364","doc":"alxo-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007013","doc":"alxo-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027955","doc":"alxo-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-034761","doc":"alxo-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-098454","doc":"alxo-20251231.htm","q":null}]},{"cik":1810560,"name":"REVELATION BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-020179","doc":"f10k2021_revelationbio.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0000950170-23-011000","doc":"revb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-035322","doc":"revb-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-034584","doc":"revb-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":16,"adsh":"0001193125-26-076552","doc":"revb-20251231.htm","q":"Artificial intelligence is playing an increasingly important role in biotechnology which may have an effect on us."}]},{"cik":1810806,"name":"UNITY SOFTWARE INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":2,"n":13,"adsh":"0001810806-21-000052","doc":"unity-20201231.htm","q":"Our Create Solutions also include our Assisted Artistry tools, including ArtEngine and Granite, which use machine-learning algorithms to accelerate material creation and editing. \u2022 ArtEngine: our powerful 3D content creation tool that uses \u2026"},{"fy":2021,"lvl":2,"n":7,"adsh":"0001810806-22-000004","doc":"unity-20211231.htm","q":"As a result, a large number of our advertisers have open spending limits with us as they can clearly measure the positive return on their spend. \u2022 Personalized Advertising : an end-user acquisition product that uses machine learning combine\u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0001810806-23-000016","doc":"unity-20221231.htm","q":"Competition is intense, particularly in the San Francisco Bay Area, Tel Aviv, and other areas in which we have offices, for engineers experienced in designing and developing cloud-based platform products, data scientists with experience in \u2026"},{"fy":2023,"lvl":3,"n":53,"adsh":"0001810806-24-000053","doc":"unity-20231231.htm","q":"Our comprehensive set of software, including AI solutions, supports creators through the entire development lifecycle as they build, run, and grow immersive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augment\u2026"},{"fy":2024,"lvl":3,"n":65,"adsh":"0001810806-25-000026","doc":"unity-20241231.htm","q":"Our comprehensive set of software, including AI solutions, supports developers through the entire development lifecycle \u2013 from prototyping to live service operation, user acquisition, and monetization."},{"fy":2025,"lvl":3,"n":72,"adsh":"0001810806-26-000011","doc":"unity-20251231.htm","q":"Our comprehensive set of software, including AI solutions, supports developers through the entire development lifecycle \u2013 from prototyping to live service operation, user acquisition, and monetization."}]},{"cik":1811063,"name":"NUVATION BIO INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-077880","doc":"d124332d10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002332","doc":"nuvb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008180","doc":"nuvb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023247","doc":"nuvb-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-034903","doc":"nuvb-20241231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-085584","doc":"nuvb-20251231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"}]},{"cik":1811210,"name":"LUCID GROUP, INC.","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-067004","doc":"tm2116246d1_10ka.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-004253","doc":"lcid-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005540","doc":"lcid-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-007209","doc":"lcid-20231231.htm","q":"Advances in technology, such as artificial intelligence, new vulnerability discoveries, an increased level of sophistication and diversity of our products and services, an increased level of expertise of cyber threat actors and new discover\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0001628280-25-007725","doc":"lcid-20241231.htm","q":"The EU\u2019s General Data Protection Regulation (\u201cGDPR\u201d), Cyber Resiliency Act, Data Act and AI Act, as well as other global regulations such as the United Kingdom General Data Protection Regulation (i.e., a version of the GDPR as implemented i\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-011053","doc":"lcid-20251231.htm","q":"This next-generation AI computing platform, with its centralized architecture and redundant processors, is expected to unify all automated driving functions, enabling a seamless evolution through the autonomy spectrum. \u2022 Advanced Safety Per\u2026"}]},{"cik":1811623,"name":"PAXMEDICA, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-004966","doc":"pxmd-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-002911","doc":"pxmd-20231231x10k.htm","q":null}]},{"cik":1811764,"name":"POINT BIOPHARMA GLOBAL INC.","industry":"Pharma & biotech","sic":2834,"state":"IN","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001811764-22-000027","doc":"pnt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001811764-23-000007","doc":"pnt-20221231.htm","q":null}]},{"cik":1811999,"name":"FARMHOUSE, INC. /NV","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001096906-21-000951","doc":"fmhs-20201231.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001096906-22-000930","doc":"fmhs-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001096906-23-000882","doc":"fmhs-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":2,"adsh":"0001096906-24-001512","doc":"fmhs-20231231.htm","q":"Katz is an experienced attorney, former elected official, and former technology company executive, specializing in blockchain & FinTech, as well as corporate, cybersecurity, and the developing areas of generative AI and Web3 law."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001096906-25-000995","doc":"fmhs-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001096906-26-000562","doc":"fmhs-20251231_10k.htm","q":null}]},{"cik":1812360,"name":"FOXO TECHNOLOGIES INC.","industry":"Pharma & biotech","sic":8731,"state":"FL","cells":[{"fy":2023,"lvl":"x","n":104,"adsh":"0001213900-24-050377","doc":"ea0206840-10k_foxotech.htm","q":"Exploration of Strategic Alternatives and Restructuring In conjunction with the recent departure of our former Interim Chief Executive Officer and our former Chief Science Officer and the appointment of Mark White as our Interim Chief Execu\u2026"},{"fy":2024,"lvl":3,"n":44,"adsh":"0001641172-25-004858","doc":"form10-k.htm","q":"The Company applies automated machine learning and AI technologies to discover epigenetic biomarkers of human health, wellness and aging and, with the acquisitions of Myrtle Recovery Centers, Inc."},{"fy":2025,"lvl":3,"n":29,"adsh":"0001493152-26-016725","doc":"form10-k.htm","q":"We believe there is growing demand for direct-to-consumer wellness testing and epigenetic data analysis tools and are concentrating efforts on: (1) our Bioinformatics Services offering, a suite of bioinformatic tools to help researchers pro\u2026"}]},{"cik":1812364,"name":"RELAY THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":2,"n":9,"adsh":"0001564590-21-015518","doc":"rlay-10k_20201231.htm","q":"Our Dynamo Platform The continued and rapid development of new experimental techniques, such as room-temperature crystallography, and computational techniques, such as molecular dynamics and machine learning, is now enabling the deep unders\u2026"},{"fy":2021,"lvl":2,"n":12,"adsh":"0000950170-22-001978","doc":"rlay-20211231.htm","q":"Acquisition of ZebiAI On April 22, 2021 (the \u201cAcquisition Date\u201d), the Company acquired ZebiAI, a privately held company focused on using machine learning combined with DNA encoded library data sets for drug discovery."},{"fy":2022,"lvl":2,"n":10,"adsh":"0000950170-23-004123","doc":"rlay-20221231.htm","q":"In April 2021, we acquired ZebiAI Therapeutics, Inc., or ZebiAI, to augment our platform with additional computational and machine learning capabilities as well as an extensive experimental DNA-encoded library, or DEL, data sets, consisting\u2026"},{"fy":2023,"lvl":2,"n":10,"adsh":"0000950170-24-018797","doc":"rlay-20231231.htm","q":"We have expanded our experimental and computation tools internally, including in-house automated chemical design, or ACD, degrader design, and DNA-encoded library, or DEL, long timescale molecular dynamics, or MD, and machine learning, or M\u2026"},{"fy":2024,"lvl":3,"n":18,"adsh":"0000950170-25-027756","doc":"rlay-20241231.htm","q":"As each cycle generates new learnings for both our team and our underlying machine learning models, our successful iteration of this process continuously improves our understanding of protein motion which leads to a more effective and effic\u2026"},{"fy":2025,"lvl":3,"n":26,"adsh":"0001193125-26-076739","doc":"rlay-20251231.htm","q":"The use of new and evolving technologies, such as artificial intelligence, in our business may result in spending material resources and presents risks and challenges that can impact our business, including by posing security and other risk\u2026"}]},{"cik":1813658,"name":"ACE CONVERGENCE ACQUISITION CORP.","industry":"Computers & chips","sic":3674,"state":"DE","cells":[{"fy":2020,"lvl":1,"n":4,"adsh":"0001104659-21-037245","doc":"tm214053d1_10k.htm","q":"Ltd., a datacenter chip design start-up, and before that, he served as Co-Founder and President of ProphetStor Data Services Inc., an emerging solution provider in the artificial intelligence for IT Operations market."},{"fy":2021,"lvl":1,"n":3,"adsh":"0001410578-22-000335","doc":"acev-20211231x10k.htm","q":"He is currently Chief Executive Officer and co-founder of Praisidio, Inc. a venture capital-backed AI software company in the Enterprise Risk Management space."}]},{"cik":1814140,"name":"APEXIGEN, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003749","doc":"apgn-20221231.htm","q":null}]},{"cik":1815442,"name":"KYMERA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-012240","doc":"kymr-10k_20201231.htm","q":null},{"fy":2021,"lvl":2,"n":5,"adsh":"0000950170-22-001860","doc":"kymr-20211231.htm","q":"Using this Atlas, we are able to match target proteins with appropriate E3 ubiquitin ligases based on expression, distribution, intracellular localization and biology, a process that is enabled with our machine learning-based algorithms. \u2022 \u2026"},{"fy":2022,"lvl":2,"n":5,"adsh":"0000950170-23-003935","doc":"kymr-20221231.htm","q":"Using this Atlas, we are able to match target proteins with appropriate E3 ubiquitin ligases based on expression, distribution, intracellular localization and biology, a process that is enabled with our machine learning-based algorithms. \u2022 \u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-018414","doc":"kymr-20231231.htm","q":"Our proprietary chemistry expertise enables the design and optimization of both E3 ligase and target protein binders, with artificial intelligence (AI) enabled insights, allowing for the opportunity to design of targeted protein degraders w\u2026"},{"fy":2024,"lvl":3,"n":16,"adsh":"0000950170-25-028355","doc":"kymr-20241231.htm","q":"Critical components of our capabilities include the following: \u2022 A comprehensive hit identification strategy using high-content as well as fit-for-purpose technologies such as DNA encoded libraries and fragment based as well as X-ray based \u2026"},{"fy":2025,"lvl":3,"n":42,"adsh":"0001193125-26-073395","doc":"kymr-20251231.htm","q":"Critical components of our capabilities include the following: \u2022 A comprehensive hit identification strategy using high-content as well as fit-for-purpose technologies such as DNA encoded libraries and fragment-based as well as X-ray-based \u2026"}]},{"cik":1815632,"name":"TEGO CYBER, INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001654954-21-010487","doc":"tego_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-22-015167","doc":"tgcb_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-24-000687","doc":"tgcb_10k.htm","q":null}]},{"cik":1815776,"name":"LENZ THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011123","doc":"grph-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008764","doc":"grph-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021135","doc":"grph-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001815776-25-000019","doc":"lenz-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001815776-26-000011","doc":"lenz-20251231.htm","q":null}]},{"cik":1815903,"name":"PETROS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000783","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000575","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000401","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":40,"adsh":"0001410578-25-000579","doc":"tmb-20241231x10k.htm","q":"In contrast, our platform is being developed to not only incorporate a questionnaire feature but also is being developed to integrate innovative elements, such as Artificial Intelligence (\u201cAI\u201d) to validate critical factors like patient iden\u2026"},{"fy":2025,"lvl":"x","n":39,"adsh":"0001104659-26-043822","doc":"tmb-20251231x10k.htm","q":"In contrast, our platform is being developed to not only incorporate a questionnaire feature but also is being developed to integrate innovative elements, such as Artificial Intelligence (\u201cAI\u201d) to validate critical factors like patient iden\u2026"}]},{"cik":1815974,"name":"ANEBULO PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-21-023373","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-22-025448","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001493152-23-033452","doc":"form10-k.htm","q":"Additionally, our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with our employee\u2019s, personnel\u2019s, or vendor\u2019s use of generative AI technologies, resulting in adverse consequences."},{"fy":2024,"lvl":"x","n":2,"adsh":"0001493152-24-038127","doc":"form10-k.htm","q":"Additionally, our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with our employee\u2019s, personnel\u2019s, or vendor\u2019s use of generative AI technologies, resulting in adverse consequences."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001493152-25-016015","doc":"form10-k.htm","q":"Additionally, our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with our employee\u2019s, personnel\u2019s, or vendor\u2019s use of generative AI technologies, resulting in adverse consequences."}]},{"cik":1816590,"name":"COMPASS PATHWAYS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2021,"lvl":2,"n":8,"adsh":"0001628280-22-003651","doc":"cmps-20211231.htm","q":"We are also developing solutions using AI-assisted therapist feedback and monitoring."},{"fy":2022,"lvl":2,"n":9,"adsh":"0001628280-23-005356","doc":"cmps-20221231.htm","q":"We are also developing Chanterelle, our AI (which we refer to as Augmented Intelligence as well as Artificial Intelligence) and an analytics solution through which we aim to generate novel insights into the predictors and drivers of therape\u2026"},{"fy":2023,"lvl":2,"n":10,"adsh":"0001628280-24-007787","doc":"cmps-20231231.htm","q":"We are also developing Chanterelle, our AI (which we refer to as Augmented Intelligence as well as Artificial Intelligence) and analytics solution through which we aim to generate novel insights into the predictors and drivers of therapeuti\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001628280-25-008412","doc":"cmps-20241231.htm","q":"Working with third parties, we currently use digital technology in our clinical trials in a number of ways: \u2022 An online and mobile app preparation platform for participants in our TRD trial to educate them and help prepare them for their ps\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001816590-26-000020","doc":"cmps-20251231.htm","q":"In addition, we use certain systems that rely on machine learning systems, which are complex and may have errors or inadequacies that are not easily detectable."}]},{"cik":1816736,"name":"DISC MEDICINE, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018272","doc":"f10k2020_geminitherape.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003288","doc":"gmtx-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":10,"adsh":"0000950170-23-011139","doc":"iron-20221231.htm","q":"Number of Shares of Common Stock Beneficially Owned Percentage of Shares Beneficially Owned 5% or Greater Stockholders Entities affiliated with Atlas Venture Fund (1) 3,461,784 18.23 % AI DMI LLC (2) 3,141,759 16.55 % Novo Holdings A/S (3) \u2026"},{"fy":2023,"lvl":3,"n":26,"adsh":"0000950170-24-034432","doc":"iron-20231231.htm","q":"Number of Shares of Common Stock Beneficially Owned Percentage of Shares Beneficially Owned 5% or Greater Stockholders AI DMI LLC (1) 3,345,840 13.45 % Entities affiliated with Paradigm (2) 2,385,857 9.67 % Entities affiliated with Atlas Ve\u2026"},{"fy":2024,"lvl":3,"n":22,"adsh":"0000950170-25-028390","doc":"iron-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":29,"adsh":"0001193125-26-073602","doc":"iron-20251231.htm","q":null}]},{"cik":1816906,"name":"GAMING TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-001442","doc":"gametech_10k-123120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-002295","doc":"gaming_i10k-123121.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-23-002801","doc":"gamingtech_i10k-123122.htm","q":null}]},{"cik":1816937,"name":"BOXABL INC.","industry":"Construction","sic":1520,"state":"NV","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-012367","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001641172-25-004605","doc":"form10-k.htm","q":"Costs are estimated to be $50,000 per state. \u25cf Begin Production of Phase 2 Modular Building System Boxes, depending on receipt of sufficient orders for Phase 2 products. \u25cf Develop a smart home, AI-enabled, solution to enhance our products e\u2026"},{"fy":2025,"lvl":1,"n":3,"adsh":"0001493152-26-013273","doc":"form10-k.htm","q":"The Company expects this integration of AI to assist customers with product inquiries, guide them through available options, and streamline the process of placing orders for Boxes."}]},{"cik":1817229,"name":"VOR BIOPHARMA INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003577","doc":"vor-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009472","doc":"vor-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-034146","doc":"vor-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":10,"adsh":"0000950170-25-042623","doc":"vor-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":10,"adsh":"0001193125-26-130451","doc":"vor-20251231.htm","q":null}]},{"cik":1817241,"name":"ARTIVA BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-043837","doc":"artv-20241231.htm","q":"Despite our security measures, our information technology and infrastructure, and those of third parties upon which we rely, including our current and future CROs, may be subject to attacks, damage and interruption 109 from hackers or inter\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-100135","doc":"artv-20251231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) and/or automated decision-making technologies to perform their work, and the disclosure and use of personal data in AI technologies is subject to various privacy laws a\u2026"}]},{"cik":1817713,"name":"JANUX THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004171","doc":"janx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007311","doc":"janx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-028659","doc":"janx-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including, but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, \u2026"},{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-029177","doc":"janx-20241231.htm","q":"For example, under the GDPR, government regulators impose temporary or definitive bans on data processing, as well as fines of up to 20 million euros under the EU GDPR, \u00a317.5 million under the UK GDPR) or 4% of annual global revenue, whiche\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001193125-26-076918","doc":"janx-20251231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"}]},{"cik":1817760,"name":"SMARTKEM, INC.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004423","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-005133","doc":"smtk-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-004098","doc":"smtk-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":1,"adsh":"0001558370-25-004151","doc":"smtk-20241231x10k.htm","q":"Peruvemba has served on the board of directors of Datavault AI Inc."},{"fy":2025,"lvl":"x","n":6,"adsh":"0001104659-26-040562","doc":"smtk-20251231x10k.htm","q":"Our semiconductor platform can be used in a range of display technologies, including MicroLED, liquid crystal display (\u201cLCD\u201d), and AMOLED, as well as in applications in advanced computer and artificial intelligence chip packaging, sensors, \u2026"}]},{"cik":1817944,"name":"CLARUS THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"IL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-092120","doc":"d288074d10k.htm","q":"In May 2021, we entered into a licensing agreement to acquire the exclusive worldwide (excluding Australia) development and commercialization rights for HAVAH T+Ai \u2122 (CLAR-121)."}]},{"cik":1818201,"name":"CCC INTELLIGENT SOLUTIONS HOLDINGS INC.","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-098450","doc":"d114101d10k.htm","q":null},{"fy":2021,"lvl":3,"n":50,"adsh":"0001193125-22-061328","doc":"d201186d10k.htm","q":"Founded in 1980, CCC is a leading provider of innovative cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty (\u201cP&C\u201d) insurance economy."},{"fy":2022,"lvl":3,"n":54,"adsh":"0000950170-23-005611","doc":"cccs-20221231.htm","q":"Founded in 1980, CCC is a leading provider of innovative cloud, mobile, artificial intelligence (\u201cAI\u201d), telematics, hyperscale technologies and applications for the property and casualty (\u201cP&C\u201d) insurance economy."},{"fy":2023,"lvl":3,"n":80,"adsh":"0000950170-24-022253","doc":"cccs-20231231.htm","q":"A trusted leader in AI, internet of things (\"IoT\"), customer experience, network and workflow management, CCC delivers innovations that keep people's lives moving forward when it matters most."},{"fy":2024,"lvl":3,"n":81,"adsh":"0000950170-25-026848","doc":"cccs-20241231.htm","q":"A trusted leader in AI, customer experience, network and workflow management, CCC delivers technology that turns crucial moments into intelligent experiences, with the goal of shaping a world where life just works."},{"fy":2025,"lvl":3,"n":102,"adsh":"0001193125-26-067448","doc":"ccc-20251231.htm","q":"Founded in 1980, CCC is a leading Software-as-a-Service (\u201cSaaS\u201d) and AI platform provider for the multi-trillion-dollar insurance economy powering operations for insurers, repairers, automakers, part suppliers, and more."}]},{"cik":1818382,"name":"HUMACYTE, INC.","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-026404","doc":"f10k2020a1_alphahealth.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001818382-22-000011","doc":"huma-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001818382-23-000016","doc":"huma-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001818382-24-000040","doc":"huma-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001818382-25-000034","doc":"huma-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001818382-26-000004","doc":"huma-20251231.htm","q":null}]},{"cik":1818644,"name":"AEYE, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":23,"adsh":"0001818644-22-000008","doc":"lidr-20211231.htm","q":"With a sophisticated workforce of leaders and researchers, AEye has developed an artificial intelligence technology that enables adaptive \u201cintelligent sensing,\u201d differentiating AEye in the marketplace from its competition."},{"fy":2022,"lvl":3,"n":16,"adsh":"0001818644-23-000003","doc":"lidr-20221231.htm","q":"We have developed an artificial intelligence technology that enables adaptive \u201cintelligent sensing,\u201d differentiating us in the marketplace from our competition."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001818644-24-000003","doc":"lidr-20231231.htm","q":"We have developed an artificial intelligence technology that enables adaptive \u201cintelligent sensing,\u201d differentiating us in the marketplace from our competition."},{"fy":2024,"lvl":2,"n":11,"adsh":"0001437749-25-004906","doc":"aeye20241231_10k.htm","q":"We have developed an artificial intelligence technology that enables adaptive \u201cintelligent sensing,\u201d differentiating us in the marketplace from our competition."},{"fy":2025,"lvl":3,"n":17,"adsh":"0001437749-26-008858","doc":"lidr20251231_10k.htm","q":"Business General We are a provider of physical AI sensing solutions built on high-performance, active lidar systems for vehicle autonomy, advanced driver-assistance systems (ADAS), robotic vision and a range of Non-Automotive applications."}]},{"cik":1818674,"name":"SYBLEU INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001607062-21-000341","doc":"sybleu063021form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001607062-22-000470","doc":"sybleu063022form10k.htm","q":null},{"fy":2023,"lvl":"x","n":10,"adsh":"0001607062-23-000380","doc":"sybleu063023form10k.htm","q":"\u201cTechnology\u201d is defined in the License as\u201d Artificial intelligence/machine learning engine designed to utilize existing chemical library structures in an integrated model to predict highly specific and sensitive novel chemical structures fo\u2026"}]},{"cik":1818794,"name":"DYNE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-010726","doc":"dyn-10k_20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003290","doc":"dyn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005708","doc":"dyn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-025402","doc":"dyn-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-028356","doc":"dyn-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-084178","doc":"dyn-20251231.htm","q":"In addition, we maintain two management\u2011level governance bodies that provide cross\u2011functional oversight and escalation pathways: \u2022 An AI Governance Committee, which meets periodically to review risks associated with the development and use \u2026"}]},{"cik":1818844,"name":"DOGWOOD THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003885","doc":"tmb-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001558370-23-003650","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001558370-24-002239","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-004167","doc":"dwtx-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-031061","doc":"dwtx-20251231x10k.htm","q":null}]},{"cik":1819113,"name":"SCIENCE 37 HOLDINGS, INC.","industry":"Pharma & biotech","sic":8731,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-21-110580","doc":"tm2118724d1_10k.htm","q":null},{"fy":2022,"lvl":1,"n":2,"adsh":"0001819113-23-000009","doc":"snce-20221231.htm","q":"Digital media supports the targeting of the right messages for the right audience at the right time and Science 37 uses artificial intelligence and machine learning to target its outreach to attract individuals who are the most likely to pa\u2026"}]},{"cik":1819133,"name":"TANGO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004721","doc":"tngx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009854","doc":"tngx-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":20,"adsh":"0000950170-24-032516","doc":"tngx-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":29,"adsh":"0000950170-25-028353","doc":"tngx-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":41,"adsh":"0001193125-26-092518","doc":"tngx-20251231.htm","q":"Cyberattacks could include wrongful conduct by hostile foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware, ransomware, the theft, fraud, and subsequent misuse of employee \u2026"}]},{"cik":1819157,"name":"NORTH MOUNTAIN MERGER CORP.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-010413","doc":"brhc10035074_10k.htm","q":null}]},{"cik":1819394,"name":"MATTERPORT, INC./DE","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-028777","doc":"ghvi-10ka_20201231.htm","q":null},{"fy":2021,"lvl":3,"n":65,"adsh":"0001819394-22-000023","doc":"mttr-20211231.htm","q":"With the help of artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d) and deep learning (\u201cDL\u201d) technologies, we believe that, with the additional monetization opportunities from powerful spatial data-driven property insights and analytic\u2026"},{"fy":2022,"lvl":3,"n":76,"adsh":"0001819394-23-000011","doc":"mttr-20221231.htm","q":"With the help of artificial intelligence (\u201cAI\u201d), machine learning (\u201cML\u201d) and deep learning (\u201cDL\u201d) technologies, we believe that, with the additional monetization opportunities from powerful spatial data-driven property insights and analytic\u2026"},{"fy":2023,"lvl":3,"n":90,"adsh":"0001819394-24-000006","doc":"mttr-20231231.htm","q":"We deliver value to our customers by leveraging proprietary artificial intelligence (\u201cAI\u2019) insights to enhance customer experiences, improve operational efficiency, lower costs associated with promoting and operating buildings and accelerat\u2026"},{"fy":2024,"lvl":3,"n":95,"adsh":"0001819394-25-000007","doc":"mttr-20241231.htm","q":"We deliver value to our customers by leveraging proprietary artificial intelligence (\u201cAI\u2019) insights to enhance customer experiences, improve operational efficiency, lower costs associated with promoting and operating buildings and accelerat\u2026"}]},{"cik":1819404,"name":"NERDY INC.","industry":"Software & IT services","sic":7372,"state":"MO","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001564590-21-028066","doc":"paceu-10ka_20201231.htm","q":null},{"fy":2021,"lvl":3,"n":24,"adsh":"0001819404-22-000016","doc":"nrdy-20211231.htm","q":"Our purpose-built proprietary platform leverages technology, including artificial intelligence (\u201cAI\u201d), to connect students, users, parents, guardians, and purchasers (\u201cLearner(s)\u201d) of all ages to tutors, instructors, subject matter experts,\u2026"}]},{"cik":1819411,"name":"GAIN THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004363","doc":"ganx-20211231x10k.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001558370-23-004460","doc":"ganx-20221231x10k.htm","q":"Allosteric Binding Site Identification Using the three-dimensional structure of proteins that have been experimentally derived or generated or predictive protein structures from AI-powered databases such as Alphafold, our SEE-Tx\u00ae platform a\u2026"},{"fy":2023,"lvl":3,"n":27,"adsh":"0001558370-24-003943","doc":"ganx-20231231x10k.htm","q":"Magellan\u2122 integrates and adds to the foundational models of SEE-Tx\u00ae with proprietary AI and machine learning tools that enable the screening of over 50 billion compounds."},{"fy":2024,"lvl":3,"n":25,"adsh":"0001558370-25-003823","doc":"ganx-20241231x10k.htm","q":"The graphic below provides an overview of Magellan\u2122. \u200b Allosteric Binding Site Identification Using the three-dimensional structure of proteins that have been experimentally derived or generated or predictive protein structures from AI-powe\u2026"},{"fy":2025,"lvl":3,"n":26,"adsh":"0001104659-26-035188","doc":"ganx-20251231x10k.htm","q":"Allosteric Binding Site Identification Using the three-dimensional structure of proteins that have been experimentally derived or generated or predictive protein structures from AI-powered databases such as Alphafold, our Magellan\u2122 platform\u2026"}]},{"cik":1819493,"name":"XOS, INC.","industry":"Auto manufacturing","sic":3714,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001819493-22-000013","doc":"xos-20211231.htm","q":null},{"fy":2022,"lvl":2,"n":5,"adsh":"0001819493-23-000066","doc":"xos-20221231.htm","q":"Additionally, several states and localities have enacted measures related to the use of artificial intelligence and machine learning in products and services."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001819493-24-000050","doc":"xos-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001819493-25-000043","doc":"xos-20241231.htm","q":"We and the third-parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001819493-26-000008","doc":"xos-20251231.htm","q":"As a modular architecture that scales as customer needs grow, the Xos Hub ensures mission-critical reliability, suitable for powering everything from AI data centers and construction sites to utilities, major events, and more."}]},{"cik":1819576,"name":"LIQUIDIA CORP","industry":"Pharma & biotech","sic":2834,"state":"NC","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001437749-21-007174","doc":"lqda20201231_10k.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003850","doc":"lqda-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004191","doc":"lqda-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003051","doc":"lqda-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":23,"adsh":"0001558370-25-003237","doc":"lqda-20241231x10k.htm","q":"We, directly or through our third-party service providers, may adopt, use or incorporate artificial intelligence (\u201cAI\u201d) technology and capabilities into the information technology systems or software that we use in our business and operatio\u2026"},{"fy":2025,"lvl":3,"n":29,"adsh":"0001104659-26-023804","doc":"lqda-20251231x10k.htm","q":"We, directly or through our third-party service providers, may adopt, use or incorporate artificial intelligence (\u201cAI\u201d) technology and capabilities into the information technology systems or software that we use in our business and operatio\u2026"}]},{"cik":1819615,"name":"CLEVER LEAVES HOLDINGS INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001819615-21-000025","doc":"clvr-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001819615-22-000056","doc":"clvr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001819615-23-000030","doc":"clvr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001819615-24-000031","doc":"clvr-20231231.htm","q":null}]},{"cik":1819663,"name":"COEPTIS THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2020,"lvl":"x","n":0,"adsh":"0001683168-21-001891","doc":"vinings_10kt-123120.htm","q":null},{"fy":2021,"lvl":"x","n":0,"adsh":"0001683168-22-001616","doc":"coeptis_i10k-123121.htm","q":null}]},{"cik":1819790,"name":"TARSUS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001819790-21-000010","doc":"tars-20201231.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001819790-22-000010","doc":"tars-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001819790-23-000007","doc":"tars-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001819790-24-000018","doc":"tars-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001819790-25-000011","doc":"tars-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":31,"adsh":"0001819790-26-000019","doc":"tars-20251231.htm","q":"We also perform cybersecurity assessments of all our third-party providers who have access to our information technology systems and data. 20 Artificial Intelligence Policy and Governance In November 2025, we implemented an Artificial Intel\u2026"}]},{"cik":1819848,"name":"JOBY AVIATION, INC.","industry":"Aerospace & defense","sic":3721,"state":"CA","cells":[{"fy":2020,"lvl":2,"n":7,"adsh":"0001193125-21-159775","doc":"d157534d10ka.htm","q":"Business Combination Criteria While we may decide to enter into a Business Combination with a business that does not meet these criteria if the proposed Joby Business Combination is not consummated, we intend to seek a Business Combination \u2026"},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004706","doc":"joby-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001819848-23-000059","doc":"joby-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001819848-24-000125","doc":"joby-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001819848-25-000196","doc":"joby-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001819848-26-000160","doc":"joby-20251231.htm","q":null}]},{"cik":1819928,"name":"DOUBLEVERIFY HOLDINGS, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001558370-22-003061","doc":"dv-20211231x10k.htm","q":"Our approach combines rich content ontology and proprietary artificial intelligence tools with human expertise to appropriately categorize content across over 40 languages."},{"fy":2022,"lvl":1,"n":4,"adsh":"0001558370-23-002596","doc":"dv-20221231x10k.htm","q":"Our approach combines rich content ontology and proprietary artificial intelligence tools with human expertise to appropriately categorize content across over 40 languages."},{"fy":2023,"lvl":3,"n":51,"adsh":"0001558370-24-002008","doc":"dv-20231231x10k.htm","q":"Business Our Company We are one of the industry\u2019s leading media effectiveness platforms that leverages artificial intelligence (\u201cAI\u201d) to drive superior outcomes for global brands."},{"fy":2024,"lvl":3,"n":53,"adsh":"0001558370-25-001814","doc":"dv-20241231x10k.htm","q":"Business Our Company We are one of the industry\u2019s leading media effectiveness platforms that leverages artificial intelligence (\u201cAI\u201d) to drive superior outcomes for global brands."},{"fy":2025,"lvl":3,"n":66,"adsh":"0001104659-26-020499","doc":"dv-20251231x10k.htm","q":"Business Our Company We are one of the industry\u2019s leading media effectiveness platforms that leverages artificial intelligence (\u201cAI\u201d) to drive superior outcomes for global brands."}]},{"cik":1819974,"name":"SKYWATER TECHNOLOGY, INC","industry":"Computers & chips","sic":3674,"state":"MN","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001819974-22-000013","doc":"skyt-20220102.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001819974-23-000011","doc":"skyt-20230101.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001819974-24-000008","doc":"skyt-20231231.htm","q":"This contract also includes an option for DoD to fund enhancements and extensions to this technology. 12 Advanced Packaging While transistor scaling is slowing and the industry at large considers new avenues for improving system performance\u2026"},{"fy":2024,"lvl":2,"n":14,"adsh":"0001819974-25-000010","doc":"skyt-20241229.htm","q":"This new process technology, which is forecasted to double the performance of devices, is expected to become the most advanced strategic RHBP foundry in the United States. 13 Advanced Packaging While transistor scaling is slowing and the in\u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001819974-26-000009","doc":"skyt-20251228.htm","q":"We may use artificial intelligence in our business and operations, and challenges with properly managing its use could harm our business and expose us to costly liability."}]},{"cik":1820144,"name":"GRINDR INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2022,"lvl":1,"n":3,"adsh":"0001820144-23-000005","doc":"grnd-20221231.htm","q":"Additionally, we are collaborating with several partners in related industries to explore complementary functions and products and services to serve the core social interaction needs of our users. \u2022 Invest in Machine Learning and Data Scien\u2026"},{"fy":2023,"lvl":3,"n":69,"adsh":"0001820144-24-000011","doc":"grnd-20231231.htm","q":"We believe our efforts in machine learning and data science will help our users have more successful connections and improve the overall experience on our platform. \u2022 Strategic Investments and Acquisitions."},{"fy":2024,"lvl":3,"n":119,"adsh":"0001820144-25-000013","doc":"grnd-20241231.htm","q":"In 2024 we made a number of product and feature innovations, driven by an enhanced focus on AI, ML, and user-centric design, including: \u2022 Right Now, which is Grindr\u2019s first intent-based product for enabling people to easily find others who \u2026"},{"fy":2025,"lvl":3,"n":150,"adsh":"0001820144-26-000007","doc":"grnd-20251231.htm","q":"In 2025, we began testing Edge, a premium AI-native product tier, designed to aggregate our AI-native capabilities specifically for users seeking advanced capabilities."}]},{"cik":1820190,"name":"SCILEX HOLDING CO","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006493","doc":"sclx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-029473","doc":"sclx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-047800","doc":"sclx-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":28,"adsh":"0001193125-26-151455","doc":"sclx-20251231.htm","q":"As of March 31, 2026, we have nil shares of common stock of Datavault AI Inc. pledged as collateral under the Scilex-St."}]},{"cik":1820302,"name":"BAKKT HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"GA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-100874","doc":"d25798d10k.htm","q":null},{"fy":2021,"lvl":1,"n":4,"adsh":"0001820302-22-000005","doc":"bakkt-20211231.htm","q":"Furthermore, laws relating to privacy and data protection, including with respect to the use of data in artificial intelligence and machine learning, are rapidly evolving, extensive, complex and include inconsistencies and uncertainties."}]},{"cik":1820630,"name":"PROTERRA INC","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018879","doc":"f10k2020_arclightclean.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-006109","doc":"ptra-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-008519","doc":"ptra-20221231.htm","q":null}]},{"cik":1820875,"name":"CXAPP INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":10,"adsh":"0001410578-23-000307","doc":"cxai-20221231x10k.htm","q":"In connection with that goal, we have multi-year product roadmap development plans which include activities related to expanding the use of augmented reality (or AR) and 3D mapping, new integrations with our partners to connect enterprise s\u2026"},{"fy":2023,"lvl":3,"n":39,"adsh":"0001829126-24-003713","doc":"cxappinc_10k.htm","q":"The CXAI software-as-a-service (or SaaS) platform is anchored on the intersection of customer experience (CX) and artificial intelligence (AI) providing digital transformation for the physical workplace for enhanced experiences across peopl\u2026"},{"fy":2024,"lvl":"x","n":83,"adsh":"0001829126-25-002438","doc":"cxappinc_10k.htm","q":"(\u201cCXApp\u201d or the \u201cCompany\u201d) is a leading provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency."},{"fy":2025,"lvl":3,"n":98,"adsh":"0001829126-26-002840","doc":"cxappinc_10k.htm","q":"(\u201cCXApp\u201d or the \u201cCompany\u201d) is a leading provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency."}]},{"cik":1821169,"name":"GLOBAL SPAC PARTNERS CO,","industry":"Software & IT services","sic":7372,"state":"DE","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001213900-22-016949","doc":"f10k2021_globalspac.htm","q":"Gorilla is a leading market provider of video intelligence, Internet of Things security, edge AI data analytics and operational technology security solutions and services in Asia Pacific with operations and established distribution and sale\u2026"}]},{"cik":1821175,"name":"MOTORSPORT GAMES INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2020,"lvl":1,"n":1,"adsh":"0001493152-21-006719","doc":"form10-k.htm","q":"This is a first installment of the new series, which changes the game engine, physics, artificial intelligence and many other game fundamental components."},{"fy":2021,"lvl":1,"n":4,"adsh":"0001493152-22-008160","doc":"form10-k.htm","q":"This is a first installment of the new series, which changes the game engine, physics, artificial intelligence, and many other game fundamental components."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-23-008878","doc":"form10-k.htm","q":"This is a first installment of the new series, which changes the game engine, physics, artificial intelligence, and many other game fundamental components."},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012233","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-011033","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-009532","doc":"form10-k.htm","q":null}]},{"cik":1821323,"name":"SIGILON THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003555","doc":"sgtx-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003716","doc":"sgtx-20221231x10k.htm","q":null}]},{"cik":1821586,"name":"MOONLAKE IMMUNOTHERAPEUTICS","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-065246","doc":"f10k2020a1_helixacquisition.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-008253","doc":"f10k2021_helixacq.htm","q":null},{"fy":2022,"lvl":2,"n":5,"adsh":"0001821586-23-000007","doc":"mnlk-20221231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and antidiscrimination. 21 MOONL\u2026"},{"fy":2023,"lvl":2,"n":5,"adsh":"0001821586-24-000008","doc":"mnlk-20231231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and antidiscrimination. 22 MOONL\u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001821586-25-000006","doc":"mnlk-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."},{"fy":2025,"lvl":2,"n":7,"adsh":"0001821586-26-000002","doc":"mnlk-20251231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."}]},{"cik":1821595,"name":"10X CAPITAL VENTURE ACQUISITION CORP","industry":"Auto manufacturing","sic":3714,"state":"NY","cells":[{"fy":2020,"lvl":1,"n":2,"adsh":"0001213900-21-018726","doc":"f10k2020_10xcapital.htm","q":"Selection of a target business and structuring of our initial business combination While we may pursue an initial business combination target in any industry or geographic region, we intend to focus on high growth technology and tech-enable\u2026"}]},{"cik":1821769,"name":"NAVITAS SEMICONDUCTOR CORP","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2020,"lvl":1,"n":1,"adsh":"0001213900-21-061702","doc":"f10k2020a2_navitassemi.htm","q":"Hendrix served as Arlington Asset Investment Corp.\u2019s (NYSE: AI) President and Chief Operating Officer from 2004 to 2007 and its Chief Investment Officer from 2003 to 2004."},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-008077","doc":"nvts-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001821769-23-000049","doc":"nvts-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001821769-24-000024","doc":"nvts-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":6,"adsh":"0001821769-25-000021","doc":"nvts-20241231.htm","q":"GaN devices rated from 80-120 V optimize and enable 48 V-based systems such as AI data centers, EV, and AI robotics."},{"fy":2025,"lvl":3,"n":39,"adsh":"0001821769-26-000007","doc":"nvts-20251231.htm","q":"We focus on high-power markets including artificial intelligence (\u201cAI\u201d) data centers, energy and grid infrastructure, performance computing and industrial electrification."}]},{"cik":1821825,"name":"ORGANON & CO.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001821825-22-000002","doc":"ogn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001821825-23-000003","doc":"ogn-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-006733","doc":"ogn-20231231.htm","q":"We depend on sophisticated software applications (including artificial intelligence), complex information technology systems, computing infrastructure and cloud service providers (collectively, \"IT systems\") to conduct critical operations."},{"fy":2024,"lvl":3,"n":16,"adsh":"0001821825-25-000006","doc":"ogn-20241231.htm","q":"The legislative and regulatory landscape for privacy, data protection and artificial intelligence (\u201cAI\u201d) continues to evolve."},{"fy":2025,"lvl":3,"n":21,"adsh":"0001628280-26-011125","doc":"ogn-20251231.htm","q":"Expiry of patent protection and market exclusivity for products that contribute significantly to our sales will adversely affect our business. \u2022 We depend on our patent rights for the marketing of certain of our products, and invalidation o\u2026"}]},{"cik":1822145,"name":"PRESTO AUTOMATION INC.","industry":"Software & IT services","sic":7372,"state":"CT","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-009002","doc":"f10k2021_ventouxccmacq.htm","q":null},{"fy":2023,"lvl":3,"n":53,"adsh":"0001558370-23-016336","doc":"prst-20230630x10k.htm","q":"Business Overview We provide enterprise grade AI and automation solutions to the restaurant technology industry."}]},{"cik":1822462,"name":"FOGHORN THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2020,"lvl":1,"n":4,"adsh":"0001193125-21-085777","doc":"d105868d10k.htm","q":"While initially focused in oncology, we believe our platform is broadly applicable across other disease areas. 5 Table of Contents Our Gene Traffic Control platform encompasses the following: \u0095 Target Identification and Validation\u0097 We use g\u2026"},{"fy":2021,"lvl":2,"n":5,"adsh":"0001628280-22-005753","doc":"fhtx-20211231.htm","q":"Our Gene Traffic Control platform encompasses the following: \u2022 Target Identification and Validation\u2014 We use genomic screens, and a suite of epi-genome sequencing and computational tools, including aspects of artificial intelligence, or AI, \u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001628280-23-007297","doc":"fhtx-20221231.htm","q":"While initially focused in oncology, we believe our platform is broadly applicable across other disease areas with efforts underway in autoimmune diseases. 6 Table of Contents Our Gene Traffic Control platform encompasses the following: \u2022 T\u2026"},{"fy":2023,"lvl":1,"n":4,"adsh":"0001628280-24-009539","doc":"fhtx-20231231.htm","q":"Our Gene Traffic Control platform encompasses the following: \u2022 Target Identification and Validation\u2014 We use genomic screens, and a suite of epi-genome sequencing and computational tools, including aspects of artificial intelligence and mach\u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0001628280-25-010933","doc":"fhtx-20241231.htm","q":"While initially focused in oncology, we believe our platform is broadly applicable across other disease areas. 6 Table of Contents Our Gene Traffic Control platform encompasses the following: \u2022 Target Identification and Validation\u2014 We use g\u2026"},{"fy":2025,"lvl":3,"n":16,"adsh":"0001628280-26-016814","doc":"fhtx-20251231.htm","q":"Our Gene Traffic Control platform encompasses the following: \u2022 Target Identification and Validation\u2014 We use genomic screens, and a suite of epigenome sequencing and computational tools, including aspects of artificial intelligence and machi\u2026"}]},{"cik":1822691,"name":"GREENLIGHT BIOSCIENCES HOLDINGS, PBC","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001193125-22-092115","doc":"d52751d10k.htm","q":"Our platform gives rise to three distinct capabilities that underpin a sustainable business model and bring capabilities normally used in advanced pharma discovery to agriculture and human health: \u2022 Identification: Machine learning and prop\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-010351","doc":"grna-20221231.htm","q":"Our technology platform provides for integrated discovery, design, and development of RNA-based products and gives rise to three distinct capabilities that underpin a sustainable business model and bring capabilities normally used in advanc\u2026"}]},{"cik":1822711,"name":"PARDES BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004946","doc":"prds-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007860","doc":"prds-20221231.htm","q":null}]},{"cik":1822791,"name":"CLENE INC.","industry":"Pharma & biotech","sic":2834,"state":"UT","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001213900-21-018061","doc":"f10k2020_cleneinc.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003410","doc":"clnn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-006264","doc":"clnn20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-007542","doc":"clnn20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-008956","doc":"clnn20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-008502","doc":"clnn20251231_10k.htm","q":null}]},{"cik":1822928,"name":"HOLLEY INC.","industry":"Auto manufacturing","sic":3714,"state":"TN","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001193125-21-165738","doc":"d934333d10ka.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003648","doc":"hlly-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-006585","doc":"hlly20221231_10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001437749-24-007848","doc":"hlly20231231_10k.htm","q":"Cybercriminals have increasingly demonstrated advanced capabilities, such as use of zero-day vulnerabilities, and rapid integration of new technology such as generative artificial intelligence."},{"fy":2024,"lvl":2,"n":8,"adsh":"0001437749-25-007614","doc":"hlly20241112_10k.htm","q":"Cybercriminals have increasingly demonstrated advanced capabilities, such as use of zero-day vulnerabilities, and rapid integration of new technology such as generative artificial intelligence."},{"fy":2025,"lvl":2,"n":8,"adsh":"0001628280-26-018218","doc":"hlly-20251231.htm","q":"Cybercriminals have increasingly demonstrated advanced capabilities, such as use of zero-day vulnerabilities, and rapid integration of new technology such as generative artificial intelligence."}]},{"cik":1823239,"name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001823239-22-000012","doc":"mrvi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001823239-23-000014","doc":"mrvi-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001823239-24-000032","doc":"mrvi-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0001823239-25-000034","doc":"mrvi-20241231.htm","q":"Notwithstanding ongoing liquidity challenges, global venture capital investment increased slightly in 2024, however, investments in information technology and artificial intelligence (\u201cAI\u201d) companies overshadowed other sector categories, wi\u2026"},{"fy":2025,"lvl":3,"n":37,"adsh":"0001823239-26-000011","doc":"mrvi-20251231.htm","q":"Global venture capital investments in healthcare and biotech companies in 2025 increased slightly from 2024 amounts, however, investments in artificial intelligence (\u201cAI\u201d) companies still overshadowed other sector categories, with roughly t\u2026"}]},{"cik":1823635,"name":"CXJ GROUP CO., LTD","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001493152-21-024405","doc":"form10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-24-001811","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-017474","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-24-044128","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-25-013547","doc":"form10-k.htm","q":null}]},{"cik":1823652,"name":"EVE HOLDING, INC.","industry":"Aerospace & defense","sic":3721,"state":"FL","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001193125-22-042665","doc":"d297811dex21.htm","q":"(e) \u0093 Autonomous Systems \u0094 mean systems that incorporate artificial intelligence (AI) into the management and control of complex systems."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001554855-23-000184","doc":"evex-20221231.htm","q":"According to a 2019 report published by Deloitte Touche Tohmatsu Limited titled Autonomous Driving, Moonshot Project with Quantum Leap from Hardware to Software & AI Focus , 33 million autonomous ground vehicles are expected to be sold in 2\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0001554855-24-000091","doc":"evex-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001554855-25-000157","doc":"evex-20241231.htm","q":"The techniques and tools used in cyber threats can evolve rapidly and include new technologies, such as advanced automation and artificial intelligence."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001554855-26-000300","doc":"evex-20251231.htm","q":"The techniques and tools used in cyber threats can evolve rapidly and include new technologies, such as advanced automation and artificial intelligence."}]},{"cik":1823857,"name":"VIVEON HEALTH ACQUISITION CORP.","industry":"Pharma & biotech","sic":2834,"state":"GA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-030029","doc":"form10-k.htm","q":null}]},{"cik":1823878,"name":"PLAYSTUDIOS, INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-044079","doc":"tm2037998d3_10ka.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001823878-22-000013","doc":"myps-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001823878-23-000015","doc":"myps-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001823878-24-000005","doc":"myps-20231231.htm","q":"Cybersecurity attacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are becoming increasingly sophisticated in using techniques and tools \u2013 including artificial intelligence \u2013 that circumvent secur\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001823878-25-000017","doc":"myps-20241231.htm","q":"Cybersecurity attacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are becoming increasingly sophisticated in using techniques and tools \u2013 including artificial intelligence \u2013 that circumvent secur\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001823878-26-000020","doc":"myps-20251231.htm","q":"Cybersecurity attacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are becoming increasingly sophisticated in using techniques and tools \u2013 including artificial intelligence and automation \u2013 that c\u2026"}]},{"cik":1824293,"name":"GRI BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001824293-22-000004","doc":"ck0001824293-20211231.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001824293-23-000016","doc":"ck0001824293-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001824293-24-000033","doc":"ck0001824293-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001824293-25-000050","doc":"ck0001824293-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001824293-26-000033","doc":"ck0001824293-20251231.htm","q":null}]},{"cik":1824502,"name":"ARCHER AVIATION INC.","industry":"Aerospace & defense","sic":3721,"state":"CA","cells":[{"fy":2020,"lvl":0,"n":0,"adsh":"0001104659-21-071312","doc":"tm2114751d1_10ka.htm","q":null},{"fy":2021,"lvl":0,"n":0,"adsh":"0001628280-22-006078","doc":"achr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-008091","doc":"achr-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-007963","doc":"achr-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001628280-25-008823","doc":"achr-20241231.htm","q":"Our goal is to bring together our ability to rapidly develop advanced VTOL aircraft using existing commercial parts and supply chains and Anduril's deep expertise in artificial intelligence, missionization, and systems integration, to accel\u2026"},{"fy":2025,"lvl":3,"n":32,"adsh":"0001824502-26-000019","doc":"achr-20251231.htm","q":"We plan for the airport to serve as the operational hub for our Los Angeles network and an innovation hub for developing and commercializing next-generation AI-powered aviation technologies. \u2022 Outside the U.S., through our Launch Edition pr\u2026"}]},{"cik":1824893,"name":"SURROZEN, INC./DE","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004787","doc":"srzn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011118","doc":"srzn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-043399","doc":"srzn-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-047712","doc":"srzn-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-119818","doc":"srzn-20251231.htm","q":null}]},{"cik":1825088,"name":"DREAM FINDERS HOMES, INC.","industry":"Construction","sic":1531,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-009752","doc":"brhc10035061_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001825088-23-000011","doc":"dfh-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":9,"adsh":"0001825088-24-000015","doc":"dfh-20231231.htm","q":"Presently, we employ a limited array of both traditional and generative artificial intelligence (\u201cAI\u201d) solutions for specific sales, administrative, and operational functions, including aiding in the drafting of disclosures subject to manag\u2026"},{"fy":2024,"lvl":2,"n":9,"adsh":"0001825088-25-000014","doc":"dfh-20241231.htm","q":"Presently, we employ a limited array of both traditional and generative artificial intelligence (\u201cAI\u201d) solutions for specific sales, administrative, and operational functions, including aiding in research used for disclosures subject to man\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001628280-26-010837","doc":"dfh-20251231.htm","q":"In addition, we presently employ a limited array of artificial intelligence (\u201cAI\u201d) solutions for specific sales, administrative, and operational functions, including aiding in research used for disclosures subject to management review."}]},{"cik":1825413,"name":"BIOTECH ACQUISITION CO","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-010984","doc":"f10k2021_biotechacq.htm","q":null}]},{"cik":1826011,"name":"BANZAI INTERNATIONAL, INC.","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2023,"lvl":"x","n":16,"adsh":"0000950170-24-039543","doc":"bnzi-20231231.htm","q":"We plan to do this by delivering software-as-a-service (\u201cSaaS\u201d) MarTech tools that leverage data, analytics, and artificial intelligence (\u201cAI\u201d) to improve all types of customer interactions and provide powerful benefits to our customers acr\u2026"},{"fy":2024,"lvl":2,"n":11,"adsh":"0000950170-25-054303","doc":"bnzi-20241231.htm","q":"By integrating these tools, we aim to create efficiencies and unlock shared data and assets that power more advanced AI capabilities."},{"fy":2025,"lvl":3,"n":22,"adsh":"0001193125-26-134714","doc":"bnzi-20251231.htm","q":"By integrating these tools, we aim to create efficiencies and unlock shared data and assets that power more advanced AI capabilities."}]},{"cik":1826457,"name":"MONTE ROSA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":3,"n":16,"adsh":"0000950170-22-004927","doc":"glue-20211231.htm","q":"Identified targets are recorded in our Degron encyclopedia, described below, for analysis using our artificial intelligence (\u201cAI\u201d) platforms and for potential MGD design and development."},{"fy":2022,"lvl":3,"n":25,"adsh":"0000950170-23-008440","doc":"glue-20221231.htm","q":"We identify therapeutically-relevant target proteins amenable to our approach using our artificial intelligence or \u201cAI\u201d / machine learning or \u201cML\u201d engines, as well as multiple experimental approaches."},{"fy":2023,"lvl":3,"n":48,"adsh":"0000950170-24-031150","doc":"glue-20231231.htm","q":"We combine our artificial intelligence or \u201cAI\u201d / machine learning or \u201cML\u201d engines with multiple proprietary experimental tools to identify therapeutically-relevant target proteins amenable to degradation by our MGDs."},{"fy":2024,"lvl":3,"n":38,"adsh":"0000950170-25-042344","doc":"glue-20241231.htm","q":"We combine our artificial intelligence or \u201cAI\u201d / machine learning or \u201cML\u201d engines with multiple proprietary experimental tools to identify therapeutically relevant target proteins amenable to degradation by our MGDs."},{"fy":2025,"lvl":3,"n":53,"adsh":"0001193125-26-109360","doc":"glue-20251231.htm","q":"We combine our artificial intelligence or \u201cAI\u201d / machine learning or \u201cML\u201d engines with multiple proprietary experimental tools to identify therapeutically relevant target proteins amenable to degradation by our MGDs."}]},{"cik":1826681,"name":"PALLADYNE AI CORP.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2024,"lvl":3,"n":238,"adsh":"0000950170-25-024148","doc":"pdyn-20241231.htm","q":"We were unsuccessful in our efforts to commercialize the hardware technologies that we and our predecessor companies developed over the past several decades. \u2022 Successful commercialization of our AI/ML Foundational Technology and related pr\u2026"},{"fy":2025,"lvl":3,"n":181,"adsh":"0001193125-26-092443","doc":"pdyn-20251231.htm","q":"We were unsuccessful in our efforts to commercialize our legacy hardware technologies that we and our predecessor companies developed over the past several decades. \u2022 Any issues in the development and use of our AI/ML Foundational Technolog\u2026"}]},{"cik":1826892,"name":"BIOATLA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002303","doc":"bcab-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009551","doc":"bcab-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036548","doc":"bcab-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":5,"adsh":"0000950170-25-046217","doc":"bcab-20241231.htm","q":"Furthermore, the application of newly developed artificial intelligence (\u201cAI\u201d) and other technologies may have the impact of reducing the development time to bring new products to market, which may materially increase the volume of applicat\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0001193125-26-134499","doc":"bcab-20251231.htm","q":"Investment Agreement with Inversagen AI On December 30, 2025, we entered into an Investment Agreement (the \u201cInvestment Agreement\u201d) with Inversagen AI, LLC, a Delaware limited liability company (\u201cInversagen AI\u201d), and Alliance International R\u2026"}]},{"cik":1827075,"name":"CVENT HOLDING CORP.","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003009","doc":"cvt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007888","doc":"cvt-20221231.htm","q":null}]},{"cik":1827087,"name":"VIGIL NEUROSCIENCE, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008835","doc":"vigl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036158","doc":"vigl-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-038329","doc":"vigl-20241231.htm","q":"Further, bad actors around the world use increasingly sophisticated methods, including the use of artificial intelligence (AI) systems, to engage in illegal activities, including security incidents, that can result in the theft and misuse o\u2026"}]},{"cik":1827090,"name":"CERTARA, INC.","industry":"Software & IT services","sic":7372,"state":"PA","cells":[{"fy":2021,"lvl":2,"n":5,"adsh":"0001558370-22-002608","doc":"0001558370-22-002608.txt","q":"Our differentiated regulatory services are powered by submissions management software and natural language processing for scalability and speed, allowing us to deliver more than 250 regulatory submissions over the past four years."},{"fy":2022,"lvl":3,"n":15,"adsh":"0001558370-23-002605","doc":"0001558370-23-002605.txt","q":"Our differentiated regulatory services are powered by submissions management software and natural language processing for scalability and speed, allowing us to deliver more than 300 regulatory submissions over the past five years."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001827090-26-000011","doc":"exhibit1018-employmentagre.htm","q":null}]},{"cik":1827506,"name":"TOURMALINE BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004105","doc":"tals-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-011131","doc":"tals-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001827506-24-000015","doc":"trml-20231231.htm","q":"For example, these threats may include (without limitation) malware (including as a result of advanced persistent threat intrusions), viruses, worms, software vulnerabilities and bugs, software or hardware failures, hacking, denial of servi\u2026"},{"fy":2024,"lvl":2,"n":13,"adsh":"0001827506-25-000027","doc":"trml-20241231.htm","q":"These actions may include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (\u201cCMMI\u201d) to consider new payment and healthcare models to limit drug \u2026"}]},{"cik":1827635,"name":"VERADERMICS, INC","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2025,"lvl":2,"n":9,"adsh":"0001827635-26-000013","doc":"mane-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, an\u2026"}]},{"cik":1828161,"name":"FTC SOLAR, INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004184","doc":"ftci-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-004885","doc":"ftci-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-032250","doc":"ftci-20231231.htm","q":"Rela ted party transactions Transactions with Ayna.AI LLC In February 2022, we engaged Ayna.AI LLC (as successor in interest to Fernweh Engaged Operator Company LLC) (\u201cAyna\u201d) to support us with improvements to our processes and performance \u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-047224","doc":"ftci-20241231.htm","q":"Based on the U.S. dollar amount of purchase orders we issued during the year ended December 31, 2024, the percentage of our spending involved partners located in the following countries: Vendor location Year ended December 31, 2024 United S\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-120372","doc":"ftci-20251231.htm","q":"Due to the limited number of such contract manufacturers, any cessation of operations or production or any shortage, delay, price change, imposition of tariffs or duties or other limitation on our ability to obtain the components we use cou\u2026"}]},{"cik":1828185,"name":"BARINTHUS BIOTHERAPEUTICS PLC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-037794","doc":"vacc-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-036275","doc":"vacc-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001828185-24-000011","doc":"brns-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001828185-25-000021","doc":"brns-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":24,"adsh":"0001828185-26-000012","doc":"brns-20251231.htm","q":"A growing number of legislators and regulators are adopting laws and regulations and have focused enforcement efforts on the adoption of artificial intelligence (\u201cAI\u201d) and use of such technologies in compliance with ethical standards and so\u2026"}]},{"cik":1828522,"name":"EFFECTOR THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003922","doc":"eftr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006707","doc":"eftr-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-036169","doc":"eftr-20231231.htm","q":"This trial, being led by Jennifer Caswell-Jin, M.D., Assistant Professor of Medicine at Stanford Medicine, is bringing to the clinic the science of integrative subgroups of breast cancer, building on work done by Christian Curtis, Ph.D., Pr\u2026"}]},{"cik":1828673,"name":"HCW BIOLOGICS INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004847","doc":"hcwb-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010315","doc":"hcwb-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-039384","doc":"hcwb-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-046724","doc":"hcwb-20241231.htm","q":"We currently leverage an AI-driven endpoint threat detection and prevention system."},{"fy":2025,"lvl":3,"n":34,"adsh":"0001193125-26-134934","doc":"hcwb-20251231.htm","q":"Additionally, we may implement, and we continue to evaluate, artificial intelligence-based information technology systems in certain aspects of our operations."}]},{"cik":1828723,"name":"ALTUS POWER, INC.","industry":"Utilities","sic":4911,"state":"CT","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001828723-22-000015","doc":"amps-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001828723-23-000051","doc":"amps-20221231.htm","q":"Our next generation proprietary software stack with AI/ML will support our growth and security, and increase our efficiency."},{"fy":2023,"lvl":1,"n":2,"adsh":"0001828723-24-000026","doc":"amps-20231231.htm","q":"Our next generation proprietary software stack with artificial intelligence and machine learning will support our growth and security, and increase our efficiency."},{"fy":2024,"lvl":"x","n":2,"adsh":"0001828723-25-000010","doc":"amps-20241231.htm","q":"Our next generation proprietary software stack with artificial intelligence and machine learning will support our growth and security, and increase our efficiency."}]},{"cik":1828791,"name":"VIANT TECHNOLOGY INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":8,"adsh":"0001564590-22-009695","doc":"dsp-10k_20211231.htm","q":"Our technology leverages artificial intelligence (\u201cAI\u201d) and machine learning to identify the best supply partners, formats and impressions based on our customers\u2019 goals."},{"fy":2022,"lvl":2,"n":12,"adsh":"0001828791-23-000012","doc":"dsp-20221231.htm","q":"Our technology leverages artificial intelligence (\u201cAI\u201d) and machine learning to identify the best supply partners, formats and impressions based on our customers\u2019 goals."},{"fy":2023,"lvl":3,"n":41,"adsh":"0001828791-24-000011","doc":"dsp-20231231.htm","q":"Additionally, as marketers desire more control over programmatic advertising and move some functions of programmatic ad buying in-house, our push to further simplify and automate our platform by leveraging machine learning and artificial in\u2026"},{"fy":2024,"lvl":3,"n":74,"adsh":"0001828791-25-000010","doc":"dsp-20241231.htm","q":"Additionally, as marketers desire more control over programmatic advertising and move some functions of programmatic ad buying in-house, our push to further simplify and automate our platform by leveraging machine learning and artificial in\u2026"},{"fy":2025,"lvl":3,"n":95,"adsh":"0001828791-26-000019","doc":"dsp-20251231.htm","q":"Additionally, as marketers desire more control over programmatic advertising and move some functions of programmatic ad buying in-house, we have automated our platform by leveraging machine learning, automated decision-making and artificial\u2026"}]},{"cik":1828805,"name":"AELUMA, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":1,"adsh":"0001213900-21-050076","doc":"f10kt2021_aelumainc.htm","q":"The major suppliers of InGaAs sensors include Hamamatsu, FLIR/Teledyne, Princeton Lightwave/Argo AI, Sensors Unlimited, Excelitas, and others (Source: Markets and Markets, www.marketsandmarkets.com)."},{"fy":2022,"lvl":"x","n":1,"adsh":"0001213900-22-059543","doc":"f10k2022_aelumainc.htm","q":"The major suppliers of InGaAs sensors include Hamamatsu, Sumitomo, FLIR/Teledyne, Princeton Lightwave/Argo AI, Sensors Unlimited, Excelitas, and others (Source: Markets and Markets, www.marketsandmarkets.com)."},{"fy":2023,"lvl":"x","n":3,"adsh":"0001213900-23-078910","doc":"f10k2023_aelumainc.htm","q":"Initial efforts aim to penetrate the 3D imaging and sensing (mobile and consumer, defense and aerospace, industrial, medical, auto), LiDAR (robotic vehicles, autonomous driving (AD), advanced driver assistance systems (ADAS), topography, wi\u2026"},{"fy":2024,"lvl":"x","n":7,"adsh":"0001213900-24-082694","doc":"ea0215719-10k_aelumainc.htm","q":"Initial efforts aim to penetrate the 3D imaging and sensing (mobile and consumer, defense and aerospace, industrial, medical, auto), LiDAR (robotic vehicles, autonomous driving (AD), advanced driver assistance systems (ADAS), topography, wi\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001213900-25-086227","doc":"ea0256331-10k_aelumainc.htm","q":"Technology applications include artificial intelligence (\u201cAI\u201d), mobile devices, and 5G/6G wireless networking."}]},{"cik":1829247,"name":"BULLFROG AI HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2022,"lvl":"x","n":114,"adsh":"0001493152-23-013524","doc":"form10-k.htm","q":"BUSINESS Our Corporate History and Background BullFrog AI Holdings, Inc. was incorporated in the State of Nevada on February 18, 2020."},{"fy":2023,"lvl":"x","n":127,"adsh":"0001493152-24-011964","doc":"form10-k.htm","q":"BUSINESS Our Corporate History and Background Bullfrog AI Holdings, Inc. was incorporated in the State of Nevada on February 6, 2020."},{"fy":2024,"lvl":"x","n":128,"adsh":"0001493152-25-010367","doc":"form10-k.htm","q":"BUSINESS Our Corporate History and Background Bullfrog AI Holdings, Inc. was incorporated in the State of Nevada on February 6, 2020."},{"fy":2025,"lvl":"x","n":167,"adsh":"0001493152-26-011644","doc":"form10-k.htm","q":"BUSINESS Our Corporate History and Background BullFrog AI Holdings, Inc. was incorporated in the State of Nevada in February 2020."}]},{"cik":1829635,"name":"TRANSCODE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001104659-22-040778","doc":"rnaz-20211231x10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001104659-23-040158","doc":"rnaz-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001410578-24-000413","doc":"rnaz-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001558370-25-004843","doc":"rnaz-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-043810","doc":"rnaz-20251231x10k.htm","q":null}]},{"cik":1829794,"name":"EMPERY DIGITAL INC.","industry":"Auto manufacturing","sic":3711,"state":"TX","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001683168-22-001882","doc":"volcon_i10k-123121.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001683168-23-001344","doc":"volcon_i10k-123122.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001683168-24-001823","doc":"volcon_i10k-123123.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-25-002047","doc":"volcon_i10k-123124.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001683168-26-002333","doc":"empery_i10k-123125.htm","q":null}]},{"cik":1829802,"name":"SENSEI BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MD","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003646","doc":"snse-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010432","doc":"snse-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-023148","doc":"snse-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":13,"adsh":"0000950170-25-046338","doc":"snse-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":14,"adsh":"0001193125-26-132014","doc":"snse-20251231.htm","q":null}]},{"cik":1829999,"name":"FOXWAYNE ENTERPRISES ACQUISITION CORP.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001493152-22-008595","doc":"form10-k.htm","q":"Some of these breakthroughs include breakthroughs in cloud computing, artificial intelligence, machine learning, data analytics and cybersecurity, which have upended industries both large and small."}]},{"cik":1830043,"name":"BUMBLE INC.","industry":"Software & IT services","sic":7370,"state":"TX","cells":[{"fy":2021,"lvl":2,"n":9,"adsh":"0000950170-22-003960","doc":"bmbl-20211231.htm","q":"Key investment areas for our platform include machine learning capabilities, including improving our matching and content moderation technologies; features that enhance trust and safety on our platform; new offerings that enhance user engag\u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0000950170-23-005080","doc":"bmbl-20221231.htm","q":"Key investment areas for our platform include machine learning capabilities, including improving our matching and content moderation technologies; features that enhance trust and safety on our platform; new offerings that enhance user engag\u2026"},{"fy":2023,"lvl":3,"n":45,"adsh":"0000950170-24-022104","doc":"bmbl-20231231.htm","q":"We are continuously introducing new artificial intelligence capabilities to enhance our users' experience and safety, such as the recently announced Deception Detector, which uses artificial intelligence to help identify spam, scam, and fak\u2026"},{"fy":2024,"lvl":3,"n":71,"adsh":"0000950170-25-030151","doc":"bmbl-20241231.htm","q":"We are also continuously introducing new artificial intelligence capabilities to enhance our users' experience and safety, such as a new algorithm that allows Bumble app users to see the most relevant potential matches, and the detection of\u2026"},{"fy":2025,"lvl":3,"n":92,"adsh":"0001830043-26-000027","doc":"bmbl-20251231.htm","q":"We are also continuously introducing new artificial intelligence capabilities to enhance our members' experience and safety, such as detection of inauthentic profiles and usage, and to improve our matching algorithm to help Bumble app membe\u2026"}]},{"cik":1830081,"name":"RUMBLE INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-014871","doc":"f10k2021_cfacquisition6.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001213900-23-024638","doc":"f10k2022_rumbleinc.htm","q":"New laws could restrict our ability to conduct marketing by, for example, restricting the emailing or targeting users or use certain technologies like artificial intelligence."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001213900-24-026599","doc":"ea0202455-10k_rumble.htm","q":"New laws could restrict our ability to conduct marketing by, for example, restricting the emailing or targeting users or use certain technologies like artificial intelligence."},{"fy":2024,"lvl":3,"n":29,"adsh":"0001013762-25-001863","doc":"ea0234307-10k_rumble.htm","q":"Notwithstanding our efforts, a cyber incident could occur and result in information theft, data corruption, operational disruption and/or financial loss; \u25cf spam activity, including inauthentic and fraudulent user activity, if undetected, ma\u2026"},{"fy":2025,"lvl":3,"n":48,"adsh":"0001213900-26-024099","doc":"ea0277968-10k_rumble.htm","q":"In November 2025, Rumble signed a business combination agreement with Northern Data AG (ETR: NB2), (\u201cNorthern Data\u201d) a leader in AI and high-performance-computing (HPC) infrastructure."}]},{"cik":1830188,"name":"UNITED HOMES GROUP, INC.","industry":"Construction","sic":1531,"state":"SC","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-037682","doc":"dhhcu-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001830188-24-000010","doc":"uhg-20231231.htm","q":"UHG\u2019s Chief Administrative Officer represented companies in IT integration, AI, and SaaS businesses over a span of two decades in private legal practice, and UHG\u2019s Director of IT has more than 17 years of experience in data, application, an\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001830188-25-000012","doc":"uhg-20241231.htm","q":"UHG\u2019s Chief Administrative Officer represented companies in IT integration, AI, and SaaS businesses over a span of two decades in private legal practice, and UHG\u2019s Director of IT has more than 18 years of experience in data, application, an\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001830188-26-000009","doc":"uhg-20251231.htm","q":"UHG\u2019s Chief Administrative Officer represented companies in IT integration, AI, and SaaS businesses over a span of two decades in private legal practice, and UHG\u2019s Director of IT has more than 18 years of experience in data, application, an\u2026"}]},{"cik":1830214,"name":"GINKGO BIOWORKS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0000950170-22-004821","doc":"dna-20211231.htm","q":"Recent advances in machine learning, molecular simulation, and other computational techniques also hold great promise to improve our ability to program cells."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-007461","doc":"dna-20221231.htm","q":"Recent advances in machine learning, molecular simulation, and other computational techniques also hold great promise to improve our ability to program cells."},{"fy":2023,"lvl":3,"n":88,"adsh":"0001628280-24-008052","doc":"dna-20231231.htm","q":"Our Codebase includes vast amounts of data at different levels of characterization and usability in engineering projects, including: proprietary libraries of genetic sequence data that can be used for pretraining large language models via u\u2026"},{"fy":2024,"lvl":3,"n":76,"adsh":"0001628280-25-007819","doc":"dna-20241231.htm","q":"Compounding and mutually reinforcing improvements of our laboratory automation and software infrastructure\u2014our Foundry\u2014and our reusable data assets\u2014our Codebase\u2014enable us to improve our services with each successive project. 1 Table of Cont\u2026"},{"fy":2025,"lvl":3,"n":77,"adsh":"0001628280-26-012346","doc":"dna-20251231.htm","q":"Compounding and mutually reinforcing improvements of our laboratory automation and software infrastructure\u2014our Autonomous Lab\u2014and our reusable data assets enable us to improve our services with each successive project. 1 Table of Contents O\u2026"}]},{"cik":1830503,"name":"BUSINESS WARRIOR CORP","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2022,"lvl":"x","n":5,"adsh":"0001477932-23-001035","doc":"bzwr_10k.htm","q":"We have built a scalable, highly available platform ready for future expansion into big data frameworks that power data science, machine learning, and Artificial Intelligence (AI). 19 Table of Contents Our platform\u2019s uptime in the last year\u2026"},{"fy":2023,"lvl":"x","n":7,"adsh":"0001477932-24-001283","doc":"bzwr_10k.htm","q":"The deployment of data analytics and artificial intelligence is expected to further accelerate in the coming years, bolstering the fintech market growth."}]},{"cik":1831096,"name":"GREAT ELM GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-21-048342","doc":"geg-10k_20210630.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-22-018351","doc":"geg-20220630.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-23-049001","doc":"geg-20230630.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-101834","doc":"geg-20240630.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-194119","doc":"geg-20250630.htm","q":null}]},{"cik":1831283,"name":"LIANBIO","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001831283-22-000014","doc":"adr-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001831283-23-000041","doc":"adr-20221231.htm","q":null}]},{"cik":1831363,"name":"TERNS PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0000950170-22-002962","doc":"tern-20211231.htm","q":"Taylor also serves on the board of directors of Unlearn.AI, a company seeking to accelerate clinical development through the use of artificial intelligence."},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010016","doc":"tern-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-031497","doc":"tern-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-042695","doc":"tern-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-131828","doc":"tern-20251231.htm","q":null}]},{"cik":1831651,"name":"SHOALS TECHNOLOGIES GROUP, INC.","industry":"Computers & chips","sic":3674,"state":"TN","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001831651-22-000008","doc":"shls-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001831651-23-000024","doc":"shls-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001831651-24-000011","doc":"shls-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001831651-25-000019","doc":"shls-20241231.htm","q":"While we expect the global demand for solar power to increase as a result of the needs of emerging and developing economies, the rapid proliferation of data centers for the development and use of artificial intelligence, industry shifts fro\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001831651-26-000021","doc":"shls-20251231.htm","q":"In addition, we are seeing an acceleration of artificial intelligence (AI) adoption, driving an unprecedented increase in energy demand as each new data center gets built."}]},{"cik":1831828,"name":"VERA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004701","doc":"vera-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010288","doc":"vera-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-036729","doc":"vera-20231231.htm","q":"Our employees and personnel use generative artificial intelligence (AI) technologies to perform their work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy oblig\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-029969","doc":"vera-20241231.htm","q":"We and our third-party partners are also subject to a variety of evolving threats, including but not limited to errors or malfeasance by personnel, malware (including as a result of advanced persistent threat intrusions), malicious code (su\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-077442","doc":"vera-20251231.htm","q":"Use of generative artificial intelligence in the workplace In July 2025, we adopted a generative artificial intelligence (GenAI) policy to provide all employees and contractors with guidelines for the responsible use of GenAI tools and miti\u2026"}]},{"cik":1831840,"name":"SEMRUSH HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2021,"lvl":2,"n":5,"adsh":"0001628280-22-006731","doc":"semr-20211231.htm","q":"We utilize machine learning capabilities to synthesize broad and deep data sets to derive actionable insights and analytics."},{"fy":2022,"lvl":2,"n":5,"adsh":"0001628280-23-008111","doc":"semr-20221231.htm","q":"We utilize machine learning capabilities to synthesize broad and deep data sets to derive actionable insights and analytics."},{"fy":2023,"lvl":3,"n":33,"adsh":"0001628280-24-009657","doc":"semr-20231231.htm","q":"We utilize machine learning capabilities to synthesize broad and deep data sets to derive actionable insights and analytics."},{"fy":2024,"lvl":3,"n":55,"adsh":"0001628280-25-009448","doc":"semr-20241231.htm","q":"Our platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing."},{"fy":2025,"lvl":3,"n":102,"adsh":"0001628280-26-013259","doc":"semr-20251231.htm","q":"Our platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on generative engine optimization, search engine optimization, paid advertising, social media management, local marketing, brand ma\u2026"}]},{"cik":1832038,"name":"INVIVYD, INC.","industry":"Pharma & biotech","sic":2836,"state":"CT","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005112","doc":"adgi-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009516","doc":"ivvd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037610","doc":"ivvd-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":17,"adsh":"0000950170-25-042332","doc":"ivvd-20241231.htm","q":"Moreover, as a result of the broad scale release and availability of Artificial Intelligence (\u201cAI\u201d) technologies such as generative AI, there is a global trend towards more regulation (e.g., the European Union AI Act and AI laws passed by U\u2026"},{"fy":2025,"lvl":3,"n":20,"adsh":"0001193125-26-092547","doc":"ivvd-20251231.htm","q":"Moreover, as a result of the broad scale release and availability of Artificial Intelligence (\u201cAI\u201d) technologies such as generative AI, there is a global trend towards more regulation (e.g., the European Union AI Act and AI laws passed by U\u2026"}]},{"cik":1832168,"name":"LONGBOARD PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0000950170-22-002818","doc":"lbph-20211231.htm","q":"Lack of GABA-mediated inhibition subsequently leads to the chronic activation of post-synaptic neurons characteristic of seizures. 5-HT2 Receptors 7 5-HT receptors, or serotonin receptors, are widely expressed in neural networks."},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-005832","doc":"lbph-20221231.htm","q":"Lack of GABA-mediated inhibition subsequently leads to the chronic activation of post-synaptic neurons characteristic of seizures. 5-HT2 Receptors 5-HT receptors, or serotonin receptors, are widely expressed in neural networks."},{"fy":2023,"lvl":3,"n":28,"adsh":"0000950170-24-029952","doc":"lbph-20231231.htm","q":"Lack of GABA-mediated inhibition subsequently leads to the chronic activation of post-synaptic neurons characteristic of seizures. 5-HT2 Receptors 5-HT receptors, or serotonin receptors, are widely expressed in neural networks."}]},{"cik":1832487,"name":"GUERRILLA RF, INC.","industry":"Computers & chips","sic":3674,"state":"NC","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001437749-22-007905","doc":"guer20211217_10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-005378","doc":"guer20221231_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001437749-24-010107","doc":"guer20231231_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-009538","doc":"guer20241231_10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001437749-26-009848","doc":"guer20251231_10k.htm","q":null}]},{"cik":1833214,"name":"SAB BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004935","doc":"sabs-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001437749-23-010343","doc":"sabs20221231_10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-038219","doc":"sabs-20231231.htm","q":"Our existing competitors and new market entrants may respond more quickly to or integrate new or emerging technologies such as artificial intelligence and machine learning, undertake more extensive marketing campaigns, have greater access t\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-046994","doc":"sabs-20241231.htm","q":"Our existing competitors and new market entrants may respond more quickly to or integrate new or emerging technologies such as artificial intelligence and machine learning, undertake more extensive marketing campaigns, have greater access t\u2026"},{"fy":2025,"lvl":1,"n":2,"adsh":"0001833214-26-000003","doc":"sabs-20251231.htm","q":"Our existing competitors and new market entrants may respond more quickly to or integrate new or emerging technologies such as artificial intelligence and machine learning, undertake more extensive marketing campaigns, have greater access t\u2026"}]},{"cik":1833756,"name":"LEONARDO DRS, INC.","industry":"Aerospace & defense","sic":3812,"state":"VA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001628280-22-007409","doc":"drs-20211231.htm","q":"In particular, our results can be affected by shifts in strategies and priorities on homeland security, intelligence, defense-related programs, infrastructure and urbanization and continued increased spending on technology and innovation, i\u2026"},{"fy":2022,"lvl":1,"n":1,"adsh":"0001628280-23-009545","doc":"drs-20221231.htm","q":"In particular, our results can be affected by shifts in strategies and priorities on homeland security, intelligence, defense-related programs, 71 infrastructure and urbanization and continued increased spending on technology and innovation\u2026"},{"fy":2023,"lvl":1,"n":1,"adsh":"0001628280-24-007359","doc":"drs-20231231.htm","q":"In particular, our results can be affected by shifts in strategies and priorities on homeland security, intelligence, defense-related programs, infrastructure and urbanization and continued increased spending on technology and innovation, i\u2026"},{"fy":2024,"lvl":1,"n":3,"adsh":"0001628280-25-009248","doc":"drs-20241231.htm","q":"Artificial Intelligence technologies have rapidly developed, and our business may be adversely affected if we cannot successfully integrate the technology into our internal business processes and product and service offerings in a timely, c\u2026"},{"fy":2025,"lvl":3,"n":18,"adsh":"0001833756-26-000013","doc":"drs-20251231.htm","q":"Enhancements in sensing, artificial intelligence (\u201cAI\u201d)-enabled computing, self-protection, and power generation and management are central to these priorities."}]},{"cik":1833908,"name":"ALFI, INC.","industry":"Software & IT services","sic":7370,"state":"DC","cells":[{"fy":2021,"lvl":3,"n":26,"adsh":"0001410578-22-001567","doc":"alf-20211231x10k.htm","q":"Alfi uses artificial intelligence and big data analytics to measure and disseminate audience presence and audience demographics."}]},{"cik":1834105,"name":"IMPACT BIOMEDICAL INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-007229","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-001199","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-009711","doc":"form10-k.htm","q":null}]},{"cik":1834488,"name":"N-ABLE, INC.","industry":"Software & IT services","sic":7372,"state":"DE","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001834488-22-000040","doc":"nabl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001834488-23-000039","doc":"nabl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001834488-24-000032","doc":"nabl-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0001834488-25-000053","doc":"nabl-20241231.htm","q":"We offer a powerful cloud-native extended detection and response (\u201cXDR\u201d) platform that leverages machine learning to identify cyber-threats, automate remediation rules and system updates, and provide continuous compliance reporting."},{"fy":2025,"lvl":3,"n":55,"adsh":"0001834488-26-000007","doc":"nabl-20251231.htm","q":"Cyberthreats are increasing in speed, sophistication, and scale, while the growth of hybrid systems, multi-cloud infrastructure, data volumes, SaaS applications, and AI-enabled processes is driving IT complexity."}]},{"cik":1834494,"name":"MERIDIANLINK, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001834494-22-000015","doc":"mlnk-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001834494-23-000026","doc":"mlnk-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001834494-24-000038","doc":"mlnk-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":8,"adsh":"0001834494-25-000018","doc":"mlnk-20241231.htm","q":"As we integrate artificial intelligence, or AI, technologies to enhance efficiency and innovation, we must acknowledge associated cybersecurity risks."}]},{"cik":1834645,"name":"PEAK BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0000950170-23-030817","doc":"pkbo-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-091127","doc":"pkbo-20231231.htm","q":null}]},{"cik":1835022,"name":"COYA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0000950170-23-010599","doc":"coya-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-033161","doc":"coya-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-040782","doc":"coya-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-107281","doc":"coya-20251231.htm","q":null}]},{"cik":1835268,"name":"CONNECT BIOPHARMA HOLDINGS LTD","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":1,"n":1,"adsh":"0001835268-25-000014","doc":"cntb-20241231.htm","q":"Increasingly complex methods, including through the use of artificial intelligence, have been used in cyberattacks, including ransomware, phishing, structured query language injections and distributed denial-of-service attacks."},{"fy":2025,"lvl":3,"n":54,"adsh":"0001835268-26-000013","doc":"cntb-20251231.htm","q":"Risks Related to Our Business Operations and Industry The increasing use of AI and machine learning in drug discovery and development introduces new and evolving risks that could harm our business and competitive position."}]},{"cik":1835378,"name":"INNOVID CORP.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001835378-22-000032","doc":"iacb-20211231.htm","q":"We Provide Infrastructure To Improve Advertising Our goal is to allow customers to do more in less time, with easy-to-use AI-powered workflows that eliminate manual dependencies on individuals."},{"fy":2022,"lvl":0,"n":0,"adsh":"0001835378-23-000022","doc":"ctv-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":4,"adsh":"0001835378-24-000010","doc":"ctv-20231231.htm","q":"We leverage this data to power all of our solutions, and it serves as the foundation for our Artificial Intelligence (AI) implementation and optimization strategies, which we are using to drive future growth."}]},{"cik":1835579,"name":"IMAGENEBIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003998","doc":"ikna-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007681","doc":"ikna-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":12,"adsh":"0000950170-24-029651","doc":"ikna-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":22,"adsh":"0000950170-25-034188","doc":"ikna-20241231.htm","q":"Claims that we have violated individuals\u2019 privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result\u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-099434","doc":"ima-20251231.htm","q":"Our personnel use generative artificial intelligence (\u201cAI\u201d) technologies to perform their work, and the disclosure and use of personal data in AI technologies is subject to various privacy laws and other privacy obligations."}]},{"cik":1835597,"name":"PEPGEN INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009500","doc":"pepg-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-027178","doc":"pepg-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-025226","doc":"pepg-20241231.htm","q":"Further, the use of new and evolving technologies, such as artificial intelligence, in our business may result in spending material resources and presents risks and challenges that can impact our business including by posing security and ot\u2026"},{"fy":2025,"lvl":3,"n":33,"adsh":"0001193125-26-091536","doc":"pepg-20251231.htm","q":"Further, the use of new and evolving technologies, such as artificial intelligence, in our business may result in spending material resources and presents risks and challenges that can impact our business including by posing security and ot\u2026"}]},{"cik":1835632,"name":"MARVELL TECHNOLOGY, INC.","industry":"Computers & chips","sic":3674,"state":"DE","cells":[{"fy":2021,"lvl":"x","n":3,"adsh":"0001835632-22-000016","doc":"mrvl-20220129.htm","q":"Custom ASICs We develop custom SoC (System-on-a-Chip) solutions tailored to individual customer specifications that deliver system-level differentiation for next-generation carrier, networking, data center, machine learning, automotive, aer\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001835632-23-000013","doc":"mrvl-20230128.htm","q":"Custom ASICs We develop custom SoC (System-on-a-Chip) solutions tailored to individual customer specifications that deliver system-level differentiation for next-generation carrier, networking, data center, machine learning, automotive, aer\u2026"},{"fy":2023,"lvl":3,"n":29,"adsh":"0001835632-24-000009","doc":"mrvl-20240203.htm","q":"Custom ASICs We develop custom SoC (System-on-a-Chip) solutions tailored to individual customer specifications that deliver system-level differentiation for next-generation carrier, networking, data center, artificial intelligence, automoti\u2026"},{"fy":2024,"lvl":3,"n":34,"adsh":"0001835632-25-000057","doc":"mrvl-20250201.htm","q":"Custom ASICs We develop custom semiconductor solutions tailored to individual customer specifications that deliver system-level differentiation for next-generation artificial intelligence, data center, compute, networking, carrier, storage,\u2026"}]},{"cik":1835681,"name":"POWERSCHOOL HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":10,"adsh":"0001835681-22-000007","doc":"pwsc-20211231.htm","q":"Through our Unified Platform approach, we help our customers streamline operations, aggregate disparate data sets, and develop insights using predictive modelling and machine learning."},{"fy":2022,"lvl":2,"n":11,"adsh":"0001835681-23-000012","doc":"pwsc-20221231.htm","q":"Through our platform approach, we help our customers streamline operations, aggregate disparate data sets and develop insights using predictive modelling and machine learning."},{"fy":2023,"lvl":3,"n":58,"adsh":"0001835681-24-000016","doc":"pwsc-20231231.htm","q":"A digital transformation in education is currently under way, unleashing tremendous potential, surfacing insights, and driving efficiencies, and we believe all administrators, educators, and students are entitled to benefit from this advanc\u2026"}]},{"cik":1835830,"name":"KLAVIYO, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2023,"lvl":3,"n":60,"adsh":"0001835830-24-000022","doc":"kvyo-20231231.htm","q":"Our modern and intuitive SaaS platform combines our proprietary data and application layers into one vertically-integrated solution with advanced machine learning and artificial intelligence capabilities."},{"fy":2024,"lvl":3,"n":85,"adsh":"0001835830-25-000014","doc":"kvyo-20241231.htm","q":"Our modern and intuitive SaaS platform combines our proprietary data and application layers into one vertically-integrated solution with advanced machine learning and artificial intelligence capabilities."},{"fy":2025,"lvl":3,"n":161,"adsh":"0001835830-26-000007","doc":"kvyo-20251231.htm","q":"Built for the AI era and open by design, Klaviyo populates consumer profiles with data from first-party systems using over 350 third-party integrations."}]},{"cik":1835972,"name":"ARROWROOT ACQUISITION CORP.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028818","doc":"ea0201950-10k_arrowroot.htm","q":null}]},{"cik":1836056,"name":"AMBRX BIOPHARMA INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010930","doc":"amam-20221231.htm","q":null}]},{"cik":1836981,"name":"BIGBEAR.AI HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"VA","cells":[{"fy":2021,"lvl":3,"n":93,"adsh":"0001628280-22-008031","doc":"bbai-20211231.htm","q":"Business Company Overview BigBear.ai Holdings, Inc.\u2019s (\u201c BigBear.ai \u201d or the \u201c Company \u201d) mission is guiding our customers to realize their best possible future by delivering transformative technologies and expert, actionable advice."},{"fy":2022,"lvl":3,"n":98,"adsh":"0001628280-23-010166","doc":"bbai-20221231.htm","q":"Business Company Overview BigBear.ai Holdings, Inc.\u2019s (\u201c BigBear.ai \u201d or the \u201c Company \u201d) mission is to help deliver clarity for our clients as they face their most complex decisions."},{"fy":2023,"lvl":3,"n":86,"adsh":"0001628280-24-011538","doc":"bbai-20231231.htm","q":"Business Company Overview BigBear.ai Holdings, Inc.\u2019s (\u201c BigBear.ai \u201d or the \u201c Company \u201d) mission is to help deliver clarity for the world\u2019s most complex decisions."},{"fy":2024,"lvl":3,"n":111,"adsh":"0001628280-25-014752","doc":"bbai-20241231.htm","q":"Business Company Overview BigBear.ai Holdings, Inc.\u2019s (\u201cBigBear.ai\u201d or the \u201cCompany\u201d) is an AI-driven technology solutions company."},{"fy":2025,"lvl":3,"n":151,"adsh":"0001836981-26-000018","doc":"bbai-20251231.htm","q":"Business Company Overview BigBear.ai Holdings, Inc.\u2019s (\u201cBigBear.ai\u201d or the \u201cCompany\u201d) is a specialized provider of mission-ready artificial intelligence (\u201cAI\u201d) technology, founded originally to serve defense and national security mission cu\u2026"}]},{"cik":1837240,"name":"SVF INVESTMENT CORP. 3","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001193125-22-082751","doc":"d315600d10k.htm","q":"If demand for our warehouse automation systems does not grow as we expect, or if market adoption of A.I.-enabled robotics and warehouse automation systems does not continue to develop, or develops more slowly than we expect, our future reve\u2026"}]},{"cik":1837412,"name":"SOMALOGIC, INC.","industry":"Pharma & biotech","sic":8731,"state":"NY","cells":[{"fy":2021,"lvl":2,"n":14,"adsh":"0001628280-22-007711","doc":"slgc-20211231.htm","q":"Additionally, if there are advancements in artificial intelligence technologies that we do not have access to or the ability to use and our competitors can use them then they may create a superior or more desirable service."},{"fy":2022,"lvl":2,"n":9,"adsh":"0001628280-23-009564","doc":"slgc-20221231.htm","q":"Additionally, if there are advancements in artificial intelligence technologies that we do not have access to or the ability to use and our competitors can use them then they may create a superior or more desirable service."}]},{"cik":1837607,"name":"AEON BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-023947","doc":"pmgmu-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001837607-24-000015","doc":"aeon-20231231x10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001837607-25-000022","doc":"aeon-20241231x10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001837607-26-000019","doc":"aeon-20251231x10k.htm","q":null}]},{"cik":1837686,"name":"VIMEO, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001837686-22-000006","doc":"vmeo-20211231.htm","q":"In 2019, we acquired Magisto, a provider of AI-driven video creation and editing tools."},{"fy":2022,"lvl":1,"n":2,"adsh":"0001837686-23-000006","doc":"vmeo-20221231.htm","q":"In 2019, we acquired Magisto, a provider of AI-driven video creation and editing tools."},{"fy":2023,"lvl":3,"n":24,"adsh":"0001837686-24-000021","doc":"vmeo-20231231.htm","q":"From pioneering HD video streaming to acquiring companies at the forefront of video technology like Wibbitz, Wirewax, and Livestream, Vimeo continues to push the boundaries of video technology with groundbreaking products and AI-powered sol\u2026"},{"fy":2024,"lvl":3,"n":41,"adsh":"0001837686-25-000024","doc":"vmeo-20241231.htm","q":"We provide a turnkey cloud-based solution that eliminates barriers to using video and solves essential video needs, including video hosting and management, intuitive video creation and editing, insightful analytics, AI language translations\u2026"}]},{"cik":1838238,"name":"PINE TECHNOLOGY ACQUISITION CORP.","industry":"Software & IT services","sic":7372,"state":"OH","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-011908","doc":"f10k2021_pinetechnology.htm","q":null}]},{"cik":1838359,"name":"RIGETTI COMPUTING, INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":38,"adsh":"0001558370-25-002499","doc":"rgti-20241231x10k.htm","q":"The availability of scalable quantum computers is expected to enable scientists and engineers to address problems in areas like climate change, fusion energy, quantitative finance, drug development and discovery, materials science, and arti\u2026"},{"fy":2025,"lvl":3,"n":35,"adsh":"0001104659-26-023454","doc":"rgti-20251231x10k.htm","q":"The availability of scalable quantum computers is expected to enable scientists and engineers to address problems in areas like climate change, fusion energy, quantitative finance, drug development and discovery, materials science, and arti\u2026"}]},{"cik":1838672,"name":"ADTHEORENT HOLDING COMPANY, INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":3,"n":53,"adsh":"0000950170-22-004082","doc":"adth-20211231.htm","q":"Without relying on individualized profiles or sensitive personal data for targeting, we utilize machine learning and advanced data analytics to make programmatic digital advertising more effective and efficient at scale, delivering measurab\u2026"},{"fy":2022,"lvl":3,"n":59,"adsh":"0000950170-23-005868","doc":"adth-20221231.htm","q":"Without relying on individualized profiles or sensitive personal data for targeting, we utilize machine learning and advanced data analytics to make programmatic digital advertising more effective and efficient at scale, delivering measurab\u2026"},{"fy":2023,"lvl":3,"n":60,"adsh":"0000950170-24-030136","doc":"adth-20231231.htm","q":"Without relying on individualized profiles or sensitive personal data for targeting, we utilize machine learning and advanced data analytics to make programmatic digital advertising more effective and efficient at scale, delivering measurab\u2026"}]},{"cik":1838697,"name":"BROADSCALE ACQUISITION CORP.","industry":"Utilities","sic":4911,"state":"PA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-012604","doc":"f10k2021_broadscaleacq.htm","q":null}]},{"cik":1838821,"name":"ARYA SCIENCES ACQUISITION CORP IV","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001140361-22-012071","doc":"brhc10035342_10k.htm","q":null}]},{"cik":1838987,"name":"COMPLETE SOLARIA, INC.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-027997","doc":"f10k2022_freedomacq1.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028747","doc":"ea0201914-10k_complete.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001213900-25-037748","doc":"ea0237834-10k_complete.htm","q":"Ayna Warrant On June 17, 2024, a warrant to purchase shares of the Company\u2019s common stock (\u201cAyna Warrant\u201d) was issued to Ayna.AI LLC (\u201cAyna\u201d) for the purchase of 6,000,000 shares of the Company\u2019s common stock at an exercise price per share \u2026"}]},{"cik":1838987,"name":"SUNPOWER INC.","industry":"Construction","sic":1700,"state":"UT","cells":[{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-043623","doc":"ea0283920-10k_sunpower.htm","q":"Ayna warrant On June 17, 2024, a warrant to purchase 6,000,000 shares of the Company\u2019s common stock (\u201cAyna Warrant\u201d) was issued to Ayna.AI LLC (\u201cAyna\u201d) at an exercise price per share of $ 0.01 , subject to the provisions and upon the terms \u2026"}]},{"cik":1839132,"name":"MOVELLA HOLDINGS INC.","industry":"Software & IT services","sic":7372,"state":"NV","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-017432","doc":"f10k2021_pathfinderacq.htm","q":null},{"fy":2022,"lvl":3,"n":17,"adsh":"0001193125-23-088014","doc":"d429303d10k.htm","q":"Our full-stack product portfolio includes differentiated sensor fusion modules, motion capture systems, visualization software, and AI cloud analytics enabled by our proprietary technologies."}]},{"cik":1839140,"name":"REVIUM RX.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2025,"lvl":"x","n":2,"adsh":"0001213900-26-037573","doc":"ea0283368-10k_reviumrx.htm","q":"(OTCQB: IRME), a clinical stage medical device company focused on the development of infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices."}]},{"cik":1839412,"name":"QUALTEK SERVICES INC.","industry":"Construction","sic":1623,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001410578-22-000957","doc":"qtekw-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-014277","doc":"qtek-20221231.htm","q":null}]},{"cik":1839439,"name":"PAYCOR HCM, INC.","industry":"Software & IT services","sic":7372,"state":"OH","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001839439-21-000011","doc":"pycr-20210630.htm","q":"Interactive learning tools and AI-powered surveys that use natural language processing to surface actionable, easy-to-understand insights from feedback allowing leaders to solve issues like turnover and low morale. \u2022 Uniquely Unified Platfo\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0001839439-22-000021","doc":"pycr-20220630.htm","q":"AI-powered surveys use natural language processing to surface actionable, easy-to-understand insights from feedback enabling leaders to solve issues like turnover and low morale."},{"fy":2023,"lvl":3,"n":15,"adsh":"0001839439-23-000026","doc":"pycr-20230630.htm","q":"We have achieved several key milestones since the Apax Acquisition, including: \u2022 Fiscal Year 2019: Acquired Ximble Scheduling Software. \u2022 Fiscal Year 2020: Hired Raul Villar Jr. as CEO, launched Paycor Analytics and surpassed $300 million i\u2026"},{"fy":2024,"lvl":3,"n":38,"adsh":"0001839439-24-000051","doc":"pycr-20240630.htm","q":"In October 2022, we acquired Talenya Ltd., an artificial intelligence-driven solution for talent sourcing."}]},{"cik":1840229,"name":"MINK THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001564590-22-011026","doc":"inkt-10k_20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009762","doc":"inkt-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-034672","doc":"inkt-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0000950170-25-041379","doc":"inkt-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-134813","doc":"inkt-20251231.htm","q":null}]},{"cik":1840233,"name":"XILIO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-002552","doc":"xlo-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-002687","doc":"xlo-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001558370-24-004530","doc":"xlo-20231231x10k.htm","q":"Additionally, attackers may use artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-002640","doc":"xlo-20241231x10k.htm","q":"Additionally, attackers may use artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-118550","doc":"xlo-20251231.htm","q":"Additionally, attackers may use artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets."}]},{"cik":1840292,"name":"HELIOGEN, INC.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":21,"adsh":"0001628280-22-008070","doc":"hlg-20211231.htm","q":"We are developing a modular, A.I.-enabled, concentrated solar energy plant that will use an array of mirrors to reflect sunlight and capture, concentrate, store and convert it into cost-effective energy on demand."},{"fy":2022,"lvl":3,"n":20,"adsh":"0001840292-23-000015","doc":"hlg-20221231.htm","q":"We are developing a modular, AI-enabled, concentrated solar energy plant that will use an array of mirrors to reflect sunlight and capture, concentrate, store and convert it into cost-effective energy on demand."},{"fy":2023,"lvl":3,"n":21,"adsh":"0001840292-24-000010","doc":"hlg-20231231.htm","q":"We are developing a modular, AI-enabled, concentrated solar energy plant that will use an array of mirrors to reflect sunlight and capture, concentrate, store and convert it into cost-effective energy on demand."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001840292-25-000012","doc":"hlg-20241231.htm","q":"Data centers power demand is expected to double over the next 10 years due to the requirements of artificial intelligence, the continued growth of cloud computing/streaming and the impact of electrification across multiple sectors, includin\u2026"}]},{"cik":1840416,"name":"SONO GROUP N.V.","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001171843-25-002284","doc":"sev20241231_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001171843-26-002178","doc":"sev20251231_10k.htm","q":null}]},{"cik":1840439,"name":"BIOMEA FUSION, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001564590-22-007624","doc":"bmea-10k_20211231.htm","q":"Our FUSION\u2122 System discovery platform encompasses the following: \u2022 Target Selection Validation and AI/VR Matching : We use our expertise in structural biology and irreversible covalent binding chemistry to identify both validated and novel \u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-010312","doc":"bmea-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-038026","doc":"bmea-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-047775","doc":"bmea-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-121825","doc":"bmea-20251231.htm","q":"Additionally, we may use and integrate artificial intelligence into our business processes, both in our own development and implementation of artificial intelligence through the adoption of commercially available tools."}]},{"cik":1840502,"name":"TABOOLA.COM LTD.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2022,"lvl":3,"n":57,"adsh":"0001140361-23-011303","doc":"brhc10049391_10k.htm","q":"Our Company Taboola is a technology company that powers recommendations across the Open Web with an artificial intelligence, or AI-based, algorithmic engine that we have developed over the past 1 5 years."},{"fy":2023,"lvl":3,"n":94,"adsh":"0001140361-24-009866","doc":"ef20015295_10k.htm","q":"Our Company Taboola is a technology company that powers recommendations across the Open Web with an artificial intelligence, or AI-based, algorithmic engine that we have developed since the Company began operations in 2007."},{"fy":2024,"lvl":3,"n":115,"adsh":"0001840502-25-000019","doc":"tbla-20241231.htm","q":"This gives us unique \u201cpulse of the internet\u201d data - which alongside our artificial intelligence (AI) - is our competitive advantage and helps our advertiser clients achieve exceptional returns on their advertising spend."},{"fy":2025,"lvl":3,"n":114,"adsh":"0001840502-26-000004","doc":"tbla-20251231.htm","q":"This gives us unique \u201cpulse of the internet\u201d data - which alongside our artificial intelligence (AI) - is our competitive advantage and helps our advertiser clients achieve exceptional returns on their advertising spend."}]},{"cik":1840563,"name":"PMGC HOLDINGS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2023,"lvl":"x","n":4,"adsh":"0001213900-24-027576","doc":"ea0202347-10k_elevai.htm","q":"These threats include, but are not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), malwar\u2026"},{"fy":2024,"lvl":"x","n":1,"adsh":"0001013762-25-003553","doc":"ea0234665-10k_pmgchold.htm","q":"Threats include traditional computer \u201chackers,\u201d malicious code (such as viruses and worms), phishing attacks, employee theft or misuse and denial-of-service attacks, and use of artificial intelligence."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001213900-26-035937","doc":"ea0282650-10k_pmgc.htm","q":"Broadening its Customer Base \u2013 targeting new OEMs, distributors, and ITAD firms in growing sectors such as cloud computing and AI infrastructure. 2."}]},{"cik":1840574,"name":"VERVE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-003499","doc":"verv-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-005713","doc":"verv-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0000950170-24-020633","doc":"verv-20231231.htm","q":"Cyber-attacks also could include phishing attempts or e-mail fraud to cause payments or information to be transmitted to an unintended recipient and could include the use of artificial intelligence and machine learning to launch more automa\u2026"},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-028376","doc":"verv-20241231.htm","q":"Cyber-attacks also could include phishing attempts or e-mail fraud to cause payments or information to be transmitted to an unintended recipient and could include the use of artificial intelligence and machine learning to launch more automa\u2026"}]},{"cik":1840748,"name":"LAVA THERAPEUTICS NV","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2024,"lvl":3,"n":16,"adsh":"0001558370-25-003988","doc":"lvtx-20241231x10k.htm","q":"In addition, we and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identif\u2026"}]},{"cik":1840856,"name":"SOUNDHOUND AI, INC.","industry":"Software & IT services","sic":7372,"state":"DE","cells":[{"fy":2021,"lvl":3,"n":22,"adsh":"0001213900-22-011342","doc":"f10k2021_archimedestech.htm","q":"Our focus will be on the artificial intelligence, cloud services and automotive technology sectors."},{"fy":2022,"lvl":3,"n":194,"adsh":"0001840856-23-000019","doc":"soun-20221231.htm","q":"Business Our Mission SoundHound\u2019s mission is to voice-enable the world with conversational intelligence through an independent AI platform enabling humans to interact with products and services like they interact with each other \u2014 by speaki\u2026"},{"fy":2023,"lvl":3,"n":229,"adsh":"0001840856-24-000013","doc":"soun-20231231.htm","q":"Business Our Mission SoundHound\u2019s mission is to voice-enable the world with conversational intelligence through an independent AI platform enabling humans to interact with products and services like they interact with each other \u2014 by speaki\u2026"},{"fy":2024,"lvl":3,"n":295,"adsh":"0001628280-25-011821","doc":"soun-20241231.htm","q":"Business Our Mission SoundHound\u2019s mission is to voice-enable the world with conversational intelligence through an independent AI platform enabling humans to interact with products and services like they interact with each other \u2014 by speaki\u2026"},{"fy":2025,"lvl":3,"n":317,"adsh":"0001840856-26-000006","doc":"soun-20251231.htm","q":"Business Our Mission SoundHound\u2019s mission is to voice-enable the world with conversational intelligence through an independent AI platform enabling humans to interact with products and services like they interact with each other \u2014 by speaki\u2026"}]},{"cik":1840904,"name":"ATAI LIFE SCIENCES N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2021,"lvl":2,"n":6,"adsh":"0000950170-22-005013","doc":"atai-20211231.htm","q":"In November 2019, we acquired a majority interest in EntheogeniX Biosciences, a controlled variable interest entity, that is an AI-enabled computational biophysics platform designed to optimize and accelerate drug discovery."},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-009756","doc":"atai-20221231.htm","q":"(\"EntheogeniX\"), a company dedicated to developing the next generation of innovative mental health drugs employing an AI-enabled computational biophysics platform designed to optimize and accelerate drug discovery."},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-038138","doc":"atai-20231231.htm","q":"EGX-A and EGX-B: Novel 5-HT2A Receptor Agonists \u2022 Product Candidate Concept: EGX-A and EGX-B are lead candidates from atai\u2019s internal drug discovery engine, which were discovered using an artificial intelligence/machine learning-driven appr\u2026"},{"fy":2024,"lvl":3,"n":19,"adsh":"0000950170-25-040244","doc":"atai-20241231.htm","q":"Novel 5-HT2A Receptor Agonists (including non-hallucinogenic neuroplastogens) \u2022 Product Candidate Concept: EGX-A and EGX-B are lead candidates from our internal drug discovery engine, which were discovered using an artificial intelligence/m\u2026"}]},{"cik":1841209,"name":"MICROCLOUD HOLOGRAM INC.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001829126-22-007172","doc":"goldenpathacq_10k.htm","q":null},{"fy":2022,"lvl":2,"n":12,"adsh":"0001829126-23-002018","doc":"microcloud_10k.htm","q":"Moreover, we are aligned to the rapid development of the Internet of Things, machine learning, and artificial intelligence (\u201cAI\u201d)."}]},{"cik":1841330,"name":"PASITHEA THERAPEUTICS CORP.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001213900-22-016160","doc":"f10k2021_pasitheathera.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024755","doc":"f10k2022_pasitheathera.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0001213900-24-027508","doc":"ea0200415-10k_pasithea.htm","q":"Rastelli is the Chief Scientific Officer of Deepcure, an emerging biotech that uses AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001013762-25-001646","doc":"ea0230888-10k_pasithea.htm","q":"Rastelli is the Chief Scientific Officer of Deepcure, an emerging biotech that uses AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-26-036434","doc":"ea0275535-10k_pasithea.htm","q":"Rastelli is the Chief Scientific Officer of Deepcure, an emerging biotech that uses AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target."}]},{"cik":1841387,"name":"CANDEL THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004857","doc":"cadl-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010760","doc":"cadl-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-037637","doc":"cadl-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":19,"adsh":"0000950170-25-038803","doc":"cadl-20241231.htm","q":"Our enLIGHTEN\u0099 Discovery Platform enables rapid vector engineering to generate a range of new candidates in a data driven and indication specific manner, using computational biology and artificial intelligence."},{"fy":2025,"lvl":3,"n":33,"adsh":"0001193125-26-103134","doc":"cadl-20251231.htm","q":"We recently obtained clearance for an IND. \u25aa Leverage our enLIGHTEN\u0099 Discovery Platform to enable rapid vector engineering, generating a range of new candidates in a data driven and indication specific manner, using computational biology an\u2026"}]},{"cik":1841804,"name":"INSTRUCTURE HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-001776","doc":"inst-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0000950170-23-003203","doc":"inst-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-017904","doc":"inst-20231231.htm","q":null}]},{"cik":1841873,"name":"KHOSLA VENTURES ACQUISITION CO.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":9,"adsh":"0001193125-22-092371","doc":"d332382d10k.htm","q":"With over $14.5 billion of assets under management, the firm focuses on a broad range of sectors including consumer, enterprise, financial services, health, artificial intelligence, agriculture/food, sustainable energy, space, 3D printing, \u2026"},{"fy":2022,"lvl":2,"n":9,"adsh":"0001193125-23-087377","doc":"d484343d10k.htm","q":"With over $14.5 billion of assets under management, the firm focuses on a broad range of sectors including consumer, enterprise, financial services, health, artificial intelligence, agriculture/food, sustainable energy, space, 3D printing, \u2026"}]},{"cik":1841925,"name":"INDIE SEMICONDUCTOR, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001628280-22-008866","doc":"indi-20211231.htm","q":"In the medium term, we plan to deliver expanded LiDAR solutions and bring Artificial Intelligence (\u201cAI\u201d) and Machine Learning (\u201cML\u201d) processor acceleration capabilities into new deployments in radar and vision applications. \u2022 Pursuing selec\u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0001628280-23-009556","doc":"indi-20221231.htm","q":"The Company focuses on edge sensors across multiple modalities spanning light detection and ranging (\u201cLiDAR\u201d), radar, ultrasound and computer vision."},{"fy":2023,"lvl":2,"n":8,"adsh":"0001628280-24-008027","doc":"indi-20231231.htm","q":"The Company focuses on edge sensors across multiple modalities spanning light detection and ranging (\u201cLiDAR\u201d), radar, ultrasound and computer vision."},{"fy":2024,"lvl":2,"n":8,"adsh":"0001628280-25-009207","doc":"indi-20241231.htm","q":"The Company focuses on edge sensors across multiple modalities spanning light detection and ranging (\u201cLiDAR\u201d), radar, ultrasound and computer vision."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001193125-26-082535","doc":"indi-20251231.htm","q":"The U.S. government has continued to expand export controls restricting the ability to send certain products and technology related to semiconductors, semiconductor manufacturing, AI chips, and advanced computing technology to certain count\u2026"}]},{"cik":1842295,"name":"MAZE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":29,"adsh":"0001193125-26-122778","doc":"maze-20251231.htm","q":"Further, precision medicine is a rapidly developing field, with increasing usage within the pharmaceutical and biotechnology industry of machine learning and artificial intelligence, or AI, technologies to analyze genetic data."}]},{"cik":1842563,"name":"GO GO BUYERS, INC.","industry":"Software & IT services","sic":7370,"state":"NV","cells":[{"fy":2022,"lvl":"x","n":1,"adsh":"0001842563-23-000006","doc":"gogo_10k2022.htm","q":"Go Go Buyers Inc. develops and and plans to market two AI-enabled API services."},{"fy":2023,"lvl":"x","n":4,"adsh":"0001842563-24-000015","doc":"gogo10k.htm","q":"API Hotels utilizes artificial intelligence to generate and compare hotel prices from a wide range of suppliers."},{"fy":2024,"lvl":"x","n":4,"adsh":"0001842563-25-000009","doc":"ggby10k2024.htm","q":"API Hotels utilizes artificial intelligence to generate and compare hotel prices from a wide range of suppliers."},{"fy":2025,"lvl":"x","n":4,"adsh":"0001842563-26-000006","doc":"gogo_10k2026.htm","q":"API Hotels utilizes artificial intelligence to generate and compare hotel prices from a wide range of suppliers."}]},{"cik":1842566,"name":"AIRSHIP AI HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"WA","cells":[{"fy":2023,"lvl":3,"n":365,"adsh":"0001654954-24-004059","doc":"airsp_10k.htm","q":"History The Company has been in business since 2003 and on December 21, 2023, the Company completed the merger (the \u201cMerger\u201d) contemplated by the Merger Agreement, dated as of June 27, 2023 (as amended on September 22, 2023 and as may be fu\u2026"},{"fy":2024,"lvl":3,"n":378,"adsh":"0001654954-25-002153","doc":"airsp_10k.htm","q":"(the \u201cCompany\u201d or \u201cAirship\u201d) is a holding company incorporated in Delaware that executes business through its wholly owned subsidiary, Airship AI, Inc."},{"fy":2025,"lvl":3,"n":338,"adsh":"0001654954-26-001280","doc":"airsp_10k.htm","q":"(the \u201cCompany\u201d or \u201cAirship\u201d) is a holding company incorporated in Delaware that executes business through its wholly owned subsidiary, Airship AI, Inc."}]},{"cik":1842718,"name":"INTEGRAL AD SCIENCE HOLDING CORP.","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2021,"lvl":3,"n":20,"adsh":"0001628280-22-004899","doc":"ias-20211231.htm","q":"Our platform uses advanced artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) technologies to process over 100 billion daily web transactions on average."},{"fy":2022,"lvl":3,"n":19,"adsh":"0001842718-23-000005","doc":"ias-20221231.htm","q":"Our platform uses advanced artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) technologies to process over 100 billion daily web transactions on average."},{"fy":2023,"lvl":3,"n":61,"adsh":"0001842718-24-000013","doc":"ias-20231231.htm","q":"Examples of innovation and technological changes that we have had to manage include, for example: (i) developing solutions for measuring in a mobile and in-app context as consumers and advertisers are shifted to these environments, (ii) dev\u2026"},{"fy":2024,"lvl":3,"n":70,"adsh":"0001842718-25-000023","doc":"ias-20241231.htm","q":"Examples of innovation and technological changes that we have had to manage include, for example: (i) developing solutions for measuring in a mobile and in-app context as consumers and advertisers are shifted to these environments, (ii) dev\u2026"}]},{"cik":1842952,"name":"CONTEXT THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001842952-22-000029","doc":"cntx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001842952-23-000041","doc":"cntx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001842952-24-000011","doc":"cntx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001842952-25-000028","doc":"cntx-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001628280-26-020498","doc":"cntx-20251231.htm","q":null}]},{"cik":1843248,"name":"GLOBAL SYSTEM DYNAMICS, INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001663577-23-000279","doc":"gsd10k123122.htm","q":null}]},{"cik":1843388,"name":"VIRGIN ORBIT HOLDINGS, INC.","industry":"Aerospace & defense","sic":3812,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001628280-22-007951","doc":"vorb-20211231.htm","q":"Department of Defense, Department of Army, and Intelligence Community procurement with focus on Space applications, Artificial Intelligence, Cyber, and IT technologies.in defense acquisition, program management, logistics and technology."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001628280-23-011773","doc":"vorb-20221231.htm","q":"Department of Defense, Department of Army, and Intelligence Community procurement with focus on Space applications, Artificial Intelligence, Cyber, and IT technologies.in defense acquisition, program management, logistics and technology."}]},{"cik":1843714,"name":"ZAPATA QUANTUM, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001193125-24-076744","doc":"d68575d10k.htm","q":null},{"fy":2024,"lvl":"x","n":47,"adsh":"0001079973-25-001836","doc":"zpat_10k-123124.htm","q":"Following a period of broader AI exploration, the Company undertook, in 2024 and 2025, a strategic realignment to refocus on its core quantum mission: developing the software and tooling layer that enables enterprises, governments, and rese\u2026"},{"fy":2025,"lvl":"x","n":48,"adsh":"0001079973-26-000401","doc":"zpat_10k-123125.htm","q":"Following a period of broader AI exploration, the Company undertook, in 2024 and 2025, a strategic realignment to refocus on its core quantum mission: developing the software and tooling layer that enables enterprises, governments, and rese\u2026"}]},{"cik":1843762,"name":"EQRX, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":2,"n":8,"adsh":"0001558370-22-004161","doc":"eqrx-20211231x10k.htm","q":"With the proliferation of cutting-edge artificial intelligence (AI), machine-learning and technology enabled experimental drug discovery engineering platforms, this trend is expected to further accelerate, leading to more rapid engineering \u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0001558370-23-001902","doc":"eqrx-20221231x10k.htm","q":"With the proliferation of cutting-edge artificial intelligence (AI), machine-learning and technology-enabled experimental drug discovery engineering platforms, this trend is expected to further accelerate, leading to more rapid engineering \u2026"}]},{"cik":1844280,"name":"THORNE HEALTHTECH, INC.","industry":"Pharma & biotech","sic":2834,"state":"SC","cells":[{"fy":2021,"lvl":3,"n":42,"adsh":"0000950170-22-003967","doc":"thrn-20211231.htm","q":"By combining our proprietary multi-omics database, artificial intelligence (AI) and digital health content with our science-backed nutritional supplements, we deliver a total system for wellness."},{"fy":2022,"lvl":3,"n":34,"adsh":"0000950170-23-011358","doc":"thrn-20221231.htm","q":"By combining our proprietary multi-omics database, artificial intelligence (AI) and digital health content with our science-backed nutritional supplements, we deliver a total system for wellness."}]},{"cik":1844417,"name":"ESTRELLA IMMUNOPHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":2,"adsh":"0001575872-23-000353","doc":"uptd-20221231.htm","q":"Li served as Vice President at Sequoia Capital China and led the investments in artificial intelligence hardware and corporate service sectors."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-24-082374","doc":"ea0212338-10k_estrella.htm","q":null},{"fy":2025,"lvl":"x","n":19,"adsh":"0001213900-26-029357","doc":"ea0276230-10k_estrella.htm","q":"Our management has a limited understanding of artificial intelligence (\u201cAI\u201d), and may not be able to fully assess potential risks posed to our business by AI or to capture any potential benefits to our business AI could provide."}]},{"cik":1844419,"name":"MAQUIA CAPITAL ACQUISITION CORP","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2023,"lvl":2,"n":12,"adsh":"0001410578-24-000477","doc":"maqcu-20231231x10k.htm","q":"Immersed is one of the leading providers of enterprise AR/VR productivity solutions that is building artificial intelligence (\u201cAI\u201d) productivity solutions to digitally transform the working environment to enhance worker and company efficien\u2026"}]},{"cik":1844452,"name":"INTUITIVE MACHINES, INC.","industry":"Aerospace & defense","sic":3812,"state":"TX","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001213900-23-024857","doc":"f10k2022_intuitivemac.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001844452-24-000036","doc":"lunr-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":13,"adsh":"0001844452-25-000023","doc":"lunr-20241231.htm","q":"Our innovative approach focuses on three core pillars (as described below) designed to meet the growing demand for lunar services and establish a robust lunar economy. \u2022 Delivery Services provides for the transportation and delivery of payl\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-019865","doc":"lunr-20251231.htm","q":"We may use artificial intelligence (\u201cAI\u201d) in our business or systems, and challenges with properly managing its use could result in competitive and reputational harm and negatively impact the operations and profitability of our business."}]},{"cik":1844981,"name":"DIGIASIA CORP.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-033508","doc":"ea0203329-10k_digiasia.htm","q":null}]},{"cik":1845022,"name":"COUCHBASE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001845022-22-000031","doc":"base-20220131.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001845022-23-000038","doc":"base-20230131.htm","q":null},{"fy":2023,"lvl":3,"n":36,"adsh":"0001845022-24-000020","doc":"base-20240131.htm","q":"With nearly every aspect of our lives being transformed by digital innovation and increasingly, artificial intelligence (\u201cAI\u201d), enterprises are charged with building AI-powered adaptive applications that enable delightful, highly-personaliz\u2026"},{"fy":2024,"lvl":3,"n":127,"adsh":"0001845022-25-000026","doc":"base-20250131.htm","q":"Business Overview Couchbase is the developer data platform for critical applications in our AI world."}]},{"cik":1845337,"name":"DAY ONE BIOPHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002959","doc":"dawn-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-006269","doc":"dawn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-020212","doc":"dawn-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-026654","doc":"dawn-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-066956","doc":"dawn-20251231.htm","q":null}]},{"cik":1845459,"name":"NKGEN BIOTECH, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2023,"lvl":1,"n":1,"adsh":"0001845459-24-000007","doc":"0001845459-24-000007.txt","q":"In addition, NKMAX donated an aggregate of 2,500,000 shares of NKGen Common Stock to eight charitable organizations or entities, including Alzheimer\u2019s Drug Discovery Foundation, Alzheimer\u2019s Research and Prevention Foundation, American Brian\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0001845459-25-000004","doc":"nkgn-20241231.htm","q":"In addition, NKMAX donated an aggregate of 2,500,000 shares of NKGen Common Stock to eight charitable organizations or entities, including Alzheimer\u2019s Drug Discovery Foundation, Alzheimer\u2019s Research and Prevention Foundation, American Brian\u2026"}]},{"cik":1845942,"name":"BANNIX ACQUISITION CORP.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2023,"lvl":1,"n":4,"adsh":"0001731122-24-000909","doc":"e5696_10-k.htm","q":"(\u201cTokenize\u201d), which is 50% owned by GBT Technologies Inc., which provided its consent, to acquire the entire rights, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learn\u2026"},{"fy":2024,"lvl":"x","n":5,"adsh":"0001731122-25-000237","doc":"e6347_10-k.htm","q":"(\u201cTokenize\u201d), which is 50% owned by GBT Technologies Inc., which provided its consent, to acquire the entire rights, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learn\u2026"}]},{"cik":1846069,"name":"NEXTDOOR HOLDINGS, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0001846069-22-000006","doc":"kvsb-20211231.htm","q":"Using machine-learning and proprietary technology, we enable locally relevant conversations, keeping neighbors informed and connected while nurturing civil and kind discussions with solutions like the Good Neighbor Pledge and the Kindness R\u2026"},{"fy":2022,"lvl":1,"n":3,"adsh":"0001846069-23-000010","doc":"kind-20221231.htm","q":"As neighbors interact through the platform we use a combination of human review and machine learning and predictive technology solutions, like our Kindness Reminder and Constructive Conversations Reminder, launched in 2022, to enforce our c\u2026"},{"fy":2023,"lvl":3,"n":41,"adsh":"0001846069-24-000047","doc":"kind-20231231.htm","q":"Other artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) applications allow us to improve notifications, drive positive interactions, optimize ad delivery, drive growth of comments and replies, and analyze data."},{"fy":2024,"lvl":3,"n":48,"adsh":"0001846069-25-000017","doc":"kind-20241231.htm","q":"With continually improving artificial intelligence (AI) and machine learning (ML) capabilities, Nextdoor improves the relevance and timeliness of notifications, provides proximate and personalized local content, optimizes ad creation and de\u2026"},{"fy":2025,"lvl":3,"n":104,"adsh":"0001846069-26-000023","doc":"kind-20251231.htm","q":"This evolution expands the platform beyond primarily neighbor-generated content to a dynamic feed enriched with timely, locally relevant information \u2014 including news and alerts \u2014 with artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u2026"}]},{"cik":1846253,"name":"OMNIAB, INC.","industry":"Pharma & biotech","sic":8731,"state":"CA","cells":[{"fy":2022,"lvl":2,"n":6,"adsh":"0001846253-23-000026","doc":"ck0001846253-20221231.htm","q":"Our proprietary xPloration\u00ae microcapillary technology, which we own or license, and Gel Encapsulated Microenvironment (\u201cGEM\u201d) technology, which we own, screen repertoires of antibody-secreting B cells at a single-cell level to quickly ident\u2026"},{"fy":2023,"lvl":3,"n":15,"adsh":"0001846253-24-000006","doc":"ck0001846253-20231231.htm","q":"In May 2023, we announced the launch of OmniDeep\u2122, a suite of in silico, AI and machine learning tools for therapeutic discovery and optimization that are woven throughout our various technologies and capabilities."},{"fy":2024,"lvl":3,"n":51,"adsh":"0001846253-25-000024","doc":"ck0001846253-20241231.htm","q":"Our proprietary technologies are joined with and leverage OmniDeep \u2122 , which is a suite of in silico , artificial intelligence (\u201cAI\u201d) and machine learning tools for therapeutic discovery and optimization that are woven throughout our variou\u2026"},{"fy":2025,"lvl":3,"n":53,"adsh":"0001846253-26-000009","doc":"ck0001846253-20251231.htm","q":"Our proprietary technologies are joined with and leverage OmniDeep \u2122 , which is a suite of in silico , artificial intelligence (\u201cAI\u201d) and machine learning tools for therapeutic discovery and optimization that are woven throughout our variou\u2026"}]},{"cik":1846416,"name":"HENNESSY CAPITAL INVESTMENT CORP. VII","industry":"Utilities","sic":4911,"state":"NV","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-009187","doc":"form10-k.htm","q":null}]},{"cik":1847345,"name":"ASPIRE BIOPHARMA HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-009602","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-002917","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-013682","doc":"form10-k.htm","q":null}]},{"cik":1847367,"name":"ALUMIS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":15,"adsh":"0001847367-25-000012","doc":"tmb-20241231x10k.htm","q":"Our information technology systems and those of our CROs, CMOs, clinical sites and other third parties with whom we work are vulnerable to attack, damage and interruption from a variety of evolving threats, including but not limited to comp\u2026"},{"fy":2025,"lvl":3,"n":16,"adsh":"0001847367-26-000006","doc":"alms-20251231x10k.htm","q":"Our information technology systems and those of our CROs, CMOs, clinical sites and other third parties with whom we work are vulnerable to attack, damage and interruption from a variety of evolving threats, including but not limited to comp\u2026"}]},{"cik":1847903,"name":"CENTESSA PHARMACEUTICALS PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001847903-22-000022","doc":"cnta-20211231.htm","q":"Sleep/wake was detected by piezoelectric monitoring, which is a rapid, non-invasive method for classifying sleep and wakefulness by unsupervised machine learning on physiologically relevant readouts, such as body movement and breath rate, w\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001847903-23-000063","doc":"cnta-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001847903-24-000054","doc":"cnta-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001847903-25-000051","doc":"cnta-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":37,"adsh":"0001847903-26-000025","doc":"cnta-20251231.htm","q":"These attacks and activity are also being facilitated or enhanced by evolving technologies, including artificial intelligence."}]},{"cik":1848097,"name":"SPK ACQUISITION CORP.","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0001575705-22-000499","doc":"spk_10k.htm","q":"(NASDAQ: QFIN), a leading fintech platform in China, Tricorn Technology, a leading China-based AI company focused on natural language processing which was later acquired by Tencent in 2020, Shanghai Canxing Culture & Broadcast Company, the \u2026"}]},{"cik":1848672,"name":"GLIDELOGIC CORP.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001848672-22-000008","doc":"glidelogic10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001848672-23-000007","doc":"gdlg10k2023.htm","q":null},{"fy":2023,"lvl":"x","n":31,"adsh":"0001096906-24-001101","doc":"gdlg-20240131.htm","q":"The Company is a diversified software development and consulting firm specializing in the development of AI-based software, financial technologies (FinTech), and blockchain technologies."},{"fy":2024,"lvl":"x","n":41,"adsh":"0001096906-25-000593","doc":"gdlg-20250131.htm","q":"The Company is a diversified software development and consulting firm specializing in the development of AI-based software, financial technologies (FinTech), and blockchain technologies."}]},{"cik":1849056,"name":"OKLO INC.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2023,"lvl":2,"n":5,"adsh":"0001410578-24-000365","doc":"alcc-20231231x10k.htm","q":"He is also the co-founder and CEO of OpenAI, a leading AI research and deployment company, and the Chairman of Y Combinator."},{"fy":2024,"lvl":3,"n":17,"adsh":"0001628280-25-014490","doc":"oklo-20241231.htm","q":"Together, we aim to meet the increasing demands 5 Table of Contents for radioisotopes in medical, energy, industry, defense and artificial intelligence applications."},{"fy":2025,"lvl":3,"n":25,"adsh":"0001628280-26-018698","doc":"oklo-20251231.htm","q":"Together, we aim to meet the increasing demands for radioisotopes in medical, energy, industry, defense, and artificial intelligence applications."}]},{"cik":1849380,"name":"ONEMEDNET CORP","industry":"Pharma & biotech","sic":8731,"state":null,"cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000553","doc":"dkdcu-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":38,"adsh":"0001493152-24-014092","doc":"form10-k.htm","q":"Today, life science companies, including pharmaceutical companies, artificial intelligence (AI) developers, medical device businesses, and clinical research organizations share the same widespread challenge in obtaining insight-rich, high-q\u2026"},{"fy":2024,"lvl":"x","n":45,"adsh":"0001641172-25-004815","doc":"form10-k.htm","q":"Today, life science companies, including pharmaceutical companies, artificial intelligence (\u201cAI\u201d) developers, medical device businesses, and clinical research organizations, share the same widespread challenge in obtaining insight-rich, hig\u2026"},{"fy":2025,"lvl":"x","n":40,"adsh":"0001493152-26-013681","doc":"form10-k.htm","q":"Today, life science companies, including pharmaceutical companies, artificial intelligence (\u201cAI\u201d) developers, medical device businesses, and clinical research organizations, share the same widespread challenge in obtaining insight-rich, hig\u2026"}]},{"cik":1849635,"name":"TRUMP MEDIA & TECHNOLOGY GROUP CORP.","industry":"Software & IT services","sic":7370,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-116102","doc":"d474123d10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001140361-24-017011","doc":"ef20025355_10k.htm","q":"Using human moderators and an artificial intelligence vendor known as HIVE, Truth Social has developed what TMTG believes is a robust, fair, and viewpoint-neutral moderation system and that its moderation practices are consistent with, and \u2026"},{"fy":2024,"lvl":2,"n":7,"adsh":"0001140361-25-004822","doc":"ef20039039_10k.htm","q":"Using human moderators and an artificial intelligence vendor known as HIVE, Truth Social has developed what TMTG believes is a robust, fair, and viewpoint-neutral moderation system and that its moderation practices are consistent with, and \u2026"},{"fy":2025,"lvl":2,"n":12,"adsh":"0001140361-26-007174","doc":"ef20062365_10k.htm","q":"In August 2025, TMTG announced that it had begun beta testing its new AI search feature, Truth Search AI, on the Truth Social platform."}]},{"cik":1850119,"name":"CENTURY THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-003867","doc":"ipsc-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003962","doc":"ipsc-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-003165","doc":"ipsc-20231231x10k.htm","q":null},{"fy":2024,"lvl":2,"n":10,"adsh":"0001558370-25-003299","doc":"ipsc-20241231x10k.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001104659-26-026759","doc":"ipsc-20251231x10k.htm","q":"Despite our implementation of security measures, our internal computer systems, and those of our CROs, CMOs, information technology suppliers, and other contractors and consultants are vulnerable to damage from computer viruses, cyberattack\u2026"}]},{"cik":1850270,"name":"PROKIDNEY CORP.","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-082906","doc":"d321177d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010324","doc":"prok-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034946","doc":"prok-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-040483","doc":"prok-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":27,"adsh":"0001193125-26-113881","doc":"prok-20251231.htm","q":"Artificial Intelligence Artificial Intelligence (\u201cAI\u201d) is an emerging and rapidly evolving technology."}]},{"cik":1850767,"name":"ACCUSTEM SCIENCES INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001493152-23-005208","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":1,"adsh":"0001493152-24-010938","doc":"form10-k.htm","q":"McDonald served as the CEO of Precision Therapeutics, one of the first biotechnology companies to marry breakthroughs in understanding of cancer biology and the use of machine learning with the goal of developing products that would help ca\u2026"},{"fy":2024,"lvl":"x","n":1,"adsh":"0001641172-25-002594","doc":"form10-k.htm","q":"McDonald served as the CEO of Precision Therapeutics, one of the first biotechnology companies to marry breakthroughs in understanding of cancer biology and the use of machine learning with the goal of developing products that would help ca\u2026"},{"fy":2025,"lvl":"x","n":1,"adsh":"0001493152-26-016559","doc":"form10-k.htm","q":"McDonald served as the CEO of Precision Therapeutics, one of the first biotechnology companies to marry breakthroughs in understanding of cancer biology and the use of machine learning with the goal of developing products that would help ca\u2026"}]},{"cik":1850838,"name":"OMEGA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2021,"lvl":2,"n":5,"adsh":"0000950170-22-003350","doc":"omga-20211231.htm","q":"Thousands of novel DNA-sequence-based epigenomic targets covering over 90% of human IGDs, identified through proprietary algorithms and machine-learning tools mining our own and public databases. 2."},{"fy":2022,"lvl":1,"n":3,"adsh":"0000950170-23-005328","doc":"omga-20221231.htm","q":"We use proprietary algorithms and machine-learning tools to mine our own and 10 public databases to develop a comprehensive profile of the target IGD to understand how it is dysregulated in diseased states."},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-038094","doc":"omga-20231231.htm","q":"We use proprietary algorithms and machine-learning tools to mine our own and 10 public databases to develop a comprehensive profile of the target IGD to understand how it is dysregulated in diseased states."}]},{"cik":1851003,"name":"ZETA GLOBAL HOLDINGS CORP.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":3,"n":26,"adsh":"0001193125-22-053214","doc":"d34083d10k.htm","q":"The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry\u2019s largest opted-in data set for omnichannel marketing."},{"fy":2022,"lvl":3,"n":25,"adsh":"0000950170-23-004243","doc":"zeta-20221231.htm","q":"The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry\u2019s largest opted-in data set for omnichannel marketing."},{"fy":2023,"lvl":3,"n":60,"adsh":"0000950170-24-021671","doc":"zeta-20231231.htm","q":"The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry\u2019s largest opted-in data set for omnichannel marketing."},{"fy":2024,"lvl":3,"n":112,"adsh":"0000950170-25-027338","doc":"zeta-20241231.htm","q":"Overview Zeta is a leading AI-powered omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software."},{"fy":2025,"lvl":3,"n":148,"adsh":"0001193125-26-068598","doc":"zeta-20251231.htm","q":"Overview Zeta is a leading AI-powered omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software."}]},{"cik":1851048,"name":"CYBER APP SOLUTIONS CORP.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001477932-22-003940","doc":"cyber_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-23-004175","doc":"cyber_10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-028588","doc":"ea0202982-10k_cyberapp.htm","q":null}]},{"cik":1851194,"name":"VENTYX BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004442","doc":"vtyx-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009501","doc":"vtyx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021160","doc":"vtyx-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-029245","doc":"vtyx-20241231.htm","q":"Moreover, advancements in technology, such as artificial intelligence and machine learning, are changing and may continue to change the way companies are subjected to attempts to gain unauthorized access and disrupt systems, thereby increas\u2026"}]},{"cik":1851484,"name":"CITIUS ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-014850","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-24-113150","doc":"ea0225372-10k_citius.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001213900-25-125331","doc":"ea0270097-10k_citius.htm","q":"In addition, we have contracted with EVERSANA an innovative AI platform, to support the launch and commercialization of LYMPHIR whereby EVERSANA provides an integrated suite of pre- and post-launch services, including medical information, p\u2026"}]},{"cik":1851657,"name":"VAXXINITY, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001562762-22-000139","doc":"vaxxq410k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001562762-23-000132","doc":"vaxxq410k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001562762-24-000071","doc":"vaxxq410k.htm","q":null}]},{"cik":1851961,"name":"GCT SEMICONDUCTOR HOLDING, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000166","doc":"cndb-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0000950170-25-044438","doc":"gcts-20241231.htm","q":"Building on this competitive advantage, we are currently developing RF and modem chipsets based on 5th generation (\u201c5G\u201d) new radio (\u201cNR\u201d), which is at the core of the next-generation mobile communication technology. 5G technology provides s\u2026"},{"fy":2025,"lvl":2,"n":5,"adsh":"0001193125-26-124183","doc":"gcts-20251231.htm","q":"The Fourth Industrial Revolution represents the convergence of ICT-based technologies and advanced digital technologies, like artificial intelligence, robotics, virtual reality, augmented reality, 3D printing, biotechnology and quantum comp\u2026"}]},{"cik":1852016,"name":"ALTENERGY ACQUISITION CORP","industry":"Auto manufacturing","sic":3714,"state":"CT","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001193125-25-066878","doc":"d931973d10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001193125-26-114361","doc":"d67185d10k.htm","q":null}]},{"cik":1852117,"name":"ROCKLEY PHOTONICS HOLDINGS LTD","industry":"Computers & chips","sic":3674,"state":null,"cells":[{"fy":2021,"lvl":3,"n":24,"adsh":"0001852117-22-000072","doc":"rkly-20211231.htm","q":"The summation of our technologies and manufacturing expertise is Rockley\u2019s \u201ccohesive end-to-end platform.\u201d Our end-to-end platform encompasses photonic integrated circuits (\u201cPICs\u201d) in silicon with integrated III-V devices (devices incorpora\u2026"},{"fy":2022,"lvl":3,"n":23,"adsh":"0001193125-23-144168","doc":"d354252d10k.htm","q":"The summation of our technologies and manufacturing expertise is Rockley\u2019s \u201ccohesive end-to-end platform.\u201d Our end-to-end platform encompasses photonic integrated circuits (\u201cPICs\u201d) in silicon with integrated III-V devices (devices incorpora\u2026"}]},{"cik":1852131,"name":"NEXTRACKER INC.","industry":"Aerospace & defense","sic":3812,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":4,"adsh":"0001193125-23-163921","doc":"d502138d10k.htm","q":"Our tightly-integrated software solutions use advanced algorithms and artificial intelligence technologies to further optimize the performance and capabilities of our tracker products."},{"fy":2023,"lvl":1,"n":4,"adsh":"0001628280-24-025460","doc":"nxt-20240331.htm","q":"Our tightly-integrated software solutions use advanced algorithms and artificial intelligence technologies to further optimize the performance and capabilities of our tracker products."},{"fy":2024,"lvl":3,"n":42,"adsh":"0001852131-25-000021","doc":"nxt-20250331.htm","q":"The rise of artificial intelligence (\u201cAI\u201d), which has driven energy demand use in data centers and increasing demands for electrification to help achieve greenhouse gas emissions reductions, has created a significant demand for clean energy\u2026"}]},{"cik":1853145,"name":"EVERCOMMERCE INC.","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001853145-22-000011","doc":"evcm-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001853145-23-000011","doc":"evcm-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001853145-24-000026","doc":"evcm-20231231.htm","q":null},{"fy":2024,"lvl":3,"n":44,"adsh":"0001853145-25-000009","doc":"evcm-20241231.htm","q":"Our use of artificial intelligence technologies may not be beneficial to our business, and may cause the performance of our products, services and business, as well as our reputation and the reputations of our customers, to suffer or cause \u2026"},{"fy":2025,"lvl":3,"n":94,"adsh":"0001853145-26-000010","doc":"evcm-20251231.htm","q":"On September 15, 2025, we acquired 100% of the interest of Joblyt LLC, dba ZyraTalk (\u201cZyraTalk\u201d), an AI-powered customer engagement solution that combines virtual assistant capabilities with an agentic automation platform (see \u201c Note 3."}]},{"cik":1853816,"name":"DERMATA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001654954-22-003869","doc":"drma_10k.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001654954-23-001926","doc":"drma_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001654954-24-003501","doc":"drma_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001654954-25-002885","doc":"drma_10k.htm","q":null},{"fy":2025,"lvl":"x","n":12,"adsh":"0001493152-26-012992","doc":"form10-k.htm","q":"The skincare industry is highly competitive and can rapidly change due to consumer preferences and industry trends, such as the expansion of digital channels, DTC channels, new \u201cdisruptor\u201d brands, and advances in technology such as artifici\u2026"}]},{"cik":1854270,"name":"SENTI BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-067994","doc":"d170582d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001854270-23-000033","doc":"snti-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001854270-24-000029","doc":"snti-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001854270-25-000042","doc":"snti-20241231.htm","q":"Rajangam has served as a member of the scientific advisory board of Vibe Bio, a privately held company with AI powered pipeline analyses for asset diligence and investment choices."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001628280-26-021580","doc":"snti-20251231.htm","q":"Our personnel occasionally use generative artificial intelligence (\u201cAI\u201d) technologies to perform their work, and the disclosure and use of personal data in AI technologies is subject to various privacy laws and other privacy obligations."}]},{"cik":1854445,"name":"GLIMPSE GROUP, INC.","industry":"Software & IT services","sic":7371,"state":"NY","cells":[{"fy":2021,"lvl":"x","n":4,"adsh":"0001493152-21-023976","doc":"form10-k.htm","q":"The platform provides users the unique ability to create multiple sessions of a corporate VR training experience, incorporating data visualization, computer graphics, blended real-life 360 videos, artificial intelligence, data and analytics\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-22-027032","doc":"form10-k.htm","q":"XR is also expected to increasingly interconnect with other emerging technologies such as artificial intelligence, computer vision, big data, NFT and crypto currencies."},{"fy":2023,"lvl":2,"n":6,"adsh":"0001493152-23-034624","doc":"form10-k.htm","q":"COMPANY OVERVIEW We are an Immersive technology (Virtual Reality (\u201cVR\u201d), Augmented Reality (\u201cAR\u201d), Spatial Computing, Artificial Intelligence (\u201cAI\u201d)) platform company, comprised of a diversified group of wholly-owned and operated Immersive \u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001493152-24-038786","doc":"form10-k.htm","q":"In fiscal year 2024, we shifted our businesses focus to providing immersive technology solutions software and services that are primarily driven by Spatial Computing, Cloud and Artificial Intelligence (\u201cAI\u201d), which we refer to as \u201cSpatial C\u2026"},{"fy":2025,"lvl":3,"n":15,"adsh":"0001493152-25-016073","doc":"form10-k.htm","q":"In fiscal year 2024, we shifted our businesses (\u201cStrategic Shift\u201d) to focus on providing immersive technology solutions software and services that are primarily driven by Spatial Computing, Cloud and Artificial Intelligence (\u201cAI\u201d), includin\u2026"}]},{"cik":1855175,"name":"CONTINEUM THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001437749-25-006458","doc":"cont20241231_10k.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001628280-26-015165","doc":"ctnm-20251231.htm","q":"Sensitive information of the company could also be leaked, disclosed, or revealed as a result of or in connection with our employees\u2019, personnel\u2019s, or third parties\u2019 with whom we work use of generative AI technologies."}]},{"cik":1855447,"name":"TIGO ENERGY, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000564","doc":"rocg-20221231x10k.htm","q":null},{"fy":2023,"lvl":2,"n":6,"adsh":"0000950170-24-034765","doc":"tygo-20231231.htm","q":"This innovative Software as a Service (\u201cSaaS\u201d) solution leverages artificial intelligence (\u201cAI\u201d) and machine learning technologies to offer accurate, customizable forecasting models for electricity generation and consumption."},{"fy":2024,"lvl":3,"n":19,"adsh":"0000950170-25-042645","doc":"tygo-20241231.htm","q":"Risks Related to Intellectual Property and Technology \u2022 Our patent applications may not result in issued patents, and our issued patents may not provide adequate protection. \u2022 Our failure to protect our intellectual property rights may unde\u2026"},{"fy":2025,"lvl":3,"n":22,"adsh":"0001193125-26-115952","doc":"tygo-20251231.htm","q":"Risks Related to Intellectual Property and Technology \u2022 Our patent applications may not result in issued patents, and our issued patents may not provide adequate protection. \u2022 Our failure to protect our intellectual property rights may unde\u2026"}]},{"cik":1855467,"name":"MOBIX LABS, INC","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2024,"lvl":2,"n":10,"adsh":"0001493152-24-051917","doc":"form10-k.htm","q":"Moreover, we believe ongoing deployment of applications for artificial intelligence (\u201cAI\u201d), alternative reality (\u201cAR\u201d), virtual reality (\u201cVR\u201d), autonomous vehicles, and industrial Internet of Things (\u201cIoT\u201d) sensors, will compound the strain\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0001493152-26-001921","doc":"form10-k.htm","q":"Moreover, we believe ongoing deployment of applications for artificial intelligence (\u201cAI\u201d), alternative reality (\u201cAR\u201d), virtual reality (\u201cVR\u201d), autonomous vehicles, and industrial Internet of Things (\u201cIoT\u201d) sensors, will compound the strain\u2026"}]},{"cik":1855485,"name":"CALIDI BIOTHERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001193125-23-088349","doc":"d421525d10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-010158","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-001810","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-013242","doc":"form10-k.htm","q":null}]},{"cik":1855631,"name":"AERWINS TECHNOLOGIES INC.","industry":"Aerospace & defense","sic":3721,"state":null,"cells":[{"fy":2022,"lvl":3,"n":21,"adsh":"0001193125-23-087988","doc":"d454525d10k.htm","q":"To realize this vision, we are developing the following business areas: (1) manned air mobility area, which involves the sale and development of hoverbikes that can float at low altitude through impassable zones in times of disaster, etc., \u2026"},{"fy":2023,"lvl":"x","n":3,"adsh":"0001493152-24-017204","doc":"form10-k.htm","q":"Bankruptcy. 5 ALI\u2019s discontinued operations include the manned air mobility business, including the further development of the XTURISMO limited edition hoverbike, the air mobility platform COSMOS (Centralized Operating System for Managing O\u2026"}]},{"cik":1855644,"name":"ZURA BIO LTD","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000374","doc":"jatt-20221231x10k.htm","q":null},{"fy":2023,"lvl":1,"n":2,"adsh":"0001410578-24-000329","doc":"zura-20231231x10k.htm","q":"(4) 4,205,000 9.6 % AI Biotechnology LLC (5) 4,388,560 10.1 % Ewon Comfortech Co., Ltd."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001410578-25-000443","doc":"zura-20241231x10k.htm","q":"Such cyber-attacks may include, but are not limited to, social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), \u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001104659-26-032080","doc":"zura-20251231x10k.htm","q":"The rule applies regardless of whether data is anonymized, key-coded, pseudonymized, de-identified or encrypted, which presents particular challenges for companies like ours and may impact our ability to transfer data in connection with cer\u2026"}]},{"cik":1855747,"name":"BLEND LABS, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001855747-22-000013","doc":"blnd-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001855747-23-000016","doc":"blnd-20221231.htm","q":null},{"fy":2023,"lvl":3,"n":18,"adsh":"0001855747-24-000015","doc":"blnd-20231231.htm","q":"We also have incorporated, and may continue to incorporate, artificial intelligence (\u201cAI\u201d) technologies into our platform and otherwise in our business, which may increase cybersecurity risks."},{"fy":2024,"lvl":3,"n":24,"adsh":"0001855747-25-000017","doc":"blnd-20241231.htm","q":"We also have incorporated, and may continue to incorporate, artificial intelligence (\u201cAI\u201d) technologies into our platform and otherwise in our business, which may increase cybersecurity risks."},{"fy":2025,"lvl":3,"n":27,"adsh":"0001855747-26-000016","doc":"blnd-20251231.htm","q":"Our platform brings together the data, technology, and AI-powered architecture needed to streamline and personalize every step of origination."}]},{"cik":1856314,"name":"CLEAR SECURE, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001856314-22-000008","doc":"you-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001628280-23-005937","doc":"you-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001856314-24-000023","doc":"you-20231231.htm","q":null},{"fy":2024,"lvl":2,"n":12,"adsh":"0001856314-25-000008","doc":"you-20241231.htm","q":"These laws and regulations pertain to matters including but not limited to, the collection and use of personal information, biometric and health information, data privacy, cybersecurity and information protection, labor and employment, inte\u2026"},{"fy":2025,"lvl":2,"n":10,"adsh":"0001856314-26-000006","doc":"you-20251231.htm","q":"These laws and regulations pertain to matters including but not limited to, the collection and use of personal information, biometric and health information, data privacy, cybersecurity and information protection, labor and employment, inte\u2026"}]},{"cik":1856725,"name":"RANI THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005088","doc":"rani-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009178","doc":"rani-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-034163","doc":"rani-20231231.htm","q":"We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, a\u2026"},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-047740","doc":"rani-20241231.htm","q":"These actions may include, for example, directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation to consider new payment and healthcare models to limit \u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-126417","doc":"rani-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which are increasingly more difficult to identify as fake, and p\u2026"}]},{"cik":1857044,"name":"INDAPTUS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-007319","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-008010","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-009769","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001493152-25-010136","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-010585","doc":"form10-k.htm","q":null}]},{"cik":1858257,"name":"AVIDXCHANGE HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2021,"lvl":1,"n":2,"adsh":"0000950170-22-003480","doc":"avdx-20211231.htm","q":"If a new or revised visa program is implemented, it may impact our ability to recruit, hire, retain or effectively collaborate with qualified skilled personnel, including in the areas of artificial intelligence and machine learning, payment\u2026"},{"fy":2022,"lvl":1,"n":2,"adsh":"0000950170-23-005490","doc":"avdx-20221231.htm","q":"If a new or revised visa program is implemented, it may impact our ability to recruit, hire, retain or effectively collaborate with qualified skilled personnel, including in the areas of artificial intelligence and machine learning, payment\u2026"},{"fy":2023,"lvl":3,"n":20,"adsh":"0000950170-24-023077","doc":"avdx-20231231.htm","q":"Actions taken to control our operating costs included leveraging off-shore resources when appropriate, restructuring select areas of our U.S. workforce, pursuing cost management strategies across our operations, and utilizing artificial int\u2026"},{"fy":2024,"lvl":3,"n":64,"adsh":"0000950170-25-029974","doc":"avdx-20241231.htm","q":"Actions taken to control costs included continued discipline in the pursuit of unit cost efficiencies in our processing of invoices and payments, the pursuit of cost management strategies in our portfolio of office locations outside of Char\u2026"}]},{"cik":1858685,"name":"BIOFRONTERA INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001493152-22-009519","doc":"form10-k.htm","q":"To ensure collection of highly consistent data across all participating sites, the study will combine clinical assessments performed by the physicians conducting the study with a cutting-edge, FDA-approved, artificial intelligence analysis \u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007472","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-010133","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001493152-25-011052","doc":"form10-k.htm","q":"Further, these risks may be exacerbated by recent developments in artificial intelligence and its increased use to produce sophisticated malware, phishing schemes, and other fraudulent activities."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001493152-26-011625","doc":"form10-k.htm","q":"Further, these risks may be exacerbated by recent developments in artificial intelligence and its increased use to produce sophisticated malware, phishing schemes, and other fraudulent activities."}]},{"cik":1858848,"name":"TENAYA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":8,"adsh":"0000950170-22-004426","doc":"tnya-20211231.htm","q":"Our Precision Medicine platform uses human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as proprietary disease models combined with analysis of human genetics and the use of machine learning algorithms for the identifica\u2026"},{"fy":2022,"lvl":2,"n":10,"adsh":"0000950170-23-006725","doc":"tnya-20221231.htm","q":"We also continue to invest in complementary new technologies and the optimization of our existing proprietary capabilities, including the use of human-induced Pluripotent Stem Cell (iPSC) disease models, machine learning and phenotypic scre\u2026"},{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-032828","doc":"tnya-20231231.htm","q":"We have invested in our interrelated capabilities, including the use of human-induced Pluripotent Stem Cell (iPSC) and engineered heart tissue disease models, machine learning and phenotypic screening, capsid engineering and novel promoter \u2026"},{"fy":2024,"lvl":2,"n":6,"adsh":"0000950170-25-036329","doc":"tnya-20241231.htm","q":"We have invested in our interrelated capabilities, including the use of human-induced Pluripotent Stem Cell (iPSC) and engineered heart tissue disease models, machine learning and phenotypic screening, capsid engineering and novel promoter \u2026"},{"fy":2025,"lvl":1,"n":4,"adsh":"0001193125-26-102252","doc":"tnya-20251231.htm","q":"Our interrelated capabilities include the use of human-induced Pluripotent Stem Cell (iPSC)-derived and engineered heart tissue disease models, machine learning and phenotypic screening and capsid engineering and novel promoter constructs, \u2026"}]},{"cik":1859007,"name":"ZYVERSA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-010259","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011073","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-000862","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-014271","doc":"form10-k.htm","q":null}]},{"cik":1860173,"name":"PRIVACY & VALUE INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2021,"lvl":"x","n":0,"adsh":"0001575705-22-000108","doc":"privacyvalue_10ka.htm","q":null},{"fy":2022,"lvl":"x","n":0,"adsh":"0001903596-22-000701","doc":"privacyvalue_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001139020-25-000209","doc":"pcvl-20230731.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001139020-25-000217","doc":"pcvl-20240731.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001860173-25-000004","doc":"pcvl-20250731_10k.htm","q":null}]},{"cik":1860657,"name":"ALLARITY THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":2,"n":5,"adsh":"0001213900-22-027311","doc":"f10k2021_allaritytherap.htm","q":"Indeed, many patients who are HER2 positive do not respond well to drugs targeting this receptor and/or patients that initially respond become resistant, indicating other, more complex underlying tumor biology. \u25cf \u201cArtificial Intelligence\u201d (\u2026"},{"fy":2022,"lvl":2,"n":5,"adsh":"0001213900-23-019295","doc":"f10k2022_allaritytherap.htm","q":"Indeed, many patients who are HER2 positive do not respond well to drugs targeting this receptor and/or patients that initially respond become resistant, indicating other, more complex underlying tumor biology. \u25cf \u201cArtificial Intelligence\u201d (\u2026"},{"fy":2023,"lvl":2,"n":5,"adsh":"0001213900-24-020864","doc":"ea0200752-10k_allarity.htm","q":"Indeed, many patients who are HER2 positive do not respond well to drugs targeting this receptor and/or patients that initially respond become resistant, indicating other, more complex underlying tumor biology. \u25cf \u201cArtificial Intelligence\u201d (\u2026"},{"fy":2024,"lvl":3,"n":18,"adsh":"0001437749-25-010198","doc":"allr20241231_10k.htm","q":"The development and use of artificial intelligence, or AI, presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data and could g\u2026"},{"fy":2025,"lvl":3,"n":19,"adsh":"0001437749-26-010310","doc":"allr20251231_10k.htm","q":"The development and use of artificial intelligence, or AI, presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data and could g\u2026"}]},{"cik":1860782,"name":"2SEVENTY BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001860782-22-000005","doc":"tsvt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001860782-23-000038","doc":"tsvt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001860782-24-000027","doc":"tsvt-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001860782-25-000024","doc":"tsvt-20241231.htm","q":null}]},{"cik":1860871,"name":"TEVOGEN BIO HOLDINGS INC.","industry":"Pharma & biotech","sic":2836,"state":"NJ","cells":[{"fy":2023,"lvl":3,"n":22,"adsh":"0001493152-24-016796","doc":"form10-k.htm","q":"We also intend to explore options to work with partners to augment the study and treatment of patients and the impact of our product candidates, including medical professionals, healthcare professional networks, pharmacy benefit managers, i\u2026"},{"fy":2024,"lvl":"x","n":66,"adsh":"0001641172-25-002426","doc":"form10-k.htm","q":"We also intend to explore options to work with partners to augment the study and treatment of patients and the impact of our product candidates, including medical professionals, healthcare professional networks, pharmacy benefit managers, i\u2026"},{"fy":2025,"lvl":"x","n":81,"adsh":"0001493152-26-014326","doc":"form10-k.htm","q":"We also intend to explore options to work with partners to augment the study and treatment of patients and the impact of our product candidates, including medical professionals, healthcare professional networks, pharmacy benefit managers, i\u2026"}]},{"cik":1861560,"name":"NUVALENT, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001193125-22-087401","doc":"d319667d10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008284","doc":"nuvl-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0000950170-24-020607","doc":"nuvl-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2024,"lvl":2,"n":10,"adsh":"0000950170-25-028328","doc":"nuvl-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2025,"lvl":2,"n":10,"adsh":"0001193125-26-073317","doc":"nuvl-20251231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information and personal data."}]},{"cik":1861657,"name":"CANTON STRATEGIC HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2021,"lvl":"x","n":21,"adsh":"0001493152-22-008703","doc":"form10-k.htm","q":"In addition, TridentAI, our artificial intelligence precision medicine platform, is used to identify biomarkers in our clinical programs to target specific patient segments."},{"fy":2022,"lvl":"x","n":1,"adsh":"0001493152-23-007977","doc":"form10-k.htm","q":"Our Chief Executive Officer and directors have held various research, clinical development, artificial intelligence, strategy, corporate development and operational positions at large biopharmaceutical companies , public biotechnology compa\u2026"},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-007612","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-000654","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001493152-26-013861","doc":"form10-k.htm","q":"Toomey served as the Head of Distribution for Galaxy Digital, a digital asset and artificial intelligence company, from March 2021 to March 2025."}]},{"cik":1861795,"name":"DEFINITIVE HEALTHCARE CORP.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2021,"lvl":3,"n":22,"adsh":"0000950170-22-003770","doc":"dh-20211231.htm","q":"Our healthcare commercial intelligence platform brings together comprehensive, in-depth and high-quality intelligence, a powerful artificial intelligence (\"A.I.\") engine, and an intuitive front-end SaaS platform, which have all been built, \u2026"},{"fy":2022,"lvl":3,"n":26,"adsh":"0000950170-23-004643","doc":"dh-20221231.htm","q":"Our healthcare commercial intelligence platform brings together comprehensive, in-depth and high-quality intelligence, a powerful artificial intelligence (\u201cA.I.\u201d) engine, and an intuitive front-end SaaS platform, which have all been built, \u2026"},{"fy":2023,"lvl":3,"n":31,"adsh":"0000950170-24-022134","doc":"dh-20231231.htm","q":"Our healthcare commercial intelligence platform brings together comprehensive, in-depth and high-quality intelligence, a powerful artificial intelligence (\u201cA.I.\u201d) engine, and an intuitive front-end SaaS platform, which have all been built, \u2026"},{"fy":2024,"lvl":3,"n":47,"adsh":"0000950170-25-029086","doc":"dh-20241231.htm","q":"Our healthcare commercial intelligence platform brings together comprehensive, in-depth and high-quality intelligence, a powerful artificial intelligence engine, and an intuitive front-end SaaS platform, which have all been built, modified \u2026"},{"fy":2025,"lvl":3,"n":43,"adsh":"0001193125-26-076782","doc":"dh-20251231.htm","q":"We transform this data into intelligence through AI and machine learning algorithms that ingest, cleanse, link, and analyze the data to create powerful new intelligence and analytics."}]},{"cik":1862068,"name":"RUBICON TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7372,"state":"KY","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001829126-22-006864","doc":"founderspac_10k.htm","q":"Our Business Strategy From infrastructure to applications, including artificial intelligence and machine learning, Digital Transformation spans a wide addressable market."},{"fy":2022,"lvl":2,"n":9,"adsh":"0001829126-23-002201","doc":"rubicontech_10k.htm","q":"Using proprietary technology in Machine Learning, Artificial Intelligence (\u201cAI\u201d), computer vision, and Industrial Internet of Things (\u201cIoT\u201d), for which we have secured more than 60 U.S. and international patents, we have built an innovative\u2026"},{"fy":2023,"lvl":2,"n":7,"adsh":"0001437749-24-009871","doc":"rbt20231231_10k.htm","q":"Using proprietary technology in Machine Learning, Artificial Intelligence (\u201cAI\u201d), computer vision, and Industrial Internet of Things (\u201cIoT\u201d), for which we have secured more than 60 U.S. and international patents, we have built an innovative\u2026"}]},{"cik":1862150,"name":"CINGULATE INC.","industry":"Pharma & biotech","sic":2834,"state":"KS","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-007903","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-007252","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012159","doc":"0001493152-24-012159.txt","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001641172-25-000970","doc":"form10-k.htm","q":"The rapid evolution and increased adoption of artificial intelligence (\u201cAI\u201d) technologies may also heighten our cybersecurity risks by making cyber-attacks more difficult to detect, contain, and mitigate."},{"fy":2025,"lvl":2,"n":11,"adsh":"0001493152-26-010882","doc":"form10-k.htm","q":"The rapid evolution and increased adoption of artificial intelligence (\u201cAI\u201d) technologies may also heighten our cybersecurity risks by making cyber-attacks more difficult to detect, contain, and mitigate."}]},{"cik":1863105,"name":"ENGAGESMART, INC.","industry":"Software & IT services","sic":7372,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002829","doc":"esmt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-003943","doc":"esmt-20221231.htm","q":null}]},{"cik":1863127,"name":"TYRA BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-002814","doc":"tyra-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009181","doc":"tyra-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-033461","doc":"tyra-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-046124","doc":"tyra-20241231.htm","q":null},{"fy":2025,"lvl":1,"n":2,"adsh":"0001193125-26-085490","doc":"tyra-20251231.htm","q":"Cyberattacks are expected to accelerate on a global basis in frequency and magnitude as threat actors are becoming increasingly sophisticated in using techniques and tools \u2013 including artificial intelligence \u2013 that circumvent security contr\u2026"}]},{"cik":1865045,"name":"FAT PROJECTS ACQUISITION CORP","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001829126-23-002008","doc":"fatprojects_10k.htm","q":null}]},{"cik":1865111,"name":"ALPHA STAR ACQUISITION CORP","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-011791","doc":"form10-k.htm","q":null}]},{"cik":1865127,"name":"LUCY SCIENTIFIC DISCOVERY, INC.","industry":"Pharma & biotech","sic":2834,"state":"BC","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001013762-23-003864","doc":"f10k2023_lucyscientific.htm","q":null}]},{"cik":1865494,"name":"IO BIOTECH, INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-005244","doc":"iobt-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-007902","doc":"iobt-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-026275","doc":"iobt-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-047744","doc":"iobt-20241231.htm","q":null}]},{"cik":1865506,"name":"ZEO ENERGY CORP.","industry":"Construction","sic":1700,"state":"TX","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-26-037791","doc":"ea0283937-10k_zeoenergy.htm","q":null}]},{"cik":1865631,"name":"NEXTNAV INC.","industry":"Aerospace & defense","sic":3812,"state":"VA","cells":[{"fy":2021,"lvl":1,"n":1,"adsh":"0001213900-22-014480","doc":"f10k2021_nextnavinc.htm","q":"Crowd-sourced systems, such as those provided by Google and Apple through APIs in their mobile operation system platforms, rely on the application of machine learning techniques to location information gathered from mobile devices."},{"fy":2022,"lvl":1,"n":1,"adsh":"0001213900-23-024631","doc":"nn-20221231.htm","q":"Crowd-sourced systems, such as those provided by Google and Apple through APIs in their mobile operation system platforms, rely on the application of machine learning techniques to location information gathered from mobile devices."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001213900-24-022183","doc":"nn-20231231.htm","q":"Crowd-sourced systems, such as those provided by Google and Apple through APIs in their mobile operation system platforms, rely on the application of machine learning techniques to location information gathered from mobile devices."},{"fy":2024,"lvl":1,"n":1,"adsh":"0001213900-25-023287","doc":"nn-20241231.htm","q":"The rise in the use and sophistication of artificial intelligence systems may also increase the risk and severity of cyber incidents."},{"fy":2025,"lvl":1,"n":1,"adsh":"0001554855-26-000328","doc":"nn-20251231.htm","q":"The rise in the use and sophistication of artificial intelligence systems may also increase the risk and severity of cyber incidents. 15 Any event that leads to unauthorized access, use or disclosure of personal information could disrupt ou\u2026"}]},{"cik":1866368,"name":"CLEARWATER ANALYTICS HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"ID","cells":[{"fy":2021,"lvl":1,"n":4,"adsh":"0000950170-22-003915","doc":"cwan-20211231.htm","q":"By leveraging machine learning, automation and our direct connections with approximately 1,000 custodians, more than 1,400 managers, more than 240 trading data sources and all of the leading third party market data providers, our platform a\u2026"},{"fy":2022,"lvl":1,"n":4,"adsh":"0000950170-23-005990","doc":"cwan-20221231.htm","q":"By leveraging machine learning, automation and our direct connections with approximately 1,000 custodians, more than 1,400 managers, more than 400 trading data sources and all of the leading third-party market data providers, our platform a\u2026"},{"fy":2023,"lvl":3,"n":31,"adsh":"0001628280-24-007825","doc":"cwan-20231231.htm","q":"Using machine learning (\u201cML\u201d) and artificial intelligence (\u201cAI\u201d), we harvest the most important data about these alternative assets so that investors have the details they need to act quickly and report confidently."},{"fy":2024,"lvl":3,"n":32,"adsh":"0001628280-25-008169","doc":"cwan-20241231.htm","q":"Using machine learning (\u201cML\u201d) and artificial intelligence (\u201cAI\u201d), we harvest the most important data about these alternative assets so that investors have the details they need to act quickly and report confidently."},{"fy":2025,"lvl":3,"n":50,"adsh":"0001866368-26-000011","doc":"cwan-20251231.htm","q":"Our cloud-native AI-powered software allows clients to radically simplify their investment management operations, enabling them to focus on higher-value business functions such as asset allocation strategy and investment selection."}]},{"cik":1866550,"name":"THOUGHTWORKS HOLDING, INC.","industry":"Software & IT services","sic":7371,"state":"IL","cells":[{"fy":2021,"lvl":2,"n":11,"adsh":"0001866550-22-000006","doc":"twks-20211231.htm","q":"Our four global service lines provide specialized capabilities and thought leadership to drive digital transformation: \u2022 Enterprise Modernization, Platforms & Cloud \u2022 Customer Experience, Product & Design \u2022 Data & Artificial Intelligence (\"\u2026"},{"fy":2022,"lvl":2,"n":8,"adsh":"0001866550-23-000008","doc":"twks-20221231.htm","q":"Our four global service lines provide specialized capabilities and thought leadership to drive digital transformation: \u2022 Enterprise Modernization, Platforms & Cloud \u2022 Customer Experience, Product & Design \u2022 Data & Artificial Intelligence (\"\u2026"},{"fy":2023,"lvl":3,"n":36,"adsh":"0001866550-24-000022","doc":"twks-20231231.htm","q":"We leverage our vast experience to improve our clients\u2019 ability to harness the benefits of cloud, data, and AI to deliver value and adapt to change."}]},{"cik":1866633,"name":"CONSENSUS CLOUD SOLUTIONS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":1,"n":3,"adsh":"0001866633-22-000021","doc":"ccs-20211231.htm","q":"Clarity: Using Natural Language Processing and Artificial Intelligence (NLP/AI) Clarity\u2019s valuable insightful information can transform unstructured documents into structured actionable data."},{"fy":2022,"lvl":1,"n":3,"adsh":"0001866633-23-000019","doc":"ccs-20221231.htm","q":"Clarity: Using Natural Language Processing and Artificial Intelligence (NLP/AI) Clarity\u2019s valuable insightful information can transform unstructured documents into structured actionable data."},{"fy":2023,"lvl":2,"n":5,"adsh":"0001866633-24-000004","doc":"ccs-20231231.htm","q":"In 2022, Consensus launched Clarity, an intelligent data extraction technology which uses artificial intelligence and machine learning to extract and, combined with other Consensus offerings, transform unstructured information in documents \u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001866633-25-000004","doc":"ccs-20241231.htm","q":"Clarity: Using Natural Language Processing and Artificial Intelligence (\u201cNLP/AI\u201d), the Clarity platform can transform unstructured documents into structured actionable data."},{"fy":2025,"lvl":3,"n":23,"adsh":"0001866633-26-000004","doc":"ccs-20251231.htm","q":"ECFax \u00ae is a SaaS offering authorized at the FedRAMP High Impact level operating in a government cloud environment. eFax Unite TM : eFax Unite TM is a single platform that allows the user to choose between several protocols to send and rece\u2026"}]},{"cik":1866692,"name":"AMPLITUDE, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":2,"n":10,"adsh":"0000950170-22-001372","doc":"ampl-20211231.htm","q":"The best-in-class digital companies leverage product data to build robust recommendation engines based on artificial intelligence (\u201cAI\u201d) and machine learning (\u201cML\u201d) algorithms to deliver highly differentiated experiences at scale. \u2022 Leverag\u2026"},{"fy":2022,"lvl":2,"n":6,"adsh":"0000950170-23-003045","doc":"ampl-20221231.htm","q":"This is foundational functionality embedded in Analytics that supports how customers analyze, activate, and test new digital products and experiences. \u2022 Amplitude Analytics, consistently ranked #1 in multiple categories by G2, provides real\u2026"},{"fy":2023,"lvl":2,"n":5,"adsh":"0000950170-24-017102","doc":"ampl-20231231.htm","q":"Best-in-class digital companies leverage product data and artificial intelligence (\u201cAI\u201d) to deliver technology that adapts to people, not the other way around. \u2022 Leverage Data Democratization and Common Visibility."},{"fy":2024,"lvl":3,"n":84,"adsh":"0000950170-25-024135","doc":"ampl-20241231.htm","q":"Delivers Personalization at Scale: As consumer expectations for tailored experiences rise, we are seeing a gradual increase in companies using product data and AI to create adaptive and personalized user-centric solutions. 3."},{"fy":2025,"lvl":3,"n":270,"adsh":"0001193125-26-057847","doc":"ampl-20251231.htm","q":"Business Overview Founded in 2012, Amplitude is driving the evolution of AI analytics as part of our mission to help companies build better products and digital experiences."}]},{"cik":1867066,"name":"JOURNEY MEDICAL CORP","industry":"Pharma & biotech","sic":2834,"state":"AZ","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001410578-22-000558","doc":"derm-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000485","doc":"derm-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000347","doc":"derm-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":16,"adsh":"0001410578-25-000490","doc":"derm-20241231x10k.htm","q":"Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. 37 Table of Contents The use of artificial intelligence in the healthcare industry and challenges with properly managi\u2026"},{"fy":2025,"lvl":3,"n":16,"adsh":"0001104659-26-034629","doc":"derm-20251231x10k.htm","q":"The use of artificial intelligence in the healthcare industry and challenges with properly managing its use could adversely affect our business."}]},{"cik":1867096,"name":"XERIS BIOPHARMA HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001867096-22-000040","doc":"xers-20211231.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001867096-23-000031","doc":"xers-20221231.htm","q":null},{"fy":2023,"lvl":2,"n":10,"adsh":"0001867096-24-000031","doc":"xers-20231231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2024,"lvl":3,"n":18,"adsh":"0001867096-25-000039","doc":"xers-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":51,"adsh":"0001867096-26-000016","doc":"xers-20251231.htm","q":"Attempts to disrupt or gain unauthorized access to our and our third-party vendors' information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or\u2026"}]},{"cik":1867956,"name":"LINKTORY INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001683168-22-005073","doc":"linktory_i10k-053122.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-23-005190","doc":"linktory_i10k-053123.htm","q":null}]},{"cik":1868275,"name":"CONSTELLATION ENERGY CORP","industry":"Utilities","sic":4911,"state":"MD","cells":[{"fy":2021,"lvl":"x","n":1,"adsh":"0001868275-22-000020","doc":"ceg-20211231.htm","q":"Admiral Richardson also currently serves as a director of Sparkcognition Government Systems, a developer of A.I. solutions for multiple industries including energy, defense and finance, and of the Center for New American Security, a biparti\u2026"},{"fy":2022,"lvl":0,"n":0,"adsh":"0001868275-23-000014","doc":"ceg-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":3,"adsh":"0001868275-24-000014","doc":"ceg-20231231.htm","q":"For example, as Artificial Intelligence (AI) continues to evolve, threat actors could use AI to develop malicious code and sophisticated phishing attempts."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001868275-25-000023","doc":"ceg-20241231.htm","q":"Significant planned investments from hyperscalers such as Microsoft, Google, and Amazon in artificial intelligence (AI) technology and infrastructure are further contributing to unprecedented demand for reliable, around-the-clock energy in \u2026"},{"fy":2025,"lvl":3,"n":21,"adsh":"0001868275-26-000032","doc":"ceg-20251231.htm","q":"The rapid expansion of data centers continues to accelerate, driven by widespread adoption of AI technologies and large-scale infrastructure investments by major hyperscalers such as Microsoft, Google, Meta, and Amazon."}]},{"cik":1868279,"name":"ARRIVENT BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2024,"lvl":1,"n":2,"adsh":"0001558370-25-001999","doc":"avbp-20241231x10k.htm","q":"Finally, developments in artificial intelligence and machine learning provide threat actors with the capability to use more sophisticated means to attack our systems and may exacerbate cybersecurity risk."},{"fy":2025,"lvl":1,"n":2,"adsh":"0001104659-26-024127","doc":"avbp-20251231x10k.htm","q":"Finally, developments in artificial 107 Table of Contents intelligence (AI) and machine learning provide threat actors with the capability to use more sophisticated means to attack our systems and may exacerbate cybersecurity risk."}]},{"cik":1868419,"name":"CYCURION, INC.","industry":"Software & IT services","sic":7371,"state":"VA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000570","doc":"wavs-20221231x10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001410578-24-000540","doc":"wavs-20231231x10k.htm","q":null},{"fy":2024,"lvl":3,"n":17,"adsh":"0001641172-25-005155","doc":"form10-k.htm","q":"This process is directed by our Cycurion Security Platform\u2019s proprietary, cloud-based artificial intelligence (\u201cAI\u201d) algorithm."},{"fy":2025,"lvl":3,"n":20,"adsh":"0001868419-26-000010","doc":"cycu-20251231.htm","q":"(collectively with its subsidiaries, the \"Company,\" \"Cycurion,\" \"we,\" \"us\" or \"our\") is a publicly traded, cybersecurity and artificial intelligence (\"AI\")-powered IT solutions provider headquartered in McLean, Virginia."}]},{"cik":1868734,"name":"CINCOR PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0000950170-22-004307","doc":"cinc-20211231.htm","q":null}]},{"cik":1868778,"name":"INFORMATICA INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":41,"adsh":"0001868778-22-000010","doc":"infa-20211231.htm","q":"Our AI-powered IDMC platform delivers best-of-breed solutions that enables enterprises to create a single source of truth for their data, allowing them to create compelling 360-degree customer experiences, automate data operations across en\u2026"},{"fy":2022,"lvl":3,"n":28,"adsh":"0001868778-23-000010","doc":"infa-20221231.htm","q":"Our AI-powered IDMC platform delivers best-of-breed solutions that enables enterprises to create a single source of truth for their data, allowing them to create compelling 360-degree customer experiences, automate data operations across en\u2026"},{"fy":2023,"lvl":3,"n":121,"adsh":"0001868778-24-000006","doc":"infa-20231231.htm","q":"BUSINESS Overview We deliver innovation-led products powered by the industry's only artificial intelligence (\"AI\") powered data management cloud platform in a multi-vendor, multi-cloud, hybrid approach."},{"fy":2024,"lvl":3,"n":153,"adsh":"0001868778-25-000007","doc":"infa-20241231.htm","q":"BUSINESS Overview We deliver innovation-led products powered by the industry leading artificial intelligence (\"AI\") enabled data management products on a cloud native platform in a multi-vendor, multi-cloud, hybrid approach."}]},{"cik":1868912,"name":"ENFUSION, INC.","industry":"Software & IT services","sic":7372,"state":"IL","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001558370-22-004676","doc":"enfn-20211231x10k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003450","doc":"enfn-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002987","doc":"enfn-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002043","doc":"enfn-20241231x10k.htm","q":null}]},{"cik":1869105,"name":"BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":34,"adsh":"0001193125-26-094112","doc":"bbot-20251231.htm","q":"These attacks and activity are also being facilitated or enhanced by evolving technologies, including artificial intelligence."}]},{"cik":1869974,"name":"OCEAN BIOMEDICAL, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-010129","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-047661","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":1,"adsh":"0001641172-25-003155","doc":"form10-k.htm","q":"As such it is exploring opportunities in different business segments including but not limited to data centers and artificial intelligence and other related areas."}]},{"cik":1870404,"name":"CERO THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-029051","doc":"ea0201955-10k_cerothera.htm","q":null},{"fy":2024,"lvl":"x","n":25,"adsh":"0001213900-25-032134","doc":"ea0237245-10k_cero.htm","q":"Like many companies, we may use artificial intelligence and machine learning (AI) technologies, including generative AI, to efficiently grow and manage our business."},{"fy":2025,"lvl":"x","n":31,"adsh":"0001213900-26-044040","doc":"ea0285271-10k_cero.htm","q":"Like many companies, we may use artificial intelligence and machine learning (AI) technologies, including generative AI, to efficiently grow and manage our business."}]},{"cik":1871638,"name":"BLAIZE HOLDINGS, INC.","industry":"Computers & chips","sic":3674,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":202,"adsh":"0000950170-25-053870","doc":"bzai-20241231.htm","q":"If we fail to comply with applicable laws or obligations, or if the confidentiality, integrity, or availability of this information or our information technology systems is compromised, our reputation may be harmed and we may be exposed to \u2026"},{"fy":2025,"lvl":3,"n":110,"adsh":"0001871638-26-000011","doc":"blz-20251231.htm","q":"(\u201cBlaize,\u201d the \u201cCompany,\u201d \u201cwe,\u201d \u201cus,\u201d and \u201cour\u201d) develops purpose-built AI-enabled computing solutions comprised of both our proprietary hardware and software, and complementary third-party hardware solutions, as further described below."}]},{"cik":1872812,"name":"TC BIOPHARM (HOLDINGS) PLC","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012486","doc":"form10-k.htm","q":null}]},{"cik":1873722,"name":"BUBBLR INC.","industry":"Software & IT services","sic":7370,"state":"WY","cells":[{"fy":2021,"lvl":"x","n":5,"adsh":"0001663577-22-000190","doc":"bblr10k.htm","q":"Additionally, we have been building complex AI and machine learning to optimize search results regarding relevance and salience for searching for news."},{"fy":2022,"lvl":"x","n":2,"adsh":"0001663577-23-000131","doc":"bblr10k123122.htm","q":"Additionally, we are building complex AI and machine learning to optimize search results regarding relevance and salience for searching for critical information."},{"fy":2023,"lvl":"x","n":132,"adsh":"0001493152-24-010665","doc":"form10-k.htm","q":"Except as otherwise indicated herein or as the context otherwise requires, references in this Annual Report to \u201cBubblr,\u201d the \u201cCompany,\u201d \u201cEthical Web.AI,\u201d \u201cwe,\u201d \u201cus,\u201d and \u201cour\u201d refer to Bubblr, Inc. and its wholly-owned subsidiaries, includi\u2026"},{"fy":2024,"lvl":"x","n":64,"adsh":"0001641172-25-001484","doc":"form10-k.htm","q":"Except as otherwise indicated herein or as the context otherwise requires, references in this Annual Report to \u201cBubblr,\u201d the \u201cCompany,\u201d \u201cEthical Web.AI,\u201d \u201cwe,\u201d \u201cus,\u201d and \u201cour\u201d refer to Bubblr, Inc. and fully-owned subsidiaries, including Bu\u2026"},{"fy":2025,"lvl":"x","n":65,"adsh":"0001493152-26-013999","doc":"form10-k.htm","q":"Except as otherwise specified here or as the context requires, references in this Annual Report to \u201cBubblr,\u201d the \u201cCompany,\u201d \u201cEthicalWeb.AI,\u201d \u201cEW\u201d, \u201cwe,\u201d \u201cus,\u201d and \u201cour\u201d refer to Bubblr, Inc. and its fully owned subsidiaries, including Bubbl\u2026"}]},{"cik":1873835,"name":"IMMIX BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001493152-22-007921","doc":"form10-k.htm","q":null},{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-009091","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011975","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-000387","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":3,"n":21,"adsh":"0001493152-26-012714","doc":"form10-k.htm","q":"Likewise, we rely on other third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could have a material adverse effect on our business. 50 Use of art\u2026"}]},{"cik":1873875,"name":"INCANNEX HEALTHCARE INC.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-24-082937","doc":"ea0212488-10k_incannex.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-25-092837","doc":"ea0258594-10k_incannex.htm","q":null}]},{"cik":1873951,"name":"EXZEO GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2025,"lvl":1,"n":3,"adsh":"0001193125-26-076686","doc":"xzo-20251231.htm","q":"Carriers can better analyze risk through enhanced pricing models, artificial intelligence and machine learning technology."}]},{"cik":1874097,"name":"CYNGN INC.","industry":"Software & IT services","sic":7371,"state":"CA","cells":[{"fy":2021,"lvl":3,"n":20,"adsh":"0001213900-22-014911","doc":"f10k2021_cyngninc.htm","q":"Complements the core competencies of existing industry players by introducing leading-edge technologies like Artificial Intelligence (AI) & Machine Learning (ML), cloud/connectivity, sensor fusion, high-definition mapping, and real-time dyn\u2026"},{"fy":2022,"lvl":3,"n":20,"adsh":"0001213900-23-020719","doc":"f10k2022_cyngninc.htm","q":"Complements the core competencies of existing industry players by introducing leading-edge technologies like Artificial Intelligence (\u201cAI\u201d) & Machine Learning (\u201cML\u201d), cloud/connectivity, sensor fusion, high-definition mapping, and real-time\u2026"},{"fy":2023,"lvl":3,"n":21,"adsh":"0001213900-24-020777","doc":"f10k2023_cyngninc.htm","q":"Complement the core competencies of existing industry players by introducing the leading-edge technologies of Artificial Intelligence (\u201cAI\u201d) & Machine Learning (\u201cML\u201d), cloud/connectivity, sensor fusion, high- definition mapping, and real-ti\u2026"},{"fy":2024,"lvl":3,"n":21,"adsh":"0001213900-25-021260","doc":"ea0229992-10k_cyngn.htm","q":"Complement the core competencies of existing industry players by introducing the leading-edge technologies of Artificial Intelligence (\u201cAI\u201d) & Machine Learning (\u201cML\u201d), cloud/connectivity, sensor fusion, high- definition mapping, and real-ti\u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001213900-26-034900","doc":"ea0277796-10k_cyngn.htm","q":"Complement the core competencies of existing industry players by introducing the leading-edge technologies of Artificial Intelligence (\u201cAI\u201d) & Machine Learning (\u201cML\u201d), cloud/connectivity, sensor fusion, high- definition mapping, and real-ti\u2026"}]},{"cik":1874178,"name":"RIVIAN AUTOMOTIVE, INC. / DE","industry":"Auto manufacturing","sic":3711,"state":"CA","cells":[{"fy":2021,"lvl":0,"n":0,"adsh":"0001874178-22-000008","doc":"rivn-20211231.htm","q":null},{"fy":2022,"lvl":1,"n":1,"adsh":"0001874178-23-000009","doc":"rivn-20221231.htm","q":"Our vehicles provide advanced driver assistance capabilities to our customers supported by hardware, software, and machine learning models."},{"fy":2023,"lvl":2,"n":8,"adsh":"0001874178-24-000014","doc":"rivn-20231231.htm","q":"Our vehicles provide advanced driver assistance capabilities to our customers supported by hardware, software, and machine learning models."},{"fy":2024,"lvl":3,"n":28,"adsh":"0001874178-25-000007","doc":"rivn-20241231.htm","q":"Our vehicles provide advanced driver assistance capabilities to our customers supported by hardware, software, and machine learning models."},{"fy":2025,"lvl":3,"n":35,"adsh":"0001874178-26-000008","doc":"rivn-20251231.htm","q":"Through innovation across its electrical architecture, end-to-end software, autonomous driving platform, artificial intelligence, and propulsion, the Company creates vehicles that excel at work and play with the goal of accelerating the glo\u2026"}]},{"cik":1874252,"name":"MAINZ BIOMED N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2025,"lvl":"x","n":4,"adsh":"0001213900-26-037676","doc":"ea0283918-10k_mainz.htm","q":"In March 2025, we acquired a license from Liquid Bioscience, Inc. to access a portfolio of novel mRNA biomarkers and AI developed proprietary algorithm, for the non-invasive detection of pancreatic cancer with a blood test."}]},{"cik":1875558,"name":"NUVECTIS PHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-003181","doc":"tmb-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002497","doc":"tmb-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-001496","doc":"tmb-20241231x10k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-013044","doc":"tmb-20251231x10k.htm","q":null}]},{"cik":1877461,"name":"1606 CORP.","industry":"Software & IT services","sic":7372,"state":"AZ","cells":[{"fy":2024,"lvl":"x","n":29,"adsh":"0001477932-25-002206","doc":"onesix_10k.htm","q":"In August of 2023, we decided to use our knowledge of the cannabidiol (\u201c CBD \u201d) industry to move into AI chatbots specifically made for the CBD industry."},{"fy":2025,"lvl":"x","n":35,"adsh":"0001477932-26-001635","doc":"cbdw_10k.htm","q":"In August of 2023, we decided to use our knowledge of the cannabidiol (\u201c CBD \u201d) industry to move into AI chatbots specifically made for the CBD industry."}]},{"cik":1878313,"name":"MAIA BIOTECHNOLOGY, INC.","industry":"Pharma & biotech","sic":2834,"state":"IL","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-009766","doc":"maia-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0000950170-24-034764","doc":"maia-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-043190","doc":"maia-20241231.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-012088","doc":"form10-k.htm","q":null}]},{"cik":1879001,"name":"VERSES AI INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2025,"lvl":"x","n":135,"adsh":"0001641172-25-019545","doc":"form10-k.htm","q":"The initial target audience for Genius is machine learning and data science professionals trying to solve enterprise problems that require prediction where there is uncertainty or hidden factors."}]},{"cik":1879848,"name":"PHOENIX MOTOR INC.","industry":"Auto manufacturing","sic":3713,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001410578-23-000543","doc":"pev-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001410578-24-000471","doc":"pev-20231231x10k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001641172-25-013062","doc":"form10-k.htm","q":"Liu holds a Ph.D. in Automotive Engineering from Tsinghua University, an MBA in Finance from the University of Chicago, an MS in Artificial Intelligence from the University of Mississippi, and a BS in Computer Science from Beijing Polytechn\u2026"}]},{"cik":1880431,"name":"VOCODIA HOLDINGS CORP","industry":"Software & IT services","sic":7371,"state":"FL","cells":[{"fy":2023,"lvl":"x","n":75,"adsh":"0001213900-24-033415","doc":"ea0203535-10k_vocodia.htm","q":"BUSINESS Overview Vocodia Holdings Corp (\u201cVHC\u201d) was incorporated in the State of Wyoming on April 27, 2021 and is a conversational AI technology provider."},{"fy":2024,"lvl":"x","n":70,"adsh":"0001213900-25-037129","doc":"ea0238485-10k_vocodia.htm","q":"BUSINESS Overview Vocodia Holdings Corp (\u201cVHC\u201d) was incorporated in the State of Wyoming on April 27, 2021 and is a conversational AI technology provider."}]},{"cik":1880438,"name":"AN2 THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010627","doc":"antx-20221231.htm","q":null},{"fy":2023,"lvl":1,"n":1,"adsh":"0000950170-24-038681","doc":"antx-20231231.htm","q":"Cybersecurity incidents are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives (including industria\u2026"},{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-044366","doc":"antx-20241231.htm","q":"Cybersecurity incidents are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives (including industria\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001193125-26-110693","doc":"antx-20251231.htm","q":"Cybersecurity incidents are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives (including industria\u2026"}]},{"cik":1881741,"name":"AROGO CAPITAL ACQUISITION CORP.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2022,"lvl":2,"n":7,"adsh":"0001213900-23-025215","doc":"f10k2022_arogocap.htm","q":"Our Board believes that the demand for AI and XR is growing, not just in education, and entertainment landscape but also in the enterprise space and the EON SaaS platform, EON-XR\u2122 is well-suited to meet this increasing demand."},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-041641","doc":"ea0204333-10k_arogo.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-066931","doc":"ea0242320-10k_arogocap.htm","q":null}]},{"cik":1883814,"name":"SOUTHLAND HOLDINGS, INC.","industry":"Construction","sic":1600,"state":"TX","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001558370-23-004297","doc":"slnd-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001558370-24-002367","doc":"slnd-20231231x10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002183","doc":"slnd-20241231x10k.htm","q":null},{"fy":2025,"lvl":1,"n":1,"adsh":"0001104659-26-035302","doc":"slnd-20251231x10k.htm","q":"Many factors, including the financial condition of the industries we serve and potential disruptions to such industries caused by the implementation of artificial intelligence, could adversely affect our customers and their willingness to f\u2026"}]},{"cik":1883835,"name":"ESG INC.","industry":"Pharma & biotech","sic":2836,"state":"PA","cells":[{"fy":2022,"lvl":"x","n":1,"adsh":"0001520138-22-000523","doc":"pmin-20220831_10k.htm","q":"Yang received an Master Degree in Law from China University of Political Science and Law (PRC) and received a LLM in Law from Temple University."},{"fy":2023,"lvl":1,"n":1,"adsh":"0001520138-23-000465","doc":"pmin-20220831_10k.htm","q":"Yang received an Master Degree in Law from China University of Political Science and Law (PRC) and received a LLM in Law from Temple University."},{"fy":2024,"lvl":1,"n":2,"adsh":"0001520138-25-000120","doc":"esgh-20241231_10k.htm","q":"Although our growing facilities are indoors under the control of AI monitor, we are still potential to encounter the malfunction of cooling, airflow, and heating system."}]},{"cik":1883984,"name":"ALTERNUS CLEAN ENERGY, INC.","industry":"Utilities","sic":4931,"state":"NY","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-039243","doc":"clinu-20221231x10k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-033052","doc":"ea0203655-10k_alternus.htm","q":"Present board positions include Atlantic Sapphire ASA (Audit Committee Chair), Aqua Bio Technology ASA, Filmparken AS (Chair), Storyline Studios AS (Chair), Hausmann AS (Chair), Dugnad.ai.AS (Chair), TF Bank AB (Audit Committee Chair), Omso\u2026"},{"fy":2024,"lvl":2,"n":9,"adsh":"0001213900-25-052242","doc":"ea0244740-10k_alternus.htm","q":"These additions enhance our technical capabilities, diversify revenue streams, and strengthen our ability to meet the rising demand for consistent power driven by AI, data centers, and industrial onshoring."},{"fy":2025,"lvl":3,"n":18,"adsh":"0001437749-26-020545","doc":"alce20241231_10k.htm","q":"Our near-term focus is the microgrid and onsite energy market, a rapidly growing segment driven by surging electricity demand from artificial intelligence infrastructure, data centers, and the onshoring of heavy industry."}]},{"cik":1885522,"name":"NEUMORA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2023,"lvl":3,"n":21,"adsh":"0000950170-24-027927","doc":"nmra-20231231.htm","q":"The Company acquired Syllable to gain access the rights granted to Syllable under an exclusive license agreement (as amended, the Harvard License Agreement) with President and Fellows of Harvard College (Harvard) and an associated behavior \u2026"},{"fy":2024,"lvl":3,"n":49,"adsh":"0000950170-25-030401","doc":"nmra-20241231.htm","q":null},{"fy":2025,"lvl":3,"n":49,"adsh":"0001193125-26-130388","doc":"nmra-20251231.htm","q":null}]},{"cik":1885849,"name":"TOFLA MEGALINE INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2022,"lvl":"x","n":1,"adsh":"0001885849-22-000015","doc":"annualreport.htm","q":null},{"fy":2023,"lvl":"x","n":1,"adsh":"0001885849-23-000017","doc":"tflm_10k2023.htm","q":null},{"fy":2024,"lvl":"x","n":8,"adsh":"0001885849-24-000015","doc":"tflm10k31jul24.htm","q":null}]},{"cik":1886894,"name":"SNAIL, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001104659-23-038408","doc":"snal-20221231x10k.htm","q":null},{"fy":2023,"lvl":3,"n":28,"adsh":"0001493152-24-012392","doc":"form10-k.htm","q":"The Company is strategically integrating artificial intelligence technology into our game development process."},{"fy":2024,"lvl":3,"n":34,"adsh":"0001641172-25-000784","doc":"form10-k.htm","q":"The Company is strategically integrating artificial intelligence technology into our game development process."},{"fy":2025,"lvl":3,"n":43,"adsh":"0001493152-26-011617","doc":"form10-k.htm","q":"The Company is strategically integrating artificial intelligence technology into our game development process."}]},{"cik":1887944,"name":"SHIMMICK CORP","industry":"Construction","sic":1600,"state":"CA","cells":[{"fy":2023,"lvl":1,"n":3,"adsh":"0000950170-24-038024","doc":"shim-20231229.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."},{"fy":2024,"lvl":"x","n":3,"adsh":"0000950170-25-042721","doc":"shim-20250103.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."},{"fy":2025,"lvl":2,"n":5,"adsh":"0001193125-26-105064","doc":"shim-20260102.htm","q":"In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks."}]},{"cik":1888012,"name":"HILLEVAX, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-008647","doc":"hlvx-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-034166","doc":"hlvx-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-046924","doc":"hlvx-20241231.htm","q":null}]},{"cik":1888886,"name":"STRUCTURE THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2023,"lvl":3,"n":28,"adsh":"0001558370-24-002791","doc":"gpcr-20231231x10k.htm","q":"Through our discovery engine, we leverage the power of cryo-electron microscopy (\u201ccryo-EM\u201d) machine learning and X-ray crystallography, as the basis for our molecular designs."},{"fy":2024,"lvl":3,"n":38,"adsh":"0001558370-25-001826","doc":"gpcr-20241231x10k.htm","q":"We are integrating advancements in computational chemistry, molecular imaging technologies, structural biology techniques and machine learning while continuing to deepen our understanding of GPCR signaling pathways and pharmacology."},{"fy":2025,"lvl":3,"n":42,"adsh":"0001104659-26-020562","doc":"gpcr-20251231x10k.htm","q":"We are integrating advancements in computational chemistry, molecular imaging technologies, structural biology techniques and machine learning while continuing to deepen our understanding of GPCR signaling pathways and pharmacology."}]},{"cik":1889450,"name":"FUTURETECH II ACQUISITION CORP.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2024,"lvl":2,"n":6,"adsh":"0001641172-25-003384","doc":"form10-k.htm","q":"Although there is no restriction or limitation on what industry or geographic region our target operates in, it is our intention to pursue prospective targets in the U.S. in the disruptive technology sector, for example, artificial intellig\u2026"}]},{"cik":1889956,"name":"ONESTREAM, INC.","industry":"Software & IT services","sic":7372,"state":"MI","cells":[{"fy":2024,"lvl":3,"n":91,"adsh":"0000950170-25-029037","doc":"ck0001889956-20241231.htm","q":"Overview OneStream delivers a unified, AI-enabled and extensible software platform\u2014the Digital Finance Cloud\u2014that modernizes and increases the strategic impact of the Office of the CFO."},{"fy":2025,"lvl":3,"n":95,"adsh":"0001193125-26-076771","doc":"ck0001889956-20251231.htm","q":"Overview OneStream delivers a unified, AI-enabled and extensible software platform\u2014the Digital Finance Cloud\u2014that modernizes and increases the strategic impact of the Office of the CFO."}]},{"cik":1892025,"name":"OPTIMUS HEALTHCARE SERVICES, INC.","industry":"Pharma & biotech","sic":8731,"state":"NY","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024979","doc":"f10k2022_optimushealth.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-053154","doc":"ea0207615-10k_optimus.htm","q":null}]},{"cik":1892292,"name":"MAISON SOLUTIONS INC.","industry":"Retail","sic":5411,"state":"CA","cells":[{"fy":2023,"lvl":1,"n":2,"adsh":"0001213900-23-061379","doc":"f10k2023_maison.htm","q":"Walmart China\u2019s traceability system uses state of the art blockchain and AI to track the movement of over 50% of all packaged fresh meat, 40% of packaged vegetables, and 12.5% of seafood at each stage of the supply chain."},{"fy":2024,"lvl":1,"n":4,"adsh":"0001213900-24-068336","doc":"ea0210140-10k_maison.htm","q":"Walmart China\u2019s traceability system uses state of the art blockchain and AI to track the movement of over 50% of all packaged fresh meat, 40% of packaged vegetables, and 12.5% of seafood at each stage of the supply chain."},{"fy":2025,"lvl":1,"n":4,"adsh":"0001213900-25-075991","doc":"ea0252603-10k_maison.htm","q":"Walmart China\u2019s traceability system uses state of the art blockchain and AI to track the movement of over 50% of all packaged fresh meat, 40% of packaged vegetables, and 12.5% of seafood at each stage of the supply chain."}]},{"cik":1893219,"name":"ABPRO HOLDINGS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2023,"lvl":1,"n":2,"adsh":"0001193125-24-081194","doc":"d764021d10k.htm","q":"Bryan also served as a board director at a privately held artificial intelligence company specializing in the real estate and financial sectors (July 2020 to April 2021)."},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-032133","doc":"ea0234048-10k_abpro.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-044166","doc":"ea0286397-10k_abpro.htm","q":null}]},{"cik":1893657,"name":"RUBBER LEAF INC","industry":"Auto manufacturing","sic":3714,"state":null,"cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001493152-23-010221","doc":"form10-k.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-011558","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-000072","doc":"0001641172-25-000072.txt","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-005480","doc":"form10-k.htm","q":null}]},{"cik":1894525,"name":"APIMEDS PHARMACEUTICALS US, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2024,"lvl":"x","n":2,"adsh":"0001213900-25-032206","doc":"ea0237283-10k_apimeds.htm","q":"Yoon was previously the Chief Executive Officer of Digital Domain Virtual Human, Inc. from January 2020 to November 2021 where he managed a global organization of developers throughout the United States, Canada and Taiwan using AI technolog\u2026"},{"fy":2025,"lvl":2,"n":14,"adsh":"0001213900-26-051139","doc":"ea0288344-10k_apimeds.htm","q":"The ai\u00b2 Futures Lab\u2122 functions as both a discovery engine for potential therapeutic assets and a training ground for the next generation of biotech and business leaders. 5 Our Product Candidate Apitox is purified honeybee (Apis mellifera) v\u2026"}]},{"cik":1894562,"name":"PRIME MEDICINE, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2022,"lvl":2,"n":8,"adsh":"0001628280-23-007266","doc":"prme-20221231.htm","q":"An important element of our capability is leveraging high-throughput screening and machine learning, coupled with automation of workflow, to build a data-driven model for designing optimized Prime Editing systems that can potentially accele\u2026"},{"fy":2023,"lvl":3,"n":18,"adsh":"0001628280-24-008116","doc":"prme-20231231.htm","q":"In addition, our focus on high-throughput screening and machine learning are allowing us to grow our internal technical expertise for Prime Editing optimization and are being used to develop Prime Editors that are both 8 more efficient and \u2026"},{"fy":2024,"lvl":3,"n":29,"adsh":"0001628280-25-008884","doc":"prme-20241231.htm","q":"In addition, our focus on high-throughput screening and machine learning are allowing us to grow our internal technical expertise for Prime Editing optimization and are being used to develop Prime Editors that are both more efficient and mo\u2026"},{"fy":2025,"lvl":3,"n":41,"adsh":"0001628280-26-013569","doc":"prme-20251231.htm","q":"Multiple companies are also developing alternative gene editing technologies, including Tessera Therapeutics, which states it is pioneering Gene Writing\u2122, a new genome engineering technology that writes therapeutic messages into the genome \u2026"}]},{"cik":1895249,"name":"CONNECTM TECHNOLOGY SOLUTIONS, INC.","industry":"Construction","sic":1700,"state":"MA","cells":[{"fy":2023,"lvl":1,"n":4,"adsh":"0001410578-24-000186","doc":"mcac-20231231x10k.htm","q":"Some of the major opportunities that we find very attractive are: \u25cf EV charging infrastructure, advanced battery chemistries and fuel cells and hydrogen infrastructure; \u25cf Advanced powertrain and battery management and vehicle-to-grid soluti\u2026"},{"fy":2024,"lvl":3,"n":20,"adsh":"0001558370-25-010044","doc":"cntm-20241231x10k.htm","q":"Leveraging technology, data, artificial intelligence, and behavioral economics, ConnectM aims to lower energy costs and reduce carbon emissions globally."},{"fy":2025,"lvl":3,"n":71,"adsh":"0001104659-26-044467","doc":"cntm-20251231x10k.htm","q":"Through its six reportable segments\u2014Owned Service Network, Managed Solutions, Distributed Energy & Renewables, Transportation, Logistics, and Corporate & Strategic Assets\u2014ConnectM delivers artificial intelligence (\u201cAI\u201d)-enabled electrificat\u2026"}]},{"cik":1895618,"name":"GAXOS.AI INC.","industry":"Software & IT services","sic":7372,"state":"NJ","cells":[{"fy":2022,"lvl":"x","n":4,"adsh":"0001213900-23-025417","doc":"f10k2022_nftgaming.htm","q":"In addition, we will continuously seek to expand and improve the functionality of the Platform through the adoption and implementation of new technologies, such as augmented and virtual reality (AR/VR), artificial intelligence (AI), machine\u2026"},{"fy":2023,"lvl":"x","n":82,"adsh":"0001213900-24-026681","doc":"ea0202356-10k_gaxosai.htm","q":"BUSINESS Overview We are a technology based company that is developing applications aimed at redefining the way we utilize artificial intelligence (\u201cAI\u201d) to optimize the user experience."},{"fy":2024,"lvl":3,"n":87,"adsh":"0001013762-25-004271","doc":"ea0234668-10k_gaxosai.htm","q":"BUSINESS Overview We are a technology-based company that is developing applications aimed at redefining the way we utilize artificial intelligence (\u201cAI\u201d) to optimize the user experience."},{"fy":2025,"lvl":3,"n":183,"adsh":"0001213900-26-029223","doc":"ea0281075-10k_gaxos.htm","q":"BUSINESS Gaxos.AI is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries."}]},{"cik":1895939,"name":"TANICO INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001477932-22-009520","doc":"tanico_10k.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001477932-23-009296","doc":"tanico_10k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-24-008399","doc":"tanico_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001477932-25-009202","doc":"tanico_10k.htm","q":null}]},{"cik":1896212,"name":"CDT EQUITY INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2022,"lvl":1,"n":2,"adsh":"0001493152-23-009306","doc":"form10-k.htm","q":"Examples of innovative technology trends driving technological transformation in the real estate sector include: artificial intelligence and machine learning, data and analytics, cloud technologies, the Internet of Things, virtual and augme\u2026"},{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-014889","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":25,"adsh":"0001641172-25-001246","doc":"form10-k.htm","q":"We continue to evaluate novel artificial intelligence (\u201cAI\u201d) and cybernetics approaches to drug re-purposing, intellectual property and asset selection to give Conduit a competitive advantage."},{"fy":2025,"lvl":"x","n":32,"adsh":"0001493152-26-016858","doc":"form10-k.htm","q":"The Company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments."}]},{"cik":1897982,"name":"ASPEN TECHNOLOGY, INC.","industry":"Software & IT services","sic":7371,"state":"MA","cells":[{"fy":2022,"lvl":3,"n":20,"adsh":"0001897982-22-000023","doc":"azpn-20220630.htm","q":"As a global leader in asset optimization software, Heritage AspenTech combines decades of modeling and operations expertise with big data, artificial intelligence, and advanced analytics."},{"fy":2023,"lvl":2,"n":9,"adsh":"0001897982-23-000045","doc":"azpn-20230630.htm","q":"Our APM suite is a comprehensive set of machine learning and analytics technologies which can be used with historical and real time asset and process data to help our customers ensure high asset availability and receive early, accurate warn\u2026"},{"fy":2024,"lvl":3,"n":21,"adsh":"0001897982-24-000053","doc":"azpn-20240630.htm","q":"We help customers solve some of their critical challenges via our purpose-built software that combines engineering first principles, deep industry domain knowledge, and advanced technologies, such as Industrial Artificial Intelligence (\u201cInd\u2026"}]},{"cik":1900520,"name":"LOMOND THERAPEUTICS HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"DE","cells":[{"fy":2024,"lvl":3,"n":41,"adsh":"0001213900-25-032200","doc":"ea0234915-10k_lomond.htm","q":"We believe the targeted nature of our research and discovery approach, which is guided in part by an AI/ML platform offered by Expert Systems, allows for efficient and focused clinical development."},{"fy":2025,"lvl":3,"n":40,"adsh":"0001213900-26-044136","doc":"ea0283646-10k_lomond.htm","q":"We believe the targeted nature of our research and discovery approach, which is guided in part by an AI/ML platform offered by Expert Systems, allows for efficient and focused clinical development."}]},{"cik":1902733,"name":"NCINO, INC.","industry":"Software & IT services","sic":7372,"state":"NC","cells":[{"fy":2021,"lvl":"x","n":13,"adsh":"0001902733-22-000013","doc":"ncno-20220131.htm","q":"Our solution, the nCino Bank Operating System \u00ae , digitizes, automates, and streamlines inefficient and complex processes and workflow and utilizes data analytics and artificial intelligence and machine learning (\"AI/ML\") to enable banks an\u2026"},{"fy":2022,"lvl":2,"n":13,"adsh":"0001902733-23-000024","doc":"ncno-20230131.htm","q":"In an industry where every moment matters, this centralized hub enables data to be more easily accessed, modeled and analyzed to help deliver greater operational, portfolio and financial intelligence, a more complete client view and improve\u2026"},{"fy":2023,"lvl":3,"n":41,"adsh":"0001902733-24-000053","doc":"ncno-20240131.htm","q":"Key to the nCino Bank Operating System is infusing intelligence into every stage of the banking lifecycle. nCino provides FIs with innovative technology that helps them meet the challenges of today and tomorrow, including predictive artific\u2026"},{"fy":2024,"lvl":3,"n":73,"adsh":"0001902733-25-000026","doc":"ncno-20250131.htm","q":"To solve the problem, FIs need technology that helps them reengineer every experience, intelligently and with agility as market needs shift, and a partner with the experience to help advise on best practices. nCino's trusted platform enable\u2026"}]},{"cik":1904286,"name":"MIRA PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001493152-24-012141","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-001183","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-014001","doc":"form10-k.htm","q":null}]},{"cik":1906133,"name":"ICORECONNECT INC.","industry":"Software & IT services","sic":7372,"state":"FL","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001477932-24-002244","doc":"icct_10k.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001477932-25-004247","doc":"icct_10k.htm","q":null}]},{"cik":1907108,"name":"LEXEO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"NY","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-028941","doc":"lxeo-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-043486","doc":"lxeo-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-132085","doc":"lxeo-20251231.htm","q":null}]},{"cik":1907223,"name":"GREENLAND MINES LTD","industry":"Pharma & biotech","sic":2836,"state":"NE","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001013762-23-004606","doc":"f10k2022a1_redwoods.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-033573","doc":"ea0202986-10k_redwoods.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001213900-25-026372","doc":"ea0232051-10k_klotho.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-038629","doc":"ea0275233-10k_green.htm","q":null}]},{"cik":1907685,"name":"COMERA LIFE SCIENCES HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0000950170-23-008654","doc":"cmra-20221231.htm","q":null}]},{"cik":1909770,"name":"KHEOBA CORP.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2023,"lvl":"x","n":3,"adsh":"0001477932-24-000458","doc":"kheo_10k.htm","q":null},{"fy":2024,"lvl":"x","n":3,"adsh":"0001477932-25-000026","doc":"kheo_10k.htm","q":"We are developing travel oriented online platform with the following features: - booking multi-day private and group tours. - tour guide ranking algorithm by professional experience and clients\u2019 feedbacks. - artificial intelligence-based al\u2026"}]},{"cik":1910139,"name":"MOBILEYE GLOBAL INC.","industry":"Software & IT services","sic":7372,"state":null,"cells":[{"fy":2022,"lvl":3,"n":53,"adsh":"0001104659-23-030588","doc":"mbly-20221231x10k.htm","q":"Our EyeQ\u00ae5 SoCs and subsequent generations feature EyeQ Kit\u2122 - an end-to-end software development kit (\u201cSDK\u201d) intended to enable the co-hosting of our partners\u2019 and customers\u2019 workloads alongside our cutting-edge AI technologies."},{"fy":2023,"lvl":3,"n":43,"adsh":"0001104659-24-026792","doc":"mbly-20231230x10k.htm","q":"EyeQ Kit\u2122 is an end-to-end software development kit (\u201cSDK\u201d) intended to enable the co-hosting of our partners\u2019 and customers\u2019 workloads alongside our cutting-edge AI technologies in a variety of areas including vehicle control systems, driv\u2026"},{"fy":2024,"lvl":3,"n":81,"adsh":"0001410578-25-000127","doc":"mbly-20241228x10k.htm","q":"Our platform is built on five fundamental pillars: \u25cf Computer Vision Processing ."},{"fy":2025,"lvl":3,"n":111,"adsh":"0001104659-26-014300","doc":"mbly-20251227x10k.htm","q":"This acquisition combines Mobileye\u2019s advanced artificial intelligence (\u201cAI\u201d) technology and global production expertise with Mentee Robotics\u2019 breakthrough humanoid platform and deep AI talent, creating a comprehensive provider of Physical A\u2026"}]},{"cik":1911545,"name":"GLOBAL INTERACTIVE TECHNOLOGIES, INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2023,"lvl":2,"n":10,"adsh":"0001213900-24-061514","doc":"ea0209209-10k_hanryuhold.htm","q":"Privacy and safety is provided by the FANTOO platform through the implementation of artificial intelligence (\u201c AI \u201d). \u25cf High User Engagement."},{"fy":2024,"lvl":"x","n":10,"adsh":"0001213900-25-036973","doc":"ea0239736-10k_global.htm","q":"Privacy and safety is provided by the FANING platform through the implementation of artificial intelligence (\u201c AI \u201d). \u25cf High User Engagement."},{"fy":2025,"lvl":"x","n":13,"adsh":"0001493152-26-025106","doc":"form10-k.htm","q":"Our proprietary infrastructure is designed to handle global traffic while providing specialized tools for fandom engagement. \u25cf Integrated Suite of Tools: Faning differentiates itself through live-streaming, real-time interaction, and divers\u2026"}]},{"cik":1912582,"name":"THUNDER POWER HOLDINGS, INC.","industry":"Auto manufacturing","sic":3711,"state":null,"cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-020453","doc":"ea0200850-10k_feutune.htm","q":null},{"fy":2024,"lvl":2,"n":6,"adsh":"0001213900-25-026239","doc":"ea0235674-10k_thunder.htm","q":"You can find additional information on our website at https://aiev.ai/."},{"fy":2025,"lvl":2,"n":6,"adsh":"0001213900-26-041108","doc":"ea0285006-10k_thunder.htm","q":"Key features of our Compact City Car include: \u25cf Italian Craftsmanship: An affordable, compact sports car that reflects Italian design, quality, and driving spirit. \u25cf Driver-Focused Experience: Engineered for superior ride and handling, prio\u2026"}]},{"cik":1912954,"name":"WIDFIT INC.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001558891-23-000023","doc":"wdfi-20221231.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001139020-25-000021","doc":"wdfi-20231231.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001139020-25-000234","doc":"wdfi-20241231.htm","q":null}]},{"cik":1913577,"name":"SEMNUR PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":1,"n":2,"adsh":"0001213900-25-027319","doc":"ea0232165-10k_denalicap.htm","q":"Mao has served as a founding and managing partner of Citta Capital (\u201cCitta\u201d), a firm focused on investing in early growth stage technology startups in Enterprise/SaaS, Blockchain, ESG, AI applications, cloud computing and healthcare technol\u2026"},{"fy":2025,"lvl":"x","n":20,"adsh":"0001193125-26-082642","doc":"smnr-20251231.htm","q":"Risks Related to Artificial Intelligence The development, adoption, and use of artificial intelligence (\u201cAI\u201d) technologies are rapidly transforming the life sciences industry, enabling faster data analysis, personalized medicine, and advanc\u2026"}]},{"cik":1918102,"name":"DEEP FISSION, INC.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":15,"adsh":"0001104659-26-043870","doc":"tmb-20251231x10k.htm","q":"We also want to prove that we can do this in time to meet the AI-driven surge in demand for energy."}]},{"cik":1919246,"name":"PELTHOS THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2023,"lvl":"x","n":1,"adsh":"0001753926-24-000740","doc":"g084167_10k.htm","q":"Simmons served as the Chief Executive Officer and co-founder of LookyLoo, Inc., an artificial intelligence social commerce company."},{"fy":2024,"lvl":"x","n":1,"adsh":"0001753926-25-000503","doc":"g084720_10k.htm","q":"Simmons served as the Chief Executive Officer and co-founder of LookyLoo, Inc., an artificial intelligence social commerce company."},{"fy":2025,"lvl":0,"n":0,"adsh":"0001919246-26-000013","doc":"pths-20251231.htm","q":null}]},{"cik":1920406,"name":"ASSET ENTITIES INC.","industry":"Software & IT services","sic":7372,"state":"TX","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-025411","doc":"f10k2022_assetentities.htm","q":null},{"fy":2023,"lvl":"x","n":6,"adsh":"0001213900-24-029033","doc":"ea0202974-10k_assetenti.htm","q":"Ternary generates revenue by charging community owners a monthly subscription plus a processing fee to use its platform. \u25cf We launched a new AE.360.DDM website; engaged music producer Jeff Blue as Head of Entertainment to lead the developme\u2026"},{"fy":2024,"lvl":"x","n":5,"adsh":"0001213900-25-026431","doc":"ea0235693-10k_assetenti.htm","q":"Features may include the following: \u25cf Moderating and interacting in daily chats; \u25cf Answering support tickets; \u25cf Acting as a moderator and team leader; team leaders usually have the ability to create channels, create and delete roles, and pe\u2026"}]},{"cik":1921963,"name":"ATMUS FILTRATION TECHNOLOGIES INC.","industry":"Auto manufacturing","sic":3714,"state":"TN","cells":[{"fy":2023,"lvl":1,"n":3,"adsh":"0001921963-24-000007","doc":"atmu-20231231.htm","q":"Atmus is also extending into smart filtration solutions, including embedded sensors, prediction algorithms and data analytics tools . \u2022 Accelerate new product development : Atmus is accelerating its new product development cycle by continue\u2026"},{"fy":2024,"lvl":0,"n":0,"adsh":"0001921963-25-000029","doc":"atmu-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001921963-26-000015","doc":"atmu-20251231.htm","q":null}]},{"cik":1922858,"name":"ECD AUTOMOTIVE DESIGN, INC.","industry":"Auto manufacturing","sic":3711,"state":"MA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001213900-24-039311","doc":"ea0203686-10k_ecdauto.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-032218","doc":"ea0235351-10k_ecdaut.htm","q":null}]},{"cik":1923840,"name":"THIRD HARMONIC BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0000950170-23-010435","doc":"thrd-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036161","doc":"thrd-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-045736","doc":"thrd-20241231.htm","q":null}]},{"cik":1923891,"name":"NANO NUCLEAR ENERGY INC.","industry":"Utilities","sic":4911,"state":"NY","cells":[{"fy":2024,"lvl":2,"n":8,"adsh":"0001493152-24-052393","doc":"form10-k.htm","q":"The newly acquired technologies align closely with our intended uses for ZEUS and ODIN , which are designed for remote, industrial, infrastructural, maritime, and extra-terrestrial applications, including large-scale data and artificial int\u2026"},{"fy":2025,"lvl":2,"n":11,"adsh":"0001493152-25-028285","doc":"form10-k.htm","q":"The KRONOS MMR \u2122 reactor will also target larger population centers, larger industrial operations, industrial heat for larger industries, and data and artificial intelligence centers for the tech industry."}]},{"cik":1927958,"name":"AIRO GROUP HOLDINGS, INC.","industry":"Aerospace & defense","sic":3721,"state":"VA","cells":[{"fy":2025,"lvl":3,"n":35,"adsh":"0001493152-26-014116","doc":"form10-k.htm","q":"This capability also helps us swiftly integrate new avionics, electronics, and artificial intelligence (\u201cAI\u201d) into our products, all while sharing the intra-segment R&D insights that drive our high-quality, interconnected products and servi\u2026"}]},{"cik":1929589,"name":"MARIADB PLC","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2023,"lvl":2,"n":14,"adsh":"0001929589-23-000010","doc":"mrdb-20230930.htm","q":"Social, ethical and security issues relating to the use of new and evolving technologies, such as artificial intelligence (\u201cAI\u201d), in our features, offerings or partnerships may result in reputational harm and liability."}]},{"cik":1930021,"name":"NEW HORIZON AIRCRAFT LTD.","industry":"Aerospace & defense","sic":3721,"state":"ON","cells":[{"fy":2023,"lvl":1,"n":1,"adsh":"0001213900-24-027309","doc":"ea0201280-10k_newhorizon.htm","q":"Our applications and uses of trademarks relating to our design, software or artificial intelligence technologies could be found to infringe upon existing trademark ownership and rights."},{"fy":2024,"lvl":"x","n":1,"adsh":"0001213900-24-069692","doc":"ea0210610-10k_newhorizon.htm","q":"Our applications and uses of trademarks relating to our design, software or artificial intelligence technologies could be found to infringe upon existing trademark ownership and rights."},{"fy":2025,"lvl":"x","n":1,"adsh":"0001213900-25-079570","doc":"ea0245807-10k_newhorizon.htm","q":"Our applications and uses of trademarks relating to our design, software or artificial intelligence technologies could be found to infringe upon existing trademark ownership and rights."}]},{"cik":1932244,"name":"LEVER GLOBAL CORP","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2022,"lvl":"x","n":18,"adsh":"0001493152-23-023444","doc":"form10-k.htm","q":"Our Application Program Interface (APIs) and artificial intelligence (AI) driven programming connect them to the right and relevant federal loan programs with the most favorable terms \u2013 qualifying amount and rate, enrolling, and saving with\u2026"},{"fy":2023,"lvl":"x","n":18,"adsh":"0001493152-24-015139","doc":"form10-k.htm","q":"Our Application Program Interface (APIs) and artificial intelligence (AI) driven programming connect them to the right and relevant federal loan programs with the most favorable terms \u2013 qualifying amount and rate, enrolling, and saving with\u2026"}]},{"cik":1933414,"name":"MINERALYS THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001628280-24-012358","doc":"mlys-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001933414-25-000009","doc":"mlys-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001933414-26-000056","doc":"mlys-20251231.htm","q":null}]},{"cik":1935979,"name":"BIOHAVEN LTD.","industry":"Pharma & biotech","sic":2834,"state":"CT","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001935979-23-000009","doc":"bhvn-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001935979-24-000010","doc":"bhvn-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001935979-25-000015","doc":"bhvn-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001935979-26-000020","doc":"bhvn-20251231.htm","q":null}]},{"cik":1936258,"name":"NEWAMSTERDAM PHARMA CO N.V.","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-021668","doc":"nams-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-027339","doc":"nams-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-056029","doc":"nams-20251231.htm","q":null}]},{"cik":1937653,"name":"ZYMEWORKS INC.","industry":"Pharma & biotech","sic":2834,"state":"DE","cells":[{"fy":2022,"lvl":0,"n":0,"adsh":"0001937653-23-000011","doc":"zyme-20221231.htm","q":null},{"fy":2023,"lvl":0,"n":0,"adsh":"0001937653-24-000019","doc":"zyme-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001937653-25-000014","doc":"zyme-20241231.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001937653-26-000015","doc":"zyme-20251231.htm","q":null}]},{"cik":1937993,"name":"CADRENAL THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2022,"lvl":"x","n":0,"adsh":"0001213900-23-024260","doc":"f10k2022_cadrenalth.htm","q":null},{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-021133","doc":"ea0201078-10k_cadrenal.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-023759","doc":"ea0232553-10k_cadrenal.htm","q":null},{"fy":2025,"lvl":"x","n":22,"adsh":"0001213900-26-036946","doc":"ea0283741-10k_cadrenal.htm","q":"Use of artificial intelligence in research, development, and commercial activities presents operational, regulatory, ethical, and reputational risks that could adversely affect our business."}]},{"cik":1938571,"name":"ADAPTIN BIO, INC.","industry":"Pharma & biotech","sic":2836,"state":"NC","cells":[{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-038568","doc":"ea0282858-10k_adaptin.htm","q":null}]},{"cik":1940177,"name":"PODCASTONE, INC.","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001437749-24-021729","doc":"podc20240331_10k.htm","q":null},{"fy":2025,"lvl":3,"n":43,"adsh":"0001437749-25-022022","doc":"podc20250331_10k.htm","q":"We may be subject to risks associated with artificial intelligence and machine learning technology."}]},{"cik":1941360,"name":"NEOLARA CORP.","industry":"Construction","sic":1520,"state":"WY","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001683168-23-006160","doc":"neolara_i10k-063023.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001683168-24-006701","doc":"neolara_i10k-063024.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-25-007116","doc":"neolara_10k-063025.htm","q":null}]},{"cik":1943289,"name":"SILVACO GROUP, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":33,"adsh":"0001628280-25-010567","doc":"svco-20241231.htm","q":"In addition, we have combined our expertise in semiconductor technologies with machine learning and data analysis to develop an artificial intelligence-based solution named fab technology co-optimization, or FTCO TM , for wafer-level fabric\u2026"},{"fy":2025,"lvl":3,"n":51,"adsh":"0001628280-26-017378","doc":"svco-20251231.htm","q":"This includes foundational TCAD software and more advanced artificial intelligence (\u201cAI\u201d) machine learning (\u201cML\u201d) for process development, called Fabrication Technology Co-Optimization (\u201cFTCO TM \u201d)."}]},{"cik":1943896,"name":"RUBRIK, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":123,"adsh":"0001943896-25-000012","doc":"rbrk-20250131.htm","q":"This allows us to apply artificial intelligence and machine learning directly to business data to understand emergent data threats and deliver cyber recovery."}]},{"cik":1946563,"name":"60 DEGREES PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"DC","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-028577","doc":"ea0202353-10k_60degree.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001013762-25-003343","doc":"ea0232429-10k_60degrees.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001554855-26-000467","doc":"sxtp-20251231.htm","q":null}]},{"cik":1947861,"name":"NATURE'S MIRACLE HOLDING INC.","industry":"Construction machinery","sic":3523,"state":"CA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001213900-25-032230","doc":"0001213900-25-032230.txt","q":null},{"fy":2025,"lvl":2,"n":5,"adsh":"0001213900-26-044157","doc":"ea0284252-10k_natures.htm","q":"On October 28, 2025 we entered into a licensing agreement with Datavault AI (Nasdaq: DVLT), a leader in patented data tokenization and monetization."}]},{"cik":1948864,"name":"HEALTHY CHOICE WELLNESS CORP.","industry":"Retail","sic":5411,"state":"FL","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001641172-25-001000","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-010208","doc":"form10-k.htm","q":null}]},{"cik":1953926,"name":"ZENAS BIOPHARMA, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0001558370-25-002631","doc":"zbio-20241231x10k.htm","q":"SLE: \u25cf approved therapies including an anti-BLyS antibody Benlysta marketed by GSK plc., an anti-IFNAR (type I interferon receptor) antibody Saphnelo marketed by AstraZeneca plc., and a dual antagonist of BlyS and APRIL Tai\u2019ai approved and \u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-027964","doc":"zbio-20251231x10k.htm","q":"SLE: \u25cf approved therapies including an anti-BLyS antibody Benlysta \u00ae (belimumab) marketed by GSK plc., an anti-IFNAR (type I interferon receptor) antibody Saphnelo \u00ae (anifrolumab) marketed by AstraZeneca plc., and a dual antagonist of BlyS \u2026"}]},{"cik":1958777,"name":"FIBROBIOLOGICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"TX","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-008361","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":1,"n":1,"adsh":"0001641172-25-001691","doc":"form10-k.htm","q":"Information security risks for us and our third-party vendors have increased significantly in recent years, in part because of the proliferation of new technologies, including artificial intelligence, the ubiquity of internet connections, a\u2026"},{"fy":2025,"lvl":"x","n":1,"adsh":"0001193125-26-066965","doc":"fblg-20251231.htm","q":"Information security risks for us and our third-party vendors have increased significantly in recent years, in part because of the proliferation of new technologies, including artificial intelligence, the ubiquity of internet connections, a\u2026"}]},{"cik":1962011,"name":"KAIROS PHARMA, LTD.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-004920","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001493152-26-014159","doc":"form10-k.htm","q":null}]},{"cik":1962918,"name":"ACELYRIN, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2023,"lvl":1,"n":1,"adsh":"0001962918-24-000032","doc":"slrn-20231231.htm","q":"Our internal information technology systems and those of our CROs, CMOs, clinical sites and other contractors and consultants upon which we rely are vulnerable to cyberattacks, computer viruses, bugs, worms, or other malicious codes, malwar\u2026"},{"fy":2024,"lvl":2,"n":8,"adsh":"0001962918-25-000022","doc":"slrn-20241231.htm","q":"Our internal information technology systems and those of our CROs, CMOs, clinical sites and other contractors, consultants and service providers upon which we rely are vulnerable to cyberattacks, computer viruses, bugs, worms, or other mali\u2026"}]},{"cik":1966494,"name":"CARGO THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2023,"lvl":2,"n":14,"adsh":"0000950170-24-034730","doc":"crgx-20231231.htm","q":"Our employees and personnel may use generative artificial intelligence (AI) technologies to perform their work, and the use of such generative AI in connection with our Confidential Information may result in leaks, disclosure, or otherwise \u2026"},{"fy":2024,"lvl":3,"n":20,"adsh":"0000950170-25-037929","doc":"crgx-20241231.htm","q":"Our employees and personnel may use generative artificial intelligence (AI) technologies to perform their work, and the use of such generative AI in connection with our Confidential Information may result in leaks, disclosure, or otherwise \u2026"}]},{"cik":1968915,"name":"PHINIA INC.","industry":"Auto manufacturing","sic":3714,"state":"MI","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001968915-24-000007","doc":"phin-20231231.htm","q":null},{"fy":2024,"lvl":1,"n":3,"adsh":"0001968915-25-000006","doc":"phin-20241231.htm","q":"Price, quality, speed of delivery, technological innovation, supply chain resilience, sourcing strategies (which 12 Table of Contents could include the use of artificial intelligence and machine learning), engineering development, and progr\u2026"},{"fy":2025,"lvl":2,"n":9,"adsh":"0001968915-26-000023","doc":"phin-20251231.htm","q":"In addition, the global transportation industry is experiencing a period of technological change, including related to advances in artificial intelligence (AI) technologies."}]},{"cik":1971387,"name":"LIMINATUS PHARMA, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2025,"lvl":"x","n":2,"adsh":"0001104659-26-037933","doc":"limn-20251231x10k.htm","q":"Chris Kim, JD, LLM \u2014Chief Executive Officer \u200b Mr."}]},{"cik":1971532,"name":"TELOMIR PHARMACEUTICALS, INC.","industry":"Pharma & biotech","sic":2834,"state":"FL","cells":[{"fy":2023,"lvl":"x","n":3,"adsh":"0001493152-24-012049","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":1,"adsh":"0001493152-25-004872","doc":"form10-k.htm","q":null},{"fy":2025,"lvl":"x","n":1,"adsh":"0001493152-26-010625","doc":"form10-k.htm","q":null}]},{"cik":1971543,"name":"MURAL ONCOLOGY PLC","industry":"Pharma & biotech","sic":2834,"state":null,"cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-036484","doc":"mura-20231231.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-25-037138","doc":"mura-20241231.htm","q":null}]},{"cik":1973047,"name":"MARKY CORP.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001973047-24-000012","doc":"marky_10k2024.htm","q":null},{"fy":2024,"lvl":"x","n":0,"adsh":"0001973047-25-000008","doc":"report10k_31012025mrky.htm","q":null}]},{"cik":1974640,"name":"APOGEE THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"MA","cells":[{"fy":2023,"lvl":2,"n":9,"adsh":"0001558370-24-002406","doc":"apge-20231231x10k.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence/machine learning, controlling for data bias, and antidiscrimination."},{"fy":2024,"lvl":1,"n":4,"adsh":"0000950170-25-030385","doc":"apge-20241231.htm","q":"Additionally, our use of artificial intelligence and machine learning may be subject to laws and evolving regulations regarding the use of artificial intelligence and machine learning, controlling for data bias, and antidiscrimination."},{"fy":2025,"lvl":3,"n":24,"adsh":"0001974640-26-000002","doc":"0001974640-26-000002.txt","q":"Additionally, our use of artificial intelligence (\u201dAI\u201d) and machine learning may be subject to laws and evolving regulations regarding the use of AI and machine learning, controlling for data bias, and antidiscrimination."}]},{"cik":1975940,"name":"FLY-E GROUP, INC.","industry":"Auto manufacturing","sic":3711,"state":"NY","cells":[{"fy":2023,"lvl":"x","n":0,"adsh":"0001213900-24-056786","doc":"ea0208336-10k_flye.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001213900-25-064293","doc":"ea0248602-10k_flye.htm","q":null}]},{"cik":1976663,"name":"NEXSCIENT, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":18,"adsh":"0001477932-24-006074","doc":"nexscient_10k.htm","q":"(the \u201cCompany\u201d) is early-stage company engaged in the business of developing a Software as a Service (SaaS) platform for commercialization that intends to exploit Industrial Internet-of-Things (IIoT), Artificial Intelligence (AI), and Cloud\u2026"},{"fy":2025,"lvl":"x","n":148,"adsh":"0001477932-25-007240","doc":"nexscient_10k.htm","q":"(the \u201cCompany\u201d) is an emerging growth company focused on building a global collaborative network of AI-enabled intelligent enterprise solutions and technologies through internal development, synergistic acquisitions, and capital investments\u2026"}]},{"cik":1979414,"name":"NEONC TECHNOLOGIES HOLDINGS, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":"x","n":12,"adsh":"0001829126-26-002860","doc":"neonctechnologies_10k.htm","q":"In 2025, we completed the acquisition of an intellectual property portfolio comprising artificial intelligence\u2013driven drug discovery tools, rapid magnetic 3D bioprinting technology, and quantum molecular modeling capabilities, including U.S\u2026"}]},{"cik":1980295,"name":"IMA TECH","industry":"Software & IT services","sic":7372,"state":"WY","cells":[{"fy":2024,"lvl":"x","n":23,"adsh":"0001980295-24-000010","doc":"report10k_ima30042024.htm","q":"Utilizing advanced technology, the company creates a unique blend of human intelligence, artificial intelligence, and niche databases."},{"fy":2025,"lvl":"x","n":22,"adsh":"0001980295-25-000008","doc":"report10k_ima2025.htm","q":"Utilizing advanced technology, the Company creates a unique blend of human intelligence, artificial intelligence, and niche databases."}]},{"cik":1980845,"name":"ENGENE HOLDINGS INC.","industry":"Pharma & biotech","sic":2836,"state":"QC","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0000950170-24-008125","doc":"engn-20231031.htm","q":null},{"fy":2024,"lvl":0,"n":0,"adsh":"0000950170-24-138472","doc":"engn-20241031.htm","q":null},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-25-328743","doc":"engn-20251031.htm","q":null}]},{"cik":1981535,"name":"SHARPLINK GAMING, INC.","industry":"Software & IT services","sic":7372,"state":"MN","cells":[{"fy":2023,"lvl":0,"n":0,"adsh":"0001493152-24-012028","doc":"form10-k.htm","q":null},{"fy":2024,"lvl":"x","n":2,"adsh":"0001437749-25-007734","doc":"sbet20250131_10k.htm","q":"Due to technical tools and features like Artificial Intelligence, machine learning, digital marketing, analytics and the extended usage of cookies, the landscape of iGaming affiliate marketing has not just grown, it has transformed into a c\u2026"}]},{"cik":1982518,"name":"SMITH DOUGLAS HOMES CORP.","industry":"Construction","sic":1531,"state":"GA","cells":[{"fy":2024,"lvl":1,"n":1,"adsh":"0001982518-25-000007","doc":"sdhc-20241231.htm","q":"The risk of such damage or interruption to the confidentiality, integrity, and availability of our IT Systems and Confidential Information has grown with the increased frequency and sophistication of cybersecurity attacks on companies in re\u2026"},{"fy":2025,"lvl":1,"n":1,"adsh":"0001628280-26-017245","doc":"sdhc-20251231.htm","q":"The risk of such damage or interruption to the confidentiality, integrity, and availability of our IT Systems and Confidential Information has grown with the increased frequency and sophistication of cybersecurity attacks on companies in re\u2026"}]},{"cik":1983736,"name":"EVA LIVE INC","industry":"Software & IT services","sic":7370,"state":"CA","cells":[{"fy":2023,"lvl":"x","n":11,"adsh":"0001493152-24-014165","doc":"form10-k.htm","q":"We execute our business through Eva Platform based on Artificial Intelligence, or AI, to match advertising campaigns to specific ad spots one at a time."},{"fy":2024,"lvl":"x","n":20,"adsh":"0001641172-25-004026","doc":"form10-k.htm","q":"Current Operations We execute our business through the Eva Platform based on Artificial Intelligence, or AI, to match advertising campaigns to specific ad spots one at a time."},{"fy":2025,"lvl":3,"n":107,"adsh":"0001493152-26-010305","doc":"form10-k.htm","q":"We execute our business through the Eva Platform based on Artificial Intelligence, or AI, to match advertising campaigns to specific ad spots one at a time."}]},{"cik":1984086,"name":"SEPTERNA, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":28,"adsh":"0000950170-25-045745","doc":"sepn-20241231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to the deployment of harmful malware (including as a result of advanced persistent threat intrusions), ransomware, denial-of-\u2026"},{"fy":2025,"lvl":3,"n":43,"adsh":"0001193125-26-098507","doc":"sepn-20251231.htm","q":"Attempts to disrupt or gain unauthorized access to our and our third-party vendors\u2019 information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or\u2026"}]},{"cik":1985554,"name":"LONDAX CORP.","industry":"Software & IT services","sic":7371,"state":"WY","cells":[{"fy":2024,"lvl":"x","n":3,"adsh":"0001683168-24-005873","doc":"londax_10k-053124.htm","q":"Currently, we are in negotiations with potential clients for the use of our program, located at https://londax.ai/."},{"fy":2025,"lvl":"x","n":3,"adsh":"0001683168-25-006612","doc":"londax_10k-053125.htm","q":"Currently, we have developed and implemented our flagship product https://londax.ai/, which comprises a Customer Relationship Management (CRM) System, Applicant Tracking Systems (ATS), and out-staffing services."}]},{"cik":1989788,"name":"GURU APP FACTORY CORP","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001477932-24-006973","doc":"guruapp_10k.htm","q":null},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-25-008439","doc":"guru_i10k-073125.htm","q":null}]},{"cik":1991792,"name":"CG ONCOLOGY, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2024,"lvl":1,"n":2,"adsh":"0000950170-25-046351","doc":"ck0001991792-20241231.htm","q":"These actions may, for example, include directives to reduce agency workforce, rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation (CMMI) to consider new payment and healthcare models to\u2026"},{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-079498","doc":"ck0001991792-20251231.htm","q":null}]},{"cik":1992243,"name":"T1 ENERGY INC.","industry":"Computers & chips","sic":3674,"state":"TX","cells":[{"fy":2024,"lvl":1,"n":1,"adsh":"0001992243-25-000010","doc":"frey-20241231.htm","q":"We are exclusively focusing our commercial strategy on the U.S. solar market, which exhibits strong industry fundamentals, including the emergence of power intensive technologies such as artificial intelligence and crypto-currencies, suppor\u2026"},{"fy":2025,"lvl":3,"n":25,"adsh":"0001992243-26-000007","doc":"t1-20251231.htm","q":"We are exclusively focusing our commercial strategy on the U.S. solar market, which we believe exhibits strong industry fundamentals, including the rapid deployment of hyperscale data centers supporting artificial intelligence and crypto-cu\u2026"}]},{"cik":1993004,"name":"NORTHWESTERN ENERGY GROUP, INC.","industry":"Utilities","sic":4931,"state":"SD","cells":[{"fy":2023,"lvl":1,"n":2,"adsh":"0001993004-24-000006","doc":"nweg-20231231.htm","q":"The advancement of artificial intelligence and large language models has given rise to additional vulnerabilities and potential entry points for cyber crime."},{"fy":2024,"lvl":1,"n":3,"adsh":"0001993004-25-000021","doc":"nweg-20241231.htm","q":"The advancement of artificial intelligence and large language models has given rise to additional vulnerabilities and potential entry points for cyber crime."},{"fy":2025,"lvl":1,"n":3,"adsh":"0001993004-26-000006","doc":"nweg-20251231.htm","q":"The advancement of artificial intelligence and large language models has given rise to additional vulnerabilities and potential entry points for cyber crime."}]},{"cik":1993400,"name":"FATPIPE INC/UT","industry":"Software & IT services","sic":7372,"state":"UT","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001641172-25-017162","doc":"form10-k.htm","q":null}]},{"cik":1994702,"name":"KYVERNA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2024,"lvl":2,"n":12,"adsh":"0000950170-25-046074","doc":"kytx-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing security risks to our confidential information, proprietary information and personal data."},{"fy":2025,"lvl":3,"n":21,"adsh":"0001193125-26-126242","doc":"kytx-20251231.htm","q":"These actions and proposals may, for example, include directives: (1) reducing agency workforce and cutting programs; (2) rescinding a Biden administration executive order tasking the Center for Medicare and Medicaid Innovation, or CMNI, to\u2026"}]},{"cik":1995920,"name":"E-SMART CORP.","industry":"Software & IT services","sic":7371,"state":"PA","cells":[{"fy":2024,"lvl":"x","n":5,"adsh":"0001995920-24-000026","doc":"esmart_10k2024.htm","q":"The Company offers the \"AI Powered Tattoo Artist,\" a subscription-based API service that utilizes artificial intelligence to generate custom tattoo designs."},{"fy":2025,"lvl":"x","n":6,"adsh":"0001995920-25-000021","doc":"esmart_10k2025.htm","q":"Monetization Strategy Our monetization strategy includes offering an API - AI textual tattoo idea generator, enabling businesses and developers to leverage our technology to enhance their own products and services."}]},{"cik":1997296,"name":"MEDICUS PHARMA LTD.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2024,"lvl":"x","n":0,"adsh":"0001062993-25-006485","doc":"form10k.htm","q":null},{"fy":2025,"lvl":3,"n":16,"adsh":"0001062993-26-001606","doc":"form10k.htm","q":"AI Enabled Clinical Development In December 2025, the Company signed a non-binding letter of intent to collaborate with Reliant AI Inc., a decision-intelligence company specializing in generative AI for the life sciences, to develop an AI-d\u2026"}]},{"cik":1997698,"name":"IGTA MERGER SUB LTD","industry":"Software & IT services","sic":7370,"state":"NY","cells":[{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-043994","doc":"ea0281021-10k_igta.htm","q":null}]},{"cik":1999480,"name":"ALTO NEUROSCIENCE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2024,"lvl":3,"n":19,"adsh":"0001999480-25-000025","doc":"alto-20241231.htm","q":"With our Platform, we employ quantitative analytics, including machine learning, to discover and evaluate unique biomarkers."},{"fy":2025,"lvl":3,"n":22,"adsh":"0001999480-26-000002","doc":"alto-20251231.htm","q":"With our Platform, we employ quantitative analytics, including machine learning, to discover and evaluate unique biomarkers."}]},{"cik":2000762,"name":"GMTECH INC.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2024,"lvl":"x","n":7,"adsh":"0001683168-25-000206","doc":"gmtech_i10k-103124.htm","q":"In addition to the IT consulting services, we are also planning to develop an automated and AI powered development tool (\u201cAI-Development Tool\u201d) that can be used by businesses to design, develop and maintain their CRM system, website, and Ap\u2026"},{"fy":2025,"lvl":"x","n":0,"adsh":"0001683168-26-001549","doc":"gmtech_i10k-103125.htm","q":null}]},{"cik":2000775,"name":"BLACK HAWK ACQUISITION CORP","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001829126-26-002021","doc":"blackhawkacq_10k.htm","q":null}]},{"cik":2006815,"name":"VOYAGER ACQUISITION CORP./CAYMAN ISLANDS","industry":"Pharma & biotech","sic":2836,"state":"TX","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001829126-26-002162","doc":"voyageracq_10k.htm","q":null}]},{"cik":2007919,"name":"INHIBRX BIOSCIENCES, INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2024,"lvl":0,"n":0,"adsh":"0002007919-25-000019","doc":"inbx-20241231.htm","q":null},{"fy":2025,"lvl":2,"n":7,"adsh":"0002007919-26-000006","doc":"inbx-20251231.htm","q":"Our employees can use generative artificial intelligence (\u201cAI\u201d) technologies in certain circumstances to perform portions of their work."}]},{"cik":2008861,"name":"ENDO, INC.","industry":"Pharma & biotech","sic":2834,"state":"PA","cells":[{"fy":2024,"lvl":1,"n":3,"adsh":"0002008861-25-000007","doc":"ndoi-20241231.htm","q":"Marc Yoskowitz serves as Chief Executive Officer of Evozyne, Inc. a venture capital backed biotech designing novel proteins leveraging generative AI."}]},{"cik":2010788,"name":"EXOZYMES INC.","industry":"Pharma & biotech","sic":2836,"state":"CA","cells":[{"fy":2024,"lvl":1,"n":4,"adsh":"0001641172-25-001744","doc":"form10-k.htm","q":"We believe this could represent a paradigm shift in how humans get access to chemicals in the future by leveraging this new way of using AI-designed and highly engineered enzymes (called exozymes) that allows for a new generation of \u201ccell-f\u2026"},{"fy":2025,"lvl":"x","n":4,"adsh":"0001493152-26-013563","doc":"form10-k.htm","q":"We believe, that with time, a paradigm shift in how humans get access to chemicals is possible by leveraging AI-designed and highly engineered enzymes (called exozymes), allowing for a new generation of \u201ccell-free\u201d biosolutions."}]},{"cik":2012593,"name":"RAPPORT THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2024,"lvl":3,"n":26,"adsh":"0000950170-25-036828","doc":"rapp-20241231.htm","q":"Such risks come from a variety of evolving threats, including but not limited to, social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code \u2026"},{"fy":2025,"lvl":3,"n":33,"adsh":"0001193125-26-099360","doc":"rapp-20251231.htm","q":"Such obligations may include, without limitation, federal health information privacy laws, state information security and data breach notification laws, state health information privacy laws, state and federal regulation and guidance relate\u2026"}]},{"cik":2015845,"name":"EVERUS CONSTRUCTION GROUP, INC.","industry":"Construction","sic":1531,"state":"ND","cells":[{"fy":2024,"lvl":3,"n":15,"adsh":"0002015845-25-000012","doc":"q42024-20241231.htm","q":"The growth in the E&M construction services industry can be attributed to several different factors such as (i) the increased intricacy and sophistication of E&M systems due to the adoption of artificial intelligence, automation and control\u2026"},{"fy":2025,"lvl":3,"n":19,"adsh":"0002015845-26-000010","doc":"q42025-20251231.htm","q":"The growth in the E&M construction services industry can be attributed to several different factors such as (i) the increased intricacy and sophistication of E&M systems due to the adoption of artificial intelligence, automation and control\u2026"}]},{"cik":2016167,"name":"TRANSIT PRO TECH INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2024,"lvl":"x","n":32,"adsh":"0001753926-24-002159","doc":"g084614_10-k.htm","q":"Because Beyebe is owned by the initial shareholders of Transit Pro Delaware, conflicts of interest are inherent in any transaction between Transit Pro Delaware and Beyebe and its subsidiary, Beyebe AI. 4 Intellectual Property Although certa\u2026"},{"fy":2025,"lvl":"x","n":30,"adsh":"0001753926-25-002005","doc":"g085058_10k.htm","q":"Because Beyebe is owned by the initial shareholders of Transit Pro Delaware, conflicts of interest are inherent in any transaction between Transit Pro Delaware and Beyebe and its subsidiary, Beyebe AI. 3 Intellectual Property Although certa\u2026"}]},{"cik":2020919,"name":"DELTASOFT CORP","industry":"Software & IT services","sic":7371,"state":"WY","cells":[{"fy":2025,"lvl":"x","n":5,"adsh":"0001683168-25-006862","doc":"deltasoft_i10k-033125.htm","q":"Here are the current benefits users can experience: Planning: Quickly create detailed project descriptions using smart forms or AI."}]},{"cik":2022416,"name":"SILEXION THERAPEUTICS CORP","industry":"Pharma & biotech","sic":2836,"state":null,"cells":[{"fy":2024,"lvl":"x","n":2,"adsh":"0001178913-25-000887","doc":"zk2532833.htm","q":"We also intend to explore options to work with partners to augment the study and treatment of patients and the impact of our product candidates, including medical professionals, healthcare professional networks, pharmacy benefit managers, i\u2026"},{"fy":2025,"lvl":"x","n":2,"adsh":"0001178913-26-000953","doc":"zk2634529.htm","q":"We also intend to explore options to work with partners to augment the study and treatment of patients and the impact of our product candidates, including medical professionals, healthcare professional networks, pharmacy benefit managers, i\u2026"}]},{"cik":2022626,"name":"UPSTREAM BIO, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2024,"lvl":3,"n":23,"adsh":"0000950170-25-037621","doc":"upb-20241231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."},{"fy":2025,"lvl":3,"n":42,"adsh":"0001193125-26-126188","doc":"upb-20251231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data."}]},{"cik":2023016,"name":"TURN THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":1,"n":3,"adsh":"0001213900-26-037505","doc":"ea0281342-10k_turntherap.htm","q":"Attacks of this nature may see their effectiveness enhanced by the use of artificial intelligence and may be conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise, including organized cri\u2026"}]},{"cik":2023658,"name":"BICARA THERAPEUTICS INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2024,"lvl":3,"n":20,"adsh":"0002023658-25-000012","doc":"bcax-20241231.htm","q":"Under certain circumstances and to guarantee our freedom to operate, we may also decide to publish some know-how to prevent others from obtaining patent rights covering such know-how. 74 Table of Contents The use of new and evolving technol\u2026"},{"fy":2025,"lvl":3,"n":28,"adsh":"0001628280-26-022010","doc":"bcax-20251231.htm","q":"Under certain circumstances and to guarantee our freedom to operate, we may also decide to publish some know-how to prevent others from obtaining patent rights covering such know-how. 53 Table of Contents The use of new and evolving technol\u2026"}]},{"cik":2023730,"name":"GIGCAPITAL7 CORP.","industry":"Utilities","sic":4911,"state":"CA","cells":[{"fy":2025,"lvl":2,"n":11,"adsh":"0001193125-26-096526","doc":"ck0002023730-20251231.htm","q":"Our efforts to identify a prospective target business have not been limited to a particular industry or geographic region, although we focused on companies in the technology, media, and telecommunications (\u201cTMT\u201d), artificial intelligence an\u2026"}]},{"cik":2024306,"name":"JFB CONSTRUCTION HOLDINGS","industry":"Construction","sic":1540,"state":"FL","cells":[{"fy":2025,"lvl":2,"n":8,"adsh":"0001193125-26-134406","doc":"jfb-20251231.htm","q":"(\u201cXTEND\u201d), an AI\u2011driven, software\u2011first defense technology company focused on human\u2011guided autonomy for unmanned systems."}]},{"cik":2025942,"name":"CURANEX PHARMACEUTICALS INC","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001493152-26-013677","doc":"form10-k.htm","q":null}]},{"cik":2026353,"name":"AETHER HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2025,"lvl":"x","n":103,"adsh":"0001493152-25-028195","doc":"form10-k.htm","q":"By integrating advanced technologies, including artificial intelligence (\u201cAI\u201d) tools, with the critical thinking and analytical abilities of our team of evidenced-based trading veterans, we aim to provide our Users with a powerful combinati\u2026"}]},{"cik":2029303,"name":"TECH TONIC GROUP CORP.","industry":"Software & IT services","sic":7371,"state":null,"cells":[{"fy":2025,"lvl":"x","n":0,"adsh":"0001477932-25-007073","doc":"techtonic_10k.htm","q":null}]},{"cik":2032341,"name":"TRAILBLAZER HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2025,"lvl":"x","n":0,"adsh":"0001213900-26-034218","doc":"ea028272901ex2-1.htm","q":null}]},{"cik":2036042,"name":"SIONNA THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"MA","cells":[{"fy":2025,"lvl":2,"n":13,"adsh":"0001628280-26-012996","doc":"sionna-20251231.htm","q":"Artificial intelligence presents risks and challenges that can impact our business, including by posing cybersecurity risks to our confidential information, proprietary information, and personal data."}]},{"cik":2038118,"name":"FIRSTENERGY TRANSMISSION, LLC","industry":"Utilities","sic":4911,"state":"WV","cells":[{"fy":2024,"lvl":1,"n":1,"adsh":"0002038118-25-000004","doc":"fet-20241231.htm","q":"We cannot anticipate, detect, or implement fully preventive measures against all cybersecurity threats because the techniques used are increasingly sophisticated and constantly evolving, and in some cases, assisted by artificial intelligenc\u2026"},{"fy":2025,"lvl":2,"n":8,"adsh":"0002038118-26-000013","doc":"fet-20251231.htm","q":"Factors that may affect our revenue growth may include: (1) FERC's timely approval of rates to recover such investments; (2) whether investments are included in PJM's RTEP; (3) FERC's evolving policies with respect to incentive rates for tr\u2026"}]},{"cik":2038439,"name":"VISIONWAVE HOLDINGS, INC.","industry":"Software & IT services","sic":7372,"state":"CA","cells":[{"fy":2025,"lvl":"x","n":38,"adsh":"0001731122-25-001750","doc":"e7126_10-k.htm","q":"We are a technology company focused on the development and commercialization of advanced artificial intelligence (\u201cAI\u201d) and autonomous solutions for multi-domain operations across air, ground, and sea environments."}]},{"cik":2040807,"name":"METSERA, INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2024,"lvl":1,"n":1,"adsh":"0000950170-25-044778","doc":"mtsr-20241231.htm","q":"Furthermore, because the techniques (including artificial intelligence) used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized until launched against a target, we may be unable to antic\u2026"}]},{"cik":2044725,"name":"EVOMMUNE, INC.","industry":"Pharma & biotech","sic":2834,"state":"CA","cells":[{"fy":2025,"lvl":2,"n":9,"adsh":"0001193125-26-093932","doc":"evmn-20251231.htm","q":"We and the third parties with whom we work are subject to a variety of evolving threats, including social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks)\u2026"}]},{"cik":2048519,"name":"AEBI SCHMIDT HOLDING AG","industry":"Construction machinery","sic":3531,"state":null,"cells":[{"fy":2025,"lvl":2,"n":14,"adsh":"0001628280-26-019616","doc":"aebi-20251231.htm","q":"Emerging issues related to the development and use of artificial intelligence (\u201cAI\u201d) could give rise to legal or regulatory action, damage our reputation or otherwise materially harm our business."}]},{"cik":2052568,"name":"LEGENCE CORP.","industry":"Construction","sic":1700,"state":"CA","cells":[{"fy":2025,"lvl":3,"n":19,"adsh":"0002052568-26-000008","doc":"lgn-20251231.htm","q":"(2) Includes facilities housing servers, networking equipment, systems critical for storing and managing data, operational facilities for internet service providers, software companies, information technologies (\"IT\") development hubs, AI (\u2026"}]},{"cik":2053927,"name":"WINTERGREEN ACQUISITION CORP.","industry":"Software & IT services","sic":7370,"state":null,"cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001829126-26-001698","doc":"wintergreenacq_10k.htm","q":null}]},{"cik":2054696,"name":"NIQ GLOBAL INTELLIGENCE PLC","industry":"Software & IT services","sic":7370,"state":"IL","cells":[{"fy":2025,"lvl":3,"n":239,"adsh":"0001628280-26-012572","doc":"niq-20251231.htm","q":"Our unified, artificial intelligence (\u201cAI\u201d) and machine learning powered technology platform aggregates, harmonizes and enriches vast amounts of global consumer shopping data from a myriad of diverse sources, generates rich, proprietary ref\u2026"}]},{"cik":2058873,"name":"QNITY ELECTRONICS, INC.","industry":"Computers & chips","sic":3674,"state":"DE","cells":[{"fy":2025,"lvl":3,"n":21,"adsh":"0002058873-26-000010","doc":"q-20251231.htm","q":"We empower our customers\u2019 technology roadmaps to enable advancements in megatrends such as artificial intelligence, high-performance computing and advanced connectivity."}]},{"cik":2065779,"name":"D. BORAL ARC ACQUISITION I CORP.","industry":"Software & IT services","sic":7372,"state":"NY","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001829126-26-002312","doc":"dboralarcacq1_10k.htm","q":null}]},{"cik":2074850,"name":"SPRING VALLEY ACQUISITION CORP. III","industry":"Utilities","sic":4911,"state":"TX","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001104659-26-024740","doc":"none-20251231x10k.htm","q":null}]},{"cik":2075320,"name":"POLARYX THERAPEUTICS, INC.","industry":"Pharma & biotech","sic":2834,"state":"NJ","cells":[{"fy":2025,"lvl":"x","n":1,"adsh":"0001213900-26-033064","doc":"ea0281719-10k_polaryx.htm","q":"Mstone is a Hong Kong-based biotechnology, healthcare, and AI incubator structured as a holding company."}]},{"cik":2077709,"name":"RANK ONE COMPUTING CORP","industry":"Software & IT services","sic":7372,"state":"CO","cells":[{"fy":2025,"lvl":3,"n":219,"adsh":"0001213900-26-037484","doc":"ea0283745-10k_rankone.htm","q":"Business Executive Summary ROC is an independent American artificial intelligence (\u201cAI\u201d) company redefining the global standard for Vision AI in identity, security, and digital forensics."}]},{"cik":2079999,"name":"CARDINAL INFRASTRUCTURE GROUP INC.","industry":"Construction","sic":1600,"state":"NC","cells":[{"fy":2025,"lvl":0,"n":0,"adsh":"0001193125-26-120014","doc":"cdnl-20251231.htm","q":null}]},{"cik":2081043,"name":"ATAIBECKLEY INC.","industry":"Pharma & biotech","sic":2834,"state":"NY","cells":[{"fy":2025,"lvl":2,"n":14,"adsh":"0001193125-26-096926","doc":"atai-20251231.htm","q":"In addition, we use AI, ML, and automated decision-making technologies (collectively, \u201cAI Technologies\u201d) in our business."}]}]}